Citrus Sinensis ID: 002462
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 919 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGK4 | 915 | Probable LRR receptor-lik | yes | no | 0.881 | 0.885 | 0.641 | 0.0 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.737 | 0.542 | 0.314 | 6e-75 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.738 | 0.582 | 0.305 | 4e-70 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.734 | 0.539 | 0.304 | 8e-70 | |
| Q6XAT2 | 967 | LRR receptor-like serine/ | no | no | 0.761 | 0.723 | 0.293 | 8e-69 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.723 | 0.582 | 0.310 | 2e-68 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.701 | 0.585 | 0.284 | 7e-68 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.722 | 0.557 | 0.321 | 3e-66 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.741 | 0.605 | 0.278 | 8e-65 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.770 | 0.586 | 0.289 | 1e-63 |
| >sp|C0LGK4|Y2165_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g16250 OS=Arabidopsis thaliana GN=At2g16250 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1022 bits (2643), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 526/820 (64%), Positives = 638/820 (77%), Gaps = 10/820 (1%)
Query: 49 TELAALFELRSSLGLRRRDWPRKVDPCLVWNGVRCQNGSVVGINISGFRRTRLGSQNPRF 108
+E L LRSSLGLR DWP K DPC+ W G++C+NGS++GINISGFRRTR+G NP+F
Sbjct: 35 SEKLILLNLRSSLGLRGTDWPIKGDPCVDWRGIQCENGSIIGINISGFRRTRIGKLNPQF 94
Query: 109 AADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNL 168
+ D L NLT L+ FNAS LPG+IP+W G L L+ LDL SCS++GV+PF+LGNLT+L
Sbjct: 95 SVDPLRNLTRLSYFNASGLALPGTIPEWFGVSLLALEVLDLSSCSVNGVVPFTLGNLTSL 154
Query: 169 TSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTG 228
+L LS N LT +PSSLGQL LS LDLSRNS TG +P SF LKNL +LD+SSNYLTG
Sbjct: 155 RTLNLSQNSLTSLVPSSLGQLLNLSQLDLSRNSFTGVLPQSFSSLKNLLTLDVSSNYLTG 214
Query: 229 SIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSL 288
IPPGLG LSKL +LN S+NS +S IP++LGDL +LVD DLS+NSLSGSVP ELR L L
Sbjct: 215 PIPPGLGALSKLIHLNFSSNSFSSPIPSELGDLVNLVDFDLSINSLSGSVPQELRKLSKL 274
Query: 289 QKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFT 348
Q IG+N LSG L V+LF SQLQ +VLR+NGF+G PDV WS+P+LR+LDI++NNFT
Sbjct: 275 QLMAIGDNLLSGTLPVDLFSAESQLQTLVLRENGFSGSLPDVCWSLPKLRILDIAKNNFT 334
Query: 349 GPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASSL 408
G LP S + + ++IS N FYG LTP+L RFR++DLSGNYFEG++P+YV S+
Sbjct: 335 GLLPYSSYDSDQIAEMVDISSNTFYGELTPILRRFRIMDLSGNYFEGKLPDYVTGENVSV 394
Query: 409 DSNCLQNVPNQRTLVDCSSFYAARGLSFDNFGRPNATQPPPPE-TSGDSNRKIIVLSAVL 467
SNCL+N Q+ C++FY +RGL FD+FGRPN TQP +SG S R +I+L+AV
Sbjct: 395 TSNCLRNERRQKPSAICAAFYKSRGLDFDDFGRPNLTQPTSKNASSGISRRTVIILAAVG 454
Query: 468 GGFGLIVLLVLL-ALLALCFCKKRTPNQRGVGVGPVPAG--SSLPPPGA-SINFTNLGES 523
GG I+L V+L +L LC +R QRG P PAG S PP GA + + + LG +
Sbjct: 455 GGVAFILLFVILPIILVLCMRHRRRAAQRGNNDRPKPAGEASQQPPKGAQTFDLSRLGNA 514
Query: 524 FTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFF 583
F+Y+QLL AT +F+DANLIK GHSG+LFRG LE GIPVVIK+ID++ K+E Y+ EL+ F
Sbjct: 515 FSYEQLLQATEEFNDANLIKRGHSGNLFRGFLENGIPVVIKKIDVREGKSEGYISELELF 574
Query: 584 SKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTE-DDLQSLDWITRLKI 642
SK H RLVP LGHC+E E++KFLVYK+M +GDL+SSL+RK+ E D L+SLDWITRLKI
Sbjct: 575 SKAGHQRLVPFLGHCLENESQKFLVYKFMRHGDLASSLFRKSENEGDGLKSLDWITRLKI 634
Query: 643 AIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRL 702
A+GAAEGLSYLHHEC+ P VHRDVQASSILLDDKFEVRLGSLSE AQ GDA+QSRI+RL
Sbjct: 635 ALGAAEGLSYLHHECSPPLVHRDVQASSILLDDKFEVRLGSLSEAYAQ-GDAYQSRISRL 693
Query: 703 LRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYIS 762
LRLPQSSE SSG A C YDVYCFGKVLLELVTGK+GIS+ +A KE +E+ LPYIS
Sbjct: 694 LRLPQSSEPSSSGVTNAICSYDVYCFGKVLLELVTGKLGISSPDNALAKEYMEEALPYIS 753
Query: 763 IYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLKVV 822
+KELVTKI+DPSL++DEDLLEEVWAMAI+A+SCLNPKPTRRPLMR+I+ ALENPLKVV
Sbjct: 754 TNEKELVTKILDPSLMVDEDLLEEVWAMAIIAKSCLNPKPTRRPLMRHIVNALENPLKVV 813
Query: 823 REEN---SGSARLRTTSSRGSWNAALFGSWRQSSSDVAAI 859
RE+ SGS+RLRT SSRGSWNAA+FGSWRQS+SDV A+
Sbjct: 814 REDTNSGSGSSRLRTNSSRGSWNAAIFGSWRQSASDVTAV 853
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 283 bits (723), Expect = 6e-75, Method: Compositional matrix adjust.
Identities = 235/748 (31%), Positives = 362/748 (48%), Gaps = 70/748 (9%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTS 170
D+L++L +L N S L G+I G + + D+ + IP LGN NL
Sbjct: 546 DSLISLRNLTRINLSHNRLNGTIHPLCGSS--SYLSFDVTNNGFEDEIPLELGNSQNLDR 603
Query: 171 LYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSI 230
L L N LTG IP +LG++ LS+LD+S N+LTG IP L K L+ +D+++N+L+G I
Sbjct: 604 LRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPI 663
Query: 231 PPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQK 290
PP LG LS+L L +S+N S+P +L + L+ L L NSL+GS+P E+
Sbjct: 664 PPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEI-------- 715
Query: 291 FVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGP 350
GNL L ++ L +N F+G P + + +L L +SRN+ TG
Sbjct: 716 ---------GNLGA--------LNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGE 758
Query: 351 LPNSRSNVNTSTVELNISQNMFYGGLTPVLG---RFRLVDLSGNYFEGRVPEYVHSNASS 407
+P + L++S N F G + +G + +DLS N G VP V + S
Sbjct: 759 IPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSV-GDMKS 817
Query: 408 LD------SNCLQNVPNQRTLVDCSSFYAARGLSFDNFGRPNATQPPPPETSGDSNRKII 461
L +N + Q + SF GL R N + + G S R ++
Sbjct: 818 LGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQ-QGLSARSVV 876
Query: 462 VLSAV--LGGFGLIVLLVLLALLALCFCKKRTPNQRGVGVGPVPAGSSLPPPGASIN--F 517
++SA+ L GL++L++ L F K+R + VG G SS A+ F
Sbjct: 877 IISAISALTAIGLMILVIAL------FFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLF 930
Query: 518 TNLGES---FTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRI----DLQS 570
N G S ++ ++ AT + S+ +I +G SG +++ LE G V +K+I DL S
Sbjct: 931 RN-GASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMS 989
Query: 571 VKTEAYLLELDFFSKVSHARLVPLLGHCMER-ENEKFLVYKYMPNGDLSSSLYR-KTNTE 628
K+ + E+ ++ H LV L+G+C + E L+Y+YM NG + L+ K E
Sbjct: 990 NKS--FSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLE 1047
Query: 629 DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS--LSE 686
+ LDW RL+IA+G A+G+ YLHH+C P VHRD+++S++LLD E LG L++
Sbjct: 1048 KKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAK 1107
Query: 687 VCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASS 746
V + D + T + SL AT DVY G VL+E+VTGKM +
Sbjct: 1108 VLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVF 1167
Query: 747 DAQVKEI--LEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTR 804
A++ + +E L +L+ + P L +ED +V +A+ C P
Sbjct: 1168 GAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIAL---QCTKTSPQE 1224
Query: 805 RPLMRYILKALENPLKVVREENSGSARL 832
RP R +A ++ L V +G +L
Sbjct: 1225 RPSSR---QACDSLLHVYNNRTAGYKKL 1249
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 266 bits (681), Expect = 4e-70, Method: Compositional matrix adjust.
Identities = 229/750 (30%), Positives = 357/750 (47%), Gaps = 71/750 (9%)
Query: 129 LPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLG- 187
L G++P LG+ +L+ +DL ++G IP + L NL+ L + N LTGTIP +
Sbjct: 414 LSGTVPMELGK-CKSLKTIDLSFNELTGPIPKEIWMLPNLSDLVMWANNLTGTIPEGVCV 472
Query: 188 QLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSN 247
+ L L L+ N LTG+IP S N+ + +SSN LTG IP G+G LSKL L + N
Sbjct: 473 KGGNLETLILNNNLLTGSIPESISRCTNMIWISLSSNRLTGKIPSGIGNLSKLAILQLGN 532
Query: 248 NSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLF 307
NSL+ ++P QLG+ SL+ LDL+ N+L+G +P EL L + G++S F
Sbjct: 533 NSLSGNVPRQLGNCKSLIWLDLNSNNLTGDLPGELASQAGL--------VMPGSVSGKQF 584
Query: 308 PTVSQLQIIVLRQNG----FTGPPPDVLWSMPQLR-----------------------LL 340
V R G F G + L +P +
Sbjct: 585 AFVRNEGGTDCRGAGGLVEFEGIRAERLERLPMVHSCPATRIYSGMTMYTFSANGSMIYF 644
Query: 341 DISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFR---LVDLSGNYFEGRV 397
DIS N +G +P N+ V LN+ N G + G + ++DLS N +G +
Sbjct: 645 DISYNAVSGFIPPGYGNMGYLQV-LNLGHNRITGTIPDSFGGLKAIGVLDLSHNNLQGYL 703
Query: 398 PEYVHSNA--SSLD---SNCLQNVP--NQRTLVDCSSFYAARGLSFDNFGRPNATQPPPP 450
P + S + S LD +N +P Q T S + GL RP + P P
Sbjct: 704 PGSLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLCGVPL-RPCGSAPRRP 762
Query: 451 ETSGDSNRKIIVLSAVLGGFGLIVLLVLLALLALCFCKK--RTPNQRGVGVGPVPAG--- 505
TS +K V +AV+ G + ++ ++AL +K + +R + +P
Sbjct: 763 ITSRIHAKKQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTSGSC 822
Query: 506 ----SSLPPPGASINFTNLGE---SFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGG 558
SS+P P SIN + T+ LL AT FS ++ +G G++++ L G
Sbjct: 823 SWKLSSVPEP-LSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDG 881
Query: 559 IPVVIKR-IDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDL 617
V IK+ I + ++ E++ K+ H LVPLLG+C E E+ LVY+YM G L
Sbjct: 882 SVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGE-ERLLVYEYMKWGSL 940
Query: 618 SSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF 677
+ L+ K++ + + L+W R KIAIGAA GL++LHH C +HRD+++S++LLD+ F
Sbjct: 941 ETVLHEKSSKKGGIY-LNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDF 999
Query: 678 EVRLGSLSEV-CAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELV 736
E R+ D H S ++ L P S T DVY +G +LLEL+
Sbjct: 1000 EARVSDFGMARLVSALDTHLS-VSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELL 1058
Query: 737 TGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARS 796
+GK I + ++ +Y ++ +I+DP L+ D+ E++ +A
Sbjct: 1059 SGKKPIDPGEFGEDNNLVGWA---KQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQ 1115
Query: 797 CLNPKPTRRPLMRYILKALENPLKVVREEN 826
CL+ +P +RP M ++ A+ +K EE+
Sbjct: 1116 CLDDRPFKRPTMIQLM-AMFKEMKADTEED 1144
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 266 bits (679), Expect = 8e-70, Method: Compositional matrix adjust.
Identities = 225/738 (30%), Positives = 355/738 (48%), Gaps = 63/738 (8%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTS 170
D+L+NL +L N S GSI G + + D+ G IP LG TNL
Sbjct: 547 DSLINLKNLTRINFSSNKFNGSISPLCGSS--SYLSFDVTENGFEGDIPLELGKSTNLDR 604
Query: 171 LYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSI 230
L L N TG IP + G++S LS+LD+SRNSL+G IP GL K L+ +D+++NYL+G I
Sbjct: 605 LRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVI 664
Query: 231 PPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQK 290
P LG L L L +S+N S+P ++ L +++ L L NSL+GS+P E+ L++L
Sbjct: 665 PTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNA 724
Query: 291 FVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLR-LLDISRNNFTG 349
+ N LSG L + +S+L + L +N TG P + + L+ LD+S NNFTG
Sbjct: 725 LNLEENQLSGPLPSTI-GKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTG 783
Query: 350 PLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFR---LVDLSGNYFEGRVPEYVHSNAS 406
+P++ S + L++S N G + +G + ++LS N EG++ +
Sbjct: 784 RIPSTISTL-PKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKK------- 835
Query: 407 SLDSNCLQNVPNQRTLVDCSSFYAARGLSFDNFGRP--NATQPPPPETSGDSNRKIIVLS 464
Q + +F GL G P + + S + ++++S
Sbjct: 836 ------------QFSRWQADAFVGNAGLC----GSPLSHCNRAGSKNQRSLSPKTVVIIS 879
Query: 465 AV--LGGFGLIVLLVLLALLALCFCKKRTPNQRGVGVGPVPAGSSLPPPGASINFTNLGE 522
A+ L L+VL+++L F K+ + V G S+ A + F+N G
Sbjct: 880 AISSLAAIALMVLVIIL------FFKQNHDLFKKVRGGNSAFSSNSSSSQAPL-FSNGGA 932
Query: 523 S--FTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRI----DLQSVKTEAY 576
+ ++ AT ++ +I +G SG +++ L+ G + +K+I DL S K ++
Sbjct: 933 KSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNK--SF 990
Query: 577 LLELDFFSKVSHARLVPLLGHCMERENE-KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLD 635
E+ + H LV L+G+C + + L+Y+YM NG + L+ NT+ + L
Sbjct: 991 NREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKK-EVLG 1049
Query: 636 WITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS--LSEVCAQGGD 693
W TRLKIA+G A+G+ YLH++C P VHRD+++S++LLD E LG L+++ D
Sbjct: 1050 WETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYD 1109
Query: 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEI 753
+ T + SL AT DVY G VL+E+VTGKM A D + +
Sbjct: 1110 TNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMV 1169
Query: 754 LEQTLPYISIYDKELVTKIVD---PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMR- 809
+ E K++D SL+ E+ E + + +A C P RP R
Sbjct: 1170 RWVETVLDTPPGSEAREKLIDSELKSLLPCEE--EAAYQVLEIALQCTKSYPQERPSSRQ 1227
Query: 810 ---YILKALENPLKVVRE 824
Y+L N RE
Sbjct: 1228 ASEYLLNVFNNRAASYRE 1245
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 8e-69, Method: Compositional matrix adjust.
Identities = 235/801 (29%), Positives = 380/801 (47%), Gaps = 101/801 (12%)
Query: 60 SLGLRRRDWPRKVDPCLVWNGVRCQNGSVVGINISGFRRTRL-GSQNPRFAADALVNLTH 118
+L L R ++ L WN V + G R L G+ +P + LT
Sbjct: 173 TLDLARNQLTGEIPRLLYWNEV---------LQYLGLRGNMLTGTLSPD-----MCQLTG 218
Query: 119 LASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGL 178
L F+ L G+IP+ +G + + LD+ I+GVIP+++G L + +L L N L
Sbjct: 219 LWYFDVRGNNLTGTIPESIGN-CTSFEILDVSYNQITGVIPYNIGFL-QVATLSLQGNKL 276
Query: 179 TGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLS 238
TG IP +G + L+VLDLS N LTG IP G L L + N LTG IPP LG +S
Sbjct: 277 TGRIPEVIGLMQALAVLDLSDNELTGPIPPILGNLSFTGKLYLHGNKLTGQIPPELGNMS 336
Query: 239 KLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFL 298
+L YL +++N L IP +LG L+ L +L+L+ N+L G +PS + +L +F + NFL
Sbjct: 337 RLSYLQLNDNELVGKIPPELGKLEQLFELNLANNNLVGLIPSNISSCAALNQFNVHGNFL 396
Query: 299 SGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNV 358
SG + + F + L + L N F G P L + L LD+S NNF+G +P + ++
Sbjct: 397 SGAVPLE-FRNLGSLTYLNLSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDL 455
Query: 359 NTSTVELNISQNMFYGGLTPVLGRFR---LVDLSGNYFEGRVPEYV-----HSNASSLDS 410
+ LN+S+N G L G R ++D+S N+ G +P + ++ ++
Sbjct: 456 EHLLI-LNLSRNHLNGTLPAEFGNLRSIQIIDVSFNFLAGVIPTELGQLQNINSLILNNN 514
Query: 411 NCLQNVPNQRTLVDCSSFYAARGLSFDN-------------------FGRP--------N 443
+P+Q L +C S A +SF+N FG P +
Sbjct: 515 KIHGKIPDQ--LTNCFSL-ANLNISFNNLSGIIPPMKNFTRFSPASFFGNPFLCGNWVGS 571
Query: 444 ATQPPPPETSGDSNRKIIVLSAVLGGFGLIVLLVLLALLALCFCKKRTPNQRGVGVGPVP 503
P P++ + ++ V+ VLG + L+ + +A+ K++ P V
Sbjct: 572 ICGPSLPKSQVFT--RVAVICMVLG----FITLICMIFIAVYKSKQQKP---------VL 616
Query: 504 AGSSLPPPGAS-INFTNLGESF-TYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPV 561
GSS P G++ + ++ + T+ ++ T + + +I G S +++ + P+
Sbjct: 617 KGSSKQPEGSTKLVILHMDMAIHTFDDIMRVTENLDEKYIIGYGASSTVYKCTSKTSRPI 676
Query: 562 VIKRIDLQSVKT-EAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSS 620
IKRI Q + EL+ + H +V L G+ + L Y YM NG S
Sbjct: 677 AIKRIYNQYPSNFREFETELETIGSIRHRNIVSLHGYALSPFG-NLLFYDYMENG----S 731
Query: 621 LYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVR 680
L+ + LDW TRLKIA+GAA+GL+YLHH+CT +HRD+++S+ILLD FE R
Sbjct: 732 LWDLLHGPGKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDGNFEAR 791
Query: 681 L---GSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT 737
L G + A A + + + E + L D+Y FG VLLEL+T
Sbjct: 792 LSDFGIAKSIPATKTYASTYVLGTIGYI--DPEYARTSRLNEKS--DIYSFGIVLLELLT 847
Query: 738 GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSL---IIDEDLLEEVWAMAIVA 794
GK + ++A + +++ +S D V + VD + +D +++ + +A++
Sbjct: 848 GKKAV--DNEANLHQMI------LSKADDNTVMEAVDAEVSVTCMDSGHIKKTFQLALL- 898
Query: 795 RSCLNPKPTRRPLMRYILKAL 815
C P RP M+ + + L
Sbjct: 899 --CTKRNPLERPTMQEVSRVL 917
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (667), Expect = 2e-68, Method: Compositional matrix adjust.
Identities = 227/731 (31%), Positives = 357/731 (48%), Gaps = 66/731 (9%)
Query: 113 LVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLY 172
L LT L F A L GSIP L LQALDL S++G IP L L NLT L
Sbjct: 390 LGTLTKLTLFFAWSNQLEGSIPPGLAD-CTDLQALDLSRNSLTGTIPSGLFMLRNLTKLL 448
Query: 173 LSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPP 232
L N L+G IP +G S L L L N +TG IP+ G LK ++ LD SSN L G +P
Sbjct: 449 LISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPD 508
Query: 233 GLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFV 292
+G+ S+LQ +++SNNSL S+P + L L LD+S N SG +P+ L L SL K +
Sbjct: 509 EIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLI 568
Query: 293 IGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRL-LDISRNNFTGPL 351
+ N SG++ +L S LQ++ L N +G P L + L + L++S N TG +
Sbjct: 569 LSKNLFSGSIPTSL-GMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKI 627
Query: 352 PNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDL--SGNYFEGRVPEYVHSNASSLD 409
P+ +++N ++ L++S NM G L P+ LV L S N F G +P+ S
Sbjct: 628 PSKIASLNKLSI-LDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLS-- 684
Query: 410 SNCLQNVPNQRTLVDCSSFYAARGLSFDNFGRPNATQPPPPETSGDSNRKIIVLSAVLGG 469
Q++ + L CSS + F + + N GD++R + +
Sbjct: 685 ---PQDLEGNKKL--CSSTQDS---CFLTYRKGNGLG-----DDGDASRTRKLRLTLALL 731
Query: 470 FGLIVLLVLLALLALCFCKKRTPNQRGVGVGPVPAGSSLPPPGASINFTNLGESFTYQQL 529
L V+L++L +A+ ++ N+R +G P F L +F+ Q+
Sbjct: 732 ITLTVVLMILGAVAVIRARRNIDNERDSELGETYKWQFTP-------FQKL--NFSVDQI 782
Query: 530 LAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRI-----------DLQSVKTEAYLL 578
+ + N+I G SG ++R ++ G + +K++ ++V+ +++
Sbjct: 783 IRC---LVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVR-DSFSA 838
Query: 579 ELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWIT 638
E+ + H +V LG C R N + L+Y YMPNG L S L+ + + SLDW
Sbjct: 839 EVKTLGTIRHKNIVRFLGCCWNR-NTRLLMYDYMPNGSLGSLLHERRGS-----SLDWDL 892
Query: 639 RLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS--LSEVCAQGGDAHQ 696
R +I +GAA+GL+YLHH+C P VHRD++A++IL+ FE + L+++ +G
Sbjct: 893 RYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRC 952
Query: 697 SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGI--SASSDAQVKEIL 754
S + E G S +T DVY +G V+LE++TGK I + + + +
Sbjct: 953 SNTVAGSYGYIAPEYGYSMKITEKS--DVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWV 1010
Query: 755 EQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814
Q + + D L ++ + D + +V A++ C+N P RP M+ + A
Sbjct: 1011 RQNRGSLEVLDSTLRSRTE-----AEADEMMQVLGTALL---CVNSSPDERPTMKDV-AA 1061
Query: 815 LENPLKVVREE 825
+ +K REE
Sbjct: 1062 MLKEIKQEREE 1072
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 259 bits (662), Expect = 7e-68, Method: Compositional matrix adjust.
Identities = 206/724 (28%), Positives = 338/724 (46%), Gaps = 79/724 (10%)
Query: 129 LPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQ 188
L G IP +G LD+ + S+SG IP L L L N L+G IP L
Sbjct: 391 LEGKIPPLIGFY-SNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKT 449
Query: 189 LSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNN 248
L+ L L N LTG++P L+NL++L++ N+L+G+I LG L L+ L ++NN
Sbjct: 450 CKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANN 509
Query: 249 SLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFP 308
+ IP ++G+L +V ++S N L+G +P EL ++Q+ + N SG ++ L
Sbjct: 510 NFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQ 569
Query: 309 TVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNIS 368
V L+I+ L N TG P + +L L + N + +P + + + LNIS
Sbjct: 570 LV-YLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNIS 628
Query: 369 QNMFYGGLTPVLGRFRLVD---LSGNYFEGRVPEYVHSNASSL-----DSNCLQNVPNQR 420
N G + LG ++++ L+ N G +P + + S L ++N + VP+
Sbjct: 629 HNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTA 688
Query: 421 TL--VDCSSFYAARGLSFDNFGRPNATQPPPPET--------SGDSNRKIIVLSAVLGGF 470
+D S+F GL N R + QP P + +G +KI+ ++ ++ G
Sbjct: 689 VFQRMDSSNFAGNHGLC--NSQRSHC-QPLVPHSDSKLNWLINGSQRQKILTITCIVIGS 745
Query: 471 GLIVLLVLLALLALCFCKKRTPNQRGVGVGPVPAGSSLP---PPGASINFTNLGESFTYQ 527
+ L+ L LC+ KR PA +L P ++ + FTYQ
Sbjct: 746 -----VFLITFLGLCWTIKRRE----------PAFVALEDQTKPDVMDSYYFPKKGFTYQ 790
Query: 528 QLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQ---SVKTEAYLLELDFFS 584
L+ AT +FS+ ++ G G +++ + GG + +K+++ + + ++ E+
Sbjct: 791 GLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEISTLG 850
Query: 585 KVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAI 644
K+ H +V L G C +N L+Y+YM G L L R LDW R +IA+
Sbjct: 851 KIRHRNIVKLYGFCYH-QNSNLLLYEYMSKGSLGEQLQRGEKN----CLLDWNARYRIAL 905
Query: 645 GAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLR 704
GAAEGL YLHH+C VHRD+++++ILLD++F+ +G A+ D S+
Sbjct: 906 GAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFG--LAKLIDLSYSK------ 957
Query: 705 LPQSSEQGSSGSLTATCPY--------DVYCFGKVLLELVTGKMGISASSDA-----QVK 751
S+ GS G + Y D+Y FG VLLEL+TGK + V+
Sbjct: 958 -SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVR 1016
Query: 752 EILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYI 811
+ +P I ++D L T D+ + E+ + +A C + P RP MR +
Sbjct: 1017 RSIRNMIPTIEMFDARLDTN--------DKRTVHEMSLVLKIALFCTSNSPASRPTMREV 1068
Query: 812 LKAL 815
+ +
Sbjct: 1069 VAMI 1072
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 253 bits (647), Expect = 3e-66, Method: Compositional matrix adjust.
Identities = 235/731 (32%), Positives = 343/731 (46%), Gaps = 67/731 (9%)
Query: 129 LPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQ 188
L G IP +G+ L +L L+L + G IP LG+ T+LT+L L N L G IP +
Sbjct: 484 LTGEIPREIGK-LTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITA 542
Query: 189 LSVLSVLDLSRNSLTGNIPTS------------FGLLKNLSSLDISSNYLTGSIPPGLGT 236
L+ L L LS N+L+G+IP+ L++ D+S N L+G IP LG
Sbjct: 543 LAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGE 602
Query: 237 LSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNN 296
L +++SNN L+ IPA L L +L LDLS N+L+GS+P E+ LQ + NN
Sbjct: 603 CLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANN 662
Query: 297 FLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRS 356
L+G++ + F + L + L +N GP P L ++ +L +D+S NN +G L + S
Sbjct: 663 QLNGHIPES-FGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELS 721
Query: 357 NVNTSTVELNISQNMFYGGLTPVLG---RFRLVDLSGNYFEGRVPEYVHS--NASSLD-- 409
+ V L I QN F G + LG + +D+S N G +P + N L+
Sbjct: 722 TME-KLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLA 780
Query: 410 -SNCLQNVPNQRTLVDCSSFYAARGLSFDNFGRPNATQPPPPETSGDSNRKIIVLSAVLG 468
+N VP+ D S + GR + + G R ++ ++
Sbjct: 781 KNNLRGEVPSDGVCQDPSKALLSGNKEL--CGRVVGSDC---KIEGTKLRSAWGIAGLML 835
Query: 469 GFGLIVLLVLLALLALCFCKK--------RTPNQRGVGVGP----VPAGSSLPPPGASIN 516
GF +IV + + +L K+ R R G +GS P SIN
Sbjct: 836 GFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREP-LSIN 894
Query: 517 FTNLGESFTYQQL---LAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKT 573
+ +L + AT FS N+I +G G +++ L G V +K+ L KT
Sbjct: 895 IAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKK--LSEAKT 952
Query: 574 EA---YLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDD 630
+ ++ E++ KV H LV LLG+C E EK LVY+YM NG L L +T
Sbjct: 953 QGNREFMAEMETLGKVKHPNLVSLLGYCSFSE-EKLLVYEYMVNGSLDHWLRNQTGM--- 1008
Query: 631 LQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVR-----LGSLS 685
L+ LDW RLKIA+GAA GL++LHH +HRD++AS+ILLD FE + L L
Sbjct: 1009 LEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLI 1068
Query: 686 EVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISAS 745
C ++H S + E G S AT DVY FG +LLELVTGK
Sbjct: 1069 SAC----ESHVSTVIAGTFGYIPPEYGQSAR--ATTKGDVYSFGVILLELVTGKE--PTG 1120
Query: 746 SDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRR 805
D + E I ++ ++DP L++ L + +A CL P +R
Sbjct: 1121 PDFKESEGGNLVGWAIQKINQGKAVDVIDP-LLVSVALKNSQLRLLQIAMLCLAETPAKR 1179
Query: 806 PLMRYILKALE 816
P M +LKAL+
Sbjct: 1180 PNMLDVLKALK 1190
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 249 bits (635), Expect = 8e-65, Method: Compositional matrix adjust.
Identities = 222/796 (27%), Positives = 365/796 (45%), Gaps = 115/796 (14%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTS 170
+ L L +LA + S L G IP Q L +++ L L S+SGVIP LG + L
Sbjct: 367 NELSKLRNLAKLDLSINSLTGPIPPGF-QNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWV 425
Query: 171 LYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIP----------------------- 207
+ S+N L+G IP + Q S L +L+L N + GNIP
Sbjct: 426 VDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQF 485
Query: 208 -TSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVD 266
T L NLS++++ N +G +PP +GT KLQ L+++ N +S++P ++ L +LV
Sbjct: 486 PTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVT 545
Query: 267 LDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGP 326
++S NSL+G +PSE+ + LQ+ + N G+L L ++ QL+I+ L +N F+G
Sbjct: 546 FNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPEL-GSLHQLEILRLSENRFSGN 604
Query: 327 PPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLV 386
P + ++ L L + N F+G +P +++ + +N+S N F G + P +G L+
Sbjct: 605 IPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLL 664
Query: 387 ---DLSGNYFEGRVPEYVHSNASSLDSNCLQN-----VPNQRTL--VDCSSFYAARGLSF 436
L+ N+ G +P + +S L N N +P+ + + +SF +GL
Sbjct: 665 MYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCG 724
Query: 437 DNFGRPNATQPPPPETS----GDSNRKIIVLSAVLGGFGLIVLLVLLALLALCFCKKRTP 492
+ + + P S G + R I++ G+ +LL+ + + L R P
Sbjct: 725 GHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFL-----RNP 779
Query: 493 NQRGVGVGPVPAGSSLPPP---GASINFTNLGESFTYQQLLAATGDFSDANLIKNGHSGD 549
V P P + I F E FT + +L AT F D+ ++ G G
Sbjct: 780 ------VEPTAPYVHDKEPFFQESDIYFVP-KERFTVKDILEATKGFHDSYIVGRGACGT 832
Query: 550 LFRGILEGGIPVVIKRIDLQSVKTEA--------YLLELDFFSKVSHARLVPLLGHCMER 601
+++ ++ G + +K+++ + E+ K+ H +V L C +
Sbjct: 833 VYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQ 892
Query: 602 -ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLP 660
N L+Y+YM G L L+ + S+DW TR IA+GAAEGL+YLHH+C
Sbjct: 893 GSNSNLLLYEYMSRGSLGELLHGGKS-----HSMDWPTRFAIALGAAEGLAYLHHDCKPR 947
Query: 661 FVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSE----QGSSGS 716
+HRD+++++IL+D+ FE +G + +++ +P S GS G
Sbjct: 948 IIHRDIKSNNILIDENFEAHVGDFG-------------LAKVIDMPLSKSVSAVAGSYGY 994
Query: 717 LTATCPY--------DVYCFGKVLLELVTGKMGISASSDAQVKEILEQ-----TLPYISI 763
+ Y D+Y FG VLLEL+TGK + LEQ T I
Sbjct: 995 IAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQP---------LEQGGDLATWTRNHI 1045
Query: 764 YDKELVTKIVDPSLIIDED--LLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLKV 821
D L ++I+DP L ED +L + + +A C P+ RP MR ++ L +
Sbjct: 1046 RDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLML-----I 1100
Query: 822 VREENSGSARLRTTSS 837
E +G + TT S
Sbjct: 1101 ESGERAGKVIVSTTCS 1116
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 245 bits (625), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 233/805 (28%), Positives = 359/805 (44%), Gaps = 97/805 (12%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQ-LPTLQALDLRSCSISGVIPFSLGNLTNLT 169
D+ NL L + + S L G IP + + + L+ L L++ G IP SL N + L
Sbjct: 395 DSFSNLPKLETLDMSSNNLTGIIPSGICKDPMNNLKVLYLQNNLFKGPIPDSLSNCSQLV 454
Query: 170 SLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGS 229
SL LS N LTG+IPSSLG LS L L L N L+G IP L+ L +L + N LTG
Sbjct: 455 SLDLSFNYLTGSIPSSLGSLSKLKDLILWLNQLSGEIPQELMYLQALENLILDFNDLTGP 514
Query: 230 IPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQ 289
IP L +KL ++++SNN L+ IPA LG L +L L L NS+SG++P+EL +SL
Sbjct: 515 IPASLSNCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLI 574
Query: 290 KFVIGNNFL-----------SGNLSVNL-------------------------FPTVSQL 313
+ NFL SGN++V L F + Q
Sbjct: 575 WLDLNTNFLNGSIPPPLFKQSGNIAVALLTGKRYVYIKNDGSKECHGAGNLLEFGGIRQE 634
Query: 314 QI--IVLRQ--------NGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTV 363
Q+ I R G T P + SM LD+S N G +P + ++
Sbjct: 635 QLDRISTRHPCNFTRVYRGITQPTFNHNGSM---IFLDLSYNKLEGSIPKELGAMYYLSI 691
Query: 364 ELNISQNMFYGGLTPVLGRFR---LVDLSGNYFEGRVPEYVHS----NASSLDSNCLQNV 416
LN+ N G + LG + ++DLS N F G +P + S L +N L +
Sbjct: 692 -LNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGM 750
Query: 417 PNQRTLVDCSSFYAARGLSFDNFGRPNATQPPPPETSGDSNRKIIVLSAVLGGFGLIVLL 476
+ D Y S + P P + + +++ G + +L
Sbjct: 751 IPESAPFDTFPDYRFANNSLCGYPLPLPCSSGPKSDANQHQKSHRRQASLAGSVAMGLLF 810
Query: 477 VLLALLALCFC----KKRTPNQRGVGVGPVPAGSSLPPPGASINFTNLGESF-------- 524
L + L KKR + + S ++ FT+ E+
Sbjct: 811 SLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSAREALSINLAAFE 870
Query: 525 ------TYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKR-IDLQSVKTEAYL 577
T+ LL AT F + +L+ +G GD+++ L+ G V IK+ I + +
Sbjct: 871 KPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGDREFT 930
Query: 578 LELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWI 637
E++ K+ H LVPLLG+C E E+ LVY+YM G L L+ + T L+W
Sbjct: 931 AEMETIGKIKHRNLVPLLGYCKVGE-ERLLVYEYMKYGSLEDVLHDRKKTG---IKLNWP 986
Query: 638 TRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV-CAQGGDAHQ 696
R KIAIGAA GL++LHH C +HRD+++S++LLD+ E R+ D H
Sbjct: 987 ARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHL 1046
Query: 697 SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQ 756
S ++ L P S + DVY +G VLLEL+TGK ++
Sbjct: 1047 S-VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGD-----NN 1100
Query: 757 TLPYISIYDKELVTKIVDPSLIIDEDLLE-EVWAMAIVARSCLNPKPTRRPLMRYILKAL 815
+ ++ ++ K +T + D L+ ++ +E E+ VA +CL+ + +RP M +
Sbjct: 1101 LVGWVKLHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLDDRHWKRPTMIQV---- 1156
Query: 816 ENPLKVVREENSGSARLRTTSSRGS 840
+ + +E +GS + +TS+ G+
Sbjct: 1157 ---MAMFKEIQAGSG-MDSTSTIGA 1177
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 919 | ||||||
| 255536845 | 901 | lrr receptor protein kinase, putative [R | 0.978 | 0.997 | 0.734 | 0.0 | |
| 359475328 | 908 | PREDICTED: probable LRR receptor-like se | 0.981 | 0.993 | 0.718 | 0.0 | |
| 224103409 | 893 | predicted protein [Populus trichocarpa] | 0.944 | 0.972 | 0.741 | 0.0 | |
| 356509565 | 900 | PREDICTED: probable LRR receptor-like se | 0.946 | 0.966 | 0.676 | 0.0 | |
| 356517903 | 898 | PREDICTED: probable LRR receptor-like se | 0.946 | 0.968 | 0.679 | 0.0 | |
| 449462274 | 896 | PREDICTED: probable LRR receptor-like se | 0.944 | 0.968 | 0.686 | 0.0 | |
| 225458279 | 903 | PREDICTED: probable LRR receptor-like se | 0.944 | 0.961 | 0.657 | 0.0 | |
| 449496837 | 908 | PREDICTED: probable LRR receptor-like se | 0.960 | 0.972 | 0.662 | 0.0 | |
| 449463390 | 908 | PREDICTED: probable LRR receptor-like se | 0.960 | 0.972 | 0.662 | 0.0 | |
| 297836662 | 907 | hypothetical protein ARALYDRAFT_480795 [ | 0.912 | 0.925 | 0.644 | 0.0 |
| >gi|255536845|ref|XP_002509489.1| lrr receptor protein kinase, putative [Ricinus communis] gi|223549388|gb|EEF50876.1| lrr receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1268 bits (3280), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 665/905 (73%), Positives = 752/905 (83%), Gaps = 6/905 (0%)
Query: 17 MVDQRSVVMFFVMFLLL-FEPTFEQQLERLSSRTELAALFELRSSLGLRRRDWPRKVDPC 75
MVDQR V+ + LLL F+P+F QQ+E L+S E AAL +LRSSLG+R ++WPRK +PC
Sbjct: 1 MVDQRIVIALAFLLLLLKFQPSF-QQVETLNSPVERAALLQLRSSLGIRSKEWPRKTNPC 59
Query: 76 LVWNGVRCQNGSVVGINISGFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPD 135
W G+ C NGSV GINISGFRRTRLGSQNP+F DALVNLTHL SFNASRF LPGSIPD
Sbjct: 60 SNWTGISCTNGSVSGINISGFRRTRLGSQNPQFVVDALVNLTHLISFNASRFQLPGSIPD 119
Query: 136 WLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVL 195
W GQ L +LQALDL C I IP SLGNLTNLTSLYLS N L G+IPSSLGQL +LS+L
Sbjct: 120 WFGQSLGSLQALDLSFCDIRNAIPASLGNLTNLTSLYLSGNRLVGSIPSSLGQLVLLSIL 179
Query: 196 DLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIP 255
+LS+NSLT +IP SFG L NL+ LDISSN+L+GSIPPG+G L KLQYLN+SNN L+S IP
Sbjct: 180 NLSQNSLTVSIPVSFGFLANLTILDISSNFLSGSIPPGIGMLLKLQYLNLSNNQLSSPIP 239
Query: 256 AQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQI 315
AQLGDL LVDLDLS NSLSGSVP+ELRGLR+L++ +IGNN L G+L VNLF QLQI
Sbjct: 240 AQLGDLVQLVDLDLSFNSLSGSVPAELRGLRNLKRMLIGNNMLVGSLPVNLFSASIQLQI 299
Query: 316 IVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGG 375
+V++ NGFTG P+VLW+MP L LDIS NNFTG LPN N NTST ELNIS N+ YG
Sbjct: 300 VVMKNNGFTGSVPNVLWTMPGLSFLDISGNNFTGLLPNVTFNANTSTAELNISGNLLYGF 359
Query: 376 LTPVLGRFRLVDLSGNYFEGRVPEYVHSNASSLDSNCLQNVPNQRTLVDCSSFYAARGLS 435
L P+L RF VDLSGNYFEG+V + V NAS L SNCLQNV NQR+L +C+SFYA RGL
Sbjct: 360 LNPILRRFSFVDLSGNYFEGKVLDLVPDNASLL-SNCLQNVSNQRSLSECTSFYAERGLI 418
Query: 436 FDNFGRPNATQPPPPETSGDSNRKIIVLSAVLGGFGLIVLLVLLALLALCFCKKRTPNQR 495
FDNFG PN+TQPP E+ G SNR +I+L++VLGG GL+VLL++L LL +C CK+ T NQR
Sbjct: 419 FDNFGLPNSTQPPAGESEGKSNRMVIILASVLGGVGLVVLLIILVLLFVCHCKRGTANQR 478
Query: 496 GVGVGPVPAGSSLPPPGASINFTNLGESFTYQQLLAATGDFSDANLIKNGHSGDLFRGIL 555
G GVGPVPAGSS PPP A+I+ ++LG++FTYQQLL AT DFSD NLIK+GHSGDL+RG+L
Sbjct: 479 GTGVGPVPAGSSPPPPEAAIDLSSLGDTFTYQQLLQATSDFSDENLIKHGHSGDLYRGVL 538
Query: 556 EGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNG 615
E GI VVIKR+ LQS+K E+Y++ELD FSKVSH RLVP LGHC+ ENEKFLVYKYMPN
Sbjct: 539 ENGISVVIKRVHLQSIKKESYVMELDIFSKVSHPRLVPFLGHCLANENEKFLVYKYMPNR 598
Query: 616 DLSSSLYRKTNTEDD-LQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLD 674
DLSSSLYRKT+++DD LQSLDWITRLKIA GAAE LS LHHECT P VHRDVQASSILLD
Sbjct: 599 DLSSSLYRKTSSDDDSLQSLDWITRLKIATGAAEALSCLHHECTPPIVHRDVQASSILLD 658
Query: 675 DKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLE 734
DKFEVRLGSLSEVC Q GDAHQSRITRLLRLPQSSEQ +SGSLTA C YDVYCFGKVLLE
Sbjct: 659 DKFEVRLGSLSEVCPQEGDAHQSRITRLLRLPQSSEQSTSGSLTAMCAYDVYCFGKVLLE 718
Query: 735 LVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVA 794
LVTGK+G SASS+AQ+KE LEQTLPYISIYDKELVTKIVDPSLI+DEDLLEEVWAMAIVA
Sbjct: 719 LVTGKLGTSASSEAQLKEWLEQTLPYISIYDKELVTKIVDPSLIVDEDLLEEVWAMAIVA 778
Query: 795 RSCLNPKPTRRPLMRYILKALENPLKVVREENSGSARLRTTSSRGSWNAALFGSWRQSSS 854
RSCLNPKP+RRPLMRYILKALENPLKVVREE+S SARLRTTSSRGSWNAA+FGSWR SSS
Sbjct: 779 RSCLNPKPSRRPLMRYILKALENPLKVVREESSSSARLRTTSSRGSWNAAIFGSWR-SSS 837
Query: 855 DVAAIPVPPNTKAEGTSSLKQSGTTGSQGSGQIGGGEHSSSQRRQSRDIFPEPSDTQDVE 914
DVA IP NT+ EG+SSLK S T + G GGEHSSS RR SR+IFPEPS+ QD+E
Sbjct: 838 DVAVIPAGSNTRPEGSSSLKHS-GTSNSGGSGQNGGEHSSSHRRYSREIFPEPSEGQDIE 896
Query: 915 TQVQD 919
Q QD
Sbjct: 897 RQGQD 901
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475328|ref|XP_003631657.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g16250-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1180 bits (3053), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 653/909 (71%), Positives = 748/909 (82%), Gaps = 7/909 (0%)
Query: 17 MVDQRSVVMFF----VMFLLLFEPTFEQQLERLSSRTELAALFELRSSLGLRRRDWPRKV 72
MV++RS V+ F V+ LLL E TFEQ RLSS E AL ELRSSLGLR ++WP K
Sbjct: 1 MVNRRSRVVTFGLLLVVLLLLVESTFEQTQARLSSSAEFTALLELRSSLGLRSKEWPIKS 60
Query: 73 DPCLVWNGVRCQNGSVVGINISGFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGS 132
DPC W GV+C+NGSVVGI+ISGFRRTRLGS+NP FA DAL NLT L SFNAS FLLPGS
Sbjct: 61 DPCWFWRGVQCRNGSVVGIDISGFRRTRLGSRNPEFAVDALANLTLLESFNASMFLLPGS 120
Query: 133 IPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVL 192
IPDW G++L +L+ LDLRSCSI G IP SLGNL+NL +L+LS N LTG IPSSLGQLS L
Sbjct: 121 IPDWFGERLSSLKVLDLRSCSIIGPIPSSLGNLSNLNALFLSYNNLTGIIPSSLGQLSHL 180
Query: 193 SVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLAS 252
SVLDLS+N TG+IP+SFG +NLS L+IS N+L+ +IPPG+G +S LQYLN+S NSL+S
Sbjct: 181 SVLDLSQNRFTGSIPSSFGSFRNLSVLNISVNFLSDTIPPGIGNISSLQYLNLSGNSLSS 240
Query: 253 SIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQ 312
SIPAQLGDLD+LV+LDLS NSLSGS+P++ RGL++LQK I N L+G+L NLFP +SQ
Sbjct: 241 SIPAQLGDLDNLVELDLSFNSLSGSLPADFRGLKNLQKMAIRKNSLAGSLPGNLFPALSQ 300
Query: 313 LQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMF 372
LQ++VL QN FTG PDVLW+MP L LD+S NNFT LPN N N + N+SQNMF
Sbjct: 301 LQLVVLSQNAFTGNLPDVLWTMPNLSFLDVSGNNFTSVLPNFSFNGNATASVFNLSQNMF 360
Query: 373 YGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASSLDSNCLQNVPNQRTLVDCSSFYAAR 432
YGGL + RF +D+S NYFEGRV +Y SNA S NCLQNV NQRTL C+SFYA +
Sbjct: 361 YGGLPSLPRRFSSIDMSQNYFEGRVRDYAPSNA-SFGMNCLQNVSNQRTLEVCASFYAEK 419
Query: 433 GLSFDNFGRPNATQPPPPETSGDSNRKIIVLSAVLGGFGLIVLLVLLALLALCFCKKRTP 492
GL FDNFG+PN+TQP +TSG SN+K I+L+ VLGG GLI+ LVL+ +L LC +K
Sbjct: 420 GLPFDNFGQPNSTQPTTNDTSGKSNKKWIILAGVLGGLGLILFLVLVLVLFLCCWRKGGT 479
Query: 493 NQRGVGVGPVPAGSSLPPPGASINFTNLGESFTYQQLLAATGDFSDANLIKNGHSGDLFR 552
+QRG GVGPVPAG S PPPG INF++LGE+FTYQQ+L ATGDFSDAN IK+GHSGDL+
Sbjct: 480 SQRGNGVGPVPAGGSPPPPGMPINFSSLGEAFTYQQILQATGDFSDANFIKHGHSGDLYW 539
Query: 553 GILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612
GILEGG+ +VIKRIDL S+K E YLLELDFFSKVSH R VPLLG C+E +NEKFLVYKYM
Sbjct: 540 GILEGGVRIVIKRIDLSSIKKETYLLELDFFSKVSHTRFVPLLGQCLENDNEKFLVYKYM 599
Query: 613 PNGDLSSSLYRKTNTEDD-LQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSI 671
PNGDLS+SL+RKTN EDD LQSLDWITRLKIAIGAAE LS+LHHEC P VHRDVQASSI
Sbjct: 600 PNGDLSNSLFRKTNLEDDGLQSLDWITRLKIAIGAAEALSHLHHECNPPLVHRDVQASSI 659
Query: 672 LLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKV 731
LLDDKFEVRLGSLSEVC+Q GD HQ+ ITR LRLPQ+SEQG SGS +ATC YDVYCFGKV
Sbjct: 660 LLDDKFEVRLGSLSEVCSQEGDTHQNVITRFLRLPQTSEQGPSGSPSATCAYDVYCFGKV 719
Query: 732 LLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMA 791
LLELVTG++GISAS+DAQVKE L+QTLP ISIYDKELV KIVDPSLIIDEDLLEEVWAMA
Sbjct: 720 LLELVTGRLGISASNDAQVKEWLDQTLPCISIYDKELVQKIVDPSLIIDEDLLEEVWAMA 779
Query: 792 IVARSCLNPKPTRRPLMRYILKALENPLKVVREENSGSARLRTTSSRGSWNAALFGSWRQ 851
IVARSCLNPK +RRPLMRYILKALENPLKVVREENS SARL+TTSSRGSWNAALFGSWR
Sbjct: 780 IVARSCLNPKISRRPLMRYILKALENPLKVVREENSSSARLKTTSSRGSWNAALFGSWRH 839
Query: 852 SSSDVAAIPVPPNT-KAEGTSSLKQSGTTGSQGSGQIGGGEHSSSQRRQSRDIFPEPSDT 910
SS DVAA PV +T + EGTSSLKQSGTTGSQGSGQ GGG+HSSSQRR S+++FPEPS
Sbjct: 840 SSLDVAANPVAASTHRIEGTSSLKQSGTTGSQGSGQNGGGDHSSSQRRHSKEVFPEPSSM 899
Query: 911 QDVETQVQD 919
Q+VE ++
Sbjct: 900 QNVERHDEN 908
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103409|ref|XP_002313045.1| predicted protein [Populus trichocarpa] gi|222849453|gb|EEE87000.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1173 bits (3035), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 658/887 (74%), Positives = 733/887 (82%), Gaps = 19/887 (2%)
Query: 35 EPTFEQQL-ERLSSRTELAALFELRSSLGLRRRDWPRKVDPCLVWNGVRCQNGSVVGINI 93
E TFEQQ ERL+S E AAL LRSSLGLR RDWP K DPC +WNG++C+NGSV INI
Sbjct: 20 ESTFEQQQQERLTSPIERAALLGLRSSLGLRSRDWPIKADPCSIWNGIKCENGSVSEINI 79
Query: 94 SGFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCS 153
SGF+RTRLGSQNP+F D+LVNLT L SFNAS F LPGSIPDW GQ+L +LQALDL SC
Sbjct: 80 SGFKRTRLGSQNPQFRVDSLVNLTRLKSFNASGFYLPGSIPDWFGQRLVSLQALDLSSCL 139
Query: 154 ISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLL 213
IS IP SLGNLT+LT LYL DN LTG IPSSLGQL LSVLDLS N TG+IP SFG L
Sbjct: 140 ISNAIPGSLGNLTSLTVLYLHDNNLTGMIPSSLGQLVGLSVLDLSSNMFTGSIPVSFGSL 199
Query: 214 KNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNS 273
+NL+ LDIS N+L GS+PPG+G LSKLQYLN+S N L+SSIPAQLGDL +LVDLDLS NS
Sbjct: 200 QNLTRLDISMNFLFGSVPPGIGMLSKLQYLNLSINDLSSSIPAQLGDLRNLVDLDLSFNS 259
Query: 274 LSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWS 333
LSGS+P+ELRGLR+LQ+ +IG N L G+L VNLFP SQLQ +VL+ NGF G PDVLWS
Sbjct: 260 LSGSLPAELRGLRNLQRMLIGINLLGGSLPVNLFPVPSQLQTVVLKSNGFIGAVPDVLWS 319
Query: 334 MPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYF 393
MP+LRLLDIS NNFTG L N+ N NT+T ELN+SQN+FYGGLTPVL RF VDLSGNYF
Sbjct: 320 MPRLRLLDISGNNFTGMLSNASLNTNTTTAELNVSQNLFYGGLTPVLRRFSFVDLSGNYF 379
Query: 394 EGRVPEYVHSNASSLDSNCLQNVPNQRTLVDCSSFYAARGLSFDNFGRPNATQPPPPETS 453
EGRVP+YV NA SL SNCLQN+ NQR+L+ C+SFY +GL FDNFG PN+TQPP E S
Sbjct: 380 EGRVPDYVSDNA-SLVSNCLQNLSNQRSLLGCTSFYTEKGLIFDNFGLPNSTQPPARENS 438
Query: 454 GDSNRKIIVLSAVLGGFGLIVLLVLLALLALCFCKKR-TPNQRGVGVGPVP---AGSSLP 509
G S RK+I+L +VLGGFGLI+LLV+L +L L F +K QRGVGVGP +GSS P
Sbjct: 439 GKSKRKVIILVSVLGGFGLILLLVILIVLLLFFIRKTGNKTQRGVGVGPATPVPSGSSPP 498
Query: 510 PPGASINFTNLGESFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQ 569
PPG SI+F++LG+ +TYQQLL ATGDF D NLIK GHSGDL++GI E GIPVVIK+IDLQ
Sbjct: 499 PPGVSIDFSSLGDIYTYQQLLLATGDFGDVNLIKYGHSGDLYKGISESGIPVVIKKIDLQ 558
Query: 570 SVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTED 629
S + EAYLLELDFFSKVS+ RLVPLLGHC+E+ENEKFL+YK+MPNGDLSSSLYRKTN+ED
Sbjct: 559 SHRKEAYLLELDFFSKVSNPRLVPLLGHCLEKENEKFLIYKHMPNGDLSSSLYRKTNSED 618
Query: 630 DLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689
L+SLDWITRLKIAIGAAEGLSYLHHECT P VHRDVQASSILLDDKFEVRLGSLSEVC
Sbjct: 619 GLKSLDWITRLKIAIGAAEGLSYLHHECTPPIVHRDVQASSILLDDKFEVRLGSLSEVCT 678
Query: 690 QGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ 749
Q GD H SRITR LR SLT TC YDVYCFGKVLLELVTGK+GISASSDAQ
Sbjct: 679 QEGDTHHSRITRFLR-----------SLTTTCAYDVYCFGKVLLELVTGKLGISASSDAQ 727
Query: 750 VKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMR 809
+KE EQ LP+ISIYDKELV KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKP+RRPLMR
Sbjct: 728 LKEFSEQILPFISIYDKELVIKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPSRRPLMR 787
Query: 810 YILKALENPLKVVREENSGSARLRTTSSRGSWNAALFGSWRQSSSDVAAIPVPPNTKAEG 869
YILKALENPLKVVREENSGSARLRTTSSR SWN +LFGSWR SSSDVA IP + + G
Sbjct: 788 YILKALENPLKVVREENSGSARLRTTSSR-SWNGSLFGSWRHSSSDVAVIPAASSARP-G 845
Query: 870 TSSLKQSGTTGSQGSGQIGGGEHSSSQRRQSRDIFPEPSDTQDVETQ 916
SS KQSGT+ SQGSGQ GGG+HSSS RR SR+IFPEP D +DVE Q
Sbjct: 846 GSSFKQSGTSNSQGSGQNGGGDHSSSHRRHSREIFPEPYDERDVEKQ 892
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356509565|ref|XP_003523518.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g16250-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1154 bits (2984), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 597/882 (67%), Positives = 693/882 (78%), Gaps = 12/882 (1%)
Query: 40 QQLERLSSRTELAALFELRSSLGLRRRDWPRKVDPCLVWNGVRCQNGSVVGINISGFRRT 99
+Q+E LSS E +L ELR+SLGLR ++WPRK DPCL+W G+ CQNG VVGINISGFRRT
Sbjct: 19 EQIEPLSSAEERESLLELRASLGLRSKEWPRKPDPCLIWVGITCQNGRVVGINISGFRRT 78
Query: 100 RLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIP 159
R+G +NP+FA DAL N T L +FNAS F+L G IPDW G LP+L+ LDLR CSI IP
Sbjct: 79 RIGRRNPQFAVDALANFTLLQTFNASNFVLSGPIPDWFGLSLPSLRVLDLRFCSIVDAIP 138
Query: 160 FSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSL 219
+LGNLTNLT LYLSDN L G +P +LGQL LSVLDLSRNSLTG++P SF L NLSSL
Sbjct: 139 STLGNLTNLTGLYLSDNNLIGNVPGTLGQLLALSVLDLSRNSLTGSVPASFAFLSNLSSL 198
Query: 220 DISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSG-SV 278
D+S+N+L+G++P G+GTLS+LQYLN+SNN LAS +PAQLG L SLVDLDLS NS G +
Sbjct: 199 DLSANFLSGAVPTGIGTLSRLQYLNLSNNGLAS-LPAQLGGLASLVDLDLSENSFVGVGL 257
Query: 279 PSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLR 338
P +L GLR+L++ ++ N+ LSG L LF LQ +VLRQN F+G P LWS+P+L
Sbjct: 258 PLDLTGLRNLRRMILANSMLSGVLPGRLFS--DSLQFLVLRQNNFSGSLPVELWSLPRLS 315
Query: 339 LLDISRNNFTGPLPNSRSNVNTSTVE-LNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRV 397
LD+S NNF+G LPNS S N +TV LNIS N FYGGLTP L RF VDLS NYFEG+V
Sbjct: 316 FLDVSANNFSGLLPNSSSAANNATVAVLNISHNKFYGGLTPALRRFAFVDLSSNYFEGKV 375
Query: 398 PEYVHSNASSLDSNCLQNVPNQRTLVDCSSFYAARGLSFDNFGRPNATQPPPP-ETSGDS 456
+++ + SLD NCLQN NQR+ V C+SFYA RGLSFDNFGRPN T+PP ++SG S
Sbjct: 376 LDFMRN--VSLDINCLQNATNQRSTVKCASFYAERGLSFDNFGRPNTTKPPAAAKSSGKS 433
Query: 457 NRKIIVLSAVLGGFGLIVLLVLLALLALCFCKKR-TPNQRGVGVGPVPAGSSLPPPGASI 515
N+ I+L+AVLGG GLI +LV L +L L +KR NQRG GVGP P GSS P PG I
Sbjct: 434 NKTKIILAAVLGGVGLIAILVFLLVLLLLCARKRGNSNQRGNGVGPAPVGSSPPNPGVPI 493
Query: 516 NFTNLGESFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEA 575
+F N+G+SFTY QLL ATGDF+DANLIK+GH+GD F G+LE GIP+VIKRID +S K EA
Sbjct: 494 DFPNVGDSFTYHQLLQATGDFNDANLIKHGHTGDFFNGVLESGIPIVIKRIDTRSAKKEA 553
Query: 576 YLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDL-QSL 634
YL ELDFF+KVSH R VPLLGHC E ENEKFLVYK PNGDLS+ LY K +ED QSL
Sbjct: 554 YLSELDFFNKVSHQRFVPLLGHCFENENEKFLVYKRTPNGDLSNCLYYKNTSEDGTSQSL 613
Query: 635 DWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694
DWITRLKIA GAAE LSYLHHEC P VHRD+QASSILLDDK+EVRLGSLSEVCAQ D
Sbjct: 614 DWITRLKIATGAAEALSYLHHECVPPIVHRDIQASSILLDDKYEVRLGSLSEVCAQEADI 673
Query: 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEIL 754
HQS+ITR LRLPQSSEQG+SGS T+ C YDVYCFGKVLLELVTGK+G+SA+S+A+VKE
Sbjct: 674 HQSKITRFLRLPQSSEQGTSGSSTSICAYDVYCFGKVLLELVTGKLGMSAASEAEVKEWF 733
Query: 755 EQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814
+Q LP IS+YDKELVTKIVDPS+++DED LEE+WA++IVARSCLNPKP+RRP MRY+LKA
Sbjct: 734 DQILPCISMYDKELVTKIVDPSMVVDEDFLEEIWAISIVARSCLNPKPSRRPPMRYVLKA 793
Query: 815 LENPLKVVREENSGSARLRTTSSRGSWNAALFGSWRQSSSDVAAIPVPPNTKAEGTSSLK 874
LENPLKVVREENS SARLR TSSRGSWNA LFGSWRQSSSDV P TK E SSLK
Sbjct: 794 LENPLKVVREENSSSARLRATSSRGSWNATLFGSWRQSSSDVTVTPAASGTKLERASSLK 853
Query: 875 QSGTTGSQGSGQI--GGGEHSSSQRRQSRDIFPEPSDTQDVE 914
SGTTGSQ G GGGE SSS+RR S++IFPEPS DVE
Sbjct: 854 LSGTTGSQSQGSFHNGGGEISSSRRRHSKEIFPEPSGVHDVE 895
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356517903|ref|XP_003527625.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g16250-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1147 bits (2968), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 598/880 (67%), Positives = 690/880 (78%), Gaps = 10/880 (1%)
Query: 40 QQLERLSSRTELAALFELRSSLGLRRRDWPRKVDPCLVWNGVRCQNGSVVGINISGFRRT 99
+Q E LSS E +L ELR SLGLR ++WPRK DPCL+W G+ CQNG VVGINISGFRRT
Sbjct: 19 EQNEPLSSVEERESLLELRGSLGLRSKEWPRKPDPCLIWVGITCQNGRVVGINISGFRRT 78
Query: 100 RLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIP 159
RLG +NP+FA DAL N T L SFNAS F LPGSIPDW G LP+L LDLRSCSI IP
Sbjct: 79 RLGRRNPQFAVDALANFTLLRSFNASNFPLPGSIPDWFGLSLPSLTVLDLRSCSIVDAIP 138
Query: 160 FSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSL 219
+LGNLTNLTSLYLSDN L G +P +LGQL LSVLDLSRNSLTG+IP SF L NLSSL
Sbjct: 139 STLGNLTNLTSLYLSDNNLIGNVPGTLGQLLALSVLDLSRNSLTGSIPASFAFLGNLSSL 198
Query: 220 DISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNS-LSGSV 278
D+S+N+L+G+IP G+GTLS+LQYLN+SNN L SS+PA+LG L SLVDLDLS NS + G +
Sbjct: 199 DMSANFLSGAIPTGIGTLSRLQYLNLSNNGL-SSLPAELGGLASLVDLDLSENSFVGGGL 257
Query: 279 PSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLR 338
P + LR+L++ ++ N+ L+G L LF LQ +VLRQN F+G P LWS+P+L
Sbjct: 258 PPDFTRLRNLRRMILANSMLTGALPGRLFS--DSLQFLVLRQNNFSGSLPVELWSLPRLS 315
Query: 339 LLDISRNNFTGPLPNSRSNVNTSTVE-LNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRV 397
LD+S NNF+G LPNS S N +T LNIS N FYGGLTP L RF VDLS NYFEG++
Sbjct: 316 FLDVSANNFSGLLPNSTSAANNATAAVLNISHNKFYGGLTPALRRFGFVDLSRNYFEGKI 375
Query: 398 PEYVHSNASSLDSNCLQNVPNQRTLVDCSSFYAARGLSFDNFGRPNATQPPPPETSGDSN 457
+Y+ + SLD NCLQ NQR+ ++C+SFYA RGLSFDNFG+PN T+PP E+SG SN
Sbjct: 376 LDYMLN--VSLDINCLQKATNQRSTMECASFYAERGLSFDNFGQPNTTKPPTAESSGKSN 433
Query: 458 RKIIVLSAVLGGFGLIVLLVLLALLALCFCKKR-TPNQRGVGVGPVPAGSSLPPPGASIN 516
+ I+L+AV GG GLI LLVLL +L L +KR NQRG GVGP P GSS P PG ++
Sbjct: 434 KTKIILAAVFGGVGLIALLVLLLVLLLLCARKRGNSNQRGNGVGPAPVGSSPPNPGVLVD 493
Query: 517 FTNLGESFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAY 576
F N+G+SFTY QLL ATGDF+DANLIK+GH+GD F G+LE GIPVVIKRID++S K EAY
Sbjct: 494 FPNVGDSFTYHQLLQATGDFNDANLIKHGHTGDFFNGVLESGIPVVIKRIDMRSTKKEAY 553
Query: 577 LLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTED-DLQSLD 635
L ELDFF+KVSH R VPLLGHC+E ENEKFLVYK M NGDLS+ LY K +ED LQSLD
Sbjct: 554 LSELDFFNKVSHQRFVPLLGHCLENENEKFLVYKRMTNGDLSNCLYYKNTSEDGTLQSLD 613
Query: 636 WITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAH 695
WITRLKIA GAAE LSYLHHEC P VHRD+QASSILLDDK+EVRLGSLSE CAQ GD H
Sbjct: 614 WITRLKIATGAAEALSYLHHECVPPIVHRDIQASSILLDDKYEVRLGSLSESCAQEGDIH 673
Query: 696 QSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILE 755
QS+ITR LRLPQSSEQG+SGS T+ C YDVYCFGKVLLELVTGK+G+SA+SD +VKE +
Sbjct: 674 QSKITRFLRLPQSSEQGTSGSSTSICVYDVYCFGKVLLELVTGKLGMSAASDTEVKEWFD 733
Query: 756 QTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815
Q LP IS+YDKELVTKIVDPS+++DED LEEVWA++IVARSCLNPKP+RRP MRY+LKAL
Sbjct: 734 QILPCISMYDKELVTKIVDPSMVVDEDFLEEVWAISIVARSCLNPKPSRRPPMRYVLKAL 793
Query: 816 ENPLKVVREENSGSARLRTTSSRGSWNAALFGSWRQSSSDVAAIPVPPNTKAEGTSSLKQ 875
ENPLKVVREENS SARLR TSSRGSWNA LFGSWRQSSSDV P TK E SSLK
Sbjct: 794 ENPLKVVREENSSSARLRATSSRGSWNATLFGSWRQSSSDVTLTPAASGTKLERASSLKL 853
Query: 876 SGTTGSQGSGQI-GGGEHSSSQRRQSRDIFPEPSDTQDVE 914
SGTTGSQ G GGE SS+RR S++I PEPS DVE
Sbjct: 854 SGTTGSQSQGSFHNGGEILSSRRRHSKEILPEPSGVHDVE 893
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462274|ref|XP_004148866.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g16250-like [Cucumis sativus] gi|449507355|ref|XP_004163008.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g16250-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1137 bits (2941), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 604/880 (68%), Positives = 710/880 (80%), Gaps = 12/880 (1%)
Query: 34 FEPTFEQQLERLSSRTELAALFELRSSLGLRRRDWPRKVDPCLVWNGVRCQNGSVVGINI 93
FEPTF+Q LSSR E AL LRSSLGLR +DWP K DPC VW G+ CQNG VVGIN+
Sbjct: 18 FEPTFQQ----LSSRAERVALLNLRSSLGLRSKDWPIKADPCSVWRGIECQNGRVVGINV 73
Query: 94 SGFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCS 153
SGFRRTRLGS +P+F DAL NLT L SFNAS FLLPG IPDW+G L +LQ LDLRSCS
Sbjct: 74 SGFRRTRLGSLHPQFVVDALANLTLLQSFNASNFLLPGVIPDWVGSTLKSLQVLDLRSCS 133
Query: 154 ISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLL 213
I G IP S GNLTNLT+LYLS+N L GTIP+S+GQL LSVLDLS N LTG+IP SF L
Sbjct: 134 ILGSIPLSFGNLTNLTALYLSNNKLNGTIPTSIGQLVQLSVLDLSHNELTGSIPLSFSSL 193
Query: 214 KNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNS 273
NLS LD+SSN L GSIPP +G++ +LQ LN+S+N++ SS+PA LGDL LVDLDLS N
Sbjct: 194 ANLSFLDLSSNGLDGSIPPLIGSIRQLQSLNLSSNNITSSLPASLGDLSRLVDLDLSFNK 253
Query: 274 LSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWS 333
SG +P++LR + SLQ+ VIGNN L G+L +LFP++ QLQ + L NGFTG PDVL+
Sbjct: 254 FSGLLPTDLRSMSSLQRMVIGNNLLGGSLPEDLFPSLRQLQELTLNDNGFTGAVPDVLFL 313
Query: 334 MPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYF 393
+P LRLLDIS NNFTG LPNS N++ LNIS+NMFYG L PV+GRF VDLSGNYF
Sbjct: 314 IPGLRLLDISGNNFTGMLPNSSLASNSTGGALNISRNMFYGSLMPVIGRFSAVDLSGNYF 373
Query: 394 EGRVPEYVHSNASSLDSNCLQNVPNQRTLVDCSSFYAARGLSFDNFGRPNATQPPPPETS 453
EGR+P +V +A SL+SNCLQNV +QRTL DCSSFYA +GLSFDNFG+PN+ QPP E S
Sbjct: 374 EGRIPNFVPRDA-SLESNCLQNVSSQRTLADCSSFYAEKGLSFDNFGKPNSVQPPLAEKS 432
Query: 454 GDSNRKIIVLSAVLGGFGLIVLLVLLALLALCFCKKRTP-NQRGVGVGPVPAGSSLPPPG 512
+N+++I L +V+GG G IVL++L+ LL L KR NQRGV VGP+P GSS PP G
Sbjct: 433 SKNNKRVI-LGSVIGGVGFIVLVLLVVLLFLYIGGKRASGNQRGVSVGPIPTGSSEPPSG 491
Query: 513 ASINFTNLGESFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK 572
SINF +LGESFT +QLL A+G SD NLIK GHSGDLFRG+L+ G VVIK+IDL++VK
Sbjct: 492 LSINFASLGESFTDKQLLQASGGLSDENLIKLGHSGDLFRGVLDNGANVVIKKIDLRTVK 551
Query: 573 TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDD-L 631
E YL+ELD FSKVSH RLVP LGHC++ E+EK+LVYK+MPNGDL+SSL RKTN +D+ +
Sbjct: 552 KETYLVELDLFSKVSHTRLVPFLGHCLDNEHEKYLVYKHMPNGDLASSLVRKTNVDDENI 611
Query: 632 QSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691
QSLDWITRLKIA+GAAEGL+Y+HHEC+ P VHRDVQASSILLDDKFEVRLGSLSEVCAQ
Sbjct: 612 QSLDWITRLKIALGAAEGLAYMHHECSPPLVHRDVQASSILLDDKFEVRLGSLSEVCAQD 671
Query: 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVK 751
GD+HQ+RI+RLLRLPQSSEQGSSGS T+ C YDVYCFGKVLLELVTGK+GISA+ D Q++
Sbjct: 672 GDSHQNRISRLLRLPQSSEQGSSGSQTSICSYDVYCFGKVLLELVTGKVGISATPDTQLR 731
Query: 752 EILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYI 811
E +QT PYISI+DKELV+KI+DP+LI+DED LEEVWAMA+VA+SCLNPKP+RRP MRYI
Sbjct: 732 EFYDQTFPYISIHDKELVSKIIDPNLIVDEDFLEEVWAMAVVAKSCLNPKPSRRPQMRYI 791
Query: 812 LKALENPLKVVREENSGSARLRTTSSRGSWNAALFGSWRQSSSDVAAIPVPPNTKAEGTS 871
LKALENPLKVVREE+SGSARLR TSSR SWNAALFGSWRQS SD+ +P ++ G
Sbjct: 792 LKALENPLKVVREESSGSARLRATSSR-SWNAALFGSWRQSLSDLTIVPAAAMSRTVG-G 849
Query: 872 SLKQSGTTGSQGSGQIGGGEHSSSQRRQSRDIFPEPSDTQ 911
S KQSGT+GSQGSGQ GE +S+RR S++IFPEP D Q
Sbjct: 850 SFKQSGTSGSQGSGQNNSGE--ASRRRHSKEIFPEPPDEQ 887
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225458279|ref|XP_002281409.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g16250-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1115 bits (2885), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 577/877 (65%), Positives = 687/877 (78%), Gaps = 9/877 (1%)
Query: 45 LSSRTELAALFELRSSLGLRRRDWPRKVDPCLVWNGVRCQNGSVVGINISGFRRTRLGSQ 104
L + TE +ALF+LRSSLGLR +DWPR+ +PC W GV CQNG VVGI++SG +RT G
Sbjct: 32 LRNDTERSALFDLRSSLGLRAKDWPRRSEPCWNWTGVACQNGRVVGISVSGLQRTHAGRV 91
Query: 105 NPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGN 164
NP+FA D+L NL+ LA+FN+S F LPGSIPDWLGQ L LQ LDLRS S+ G IP SLG+
Sbjct: 92 NPQFAVDSLANLSLLATFNSSGFELPGSIPDWLGQSLSALQVLDLRSASVKGPIPQSLGS 151
Query: 165 LTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSN 224
L +L SLYLS N LTG IPS LGQLS LSVL+LS+NSLTG+IP +F L NL+SLD+SSN
Sbjct: 152 LGSLHSLYLSGNSLTGAIPSQLGQLSALSVLNLSQNSLTGSIPQTFSTLSNLTSLDLSSN 211
Query: 225 YLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRG 284
YL+GS+P GL L+KLQ+LN+S+N L +SIP QLG L LV+LDLS+N+L G+VP +L G
Sbjct: 212 YLSGSVPSGLANLTKLQFLNLSSNILTASIPNQLGQLFQLVELDLSLNNLMGTVPVDLGG 271
Query: 285 LRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISR 344
LRSLQK ++GNN L G+LS LF +++LQ +VL N G P VLWSM +LR LD+S
Sbjct: 272 LRSLQKMLLGNNGLQGSLSDKLFSNLTRLQFLVLSDNKIEGDIPGVLWSMHELRFLDVSG 331
Query: 345 NNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSN 404
NNFTG L N NVN++ N+S N+FYG L LG+F L+DLSGNYF+G+VP + +N
Sbjct: 332 NNFTGVLANLSWNVNSTNTMFNLSNNLFYGALPTPLGKFSLIDLSGNYFQGKVPNDIETN 391
Query: 405 ASSLDSNCLQNVPNQRTLVDCSSFYAARGLSFDNFGRPNATQPPPPETSGDSNRK-IIVL 463
+SL+ NCLQ+V +QR+L DC FYA R LSFDNFG P+ QPP P +S +S+++ I +L
Sbjct: 392 -TSLNRNCLQSVLDQRSLEDCRLFYAERNLSFDNFGAPSPAQPPLPGSSTNSSKRWIFIL 450
Query: 464 SAVLGGFGLIVLLVLLALLALCFCKKRTPNQRGVG-VGPVPAGSSLPPPGASINFTNLGE 522
+ GG G IVLLVL+ +L + C KR +QR + VGP P G S P SINF+ +G+
Sbjct: 451 VGLFGGLGFIVLLVLVLVLLIRRCDKRIASQREIANVGPAPEGRSPLPAKVSINFSGVGD 510
Query: 523 SFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDF 582
FTY+Q+L T FS+ NLIK+GHSGDLFRGILE G PVV+KR+DL+++K E+Y++ELD
Sbjct: 511 LFTYEQILCYTDGFSEINLIKHGHSGDLFRGILESGAPVVVKRVDLRALKKESYMMELDV 570
Query: 583 FSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDD-LQSLDWITRLK 641
+KVSH RLVPLLGHC+E ++EK LVYKYMPNGDLS+SLYR TN EDD LQSLDWITRLK
Sbjct: 571 LNKVSHMRLVPLLGHCLEHDSEKLLVYKYMPNGDLSNSLYRVTNLEDDNLQSLDWITRLK 630
Query: 642 IAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITR 701
IAIGAAEGLSYLHHEC+ P VHRDVQASSILLDDKFEVRLGSLSEVCAQ GD+HQ+ IT+
Sbjct: 631 IAIGAAEGLSYLHHECSPPLVHRDVQASSILLDDKFEVRLGSLSEVCAQEGDSHQNVITK 690
Query: 702 LLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYI 761
LLR PQ+SEQGSSG L+ATC YDVYCFGKVLLELVTGK+GIS S DA +E LE TLP I
Sbjct: 691 LLRKPQTSEQGSSGLLSATCAYDVYCFGKVLLELVTGKLGISKSDDATTREWLEHTLPCI 750
Query: 762 SIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLKV 821
SIYDKELVTKIVDPSLI+DEDLLEEVWAMAIVARSCLNPKP+RRPLMR ILKALENPLKV
Sbjct: 751 SIYDKELVTKIVDPSLIVDEDLLEEVWAMAIVARSCLNPKPSRRPLMRNILKALENPLKV 810
Query: 822 VREENSGSARLRTTSSRGSWNAALFGSWRQSSSDVAAIPVPPNTKAEGTSSLKQSGTTGS 881
VREE+S SARLRTTSSR SW+ A FGSWR SSS+ A +P N EG S KQSG GS
Sbjct: 811 VREESSSSARLRTTSSRRSWSTAFFGSWRHSSSEGAIVPGQINR--EGISGSKQSGRVGS 868
Query: 882 QGSGQIGGGEHSSSQRRQSRDIFPEPSDTQDVETQVQ 918
QGS GG + SSS +R S +IFPEP D QD+E Q Q
Sbjct: 869 QGS---GGNDLSSSHKRSSNEIFPEPVDMQDIERQDQ 902
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449496837|ref|XP_004160239.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g16250-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1077 bits (2786), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 589/889 (66%), Positives = 699/889 (78%), Gaps = 6/889 (0%)
Query: 35 EPTFEQQLERLSSRTELAALFELRSSLGLRRRDWPRKVDPCLVWNGVRCQNGSVVGINIS 94
EPTF+QQ S E AL ELRSSLGLR ++WP K DPCL W G++CQNG V INI+
Sbjct: 22 EPTFQQQGSLRSLPAERVALLELRSSLGLRSKEWPIKSDPCLGWKGIKCQNGRVTEINIA 81
Query: 95 GFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSI 154
GFRRTR+G NP+F+ +AL NLT L FNAS FLLPG +P+W GQ+L LQ LDLRSCSI
Sbjct: 82 GFRRTRIGRLNPQFSVEALGNLTFLQFFNASNFLLPGVVPEWFGQRLSLLQVLDLRSCSI 141
Query: 155 SGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLK 214
G IP SLG+L NLT+LYLSDN LTGTIPS+ QL LS+LDLS N+LTG IP+ G L
Sbjct: 142 FGSIPLSLGSLNNLTALYLSDNKLTGTIPSTFSQLLSLSLLDLSHNTLTGMIPSLIGSLA 201
Query: 215 NLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSL 274
LS LD+SSNYL G IPP G L KLQYLN+S+NSL+SSIP QLG L SLVDLDLS+N+L
Sbjct: 202 QLSLLDLSSNYLAGPIPPSTGGLLKLQYLNLSSNSLSSSIPTQLGGLVSLVDLDLSVNAL 261
Query: 275 SGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSM 334
SG +P +L L SL+ V+ +N L G+L+ NLF T++QLQ + L+ N FTG P+VLWSM
Sbjct: 262 SGPLPLDLSELTSLRNVVLASNLLVGSLTDNLFHTLTQLQSLDLKHNNFTGSIPEVLWSM 321
Query: 335 PQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFE 394
P L+LLD+S N+FTG LPNS S++N + LN+S+NM YG LTPVL RF +DLS NYFE
Sbjct: 322 PGLQLLDLSGNSFTGKLPNSSSSLNVTGAVLNVSKNMIYGNLTPVLRRFSAIDLSENYFE 381
Query: 395 GRVPEYVHSNASSLDSNCLQNVPNQRTLVDCSSFYAARGLSFDNFGRPNATQPPPPET-S 453
G+VPEY+ +N S SNCLQNV QRTL C+SFY ARGL+FDNFG P ATQPP E
Sbjct: 382 GKVPEYLPTNI-SFASNCLQNVSRQRTLDVCTSFYLARGLTFDNFGFPKATQPPLAEAPK 440
Query: 454 GDSNRKIIVLSAVLGGFGLIVLLVLLALLALCFCKKRTPNQR-GVGVGPVPAGSSLP-PP 511
SNR I+L +V+GG I LLVLL + L + T NQR GV VGP +G + PP
Sbjct: 441 KKSNRNAIILGSVIGGTAFIFLLVLLIFIFLRRRTRSTTNQRGGVVVGPDLSGDTAETPP 500
Query: 512 GASINFTNLGESFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSV 571
G I+F +LGE+F QQLL AT DFSD+NLIK+GHSGDL+ G+L+ GI +VIKR+DL+ +
Sbjct: 501 GLLIDFASLGETFKLQQLLQATNDFSDSNLIKHGHSGDLYHGVLQNGIRIVIKRVDLRVI 560
Query: 572 KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDD- 630
K +AYL+EL+FFSKVS+ RLVPL GHC+E ++EKFLVYKY+PNGDLS+SL++K T+DD
Sbjct: 561 KNDAYLVELEFFSKVSNVRLVPLTGHCLENDDEKFLVYKYLPNGDLSASLFKKVKTDDDG 620
Query: 631 LQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690
LQSLDWITRLKIA+GAAEGLS+LHH+CT P VHRDVQASSILLDDKFEVRLGSLS VC+Q
Sbjct: 621 LQSLDWITRLKIALGAAEGLSFLHHDCTPPLVHRDVQASSILLDDKFEVRLGSLSNVCSQ 680
Query: 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV 750
GD QSRIT+LL+LPQSSEQGS G TA C YDVYCFGKVLLELVTGK+GISAS +A++
Sbjct: 681 EGDGQQSRITKLLKLPQSSEQGSLGLHTAVCTYDVYCFGKVLLELVTGKLGISASPEAEI 740
Query: 751 KEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRY 810
KE L+QTL ISI +KELVTKI+DPSLI+DEDLLEEVWA+A+VA+SCLNPKP+RRPLM+Y
Sbjct: 741 KEWLDQTLSCISINNKELVTKILDPSLIVDEDLLEEVWAVAVVAKSCLNPKPSRRPLMKY 800
Query: 811 ILKALENPLKVVREENSGSARLRTTSSRGSWNAALFGSWRQSSSDVAAIPVPPNTKAEGT 870
ILKALENPLKVVREENSGS R R+TS SWNAALFGSWRQS SD+ +P KA G
Sbjct: 801 ILKALENPLKVVREENSGSGRFRSTSIGSSWNAALFGSWRQSLSDLTVLPSASLLKA-GG 859
Query: 871 SSLKQSGTTGSQGSGQIGGGEHSSSQRRQSRDIFPEPSDTQDVETQVQD 919
SS K+SGT GSQGSGQ GGGEHSSS+R+ S++IFPEPSD QD+E D
Sbjct: 860 SSFKRSGTMGSQGSGQNGGGEHSSSRRQHSKEIFPEPSDVQDIERLEND 908
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463390|ref|XP_004149417.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g16250-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1077 bits (2785), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 589/889 (66%), Positives = 698/889 (78%), Gaps = 6/889 (0%)
Query: 35 EPTFEQQLERLSSRTELAALFELRSSLGLRRRDWPRKVDPCLVWNGVRCQNGSVVGINIS 94
EPTF+QQ S E AL ELRSSLGLR ++WP K DPCL W G++CQNG V INI+
Sbjct: 22 EPTFQQQGSLRSLPAERVALLELRSSLGLRSKEWPIKSDPCLGWKGIKCQNGRVTEINIA 81
Query: 95 GFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSI 154
GFRRTR+G NP+F+ +AL NLT L SFNAS FLLPG +P+W GQ+L LQ LDLRSCSI
Sbjct: 82 GFRRTRIGRLNPQFSVEALGNLTFLQSFNASNFLLPGVVPEWFGQRLSLLQVLDLRSCSI 141
Query: 155 SGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLK 214
G IP SLG+L NLT+LYLSDN LTGTIPS+ QL LS+LDLS N+LTG IP+ G L
Sbjct: 142 FGSIPLSLGSLNNLTALYLSDNKLTGTIPSTFSQLLSLSLLDLSHNTLTGMIPSLIGSLA 201
Query: 215 NLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSL 274
LS LD+SSNYL G IPP G L KLQYLN+S+NSL+SSIP QLG L SLVDLD S+N+L
Sbjct: 202 QLSLLDLSSNYLAGPIPPSTGGLLKLQYLNLSSNSLSSSIPTQLGGLVSLVDLDFSVNAL 261
Query: 275 SGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSM 334
SG +P +L L SL+ V+ +N L G+L+ NLF T++QLQ + L+ N FTG P+VLWSM
Sbjct: 262 SGPLPLDLSELTSLRNVVLASNLLVGSLTDNLFHTLTQLQSLDLKHNNFTGSIPEVLWSM 321
Query: 335 PQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFE 394
P L+LLD+S N+FTG LPNS S++N + LN+S+NM YG LTPVL RF +DLS NYFE
Sbjct: 322 PGLQLLDLSGNSFTGKLPNSSSSLNVTGAVLNVSKNMIYGNLTPVLRRFSAIDLSENYFE 381
Query: 395 GRVPEYVHSNASSLDSNCLQNVPNQRTLVDCSSFYAARGLSFDNFGRPNATQPPPPET-S 453
G+VPEY+ +N S SNCLQNV QRTL C+SFY ARGL+FDNFG P ATQPP E
Sbjct: 382 GKVPEYLPTNI-SFASNCLQNVSRQRTLDVCTSFYLARGLTFDNFGFPKATQPPLAEAPK 440
Query: 454 GDSNRKIIVLSAVLGGFGLIVLLVLLALLALCFCKKRTPNQR-GVGVGPVPAGSSLP-PP 511
SNR I+L +V+GG I LLVLL + L + T NQR GV VGP +G + PP
Sbjct: 441 KKSNRNAIILGSVIGGTAFIFLLVLLIFIFLRRRTRSTTNQRGGVVVGPDLSGDTAETPP 500
Query: 512 GASINFTNLGESFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSV 571
G I+F +LGE+F QQLL AT DFSD+NLIK+GHSGDL+ G+L+ GI +VIKR+DL+ +
Sbjct: 501 GLLIDFASLGETFKLQQLLQATNDFSDSNLIKHGHSGDLYHGVLQNGIRIVIKRVDLRVI 560
Query: 572 KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDD- 630
K AYL+EL+FFSKVS+ RLVPL GHC+E ++EKFLVYKY+PNGDLS+SL++K T+DD
Sbjct: 561 KNNAYLVELEFFSKVSNVRLVPLTGHCLENDDEKFLVYKYLPNGDLSASLFKKVKTDDDG 620
Query: 631 LQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690
LQSLDWITRLKIA+GAAEGLS+LHH+CT P VHRDVQASSILLDDKFEVRLGSLS VC+Q
Sbjct: 621 LQSLDWITRLKIALGAAEGLSFLHHDCTPPLVHRDVQASSILLDDKFEVRLGSLSNVCSQ 680
Query: 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV 750
GD QSRIT+LL+LPQSSEQGS G TA C YDVYCFGKVLLELVTGK+GISAS +A++
Sbjct: 681 EGDGQQSRITKLLKLPQSSEQGSLGLHTAVCTYDVYCFGKVLLELVTGKLGISASPEAEI 740
Query: 751 KEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRY 810
KE L+QTL ISI +KELVTKI+DPSLI+DEDLLEEVWA+A+VA+SCLNPKP+RRPLM+Y
Sbjct: 741 KEWLDQTLSCISINNKELVTKILDPSLIVDEDLLEEVWAVAVVAKSCLNPKPSRRPLMKY 800
Query: 811 ILKALENPLKVVREENSGSARLRTTSSRGSWNAALFGSWRQSSSDVAAIPVPPNTKAEGT 870
ILKALENPLKVVREENSGS R R+TS SWNAALFGSWRQS SD+ +P KA G
Sbjct: 801 ILKALENPLKVVREENSGSGRFRSTSIGSSWNAALFGSWRQSLSDLTVLPSASLLKA-GG 859
Query: 871 SSLKQSGTTGSQGSGQIGGGEHSSSQRRQSRDIFPEPSDTQDVETQVQD 919
SS K+SGT GSQGSGQ GGGEHSSS+R+ S++IFPEPSD QD+E D
Sbjct: 860 SSFKRSGTMGSQGSGQNGGGEHSSSRRQHSKEIFPEPSDVQDIERLEND 908
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297836662|ref|XP_002886213.1| hypothetical protein ARALYDRAFT_480795 [Arabidopsis lyrata subsp. lyrata] gi|297332053|gb|EFH62472.1| hypothetical protein ARALYDRAFT_480795 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1060 bits (2740), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 551/855 (64%), Positives = 664/855 (77%), Gaps = 16/855 (1%)
Query: 17 MVDQRSVVMFFVMFLL---LFEPTFEQQLERLSSRTELAALFELRSSLGLRRRDWPRKVD 73
MVDQR + FV+ +L LF+ Q + + +E L LRSSLGLR DWP K D
Sbjct: 1 MVDQRRSALGFVLLMLCLVLFDGVVVGQTQ--TRFSEKLILLNLRSSLGLRGTDWPIKGD 58
Query: 74 PCLVWNGVRCQNGSVVGINISGFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSI 133
PC+VW G++C+NGS++GINISGFRRTR+G QNP+FA D L NLT L+ FNAS LPG+I
Sbjct: 59 PCVVWRGIQCENGSIIGINISGFRRTRIGKQNPQFAVDPLRNLTRLSYFNASGLALPGTI 118
Query: 134 PDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLS 193
P+W G L LQ LDL SCS+SGVIPF+LGNLT+L +L LS N LT +PSSLGQL LS
Sbjct: 119 PEWFGVSLLALQVLDLSSCSVSGVIPFTLGNLTSLRTLNLSQNSLTSLVPSSLGQLLNLS 178
Query: 194 VLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASS 253
LDLSRNSLTG +P SF LKNL +LD+SSNYLTG IPPGLGTLSKL +LN S+NS +S
Sbjct: 179 ELDLSRNSLTGILPQSFSSLKNLLTLDVSSNYLTGPIPPGLGTLSKLLHLNFSSNSFSSP 238
Query: 254 IPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQL 313
IP +LGDL +LVD DLS+NSLSGSVP ELR LR+LQ IG+N LSG L V+LF SQL
Sbjct: 239 IPPELGDLVNLVDFDLSINSLSGSVPQELRKLRNLQLMAIGDNLLSGTLPVDLFSAESQL 298
Query: 314 QIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFY 373
Q +VLR+NGF+G PDV WS+P+LR+LDI++NNFTG LPNS S + ++IS N FY
Sbjct: 299 QTLVLRENGFSGSLPDVCWSLPKLRILDIAKNNFTGMLPNSSSYPDQLAEMVDISSNTFY 358
Query: 374 GGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASSLDSNCLQNVPNQRTLVDCSSFYAARG 433
G LTP+L RFR VDLSGNYFEG+VP+YV S+ SNCLQN Q+ CS+FY +RG
Sbjct: 359 GELTPILRRFREVDLSGNYFEGKVPDYVTGENVSVTSNCLQNERRQKPSAICSAFYKSRG 418
Query: 434 LSFDNFGRPNATQPPPPE-TSGDSNRKIIVLSAVLGGFGLIVLLVLL-ALLALCFCKKRT 491
L FD+FGRPN+TQP +SG S+R +I+L AV GG G I++ V+L +L LC +R
Sbjct: 419 LHFDDFGRPNSTQPTSKNASSGISHRTVIIL-AVAGGVGFILIFVILPIILVLCIRHRRR 477
Query: 492 PNQRGVGVGPVPAG--SSLPPPGA-SINFTNLGESFTYQQLLAATGDFSDANLIKNGHSG 548
QRG P PAG S PP GA + + + LG +F+Y+QLL AT +F+DANLIK+GHSG
Sbjct: 478 AAQRGNNDRPKPAGEASQQPPKGAQTFDLSRLGNAFSYEQLLQATEEFNDANLIKHGHSG 537
Query: 549 DLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608
+ FRG LE GIPVVIK+ID++ K+E Y+ EL+ FSK H RLVP LGHC+E E++KFLV
Sbjct: 538 NFFRGFLENGIPVVIKKIDVRESKSEGYISELELFSKAGHQRLVPFLGHCLENESQKFLV 597
Query: 609 YKYMPNGDLSSSLYRKTNTE-DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQ 667
YK+M +GDL+SSL+RK+ E D L+SLDWITRLKIA+GAAEGLSY HHEC+ P VHRDVQ
Sbjct: 598 YKFMRHGDLASSLFRKSENEGDGLKSLDWITRLKIALGAAEGLSYFHHECSPPLVHRDVQ 657
Query: 668 ASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYC 727
ASSILLDDKFEVRLGSLSEV AQ GDA+QSRI+RLLRLPQS+E SSG+ ATC YDVYC
Sbjct: 658 ASSILLDDKFEVRLGSLSEVYAQ-GDAYQSRISRLLRLPQSTEPSSSGATNATCSYDVYC 716
Query: 728 FGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEV 787
FGKVLLELVTGK+GIS+ +A KE +E+ LPYIS +KELVTKI+DPSL++DEDLLEEV
Sbjct: 717 FGKVLLELVTGKLGISSPDNALAKEYMEEALPYISTNEKELVTKILDPSLMVDEDLLEEV 776
Query: 788 WAMAIVARSCLNPKPTRRPLMRYILKALENPLKVVREEN---SGSARLRTTSSRGSWNAA 844
WAMAI+A+SCLNPKPTRRPLMR+I+ ALENPLKVVRE+ SGS+RLRT SSRGSWNAA
Sbjct: 777 WAMAIIAKSCLNPKPTRRPLMRHIVNALENPLKVVREDTNSGSGSSRLRTNSSRGSWNAA 836
Query: 845 LFGSWRQSSSDVAAI 859
+FGSWRQS+SDV A+
Sbjct: 837 IFGSWRQSASDVTAV 851
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 919 | ||||||
| TAIR|locus:2042599 | 915 | AT2G16250 [Arabidopsis thalian | 0.934 | 0.938 | 0.556 | 9.3e-249 | |
| TAIR|locus:2136313 | 864 | AT4G39270 [Arabidopsis thalian | 0.762 | 0.811 | 0.518 | 1.2e-177 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.373 | 0.273 | 0.317 | 1e-63 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.304 | 0.216 | 0.335 | 1.3e-61 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.746 | 0.549 | 0.279 | 8.6e-60 | |
| TAIR|locus:2032697 | 1123 | PEPR1 "PEP1 receptor 1" [Arabi | 0.331 | 0.271 | 0.308 | 2.4e-58 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.309 | 0.248 | 0.348 | 1.9e-57 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.325 | 0.266 | 0.294 | 6.6e-57 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.299 | 0.249 | 0.302 | 7.5e-57 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.342 | 0.281 | 0.326 | 4.4e-56 |
| TAIR|locus:2042599 AT2G16250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2396 (848.5 bits), Expect = 9.3e-249, P = 9.3e-249
Identities = 486/873 (55%), Positives = 594/873 (68%)
Query: 49 TELAALFELRSSLGLRRRDWPRKVDPCLVWNGVRCQNGSVVGINISGFRRTRLGSQNPRF 108
+E L LRSSLGLR DWP K DPC+ W G++C+NGS++GINISGFRRTR+G NP+F
Sbjct: 35 SEKLILLNLRSSLGLRGTDWPIKGDPCVDWRGIQCENGSIIGINISGFRRTRIGKLNPQF 94
Query: 109 AADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNL 168
+ D L NLT L+ FNAS LPG+IP+W G L L+ LDL SCS++GV+PF+LGNLT+L
Sbjct: 95 SVDPLRNLTRLSYFNASGLALPGTIPEWFGVSLLALEVLDLSSCSVNGVVPFTLGNLTSL 154
Query: 169 TSLYLSDNGLTGTIPXXXXXXXXXXXXXXXXXXXTGNIPTSFGLLKNLSSLDISSNYLTG 228
+L LS N LT +P TG +P SF LKNL +LD+SSNYLTG
Sbjct: 155 RTLNLSQNSLTSLVPSSLGQLLNLSQLDLSRNSFTGVLPQSFSSLKNLLTLDVSSNYLTG 214
Query: 229 SIPPGLGTLSKLQYLNVSNNSLASSIPAQXXXXXXXXXXXXXXXXXXGSVPSELRGLRSL 288
IPPGLG LSKL +LN S+NS +S IP++ GSVP ELR L L
Sbjct: 215 PIPPGLGALSKLIHLNFSSNSFSSPIPSELGDLVNLVDFDLSINSLSGSVPQELRKLSKL 274
Query: 289 QKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFT 348
Q IG+N LSG L V+LF SQLQ +VLR+NGF+G PDV WS+P+LR+LDI++NNFT
Sbjct: 275 QLMAIGDNLLSGTLPVDLFSAESQLQTLVLRENGFSGSLPDVCWSLPKLRILDIAKNNFT 334
Query: 349 GPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASSL 408
G LP S + + ++IS N FYG LTP+L RFR++DLSGNYFEG++P+YV S+
Sbjct: 335 GLLPYSSYDSDQIAEMVDISSNTFYGELTPILRRFRIMDLSGNYFEGKLPDYVTGENVSV 394
Query: 409 DSNCLQNVPNQRTLVDCSSFYAARGLSFDNFGRPNATQPPPPE-TSGDSNRKIIVLSXXX 467
SNCL+N Q+ C++FY +RGL FD+FGRPN TQP +SG S R +I+L+
Sbjct: 395 TSNCLRNERRQKPSAICAAFYKSRGLDFDDFGRPNLTQPTSKNASSGISRRTVIILAAVG 454
Query: 468 XXXXXXXXXXXX-XXXXXCFCKKRTPNQRXXXXXXXXXXXXXXX---XXXXINFTNLGES 523
C +R QR + + LG +
Sbjct: 455 GGVAFILLFVILPIILVLCMRHRRRAAQRGNNDRPKPAGEASQQPPKGAQTFDLSRLGNA 514
Query: 524 FTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFF 583
F+Y+QLL AT +F+DANLIK GHSG+LFRG LE GIPVVIK+ID++ K+E Y+ EL+ F
Sbjct: 515 FSYEQLLQATEEFNDANLIKRGHSGNLFRGFLENGIPVVIKKIDVREGKSEGYISELELF 574
Query: 584 SKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDD-LQSLDWITRLKI 642
SK H RLVP LGHC+E E++KFLVYK+M +GDL+SSL+RK+ E D L+SLDWITRLKI
Sbjct: 575 SKAGHQRLVPFLGHCLENESQKFLVYKFMRHGDLASSLFRKSENEGDGLKSLDWITRLKI 634
Query: 643 AIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRL 702
A+GAAEGLSYLHHEC+ P VHRDVQASSILLDDKFEVRLGSLSE AQG DA+QSRI+RL
Sbjct: 635 ALGAAEGLSYLHHECSPPLVHRDVQASSILLDDKFEVRLGSLSEAYAQG-DAYQSRISRL 693
Query: 703 LRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYIS 762
LRLPQSSE SSG A C YDVYCFGKVLLELVTGK+GIS+ +A KE +E+ LPYIS
Sbjct: 694 LRLPQSSEPSSSGVTNAICSYDVYCFGKVLLELVTGKLGISSPDNALAKEYMEEALPYIS 753
Query: 763 IYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLKVV 822
+KELVTKI+DPSL++DEDLLEEVWAMAI+A+SCLNPKPTRRPLMR+I+ ALENPLKVV
Sbjct: 754 TNEKELVTKILDPSLMVDEDLLEEVWAMAIIAKSCLNPKPTRRPLMRHIVNALENPLKVV 813
Query: 823 REEN---SGSARLRTTSSRGSWNAALFGSWRQSSSDVAAIPVPPNTKAEXXXXXXXXXXX 879
RE+ SGS+RLRT SSRGSWNAA+FGSWRQS+SDV A+ T
Sbjct: 814 REDTNSGSGSSRLRTNSSRGSWNAAIFGSWRQSASDVTAVQAGATTSGGGGGGGGNGLRN 873
Query: 880 XXXXXXXXXXXX----XXXXXRRQSRDIFPEPS 908
RRQS +I PEP+
Sbjct: 874 SGSQGSSGRNNNNNGNSSSSRRRQSSEIVPEPA 906
|
|
| TAIR|locus:2136313 AT4G39270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1725 (612.3 bits), Expect = 1.2e-177, P = 1.2e-177
Identities = 374/722 (51%), Positives = 476/722 (65%)
Query: 154 ISGVIPFSLGN-LTNLTSLYLSDNGLTGTIPXXXXXXXXXXXXXXXXXXXTGNIPTSFGL 212
+ G IP G+ L L L LS +TGTIP G+IP S
Sbjct: 113 LPGPIPALFGSSLLTLEVLDLSSCSITGTIPESLTRLSHLKVLDLSKNAINGDIPLSLTS 172
Query: 213 LKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQXXXXXXXXXXXXXXX 272
L+NLS LD+SSN + GSIP +G LSKLQ LN+S N+L SSIP
Sbjct: 173 LQNLSILDLSSNSVFGSIPANIGALSKLQRLNLSRNTLTSSIPPSLGDLSVLIDLDLSFN 232
Query: 273 XXXGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLW 332
GSVPS+L+GLR+LQ VI N LSG+L +LF +S+LQII R +GF G P LW
Sbjct: 233 GMSGSVPSDLKGLRNLQTLVIAGNRLSGSLPPDLFSLLSKLQIIDFRGSGFIGALPSRLW 292
Query: 333 SMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNY 392
S+P+L+ LDIS N+F+ LPN+ + +++ LNIS NMFYG LT +L RF++VDLS NY
Sbjct: 293 SLPELKFLDISGNHFSDMLPNTTVSFDSTVSMLNISGNMFYGNLTLLLTRFQVVDLSENY 352
Query: 393 FEGRVPEYVHSNASSLDSNCLQNVPNQRTLVDCSSFYAARGLSFDNFGRPNATQPPPPET 452
FEG++P++V + AS L +NCLQ QR L DC+ FY+ +GL+F+NFG+ + +T
Sbjct: 353 FEGKIPDFVPTRAS-LSNNCLQGPEKQRKLSDCTLFYSKKGLTFNNFGQHE--EKKSSKT 409
Query: 453 SGDSNRKIIVLSXXXXXXXXXXXXXXXXXXXXCFCKKR-----TPNQRXXXXXXXX---- 503
S S+ KI++L+ FC +R T N
Sbjct: 410 SWLSHTKIVILAAVGGSILLMLILIVLPITVS-FCVRRRNRSSTSNHPRGRHNGVGPLPP 468
Query: 504 XXXXXXXXXXXINFTNLGESFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVI 563
INF +LG SFTYQQLL AT +FSD+NLIK G SGDLF+G+LE G+ +V+
Sbjct: 469 DETLPSRGGVSINFGSLGSSFTYQQLLNATKEFSDSNLIKKGQSGDLFKGVLENGVQIVV 528
Query: 564 KRIDLQSVKT-EAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLY 622
KRI L+S K EAYL ELDFFS+ +H R++P +G +E KFLVYKYM N DL SSL+
Sbjct: 529 KRISLESTKNNEAYLTELDFFSRFAHPRIIPFVGKSLESATHKFLVYKYMLNRDLPSSLF 588
Query: 623 RKTNT--EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVR 680
K+N+ ++ L+SLDWITRLKIA+G AEGL+YLHH+C+ VHRD+QASSILLDDKFEVR
Sbjct: 589 YKSNSLVDNGLRSLDWITRLKIALGVAEGLAYLHHDCSPSVVHRDIQASSILLDDKFEVR 648
Query: 681 LGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSL-TATCPYDVYCFGKVLLELVTGK 739
LGS S+ C Q + +I RLLRL QSS++ GS TATC YDVYCFGK+LLEL+TGK
Sbjct: 649 LGSFSKACHQENNGRPRKIARLLRLSQSSQESVPGSAATATCAYDVYCFGKILLELITGK 708
Query: 740 MGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLN 799
+GIS+ + Q K+IL + +PYIS +KE V I+D SL++DEDLLEEVWAMAIVARSCLN
Sbjct: 709 LGISSCKETQFKKILTEIMPYISSQEKEPVMNILDQSLLVDEDLLEEVWAMAIVARSCLN 768
Query: 800 PKPTRRPLMRYILKALENPLKVVREENSGSARLRTT-SSRGSWNAA-LFGSWRQSSSD-V 856
PKPTRRPLMR+I++ALENPL+VVRE++S S R RTT SSRGS ++ +FGSWRQS SD V
Sbjct: 769 PKPTRRPLMRHIVQALENPLRVVREDSSESERFRTTGSSRGSSSSGRIFGSWRQSVSDPV 828
Query: 857 AA 858
AA
Sbjct: 829 AA 830
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 390 (142.3 bits), Expect = 1.0e-63, Sum P(2) = 1.0e-63
Identities = 115/362 (31%), Positives = 165/362 (45%)
Query: 48 RTELAALFELRSSLGLRR------RDWPRKVDPCLVWNGVRCQNGSVVGINISGFRRTRL 101
R +L L EL++S RDW W GV C ++G+N+SG T
Sbjct: 27 RDDLQTLLELKNSFITNPKEEDVLRDWNSGSPSYCNWTGVTCGGREIIGLNLSGLGLT-- 84
Query: 102 GSQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFS 161
GS +P NL H+ +++R L G IP L +L++L L S +SG IP
Sbjct: 85 GSISPSIGR--FNNLIHI-DLSSNR--LVGPIPTTLSNLSSSLESLHLFSNLLSGDIPSQ 139
Query: 162 LGNLTNLTSLYLSDNGLTGTIPXXXXXXXXXXXXXXXXXXXTGNIPTSFGLLKNLSSLDI 221
LG+L NL SL L DN L GTIP TG IP+ FG L L +L +
Sbjct: 140 LGSLVNLKSLKLGDNELNGTIPETFGNLVNLQMLALASCRLTGLIPSRFGRLVQLQTLIL 199
Query: 222 SSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQXXXXXXXXXXXXXXXXXXGSVPSE 281
N L G IP +G + L + N L S+PA+ G +PS+
Sbjct: 200 QDNELEGPIPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQ 259
Query: 282 LRGLRSLQKF-VIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLL 340
L L S+Q +IGN L G + L ++ LQ + L N TG + W M QL L
Sbjct: 260 LGDLVSIQYLNLIGNQ-LQGLIPKRL-TELANLQTLDLSSNNLTGVIHEEFWRMNQLEFL 317
Query: 341 DISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGR---FRLVDLSGNYFEGRV 397
+++N +G LP + + NTS +L +S+ G + + +L+DLS N G++
Sbjct: 318 VLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQI 377
Query: 398 PE 399
P+
Sbjct: 378 PD 379
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 364 (133.2 bits), Expect = 1.3e-61, Sum P(2) = 1.3e-61
Identities = 100/298 (33%), Positives = 160/298 (53%)
Query: 525 TYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRID--LQSVKTEAYLLELDF 582
T +L AT +FS ++I +G G +++ L G V IKR+ Q +L E++
Sbjct: 991 TADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQFQGDREFLAEMET 1050
Query: 583 FSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKI 642
KV H LVPLLG+C+ + E+FL+Y+YM NG L L N D L++L W RLKI
Sbjct: 1051 IGKVKHPNLVPLLGYCVCGD-ERFLIYEYMENGSLEMWL---RNRADALEALGWPDRLKI 1106
Query: 643 AIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS--LSEVCAQGGDAHQSR-I 699
+G+A GL++LHH +HRD+++S+ILLD+ FE R+ L+ + + + H S I
Sbjct: 1107 CLGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIIS-ACETHVSTDI 1165
Query: 700 TRLLR-LPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTL 758
+P E G + + +T DVY FG V+LEL+TG+ + + Q L +
Sbjct: 1166 AGTFGYIPP--EYGLT--MKSTTKGDVYSFGVVMLELLTGRPP-TGQEEVQGGGNLVGWV 1220
Query: 759 PYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816
++ K+ ++ DP L + E++ + +AR C +P +RP M ++K L+
Sbjct: 1221 RWMIARGKQ--NELFDPCLPVSSVWREQMARVLAIARDCTADEPFKRPTMLEVVKGLK 1276
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 623 (224.4 bits), Expect = 8.6e-60, P = 8.6e-60
Identities = 207/740 (27%), Positives = 325/740 (43%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTS 170
D+L++L +L N S L G+I G + + D+ + IP LGN NL
Sbjct: 546 DSLISLRNLTRINLSHNRLNGTIHPLCGSS--SYLSFDVTNNGFEDEIPLELGNSQNLDR 603
Query: 171 LYLSDNGLTGTIPXXXXXXXXXXXXXXXXXXXTGNIPTSFGLLKNLSSLDISSNYLTGSI 230
L L N LTG IP TG IP L K L+ +D+++N+L+G I
Sbjct: 604 LRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPI 663
Query: 231 PPGLGTLSKLQYLNVSNNSLASSIPAQXXXXXXXXXXXXXXXXXXGSVPSELRGLRSLQK 290
PP LG LS+L L +S+N S+P + GS+P E+ L +L
Sbjct: 664 PPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNV 723
Query: 291 FVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLR-LLDISRNNFTG 349
+ N SG+L +S+L + L +N TG P + + L+ LD+S NNFTG
Sbjct: 724 LNLDKNQFSGSLP-QAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTG 782
Query: 350 PLPNSRSNVNT-STVE-LNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASS 407
+P S + T S +E L++S N G + +G + + Y++ + ++
Sbjct: 783 DIP---STIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLG------------YLNVSFNN 827
Query: 408 LDSNCLQNVPNQRTLVDCSSFYAARGLSFDNFGRPNATQPPPPETSGDSNRKIIVLSXXX 467
L + Q + SF GL R N + + G S R ++++S
Sbjct: 828 LGGK----LKKQFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQ-QGLSARSVVIISAIS 882
Query: 468 XXXXXXXXXXXXXXXXXCFCKKRTPNQRXXXXXXXXXXXXXXXXXXXIN--FTNLGES-- 523
F K+R + F N G S
Sbjct: 883 ALTAIGLMILVIAL----FFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRN-GASKS 937
Query: 524 -FTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRI----DLQSVKTEAYLL 578
++ ++ AT + S+ +I +G SG +++ LE G V +K+I DL S K+ +
Sbjct: 938 DIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKS--FSR 995
Query: 579 ELDFFSKVSHARLVPLLGHCMER-ENEKFLVYKYMPNGDLSSSLYR-KTNTEDDLQSLDW 636
E+ ++ H LV L+G+C + E L+Y+YM NG + L+ K E + LDW
Sbjct: 996 EVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDW 1055
Query: 637 ITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS--LSEVCAQGGDA 694
RL+IA+G A+G+ YLHH+C P VHRD+++S++LLD E LG L++V + D
Sbjct: 1056 EARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDT 1115
Query: 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEI- 753
+ T + SL AT DVY G VL+E+VTGKM + A++ +
Sbjct: 1116 NTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVR 1175
Query: 754 -LEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYIL 812
+E L +L+ + P L +ED +V +A+ C P RP R
Sbjct: 1176 WVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIAL---QCTKTSPQERPSSR--- 1229
Query: 813 KALENPLKVVREENSGSARL 832
+A ++ L V +G +L
Sbjct: 1230 QACDSLLHVYNNRTAGYKKL 1249
|
|
| TAIR|locus:2032697 PEPR1 "PEP1 receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 361 (132.1 bits), Expect = 2.4e-58, Sum P(2) = 2.4e-58
Identities = 98/318 (30%), Positives = 158/318 (49%)
Query: 521 GESFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQS-VKT-EAYLL 578
G S ++LAAT + ++ I G G ++R L G +KR+ S ++ ++ +
Sbjct: 812 GPSLLLNKVLAATDNLNEKYTIGRGAHGIVYRASLGSGKVYAVKRLVFASHIRANQSMMR 871
Query: 579 ELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWIT 638
E+D KV H L+ L G + R+++ ++Y+YMP G L L+ + E+ LDW
Sbjct: 872 EIDTIGKVRHRNLIKLEGFWL-RKDDGLMLYRYMPKGSLYDVLHGVSPKEN---VLDWSA 927
Query: 639 RLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSR 698
R +A+G A GL+YLH++C P VHRD++ +IL+D E +G + D+ S
Sbjct: 928 RYNVALGVAHGLAYLHYDCHPPIVHRDIKPENILMDSDLEPHIGDFG-LARLLDDSTVST 986
Query: 699 ITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISAS--SDAQVKEILEQ 756
T + + + ++ DVY +G VLLELVT K + S + +
Sbjct: 987 ATVTGTTGYIAPENAFKTVRGR-ESDVYSYGVVLLELVTRKRAVDKSFPESTDIVSWVRS 1045
Query: 757 TLPYISIYDKELVTKIVDPSLI---IDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
L + +++VT IVDP L+ +D L E+V + +A SC P RP MR +K
Sbjct: 1046 ALSSSNNNVEDMVTTIVDPILVDELLDSSLREQVMQVTELALSCTQQDPAMRPTMRDAVK 1105
Query: 814 ALENPLKVVREENSGSAR 831
LE+ + R +S S R
Sbjct: 1106 LLEDVKHLARSCSSDSVR 1123
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 377 (137.8 bits), Expect = 1.9e-57, Sum P(2) = 1.9e-57
Identities = 101/290 (34%), Positives = 143/290 (49%)
Query: 113 LVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLY 172
L LT L F A L GSIP L LQALDL S++G IP L L NLT L
Sbjct: 390 LGTLTKLTLFFAWSNQLEGSIPPGLAD-CTDLQALDLSRNSLTGTIPSGLFMLRNLTKLL 448
Query: 173 LSDNGLTGTIPXXXXXXXXXXXXXXXXXXXTGNIPTSFGLLKNLSSLDISSNYLTGSIPP 232
L N L+G IP TG IP+ G LK ++ LD SSN L G +P
Sbjct: 449 LISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPD 508
Query: 233 GLGTLSKLQYLNVSNNSLASSIPAQXXXXXXXXXXXXXXXXXXGSVPSELRGLRSLQKFV 292
+G+ S+LQ +++SNNSL S+P G +P+ L L SL K +
Sbjct: 509 EIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLI 568
Query: 293 IGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRL-LDISRNNFTGPL 351
+ N SG++ +L S LQ++ L N +G P L + L + L++S N TG +
Sbjct: 569 LSKNLFSGSIPTSL-GMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKI 627
Query: 352 PNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNY--FEGRVPE 399
P+ +++N ++ L++S NM G L P+ LV L+ +Y F G +P+
Sbjct: 628 PSKIASLNKLSI-LDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPD 676
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 350 (128.3 bits), Expect = 6.6e-57, Sum P(2) = 6.6e-57
Identities = 97/329 (29%), Positives = 164/329 (49%)
Query: 522 ESFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQ-------SVKTE 574
E FT + +L AT F D+ ++ G G +++ ++ G + +K+++ S T+
Sbjct: 805 ERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTD 864
Query: 575 -AYLLELDFFSKVSHARLVPLLGHCMER-ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQ 632
++ E+ K+ H +V L C + N L+Y+YM G L L+ +
Sbjct: 865 NSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKS-----H 919
Query: 633 SLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS--LSEVCAQ 690
S+DW TR IA+GAAEGL+YLHH+C +HRD+++++IL+D+ FE +G L++V
Sbjct: 920 SMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDM 979
Query: 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV 750
S + + E + +T C D+Y FG VLLEL+TGK + Q
Sbjct: 980 PLSKSVSAVAGSYGYI-APEYAYTMKVTEKC--DIYSFGVVLLELLTGKAPVQPLE--QG 1034
Query: 751 KEILEQTLPYISIYDKELVTKIVDPSLI-IDED-LLEEVWAMAIVARSCLNPKPTRRPLM 808
++ T +I D L ++I+DP L +++D +L + + +A C P+ RP M
Sbjct: 1035 GDLATWTRNHIR--DHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTM 1092
Query: 809 RYILKALENPLKVVREENSGSARLRTTSS 837
R ++ L + E +G + TT S
Sbjct: 1093 REVVLML-----IESGERAGKVIVSTTCS 1116
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 353 (129.3 bits), Expect = 7.5e-57, Sum P(2) = 7.5e-57
Identities = 91/301 (30%), Positives = 153/301 (50%)
Query: 522 ESFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQ---SVKTEAYLL 578
+ FTYQ L+ AT +FS+ ++ G G +++ + GG + +K+++ + + ++
Sbjct: 785 KGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRA 844
Query: 579 ELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWIT 638
E+ K+ H +V L G C +N L+Y+YM G L L R ++ L LDW
Sbjct: 845 EISTLGKIRHRNIVKLYGFCYH-QNSNLLLYEYMSKGSLGEQLQR--GEKNCL--LDWNA 899
Query: 639 RLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS--LSEVCAQGGDAHQ 696
R +IA+GAAEGL YLHH+C VHRD+++++ILLD++F+ +G L+++
Sbjct: 900 RYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSM 959
Query: 697 SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGK---MGISASSDAQ--VK 751
S + + E + +T C D+Y FG VLLEL+TGK + D V+
Sbjct: 960 SAVAGSYGYI-APEYAYTMKVTEKC--DIYSFGVVLLELITGKPPVQPLEQGGDLVNWVR 1016
Query: 752 EILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYI 811
+ +P I ++D L T D+ + E+ + +A C + P RP MR +
Sbjct: 1017 RSIRNMIPTIEMFDARLDTN--------DKRTVHEMSLVLKIALFCTSNSPASRPTMREV 1068
Query: 812 L 812
+
Sbjct: 1069 V 1069
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 389 (142.0 bits), Expect = 4.4e-56, Sum P(2) = 4.4e-56
Identities = 107/328 (32%), Positives = 156/328 (47%)
Query: 75 CLVWNGVRCQN-GSVVGINISGFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSI 133
C W GV C + GS+ +N+ T G + F ++L++LA + S LL G+I
Sbjct: 65 CTSWYGVSCNSRGSIEELNL-----TNTGIEGT-FQDFPFISLSNLAYVDLSMNLLSGTI 118
Query: 134 PDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPXXXXXXXXXX 193
P G L L DL + ++G I SLGNL NLT LYL N LT IP
Sbjct: 119 PPQFGN-LSKLIYFDLSTNHLTGEISPSLGNLKNLTVLYLHQNYLTSVIPSELGNMESMT 177
Query: 194 XXXXXXXXXTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASS 253
TG+IP+S G LKNL L + NYLTG IPP LG + + L +S N L S
Sbjct: 178 DLALSQNKLTGSIPSSLGNLKNLMVLYLYENYLTGVIPPELGNMESMTDLALSQNKLTGS 237
Query: 254 IPAQXXXXXXXXXXXXXXXXXXGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQL 313
IP+ G +P E+ + S+ + N L+G++ +L + L
Sbjct: 238 IPSTLGNLKNLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSL-GNLKNL 296
Query: 314 QIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFY 373
++ L QN TG P L ++ + L++S N TG +P+S N+ T+ L + +N
Sbjct: 297 TLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTI-LYLYENYLT 355
Query: 374 GGLTPVLGRFR-LVDL--SGNYFEGRVP 398
G + P LG ++DL + N G +P
Sbjct: 356 GVIPPELGNMESMIDLQLNNNKLTGSIP 383
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| C0LGK4 | Y2165_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6414 | 0.8813 | 0.8852 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 919 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-49 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-43 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-23 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-20 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-20 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-19 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-19 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-19 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-16 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-15 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-14 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-12 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-10 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-10 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-10 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-10 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-09 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-08 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-08 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-08 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-07 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-06 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-06 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-06 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-06 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-05 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-05 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 4e-05 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-05 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-05 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-04 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-04 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-04 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-04 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-04 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-04 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-04 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-04 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 0.001 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 0.001 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 0.001 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 0.001 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 0.001 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 0.001 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.002 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.002 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 0.002 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.002 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.002 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.003 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 0.003 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 0.003 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 0.004 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.004 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.004 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.004 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 0.004 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 188 bits (478), Expect = 4e-49
Identities = 215/755 (28%), Positives = 337/755 (44%), Gaps = 102/755 (13%)
Query: 112 ALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSL 171
+L NL +L + L G IP + L L +LDL S+SG IP + L NL L
Sbjct: 255 SLGNLKNLQYLFLYQNKLSGPIPPSIFS-LQKLISLDLSDNSLSGEIPELVIQLQNLEIL 313
Query: 172 YLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIP 231
+L N TG IP +L L L VL L N +G IP + G NL+ LD+S+N LTG IP
Sbjct: 314 HLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373
Query: 232 PGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKF 291
GL + L L + +NSL IP LG SL + L NS SG +PSE L +
Sbjct: 374 EGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFL 433
Query: 292 VIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPL 351
I NN L G ++ + + LQ++ L +N F G PD S +L LD+SRN F+G +
Sbjct: 434 DISNNNLQGRINSRKW-DMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAV 491
Query: 352 PNSRSNVNTSTVELNISQNMFYGGLTPVLGRFR-LV--DLSGNYFEGRVPEYVHSNA--S 406
P ++ + ++L +S+N G + L + LV DLS N G++P S
Sbjct: 492 PRKLGSL-SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS 550
Query: 407 SLDSNCLQ-------NVPNQRTLVDCS--------------SFYA--ARGLSFDNF--GR 441
LD + Q N+ N +LV + +F A A ++ + G
Sbjct: 551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG 610
Query: 442 PNATQPPPPETSGDSNRKIIVLSAVLGGFGLIVLLVLLALLALCFCK-------KRTPNQ 494
+ PP + + ++ LG F L++ L F + KR N+
Sbjct: 611 DTTSGLPPCKRVRKTPSWWFYITCTLGAF----LVLALVAFGFVFIRGRNNLELKRVENE 666
Query: 495 RGVGVGPVPAGSSLPPPGASINFTN--LGESFTYQQLLAATGDFSDANLIKNGHSGDLFR 552
G + F + + +S T +L++ + N+I G G ++
Sbjct: 667 DGTW---------------ELQFFDSKVSKSITINDILSSL---KEENVISRGKKGASYK 708
Query: 553 G-ILEGGIPVVIKRI-DLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610
G ++ G+ V+K I D+ S+ E+ K+ H +V L+G C E +L+++
Sbjct: 709 GKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLC-RSEKGAYLIHE 763
Query: 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASS 670
Y+ +LS L++L W R KIAIG A+ L +LH C+ V ++
Sbjct: 764 YIEGKNLSEV----------LRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEK 813
Query: 671 ILLDDKFE--VRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCF 728
I++D K E +RL +C + I+ P++ E + T D+Y F
Sbjct: 814 IIIDGKDEPHLRLSLPGLLCTD----TKCFISSAYVAPETRE-----TKDITEKSDIYGF 864
Query: 729 GKVLLELVTGKMGISASSDAQ--VKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLE- 785
G +L+EL+TGK + +DA+ V + + Y Y + +DPS+ D + +
Sbjct: 865 GLILIELLTGK----SPADAEFGVHGSIVEWARY--CYSDCHLDMWIDPSIRGDVSVNQN 918
Query: 786 EVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820
E+ + +A C PT RP +LK LE+ +
Sbjct: 919 EIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 2e-43
Identities = 136/420 (32%), Positives = 214/420 (50%), Gaps = 32/420 (7%)
Query: 25 MFFVMFLLLFEPTFEQQLERLSSRTELAALFELRSSLGLRRR---DWPRKVDPCLVWNGV 81
M LF + EL L +SS+ + +W D CL W G+
Sbjct: 11 YLIFMLFFLFLNF------SMLHAEELELLLSFKSSINDPLKYLSNWNSSADVCL-WQGI 63
Query: 82 RCQNGS-VVGINISGFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQ 140
C N S VV I++SG + G + A+ L ++ + N S L G IPD +
Sbjct: 64 TCNNSSRVVSIDLSG--KNISGKISS-----AIFRLPYIQTINLSNNQLSGPIPDDIFTT 116
Query: 141 LPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRN 200
+L+ L+L + + +G IP G++ NL +L LS+N L+G IP+ +G S L VLDL N
Sbjct: 117 SSSLRYLNLSNNNFTGSIP--RGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGN 174
Query: 201 SLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGD 260
L G IP S L +L L ++SN L G IP LG + L+++ + N+L+ IP ++G
Sbjct: 175 VLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGG 234
Query: 261 LDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQ 320
L SL LDL N+L+G +PS L L++LQ + N LSG + ++F ++ +L + L
Sbjct: 235 LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF-SLQKLISLDLSD 293
Query: 321 NGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVL 380
N +G P+++ + L +L + NNFTG +P + +++ V L + N F G + L
Sbjct: 294 NSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQV-LQLWSNKFSGEIPKNL 352
Query: 381 GR---FRLVDLSGNYFEGRVPEYVHSNAS----SLDSNCLQN-VPNQRTLVDCSSFYAAR 432
G+ ++DLS N G +PE + S+ + L SN L+ +P ++L C S R
Sbjct: 353 GKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP--KSLGACRSLRRVR 410
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 3e-26
Identities = 85/243 (34%), Positives = 115/243 (47%), Gaps = 24/243 (9%)
Query: 69 PRKVDPCLVWNGVRCQNGSVVGINISGFRRTRLGSQNPRFAADALVNLTHLASFNASRFL 128
P+ + C VR Q+ S G S F T+L LV +++ N
Sbjct: 397 PKSLGACRSLRRVRLQDNSFSGELPSEF--TKL----------PLVYFLDISNNN----- 439
Query: 129 LPGSIPD--WLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSL 186
L G I W +P+LQ L L G +P S G+ L +L LS N +G +P L
Sbjct: 440 LQGRINSRKW---DMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKL 495
Query: 187 GQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVS 246
G LS L L LS N L+G IP K L SLD+S N L+G IP + L L++S
Sbjct: 496 GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555
Query: 247 NNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFL-SGNLSVN 305
N L+ IP LG+++SLV +++S N L GS+PS L V GN L G+ +
Sbjct: 556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG 615
Query: 306 LFP 308
L P
Sbjct: 616 LPP 618
|
Length = 968 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 74/299 (24%), Positives = 119/299 (39%), Gaps = 59/299 (19%)
Query: 540 NLIKNGHSGDLFRGILEGG----IPVVIKRI--DLQSVKTEAYLLELDFFSKVSHARLVP 593
+ G G++++G L+G V +K + D + + +L E K+ H +V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 594 LLGHCMERENEKFLVYKYMPNGDLSSSL--YRKTNTEDDLQSLDWITRLKIAIGAAEGLS 651
LLG C E E +LV +YM GDL L R + +L L AI A+G+
Sbjct: 61 LLGVCTEEEPL-YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 652 YLHHECTLPFVHRDVQASSILLDDKFEVRLGS--LSEVCAQGGDAHQSRITRL-LRL--P 706
YL FVHRD+ A + L+ + V++ LS + +L +R P
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 707 QSSEQG--SSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISI 763
+S + G +S S DV+ FG +L E+ T G PY +
Sbjct: 177 ESLKDGIFTSKS-------DVWSFGVLLWEIFTLGAT------------------PYPGL 211
Query: 764 YDKELVTKIVD------PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816
++E++ + P DE + + SC P RP +++ LE
Sbjct: 212 SNEEVLEYLRKGYRLPKPEYCPDE--------LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 69/296 (23%), Positives = 114/296 (38%), Gaps = 70/296 (23%)
Query: 544 NGHSGDLFRGILEGG-----IPVVIKRI--DLQSVKTEAYLLELDFFSKVSHARLVPLLG 596
G G++++G L+G + V +K + D + E +L E K+ H +V LLG
Sbjct: 9 EGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLG 68
Query: 597 HCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHE 656
C E E +V +YMP GDL Y + N +L L A+ A G+ YL
Sbjct: 69 VCTEEEPL-MIVMEYMPGGDLLD--YLRKNRPKELS---LSDLLSFALQIARGMEYLES- 121
Query: 657 CTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRLP------QS 708
F+HRD+ A + L+ + V++ LS + +LP +S
Sbjct: 122 --KNFIHRDLAARNCLVGENLVVKISDFGLSRD----LYDDDYYKVKGGKLPIRWMAPES 175
Query: 709 SEQG--SSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYD 765
++G +S S DV+ FG +L E+ T G+ PY + +
Sbjct: 176 LKEGKFTSKS-------DVWSFGVLLWEIFTLGEE------------------PYPGMSN 210
Query: 766 KELVTKIVD------PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815
E++ + P E + + C P RP +++ L
Sbjct: 211 AEVLEYLKKGYRLPKPPNCPPE--------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 5e-20
Identities = 70/296 (23%), Positives = 116/296 (39%), Gaps = 71/296 (23%)
Query: 544 NGHSGDLFRGILEG-----GIPVVIKRI--DLQSVKTEAYLLELDFFSKVSHARLVPLLG 596
G G++++G L+G + V +K + D + E +L E K+ H +V LLG
Sbjct: 9 EGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLG 68
Query: 597 HCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHE 656
C E E ++V +YM GDL S Y + N L L A+ A G+ YL
Sbjct: 69 VCTEEEPL-YIVMEYMEGGDLLS--YLRKNRP----KLSLSDLLSFALQIARGMEYLES- 120
Query: 657 CTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRLP------QS 708
F+HRD+ A + L+ + V++ LS R +LP +S
Sbjct: 121 --KNFIHRDLAARNCLVGENLVVKISDFGLSRD----LYDDDYYRKRGGKLPIRWMAPES 174
Query: 709 SEQG--SSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYD 765
++G +S S DV+ FG +L E+ T G+ PY + +
Sbjct: 175 LKEGKFTSKS-------DVWSFGVLLWEIFTLGEQ------------------PYPGMSN 209
Query: 766 KELVTKIVD------PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815
+E++ + + P E + + C P RP +++ L
Sbjct: 210 EEVLEYLKNGYRLPQPPNCPPE--------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 67/278 (24%), Positives = 112/278 (40%), Gaps = 40/278 (14%)
Query: 545 GHSGDLFRGILEG-GIPVVIKRIDLQ---SVKTEAYLLELDFFSKVSHARLVPLLGHCME 600
G G +++ +G G V +K + + S K + E+ ++SH +V L+ E
Sbjct: 10 GSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID-AFE 68
Query: 601 RENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLP 660
++ +LV +Y GDL L R L KIA+ GL YLH
Sbjct: 69 DKDHLYLVMEYCEGGDLFDYLSRGGP-------LSEDEAKKIALQILRGLEYLHSN---G 118
Query: 661 FVHRDVQASSILLDDKFEVRLGS--LSEVCAQ-GGDAHQSRITRLLRLPQSSE--QGSSG 715
+HRD++ +ILLD+ V++ L++ + T P E G +G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP---EVLLGGNG 175
Query: 716 SLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDP 775
DV+ G +L EL+TGK S + +++ + L +D+ +
Sbjct: 176 YGPKV---DVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSG-SE 231
Query: 776 SLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
DL++ CLN P++RP IL+
Sbjct: 232 EAK---DLIK----------KCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 51/207 (24%), Positives = 82/207 (39%), Gaps = 33/207 (15%)
Query: 542 IKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKT--EAYLLELDFFSKVSHARLVPLLGHC 598
+ G G ++ + G V IK I + + E L E++ K++H +V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 599 MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECT 658
+ EN +LV +Y G L L L L+I + EGL YLH
Sbjct: 61 ED-ENHLYLVMEYCEGGSLKDLLKENEGK------LSEDEILRILLQILEGLEYLHSN-- 111
Query: 659 LPFVHRDVQASSILLD-DKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGS---- 713
+HRD++ +ILLD D +V+L D S++ + + G+
Sbjct: 112 -GIIHRDLKPENILLDSDNGKVKL----------ADFGLSKLLTSDKSLLKTIVGTPAYM 160
Query: 714 -----SGSLTATCPYDVYCFGKVLLEL 735
G + D++ G +L EL
Sbjct: 161 APEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 9e-19
Identities = 72/294 (24%), Positives = 119/294 (40%), Gaps = 68/294 (23%)
Query: 545 GHSGDLFRGIL-----EGGIPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGH 597
G G++++G L V +K + + E +L E K+SH +V LLG
Sbjct: 10 GAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGV 69
Query: 598 CMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHEC 657
C + E ++V +YMP GDL L + + L L++A+ A+G+ YL
Sbjct: 70 CTQGE-PLYIVTEYMPGGDLLDFLRKHG------EKLTLKDLLQMALQIAKGMEYLE--- 119
Query: 658 TLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRL----PQSSEQ 711
+ FVHRD+ A + L+ + V++ LS D ++ R L + P+S +
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRD-IYEDDYYRKRGGGKLPIKWMAPESLKD 178
Query: 712 G--SSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQT--LPY-----I 761
G +S S DV+ FG +L E+ T G+ S+ +V E+LE LP
Sbjct: 179 GKFTSKS-------DVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPD 231
Query: 762 SIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815
+Y+ + C P RP +++ L
Sbjct: 232 ELYE---------------------------LMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-17
Identities = 62/174 (35%), Positives = 87/174 (50%), Gaps = 33/174 (18%)
Query: 43 ERLSSRTELAALFELRSSLGLRRR-DWPRKVDPCLV----WNGVRCQNGSVVGINISGFR 97
E + E++AL L+SSLGL R W DPC+ W+G CQ S G
Sbjct: 366 ESKTLLEEVSALQTLKSSLGLPLRFGW--NGDPCVPQQHPWSGADCQFDSTKG------- 416
Query: 98 RTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGV 157
++ D L L + R +P I +L LQ+++L SI G
Sbjct: 417 ---------KWFIDGL-GLDN----QGLRGFIPNDIS-----KLRHLQSINLSGNSIRGN 457
Query: 158 IPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFG 211
IP SLG++T+L L LS N G+IP SLGQL+ L +L+L+ NSL+G +P + G
Sbjct: 458 IPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-17
Identities = 41/89 (46%), Positives = 57/89 (64%)
Query: 171 LYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSI 230
L L + GL G IP+ + +L L ++LS NS+ GNIP S G + +L LD+S N GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 231 PPGLGTLSKLQYLNVSNNSLASSIPAQLG 259
P LG L+ L+ LN++ NSL+ +PA LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-16
Identities = 41/95 (43%), Positives = 58/95 (61%)
Query: 191 VLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSL 250
+ L L L G IP L++L S+++S N + G+IPP LG+++ L+ L++S NS
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 251 ASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGL 285
SIP LG L SL L+L+ NSLSG VP+ L G
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-15
Identities = 63/190 (33%), Positives = 99/190 (52%), Gaps = 9/190 (4%)
Query: 158 IPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLS 217
+L NL L SL L+ N L I S L +L+ L+ LDL N++T P L NL
Sbjct: 85 GSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNITDIPPLIGLLKSNLK 143
Query: 218 SLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGS 277
LD+S N + S+P L L L+ L++S N L S +P L +L +L +LDLS N +S
Sbjct: 144 ELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDL-SDLPKLLSNLSNLNNLDLSGNKIS-D 200
Query: 278 VPSELRGLRSLQKFVIGNNFLSGNLS-VNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQ 336
+P E+ L +L++ + NN + LS ++ +S L++ + P+ + ++
Sbjct: 201 LPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDL----PESIGNLSN 256
Query: 337 LRLLDISRNN 346
L LD+S N
Sbjct: 257 LETLDLSNNQ 266
|
Length = 394 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-14
Identities = 75/261 (28%), Positives = 130/261 (49%), Gaps = 11/261 (4%)
Query: 112 ALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSL 171
L+NL L S + + L +I + L +L L +LDL + +I+ + P +NL L
Sbjct: 88 NLLNLLPLPSLDLNLNRLRSNISELL--ELTNLTSLDLDNNNITDIPPLIGLLKSNLKEL 145
Query: 172 YLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIP 231
LSDN + ++PS L L L LDLS N L+ ++P L NL++LD+S N +P
Sbjct: 146 DLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGN-KISDLP 202
Query: 232 PGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKF 291
P + LS L+ L++SNNS+ + + L +L +L L+LS N L +P + L +L+
Sbjct: 203 PEIELLSALEELDLSNNSIIELLSS-LSNLKNLSGLELSNNKLE-DLPESIGNLSNLETL 260
Query: 292 VIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPD-VLWSMPQLRLLDISRNNFTGP 350
+ NN +S S++ +++ L+ + L N + P L + LL++
Sbjct: 261 DLSNNQIS---SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALE 317
Query: 351 LPNSRSNVNTSTVELNISQNM 371
L + +N + + + +
Sbjct: 318 LKLNSILLNNNILSNGETSSP 338
|
Length = 394 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-14
Identities = 35/87 (40%), Positives = 49/87 (56%)
Query: 216 LSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLS 275
+ L + + L G IP + L LQ +N+S NS+ +IP LG + SL LDLS NS +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 276 GSVPSELRGLRSLQKFVIGNNFLSGNL 302
GS+P L L SL+ + N LSG +
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 37/218 (16%)
Query: 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQS-VKTEAYLLELDFFSKVSHARLV 592
F I G G++++ G V IK I L+S K E + E+ K H +V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 593 PLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSY 652
G +++E ++V ++ G L L + TN I + +GL Y
Sbjct: 61 KYYG-SYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTES---QIA--YVCKELLKGLEY 113
Query: 653 LHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQG 712
LH + +HRD++A++ILL EV+L + AQ D ++R T +
Sbjct: 114 LH---SNGIIHRDIKAANILLTSDGEVKLIDFG-LSAQLSDT-KARNTMV---------- 158
Query: 713 SSGSL-----------TATCPYDVYCFGKVLLELVTGK 739
G+ D++ G +EL GK
Sbjct: 159 --GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 33/225 (14%)
Query: 544 NGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMEREN 603
G G+++ G G V +K + ++ EA+L E K+ H +LV L C E E
Sbjct: 16 AGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE- 74
Query: 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVH 663
++V +YM G L L + + L + +A AEG++YL ++H
Sbjct: 75 PIYIVTEYMSKGSLLDFL-----KSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIH 126
Query: 664 RDVQASSILLDDKFEV--------RLGSLSEVCAQGGDAHQSRITRLLRLP---QSSEQG 712
RD+ A +IL+ + RL E A+ G + P + E
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG----------AKFPIKWTAPEAA 176
Query: 713 SSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQ 756
+ G T DV+ FG +L E+VT G++ ++ +V E +E+
Sbjct: 177 NYGRFTIKS--DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 4e-12
Identities = 66/285 (23%), Positives = 104/285 (36%), Gaps = 42/285 (14%)
Query: 536 FSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKT--EAYLLELDFFSKVSHARLV 592
+ + G G ++ + G V IK I + +K E L E+ K+ H +V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 593 PLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTN-TEDDLQSLDWITRLKIAIGAAEGLS 651
L E E++ +LV +Y GDL L ++ +ED+ + L
Sbjct: 61 RLYDVF-EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR--------FYLRQILSALE 111
Query: 652 YLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRLPQSS 709
YLH + VHRD++ +ILLD+ V+L L+ G T P
Sbjct: 112 YLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAP--- 165
Query: 710 EQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTL-PYISIYDKEL 768
E D++ G +L EL+TGK D Q+ E+ ++ P E
Sbjct: 166 EVLLGKGYGKAV--DIWSLGVILYELLTGK--PPFPGDDQLLELFKKIGKPKPPFPPPE- 220
Query: 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
+ P DL+ R L P +R L+
Sbjct: 221 --WDISPEAK---DLI----------RKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 62/285 (21%), Positives = 124/285 (43%), Gaps = 32/285 (11%)
Query: 535 DFSDANLIKNGHSGDLFRGILEG-GIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVP 593
D + + + G G+++ G+ + + V +K + +++ E +L E ++ H LV
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 66
Query: 594 LLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL 653
LLG C RE +++ ++M G+L L R+ N + ++ + L +A + + YL
Sbjct: 67 LLGVCT-REPPFYIITEFMTYGNLLDYL-RECNRQ----EVNAVVLLYMATQISSAMEYL 120
Query: 654 HHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGS 713
+ F+HRD+ A + L+ + V++ GD + + + ++ +
Sbjct: 121 EKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 177
Query: 714 SGSLTATCPYDVYCFGKVLLELVTGKMGISASSD-AQVKEILEQTLPYISIYDKELVTKI 772
+ + + DV+ FG +L E+ T M D +QV E+LE+ ++
Sbjct: 178 AYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY------------RM 224
Query: 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817
P E +V+ + R+C P+ RP I +A E
Sbjct: 225 ERP-----EGCPPKVYEL---MRACWQWNPSDRPSFAEIHQAFET 261
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 77/305 (25%), Positives = 129/305 (42%), Gaps = 54/305 (17%)
Query: 536 FSDANL-----IKNGHSGDLF----RGILEGG--IPVVIKRIDLQSVKTEAYLL----EL 580
F +NL + G G++F +GI E G V++K LQ K E EL
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKA--LQKTKDENLQSEFRREL 59
Query: 581 DFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDL---QSLDWI 637
D F K+SH +V LLG C E E +++ +Y GDL L R T ++D+ L
Sbjct: 60 DMFRKLSHKNVVRLLGLCREAE-PHYMILEYTDLGDLKQFL-RATKSKDEKLKPPPLSTK 117
Query: 638 TRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS---EVCAQGGDA 694
++ + A G+ +L FVHRD+ A + L+ + EV++ LS +V
Sbjct: 118 QKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK 174
Query: 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEIL 754
++ + L L + Q S + DV+ FG ++ E+ T
Sbjct: 175 LRNALIPLRWLAPEAVQEDDFSTKS----DVWSFGVLMWEVFT----------------- 213
Query: 755 EQTLPYISIYDKELVTKIVDPSL--IIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYIL 812
+ LP+ + D+E++ ++ L + E ++ ++ R C P RP ++
Sbjct: 214 QGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY--KLMTR-CWAVNPKDRPSFSELV 270
Query: 813 KALEN 817
AL
Sbjct: 271 SALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 69/282 (24%), Positives = 126/282 (44%), Gaps = 48/282 (17%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENE 604
G G+++ G G V IK + S+ EA+L E + ++ H RLV L + + +
Sbjct: 17 GQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL--YAVVTQEP 74
Query: 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHR 664
+++ +YM NG L + KT + L + +A AEG++++ + ++HR
Sbjct: 75 IYIITEYMENGSLVD--FLKT---PEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHR 126
Query: 665 DVQASSILLDDKFE--------VRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGS 716
D++A++IL+ + RL +E A+ G + T P++ G
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYG---- 178
Query: 717 LTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDP 775
T T DV+ FG +L E+VT G++ ++ +V + LE+ ++ P
Sbjct: 179 -TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY------------RMPRP 225
Query: 776 SLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817
++ EE++ + R C KP RP Y+ LE+
Sbjct: 226 -----DNCPEELYE---LMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 55/225 (24%)
Query: 540 NLIKNGHSGDLFRGILE--GGIPVVIKRIDLQSVKT---EAYLLELDFFSKVSHARLVPL 594
L+ G G ++ + + G + + +K ++L EA E+ S + H +V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGEL-MAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 595 LGHCMERENEKFLVY-KYMPNGDLSSSLYRKTN-TEDDLQSLDWITR--LKIAIGAAEGL 650
G + E ++ +Y+ G LSS L + E ++ TR L EGL
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY---TRQIL-------EGL 114
Query: 651 SYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSE 710
+YLH VHRD++ ++IL+D V+L D ++ RL
Sbjct: 115 AYLHSNG---IVHRDIKGANILVDSDGVVKL----------ADFGCAK-----RLGDIET 156
Query: 711 QGSSGSLTATCPY----------------DVYCFGKVLLELVTGK 739
+GS+ T PY D++ G ++E+ TGK
Sbjct: 157 GEGTGSVRGT-PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 62.5 bits (150), Expect = 4e-10
Identities = 58/287 (20%), Positives = 96/287 (33%), Gaps = 33/287 (11%)
Query: 541 LIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLL----ELDFFSKVSHARLVPLLG 596
+ G G+++ V +K + + + E+ + ++H + L
Sbjct: 7 KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 597 HCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHE 656
+ E +LV +Y+ G L L K S + I L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQI--LSALEYLH-- 118
Query: 657 CTLPFVHRDVQASSILLD-DKFEVRL---GSLSEVCAQGGDAHQSRI------TRLLRLP 706
+ +HRD++ +ILLD D V+L G + G + + T P
Sbjct: 119 -SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 707 QSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDK 766
+ S A+ D++ G L EL+TG ++ QTL I
Sbjct: 178 EVLLGLSLAY--ASSSSDIWSLGITLYELLTGLPPFEGEKNSS---ATSQTLKII----L 228
Query: 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
EL T + L L A ++ + L P R L
Sbjct: 229 ELPTPSLASPLSPSNPELISKAASDLL-KKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 66/288 (22%), Positives = 119/288 (41%), Gaps = 60/288 (20%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENE 604
G G+++ G G V IK + ++ EA+L E K+ H +LVPL + + E
Sbjct: 17 GCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL--YAVVSEEP 74
Query: 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHR 664
++V ++M G L L E D + L + +A A+G++Y+ + ++HR
Sbjct: 75 IYIVTEFMGKGSLLDFL-----KEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHR 126
Query: 665 DVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSE----QGSSGSLTAT 720
D++A++IL+ D ++ L RL + +E QG+ + T
Sbjct: 127 DLRAANILVGDNLVCKIADFG----------------LARLIEDNEYTARQGAKFPIKWT 170
Query: 721 CP-----------YDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELV 769
P DV+ FG +L ELVT + +PY + ++E++
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVT-----------------KGRVPYPGMVNREVL 213
Query: 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817
++ + E ++ + + C P RP YI LE+
Sbjct: 214 EQVERGYRMPCPQGCPE--SLHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 73/271 (26%), Positives = 108/271 (39%), Gaps = 52/271 (19%)
Query: 561 VVIKRI-DLQSVKT-EAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLS 618
V IK + + K + + E + S + H +V LLG C + + L ++Y+ +GDL
Sbjct: 38 VAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML-FEYLAHGDLH 96
Query: 619 SSLYRKTNTED---------DLQSLDWITRLKIAIGAAEGLSYL--HHECTLPFVHRDVQ 667
L R + D SLD L IAI A G+ YL HH FVHRD+
Sbjct: 97 EFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLA 151
Query: 668 ASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLR---LP---QSSEQGSSGSLTATC 721
A + L+ + V++ D + + R+ LP E G T
Sbjct: 152 ARNCLVGEGLTVKISDF----GLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTES 207
Query: 722 PYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLI-ID 780
D++ FG VL E+ S Q PY ++E++ I L+
Sbjct: 208 --DIWSFGVVLWEIF--------SYGLQ---------PYYGFSNQEVIEMIRSRQLLPCP 248
Query: 781 EDLLEEVWAMAIVARSCLNPKPTRRPLMRYI 811
ED V+A+ I C N P RRP + I
Sbjct: 249 EDCPARVYALMI---ECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 50/218 (22%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENE 604
G G+++ G+ PV +K + ++ + +L E K+ H +L+ L C E
Sbjct: 17 GQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT-LEEP 75
Query: 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHR 664
++V + M G L L L L + +A A G++YL + ++HR
Sbjct: 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQL-----IDMAAQVASGMAYLEAQ---NYIHR 127
Query: 665 DVQASSILLDDKFEVRLGS--LSEVCAQGGDAHQSRITRLLRLP---QSSEQGSSGSLTA 719
D+ A ++L+ + ++ L+ V + D +++R + P + E +
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKE--DIYEAREG--AKFPIKWTAPEAALYNRFSI 183
Query: 720 TCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQ 756
DV+ FG +L E+VT G+M ++A+V + ++Q
Sbjct: 184 KS--DVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ 219
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 40/138 (28%), Positives = 60/138 (43%), Gaps = 16/138 (11%)
Query: 541 LIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCME 600
I G GD+ G G V +K + S +A+L E + + H LV LLG ++
Sbjct: 13 TIGKGEFGDVMLGDYRGQ-KVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 601 RENEKFLVYKYMPNGDLSSSLY---RKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHEC 657
N ++V +YM G L L R T L A+ EG+ YL +
Sbjct: 72 -GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQ--------LGFALDVCEGMEYLEEK- 121
Query: 658 TLPFVHRDVQASSILLDD 675
FVHRD+ A ++L+ +
Sbjct: 122 --NFVHRDLAARNVLVSE 137
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 52/220 (23%), Positives = 102/220 (46%), Gaps = 17/220 (7%)
Query: 541 LIKNGHSGDLFRGILEGGIPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHC 598
I G+ GD+++G+L+G V +K R L +L E + + H +V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 599 MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECT 658
++++ ++V + +P G L + L +K N L L++++ AA G+ YL +
Sbjct: 62 VQKQ-PIYIVMELVPGGSLLTFLRKKKN------RLTVKKLLQMSLDAAAGMEYLESKNC 114
Query: 659 LPFVHRDVQASSILLDDKFEVRLGS--LSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGS 716
+HRD+ A + L+ + +++ +S G + ++ + E + G
Sbjct: 115 ---IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 717 LTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILE 755
T+ DV+ +G +L E + G S+ Q +E +E
Sbjct: 172 YTSES--DVWSYGILLWETFSLGDTPYPGMSNQQTRERIE 209
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (144), Expect = 2e-09
Identities = 75/312 (24%), Positives = 108/312 (34%), Gaps = 100/312 (32%)
Query: 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHAR 590
G F L++ G L+ V+K IDL ++ E L E+ K++H
Sbjct: 11 GSFGKVYLVRRKSDGKLY----------VLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 591 LVPLLGHCMER--ENEKFL-VYKYMPNGDLSSSL--YRKTN---TEDDLQSLDWITRLKI 642
++ E E K V +Y GDLS + +K E+ Q LDW +L
Sbjct: 61 II----KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE--QILDWFVQL-- 112
Query: 643 AIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRL 702
L YLH L HRD++ +I L V+LG I+++
Sbjct: 113 ----CLALKYLHSRKIL---HRDIKPQNIFLTSNGLVKLGDFG-------------ISKV 152
Query: 703 LRLPQSSEQGSSGSLTATC---------------PY----DVYCFGKVLLELVTGKMGIS 743
L S+ L T PY D++ G VL EL T K
Sbjct: 153 L--------SSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE 204
Query: 744 ASSDAQ-VKEILEQTLPYI-SIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPK 801
+ + +IL+ P I S Y EL +V S L
Sbjct: 205 GENLLELALKILKGQYPPIPSQYSSEL-RNLVS---------------------SLLQKD 242
Query: 802 PTRRPLMRYILK 813
P RP + IL+
Sbjct: 243 PEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 3e-09
Identities = 29/60 (48%), Positives = 35/60 (58%)
Query: 167 NLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYL 226
NL SL LS+N LT + L L VLDLS N+LT P +F L +L SLD+S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 64/299 (21%), Positives = 110/299 (36%), Gaps = 54/299 (18%)
Query: 542 IKNGHSGDLFRGILEGGIP------VVIKRIDLQSVKT--EAYLLELDFFSKVSHARLVP 593
+ G G +F G P V +K + + + + E + + H +V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 594 LLGHCMERENEKFLVYKYMPNGDLSSSLYRK-------TNTEDDLQSLDWITRLKIAIGA 646
G C E + +V++YM +GDL+ L + + + L L+IA+
Sbjct: 73 FYGVCTE-GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 647 AEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS---EVCAQGGDAHQSRITRLL 703
A G+ YL + FVHRD+ + L+ V++G +V D ++ +L
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT--DYYRVGGHTML 186
Query: 704 RL----PQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTL 758
+ P+S T DV+ FG VL E+ T GK S+ +V E + Q
Sbjct: 187 PIRWMPPESIMYR-----KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241
Query: 759 PYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817
L EV+ + C P +R ++ I + L+
Sbjct: 242 -----------------LLQRPRTCPSEVYD---IMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 55/229 (24%), Positives = 103/229 (44%), Gaps = 45/229 (19%)
Query: 544 NGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMEREN 603
NG G+++ G G V +K + ++ E++L E K+ H +LV L + + E
Sbjct: 16 NGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL--YAVVSEE 73
Query: 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVH 663
++V +YM G L L + + ++L + +A A G++Y+ + ++H
Sbjct: 74 PIYIVTEYMSKGSLLDFL-----KDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIH 125
Query: 664 RDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSE----QGSSGSLTA 719
RD+++++IL+ D ++ L RL + +E QG+ +
Sbjct: 126 RDLRSANILVGDGLVCKIADFG----------------LARLIEDNEYTARQGAKFPIKW 169
Query: 720 TCP-----------YDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQ 756
T P DV+ FG +L ELVT G++ ++ +E+LEQ
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQ 215
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 40/223 (17%)
Query: 540 NLIKNGHSGDLFRGIL-------EGGIPVVIKRIDLQSVKTE--AYLLELDFFSKVSHAR 590
N + +G G+++ G G I V +K + + E +L E S +H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLY--RKTNTEDDLQSLDWITRLKIAIGAAE 648
+V LLG C+ E + +++ + M GDL S L R L +L + L I + A+
Sbjct: 61 IVKLLGVCLLNEPQ-YIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL--LDICLDVAK 117
Query: 649 GLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG----------GDAHQSR 698
G YL + F+HRD+ A + L+ +K V G D ++
Sbjct: 118 GCVYLEQ---MHFIHRDLAARNCLVSEK----GYDADRVVKIGDFGLARDIYKSDYYRKE 170
Query: 699 ITRLLRL----PQSSEQGSSGSLTATCPYDVYCFGKVLLELVT 737
LL + P+S G T DV+ FG ++ E++T
Sbjct: 171 GEGLLPVRWMAPESLLDG-----KFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 41/208 (19%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENE 604
G G+++ G G V IK + ++ EA+L E K+ H +LV L + + E
Sbjct: 17 GCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEP 74
Query: 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHR 664
++V +YM G L L + L L + +A A G++Y+ + +VHR
Sbjct: 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQL-----VDMAAQIASGMAYVER---MNYVHR 126
Query: 665 DVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSE----QGSSGSLTAT 720
D++A++IL+ + ++ L RL + +E QG+ + T
Sbjct: 127 DLRAANILVGENLVCKVADFG----------------LARLIEDNEYTARQGAKFPIKWT 170
Query: 721 CP-----------YDVYCFGKVLLELVT 737
P DV+ FG +L EL T
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 41/138 (29%), Positives = 74/138 (53%), Gaps = 14/138 (10%)
Query: 541 LIKNGHSGDLFRGILEGGIPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHC 598
L+ G+ G++F+G L+ PV +K + DL +L E + H +V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 599 MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHE-C 657
+R+ ++V + +P GD S L +K +D+L++ + K A+ AA G++YL + C
Sbjct: 62 TQRQ-PIYIVMELVPGGDFLSFLRKK---KDELKTKQLV---KFALDAAAGMAYLESKNC 114
Query: 658 TLPFVHRDVQASSILLDD 675
+HRD+ A + L+ +
Sbjct: 115 ----IHRDLAARNCLVGE 128
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 59/284 (20%), Positives = 120/284 (42%), Gaps = 51/284 (17%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENE 604
G G+++ G V +K + ++ +A+L E + + H +LV L + +E
Sbjct: 17 GQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYA-VVTKEEP 75
Query: 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHR 664
+++ +YM G L L + L L + + AEG++Y+ + ++HR
Sbjct: 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKL-----IDFSAQIAEGMAYIERK---NYIHR 127
Query: 665 DVQASSILLDDKFEVRLGSL--------SEVCAQGGDAHQSRITRLLRLPQSSEQGSSGS 716
D++A+++L+ + ++ +E A+ G + T P++ GS
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGS--- 180
Query: 717 LTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQ--TLPYISIYDKELVTKIV 773
T DV+ FG +L E+VT GK+ S++ V L++ +P +
Sbjct: 181 --FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRM------------ 226
Query: 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817
E+ +E++ + ++C K RP Y+ L++
Sbjct: 227 -------ENCPDELYD---IMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 12/214 (5%)
Query: 542 IKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMER 601
I +G G ++ G V IK I ++ E ++ E K+SH +LV L G C ER
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 602 ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPF 661
+ LV+++M +G LS L + T L + + EG++YL
Sbjct: 72 -SPICLVFEFMEHGCLSDYLRAQRG------KFSQETLLGMCLDVCEGMAYLESSN---V 121
Query: 662 VHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATC 721
+HRD+ A + L+ + V++ D + S + SS + S S ++
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS- 180
Query: 722 PYDVYCFGKVLLELVT-GKMGISASSDAQVKEIL 754
DV+ FG ++ E+ + GK S+++V E +
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI 214
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 61/261 (23%), Positives = 100/261 (38%), Gaps = 65/261 (24%)
Query: 565 RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSS--SLY 622
R+++ + L ELD K + +V G + + +YM G L
Sbjct: 35 RLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-NNGDISICMEYMDGGSLDKILKEV 93
Query: 623 RKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRL- 681
+ E L KIA+ +GL+YLH +HRDV+ S+IL++ + +++L
Sbjct: 94 QGRIPERILG--------KIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLC 143
Query: 682 -----GSLSEVCAQ---GGDAHQS--RITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKV 731
G L A+ G ++ + RI QG+ S+ + D++ G
Sbjct: 144 DFGVSGQLVNSLAKTFVGTSSYMAPERI-----------QGNDYSVKS----DIWSLGLS 188
Query: 732 LLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVD------PSLIIDEDLLE 785
L+EL TG+ +D P I++ L+ IV+ PS D +
Sbjct: 189 LIELATGRFPYPPEND-----------PPDGIFE--LLQYIVNEPPPRLPSGKFSPDFQD 235
Query: 786 EVWAMAIVARSCLNPKPTRRP 806
V CL P RP
Sbjct: 236 FV-------NLCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 63/259 (24%), Positives = 101/259 (38%), Gaps = 44/259 (16%)
Query: 574 EAYLLELDFFSKVSHARLVPLLGHCME-RENEKF----LVYKYMPNGDLSSSLYRKTNTE 628
E +L E H ++ L+G C E +K ++ +M +GDL S L +
Sbjct: 46 EEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY-SRLG 104
Query: 629 DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS--LSE 686
+ L T LK + A G+ YL F+HRD+ A + +L + V + LS+
Sbjct: 105 GLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
Query: 687 VCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASS 746
G Q RI ++ + E S T DV+ FG + E+ T G +
Sbjct: 162 KIYSGDYYRQGRIAKMPVKWIAIE--SLADRVYTSKSDVWAFGVTMWEIAT--RGQT--- 214
Query: 747 DAQVKEILEQTLPYISIYDKELV------TKIVDPSLIIDEDLLEEVWAMAIVARSCLNP 800
PY + + E+ ++ P ED L+E++ + SC
Sbjct: 215 ------------PYPGVENHEIYDYLRHGNRLKQP-----EDCLDELYDLMY---SCWRA 254
Query: 801 KPTRRPLMRYILKALENPL 819
P RP + + LEN L
Sbjct: 255 DPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 23/152 (15%)
Query: 540 NLIKNGHSGDLFRGIL----EGGIPVVIK---RI-DLQSVKTEAYLLELDFFSKVSHARL 591
+I GH G ++ G L I +K RI DL+ V E +L E SH +
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV--EQFLKEGIIMKDFSHPNV 58
Query: 592 VPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTN--TEDDLQSLDWITRLKIAIGAAEG 649
+ LLG C+ E +V YM +GDL + + +T+ T DL + + A+G
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL--------IGFGLQVAKG 110
Query: 650 LSYLHHECTLPFVHRDVQASSILLDDKFEVRL 681
+ YL + FVHRD+ A + +LD+ F V++
Sbjct: 111 MEYLASK---KFVHRDLAARNCMLDESFTVKV 139
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 3e-08
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAY---LLELDFFSKVSHAR 590
++ +LI G G +++G+ LE G V IK+I L+ +K EA + E+D + H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 591 LVPLLGHCMERENEKFL--VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAE 648
+V +G E L + +Y NG L + +K + ++ ++ +
Sbjct: 61 IVKYIGS---IETSDSLYIILEYAENGSLRQ-IIKKFGPFPESLVAVYVYQV------LQ 110
Query: 649 GLSYLHHECTLPFVHRDVQASSILLDDKFEVRL---GSLSEVCAQGGDAHQSRITRLLRL 705
GL+YLH + +HRD++A++IL V+L G +++ D T
Sbjct: 111 GLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMA 167
Query: 706 PQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGK 739
P+ E SG+ TA+ D++ G ++EL+TG
Sbjct: 168 PEVIEM--SGASTAS---DIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 65/290 (22%), Positives = 112/290 (38%), Gaps = 46/290 (15%)
Query: 545 GHSGDLFRGIL------EGGIPVVIKRIDLQSVKTE--AYLLELDFFSKVSHARLVPLLG 596
G G ++ G+ E V IK ++ + E +L E + + +V LLG
Sbjct: 17 GSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLG 76
Query: 597 HCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKI---AIGAAEGLSYL 653
+V + M GDL S L + ++ L T K A A+G++YL
Sbjct: 77 VV-STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL 135
Query: 654 HHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQS---RITRLLRLP---Q 707
FVHRD+ A + ++ + V++G D +++ R LP
Sbjct: 136 A---AKKFVHRDLAARNCMVAEDLTVKIGDF----GMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 708 SSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKE 767
+ E G T DV+ FG VL E+ T + EQ PY + ++E
Sbjct: 189 APESLKDGVFTTKS--DVWSFGVVLWEMAT---------------LAEQ--PYQGLSNEE 229
Query: 768 LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817
++ ++D + + + + R C P RP I+ +L++
Sbjct: 230 VLKFVIDGGHLDLPENCPDKLLE--LMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 67/287 (23%), Positives = 112/287 (39%), Gaps = 56/287 (19%)
Query: 542 IKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMER 601
+ +G G + G G I V IK I ++ + ++ E K+SH LV L G C ++
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 602 ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPF 661
F+V +YM NG L + L + LD + E + YL F
Sbjct: 72 R-PIFIVTEYMANGCLLNYLRERKGKLGTEWLLD------MCSDVCEAMEYLESNG---F 121
Query: 662 VHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQ-SSEQGSSGSLTAT 720
+HRD+ A + L+ + V++ + R + Q +S QG+ +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFG-------------LARYVLDDQYTSSQGTKFPVKWA 168
Query: 721 CP-----------YDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKEL 768
P DV+ FG ++ E+ + GKM S+++V +E +Y +L
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VESVSAGYRLYRPKL 225
Query: 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815
EV+ + SC + KP RP + +L L
Sbjct: 226 APT--------------EVYT---IMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 67/278 (24%), Positives = 120/278 (43%), Gaps = 42/278 (15%)
Query: 542 IKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMER 601
I G G + +G G V +K I V +A+L E +K+ H LV LLG +
Sbjct: 14 IGEGEFGAVLQGEYTGQ-KVAVKNIKC-DVTAQAFLEETAVMTKLHHKNLVRLLGVIL-- 69
Query: 602 ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPF 661
N ++V + M G+L + L + + L L+ ++ AEG+ YL +
Sbjct: 70 HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQL-----LQFSLDVAEGMEYLESK---KL 121
Query: 662 VHRDVQASSILLDDKFEVRLGS--LSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTA 719
VHRD+ A +IL+ + ++ L+ V + G D S++ P++ + S +
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN--SKLPVKWTAPEALKHKKFSSKS- 178
Query: 720 TCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLI 778
DV+ +G +L E+ + G+ S +VKE +E+ ++P
Sbjct: 179 ----DVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-------------MEPP-- 219
Query: 779 IDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816
E +V+ ++ SC +P +RP + + LE
Sbjct: 220 --EGCPADVY---VLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 62/246 (25%), Positives = 91/246 (36%), Gaps = 50/246 (20%)
Query: 577 LLELDFFSKVSHARLVPLLGHCM-ERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLD 635
L EL+ +V G + E + + +Y G L S +Y+K ++
Sbjct: 47 LRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKK------VKKRG 99
Query: 636 WITR----LKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691
KIA +GLSYLH +HRD++ S+ILL K +V+L C G
Sbjct: 100 GRIGEKVLGKIAESVLKGLSYLHSRKI---IHRDIKPSNILLTRKGQVKL------CDFG 150
Query: 692 --GDAHQSRI-----TRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISA 744
G+ S T P E+ + T DV+ G LLE+ +
Sbjct: 151 VSGELVNSLAGTFTGTSFYMAP---ERIQGKPYSITS--DVWSLGLTLLEVAQNRFPFPP 205
Query: 745 SSDAQVKEILEQTLPYISIYDKELVTKIVD--PSLIIDEDLLEEVWAMAI--VARSCLNP 800
E L I EL++ IV+ + DE W+ + CL
Sbjct: 206 EG--------EPPLGPI-----ELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEK 252
Query: 801 KPTRRP 806
PTRRP
Sbjct: 253 DPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 39/150 (26%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 540 NLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSK-------VSHARLV 592
+L++ G G +F GIL P + + +++VK A +++ + +SH ++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 593 PLLGHCMERENEKFLVYKYMPNGDLSSSLYR-KTNTEDDLQSLDWITRLKIAIGAAEGLS 651
P+L C+E F++Y YM G+L L + + ++ Q+L + +AI A G+S
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 652 YLHHECTLPFVHRDVQASSILLDDKFEVRL 681
YLH +H+D+ A + ++D++ +V++
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKI 158
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 1e-07
Identities = 22/59 (37%), Positives = 31/59 (52%)
Query: 144 LQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSL 202
L++LDL + ++ + + L NL L LS N LT P + L L LDLS N+L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 1e-07
Identities = 32/130 (24%), Positives = 61/130 (46%), Gaps = 22/130 (16%)
Query: 561 VVIKRIDLQSVKTE---AYLLELDFFSKVSHARLVPLLGHCMERENEK---FLVYKYMPN 614
V +K+I +++ K + E+ K+ H +V L + K ++V++YM +
Sbjct: 27 VALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRL--KEIVTSKGKGSIYMVFEYMDH 84
Query: 615 GDLSSSLYRKTN--TEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSIL 672
DL+ L TE ++ + +L EGL YLH +HRD++ S+IL
Sbjct: 85 -DLTGLLDSPEVKFTESQIKCY--MKQL------LEGLQYLHSN---GILHRDIKGSNIL 132
Query: 673 LDDKFEVRLG 682
+++ ++L
Sbjct: 133 INNDGVLKLA 142
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 2e-07
Identities = 27/60 (45%), Positives = 33/60 (55%), Gaps = 2/60 (3%)
Query: 192 LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVSNNSL 250
L LDLS N LT +F L NL LD+S N LT SI P L L+ L++S N+L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 65/266 (24%), Positives = 111/266 (41%), Gaps = 48/266 (18%)
Query: 559 IPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLS 618
I V IK I+ ++ E ++ E K+SH +LV L G C +++ ++V ++M NG L
Sbjct: 29 IKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK-PLYIVTEFMENGCLL 87
Query: 619 SSLYRKTN--TEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK 676
+ L ++ ++D L L + EG+ YL F+HRD+ A + L+
Sbjct: 88 NYLRQRQGKLSKDML--------LSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSST 136
Query: 677 FEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSS------EQGSSGSLTATCPYDVYCFGK 730
V++ D + S + S + SS S DV+ FG
Sbjct: 137 GVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS-------DVWSFGV 189
Query: 731 VLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWA 789
++ E+ T GKM S+ +V E++ + +Y +L + V
Sbjct: 190 LMWEVFTEGKMPFEKKSNYEVVEMISRGF---RLYRPKLASMTVYE-------------- 232
Query: 790 MAIVARSCLNPKPTRRPLMRYILKAL 815
V SC + KP RP +L+A+
Sbjct: 233 ---VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 559 IPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLS 618
+ V + R D+ +L E+ S++ + ++ LLG C+ ++ ++ +YM NGDL+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV-SDDPLCMITEYMENGDLN 105
Query: 619 SSL-----YRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILL 673
L +++ S+ L +A+ A G+ YL +L FVHRD+ + L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 674 DDKFEVRLGSLS-EVCAQGGDAHQSRITRLLRLP---QSSEQGSSGSLTATCPYDVYCFG 729
+ + +++ GD + RI LP + E G T T DV+ FG
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMAWESILLGKFT-TAS-DVWAFG 218
Query: 730 KVLLELVT--GKMGISASSDAQVKE 752
L E+ T + S SD QV E
Sbjct: 219 VTLWEMFTLCKEQPYSLLSDEQVIE 243
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 37/128 (28%), Positives = 56/128 (43%), Gaps = 8/128 (6%)
Query: 550 LFRGILEGGIPVVIKRIDLQSVKTEA----YLLELDFFSKVSHARLVPLLGHCMERENEK 605
L+RG + + + L +E +L+E SK +H +V L+G ER +
Sbjct: 26 LYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER-LPR 84
Query: 606 FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRD 665
F++ + M GDL S L + SL L A A+G YL F+HRD
Sbjct: 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRD 141
Query: 666 VQASSILL 673
+ A + LL
Sbjct: 142 IAARNCLL 149
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 3e-07
Identities = 29/61 (47%), Positives = 36/61 (59%), Gaps = 2/61 (3%)
Query: 215 NLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNS 273
NL SLD+S+N LT IP G L L+ L++S N+L S P L SL LDLS N+
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 274 L 274
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 43/209 (20%), Positives = 85/209 (40%), Gaps = 35/209 (16%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQS-VKTEAYLLELDFFSKVSHARLVPLLGHCMEREN 603
G+ G+++ G+ + + V IK + +K + + E+ ++ H L+ L C E
Sbjct: 17 GYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE- 75
Query: 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVH 663
+++ + M G L + L + Q L + + +A AEG++YL + +H
Sbjct: 76 PVYIITELMEKGSLLAFL-----RSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIH 127
Query: 664 RDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCP- 722
RD+ A +IL+ + ++ + RL++ T P
Sbjct: 128 RDLAARNILVGEDLVCKVADFG-------------LARLIKEDVYLSSDKKIPYKWTAPE 174
Query: 723 ----------YDVYCFGKVLLELVT-GKM 740
DV+ FG +L E+ T G++
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFTYGQV 203
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 542 IKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLL--ELDFFSKVSHARLVPLLGHC 598
I G + ++ I L V IKRIDL+ +T L E+ S+ +H +V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 599 MERENEKFLVYKYMPNG---DLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHH 655
+ + E +LV Y+ G D+ S Y + ++ + + T LK +GL YLH
Sbjct: 69 VVGD-ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA----TVLK---EVLKGLEYLHS 120
Query: 656 ECTLPFVHRDVQASSILLDDKFEVRLGS--LSEVCAQGGD-AHQSRITRL----LRLPQS 708
+HRD++A +ILL + V++ +S A GGD + R T + P+
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 709 SEQGSSGSLTATCPYDVYCFGKVLLELVTGK 739
EQ A D++ FG +EL TG
Sbjct: 178 MEQVHGYDFKA----DIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 64/279 (22%), Positives = 113/279 (40%), Gaps = 40/279 (14%)
Query: 542 IKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMER 601
I G GD+ G G V +K I +A+L E +++ H+ LV LLG +E
Sbjct: 14 IGKGEFGDVMLGDYRG-NKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 602 ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPF 661
+ ++V +YM G L L + + L LK ++ E + YL F
Sbjct: 72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEAN---NF 123
Query: 662 VHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLP--QSSEQGSSGSLTA 719
VHRD+ A ++L+ + ++++V G S +LP ++ + +
Sbjct: 124 VHRDLAARNVLVSED------NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 720 TCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLI 778
T DV+ FG +L E+ + G+ +PY I K++V ++ +
Sbjct: 178 T-KSDVWSFGILLWEIYSFGR------------------VPYPRIPLKDVVPRVEKGYKM 218
Query: 779 IDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817
D V + V + C + RP + + LE+
Sbjct: 219 DAPDGCPPV--VYDVMKQCWHLDAATRPSFLQLREQLEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 25/88 (28%), Positives = 49/88 (55%), Gaps = 1/88 (1%)
Query: 267 LDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGP 326
L L L G +P+++ LR LQ + N + GN+ + +++ L+++ L N F G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPS-LGSITSLEVLDLSYNSFNGS 481
Query: 327 PPDVLWSMPQLRLLDISRNNFTGPLPNS 354
P+ L + LR+L+++ N+ +G +P +
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 45/216 (20%), Positives = 90/216 (41%), Gaps = 32/216 (14%)
Query: 540 NLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEA-------YLLELDFFSKVSHARLV 592
++ G G ++ G+ G + +K+++L + A E+D + H +V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 593 PLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSY 652
LG C++ +N + +++P G +SS L R L K +G++Y
Sbjct: 66 QYLGTCLD-DNTISIFMEFVPGGSISSILNR-------FGPLPEPVFCKYTKQILDGVAY 117
Query: 653 LHHECTLPFVHRDVQASSILLDDKFEVRL---GSLSEVCAQGGDAHQSRITRLLR----- 704
LH+ C VHRD++ ++++L ++L G + G S + + +
Sbjct: 118 LHNNCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 705 -LPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGK 739
P+ + G + D++ G + E+ TGK
Sbjct: 175 MAPEVINESGYGRKS-----DIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 60/284 (21%), Positives = 116/284 (40%), Gaps = 52/284 (18%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENE 604
G G+++ V +K + S+ EA+L E + + H +LV L H + +
Sbjct: 17 GQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--HAVVTKEP 74
Query: 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHR 664
+++ ++M G L L ++ L L + + AEG++++ ++HR
Sbjct: 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIEQR---NYIHR 126
Query: 665 DVQASSILLDDKFEVRLGSL--------SEVCAQGGDAHQSRITRLLRLPQSSEQGSSGS 716
D++A++IL+ ++ +E A+ G + T P++ GS
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGS--- 179
Query: 717 LTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQ--TLPYISIYDKELVTKIV 773
T DV+ FG +L+E+VT G++ S+ +V LE+ +P +EL
Sbjct: 180 --FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY---- 233
Query: 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817
+++ W +P RP YI L++
Sbjct: 234 --------NIMMRCW----------KNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 75/297 (25%), Positives = 126/297 (42%), Gaps = 57/297 (19%)
Query: 535 DFSDANLIKN---GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARL 591
D D +K G G + G G V IK I S+ + ++ E K+SH +L
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKL 61
Query: 592 VPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLS 651
V L G C ++ ++V +YM NG L + L R+ L L++ EG++
Sbjct: 62 VQLYGVC-TKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQL-----LEMCKDVCEGMA 114
Query: 652 YLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQ 711
YL + F+HRD+ A + L+DD+ V++ D SR +L +S
Sbjct: 115 YLESK---QFIHRDLAARNCLVDDQGCVKV----------SDFGLSRY--VLDDEYTSSV 159
Query: 712 GSSGSLTATCP-----------YDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLP 759
GS + + P DV+ FG ++ E+ + GKM ++++ E + Q L
Sbjct: 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL- 218
Query: 760 YISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816
+Y L + E+V+A + SC + K RP + +L ++E
Sbjct: 219 --RLYRPHLAS--------------EKVYA---IMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 51/274 (18%), Positives = 100/274 (36%), Gaps = 45/274 (16%)
Query: 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRID---LQSVKTEAY-LLELDFFSKVSHA 589
DF +I G + E IK +D L K Y +E + ++++
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 590 RLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAE- 648
+ L + + E + V +Y PNG+L + + D + + AE
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYA--------AEI 111
Query: 649 --GLSYLHHECTLPFVHRDVQASSILLDDKFEVRL---GSLSEVCAQGGDAHQSRITRLL 703
L YLH + +HRD++ +ILLD +++ G+ + +
Sbjct: 112 LLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 704 RLPQSSEQGSSGSLTATCPY---------------DVYCFGKVLLELVTGKMGISASSDA 748
+ S T Y D++ G ++ +++TGK S++
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228
Query: 749 QV-KEILEQTLPYISIYD---KELVTKI--VDPS 776
++IL+ + + K+L+ K+ +DP
Sbjct: 229 LTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQ 262
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 17/148 (11%)
Query: 541 LIKNGHSGDLFRGI---LEG-GIPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPL 594
I G GD+++G+ E I V +K + E +L E + H +V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 595 LGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLH 654
+G EN ++V + P G+L S Y + N SLD + + + + L+YL
Sbjct: 73 IGVI--TENPVWIVMELAPLGELRS--YLQVNKY----SLDLASLILYSYQLSTALAYLE 124
Query: 655 HECTLPFVHRDVQASSILLDDKFEVRLG 682
+ FVHRD+ A ++L+ V+LG
Sbjct: 125 ---SKRFVHRDIAARNVLVSSPDCVKLG 149
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 38/146 (26%), Positives = 65/146 (44%), Gaps = 11/146 (7%)
Query: 542 IKNGHSGDLFRGILEGGIP---VVIKRIDLQSVKTE--AYLLELDFFSKVSHARLVPLLG 596
I NG G + G G+ VV+K + + E +L E+ + +++H ++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 597 HCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHE 656
C+E LV ++ P GDL + Y ++N Q ++A A GL +LH
Sbjct: 63 QCIE-SIPYLLVLEFCPLGDLKN--YLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118
Query: 657 CTLPFVHRDVQASSILLDDKFEVRLG 682
F+H D+ + L V++G
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIG 142
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 2e-06
Identities = 62/279 (22%), Positives = 96/279 (34%), Gaps = 59/279 (21%)
Query: 545 GHSGDLFRGILEG-GIPVVIKRI--DLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMER 601
G SG +++ + G +K+I D + L EL +V G +
Sbjct: 12 GSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG-AFYK 70
Query: 602 ENEKFLVYKYMPNGDLSSSLYR-KTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLP 660
E E +V +YM G L+ L + E L IA +GL YLH
Sbjct: 71 EGEISIVLEYMDGGSLADLLKKVGKIPEPVLA--------YIARQILKGLDYLHT--KRH 120
Query: 661 FVHRDVQASSILLDDKFEVRLGSL--SEVCAQGGDAHQS-----------RITRLLRLPQ 707
+HRD++ S++L++ K EV++ S+V D + RI
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI-------- 172
Query: 708 SSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKE 767
QG S S A D++ G LLE GK E+++
Sbjct: 173 ---QGESYSYAA----DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPP--S 222
Query: 768 LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP 806
L + P ++ CL P +RP
Sbjct: 223 LPAEEFSPEFR------------DFISA-CLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 42/137 (30%), Positives = 66/137 (48%), Gaps = 22/137 (16%)
Query: 561 VVIKRIDL---QSV-KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGD 616
V IK++ QS K + + E+ F ++ H + G C RE+ +LV +Y G
Sbjct: 43 VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG-CYLREHTAWLVMEYCL-GS 100
Query: 617 LSSSL--YRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLD 674
S L ++K E ++ + I GA +GL+YLH +HRD++A +ILL
Sbjct: 101 ASDILEVHKKPLQEVEIAA--------ICHGALQGLAYLHSHER---IHRDIKAGNILLT 149
Query: 675 DKFEVRL---GSLSEVC 688
+ V+L GS S V
Sbjct: 150 EPGTVKLADFGSASLVS 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 32/215 (14%)
Query: 540 NLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLL---ELDFFSKVSHARLVPLL 595
N I G G ++ + L+ G + +K I +Q + E+ + H LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 596 GHCMERENEKFLVY-KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLH 654
G +E EK ++ +Y G L L D+ + R+ + EGL+YLH
Sbjct: 66 G--VEVHREKVYIFMEYCSGGTLEELL-EHGRILDEH-----VIRV-YTLQLLEGLAYLH 116
Query: 655 HECTLPFVHRDVQASSILLDD----KF-----EVRLGSLSEVCAQGGDAHQSRITRLLRL 705
+ VHRD++ ++I LD K V+L + + + + T
Sbjct: 117 -SHGI--VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAG--TPAYMA 171
Query: 706 PQS-SEQGSSGSLTATCPYDVYCFGKVLLELVTGK 739
P+ + G A D++ G V+LE+ TGK
Sbjct: 172 PEVITGGKGKGHGRAA---DIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 5e-06
Identities = 64/260 (24%), Positives = 98/260 (37%), Gaps = 51/260 (19%)
Query: 141 LPTLQALDLRSCSISGV-IPFSLGNLT---NLTSLYLSDNGL------TGTIPSSLGQLS 190
L LQ L L ++ L +L L LS N ++ L +
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81
Query: 191 VLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSL 250
L LDLS N+L P G+L++L S LQ L ++NN L
Sbjct: 82 GLQELDLSDNALG---PDGCGVLESLLR------------------SSSLQELKLNNNGL 120
Query: 251 ASS----IPAQLGDLD-SLVDLDLSMNSLSG----SVPSELRGLRSLQKFVIGNNFLSGN 301
+ L DL +L L L N L G ++ LR R L++ + NN +
Sbjct: 121 GDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDA 180
Query: 302 LSVNL---FPTVSQLQIIVLRQNGFT----GPPPDVLWSMPQLRLLDISRNNFTGP---- 350
L L+++ L NG T + L S+ L +L++ NN T
Sbjct: 181 GIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAA 240
Query: 351 LPNSRSNVNTSTVELNISQN 370
L ++ + N S + L++S N
Sbjct: 241 LASALLSPNISLLTLSLSCN 260
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 8/111 (7%)
Query: 574 EAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDL-- 631
E +L E+ S++S + LLG C + ++ +YM NGDL+ L + L
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCT-VDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 632 --QSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVR 680
+SL + T L +A A G+ YL +L FVHRD+ + L+ + ++
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIK 170
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 61/290 (21%), Positives = 116/290 (40%), Gaps = 57/290 (19%)
Query: 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKT---EAYLLELDFFSKVSHAR 590
G + + +L+++ G + VIK+++L++ +A E S++ H
Sbjct: 11 GSYGEVSLVRHRTDGKQY----------VIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLY-RKTNTEDDLQSLDWITRLKIAIGAAEG 649
+V + ++V + GDL L +K + Q ++W ++ +A
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------ 114
Query: 650 LSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSS 709
L YLH + L HRD++ ++ L +++G L A+ + + L+ P
Sbjct: 115 LQYLHEKHIL---HRDLKTQNVFLTRTNIIKVGDLG--IARVLENQCDMASTLIGTPYYM 169
Query: 710 EQGSSGSLTATCPY----DVYCFGKVLLELVTGKMGISASS-DAQVKEILEQTLPYI-SI 763
S L + PY DV+ G + E+ T K +A ++ V I+E LP +
Sbjct: 170 ----SPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKD 225
Query: 764 YDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
Y EL I + L+ +P +RP ++ IL+
Sbjct: 226 YSPELGELI----------------------ATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 1e-05
Identities = 20/58 (34%), Positives = 28/58 (48%)
Query: 239 KLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNN 296
L+ L++SNN L L +L LDLS N+L+ P GL SL+ + N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 69/298 (23%), Positives = 112/298 (37%), Gaps = 79/298 (26%)
Query: 535 DFSDANLIKNGHSGDLFRGILEGGIPV-VIKRIDLQSVKT---EAYLLELDFFSKVSHAR 590
DF N I G G +F+ + + V +K+IDL + E + E +K+ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 591 LVPLLGHCMERENEKFL-------VYKYMPNGDLSSSL--YRKTNTEDDLQSLDWITRLK 641
++ R E FL V +Y NGDL L R +D W +
Sbjct: 61 II--------RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV---W----R 105
Query: 642 IAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITR 701
I GL++LH + +HRD+++ ++ LD V++G L + +
Sbjct: 106 FFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLG-------------VAK 149
Query: 702 LLRLPQSSEQGSSGS-------LTATCPY----DVYCFGKVLLELVTGKMGISASSD-AQ 749
LL + G+ L PY DV+ G VL E TGK A++ A
Sbjct: 150 LLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL 209
Query: 750 VKEILEQTLPYIS-IYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP 806
+ +I+ P +S +Y ++L L+ CL +RP
Sbjct: 210 ILKIIRGVFPPVSQMYSQQLA------------QLI----------DQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 49/192 (25%), Positives = 86/192 (44%), Gaps = 16/192 (8%)
Query: 574 EAYLLELDFFSKVSHARLVPLLGHCMER-ENEKF----LVYKYMPNGDLSSSL-YRKTNT 627
E +L E + H ++ L+G C++ E+E + ++ +M +GDL S L Y +
Sbjct: 45 EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG- 103
Query: 628 EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS--LS 685
D Q L +K A G+ YL + F+HRD+ A + +L++ V + LS
Sbjct: 104 -DCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLS 159
Query: 686 EVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISA 744
+ G Q RI ++ + E S T DV+ FG + E+ T G+
Sbjct: 160 KKIYNGDYYRQGRIAKMPVKWIAIE--SLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217
Query: 745 SSDAQVKEILEQ 756
++++ + L Q
Sbjct: 218 VENSEIYDYLRQ 229
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 39/169 (23%), Positives = 68/169 (40%), Gaps = 18/169 (10%)
Query: 536 FSDANLIKNGHSGDLFRGILEG-GIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPL 594
+ + I G SG++++ G V IK++ L+ E + E+ H +V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 595 LGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAE---GLS 651
+E ++V +YM G L+ + + ++ Q IA E GL
Sbjct: 81 YD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQ---------IAYVCREVLQGLE 130
Query: 652 YLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRIT 700
YLH + +HRD+++ +ILL V+L AQ R +
Sbjct: 131 YLH---SQNVIHRDIKSDNILLSKDGSVKLADFG-FAAQLTKEKSKRNS 175
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 32/119 (26%), Positives = 54/119 (45%), Gaps = 17/119 (14%)
Query: 559 IPVVIKRIDLQS--VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGD 616
IPV IK + ++ + L E + V H +V LLG C+ + + L+ + MP G
Sbjct: 37 IPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQ--LITQLMPLGC 94
Query: 617 LSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL--HHECTLPFVHRDVQASSILL 673
L + + L+W ++ A+G+SYL VHRD+ A ++L+
Sbjct: 95 LLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEEKR-----LVHRDLAARNVLV 142
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 59/251 (23%), Positives = 111/251 (44%), Gaps = 49/251 (19%)
Query: 579 ELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKT-------NTEDD- 630
E +++ H +V LLG + +E ++++Y+ GDL L ++ ++++D
Sbjct: 57 EASLMAELHHPNIVCLLG-VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115
Query: 631 --LQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS--- 685
SLD L IAI A G+ YL FVH+D+ A +IL+ ++ V++ L
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR 172
Query: 686 EVCAQGGDAHQSRITRLLRL----PQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMG 741
E+ + D ++ + LL + P++ G S + D++ FG VL E+ + G
Sbjct: 173 EIYS--ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDS-----DIWSFGVVLWEIFS--FG 223
Query: 742 ISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLI-IDEDLLEEVWAMAIVARSCLNP 800
+ PY ++E++ + L+ ED ++++ C
Sbjct: 224 LQ---------------PYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMT---ECWQE 265
Query: 801 KPTRRPLMRYI 811
P+RRP + I
Sbjct: 266 GPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 51/222 (22%), Positives = 99/222 (44%), Gaps = 20/222 (9%)
Query: 542 IKNGHSGDLFRGILEG-GIPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHC 598
I G+ G++F G L PV +K R L +L E + SH +V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 599 MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECT 658
+++ ++V + + GD + L + L +++ AA G+ YL +
Sbjct: 63 TQKQ-PIYIVMELVQGGDFLTFL------RTEGPRLKVKELIQMVENAAAGMEYLESKHC 115
Query: 659 LPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLP---QSSEQGSSG 715
+HRD+ A + L+ +K +++ + + D + + ++P + E + G
Sbjct: 116 ---IHRDLAARNCLVTEKNVLKISDFG-MSREEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 716 SLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQ 756
++ DV+ FG +L E + G + + S+ Q +E +EQ
Sbjct: 172 RYSSES--DVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ 211
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 61/258 (23%), Positives = 107/258 (41%), Gaps = 48/258 (18%)
Query: 579 ELDFFSKVS-HARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDD------- 630
EL+ K+ H ++ LLG C E +L +Y P+G+L L + E D
Sbjct: 57 ELEVLCKLGHHPNIINLLGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 115
Query: 631 --LQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688
+L L A A G+ YL + F+HRD+ A +IL+ + + ++
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG--L 170
Query: 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTA-TCPYDVYCFGKVLLELVTGKMGISASSD 747
++G + + + + RLP S + + T DV+ +G +L E+V+ +G +
Sbjct: 171 SRGQEVYVKKT--MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--LGGT---- 222
Query: 748 AQVKEILEQTLPYISIYDKELVTKI-----VDPSLIIDEDLLEEVWAMAIVARSCLNPKP 802
PY + EL K+ ++ L D+++ + + R C KP
Sbjct: 223 -----------PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYD-------LMRQCWREKP 264
Query: 803 TRRPLMRYILKALENPLK 820
RP IL +L L+
Sbjct: 265 YERPSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 45/218 (20%)
Query: 541 LIKNGHSGDLFRGILE----GGIPVVIKRIDLQSVKTEA----YLLELDFFSKVSHARLV 592
+I G G++FRGIL+ + V IK L+ TE +L E + SH ++
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIK--TLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 593 PLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSY 652
L G + + ++ +YM NG L L + + S + L+ G A G+ Y
Sbjct: 70 RLEG-VVTKFKPAMIITEYMENGALDKYLRDH---DGEFSSYQLVGMLR---GIAAGMKY 122
Query: 653 LHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQG 712
L + +VHRD+ A +IL++ E ++ D SR+ L P+ +
Sbjct: 123 LSD---MNYVHRDLAARNILVNSNLECKV----------SDFGLSRV--LEDDPEGTYTT 167
Query: 713 SSGSL----TA---------TCPYDVYCFGKVLLELVT 737
S G + TA T DV+ FG V+ E+++
Sbjct: 168 SGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 30/166 (18%)
Query: 602 ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPF 661
E+ FLV ++ G L S + + N ++ W + +A+ A LH E
Sbjct: 57 EDSVFLVLQHAEGGKLWSHISKFLNIPEE-CVKRWAAEMVVALDA------LHRE---GI 106
Query: 662 VHRDVQASSILLDDKFEVRL---GSLSEVCAQ-GGDAHQSRITRLLRLPQSSEQGSSGSL 717
V RD+ ++ILLDD+ ++L SEV G+A + + P E G
Sbjct: 107 VCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEA----VENMYCAP---EVGGISEE 159
Query: 718 TATCPYDVYCFGKVLLELVTGKM-------GISASSDAQVKEILEQ 756
T C D + G +L EL+TGK GI+ + + E + +
Sbjct: 160 TEAC--DWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSE 203
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 32/190 (16%)
Query: 137 LGQQLPT---LQALDLRSCSISGVIPFSLGNLTNLTSL---YLSDNGLTGT----IPSSL 186
L Q L LQ LDL ++ L +L +SL L++NGL + L
Sbjct: 73 LLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGL 132
Query: 187 GQLSV-LSVLDLSRNSLTGNIPTSFGLLKNLSS------LDISSNYLTG----SIPPGLG 235
L L L L RN L G + L K L + L++++N + ++ GL
Sbjct: 133 KDLPPALEKLVLGRNRLEGA--SCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLK 190
Query: 236 TLSKLQYLNVSNNSL----ASSIPAQLGDLDSLVDLDLSMNSLSGSVPSEL-----RGLR 286
L+ L+++NN L AS++ L L SL L+L N+L+ + + L
Sbjct: 191 ANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNI 250
Query: 287 SLQKFVIGNN 296
SL + N
Sbjct: 251 SLLTLSLSCN 260
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 51/220 (23%), Positives = 83/220 (37%), Gaps = 43/220 (19%)
Query: 603 NEKFL-------VYKYMPNGDLSSSLYRKTNTEDDL-QSLDWITRLKIAIGAAEGLSYLH 654
E FL V +Y P GDLS ++ ++ + + W +I I GL LH
Sbjct: 65 KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGLQALH 120
Query: 655 HECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS 714
+HRD+++++ILL V++G L + +++I + +G
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRP 177
Query: 715 GSLTATCPYDVYCFGKVLLELVTGKMGISASS--DAQVKEILEQTLPYISIYDKELVTKI 772
S + D++ G +L E+ T A S D + K + P IY ++L
Sbjct: 178 YSYKS----DIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDL-QNF 232
Query: 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYIL 812
+ RS L KP RP IL
Sbjct: 233 I---------------------RSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 5e-05
Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 15/155 (9%)
Query: 534 GDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHAR-L 591
G F L+ NG G +++G ++ G IK +D+ + E E++ K SH R +
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI 65
Query: 592 VPLLGHCMER-----ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGA 646
G +++ +++ +LV ++ G ++ + NT+ + +WI + I
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---KNTKGNTLKEEWIAYICREI-- 120
Query: 647 AEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRL 681
GLS+LH +HRD++ ++LL + EV+L
Sbjct: 121 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL 152
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 42/217 (19%)
Query: 541 LIKNGHSGDLFRGI-LEGGIPVVIKR--IDLQSVKTEAYLLELD----FFSKVSHARLVP 593
L+ +G G ++ G+ L+ G +K + + + +L+ SK+ H +V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 594 LLGHCMERENEKFLVY-KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSY 652
LG ERE + ++ + +P G L+ L +K + + + TR + GL Y
Sbjct: 67 YLG--TEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLY-TRQILL-----GLEY 117
Query: 653 LHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSS--- 709
LH T VHRD++ ++IL+D V+L A G A Q + + S
Sbjct: 118 LHDRNT---VHRDIKGANILVDTNGVVKL-------ADFGMAKQVVEFSFAKSFKGSPYW 167
Query: 710 -------EQGSSGSLTATCPYDVYCFGKVLLELVTGK 739
+QG G D++ G +LE+ TGK
Sbjct: 168 MAPEVIAQQGGYGL-----AADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 18/155 (11%)
Query: 536 FSDANLIKNGHSGDLF--RGILEGGIPVVIKRIDLQSVKT----EAYLLELDFFSKVSHA 589
FSD I +G G ++ R + + V IK++ ++ + + E+ F K+ H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 590 RLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEG 649
+ G C RE+ +LV +Y G S L E + L + + GA +G
Sbjct: 76 NTIQYRG-CYLREHTAWLVMEYCL-GSASDLL------EVHKKPLQEVEIAAVTHGALQG 127
Query: 650 LSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSL 684
L+YLH +HRDV+A +ILL + V+LG
Sbjct: 128 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 34/141 (24%), Positives = 70/141 (49%), Gaps = 16/141 (11%)
Query: 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVP 593
G F + +++ +GD++ + V+ K + L + E D S +S++ +P
Sbjct: 12 GHFGEVQVVREKATGDIY------AMKVMKKSVLLAQETVSFFEEERDILS-ISNSPWIP 64
Query: 594 LLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL 653
L + + ++ +LV +Y P GDL S L R + D+ + ++ L +AI + +
Sbjct: 65 QLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHS------V 118
Query: 654 HHECTLPFVHRDVQASSILLD 674
H + +VHRD++ ++L+D
Sbjct: 119 H---QMGYVHRDIKPENVLID 136
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 9e-05
Identities = 38/153 (24%), Positives = 65/153 (42%), Gaps = 21/153 (13%)
Query: 536 FSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLL--ELDFFSKVSHARLV 592
F+ I G G++++ I V IK IDL+ + E + E+ F S+ +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 593 PLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAE---G 649
G + ++ +++ +Y G L E IA E G
Sbjct: 63 KYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDET-----------YIAFILREVLLG 110
Query: 650 LSYLHHECTLPFVHRDVQASSILLDDKFEVRLG 682
L YLH E +HRD++A++ILL ++ +V+L
Sbjct: 111 LEYLHEEGK---IHRDIKAANILLSEEGDVKLA 140
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 41/172 (23%), Positives = 82/172 (47%), Gaps = 22/172 (12%)
Query: 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYL-LELDFFSKVSHARLV 592
G F + L++ +G ++ ++++ D+ + A++ E D + A +V
Sbjct: 12 GAFGEVRLVQKKDTGHIY-------AMKILRKADMLEKEQVAHIRAERDILVEADGAWVV 64
Query: 593 PLLGHCMERENEKFLVYKYMPNGDLSSSLYRK-TNTEDDLQSLDWITRLKIAIGAAEGLS 651
+ ++ N +L+ +++P GD+ + L +K T +E+ Q +I +AI A
Sbjct: 65 KMFYSFQDKRN-LYLIMEFLPGGDMMTLLMKKDTLSEEATQF--YIAETVLAIDA----- 116
Query: 652 YLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLL 703
+H L F+HRD++ ++LLD K V+L +C AH++ R L
Sbjct: 117 -IHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFG-LCTGLKKAHRTEFYRNL 163
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 63/270 (23%), Positives = 103/270 (38%), Gaps = 49/270 (18%)
Query: 565 RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRK 624
R++L K ++ELD K +V G E ++ +YM G SL +
Sbjct: 35 RLELDESKFNQIIMELDILHKAVSPYIVDFYG-AFFIEGAVYMCMEYMDAG----SLDKL 89
Query: 625 TNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRL--- 681
+ + +I +GL +L E +HRDV+ +++L++ +V+L
Sbjct: 90 YAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDF 147
Query: 682 ---GSLSEVCAQGGDAHQSRITRLLRLPQS-SEQGSSGSLTATCPYDVYCFGKVLLELVT 737
G+L A+ QS + P+ G + + T T DV+ G +LE+
Sbjct: 148 GVSGNLVASLAKTNIGCQSYMA-----PERIKSGGPNQNPTYTVQSDVWSLGLSILEMAL 202
Query: 738 GKM----GISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIV 793
G+ A+ AQ+ I++ P + PS D+ A V
Sbjct: 203 GRYPYPPETYANIFAQLSAIVDGDPPTL-------------PSGYSDD-------AQDFV 242
Query: 794 ARSCLNPKPTRRP-----LMRYILKALENP 818
A CLN P RRP L L +N
Sbjct: 243 A-KCLNKIPNRRPTYAQLLEHPWLVKYKNA 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 59/260 (22%), Positives = 106/260 (40%), Gaps = 42/260 (16%)
Query: 570 SVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFL-----VYKYMPNGDLSSSLYRK 624
S E +L E + H ++ L+G + + L + +M +GDL + L
Sbjct: 42 SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMS 101
Query: 625 TNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS- 683
E+ +L T ++ I A G+ YL + F+HRD+ A + +L++ V +
Sbjct: 102 RIGEEPF-TLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157
Query: 684 -LSEVCAQGGDAHQSRITRL----LRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTG 738
LS+ G Q ++L L L ++ T DV+ FG + E++T
Sbjct: 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADN------VYTTHSDVWAFGVTMWEIMT- 210
Query: 739 KMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPS-LIIDEDLLEEVWAMAIVARSC 797
QT PY + + E+ ++ + L D LE+V+ + C
Sbjct: 211 ---------------RGQT-PYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMC---QC 251
Query: 798 LNPKPTRRPLMRYILKALEN 817
+P+P RP +++ LE
Sbjct: 252 WSPEPKCRPSFQHLRDQLEL 271
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 49/191 (25%), Positives = 80/191 (41%), Gaps = 32/191 (16%)
Query: 630 DLQSLDWITRL----------KIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEV 679
D SLD I + KIA+ EGL+YL++ +HRD++ S+IL++ + ++
Sbjct: 86 DCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQI 143
Query: 680 RL---GSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELV 736
+L G E+ D T + S E+ G T DV+ G ++EL
Sbjct: 144 KLCDFGVSGELINSIADTFVGTSTYM-----SPERIQGGKYTVKS--DVWSLGISIIELA 196
Query: 737 TGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV-DPSLIIDEDLLEEVWAMAIVAR 795
GK + S+ + + I D L+ +IV +P + E +
Sbjct: 197 LGKFPFAFSNIDDDGQ-----DDPMGILD--LLQQIVQEPPPRLPSSDFPED--LRDFVD 247
Query: 796 SCLNPKPTRRP 806
+CL PT RP
Sbjct: 248 ACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 40/156 (25%), Positives = 78/156 (50%), Gaps = 17/156 (10%)
Query: 534 GDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHAR-L 591
G F ++ NG G +++G ++ G IK +D+ + E LE++ K SH R +
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNI 75
Query: 592 VPLLGHCMER-----ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGA 646
G +++ +++ +LV ++ G ++ + NT+ + DWI + I
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV---KNTKGNALKEDWIAYICREI-- 130
Query: 647 AEGLSYLH-HECTLPFVHRDVQASSILLDDKFEVRL 681
GL++LH H+ +HRD++ ++LL + EV+L
Sbjct: 131 LRGLAHLHAHKV----IHRDIKGQNVLLTENAEVKL 162
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 36/135 (26%), Positives = 65/135 (48%), Gaps = 16/135 (11%)
Query: 559 IPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDL- 617
+ V I R D +L E+ S++ ++ LLG C++ E+ ++ +YM NGDL
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-EDPLCMITEYMENGDLN 107
Query: 618 ----SSSLYRKTNTEDD-------LQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDV 666
S L K +D L ++ + + L +A+ A G+ YL +L FVHRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164
Query: 667 QASSILLDDKFEVRL 681
+ L+ + +++
Sbjct: 165 ATRNCLVGENLTIKI 179
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 70/287 (24%), Positives = 119/287 (41%), Gaps = 49/287 (17%)
Query: 536 FSDANLIKNGHSGDLFRGILEGGIPVV-IKRIDLQSVKTEAYLL--ELDFFSKVSHARLV 592
F+ I G G++F+GI VV IK IDL+ + E + E+ S+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 593 PLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSY 652
G + + + +++ +Y+ G L + D+ Q T LK + +GL Y
Sbjct: 66 KYYGSYL-KGTKLWIIMEYLGGGSALDLL--RAGPFDEFQI---ATMLKEIL---KGLDY 116
Query: 653 LHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRI----TRLLRLPQS 708
LH E +HRD++A+++LL ++ +V+L V Q D R T P+
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEQGDVKLADFG-VAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 709 SEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768
+Q + S D++ G +EL G+ +SD +L L
Sbjct: 173 IQQSAYDSKA-----DIWSLGITAIELAKGE---PPNSDMHPMRVL------------FL 212
Query: 769 VTKIVDPSLIID--EDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
+ K P+L + + E + A CLN P+ RP + +LK
Sbjct: 213 IPKNNPPTLTGEFSKPFKEFIDA-------CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 36/166 (21%), Positives = 70/166 (42%), Gaps = 21/166 (12%)
Query: 579 ELDFFSKVSHARLVPLLGHCMER-ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWI 637
E++ + H +V G C + L+ +Y+P+G L L R + ++
Sbjct: 56 EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD------QINLK 109
Query: 638 TRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS--LSEVCAQGGDAH 695
L + +G+ YL + ++HRD+ A +IL++ + V++ L++V + D +
Sbjct: 110 RLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYY 166
Query: 696 QSRITRLLRLPQSSEQGSSGSLTATCPY----DVYCFGKVLLELVT 737
+ +S + T + DV+ FG L EL T
Sbjct: 167 YVKEPG-----ESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 47/178 (26%), Positives = 69/178 (38%), Gaps = 24/178 (13%)
Query: 570 SVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV--YKYMPNGDLSSSLYRKTNT 627
S + A E+ + H R+V G C+ EK L +YMP G + L
Sbjct: 45 SKEVSALECEIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGAL 103
Query: 628 EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS---- 683
+ +TR K EG+SYLH VHRD++ ++IL D V+LG
Sbjct: 104 TES------VTR-KYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS 153
Query: 684 --LSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGK 739
L +C G T P+ G DV+ G ++E++T K
Sbjct: 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKA-----DVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 19/170 (11%)
Query: 579 ELDFFSKVS-HARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDD------- 630
EL+ K+ H ++ LLG C E ++ +Y P G+L L + E D
Sbjct: 52 ELEVLCKLGHHPNIINLLGAC-ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEH 110
Query: 631 --LQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688
+L L+ A A G+ YL + F+HRD+ A ++L+ + ++
Sbjct: 111 GTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFG--L 165
Query: 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTA-TCPYDVYCFGKVLLELVT 737
++G + + + + RLP S + + T DV+ FG +L E+V+
Sbjct: 166 SRGEEVYVKKT--MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-04
Identities = 62/220 (28%), Positives = 81/220 (36%), Gaps = 38/220 (17%)
Query: 162 LGNLTNLTSLYLSDNGLTGTIP---SSLGQLSVLSVLDLSRNSLTGNI-PTSFGLLK--- 214
L L L LSDN L SL + S L L L+ N L LK
Sbjct: 77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLP 136
Query: 215 -NLSSLDISSNYLTG-SIPPGLGTLS---KLQYLNVSNNSL-ASSIPA---QLGDLDSLV 265
L L + N L G S L L+ LN++NN + + I A L +L
Sbjct: 137 PALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLE 196
Query: 266 DLDLSMNSLS---GSVPSE-LRGLRSLQKFVIGNN---------FLSGNLSVNLFPTVSQ 312
LDL+ N L+ S +E L L+SL+ +G+N S LS N
Sbjct: 197 VLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPN-----IS 251
Query: 313 LQIIVLRQNGFTGPP----PDVLWSMPQLRLLDISRNNFT 348
L + L N T +VL L LD+ N F
Sbjct: 252 LLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 18/187 (9%)
Query: 576 YLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTED----DL 631
+L E+ S++ ++ LL C+ + ++ +YM NGDL+ L R E D+
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCIT-SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 632 QSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS-EVCAQ 690
++ + T + +A A G+ YL +L FVHRD+ + L+ + +++
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 691 GGDAHQSRITRLLRLP---QSSEQGSSGSLTATCPYDVYCFGKVLLELVT--GKMGISAS 745
GD + RI LP S E G T DV+ FG L E++T + S
Sbjct: 182 SGDYY--RIQGRAVLPIRWMSWESILLGKFTTAS--DVWAFGVTLWEILTLCKEQPYSQL 237
Query: 746 SDAQVKE 752
SD QV E
Sbjct: 238 SDEQVIE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 3e-04
Identities = 64/257 (24%), Positives = 104/257 (40%), Gaps = 63/257 (24%)
Query: 561 VVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEK-FLVYKYMPNGDLSS 619
+IKR +++ TE +L +++H +V L H + EK +LV +Y P G+L S
Sbjct: 30 KIIKRKEVEHTLTERNILS-----RINHPFIVKL--HYAFQTEEKLYLVLEYAPGGELFS 82
Query: 620 SLYRKTN-TEDDLQSLDWITRLKIA-IGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF 677
L ++ +E+ R A I L YLH +L ++RD++ +ILLD
Sbjct: 83 HLSKEGRFSEER-------ARFYAAEI--VLALEYLH---SLGIIYRDLKPENILLDADG 130
Query: 678 EVRL---GSLSEVCAQGGDAHQSRITRLLRLPQ--SSEQGSSGSLTATCPYDVYCFGKVL 732
++L G E+ ++G + T P+ + E D + G +L
Sbjct: 131 HIKLTDFGLAKELSSEGSRTNTFCGT-----PEYLAPEVLLGKGYGKAV--DWWSLGVLL 183
Query: 733 LELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAI 792
E++TGK P+ + KE+ KI+ L E L E
Sbjct: 184 YEMLTGK------------------PPFYAEDRKEIYEKILKDPLRFPEFLSPE------ 219
Query: 793 VARS----CLNPKPTRR 805
AR L PT+R
Sbjct: 220 -ARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 67/288 (23%), Positives = 119/288 (41%), Gaps = 54/288 (18%)
Query: 548 GDLFRGILEGGIP------VVIKRID--LQSVKTEAYLLELDFFSKVSHARLVPLLGHCM 599
G +++G L G P V IK + + E + E S++ H +V LLG +
Sbjct: 19 GKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLG-VV 77
Query: 600 ERENEKFLVYKYMPNGDLSSSLYRKT------NTEDDL---QSLDWITRLKIAIGAAEGL 650
+E +++ Y + DL L ++ +T+DD +L+ + I A G+
Sbjct: 78 TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGM 137
Query: 651 SYL--HHECTLPFVHRDVQASSILLDDKFEVR---LGSLSEVCAQGGDAHQSRITRLLRL 705
+L HH H+D+ ++L+ DK V+ LG EV A D ++ LL +
Sbjct: 138 EFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFREVYA--ADYYKLMGNSLLPI 190
Query: 706 P-QSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIY 764
S E G + D++ +G VL E+ + G+ PY
Sbjct: 191 RWMSPEAIMYGKFSIDS--DIWSYGVVLWEVFS--YGLQ---------------PYCGYS 231
Query: 765 DKELVTKIVDPS-LIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYI 811
+++++ I + L +D V+ + + C N P+RRP + I
Sbjct: 232 NQDVIEMIRNRQVLPCPDDCPAWVYTLML---ECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 19/170 (11%)
Query: 579 ELDFFSKVSH-ARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDD------- 630
EL+ K+ H ++ LLG C E +L +Y P+G+L L + E D
Sbjct: 45 ELEVLCKLGHHPNIINLLGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 103
Query: 631 --LQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688
+L L A A G+ YL + F+HRD+ A +IL+ + + ++
Sbjct: 104 STASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG--L 158
Query: 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTA-TCPYDVYCFGKVLLELVT 737
++G + + + + RLP S + + T DV+ +G +L E+V+
Sbjct: 159 SRGQEVYVKKT--MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 57/263 (21%), Positives = 108/263 (41%), Gaps = 52/263 (19%)
Query: 573 TEAYLLELDFFSKVSHARLVPLLGHCMERENEKF-LVYKYMPNGDLSSSLYRKTNTEDDL 631
T + E++ + H +V G C E+ + L+ +Y+P G L L +
Sbjct: 50 TSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-------- 101
Query: 632 QSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS--LSEVCA 689
L+ L A EG++YLH + ++HRD+ A ++LLD+ V++G L++
Sbjct: 102 HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158
Query: 690 QGGDAHQSRITRLLRLPQSSEQGSSGSL--TATC--------PYDVYCFGKVLLELVTGK 739
+G + ++ R E G S C DV+ FG L EL+T
Sbjct: 159 EGHEYYRVR-----------EDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-H 206
Query: 740 MGISASSDAQVKEILEQT------LPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIV 793
S + +E++ + I + ++ + L ++ +EV+ I+
Sbjct: 207 CDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM-------RLPCPKNCPQEVY---IL 256
Query: 794 ARSCLNPKPTRRPLMRYILKALE 816
++C + RP R ++ L+
Sbjct: 257 MKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 67/297 (22%), Positives = 133/297 (44%), Gaps = 60/297 (20%)
Query: 545 GHSGDLFRGILEGGIPVVIK-----RIDLQSVKTEAYLLE-LDFFSKVSHAR------LV 592
G G ++ GI +G V+K R+ +++V A + E ++F ++ S + +V
Sbjct: 17 GSFGMVYEGIAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 593 PLLGHCMERENEKFLVYKYMPNGDLSSSL--YRKTNTEDDLQSLDWITRL-KIAIGAAEG 649
LLG + + ++ + M GDL S L R + +Q+ + ++ ++A A+G
Sbjct: 73 RLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 650 LSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITR-----LLR 704
++YL+ FVHRD+ A + ++ + F V++G D +++ R LL
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF----GMTRDIYETDYYRKGGKGLLP 184
Query: 705 L----PQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPY 760
+ P+S + G T DV+ FG VL E+ T + EQ PY
Sbjct: 185 VRWMSPESLKDG-----VFTTYSDVWSFGVVLWEIAT---------------LAEQ--PY 222
Query: 761 ISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817
+ +++++ +++ L+ D ++ + + R C P RP I+ +++
Sbjct: 223 QGMSNEQVLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 13/99 (13%)
Query: 606 FLVYKYMPNGDLSSSLYRK-TNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHR 664
+L+ +++P GD+ + L +K T TE++ Q +I +AI + +H L F+HR
Sbjct: 77 YLIMEFLPGGDMMTLLMKKDTLTEEETQF--YIAETVLAIDS------IHQ---LGFIHR 125
Query: 665 DVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLL 703
D++ ++LLD K V+L +C AH++ R L
Sbjct: 126 DIKPDNLLLDSKGHVKLSDFG-LCTGLKKAHRTEFYRNL 163
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 66/295 (22%), Positives = 128/295 (43%), Gaps = 52/295 (17%)
Query: 541 LIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLE-LDFFSKVSHAR------LVP 593
++ G++ D+ +G E R+ +++V A L E ++F ++ S + +V
Sbjct: 21 MVYEGNARDIIKGEAE-------TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 594 LLGHCMERENEKFLVYKYMPNGDLSSSLYR-KTNTEDDLQSLDWITRLKIAIGA--AEGL 650
LLG + + +V + M +GDL S L + E++ + I + A A+G+
Sbjct: 74 LLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 651 SYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITR-----LLRL 705
+YL+ + FVHRD+ A + ++ F V++G D +++ R LL +
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDF----GMTRDIYETDYYRKGGKGLLPV 185
Query: 706 P-QSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIY 764
+ E G T + D++ FG VL E+ + + EQ PY +
Sbjct: 186 RWMAPESLKDGVFTTSS--DMWSFGVVLWEITS---------------LAEQ--PYQGLS 226
Query: 765 DKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819
+++++ ++D + D E + + R C P RP I+ L++ L
Sbjct: 227 NEQVLKFVMDGGYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 41/153 (26%), Positives = 64/153 (41%), Gaps = 14/153 (9%)
Query: 561 VVIKRIDLQSVKTEAYLL---ELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDL 617
V +K+I+L S E L E+ ++ H ++P + ++E ++V M G
Sbjct: 28 VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-TSFIVDSELYVVSPLMAYG-- 84
Query: 618 SSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF 677
S KT+ + L L LK L Y+H + F+HR V+AS ILL
Sbjct: 85 SCEDLLKTHFPEGLPELAIAFILK---DVLNALDYIHSK---GFIHRSVKASHILLSGDG 138
Query: 678 EVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSE 710
+V L L + H R + P+SS
Sbjct: 139 KVVLSGLRYSVSM--IKHGKRQRVVHDFPKSSV 169
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 60/231 (25%), Positives = 89/231 (38%), Gaps = 54/231 (23%)
Query: 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEA--YLLELDFFSKVSH--- 588
D D I G G + + + G + +KRI + E L++LD + S
Sbjct: 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPY 64
Query: 589 -ARLVPLLGH------CMEREN---EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWIT 638
+ L CME + +KF YKY +Y + + L
Sbjct: 65 IVKFYGALFREGDCWICMELMDISLDKF--YKY---------VYEVLKSVIPEEILG--- 110
Query: 639 RLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRL------GSLSEVCAQGG 692
KIA+ + L+YL E L +HRDV+ S+ILLD ++L G L + A+
Sbjct: 111 --KIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTR 166
Query: 693 DAHQSRITRLLRLPQSSEQGSSGSLTATCPYD----VYCFGKVLLELVTGK 739
DA R+ S+ G YD V+ G L E+ TGK
Sbjct: 167 DAGCRPYMAPERIDPSARDG----------YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-04
Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 5/106 (4%)
Query: 243 LNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNL 302
L + N L IP + L L ++LS NS+ G++P L + SL+ + N +G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 303 SVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFT 348
+L ++ L+I+ L N +G P L RLL + NFT
Sbjct: 483 PESL-GQLTSLRILNLNGNSLSGRVPAALGG----RLLHRASFNFT 523
|
Length = 623 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 37/161 (22%), Positives = 68/161 (42%), Gaps = 15/161 (9%)
Query: 529 LLAATGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVS 587
L TG F +I G G +++ + G V IK +D+ + E E + K S
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 588 HARLVP------LLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLK 641
+ + + + +++ +LV + G ++ L + + +WI
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIAY-- 117
Query: 642 IAIGAAEGLSYLH-HECTLPFVHRDVQASSILLDDKFEVRL 681
I GL+YLH ++ +HRD++ +ILL EV+L
Sbjct: 118 ILRETLRGLAYLHENKV----IHRDIKGQNILLTKNAEVKL 154
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 35/141 (24%), Positives = 59/141 (41%), Gaps = 16/141 (11%)
Query: 540 NLIKNGHSGDLFRGIL----EGGIPVVIKRIDLQSVKTE--AYLLELDFFSKVSHARLVP 593
+I G G++ RG L + I V IK + S + +L E + H ++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 594 LLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL 653
L G + ++ +YM NG L L R+ + + + G A G+ YL
Sbjct: 70 LEGVVTKSR-PVMIITEYMENGSLDKFL-REND-----GKFTVGQLVGMLRGIASGMKYL 122
Query: 654 HHECTLPFVHRDVQASSILLD 674
+VHRD+ A +IL++
Sbjct: 123 SEMN---YVHRDLAARNILVN 140
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 28/161 (17%)
Query: 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKT----EAYLLELDFFSKVSHA 589
G F N H+ ++ V +K++ +T + + E+ F ++ H
Sbjct: 32 GSFGAVYFATNSHTNEV----------VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHP 81
Query: 590 RLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEG 649
+ G C +E+ +LV +Y G S L E + L + I GA +G
Sbjct: 82 NTIEYKG-CYLKEHTAWLVMEYCL-GSASDLL------EVHKKPLQEVEIAAITHGALQG 133
Query: 650 LSYLHHECTLPFVHRDVQASSILLDDKFEVRL---GSLSEV 687
L+YLH +HRD++A +ILL + +V+L GS S+
Sbjct: 134 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS 171
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 35/124 (28%), Positives = 54/124 (43%), Gaps = 25/124 (20%)
Query: 579 ELDFFSKVSHARLVPLLGHCMERENEKFLVY-KYMPNGDLSSSLYRK---TNTEDDLQSL 634
E+ + H R+V G R++E ++ +YMP G + L T T
Sbjct: 54 EIQLLKNLQHERIVQYYG--CLRDDETLSIFMEYMPGGSVKDQLKAYGALTET------- 104
Query: 635 DWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS------LSEVC 688
+TR K EG+ YLH + VHRD++ ++IL D V+LG L +C
Sbjct: 105 --VTR-KYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158
Query: 689 AQGG 692
+ G
Sbjct: 159 SSGT 162
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 7e-04
Identities = 40/169 (23%), Positives = 71/169 (42%), Gaps = 28/169 (16%)
Query: 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVP 593
G F + L+++ +G ++ + V+ K ++ + E D + +V
Sbjct: 12 GAFGEVWLVRDKDTGQVY------AMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 594 LLGHC-MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIA-IGAAEGLS 651
L + + E +LV +YMP GDL + L RK ++ R IA + A L
Sbjct: 66 L--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE------TARFYIAELVLA--LD 115
Query: 652 YLHHECTLPFVHRDVQASSILLDDKFEVRL---GSLSEVCAQGGDAHQS 697
+H L F+HRD++ +IL+D ++L G C + A
Sbjct: 116 SVH---KLGFIHRDIKPDNILIDADGHIKLADFGL----CKKMNKAKDR 157
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 9e-04
Identities = 18/61 (29%), Positives = 30/61 (49%), Gaps = 1/61 (1%)
Query: 287 SLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNN 346
+L+ + NN L+ + F + L+++ L N T P+ +P LR LD+S NN
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 347 F 347
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 15/40 (37%), Positives = 23/40 (57%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGL 178
+ LP L+ LDL +++ + P + L +L SL LS N L
Sbjct: 21 KGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 62/264 (23%), Positives = 98/264 (37%), Gaps = 74/264 (28%)
Query: 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRID---LQSVKTEAYLLELDFFSKVSHAR 590
G F A L+K+ G + VIK I+ + + E E+ S + H
Sbjct: 11 GSFGKAILVKSKEDGKQY----------VIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDL-----QSLDWITRLKIAIG 645
+V E ++V Y GDL Y+K N + + Q LDW ++ +A
Sbjct: 61 IV-QYQESFEENGNLYIVMDYCEGGDL----YKKINAQRGVLFPEDQILDWFVQICLA-- 113
Query: 646 AAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRL 705
L ++H L HRD+++ +I L ++LG I R+L
Sbjct: 114 ----LKHVHDRKIL---HRDIKSQNIFLTKDGTIKLGDFG-------------IARVLN- 152
Query: 706 PQSSEQGSSGSLTATC---PY----------------DVYCFGKVLLELVTGKMGISASS 746
S+ L TC PY D++ G VL E+ T K A +
Sbjct: 153 -------STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205
Query: 747 DAQ-VKEILEQTLPYISI-YDKEL 768
V +I+ + P +S Y +L
Sbjct: 206 MKNLVLKIIRGSYPPVSSHYSYDL 229
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 63/254 (24%), Positives = 106/254 (41%), Gaps = 43/254 (16%)
Query: 579 ELDFFSKVSHARLVPLLGHC--MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDW 636
E++ + H +V G C R N + LV +Y+P G L L + + LD
Sbjct: 55 EIEILKSLQHDNIVKYKGVCYSAGRRNLR-LVMEYLPYGSLRDYL------QKHRERLDH 107
Query: 637 ITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS--LSEVCAQGGDA 694
L A +G+ YL + +VHRD+ +IL++ + V++G L++V Q +
Sbjct: 108 RKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY 164
Query: 695 HQSRITRLLRLPQSSEQGSS-------GSLTA---TCPYDVYCFGKVLLELVTGKMGISA 744
++ R E G S SLT + DV+ FG VL EL T S
Sbjct: 165 YKVR-----------EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YSDKSC 212
Query: 745 SSDAQVKEIL--EQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKP 802
S A+ ++ ++ I + EL+ + L E++A+ + C N P
Sbjct: 213 SPPAEFMRMMGNDKQGQMIVYHLIELLKN--NGRLPAPPGCPAEIYAI---MKECWNNDP 267
Query: 803 TRRPLMRYILKALE 816
++RP + +E
Sbjct: 268 SQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 67/287 (23%), Positives = 115/287 (40%), Gaps = 49/287 (17%)
Query: 536 FSDANLIKNGHSGDLFRGILEGGIPVV-IKRIDLQSVKTEAYLL--ELDFFSKVSHARLV 592
F+ I G G++F+GI VV IK IDL+ + E + E+ S+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 593 PLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSY 652
G + ++ + +++ +Y+ G L + LD I +GL Y
Sbjct: 66 KYYGSYL-KDTKLWIIMEYLGGGSALDLL--------EPGPLDETQIATILREILKGLDY 116
Query: 653 LHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRI----TRLLRLPQS 708
LH E +HRD++A+++LL + EV+L V Q D R T P+
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEHGEVKLADFG-VAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 709 SEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYI--SIYDK 766
+Q + S D++ G +EL G+ S +V ++ + P Y K
Sbjct: 173 IKQSAYDSKA-----DIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSK 227
Query: 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
L ++ +E +CLN +P+ RP + +LK
Sbjct: 228 PL------------KEFVE----------ACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 0.001
Identities = 41/144 (28%), Positives = 70/144 (48%), Gaps = 21/144 (14%)
Query: 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVP 593
G + L K +GD++ I V+ K ++ + + L E D S+ +V
Sbjct: 4 GAYGRVFLAKKKSTGDIY------AIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 594 LLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLD-WITRLKIA-IGAAEGLS 651
L + + + +LV +Y+P GDL+S L +++ SLD + R+ IA I A L
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDLASLL-------ENVGSLDEDVARIYIAEIVLA--LE 107
Query: 652 YLHHECTLPFVHRDVQASSILLDD 675
YLH + +HRD++ +IL+D
Sbjct: 108 YLH---SNGIIHRDLKPDNILIDS 128
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 32/111 (28%), Positives = 52/111 (46%), Gaps = 25/111 (22%)
Query: 641 KIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRL------GSLSEVCAQGGDA 694
KIA+ + L YLH L +HRDV+ S++L++ +V+L G L + A+ DA
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164
Query: 695 ------HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGK 739
RI P+ +++G DV+ G ++EL TG+
Sbjct: 165 GCKPYMAPERIN-----PELNQKGYD------VKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 32/106 (30%), Positives = 50/106 (47%), Gaps = 11/106 (10%)
Query: 579 ELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWIT 638
E+ F ++ H + G C RE+ +LV +Y G S L E + L +
Sbjct: 75 EVKFLQRIKHPNSIEYKG-CYLREHTAWLVMEYCL-GSASDLL------EVHKKPLQEVE 126
Query: 639 RLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSL 684
I GA +GL+YLH +HRD++A +ILL + +V+L
Sbjct: 127 IAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADF 169
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.002
Identities = 27/84 (32%), Positives = 46/84 (54%), Gaps = 4/84 (4%)
Query: 318 LRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLT 377
L G G P+ + + L+ +++S N+ G +P S ++ TS L++S N F G +
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSI-TSLEVLDLSYNSFNGSIP 483
Query: 378 PVLGR---FRLVDLSGNYFEGRVP 398
LG+ R+++L+GN GRVP
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 69/271 (25%), Positives = 104/271 (38%), Gaps = 57/271 (21%)
Query: 559 IPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLS 618
+ VV+K + + A+ S++SH LV L G C+ EN +V +Y+ G L
Sbjct: 31 VSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI--MVEEYVKFGPLD 88
Query: 619 SSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFE 678
L+R+ N SL W +L +A A L YL + L VH +V +IL+
Sbjct: 89 VFLHREKNN----VSLHW--KLDVAKQLASALHYL-EDKKL--VHGNVCGKNILV----- 134
Query: 679 VRLGSLSE--VCAQGGD-----AHQSRITRLLRLP----QSSEQGSSGSLTATCPYDVYC 727
R G + D SR R+ R+P + G + A D +
Sbjct: 135 ARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAA---DKWS 191
Query: 728 FGKVLLELVT-GKMGISASSDAQVKEILEQ--TLPYISIYDKELVTKIVDPSLIIDEDLL 784
FG LLE+ + G+ +S S ++ + + LP EL I
Sbjct: 192 FGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDC--AELANLI------------ 237
Query: 785 EEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815
C PT+RP R IL+ L
Sbjct: 238 ----------NQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 51/259 (19%), Positives = 98/259 (37%), Gaps = 40/259 (15%)
Query: 561 VVIKRIDLQSV-KTEAYLL--ELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDL 617
VV K ++L + + E E+ S + H ++ H M+ +N + +Y G L
Sbjct: 28 VVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-DNTLLIEMEYANGGTL 86
Query: 618 SSSL-YRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK 676
+ +K ++ L ++ ++ A+ SY+H L HRD++ +I L
Sbjct: 87 YDKIVRQKGQLFEEEMVLWYLFQIVSAV------SYIHKAGIL---HRDIKTLNIFLTKA 137
Query: 677 FEVRLGS--LSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLE 734
++LG +S++ ++ + + QG + + D++ G VL E
Sbjct: 138 GLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKS----DIWALGCVLYE 193
Query: 735 LVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVA 794
L+T K A++ LV KIV + + + +
Sbjct: 194 LLTLKRTFDATNPL------------------NLVVKIVQGNYTPVVSVYSS--ELISLV 233
Query: 795 RSCLNPKPTRRPLMRYILK 813
S L P +RP +L
Sbjct: 234 HSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 63/243 (25%), Positives = 107/243 (44%), Gaps = 51/243 (20%)
Query: 584 SKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIA 643
S+VSH L + G C+ R +E +V +++ +G L L + E + W ++ +A
Sbjct: 71 SQVSHIHLAFVHGVCV-RGSENIMVEEFVEHGPLDVCLRK----EKGRVPVAW--KITVA 123
Query: 644 IGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG---------SLSEV-CAQGGD 693
A LSYL + VH +V A +ILL RLG LS+ +
Sbjct: 124 QQLASALSYLEDK---NLVHGNVCAKNILL-----ARLGLAEGTSPFIKLSDPGVSFTAL 175
Query: 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELV-TGKMGISASSDAQVKE 752
+ + R+ R+ + G + TA D + FG LLE+ G++ + + ++ KE
Sbjct: 176 SREERVERIPWIAPECVPGGNSLSTAA---DKWSFGTTLLEICFDGEVPLKERTPSE-KE 231
Query: 753 ILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYIL 812
Y+K+ ++ +PS ++L A + CL +PT+RP R IL
Sbjct: 232 ---------RFYEKKH--RLPEPSC---KEL-------ATLISQCLTYEPTQRPSFRTIL 270
Query: 813 KAL 815
+ L
Sbjct: 271 RDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 36.3 bits (85), Expect = 0.002
Identities = 16/38 (42%), Positives = 22/38 (57%), Gaps = 2/38 (5%)
Query: 142 PTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLT 179
L+ LDL + I+ + P L NL NL +L LS N +T
Sbjct: 1 TNLETLDLSNNQITDLPP--LSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 34/120 (28%), Positives = 55/120 (45%), Gaps = 16/120 (13%)
Query: 562 VIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSL 621
V+ R VK E D ++ + +V L +++N F V Y+P GD+ S L
Sbjct: 39 VLMRNQAAHVKAER-----DILAEADNEWVVKLYYSFQDKDNLYF-VMDYIPGGDMMSLL 92
Query: 622 YRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRL 681
R E+DL +I L AI +H + F+HRD++ +IL+D ++L
Sbjct: 93 IRLGIFEEDLARF-YIAELTCAI------ESVHK---MGFIHRDIKPDNILIDRDGHIKL 142
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 36/146 (24%), Positives = 70/146 (47%), Gaps = 16/146 (10%)
Query: 556 EGGIPVVIKRIDLQSVKT-EAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPN 614
E G K I+ +S + E Y++E++ + +H +V LLG + + +++ ++ P
Sbjct: 35 ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG-AFYWDGKLWIMIEFCPG 93
Query: 615 GDLSSSLYR--KTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSIL 672
G + + + + TE +Q I R + E L YLH ++ +HRD++A ++L
Sbjct: 94 GAVDAIMLELDRGLTEPQIQV---ICRQML-----EALQYLH---SMKIIHRDLKAGNVL 142
Query: 673 LDDKFEVRLGSLSEVCAQGGDAHQSR 698
L +++L V A+ Q R
Sbjct: 143 LTLDGDIKLADFG-VSAKNVKTLQRR 167
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.003
Identities = 27/105 (25%), Positives = 53/105 (50%), Gaps = 10/105 (9%)
Query: 579 ELDFFSKVSHARLVPLLGHCMERENEKF-LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWI 637
E++ + H +V G C E L+ +++P+G L L R N ++
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN------KINLK 109
Query: 638 TRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG 682
+LK A+ +G+ YL + +VHRD+ A ++L++ + +V++G
Sbjct: 110 QQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIG 151
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 31/114 (27%), Positives = 52/114 (45%), Gaps = 11/114 (9%)
Query: 570 SVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY-KYMPNGDLSSSLYRKTNTE 628
S + A E+ + H R+V G + E +K ++ +YMP G + L
Sbjct: 45 SKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALT 104
Query: 629 DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG 682
++ +TR + +G+SYLH VHRD++ ++IL D V+LG
Sbjct: 105 EN------VTR-RYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLG 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 41/125 (32%), Positives = 56/125 (44%), Gaps = 18/125 (14%)
Query: 564 KRIDLQSVKTEAYLL-ELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLY 622
KRI + K EA L E KV ++R V L + E ++ LV M GDL +Y
Sbjct: 36 KRI--KKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY 92
Query: 623 RKTNTEDDLQSLDWITRLKIAIGAAE---GLSYLHHECTLPFVHRDVQASSILLDDKFEV 679
N D Q + AAE GL L E V+RD++ +ILLDD+ +
Sbjct: 93 NMGNPGFDEQ--------RAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHI 141
Query: 680 RLGSL 684
R+ L
Sbjct: 142 RISDL 146
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 56/264 (21%), Positives = 104/264 (39%), Gaps = 43/264 (16%)
Query: 560 PVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLS 618
V++K +D +E++ S++SH LV G C+ + E +V +Y+ G L
Sbjct: 29 EVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-ESIMVQEYVKFGSLD 87
Query: 619 SSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFE 678
+ L + N + W +L++A A L +L + H +V A ++LL + +
Sbjct: 88 TYLKKNKNLINIS----W--KLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREED 138
Query: 679 VRLGSLSEVCAQGGD-----AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLL 733
+ G+ + + D + L R+P + + D + FG L
Sbjct: 139 RKTGNPPFI--KLSDPGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLW 196
Query: 734 ELVTG-KMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWA-MA 791
E+ +G +SA D+Q K + Y+ L W +A
Sbjct: 197 EIFSGGDKPLSA-LDSQKK---------LQFYEDRH-------------QLPAPKWTELA 233
Query: 792 IVARSCLNPKPTRRPLMRYILKAL 815
+ C++ +P RP R I++ L
Sbjct: 234 NLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 37/126 (29%), Positives = 55/126 (43%), Gaps = 20/126 (15%)
Query: 565 RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYR- 623
R D Q EA LL + + H +V G C E +V++YM +GDL+ L
Sbjct: 51 RQDFQR---EAELLTV-----LQHQHIVRFYGVCTEGR-PLLMVFEYMRHGDLNRFLRSH 101
Query: 624 ----KTNTEDDLQSLDWIT---RLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK 676
K + + +T L IA A G+ YL +L FVHRD+ + L+
Sbjct: 102 GPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQG 158
Query: 677 FEVRLG 682
V++G
Sbjct: 159 LVVKIG 164
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.004
Identities = 23/77 (29%), Positives = 45/77 (58%), Gaps = 12/77 (15%)
Query: 606 FLVYKYMPNGDLSSSLYRK-TNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHR 664
+L+ +Y+P GD+ + L +K T TE+ ++ +I +AI + +H L ++HR
Sbjct: 77 YLIMEYLPGGDMMTLLMKKDTFTEE--ETRFYIAETILAIDS------IH---KLGYIHR 125
Query: 665 DVQASSILLDDKFEVRL 681
D++ ++LLD K ++L
Sbjct: 126 DIKPDNLLLDAKGHIKL 142
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 38/170 (22%), Positives = 71/170 (41%), Gaps = 27/170 (15%)
Query: 579 ELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWIT 638
E++ + H +V LG E + +Y+P G + S L E+ L + T
Sbjct: 58 EIETLKDLDHLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR--FFT 114
Query: 639 RLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSR 698
+ EGL+YLH + L HRD++A ++L+D ++ + + D + +
Sbjct: 115 EQVL-----EGLAYLHSKGIL---HRDLKADNLLVDADGICKISDFG-ISKKSDDIYDND 165
Query: 699 ITRLLR---------LPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGK 739
++ + S QG S + D++ G V+LE+ G+
Sbjct: 166 QNMSMQGSVFWMAPEVIHSYSQGYSAKV------DIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 38/150 (25%), Positives = 71/150 (47%), Gaps = 13/150 (8%)
Query: 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSK-VSHARLV 592
D+ + +G GD+++ L G +K I L+ + + + F K H +V
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 593 PLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSY 652
G + RE + ++ +Y G L +Y T +LQ + ++ R + +GL+Y
Sbjct: 70 AYFGSYLSRE-KLWICMEYCGGGSLQD-IYHVTGPLSELQ-IAYVCRETL-----QGLAY 121
Query: 653 LHHECTLPFVHRDVQASSILLDDKFEVRLG 682
LH + + HRD++ ++ILL D +V+L
Sbjct: 122 LHSKGKM---HRDIKGANILLTDNGDVKLA 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 919 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.98 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.98 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.98 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.98 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.98 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.98 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.98 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.98 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.98 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.98 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.98 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.95 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.94 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.94 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.94 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.93 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.93 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.92 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.92 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.92 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.91 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.9 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.89 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.88 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.88 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.88 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.87 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.85 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.85 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.85 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.85 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.83 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.82 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.82 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.81 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.81 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.81 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.81 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.8 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.8 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.8 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.77 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.77 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.73 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.72 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.72 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.71 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.71 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.7 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.69 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.62 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.5 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.47 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.47 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.44 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.4 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.4 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.37 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.34 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.32 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.31 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.31 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.3 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.24 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.23 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.23 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.21 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.03 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.96 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.92 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.89 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.88 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.88 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.86 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.86 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.76 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.71 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.69 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.67 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.66 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.61 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.54 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.53 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.5 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.44 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.42 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.38 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.33 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.31 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.28 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.19 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.16 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.05 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.02 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.98 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.96 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.89 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 97.89 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.8 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.79 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-81 Score=793.33 Aligned_cols=722 Identities=28% Similarity=0.431 Sum_probs=429.8
Q ss_pred CCHHHHHHHHHHHHhCCCC---CCCCCCCCCCCCCCCCeeec-CCCEEEEEcCCCcccCCCCCCCccChhhhcCCCCCCE
Q 002462 46 SSRTELAALFELRSSLGLR---RRDWPRKVDPCLVWNGVRCQ-NGSVVGINISGFRRTRLGSQNPRFAADALVNLTHLAS 121 (919)
Q Consensus 46 ~~~~e~~aLl~~k~~l~~~---~~~W~~~~~~C~~W~gv~C~-~~~v~~l~l~~~~~~~~g~~~~~~~~~~l~~L~~L~~ 121 (919)
..++|+.||++||+++... ..+|+...+ ||.|.||+|+ .++|+.+++++.... |.++ ..+..+++|+.
T Consensus 26 ~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~-~c~w~gv~c~~~~~v~~L~L~~~~i~--~~~~-----~~~~~l~~L~~ 97 (968)
T PLN00113 26 LHAEELELLLSFKSSINDPLKYLSNWNSSAD-VCLWQGITCNNSSRVVSIDLSGKNIS--GKIS-----SAIFRLPYIQT 97 (968)
T ss_pred CCHHHHHHHHHHHHhCCCCcccCCCCCCCCC-CCcCcceecCCCCcEEEEEecCCCcc--ccCC-----hHHhCCCCCCE
Confidence 3668999999999999642 478976555 5599999997 579999999875432 2222 23444555555
Q ss_pred EecCCCCCCCCCchhhhhC----------------------CCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCC
Q 002462 122 FNASRFLLPGSIPDWLGQQ----------------------LPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLT 179 (919)
Q Consensus 122 l~ls~n~l~g~ip~~~~~~----------------------L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 179 (919)
|++++|.+.|.+|..++.. +++|++|+|++|.+++.+|..++++++|++|+|++|.+.
T Consensus 98 L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~ 177 (968)
T PLN00113 98 INLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177 (968)
T ss_pred EECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCccc
Confidence 5555555555555444322 344444444444444555556666666666666666666
Q ss_pred CCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCccccC
Q 002462 180 GTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLG 259 (919)
Q Consensus 180 g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 259 (919)
+.+|..++++++|++|+|++|++++.+|..|+++++|+.|+|++|.+++.+|..++++++|++|+|++|++++.+|..++
T Consensus 178 ~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~ 257 (968)
T PLN00113 178 GKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG 257 (968)
T ss_pred ccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHh
Confidence 66666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred CCCCCCEEEcCCCCCCCCCchhhhccccCCEEEccCCcCCCCCCCcc-----------------------cCCCCCCCEE
Q 002462 260 DLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNL-----------------------FPTVSQLQII 316 (919)
Q Consensus 260 ~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~ls~N~l~g~i~~~~-----------------------~~~l~~L~~L 316 (919)
++++|++|+|++|++.+.+|..+.++++|+.|++++|.+.+.+|..+ +..+++|+.|
T Consensus 258 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L 337 (968)
T PLN00113 258 NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVL 337 (968)
T ss_pred CCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEE
Confidence 66666666666666555555555555555555555555554443321 2455666777
Q ss_pred EccCCCCCCCCccccCCCCCCCEEEccCCCCCCCCCcccc----------------------------------------
Q 002462 317 VLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRS---------------------------------------- 356 (919)
Q Consensus 317 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~---------------------------------------- 356 (919)
+|++|.+++.+|..++.+++|+.|+|++|++++.+|....
T Consensus 338 ~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~ 417 (968)
T PLN00113 338 QLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417 (968)
T ss_pred ECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEee
Confidence 7777766666665555555555555555444433321100
Q ss_pred -------c------------------------CC-----------------------CCCcEEEccCCcCc---------
Q 002462 357 -------N------------------------VN-----------------------TSTVELNISQNMFY--------- 373 (919)
Q Consensus 357 -------~------------------------~~-----------------------~~l~~L~ls~N~~~--------- 373 (919)
. .. .+|+.|++++|.+.
T Consensus 418 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~ 497 (968)
T PLN00113 418 GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGS 497 (968)
T ss_pred eECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhh
Confidence 0 00 11223333333333
Q ss_pred ---------------cCCCC---CCCCCcEEEccCCcCCCcCCccccc--cc--CCCCcccCCCCCCC-C---------c
Q 002462 374 ---------------GGLTP---VLGRFRLVDLSGNYFEGRVPEYVHS--NA--SSLDSNCLQNVPNQ-R---------T 421 (919)
Q Consensus 374 ---------------g~~~~---~l~~L~~ldLs~N~l~g~ip~~~~~--~~--~~l~~n~l~~~~~~-~---------~ 421 (919)
+.+|. .+.+|+.|+|++|.++|.+|..+.. ++ -.+++|.+.+.... . .
T Consensus 498 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ 577 (968)
T PLN00113 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVN 577 (968)
T ss_pred hhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEe
Confidence 33332 2356778888888888888876531 11 13455555432110 0 0
Q ss_pred ccccc-----------------cccccCCCccCCCCCCCCCCCCCCCCCCCCcceeeeeeeehhhHHHHHHHHHHHHHHH
Q 002462 422 LVDCS-----------------SFYAARGLSFDNFGRPNATQPPPPETSGDSNRKIIVLSAVLGGFGLIVLLVLLALLAL 484 (919)
Q Consensus 422 ~~~c~-----------------~~~~~~~l~~~~~~~p~~~~p~~~~~~~~~~~~~~i~~~v~~~~~~~~~~~~~~~~~~ 484 (919)
...|. .+.++.++|... +....+++.. ..+.....++++++++ +++++++++++++
T Consensus 578 ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~---~~~~~~~c~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 650 (968)
T PLN00113 578 ISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGD---TTSGLPPCKR-VRKTPSWWFYITCTLG---AFLVLALVAFGFV 650 (968)
T ss_pred ccCCcceeeCCCcchhcccChhhhcCCccccCCc---cccCCCCCcc-ccccceeeeehhHHHH---HHHHHHHHHHHHH
Confidence 00110 111111111100 0000111111 1111122222222222 2222222222222
Q ss_pred hhhcccCCCCCCCCCCcCCCCCCCCCCCCccccccCCcccCHHHHHHHhCCCCcccccccCCCCcEEEEEe-cCCccEEE
Q 002462 485 CFCKKRTPNQRGVGVGPVPAGSSLPPPGASINFTNLGESFTYQQLLAATGDFSDANLIKNGHSGDLFRGIL-EGGIPVVI 563 (919)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~at~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vav 563 (919)
++++|+....+.... ..+. .............++++++.. .|.+.++||+|+||.||+|+. .+|..|||
T Consensus 651 ~~~~~~~~~~~~~~~---~~~~----~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ig~G~~g~Vy~~~~~~~~~~vav 720 (968)
T PLN00113 651 FIRGRNNLELKRVEN---EDGT----WELQFFDSKVSKSITINDILS---SLKEENVISRGKKGASYKGKSIKNGMQFVV 720 (968)
T ss_pred HHHhhhccccccccc---cccc----ccccccccccchhhhHHHHHh---hCCcccEEccCCCeeEEEEEECCCCcEEEE
Confidence 222222111110000 0000 000000011123466666654 467788999999999999996 67899999
Q ss_pred EEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHH
Q 002462 564 KRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIA 643 (919)
Q Consensus 564 K~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia 643 (919)
|+++..... ...|++++++++|||||+++|+|.+. +..++|||||++|+|.++++ .++|.++.+||
T Consensus 721 K~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~----------~l~~~~~~~i~ 786 (968)
T PLN00113 721 KEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSE-KGAYLIHEYIEGKNLSEVLR----------NLSWERRRKIA 786 (968)
T ss_pred EEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcC-CCCEEEEeCCCCCcHHHHHh----------cCCHHHHHHHH
Confidence 998643322 23568999999999999999999764 57899999999999999984 27899999999
Q ss_pred HHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCC
Q 002462 644 IGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPY 723 (919)
Q Consensus 644 ~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~ 723 (919)
.|+|+||+|||+.+.++||||||||+||++|.++.+++. |+.......... ..+++.|.+++......++.|+
T Consensus 787 ~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~------~~~t~~y~aPE~~~~~~~~~~s 859 (968)
T PLN00113 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTK------CFISSAYVAPETRETKDITEKS 859 (968)
T ss_pred HHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCC------ccccccccCcccccCCCCCccc
Confidence 999999999999888999999999999999999988875 443322211111 1223344455555555788999
Q ss_pred cchhHHHHHHHHHcCCCCCCCCCh--hHHHHHHHhhcccccccccccccccccCCCCCC-cchHHHHHHHHHHHHHccCC
Q 002462 724 DVYCFGKVLLELVTGKMGISASSD--AQVKEILEQTLPYISIYDKELVTKIVDPSLIID-EDLLEEVWAMAIVARSCLNP 800 (919)
Q Consensus 724 DVySfGvvLlEllTGk~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~~~~~la~~C~~~ 800 (919)
|||||||++|||+||+.|++.... ....+|+.... .......++||.+... +...+++.++.+++.+||+.
T Consensus 860 Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~ 933 (968)
T PLN00113 860 DIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCY------SDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTAT 933 (968)
T ss_pred chhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhc------CccchhheeCccccCCCCccHHHHHHHHHHHHhhCcC
Confidence 999999999999999999865322 23444443322 1123445566655322 22345667788999999999
Q ss_pred CCCCCCCHHHHHHHhhccc
Q 002462 801 KPTRRPLMRYILKALENPL 819 (919)
Q Consensus 801 ~P~~RPsm~~V~~~L~~~~ 819 (919)
+|++||+|+||+++|+...
T Consensus 934 ~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 934 DPTARPCANDVLKTLESAS 952 (968)
T ss_pred CchhCcCHHHHHHHHHHhh
Confidence 9999999999999998654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-61 Score=533.29 Aligned_cols=288 Identities=38% Similarity=0.626 Sum_probs=242.7
Q ss_pred CcccCHHHHHHHhCCCCcccccccCCCCcEEEEEecCCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEe
Q 002462 521 GESFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCM 599 (919)
Q Consensus 521 ~~~~~~~~l~~at~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~ 599 (919)
...|+|+||.+||++|+..++||+|+||.||||.+++|..||||++...... .++|.+|++++++++|||+|+|+|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 4679999999999999999999999999999999999999999999876655 667999999999999999999999999
Q ss_pred ecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCce
Q 002462 600 ERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEV 679 (919)
Q Consensus 600 ~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~ 679 (919)
+.+++++||||||+||+|.++|+.+... +|+|.+|++||+|+|+||+|||+.|.|+||||||||+|||||+++++
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~-----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE-----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC-----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 8543599999999999999999976431 68999999999999999999999999999999999999999999999
Q ss_pred eeCCcchhhhcCC-CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhc
Q 002462 680 RLGSLSEVCAQGG-DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTL 758 (919)
Q Consensus 680 kl~dfg~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~ 758 (919)
||+|||+++.... ..+.... ..++..|.++++......|.|+|||||||||+||+|||+|++..........++|+.
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~--~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTT--VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred EccCccCcccCCccccceeee--cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 9999999976554 3322211 156666777776666678999999999999999999999998654222222444444
Q ss_pred ccccccccccccccccCCCCCCcch-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 759 PYISIYDKELVTKIVDPSLIIDEDL-LEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 759 ~~~~~~~~~~~~~i~d~~l~~~~~~-~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
+.+ ....+.+++||++...+.. .+++.+++.+|.+|++.+|.+||+|.+|+++|+..
T Consensus 295 ~~~---~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 295 PLL---EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HHH---HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 433 2347899999998633332 37889999999999999999999999999999643
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=395.77 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=199.8
Q ss_pred ccccccCCCCcEEEEEecCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCC
Q 002462 539 ANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNG 615 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~G 615 (919)
.+.||+|+||+||+|.+.+...||||++...... .++|.+|+.+|++++|||||+++|+|.+.....+||||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 3459999999999999987777999999765433 4589999999999999999999999987543689999999999
Q ss_pred ChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCC-ceeeCCcchhhhcCCCC
Q 002462 616 DLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF-EVRLGSLSEVCAQGGDA 694 (919)
Q Consensus 616 sL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~-~~kl~dfg~~~~~~~~~ 694 (919)
+|.++|+++. ...++|..+++||.|||+||.|||+.. + ||||||||+|||||.++ .+||+|||+++......
T Consensus 126 sL~~~l~~~~-----~~~l~~~~~l~~aldiArGm~YLH~~~-~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 126 SLSVLLHKKR-----KRKLPLKVRLRIALDIARGMEYLHSEG-P-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred cHHHHHhhcc-----cCCCCHHHHHHHHHHHHHHHHHHhcCC-C-eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999998741 135999999999999999999999862 2 99999999999999997 99999999998765421
Q ss_pred cceeeeeeccCCCCccccCCC--CCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 695 HQSRITRLLRLPQSSEQGSSG--SLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~--~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
...+...+++.+++++... ...++.|+||||||||||||+||+.||....+.+....+....
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~-------------- 262 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGG-------------- 262 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC--------------
Confidence 1112234556666666655 4579999999999999999999999998877644333221110
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~~ 820 (919)
..|.+ ...... .+..++..||+.+|.+||+|.+|+..|+....
T Consensus 263 ~Rp~~--p~~~~~---~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 263 LRPPI--PKECPP---HLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCC--CccCCH---HHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 01111 111112 25567788999999999999999999986654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=392.11 Aligned_cols=250 Identities=28% Similarity=0.466 Sum_probs=204.2
Q ss_pred ccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCChh
Q 002462 539 ANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLS 618 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL~ 618 (919)
.+.||+|.||.||.|.+++...||||.++......++|.+|+++|++++|+|||+++|+|... +..+||||||++|+|.
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-~piyIVtE~m~~GsLl 289 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-EPIYIVTEYMPKGSLL 289 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecC-CceEEEEEecccCcHH
Confidence 467999999999999999989999999988888889999999999999999999999999863 4799999999999999
Q ss_pred hhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCccee
Q 002462 619 SSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSR 698 (919)
Q Consensus 619 ~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~~~ 698 (919)
++|.... ...+.-.+-+++|.|||+||+||++. .+|||||.++||||+++..+||+|||+++....+.....
T Consensus 290 ~yLr~~~-----~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 290 DYLRTRE-----GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred HHhhhcC-----CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 9997632 23477888999999999999999985 899999999999999999999999999996555444322
Q ss_pred eeeeccCC-CCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccccccccccCC
Q 002462 699 ITRLLRLP-QSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPS 776 (919)
Q Consensus 699 ~~~~~~~~-~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 776 (919)
.. ...| .+.+|+......++.|||||||||+||||+| |+.|+...+..+..+.++.-..
T Consensus 362 ~~--~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR----------------- 422 (468)
T KOG0197|consen 362 EG--GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR----------------- 422 (468)
T ss_pred CC--CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc-----------------
Confidence 21 1222 2344555566689999999999999999999 9999998887776666554321
Q ss_pred CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 777 LIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 777 l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
+...+..++++. +|+..||+.+|++||||+.....|++..
T Consensus 423 lp~P~~CP~~vY---~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 423 LPRPEGCPDEVY---ELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCCCCCCHHHH---HHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 112223344443 4889999999999999999988887643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=400.62 Aligned_cols=263 Identities=25% Similarity=0.330 Sum_probs=204.6
Q ss_pred CCCCcccccccCCCCcEEEEEecC------CccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEG------GIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEK 605 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~------g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~ 605 (919)
.+....+.||+|.||+||+|+..+ .+.||||.++..... +++|.+|+++|+.++|||||+|+|.|.+. +..
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~-~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG-DPL 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC-Cee
Confidence 344455679999999999998643 467999999765543 57899999999999999999999999974 589
Q ss_pred EEEEEecCCCChhhhhhccCCCCC---c----cCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCc
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTED---D----LQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFE 678 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~~~---~----~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~ 678 (919)
++|+|||..|||.++|+......+ . ..+|+-.+.+.||.|||.||+||-+. .+|||||.++|+|+.+++.
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 999999999999999975432211 1 23489999999999999999999875 7999999999999999999
Q ss_pred eeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhh
Q 002462 679 VRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQT 757 (919)
Q Consensus 679 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~ 757 (919)
+||+|||+.+..-.......-...+-.-.++.++..-+.++|++||||||||||||++| |+.|+.+.+.++..+.+..-
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 99999999886532221111101111112445555566789999999999999999998 99999998887766665431
Q ss_pred cccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 002462 758 LPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 758 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~~ 820 (919)
.+ +...+..+.++. .|++.||+.+|++||+|+||-..|+...+
T Consensus 722 ----------~l-------L~~Pe~CP~~vY---~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 722 ----------QL-------LSCPENCPTEVY---SLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ----------Cc-------ccCCCCCCHHHH---HHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 11 112344455544 48899999999999999999999986543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=384.54 Aligned_cols=270 Identities=23% Similarity=0.362 Sum_probs=210.9
Q ss_pred CcccCHHHHHHHhCCCC---------cccccccCCCCcEEEEEec----CCccEEEEEeccccc--cHHHHHHHHHHHhh
Q 002462 521 GESFTYQQLLAATGDFS---------DANLIKNGHSGDLFRGILE----GGIPVVIKRIDLQSV--KTEAYLLELDFFSK 585 (919)
Q Consensus 521 ~~~~~~~~l~~at~~f~---------~~~~ig~G~~G~Vy~g~l~----~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~ 585 (919)
.+.+||||=-+|...|. .+++||.|.||+||+|+|+ ....||||.++.... ++.+|+.|+.||++
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 45688887766666653 4688999999999999974 246899999987654 35789999999999
Q ss_pred cCCCCccceeeEEeecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeecc
Q 002462 586 VSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRD 665 (919)
Q Consensus 586 l~H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrD 665 (919)
+.||||++|.|.... ....+||.|||+||+|+.+|+.+.+ .+.|.|-+.+..|||.||.||-+ ...||||
T Consensus 687 FdHPNIIrLEGVVTk-s~PvMIiTEyMENGsLDsFLR~~DG------qftviQLVgMLrGIAsGMkYLsd---m~YVHRD 756 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTK-SKPVMIITEYMENGSLDSFLRQNDG------QFTVIQLVGMLRGIASGMKYLSD---MNYVHRD 756 (996)
T ss_pred CCCCcEEEEEEEEec-CceeEEEhhhhhCCcHHHHHhhcCC------ceEeehHHHHHHHHHHHhHHHhh---cCchhhh
Confidence 999999999997654 5688999999999999999987643 38999999999999999999987 4899999
Q ss_pred CCCCceecCCCCceeeCCcchhhhcCCCCcceeeeeeccCC-CCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCC
Q 002462 666 VQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLP-QSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGIS 743 (919)
Q Consensus 666 lK~~NILld~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~ 743 (919)
|.++|||++.+...||+|||+++....+......++.-..| .+.+++...+.++|.+|||||||||+||.++ |.+|+=
T Consensus 757 LAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW 836 (996)
T KOG0196|consen 757 LAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 836 (996)
T ss_pred hhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc
Confidence 99999999999999999999999775554222222211222 2445555566788999999999999999997 999986
Q ss_pred CCChhHHHHHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 002462 744 ASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~~ 820 (919)
..+..+..+-++..+ +|....+.+. ++-+||+.||++|-.+||.|.+|+..|++.+.
T Consensus 837 dmSNQdVIkaIe~gy-----------------RLPpPmDCP~---aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 837 DMSNQDVIKAIEQGY-----------------RLPPPMDCPA---ALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred ccchHHHHHHHHhcc-----------------CCCCCCCCcH---HHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 665544444433322 1222222333 24458999999999999999999999987654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=338.41 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=194.2
Q ss_pred ccCHHHHHHHhCCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccc--cccHHHHHHHHHHHhhcCCCCccceeeEEe
Q 002462 523 SFTYQQLLAATGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQ--SVKTEAYLLELDFFSKVSHARLVPLLGHCM 599 (919)
Q Consensus 523 ~~~~~~l~~at~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~--~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~ 599 (919)
.++..||.+. +.||+|..|+|||+.. .+++.+|+|++... ...+++..+|++++.+.+||+||+++|.++
T Consensus 75 ~i~~~dle~~-------~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLERL-------GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhhh-------hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 3566666543 6899999999999996 46789999999443 334678999999999999999999999887
Q ss_pred ecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCce
Q 002462 600 ERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEV 679 (919)
Q Consensus 600 ~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~ 679 (919)
....+..|+||||++|||++.+.+.+ .++...--+||.+|.+||.|||++ ..||||||||+|||++..+++
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~g-------~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeV 218 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRVG-------RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEV 218 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCE
Confidence 64325999999999999999886432 366777789999999999999975 589999999999999999999
Q ss_pred eeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCCh--hHHHHHHHhh
Q 002462 680 RLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSD--AQVKEILEQT 757 (919)
Q Consensus 680 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~--~~~~~~~~~~ 757 (919)
||+|||.++..... ...+..++..|+.++......|+.++||||||++++|+++|+.|+....+ ....
T Consensus 219 KicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~------ 288 (364)
T KOG0581|consen 219 KICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIF------ 288 (364)
T ss_pred EeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHH------
Confidence 99999987765433 22344556666666666666889999999999999999999999976511 1111
Q ss_pred ccccccccccccccccc---CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 758 LPYISIYDKELVTKIVD---PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 758 ~~~~~~~~~~~~~~i~d---~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+.+..|++ |++..+ ...+| +......|++++|.+||+.+++++
T Consensus 289 ---------~Ll~~Iv~~ppP~lP~~-~fS~e---f~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 289 ---------ELLCAIVDEPPPRLPEG-EFSPE---FRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ---------HHHHHHhcCCCCCCCcc-cCCHH---HHHHHHHHhcCCcccCCCHHHHhc
Confidence 11222333 222211 12233 455778999999999999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=382.07 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=202.2
Q ss_pred CcccccccCCCCcEEEEEecC--C----ccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 537 SDANLIKNGHSGDLFRGILEG--G----IPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 537 ~~~~~ig~G~~G~Vy~g~l~~--g----~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
...+.||+|.||.||+|.+.+ | ..||||.+..... +..+|++|..+|++++|||||+++|.|++ ....+|+
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~~~~i~ 773 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SGPPLIL 773 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CCCcEEE
Confidence 345689999999999999754 3 3489999965533 35689999999999999999999999998 5678999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
+|||++|||..+|++.+........|.-.+-+.||+|||+|+.||++. ++|||||.++|+||++...|||+|||+++
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhH
Confidence 999999999999987654444455688899999999999999999985 89999999999999999999999999999
Q ss_pred hcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHH-HHHhhccccccccc
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKE-ILEQTLPYISIYDK 766 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 766 (919)
..-.......-.+..-.-.+++++......+|+|+|||||||+|||++| |..||...+..++.. +++..
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--------- 921 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--------- 921 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---------
Confidence 5433222111111111113455555555689999999999999999999 899998877665544 32221
Q ss_pred ccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~~ 820 (919)
+|...+...+.++ +|+..||+.+|++||+|..+++.++.+..
T Consensus 922 ---------RL~~P~~CP~~ly---~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 922 ---------RLDPPSYCPEKLY---QLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred ---------ccCCCCCCChHHH---HHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 2222333444444 68899999999999999999998876554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=336.39 Aligned_cols=210 Identities=23% Similarity=0.330 Sum_probs=178.5
Q ss_pred hCCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc--c-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 533 TGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV--K-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~--~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
.++|.....||+|+||+||+|+. +++..||||++..... + .+-...|+++|+.++|||||.|+.++. .++..+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~-~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE-DDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe-cCCeEEEE
Confidence 35677777799999999999995 4579999999976642 2 456788999999999999999999665 46789999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC------CceeeC
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK------FEVRLG 682 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~------~~~kl~ 682 (919)
||||.+|||.++|++++. ++..+......|+|.||+|||+. .||||||||.||||+.. -..||+
T Consensus 88 MEyC~gGDLs~yi~~~~~-------l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIA 157 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGR-------LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIA 157 (429)
T ss_pred EEeCCCCCHHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEec
Confidence 999999999999987653 67777788999999999999986 89999999999999875 457999
Q ss_pred CcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHh
Q 002462 683 SLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQ 756 (919)
Q Consensus 683 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~ 756 (919)
|||+++....... ..++.+.|.|++++......|+.|+|+||.|+||||++||+.||+..+..++...++.
T Consensus 158 DFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k 228 (429)
T KOG0595|consen 158 DFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK 228 (429)
T ss_pred ccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc
Confidence 9999997764332 3456788888888888788999999999999999999999999999888777665554
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=342.12 Aligned_cols=257 Identities=23% Similarity=0.369 Sum_probs=206.4
Q ss_pred hCCCCcccccccCCCCcEEEEEecC-CccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 533 TGDFSDANLIKNGHSGDLFRGILEG-GIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l~~-g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
..+..-.++||-|.||.||.|+|+. ...||||.++.+....++|+.|+.+|+.++|||+|+|+|.|.. +...|||.||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~-EpPFYIiTEf 344 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-EPPFYIITEF 344 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc-CCCeEEEEec
Confidence 3455567899999999999999875 4689999999888888999999999999999999999999974 5678999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
|.+|+|.++|++... ..++-.--+.+|.||+.||+||... .+|||||.++|+|+.++-.+||+|||+++...
T Consensus 345 M~yGNLLdYLRecnr-----~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNR-----SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred ccCccHHHHHHHhch-----hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999987543 2255566788999999999999874 79999999999999999999999999999998
Q ss_pred CCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
+++.+.+...-+.. .+.+++...+..++.|+|||+|||+|||+.| |..|+.+-+-.+...+++..+
T Consensus 417 gDTYTAHAGAKFPI-KWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy------------ 483 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPI-KWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY------------ 483 (1157)
T ss_pred CCceecccCccCcc-cccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc------------
Confidence 88765443221111 2344555566678899999999999999998 888888766555544444322
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
++...+.+.+. +-+|++.||+..|++||+++|+-+.+|.+.
T Consensus 484 -----RM~~PeGCPpk---VYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 484 -----RMDGPEGCPPK---VYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred -----cccCCCCCCHH---HHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 11122333443 445889999999999999999999888654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=348.08 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=195.6
Q ss_pred cccccccCCCCcEEEEEecC--C--cc-EEEEEecccc----ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 538 DANLIKNGHSGDLFRGILEG--G--IP-VVIKRIDLQS----VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 538 ~~~~ig~G~~G~Vy~g~l~~--g--~~-vavK~l~~~~----~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
..++||+|.||.||+|++.. + .. ||||..+... .+.++|++|+++|++++|||||+++|+|... ...+||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~-~Pl~iv 239 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE-EPLMLV 239 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-CccEEE
Confidence 34789999999999999754 3 23 8999987522 2357899999999999999999999999864 579999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
||+|+||+|.++|.+... .++..+++.++.++|+||+|||.. .+|||||.++|||++.+..+||+|||+++
T Consensus 240 mEl~~gGsL~~~L~k~~~------~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKK------SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEecCCCcHHHHHHhCCC------CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999976542 489999999999999999999985 89999999999999999999999999976
Q ss_pred hcCCCCcceeeeeeccCC-CCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHH-Hhhcccccccc
Q 002462 689 AQGGDAHQSRITRLLRLP-QSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEIL-EQTLPYISIYD 765 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~-~~~~~~~~~~~ 765 (919)
.......... ....| .+.+|++.....++.++|||||||++||+.+ |..|+.+....+...++ ...++.
T Consensus 311 ~~~~~~~~~~---~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~----- 382 (474)
T KOG0194|consen 311 AGSQYVMKKF---LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM----- 382 (474)
T ss_pred CCcceeeccc---cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC-----
Confidence 5431111110 11122 2445666666689999999999999999998 89999998877776665 322211
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 002462 766 KELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 766 ~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~~ 820 (919)
.......++ +..++..||..+|++||+|.+|.+.|+....
T Consensus 383 ------------~~~~~~p~~---~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 383 ------------PIPSKTPKE---LAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred ------------CCCCCCHHH---HHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 011112233 3446679999999999999999999986544
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=346.89 Aligned_cols=252 Identities=24% Similarity=0.399 Sum_probs=188.8
Q ss_pred cccccccCCCCcEEEEEecCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCC
Q 002462 538 DANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPN 614 (919)
Q Consensus 538 ~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~ 614 (919)
....||+|+||+||||.+.+. ||||.++..... .++|.+||.++++-||.||+-+.|||..+ ...||..+|++
T Consensus 396 l~~rIGsGsFGtV~Rg~whGd--VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p--~~AIiTqwCeG 471 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRWHGD--VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP--PLAIITQWCEG 471 (678)
T ss_pred ccceeccccccceeecccccc--eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC--ceeeeehhccC
Confidence 346899999999999999864 999999876543 57899999999999999999999999864 35999999999
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC-
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD- 693 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~- 693 (919)
-+|+.+||..+ ..++..+-++||.|||+||.|||.. .|||||||+.||+|+++++|||+|||++.....-
T Consensus 472 sSLY~hlHv~e------tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 472 SSLYTHLHVQE------TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred chhhhhccchh------hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 99999998643 3488889999999999999999985 8999999999999999999999999987544211
Q ss_pred ----CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccc
Q 002462 694 ----AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELV 769 (919)
Q Consensus 694 ----~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (919)
..+......+.+|+..- ......++..+||||||+|+|||+||..|+.....+++.-. ..++.+
T Consensus 543 g~~q~~qp~gsilwmAPEvIR--mqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm----------VGrG~l 610 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIR--MQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM----------VGRGYL 610 (678)
T ss_pred cccccCCCccchhhhcHHHHh--hcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE----------eccccc
Confidence 01111122233333221 11245688999999999999999999999984443322111 111111
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 002462 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 770 ~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~~ 820 (919)
. .|.... .....+ +|.+|...||+.++++||.+.+|+..|+..+.
T Consensus 611 ~--pd~s~~-~s~~pk---~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 611 M--PDLSKI-RSNCPK---AMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred C--ccchhh-hccCHH---HHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 0 111110 111223 45668889999999999999999998887654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=343.43 Aligned_cols=263 Identities=19% Similarity=0.236 Sum_probs=190.7
Q ss_pred CCCCcccccccCCCCcEEEEEe------cCCccEEEEEecccccc--HHHHHHHHHHHhhc-CCCCccceeeEEeecCCc
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL------EGGIPVVIKRIDLQSVK--TEAYLLELDFFSKV-SHARLVPLLGHCMERENE 604 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l------~~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~ 604 (919)
++|...++||+|+||.||+|.. .++..||||++...... .+.|.+|++++.++ +|||||+++|+|...++.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 4577778999999999999974 23568999998654322 35789999999999 899999999998866566
Q ss_pred EEEEEEecCCCChhhhhhccCCCC-------------------------------------------------------C
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTE-------------------------------------------------------D 629 (919)
Q Consensus 605 ~~lV~Ey~~~GsL~~~L~~~~~~~-------------------------------------------------------~ 629 (919)
.++||||+++|+|.+++....... .
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 899999999999999997532100 0
Q ss_pred ccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcceeeeeeccCCCCc
Q 002462 630 DLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSS 709 (919)
Q Consensus 630 ~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 709 (919)
....++|.+.++++.|+|+||+|||+. +||||||||+|||+++++.+||+|||+++.................+.+.
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 023588999999999999999999985 89999999999999999999999999887542221111111111122344
Q ss_pred cccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChh-HHHHHHHhhcccccccccccccccccCCCCCCcchHHHH
Q 002462 710 EQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDA-QVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEV 787 (919)
Q Consensus 710 ~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~ 787 (919)
+++......++.++|||||||++|||+| |+.|+...... .....+... .. +.. .....+
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---------~~------~~~--~~~~~~-- 304 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG---------TR------MRA--PENATP-- 304 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcC---------CC------CCC--CCCCCH--
Confidence 4443333457889999999999999997 99998764322 111111100 00 000 011112
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 788 WAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 788 ~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
.+..++..||+.+|++||+|.+|++.|+..+
T Consensus 305 -~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 305 -EIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred -HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2556889999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=316.65 Aligned_cols=255 Identities=19% Similarity=0.262 Sum_probs=199.4
Q ss_pred CCCcccccccCCCCcEEEEE-ecCCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCc-EEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERENE-KFLVY 609 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~-~~lV~ 609 (919)
+|...++||+|+||+|||+. +.+|..||.|.++... ...++...||.+|++++|||||+++++-+..+++ .+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 34556789999999999998 7899999999997443 3356789999999999999999999965554555 78999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCC--eeeccCCCCceecCCCCceeeCCcchh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLP--FVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~--ivHrDlK~~NILld~~~~~kl~dfg~~ 687 (919)
|||..|||...+.+-+. ..+.++..+..++..|.++||..+|... +. |+||||||.||+||.++.+|+||||++
T Consensus 100 E~c~~GDLsqmIk~~K~---qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKK---QKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HhhcccCHHHHHHHHHh---ccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhH
Confidence 99999999999854221 2245788889999999999999999843 34 999999999999999999999999999
Q ss_pred hhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhh-ccccccccc
Q 002462 688 CAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQT-LPYISIYDK 766 (919)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 766 (919)
+....... ......++|.|+.++......|+.||||||+||++|||+.-+.||.+.+-.++.+-+.+. .|
T Consensus 176 r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~------- 246 (375)
T KOG0591|consen 176 RFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP------- 246 (375)
T ss_pred hHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC-------
Confidence 98754432 234567888888888777788999999999999999999999999987655544433321 11
Q ss_pred ccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L 815 (919)
++ .++...++ +..|+..|+..+|..||+.-..+..+
T Consensus 247 ---------~~-p~~~YS~~---l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 247 ---------PL-PDEHYSTD---LRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred ---------CC-cHHHhhhH---HHHHHHHHccCCcccCCCcchHHHHH
Confidence 11 11222232 44578899999999999954444433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=336.80 Aligned_cols=244 Identities=20% Similarity=0.332 Sum_probs=198.1
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEeccc----cccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQ----SVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~----~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
.|...++||+|||..||+++- ..|..||+|++... ...++...+||++.++|+|||||++++|+ ++.+..|||.
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-EDs~nVYivL 97 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-EDSNNVYIVL 97 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-ecCCceEEEE
Confidence 466778999999999999995 89999999999763 33467789999999999999999999955 5567899999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
|+|++|+|.+++.++ .+|+..+...+..||+.||.|||+. +|||||||-.|++|++++++||||||+|..
T Consensus 98 ELC~~~sL~el~Krr-------k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~ 167 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR-------KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQ 167 (592)
T ss_pred EecCCccHHHHHHhc-------CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeee
Confidence 999999999888643 2488888889999999999999985 899999999999999999999999999987
Q ss_pred cCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH-HHHHHhhccccccccccc
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTLPYISIYDKEL 768 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 768 (919)
...+... -.++.++|.|.+++.......+..+||||.|||+|-|++|++||....-.+. ..+....+
T Consensus 168 le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y---------- 235 (592)
T KOG0575|consen 168 LEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY---------- 235 (592)
T ss_pred ecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc----------
Confidence 7644332 2457899999999887777788899999999999999999999987643322 22211111
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.-|. ....+ ..+|+..-++++|++|||..+|+.
T Consensus 236 ----~~P~-----~ls~~---A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 ----SMPS-----HLSAE---AKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ----cccc-----ccCHH---HHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 11122 355788899999999999999986
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.70 Aligned_cols=257 Identities=23% Similarity=0.319 Sum_probs=191.3
Q ss_pred cccccccCCCCcEEEEEecCCccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCC
Q 002462 538 DANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNG 615 (919)
Q Consensus 538 ~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~G 615 (919)
..++||+|.||.|..+..+++..||||.++....+ +.+|.+||++|++++|||||+|+|.|... +..++|+|||+||
T Consensus 542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-ePicmI~EYmEnG 620 (807)
T KOG1094|consen 542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-DPLCMITEYMENG 620 (807)
T ss_pred hhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-CchHHHHHHHhcC
Confidence 35779999999999999999999999999876654 57999999999999999999999999974 5789999999999
Q ss_pred ChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC-CCC
Q 002462 616 DLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG-GDA 694 (919)
Q Consensus 616 sL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~-~~~ 694 (919)
+|..+|.++..+. +.-..-+.||.|||.||+||.+- .+||||+.++|||+|.+|++||+|||+++..- ++.
T Consensus 621 DLnqFl~aheapt-----~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 621 DLNQFLSAHELPT-----AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred cHHHHHHhccCcc-----cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence 9999997664321 22234567999999999999974 89999999999999999999999999988442 222
Q ss_pred cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc--CCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT--GKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT--Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
+... .+..-.-.+++.+..--..+|+++|||+|||+|||+++ ..+|+....+++..+-.....+. ...-.-.
T Consensus 693 y~vq-gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~-----~~~~~~l 766 (807)
T KOG1094|consen 693 YRVQ-GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRD-----QGRQVVL 766 (807)
T ss_pred eeee-cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCC-----CCcceec
Confidence 2111 11111111222333223478999999999999999974 78899887776654433322211 1110011
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
..|.. ...+ +.++++.||..+-++||+++++...|+.
T Consensus 767 ~~P~~-----cp~~---lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 767 SRPPA-----CPQG---LYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred cCCCc-----CcHH---HHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 12222 2222 4468899999999999999999998864
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=328.53 Aligned_cols=257 Identities=17% Similarity=0.266 Sum_probs=190.9
Q ss_pred ccCHHHHHHHhCCCCcccccccCCCCcEEEEEecCCccEEEEEecccccc----HHHHHHHHHHHhhcCCCCccceeeEE
Q 002462 523 SFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK----TEAYLLELDFFSKVSHARLVPLLGHC 598 (919)
Q Consensus 523 ~~~~~~l~~at~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l~H~niV~l~g~c 598 (919)
.++++++ ++.....||+|++|.||+|.+ +|..||||++...... .+.|.+|+++|++++|||||+++|++
T Consensus 14 ~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~ 87 (283)
T PHA02988 14 CIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87 (283)
T ss_pred ecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence 3566666 333346899999999999998 5789999999654332 35788999999999999999999988
Q ss_pred ee--c-CCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCC
Q 002462 599 ME--R-ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD 675 (919)
Q Consensus 599 ~~--~-~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~ 675 (919)
.+ . ....++||||+++|+|.+++.... .++|.++++|+.++|+||+|||.. ..++||||||+|||+++
T Consensus 88 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-------~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~ 158 (283)
T PHA02988 88 IDIVDDLPRLSLILEYCTRGYLREVLDKEK-------DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTE 158 (283)
T ss_pred EecccCCCceEEEEEeCCCCcHHHHHhhCC-------CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECC
Confidence 75 2 235789999999999999996532 488999999999999999999973 25779999999999999
Q ss_pred CCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCC--CCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHH
Q 002462 676 KFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGS--LTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEI 753 (919)
Q Consensus 676 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~ 753 (919)
++.+|++|||.++......... .+...+.+++.... ..++.++|||||||++|||+||+.||......+....
T Consensus 159 ~~~~kl~dfg~~~~~~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~ 233 (283)
T PHA02988 159 NYKLKIICHGLEKILSSPPFKN-----VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL 233 (283)
T ss_pred CCcEEEcccchHhhhccccccc-----cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9999999999887543322111 11222223332221 3578899999999999999999999987665443322
Q ss_pred HHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 754 LEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
+..... .+.+ +....++ +.+++.+||+.+|++||+|.||++.|+..
T Consensus 234 i~~~~~--------------~~~~--~~~~~~~---l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 234 IINKNN--------------SLKL--PLDCPLE---IKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred HHhcCC--------------CCCC--CCcCcHH---HHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 211000 0011 1111222 55688899999999999999999999753
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=326.14 Aligned_cols=266 Identities=20% Similarity=0.284 Sum_probs=188.0
Q ss_pred CCCCcccccccCCCCcEEEEEecC-----------------CccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccce
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEG-----------------GIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPL 594 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~-----------------g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l 594 (919)
++|...+.||+|+||.||++..++ +..||||.+..... ...+|.+|++++.+++|||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 346667889999999999998543 34699999865432 24679999999999999999999
Q ss_pred eeEEeecCCcEEEEEEecCCCChhhhhhccCCCC------------CccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCee
Q 002462 595 LGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTE------------DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFV 662 (919)
Q Consensus 595 ~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~------------~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~iv 662 (919)
+|+|.+ .+..++||||+++|+|.+++....... .....++|.+..+|+.|+|+||+|||+. +|+
T Consensus 85 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 85 LGVCVD-EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEec-CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 998876 457899999999999999986432111 1123578999999999999999999985 799
Q ss_pred eccCCCCceecCCCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc--CCC
Q 002462 663 HRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT--GKM 740 (919)
Q Consensus 663 HrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT--Gk~ 740 (919)
||||||+|||+++++.+||+|||.+.............+......+..++......++.++|||||||++|||++ ++.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999998765422211111111112223344443333457888999999999999987 556
Q ss_pred CCCCCChhHHHHHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 741 GISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 741 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
|+......+....+..... ..........+ +...+ .+.+++.+||+.+|++||+|.+|.+.|+
T Consensus 241 p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~-----~~~~~---~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQVIENAGEFFR-----DQGRQVYLFRP-----PPCPQ---GLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHHHHHHHHHhh-----hccccccccCC-----CCCCH---HHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7765554433322221110 00000000011 11112 3567889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=323.23 Aligned_cols=248 Identities=29% Similarity=0.431 Sum_probs=178.4
Q ss_pred ccccccCCCCcEEEEEec-----CCccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 539 ANLIKNGHSGDLFRGILE-----GGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~l~-----~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
.+.||+|.||.||+|.+. .+..|+||.++..... .++|.+|++.+++++|||||+++|+|.. .+..++||||
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-~~~~~lv~e~ 82 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-NEPLFLVMEY 82 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-SSSEEEEEE-
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-cccccccccc
Confidence 467999999999999987 2578999999654332 5789999999999999999999999985 4568999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
|++|+|.++|+... ...++|.++++|+.|||+||+|||+. +||||||+++|||+++++.+||+|||......
T Consensus 83 ~~~g~L~~~L~~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN-----KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp -TTEBHHHHHHHTC-----TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccc-----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence 99999999998752 13489999999999999999999985 79999999999999999999999999877652
Q ss_pred CCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
................+..++......++.++||||||+++|||+| |+.|+......+....+..... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~----------~ 224 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR----------L 224 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE----------T
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------c
Confidence 2211110000011111223332222347889999999999999999 7888877655443333322110 0
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L 815 (919)
.. ...... .+..++..||+.+|.+||+|.+|++.|
T Consensus 225 ~~-------~~~~~~---~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PI-------PDNCPK---DIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TS-------BTTSBH---HHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ee-------ccchhH---HHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00 001112 245688999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=325.00 Aligned_cols=255 Identities=20% Similarity=0.309 Sum_probs=189.9
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCc----cEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGI----PVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKF 606 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~----~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~ 606 (919)
.+|...+.||+|+||.||+|++. +|. .||||.++.... ..++|.+|+.++++++|||||+++|+|.. +..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~--~~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC--CCce
Confidence 35888899999999999999853 343 389999864332 24679999999999999999999999875 3578
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcch
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~ 686 (919)
+|+||+++|+|.+++.... ..++|...++++.+||+||+|||+. +|+||||||+|||+++++.+||+|||.
T Consensus 85 ~v~e~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~ 155 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGL 155 (316)
T ss_pred eeeecCCCCCHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccc
Confidence 9999999999999997543 2478899999999999999999985 899999999999999999999999998
Q ss_pred hhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccc
Q 002462 687 VCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYD 765 (919)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~ 765 (919)
++...................+..++......++.++|||||||++|||+| |+.|+......+...++.....
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------ 229 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER------ 229 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCC------
Confidence 876543221111111111112333333333457788999999999999998 9999987665544443332110
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 766 KELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 766 ~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
.-.+. ... ..+..++..||+.+|++||+|.+|+..+....
T Consensus 230 ------~~~~~-----~~~---~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 230 ------LPQPP-----ICT---IDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ------CCCCC-----CCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00010 001 12456889999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=334.55 Aligned_cols=260 Identities=22% Similarity=0.335 Sum_probs=189.3
Q ss_pred CCCCcccccccCCCCcEEEEEe------cCCccEEEEEeccccc--cHHHHHHHHHHHhhc-CCCCccceeeEEeecCCc
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL------EGGIPVVIKRIDLQSV--KTEAYLLELDFFSKV-SHARLVPLLGHCMERENE 604 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l------~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~ 604 (919)
++|...+.||+|+||.||+|+. +++..||||+++.... ..+.|.+|++++.++ +|||||+++|+|.+ .+.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-~~~ 113 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV-GGP 113 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc-CCc
Confidence 3567778999999999999973 3456899999864432 245789999999999 89999999998876 457
Q ss_pred EEEEEEecCCCChhhhhhccCCC---------------------------------------------------------
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNT--------------------------------------------------------- 627 (919)
Q Consensus 605 ~~lV~Ey~~~GsL~~~L~~~~~~--------------------------------------------------------- 627 (919)
.++|||||++|+|.++++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 89999999999999999653210
Q ss_pred -----------CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcc
Q 002462 628 -----------EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQ 696 (919)
Q Consensus 628 -----------~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~ 696 (919)
......++|.+.++|+.++|+||+|||+. +|+||||||+|||++++..+||+|||.+.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 00123589999999999999999999974 8999999999999999999999999987654322211
Q ss_pred eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCCh-hHHHHHHHhhccccccccccccccccc
Q 002462 697 SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSD-AQVKEILEQTLPYISIYDKELVTKIVD 774 (919)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~d 774 (919)
...........+..++......++.++|||||||++|||+| |+.|+..... .....++..... ...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~------------~~~ 338 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR------------MLS 338 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc------------CCC
Confidence 11111111122333443334467889999999999999998 8888865432 222222221110 001
Q ss_pred CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 775 PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 775 ~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
+.. ... .+..++..|++.+|++||+|.+|++.|+.
T Consensus 339 ~~~-----~~~---~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 339 PEC-----APS---EMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCC-----CCH---HHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 111 111 25568899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=312.28 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=190.0
Q ss_pred CCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCC
Q 002462 535 DFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPN 614 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~ 614 (919)
+|...+.||+|+||.||+|.+.++..+|+|.+.......++|.+|++++++++||||++++++|.+ .+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~e~~~~ 83 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-QKPLYIVTEFMEN 83 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEcc-CCCEEEEEEcCCC
Confidence 466677899999999999999888899999987655556789999999999999999999998865 4678999999999
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCC
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~ 694 (919)
|+|.++++... ..++|..+..++.++++||+|||+. +|+||||||+||++++++.+|++|||.+.......
T Consensus 84 ~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 84 GCLLNYLRQRQ------GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred CcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 99999987532 1388999999999999999999975 89999999999999999999999999776442211
Q ss_pred cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
.... ........+..++......++.++|||||||++|||+| |+.|+......+....+.... ...
T Consensus 155 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~------------~~~ 221 (256)
T cd05114 155 YTSS-SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF------------RLY 221 (256)
T ss_pred eecc-CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC------------CCC
Confidence 1100 00011112333443333456788999999999999999 899997765443332222110 001
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L 815 (919)
.+.. .. ..+..++.+||+.+|++||+|.++++.|
T Consensus 222 ~~~~-----~~---~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 RPKL-----AS---MTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCC-----CC---HHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1111 11 1357789999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=315.09 Aligned_cols=253 Identities=20% Similarity=0.295 Sum_probs=187.7
Q ss_pred CCCCcccccccCCCCcEEEEEec----CCccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE----GGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~----~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~l 607 (919)
++|...+.||+|+||.||+|.+. .+..||+|.++..... .+.|.+|+.++++++|||||+++|++.. ++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-GNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-CCCcEE
Confidence 35667789999999999999863 3578999998754322 4579999999999999999999998765 467999
Q ss_pred EEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchh
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~ 687 (919)
||||+++|+|.+++.+.. ..++|.++++++.++++||+|||+. +|+||||||+|||++.++.+|++|||..
T Consensus 84 v~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE------GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred EEEeCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccc
Confidence 999999999999997542 2488999999999999999999975 8999999999999999999999999965
Q ss_pred hhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccc
Q 002462 688 CAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDK 766 (919)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (919)
........... ........+..++......++.++|||||||++||+++ |+.|+......+..+.+.....
T Consensus 155 ~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~------- 226 (266)
T cd05064 155 QEDKSEAIYTT-MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR------- 226 (266)
T ss_pred ccccccchhcc-cCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-------
Confidence 54322111100 00011112333333333457788999999999999875 9999987665443333221110
Q ss_pred ccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
+. ....... .+.+++..||+.+|.+||+|.+|.+.|++
T Consensus 227 --------~~--~~~~~~~---~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 --------LP--APRNCPN---LLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred --------CC--CCCCCCH---HHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 00 0111111 25568889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=315.71 Aligned_cols=264 Identities=20% Similarity=0.291 Sum_probs=190.8
Q ss_pred CCcccccccCCCCcEEEEE-ecCCccEEEEEeccccccH---HHHHHHHHHHhhcCCCCccceeeEEeec-CCcEEEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKT---EAYLLELDFFSKVSHARLVPLLGHCMER-ENEKFLVYK 610 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~~---~~f~~Ei~~l~~l~H~niV~l~g~c~~~-~~~~~lV~E 610 (919)
|...++||+|.||.||||+ +.+|..||+|++..+..+. .-..+||.+|+++.|||||+|.|...+. ....|||+|
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence 4455689999999999998 7889999999997766432 3346899999999999999999988876 457999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
||+. ||.-++.... ..++..+.-.+..|++.||+|+|+. +|+|||||.+|||||.++..||+|||+|+..
T Consensus 199 YMdh-DL~GLl~~p~------vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 199 YMDH-DLSGLLSSPG------VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred cccc-hhhhhhcCCC------cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 9997 8887775432 2477888889999999999999985 8999999999999999999999999999966
Q ss_pred CCCCc---c-eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhc--cccccc
Q 002462 691 GGDAH---Q-SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTL--PYISIY 764 (919)
Q Consensus 691 ~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~--~~~~~~ 764 (919)
..... + ..++..++.|+. ..|...|+.+.|+||.||||.||++||+.+.+.++.+..+.+-... |....+
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPEL----LLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPEL----LLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred cCCCCcccccceEEeeccChHH----hcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 54332 2 234445555542 2355678888999999999999999999999887654333222111 100000
Q ss_pred cccccc--ccccCCCCCCcchHHHH----HHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 765 DKELVT--KIVDPSLIIDEDLLEEV----WAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 765 ~~~~~~--~i~d~~l~~~~~~~~~~----~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
....+. .++.|.-.......|.. ..++.|....+..||++|.|+.+++.
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 000000 11112111111111111 13455677788899999999999875
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=315.18 Aligned_cols=243 Identities=19% Similarity=0.247 Sum_probs=185.1
Q ss_pred cccccccCCCCcEEEEE-ecCCccEEEEEeccccc--------cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 538 DANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSV--------KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 538 ~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~--------~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
..+.+|+|+||.|-.|. -.+|+.||||.++.... +.....+|+++|++++|||||++++++.. .+..|+|
T Consensus 176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-~ds~YmV 254 (475)
T KOG0615|consen 176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-PDSSYMV 254 (475)
T ss_pred eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec-CCceEEE
Confidence 35789999999999998 56799999999964321 12234689999999999999999998765 4678999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC---CceeeCCcc
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK---FEVRLGSLS 685 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~---~~~kl~dfg 685 (919)
||||++|+|.+.+-.++. +....---++.|+..|+.|||+. +|+||||||.|||+..+ ..+||+|||
T Consensus 255 lE~v~GGeLfd~vv~nk~-------l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 255 LEYVEGGELFDKVVANKY-------LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred EEEecCccHHHHHHhccc-------cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999976543 32333345889999999999985 99999999999999766 789999999
Q ss_pred hhhhcCCCCcceeeeeeccCCCCccccCC---CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HH-HHHHhhccc
Q 002462 686 EVCAQGGDAHQSRITRLLRLPQSSEQGSS---GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VK-EILEQTLPY 760 (919)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~-~~~~~~~~~ 760 (919)
+++..+.. +.+.+..++|.|.+|+.. |...+..|.|+||+|||||-++||-+||+...... +. .+..+.+++
T Consensus 325 lAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f 401 (475)
T KOG0615|consen 325 LAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF 401 (475)
T ss_pred hhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc
Confidence 99987632 334567888888777654 23333457899999999999999999998765433 22 222232222
Q ss_pred ccccccccccccccCCCCCCcchHHH-HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 761 ISIYDKELVTKIVDPSLIIDEDLLEE-VWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 761 ~~~~~~~~~~~i~d~~l~~~~~~~~~-~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.+....+ -.+...++.+.+..||++||++.|+++
T Consensus 402 -------------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 402 -------------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -------------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1111111 123566888999999999999999986
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=324.11 Aligned_cols=246 Identities=19% Similarity=0.345 Sum_probs=184.7
Q ss_pred cCHHHHHHHhCCCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCC
Q 002462 524 FTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMEREN 603 (919)
Q Consensus 524 ~~~~~l~~at~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~ 603 (919)
+.|++|.+ .+.+|.|.-|.||+|++++ ..||||+++.- -..+|+-|++++||||+.+.|+|.+. .
T Consensus 121 iPFe~IsE-------LeWlGSGaQGAVF~Grl~n-etVAVKKV~el------kETdIKHLRkLkH~NII~FkGVCtqs-P 185 (904)
T KOG4721|consen 121 IPFEEISE-------LEWLGSGAQGAVFLGRLHN-ETVAVKKVREL------KETDIKHLRKLKHPNIITFKGVCTQS-P 185 (904)
T ss_pred CCHHHhhh-------hhhhccCcccceeeeeccC-ceehhHHHhhh------hhhhHHHHHhccCcceeeEeeeecCC-c
Confidence 45666543 4689999999999999985 47999988422 13689999999999999999999875 3
Q ss_pred cEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCC
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS 683 (919)
Q Consensus 604 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~d 683 (919)
-++||||||+.|-|...|...+. +.-..-++...+||.||.|||.+ .|||||||+-||||..+-.+||+|
T Consensus 186 cyCIiMEfCa~GqL~~VLka~~~-------itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsD 255 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAGRP-------ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISD 255 (904)
T ss_pred eeEEeeeccccccHHHHHhccCc-------cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEecc
Confidence 68999999999999999975432 34444556678999999999985 899999999999999999999999
Q ss_pred cchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccc
Q 002462 684 LSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISI 763 (919)
Q Consensus 684 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~ 763 (919)
||..+..... ++...+.++..+++++....-..++|.||||||||||||+||..||..-+... ++ |.
T Consensus 256 FGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---II-wG------ 322 (904)
T KOG4721|consen 256 FGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---II-WG------ 322 (904)
T ss_pred ccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---eE-Ee------
Confidence 9987765432 22233445555666666666678999999999999999999999986533211 00 00
Q ss_pred cccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 764 YDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 764 ~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
.... ... |.......+. +..|+..||+.+|..||+|++|+..|+
T Consensus 323 VGsN-sL~-----LpvPstcP~G---fklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 323 VGSN-SLH-----LPVPSTCPDG---FKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred ccCC-ccc-----ccCcccCchH---HHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 0001 111 1122233333 345788999999999999999998876
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=330.97 Aligned_cols=261 Identities=21% Similarity=0.317 Sum_probs=188.6
Q ss_pred CCCCcccccccCCCCcEEEEEe------cCCccEEEEEeccccc--cHHHHHHHHHHHhhc-CCCCccceeeEEeecCCc
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL------EGGIPVVIKRIDLQSV--KTEAYLLELDFFSKV-SHARLVPLLGHCMERENE 604 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l------~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~ 604 (919)
++|...+.||+|+||.||+|+. .++..||||++..... ..+.+.+|+++++++ +|+|||+++|+|.+. +.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-~~ 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG-GP 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC-CC
Confidence 3577788999999999999873 2345799999965432 245788999999999 899999999988764 57
Q ss_pred EEEEEEecCCCChhhhhhccCCC---------------------------------------------------------
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNT--------------------------------------------------------- 627 (919)
Q Consensus 605 ~~lV~Ey~~~GsL~~~L~~~~~~--------------------------------------------------------- 627 (919)
.++|||||++|+|.++++++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999998643210
Q ss_pred ------CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcceeeee
Q 002462 628 ------EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITR 701 (919)
Q Consensus 628 ------~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~~~~~~ 701 (919)
......++|.+.++|+.++++||+|||+. +|+||||||+|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 01123588999999999999999999984 899999999999999999999999998765432211111111
Q ss_pred eccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhH-HHHHHHhhcccccccccccccccccCCCCC
Q 002462 702 LLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQ-VKEILEQTLPYISIYDKELVTKIVDPSLII 779 (919)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~ 779 (919)
......+..++......++.++|||||||++|||+| |+.||....... ....+.... ....+..
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~------------~~~~~~~-- 339 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY------------QMSRPDF-- 339 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc------------CccCCCC--
Confidence 111122333443334467889999999999999997 999987543322 111111100 0000110
Q ss_pred CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 780 DEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 780 ~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
... .+..++..||+.+|++||++.+|+++|++.
T Consensus 340 ---~~~---~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 340 ---APP---EIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ---CCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011 255688899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=310.47 Aligned_cols=254 Identities=20% Similarity=0.369 Sum_probs=192.5
Q ss_pred CCCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++|...+.||+|+||.||+|...++..||+|++.......+.|.+|+.++++++|+||+++++++.+ .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK-EEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCcEEEEecCC
Confidence 3566778999999999999998888899999987655556789999999999999999999997765 467899999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|.+++++... ..+++.+++.++.++++||+|||+. +++||||||+||++++++.+|++|||.+......
T Consensus 85 ~~~L~~~l~~~~~-----~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 85 KGSLLDFLKSDEG-----GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred CCcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999975422 2478899999999999999999974 8999999999999999999999999988654322
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
..... ........+.+++......++.++|||||||++|||+| |+.|+...........+....+.
T Consensus 157 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------------ 223 (261)
T cd05072 157 EYTAR-EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM------------ 223 (261)
T ss_pred ceecc-CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 11100 00011112333333233356778999999999999999 99999766554443333221110
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
+. .+...+ .+..++.+|++.+|++||+|.++.+.|++
T Consensus 224 --~~---~~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 --PR---MENCPD---ELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CC---CCCCCH---HHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00 011112 24568899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=308.33 Aligned_cols=255 Identities=20% Similarity=0.327 Sum_probs=194.3
Q ss_pred hCCCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 533 TGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
.++|...+.||+|+||.||+|...++..||||.+.......++|.+|++++++++||||+++++++.. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-EEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEec-CCCeeeeeecc
Confidence 34577788999999999999998888899999997665556789999999999999999999998765 46789999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++|+|.+++.... ...++|.+..+|+.+++.||+|||+. +|+||||||+||++++++.+||+|||.+.....
T Consensus 84 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 84 KYGSLLEYLQGGA-----GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cCCcHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999986532 13489999999999999999999975 899999999999999999999999998765432
Q ss_pred CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccccccc
Q 002462 693 DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTK 771 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 771 (919)
....... .......+..++......++.++|||||||++|||+| |+.|+...........+....+
T Consensus 156 ~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------ 222 (261)
T cd05068 156 DIYEARE-GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------------ 222 (261)
T ss_pred CcccccC-CCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 2111100 0000112333444344467889999999999999999 9999876554433322221110
Q ss_pred cccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 772 IVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 772 i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
.+ ...... ..+..++.+|++.+|.+||+|.++.+.|++
T Consensus 223 -~~----~~~~~~---~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 -MP----CPPGCP---KELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CC----CCCcCC---HHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00 001111 235668899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=309.99 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=191.5
Q ss_pred CCCCcccccccCCCCcEEEEEecC----CccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEG----GIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~----g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~l 607 (919)
++|...+.||+|+||.||+|++.. ...||||.++..... .++|.+|+.++++++||||+++++++.+ .+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-SRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-CCceEE
Confidence 467888999999999999999743 457999998654322 4679999999999999999999998765 467899
Q ss_pred EEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchh
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~ 687 (919)
||||+++|+|.+++.... ..++|.+.++++.+++.||+|||+. +|+||||||+|||+++++.+|++|||.+
T Consensus 83 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 83 ITEYMENGSLDKFLREND------GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred EEEcCCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchh
Confidence 999999999999986543 2488999999999999999999984 8999999999999999999999999988
Q ss_pred hhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccc
Q 002462 688 CAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDK 766 (919)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (919)
....................+..++......++.++||||||+++|||+| |+.|+...........+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------ 227 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL------ 227 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 76542111111111111122333444444467788999999999999998 99998765544433333211100
Q ss_pred ccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
+. .....+ .+.+++..|++.+|++||+|.+|++.|+.
T Consensus 228 --------~~---~~~~~~---~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 228 --------PP---PMDCPS---ALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred --------CC---CCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 00 011112 35678899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=315.11 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=184.4
Q ss_pred CCcccccccCCCCcEEEEEecC-CccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCC-cEEEEEEec
Q 002462 536 FSDANLIKNGHSGDLFRGILEG-GIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMEREN-EKFLVYKYM 612 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~~-g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~-~~~lV~Ey~ 612 (919)
+...+.||+|+||.||.+...+ |...|||.+...... .+...+|+++|++++|||||+.+|.....++ ..++.|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 4456789999999999999654 899999998765322 4668899999999999999999996444433 589999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCC-CCceeeCCcchhhhcC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD-KFEVRLGSLSEVCAQG 691 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~-~~~~kl~dfg~~~~~~ 691 (919)
++|+|.+++.+.++ .|+.....+.+.+|.+||+|||+. +||||||||+||||+. ++.+||+|||.++...
T Consensus 99 ~~GsL~~~~~~~g~------~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGG------KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred CCCcHHHHHHHcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999976542 377778888999999999999975 9999999999999999 7999999999887665
Q ss_pred CCC-cceeeeeeccCCCCccccCCCCC-CCCCCCcchhHHHHHHHHHcCCCCCCCC-ChhHHHHHHHhhccccccccccc
Q 002462 692 GDA-HQSRITRLLRLPQSSEQGSSGSL-TATCPYDVYCFGKVLLELVTGKMGISAS-SDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 692 ~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~t~~~DVySfGvvLlEllTGk~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 768 (919)
... .........+++.++.|+..... ....++|||||||+++||+||++||... ...+ ..+.-.. ...
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~--~~~~ig~-------~~~ 240 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE--ALLLIGR-------EDS 240 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHH--HHHHHhc-------cCC
Confidence 311 11111224455666666655432 2224789999999999999999999763 1111 1111000 000
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L 815 (919)
-|.+ .+...++. .+....|++.+|++|||+.+.+..-
T Consensus 241 -----~P~i--p~~ls~~a---~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 241 -----LPEI--PDSLSDEA---KDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -----CCCC--CcccCHHH---HHHHHHHhhcCcccCcCHHHHhhCh
Confidence 0111 11222333 3466799999999999999998743
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=311.49 Aligned_cols=257 Identities=21% Similarity=0.307 Sum_probs=186.9
Q ss_pred CcccccccCCCCcEEEEEecCCc---cEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecC-----CcE
Q 002462 537 SDANLIKNGHSGDLFRGILEGGI---PVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERE-----NEK 605 (919)
Q Consensus 537 ~~~~~ig~G~~G~Vy~g~l~~g~---~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~-----~~~ 605 (919)
....+||+|+||.||+|+..+.. .||||.++... ...+.|.+|++++++++|+||++++|+|.... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 34578999999999999975532 58999886542 22467899999999999999999999886432 246
Q ss_pred EEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcc
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS 685 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg 685 (919)
++|||||++|+|.+++..... ......++|.+...++.++++||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRL-GDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcc-cCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 899999999999998853221 11224589999999999999999999974 89999999999999999999999999
Q ss_pred hhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccc
Q 002462 686 EVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIY 764 (919)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~ 764 (919)
.++.................+.+..++......++.++|||||||++|||+| |+.|+......+..+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~------- 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG------- 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-------
Confidence 8875432211111111112233444444444567888999999999999999 88898765544332222211
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 765 DKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 765 ~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
+... . .+...+ .+..++..||+.+|++||+|.+|++.|+.
T Consensus 231 --~~~~---~-----~~~~~~---~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 --NRLK---Q-----PPDCLD---GLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred --CCCC---C-----CCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0000 0 111112 25678899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=311.65 Aligned_cols=254 Identities=22% Similarity=0.277 Sum_probs=187.3
Q ss_pred CCCcccccccCCCCcEEEEEec-CCc----cEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGI----PVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~----~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~l 607 (919)
+|...+.||+|+||.||+|+.. +|. .|++|.+...... .+++..|+..+++++|||||+++|+|.. ...++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--~~~~~ 85 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--ASLQL 85 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC--CccEE
Confidence 5666789999999999999863 444 4788887543322 3568889999999999999999998753 45789
Q ss_pred EEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchh
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~ 687 (919)
|+||+++|+|.+++..+. ..++|....+|+.|+|+||+|||+. +|+||||||+|||+++++.+|++|||.+
T Consensus 86 i~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR------DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred EEEeCCCCcHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccc
Confidence 999999999999997543 2489999999999999999999974 7999999999999999999999999988
Q ss_pred hhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccc
Q 002462 688 CAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDK 766 (919)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (919)
+...............+...+..++......++.++|||||||++|||+| |+.|+.........+++.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~------- 229 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER------- 229 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-------
Confidence 75432221111111112222333333333457889999999999999998 9999987655544444332110
Q ss_pred ccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
...+.. .. . .+..++..||..+|++||+|.|+++.|+...
T Consensus 230 -----~~~~~~-~~----~---~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 230 -----LAQPQI-CT----I---DVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred -----CCCCCC-CC----H---HHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 011111 01 1 2455788999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=308.20 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=191.4
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
+|...+.||+|+||.||+|... .+..||+|.+.......++|.+|++++.+++|+||++++++|.. ++..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcC-CCCcEEEEEeCC
Confidence 4667789999999999999965 57899999987655456789999999999999999999998875 457899999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|.+++..... ..++|.+++.|+.++++||+|||.. +|+||||||+||++++++.+|++|||.+......
T Consensus 86 ~~~L~~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 86 YGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred CCcHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999865321 3489999999999999999999975 8999999999999999999999999987655432
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
...... .......+..++......++.++|||||||++|||+| |+.|+......+....+....+
T Consensus 158 ~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~------------- 223 (263)
T cd05052 158 TYTAHA-GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR------------- 223 (263)
T ss_pred eeeccC-CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-------------
Confidence 211100 0111122333443334467788999999999999998 9999876554433222221110
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
+. ..+.... .+..++.+|++.+|++||+|.+++++|+.
T Consensus 224 --~~--~~~~~~~---~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 224 --ME--RPEGCPP---KVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred --CC--CCCCCCH---HHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 00 0111122 24568889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=327.01 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=196.6
Q ss_pred CcccccccCCCCcEEEEEe-cCC----ccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 537 SDANLIKNGHSGDLFRGIL-EGG----IPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 537 ~~~~~ig~G~~G~Vy~g~l-~~g----~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
....+||+|.||+||||.+ +.| .+||||++...... .++|+.|+-+|++++|||+++|+|+|... ...||.
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s--~~qlvt 776 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS--TLQLVT 776 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc--hHHHHH
Confidence 3457899999999999985 444 58999998654433 67899999999999999999999999853 588999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
+|||.|.|.++++.++. .+.-...+.+..|||+||.|||.. .+|||||.++|||+..--.+|+.|||+++.
T Consensus 777 q~mP~G~LlDyvr~hr~------~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD------NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred HhcccchHHHHHHHhhc------cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 99999999999986543 355567788999999999999975 899999999999999999999999999998
Q ss_pred cCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccccc
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (919)
...+.........-....+++-+......+|.++|||||||++||++| |.+|+++...+++.+.++.- ++
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g---------eR 918 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG---------ER 918 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc---------cc
Confidence 876655443332222233444444555678999999999999999999 99999998877776665531 11
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
|...+...-.+ -.++..||..|+..||++++........+
T Consensus 919 --------LsqPpiCtiDV---y~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 919 --------LSQPPICTIDV---YMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred --------CCCCCCccHHH---HHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 11122222223 33678999999999999999887665443
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=313.12 Aligned_cols=261 Identities=20% Similarity=0.296 Sum_probs=190.3
Q ss_pred CCCcccccccCCCCcEEEEEec------CCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE------GGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKF 606 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~------~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~ 606 (919)
+|...+.||+|+||.||+|+.. +...||+|.+..... ..++|.+|++++++++|||||+++++|.. ++..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-DGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCCcE
Confidence 3556789999999999999853 235689998864432 24579999999999999999999998765 46789
Q ss_pred EEEEecCCCChhhhhhccCCC-----------------CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCC
Q 002462 607 LVYKYMPNGDLSSSLYRKTNT-----------------EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQAS 669 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~-----------------~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~ 669 (919)
+||||+++|+|.+++...... ......++|.+.+.|+.+++.||+|||+. +|+||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhh
Confidence 999999999999998643211 11224589999999999999999999974 8999999999
Q ss_pred ceecCCCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChh
Q 002462 670 SILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDA 748 (919)
Q Consensus 670 NILld~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~ 748 (919)
|||+++++.+||+|||.++...................+..++......++.++||||||+++|||+| |+.|+....+.
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999998765422211100011111112333333333457788999999999999999 99999776655
Q ss_pred HHHHHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 749 QVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
...+.+..... +.. .....+ .+..++..|++.+|++||+|.+|++.|++..
T Consensus 237 ~~~~~~~~~~~---------------~~~--~~~~~~---~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 RLFNLLKTGYR---------------MER--PENCSE---EMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHHHHHhCCCC---------------CCC--CCCCCH---HHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 54443322110 000 011112 3556889999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=311.44 Aligned_cols=259 Identities=25% Similarity=0.351 Sum_probs=191.0
Q ss_pred CCCcccccccCCCCcEEEEEecCC------ccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILEGG------IPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKF 606 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~g------~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~ 606 (919)
+|...+.||+|+||.||+|...+. ..||+|.+..... ..++|.+|++++++++||||+++++++.. .+..+
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-EQPTC 84 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-CCceE
Confidence 566678899999999999986432 5799999865432 24679999999999999999999998765 45789
Q ss_pred EEEEecCCCChhhhhhccCCCC---------CccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCC
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTE---------DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF 677 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~---------~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~ 677 (919)
++|||+++|+|.+++.+..... .....+++.+.+.++.++++||+|||+. +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 9999999999999997542211 0114588999999999999999999985 899999999999999999
Q ss_pred ceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHh
Q 002462 678 EVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQ 756 (919)
Q Consensus 678 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~ 756 (919)
.+||+|||.+..................+.+.+++......++.++|||||||++|||+| |+.|+.+....+....+..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999998764322111111111112223444443333457788999999999999998 9999987665544333321
Q ss_pred hcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 757 TLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 757 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
... .. ....... .+..++..||+.+|.+||++.+|++.|+.
T Consensus 242 ~~~----------~~-------~~~~~~~---~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 242 RQL----------LP-------CPEDCPA---RVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CCc----------CC-------CcccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 110 00 0111122 35668899999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=305.49 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=192.9
Q ss_pred CCCCcccccccCCCCcEEEEE-ecCCccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
++|....+||.|..+.||+|+ .+.+..||||+++..... .++..+|+..|+.++|||||+++..+. .+.+.|+||.
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv-v~~~LWvVmp 104 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV-VDSELWVVMP 104 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE-ecceeEEeeh
Confidence 456677899999999999998 677899999999987765 357889999999999999999997544 4678999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
||.+||+.+.+...-. ..++....-.|..++.+||.|||+. +-||||||+.|||||++|.+||+|||.....
T Consensus 105 fMa~GS~ldIik~~~~-----~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP-----DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred hhcCCcHHHHHHHHcc-----ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999865422 1266777778999999999999986 8999999999999999999999999865433
Q ss_pred CCCC--cceeeeeeccCCCCccccC--CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH-HHHHHhhcccccccc
Q 002462 691 GGDA--HQSRITRLLRLPQSSEQGS--SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTLPYISIYD 765 (919)
Q Consensus 691 ~~~~--~~~~~~~~~~~~~~~~~~~--~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~-~~~~~~~~~~~~~~~ 765 (919)
.... ...++....++|.++.++. ..-..|+.|+||||||++..||++|..||....+... ..-+....|.+.
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~--- 253 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL--- 253 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc---
Confidence 2222 2222234556666666554 1233588999999999999999999999987766442 222233322111
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 766 KELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 766 ~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
....|. + ....--..+.++.-.|++.||++|||+++.++
T Consensus 254 ----t~~~~~----d-~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 ----TSGLDK----D-EDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ----cccCCh----H-HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111110 1 11111123455677999999999999999875
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=322.51 Aligned_cols=262 Identities=20% Similarity=0.252 Sum_probs=190.6
Q ss_pred CCCcccccccCCCCcEEEEEec------CCccEEEEEecccccc--HHHHHHHHHHHhhc-CCCCccceeeEEeecCCcE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE------GGIPVVIKRIDLQSVK--TEAYLLELDFFSKV-SHARLVPLLGHCMERENEK 605 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~------~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~ 605 (919)
.|...++||+|+||.||+|+.. .+..||||+++..... .+.+..|++++.++ +|+|||+++++|...+...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 4666789999999999999742 2468999998654322 35688899999999 8999999999988766678
Q ss_pred EEEEEecCCCChhhhhhccCCC------------------------------------------------------CCcc
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNT------------------------------------------------------EDDL 631 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~------------------------------------------------------~~~~ 631 (919)
++||||+++|+|.+++...... ....
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 9999999999999998643210 0001
Q ss_pred CCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccc
Q 002462 632 QSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQ 711 (919)
Q Consensus 632 ~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (919)
..++|.++.+|+.+|++||+|||+. +|+||||||+|||+++++.+||+|||.+................+...|..+
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 3689999999999999999999975 8999999999999999999999999988754322111111111122234444
Q ss_pred cCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhH-HHHHHHhhcccccccccccccccccCCCCCCcchHHHHHH
Q 002462 712 GSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQ-VKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWA 789 (919)
Q Consensus 712 ~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~ 789 (919)
+......++.++|||||||++|||+| |+.|+......+ ....+.... ... .+ ....+ .
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-----------~~~-~~-----~~~~~---~ 304 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT-----------RMR-AP-----EYATP---E 304 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC-----------CCC-CC-----ccCCH---H
Confidence 43334567889999999999999998 999987643221 111111100 000 01 11112 3
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 790 MAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 790 ~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
+..++.+||+.+|++||++.||++.|+..+
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 567889999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=313.25 Aligned_cols=249 Identities=19% Similarity=0.233 Sum_probs=184.7
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc----HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK----TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
|...+.||+|+||.||+|.. .+|..||||.+...... ...+.+|++++++++|+|||++++++.+ ++..++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-KDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-CCeEEEEEE
Confidence 66778999999999999985 67899999998644322 3468899999999999999999997765 467999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
||++|+|..++..... ..+++.+...++.++++||+|||+. +|+||||||+|||+++++.+||+|||.+...
T Consensus 81 ~~~~g~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-----PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQI 152 (285)
T ss_pred ecCCCcHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence 9999999988864321 2488999999999999999999985 8999999999999999999999999987654
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
..... .....+++.+..++......++.++|||||||++|||+||+.||.........+.+.....
T Consensus 153 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----------- 218 (285)
T cd05631 153 PEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK----------- 218 (285)
T ss_pred CCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh-----------
Confidence 22111 1122334445555554455678899999999999999999999986543221111111100
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPL-----MRYILK 813 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPs-----m~~V~~ 813 (919)
++.........+ .+..++..|++.+|.+||+ +.++++
T Consensus 219 ---~~~~~~~~~~s~---~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 219 ---EDQEEYSEKFSE---DAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ---cccccCCccCCH---HHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 000000111112 2456889999999999997 666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=313.88 Aligned_cols=262 Identities=22% Similarity=0.280 Sum_probs=193.6
Q ss_pred CCCcccccccCCCCcEEEEEec------CCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE------GGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~------~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~l 607 (919)
+|...+.||+|+||.||+|+.. ++..||+|++...... .+.|.+|++++++++|+||++++++|.. .+..++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 84 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD-GDPLIM 84 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-CCceEE
Confidence 4666789999999999999743 3567899998655443 4679999999999999999999998875 457899
Q ss_pred EEEecCCCChhhhhhccCCC---------CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCc
Q 002462 608 VYKYMPNGDLSSSLYRKTNT---------EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFE 678 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~---------~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~ 678 (919)
||||+++|+|.+++...... ......++|.++++|+.+++.||+|||+. +|+||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 99999999999999754311 01123489999999999999999999985 8999999999999999999
Q ss_pred eeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhh
Q 002462 679 VRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQT 757 (919)
Q Consensus 679 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~ 757 (919)
+||+|||.+................+...+..++......++.++|||||||++|||+| |+.|+......+..+.+...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 241 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence 99999998865433221111111112223344444444467788999999999999999 99998776554433222111
Q ss_pred cccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 002462 758 LPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 758 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~~ 820 (919)
. .... + .... ..+..++.+||+.+|++||+|.+|+++|+...+
T Consensus 242 ~----------~~~~--~-----~~~~---~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 242 R----------VLER--P-----RVCP---KEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred C----------CCCC--C-----ccCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 0 0000 0 0011 235678899999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=307.57 Aligned_cols=258 Identities=22% Similarity=0.336 Sum_probs=187.6
Q ss_pred CCcccccccCCCCcEEEEEecC----CccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCC-----
Q 002462 536 FSDANLIKNGHSGDLFRGILEG----GIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMEREN----- 603 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~~----g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~----- 603 (919)
|...+.||+|+||.||+|.... +..||||++...... .++|.+|++.+++++||||++++|++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 3456789999999999998643 367999998754322 3578999999999999999999998875332
Q ss_pred cEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCC
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS 683 (919)
Q Consensus 604 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~d 683 (919)
..++||||+++|+|..++...... .....+++.+...++.+++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence 368999999999999998654321 1224589999999999999999999985 899999999999999999999999
Q ss_pred cchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccc
Q 002462 684 LSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYIS 762 (919)
Q Consensus 684 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~ 762 (919)
||.++...................+.+++......++.++|||||||++|||+| |+.|+......+..+.+.....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--- 233 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR--- 233 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---
Confidence 998765432211100000011122333343334457788999999999999999 8889876554443333221100
Q ss_pred ccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 763 IYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 763 ~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
... .....+ .+.+++.+|++.+|++||++.+|++.|++
T Consensus 234 -------~~~-------~~~~~~---~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 234 -------LKQ-------PEDCLD---ELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred -------CCC-------CcCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 000 011112 35668889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=306.32 Aligned_cols=251 Identities=25% Similarity=0.338 Sum_probs=188.1
Q ss_pred CCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCC
Q 002462 535 DFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPN 614 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~ 614 (919)
+|.....||+|+||.||+|...++..||||.+.......++|.+|+.++.+++||||++++|+|.+ .+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-QRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-CCCcEEEEEcCCC
Confidence 355567899999999999998888889999987655556789999999999999999999998865 4568999999999
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCC
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~ 694 (919)
|+|.+++.... ..++|.++++|+.++++||+|||+. +|+||||||+||++++++.+|++|||.+.......
T Consensus 84 ~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 84 GCLLNYLREHG------KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred CcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 99999986532 1488999999999999999999975 89999999999999999999999999776443221
Q ss_pred cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
..... .......+..++......++.++|||||||++|||+| |+.|+...........+...... -
T Consensus 155 ~~~~~-~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------~ 221 (256)
T cd05113 155 YTSSV-GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL------------Y 221 (256)
T ss_pred eeecC-CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC------------C
Confidence 11100 0001111223333333356788999999999999999 99998766544332222111100 0
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
.+. ... ..+.+++..||+.+|.+||++.+|++.|+
T Consensus 222 ~~~-----~~~---~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPH-----LAS---EKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCC-----CCC---HHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 000 011 13566888999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=310.84 Aligned_cols=263 Identities=22% Similarity=0.324 Sum_probs=195.8
Q ss_pred CCCCcccccccCCCCcEEEEEecC-----CccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEG-----GIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKF 606 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~-----g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~ 606 (919)
++|...++||+|+||.||+|...+ +..||+|++..... ..+.+.+|+.++++++|+||++++|+|.+.+...+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 467778899999999999999765 78899998864322 24678899999999999999999999887666789
Q ss_pred EEEEecCCCChhhhhhccCCC-CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcc
Q 002462 607 LVYKYMPNGDLSSSLYRKTNT-EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS 685 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~-~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg 685 (919)
+++||+++|+|.+++...... ......++|.+++.|+.+++.||+|||+. +|+||||||+||++++++.+|++|||
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCC
Confidence 999999999999999654321 11224689999999999999999999974 89999999999999999999999999
Q ss_pred hhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccc
Q 002462 686 EVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIY 764 (919)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~ 764 (919)
.++...............+...+..++......++.++|||||||++||++| |+.|+......+...++....+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----- 237 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR----- 237 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC-----
Confidence 8865432211110011111112333333333457888999999999999999 9999987655444333322110
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 765 DKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 765 ~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
.. .+ ....+ .+.+++.+||+.+|++||++.+|++.|+...
T Consensus 238 ----~~---~~-----~~~~~---~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 238 ----LA---QP-----INCPD---ELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred ----CC---CC-----CcCCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00 00 00112 3567889999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=309.04 Aligned_cols=259 Identities=23% Similarity=0.300 Sum_probs=188.9
Q ss_pred CCCcccccccCCCCcEEEEEe-----cCCccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-----EGGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-----~~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~l 607 (919)
+|...+.||+|+||.||+|+. .++..||+|.+...... .++|.+|++++++++|||||+++|++.. ++..++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l 84 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-EQPVCM 84 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-CCceEE
Confidence 466678899999999999984 35678999998643322 3578999999999999999999998765 457899
Q ss_pred EEEecCCCChhhhhhccCCC----------CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCC
Q 002462 608 VYKYMPNGDLSSSLYRKTNT----------EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF 677 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~----------~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~ 677 (919)
||||+++|+|.+++..+... ......++|.+.+.|+.++++||+|||+. +|+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 99999999999998643210 01123589999999999999999999985 899999999999999999
Q ss_pred ceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHh
Q 002462 678 EVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQ 756 (919)
Q Consensus 678 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~ 756 (919)
.+|++|||.+....................+..++......++.++|||||||++|||+| |+.|+....+....+.+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999998765432211110111111112333333333457788999999999999999 9999877655444333332
Q ss_pred hcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 757 TLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 757 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
.... ...+...+ ++..++..|++++|++||++.+|.+.|..
T Consensus 242 ~~~~-----------------~~~~~~~~---~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 242 RQLL-----------------PCSEDCPP---RMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCcC-----------------CCCCCCCH---HHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1100 00111112 24567889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=310.58 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=191.0
Q ss_pred hCCCCcccccccCCCCcEEEEEecC------CccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCc
Q 002462 533 TGDFSDANLIKNGHSGDLFRGILEG------GIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENE 604 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l~~------g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~ 604 (919)
+++|...+.||+|+||.||+|...+ +..||+|.+...... ..+|.+|+.++++++|+||+++++++.+. +.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER-LP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CC
Confidence 4568888899999999999999754 568899988644322 45799999999999999999999988764 57
Q ss_pred EEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCC---ceee
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF---EVRL 681 (919)
Q Consensus 605 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~---~~kl 681 (919)
.++||||+++|+|.+++.+..........++|.++++|+.+|++||+|||+. +++||||||+||++++++ .+|+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 8999999999999999976543222334589999999999999999999985 799999999999998754 5999
Q ss_pred CCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccc
Q 002462 682 GSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPY 760 (919)
Q Consensus 682 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~ 760 (919)
+|||.++...................+..++......++.++|||||||++|||+| |+.||...........+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~- 239 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR- 239 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-
Confidence 99998775432211110111111112333333333457889999999999999997 9999987655443333221100
Q ss_pred ccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 761 ISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 761 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
...+ ..... .+..++.+|++.+|++||++.+|++.|+
T Consensus 240 -----------~~~~-----~~~~~---~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 -----------LDPP-----KGCPG---PVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -----------CCCC-----CCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0000 11112 3556889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=325.69 Aligned_cols=262 Identities=19% Similarity=0.276 Sum_probs=189.3
Q ss_pred hCCCCcccccccCCCCcEEEEEecC------CccEEEEEecccccc--HHHHHHHHHHHhhcC-CCCccceeeEEeecCC
Q 002462 533 TGDFSDANLIKNGHSGDLFRGILEG------GIPVVIKRIDLQSVK--TEAYLLELDFFSKVS-HARLVPLLGHCMEREN 603 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l~~------g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~~ 603 (919)
.+.|...++||+|+||.||+|+... +..||||++...... .+.|.+|+++++++. |||||+++|+|.+ .+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-SG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc-CC
Confidence 3456677899999999999998532 346999999654332 467999999999996 9999999998875 46
Q ss_pred cEEEEEEecCCCChhhhhhccCCCC-------------------------------------------------------
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNTE------------------------------------------------------- 628 (919)
Q Consensus 604 ~~~lV~Ey~~~GsL~~~L~~~~~~~------------------------------------------------------- 628 (919)
..++|||||++|+|.++|++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 7999999999999999987532100
Q ss_pred ----------------------------------CccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecC
Q 002462 629 ----------------------------------DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLD 674 (919)
Q Consensus 629 ----------------------------------~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld 674 (919)
.....++|.++++++.++|+||+|||+. +|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 0113488999999999999999999985 899999999999999
Q ss_pred CCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChh-HHHH
Q 002462 675 DKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDA-QVKE 752 (919)
Q Consensus 675 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~-~~~~ 752 (919)
+++.+|++|||++................+.+.+..++......++.++|||||||++|||+| |+.|+...... ....
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 999999999998765432211111111122223334443334457889999999999999997 99998754322 1111
Q ss_pred HHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 753 ILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 753 ~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
.+..... ......... .+..++..||+.+|++||+|.+|+++|+..
T Consensus 352 ~~~~~~~-----------------~~~~~~~~~---~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 352 KIKSGYR-----------------MAKPDHATQ---EVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHhcCCC-----------------CCCCccCCH---HHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 1111100 000111112 356688999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=313.78 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=196.8
Q ss_pred CCcccccccCCCCcEEEEEecC---C--ccEEEEEeccc--cccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGILEG---G--IPVVIKRIDLQ--SVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~~---g--~~vavK~l~~~--~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
....++||+|.||.||+|++.+ | ..||||.-+.+ ..+.+.|+.|..+|++++|||||+|+|.|.+ ...|||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e--~P~Wiv 468 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE--QPMWIV 468 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec--cceeEE
Confidence 3345789999999999999643 2 46899987653 3346889999999999999999999999975 479999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
||.++.|.|..+|..+. ..|+..+-..++.|++.||+|||+. .+|||||.++|||+...-.+|++|||+++
T Consensus 469 mEL~~~GELr~yLq~nk------~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNK------DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred EecccchhHHHHHHhcc------ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence 99999999999997654 2488888899999999999999985 89999999999999999999999999999
Q ss_pred hcCCCCcceeeeeeccCC-CCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccc
Q 002462 689 AQGGDAHQSRITRLLRLP-QSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDK 766 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (919)
....+...... + ...| .++.+++....++|+++|||-|||.+||++. |.+||.+-...
T Consensus 540 ~~ed~~yYkaS-~-~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs------------------ 599 (974)
T KOG4257|consen 540 YLEDDAYYKAS-R-GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS------------------ 599 (974)
T ss_pred hccccchhhcc-c-cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc------------------
Confidence 88765543221 1 1122 3556666677789999999999999999986 99998764321
Q ss_pred cccccccc-CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 002462 767 ELVTKIVD-PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 767 ~~~~~i~d-~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~~ 820 (919)
+.+..+-. .++...+..+..+ --++.+||+++|.+||.+.++...|.+.+.
T Consensus 600 DVI~~iEnGeRlP~P~nCPp~L---YslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 600 DVIGHIENGERLPCPPNCPPAL---YSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ceEEEecCCCCCCCCCCCChHH---HHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 22222221 2233334444433 358889999999999999999999986554
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=308.58 Aligned_cols=238 Identities=23% Similarity=0.364 Sum_probs=175.1
Q ss_pred ccccCCCCcEEEEEecC-------------------------CccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccce
Q 002462 541 LIKNGHSGDLFRGILEG-------------------------GIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPL 594 (919)
Q Consensus 541 ~ig~G~~G~Vy~g~l~~-------------------------g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l 594 (919)
.||+|+||.||+|++.. ...||||.++..... .++|.+|++++++++|||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998521 145899998654333 4578999999999999999999
Q ss_pred eeEEeecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecC
Q 002462 595 LGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLD 674 (919)
Q Consensus 595 ~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld 674 (919)
+|+|.+. ...++||||+++|+|..++.+.. ..++|..+++|+.|+|+||+|||+. +|+||||||+|||++
T Consensus 82 ~~~~~~~-~~~~lv~ey~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~ 151 (274)
T cd05076 82 HGVCVRG-SENIMVEEFVEHGPLDVCLRKEK------GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLA 151 (274)
T ss_pred EEEEEeC-CceEEEEecCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEe
Confidence 9999864 57899999999999999886532 2378889999999999999999974 899999999999998
Q ss_pred CCC-------ceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHH-cCCCCCCCC
Q 002462 675 DKF-------EVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELV-TGKMGISAS 745 (919)
Q Consensus 675 ~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEll-TGk~p~~~~ 745 (919)
+++ .+|++|||.+......... .+...+..++.. +...++.++|||||||++|||+ +|+.|+...
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~~~~------~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSREER------VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred ccCcccCccceeeecCCcccccccccccc------ccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 653 3799999976533221110 111122222222 2245678899999999999994 799998766
Q ss_pred ChhHHHHHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 746 SDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 746 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
...+...+.....+. .+.... .+..++..||+.+|++||+|.+|++.|.
T Consensus 226 ~~~~~~~~~~~~~~~-------------------~~~~~~---~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 226 TPSEKERFYEKKHRL-------------------PEPSCK---ELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ChHHHHHHHHhccCC-------------------CCCCCh---HHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 544433332211100 000011 2566889999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=304.25 Aligned_cols=254 Identities=24% Similarity=0.323 Sum_probs=179.6
Q ss_pred ccccCCCCcEEEEEecCC---ccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCC
Q 002462 541 LIKNGHSGDLFRGILEGG---IPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNG 615 (919)
Q Consensus 541 ~ig~G~~G~Vy~g~l~~g---~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~G 615 (919)
.||+|+||.||+|...++ ..+|+|+++..... ...|.+|+.++++++|||||+++|+|.+ ....++|||||++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-VTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCCcEEEEECCCCC
Confidence 689999999999986543 57899988654432 3478899999999999999999998865 45789999999999
Q ss_pred ChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCc
Q 002462 616 DLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAH 695 (919)
Q Consensus 616 sL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~ 695 (919)
+|.++++..... .....+|..+.+++.++|+||+|||+. +|+||||||+||++++++.+|++|||.++.......
T Consensus 81 ~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 81 DLKGYLRSCRKA--ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred cHHHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 999999754321 123467888889999999999999985 899999999999999999999999998764332211
Q ss_pred ceeeeeeccCCCCccccCCC-------CCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccc
Q 002462 696 QSRITRLLRLPQSSEQGSSG-------SLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKE 767 (919)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~-------~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 767 (919)
........+...+..++... ...++.++|||||||++|||+| |+.|+......+....... +
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~----------~ 225 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR----------E 225 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh----------c
Confidence 11111111122233333221 1235778999999999999996 9999976554432221110 1
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 768 LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 768 ~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
....+.++.+... ..+ .+..++..|+ .+|++||++.||++.|+
T Consensus 226 ~~~~~~~~~~~~~--~~~---~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 QQLKLPKPRLKLP--LSD---RWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCCCCccCCC--CCh---HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1112222222111 112 2345778898 57999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=311.31 Aligned_cols=262 Identities=22% Similarity=0.263 Sum_probs=193.3
Q ss_pred CCCCcccccccCCCCcEEEEEec------CCccEEEEEeccccc-cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE------GGIPVVIKRIDLQSV-KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKF 606 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~------~g~~vavK~l~~~~~-~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~ 606 (919)
.+|...+.||+|+||.||++... ++..+|||.+..... ..+.|.+|++++++++||||++++++|.. .+..+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-GDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCccE
Confidence 45777889999999999999842 345689998865433 24679999999999999999999998875 46789
Q ss_pred EEEEecCCCChhhhhhccCCC------CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCcee
Q 002462 607 LVYKYMPNGDLSSSLYRKTNT------EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVR 680 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~------~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~k 680 (919)
+||||+++|+|.+++...... ......++|.++++|+.+++.||+|||+. +|+||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 999999999999999753310 01223589999999999999999999975 899999999999999999999
Q ss_pred eCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcc
Q 002462 681 LGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLP 759 (919)
Q Consensus 681 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~ 759 (919)
++|||.+................+...+..++......++.++|||||||++|||+| |+.|+...........+....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~- 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR- 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-
Confidence 999998765432221111111111223444444444567889999999999999999 899987665443222221110
Q ss_pred cccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 760 YISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 760 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
... . ..... ..+..++..|++.+|.+||+|.+|.+.|++..
T Consensus 240 ---------~~~-----~--~~~~~---~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 240 ---------VLQ-----R--PRTCP---KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred ---------cCC-----C--CCCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 000 0 00011 13667899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.10 Aligned_cols=272 Identities=20% Similarity=0.296 Sum_probs=187.1
Q ss_pred CcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHh--hcCCCCccceeeEEeecCC----cEEEEEE
Q 002462 537 SDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFS--KVSHARLVPLLGHCMEREN----EKFLVYK 610 (919)
Q Consensus 537 ~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~--~l~H~niV~l~g~c~~~~~----~~~lV~E 610 (919)
...++||+|+||.||||.+.+ +.||||.+.... .+.|.+|-++.+ .++|+||++++|+- +... +++||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~~--kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~e-kr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQE--KQSFQNEKNIYSLPGMKHENILQFIGAE-KRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhccC-ceeEEEecCHHH--HHHHHhHHHHHhccCccchhHHHhhchh-ccCCccccceeEEee
Confidence 345689999999999999976 799999996543 456888777766 57899999999853 3333 7899999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcC------CCCCeeeccCCCCceecCCCCceeeCCc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHE------CTLPFVHRDVQASSILLDDKFEVRLGSL 684 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~------~~~~ivHrDlK~~NILld~~~~~kl~df 684 (919)
|-++|+|.++|..+ .++|..-.+||..+|+||+|||++ ..|+|+|||||++||||..|+++.|+||
T Consensus 289 fh~kGsL~dyL~~n--------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN--------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eccCCcHHHHHHhc--------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 99999999999654 489999999999999999999985 4689999999999999999999999999
Q ss_pred chhhhcCC-----CCcceeeeeeccCCCCccccCCCC-CCCCCCCcchhHHHHHHHHHcCCCCCCCC-Chh-H--HHHHH
Q 002462 685 SEVCAQGG-----DAHQSRITRLLRLPQSSEQGSSGS-LTATCPYDVYCFGKVLLELVTGKMGISAS-SDA-Q--VKEIL 754 (919)
Q Consensus 685 g~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~-~~~t~~~DVySfGvvLlEllTGk~p~~~~-~~~-~--~~~~~ 754 (919)
|++..... +.+....++.+++|+..+-...-. ..+-.+.||||.|.|||||+++-...+.. .++ + .+.-+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 99876542 333334445555554333221111 11223469999999999999977655321 110 0 11001
Q ss_pred HhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccc
Q 002462 755 EQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLKV 821 (919)
Q Consensus 755 ~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~~~ 821 (919)
+..|.+.....-.+.+-..|.+.........+.-+.+.+..||..||+.|-|+.=|.+.+......
T Consensus 441 -G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 441 -GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred -cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 111111111111122222333321111123344566788899999999999999998888765443
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=309.49 Aligned_cols=261 Identities=21% Similarity=0.287 Sum_probs=189.9
Q ss_pred HhCCCCcccccccCCCCcEEEEEec------CCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCC
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGILE------GGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMEREN 603 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~l~------~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~ 603 (919)
++++|...+.||+|+||.||+|... .+..||||++..... ...+|.+|+.++++++|||||+++++|.+ +.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CC
Confidence 4567888899999999999999753 246799999854332 24579999999999999999999998765 45
Q ss_pred cEEEEEEecCCCChhhhhhccCCCC---CccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCcee
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNTE---DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVR 680 (919)
Q Consensus 604 ~~~lV~Ey~~~GsL~~~L~~~~~~~---~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~k 680 (919)
..++||||+++|+|.+++.+..... .....++|.+++.++.++|+||+|||+. +++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 7899999999999999996532211 1123578999999999999999999974 899999999999999999999
Q ss_pred eCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcc
Q 002462 681 LGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLP 759 (919)
Q Consensus 681 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~ 759 (919)
++|||.+..................+.+.+++......++.++|||||||++|||+| |+.|+.........+.+....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~- 238 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG- 238 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-
Confidence 999998764432111110001111222333443333456788999999999999999 788887665443333221110
Q ss_pred cccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 760 YISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 760 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
. .+. ...... .+..++.+|++.+|++||++.|+++.|+
T Consensus 239 ---------~---~~~----~~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 239 ---------L---LDK----PDNCPD---MLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ---------c---CCC----CCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0 000 011111 3566889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=314.44 Aligned_cols=205 Identities=19% Similarity=0.280 Sum_probs=165.1
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
++|...+.||+|+||.||+++.. +|..||+|.+..... ..++|.+|++++++++|||||++++++.. ++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 83 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICME 83 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEEee
Confidence 56888889999999999999964 678899999865432 24679999999999999999999998765 467999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+++|+|.+++.... .+++....+|+.++++||+|||+. .+|+||||||+|||+++++.+||+|||.+...
T Consensus 84 ~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 84 HMDGGSLDQVLKEAK-------RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (331)
T ss_pred cCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence 999999999986532 377888899999999999999974 26999999999999999999999999987644
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHH
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKE 752 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~ 752 (919)
..... ....+++.+..++......++.++|||||||++|||+||+.|+......+...
T Consensus 155 ~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~ 212 (331)
T cd06649 155 IDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA 212 (331)
T ss_pred ccccc----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 32211 11233444445554444567889999999999999999999998766544433
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.92 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=188.1
Q ss_pred CCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCC
Q 002462 535 DFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPN 614 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~ 614 (919)
+|...+.||+|+||.||+|...++..+|||.+.......++|.+|++++++++||||+++++++.+ .+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK-QRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcC-CCceEEEEecCCC
Confidence 356678899999999999998877889999987555556689999999999999999999998765 4678999999999
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCC
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~ 694 (919)
|+|.+++..+. ..++|.+.++|+.++++||+|||+. +|+||||||+||++++++.+|++|||.+.......
T Consensus 84 ~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 84 GCLLNYLRERK------GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred CCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 99999997543 1488999999999999999999985 79999999999999999999999999776543211
Q ss_pred cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
.... ........+..++......++.++|||||||++|||+| |+.|+....+.+....+....+ ..
T Consensus 155 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------~~ 221 (256)
T cd05059 155 YTSS-QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR------------LY 221 (256)
T ss_pred cccc-CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc------------CC
Confidence 1100 00000112233333333456778999999999999999 8999876655433222221110 00
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L 815 (919)
.+. .... ++..++.+|++.+|++||+|.+|++.|
T Consensus 222 ~~~-----~~~~---~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPK-----LAPT---EVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCC-----CCCH---HHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 010 0111 356789999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.01 Aligned_cols=247 Identities=21% Similarity=0.323 Sum_probs=182.4
Q ss_pred cccccCCCCcEEEEEe-cCCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCC
Q 002462 540 NLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGD 616 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~Gs 616 (919)
+.||+|+||.||+|+. .++..||+|.+..... ....|.+|++++++++||||++++++|.. .+..++||||+++|+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCeEEEEeeccCCc
Confidence 3699999999999986 4688999998753322 24579999999999999999999998876 457899999999999
Q ss_pred hhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcc
Q 002462 617 LSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQ 696 (919)
Q Consensus 617 L~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~ 696 (919)
|.+++.+.. ..++|.+.+.++.++++||+|||+. +|+||||||+||+++.++.+|++|||.+.........
T Consensus 80 L~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 80 FLTFLRTEG------PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred HHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccc
Confidence 999986432 2478999999999999999999975 8999999999999999999999999987643321111
Q ss_pred eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccccccccccC
Q 002462 697 SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDP 775 (919)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 775 (919)
...........+..++......++.++|||||||++|||++ |+.|+...........+....+.
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~--------------- 215 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL--------------- 215 (252)
T ss_pred ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---------------
Confidence 00000000112333333333356778999999999999998 88888765544333332211100
Q ss_pred CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 776 SLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 776 ~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
...+...+ .+..++.+|++.+|++||+|.+|.++|+
T Consensus 216 --~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 --PCPELCPD---AVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred --CCcccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 00111112 3566889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=308.65 Aligned_cols=266 Identities=21% Similarity=0.302 Sum_probs=186.8
Q ss_pred CCCCcccccccCCCCcEEEEEecC-------------C--ccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceee
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEG-------------G--IPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLG 596 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~-------------g--~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g 596 (919)
++|...+.||+|+||.||+++..+ + ..||||.+..... ..+.|.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 356677889999999999987543 1 3489999865422 2457999999999999999999999
Q ss_pred EEeecCCcEEEEEEecCCCChhhhhhccCCC-----CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCce
Q 002462 597 HCMERENEKFLVYKYMPNGDLSSSLYRKTNT-----EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSI 671 (919)
Q Consensus 597 ~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~-----~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NI 671 (919)
++.. .+..++||||+++|+|.+++...... ......++|.+++.|+.++++||+|||+. +++||||||+||
T Consensus 85 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 85 VCVS-DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEcC-CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 8875 46789999999999999998653211 01123478999999999999999999975 899999999999
Q ss_pred ecCCCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc--CCCCCCCCChhH
Q 002462 672 LLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT--GKMGISASSDAQ 749 (919)
Q Consensus 672 Lld~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT--Gk~p~~~~~~~~ 749 (919)
++++++.+|++|||.+....................+.+++......++.++|||||||++|||+| |..|+......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999998764322211111111111222333333333457889999999999999998 566776655433
Q ss_pred HHHHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 750 VKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
....+.... . ..........+.. ..+ .+.+++.+|++.+|++||+|.+|++.|+
T Consensus 241 ~~~~~~~~~---~--~~~~~~~~~~~~~-----~~~---~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEFF---R--NQGRQIYLSQTPL-----CPS---PVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHhh---h--hccccccCCCCCC-----CCH---HHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 222111110 0 0000000001111 111 3677999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=306.79 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=191.1
Q ss_pred CCCCcccccccCCCCcEEEEEecC------CccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEG------GIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEK 605 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~------g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~ 605 (919)
++|...+.||+|+||.||+|...+ +..||||.+...... .++|.+|++++++++|+||+++++++... +..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG-DPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC-CCe
Confidence 346667889999999999998643 478999998654433 46899999999999999999999988764 679
Q ss_pred EEEEEecCCCChhhhhhccCCC-------CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCc
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNT-------EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFE 678 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~-------~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~ 678 (919)
++||||+++|+|.+++...... ......++|.+..+++.+++.||+|||.. +|+||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 9999999999999999754321 11234589999999999999999999975 8999999999999999999
Q ss_pred eeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhh
Q 002462 679 VRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQT 757 (919)
Q Consensus 679 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~ 757 (919)
+|++|||.+..................+.+.+++......++.++|||||||++|||+| |+.|+......+....+...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999998764322111000011111223334443334457888999999999999999 99998766554433322210
Q ss_pred cccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 758 LPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 758 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
..... ...... .+..++..||+.+|++||++.||++.|+
T Consensus 241 ----------~~~~~-------~~~~~~---~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 241 ----------RLLQR-------PRTCPS---EVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----------CcCCC-------CCCCCH---HHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00000 001111 2566889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.70 Aligned_cols=254 Identities=19% Similarity=0.337 Sum_probs=192.7
Q ss_pred hCCCCcccccccCCCCcEEEEEecCCccEEEEEeccccc-cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 533 TGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSV-KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~-~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
..+|...+.||+|+||.||+|...++..||+|.+..... ..+++.+|++++++++|+||+++++++.+ .+..++||||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-GEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec-CCCeEEEEee
Confidence 445777789999999999999988899999999976554 35679999999999999999999998875 4578999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+++|+|.+++.+... ..++|.++.+++.++++||+|||+. +|+||||||+||++++++.+|++|||.+....
T Consensus 84 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 84 MEKGSLLAFLRSPEG-----QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred cccCCHHHHHhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 999999999975432 3489999999999999999999974 79999999999999999999999999876543
Q ss_pred CCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
....... .......+..++......++.++|||||||++|||+| |+.|+......+....+.....
T Consensus 156 ~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------- 222 (261)
T cd05148 156 EDVYLSS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR----------- 222 (261)
T ss_pred Ccccccc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc-----------
Confidence 2211110 1111112223333333456778999999999999998 8999976654433222221100
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
+.. .....+ .+..++.+|++.+|.+||+|+++.+.|+.
T Consensus 223 ----~~~--~~~~~~---~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 ----MPC--PAKCPQ---EIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ----CCC--CCCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 000 001112 35678899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=305.82 Aligned_cols=255 Identities=20% Similarity=0.266 Sum_probs=188.7
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCc----cEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGI----PVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKF 606 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~----~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~ 606 (919)
.+|...++||+|+||.||+|.. .+|. .||||.+...... .+++.+|+.++.+++||||++++|+|.. ...+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--STVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--CCcE
Confidence 4577788999999999999984 4554 4899998654332 4678999999999999999999999874 3578
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcch
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~ 686 (919)
++|||+++|+|.++++... ..+++.+.+.++.++++||+|||+. +|+||||||+|||+++++.+||+|||.
T Consensus 85 l~~~~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK------DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCc
Confidence 9999999999999987532 2488999999999999999999985 899999999999999999999999998
Q ss_pred hhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccc
Q 002462 687 VCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYD 765 (919)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~ 765 (919)
++.................+.+..++......++.++|||||||++|||+| |+.|+..........++......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----- 230 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL----- 230 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-----
Confidence 765432211111110111122333333333457788999999999999999 89998766554444433321100
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 766 KELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 766 ~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
. ....... .+..++..||+.+|++||++.++++.|+...
T Consensus 231 --------~----~~~~~~~---~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 231 --------P----QPPICTI---DVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred --------C----CCccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0 0000111 3456888999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=301.75 Aligned_cols=250 Identities=26% Similarity=0.361 Sum_probs=181.9
Q ss_pred cccccCCCCcEEEEEecC----CccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGILEG----GIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~----g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++||+|+||.||+|...+ +..||||++..... ..+.|.+|+.++++++|||||+++|+|...++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 479999999999998642 35799999854322 246789999999999999999999988765667899999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|.+++.+.. ..+.+..++.++.++|+||+|||+. +|+||||||+|||+++++.+|++|||.++.....
T Consensus 81 ~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 81 HGDLRNFIRSET------HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 999999997542 1367788899999999999999974 8999999999999999999999999987654322
Q ss_pred Ccce--eeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcC-CCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 694 AHQS--RITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTG-KMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 694 ~~~~--~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTG-k~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
.... ........+.+.+++......++.++|||||||++|||+|| ..|+......+....+....+
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~----------- 220 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR----------- 220 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-----------
Confidence 1110 00011112233334433334577889999999999999995 555655443333222221100
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
....+...+ .+..++..||+.+|++||++.+|++.|++.
T Consensus 221 ------~~~~~~~~~---~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 221 ------LLQPEYCPD---PLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ------CCCCCcCCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 000111112 355688999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=316.42 Aligned_cols=263 Identities=19% Similarity=0.244 Sum_probs=188.4
Q ss_pred CCCCcccccccCCCCcEEEEEe------cCCccEEEEEecccccc--HHHHHHHHHHHhhc-CCCCccceeeEEeecCCc
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL------EGGIPVVIKRIDLQSVK--TEAYLLELDFFSKV-SHARLVPLLGHCMERENE 604 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l------~~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~ 604 (919)
++|...+.||+|+||.||+|+. .++..||||+++..... .+.+.+|++++.++ +|||||+++++|...+..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 3577788999999999999973 35678999999754322 35688999999999 689999999988766667
Q ss_pred EEEEEEecCCCChhhhhhccCCCC--------------------------------------------------------
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTE-------------------------------------------------------- 628 (919)
Q Consensus 605 ~~lV~Ey~~~GsL~~~L~~~~~~~-------------------------------------------------------- 628 (919)
.++||||+++|+|.++++......
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 899999999999999986532100
Q ss_pred ----CccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcceeeeeecc
Q 002462 629 ----DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLR 704 (919)
Q Consensus 629 ----~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 704 (919)
.....++|.++.+++.++++||+|||+. +|+||||||+|||+++++++|++|||.+.................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 0012478999999999999999999975 899999999999999999999999998765422111100011111
Q ss_pred CCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChh-HHHHHHHhhcccccccccccccccccCCCCCCcc
Q 002462 705 LPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDA-QVKEILEQTLPYISIYDKELVTKIVDPSLIIDED 782 (919)
Q Consensus 705 ~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 782 (919)
.+.+..++......++.++|||||||++|||++ |..|+...... .....+... .... .|.. .+
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------~~~~--~~~~-~~-- 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG----------TRMR--APDY-TT-- 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhcc----------CCCC--CCCC-CC--
Confidence 122333333333457788999999999999997 99998654322 111111100 0000 0110 11
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 783 LLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 783 ~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
+ .+..++..||+.+|++||+|.+|++.|+...
T Consensus 309 --~---~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 309 --P---EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred --H---HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 2567889999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=282.77 Aligned_cols=263 Identities=20% Similarity=0.276 Sum_probs=194.0
Q ss_pred CCcccccccCCCCcEEEEE-ecCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 536 FSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
|...+.+|+|.||.||+|+ .+.|+.||||+++....+ ...-++||+.|+.++|+|||.|+..+ ...+..-||+||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-~~~~~l~lVfEf 82 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-PHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-cCCCceEEEEEe
Confidence 3445789999999999998 678999999999876554 35678999999999999999999954 445678899999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
|+. ||+..++.+. ..|.-.+.-.++.++.+|++|+|.. -|+||||||.|+|+++++..|++|||+++..+
T Consensus 83 m~t-dLe~vIkd~~------i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKN------IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFG 152 (318)
T ss_pred ccc-cHHHHhcccc------cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccC
Confidence 996 8999886543 3477777788999999999999985 79999999999999999999999999999876
Q ss_pred CCCc---ceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccc
Q 002462 692 GDAH---QSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 692 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (919)
.... ....+|.+++|+- -.|...|+...||||.|||+.||+-|.+=+.+.++-+....+-.+...+....-..
T Consensus 153 ~p~~~~~~~V~TRWYRAPEL----LfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPEL----LFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred CCCcccccceeeeeccChHH----hccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc
Confidence 4322 2356777777653 23566788889999999999999999887777777554443333321111111001
Q ss_pred cccccc-------CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 769 VTKIVD-------PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 769 ~~~i~d-------~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+..+-| |....+.-...+....+++....+..+|.+|.++.|+++
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 111111 110001001112223467888899999999999998875
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=302.35 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=189.0
Q ss_pred CCCCcccccccCCCCcEEEEEec-CC---ccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GG---IPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g---~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~l 607 (919)
++|...+.||+|+||.||+|+.. ++ ..+|||++..... ..++|..|++++++++||||+++++++.. .+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-FKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-CCCcEE
Confidence 46778899999999999999975 33 3699999865432 24679999999999999999999998765 467899
Q ss_pred EEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchh
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~ 687 (919)
||||+++|+|.+++..+. ..++|.++++++.+++.||+|||+. +|+||||||+||++++++.+|++|||.+
T Consensus 84 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~ 154 (268)
T cd05063 84 ITEYMENGALDKYLRDHD------GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLS 154 (268)
T ss_pred EEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccc
Confidence 999999999999986532 2488999999999999999999975 8999999999999999999999999987
Q ss_pred hhcCCCCcceeee-eeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccc
Q 002462 688 CAQGGDAHQSRIT-RLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYD 765 (919)
Q Consensus 688 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~ 765 (919)
............. .......+..++......++.++|||||||++|||+| |+.|+...........+....+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~----- 229 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL----- 229 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC-----
Confidence 6443221111110 0011112333333333456788999999999999998 99999766544333222211000
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 766 KELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 766 ~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
+. ..... ..+.+++.+|++.+|++||+|.+|++.|++.
T Consensus 230 ---------~~---~~~~~---~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 ---------PA---PMDCP---SAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---------CC---CCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 01111 2356788999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=300.64 Aligned_cols=252 Identities=22% Similarity=0.364 Sum_probs=189.8
Q ss_pred CCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCC
Q 002462 535 DFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPN 614 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~ 614 (919)
+|...+.||+|+||.||+|..+++..||+|.+.......++|.+|++++++++|+|++++++++. ++..++||||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~lv~e~~~~ 84 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS--EEPIYIVTEYMSK 84 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC--CCCcEEEEEecCC
Confidence 45556789999999999999888889999999766555678999999999999999999999764 3468999999999
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCC
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~ 694 (919)
|+|.++++.... ..++|.++.+|+.+++.||+|||+. +|+||||||+||++++++.+|++|||.+.......
T Consensus 85 ~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 85 GSLLDFLKDGEG-----RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999875321 3488999999999999999999985 79999999999999999999999999876543221
Q ss_pred cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
...... ......+..++......++.++|||||||++|||+| |+.|+......+....+....+
T Consensus 157 ~~~~~~-~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------------- 221 (260)
T cd05070 157 YTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR-------------- 221 (260)
T ss_pred cccccC-CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence 111000 001112333333333457788999999999999999 8999876554433332221100
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
+.. ...... .+..++.+|++.+|++||||.++.+.|++
T Consensus 222 -~~~--~~~~~~---~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 -MPC--PQDCPI---SLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCC--CCcCCH---HHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000 011111 35668899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=300.41 Aligned_cols=252 Identities=23% Similarity=0.392 Sum_probs=191.8
Q ss_pred CCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCC
Q 002462 535 DFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPN 614 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~ 614 (919)
+|...++||+|+||.||+|...++..||||++.......++|.+|++++++++|+||++++++.. .+..++||||+++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~~~~ 84 (260)
T cd05067 7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT--QEPIYIITEYMEN 84 (260)
T ss_pred HceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc--cCCcEEEEEcCCC
Confidence 46667899999999999999989999999999766666678999999999999999999999753 3568999999999
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCC
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~ 694 (919)
|+|.+++..... ..++|.+++.|+.+++.||+|||+. +|+||||||+||++++++.++++|||.+.......
T Consensus 85 ~~L~~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 85 GSLVDFLKTPEG-----IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999865432 3488999999999999999999974 89999999999999999999999999876543211
Q ss_pred cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
.... ........+..++......++.++|||||||++|||+| |+.|+......+....+....+. .
T Consensus 157 ~~~~-~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------~-- 223 (260)
T cd05067 157 YTAR-EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM----------P-- 223 (260)
T ss_pred cccc-cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC----------C--
Confidence 1100 00111122333333333456788999999999999999 99999876554433322211100 0
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
......+ ++.+++.+|++.+|++||+++++...|++
T Consensus 224 -----~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 -----RPDNCPE---ELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCCCCH---HHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0011112 35668889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=301.31 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=188.7
Q ss_pred CCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCC
Q 002462 535 DFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPN 614 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~ 614 (919)
+|.....||+|+||.||+|...++..||+|++.......+.|.+|++++++++|+|++++++++. .+..++||||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~~~~ 84 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS--EEPIYIVTEFMGK 84 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCcEEEEEcCCC
Confidence 35566789999999999999888878999998765555678999999999999999999999764 3468999999999
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCC
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~ 694 (919)
|+|.+++++... ..++|..+..|+.+++.||+|||+. +|+||||||+||++++++.+|++|||.+.......
T Consensus 85 ~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 85 GSLLDFLKEGDG-----KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999975321 3478999999999999999999974 79999999999999999999999999876543221
Q ss_pred cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
.... ........+..++......++.++|||||||++|||+| |+.|+....+.+....+....+.
T Consensus 157 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------- 222 (260)
T cd05069 157 YTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM------------- 222 (260)
T ss_pred cccc-CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 1110 00011112223333333457788999999999999999 89998776554433332211100
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
. ....... .+..++.+|++.+|.+||++.+|.+.|+.
T Consensus 223 --~--~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 --P--CPQGCPE---SLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --C--CCcccCH---HHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 0111112 24567889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=298.52 Aligned_cols=245 Identities=18% Similarity=0.269 Sum_probs=183.2
Q ss_pred ccccCCCCcEEEEEe---cCCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCC
Q 002462 541 LIKNGHSGDLFRGIL---EGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPN 614 (919)
Q Consensus 541 ~ig~G~~G~Vy~g~l---~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~ 614 (919)
.||+|+||.||+|++ .++..||||+++.... ..++|.+|+.++++++||||++++|+|. ++..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE--AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCcEEEEecCCC
Confidence 589999999999975 3578899999864432 2467999999999999999999999874 3467999999999
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCC
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~ 694 (919)
|+|.+++.+.. .+++....+|+.+++.||+|||.. +|+||||||+||++++++.+||+|||.+.......
T Consensus 80 ~~L~~~l~~~~-------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 80 GPLNKFLQKNK-------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149 (257)
T ss_pred CcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence 99999986432 378889999999999999999974 89999999999999999999999999887553322
Q ss_pred cceee-eeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 695 HQSRI-TRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 695 ~~~~~-~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
..... ....+...+..++......++.++|||||||++|||+| |+.|+......+..+.+.....
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~------------- 216 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER------------- 216 (257)
T ss_pred CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-------------
Confidence 11100 11111122333333333456778999999999999998 9999987655444333332110
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
.+ . .+...++ +.+++..||+.+|++||+|.+|++.|++
T Consensus 217 ~~--~--~~~~~~~---l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 ME--C--PQRCPPE---MYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CC--C--CCCCCHH---HHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 00 0 0111222 4568899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=312.37 Aligned_cols=246 Identities=20% Similarity=0.311 Sum_probs=195.6
Q ss_pred CCcccccccCCCCcEEEEE-ecCCccEEEEEeccccccH-HHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 536 FSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKT-EAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~~-~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
|..-..||+|..|.||.+. ..++..||||+++...... +-.++|+.+|+..+|+|||.++.-++.. ++.|+|||||+
T Consensus 275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVMEym~ 353 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVMEYME 353 (550)
T ss_pred hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEeecC
Confidence 4555789999999999997 6678899999998877664 4567899999999999999999977654 68999999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|.+.+-.. .++..+.-.|+.++.+||+|||.. +|||||||+.||||+.++.+||+|||+.......
T Consensus 354 ggsLTDvVt~~--------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 354 GGSLTDVVTKT--------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred CCchhhhhhcc--------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 99999987432 377888899999999999999985 8999999999999999999999999977655433
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
.. .-+++.++|.+++++......|..|.||||+|++++||+-|++||....+-.....+... -
T Consensus 423 ~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n---------------g 485 (550)
T KOG0578|consen 423 QS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN---------------G 485 (550)
T ss_pred cC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc---------------C
Confidence 22 224578899999998887778899999999999999999999999875553322222110 0
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.|.+...+....++ -+.-.+|++.|+.+||+++|+++
T Consensus 486 ~P~lk~~~klS~~~---kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 486 TPKLKNPEKLSPEL---KDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCCcCCccccCHHH---HHHHHHHhhcchhcCCCHHHHhc
Confidence 12222222222222 33556999999999999999986
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=304.74 Aligned_cols=258 Identities=20% Similarity=0.267 Sum_probs=187.3
Q ss_pred CCcccccccCCCCcEEEEEecC------CccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEE
Q 002462 536 FSDANLIKNGHSGDLFRGILEG------GIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~~------g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~l 607 (919)
|...+.||+|+||.||+|...+ +..||||++...... .+.|.+|+.++++++|||||++++++.+. +..++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-~~~~~ 85 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE-QPLSM 85 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-CceEE
Confidence 4445689999999999998643 478999999754332 46789999999999999999999988764 57899
Q ss_pred EEEecCCCChhhhhhccCCC---------CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCc
Q 002462 608 VYKYMPNGDLSSSLYRKTNT---------EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFE 678 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~---------~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~ 678 (919)
++||+++++|.+++..+... ......++|..+++++.++++||+|||+. +|+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 99999999999998633210 01123588999999999999999999974 8999999999999999999
Q ss_pred eeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhh
Q 002462 679 VRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQT 757 (919)
Q Consensus 679 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~ 757 (919)
+||+|||.++.................+.+..++......++.++|||||||++|||+| |..|+......+..+.+...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR 242 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999998765432211111111112223333333333356788999999999999998 88888765544333222211
Q ss_pred cccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 758 LPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 758 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
. ... ...+..++ +..++..|++.+|++||+|++|++.|+.
T Consensus 243 ~----------~~~-------~~~~~~~~---~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 243 Q----------VLP-------CPDDCPAW---VYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred C----------cCC-------CCCCCCHH---HHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 0 000 01111222 4568899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=314.19 Aligned_cols=252 Identities=19% Similarity=0.215 Sum_probs=189.2
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++|...+.||+|+||.||+|+.. +|..||||++..... ..+.+.+|++++.+++|||||++++++.+ ++..++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-DEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-CCEEEEE
Confidence 36777889999999999999965 588999999965422 23568899999999999999999997765 5689999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++.... .+++.+...++.+++.||+|||+. +|+||||||+|||++.++.+||+|||.+.
T Consensus 80 ~e~~~g~~L~~~l~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~ 149 (333)
T cd05600 80 MEYVPGGDFRTLLNNLG-------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSK 149 (333)
T ss_pred EeCCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCc
Confidence 99999999999996432 378888889999999999999985 89999999999999999999999999876
Q ss_pred hcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccc
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (919)
..... .....+++.+.+++......++.++|||||||++|||+||+.|+...+..+....+....... .
T Consensus 150 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---~--- 218 (333)
T cd05600 150 GIVTY-----ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL---Q--- 218 (333)
T ss_pred ccccc-----cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc---c---
Confidence 54321 112234445555554444467889999999999999999999998766544322222111000 0
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
.....++.. ...++ +..++..|++.+|.+||+++++++.
T Consensus 219 ~~~~~~~~~----~~s~~---~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVYDDPRF----NLSDE---AWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCcccc----ccCHH---HHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000111110 11122 4457789999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=320.18 Aligned_cols=260 Identities=19% Similarity=0.292 Sum_probs=188.0
Q ss_pred CCCcccccccCCCCcEEEEEecC------CccEEEEEecccccc--HHHHHHHHHHHhhcC-CCCccceeeEEeecCCcE
Q 002462 535 DFSDANLIKNGHSGDLFRGILEG------GIPVVIKRIDLQSVK--TEAYLLELDFFSKVS-HARLVPLLGHCMERENEK 605 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~------g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~~~~ 605 (919)
+|...+.||+|+||.||+|+..+ +..||||+++..... .+.|.+|+++|.++. |||||+++|+|.. ++..
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-~~~~ 116 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-GGPI 116 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc-CCCc
Confidence 45566899999999999998642 457999999754322 357899999999997 9999999998876 4578
Q ss_pred EEEEEecCCCChhhhhhccCCC----------------------------------------------------------
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNT---------------------------------------------------------- 627 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~---------------------------------------------------------- 627 (919)
++|||||++|+|.++|++.+..
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 9999999999999999754210
Q ss_pred ---------------------------------CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecC
Q 002462 628 ---------------------------------EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLD 674 (919)
Q Consensus 628 ---------------------------------~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld 674 (919)
......++|.+.++|+.++++||+|||+. +|+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEe
Confidence 01123578999999999999999999974 899999999999999
Q ss_pred CCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhH-HHH
Q 002462 675 DKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQ-VKE 752 (919)
Q Consensus 675 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~-~~~ 752 (919)
+++.+|++|||.++...............+...+..++......++.++|||||||++|||+| |+.|+......+ ...
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~ 353 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence 999999999998764322111000011122223333443333456788999999999999998 888986543322 112
Q ss_pred HHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 753 ILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 753 ~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
.+....+ ...|. .... .+..++..||+.+|.+||+|++|++.|++.
T Consensus 354 ~~~~~~~------------~~~p~-----~~~~---~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 354 AIKRGYR------------MAKPA-----HASD---EIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHcCCC------------CCCCC-----CCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111100 00111 1112 356688899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=299.78 Aligned_cols=245 Identities=19% Similarity=0.277 Sum_probs=182.1
Q ss_pred cccCCCCcEEEEEec---CCccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCC
Q 002462 542 IKNGHSGDLFRGILE---GGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGD 616 (919)
Q Consensus 542 ig~G~~G~Vy~g~l~---~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~Gs 616 (919)
||+|+||.||+|++. ++..||||.+...... .++|.+|++++++++|||||+++|+|.. ...++||||+++|+
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~--~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA--EALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC--CCeEEEEEeCCCCC
Confidence 899999999999864 3567999998654332 4679999999999999999999998743 46899999999999
Q ss_pred hhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcc
Q 002462 617 LSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQ 696 (919)
Q Consensus 617 L~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~ 696 (919)
|.+++..+. ..+++.++++++.++++||+|||+. +|+||||||+|||++.+..+|++|||.+.........
T Consensus 81 L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 151 (257)
T cd05115 81 LNKFLSGKK------DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151 (257)
T ss_pred HHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence 999986432 2488999999999999999999985 8999999999999999999999999987644322211
Q ss_pred eeeeee-ccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccccccccccc
Q 002462 697 SRITRL-LRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVD 774 (919)
Q Consensus 697 ~~~~~~-~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d 774 (919)
...... .....+..++......++.++|||||||++||+++ |+.|+......+....+....+ ...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------~~~- 219 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-----------LDC- 219 (257)
T ss_pred eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-----------CCC-
Confidence 110000 00112333333223356778999999999999996 9999987665544433332110 000
Q ss_pred CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 775 PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 775 ~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
+....++ +..++..||..+|++||+|.+|.+.|+.
T Consensus 220 -----~~~~~~~---l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 -----PAECPPE---MYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred -----CCCCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 1111222 4458899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=307.62 Aligned_cols=262 Identities=17% Similarity=0.291 Sum_probs=191.4
Q ss_pred hCCCCcccccccCCCCcEEEEEecC------CccEEEEEeccccc--cHHHHHHHHHHHhhc-CCCCccceeeEEeecCC
Q 002462 533 TGDFSDANLIKNGHSGDLFRGILEG------GIPVVIKRIDLQSV--KTEAYLLELDFFSKV-SHARLVPLLGHCMEREN 603 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l~~------g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~ 603 (919)
.++|...+.||+|+||.||+|...+ ...||+|.+..... ...++.+|++++.++ +|+||++++++|.+ ++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-EG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC-CC
Confidence 3457777899999999999998642 36799999865332 235688999999999 89999999998875 45
Q ss_pred cEEEEEEecCCCChhhhhhccCCC---------CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecC
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNT---------EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLD 674 (919)
Q Consensus 604 ~~~lV~Ey~~~GsL~~~L~~~~~~---------~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld 674 (919)
..++||||+++|+|.+++.+.... ......++|..+++|+.++|.||+|||+. +|+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 799999999999999999753210 01234589999999999999999999974 899999999999999
Q ss_pred CCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 002462 675 DKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEI 753 (919)
Q Consensus 675 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~ 753 (919)
+++.+|++|||.+....................+..++......++.++|||||||++|||++ |..|+......+....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999999998765432211111111111122333443333457788999999999999998 9999876654443332
Q ss_pred HHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 754 LEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
+.... .. + ....... .+..++..|++.+|.+||||.+|++.|++.
T Consensus 247 ~~~~~---------~~----~----~~~~~~~---~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 247 LKEGY---------RM----E----KPQNCTQ---ELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHcCC---------cC----C----CCCCCCH---HHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 22110 00 0 0011111 356788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=300.50 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=189.4
Q ss_pred CCCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++|.....||+|+||.||+|...++..||||++.......++|.+|++++++++||||+++++++. ++..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC--CCCcEEEEEcCC
Confidence 346667889999999999999877778999999765555678999999999999999999999764 346899999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|.+++.+... ..++|.++..++.++++||+|||+. +|+||||||+||++++++.+||+|||.+......
T Consensus 84 ~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 84 KGSLLDFLKGEMG-----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred CCcHHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999975321 2478999999999999999999984 8999999999999999999999999987644322
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
..... ....+...+..++......++.++|||||||++|||+| |+.|+......+.........+
T Consensus 156 ~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~------------- 221 (262)
T cd05071 156 EYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------- 221 (262)
T ss_pred ccccc-cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-------------
Confidence 11110 00111112333333333457888999999999999999 8888876554332221111100
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
. ....... ..+.+++..|++.+|++||++.++.+.|+..
T Consensus 222 --~--~~~~~~~---~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 --M--PCPPECP---ESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --C--CCccccC---HHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0 0001111 2356799999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=304.85 Aligned_cols=261 Identities=20% Similarity=0.258 Sum_probs=190.0
Q ss_pred hCCCCcccccccCCCCcEEEEEec------CCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCc
Q 002462 533 TGDFSDANLIKNGHSGDLFRGILE------GGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENE 604 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l~------~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~ 604 (919)
.++|...+.||+|+||.||++... ++..||||.+..... ..++|.+|++++++++|||||+++++|.+ ++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~-~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV-GKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCc
Confidence 457888899999999999999864 467899999865432 24579999999999999999999998865 457
Q ss_pred EEEEEEecCCCChhhhhhccCCC---------------CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCC
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNT---------------EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQAS 669 (919)
Q Consensus 605 ~~lV~Ey~~~GsL~~~L~~~~~~---------------~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~ 669 (919)
.++||||+++|+|.+++...... ......++|.+++.++.++++||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 89999999999999999743211 01123588999999999999999999975 8999999999
Q ss_pred ceecCCCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChh
Q 002462 670 SILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDA 748 (919)
Q Consensus 670 NILld~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~ 748 (919)
||++++++.+|++|||.+....................+..++......++.++|||||||++|||+| |..|+......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999997764322111000000011112333333333467888999999999999998 88888765544
Q ss_pred HHHHHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 749 QVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
+....+... .... ..+.... .+..++.+|++.+|++||+|.|+++.|++
T Consensus 240 ~~~~~~~~~----------~~~~-------~~~~~~~---~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EVIYYVRDG----------NVLS-------CPDNCPL---ELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHhcC----------CCCC-------CCCCCCH---HHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 332222211 0000 0111112 35668899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.46 Aligned_cols=241 Identities=18% Similarity=0.169 Sum_probs=184.1
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
+|...+.||+|+||.||+|... +|..||||++..... ..+.+.+|++++++++|||||++++++.+ ++..++||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~ 80 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-QRFLYMLM 80 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-CCeEEEEE
Confidence 5777889999999999999864 688999999864332 24568899999999999999999997665 46789999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
||+++|+|.+++.... .+++.....|+.++++||+|||+. +|+||||||+|||+++++.+||+|||.+..
T Consensus 81 e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~ 150 (291)
T cd05612 81 EYVPGGELFSYLRNSG-------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKK 150 (291)
T ss_pred eCCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence 9999999999986542 378888899999999999999985 899999999999999999999999998775
Q ss_pred cCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccc
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELV 769 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (919)
...... ...+++.+.+++......++.++|||||||++|||+||+.|+......+....+....+
T Consensus 151 ~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~---------- 215 (291)
T cd05612 151 LRDRTW-----TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL---------- 215 (291)
T ss_pred ccCCcc-----cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc----------
Confidence 433211 12334445555544445578889999999999999999999987665443222211100
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHH
Q 002462 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPL-----MRYIL 812 (919)
Q Consensus 770 ~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPs-----m~~V~ 812 (919)
........ .+..++..|++.+|.+||+ +.+++
T Consensus 216 --------~~~~~~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~l 252 (291)
T cd05612 216 --------EFPRHLDL---YAKDLIKKLLVVDRTRRLGNMKNGADDVK 252 (291)
T ss_pred --------CCCccCCH---HHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence 00000011 2456888999999999995 66555
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=310.69 Aligned_cols=246 Identities=22% Similarity=0.341 Sum_probs=194.3
Q ss_pred ccccccCCCCcEEEEEec--CC--ccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 539 ANLIKNGHSGDLFRGILE--GG--IPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~l~--~g--~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
.++||+|.||.|++|.|. +| ..||||.+...... ..+|++|+.+|-+++|||+|+|+|...+ ....+|+|.+
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--qp~mMV~ELa 192 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAMMVFELA 192 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--chhhHHhhhc
Confidence 368999999999999974 34 57899999766544 5789999999999999999999998875 4688999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
+.|||.+.|++... ..|--..-..+|.|||+||+||... .+|||||.++||||...-.+||+|||+.+..+.
T Consensus 193 plGSLldrLrka~~-----~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKK-----AILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred ccchHHHHHhhccc-----cceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999987221 2355566678999999999999975 899999999999999999999999999998876
Q ss_pred CCcceeeeeeccCC-CCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 693 DAHQSRITRLLRLP-QSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 693 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
......+......| .+.+++......++.++|||+|||++|||+| |+.||.+....++.+.++ +++
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD---------~~e--- 332 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID---------AGE--- 332 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc---------ccc---
Confidence 55544443333333 2455666667788999999999999999998 889998877665544433 112
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
+|...+...+.+ -.+++.||..+|++||+|..|...
T Consensus 333 -----rLpRPk~csedI---Y~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 333 -----RLPRPKYCSEDI---YQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred -----cCCCCCCChHHH---HHHHHHhccCCccccccHHHHHHh
Confidence 122233444544 457889999999999999999743
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=311.48 Aligned_cols=241 Identities=18% Similarity=0.161 Sum_probs=180.8
Q ss_pred cccCCCCcEEEEEec-CCccEEEEEecccc----ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCC
Q 002462 542 IKNGHSGDLFRGILE-GGIPVVIKRIDLQS----VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGD 616 (919)
Q Consensus 542 ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~----~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~Gs 616 (919)
||+|+||.||+|+.. ++..||||++.... ...+.+.+|++++.+++|||||++++++.+ ++..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-PEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-CCeEEEEEcCCCCCc
Confidence 799999999999864 57899999986432 123568899999999999999999997765 568999999999999
Q ss_pred hhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcc
Q 002462 617 LSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQ 696 (919)
Q Consensus 617 L~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~ 696 (919)
|.+++.+.. .+++.+...|+.++++||+|||+. +|+||||||+|||++.++.+||+|||.++........
T Consensus 80 L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 149 (312)
T cd05585 80 LFHHLQREG-------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK 149 (312)
T ss_pred HHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc
Confidence 999986532 378889999999999999999985 8999999999999999999999999987653222111
Q ss_pred eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccccCC
Q 002462 697 SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPS 776 (919)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 776 (919)
.....+++.+.+++......++.++|||||||++|||+||+.||......+....+... .
T Consensus 150 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~------------------~ 209 (312)
T cd05585 150 --TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE------------------P 209 (312)
T ss_pred --cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC------------------C
Confidence 12233455555555555556788999999999999999999999866543322111100 0
Q ss_pred CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 777 LIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 777 l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
........++ +..++..|++.+|++||++..+.+.|.
T Consensus 210 ~~~~~~~~~~---~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 210 LRFPDGFDRD---AKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCCCCcCCHH---HHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 0001111122 445778999999999997655555554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=304.72 Aligned_cols=266 Identities=21% Similarity=0.272 Sum_probs=186.6
Q ss_pred CCCCcccccccCCCCcEEEEEec-----------------CCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccce
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-----------------GGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPL 594 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-----------------~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l 594 (919)
++|...+.||+|+||.||++... ++..||||++..... ..++|.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 45777789999999999998532 234689999865432 24679999999999999999999
Q ss_pred eeEEeecCCcEEEEEEecCCCChhhhhhccCCCC----CccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCc
Q 002462 595 LGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTE----DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASS 670 (919)
Q Consensus 595 ~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~----~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~N 670 (919)
++++.. ++..++||||+++|+|.+++....... .....++|.+..+++.+++.||+|||+. +|+||||||+|
T Consensus 85 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 85 LAVCIT-SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEec-CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 998865 457899999999999999997643211 1123588999999999999999999985 79999999999
Q ss_pred eecCCCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc--CCCCCCCCChh
Q 002462 671 ILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT--GKMGISASSDA 748 (919)
Q Consensus 671 ILld~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT--Gk~p~~~~~~~ 748 (919)
||+++++.+|++|||.+.............+......+..++......++.++|||||||++|||+| |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999998765422211111111111112222222222356788999999999999998 67788665543
Q ss_pred HHHHHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 749 QVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
+....+.... . ... .....+.. .... ..+.+++.+||+.+|.+||+|.+|.+.|+
T Consensus 241 ~~~~~~~~~~---~---~~~-~~~~~~~~---~~~~---~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIENTGEFF---R---DQG-RQVYLPKP---ALCP---DSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHH---h---hcc-ccccCCCC---CCCC---HHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 3221111100 0 000 00000110 0011 23567899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=311.92 Aligned_cols=240 Identities=16% Similarity=0.190 Sum_probs=182.3
Q ss_pred cccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCC
Q 002462 540 NLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPN 614 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~ 614 (919)
++||+|+||.||+++. .+|..||||++..... ....+.+|++++++++||||+++++++.. ++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-HDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-CCEEEEEEeCCCC
Confidence 3699999999999985 5688999999864321 23467889999999999999999997655 5678999999999
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCC
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~ 694 (919)
|+|.+++.+.. .+++.+...|+.++++||+|||+. +||||||||+|||++.++.+||+|||.++......
T Consensus 80 ~~L~~~l~~~~-------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 80 GELFFHLSRER-------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC
Confidence 99999886532 378888899999999999999985 89999999999999999999999999876432211
Q ss_pred cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccccc
Q 002462 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVD 774 (919)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d 774 (919)
. ......+++.+..++......++.++|||||||++|||+||+.||...........+....
T Consensus 150 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~---------------- 211 (323)
T cd05571 150 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------------- 211 (323)
T ss_pred C--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 1 1122335555666665555567889999999999999999999997765443332221100
Q ss_pred CCCCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002462 775 PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP-----LMRYILK 813 (919)
Q Consensus 775 ~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RP-----sm~~V~~ 813 (919)
..+ .....++ +..++..|++.+|++|| +..++++
T Consensus 212 ~~~--p~~~~~~---~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 212 IRF--PRTLSPE---AKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCC--CCCCCHH---HHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 000 1111122 45578899999999999 6787764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=298.83 Aligned_cols=247 Identities=21% Similarity=0.338 Sum_probs=185.3
Q ss_pred cccccCCCCcEEEEEecC----CccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGILEG----GIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~----g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++||+|+||.||+|+... +..||+|.+..... ..++|.+|+++++++.|+|||++++++.. +..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG--EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC--CceEEEEEeCC
Confidence 369999999999997532 26899999875554 35679999999999999999999997753 46899999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|.+++.+.. .++|..+++++.++++||+|||+. +|+||||||+|||+++++.+|++|||.++.....
T Consensus 79 ~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 79 LGPLLKYLKKRR-------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred CCcHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 999999997542 478999999999999999999975 7999999999999999999999999988755332
Q ss_pred Ccceeee-eeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccccccc
Q 002462 694 AHQSRIT-RLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTK 771 (919)
Q Consensus 694 ~~~~~~~-~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 771 (919)
....... ...+...+..++......++.++|||||||++|||+| |+.|+......+....+....+
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~------------ 216 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER------------ 216 (257)
T ss_pred CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc------------
Confidence 2111000 0000112233333333457788999999999999998 9999987665544444332110
Q ss_pred cccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 772 IVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 772 i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
.-.+ ..... .+.+++.+|++.+|++||++.+|++.|++.
T Consensus 217 ~~~~-----~~~~~---~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 LPRP-----EECPQ---EIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCC-----CCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 0000 01111 355688999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=303.31 Aligned_cols=266 Identities=21% Similarity=0.270 Sum_probs=189.4
Q ss_pred CCCCcccccccCCCCcEEEEEecC-----------------CccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccce
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEG-----------------GIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPL 594 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~-----------------g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l 594 (919)
++|...+.||+|+||.||++...+ +..||+|++..... ..++|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 467778899999999999988643 24689999865432 24679999999999999999999
Q ss_pred eeEEeecCCcEEEEEEecCCCChhhhhhccCCCC----CccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCc
Q 002462 595 LGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTE----DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASS 670 (919)
Q Consensus 595 ~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~----~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~N 670 (919)
+++|.. ++..++|+||+++|+|.+++.+..... .....++|.+.+.++.++++||+|||+. +|+||||||+|
T Consensus 85 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 85 LGVCTV-DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEec-CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 998875 467899999999999999997543210 1123589999999999999999999975 89999999999
Q ss_pred eecCCCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc--CCCCCCCCChh
Q 002462 671 ILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT--GKMGISASSDA 748 (919)
Q Consensus 671 ILld~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT--Gk~p~~~~~~~ 748 (919)
|++++++.++++|||.+..................+.+..++......++.++|||||||++|||+| |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999998764322211111111112223444443333457888999999999999998 67777665443
Q ss_pred HHHHHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 749 QVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
+....+.... .........+ . .....+ .+.+++..|++.+|++||+|.+|++.|+
T Consensus 241 ~~~~~~~~~~------~~~~~~~~~~-~---~~~~~~---~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGHFF------RDDGRQIYLP-R---PPNCPK---DIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhcc------ccccccccCC-C---ccCCCH---HHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 3222211110 0000000000 0 001112 3567899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=303.55 Aligned_cols=264 Identities=20% Similarity=0.268 Sum_probs=182.3
Q ss_pred CCCcccccccCCCCcEEEEEe--cCCccEEEEEeccccc---cHHHHHHHHHHHhhc---CCCCccceeeEEee----cC
Q 002462 535 DFSDANLIKNGHSGDLFRGIL--EGGIPVVIKRIDLQSV---KTEAYLLELDFFSKV---SHARLVPLLGHCME----RE 602 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l--~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l---~H~niV~l~g~c~~----~~ 602 (919)
+|...+.||+|+||.||+|+. .+|..||||++..... ....+.+|+++++++ +|||||+++++|.. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 466678899999999999985 3468899999864332 234577788877766 69999999998852 23
Q ss_pred CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeC
Q 002462 603 NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG 682 (919)
Q Consensus 603 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~ 682 (919)
...++||||++ |+|.+++..... ..+++.++..|+.++++||+|||+. +|+||||||+|||+++++.+||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEc
Confidence 45799999997 689998865321 2488999999999999999999985 89999999999999999999999
Q ss_pred CcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhc-cc
Q 002462 683 SLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTL-PY 760 (919)
Q Consensus 683 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~-~~ 760 (919)
|||.+........ .....+++.+.+++......++.++|||||||++|||+||+.||....+.+ ....++... |.
T Consensus 153 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~ 229 (290)
T cd07862 153 DFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 229 (290)
T ss_pred cccceEeccCCcc---cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence 9998765432211 111223334444444333457788999999999999999999998776543 223332211 10
Q ss_pred ccccccc--cccccccCCCCCCcchHHHH-----HHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 761 ISIYDKE--LVTKIVDPSLIIDEDLLEEV-----WAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 761 ~~~~~~~--~~~~i~d~~l~~~~~~~~~~-----~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
......+ .......+.- ....+++ ..+..++.+|++.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKS---AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCC---CCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000 0000111000 0000000 12456889999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=315.41 Aligned_cols=267 Identities=16% Similarity=0.198 Sum_probs=182.6
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecC----CcEEE
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERE----NEKFL 607 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~----~~~~l 607 (919)
|...+.||+|+||.||+|+. .+|..||||++.... .....+.+|++++++++|||||++++++.... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 55668899999999999984 568999999986432 12356889999999999999999999876432 24799
Q ss_pred EEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchh
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~ 687 (919)
|||||+ ++|.+++.+.. .++|.....|+.|+++||+|||+. +|+||||||+|||+++++.+||+|||.+
T Consensus 82 v~e~~~-~~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 82 VFELME-SDLHQVIKAND-------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred EEecCC-CCHHHHHHhcc-------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence 999996 68988885432 388999999999999999999985 8999999999999999999999999988
Q ss_pred hhcCCCCcc-eeeeeeccCCCCccccCCCC--CCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccc
Q 002462 688 CAQGGDAHQ-SRITRLLRLPQSSEQGSSGS--LTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIY 764 (919)
Q Consensus 688 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~--~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~ 764 (919)
+........ .......+++.+.+++..+. ..++.++|||||||++|||+||+.||...........+..........
T Consensus 151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 654221111 11112233444444443322 356788999999999999999999997765433222211111000000
Q ss_pred -----c----cccccccccCCC-CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 765 -----D----KELVTKIVDPSL-IIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 765 -----~----~~~~~~i~d~~l-~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
. .+.+..+..... ...+.....-..+..++..|++.+|++||+++||++
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0 000000000000 000000000013457889999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=296.42 Aligned_cols=246 Identities=22% Similarity=0.356 Sum_probs=184.4
Q ss_pred cccccCCCCcEEEEEecCCccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCCh
Q 002462 540 NLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDL 617 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL 617 (919)
++||+|+||.||+|...++..||+|.+...... ...|.+|++++++++||||++++++|.. .+..++||||+++|+|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-RQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-CCccEEEEECCCCCcH
Confidence 379999999999999888999999998654332 3578999999999999999999998876 4578999999999999
Q ss_pred hhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcce
Q 002462 618 SSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQS 697 (919)
Q Consensus 618 ~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~~ 697 (919)
.+++.+.. ..++|.++++++.++++||.|||.. +++||||||+||++++++.+|++|||.+..........
T Consensus 80 ~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 150 (250)
T cd05085 80 LSFLRKKK------DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS 150 (250)
T ss_pred HHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccccc
Confidence 99886432 2378999999999999999999974 89999999999999999999999999775432211110
Q ss_pred eeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccccccccccCC
Q 002462 698 RITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPS 776 (919)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 776 (919)
. ........+..++......++.++|||||||++||++| |+.|+...........+..... ..
T Consensus 151 ~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~---------------~~ 214 (250)
T cd05085 151 S-GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR---------------MS 214 (250)
T ss_pred C-CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC---------------CC
Confidence 0 00011122333333333457788999999999999999 9999976654433222221100 00
Q ss_pred CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 777 LIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 777 l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
...... ..+..++..|++.+|++||+|.++++.|.
T Consensus 215 --~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 --CPQKCP---DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred --CCCCCC---HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 001111 23567889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=297.98 Aligned_cols=248 Identities=21% Similarity=0.345 Sum_probs=187.1
Q ss_pred CCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCC
Q 002462 535 DFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPN 614 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~ 614 (919)
+|...+.||+|+||.||+|... |..||+|.+.... ..+.|.+|+.++++++|+|+++++|++.+.++..++||||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 5666789999999999999875 6789999885433 3467999999999999999999999877655678999999999
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCC
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~ 694 (919)
|+|.+++..... ..++|.++++++.+++.||+|||+. +|+||||||+||++++++.+|++|||.+.......
T Consensus 85 ~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 85 GSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999865432 2478999999999999999999975 89999999999999999999999999776433221
Q ss_pred cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
...... ..+..++......++.++|||||||++|||+| |+.|+......+....+....+ ....
T Consensus 157 ~~~~~~-----~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------~~~~ 221 (256)
T cd05082 157 DTGKLP-----VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK----------MDAP 221 (256)
T ss_pred CCCccc-----eeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC----------CCCC
Confidence 111111 11222333333456788999999999999998 9999876554443333221110 0000
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
..... .+..++.+|++.+|++||+|.++++.|+.
T Consensus 222 -------~~~~~---~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 -------DGCPP---VVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -------CCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 01112 24567889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=309.27 Aligned_cols=203 Identities=19% Similarity=0.301 Sum_probs=162.0
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
++|...+.||+|+||.||++... +|..+|+|.+..... ..++|.+|++++++++|||||+++++|.+ ++..++|||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 83 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICME 83 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-CCEEEEEEe
Confidence 56788889999999999999865 578899998865432 24679999999999999999999998876 468999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+++|+|.+++.+.. .+++....+++.++++||+|||+. .+|+||||||+|||+++++.+||+|||.+...
T Consensus 84 ~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 84 HMDGGSLDQVLKKAG-------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred cCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 999999999986532 377888889999999999999973 36999999999999999999999999987644
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV 750 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~ 750 (919)
..... ....++..+..++......++.++|||||||++|||+||+.|+........
T Consensus 155 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 210 (333)
T cd06650 155 IDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210 (333)
T ss_pred hhhcc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 22111 111223334444443344577889999999999999999999986654443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=301.28 Aligned_cols=259 Identities=21% Similarity=0.298 Sum_probs=191.0
Q ss_pred CCCCcccccccCCCCcEEEEEecC------CccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEG------GIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEK 605 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~------g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~ 605 (919)
++|...+.||+|+||.||+|...+ +..||+|.+..... ...+|.+|++++++++||||++++|++.. ....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST-GQPT 84 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC-CCCc
Confidence 356677899999999999998643 36899999864432 24578999999999999999999998765 4678
Q ss_pred EEEEEecCCCChhhhhhccCCCC---CccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeC
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTE---DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG 682 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~~---~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~ 682 (919)
++||||+++|+|.+++....... .....++|.+.+.|+.+++.||+|||+. +|+||||||+||++++++.+|++
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 99999999999999997543211 1223588999999999999999999974 89999999999999999999999
Q ss_pred CcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccc
Q 002462 683 SLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYI 761 (919)
Q Consensus 683 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~ 761 (919)
|||.++...............+...+..++......++.++|||||||++||++| |+.|+...+..+..+.+....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--- 238 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG--- 238 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC---
Confidence 9998765432221111111111222333333333457788999999999999999 999987766554433332110
Q ss_pred cccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 762 SIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 762 ~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
.... ...... .+..++..|++.+|++||++.+++..|+
T Consensus 239 -------~~~~-------~~~~~~---~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 -------HLDL-------PENCPD---KLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -------CCCC-------CCCCCH---HHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0000 000111 3567899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=286.37 Aligned_cols=261 Identities=21% Similarity=0.268 Sum_probs=186.2
Q ss_pred cccccccCCCCcEEEEEe-cCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 538 DANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 538 ~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
.-.++|+|+||.|||++- +.|+.||||++-..... .+--++||++|++++|+|+|.|+..|.. ....+||+|||+
T Consensus 6 ~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-krklhLVFE~~d 84 (396)
T KOG0593|consen 6 KLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-KRKLHLVFEYCD 84 (396)
T ss_pred hhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-cceeEEEeeecc
Confidence 345799999999999995 56899999999554432 3456899999999999999999997765 457899999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
.-=| +-|.+.. ..++.....+|..|+++|+.|+|.. .||||||||+||||..++.+|++|||.|+...+.
T Consensus 85 hTvL-~eLe~~p------~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 85 HTVL-HELERYP------NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred hHHH-HHHHhcc------CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 7444 3343322 2266666778999999999999986 7999999999999999999999999999977532
Q ss_pred C---cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccc-c----cccc
Q 002462 694 A---HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPY-I----SIYD 765 (919)
Q Consensus 694 ~---~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~-~----~~~~ 765 (919)
. .....+|.+++|+-. .|...|..+.||||.|||+.||+||.+=|.+.++.+....+...... + ++..
T Consensus 155 gd~YTDYVATRWYRaPELL----vGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELL----VGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred cchhhhhhhhhhccChhhh----cccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 2 123456667766533 24456777889999999999999999989888876543333222210 0 0111
Q ss_pred c-ccccccccCCCCCCcch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 766 K-ELVTKIVDPSLIIDEDL----LEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 766 ~-~~~~~i~d~~l~~~~~~----~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
. .....+.=|.....+.+ ..-...+++++..|++.||++|++-++.+.
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1 11111111111111111 111224678999999999999999998864
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=302.95 Aligned_cols=269 Identities=19% Similarity=0.278 Sum_probs=184.9
Q ss_pred CCCCcccccccCCCCcEEEEEec-----CCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecC-CcEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-----GGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERE-NEKF 606 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-----~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~-~~~~ 606 (919)
.+|...+.||+|+||.||+|... ++..||||++...... .+.|.+|++++++++|||||+++++|...+ ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 35666788999999999999853 5788999998654433 467899999999999999999999876433 3578
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcch
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~ 686 (919)
+||||+++|+|.+++.+.. ..++|.++..++.++++||+|||+. +|+||||||+||++++++.+||+|||.
T Consensus 84 lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR------ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred EEEEecCCCCHHHHHHhcC------cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcc
Confidence 9999999999999986532 2389999999999999999999975 899999999999999999999999998
Q ss_pred hhhcCCCCcceeeeee-ccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccc
Q 002462 687 VCAQGGDAHQSRITRL-LRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYD 765 (919)
Q Consensus 687 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~ 765 (919)
+............... .....+..++......++.++|||||||++|||+||..+....... ....+....+. ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~ 232 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQG-QMIV 232 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhccccccc-ccch
Confidence 7754322111111000 0001122222222234677899999999999999998765432211 10000000000 0000
Q ss_pred cccccccccC--CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 766 KELVTKIVDP--SLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 766 ~~~~~~i~d~--~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
..+.+++.. .....+...+ .+..++..||+.+|++||||.+|++.|+.
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~---~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 233 -YHLIELLKNNGRLPAPPGCPA---EIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred -HHHHHHHhcCCcCCCCCCCCH---HHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 000011110 0011111122 35668899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=298.34 Aligned_cols=253 Identities=20% Similarity=0.357 Sum_probs=190.9
Q ss_pred CCCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++|...+.||+|+||.||+|...++..+|+|.+.......+.|.+|++++++++|+||+++++++.+ ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEEeCC
Confidence 3567788999999999999998888889999987554445689999999999999999999997764 56899999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|.+++.+... ..++|.+++.++.+++.||+|||+. +++||||||+||+++.++.+|++|||.+......
T Consensus 84 ~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 84 KGSLLDFLKSDEG-----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred CCcHHHHHHhCCc-----cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999965432 3478999999999999999999974 8999999999999999999999999977644322
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
..... ........+..++......++.++|||||||++||++| |+.|+...+.......+....+.
T Consensus 156 ~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------------ 222 (260)
T cd05073 156 EYTAR-EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM------------ 222 (260)
T ss_pred Ccccc-cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC------------
Confidence 11110 00011112223333333356778999999999999999 99999776554444333321110
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
+ ......+ .+..++.+|++.+|++||++.++.+.|++
T Consensus 223 --~---~~~~~~~---~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 --P---RPENCPE---ELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --C---CcccCCH---HHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 0011112 25567889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=312.86 Aligned_cols=242 Identities=16% Similarity=0.186 Sum_probs=184.3
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++|...+.||+|+||.||+|+.. +|..||||.+..... ..+.+.+|++++++++|||||++++++.+ ++..++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-ENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-CCEEEEE
Confidence 46777889999999999999965 578999999864322 23568899999999999999999997765 5689999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++.+.. .+++.....++.++++||+|||+. +|+||||||+|||+++++.+||+|||.+.
T Consensus 97 ~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 166 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG-------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK 166 (329)
T ss_pred EcCCCCChHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCce
Confidence 99999999999986542 367777788999999999999985 89999999999999999999999999877
Q ss_pred hcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccc
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (919)
....... ...+++.+.+++......++.++|||||||++|||+||+.||.........+.+....
T Consensus 167 ~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~---------- 231 (329)
T PTZ00263 167 KVPDRTF-----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR---------- 231 (329)
T ss_pred EcCCCcc-----eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC----------
Confidence 5433221 1234455555555444567888999999999999999999997765443222211110
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHH
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPL-----MRYIL 812 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPs-----m~~V~ 812 (919)
+.......+ .+..++..|++.+|.+||+ +++++
T Consensus 232 --------~~~p~~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 232 --------LKFPNWFDG---RARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred --------cCCCCCCCH---HHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 000000111 2456888999999999997 45554
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=301.90 Aligned_cols=254 Identities=18% Similarity=0.302 Sum_probs=187.0
Q ss_pred HHhCCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccccHHHHHHHHHHHhhc-CCCCccceeeEEeecC-----C
Q 002462 531 AATGDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVKTEAYLLELDFFSKV-SHARLVPLLGHCMERE-----N 603 (919)
Q Consensus 531 ~at~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~-----~ 603 (919)
.+++.|...+.||+|+||.||+|... ++..||||++.......+++.+|+.++.++ +|+||++++|++...+ .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 45677888889999999999999864 578999999976655567789999999999 6999999999887532 3
Q ss_pred cEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCC
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS 683 (919)
Q Consensus 604 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~d 683 (919)
..++||||+++|+|.+++..... ..++|.....++.+++.||+|||+. +|+||||||+||++++++.+|++|
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKG-----NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence 57899999999999999865321 3488999999999999999999985 899999999999999999999999
Q ss_pred cchhhhcCCCCcceeeeeeccCCCCccccCC-----CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhc
Q 002462 684 LSEVCAQGGDAHQSRITRLLRLPQSSEQGSS-----GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTL 758 (919)
Q Consensus 684 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~ 758 (919)
||++......... .....+.+.+..++.. ....++.++|||||||++|||+||+.|+..............
T Consensus 155 fg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~-- 230 (272)
T cd06637 155 FGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-- 230 (272)
T ss_pred CCCceeccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc--
Confidence 9987654321111 1111222222222221 123567789999999999999999999975443221111100
Q ss_pred ccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 759 PYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 759 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.......+. .... .+.+++.+|++.+|.+||++.+|++
T Consensus 231 --------~~~~~~~~~------~~~~---~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 --------NPAPRLKSK------KWSK---KFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --------CCCCCCCCC------CcCH---HHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000111111 1111 2566888999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=305.06 Aligned_cols=263 Identities=16% Similarity=0.288 Sum_probs=190.4
Q ss_pred CCCCcccccccCCCCcEEEEEec--------CCccEEEEEecccc--ccHHHHHHHHHHHhhc-CCCCccceeeEEeecC
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE--------GGIPVVIKRIDLQS--VKTEAYLLELDFFSKV-SHARLVPLLGHCMERE 602 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~--------~g~~vavK~l~~~~--~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~ 602 (919)
.+|.....||+|+||.||+|+.. ++..||+|.+.... ...+++.+|+.+++++ +||||+++++++.. .
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~ 93 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-D 93 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-C
Confidence 34666788999999999999742 24579999886432 2245789999999999 89999999998765 4
Q ss_pred CcEEEEEEecCCCChhhhhhccCCCC---------CccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceec
Q 002462 603 NEKFLVYKYMPNGDLSSSLYRKTNTE---------DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILL 673 (919)
Q Consensus 603 ~~~~lV~Ey~~~GsL~~~L~~~~~~~---------~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILl 673 (919)
+..++||||+++|+|.+++.+..... .....++|.+++.++.|+++||+|||+. +|+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 67899999999999999997643210 0123589999999999999999999985 89999999999999
Q ss_pred CCCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHH
Q 002462 674 DDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKE 752 (919)
Q Consensus 674 d~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~ 752 (919)
++++.+|++|||.+..................+.+.+++......++.++|||||||++|||+| |..|+......+..+
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 9999999999998765432211111111111122333443333457788999999999999998 788887665444333
Q ss_pred HHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 002462 753 ILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 753 ~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~~ 820 (919)
.+....+ . + ......+ .+..++.+||+.+|++||+|.+|++.|+....
T Consensus 251 ~~~~~~~---------~----~----~~~~~~~---~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 251 LLKEGHR---------M----D----KPANCTN---ELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHcCCc---------C----C----CCCCCCH---HHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 3221110 0 0 0011122 24567889999999999999999999987554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=297.02 Aligned_cols=238 Identities=24% Similarity=0.358 Sum_probs=176.8
Q ss_pred cccccCCCCcEEEEEecCCc-----------cEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 540 NLIKNGHSGDLFRGILEGGI-----------PVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~g~-----------~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
+.||+|+||.||+|...+.. .|++|.+.......+.|.+|+.++++++||||++++|+|.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR--DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec--CCcEEE
Confidence 36899999999999976433 57888776544336789999999999999999999998876 468999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCC-------ceee
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF-------EVRL 681 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~-------~~kl 681 (919)
|||+++|+|.+++.+... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+|+
T Consensus 79 ~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN------NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred EEcCCCCcHHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEe
Confidence 999999999999975432 478999999999999999999974 899999999999999888 7999
Q ss_pred CCcchhhhcCCCCcceeeeeeccCCCCccccCCCC--CCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhc
Q 002462 682 GSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGS--LTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTL 758 (919)
Q Consensus 682 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~ 758 (919)
+|||.+........ . .....+..++.... ..++.++|||||||++|||++ |..|+......+...+.....
T Consensus 150 ~Dfg~a~~~~~~~~-~-----~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~ 223 (259)
T cd05037 150 SDPGIPITVLSREE-R-----VERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH 223 (259)
T ss_pred CCCCcccccccccc-c-----ccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC
Confidence 99998765432111 0 11111222222211 356788999999999999999 577776543322222211100
Q ss_pred ccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 759 PYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 759 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
. .... . . ..+..++..|++.+|.+||+|.+|++.|+
T Consensus 224 ---------~--------~~~~-~-~---~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 ---------R--------LPMP-D-C---AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ---------C--------CCCC-C-c---hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0000 0 0 24567889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=304.27 Aligned_cols=263 Identities=20% Similarity=0.265 Sum_probs=189.6
Q ss_pred hCCCCcccccccCCCCcEEEEEecC------CccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCc
Q 002462 533 TGDFSDANLIKNGHSGDLFRGILEG------GIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENE 604 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l~~------g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~ 604 (919)
+++|...+.||+|+||.||+|...+ +..||||.++..... ..+|.+|+.++++++||||+++++++.+ .+.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK-GQP 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCC
Confidence 4567778899999999999997542 458999988644322 3568899999999999999999998765 457
Q ss_pred EEEEEEecCCCChhhhhhccCCC---CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceee
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNT---EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRL 681 (919)
Q Consensus 605 ~~lV~Ey~~~GsL~~~L~~~~~~---~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl 681 (919)
.++||||+++|+|.+++.+.... ......+++....+|+.+++.||+|||+. +|+||||||+|||+++++.+|+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 89999999999999999753211 11234467888899999999999999974 8999999999999999999999
Q ss_pred CCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccc
Q 002462 682 GSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPY 760 (919)
Q Consensus 682 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~ 760 (919)
+|||.++...................+..++......++.++|||||||++|||++ |+.|+......+..+.+...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~--- 237 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG--- 237 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---
Confidence 99998764322111110111111112333333333456788999999999999999 78888765544433222110
Q ss_pred ccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 761 ISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 761 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
+.. .. .+... ..+..++..|++.+|++||+|.++++.|++.+
T Consensus 238 ------~~~------~~--~~~~~---~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 238 ------GYL------DQ--PDNCP---ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ------CCC------CC--CCCCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 000 00 01111 13567889999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=303.22 Aligned_cols=260 Identities=22% Similarity=0.346 Sum_probs=188.3
Q ss_pred CCCCcccccccCCCCcEEEEEecC-Cc--cEEEEEecccc--ccHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEG-GI--PVVIKRIDLQS--VKTEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~-g~--~vavK~l~~~~--~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~l 607 (919)
++|...++||+|+||.||+|+..+ +. .+|+|.++... ...+.|.+|++++.++ +|||||++++++.+ .+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-RGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-CCcceE
Confidence 467778899999999999998754 33 47888886422 2246799999999999 79999999998765 457899
Q ss_pred EEEecCCCChhhhhhccCCCC---------CccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCc
Q 002462 608 VYKYMPNGDLSSSLYRKTNTE---------DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFE 678 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~---------~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~ 678 (919)
||||+++|+|.+++++..... .....++|.+..+|+.++++||+|||+. +|+||||||+|||+++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence 999999999999997543110 1123589999999999999999999974 8999999999999999999
Q ss_pred eeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhh
Q 002462 679 VRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQT 757 (919)
Q Consensus 679 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~ 757 (919)
+||+|||.+.......... .. .....+..++......++.++|||||||++|||+| |+.|+......+....+...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~-~~--~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~ 234 (297)
T cd05089 158 SKIADFGLSRGEEVYVKKT-MG--RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234 (297)
T ss_pred EEECCcCCCccccceeccC-CC--CcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 9999999775322110000 00 00112333333333456788999999999999998 99999776544322211110
Q ss_pred cccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 002462 758 LPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 758 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~~ 820 (919)
. .+.. .+.... .+.+++..|++.+|.+||++.+|++.|++...
T Consensus 235 ~---------------~~~~--~~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 235 Y---------------RMEK--PRNCDD---EVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred C---------------CCCC--CCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 0000 011112 24568899999999999999999999986653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=296.25 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=174.2
Q ss_pred ccccCCCCcEEEEEecCCc---cEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCC
Q 002462 541 LIKNGHSGDLFRGILEGGI---PVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNG 615 (919)
Q Consensus 541 ~ig~G~~G~Vy~g~l~~g~---~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~G 615 (919)
.||+|+||.||+|...++. .+++|.+..... ..+.|.+|++++++++|||||+++|+|.. ....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-AIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-CCccEEEEecCCCC
Confidence 6999999999999865443 456777654432 24689999999999999999999998876 45789999999999
Q ss_pred ChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCc
Q 002462 616 DLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAH 695 (919)
Q Consensus 616 sL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~ 695 (919)
+|.+++++.... ...+++....+++.++|+||+|||+. +|+||||||+|||++.++.+|++|||.+........
T Consensus 81 ~L~~~l~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 81 DLKSYLSQEQWH---RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred cHHHHHHhhhcc---cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 999999764321 12366777788999999999999974 799999999999999999999999997653221111
Q ss_pred cee-----eeeeccCCCCccccCC--CCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHH-HHHhhccccccccc
Q 002462 696 QSR-----ITRLLRLPQSSEQGSS--GSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKE-ILEQTLPYISIYDK 766 (919)
Q Consensus 696 ~~~-----~~~~~~~~~~~~~~~~--~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 766 (919)
... .+..+.+|+....... .....+.++|||||||++|||+| |+.|+....+.+... ....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~---------- 224 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD---------- 224 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhh----------
Confidence 000 0111222322211111 11245778999999999999997 566876655433221 1111
Q ss_pred ccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
....+.+|.+... ..+. +..+...|| .+|++||+|++|++.|.
T Consensus 225 -~~~~~~~~~~~~~--~~~~---~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 225 -QQVKLFKPQLELP--YSER---WYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -cccccCCCccCCC--CcHH---HHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1112233333211 1122 334667899 56999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=313.66 Aligned_cols=244 Identities=16% Similarity=0.236 Sum_probs=173.8
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
|...+.||+|+||.||+|+. .+|..||||++...... .+.|.+|++++++++|+|||++++++.+ ++..++|||||
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~ 154 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEIQVLLEFM 154 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-CCeEEEEEecC
Confidence 34457899999999999985 46899999998543322 4678999999999999999999997754 56889999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++|+|.+.. ...+....+|+.++++||+|||+. +||||||||+|||+++++.+||+|||.+.....
T Consensus 155 ~~~~L~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 155 DGGSLEGTH-----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CCCcccccc-----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 999986532 134566778999999999999985 899999999999999999999999998765432
Q ss_pred CCcceeeeeeccCCCCccccCC-----CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccc
Q 002462 693 DAHQSRITRLLRLPQSSEQGSS-----GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKE 767 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 767 (919)
.... .....++..|..++.. .....+.++|||||||++|||++|+.||...........+..... ..
T Consensus 221 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----~~-- 292 (353)
T PLN00034 221 TMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM----SQ-- 292 (353)
T ss_pred cccc--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc----cC--
Confidence 2110 0111223333333322 112234578999999999999999999974332222211111000 00
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 768 LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 768 ~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.+.. ...... .+..++..||+.+|++||++.||++
T Consensus 293 ------~~~~--~~~~~~---~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 293 ------PPEA--PATASR---EFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred ------CCCC--CCccCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 011112 2456788999999999999999986
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=299.97 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=187.3
Q ss_pred CCCcccccccCCCCcEEEEEecC-C---ccEEEEEecccc--ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILEG-G---IPVVIKRIDLQS--VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~-g---~~vavK~l~~~~--~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++...+.||+|+||.||+|.... + ..||||.+.... ...++|..|++++++++||||+++++++.+ ++..++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv 83 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SRPVMII 83 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-CCceEEE
Confidence 35567899999999999999653 3 369999986532 224689999999999999999999997765 5678999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++.... ..++|.+++.|+.+++.||+|||+. +++||||||+||+++.++.+|++|||.+.
T Consensus 84 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 84 TEFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred EecCCCCcHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccc
Confidence 99999999999986543 2378999999999999999999974 89999999999999999999999999876
Q ss_pred hcCCCCcceeeeeecc---CCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccc
Q 002462 689 AQGGDAHQSRITRLLR---LPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIY 764 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~ 764 (919)
...............+ ...+..++......++.++|||||||++||++| |+.|+.........+++....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~----- 229 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR----- 229 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc-----
Confidence 5432211111110000 112333333334467788999999999999987 9999977655444333321110
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 765 DKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 765 ~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
....++... .+..++..|++.+|++||+|++|+..|+.
T Consensus 230 ------------~~~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 230 ------------LPPPMDCPT---ALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ------------CCCcccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 000111112 24568889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=300.64 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=183.8
Q ss_pred cccccCCCCcEEEEEecC-------CccEEEEEecccc--ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 540 NLIKNGHSGDLFRGILEG-------GIPVVIKRIDLQS--VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~-------g~~vavK~l~~~~--~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
+.||+|+||.||+|...+ +..||||.+.... ....+|.+|++++++++|||||+++|+|.. .+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-NEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-CCCeEEEEe
Confidence 469999999999998643 2579999885443 234679999999999999999999998875 457899999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCC-----ceeeCCcc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF-----EVRLGSLS 685 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~-----~~kl~dfg 685 (919)
|+++|+|.+++.+..........++|.+++.|+.++++||+|||+. +|+||||||+||+++.+. .+|++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999999975432111223489999999999999999999974 799999999999999877 89999999
Q ss_pred hhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccc
Q 002462 686 EVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIY 764 (919)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~ 764 (919)
.+....................+..++......++.++|||||||++|||+| |+.|+......+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~------ 230 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG------ 230 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC------
Confidence 8764422111100001111122333333333456788999999999999998 999987655443332221100
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 765 DKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 765 ~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
.........+ .+.+++.+|++.+|.+||+|.+|.+.|+
T Consensus 231 -----------~~~~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 -----------RLQKPENCPD---KIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -----------ccCCcccchH---HHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0000111122 3456888999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=297.65 Aligned_cols=253 Identities=22% Similarity=0.296 Sum_probs=175.4
Q ss_pred ccccCCCCcEEEEEecCC---ccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCC
Q 002462 541 LIKNGHSGDLFRGILEGG---IPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNG 615 (919)
Q Consensus 541 ~ig~G~~G~Vy~g~l~~g---~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~G 615 (919)
.||+|+||.||+|...++ ..+|||.+...... .+.|.+|++++++++|+||++++|+|.+ .+..++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-SIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-CCceEEEEEeCCCC
Confidence 589999999999986543 46888877543322 3578999999999999999999998876 45799999999999
Q ss_pred ChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCc
Q 002462 616 DLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAH 695 (919)
Q Consensus 616 sL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~ 695 (919)
+|.+++....... ....+|.....|+.|+++||+|||+. +|+||||||+|||+++++.+||+|||.+........
T Consensus 81 ~L~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 81 DLKNYLRSNRGMV--AQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred cHHHHHHhccccc--cccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 9999997653211 12356888889999999999999985 899999999999999999999999998754322111
Q ss_pred ceeeeeeccCCCCccccC-------CCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHH-HHHHhhccccccccc
Q 002462 696 QSRITRLLRLPQSSEQGS-------SGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVK-EILEQTLPYISIYDK 766 (919)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~-------~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 766 (919)
............+..++. ......+.++|||||||++|||+| |+.|+....+.+.. ..+....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-------- 227 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD-------- 227 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC--------
Confidence 000011111111222221 112345778999999999999999 78888765543321 1111110
Q ss_pred ccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
.++.++.+ +....++ +..+...|| .+|++||++++|++.|.
T Consensus 228 ---~~~~~~~~--~~~~~~~---~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 ---IKLPKPQL--DLKYSDR---WYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ---ccCCCCcc--cccCCHH---HHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111211 1111122 234667888 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=297.78 Aligned_cols=238 Identities=23% Similarity=0.353 Sum_probs=174.6
Q ss_pred cccccCCCCcEEEEEecC-------------CccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcE
Q 002462 540 NLIKNGHSGDLFRGILEG-------------GIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEK 605 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~-------------g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~ 605 (919)
+.||+|+||.||+|.+.+ ...||||.+...... .+.|..|+.++++++|||||+++|+|.+. ...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD-VEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CCC
Confidence 368999999999998642 235899987654433 45788999999999999999999998764 578
Q ss_pred EEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCc-------
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFE------- 678 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~------- 678 (919)
++||||+++|+|..+++++. ..+++.++++|+.|+|+||+|||+. +|+||||||+|||++.++.
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKS------DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred EEEEecccCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCce
Confidence 99999999999998886543 2478899999999999999999974 8999999999999987664
Q ss_pred eeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCC-CCCCCCCCcchhHHHHHHHHH-cCCCCCCCCChhHHHHHHHh
Q 002462 679 VRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSG-SLTATCPYDVYCFGKVLLELV-TGKMGISASSDAQVKEILEQ 756 (919)
Q Consensus 679 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~t~~~DVySfGvvLlEll-TGk~p~~~~~~~~~~~~~~~ 756 (919)
+|++|||.+........ ..+...+.+++... ...++.++|||||||++|||+ +|+.|+......+.......
T Consensus 151 ~~l~d~g~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 224 (262)
T cd05077 151 IKLSDPGIPITVLSRQE------CVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEG 224 (262)
T ss_pred eEeCCCCCCccccCccc------ccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhc
Confidence 89999997654322111 11112233333222 345677899999999999998 58888765443332222111
Q ss_pred hcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 002462 757 TLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815 (919)
Q Consensus 757 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L 815 (919)
.. .... + ..+ .+..++..||+.+|.+||++.+|++.+
T Consensus 225 ~~------------~~~~------~-~~~---~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 QC------------MLVT------P-SCK---ELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred Cc------------cCCC------C-ChH---HHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 0001 1 112 356788999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=303.48 Aligned_cols=263 Identities=19% Similarity=0.292 Sum_probs=186.6
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
++|...+.||+|+||.||++.. .+|..+|+|.+..... ..+++.+|++++.+++|||||+++++|.+ ++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-DGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCEEEEEee
Confidence 3678889999999999999985 4678899998865432 23568899999999999999999998876 568999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+++|+|.+++.+.. .+++.....|+.++++||+|||+. .+|+||||||+|||+++++.+|++|||.+...
T Consensus 80 y~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (308)
T cd06615 80 HMDGGSLDQVLKKAG-------RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 150 (308)
T ss_pred ccCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence 999999999996542 377888899999999999999973 37999999999999999999999999977543
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccc----
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDK---- 766 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 766 (919)
..... ....+...+..++......++.++|||||||++|||+||+.|+..........+.............
T Consensus 151 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 151 IDSMA----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred ccccc----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 22111 1112222333333333345678899999999999999999999765544333332211100000000
Q ss_pred --------------ccccccc---cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 767 --------------ELVTKIV---DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 767 --------------~~~~~i~---d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
+....++ .|.+.. +.... .+..++.+|++.+|++||++++|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPS-GAFSD---EFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcC-cccCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 011000 00111 25678899999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=296.27 Aligned_cols=204 Identities=21% Similarity=0.279 Sum_probs=168.8
Q ss_pred hCCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEE
Q 002462 533 TGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~l 607 (919)
-.+|...++||+|+||+||..+- +.++.+|+|+++.... ..+...+|..+|.+++||.||+++- .+++.+..|+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~y-sFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIY-SFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEE-ecccCCeEEE
Confidence 35788899999999999999984 5578999999965432 2346788999999999999999995 5566778999
Q ss_pred EEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchh
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~ 687 (919)
|+||+.||+|..+|.+++. ++..+.--.+..|+.||.|||+. +||||||||+|||||++|.++++|||++
T Consensus 103 Vld~~~GGeLf~hL~~eg~-------F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~ 172 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR-------FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLC 172 (357)
T ss_pred EEeccCCccHHHHHHhcCC-------cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccc
Confidence 9999999999999976543 44443334677899999999985 8999999999999999999999999998
Q ss_pred hhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH
Q 002462 688 CAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ 749 (919)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~ 749 (919)
+........ ..++.++++|++++..-...++..+|.||+||++|||+||.+||...+...
T Consensus 173 k~~~~~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~ 232 (357)
T KOG0598|consen 173 KEDLKDGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK 232 (357)
T ss_pred hhcccCCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH
Confidence 855433221 234688999999887766788889999999999999999999998876443
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=326.73 Aligned_cols=251 Identities=16% Similarity=0.195 Sum_probs=188.8
Q ss_pred CCcccccccCCCCcEEEEEec-C-CccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 536 FSDANLIKNGHSGDLFRGILE-G-GIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~-~-g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
|...++||+|+||.||+|... + +..||+|.+...... ...+.+|++++++++|||||+++++|.. ++..+|||||+
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv~E~~ 147 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-DDKLLLIMEYG 147 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-CCEEEEEEECC
Confidence 666789999999999999743 3 577888887554433 3467789999999999999999998875 46899999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++|+|.++|+.... ...++++.+...|+.+++.||+|||+. +||||||||+|||++.++.+||+|||+++....
T Consensus 148 ~gg~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 148 SGGDLNKQIKQRLK---EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred CCCCHHHHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 99999998864321 123578888999999999999999984 899999999999999999999999998875543
Q ss_pred CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 693 DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
...........+++.|..++......++.++|||||||++|||+||+.|+......+....+....
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~-------------- 287 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK-------------- 287 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------
Confidence 222111223345566666665555578889999999999999999999998765443222211100
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.++ . ...... .+..++..|++.+|++||++++++.
T Consensus 288 ~~~-~--~~~~s~---~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 288 YDP-F--PCPVSS---GMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCC-C--CccCCH---HHHHHHHHHhccChhhCcCHHHHHh
Confidence 000 0 000111 2556888999999999999999875
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=306.57 Aligned_cols=259 Identities=24% Similarity=0.363 Sum_probs=187.8
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCc--cEEEEEeccccc--cHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGI--PVVIKRIDLQSV--KTEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~--~vavK~l~~~~~--~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~l 607 (919)
++|...+.||+|+||.||+|... +|. .+|+|++..... ..++|.+|++++.++ +|||||++++++.+ ++..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-CCCceE
Confidence 56777889999999999999864 454 468887754322 245788999999999 89999999998765 467999
Q ss_pred EEEecCCCChhhhhhccCCCC---------CccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCc
Q 002462 608 VYKYMPNGDLSSSLYRKTNTE---------DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFE 678 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~---------~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~ 678 (919)
||||+++|+|.+++++..... .....+++.+++.++.++++||+|||+. +|+||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 999999999999997543211 1123589999999999999999999974 8999999999999999999
Q ss_pred eeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhh
Q 002462 679 VRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQT 757 (919)
Q Consensus 679 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~ 757 (919)
+||+|||.+.......... .......+..++......++.++|||||||++|||+| |..|+......+....+...
T Consensus 163 ~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKT---MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred EEeCccccCcccchhhhcc---cCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 9999999875322111100 0001112333333333456788999999999999998 99998765543322222110
Q ss_pred cccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 758 LPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 758 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
. ..+ . ...... .+..++.+|++.+|++||++.++++.|+.+.
T Consensus 240 ~------~~~---------~--~~~~~~---~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 240 Y------RLE---------K--PLNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred C------cCC---------C--CCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 000 0 000111 2567889999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=299.95 Aligned_cols=257 Identities=20% Similarity=0.267 Sum_probs=185.6
Q ss_pred HHHHhCCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc-cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEE
Q 002462 529 LLAATGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV-KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKF 606 (919)
Q Consensus 529 l~~at~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~-~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~ 606 (919)
+..++.++....+||+|+||.||+|.. +++..||||.+..... ..+.|.+|++++++++|+|||+++|+|.. ++..+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 81 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-NGFFK 81 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-CCEEE
Confidence 455788898899999999999999985 4678899999865543 34679999999999999999999998875 46789
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCC-CCceeeCCcc
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD-KFEVRLGSLS 685 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~-~~~~kl~dfg 685 (919)
+||||+++++|.+++..+... ...++.+...++.++++||+|||+. +|+||||||+||++|. ++.+||+|||
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg 154 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGP----LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFG 154 (268)
T ss_pred EEEecCCCCCHHHHHHHhccc----CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecch
Confidence 999999999999999754211 1127788889999999999999974 8999999999999986 6799999999
Q ss_pred hhhhcCCCCcceeeeeeccCCCCccccCC--CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccc
Q 002462 686 EVCAQGGDAHQSRITRLLRLPQSSEQGSS--GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISI 763 (919)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~ 763 (919)
.+......... .....+.+.+..++.. +...++.++|||||||++|||+||+.|+..........+..... .
T Consensus 155 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~---~- 228 (268)
T cd06624 155 TSKRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF---K- 228 (268)
T ss_pred hheecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh---c-
Confidence 77644321111 0111122223333322 12236778999999999999999999986543222111110000 0
Q ss_pred cccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 764 YDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 764 ~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..+.+ +....++ +..++.+|++.+|.+||+|.+|+.
T Consensus 229 ---------~~~~~--~~~~~~~---~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 ---------IHPEI--PESLSAE---AKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ---------cCCCC--CcccCHH---HHHHHHHHcCCCchhCCCHHHHHh
Confidence 00111 1111222 455788999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=302.08 Aligned_cols=263 Identities=18% Similarity=0.235 Sum_probs=193.2
Q ss_pred cccccccCCCCcEEEEE-ecCCccEEEEEeccccccHHHH--HHHHHHHhhcC-CCCccceeeEEeecCCcEEEEEEecC
Q 002462 538 DANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAY--LLELDFFSKVS-HARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 538 ~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~~~~f--~~Ei~~l~~l~-H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
..+.||.|.||.||+|+ .+.|..||||+++..-...++. ++|++.|++++ |||||+|.....+.+...++|||||+
T Consensus 14 ~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md 93 (538)
T KOG0661|consen 14 VIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD 93 (538)
T ss_pred HHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh
Confidence 34679999999999998 6778899999997655444443 57999999999 99999999988886658999999998
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
. +|.+.+.+++ ..++..+...|+.||.+||+|+|.+ ++.|||+||+|||+.....+||+|||+|+.....
T Consensus 94 ~-NLYqLmK~R~------r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 94 C-NLYQLMKDRN------RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred h-hHHHHHhhcC------CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccC
Confidence 5 8998886553 3588889999999999999999986 9999999999999999999999999999976432
Q ss_pred C--cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhc--cccccccc-cc
Q 002462 694 A--HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTL--PYISIYDK-EL 768 (919)
Q Consensus 694 ~--~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~--~~~~~~~~-~~ 768 (919)
. .....+|.+++|+..-. ...|+.+.|+||+|||++|+.+-|+=|.+.++.+...-+...+ |....... ..
T Consensus 164 pPYTeYVSTRWYRAPEvLLr----s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLR----SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred CCcchhhhcccccchHHhhh----ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 1 22345677777764432 2367889999999999999999998888776644222222221 11111111 11
Q ss_pred ccccccCCCCCC-c----c-hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 769 VTKIVDPSLIID-E----D-LLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 769 ~~~i~d~~l~~~-~----~-~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
+...+.=++..- + . ........+.++..|++.||.+|||+.+.++.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 122221111100 0 0 01122346778899999999999999998763
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=300.38 Aligned_cols=258 Identities=22% Similarity=0.288 Sum_probs=188.0
Q ss_pred CCCcccccccCCCCcEEEEEec------CCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE------GGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~------~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~l 607 (919)
++.....||+|+||.||++... ++..+|+|.+...... .++|.+|++++++++|+||+++++++.. .+..++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 84 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-GRPLLM 84 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-CCceEE
Confidence 4555678999999999999642 3568999988654333 4679999999999999999999998875 457899
Q ss_pred EEEecCCCChhhhhhccCCC--------CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCce
Q 002462 608 VYKYMPNGDLSSSLYRKTNT--------EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEV 679 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~--------~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~ 679 (919)
||||+++|+|.++++..... ......++|.+++.++.+++.||+|||+. +|+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 99999999999999754311 01113589999999999999999999974 89999999999999999999
Q ss_pred eeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhc
Q 002462 680 RLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTL 758 (919)
Q Consensus 680 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~ 758 (919)
||+|||.++.................+.+..++......++.++|||||||++|||+| |+.|+......+....+....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 9999998764432211111111111223444443334457888999999999999999 899987655443322221111
Q ss_pred ccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 759 PYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 759 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
+. ..+ ..... .+..++.+||+.+|.+||++.+|.+.|+
T Consensus 242 ~~------------~~~-----~~~~~---~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 242 EL------------ERP-----RTCPP---EVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cC------------CCC-----CCCCH---HHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00 000 01112 2456889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=296.30 Aligned_cols=249 Identities=22% Similarity=0.389 Sum_probs=189.8
Q ss_pred CCCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++|...+.||+|+||.||+|... |..||||.+.......++|.+|+.++++++|+||+++++++.+ ++..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEEEEecC
Confidence 45667789999999999999875 7789999997655445789999999999999999999998875 567999999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|.+++..... ..++|.+...++.+++.||+|||+. +|+||||||+||++++++.+|++|||.+......
T Consensus 84 ~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 84 KGSLVDYLRSRGR-----AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred CCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 9999999865431 2489999999999999999999985 8999999999999999999999999987655322
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
...... ...+..++......++.++||||||+++||+++ |+.|+...........+....+ ...
T Consensus 156 ~~~~~~-----~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------~~~ 220 (256)
T cd05039 156 QDSGKL-----PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR----------MEA 220 (256)
T ss_pred cccCCC-----cccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC----------CCC
Confidence 111111 111222222223356778999999999999997 9999877655443333221100 000
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
+ ....+ .+.+++.+|++.+|++||++.+++++|+.
T Consensus 221 --~-----~~~~~---~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 --P-----EGCPP---EVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --c-----cCCCH---HHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0 01112 24568889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=307.98 Aligned_cols=240 Identities=15% Similarity=0.194 Sum_probs=180.3
Q ss_pred cccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCC
Q 002462 540 NLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPN 614 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~ 614 (919)
++||+|+||.||++.. .+|..||+|++..... ....+.+|++++++++||||+++++++.. ++..++|||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCEEEEEEeCCCC
Confidence 3699999999999985 5689999999865321 23467889999999999999999997765 5679999999999
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCC
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~ 694 (919)
|+|..++.+.. .+++.+...++.++++||+|||+. +|+||||||+|||+++++.+||+|||.+.......
T Consensus 80 ~~L~~~l~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 80 GELFFHLSRER-------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC
Confidence 99998886432 378899999999999999999985 89999999999999999999999999876432211
Q ss_pred cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccccc
Q 002462 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVD 774 (919)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d 774 (919)
. ......+++.+..++......++.++|||||||++|||+||+.|+...+.......+....
T Consensus 150 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~---------------- 211 (323)
T cd05595 150 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------------- 211 (323)
T ss_pred C--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC----------------
Confidence 1 1112234455555555544567888999999999999999999997665443222211100
Q ss_pred CCCCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002462 775 PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP-----LMRYILK 813 (919)
Q Consensus 775 ~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RP-----sm~~V~~ 813 (919)
........++ +..+...|++.+|.+|| ++.++++
T Consensus 212 --~~~p~~~~~~---~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 212 --IRFPRTLSPE---AKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred --CCCCCCCCHH---HHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 0000111122 34577899999999998 7777764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=301.24 Aligned_cols=268 Identities=15% Similarity=0.156 Sum_probs=183.9
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
++|...+.||+|+||.||+|+.. ++..||||++..... ..+.+.+|++++++++|||||++++++.+ ++..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-RGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-CCEEEEEE
Confidence 35777889999999999999975 578899999865432 24578899999999999999999997765 56889999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
||++++.+....... ..+++.+...++.++++||+|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 80 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 149 (287)
T cd07848 80 EYVEKNMLELLEEMP-------NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARN 149 (287)
T ss_pred ecCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence 999998776543221 2378888899999999999999974 899999999999999999999999998775
Q ss_pred cCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhc-cccccc----
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTL-PYISIY---- 764 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~-~~~~~~---- 764 (919)
....... ......+++.+.+++......++.++|||||||++|||+||+.||...+.......+.... +.....
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07848 150 LSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLF 228 (287)
T ss_pred ccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhh
Confidence 4322111 1111223333444443333456788999999999999999999998765432211111110 100000
Q ss_pred -ccccccccccCCCCCCcchHH-----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 765 -DKELVTKIVDPSLIIDEDLLE-----EVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 765 -~~~~~~~i~d~~l~~~~~~~~-----~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..........+.......... --..+.+++..|++.+|++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000010000000000 0113667899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=297.06 Aligned_cols=253 Identities=24% Similarity=0.375 Sum_probs=183.3
Q ss_pred cccccCCCCcEEEEEecC-Cc--cEEEEEecccc--ccHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGILEG-GI--PVVIKRIDLQS--VKTEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~-g~--~vavK~l~~~~--~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++||+|+||.||+|+..+ |. .+|+|.+.... ...+.|.+|++++.++ +||||++++++|.. .+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-CCCceEEEEeCC
Confidence 469999999999999754 43 46888886432 2246789999999999 79999999998875 457899999999
Q ss_pred CCChhhhhhccCCCC---------CccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCc
Q 002462 614 NGDLSSSLYRKTNTE---------DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSL 684 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~---------~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~df 684 (919)
+|+|.++++...... .....++|.++..++.+++.||+|||+. +|+||||||+|||+++++.+|++||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence 999999997543110 1123588999999999999999999974 8999999999999999999999999
Q ss_pred chhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccc
Q 002462 685 SEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISI 763 (919)
Q Consensus 685 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~ 763 (919)
|++.......... . ......+..++......++.++|||||||++|||+| |+.|+......+....+....
T Consensus 157 gl~~~~~~~~~~~-~--~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~----- 228 (270)
T cd05047 157 GLSRGQEVYVKKT-M--GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----- 228 (270)
T ss_pred CCccccchhhhcc-C--CCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-----
Confidence 9865322110000 0 001112333444344467788999999999999997 999997655433222211100
Q ss_pred cccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 764 YDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 764 ~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
.. +. ...... .+.+++..|++.+|.+||++.++++.|+.++
T Consensus 229 ----~~----~~----~~~~~~---~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 ----RL----EK----PLNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----CC----CC----CCcCCH---HHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 00 000111 3567899999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=308.88 Aligned_cols=241 Identities=17% Similarity=0.208 Sum_probs=181.7
Q ss_pred cccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCC
Q 002462 540 NLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPN 614 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~ 614 (919)
++||+|+||.||++.. .+|..||||.+..... ..+.+.+|++++++++||||+++++++.. ++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-KDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCEEEEEEeCCCC
Confidence 3699999999999985 5689999999964321 23568899999999999999999987654 5679999999999
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCC
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~ 694 (919)
|+|..++.... .+++.+...|+.++++||+|||+. +|+||||||+|||+++++.+||+|||.++......
T Consensus 80 g~L~~~l~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 80 GELFFHLSRER-------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA 149 (328)
T ss_pred CCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc
Confidence 99998886432 388999999999999999999985 89999999999999999999999999876432211
Q ss_pred cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccccc
Q 002462 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVD 774 (919)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d 774 (919)
. ......+++.+..++......++.++|||||||++|||+||+.||......+..+.+.... .
T Consensus 150 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-------------~-- 212 (328)
T cd05593 150 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-------------I-- 212 (328)
T ss_pred c--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-------------c--
Confidence 1 1122334555555555544567888999999999999999999997665443322211100 0
Q ss_pred CCCCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002462 775 PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP-----LMRYILKA 814 (919)
Q Consensus 775 ~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RP-----sm~~V~~~ 814 (919)
.+ ......+ +..+...|++.+|++|| ++.++++.
T Consensus 213 -~~--p~~~~~~---~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 213 -KF--PRTLSAD---AKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -cC--CCCCCHH---HHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 00 0111122 44577899999999997 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=298.03 Aligned_cols=254 Identities=21% Similarity=0.336 Sum_probs=187.5
Q ss_pred CCCCcccccccCCCCcEEEEEec----CCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE----GGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~----~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~l 607 (919)
++|...+.||+|+||.||+|+.. .+..+|+|.++.... ..+.|.+|+.++.+++||||+++++++.. ++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCccEE
Confidence 35667789999999999999863 234799999865432 24679999999999999999999998765 567899
Q ss_pred EEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchh
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~ 687 (919)
||||+++|+|.+++.+.. ..++|.+.+.|+.+++.||+|||+. +|+||||||+|||++.++.+|++|||.+
T Consensus 83 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred EEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcc
Confidence 999999999999997543 2478999999999999999999974 8999999999999999999999999987
Q ss_pred hhcCCCCccee-eeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccc
Q 002462 688 CAQGGDAHQSR-ITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYD 765 (919)
Q Consensus 688 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~ 765 (919)
........... .........+..++......++.++|||||||++||+++ |+.|+......+....+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~----- 228 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL----- 228 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC-----
Confidence 65432211110 000001112333333333457788999999999999887 99998765544333222211100
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 766 KELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 766 ~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
+. .....+ .+..++..|++.+|.+||+|.+|++.|+.
T Consensus 229 ---------~~---~~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 ---------PA---PMDCPA---ALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ---------CC---CCCCCH---HHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 00 001111 24568889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=299.76 Aligned_cols=264 Identities=20% Similarity=0.307 Sum_probs=183.9
Q ss_pred CcccccccCCCCcEEEEEe-----cCCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecC-CcEEEE
Q 002462 537 SDANLIKNGHSGDLFRGIL-----EGGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERE-NEKFLV 608 (919)
Q Consensus 537 ~~~~~ig~G~~G~Vy~g~l-----~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~-~~~~lV 608 (919)
...+.||+|+||+||.+.. .++..||||.+..... ..+.|.+|++++++++||||++++++|...+ ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 4567899999999988653 4577899999865432 3567899999999999999999999886543 357899
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++.+. .++|.++..|+.++++||+|||+. +|+||||||+|||+++++.+|++|||.+.
T Consensus 87 ~e~~~~~~l~~~~~~~--------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 87 MEYVPLGSLRDYLPKH--------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred ecCCCCCCHHHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence 9999999999998542 389999999999999999999975 89999999999999999999999999876
Q ss_pred hcCCCCcceeeee-eccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccc
Q 002462 689 AQGGDAHQSRITR-LLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKE 767 (919)
Q Consensus 689 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 767 (919)
............. ......+..++.......+.++|||||||++|||+||+.|+...... ..+....... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~---~~~~~ 231 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQG---QMTVV 231 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhccccc---ccchh
Confidence 5432111000000 00011122222222235678899999999999999999997654321 1111111110 00001
Q ss_pred cccccccCCCC--CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 768 LVTKIVDPSLI--IDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 768 ~~~~i~d~~l~--~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
.+.+.++.... ....... .+..++..||+++|++||+|++|++.|+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~---~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 232 RLIELLERGMRLPCPKNCPQ---EVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhhhcCCCCCCCCCCCH---HHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111111111 1111122 356788999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=294.44 Aligned_cols=248 Identities=21% Similarity=0.286 Sum_probs=187.2
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
+|...+.||+|+||.||+|+. .+|..||+|.+.... ...++|.+|++++++++||||+++++++.+ ++..++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-KGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-CCEEEEEEE
Confidence 466778999999999999986 468899999986432 235679999999999999999999998876 467999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+++++|.++++.... ..+++.+..+|+.++++||+|||+. +|+||||||+||++++++.+|++|||.+...
T Consensus 80 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~ 151 (256)
T cd08529 80 YAENGDLHKLLKMQRG-----RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151 (256)
T ss_pred eCCCCcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceec
Confidence 9999999999975421 3488999999999999999999974 8999999999999999999999999977654
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
...... .....+.+.+..++......++.++|||||||++|||+||+.|+...........+.. +...
T Consensus 152 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------~~~~ 219 (256)
T cd08529 152 SDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR----------GVFP 219 (256)
T ss_pred cCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc----------CCCC
Confidence 322111 1112233334444444444567889999999999999999999976654332221110 0000
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.+ ..... ..+..++.+|++.+|++||+|.++++
T Consensus 220 ~~-------~~~~~---~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 220 PV-------SQMYS---QQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CC-------ccccC---HHHHHHHHHHccCCcccCcCHHHHhh
Confidence 00 00011 13567889999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=303.84 Aligned_cols=255 Identities=20% Similarity=0.320 Sum_probs=187.6
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCc----cEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGI----PVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKF 606 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~----~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~ 606 (919)
++|...+.||+|+||.||+|+. .+|. .||+|.+...... ..+|.+|+.++++++|||||+++|+|.. ...+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS--PTIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC--CCce
Confidence 4566778999999999999985 3443 4788988644322 3478999999999999999999998875 3578
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcch
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~ 686 (919)
+|+||+++|+|.+++..+. ..+++...++++.++++||+|||+. +|+||||||+||++++++.+||+|||.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK------DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred eeehhcCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccc
Confidence 9999999999999986542 2478899999999999999999985 899999999999999999999999998
Q ss_pred hhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccc
Q 002462 687 VCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYD 765 (919)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~ 765 (919)
+....................+..++......++.++|||||||++|||+| |+.|+......+...++.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------ 229 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER------ 229 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC------
Confidence 875432221111111111122333333333457788999999999999998 9999876654444444332110
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 766 KELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 766 ~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
.-.+.. . ...+..++..||..+|++||+|+++++.|+...
T Consensus 230 ------~~~~~~-----~---~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 230 ------LPQPPI-----C---TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred ------CCCCCC-----C---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 000100 0 113566889999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=303.13 Aligned_cols=255 Identities=20% Similarity=0.303 Sum_probs=188.1
Q ss_pred CCCCcccccccCCCCcEEEEEec------CCccEEEEEeccccc--cHHHHHHHHHHHhhc-CCCCccceeeEEeecCCc
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE------GGIPVVIKRIDLQSV--KTEAYLLELDFFSKV-SHARLVPLLGHCMERENE 604 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~------~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~ 604 (919)
++|...+.||+|+||.||+|... .+..||||+++.... ..+.|.+|+++++++ +||||++++++|.. .+.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~ 113 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI-GGP 113 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec-CCc
Confidence 45888899999999999999742 345799998865432 246799999999999 79999999998865 457
Q ss_pred EEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCc
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSL 684 (919)
Q Consensus 605 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~df 684 (919)
.++||||+++|+|.+++++... ..++|.+..+|+.+++.||+|||+. +|+||||||+|||++++..+|++||
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE-----SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence 8999999999999999975432 2389999999999999999999975 8999999999999999999999999
Q ss_pred chhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhH-HHHHHHhhccccc
Q 002462 685 SEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQ-VKEILEQTLPYIS 762 (919)
Q Consensus 685 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~-~~~~~~~~~~~~~ 762 (919)
|.+................+...+..++......++.++|||||||++|||+| |+.|+......+ ....+....+
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~--- 262 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR--- 262 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc---
Confidence 98765432211110111111223333443333456788999999999999998 999987654322 2222221100
Q ss_pred ccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 763 IYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 763 ~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
...+ ....+ .+.+++.+|++.+|++||++.+|++.|+.
T Consensus 263 ---------~~~~-----~~~~~---~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 263 ---------MAQP-----EHAPA---EIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ---------CCCC-----CCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0000 00111 35668899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=297.59 Aligned_cols=254 Identities=20% Similarity=0.317 Sum_probs=188.6
Q ss_pred CCCcccccccCCCCcEEEEEecC-Cc----cEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILEG-GI----PVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~-g~----~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~l 607 (919)
+|...+.||+|+||.||+|...+ |. .||+|.+...... .++|.+|++++++++||||++++|+|.. ...++
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 85 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQVQL 85 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CceEE
Confidence 45667899999999999998643 32 5899988655432 4679999999999999999999998875 57899
Q ss_pred EEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchh
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~ 687 (919)
||||+++|+|.+++.... ..++|...++++.++++||+|||+. +|+||||||+||++++++.+|++|||.+
T Consensus 86 v~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK------DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred EEecCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccc
Confidence 999999999999997543 2388999999999999999999984 8999999999999999999999999988
Q ss_pred hhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccc
Q 002462 688 CAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDK 766 (919)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (919)
+...................+..++......++.++|||||||++||++| |+.|+......+....+....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------- 229 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER------- 229 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-------
Confidence 75432211110000001112223333233456778999999999999999 9999987665544433321110
Q ss_pred ccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
.-.+.. .+ ..+..++..||..+|.+||++.++++.|+...
T Consensus 230 -----~~~~~~-~~-------~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 230 -----LPQPPI-CT-------IDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred -----CCCCCC-CC-------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 000110 01 12456788999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=306.01 Aligned_cols=263 Identities=17% Similarity=0.282 Sum_probs=189.7
Q ss_pred CCCCcccccccCCCCcEEEEEec--------CCccEEEEEeccccc--cHHHHHHHHHHHhhc-CCCCccceeeEEeecC
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE--------GGIPVVIKRIDLQSV--KTEAYLLELDFFSKV-SHARLVPLLGHCMERE 602 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~--------~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~ 602 (919)
++|...+.||+|+||.||++... ++..+|+|.+..... ..+++..|++++.++ +||||++++++|.. +
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-D 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-C
Confidence 35667789999999999999752 234699999875422 245688999999999 79999999998875 4
Q ss_pred CcEEEEEEecCCCChhhhhhccCCCC---------CccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceec
Q 002462 603 NEKFLVYKYMPNGDLSSSLYRKTNTE---------DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILL 673 (919)
Q Consensus 603 ~~~~lV~Ey~~~GsL~~~L~~~~~~~---------~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILl 673 (919)
+..++||||+++|+|.+++..+.... .....++|.++++|+.+++.||+|||+. +|+||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 57899999999999999997643210 1123589999999999999999999974 89999999999999
Q ss_pred CCCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHH
Q 002462 674 DDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKE 752 (919)
Q Consensus 674 d~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~ 752 (919)
++++.+|++|||.+..................+.+..++......++.++|||||||++|||+| |+.|+......+...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 9999999999998764432111000000011112333333223356788999999999999998 888887655444333
Q ss_pred HHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 002462 753 ILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 753 ~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~~ 820 (919)
.+....+ .+ ..+.... .+.+++..|++.+|++||+|.+|++.|+....
T Consensus 254 ~~~~~~~-------------~~----~~~~~~~---~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 254 LLKEGHR-------------MD----KPSNCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHcCCC-------------CC----CCCcCCH---HHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 3221110 00 0111112 35568899999999999999999999987554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=298.10 Aligned_cols=258 Identities=19% Similarity=0.285 Sum_probs=185.0
Q ss_pred CCcccccccCCCCcEEEEEec----CCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCC-----
Q 002462 536 FSDANLIKNGHSGDLFRGILE----GGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMEREN----- 603 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~----~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~----- 603 (919)
|...++||+|+||.||+|.+. .+..||||++..... ..+++.+|++++++++||||+++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 345678999999999999864 367899999865432 34678999999999999999999998764321
Q ss_pred cEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCC
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS 683 (919)
Q Consensus 604 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~d 683 (919)
..++++||+++|+|.+++...... .....+++.+..+++.+++.||+|||+. +|+||||||+||++++++.+|++|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIG-EEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence 247899999999999888543211 1123588999999999999999999975 899999999999999999999999
Q ss_pred cchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccc
Q 002462 684 LSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYIS 762 (919)
Q Consensus 684 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~ 762 (919)
||.++.................+.+..++......++.++|||||||++|||+| |+.|+......+....+....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~---- 232 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN---- 232 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC----
Confidence 998775432211100011111122223333333356778999999999999999 888887655433332222110
Q ss_pred ccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 763 IYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 763 ~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
... ...... ..+.+++.+|++.+|++||++.+|.+.|++
T Consensus 233 -----~~~--------~~~~~~---~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 233 -----RLK--------QPPDCL---EDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred -----cCC--------CCCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 000 001111 246678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=303.71 Aligned_cols=250 Identities=19% Similarity=0.284 Sum_probs=191.0
Q ss_pred HHhCCCCcccccccCCCCcEEEEE-ecCCccEEEEEeccccc----cHHHHHHHHHHHhhc-CCCCccceeeEEeecCCc
Q 002462 531 AATGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSV----KTEAYLLELDFFSKV-SHARLVPLLGHCMERENE 604 (919)
Q Consensus 531 ~at~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~ 604 (919)
+..+||...++||+|+|.+||+|+ ...+..+|||++...-. +.+-...|-++|.+| .||.||+|+-.+. ++..
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ-D~~s 148 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ-DEES 148 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee-cccc
Confidence 345688888999999999999998 56789999999865432 223456788999999 8999999997554 4567
Q ss_pred EEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCc
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSL 684 (919)
Q Consensus 605 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~df 684 (919)
.|.|+||++||+|.++|++.+. |+....--+|.+|..||+|||+. +||||||||+|||||+||.+||+||
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs-------fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDF 218 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS-------FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDF 218 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc-------chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeec
Confidence 9999999999999999987643 55555556899999999999985 9999999999999999999999999
Q ss_pred chhhhcCCCCcc-----------eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHH
Q 002462 685 SEVCAQGGDAHQ-----------SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKE 752 (919)
Q Consensus 685 g~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~ 752 (919)
|.|+........ +....++++.+|..++.......+..+|+|+||||||.|++|++||-+.++.- .++
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk 298 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK 298 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH
Confidence 998876532211 11133566666666665555567778999999999999999999998876543 333
Q ss_pred HHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 753 ILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 753 ~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
++.-.+.+ .+...+. +.+|...-+..+|.+|++..+|-+
T Consensus 299 I~~l~y~f-------------------p~~fp~~---a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 299 IQALDYEF-------------------PEGFPED---ARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHhcccC-------------------CCCCCHH---HHHHHHHHHccCccccccHHHHhh
Confidence 33332222 1222222 344667788999999999988865
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=294.25 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=191.5
Q ss_pred CCCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++|...+.||+|+||.||+|..+++..||||.+.......++|.+|++++++++|+||+++++++.. +...++||||++
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~ 84 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-EEPIYIVTEYMS 84 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeec-CCceEEEEeccC
Confidence 4577778999999999999998888899999998666667789999999999999999999997754 467899999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|.+++..... ..++|.++..|+.+++.||+|||+. +|+||||||+||++++++.+|++|||.+......
T Consensus 85 ~~~L~~~i~~~~~-----~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 85 KGSLLDFLKSGEG-----KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred CCCHHHHHhcccc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999975431 3489999999999999999999975 7999999999999999999999999977654321
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
..... ........+..++......++.++|||||||++|||+| |+.|+...........+..... .
T Consensus 157 ~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~------------~ 223 (261)
T cd05034 157 EYTAR-EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR------------M 223 (261)
T ss_pred hhhhh-hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------C
Confidence 11100 00001112222332223356778999999999999999 9999976554332222211100 0
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
.. .....+ .+..++.+|++.+|++||+++++.+.|+.
T Consensus 224 ~~-----~~~~~~---~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PR-----PPNCPE---ELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CC-----CCCCCH---HHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00 011112 35668899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=295.47 Aligned_cols=258 Identities=17% Similarity=0.278 Sum_probs=186.9
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++|...+.||+|+||.||+|+. .++..||||++..... ..++|.+|++++++++||||+++++++.+ .+..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-DNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-CCeEEEE
Confidence 4677788999999999999985 4789999998754221 23578999999999999999999998765 4678999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++..... ....++..+..+++.++++||+|||+. +|+||||||+||+++.++.++++|||.+.
T Consensus 81 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~ 154 (267)
T cd08228 81 LELADAGDLSQMIKYFKK---QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEecCCCcHHHHHHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccce
Confidence 999999999988853221 113478888899999999999999975 89999999999999999999999999766
Q ss_pred hcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccc
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (919)
........ .....+.+.+..++.......+.++|||||||++|||+||+.|+...... ...+....
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~----------- 220 (267)
T cd08228 155 FFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQKI----------- 220 (267)
T ss_pred eccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHHH-----------
Confidence 44321110 01112222333333333345677899999999999999999998654321 11111110
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
.....+.... +... ..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 221 -~~~~~~~~~~-~~~~---~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~ 264 (267)
T cd08228 221 -EQCDYPPLPT-EHYS---EKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264 (267)
T ss_pred -hcCCCCCCCh-hhcC---HHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence 0001111110 0111 235668889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=295.33 Aligned_cols=259 Identities=18% Similarity=0.317 Sum_probs=189.0
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++|...+.||+|+||.||+|.. .+|..+|||.+..... ..++|.+|++++++++|+||+++++++.+ ++..++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-CCeEEEE
Confidence 3566778999999999999994 5789999998854321 23578999999999999999999998876 4578999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++..... ....++|.+..+|+.++++||+|||+. +|+||||||+||+++.++.++++|||.+.
T Consensus 81 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~ 154 (267)
T cd08229 81 LELADAGDLSRMIKHFKK---QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEecCCCCHHHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhh
Confidence 999999999998864221 123589999999999999999999975 89999999999999999999999999776
Q ss_pred hcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccc
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (919)
........ .....+...+..++......++.++||||||+++|||+||+.|+...... ...+...
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~------------ 219 (267)
T cd08229 155 FFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKK------------ 219 (267)
T ss_pred ccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhh------------
Confidence 54322111 01112233333344333345677899999999999999999998654321 1111111
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
+.....+.... ....+ .+..++.+|++.+|.+||||.+|++.++..
T Consensus 220 ~~~~~~~~~~~-~~~~~---~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 220 IEQCDYPPLPS-DHYSE---ELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred hhcCCCCCCCc-ccccH---HHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 01111111111 11112 245678899999999999999999988753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=309.31 Aligned_cols=243 Identities=16% Similarity=0.188 Sum_probs=184.0
Q ss_pred CCCCcccccccCCCCcEEEEEecC--CccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEG--GIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~--g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~l 607 (919)
++|...+.||+|+||.||+|...+ +..||||++..... ..+.+.+|++++++++|||||++++++.+ ++..++
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~l 108 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-ESYLYL 108 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-CCEEEE
Confidence 457778899999999999998643 36899999864321 24568899999999999999999998765 467999
Q ss_pred EEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchh
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~ 687 (919)
|||||++|+|.+++.+.. .+++.....++.+++.||+|||+. +|+||||||+|||++.++.+||+|||.+
T Consensus 109 v~Ey~~~g~L~~~i~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a 178 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK-------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFA 178 (340)
T ss_pred EEeCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCC
Confidence 999999999999986542 378888899999999999999985 8999999999999999999999999987
Q ss_pred hhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccc
Q 002462 688 CAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKE 767 (919)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 767 (919)
....... ....+++.+.+++......++.++|||||||++|||+||+.||...........+....
T Consensus 179 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--------- 244 (340)
T PTZ00426 179 KVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--------- 244 (340)
T ss_pred eecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------
Confidence 6543221 12234444555554444456788999999999999999999998765433222111100
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002462 768 LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP-----LMRYILK 813 (919)
Q Consensus 768 ~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RP-----sm~~V~~ 813 (919)
...++...++ +..++..|++.+|++|+ +++++.+
T Consensus 245 ---------~~~p~~~~~~---~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 245 ---------IYFPKFLDNN---CKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ---------CCCCCCCCHH---HHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 0001111122 34578899999999995 7777764
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=305.87 Aligned_cols=241 Identities=17% Similarity=0.187 Sum_probs=181.1
Q ss_pred cccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCC
Q 002462 540 NLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPN 614 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~ 614 (919)
++||+|+||.||++.. .+|..||||.+..... ....+..|++++.+++||||+++++++.. ++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-CCEEEEEEeCCCC
Confidence 3699999999999984 5688999999864321 23567889999999999999999987654 5679999999999
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCC
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~ 694 (919)
|+|..++.+.. .+++.+...|+.++++||+|||+. .+|+||||||+|||+++++.+||+|||.+.......
T Consensus 80 ~~L~~~l~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~ 150 (325)
T cd05594 80 GELFFHLSRER-------VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 150 (325)
T ss_pred CcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC
Confidence 99998886432 378999999999999999999962 379999999999999999999999999876432211
Q ss_pred cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccccc
Q 002462 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVD 774 (919)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d 774 (919)
.. .....+++.+..++......++.++|||||||++|||+||+.||.........+.+..... .+
T Consensus 151 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~--------~~----- 215 (325)
T cd05594 151 AT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--------RF----- 215 (325)
T ss_pred cc--cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC--------CC-----
Confidence 11 1122344555555544445677889999999999999999999987665443332221100 00
Q ss_pred CCCCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002462 775 PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP-----LMRYILK 813 (919)
Q Consensus 775 ~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RP-----sm~~V~~ 813 (919)
......+ +..+...|++.+|++|+ ++.++++
T Consensus 216 -----p~~~~~~---~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 216 -----PRTLSPE---AKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred -----CCCCCHH---HHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 0111122 44577899999999996 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=325.76 Aligned_cols=257 Identities=18% Similarity=0.241 Sum_probs=190.9
Q ss_pred HhCCCCcccccccCCCCcEEEEE-ecCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCC----
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMEREN---- 603 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~---- 603 (919)
..++|...++||+|+||.||+|+ ..+|..||||++...... ...+.+|+..+..++|+|||+++..+...+.
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 34678888999999999999998 467899999998654332 3568899999999999999998876543211
Q ss_pred ---cEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCcee
Q 002462 604 ---EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVR 680 (919)
Q Consensus 604 ---~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~k 680 (919)
..++||||+++|+|.++|..+.. ....+++.....|+.++++||+|||+. +||||||||+|||++.++.+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~---~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAK---TNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEE
Confidence 36799999999999999965432 123588888999999999999999985 899999999999999999999
Q ss_pred eCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccc
Q 002462 681 LGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPY 760 (919)
Q Consensus 681 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~ 760 (919)
|+|||+++...............+++.|..++......++.++|||||||++|||+||+.||......+.. .....
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~---~~~~~- 259 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM---HKTLA- 259 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHhc-
Confidence 99999876543221111112234555566666555556788999999999999999999999876543322 11110
Q ss_pred ccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 761 ISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 761 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
.. .++ ..+...+ .+..++..|++.+|.+||++.++++.
T Consensus 260 ------~~----~~~---~~~~~~~---~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 ------GR----YDP---LPPSISP---EMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ------CC----CCC---CCCCCCH---HHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00 000 0111112 25568889999999999999999763
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=293.07 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=188.3
Q ss_pred CCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCC
Q 002462 535 DFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPN 614 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~ 614 (919)
+|...+.||+|+||.||+|...++..+|||.+.......++|.+|++++++++|||++++++++.. ....++||||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE-RSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEcc-CCceEEEEEcCCC
Confidence 456678899999999999998778899999987655556789999999999999999999997765 4578999999999
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCC
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~ 694 (919)
|+|.+++..+. ..++|.....++.+++.||+|||+. +|+||||||+||+++.++.+|++|||.+.......
T Consensus 84 ~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 84 GCLSDYLRAQR------GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred CcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 99999986543 2378999999999999999999975 79999999999999999999999999776443221
Q ss_pred cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
...... ......+..++......++.++|||||||++|||+| |+.|+.........+.+... ....
T Consensus 155 ~~~~~~-~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~------------~~~~ 221 (256)
T cd05112 155 YTSSTG-TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG------------FRLY 221 (256)
T ss_pred ccccCC-CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC------------CCCC
Confidence 111000 001112223333223456778999999999999998 99998765543322221110 0111
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
++... . ..+.+++.+|++.+|++||+|.+|++.|.
T Consensus 222 ~~~~~-----~---~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 222 KPRLA-----S---QSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCC-----C---HHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 12211 1 23667899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=301.51 Aligned_cols=265 Identities=20% Similarity=0.237 Sum_probs=193.4
Q ss_pred cCHHHHHHHhCCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccccHHHHHHHHHHHhhc-CCCCccceeeEEeec
Q 002462 524 FTYQQLLAATGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKV-SHARLVPLLGHCMER 601 (919)
Q Consensus 524 ~~~~~l~~at~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~ 601 (919)
++++++..++++|...+.||+|+||.||++.. .++..+|+|++.......+++.+|+.++.++ +|||+++++++|...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 56677778899999999999999999999986 5688999999865544456788999999999 899999999988753
Q ss_pred C----CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCC
Q 002462 602 E----NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF 677 (919)
Q Consensus 602 ~----~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~ 677 (919)
+ +..++||||+++|+|.++++.... ....++|.....|+.+++.||+|||+. +|+||||||+||++++++
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLI---CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 3 357999999999999998864221 123488999999999999999999975 899999999999999999
Q ss_pred ceeeCCcchhhhcCCCCcce---eeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHH
Q 002462 678 EVRLGSLSEVCAQGGDAHQS---RITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEI 753 (919)
Q Consensus 678 ~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~ 753 (919)
.+||+|||.+.......... ..+..+..|+....+......++.++|||||||++|||+||+.|+....... ...+
T Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~ 245 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245 (291)
T ss_pred CEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH
Confidence 99999999876543211110 0011122222211111112236788999999999999999999987654322 1111
Q ss_pred HHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 754 LEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..... ..+.++ +... ..+..++..|++.+|++||+|.++++
T Consensus 246 ~~~~~-----------~~~~~~-----~~~~---~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 246 PRNPP-----------PTLLHP-----EKWC---RSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred hcCCC-----------CCCCcc-----cccC---HHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11100 011111 1111 13567889999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=299.99 Aligned_cols=264 Identities=19% Similarity=0.228 Sum_probs=183.6
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
++|...+.||+|+||.||+|... ++..||||++..... ..+.+.+|++++++++|||||++++++.. ++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-ERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEEEEe
Confidence 45777789999999999999854 678999999865432 24568899999999999999999997654 457899999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|++ |+|.+++.... ..+++.+...++.++++||+|||+. +|+||||||+|||+++++.+||+|||.++..
T Consensus 84 ~~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 84 YLD-SDLKQYLDNCG------NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAK 153 (288)
T ss_pred CCC-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeec
Confidence 998 48988886432 2367888899999999999999985 8999999999999999999999999987654
Q ss_pred CCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccc-cc-----c
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPY-IS-----I 763 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~-~~-----~ 763 (919)
...... .....+.+.+.+++.. +...++.++|||||||++|||+||+.||......+....+....+. .. .
T Consensus 154 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 154 SVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred cCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence 321111 0111122233333322 3345678899999999999999999999876544322222111100 00 0
Q ss_pred cccccccccccCCCCCC------cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 764 YDKELVTKIVDPSLIID------EDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 764 ~~~~~~~~i~d~~l~~~------~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
...+.......+..... +...+ ...++...|++.+|.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDT---DGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCH---HHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00011111111111000 00111 2456888999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=291.59 Aligned_cols=248 Identities=24% Similarity=0.328 Sum_probs=185.7
Q ss_pred cccccCCCCcEEEEEecC--C--ccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGILEG--G--IPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~--g--~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++||+|+||.||+|...+ + ..||||.+..... ..++|.+|++++++++|||||++++++.+ ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence 368999999999998643 3 3699999976554 25689999999999999999999998876 57899999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|.+++..... ..++|.+...++.++++||+|||.. +|+||||||+||+++.++.+|++|||.+......
T Consensus 79 ~~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 79 LGSLLDRLRKDAL-----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred CCcHHHHHHhccc-----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccc
Confidence 9999999975431 3489999999999999999999975 8999999999999999999999999987655332
Q ss_pred Ccceeee-eeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccccccc
Q 002462 694 AHQSRIT-RLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTK 771 (919)
Q Consensus 694 ~~~~~~~-~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 771 (919)
....... .......+..++......++.++|||||||++|||+| |+.|+......+..+.+.... ..
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~--------~~--- 219 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG--------ER--- 219 (257)
T ss_pred ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC--------Cc---
Confidence 1111111 1111222344444444567888999999999999999 999997665544332222100 00
Q ss_pred cccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 772 IVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 772 i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
....+.... .+..++..|++.+|++||++.+|++.|.
T Consensus 220 -----~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 -----LERPEACPQ---DIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -----CCCCccCCH---HHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 000011111 3556888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=305.96 Aligned_cols=240 Identities=16% Similarity=0.182 Sum_probs=178.3
Q ss_pred cccccCCCCcEEEEEe----cCCccEEEEEeccccc-----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 540 NLIKNGHSGDLFRGIL----EGGIPVVIKRIDLQSV-----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l----~~g~~vavK~l~~~~~-----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
+.||+|+||.||+++. .++..||||.+..... ....+.+|++++++++|||||++++++.. ++..++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-GGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-CCeEEEEEe
Confidence 4799999999999985 3578899999864321 23457889999999999999999997765 567999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+++|+|.+++.+.. .+.+.....++.++++||+|||+. +|+||||||+|||+++++.+||+|||.++..
T Consensus 81 ~~~~~~L~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 81 YLSGGELFMHLEREG-------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred CCCCchHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 999999999986543 366777888999999999999985 8999999999999999999999999987643
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
...... .....+++.|.+++......++.++|||||||++|||+||+.||...........+..
T Consensus 151 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~-------------- 214 (323)
T cd05584 151 IHEGTV--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK-------------- 214 (323)
T ss_pred ccCCCc--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc--------------
Confidence 221111 1122344555555555445567889999999999999999999987654332111110
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP-----LMRYILK 813 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RP-----sm~~V~~ 813 (919)
......+...+ .+..++..|++.+|++|| ++.++++
T Consensus 215 ----~~~~~~~~~~~---~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 215 ----GKLNLPPYLTP---EARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ----CCCCCCCCCCH---HHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 00001111112 245688899999999999 6777654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=297.18 Aligned_cols=245 Identities=23% Similarity=0.340 Sum_probs=188.1
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
|.....||+|.||.||||.. ..++.||+|.++..... .++..+|+.++++++|+||.+++|.++. +...+++||||
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~-g~~LwiiMey~ 93 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-GTKLWIIMEYC 93 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee-cccHHHHHHHh
Confidence 44457899999999999984 56789999999887665 4688999999999999999999997765 45789999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
.+|++.+.|....- ++.....-|..++..||.|||++ +.+|||||++|||+..++.+|++|||.+.....
T Consensus 94 ~gGsv~~lL~~~~~-------~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 94 GGGSVLDLLKSGNI-------LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred cCcchhhhhccCCC-------CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence 99999999865432 12222334667899999999986 899999999999999999999999998765544
Q ss_pred CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 693 DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
..... .++.++|.+++++......|..|+||||+|++.+||++|.+|+....+..... .+.+-
T Consensus 164 ~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf---------------lIpk~ 226 (467)
T KOG0201|consen 164 TVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF---------------LIPKS 226 (467)
T ss_pred hhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE---------------eccCC
Confidence 33221 45678888888887776688999999999999999999999987654311000 01111
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
--|.+.. .... .+.+++..|++++|+.||++.++++
T Consensus 227 ~PP~L~~--~~S~---~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 227 APPRLDG--DFSP---PFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCCcccc--ccCH---HHHHHHHHHhhcCcccCcCHHHHhh
Confidence 1222221 1111 2445677999999999999999986
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=295.61 Aligned_cols=239 Identities=22% Similarity=0.325 Sum_probs=174.1
Q ss_pred cccccCCCCcEEEEEecC--------CccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 540 NLIKNGHSGDLFRGILEG--------GIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~--------g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
+.||+|+||.||+|.... ...||+|.+...... .++|..|+.++++++|||||+++|++... ...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-DESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-CCcEEEEe
Confidence 369999999999998532 235888888654333 46789999999999999999999988764 57899999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCc--------eeeC
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFE--------VRLG 682 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~--------~kl~ 682 (919)
|+++|+|.+++.+.. ..++|..+++++.|+|.||+|||+. +|+||||||+||+++.+.. +|++
T Consensus 80 ~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~ 150 (258)
T cd05078 80 YVKFGSLDTYLKKNK------NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLS 150 (258)
T ss_pred cCCCCcHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEec
Confidence 999999999997543 2478999999999999999999974 8999999999999988765 5889
Q ss_pred CcchhhhcCCCCcceeeeeeccCCCCccccCCC-CCCCCCCCcchhHHHHHHHHHcCC-CCCCCCChhHHHHHHHhhccc
Q 002462 683 SLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSG-SLTATCPYDVYCFGKVLLELVTGK-MGISASSDAQVKEILEQTLPY 760 (919)
Q Consensus 683 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~t~~~DVySfGvvLlEllTGk-~p~~~~~~~~~~~~~~~~~~~ 760 (919)
|||.+........ ..+...+..++... ...++.++|||||||++|||+||. .|+...............
T Consensus 151 d~g~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~--- 221 (258)
T cd05078 151 DPGISITVLPKEI------LLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDR--- 221 (258)
T ss_pred ccccccccCCchh------ccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHcc---
Confidence 9987654322111 11122233333222 234678899999999999999995 555443332222111110
Q ss_pred ccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 761 ISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 761 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
. .+ ..... ..+.+++..|++.+|++||+|+++++.|+
T Consensus 222 ------~--------~~--~~~~~---~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ------H--------QL--PAPKW---TELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------c--------cC--CCCCc---HHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00 00011 13567889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=300.99 Aligned_cols=263 Identities=17% Similarity=0.299 Sum_probs=189.6
Q ss_pred CCCCcccccccCCCCcEEEEEec--------CCccEEEEEeccccc--cHHHHHHHHHHHhhc-CCCCccceeeEEeecC
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE--------GGIPVVIKRIDLQSV--KTEAYLLELDFFSKV-SHARLVPLLGHCMERE 602 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~--------~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~ 602 (919)
.+|...+.||+|+||.||++... ....||+|.+..... ..++|..|++++.++ +|||||+++++|.. +
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ-E 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-C
Confidence 35666789999999999999742 245789998864332 235788999999999 69999999998865 4
Q ss_pred CcEEEEEEecCCCChhhhhhccCCC---------CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceec
Q 002462 603 NEKFLVYKYMPNGDLSSSLYRKTNT---------EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILL 673 (919)
Q Consensus 603 ~~~~lV~Ey~~~GsL~~~L~~~~~~---------~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILl 673 (919)
+..++||||+++|+|.+++...... ......++|.+.++|+.+++.||+|||+. +|+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 5789999999999999999654211 01124589999999999999999999974 89999999999999
Q ss_pred CCCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHH
Q 002462 674 DDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKE 752 (919)
Q Consensus 674 d~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~ 752 (919)
++++.+|++|||.++...................+..++......++.++|||||||++|||+| |+.|+......+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999998865432111100000011112333333333457788999999999999999 899987665444333
Q ss_pred HHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 002462 753 ILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 753 ~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~~ 820 (919)
.+.... . .+ ....... .+..++.+|++.+|++||++.++++.|+....
T Consensus 248 ~~~~~~----------~---~~----~~~~~~~---~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 248 LLREGH----------R---MD----KPSNCTH---ELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHcCC----------C---CC----CCCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 322110 0 00 0011112 24568899999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=302.62 Aligned_cols=238 Identities=19% Similarity=0.243 Sum_probs=177.9
Q ss_pred cccccCCCCcEEEEEec-CCccEEEEEecccc----ccHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGILE-GGIPVVIKRIDLQS----VKTEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~----~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
+.||+|+||.||+|+.. ++..||||++.... ...+.+..|..++.+. +||||+++++++.+ .+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-KENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-CCEEEEEEeCCC
Confidence 36999999999999965 47889999986542 1234577788888864 89999999997765 467899999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|.+++.... .+++.+...++.++++||+|||+. +|+||||||+|||++.++.+||+|||.+......
T Consensus 80 ~g~L~~~l~~~~-------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 80 GGDLMFHIQSCH-------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG 149 (316)
T ss_pred CCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCC
Confidence 999999986432 378889999999999999999985 8999999999999999999999999987642211
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
.. ......+++.+.+++......++.++|||||||++|||+||+.|+......+....+....+. .
T Consensus 150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~------------~ 215 (316)
T cd05619 150 DA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPC------------Y 215 (316)
T ss_pred CC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------C
Confidence 11 111223444555555444446788999999999999999999999876654433332221110 0
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH-HH
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMR-YI 811 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~-~V 811 (919)
|. ...+ .+..+...|++.+|++||++. ++
T Consensus 216 -~~-----~~~~---~~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 216 -PR-----WLTR---EAKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred -Cc-----cCCH---HHHHHHHHHhccCHhhcCCChHHH
Confidence 00 0111 234577899999999999997 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=314.44 Aligned_cols=253 Identities=18% Similarity=0.245 Sum_probs=193.2
Q ss_pred CCcccccccCCCCcEEEEEecCC-ccEEEEEeccccc-cHHHHHHHHHHHhhcC-CCCccceee-EEeec---C--CcEE
Q 002462 536 FSDANLIKNGHSGDLFRGILEGG-IPVVIKRIDLQSV-KTEAYLLELDFFSKVS-HARLVPLLG-HCMER---E--NEKF 606 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~~g-~~vavK~l~~~~~-~~~~f~~Ei~~l~~l~-H~niV~l~g-~c~~~---~--~~~~ 606 (919)
...+++|.+|||+.||.+....+ ..+|+||+-.... ..+...+||++|++|+ |+|||.+++ ..... . -|.+
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 44578999999999999997766 9999999855433 3467889999999998 999999999 33221 1 3689
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcch
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~ 686 (919)
|.||||++|+|-++|..+.. ..|+..+.++|+.|+++|+++||. +.|||||||||.+||||+.++..||+|||-
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq-----~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQ-----TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eehhhccCCcHHHHHHHHHh-----ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 99999999999999975432 238889999999999999999997 689999999999999999999999999998
Q ss_pred hhhcCCCC--c----------ceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 002462 687 VCAQGGDA--H----------QSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEIL 754 (919)
Q Consensus 687 ~~~~~~~~--~----------~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~ 754 (919)
++...... . ....|..|+.|+.... ......++|+|||++||+||-|+-...||+....
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDl--ysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------- 263 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDL--YSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------- 263 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhh--hcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------
Confidence 76543221 1 1122334555544432 2345789999999999999999999999976532
Q ss_pred HhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 755 EQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 755 ~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
..|++......+. ...-.++..|+..|++++|.+||++.+|+..+..+.
T Consensus 264 ---------------laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 264 ---------------LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred ---------------eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 1233333322221 122234677899999999999999999998776443
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=298.61 Aligned_cols=249 Identities=21% Similarity=0.227 Sum_probs=181.4
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc----HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK----TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
|...++||+|+||.||++.. .++..||||++...... ...+.+|++++++++|||||++++++.+ ++..++|||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 80 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-CCeEEEEEe
Confidence 56678999999999999985 46889999999654322 2457889999999999999999997755 457999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
||++|+|.++++.... ..+++.+...|+.++++||+|||+. +|+||||||+||++++++.++++|||.+...
T Consensus 81 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-----PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI 152 (285)
T ss_pred ccCCCcHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence 9999999988865321 2488999999999999999999985 8999999999999999999999999987654
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
...... ....+.+.+..++......++.++|||||||++|||++|+.||.........+.+.....
T Consensus 153 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~----------- 218 (285)
T cd05605 153 PEGETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK----------- 218 (285)
T ss_pred CCCCcc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh-----------
Confidence 221110 111223333334433334567889999999999999999999986544322211111110
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP-----LMRYILK 813 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RP-----sm~~V~~ 813 (919)
. ......+...+ .+..++..|++.+|++|| +++++.+
T Consensus 219 ~---~~~~~~~~~~~---~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 219 E---DQEEYSEKFSE---AARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred h---cccccCcccCH---HHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0 00000111112 245688999999999999 6666644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=302.12 Aligned_cols=239 Identities=16% Similarity=0.223 Sum_probs=175.9
Q ss_pred cccccCCCCcEEEEEec-CCccEEEEEecccc----ccHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGILE-GGIPVVIKRIDLQS----VKTEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~----~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++||+|+||.||+|+.. ++..||||+++... ...+.+..|.+++... +||||+++++++.. ++..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-KEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 36999999999999864 57889999986432 1234566787777754 89999999997654 568999999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|..++.... .++..+...|+.+++.||+|||+. +|+||||||+|||++.++.+||+|||.+......
T Consensus 80 gg~L~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 80 GGDLMFHIQSSG-------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG 149 (316)
T ss_pred CCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC
Confidence 999998886432 377788888999999999999984 8999999999999999999999999987643221
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
.. ......+++.+..++......++.++|||||||++|||+||+.||......+...-+....+. +
T Consensus 150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~------------~ 215 (316)
T cd05592 150 EG--KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPH------------F 215 (316)
T ss_pred CC--ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC------------C
Confidence 11 112223445555555444446788899999999999999999999876654432222111110 0
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYIL 812 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~ 812 (919)
......+ +..++..|++.+|++||++.+.+
T Consensus 216 ------~~~~~~~---~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 216 ------PRWISKE---AKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred ------CCCCCHH---HHHHHHHHccCCHHHcCCChHHH
Confidence 0111122 34577899999999999986433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=297.08 Aligned_cols=240 Identities=18% Similarity=0.236 Sum_probs=174.7
Q ss_pred cccCCCCcEEEEEe-cCCccEEEEEecccccc----HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCC
Q 002462 542 IKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK----TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGD 616 (919)
Q Consensus 542 ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~Gs 616 (919)
||+|+||+||++.. .+|..||||++...... .+.|..|++++++++|+||+++.+++.. ++..++|||||++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-CCeEEEEEeCCCCCC
Confidence 79999999999985 46889999998643321 2567889999999999999999986654 567999999999999
Q ss_pred hhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcc
Q 002462 617 LSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQ 696 (919)
Q Consensus 617 L~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~ 696 (919)
|..+++.... ....+++.+...|+.|+++||+|||+. +|+||||||+||++++++.+|++|||.+.........
T Consensus 80 L~~~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 80 LRYHIYNVDE---ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK 153 (280)
T ss_pred HHHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc
Confidence 9988864321 123589999999999999999999985 8999999999999999999999999987644322111
Q ss_pred eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhcccccccccccccccccC
Q 002462 697 SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLPYISIYDKELVTKIVDP 775 (919)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~d~ 775 (919)
.....+++.+..++......++.++|||||||++|||+||+.||....... ........ ...
T Consensus 154 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~---------------~~~ 216 (280)
T cd05608 154 --TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI---------------LND 216 (280)
T ss_pred --ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh---------------ccc
Confidence 111233444445554444467788999999999999999999997643221 11111111 111
Q ss_pred CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 002462 776 SLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLM 808 (919)
Q Consensus 776 ~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm 808 (919)
.....+...+ .+..++..|++.+|++||++
T Consensus 217 ~~~~~~~~~~---~~~~li~~~l~~~P~~R~~~ 246 (280)
T cd05608 217 SVTYPDKFSP---ASKSFCEALLAKDPEKRLGF 246 (280)
T ss_pred CCCCcccCCH---HHHHHHHHHhcCCHHHhcCC
Confidence 1111111112 24567889999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=307.38 Aligned_cols=237 Identities=17% Similarity=0.216 Sum_probs=178.6
Q ss_pred cccccCCCCcEEEEEe----cCCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 540 NLIKNGHSGDLFRGIL----EGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l----~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
+.||+|+||.||++.. .+|..||||++..... ....+..|++++++++|||||++++++.+ ++..++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-EGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCEEEEEEcCC
Confidence 4799999999999874 4578999999965432 23457789999999999999999997765 56899999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++|+|.+++.+.. .+++.+...|+.++++||+|||+. +|+||||||+|||+++++.+||+|||.+.....
T Consensus 81 ~~~~L~~~l~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 81 RGGDLFTRLSKEV-------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred CCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 9999999986532 378999999999999999999985 899999999999999999999999998765432
Q ss_pred CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 693 DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
.... .....+++.+..++......++.++|||||||++|||+||+.|+......+....+....
T Consensus 151 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-------------- 214 (318)
T cd05582 151 HEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-------------- 214 (318)
T ss_pred CCCc--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--------------
Confidence 2111 112234444555554444456788999999999999999999998765443322211100
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRY 810 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~ 810 (919)
........++ +..++..|++.+|++||++.+
T Consensus 215 ----~~~p~~~~~~---~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 ----LGMPQFLSPE---AQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ----CCCCCCCCHH---HHHHHHHHhhcCHhHcCCCCC
Confidence 0001111122 345778999999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=295.22 Aligned_cols=268 Identities=16% Similarity=0.227 Sum_probs=187.0
Q ss_pred CCCcccccccCCCCcEEEEEec-----CCccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeec-CCcEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-----GGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMER-ENEKF 606 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-----~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~-~~~~~ 606 (919)
+|...+.||+|+||.||+|++. .+..||||.+...... .++|.+|++++++++|+||++++++|... ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 3445578999999999999864 3678999999765543 56899999999999999999999987652 23689
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcch
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~ 686 (919)
+||||+++|+|.+++.... ..++|.+++.++.++++||+|||+. +|+||||||+||+++.++.+|++|||.
T Consensus 85 lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR------DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred EEEecCCCCCHHHHHHhCc------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccc
Confidence 9999999999999997543 1489999999999999999999974 899999999999999999999999998
Q ss_pred hhhcCCCCcceeeeee-ccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccc
Q 002462 687 VCAQGGDAHQSRITRL-LRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYD 765 (919)
Q Consensus 687 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~ 765 (919)
+............... .....+..++......++.++||||||+++|||+||+.|+......... + ..+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~---~~~~~~~~~ 231 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-M---IGIAQGQMI 231 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-c---ccccccccc
Confidence 7765422111111100 0011122222222335677899999999999999999987654321100 0 000000000
Q ss_pred cccccccccCC--CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 766 KELVTKIVDPS--LIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 766 ~~~~~~i~d~~--l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
...+.+.+... ........ .++..++.+|++.+|++||+|.||+++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 232 VTRLLELLKEGERLPRPPSCP---DEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHHcCCcCCCCccCC---HHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00001111110 00011111 2366789999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=304.92 Aligned_cols=248 Identities=21% Similarity=0.284 Sum_probs=188.0
Q ss_pred HhCCCCcccccccCCCCcEEEEE-ecCCccEEEEEeccc----cc-c-HHHHHHHHHHHhhcC-CCCccceeeEEeecCC
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQ----SV-K-TEAYLLELDFFSKVS-HARLVPLLGHCMEREN 603 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~----~~-~-~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~~ 603 (919)
..+.|...+.||+|+||+||.|. ...|..||||.++.. .. . .+...+|+.++++++ ||||++++.+... ..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t-~~ 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT-PT 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec-CC
Confidence 34667778899999999999997 556899999977553 11 1 344567999999999 9999999997654 56
Q ss_pred cEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC-CceeeC
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK-FEVRLG 682 (919)
Q Consensus 604 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~-~~~kl~ 682 (919)
..++||||+.+|+|.+++..++ .+.....-++..|++.|++|+|+. +|+||||||+|||+|.+ +++||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g-------~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~ 163 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG-------RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLS 163 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC-------CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEe
Confidence 7999999999999999997633 255667778999999999999985 89999999999999999 999999
Q ss_pred CcchhhhcCCCCcceeeeeeccCCCCccccCCCCCC-C-CCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccc
Q 002462 683 SLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLT-A-TCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPY 760 (919)
Q Consensus 683 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~ 760 (919)
|||++...... .....+..++|.|.+++...... | ..++||||+|||||.|++|+.||+......+...+..
T Consensus 164 DFG~s~~~~~~--~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~---- 237 (370)
T KOG0583|consen 164 DFGLSAISPGE--DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK---- 237 (370)
T ss_pred ccccccccCCC--CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc----
Confidence 99998866311 11233456667776666554433 4 3678999999999999999999998554333222111
Q ss_pred ccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002462 761 ISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYIL 812 (919)
Q Consensus 761 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~ 812 (919)
.......... -..+..++.+|+..+|.+|+++.+|+
T Consensus 238 --------------~~~~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 238 --------------GEFKIPSYLL--SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred --------------CCccCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1111111110 11245688899999999999999998
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=303.36 Aligned_cols=240 Identities=18% Similarity=0.236 Sum_probs=178.7
Q ss_pred cccccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++||+|+||.||+|+.. ++..||||++..... ..+.+..|.+++..+ +||||+++++++.. ++..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-KDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCeEEEEEeCCC
Confidence 36999999999999864 578999999865322 234678899999876 79999999997654 567899999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|...+.+.. .+++.....|+.++++||+|||+. +|+||||||+|||+++++.+||+|||.+......
T Consensus 80 ~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 80 GGDLMFQIQRSR-------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN 149 (321)
T ss_pred CCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccC
Confidence 999998886542 378888999999999999999985 8999999999999999999999999987643211
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
.. ......+++.+..++......++.++|||||||++|||+||+.|+......+..+.+... +..
T Consensus 150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~-------------~~~ 214 (321)
T cd05591 150 GV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD-------------DVL 214 (321)
T ss_pred Cc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------CCC
Confidence 11 111223444555555444456788999999999999999999999877654433222110 000
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHH
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP-------LMRYILK 813 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RP-------sm~~V~~ 813 (919)
.|.. ... .+..+...|++.+|++|| ++.++++
T Consensus 215 ~p~~-----~~~---~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 215 YPVW-----LSK---EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCC-----CCH---HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 1110 112 245678899999999999 6666653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=287.54 Aligned_cols=247 Identities=22% Similarity=0.368 Sum_probs=184.3
Q ss_pred cccccCCCCcEEEEEecCCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCCh
Q 002462 540 NLIKNGHSGDLFRGILEGGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDL 617 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL 617 (919)
++||+|+||.||++...++..||+|++..... ..+.|.+|++++++++|+||+++++++.+ ....++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-KQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-CCCeEEEEEcCCCCcH
Confidence 36999999999999987799999998865433 24679999999999999999999998875 4578999999999999
Q ss_pred hhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcce
Q 002462 618 SSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQS 697 (919)
Q Consensus 618 ~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~~ 697 (919)
.+++.+.. ..+++.+.+.++.++++||+|||+. +|+||||||+||++++++.+|++|||.+..........
T Consensus 80 ~~~l~~~~------~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 150 (251)
T cd05041 80 LTFLRKKK------NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV 150 (251)
T ss_pred HHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence 99986542 2478889999999999999999975 79999999999999999999999999876543211110
Q ss_pred eeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccccccccccCC
Q 002462 698 RITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPS 776 (919)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 776 (919)
..........+..++......++.++|||||||++|||+| |+.|+...........+..... ...+
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~------------~~~~- 217 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR------------MPAP- 217 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC------------CCCC-
Confidence 0000000111223333333357788999999999999999 8888876554333332221100 0001
Q ss_pred CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 777 LIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 777 l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
..... .+.+++.+|++.+|.+||++.||++.|+
T Consensus 218 ----~~~~~---~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 ----QLCPE---EIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ----ccCCH---HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11112 3566889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=303.73 Aligned_cols=262 Identities=17% Similarity=0.293 Sum_probs=188.8
Q ss_pred CCCcccccccCCCCcEEEEEecC--------CccEEEEEeccccc--cHHHHHHHHHHHhhc-CCCCccceeeEEeecCC
Q 002462 535 DFSDANLIKNGHSGDLFRGILEG--------GIPVVIKRIDLQSV--KTEAYLLELDFFSKV-SHARLVPLLGHCMEREN 603 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~--------g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~ 603 (919)
.|...+.||+|+||.||++...+ +..||+|.++.... ..++|.+|++++.++ +|||||+++++|.+ ++
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~ 91 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DG 91 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-CC
Confidence 35566789999999999997421 23689998864332 246799999999999 79999999998876 45
Q ss_pred cEEEEEEecCCCChhhhhhccCCCC---------CccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecC
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNTE---------DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLD 674 (919)
Q Consensus 604 ~~~lV~Ey~~~GsL~~~L~~~~~~~---------~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld 674 (919)
..++||||+++|+|.++|.+..... .....++|.++++|+.++++||+|||.. +|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 7899999999999999997542110 1123589999999999999999999974 899999999999999
Q ss_pred CCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 002462 675 DKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEI 753 (919)
Q Consensus 675 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~ 753 (919)
+++.+||+|||.++...................+..++......++.++|||||||++|||++ |+.|+......+....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999998765432211100011111112333333333456778999999999999999 8888876654443322
Q ss_pred HHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 002462 754 LEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~~ 820 (919)
+..... ... ...... .+..++..|++.+|.+||+|.++++.|+....
T Consensus 249 ~~~~~~----------~~~-------~~~~~~---~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 249 LKEGHR----------MDK-------PANCTH---ELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHcCCC----------CCC-------CCCCCH---HHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 221100 000 011112 35568899999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=303.21 Aligned_cols=236 Identities=17% Similarity=0.233 Sum_probs=177.4
Q ss_pred cccccCCCCcEEEEEec-CCccEEEEEecccc----ccHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGILE-GGIPVVIKRIDLQS----VKTEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~----~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++||+|+||.||+|+.. ++..||||++.... ...+.+..|++++.++ +||||+++++++.. .+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-PDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-CCEEEEEEcCCC
Confidence 36999999999999864 57899999986432 2235678899999877 69999999996654 567999999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|.+++.+.. .+++.....|+.++++||+|||+. +|+||||||+|||+++++.+||+|||.+......
T Consensus 80 ~g~L~~~i~~~~-------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 80 GGDLMFHIQKSR-------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN 149 (320)
T ss_pred CchHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC
Confidence 999999886542 378888999999999999999975 8999999999999999999999999987643211
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
.. ......+++.+.+++......++.++|||||||++|||+||+.||......+..+.+.... +.
T Consensus 150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-------------~~ 214 (320)
T cd05590 150 GK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-------------VV 214 (320)
T ss_pred CC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-------------CC
Confidence 11 1122334555555555445567788999999999999999999998766544333222110 00
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMR 809 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~ 809 (919)
.|. ....+ +..++..|++.+|++||++.
T Consensus 215 ~~~-----~~~~~---~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 215 YPT-----WLSQD---AVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCC-----CCCHH---HHHHHHHHcccCHHHCCCCC
Confidence 111 11122 45578899999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=298.22 Aligned_cols=247 Identities=17% Similarity=0.280 Sum_probs=184.2
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
.|...+.||+|+||.||+|+. .++..||||.+...... .+.+.+|+.++++++|+||+++++++.. +...++||||+
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-~~~~~lv~e~~ 99 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEYL 99 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-CCEEEEeeccc
Confidence 466677899999999999984 56889999998754433 4678899999999999999999998765 46899999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++|+|.+++... .+++.++..++.++++||+|||+. +|+||||||+||++++++.+||+|||.+.....
T Consensus 100 ~~~~L~~~~~~~--------~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 100 AGGSLTDVVTET--------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred CCCCHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 999999988532 378889999999999999999985 899999999999999999999999997765432
Q ss_pred CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 693 DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
.... .....+.+.+..++......++.++|||||||++|||+||+.||........ +..... ..
T Consensus 169 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~~--------~~---- 232 (296)
T cd06654 169 EQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIAT--------NG---- 232 (296)
T ss_pred cccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHhc--------CC----
Confidence 2111 0111233334444443344567889999999999999999999976554221 111110 00
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.+.+...+.... .+..++.+|+..+|++||++.+|++
T Consensus 233 -~~~~~~~~~~~~---~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 233 -TPELQNPEKLSA---IFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -CCCCCCccccCH---HHHHHHHHHCcCCcccCcCHHHHhh
Confidence 000000111111 2456788999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=309.64 Aligned_cols=250 Identities=16% Similarity=0.215 Sum_probs=181.1
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
.|...+.||+|+||+||+|+. .++..||||++..... ..+.+.+|++++.+++|||||++++++.+ .+..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-CCEEEEEE
Confidence 467778999999999999985 5678999999965432 23568899999999999999999998765 56799999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
||+++|+|.+++.+.. .+++.....++.+++.||+|||.. +||||||||+|||++.++.+||+|||++..
T Consensus 81 E~~~gg~L~~~l~~~~-------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 81 DYIPGGDMMSLLIRME-------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred ecCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 9999999999986543 367777788899999999999984 899999999999999999999999997643
Q ss_pred cCCCCcc---------------------------------------------eeeeeeccCCCCccccCCCCCCCCCCCc
Q 002462 690 QGGDAHQ---------------------------------------------SRITRLLRLPQSSEQGSSGSLTATCPYD 724 (919)
Q Consensus 690 ~~~~~~~---------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~t~~~D 724 (919)
....... .......+++.|.+++......++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD 230 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence 2100000 0001123455555555544456788899
Q ss_pred chhHHHHHHHHHcCCCCCCCCChhHHH-HHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHH--HHccCCC
Q 002462 725 VYCFGKVLLELVTGKMGISASSDAQVK-EILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVA--RSCLNPK 801 (919)
Q Consensus 725 VySfGvvLlEllTGk~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la--~~C~~~~ 801 (919)
||||||++|||+||+.||......+.. ..+.+... + . +.+....+ .++ ..++ +.|+.++
T Consensus 231 iwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------~-~-~~~~~~~s----~~~---~dli~~ll~~~~~ 292 (381)
T cd05626 231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT---------L-H-IPPQVKLS----PEA---VDLITKLCCSAEE 292 (381)
T ss_pred eeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------c-C-CCCCCCCC----HHH---HHHHHHHccCccc
Confidence 999999999999999999876554322 22221100 0 0 00101111 122 2233 2478888
Q ss_pred CCCCCCHHHHHH
Q 002462 802 PTRRPLMRYILK 813 (919)
Q Consensus 802 P~~RPsm~~V~~ 813 (919)
|.+||++.+|+.
T Consensus 293 ~~~R~~~~~~l~ 304 (381)
T cd05626 293 RLGRNGADDIKA 304 (381)
T ss_pred ccCCCCHHHHhc
Confidence 888999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=295.58 Aligned_cols=267 Identities=20% Similarity=0.283 Sum_probs=184.0
Q ss_pred CCcccccccCCCCcEEEEEe-----cCCccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeec-CCcEEE
Q 002462 536 FSDANLIKNGHSGDLFRGIL-----EGGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMER-ENEKFL 607 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-----~~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~-~~~~~l 607 (919)
|...+.||+|+||.||.+.. .++..||+|.++..... .++|.+|++++++++||||++++++|.+. ....++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 45667899999999999974 35788999998654322 46799999999999999999999988754 245789
Q ss_pred EEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchh
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~ 687 (919)
||||+++|+|.+++.+.. ..++|.+++.|+.+++.||+|||+. +|+||||||+||++++++.+|++|||.+
T Consensus 86 v~e~~~g~~L~~~l~~~~------~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNK------NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEccCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence 999999999999986432 2489999999999999999999975 8999999999999999999999999987
Q ss_pred hhcCCCCcceeee-eeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccc
Q 002462 688 CAQGGDAHQSRIT-RLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDK 766 (919)
Q Consensus 688 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (919)
............. ...+...+.+++......++.++|||||||++|||+|++.|......... ....|.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~----~~~~~~~~~~~~ 232 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL----KMIGPTHGQMTV 232 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh----hhcccccccccH
Confidence 6543221111111 11111122333332334577889999999999999998876432211000 000000000000
Q ss_pred ccccccc-cC-CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 767 ELVTKIV-DP-SLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 767 ~~~~~i~-d~-~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
....+.+ +. ......... ..+.+++..|++.+|++||++.+|++.|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 233 TRLVRVLEEGKRLPRPPNCP---EEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHHcCccCCCCCCCC---HHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000000 00 000011111 2466789999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=292.60 Aligned_cols=260 Identities=22% Similarity=0.249 Sum_probs=181.6
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCC----cEEEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMEREN----EKFLVYK 610 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~----~~~lV~E 610 (919)
|...+++|.|+||.||+|++ +.+..||||++-.+..-. .+|+++|+++.|||||+|+-++....+ ...+|||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 45578999999999999996 456899999985543322 269999999999999999987664332 2358999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC-CceeeCCcchhhh
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK-FEVRLGSLSEVCA 689 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~-~~~kl~dfg~~~~ 689 (919)
|||. +|.+.++...... +.++-...--+..|+.+||+|||+ .+|+||||||.|+|+|.+ +..||+|||.|+.
T Consensus 103 ymP~-tL~~~~r~~~~~~---~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 103 YMPE-TLYRVIRHYTRAN---QRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred hchH-HHHHHHHHHhhcC---CCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9997 8999887421100 112222223468899999999998 489999999999999977 9999999999886
Q ss_pred cCC--CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChh-HHHHHHHhhccccccccc
Q 002462 690 QGG--DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDA-QVKEILEQTLPYISIYDK 766 (919)
Q Consensus 690 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 766 (919)
... ......++|.+++|+-. .|...||++.||||.|||+.||+-|++-|.+.+.. ++.++++. ...++ +
T Consensus 176 L~~~epniSYicSRyYRaPELi----fga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~-lG~Pt---~ 247 (364)
T KOG0658|consen 176 LVKGEPNISYICSRYYRAPELI----FGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKV-LGTPT---R 247 (364)
T ss_pred eccCCCceeEEEeccccCHHHH----cCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHH-hCCCC---H
Confidence 543 23345678888887643 35567899999999999999999999988876654 34444332 11111 1
Q ss_pred ccccc-------cccCCCCCCc----chHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 767 ELVTK-------IVDPSLIIDE----DLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 767 ~~~~~-------i~d~~l~~~~----~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+.+.. .-.|.+.... .....-...+++..++++.+|.+|-+..|++.
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11110 0111111000 00000112567889999999999999998875
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-32 Score=289.10 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=188.6
Q ss_pred cccccCCCCcEEEEEecC----CccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGILEG----GIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~----g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
+.||+|+||.||+|.... +..||||.+...... .+++.+|++++.+++|+||+++++++.. ....++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEecc
Confidence 469999999999999754 789999999765443 5689999999999999999999998876 568999999999
Q ss_pred CCChhhhhhccCCC--CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 614 NGDLSSSLYRKTNT--EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 614 ~GsL~~~L~~~~~~--~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+|+|.+++...... ......++|.++.+++.++++||+|||+. +|+||||||+||++++++.+|++|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999754210 00124589999999999999999999984 89999999999999999999999999877654
Q ss_pred CCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
..............+.+..++......++.++||||+||++|||+| |+.|+......+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------------ 224 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY------------ 224 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------
Confidence 3221111111122223333443333367788999999999999999 699998775544333322100
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
....+ +.... .+..++..|++.+|++||++.++++.|+
T Consensus 225 ~~~~~-----~~~~~---~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 RLPKP-----EYCPD---ELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCC-----ccCCh---HHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00001 11111 3566888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=272.69 Aligned_cols=247 Identities=17% Similarity=0.230 Sum_probs=191.9
Q ss_pred hCCCCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc----HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEE
Q 002462 533 TGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK----TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~l 607 (919)
.++|...+.||+|.||.||.|+. +++..||+|++...+.. ..++.+|+++-+.++||||++++||..+. ...||
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~-~riyL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS-KRIYL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc-ceeEE
Confidence 35788899999999999999995 56789999999654432 46789999999999999999999998864 56899
Q ss_pred EEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchh
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~ 687 (919)
++||.++|+|...|...+. ..++....-.+..|+|.||.|+|. +.||||||||+|+|++.+++.|++|||.+
T Consensus 100 ilEya~~gel~k~L~~~~~-----~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRM-----KRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred EEEecCCchHHHHHHhccc-----ccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCce
Confidence 9999999999999984432 124444455788999999999997 48999999999999999999999999976
Q ss_pred hhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccc
Q 002462 688 CAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKE 767 (919)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 767 (919)
-..... .-.++.++..+.++++......+.+.|+|++||+.||++.|.+||......+.-.-+..
T Consensus 172 V~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k----------- 236 (281)
T KOG0580|consen 172 VHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK----------- 236 (281)
T ss_pred eecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH-----------
Confidence 543311 11335666677777777777788889999999999999999999986653332211111
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 768 LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 768 ~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.++-+|..+ .. .+.+++..|+..+|.+|.+..||+.
T Consensus 237 --~~~~~p~~i-----s~---~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 237 --VDLKFPSTI-----SG---GAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred --ccccCCccc-----Ch---hHHHHHHHHhccCccccccHHHHhh
Confidence 112223221 11 2567889999999999999999875
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-32 Score=291.22 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=187.0
Q ss_pred CCCcccccccCCCCcEEEEEecC----CccEEEEEecccc--ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILEG----GIPVVIKRIDLQS--VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~----g~~vavK~l~~~~--~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
+|...+.||+|+||.||+|+..+ ...||||...... ...+.|.+|+.++++++||||++++++|.+ +..++|
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~lv 84 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPVWIV 84 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCcEEE
Confidence 46667899999999999998643 2578999886543 235679999999999999999999998754 468899
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++.+.. ..++|.+++.++.++++||+|||+. +++||||||+||+++.++.+|++|||.+.
T Consensus 85 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 85 MELAPLGELRSYLQVNK------YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred EEcCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceee
Confidence 99999999999996532 2489999999999999999999974 89999999999999999999999999876
Q ss_pred hcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccc
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKE 767 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 767 (919)
......... .........+..++......++.++|||||||++||++| |+.||......+....+....+
T Consensus 156 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-------- 226 (270)
T cd05056 156 YLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER-------- 226 (270)
T ss_pred eccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc--------
Confidence 543321110 011111122333343333457788999999999999996 9999977655433222221100
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 768 LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 768 ~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
. ...+.... .+..++.+|+..+|++||++.++++.|++.
T Consensus 227 -~--------~~~~~~~~---~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 227 -L--------PMPPNCPP---TLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred -C--------CCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 00111112 245578899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=297.55 Aligned_cols=265 Identities=17% Similarity=0.238 Sum_probs=191.4
Q ss_pred cCHHHHHHHhCCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccccHHHHHHHHHHHhhc-CCCCccceeeEEee-
Q 002462 524 FTYQQLLAATGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKV-SHARLVPLLGHCME- 600 (919)
Q Consensus 524 ~~~~~l~~at~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~- 600 (919)
+.++.+..++++|.....||+|+||.||++.. .++..+|+|.+.......+++.+|+.+++++ +||||++++++|..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 45566777889999999999999999999985 4578999998865444456788999999999 69999999998753
Q ss_pred ---cCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCC
Q 002462 601 ---RENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF 677 (919)
Q Consensus 601 ---~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~ 677 (919)
.++..++||||+++|+|.++++.... ....+++.....++.++++||.|||+. +|+||||||+||++++++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLK---RGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhc---cCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 23458999999999999998864221 113478888899999999999999974 899999999999999999
Q ss_pred ceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCC-----CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHH
Q 002462 678 EVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS-----GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKE 752 (919)
Q Consensus 678 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~ 752 (919)
.+|++|||.+.......... ....+.+.+..++.. ....++.++|||||||++|||+||+.|+........
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-- 237 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-- 237 (286)
T ss_pred CEEEccCCceeecccCCCcc--ccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--
Confidence 99999999876443211110 111122233333321 123467789999999999999999999876543221
Q ss_pred HHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 753 ILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 753 ~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
+.... ........++.. ..+ .+..++.+|++.+|++||+++||++.
T Consensus 238 ~~~~~--------~~~~~~~~~~~~-----~~~---~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 LFKIP--------RNPPPTLHQPEL-----WSN---EFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred Hhhcc--------ccCCCcccCCCC-----cCH---HHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11100 000001111111 111 25568889999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=301.75 Aligned_cols=240 Identities=20% Similarity=0.250 Sum_probs=176.6
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHH---hhcCCCCccceeeEEeecCCcEEE
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFF---SKVSHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l---~~l~H~niV~l~g~c~~~~~~~~l 607 (919)
|...+.||+|+||.||+|.. .+|..||||+++.... ..+.+.+|++++ ++++||||+++++++.. .+..++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-EDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-CCEEEE
Confidence 34567899999999999985 4688999999964321 234566676554 67789999999997654 568999
Q ss_pred EEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchh
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~ 687 (919)
||||+++|+|..++++. .+++.+...++.++++||+|||+. +|+||||||+|||+++++.+||+|||.+
T Consensus 80 v~E~~~~~~L~~~~~~~--------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05589 80 VMEYAAGGDLMMHIHTD--------VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLC 148 (324)
T ss_pred EEcCCCCCcHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCC
Confidence 99999999998887532 388999999999999999999984 8999999999999999999999999987
Q ss_pred hhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccc
Q 002462 688 CAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKE 767 (919)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 767 (919)
........ ......+.+.+..++......++.++|||||||++|||+||+.|+......+....+....+
T Consensus 149 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-------- 218 (324)
T cd05589 149 KEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-------- 218 (324)
T ss_pred ccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------
Confidence 64322111 11223344555555555455678889999999999999999999987655433222111100
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002462 768 LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRY 810 (919)
Q Consensus 768 ~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~ 810 (919)
........ .+..++..|++.+|++||++.+
T Consensus 219 ----------~~p~~~~~---~~~~li~~~L~~dP~~R~~~~~ 248 (324)
T cd05589 219 ----------RYPRFLSR---EAISIMRRLLRRNPERRLGSGE 248 (324)
T ss_pred ----------CCCCCCCH---HHHHHHHHHhhcCHhHcCCCCC
Confidence 00011112 2456788999999999996543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=300.32 Aligned_cols=267 Identities=19% Similarity=0.267 Sum_probs=182.8
Q ss_pred hCCCCcccccccCCCCcEEEEEec-CCccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 533 TGDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
.++|...+.||+|+||.||+|... +|..||||.+...... ...+.+|++++++++|||||++++++.+ ++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-CCeEEEEE
Confidence 356778889999999999999964 6889999998654322 3467899999999999999999997765 46789999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
|||+ |+|.+++.... ..+++.....++.++++||+|||+. +||||||||+|||+++++.+||+|||.+..
T Consensus 83 e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 152 (303)
T cd07869 83 EYVH-TDLCQYMDKHP------GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARA 152 (303)
T ss_pred ECCC-cCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCccee
Confidence 9996 68888776432 2377788889999999999999985 899999999999999999999999998764
Q ss_pred cCCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH--HHHHHHhh-cccccccc
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ--VKEILEQT-LPYISIYD 765 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~--~~~~~~~~-~~~~~~~~ 765 (919)
....... .....+++.+.+++.. +...++.++|||||||++|||+||+.||....+.. ........ .|......
T Consensus 153 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 153 KSVPSHT--YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred ccCCCcc--CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 3321111 1111223334444432 33346778899999999999999999998654321 11111100 00000000
Q ss_pred c-ccccccccCC-C--CCCcchHHH------HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 766 K-ELVTKIVDPS-L--IIDEDLLEE------VWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 766 ~-~~~~~i~d~~-l--~~~~~~~~~------~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
. ..... .++. . .......+. ...+.+++..|++.+|++|||+.++++
T Consensus 231 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 231 GVHSLPH-FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred chhhccc-cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0 00000 0000 0 000000000 013456889999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=308.38 Aligned_cols=251 Identities=20% Similarity=0.225 Sum_probs=186.9
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEecccc----ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQS----VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~----~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++|...+.||+|+||.||+|... +|..||||++.... ...+.|..|++++.+++||||+++++++.+ ++..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-EEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-CCeEEEE
Confidence 35777889999999999999964 68899999996532 224568899999999999999999997765 5679999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++.+.. .+++.....|+.++++||+|||.. +|+||||||+|||++.++.+||+|||.+.
T Consensus 80 ~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~ 149 (350)
T cd05573 80 MEYMPGGDLMNLLIRKD-------VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCK 149 (350)
T ss_pred EcCCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCc
Confidence 99999999999997542 377888889999999999999984 89999999999999999999999999876
Q ss_pred hcCCCCc---------------------------ceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCC
Q 002462 689 AQGGDAH---------------------------QSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMG 741 (919)
Q Consensus 689 ~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p 741 (919)
....... ........+++.+.+++......++.++||||||||+|||+||+.|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCC
Confidence 5433220 0001122344445555544445678899999999999999999999
Q ss_pred CCCCChhHHH-HHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 002462 742 ISASSDAQVK-EILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPL-MRYILKA 814 (919)
Q Consensus 742 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPs-m~~V~~~ 814 (919)
|......... .+..+.. ...-|. .....++ +..+...|+. +|.+||+ +.++++.
T Consensus 230 f~~~~~~~~~~~i~~~~~------------~~~~p~---~~~~~~~---~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 230 FYSDTLQETYNKIINWKE------------SLRFPP---DPPVSPE---AIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCHHHHHHHHhccCC------------cccCCC---CCCCCHH---HHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 9876644322 2211100 000000 0001122 3456778997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=306.04 Aligned_cols=250 Identities=18% Similarity=0.225 Sum_probs=183.1
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++|...+.||+|+||.||+++. .+|..||||+++.... ..+.|..|++++++++|+||+++++++.+ ++..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-KDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCeEEEE
Confidence 3677888999999999999985 4688999999975432 23568889999999999999999987665 4678999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++.+.. ..+++.....++.++++||+|||+. +|+||||||+|||++.++.+||+|||.+.
T Consensus 80 ~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~ 150 (330)
T cd05601 80 MEYQPGGDLLSLLNRYE------DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAA 150 (330)
T ss_pred ECCCCCCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCe
Confidence 99999999999987542 2478888889999999999999985 89999999999999999999999999886
Q ss_pred hcCCCCcceeeeeeccCCCCccccCCC------CCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHH-HHHHhhcccc
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSG------SLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVK-EILEQTLPYI 761 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~-~~~~~~~~~~ 761 (919)
......... .....+++.+.+++... ...++.++|||||||++|||+||+.||......... .+....
T Consensus 151 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~---- 225 (330)
T cd05601 151 RLTANKMVN-SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ---- 225 (330)
T ss_pred ECCCCCcee-eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC----
Confidence 543322211 11122333344443321 335678899999999999999999999776543321 111110
Q ss_pred cccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 762 SIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 762 ~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
... .. |. ......+ +..+...|++ +|++||++.+++.
T Consensus 226 -----~~~-~~--~~---~~~~~~~---~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 226 -----RFL-KF--PE---DPKVSSD---FLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -----Ccc-CC--CC---CCCCCHH---HHHHHHHHcc-ChhhCCCHHHHhC
Confidence 000 00 00 0111122 3456678887 9999999998874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=306.15 Aligned_cols=205 Identities=16% Similarity=0.234 Sum_probs=163.4
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++|...+.||+|+||+||++.. .++..||||.+..... ..+.+.+|++++.+++|+|||++++++.+ +...++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-KLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCeEEEE
Confidence 3677889999999999999985 4588999999964322 23467889999999999999999997655 5678999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
||||++|+|.+++.+.. .+++.+...++.+++.||+|||+. +||||||||+|||++.++.+||+|||+++
T Consensus 80 ~E~~~gg~L~~~l~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~ 149 (363)
T cd05628 80 MEFLPGGDMMTLLMKKD-------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCT 149 (363)
T ss_pred EcCCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcc
Confidence 99999999999997542 378888899999999999999985 89999999999999999999999999876
Q ss_pred hcCCCCcc---------------------------------eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHH
Q 002462 689 AQGGDAHQ---------------------------------SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLEL 735 (919)
Q Consensus 689 ~~~~~~~~---------------------------------~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEl 735 (919)
........ .......+++.|.+++......++.++|||||||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 229 (363)
T cd05628 150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (363)
T ss_pred cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHH
Confidence 43211000 000122355556566554445678899999999999999
Q ss_pred HcCCCCCCCCChhH
Q 002462 736 VTGKMGISASSDAQ 749 (919)
Q Consensus 736 lTGk~p~~~~~~~~ 749 (919)
+||+.||......+
T Consensus 230 l~G~~Pf~~~~~~~ 243 (363)
T cd05628 230 LIGYPPFCSETPQE 243 (363)
T ss_pred HhCCCCCCCCCHHH
Confidence 99999998766543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=290.55 Aligned_cols=266 Identities=21% Similarity=0.313 Sum_probs=183.3
Q ss_pred CCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhh--cCCCCccceeeEEeecCC---cEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSK--VSHARLVPLLGHCMEREN---EKFLVY 609 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~--l~H~niV~l~g~c~~~~~---~~~lV~ 609 (919)
.....+.||+|.||+||||.+. |..||||.+... .++.|.+|.++... +||+||+.+++.-....+ +.+||.
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT 288 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT 288 (513)
T ss_pred eeEEEEEecCccccceeecccc-CCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence 4455678999999999999998 558999998543 45678888888775 699999999985432222 689999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcC-----CCCCeeeccCCCCceecCCCCceeeCCc
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHE-----CTLPFVHRDVQASSILLDDKFEVRLGSL 684 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~-----~~~~ivHrDlK~~NILld~~~~~kl~df 684 (919)
||-++|||+|+|.+. .++-..-+++|..+|.||++||.+ -.|.|.|||||+.|||+..++...|+|+
T Consensus 289 dYHe~GSL~DyL~r~--------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 289 DYHEHGSLYDYLNRN--------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred ecccCCcHHHHHhhc--------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 999999999999753 378888999999999999999974 4689999999999999999999999999
Q ss_pred chhhhcCCCCc-------ceeeeeeccCCCCccccCCCCC-CCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHh
Q 002462 685 SEVCAQGGDAH-------QSRITRLLRLPQSSEQGSSGSL-TATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQ 756 (919)
Q Consensus 685 g~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~-~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~ 756 (919)
|+|-....++. ....+..+++|+.......-.. ..-..+||||||.|+||++-+-.- +.-. -+.
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~--ggi~------eey 432 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES--GGIV------EEY 432 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc--CCEe------hhh
Confidence 98865433321 1222333444432221111100 111236999999999999853210 0000 011
Q ss_pred hccccccccc----cccccc-----ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 757 TLPYISIYDK----ELVTKI-----VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 757 ~~~~~~~~~~----~~~~~i-----~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
..||...... +...++ +.|.+.......+.+..|++++..||..+|+.|-|+--|-+.|.+..
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 1222221111 111222 12333222233466778999999999999999999988888886543
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=289.82 Aligned_cols=259 Identities=19% Similarity=0.301 Sum_probs=189.3
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEecccc---c-cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQS---V-KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~---~-~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++|...+.||+|+||.||+|... +|..||+|.++... . ..+.+.+|++++++++|+||+++++++.+ ++..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-NNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEEEE
Confidence 57888899999999999999976 78999999885322 1 24679999999999999999999998776 4678999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++..... ....+++.++..++.++++||+|||+. +|+||||||+||++++++.++++|||.+.
T Consensus 81 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~ 154 (267)
T cd08224 81 LELADAGDLSRMIKHFKK---QKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EecCCCCCHHHHHHHhcc---cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceee
Confidence 999999999998864321 123588999999999999999999975 89999999999999999999999999765
Q ss_pred hcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccc
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (919)
......... ....+.+.+..++......++.++|||||||++|||+||+.|+..... ....+.+... ...
T Consensus 155 ~~~~~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~-------~~~ 224 (267)
T cd08224 155 FFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIE-------KCD 224 (267)
T ss_pred eccCCCccc--ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHhhhh-------cCC
Confidence 432221110 111222223333333334567789999999999999999999864431 1111111100 000
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
. +... .+... ..+..++..|++.+|++||++.+|+++|+..
T Consensus 225 ----~-~~~~-~~~~~---~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 ----Y-PPLP-ADHYS---EELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ----C-CCCC-hhhcC---HHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0 0000 00111 1355688899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=308.34 Aligned_cols=205 Identities=17% Similarity=0.257 Sum_probs=163.6
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++|...++||+|+||.||+|+. .+|..||||++..... ..+.+.+|++++.+++|||||++++++.+ ++..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-ENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCeEEEE
Confidence 3678889999999999999985 4688999999965321 23467889999999999999999997765 5689999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++.... .+++.+...|+.|+++||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 80 ~E~~~~g~L~~~l~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 149 (364)
T cd05599 80 MEYLPGGDMMTLLMKKD-------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149 (364)
T ss_pred ECCCCCcHHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccce
Confidence 99999999999986542 378888889999999999999985 89999999999999999999999999875
Q ss_pred hcCCCCcce------------------------------------eeeeeccCCCCccccCCCCCCCCCCCcchhHHHHH
Q 002462 689 AQGGDAHQS------------------------------------RITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVL 732 (919)
Q Consensus 689 ~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvL 732 (919)
......... ......+++.+.+++......++.++|||||||++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 229 (364)
T cd05599 150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229 (364)
T ss_pred eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence 432110000 00012345555555555555678899999999999
Q ss_pred HHHHcCCCCCCCCChhH
Q 002462 733 LELVTGKMGISASSDAQ 749 (919)
Q Consensus 733 lEllTGk~p~~~~~~~~ 749 (919)
|||+||+.||......+
T Consensus 230 ~el~~G~~Pf~~~~~~~ 246 (364)
T cd05599 230 YEMLVGYPPFCSDNPQE 246 (364)
T ss_pred HHhhcCCCCCCCCCHHH
Confidence 99999999998766543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=290.15 Aligned_cols=246 Identities=24% Similarity=0.410 Sum_probs=184.2
Q ss_pred CCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCC
Q 002462 535 DFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPN 614 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~ 614 (919)
+|...+.||+|+||.||+|.. .+..||+|.+.... ..+.|.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~v~e~~~~ 82 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILH--NGLYIVMELMSK 82 (254)
T ss_pred HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcC--CCcEEEEECCCC
Confidence 466678999999999999975 57789999985432 34679999999999999999999998754 357999999999
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCC
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~ 694 (919)
|+|.+++..... ..+++.++++++.++++||+|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 83 ~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 83 GNLVNFLRTRGR-----ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred CCHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 999999965421 2478999999999999999999974 89999999999999999999999999775432111
Q ss_pred cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
..... ...+..++......++.++|||||||++|||+| |+.|+......+....+..... .
T Consensus 155 ~~~~~-----~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------~ 216 (254)
T cd05083 155 DNSKL-----PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-------------M 216 (254)
T ss_pred CCCCC-----CceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC-------------C
Confidence 11111 112223333333456788999999999999998 9999876654433332221110 0
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
++ .....+ .+..++.+|++.+|.+||+|.+|+..|++
T Consensus 217 ~~----~~~~~~---~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EP----PEGCPA---DVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CC----CCcCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11 011112 24568899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=300.56 Aligned_cols=240 Identities=15% Similarity=0.202 Sum_probs=178.5
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEecccc----ccHHHHHHHHHHHhhcCCCC-ccceeeEEeecCCcEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQS----VKTEAYLLELDFFSKVSHAR-LVPLLGHCMERENEKFLV 608 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~----~~~~~f~~Ei~~l~~l~H~n-iV~l~g~c~~~~~~~~lV 608 (919)
+|...+.||+|+||.||+|+.. ++..||||++.... ...+.+..|++++..++|++ |+++++++. ..+..++|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-TMDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-cCCEEEEE
Confidence 4667789999999999999865 46789999986432 22456888999999998765 677777544 45689999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++.... .+++.+...++.++++||+|||+. +|+||||||+|||+++++.+||+|||.+.
T Consensus 80 ~E~~~~g~L~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05587 80 MEYVNGGDLMYHIQQVG-------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK 149 (324)
T ss_pred EcCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcce
Confidence 99999999999886432 378889999999999999999985 89999999999999999999999999875
Q ss_pred hcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccc
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (919)
....... ......+++.+.+++......++.++|||||||++|||+||+.|+......+....+....+
T Consensus 150 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~--------- 218 (324)
T cd05587 150 ENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV--------- 218 (324)
T ss_pred ecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 4321111 11223345555555555445678889999999999999999999987665443222211100
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLM 808 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm 808 (919)
.+ .....+ .+..++..|++.+|.+||+.
T Consensus 219 -------~~--~~~~~~---~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 -------SY--PKSLSK---EAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -------CC--CCCCCH---HHHHHHHHHhhcCHHHcCCC
Confidence 00 011112 24567889999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=292.33 Aligned_cols=253 Identities=17% Similarity=0.244 Sum_probs=182.4
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
++|.....||+|+||.||+|+. .+|..||||++...... .+.+.+|+.++++++||||+++++++.. ++..++||||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-~~~~~iv~e~ 87 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-REKLWICMEY 87 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-CCEEEEEEeC
Confidence 3567778999999999999995 57889999998654433 4567889999999999999999998875 4678999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+++|+|.+++++.. .+++.+...++.++++||+|||+. +|+||||||+||++++++.+|++|||.+....
T Consensus 88 ~~~~~L~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 88 CGGGSLQDIYHVTG-------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999999986432 378889999999999999999975 89999999999999999999999999876442
Q ss_pred CCCcceeeeeeccCCCCccccCC---CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSS---GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (919)
...... ....+.+.+..++.. ....++.++|||||||++|||+||+.|+....+..... ... ...
T Consensus 158 ~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~~--------~~~ 225 (267)
T cd06646 158 ATIAKR--KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMS--------KSN 225 (267)
T ss_pred cccccc--CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--eee--------cCC
Confidence 211100 011122222222221 12345678999999999999999999986443221100 000 000
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L 815 (919)
...+......... ..+.+++.+|++.+|++||++++|++.|
T Consensus 226 ---~~~~~~~~~~~~~---~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 226 ---FQPPKLKDKTKWS---STFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ---CCCCCCccccccC---HHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0001110000111 2356788999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=289.20 Aligned_cols=254 Identities=19% Similarity=0.254 Sum_probs=184.5
Q ss_pred HhCCCCcccccccCCCCcEEEEE-ecCCccEEEEEeccccc---------------cHHHHHHHHHHHhhcCCCCcccee
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSV---------------KTEAYLLELDFFSKVSHARLVPLL 595 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~---------------~~~~f~~Ei~~l~~l~H~niV~l~ 595 (919)
..+.|.....||+|.||.|-.|+ ..++..||||.+..... .-+...+||.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 34677778889999999999998 56789999999854221 125688999999999999999999
Q ss_pred eEEeecC--CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceec
Q 002462 596 GHCMERE--NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILL 673 (919)
Q Consensus 596 g~c~~~~--~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILl 673 (919)
. |++.. +..|||+|||..|.+...= .....|+..+..+|..++..||+|||.+ +||||||||+|+||
T Consensus 175 E-vLDDP~s~~~YlVley~s~G~v~w~p-------~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl 243 (576)
T KOG0585|consen 175 E-VLDDPESDKLYLVLEYCSKGEVKWCP-------PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLL 243 (576)
T ss_pred E-eecCcccCceEEEEEeccCCccccCC-------CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEE
Confidence 9 55432 3689999999999874321 1112288889999999999999999985 99999999999999
Q ss_pred CCCCceeeCCcchhhhcCCCC---cceeeeeeccCCCCccccCCC----CCCCCCCCcchhHHHHHHHHHcCCCCCCCCC
Q 002462 674 DDKFEVRLGSLSEVCAQGGDA---HQSRITRLLRLPQSSEQGSSG----SLTATCPYDVYCFGKVLLELVTGKMGISASS 746 (919)
Q Consensus 674 d~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~----~~~~t~~~DVySfGvvLlEllTGk~p~~~~~ 746 (919)
++++.+||+|||.+....... ......+..++|..++++.-. ......+.||||+||+||-|+-|+.||.+..
T Consensus 244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 999999999999776542111 011123345666555444321 1223456799999999999999999997654
Q ss_pred hhHHHHHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 002462 747 DAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815 (919)
Q Consensus 747 ~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L 815 (919)
..++ ..+|+...+...+. .++-...-+|++..+.+||.+|-+..+|....
T Consensus 324 ~~~l------------------~~KIvn~pL~fP~~-pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 324 ELEL------------------FDKIVNDPLEFPEN-PEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHHH------------------HHHHhcCcccCCCc-ccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 3322 23344444433322 11222345578899999999999999987643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=296.45 Aligned_cols=244 Identities=21% Similarity=0.255 Sum_probs=191.8
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccccH---HHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVKT---EAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~~---~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
+|...+.||+|+||.||||+-+ +.+.||+|.+....... +...+|++++++++|||||.++.++ +...+.++|.|
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-Et~~~~~vVte 81 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-ETSAHLWVVTE 81 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-cccceEEEEeh
Confidence 4555678999999999999854 56889999997655433 4578899999999999999999965 56678999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+.+ +|..+|...+ .|+..+...||.+...||.|||+. +|+|||+||.||||+..+.+|++|||+++..
T Consensus 82 ~a~g-~L~~il~~d~-------~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-------KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAM 150 (808)
T ss_pred hhhh-hHHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhc
Confidence 9997 9999996543 377778889999999999999985 8999999999999999999999999999987
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
....+ ..++.-++|-|++++......++..+|.||+||||||+.+|++||...+-.++.+.+..
T Consensus 151 ~~~t~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~-------------- 214 (808)
T KOG0597|consen 151 STNTS--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK-------------- 214 (808)
T ss_pred ccCce--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc--------------
Confidence 65443 35666788888888777777888889999999999999999999986554333322211
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
||... ...... .+..+..--+.+||.+|-+-.+++.
T Consensus 215 ---d~v~~-p~~~S~---~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 215 ---DPVKP-PSTASS---SFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ---CCCCC-cccccH---HHHHHHHHHhhcChhhcccHHHHhc
Confidence 11110 001111 2334556778999999999988764
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=295.14 Aligned_cols=245 Identities=22% Similarity=0.337 Sum_probs=181.8
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
|+..+.||+|+||.||+|.. .++..||||.+..... ..+.|.+|++++++++||||+++++++.. ++..++||||+
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 84 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-GTKLWIIMEYL 84 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-CCceEEEEEcc
Confidence 44456799999999999985 4578999999864432 24578999999999999999999998765 46799999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++|+|.+++.. ..+++.....++.++++||+|||+. +|+|+||||+||++++++.+|++|||.+.....
T Consensus 85 ~~~~L~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 85 GGGSALDLLKP--------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 99999998853 2378889999999999999999974 899999999999999999999999998765432
Q ss_pred CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 693 DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
..... ....+...+..++......++.++|||||||++|||+||+.|+...........+...
T Consensus 154 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--------------- 216 (277)
T cd06642 154 TQIKR--NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--------------- 216 (277)
T ss_pred cchhh--hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC---------------
Confidence 21110 1111222333333333345678899999999999999999998654432221111100
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
..+.+ .+.. ...+..++..|++.+|++||+|.+|++.
T Consensus 217 ~~~~~--~~~~---~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 217 SPPTL--EGQY---SKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCC--Cccc---CHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 01111 1111 1235678899999999999999999873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=292.68 Aligned_cols=245 Identities=21% Similarity=0.248 Sum_probs=178.3
Q ss_pred cccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCC
Q 002462 542 IKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGD 616 (919)
Q Consensus 542 ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~Gs 616 (919)
||+|+||.||++.. .+|..||+|++..... ..+.+..|++++++++||||+++++++.. +...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCC
Confidence 79999999999985 4589999999864322 13456679999999999999999987654 567999999999999
Q ss_pred hhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcc
Q 002462 617 LSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQ 696 (919)
Q Consensus 617 L~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~ 696 (919)
|.++++.... ..++|.++..++.+++.||+|||+. +|+||||||+||++++++.+||+|||.+........
T Consensus 80 L~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~- 150 (277)
T cd05607 80 LKYHIYNVGE-----RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT- 150 (277)
T ss_pred HHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce-
Confidence 9988865322 3488999999999999999999974 899999999999999999999999998765432211
Q ss_pred eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhcccccccccccccccccC
Q 002462 697 SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLPYISIYDKELVTKIVDP 775 (919)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~d~ 775 (919)
.....+++.+..++......++.++|||||||++|||+||+.|+....... ...+...... .. +..
T Consensus 151 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-------~~----~~~ 217 (277)
T cd05607 151 --ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-------DE----VKF 217 (277)
T ss_pred --eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-------cc----ccc
Confidence 111223344444444434457888999999999999999999987543211 1111111100 00 000
Q ss_pred CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 002462 776 SLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815 (919)
Q Consensus 776 ~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L 815 (919)
. .....+ .+.+++..|++.+|.+||+++|+++.+
T Consensus 218 --~-~~~~~~---~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 218 --E-HQNFTE---ESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred --c-cccCCH---HHHHHHHHHhccCHhhCCCCccchhhh
Confidence 0 001112 245688899999999999998876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=299.99 Aligned_cols=240 Identities=17% Similarity=0.206 Sum_probs=179.6
Q ss_pred cccccCCCCcEEEEEec-CCccEEEEEecccc----ccHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGILE-GGIPVVIKRIDLQS----VKTEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~----~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++||+|+||.||+|+.. ++..||||++.... ...+.+..|++++..+ +||||+++++++.. .+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-KDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 36999999999999865 47899999986432 1235677899999888 69999999997654 568999999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|..++.+.. .++|.+...|+.++++||+|||+. +|+||||||+|||+++++.+||+|||.+......
T Consensus 80 ~~~L~~~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 80 GGDLMFHIQRSG-------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG 149 (318)
T ss_pred CCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcC
Confidence 999998886532 388999999999999999999975 8999999999999999999999999987542211
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
... .....+++.+..++......++.++|||||||++|||+||+.||...........+....+ .
T Consensus 150 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~-------------~ 214 (318)
T cd05570 150 GVT--TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV-------------R 214 (318)
T ss_pred CCc--ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-------------C
Confidence 111 1112344445555554445678899999999999999999999987665443222211100 0
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLM-----RYILK 813 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm-----~~V~~ 813 (919)
-| ....+ .+..++..|++.+|.+||++ .++++
T Consensus 215 ~~-----~~~~~---~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 YP-----RWLSK---EAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CC-----CcCCH---HHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 01 01111 24568889999999999999 66653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=298.82 Aligned_cols=236 Identities=18% Similarity=0.211 Sum_probs=173.2
Q ss_pred cccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHH-HHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELD-FFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~-~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++||+|+||.||+|+. .+|..||||++..... ..+.+..|.. +++.++|||||++++++.+ .+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-AEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 3699999999999986 4678999999864322 1334566654 6788999999999987755 567999999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|..++.+.. .+...+...|+.++++||+|||+. +|+||||||+|||++.++.+||+|||.+......
T Consensus 80 ~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 80 GGELFFHLQRER-------CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP 149 (321)
T ss_pred CCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC
Confidence 999998886432 366677788999999999999974 8999999999999999999999999987642211
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
.. ......+++.+..++......++.++|||||||++|||+||+.||...+.....+.+...
T Consensus 150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---------------- 211 (321)
T cd05603 150 EE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---------------- 211 (321)
T ss_pred CC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC----------------
Confidence 11 112233445555555544456788899999999999999999999876543322221110
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMR 809 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~ 809 (919)
.+........ .+..+...|++.+|.+||+..
T Consensus 212 --~~~~~~~~~~---~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 212 --PLQLPGGKTV---AACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCCCCCCCH---HHHHHHHHHccCCHhhcCCCC
Confidence 0000111111 255688899999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=318.07 Aligned_cols=272 Identities=17% Similarity=0.206 Sum_probs=188.1
Q ss_pred HHHHHHhCCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccccHHHHHHHHHHHhhcCCC------CccceeeEEe
Q 002462 527 QQLLAATGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHA------RLVPLLGHCM 599 (919)
Q Consensus 527 ~~l~~at~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~------niV~l~g~c~ 599 (919)
+++...+++|...++||+|+||+||+|+. ..+..||||+++......+++..|++++.+++|. +++++++++.
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445678899999999999999999985 4578899999965433345567788888877665 4888888876
Q ss_pred ecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCC--
Q 002462 600 ERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF-- 677 (919)
Q Consensus 600 ~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~-- 677 (919)
......++||||+ +++|.+++.+.. .+++.+...|+.||+.||+|||++ .+||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG-------PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTV 271 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcc
Confidence 5555789999988 678888886532 488999999999999999999973 3799999999999998765
Q ss_pred --------------ceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCC
Q 002462 678 --------------EVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGIS 743 (919)
Q Consensus 678 --------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~ 743 (919)
.+||+|||.++...... +...+++.|..++......++.++|||||||++|||+||+.||+
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~-----~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERHSR-----TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCcccc-----ccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 49999999765432211 12334455555555444567888999999999999999999998
Q ss_pred CCChhHHHHHHHhhcccc-ccc----ccccccccc------cCCCC--------CCcchH--HHHHHHHHHHHHccCCCC
Q 002462 744 ASSDAQVKEILEQTLPYI-SIY----DKELVTKIV------DPSLI--------IDEDLL--EEVWAMAIVARSCLNPKP 802 (919)
Q Consensus 744 ~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~i~------d~~l~--------~~~~~~--~~~~~~~~la~~C~~~~P 802 (919)
.....+....+......+ ... ..+...++. ++... ...... .+-..+.+++..|++.||
T Consensus 347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 776544333222211100 000 000000000 00000 000000 011235678999999999
Q ss_pred CCCCCHHHHHH
Q 002462 803 TRRPLMRYILK 813 (919)
Q Consensus 803 ~~RPsm~~V~~ 813 (919)
++|||++|+++
T Consensus 427 ~~R~ta~e~L~ 437 (467)
T PTZ00284 427 QKRLNARQMTT 437 (467)
T ss_pred hhCCCHHHHhc
Confidence 99999999986
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=298.39 Aligned_cols=239 Identities=18% Similarity=0.261 Sum_probs=177.5
Q ss_pred cccccCCCCcEEEEEec-CCccEEEEEecccc----ccHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGILE-GGIPVVIKRIDLQS----VKTEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~----~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++||+|+||.||+|+.. +|..||||.++... ...+.+..|..++.+. +||||+++++++.+ ++..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-KEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-CCEEEEEECCCC
Confidence 36999999999999964 57899999996532 1234567788888764 89999999997765 568999999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|..++..+. .+++.+...++.++++||+|||+. +|+||||||+|||++.++.+||+|||.+......
T Consensus 80 ~g~L~~~i~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 80 GGDLMFHIQDKG-------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG 149 (316)
T ss_pred CCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC
Confidence 999999886532 377888899999999999999985 8999999999999999999999999987532111
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
.. ......+++.+.+++......++.++|||||||++|||+||+.|+......+..+.+....+. .
T Consensus 150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~--------~---- 215 (316)
T cd05620 150 DN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPH--------Y---- 215 (316)
T ss_pred CC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------C----
Confidence 11 112233445555555444456788899999999999999999999876654433322211110 0
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMR-YIL 812 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~-~V~ 812 (919)
|. .... .+..++..|++.+|++||++. ++.
T Consensus 216 -~~-----~~~~---~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 -PR-----WITK---ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CC-----CCCH---HHHHHHHHHccCCHHHcCCChHHHH
Confidence 00 0111 234578899999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=293.19 Aligned_cols=246 Identities=20% Similarity=0.225 Sum_probs=180.3
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc----HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK----TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
|...++||+|+||+||+|.. .++..||||.+...... .+.+.+|++++++++|+||+++.+++.. ++..++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-KDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-CCEEEEEEE
Confidence 55567899999999999985 56889999998654322 2457889999999999999999987654 567899999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+++|+|.++++.... ..++|.+...++.|+++||+|||+. +|+||||||+||++++++.+|++|||.+...
T Consensus 81 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05632 81 IMNGGDLKFHIYNMGN-----PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI 152 (285)
T ss_pred eccCccHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceec
Confidence 9999999998865332 2489999999999999999999974 8999999999999999999999999977543
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
...... ....+...+..++......++.++|||||||++|||+||+.||.........+.+....... .
T Consensus 153 ~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--------~ 221 (285)
T cd05632 153 PEGESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--------E 221 (285)
T ss_pred CCCCcc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--------c
Confidence 221111 11123333444444334457788999999999999999999998765433222222111000 0
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRY 810 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~ 810 (919)
... .....+ .+..++..|++.+|++||++.+
T Consensus 222 ~~~------~~~~~~---~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05632 222 EVY------SAKFSE---EAKSICKMLLTKDPKQRLGCQE 252 (285)
T ss_pred ccc------CccCCH---HHHHHHHHHccCCHhHcCCCcc
Confidence 000 111112 2456888999999999999543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=308.67 Aligned_cols=253 Identities=17% Similarity=0.190 Sum_probs=182.7
Q ss_pred HhCCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEE
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKF 606 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~ 606 (919)
..++|...+.||+|+||.||+++. .++..||||++..... ..+.|.+|+++++.++|||||++++++. .++..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~-~~~~~~ 119 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-DDKYLY 119 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCEEE
Confidence 345788889999999999999985 4688999999864321 2345788999999999999999998665 456799
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcch
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~ 686 (919)
+|||||++|+|.+++... .++......++.++++||+|||+. +||||||||+|||+++++.+||+|||.
T Consensus 120 lv~Ey~~gg~L~~~l~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~ 188 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY--------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (370)
T ss_pred EEEcCCCCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccc
Confidence 999999999999988643 255556677899999999999985 899999999999999999999999998
Q ss_pred hhhcCCCCcceeeeeeccCCCCccccCCC----CCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccc
Q 002462 687 VCAQGGDAHQSRITRLLRLPQSSEQGSSG----SLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYIS 762 (919)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~ 762 (919)
+......... ......+++.+.+++... ...++.++|||||||++|||+||+.||...........+....
T Consensus 189 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~---- 263 (370)
T cd05596 189 CMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK---- 263 (370)
T ss_pred eeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC----
Confidence 7654322111 111223444454444321 2246788999999999999999999998765433221111100
Q ss_pred ccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002462 763 IYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTR--RPLMRYILKA 814 (919)
Q Consensus 763 ~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~--RPsm~~V~~~ 814 (919)
. .+..|. .....+ .+..++..|++.+|.+ ||++.++++.
T Consensus 264 ----~---~~~~~~---~~~~s~---~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 ----N---SLTFPD---DIEISK---QAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----C---cCCCCC---cCCCCH---HHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 000000 001112 2345778999999988 9999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=310.54 Aligned_cols=193 Identities=18% Similarity=0.232 Sum_probs=154.6
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
+|.....||+|+||.||+|+.. .+..||||... ...+.+|++++++++|+|||++++++.. ++..++||||+.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~-~~~~~lv~e~~~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVV-GGLTCLVLPKYR 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEEEccC
Confidence 5777888999999999999965 47889999642 2346789999999999999999998876 457899999995
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
|+|.+++.... ..++|.+++.|+.|+++||+|||+. +||||||||+|||++.++.+||+|||+++.....
T Consensus 244 -~~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 244 -SDLYTYLGARL------RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred -CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 78988885432 2489999999999999999999985 8999999999999999999999999988755332
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCC
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGIS 743 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~ 743 (919)
..........+++.|..++......++.++||||||||||||++|..|+.
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 22111112234455555555444567889999999999999999887654
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=306.71 Aligned_cols=193 Identities=20% Similarity=0.232 Sum_probs=155.2
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
++|...+.||+|+||.||++.. ..+..||||+.. .+.+.+|++++++++|||||++++++.. +...++|+||+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTY-NKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEE-CCeeEEEEecC
Confidence 5688889999999999999984 567899999753 3457899999999999999999997754 56789999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
. ++|.+++..+. .+++.+.+.|+.++++||+|||+. +||||||||+|||++.++.+||+|||.++....
T Consensus 166 ~-~~L~~~l~~~~-------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 166 K-TDLYCYLAAKR-------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred C-CCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 6 78888875432 378999999999999999999985 899999999999999999999999998864322
Q ss_pred CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCC
Q 002462 693 DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISA 744 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~ 744 (919)
... .......+++.+..++......++.++|||||||++|||+||+.|+..
T Consensus 235 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 235 INA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 111 111223344455555554445678899999999999999999988754
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=299.67 Aligned_cols=237 Identities=19% Similarity=0.237 Sum_probs=174.4
Q ss_pred cccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHH-HHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELD-FFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~-~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++||+|+||.||+|+. .+|..||||++..... ..+++..|.. ++++++|||||++++++.+ .+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-ADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-CCEEEEEEcCCC
Confidence 3699999999999996 4689999999864322 1234556655 5678999999999997765 567899999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|.+++.+.. .+++.+...|+.++++||+|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 80 ~g~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 80 GGELFFHLQRER-------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH 149 (323)
T ss_pred CCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC
Confidence 999999886532 377888889999999999999985 8999999999999999999999999987643211
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
.. ......+++.+..++......++.++|||||||++|||+||+.||......+..+-+...
T Consensus 150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---------------- 211 (323)
T cd05575 150 SK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---------------- 211 (323)
T ss_pred CC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC----------------
Confidence 11 112233444555555444456788899999999999999999999876543322111110
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRY 810 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~ 810 (919)
.....+.... .+..+...|++.+|++||++++
T Consensus 212 --~~~~~~~~~~---~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 212 --PLRLKPNISV---SARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred --CCCCCCCCCH---HHHHHHHHHhhcCHHhCCCCCC
Confidence 0000111112 2455788999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=288.42 Aligned_cols=249 Identities=18% Similarity=0.297 Sum_probs=187.0
Q ss_pred CCCCcccccccCCCCcEEEEEecC-CccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEG-GIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~-g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
++|...+.||+|+||.||+|...+ +..+|+|.+..... .++|.+|++++++++|+||++++|++.+ +...++||||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFK-NTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeec-CCcEEEEEecC
Confidence 567778899999999999999765 78999999865433 5789999999999999999999998876 46789999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++++|.+++.... ..++|.+...++.++++||.|||+. +|+||||+|+||++++++.+|++|||.+.....
T Consensus 81 ~~~~L~~~l~~~~------~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 81 GAGSVSDIMKITN------KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred CCCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 9999999986432 3489999999999999999999985 799999999999999999999999998765433
Q ss_pred CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 693 DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
..... ....+...+..++......++.++|||||||++|||+||+.|+...........+.. .
T Consensus 152 ~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---------------~ 214 (256)
T cd06612 152 TMAKR--NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---------------K 214 (256)
T ss_pred Ccccc--ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---------------C
Confidence 22110 111122333344433334678889999999999999999999876543321111100 0
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..+.+...+...+ .+..++..|++.+|++||++.+|++
T Consensus 215 ~~~~~~~~~~~~~---~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 215 PPPTLSDPEKWSP---EFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCCCCchhhcCH---HHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0001101111111 2456788999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=309.24 Aligned_cols=264 Identities=18% Similarity=0.214 Sum_probs=182.2
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecC----CcEE
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERE----NEKF 606 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~----~~~~ 606 (919)
+|+..+.||+|+||.||++.. .+|..||||++.... ...+.+.+|+++++.++|||||++++++...+ ...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477788999999999999985 578999999985432 12457889999999999999999999876432 1679
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcch
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~ 686 (919)
+|+||++ ++|.+.+... ..+++.....|+.++++||+|||+. +|+||||||+|||+++++.+||+|||.
T Consensus 81 lv~e~~~-~~l~~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~ 149 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-------QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGL 149 (372)
T ss_pred EEeeccc-cCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccc
Confidence 9999997 5787777532 2488899999999999999999985 899999999999999999999999998
Q ss_pred hhhcCCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccc
Q 002462 687 VCAQGGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYD 765 (919)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~ 765 (919)
+.......... .....+.+.+..++.. +...++.++|||||||++|||+||+.||...........+...........
T Consensus 150 a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 150 ARVEEPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred eeecccCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 76543221110 1111122333333322 233467789999999999999999999987665432222211110000000
Q ss_pred ----cccccccc-----cCC-----CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 766 ----KELVTKIV-----DPS-----LIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 766 ----~~~~~~i~-----d~~-----l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.+...+.+ .+. ........+ .+..++..|++.+|.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATH---EAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCH---HHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00000000 000 000001111 3556889999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=302.43 Aligned_cols=192 Identities=18% Similarity=0.229 Sum_probs=152.2
Q ss_pred cccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++||+|+||.||+++. .++..||+|.+..... ..+.+..|+.++.++ +|||||++++++.. ++..++|||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-CCEEEEEEeCCC
Confidence 3699999999999985 4578999999865322 234577899998877 79999999997654 568999999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|..++.+.. .+++.....|+.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~~L~~~~~~~~-------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 80 GGDLMFHMQRQR-------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred CCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC
Confidence 999998886432 378888999999999999999985 8999999999999999999999999987643211
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCC
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISA 744 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~ 744 (919)
... .....+++.+..++......++.++|||||||++|||+||+.||..
T Consensus 150 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 150 GDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CCc--cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 111 1122344445555544444677889999999999999999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=324.53 Aligned_cols=264 Identities=17% Similarity=0.232 Sum_probs=191.6
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++|...++||+|+||.||+|+.. +|..||||++..... ..++|.+|++++++++|||||+++++|.+ ++..++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-GDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-CCEEEEE
Confidence 46777889999999999999854 588999999864322 24679999999999999999999998875 4678999
Q ss_pred EEecCCCChhhhhhccCC----CCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCc
Q 002462 609 YKYMPNGDLSSSLYRKTN----TEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSL 684 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~----~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~df 684 (919)
|||+++|+|.+++..... .......++|.+.++|+.++++||+|||+. +||||||||+|||++.++.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEec
Confidence 999999999999864211 011123477888999999999999999985 8999999999999999999999999
Q ss_pred chhhhcCCCCc----------------ceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChh
Q 002462 685 SEVCAQGGDAH----------------QSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDA 748 (919)
Q Consensus 685 g~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~ 748 (919)
|.+........ ........+++.+.+++......++.++|||||||++|||+||+.|+......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 98875421100 00001123555566665554556788999999999999999999999764332
Q ss_pred HHHHHHHhhcccccccccccccccccCCCCC-CcchHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhcccc
Q 002462 749 QVKEILEQTLPYISIYDKELVTKIVDPSLII-DEDLLEEVWAMAIVARSCLNPKPTRRP-LMRYILKALENPLK 820 (919)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~-~~~~~~~~~~~~~la~~C~~~~P~~RP-sm~~V~~~L~~~~~ 820 (919)
..... .. +.+|.-.. ...... .+..++.+|++.+|++|| +++++.+.|+..++
T Consensus 238 ki~~~--~~--------------i~~P~~~~p~~~iP~---~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 KISYR--DV--------------ILSPIEVAPYREIPP---FLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhh--hh--------------ccChhhccccccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 21100 00 00000000 001111 245678899999999996 57778787776543
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=288.03 Aligned_cols=249 Identities=20% Similarity=0.333 Sum_probs=183.5
Q ss_pred CCcccccccCCCCcEEEEEecCCccEEEEEecccccc-------HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK-------TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~-------~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
|...+.||+|+||.||+|...+|..+|||.+...... .+.+.+|++++++++|+||++++++|.+ .+..++|
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv 80 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-DNTISIF 80 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-CCeEEEE
Confidence 4556789999999999999888999999988643211 2458889999999999999999998876 4678999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++.+.. .+++.....++.++++||+|||.. +|+|+||||+||++++++.+|++|||.+.
T Consensus 81 ~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 150 (265)
T cd06631 81 MEFVPGGSISSILNRFG-------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCAR 150 (265)
T ss_pred EecCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhH
Confidence 99999999999996532 377888889999999999999975 79999999999999999999999999876
Q ss_pred hcCCCCc----ceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccc
Q 002462 689 AQGGDAH----QSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIY 764 (919)
Q Consensus 689 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~ 764 (919)
....... ........+...+..++......++.++|||||||++|||+||+.|+................
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~------ 224 (265)
T cd06631 151 RLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR------ 224 (265)
T ss_pred hhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc------
Confidence 5421110 001111223333444444444556788999999999999999999997544322111111000
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 765 DKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 765 ~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.. .+.+ .....+ .+..++..|++.+|++||++.+|++
T Consensus 225 --~~-----~~~~--~~~~~~---~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 --GL-----MPRL--PDSFSA---AAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --CC-----CCCC--CCCCCH---HHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0111 111112 2456888999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=342.90 Aligned_cols=287 Identities=33% Similarity=0.499 Sum_probs=205.7
Q ss_pred hhhcCCCCCCEEecCCCCCCCCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCC
Q 002462 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLS 190 (919)
Q Consensus 111 ~~l~~L~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~ 190 (919)
..+.++++|+.|++++|.+.|.+|..+.. +++|++|+|++|.+.+.+|..++++++|+.|+|++|.+++.+|..++.+.
T Consensus 278 ~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~-l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~ 356 (968)
T PLN00113 278 PSIFSLQKLISLDLSDNSLSGEIPELVIQ-LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN 356 (968)
T ss_pred hhHhhccCcCEEECcCCeeccCCChhHcC-CCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCC
Confidence 35677888888888888888888887764 88888888888888888888888888888888888888888888888888
Q ss_pred CCCEEEccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcC
Q 002462 191 VLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLS 270 (919)
Q Consensus 191 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 270 (919)
+|+.|+|++|++++.+|..+..+++|+.|++++|.+.+.+|..++.+++|+.|+|++|++++.+|..+.++++|+.|+|+
T Consensus 357 ~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls 436 (968)
T PLN00113 357 NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436 (968)
T ss_pred CCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECc
Confidence 88888888888888888888777788888888888877777777777778888888887777777777777777777777
Q ss_pred CCCCCCCCchhhhccccCCEEEccCCcCCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCCC
Q 002462 271 MNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGP 350 (919)
Q Consensus 271 ~N~l~g~~p~~l~~l~~L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 350 (919)
+|++++.+|..+..+++|+.|++++|.+.+.+|... ...+|+.|+|++|++++.+|..+.++++|+.|+|++|++++.
T Consensus 437 ~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~--~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 514 (968)
T PLN00113 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF--GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGE 514 (968)
T ss_pred CCcccCccChhhccCCCCcEEECcCceeeeecCccc--ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceee
Confidence 777777777777777777777777777666655432 234556666666666655555555555666666666666555
Q ss_pred CCcccccCCCCCcEEEccCCcCccCCCCC---CCCCcEEEccCCcCCCcCCccc
Q 002462 351 LPNSRSNVNTSTVELNISQNMFYGGLTPV---LGRFRLVDLSGNYFEGRVPEYV 401 (919)
Q Consensus 351 ip~~~~~~~~~l~~L~ls~N~~~g~~~~~---l~~L~~ldLs~N~l~g~ip~~~ 401 (919)
+|... ..+.+|+.|+|++|.++|.+|.. +.+|+.|||++|+++|.+|..+
T Consensus 515 ~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 567 (968)
T PLN00113 515 IPDEL-SSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567 (968)
T ss_pred CChHH-cCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhH
Confidence 55332 33445555555555555555532 3445555555555555555443
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=286.68 Aligned_cols=251 Identities=18% Similarity=0.272 Sum_probs=183.3
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc------cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV------KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKF 606 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~------~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~ 606 (919)
++|...+.||+|+||.||+|.. .++..||+|.+..... ..+.+.+|++++++++||||++++|++.+ ++..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-DETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-CCeEE
Confidence 4688889999999999999985 5689999998864321 12468899999999999999999998765 45899
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcch
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~ 686 (919)
+||||+++|+|.+++.... .+++....+++.+++.||+|||+. +|+||||||+||++++++.+||+|||.
T Consensus 81 ~v~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~ 150 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYG-------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGA 150 (263)
T ss_pred EEEEECCCCcHHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 9999999999999886432 377888899999999999999985 899999999999999999999999998
Q ss_pred hhhcCCCCccee-eeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccc
Q 002462 687 VCAQGGDAHQSR-ITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYD 765 (919)
Q Consensus 687 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~ 765 (919)
+........... .....+...+..++......++.++|||||||++|||+||+.|+...............
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-------- 222 (263)
T cd06625 151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ-------- 222 (263)
T ss_pred ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc--------
Confidence 754322111100 01111222333344333345778899999999999999999998765432211111100
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 766 KELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 766 ~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
.. .+.+ .+...+ .+..++..|++.+|.+||++.++++.
T Consensus 223 -~~-----~~~~--~~~~~~---~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 -PT-----NPQL--PSHVSP---DARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CC-----CCCC--CccCCH---HHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00 0000 011111 24567889999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=288.25 Aligned_cols=250 Identities=21% Similarity=0.302 Sum_probs=177.8
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc------cHHHHHHHHHHHhhcCCCCccceeeEEeec-CCcE
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV------KTEAYLLELDFFSKVSHARLVPLLGHCMER-ENEK 605 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~------~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~-~~~~ 605 (919)
.+|...++||+|+||.||+|.. .++..||+|++..... ..+.+.+|++++++++||||+++++++.+. +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4678889999999999999985 4688999998864321 134688899999999999999999976543 3467
Q ss_pred EEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcc
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS 685 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg 685 (919)
++||||+++++|.+++.+.. .+++.....++.++++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg 151 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG 151 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCC
Confidence 89999999999999986432 378888999999999999999974 79999999999999999999999999
Q ss_pred hhhhcCCCCc-ceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccc
Q 002462 686 EVCAQGGDAH-QSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIY 764 (919)
Q Consensus 686 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~ 764 (919)
.+........ ........+...+..++......++.++|||||||++|||+||+.|+........ ......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~--~~~~~~------ 223 (266)
T cd06651 152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA--IFKIAT------ 223 (266)
T ss_pred CccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH--HHHHhc------
Confidence 8764321110 0001111122233333333334567889999999999999999999875432211 111000
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 765 DKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 765 ~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
....+.+. ....+. +.....|+..+|++||+|+||++
T Consensus 224 ------~~~~~~~~--~~~~~~----~~~li~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 224 ------QPTNPQLP--SHISEH----ARDFLGCIFVEARHRPSAEELLR 260 (266)
T ss_pred ------CCCCCCCc--hhcCHH----HHHHHHHhcCChhhCcCHHHHhc
Confidence 00011111 111111 22233788899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=295.74 Aligned_cols=264 Identities=16% Similarity=0.209 Sum_probs=182.5
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
++|...+.||+|+||.||+|+.. ++..||||+++..... ...+.+|++++++++||||+++++++.. ++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-DKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-CCeEEEEEe
Confidence 34667789999999999999854 5788999998654322 3568899999999999999999998765 467999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+++ +|.+++.... ..+++.+...++.++++||+|||+. +|+||||||+|||+++++.+||+|||.+...
T Consensus 85 ~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 85 YLDK-DLKQYMDDCG------NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAK 154 (309)
T ss_pred CCCC-CHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceec
Confidence 9985 8888876432 2377888889999999999999985 8999999999999999999999999987654
Q ss_pred CCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccc------c
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYIS------I 763 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~------~ 763 (919)
....... ....+++.+..++.. +...++.++|||||||++|||+||+.||...+..+....+....+... .
T Consensus 155 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 155 SVPTKTY--SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred CCCcccc--ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence 3221110 111122333333322 334567789999999999999999999987654332222111110000 0
Q ss_pred cccccccccccCCCC------CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 764 YDKELVTKIVDPSLI------IDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 764 ~~~~~~~~i~d~~l~------~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.........-.+... ..+...+ ...++..+|++.+|.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDT---EGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCH---HHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000000 0001111 2356889999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=300.86 Aligned_cols=239 Identities=18% Similarity=0.221 Sum_probs=173.8
Q ss_pred cccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++||+|+||.||++.. .++..||||.++.... ..+.+..|+.++.++ +|||||++++++.+ ++..++|||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-ESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-CCEEEEEEeCCC
Confidence 3699999999999985 4678999999965322 134578899999998 69999999997654 567899999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|.+++.+.. .+++..+..|+.+++.||+|||+. +|+||||||+|||++.++.+||+|||.++.....
T Consensus 80 ~g~L~~~~~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 80 GGDLMFHMQRQR-------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP 149 (329)
T ss_pred CCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC
Confidence 999998886432 388999999999999999999975 8999999999999999999999999987642111
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChh-----HHHHHHHhhccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDA-----QVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 768 (919)
.. ......+++.+..++......++.++|||||||++|||+||+.||+..... ...++....
T Consensus 150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----------- 216 (329)
T cd05588 150 GD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV----------- 216 (329)
T ss_pred CC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH-----------
Confidence 11 112233444455555444446778899999999999999999999642211 011111110
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLM 808 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm 808 (919)
+............. .+..++..|++.+|.+||++
T Consensus 217 ---~~~~~~~~p~~~~~---~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 217 ---ILEKQIRIPRSLSV---KASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred ---HHcCCCCCCCCCCH---HHHHHHHHHhccCHHHcCCC
Confidence 01111111111112 24568889999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=298.41 Aligned_cols=240 Identities=15% Similarity=0.211 Sum_probs=179.9
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~lV 608 (919)
+|...+.||+|+||.||+|+.. ++..||||.+..... ..+.+..|..++..+ +|++|+++++++. ..+..++|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ-TMDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe-cCCEEEEE
Confidence 4677789999999999999865 568999999864322 234577788888887 5788888888654 45678999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++.... .+++.++..++.++++||+|||+. +|+||||||+|||+++++.+||+|||.+.
T Consensus 80 ~E~~~~g~L~~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~ 149 (323)
T cd05616 80 MEYVNGGDLMYQIQQVG-------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 149 (323)
T ss_pred EcCCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCce
Confidence 99999999998886532 378889999999999999999975 89999999999999999999999999876
Q ss_pred hcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccc
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (919)
....... ......+++.+.+++......++.++|||||||++|||+||+.|+...........+....
T Consensus 150 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---------- 217 (323)
T cd05616 150 ENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------- 217 (323)
T ss_pred ecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 4321111 1122334555666665555567889999999999999999999998766544332221110
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLM 808 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm 808 (919)
........+ .+..++..|++.+|.+|++.
T Consensus 218 --------~~~p~~~s~---~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 --------VAYPKSMSK---EAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --------CCCCCcCCH---HHHHHHHHHcccCHHhcCCC
Confidence 000111112 24568889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=288.06 Aligned_cols=254 Identities=16% Similarity=0.237 Sum_probs=183.8
Q ss_pred CCCcccccccCCCCcEEEEEecC--CccEEEEEeccccc-----------cHHHHHHHHHHHhh-cCCCCccceeeEEee
Q 002462 535 DFSDANLIKNGHSGDLFRGILEG--GIPVVIKRIDLQSV-----------KTEAYLLELDFFSK-VSHARLVPLLGHCME 600 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~--g~~vavK~l~~~~~-----------~~~~f~~Ei~~l~~-l~H~niV~l~g~c~~ 600 (919)
+|...+.||+|+||.||+|...+ +..+|||++..... ..+++.+|+.++.+ ++||||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36667889999999999999765 67899998753211 12457789998875 799999999998876
Q ss_pred cCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCcee
Q 002462 601 RENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVR 680 (919)
Q Consensus 601 ~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~k 680 (919)
++..++||||+++++|.+++..... ....+++.++++++.+++.||.|||+. .+|+||||||+||++++++.+|
T Consensus 81 -~~~~~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~ 154 (269)
T cd08528 81 -NDRLYIVMDLIEGAPLGEHFNSLKE---KKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVT 154 (269)
T ss_pred -CCeEEEEEecCCCCcHHHHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEE
Confidence 4689999999999999998853211 123488899999999999999999963 3799999999999999999999
Q ss_pred eCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccc
Q 002462 681 LGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPY 760 (919)
Q Consensus 681 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~ 760 (919)
++|||.+........ .....+...+..++......++.++|||||||++|||+||+.|+...........+....
T Consensus 155 l~dfg~~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-- 229 (269)
T cd08528 155 ITDFGLAKQKQPESK---LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV-- 229 (269)
T ss_pred Eecccceeecccccc---cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc--
Confidence 999998765432211 111122222333333333456788999999999999999999987654333222211100
Q ss_pred ccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 761 ISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 761 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
...+. ...... .+..++.+|++.+|++||+|.||..+++
T Consensus 230 --------~~~~~------~~~~~~---~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 --------YEPLP------EGMYSE---DVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --------CCcCC------cccCCH---HHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00000 000111 2456888999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=276.69 Aligned_cols=262 Identities=21% Similarity=0.240 Sum_probs=186.0
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecC-CcEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERE-NEKFLVY 609 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~-~~~~lV~ 609 (919)
+|...|.|++|.||.||||+- .++..||.|++++...+ .-.-++||.+|.+++|||||.+.......+ +..|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 455668999999999999984 56789999999876533 234689999999999999999988765432 4689999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
|||+. ||...|+.-. +++.-.+.--+..|+.+|++|||+. -|+|||||++|+|+.+.|..||+|||+|+.
T Consensus 157 e~~Eh-DLksl~d~m~------q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMK------QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred HHHHh-hHHHHHHhcc------CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhh
Confidence 99996 8988886543 3466667777899999999999986 799999999999999999999999999998
Q ss_pred cCCCC---cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhcccccccc
Q 002462 690 QGGDA---HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLPYISIYD 765 (919)
Q Consensus 690 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~~~~~~~~ 765 (919)
.+... ....++-.|++|+- -.|...|+++.|+||+|||+.||+++++-+.+.+..+ +..++. ...+++...
T Consensus 227 ygsp~k~~T~lVVTLWYRaPEL----LLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~-llGtPte~i 301 (419)
T KOG0663|consen 227 YGSPLKPYTPLVVTLWYRAPEL----LLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFK-LLGTPSEAI 301 (419)
T ss_pred hcCCcccCcceEEEeeecCHHH----hcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHH-HhCCCcccc
Confidence 76542 22233444555432 2355678899999999999999999999888776543 333332 111111000
Q ss_pred cc------cccccccCCCCCCcchH----HHH---HHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 766 KE------LVTKIVDPSLIIDEDLL----EEV---WAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 766 ~~------~~~~i~d~~l~~~~~~~----~~~---~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
-. .+..+--+.. ..... ... ..-..+...-+..||.+|-|+.+.++
T Consensus 302 wpg~~~lp~~k~~~f~~~--pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEH--PYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCCccccchhhccccCCC--CchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00 0000000000 00000 000 12345667788999999999998875
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=292.01 Aligned_cols=261 Identities=18% Similarity=0.299 Sum_probs=190.4
Q ss_pred cCHHHHHHHhCCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccccHHHHHHHHHHHhhc-CCCCccceeeEEeec
Q 002462 524 FTYQQLLAATGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKV-SHARLVPLLGHCMER 601 (919)
Q Consensus 524 ~~~~~l~~at~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~ 601 (919)
.++.++..+.+.|.....||+|+||.||+|.. .++..||+|.+........++..|+.++.++ +|+||+++++++...
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 46667777788898889999999999999996 5678999999876554556788999999999 699999999987632
Q ss_pred -----CCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC
Q 002462 602 -----ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK 676 (919)
Q Consensus 602 -----~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~ 676 (919)
.+..++||||+++|+|.+++..... ..+++.+...++.++++||+|||+. +|+||||||+||+++++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~ 157 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-----NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN 157 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 3467999999999999998865332 2377888889999999999999985 89999999999999999
Q ss_pred CceeeCCcchhhhcCCCCcceeeeeeccCCCCccccC-----CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHH
Q 002462 677 FEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGS-----SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVK 751 (919)
Q Consensus 677 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~ 751 (919)
+.++|+|||.+......... .....+.+.+..++. .....++.++|||||||++|||+||+.|+....+....
T Consensus 158 ~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~ 235 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235 (282)
T ss_pred CCEEEeeCcchhhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence 99999999987644221110 011112222222221 12345677899999999999999999999755432211
Q ss_pred HHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 752 EILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 752 ~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..+... ..+.... ..... .+..++..||+.+|.+||++.|+++
T Consensus 236 ~~~~~~---------------~~~~~~~-~~~~~---~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 FLIPRN---------------PPPKLKS-KKWSK---KFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hhHhhC---------------CCCCCcc-cccCH---HHHHHHHHHhCCChhhCcCHHHHhc
Confidence 111100 0001000 00111 3566888999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=290.58 Aligned_cols=245 Identities=18% Similarity=0.286 Sum_probs=178.8
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
+|...++||+|+||.||+|+. .++..||||.+..... ..++|.+|++++++++||||++++++|.. ++..++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-ENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-CCEEEEEEec
Confidence 456667899999999999984 5788999999865422 24679999999999999999999998876 4678999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+++|+|..+. .+++.....++.+++.||+|||+. +|+||||||+|||++.++.+||+|||.+....
T Consensus 81 ~~~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~ 146 (279)
T cd06619 81 MDGGSLDVYR-----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV 146 (279)
T ss_pred CCCCChHHhh-----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence 9999996542 256778889999999999999985 89999999999999999999999999876543
Q ss_pred CCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH----HHHHHhhcccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV----KEILEQTLPYISIYDKE 767 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~----~~~~~~~~~~~~~~~~~ 767 (919)
.... ....+++.+..++......++.++|||||||++|||+||+.|+........ ..+.....
T Consensus 147 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 213 (279)
T cd06619 147 NSIA----KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV--------- 213 (279)
T ss_pred cccc----cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh---------
Confidence 2211 112233334444443334577889999999999999999999865322110 01111000
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 768 LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 768 ~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
....+.+... .... .+.+++..|++.+|++||+++++++.
T Consensus 214 ---~~~~~~~~~~-~~~~---~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 214 ---DEDPPVLPVG-QFSE---KFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---ccCCCCCCCC-cCCH---HHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0001111111 1111 24568889999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=293.43 Aligned_cols=247 Identities=19% Similarity=0.313 Sum_probs=185.8
Q ss_pred CCCcccccccCCCCcEEEEE-ecCCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
+|...+.||.|+||.||+|+ ..+|..||||.+...... .+.+.+|++++++++||||+++++++.+ ++..++||||+
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~ 98 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-GDELFVVMEYL 98 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-CceEEEEEEec
Confidence 47777899999999999998 467899999998654433 5678899999999999999999998865 46799999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++|+|.+++.+. .++|.++..|+.++++||+|||+. +|+||||||+||++++++.+|++|||.+.....
T Consensus 99 ~~~~L~~~~~~~--------~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 99 AGGSLTDVVTET--------CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred CCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 999999988532 378999999999999999999985 899999999999999999999999998765432
Q ss_pred CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 693 DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
..... ....+.+.+..++......++.++|||||||++|||+||+.|+...........+..... ...
T Consensus 168 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~----------~~~ 235 (296)
T cd06655 168 EQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT----------PEL 235 (296)
T ss_pred ccccC--CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------ccc
Confidence 21110 111223334444444444567889999999999999999999987654332221111000 000
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.. ...... .+..++.+||..+|.+||++.+|++
T Consensus 236 ~~-----~~~~~~---~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QN-----PEKLSP---IFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CC-----cccCCH---HHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00 111111 2445788999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=284.75 Aligned_cols=247 Identities=20% Similarity=0.319 Sum_probs=185.0
Q ss_pred CCcccccccCCCCcEEEEEec-CCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 536 FSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
|...+.||+|+||.||++... ++..||||++..... ..+.+.+|++++++++|+|++++++.+...+...++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 556788999999999999854 578899999865432 2456889999999999999999998765444457899999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+++++|.+++..... ..+++.+..+++.+++.||+|||+. +|+||||||+||++++++.++++|||.+....
T Consensus 82 ~~~~~l~~~l~~~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~ 153 (257)
T cd08223 82 CEGGDLYHKLKEQKG-----KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE 153 (257)
T ss_pred cCCCcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEec
Confidence 999999999975321 3488999999999999999999985 89999999999999999999999999876442
Q ss_pred CCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHH-HHHHhhccccccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVK-EILEQTLPYISIYDKELVT 770 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 770 (919)
.... ......+.+.+..++......++.++|||||||+++||+||+.|++........ .+.....+
T Consensus 154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~----------- 220 (257)
T cd08223 154 NQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP----------- 220 (257)
T ss_pred ccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-----------
Confidence 2111 111223344444555444456778899999999999999999998765533221 11111110
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.+ ...... .+.+++..|++.+|.+||+|.++++
T Consensus 221 -----~~--~~~~~~---~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 -----PM--PKDYSP---ELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -----CC--ccccCH---HHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 001111 3567889999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=292.45 Aligned_cols=251 Identities=20% Similarity=0.297 Sum_probs=183.9
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
+|...+.||+|+||.||++.. .+|..||+|.+..... ..++|.+|++++++++||||+++++++... +..++||||
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~ 84 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-NNICMCMEF 84 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-CEEEEEEec
Confidence 455567899999999999985 4688999998764432 246799999999999999999999988764 689999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+++|+|.+++.+.+ .++|.....++.++++||.|||+. .+|+||||||+||++++++.++++|||++....
T Consensus 85 ~~~~~L~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 85 MDCGSLDRIYKKGG-------PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred CCCCCHHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999886432 378999999999999999999963 369999999999999999999999999765432
Q ss_pred CCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH--------HHHHHHhhcccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ--------VKEILEQTLPYISI 763 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~--------~~~~~~~~~~~~~~ 763 (919)
..... ...+...+..++......++.++|||||||++|||+||+.|++...+.. ..+++.....
T Consensus 156 ~~~~~----~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 227 (284)
T cd06620 156 NSIAD----TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ---- 227 (284)
T ss_pred hhccC----ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh----
Confidence 11111 1122223333333333367788999999999999999999998654321 1111111110
Q ss_pred cccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 002462 764 YDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815 (919)
Q Consensus 764 ~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L 815 (919)
+ -.+.+... .... .+..++..|++.+|++||++.||++..
T Consensus 228 ---~-----~~~~~~~~-~~~~---~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 228 ---E-----PPPRLPSS-DFPE---DLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---c-----cCCCCCch-hcCH---HHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0 01111101 0111 356688899999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=285.24 Aligned_cols=253 Identities=18% Similarity=0.281 Sum_probs=187.9
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeec-CCcEEEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMER-ENEKFLVYK 610 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~-~~~~~lV~E 610 (919)
|...+.||+|+||.||++.. .+|..||+|++..... ..+.+..|++++++++|+||+++++++... +...++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 55667899999999999984 5678999999864432 245788999999999999999999977643 335789999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCC--CCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHEC--TLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~--~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|+++|+|.+++.+... ....++|.+.+.++.++++||+|||..+ ..+|+||||||+||++++++.+|++|||.+.
T Consensus 82 ~~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 82 YCEGGDLAQLIQKCKK---ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hccCCCHHHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccc
Confidence 9999999999965321 1245899999999999999999999543 4689999999999999999999999999877
Q ss_pred hcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccc
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (919)
........ .....+.+.+..++......++.++|||||||++|||+||+.|+...........+... .
T Consensus 159 ~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------~ 226 (265)
T cd08217 159 ILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG----------K 226 (265)
T ss_pred cccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC----------C
Confidence 65432211 11122333344444444445778899999999999999999999876543332222110 0
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
. +.+ .+.... .+..++..|++.+|++||+|.+|++
T Consensus 227 ~-----~~~--~~~~~~---~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 227 F-----RRI--PYRYSS---ELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred C-----CCC--ccccCH---HHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 000 111111 3556888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=283.62 Aligned_cols=248 Identities=20% Similarity=0.292 Sum_probs=185.7
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
|+..++||+|+||.||.++. .++..|++|+++.... ..++|.+|++++++++|+||+++++++.+ .+..++||||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~~~e~ 80 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-DNTLLIEMEY 80 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-CCeEEEEEEe
Confidence 56678999999999998874 5688999999865432 24678999999999999999999998876 4678999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+++|+|.+++.+... ..+++.++..++.++++||+|||+. +|+||||||+||++++++.+|++|||.+....
T Consensus 81 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 81 ANGGTLYDKIVRQKG-----QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILG 152 (256)
T ss_pred cCCCcHHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence 999999999865421 3478999999999999999999975 79999999999999999999999999776543
Q ss_pred CCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHH-HHHHhhccccccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVK-EILEQTLPYISIYDKELVT 770 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 770 (919)
.... ......+.+.+..++.......+.++||||||+++|||+||+.|+......+.. .+..... .
T Consensus 153 ~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-----------~ 219 (256)
T cd08221 153 SEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY-----------T 219 (256)
T ss_pred cccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-----------C
Confidence 2221 111122333344444333445677899999999999999999999765443322 1111100 0
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L 815 (919)
.. . ....+ .+..++..|++.+|.+||++.++++.+
T Consensus 220 ~~-~------~~~~~---~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 PV-V------SVYSS---ELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CC-c------cccCH---HHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 00 0 01112 245678899999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=289.11 Aligned_cols=244 Identities=18% Similarity=0.296 Sum_probs=179.2
Q ss_pred ccccccCCCCcEEEEEec-CCccEEEEEeccccc-cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCC
Q 002462 539 ANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV-KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGD 616 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~-~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~Gs 616 (919)
...||+|+||.||+|... ++..+|+|.+..... ..+.|.+|++++++++||||++++++|.+ ++..++||||+++|+
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~~v~e~~~~~~ 88 (282)
T cd06643 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIEFCAGGA 88 (282)
T ss_pred HhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-CCEEEEEEEecCCCc
Confidence 457999999999999965 477889999865443 34679999999999999999999998876 467899999999999
Q ss_pred hhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcc
Q 002462 617 LSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQ 696 (919)
Q Consensus 617 L~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~ 696 (919)
|..++.+.. ..++|.++..++.++++||+|||+. +|+||||||+||+++.++.+|++|||.+.........
T Consensus 89 l~~~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~ 159 (282)
T cd06643 89 VDAVMLELE------RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 159 (282)
T ss_pred HHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence 998886532 2489999999999999999999985 8999999999999999999999999987543221111
Q ss_pred eeeeeeccCCCCccccCC-----CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH-HHHHHhhccccccccccccc
Q 002462 697 SRITRLLRLPQSSEQGSS-----GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~-----~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 770 (919)
.....+.+.+..++.. ....++.++|||||||++|||+||+.|+......+. ........ .
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-----------~ 226 (282)
T cd06643 160 --RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-----------P 226 (282)
T ss_pred --cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC-----------C
Confidence 0111122223333221 223466789999999999999999999876544322 11111100 0
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.+..+. .... .+.+++..||+.+|.+||++.+|++
T Consensus 227 ~~~~~~-----~~~~---~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 227 TLAQPS-----RWSS---EFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CCCCcc-----ccCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 011111 1112 2456788999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=304.00 Aligned_cols=204 Identities=17% Similarity=0.212 Sum_probs=160.7
Q ss_pred HhCCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEE
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKF 606 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~ 606 (919)
..++|...+.||+|+||.||+++.. ++..||+|.+..... ..+.+.+|+++++.++|||||++++++.+ ++..+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-DKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEE
Confidence 3467888899999999999999964 578899999854221 23457889999999999999999997654 56899
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcch
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~ 686 (919)
+|||||++|+|.+++... .++..+...++.+++.||+|||+. +|+||||||+|||+++++.+||+|||.
T Consensus 120 lv~Ey~~gg~L~~~l~~~--------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY--------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEcCCCCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence 999999999999988542 256777888999999999999985 899999999999999999999999998
Q ss_pred hhhcCCCCcceeeeeeccCCCCccccCCC----CCCCCCCCcchhHHHHHHHHHcCCCCCCCCChh
Q 002462 687 VCAQGGDAHQSRITRLLRLPQSSEQGSSG----SLTATCPYDVYCFGKVLLELVTGKMGISASSDA 748 (919)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~ 748 (919)
+........ .......+++.+.+++... ...++.++|||||||++|||+||+.||...+..
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~ 253 (370)
T cd05621 189 CMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253 (370)
T ss_pred ceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH
Confidence 875432211 1112233455555544322 123677899999999999999999999876543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=296.68 Aligned_cols=200 Identities=21% Similarity=0.263 Sum_probs=151.5
Q ss_pred ccccccC--CCCcEEEEEe-cCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 539 ANLIKNG--HSGDLFRGIL-EGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 539 ~~~ig~G--~~G~Vy~g~l-~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
..+||+| +||+||++.. .+|..||||+++..... .+.+.+|+++++.++|||||+++++|.. ++..++|||||
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~ 81 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVVTSFM 81 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCEEEEEEecc
Confidence 3579999 7889999985 57899999999754322 3457779999999999999999998876 46899999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++|+|.+++..... ..++|.+..+|+.|+++||+|||+. +||||||||+|||++.++.++++||+.......
T Consensus 82 ~~~~l~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 82 AYGSAKDLICTHFM-----DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred CCCcHHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence 99999999864321 2388999999999999999999975 799999999999999999999999975433211
Q ss_pred CCccee-ee----eeccCCCCccccCCC--CCCCCCCCcchhHHHHHHHHHcCCCCCCCCCh
Q 002462 693 DAHQSR-IT----RLLRLPQSSEQGSSG--SLTATCPYDVYCFGKVLLELVTGKMGISASSD 747 (919)
Q Consensus 693 ~~~~~~-~~----~~~~~~~~~~~~~~~--~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~ 747 (919)
...... .. ...+...+..++... ...++.++|||||||++|||+||+.||.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 215 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 215 (327)
T ss_pred ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence 100000 00 001111122233222 13467889999999999999999999976543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=300.34 Aligned_cols=199 Identities=17% Similarity=0.226 Sum_probs=155.6
Q ss_pred hCCCCcccccccCCCCcEEEEEe-cCCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecC-----C
Q 002462 533 TGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERE-----N 603 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~-----~ 603 (919)
.++|...+.||+|+||.||++.. .+|..||||++.... ...+.+.+|+.++++++|||||++++++.... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46788889999999999999985 568899999986432 22457889999999999999999999775322 2
Q ss_pred cEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCC
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS 683 (919)
Q Consensus 604 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~d 683 (919)
..++||||+++ +|.+.++. .+++.+...++.++++||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM---------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc---------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEec
Confidence 46999999985 56555532 267778888999999999999985 899999999999999999999999
Q ss_pred cchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCCh
Q 002462 684 LSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSD 747 (919)
Q Consensus 684 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~ 747 (919)
||.++........ ....+++.+..++......++.++|||||||++|||+||+.||...+.
T Consensus 167 fg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~ 227 (359)
T cd07876 167 FGLARTACTNFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH 227 (359)
T ss_pred CCCccccccCccC---CCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9987653322111 112233344445544445678889999999999999999999986643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=299.14 Aligned_cols=249 Identities=18% Similarity=0.193 Sum_probs=178.1
Q ss_pred CCCcccccccCCCCcEEEEEe----cCCccEEEEEeccccc-----cHHHHHHHHHHHhhcC-CCCccceeeEEeecCCc
Q 002462 535 DFSDANLIKNGHSGDLFRGIL----EGGIPVVIKRIDLQSV-----KTEAYLLELDFFSKVS-HARLVPLLGHCMERENE 604 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l----~~g~~vavK~l~~~~~-----~~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~~~ 604 (919)
+|...+.||+|+||.||+++. .+|..||||++..... ..+.+..|++++.+++ |+||+++++++. .++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ-TEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe-cCCE
Confidence 466778999999999999875 3578999999864321 1356788999999995 999999998654 4567
Q ss_pred EEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCc
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSL 684 (919)
Q Consensus 605 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~df 684 (919)
.++||||+++|+|.+++.++. .+++.+...++.++++||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Df 149 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRD-------NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDF 149 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeC
Confidence 899999999999999986542 378888889999999999999975 8999999999999999999999999
Q ss_pred chhhhcCCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhccccc
Q 002462 685 SEVCAQGGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLPYIS 762 (919)
Q Consensus 685 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~~~~~ 762 (919)
|+++......... .....+++.+..++.. +...++.++||||||||+|||+||+.|+....... ...+......
T Consensus 150 G~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--- 225 (332)
T cd05614 150 GLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--- 225 (332)
T ss_pred cCCccccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc---
Confidence 9876532221111 1122344444444433 22346778999999999999999999996543211 1111111100
Q ss_pred ccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002462 763 IYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP-----LMRYILK 813 (919)
Q Consensus 763 ~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RP-----sm~~V~~ 813 (919)
.++.+ ...... .+..++..|++.+|++|| ++.++++
T Consensus 226 ----------~~~~~--~~~~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 ----------CDPPF--PSFIGP---EAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ----------CCCCC--CCCCCH---HHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 01111 011111 244578899999999999 5556554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=292.72 Aligned_cols=266 Identities=19% Similarity=0.240 Sum_probs=182.1
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
+|...+.||+|+||.||+|... ++..||+|++..... ..+.|.+|++++++++||||+++++++.. ++..++|||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEEe
Confidence 5667789999999999999975 578999998754322 24578899999999999999999998765 567999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+++++|..+.... ..++|.+...|+.++++||+|||+. +|+||||||+||++++++.+|++|||.+...
T Consensus 81 ~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07846 81 FVDHTVLDDLEKYP-------NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 150 (286)
T ss_pred cCCccHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence 99999998776432 2388999999999999999999985 8999999999999999999999999977654
Q ss_pred CCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH-HHHHHhhccccccc----
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTLPYISIY---- 764 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~-~~~~~~~~~~~~~~---- 764 (919)
...... .....+...+..++.. +...++.++|||||||++|||+||++|+......+. ..............
T Consensus 151 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 151 AAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred cCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 322111 0111112222222221 223456789999999999999999999876543221 11111100000000
Q ss_pred ccc-cccccccCCCCCCcchH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 765 DKE-LVTKIVDPSLIIDEDLL----EEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 765 ~~~-~~~~i~d~~l~~~~~~~----~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
... .......+......... .-...+..++..|++.+|++||+|.+|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 00000011100000000 00123667899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=301.18 Aligned_cols=241 Identities=19% Similarity=0.202 Sum_probs=176.4
Q ss_pred cccccCCCCcEEEEEe-cCCccEEEEEecccc----ccHHHHHHHHH-HHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQS----VKTEAYLLELD-FFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~----~~~~~f~~Ei~-~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++||+|+||.||+|+. .+|..||||++.... ...+.+..|.. +++.++|||||++++++.. ++..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-TEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-CCEEEEEEcCCC
Confidence 3699999999999984 568999999986432 12345666665 4678999999999987765 568999999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|..++.+.. .+++.+...++.++++||+|||+. +|+||||||+|||+++++.+||+|||.+......
T Consensus 80 ~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 80 GGELFFHLQRER-------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ 149 (325)
T ss_pred CCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC
Confidence 999998886432 378888899999999999999975 8999999999999999999999999987643211
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
.. ......+++.+..++......++.++|||||||++|||+||+.||...+..+....+... . ..+
T Consensus 150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~---------~---~~~ 215 (325)
T cd05604 150 SD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK---------P---LVL 215 (325)
T ss_pred CC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC---------C---ccC
Confidence 11 112223444555555544456778899999999999999999999866543322111100 0 001
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
.+ ....+ +..+...|++.+|.+||++++.+..
T Consensus 216 ~~------~~~~~---~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 216 RP------GASLT---AWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CC------CCCHH---HHHHHHHHhccCHHhcCCCCCCHHH
Confidence 11 11122 3457789999999999998754443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=304.36 Aligned_cols=204 Identities=15% Similarity=0.204 Sum_probs=159.8
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++|...+.||+|+||.||++.. .+|..||||++..... ..+.+.+|++++++++|||||++++++.+ ++..++|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-AQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCeeEEE
Confidence 3677788999999999999984 5788999999854321 23568889999999999999999997765 5689999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++.... .+++.....++.+++.||+|||+. +|+||||||+|||++.++.+|++|||+++
T Consensus 80 ~E~~~gg~L~~~l~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 80 MEFLPGGDLMTMLIKYD-------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred EeCCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999986432 367777778999999999999985 89999999999999999999999999875
Q ss_pred hcCCCCc-------------ce--------------------------------eeeeeccCCCCccccCCCCCCCCCCC
Q 002462 689 AQGGDAH-------------QS--------------------------------RITRLLRLPQSSEQGSSGSLTATCPY 723 (919)
Q Consensus 689 ~~~~~~~-------------~~--------------------------------~~~~~~~~~~~~~~~~~~~~~~t~~~ 723 (919)
....... .. ......+++.|..++......++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 229 (377)
T cd05629 150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence 2211000 00 00012244445555544444678889
Q ss_pred cchhHHHHHHHHHcCCCCCCCCChh
Q 002462 724 DVYCFGKVLLELVTGKMGISASSDA 748 (919)
Q Consensus 724 DVySfGvvLlEllTGk~p~~~~~~~ 748 (919)
||||||||+|||+||+.||......
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~ 254 (377)
T cd05629 230 DWWSLGAIMFECLIGWPPFCSENSH 254 (377)
T ss_pred eeEecchhhhhhhcCCCCCCCCCHH
Confidence 9999999999999999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=296.20 Aligned_cols=241 Identities=15% Similarity=0.211 Sum_probs=178.2
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCC-CCccceeeEEeecCCcEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSH-ARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H-~niV~l~g~c~~~~~~~~lV 608 (919)
+|...++||+|+||.||++.. .+|..||||.+..... ..+.+..|++++..+.| ++|+++++++ +.++..++|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-QTVDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-ecCCEEEEE
Confidence 466778999999999999985 4688999999864321 23567889999998865 5666777754 445678999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++.+.. .+++.+...|+.+++.||+|||+. +||||||||+|||+++++.+||+|||.+.
T Consensus 80 ~Ey~~~g~L~~~i~~~~-------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~ 149 (323)
T cd05615 80 MEYVNGGDLMYHIQQVG-------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 149 (323)
T ss_pred EcCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEecccccc
Confidence 99999999999886532 388999999999999999999985 89999999999999999999999999876
Q ss_pred hcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccc
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (919)
........ .....+++.+.+++......++.++|||||||++|||+||+.|+...........+....
T Consensus 150 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~---------- 217 (323)
T cd05615 150 EHMVDGVT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN---------- 217 (323)
T ss_pred ccCCCCcc--ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 43222111 111234455555555445567889999999999999999999998766543322211100
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMR 809 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~ 809 (919)
......... .+..++..|++.+|++|++..
T Consensus 218 --------~~~p~~~~~---~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 218 --------VSYPKSLSK---EAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred --------CCCCccCCH---HHHHHHHHHcccCHhhCCCCC
Confidence 000001111 245678899999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=293.44 Aligned_cols=248 Identities=19% Similarity=0.284 Sum_probs=183.8
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
++|...+.||+|+||.||+|+. .++..||+|.+...... .+.+.+|+.++++++|+||+++++++.. ++..++||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEeecc
Confidence 4567778999999999999984 67899999999754433 4678899999999999999999998865 4689999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+++|+|.+++.+. .+++.++.+++.++++||.|||+. +|+||||||+|||++.++.+|++|||.+....
T Consensus 98 ~~~~~L~~~~~~~--------~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 98 LAGGSLTDVVTET--------CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred cCCCCHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 9999999988532 378889999999999999999975 89999999999999999999999999776543
Q ss_pred CCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTK 771 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 771 (919)
...... ....+.+.+..++......++.++|||||||++|||+||+.||........... .. ...
T Consensus 167 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~--~~--------~~~--- 231 (297)
T cd06656 167 PEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--IA--------TNG--- 231 (297)
T ss_pred CCccCc--CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee--ec--------cCC---
Confidence 222111 111223333334433344567789999999999999999999976543211000 00 000
Q ss_pred cccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 772 IVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 772 i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.+.......... .+..++.+|++.+|++||+|++|++
T Consensus 232 --~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 232 --TPELQNPERLSA---VFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred --CCCCCCccccCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000011111 2445778999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=292.87 Aligned_cols=241 Identities=24% Similarity=0.354 Sum_probs=182.9
Q ss_pred CCcccccccCCCCcEEEEE-ecCCccEEEEEecccccc----HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK----TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
|.+-+.||.|+||.||-++ ..+...||||++.....+ .++++.||.+|.+++|||+|.+.|++. .+...|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL-re~TaWLVME 106 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL-REHTAWLVME 106 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee-ccchHHHHHH
Confidence 5566789999999999998 456789999999765543 468899999999999999999999544 5678999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
||- ||-.+.|.-.+ .+|-......|+.|+..||+|||+. ..||||||+.||||.+.+.+|++|||.+...
T Consensus 107 YCl-GSAsDlleVhk------KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIM 176 (948)
T ss_pred HHh-ccHHHHHHHHh------ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhc
Confidence 997 57777773222 2366667788999999999999985 7899999999999999999999999977655
Q ss_pred CCCCcceeeeeeccCCCCccccCC---CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH-HHHHHhhccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSS---GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTLPYISIYDK 766 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 766 (919)
... ..+.++|.+++++.. ....|+-|+||||+||+..||...|+|....+.... ..+....
T Consensus 177 ~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe--------- 241 (948)
T KOG0577|consen 177 APA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--------- 241 (948)
T ss_pred Cch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC---------
Confidence 432 234566666555533 234688899999999999999999999876654332 2222211
Q ss_pred ccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.|.+. ..+..+. +..+.-.|++.-|.+|||..++++
T Consensus 242 -------sPtLq-s~eWS~~---F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 242 -------SPTLQ-SNEWSDY---FRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -------CCCCC-CchhHHH---HHHHHHHHHhhCcccCCcHHHHhh
Confidence 12222 1222333 445667999999999999998865
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=270.80 Aligned_cols=261 Identities=22% Similarity=0.273 Sum_probs=194.1
Q ss_pred CCCcccccccCCCCcEEEEE-ecCCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecC----CcEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERE----NEKFLV 608 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~----~~~~lV 608 (919)
.|...+.+|+|||..||.++ +.++..+|+|++.....+ .+..++|++..++++|||+++++.++.... .+.||+
T Consensus 22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll 101 (302)
T KOG2345|consen 22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL 101 (302)
T ss_pred eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence 35667889999999999998 778889999999877643 567889999999999999999999886432 358999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
+.|...|+|.+.+.+... +...++..+.++|..||++||++||+. .|+.+||||||.|||+.+++.+++.|||.++
T Consensus 102 ~Pyy~~Gsl~d~i~~~k~---kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 102 LPYYKRGSLLDEIERLKI---KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred eehhccccHHHHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999965432 223588899999999999999999984 5689999999999999999999999999765
Q ss_pred hcCC---CC---------cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHh
Q 002462 689 AQGG---DA---------HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQ 756 (919)
Q Consensus 689 ~~~~---~~---------~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~ 756 (919)
...- .. .....+..+++|+-.... .....+++.|||||||+||+|+-|..||+.....
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk--~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-------- 247 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK--SHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-------- 247 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecc--cCcccccccchhhhhHHHHHHHHcCCcchHHhhc--------
Confidence 4321 00 012234455555433222 2336788999999999999999999998642110
Q ss_pred hcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 757 TLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 757 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
.......+..+.+....+. .--.++..++.+|++.||.+||++.+++..+++.
T Consensus 248 --------GgSlaLAv~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 248 --------GGSLALAVQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred --------CCeEEEeeeccccccCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 0111112223233221110 0112356688999999999999999999988753
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=309.13 Aligned_cols=267 Identities=16% Similarity=0.195 Sum_probs=179.4
Q ss_pred hCCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeec-------CCc
Q 002462 533 TGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMER-------ENE 604 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~-------~~~ 604 (919)
.++|...++||+|+||.||+|+. .++..||||++.... ....+|+.+|++++|||||++++++... ...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 45688889999999999999986 468899999885432 2345799999999999999999876431 113
Q ss_pred EEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC-CceeeCC
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK-FEVRLGS 683 (919)
Q Consensus 605 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~-~~~kl~d 683 (919)
.++||||+++ +|.+++..... ....+++.....|+.++++||+|||+. +||||||||+|||++.+ +.+||+|
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYAR---NNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 5689999995 67776643211 123588888899999999999999985 89999999999999966 4799999
Q ss_pred cchhhhcCCCCcceeeeeeccCCCCccccC-CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhh-ccc
Q 002462 684 LSEVCAQGGDAHQSRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQT-LPY 760 (919)
Q Consensus 684 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~-~~~ 760 (919)
||+++........ ....+++.|.+++. .+...++.++|||||||++|||+||+.||.+....+ ....+... .|.
T Consensus 215 FGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 215 FGSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred cccchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9988754322111 11223334444443 234457889999999999999999999998765433 22222211 010
Q ss_pred ccccc--cccccccccCCCCCCcchHH-----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 761 ISIYD--KELVTKIVDPSLIIDEDLLE-----EVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 761 ~~~~~--~~~~~~i~d~~l~~~~~~~~-----~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..... .....++--|... ...... .-..+..++..|++.+|.+||++.|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~-~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVK-PKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHHhchhhhcccCCccC-chhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000 0000000000000 000000 0013567889999999999999999874
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=299.04 Aligned_cols=240 Identities=19% Similarity=0.232 Sum_probs=174.5
Q ss_pred cccccCCCCcEEEEEe-cCCccEEEEEecccccc----HHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK----TEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
++||+|+||.||+|.. .++..||||++...... .+.+..|+.++.++ +||||+++++++. ..+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-TTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-eCCEEEEEEeCCC
Confidence 3699999999999986 45789999999754321 34578899999988 6999999999654 4567999999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|..++.+.. .+++..+..|+.++++||+|||+. +|+||||||+|||+++++.+||+|||.+......
T Consensus 80 ~~~L~~~~~~~~-------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 80 GGDLMFHMQRQR-------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP 149 (327)
T ss_pred CCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC
Confidence 999998885432 388999999999999999999985 8999999999999999999999999987642211
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH---HHHHHHhhccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ---VKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 770 (919)
.. ......+++.+.+++......++.++|||||||++|||+||+.||....... ..+++....
T Consensus 150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~------------ 215 (327)
T cd05617 150 GD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI------------ 215 (327)
T ss_pred CC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH------------
Confidence 11 1122334555555555444567889999999999999999999996432111 111111100
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMR 809 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~ 809 (919)
............. .+..++..|++.+|++||++.
T Consensus 216 --~~~~~~~p~~~~~---~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 216 --LEKPIRIPRFLSV---KASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred --HhCCCCCCCCCCH---HHHHHHHHHhccCHHHcCCCC
Confidence 0000111111112 234678899999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=286.62 Aligned_cols=245 Identities=22% Similarity=0.337 Sum_probs=182.4
Q ss_pred CCcccccccCCCCcEEEEEec-CCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 536 FSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
|+..+.||+|+||.||+|... ++..||||.+..... ..+.|.+|++++++++||||+++++++.+ ++..++||||+
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 84 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-GTKLWIIMEYL 84 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEecC
Confidence 555678999999999999864 578999999865432 24678999999999999999999998776 56899999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++|+|.+++... .+++.+...++.++++||+|||+. +++|+||||+||+++.++.++++|||.+.....
T Consensus 85 ~~~~L~~~i~~~--------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 85 GGGSALDLLRAG--------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 999999988532 377888889999999999999975 899999999999999999999999998765433
Q ss_pred CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 693 DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
..... ....+...+..++.......+.++|||||||++|||+||+.|+...........+....
T Consensus 154 ~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-------------- 217 (277)
T cd06640 154 TQIKR--NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-------------- 217 (277)
T ss_pred Ccccc--ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC--------------
Confidence 22111 11111222223332223356788999999999999999999987655433221111100
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
.+.+ .+. .-..+..++..||+.+|++||++.+|++.
T Consensus 218 -~~~~--~~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 -PPTL--TGE---FSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -CCCC--chh---hhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0111 111 11235678899999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=286.11 Aligned_cols=265 Identities=21% Similarity=0.274 Sum_probs=182.6
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
+|.....||+|+||.||+|+.. +|..||+|++..... ..+.|.+|++++++++|+||+++++++.. ....++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-KRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-CCEEEEEEe
Confidence 4666788999999999999975 588999999854322 24568899999999999999999998765 457899999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|++++.|..++... ..++|.++..++.++++||+|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 81 ~~~~~~l~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07847 81 YCDHTVLNELEKNP-------RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARIL 150 (286)
T ss_pred ccCccHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceec
Confidence 99999888776432 2388999999999999999999984 8999999999999999999999999987654
Q ss_pred CCCCcceeeeeeccCCCCccccC-CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhc-cccc----cc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTL-PYIS----IY 764 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~-~~~~----~~ 764 (919)
....... ....+...+..++. .+...++.++|||||||++|||+||+.|+....+.+....+.... .... ..
T Consensus 151 ~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 151 TGPGDDY--TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred CCCcccc--cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 3322100 00111122222222 122346778999999999999999999998765433222111110 0000 00
Q ss_pred cc-ccccccccCCCCCCcchHHH-----HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 765 DK-ELVTKIVDPSLIIDEDLLEE-----VWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 765 ~~-~~~~~i~d~~l~~~~~~~~~-----~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+. ........+....... .+. -..+..++..|++.+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 229 STNQFFKGLSIPEPETREP-LESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccccCCCcccccC-HHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 0000000111000000 000 123567889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=316.64 Aligned_cols=257 Identities=23% Similarity=0.363 Sum_probs=193.7
Q ss_pred ccccccCCCCcEEEEEecC--------CccEEEEEeccccc--cHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEEE
Q 002462 539 ANLIKNGHSGDLFRGILEG--------GIPVVIKRIDLQSV--KTEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~l~~--------g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~l 607 (919)
.+.+|+|.||.|++|.+.+ ...||||.++.... +.+++..|+++|..+ +|+|||.++|+|.+ .+..++
T Consensus 301 ~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-~~~~~~ 379 (609)
T KOG0200|consen 301 GKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-DGPLYV 379 (609)
T ss_pred cceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-CCceEE
Confidence 3489999999999998531 45799999975443 357899999999998 59999999999987 568999
Q ss_pred EEEecCCCChhhhhhccC---------CCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCc
Q 002462 608 VYKYMPNGDLSSSLYRKT---------NTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFE 678 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~---------~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~ 678 (919)
|.||+.+|+|.++|+.++ ..+.+...|.-...+.+|.|||+||+||++. ++|||||.++|||+.++..
T Consensus 380 v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 380 IVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKV 456 (609)
T ss_pred EEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCE
Confidence 999999999999998766 1111112488899999999999999999985 7999999999999999999
Q ss_pred eeeCCcchhhhcCCCCcceeeeeeccCC-CCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCC-hhHHHHHHH
Q 002462 679 VRLGSLSEVCAQGGDAHQSRITRLLRLP-QSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASS-DAQVKEILE 755 (919)
Q Consensus 679 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~-~~~~~~~~~ 755 (919)
+||+|||+++..............-..| .+++++......+|.|+|||||||+||||+| |..|+.+.. ..++.+++.
T Consensus 457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~ 536 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLK 536 (609)
T ss_pred EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHh
Confidence 9999999998654433322111000022 2444555555789999999999999999999 888887643 333333332
Q ss_pred hhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 002462 756 QTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 756 ~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~~ 819 (919)
... ++...+...+++ -.+++.||+.+|++||++.++++.++..+
T Consensus 537 ~G~-----------------r~~~P~~c~~ei---Y~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 537 EGN-----------------RMEQPEHCSDEI---YDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred cCC-----------------CCCCCCCCCHHH---HHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 111 011112223443 36889999999999999999999998743
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=291.67 Aligned_cols=242 Identities=18% Similarity=0.301 Sum_probs=181.1
Q ss_pred cccccCCCCcEEEEEe-cCCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCCh
Q 002462 540 NLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDL 617 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL 617 (919)
..||+|+||.||++.. .++..||||++...... .+.|.+|+.++++++|+||+++++++.. .+..++||||+++++|
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~lv~e~~~~~~L 106 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-GDELWVVMEFLEGGAL 106 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-CCeEEEEEeCCCCCcH
Confidence 4699999999999985 46789999998654433 4678999999999999999999998765 4678999999999999
Q ss_pred hhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcce
Q 002462 618 SSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQS 697 (919)
Q Consensus 618 ~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~~ 697 (919)
.+++... .+++.+...++.++++||+|||+. +|+||||||+||++++++.+|++|||.+..........
T Consensus 107 ~~~~~~~--------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 107 TDIVTHT--------RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred HHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 9987432 378889999999999999999985 89999999999999999999999999876443221111
Q ss_pred eeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccccCCC
Q 002462 698 RITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSL 777 (919)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l 777 (919)
....+...+..++......++.++|||||||++|||+||+.|+...........+.... .+.+
T Consensus 176 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~---------------~~~~ 238 (292)
T cd06658 176 --KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL---------------PPRV 238 (292)
T ss_pred --ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---------------CCcc
Confidence 11223334444444444467788999999999999999999997655433222111111 1111
Q ss_pred CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 778 IIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 778 ~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.......+ .+..+...|+..+|.+||++++|++
T Consensus 239 ~~~~~~~~---~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 239 KDSHKVSS---VLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred ccccccCH---HHHHHHHHHccCChhHCcCHHHHhh
Confidence 10011111 2445778999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=305.16 Aligned_cols=205 Identities=18% Similarity=0.220 Sum_probs=160.7
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++|...+.||+|+||.||+++. .++..||||.+..... ..+.+.+|++++++++|||||++++.+.+ ++..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCEEEEE
Confidence 3577788999999999999985 4588999999864322 23568899999999999999999997765 5689999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++.+.. .++......++.++++||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 80 ~E~~~~g~L~~~i~~~~-------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 80 MDYIPGGDMMSLLIRLG-------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred EeCCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 99999999999996543 256666777899999999999985 89999999999999999999999999864
Q ss_pred hcCCCCc-----------------------------------------ceeeeeeccCCCCccccCCCCCCCCCCCcchh
Q 002462 689 AQGGDAH-----------------------------------------QSRITRLLRLPQSSEQGSSGSLTATCPYDVYC 727 (919)
Q Consensus 689 ~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVyS 727 (919)
....... ........+++.|.+++......++.++||||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 229 (376)
T cd05598 150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229 (376)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeee
Confidence 2210000 00001123455555555544556788899999
Q ss_pred HHHHHHHHHcCCCCCCCCChhH
Q 002462 728 FGKVLLELVTGKMGISASSDAQ 749 (919)
Q Consensus 728 fGvvLlEllTGk~p~~~~~~~~ 749 (919)
|||++|||+||+.||......+
T Consensus 230 lGvilyell~G~~Pf~~~~~~~ 251 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAE 251 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHH
Confidence 9999999999999998766543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=285.91 Aligned_cols=259 Identities=23% Similarity=0.334 Sum_probs=185.3
Q ss_pred CCCCcccccccCCCCcEEEEEec------CCccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE------GGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEK 605 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~------~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~ 605 (919)
.+|.....||+|+||.||+|+.. +...||+|.+...... .++|.+|++++++++|+|||+++++|.+ .+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-AEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-CCcc
Confidence 35777788999999999999864 2467999988654433 4679999999999999999999998865 4578
Q ss_pred EEEEEecCCCChhhhhhccCCCC--CccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCC
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTE--DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS 683 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~~--~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~d 683 (919)
++||||+++|+|.+++....... .....++|.+++.++.++++||+|||+. +|+||||||+||++++++.+|++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999997543111 1123589999999999999999999975 799999999999999999999999
Q ss_pred cchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhccccc
Q 002462 684 LSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYIS 762 (919)
Q Consensus 684 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~ 762 (919)
||.+.......... .........+..++......++.++|||||||++|||++ |..|+....+...........
T Consensus 161 ~~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~---- 235 (275)
T cd05046 161 LSLSKDVYNSEYYK-LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK---- 235 (275)
T ss_pred cccccccCcccccc-cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC----
Confidence 99765432211100 000000111222222222245678999999999999999 788886554433222221100
Q ss_pred ccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 763 IYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 763 ~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
..... .....+ .+..++.+|++.+|++||++.++++.|.
T Consensus 236 ------~~~~~------~~~~~~---~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 ------LELPV------PEGCPS---RLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ------cCCCC------CCCCCH---HHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00000 001111 3566889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=283.62 Aligned_cols=246 Identities=19% Similarity=0.269 Sum_probs=184.1
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
|...+.||+|+||.||++.. .+|..||||++.... ...+++.+|++++++++||||+++++++.+ .+..++||||
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~ 80 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-NGNLYIVMDY 80 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-CCeEEEEEec
Confidence 66778999999999999985 568899999986532 224578999999999999999999997654 5689999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+++|+|.+++..... ..+++.+.++++.++++||+|||+. +++|+||||+||+++.++.++++|||.+....
T Consensus 81 ~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 81 CEGGDLYKKINAQRG-----VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN 152 (256)
T ss_pred CCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence 999999998865322 2478899999999999999999975 89999999999999999999999999776443
Q ss_pred CCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHH-HHHHhhccccccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVK-EILEQTLPYISIYDKELVT 770 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 770 (919)
..... .....+.+.+..++.......+.++|||||||+++||+||+.|+......+.. .+.....+
T Consensus 153 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~----------- 219 (256)
T cd08218 153 STVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP----------- 219 (256)
T ss_pred cchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC-----------
Confidence 22111 01112233333444333445778899999999999999999998765443221 11111100
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.. ...... .+..++.+|++.+|++||+|.+|++
T Consensus 220 -----~~--~~~~~~---~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 -----PV--SSHYSY---DLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -----CC--cccCCH---HHHHHHHHHhhCChhhCcCHHHHhh
Confidence 00 001111 2566888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=288.47 Aligned_cols=265 Identities=21% Similarity=0.266 Sum_probs=181.5
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
+|...+.||+|+||.||+|+.. +|..||||++..... ..+.+.+|+.++.+++||||+++++++.+ ++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-ESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-CCeEEEEEe
Confidence 4566788999999999999964 688999999865432 24678899999999999999999998875 567899999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|++ |+|.+++..... ...+++.+...++.++++||+|||+. +|+||||||+||++++++.+||+|||.+...
T Consensus 80 ~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 80 FLS-MDLKKYLDSLPK----GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAF 151 (285)
T ss_pred cCC-CCHHHHHhcCCC----CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence 998 689888854321 13488999999999999999999974 8999999999999999999999999987644
Q ss_pred CCCCcceeeeeeccCCCCccccC-CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhcccc-cccc--
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLPYI-SIYD-- 765 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~~~~-~~~~-- 765 (919)
...... .....+.+.+.+++. .+...++.++|||||||++|||+||+.|+....... ............ ....
T Consensus 152 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 152 GIPVRV--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred CCCccc--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence 322111 011111222333332 223346778999999999999999999997654322 111111110000 0000
Q ss_pred ------cccccccccCCCCC-CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 766 ------KELVTKIVDPSLII-DEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 766 ------~~~~~~i~d~~l~~-~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+........+.+.. .....+ ++.+++..|++.+|++||++.+|+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSAVKNLDE---DGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhHHHHhhccccCcchhHHhcCCCCH---HHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000000 000111 2456888999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=287.70 Aligned_cols=256 Identities=19% Similarity=0.250 Sum_probs=185.2
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeec-CCcEEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMER-ENEKFLVY 609 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~-~~~~~lV~ 609 (919)
++|...+.||.|++|.||+|... ++..+|+|.+..... ..++|.+|++++++++|||||+++++|.+. .+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778889999999999999974 578999999865433 346799999999999999999999988643 23579999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
||+++|+|.+++..... ....+++.....|+.++++||+|||+. +++||||+|+||++++++.++++|||.+..
T Consensus 81 e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK---RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EecCCCCHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 99999999988764221 123478888999999999999999985 899999999999999999999999998654
Q ss_pred cCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCCh-----hHHHHHHHhhccccccc
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSD-----AQVKEILEQTLPYISIY 764 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~-----~~~~~~~~~~~~~~~~~ 764 (919)
....... ...+...+..++......++.++|||||||++|||+||+.|+..... .+...++....
T Consensus 155 ~~~~~~~----~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 224 (287)
T cd06621 155 LVNSLAG----TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP------ 224 (287)
T ss_pred ccccccc----cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC------
Confidence 3221111 11122223333433344577889999999999999999999976521 12222211100
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 765 DKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 765 ~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
. ..+ +.....+....+ .+..++..|++.+|++||+|.||++
T Consensus 225 -~---~~~-~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 225 -N---PEL-KDEPGNGIKWSE---EFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -c---hhh-ccCCCCCCchHH---HHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 000 000000111112 3567889999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=289.68 Aligned_cols=249 Identities=20% Similarity=0.244 Sum_probs=180.9
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc----HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK----TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
|...++||+|+||.||++.. .++..||||.+...... .+.+.+|+.++.+++|+||+++++.+.+ ++..++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-CCEEEEEEE
Confidence 56678899999999999985 46889999998654322 2457889999999999999999998765 468999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+++|+|.++++.... ..+++.++..++.+++.||+|||+. +|+||||||+||++++++.++++|||.+...
T Consensus 81 ~~~g~~L~~~l~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05630 81 LMNGGDLKFHIYHMGE-----AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 152 (285)
T ss_pred ecCCCcHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence 9999999998865322 2488899999999999999999974 8999999999999999999999999987643
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
..... .....++..+.+++......++.++|||||||++|||+||+.||................. . ..
T Consensus 153 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-------~-~~ 221 (285)
T cd05630 153 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-------E-VQ 221 (285)
T ss_pred CCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-------h-hh
Confidence 32111 0111233334444444444577889999999999999999999976432211111110000 0 00
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPL-----MRYILK 813 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPs-----m~~V~~ 813 (919)
. .. ...... .+..++..|++.+|++||+ +.|+++
T Consensus 222 ~----~~--~~~~~~---~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 E----EY--SEKFSP---DARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred h----hc--CccCCH---HHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0 00 001111 2456788999999999999 667764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=303.06 Aligned_cols=204 Identities=18% Similarity=0.223 Sum_probs=160.3
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
.|...++||+|+||.||+|+. .++..||||++..... ..+.+.+|++++++++|||||++++++.+ ++..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-CCEEEEEE
Confidence 477788999999999999985 5678999999865432 23568899999999999999999997765 56899999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
|||++|+|.+++.+.. .++......++.+++.||+|||+. +||||||||+|||++.++.+||+|||++..
T Consensus 81 E~~~gg~L~~~l~~~~-------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 81 DYIPGGDMMSLLIRMG-------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred eCCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 9999999999986542 256666677899999999999985 899999999999999999999999998642
Q ss_pred cCCCC--------------------------------------------cc-eeeeeeccCCCCccccCCCCCCCCCCCc
Q 002462 690 QGGDA--------------------------------------------HQ-SRITRLLRLPQSSEQGSSGSLTATCPYD 724 (919)
Q Consensus 690 ~~~~~--------------------------------------------~~-~~~~~~~~~~~~~~~~~~~~~~~t~~~D 724 (919)
..... .. .......+++.|.+++......++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence 21000 00 0001123455555565554556788899
Q ss_pred chhHHHHHHHHHcCCCCCCCCChhH
Q 002462 725 VYCFGKVLLELVTGKMGISASSDAQ 749 (919)
Q Consensus 725 VySfGvvLlEllTGk~p~~~~~~~~ 749 (919)
||||||++|||+||+.||....+.+
T Consensus 231 iwSlGvil~elltG~~Pf~~~~~~~ 255 (382)
T cd05625 231 WWSVGVILYEMLVGQPPFLAQTPLE 255 (382)
T ss_pred EEechHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999998765543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=283.13 Aligned_cols=249 Identities=17% Similarity=0.220 Sum_probs=184.3
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
+|...+.||+|+||.||++.. .++..+|+|.++.... ..+.+.+|+.++++++|+||+++++++.+ ++..++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-DGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEee
Confidence 355678899999999999985 4678999999864332 24678899999999999999999997654 5689999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+++|+|.+++..... ..++....+.++.++++||.|||+. +|+|+||||+||++++++.++++|||.+....
T Consensus 80 ~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 80 CDGGDLMQKIKLQRG-----KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT 151 (255)
T ss_pred CCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeec
Confidence 999999998864322 2467888899999999999999975 89999999999999999999999999876443
Q ss_pred CCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTK 771 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 771 (919)
..... .....+.+.+..++.......+.++||||||+++|||+||+.|+...........+... ....
T Consensus 152 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~----------~~~~ 219 (255)
T cd08219 152 SPGAY--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG----------SYKP 219 (255)
T ss_pred ccccc--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC----------CCCC
Confidence 21110 01122333344444444456788899999999999999999999865543322111110 0000
Q ss_pred cccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 772 IVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 772 i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
+. ..... .+..++.+||+.+|++||++.+|+..
T Consensus 220 -~~------~~~~~---~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 -LP------SHYSY---ELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CC------cccCH---HHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00 11111 24567889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=285.18 Aligned_cols=246 Identities=22% Similarity=0.301 Sum_probs=184.5
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
+|.....||.|+||.||+|+.. ++..||+|.+..... ..+.|.+|++++++++|+||+++++++.+ +...++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~ 80 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-GSKLWIIMEY 80 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-CCeEEEEEEe
Confidence 4666778999999999999954 688999999865432 24578899999999999999999998776 4678999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+++|+|.+++... .+++.+...++.+++.||.|||+. +|+||||||+||++++++.++++|||.+....
T Consensus 81 ~~~~~L~~~~~~~--------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 81 CGGGSCLDLLKPG--------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLT 149 (274)
T ss_pred eCCCcHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeec
Confidence 9999999998642 488999999999999999999975 79999999999999999999999999876554
Q ss_pred CCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTK 771 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 771 (919)
..... .....+.+.+..++......++.++|||||||++|||+||+.|+...........+.... ...
T Consensus 150 ~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----------~~~ 217 (274)
T cd06609 150 STMSK--RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN----------PPS 217 (274)
T ss_pred ccccc--cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC----------CCC
Confidence 32111 111122333444444444457889999999999999999999997654332211111110 000
Q ss_pred cccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 772 IVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 772 i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+.+.. ..+ .+..++..|+..+|++||+++++++
T Consensus 218 ~~~~~------~~~---~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 LEGNK------FSK---PFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred Ccccc------cCH---HHHHHHHHHhhCChhhCcCHHHHhh
Confidence 10000 111 2455788999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=281.37 Aligned_cols=245 Identities=21% Similarity=0.285 Sum_probs=179.7
Q ss_pred CCcccccccCCCCcEEEEEec-CCccEEEEEeccccc------cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV------KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~------~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
|...+.||+|+||.||+|+.. ++..||+|.+..... ..+.|.+|++++++++|+||+++++++.+ +...++|
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv 80 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-EDNLYIF 80 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-CCeEEEE
Confidence 455678999999999999976 789999998854331 23578899999999999999999998765 4578999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++++|.+++.+.. .+++..+..++.++++||+|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 81 ~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~ 150 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK 150 (258)
T ss_pred EEecCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccce
Confidence 99999999999986432 378899999999999999999975 89999999999999999999999999766
Q ss_pred hcCCCCcceeeeeeccCCCCccccCCCCC-CCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccc
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSL-TATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKE 767 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 767 (919)
....... .....+.+.+..++..... .++.++|||||||++|||+||+.|+..........-.....
T Consensus 151 ~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--------- 218 (258)
T cd06632 151 QVVEFSF---AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK--------- 218 (258)
T ss_pred ecccccc---ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc---------
Confidence 5432211 0111122222223322222 36778999999999999999999987654322111111000
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 768 LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 768 ~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.... +.+ ...+ .+..++.+|++.+|++||++.++++
T Consensus 219 ~~~~-~~~------~~~~---~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 219 ELPP-IPD------HLSD---EAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCC-cCC------CcCH---HHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0000 011 1111 2455788999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=321.14 Aligned_cols=256 Identities=16% Similarity=0.264 Sum_probs=185.1
Q ss_pred HhCCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeec-CCcEE
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMER-ENEKF 606 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~-~~~~~ 606 (919)
..++|.....||+|+||.||++.. ..+..||+|.+..... ..+.|..|+.++.+++|||||++++++... ....+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 346788889999999999999985 4567899999865432 245789999999999999999999977643 24578
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCC----CCeeeccCCCCceecCCC------
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECT----LPFVHRDVQASSILLDDK------ 676 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~----~~ivHrDlK~~NILld~~------ 676 (919)
|||||+++|+|.++|..... ....+++...+.|+.||+.||+|||.... .+||||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~---~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYK---MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 99999999999999965321 11348999999999999999999998432 469999999999999653
Q ss_pred -----------CceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCC--CCCCCCCCCcchhHHHHHHHHHcCCCCCC
Q 002462 677 -----------FEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS--GSLTATCPYDVYCFGKVLLELVTGKMGIS 743 (919)
Q Consensus 677 -----------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~t~~~DVySfGvvLlEllTGk~p~~ 743 (919)
..+||+|||++......... ....+++.|..|+.. ....++.++||||||||||||+||+.||.
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 34899999988754322211 112344444444432 22346788999999999999999999997
Q ss_pred CCChhHHHHHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 744 ASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
...... .++..... .+.+.... ... .+..++..||+.+|.+||++.+++.
T Consensus 245 ~~~~~~--qli~~lk~--------------~p~lpi~~-~S~---eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 245 KANNFS--QLISELKR--------------GPDLPIKG-KSK---ELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cCCcHH--HHHHHHhc--------------CCCCCcCC-CCH---HHHHHHHHHhcCChhHCcCHHHHhc
Confidence 544321 11111000 00110000 011 2556888999999999999999984
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=285.10 Aligned_cols=252 Identities=19% Similarity=0.286 Sum_probs=178.5
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc-----------cHHHHHHHHHHHhhcCCCCccceeeEEeecCC
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV-----------KTEAYLLELDFFSKVSHARLVPLLGHCMEREN 603 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~-----------~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~ 603 (919)
|...+.||+|+||.||+|.. .+|..||||+++.... ..+.|..|++++++++||||++++|+|.. .+
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 81 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-EE 81 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc-CC
Confidence 34467899999999999984 5688999998853211 02467889999999999999999998865 46
Q ss_pred cEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCC
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS 683 (919)
Q Consensus 604 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~d 683 (919)
..++||||+++|+|.+++.+. ..+++..+..|+.++++||.|||+. +++||||||+||++++++.+|++|
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d 151 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISD 151 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEee
Confidence 789999999999999998654 2378888899999999999999985 899999999999999999999999
Q ss_pred cchhhhcCCCCcceeeeeeccCCCCccccCCCC--CCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccc
Q 002462 684 LSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGS--LTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYI 761 (919)
Q Consensus 684 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~ 761 (919)
||.+................+...+..++.... ..++.++||||||+++||+++|+.|+......+ .+.+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~--- 226 (272)
T cd06629 152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFKLGN--- 226 (272)
T ss_pred ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHHhhc---
Confidence 998764332111110111112222323332211 236788999999999999999999986543221 1111100
Q ss_pred cccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 762 SIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 762 ~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
......+++... ..... .+..++..|++.+|++||+|.+|++
T Consensus 227 -----~~~~~~~~~~~~--~~~~~---~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 227 -----KRSAPPIPPDVS--MNLSP---VALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred -----cccCCcCCcccc--ccCCH---HHHHHHHHHhcCChhhCCCHHHHhh
Confidence 000001111110 01112 2455778999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=299.04 Aligned_cols=200 Identities=17% Similarity=0.197 Sum_probs=156.3
Q ss_pred HhCCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecC-----
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERE----- 602 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~----- 602 (919)
..++|...+.||+|+||.||++.. ..+..||||++..... ..+.+.+|+.+++.++|||||++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 446788889999999999999984 4578999999864322 2457889999999999999999999765321
Q ss_pred CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeC
Q 002462 603 NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG 682 (919)
Q Consensus 603 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~ 682 (919)
...++||||+++ +|.+.+.. .+++.+...++.++++||+|||+. +|+||||||+|||+++++.+||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence 246999999975 56666532 277888889999999999999985 89999999999999999999999
Q ss_pred CcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCCh
Q 002462 683 SLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSD 747 (919)
Q Consensus 683 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~ 747 (919)
|||.++........ ....+++.+.+++......++.++|||||||++|||+||+.||.....
T Consensus 162 Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 223 (355)
T cd07874 162 DFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223 (355)
T ss_pred eCcccccCCCcccc---CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99988754332111 112233344444444444677889999999999999999999986653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=300.58 Aligned_cols=210 Identities=18% Similarity=0.211 Sum_probs=163.8
Q ss_pred HHHHHHHhCCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEee
Q 002462 526 YQQLLAATGDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCME 600 (919)
Q Consensus 526 ~~~l~~at~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~ 600 (919)
..++....++|...+.||+|+||.||+++.. ++..||+|.+..... ..+.+.+|+++++.++|||||++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3445555678999999999999999999864 578899999854221 23457889999999999999999997654
Q ss_pred cCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCcee
Q 002462 601 RENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVR 680 (919)
Q Consensus 601 ~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~k 680 (919)
++..++|||||++|+|.+++... .++......++.+++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 115 -~~~~~lv~Ey~~gg~L~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ik 182 (371)
T cd05622 115 -DRYLYMVMEYMPGGDLVNLMSNY--------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLK 182 (371)
T ss_pred -CCEEEEEEcCCCCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEE
Confidence 56799999999999999988542 256667778999999999999985 899999999999999999999
Q ss_pred eCCcchhhhcCCCCcceeeeeeccCCCCccccCCC----CCCCCCCCcchhHHHHHHHHHcCCCCCCCCChh
Q 002462 681 LGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSG----SLTATCPYDVYCFGKVLLELVTGKMGISASSDA 748 (919)
Q Consensus 681 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~ 748 (919)
|+|||.+......... ......+++.+.+++... ...++.++|||||||++|||+||+.||...+..
T Consensus 183 L~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 253 (371)
T cd05622 183 LADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253 (371)
T ss_pred EEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH
Confidence 9999988654322111 111223444454444322 123678899999999999999999999876543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=286.63 Aligned_cols=248 Identities=18% Similarity=0.289 Sum_probs=180.4
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
.|...+.||+|+||.||+|... ++..||+|.+...... .++|.+|++++++++||||+++++++.. ++..++||||+
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 91 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-DGKLWIMIEFC 91 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-CCeEEEEEecC
Confidence 3455678999999999999864 4889999998655433 4678999999999999999999998765 46799999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++|+|..++.+.. ..++|.+...++.++++||+|||+. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 92 ~~~~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 92 PGGAVDAIMLELD------RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred CCCcHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 9999988875432 2388999999999999999999974 899999999999999999999999997654322
Q ss_pred CCcceeeeeeccCCCCccccCC-----CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH-HHHHHhhccccccccc
Q 002462 693 DAHQSRITRLLRLPQSSEQGSS-----GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTLPYISIYDK 766 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 766 (919)
..... ....+.+.+..++.. ....++.++|||||||++|||+||+.|+........ ..+....
T Consensus 163 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--------- 231 (292)
T cd06644 163 TLQRR--DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--------- 231 (292)
T ss_pred ccccc--ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC---------
Confidence 11110 111122222222221 223457789999999999999999999866543221 1111100
Q ss_pred ccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.+.......... .+..++..|++.+|++||++.+|++
T Consensus 232 -------~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 -------PPTLSQPSKWSM---EFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -------CccCCCCcccCH---HHHHHHHHHhcCCcccCcCHHHHhc
Confidence 001100111111 2456888999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=290.62 Aligned_cols=243 Identities=19% Similarity=0.274 Sum_probs=181.7
Q ss_pred ccccccCCCCcEEEEEe-cCCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCC
Q 002462 539 ANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGD 616 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~Gs 616 (919)
...||+|+||.||+|.. .++..||||+++..... .+.+.+|+.++.+++||||+++++++.. ++..++||||+++|+
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~iv~e~~~~~~ 104 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-GEELWVLMEFLQGGA 104 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-CCeEEEEEecCCCCC
Confidence 34799999999999985 46889999998654433 4678899999999999999999998765 467999999999999
Q ss_pred hhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcc
Q 002462 617 LSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQ 696 (919)
Q Consensus 617 L~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~ 696 (919)
|.+++.. ..+++.+...++.+++.||+|||+. +|+||||||+||+++.++.+||+|||.+.........
T Consensus 105 L~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 105 LTDIVSQ--------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred HHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc
Confidence 9987743 2378899999999999999999975 7999999999999999999999999987643322111
Q ss_pred eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccccCC
Q 002462 697 SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPS 776 (919)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 776 (919)
. ....+...+..++......++.++|||||||++|||+||+.|+......+....+....+ ..
T Consensus 174 ~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------~~-------- 236 (297)
T cd06659 174 R--KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-------PK-------- 236 (297)
T ss_pred c--cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-------CC--------
Confidence 1 112233334444444444577889999999999999999999976654433222221100 00
Q ss_pred CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 777 LIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 777 l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
........+ .+..++..|++.+|.+||++.+|++
T Consensus 237 ~~~~~~~~~---~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 237 LKNAHKISP---VLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred ccccCCCCH---HHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000111 2456788999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=285.11 Aligned_cols=263 Identities=19% Similarity=0.224 Sum_probs=179.6
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc---HHHHHHHHHHHhhc---CCCCccceeeEEeec----CCc
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK---TEAYLLELDFFSKV---SHARLVPLLGHCMER----ENE 604 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l---~H~niV~l~g~c~~~----~~~ 604 (919)
|...+.||+|+||.||+|+. .+|..||||.+...... ...+.+|+++++++ +||||+++++++... ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 55667899999999999985 46889999998653221 34566788777765 699999999987542 234
Q ss_pred EEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCc
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSL 684 (919)
Q Consensus 605 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~df 684 (919)
.++||||++ ++|.+++.+... ..+++.+...++.+++.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVPP-----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence 789999998 488888865321 2378999999999999999999985 7999999999999999999999999
Q ss_pred chhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhc-cccc
Q 002462 685 SEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTL-PYIS 762 (919)
Q Consensus 685 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~-~~~~ 762 (919)
|.+......... ....++..+..++......++.++|||||||++|||+||+.|+....... ..++..... +...
T Consensus 153 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 153 GLARIYSCQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229 (288)
T ss_pred CccccccCcccC---CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence 987654322111 11122333444444434457889999999999999999999997665433 222222110 0000
Q ss_pred ccccc--cccccccCCCCC-----CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 763 IYDKE--LVTKIVDPSLII-----DEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 763 ~~~~~--~~~~i~d~~l~~-----~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..... .......+.... .+... ..+.+++..|++.+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIE---ESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcC---HHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 000000000000 00111 13457889999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=289.02 Aligned_cols=265 Identities=18% Similarity=0.224 Sum_probs=182.0
Q ss_pred CCcccccccCCCCcEEEEEec-CCccEEEEEecccccc------HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVK------TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~------~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
|...+.||+|+||.||+|... +|..||||++...... ...+..|++++++++|+||+++++++.+ ++..++|
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv 80 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINLV 80 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEEE
Confidence 556678999999999999964 6899999999654322 3457789999999999999999998876 5678999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+ +|+|.+++.+.. ..++|..+.+|+.++++||+|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 81 ~e~~-~~~L~~~i~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~ 150 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS------IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR 150 (298)
T ss_pred Eccc-CCCHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeee
Confidence 9999 999999986532 2489999999999999999999985 89999999999999999999999999876
Q ss_pred hcCCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH-HHHHHhh-ccccccc-
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQT-LPYISIY- 764 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~-~~~~~~~-~~~~~~~- 764 (919)
......... ......+.+..++.. +...++.++|||||||++|||+||..|+....+... ....... .|.....
T Consensus 151 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 151 SFGSPNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228 (298)
T ss_pred eccCCCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence 543221110 000111122222221 223457789999999999999999887776554322 1211110 0000000
Q ss_pred ccccccccccCCCCCCcc----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 765 DKELVTKIVDPSLIIDED----LLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 765 ~~~~~~~i~d~~l~~~~~----~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.................. ....-..+.+++..|++.+|++||+++||++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000000000000 0001123567889999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=302.60 Aligned_cols=265 Identities=17% Similarity=0.211 Sum_probs=184.2
Q ss_pred CCCCcccccccCCCCcEEEEEec---CCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE---GGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~---~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
..|.....||+|+||.||++... .+..||||.+... +.+.+|++++++++|||||++++++.. ++..++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRW-KSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEee-CCEEEEEeh
Confidence 46888889999999999999754 3568999987532 345689999999999999999997654 467899999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+. ++|.+++... ..++|.+++.|+.++++||+|||+. +||||||||+|||++.++.+||+|||.++..
T Consensus 167 ~~~-~~l~~~l~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 167 KYK-CDLFTYVDRS-------GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred hcC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 996 6888888432 2489999999999999999999985 8999999999999999999999999988754
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCCh----hHHHHHHHhhccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSD----AQVKEILEQTLPYISIYDK 766 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~----~~~~~~~~~~~~~~~~~~~ 766 (919)
.............+++.+..++......++.++|||||||++|||+||+.|+.+... ..+...+.........+..
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 432221111223445555555555555678899999999999999999999976432 2222222211100000000
Q ss_pred cc----------ccccccCCCCCCcchHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 767 EL----------VTKIVDPSLIIDEDLLE--EVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 767 ~~----------~~~i~d~~l~~~~~~~~--~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
.. ......+.....+.... .-..+..+...|+..+|.+||++.|++..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00000111100000000 00123457789999999999999999863
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=299.51 Aligned_cols=194 Identities=21% Similarity=0.267 Sum_probs=153.3
Q ss_pred HHhCCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 531 AATGDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 531 ~at~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
....+|...+.||+|+||.||+|+.. .+..||+|.... ..+..|+.++++++|||||++++++.+ .+..++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----GTTLIEAMLLQNVNHPSVIRMKDTLVS-GAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----cccHHHHHHHHhCCCCCCcChhheEEe-CCeeEEEE
Confidence 34467999999999999999999965 467899997432 234579999999999999999998876 45789999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
||+. |+|.+++.... ..++|.++..|+.++|+||+|||+. +||||||||+|||++.++.+||+|||.+..
T Consensus 137 e~~~-~~l~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 137 PHYS-SDLYTYLTKRS------RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred EccC-CcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccc
Confidence 9995 68888886432 3489999999999999999999985 899999999999999999999999998764
Q ss_pred cCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCC
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGIS 743 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~ 743 (919)
...... .....+++.+..++......++.++|||||||++|||+++..|+.
T Consensus 207 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 207 PVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 322211 111223444445554444567889999999999999999766653
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=278.25 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=185.2
Q ss_pred cccccccCCCCcEEEEEecC-----CccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 538 DANLIKNGHSGDLFRGILEG-----GIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 538 ~~~~ig~G~~G~Vy~g~l~~-----g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
..+.||+|+||.||+++..+ +..||+|++..... ..+.|..|++++.+++|+||+++++++.+. +..++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~i~e 81 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-EPLMIVME 81 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-CeeEEEEe
Confidence 45689999999999999754 47899999976544 356899999999999999999999988764 67899999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+++|+|.+++..... ..++|.++..++.+++.||+|||+. +|+||||||+||++++++.++++|||.+...
T Consensus 82 ~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-----KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred ccCCCCHHHHHHhhhh-----ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceec
Confidence 9999999999865321 1288999999999999999999985 8999999999999999999999999987654
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhcccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELV 769 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (919)
........ ......+.+..++......++.++||||+|++++||++ |+.|+.........+.+.....
T Consensus 154 ~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------- 222 (258)
T smart00219 154 YDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR---------- 222 (258)
T ss_pred cccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC----------
Confidence 33211110 00111223333433334467788999999999999999 7888876554443333221110
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 002462 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815 (919)
Q Consensus 770 ~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L 815 (919)
...+ ..... .+.+++.+|++.+|++||++.++++.|
T Consensus 223 --~~~~-----~~~~~---~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 --LPKP-----ENCPP---EIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCC-----CcCCH---HHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0000 01112 255688899999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=286.72 Aligned_cols=248 Identities=21% Similarity=0.308 Sum_probs=182.5
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
+|...+.||+|+||.||+|... ++..||+|.+...... .+.|.+|++++++++||||+++++++.+ +...++||||+
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 84 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-ENKLWILIEFC 84 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-CCeEEEEeecc
Confidence 4556678999999999999964 6889999998654433 4679999999999999999999998875 46789999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++|+|.+++.+.. ..+++.+...++.++|.||+|||+. +|+||||||+||+++.++.+|++|||.+.....
T Consensus 85 ~~~~L~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 85 DGGALDSIMLELE------RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred CCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 9999999886532 2488889999999999999999985 899999999999999999999999997654322
Q ss_pred CCcceeeeeeccCCCCccccC-----CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHH-HHHHhhccccccccc
Q 002462 693 DAHQSRITRLLRLPQSSEQGS-----SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVK-EILEQTLPYISIYDK 766 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 766 (919)
..... ....+.+.+..++. .....++.++|||||||++|||+||+.|+......... .+.....
T Consensus 156 ~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 225 (280)
T cd06611 156 TLQKR--DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP-------- 225 (280)
T ss_pred ccccc--ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC--------
Confidence 11110 11112222222221 12334677899999999999999999999765433221 1111100
Q ss_pred ccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+.+...+.... .+.+++..|++.+|++||++.+|++
T Consensus 226 --------~~~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 --------PTLDQPSKWSS---SFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred --------CCcCCcccCCH---HHHHHHHHHhccChhhCcCHHHHhc
Confidence 01100111112 2456788999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=288.40 Aligned_cols=264 Identities=17% Similarity=0.210 Sum_probs=182.9
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
++|.....||+|+||.||+|+.. ++..||+|.+..... ....+.+|++++++++||||+++++++.. ++..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-CCeEEEEEe
Confidence 34667788999999999999864 578999999864432 24567899999999999999999998765 567899999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|++ ++|.+++.+.. ..+++.....++.++++||+|||+. +|+||||||+||++++++.+||+|||.+...
T Consensus 85 ~~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 154 (301)
T cd07873 85 YLD-KDLKQYLDDCG------NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAK 154 (301)
T ss_pred ccc-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence 998 58988886532 2377888899999999999999984 8999999999999999999999999987654
Q ss_pred CCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccc--c----
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYIS--I---- 763 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~--~---- 763 (919)
....... ......+.+..++.. +...++.++|||||||++|||+||+.|+...+..+....+....+... .
T Consensus 155 ~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 155 SIPTKTY--SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred CCCCCcc--cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence 3211110 001112223333321 233467789999999999999999999987654433222221111100 0
Q ss_pred cccccccccccCCCCC------CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 764 YDKELVTKIVDPSLII------DEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 764 ~~~~~~~~i~d~~l~~------~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
...+.....-.+.... .+.... .+..++..|++.+|.+|||+.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDS---DGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCH---HHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000011000 001111 2456889999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=275.11 Aligned_cols=267 Identities=19% Similarity=0.249 Sum_probs=187.7
Q ss_pred CCcccccccCCCCcEEEEE-ecCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCC-ccceeeEEeecCC-----cE
Q 002462 536 FSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHAR-LVPLLGHCMEREN-----EK 605 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~n-iV~l~g~c~~~~~-----~~ 605 (919)
|...++||+|.||+||+|+ ..+|..||+|++...... ...-.+|+.++.+++|+| ||+|++++...+. ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 4445679999999999998 567899999999776542 345679999999999999 9999999886542 67
Q ss_pred EEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcc
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS 685 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg 685 (919)
++|+||+.. +|.+++....... ..++-.....+..|+.+||+|||+. +|+||||||.|||+++++..|++|||
T Consensus 93 ~lvfe~~d~-DL~~ymd~~~~~~---~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 93 YLVFEFLDR-DLKKYMDSLPKKP---QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred EEEEEeecc-cHHHHHHhccccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 899999986 8999986543211 2345466778999999999999986 89999999999999999999999999
Q ss_pred hhhhcCCCC---cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhcccc
Q 002462 686 EVCAQGGDA---HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLPYI 761 (919)
Q Consensus 686 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~~~~ 761 (919)
+++...-.. .....+..+++|+. -.|...|++..||||+|||+.||++++.=|.+.++.+ +..+.+ ....+
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEv----LlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~-~lGtP 240 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEV----LLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR-LLGTP 240 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHH----hcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH-HcCCC
Confidence 998765221 12233444554443 3355568888999999999999999888787776643 223222 11111
Q ss_pred cccccccccccccCCCCC-----CcchHHHH----HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 762 SIYDKELVTKIVDPSLII-----DEDLLEEV----WAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 762 ~~~~~~~~~~i~d~~l~~-----~~~~~~~~----~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
+...-..+....|-.... ......++ ....++...|++.+|++|.|++.++..
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111111111111111000 00111110 134568889999999999999998864
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=294.08 Aligned_cols=242 Identities=18% Similarity=0.226 Sum_probs=175.1
Q ss_pred cccccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHH-HHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELD-FFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~-~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
+.||+|+||.||+|+.. ++..||+|.+..... ....+..|.. +++.++|||||++++++.+ ++..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-CCeEEEEEeCCC
Confidence 36999999999999854 567899999864321 1234555544 5688999999999997765 567999999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|.+++.... .+...+...++.++++||+|||+. +|+||||||+|||++.++.+||+|||.++.....
T Consensus 80 ~~~L~~~~~~~~-------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 80 GGELFYHLQRER-------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 149 (325)
T ss_pred CCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC
Confidence 999999886532 255666777999999999999985 8999999999999999999999999987643221
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
.. ......+++.+..++......++.++|||||||++|||+||+.||......+....+... + . -+
T Consensus 150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~-------~----~~ 215 (325)
T cd05602 150 NG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-P-------L----QL 215 (325)
T ss_pred CC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-C-------c----CC
Confidence 11 112233455555555444456778899999999999999999999876544332221110 0 0 01
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L 815 (919)
.+ ....+ +..+...|++.+|.+||++.+.+..+
T Consensus 216 ~~------~~~~~---~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 216 KP------NITNS---ARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CC------CCCHH---HHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 11 11122 34577899999999999987655444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=282.58 Aligned_cols=246 Identities=20% Similarity=0.346 Sum_probs=179.4
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc----------HHHHHHHHHHHhhcCCCCccceeeEEeecCCc
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK----------TEAYLLELDFFSKVSHARLVPLLGHCMERENE 604 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~----------~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~ 604 (919)
|.....||+|+||.||+|.. .++..||+|.+...... .+.|.+|++++++++||||+++++++.+ .+.
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 80 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD-ADH 80 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCc
Confidence 33456899999999999985 46789999988543211 2468899999999999999999998776 457
Q ss_pred EEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCc
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSL 684 (919)
Q Consensus 605 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~df 684 (919)
.++||||+++++|.+++.+.. .+++.....|+.++++||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~df 150 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDF 150 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEeccc
Confidence 899999999999999996432 378888899999999999999974 7999999999999999999999999
Q ss_pred chhhhcCCCCcceee----eeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH-HHHHHhhcc
Q 002462 685 SEVCAQGGDAHQSRI----TRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTLP 759 (919)
Q Consensus 685 g~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~-~~~~~~~~~ 759 (919)
|.+............ ....+...+..++......++.++|||||||++|||+||+.|+........ ......
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--- 227 (267)
T cd06628 151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN--- 227 (267)
T ss_pred CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc---
Confidence 987655422111000 011122233333333333567789999999999999999999976543221 111110
Q ss_pred cccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 760 YISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 760 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..+.+. ....+ .+..++.+|++.+|.+||++.+|++
T Consensus 228 -------------~~~~~~--~~~~~---~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 -------------ASPEIP--SNISS---EAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -------------CCCcCC--cccCH---HHHHHHHHHccCCchhCcCHHHHhh
Confidence 011111 11112 2455778999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=282.52 Aligned_cols=248 Identities=21% Similarity=0.294 Sum_probs=184.1
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
+|...+.||+|+||.||+|... +|..||+|.+.... ...+.+.+|++++++++|+||++++++|.+ ++..++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEe
Confidence 3667789999999999999965 57889999986542 234578899999999999999999997765 567899999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCC-ceeeCCcchhhh
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF-EVRLGSLSEVCA 689 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~-~~kl~dfg~~~~ 689 (919)
|+++++|.+++.+... ..++|..+.+++.++++||+|||+. +|+||||||+||+++++. .+|++|||.+..
T Consensus 80 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~ 151 (257)
T cd08225 80 YCDGGDLMKRINRQRG-----VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ 151 (257)
T ss_pred cCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchh
Confidence 9999999999865432 2479999999999999999999975 799999999999999885 579999997765
Q ss_pred cCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccc
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELV 769 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (919)
........ ....+.+.+..++......++.++|||||||++|||+||+.|+........ +..... +..
T Consensus 152 ~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~-------~~~ 219 (257)
T cd08225 152 LNDSMELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL---VLKICQ-------GYF 219 (257)
T ss_pred ccCCcccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHhc-------ccC
Confidence 43322111 111233334444444444677889999999999999999999876543221 111110 001
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 770 ~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..+ .+. ..+ .+..++.+|++.+|++||+|.+|++
T Consensus 220 ~~~-~~~------~~~---~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 API-SPN------FSR---DLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCC-CCC------CCH---HHHHHHHHHhccChhhCcCHHHHhh
Confidence 110 111 111 2556778999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=287.90 Aligned_cols=264 Identities=18% Similarity=0.250 Sum_probs=181.9
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
+|...+.||+|+||.||+|+. .+|..||||++...... .+.|.+|++++++++||||+++++++.+ ++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-CCcEEEEee
Confidence 477788999999999999986 46889999998654322 3578899999999999999999998765 567999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|++ ++|.+++..... ..+++.+..+++.++++||+|||+. +|+||||||+||++++++.+|++|||.+...
T Consensus 80 ~~~-~~l~~~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~ 150 (284)
T cd07860 80 FLH-QDLKKFMDASPL-----SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 150 (284)
T ss_pred ccc-cCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence 996 689888865322 3488999999999999999999975 8999999999999999999999999987654
Q ss_pred CCCCcceeeeeeccCCCCccccC-CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhcccccc-cc--
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLPYISI-YD-- 765 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~~~~~~-~~-- 765 (919)
....... ......+.+..++. .+...++.++|||||||++|||+||+.|+....+.. ....+......... +.
T Consensus 151 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 151 GVPVRTY--THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred ccCcccc--ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 3221110 11111222223332 122335778999999999999999999997655432 22222211100000 00
Q ss_pred ------cccccccccCCCC-CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 766 ------KELVTKIVDPSLI-IDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 766 ------~~~~~~i~d~~l~-~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
...........+. ..+.... .+..++..|++.+|++||+|+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 229 TSLPDYKPSFPKWARQDFSKVVPPLDE---DGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hHHHHHHhhcccccccCHHHHcccCCH---HHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000000 0000011 2346888999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=285.30 Aligned_cols=249 Identities=25% Similarity=0.388 Sum_probs=182.5
Q ss_pred cccccccCCCCcEEEEEecC-CccEEEEEeccccccH---HHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 538 DANLIKNGHSGDLFRGILEG-GIPVVIKRIDLQSVKT---EAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 538 ~~~~ig~G~~G~Vy~g~l~~-g~~vavK~l~~~~~~~---~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
..+.||+|+||.||++...+ +..||+|.+....... +...+|+.++.+++||||+++++++.. ....++||||++
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~~~ 81 (260)
T PF00069_consen 3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEEET
T ss_pred EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-cccccccccccc
Confidence 35789999999999999654 5689999998765443 234569999999999999999998876 567899999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+++|.++|... ..+++.++..++.++++||+|||+. +|+||||||+||++++++.++|+|||.+......
T Consensus 82 ~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 82 GGSLQDYLQKN-------KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp TEBHHHHHHHH-------SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST
T ss_pred ccccccccccc-------ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999732 2478999999999999999999985 8999999999999999999999999987642111
Q ss_pred CcceeeeeeccCCCCccccCCC-CCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSG-SLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~-~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
.. ......+.+.+.+++... ....+.++||||+|+++|||+||+.|+...........+...... ..
T Consensus 152 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~----------~~ 219 (260)
T PF00069_consen 152 NE--NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR----------PL 219 (260)
T ss_dssp TS--EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT----------HH
T ss_pred cc--ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc----------cc
Confidence 11 111222333334444333 456788899999999999999999999876332222222211100 00
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
........+ .. ..+..++..|++.+|++||+|.++++
T Consensus 220 ~~~~~~~~~-~~---~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 220 PSSSQQSRE-KS---EELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHTTSHTT-SH---HHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccccch-hH---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000 01 34667889999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=300.21 Aligned_cols=200 Identities=16% Similarity=0.202 Sum_probs=156.9
Q ss_pred hCCCCcccccccCCCCcEEEEEe-cCCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecC-----C
Q 002462 533 TGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERE-----N 603 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~-----~ 603 (919)
.++|...+.||+|+||.||+++. ..+..||||++.... ...+.+.+|+.+++.++||||+++++++.... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46788889999999999999984 467899999986432 22457889999999999999999999764321 2
Q ss_pred cEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCC
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS 683 (919)
Q Consensus 604 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~d 683 (919)
..++||||+++ +|.+.+.. .+++.+...++.|+++||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM---------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh---------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence 46999999985 67666632 277888899999999999999985 899999999999999999999999
Q ss_pred cchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChh
Q 002462 684 LSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDA 748 (919)
Q Consensus 684 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~ 748 (919)
||.++........ ....+++.+.+++......++.++|||||||++|||+||+.||...+..
T Consensus 170 fG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 231 (364)
T cd07875 170 FGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 231 (364)
T ss_pred CCCccccCCCCcc---cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 9988754332111 1122333444444444456788899999999999999999999876543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=284.94 Aligned_cols=246 Identities=19% Similarity=0.306 Sum_probs=183.9
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
|...+.||+|++|.||+|.. .++..||+|+++..... .+.+.+|+.++++++||||+++++++.. .+..++|+||++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-~~~~~~v~e~~~ 99 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-GDELWVVMEFLE 99 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-CCeEEEEEeccC
Confidence 44457999999999999985 56889999998654433 4568899999999999999999997765 467999999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+++|.+++... .+++.+...|+.+++.||+|||+. +|+||||||+||++++++.++++|||.+......
T Consensus 100 ~~~L~~~~~~~--------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 100 GGALTDIVTHT--------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred CCCHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 99999988642 378889999999999999999985 8999999999999999999999999976544322
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
.... ....+.+.+..++......++.++|||||||++|||+||+.|+...........+....+
T Consensus 169 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~-------------- 232 (285)
T cd06648 169 VPRR--KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP-------------- 232 (285)
T ss_pred Cccc--ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCC--------------
Confidence 2111 112233344444444444578889999999999999999999876554332222111110
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+.......... .+..++..|++.+|++||++.++++
T Consensus 233 -~~~~~~~~~~~---~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 233 -PKLKNLHKVSP---RLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -CCCcccccCCH---HHHHHHHHHcccChhhCcCHHHHcc
Confidence 00000000111 3566889999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=295.04 Aligned_cols=243 Identities=21% Similarity=0.280 Sum_probs=189.4
Q ss_pred CCcccccccCCCCcEEEEE-ecCCccEEEEEecccc----ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQS----VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~----~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
+...+-||.|+.|.|-.|+ ...|+.+|||.+.... .......+||-+|+-+.|||+++|+..+. ...++|+|.|
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe-~~~~lylvlE 92 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE-NKQHLYLVLE 92 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec-cCceEEEEEE
Confidence 4456679999999999998 6789999999996542 22345779999999999999999999654 4568999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
||++|.|+++|.+++. |...+..+...||..|++|+|+. .|+|||+||.|+|||++..+||+|||+|...
T Consensus 93 yv~gGELFdylv~kG~-------l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGP-------LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE 162 (786)
T ss_pred ecCCchhHHHHHhhCC-------CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc
Confidence 9999999999987753 66677889999999999999985 8999999999999999999999999999876
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCC-CCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLT-ATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELV 769 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (919)
..+.. ..+..+.|.|..++...+.. -..++||||.|||||.|+||+.||++.+-..+..-|... .
T Consensus 163 ~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G----------~- 228 (786)
T KOG0588|consen 163 VPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG----------V- 228 (786)
T ss_pred cCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC----------c-
Confidence 55432 34456777777777654433 357899999999999999999999965544333222211 0
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 770 ~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+.+......+ +..|..+.+..||++|-||+||.+
T Consensus 229 -------f~MPs~Is~e---aQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 229 -------FEMPSNISSE---AQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred -------ccCCCcCCHH---HHHHHHHHhccCccccccHHHHhh
Confidence 0011111122 334667888999999999999987
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=282.46 Aligned_cols=250 Identities=17% Similarity=0.257 Sum_probs=180.6
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
+|...+.||+|+||.||+|+. .++..||+|.++..... .+.+.+|+.++++++||||+++++++.. .+..++||||+
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-~~~~~lv~e~~ 88 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-RDKLWICMEFC 88 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEEEEEEecc
Confidence 555667899999999999985 56889999998655433 3568899999999999999999998765 46889999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++|+|.+++.... .+++.+...++.+++.||.|||+. +|+||||||+||+++.++.+|++|||.+.....
T Consensus 89 ~~~~L~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 89 GGGSLQDIYHVTG-------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred CCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 9999999886432 378889999999999999999985 899999999999999999999999998754322
Q ss_pred CCcceeeeeeccCCCCccccCC---CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccc
Q 002462 693 DAHQSRITRLLRLPQSSEQGSS---GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELV 769 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (919)
.... .....+.+.+.+++.. ....++.++|||||||++|||+||+.|+................ .....
T Consensus 159 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~-----~~~~~- 230 (267)
T cd06645 159 TIAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN-----FQPPK- 230 (267)
T ss_pred cccc--cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC-----CCCCc-
Confidence 1110 0111223333333322 12346778999999999999999999986543322111100000 00000
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 770 ~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
........ + .+..++..|++.+|++||++.+|++
T Consensus 231 ---~~~~~~~~----~---~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 ---LKDKMKWS----N---SFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ---ccccCCCC----H---HHHHHHHHHccCCchhCcCHHHHhc
Confidence 00000011 1 2456888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=289.04 Aligned_cols=255 Identities=17% Similarity=0.201 Sum_probs=186.1
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++|...+.||+|+||.||++... .+..||||.+..... ..+.+.+|++++++++||||+++++.+.. ++..++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-KRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-CCEEEEE
Confidence 36777889999999999999854 578999999865432 23568899999999999999999997754 5678999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++.... .++|.....++.++++||+|||+. +|+||||||+||++++++.+|++|||.++
T Consensus 80 ~e~~~g~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~ 149 (305)
T cd05609 80 MEYVEGGDCATLLKNIG-------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSK 149 (305)
T ss_pred EecCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCcc
Confidence 99999999999995432 378888899999999999999975 89999999999999999999999999775
Q ss_pred hcCCCCcce-------------eeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHH-HH
Q 002462 689 AQGGDAHQS-------------RITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKE-IL 754 (919)
Q Consensus 689 ~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~-~~ 754 (919)
......... ......+...+..++......++.++|||||||++|||+||+.|+.+....+... ..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 321110000 0001112223333443333456788999999999999999999997655433221 11
Q ss_pred HhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 755 EQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 755 ~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
....+ .+.. ...... .+..++.+|++.+|++||++.++.+.|+.+
T Consensus 230 ~~~~~--------------~~~~--~~~~~~---~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 230 SDDIE--------------WPEG--DEALPA---DAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred hcccC--------------CCCc--cccCCH---HHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 11111 1110 001112 245688999999999999988888888754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=290.10 Aligned_cols=202 Identities=14% Similarity=0.246 Sum_probs=150.6
Q ss_pred ccccccCCCCcEEEEEecC---CccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeec-CCcEEEEEEecCC
Q 002462 539 ANLIKNGHSGDLFRGILEG---GIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMER-ENEKFLVYKYMPN 614 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~l~~---g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~-~~~~~lV~Ey~~~ 614 (919)
..+||+|+||.||+|+..+ +..||+|++..... ...+.+|++++++++|||||++++++... +...++||||+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 3589999999999999654 46899999864432 34678999999999999999999987643 3467899999885
Q ss_pred CChhhhhhccCCC--CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceec----CCCCceeeCCcchhh
Q 002462 615 GDLSSSLYRKTNT--EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILL----DDKFEVRLGSLSEVC 688 (919)
Q Consensus 615 GsL~~~L~~~~~~--~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILl----d~~~~~kl~dfg~~~ 688 (919)
+|.+++...... ......+++.....|+.|+++||+|||+. +|+||||||+|||+ ++++.+||+|||.++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777776432111 11223588999999999999999999985 89999999999999 566899999999887
Q ss_pred hcCCCCcc-eeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCC
Q 002462 689 AQGGDAHQ-SRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISAS 745 (919)
Q Consensus 689 ~~~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~ 745 (919)
........ .......+++.+.+++.. +...++.++|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 54322111 111112233334444433 2334678899999999999999999998654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=284.23 Aligned_cols=251 Identities=20% Similarity=0.323 Sum_probs=181.1
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEecccc--ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQS--VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~--~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
+|...+.||+|+||.||++... +|..||+|.+.... ...++|.+|++++.+++|+||+++++++.. ++..++||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~ 80 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-EGAVYMCMEY 80 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-CCeEEEEEee
Confidence 3555678999999999999965 68999999886532 224679999999999999999999997765 5689999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+++++|..++..... ...+++.....++.++++||.|||+. .+|+||||||+||+++.++.+|++|||.+....
T Consensus 81 ~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 81 MDAGSLDKLYAGGVA----TEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred cCCCCHHHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999888865321 23589999999999999999999964 379999999999999999999999999775432
Q ss_pred CCCcceeeeeeccCCCCccccCC------CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSS------GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYD 765 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~ 765 (919)
...... ..+.+.+..++.. ....++.++|||||||++|||+||+.|+...........+.....
T Consensus 155 ~~~~~~----~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------ 224 (286)
T cd06622 155 ASLAKT----NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD------ 224 (286)
T ss_pred CCcccc----CCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhh------
Confidence 211110 1111122222221 122357789999999999999999999975443222111111000
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 766 KELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 766 ~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
...+.+ .....+ .+..++.+|++.+|++||++.+++.
T Consensus 225 ------~~~~~~--~~~~~~---~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 225 ------GDPPTL--PSGYSD---DAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ------cCCCCC--CcccCH---HHHHHHHHHcccCcccCCCHHHHhc
Confidence 000111 111112 2456888999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=289.32 Aligned_cols=202 Identities=14% Similarity=0.241 Sum_probs=150.6
Q ss_pred ccccccCCCCcEEEEEec---CCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeec-CCcEEEEEEecCC
Q 002462 539 ANLIKNGHSGDLFRGILE---GGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMER-ENEKFLVYKYMPN 614 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~l~---~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~-~~~~~lV~Ey~~~ 614 (919)
...||+|+||.||+|+.. ++..||||.+..... ...+.+|++++++++|||||++++++... +...++||||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 458999999999999864 457899999864432 34578999999999999999999977543 3457899999974
Q ss_pred CChhhhhhccCCC--CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceec----CCCCceeeCCcchhh
Q 002462 615 GDLSSSLYRKTNT--EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILL----DDKFEVRLGSLSEVC 688 (919)
Q Consensus 615 GsL~~~L~~~~~~--~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILl----d~~~~~kl~dfg~~~ 688 (919)
+|.+++...... ......+++.....|+.|+++||+|||+. +||||||||+|||+ +.++.+||+|||.++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 788777532211 11223588888899999999999999985 89999999999999 456889999999887
Q ss_pred hcCCCCcc-eeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCC
Q 002462 689 AQGGDAHQ-SRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISAS 745 (919)
Q Consensus 689 ~~~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~ 745 (919)
........ .......+++.+.+++.. +...++.++||||+||++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 54322111 111122334444444432 3335678899999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=286.51 Aligned_cols=203 Identities=18% Similarity=0.293 Sum_probs=155.8
Q ss_pred HhCCCCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++++|...+.||+|+||.||+|.. .+|..||||++...... ...+.+|++++++++|+||+++++++.. ++..++|
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv 81 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTFV 81 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-CCeEEEE
Confidence 467788889999999999999985 46889999998644322 3467899999999999999999998765 5678999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||++ ++|.+++.... ..+.+.+...++.++++||+|||+. +|+||||||+|||++.++++||+|||.+.
T Consensus 82 ~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 82 FEYMH-TDLAQYMIQHP------GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred Eeccc-CCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccccc
Confidence 99996 67777765432 2367788888999999999999985 79999999999999999999999999876
Q ss_pred hcCCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCCh
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSD 747 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~ 747 (919)
......... ....+.+.+..++.. +...++.++|||||||++|||+||+.|+....+
T Consensus 152 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 152 AKSIPSQTY--SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred ccCCCCCCC--CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 532211110 001112223333322 223456788999999999999999999976543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=293.30 Aligned_cols=264 Identities=17% Similarity=0.200 Sum_probs=181.6
Q ss_pred HhCCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeec-----C
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMER-----E 602 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~-----~ 602 (919)
..+.|.....||+|+||.||+|.. .++..||||++..... ..+.+.+|++++++++|||||++++++... .
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 345677788999999999999985 5678999999864322 235688999999999999999999866432 1
Q ss_pred CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeC
Q 002462 603 NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG 682 (919)
Q Consensus 603 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~ 682 (919)
...++++||+ +++|.+++.. ..+++.+...|+.|+++||+|||+. +|+||||||+|||+++++.+||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC--------QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 3468999998 6889877642 2378889999999999999999985 89999999999999999999999
Q ss_pred CcchhhhcCCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhccc
Q 002462 683 SLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLPY 760 (919)
Q Consensus 683 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~~~ 760 (919)
|||.++........ ..+++.+..++.. +...++.++|||||||++|||++|+.||....... ...+.......
T Consensus 161 Dfg~~~~~~~~~~~-----~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 161 DFGLARQADDEMTG-----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred CCccceecCCCcCC-----ccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99988754432221 1223333334332 22456788999999999999999999997654332 22222211000
Q ss_pred c-cc---cccccccccccCCCC-CCcchHHH-----HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 761 I-SI---YDKELVTKIVDPSLI-IDEDLLEE-----VWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 761 ~-~~---~~~~~~~~i~d~~l~-~~~~~~~~-----~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
. .. ...+.....+. .+. .......+ -..+.+++..|++.+|.+|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 236 SPEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CHHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00 00000000000 000 00000000 012457889999999999999999885
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=285.66 Aligned_cols=266 Identities=16% Similarity=0.194 Sum_probs=183.2
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
+|...+.||+|+||.||+|... ++..||||+++.... ..+.+.+|++++++++|+||+++++++.. ++..++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEEEEe
Confidence 5777889999999999999865 578999998865322 24678999999999999999999998875 567999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|++++.+.....+. ..+++.+...++.++++||+|||+. +|+||||||+||++++++.+||+|||.+...
T Consensus 81 ~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~ 150 (288)
T cd07833 81 YVERTLLELLEASP-------GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARAL 150 (288)
T ss_pred cCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence 99987776554322 2378899999999999999999985 8999999999999999999999999987654
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCC-CCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHH-HHHHhhcccccc----c
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSL-TATCPYDVYCFGKVLLELVTGKMGISASSDAQVK-EILEQTLPYISI----Y 764 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~-~~~~~~~~~~~~----~ 764 (919)
...... ......+...+..++..... .++.++||||||+++|||+||+.|+......+.. .......+.... .
T Consensus 151 ~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 151 RARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred CCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence 432210 11111222233333333223 5678899999999999999999999765443211 111100000000 0
Q ss_pred c-cc-----cccccccCCCCCCcchHHH-HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 765 D-KE-----LVTKIVDPSLIIDEDLLEE-VWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 765 ~-~~-----~~~~i~d~~l~~~~~~~~~-~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
. .. ...++.++... +...... -..+..++..|++.+|++||+|++|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESL-ERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCccccccccCCCCCcHHH-HHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 00 00000000000 0000000 124667899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=283.84 Aligned_cols=251 Identities=18% Similarity=0.308 Sum_probs=189.2
Q ss_pred HhCCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
.+++|...+.||+|+||.||+|... ++..||+|++.......+.|.+|++++++++|+|++++++++.. ++..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV-GDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEE-CCEEEEEEe
Confidence 4566777789999999999999976 68899999997655445678999999999999999999998876 468999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+++++|.+++.... ..++|..+..|+.++++||+|||.. +|+|+||||+||+++.++.+||+|||.+...
T Consensus 96 ~~~~~~L~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 96 YMDGGSLTDIITQNF------VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred ccCCCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 999999999997543 2589999999999999999999984 8999999999999999999999999976543
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHH-HHhhcccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEI-LEQTLPYISIYDKELV 769 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 769 (919)
...... .....+.+.+..++......++.++|||||||++|||+||+.|+........... .....
T Consensus 167 ~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 233 (286)
T cd06614 167 TKEKSK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI----------- 233 (286)
T ss_pred ccchhh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence 322111 0111222333333433334567889999999999999999999876554322211 11110
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 770 ~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
....++ +.... .+..++..|++.+|.+||++.+|+.
T Consensus 234 ~~~~~~-----~~~~~---~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 234 PPLKNP-----EKWSP---EFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCCcch-----hhCCH---HHHHHHHHHhccChhhCcCHHHHhh
Confidence 000010 00112 2456889999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=277.48 Aligned_cols=252 Identities=19% Similarity=0.294 Sum_probs=184.5
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc-cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV-KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~-~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
++|...+.||+|+||.||+|.. .++..+|+|.+..... ..+.+.+|++++++++||||++++|++.. ++..++||||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-RDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-CCEEEEEEeC
Confidence 4677788999999999999986 4578899999865443 34678999999999999999999997765 5679999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+++++|.+++.... ..++..+...|+.+++.||+|||+. +|+||||||+||++++++.+||+|||.+....
T Consensus 82 ~~~~~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 82 CGGGSLQDIYQVTR------GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred CCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhh
Confidence 99999999886532 2478888999999999999999975 89999999999999999999999999776543
Q ss_pred CCCcceeeeeeccCCCCccccCCCCC---CCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSL---TATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (919)
..... .....+...+..++..... .++.++|||||||++|||+||+.|+...........+... .
T Consensus 153 ~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~----------~ 220 (262)
T cd06613 153 ATIAK--RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS----------N 220 (262)
T ss_pred hhhhc--cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------c
Confidence 21110 0111122223333333222 5677899999999999999999999876543322111110 0
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.-.+.+....... ..+..++.+|++.+|.+||++.+|+.
T Consensus 221 ---~~~~~~~~~~~~~---~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 221 ---FPPPKLKDKEKWS---PVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ---CCCccccchhhhh---HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000010011111 23567889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=274.59 Aligned_cols=266 Identities=21% Similarity=0.272 Sum_probs=199.2
Q ss_pred HHHHhCCCCcccccccCCCCcEEEEEec------CCccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEee
Q 002462 529 LLAATGDFSDANLIKNGHSGDLFRGILE------GGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCME 600 (919)
Q Consensus 529 l~~at~~f~~~~~ig~G~~G~Vy~g~l~------~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~ 600 (919)
|.-....|....++-+|.||+||+|.|. +.+.|-||.++....+ ...|+.|.-.+..+.|||+.++.|.|++
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 3333345777788999999999999654 3467888988655443 4679999999999999999999999998
Q ss_pred cCCcEEEEEEecCCCChhhhhhccCC-CCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCce
Q 002462 601 RENEKFLVYKYMPNGDLSSSLYRKTN-TEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEV 679 (919)
Q Consensus 601 ~~~~~~lV~Ey~~~GsL~~~L~~~~~-~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~ 679 (919)
.....+++|.|+.-|+|..+|...++ .....+.++-.+-+.+|.|+|.||+|||.. +|||.||.++|+++|+...+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeE
Confidence 77788999999999999999974332 234567788889999999999999999985 89999999999999999999
Q ss_pred eeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHHHHHhhc
Q 002462 680 RLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTL 758 (919)
Q Consensus 680 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~~~~~~~ 758 (919)
|++|-.+++..-..........-.+.-.++..+......++..+|||||||+||||+| |+.|+..-++.+...++...+
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy 515 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY 515 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc
Confidence 9999877765422111100000011111222222233357788999999999999998 999998888877766654322
Q ss_pred ccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 759 PYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 759 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
++.+ ....++| +..++..||+..|++||++++++.-|.+
T Consensus 516 ---------RlaQ--------P~NCPDe---Lf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 516 ---------RLAQ--------PFNCPDE---LFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ---------eecC--------CCCCcHH---HHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1111 1223344 4457889999999999999999998864
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=285.93 Aligned_cols=244 Identities=23% Similarity=0.316 Sum_probs=179.7
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
.|...+.||+|+||.||+|... +|..||+|++..... ..+++.+|++++++++||||++++|+|.. ++..++||
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 94 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-EHTAWLVM 94 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-CCeEEEEH
Confidence 3666788999999999999864 688999999864322 13568899999999999999999998876 45789999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
||++ |+|.+.+.... ..++|.++..++.|++.||.|||+. +|+||||||+||++++++.+|++|||.+..
T Consensus 95 e~~~-g~l~~~~~~~~------~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 95 EYCL-GSASDILEVHK------KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred HhhC-CCHHHHHHHcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCccee
Confidence 9998 67777765332 2488999999999999999999974 899999999999999999999999997754
Q ss_pred cCCCCcceeeeeeccCCCCccccCC---CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccc
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSS---GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDK 766 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (919)
...... ..+.+.+..++.. ....++.++|||||||++|||+||+.|+...........+....
T Consensus 165 ~~~~~~------~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-------- 230 (307)
T cd06607 165 VSPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-------- 230 (307)
T ss_pred cCCCCC------ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC--------
Confidence 432211 1122223333321 12346778999999999999999999987655433221111100
Q ss_pred ccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
.+.+. .....+ .+..++..||+.+|++||+|.+|+..
T Consensus 231 -------~~~~~-~~~~~~---~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 -------SPTLS-SNDWSD---YFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -------CCCCC-chhhCH---HHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 01110 011112 35667889999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=290.58 Aligned_cols=249 Identities=20% Similarity=0.265 Sum_probs=197.5
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
+|...++||+|+||.++..+. .++..+|+|+++..... ++.-.+|+.++++++|||||.+...+.+.+...+|||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 445567899999999987663 35678999999876543 34678899999999999999999988775544899999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|++||+|.+.+.+.++ .-++..+..+...|+..|+.|||+. .|+|||||++||++..+..+|++|||+++..
T Consensus 85 Y~eGg~l~~~i~~~k~-----~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKG-----VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred ecCCCCHHHHHHHHhh-----ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhc
Confidence 9999999999976542 2366677788899999999999965 8999999999999999999999999999987
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHH-HHHhhcccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKE-ILEQTLPYISIYDKELV 769 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 769 (919)
+... .....+.++|.|+.++......|..|+|+||+||++|||++-|++|.+.+..++.. +....
T Consensus 157 ~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~------------ 222 (426)
T KOG0589|consen 157 NPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL------------ 222 (426)
T ss_pred CCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc------------
Confidence 6654 12345678888888888888899999999999999999999999998877554332 22211
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 770 ~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
.+|- ......+ +..++..|+..+|..||++.+++..
T Consensus 223 ---~~Pl---p~~ys~e---l~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 ---YSPL---PSMYSSE---LRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---CCCC---CccccHH---HHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1111 1111222 3447789999999999999999875
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=277.04 Aligned_cols=249 Identities=21% Similarity=0.294 Sum_probs=180.7
Q ss_pred CCcccccccCCCCcEEEEEec-CCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 536 FSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
|...+.||+|+||.||+|... ++..||||.+..... ..+.+..|++++++++|+||++++|++.. .+..++|+||
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~lv~e~ 80 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-REKVYIFMEY 80 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-CCEEEEEEec
Confidence 455678999999999999864 688999999876544 34678999999999999999999998765 4678999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+++++|.+++.... .+++..+..|+.++++||+|||+. +|+||||||+||++++++.+||+|||.+....
T Consensus 81 ~~~~~L~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~ 150 (264)
T cd06626 81 CSGGTLEELLEHGR-------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK 150 (264)
T ss_pred CCCCcHHHHHhhcC-------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence 99999999986532 367888899999999999999985 79999999999999999999999999876543
Q ss_pred CCCcceee--eeeccCCCCccccCCCCC---CCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHH-HHHhhcccccccc
Q 002462 692 GDAHQSRI--TRLLRLPQSSEQGSSGSL---TATCPYDVYCFGKVLLELVTGKMGISASSDAQVKE-ILEQTLPYISIYD 765 (919)
Q Consensus 692 ~~~~~~~~--~~~~~~~~~~~~~~~~~~---~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~-~~~~~~~~~~~~~ 765 (919)
........ ....+.+.+..++..... ..+.++||||||+++||+++|+.|+.......... .+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------- 222 (264)
T cd06626 151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG-------- 222 (264)
T ss_pred CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcC--------
Confidence 32111100 001122223333322222 26788999999999999999999997553221111 11100
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 766 KELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 766 ~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..+.+........ .+..++..|++.+|.+||++.+++.
T Consensus 223 -------~~~~~~~~~~~~~---~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 -------HKPPIPDSLQLSP---EGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -------CCCCCCcccccCH---HHHHHHHHHccCCcccCCCHHHHhc
Confidence 0011110000011 2345778999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=292.08 Aligned_cols=269 Identities=19% Similarity=0.237 Sum_probs=183.8
Q ss_pred hCCCCcccccccCCCCcEEEEEec-CCccEEEEEeccc---cccHHHHHHHHHHHhhc-CCCCccceeeEEeecC-CcEE
Q 002462 533 TGDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQ---SVKTEAYLLELDFFSKV-SHARLVPLLGHCMERE-NEKF 606 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~---~~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~-~~~~ 606 (919)
.++|...+.||+|+||.||+|... +|..||||++... ......+.+|+.+++++ +||||++++|+|...+ ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456777789999999999999965 6789999988532 12235677899999999 9999999999876432 3579
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcch
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~ 686 (919)
+||||++ ++|..++... .++|.++..|+.++|.||+|||+. +|+||||||+||++++++.+|++|||.
T Consensus 86 lv~e~~~-~~L~~~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN--------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred EEecccc-cCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 9999998 5998887532 378999999999999999999974 899999999999999999999999998
Q ss_pred hhhcCCCCcc---eeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccc
Q 002462 687 VCAQGGDAHQ---SRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYIS 762 (919)
Q Consensus 687 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~ 762 (919)
+......... .......+++.+..++.. +....+.++|||||||++|||+||+.|+...........+....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 7654322211 111112233333333322 223466789999999999999999999976654332211111111000
Q ss_pred c---------cccccccccccCCCCCCcch-HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 763 I---------YDKELVTKIVDPSLIIDEDL-LEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 763 ~---------~~~~~~~~i~d~~l~~~~~~-~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
. .....+..+.+......... .+.-..+..++..|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 0 00000000000000000000 000123567889999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=282.72 Aligned_cols=258 Identities=21% Similarity=0.298 Sum_probs=186.3
Q ss_pred HHhCCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccccHHHHHHHHHHHhhc-CCCCccceeeEEeecC-----C
Q 002462 531 AATGDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVKTEAYLLELDFFSKV-SHARLVPLLGHCMERE-----N 603 (919)
Q Consensus 531 ~at~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~-----~ 603 (919)
.++++|...+.||+|+||.||+|... ++..+|+|.+.......++|.+|+++++++ +|+||+++++++.+.. .
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 35678888999999999999999974 578899999876655567899999999999 6999999999886532 2
Q ss_pred cEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCC
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS 683 (919)
Q Consensus 604 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~d 683 (919)
..++||||+++++|.+++..... ....+++..+..|+.++++||+|||+. +|+||||+|+||++++++.+|++|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRK---KGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence 47999999999999998864321 113488999999999999999999975 899999999999999999999999
Q ss_pred cchhhhcCCCCcce---eeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhcc
Q 002462 684 LSEVCAQGGDAHQS---RITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLP 759 (919)
Q Consensus 684 fg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~~ 759 (919)
||.+.......... ..+..+.+|+...........++.++|||||||++|||+||+.|+....... ...+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--- 233 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN--- 233 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---
Confidence 99765432211110 0011122222211111123346778999999999999999999997543322 1111110
Q ss_pred cccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 760 YISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 760 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
. .+.+.......+ .+..++.+|+..+|++||++.+|++
T Consensus 234 --------~-----~~~~~~~~~~~~---~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 --------P-----PPTLKSPENWSK---KFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred --------C-----CCCCCchhhcCH---HHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 011111111112 3556888999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=281.67 Aligned_cols=245 Identities=22% Similarity=0.340 Sum_probs=181.2
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
|...+.||+|+||.||+|.. .++..||||.+..... ..+.|.+|++++++++|||||++++++.+ ++..++||||+
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~ 84 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIMEYL 84 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-CCeEEEEEEeC
Confidence 44567899999999999985 4678999998864432 24578899999999999999999998765 46799999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++|+|.+++... .++|.....++.+++.||+|||+. +|+|+||||+||+++.++.++++|||.+.....
T Consensus 85 ~~~~l~~~i~~~--------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 85 GGGSALDLLEPG--------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 999999988532 378999999999999999999985 899999999999999999999999997754332
Q ss_pred CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 693 DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
.... .....+...+..++.......+.++|||||||++|||+||+.|+...........+.... . ..
T Consensus 154 ~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------~----~~ 220 (277)
T cd06641 154 TQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-------P----PT 220 (277)
T ss_pred chhh--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC-------C----CC
Confidence 1110 011112222333333333356678999999999999999999987654332222211100 0 00
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
++ +.... .+..++..|++.+|.+||+|.++++.
T Consensus 221 ~~------~~~~~---~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LE------GNYSK---PLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CC------cccCH---HHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11 11112 24567889999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=278.34 Aligned_cols=256 Identities=21% Similarity=0.311 Sum_probs=185.1
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
++|...+.||.|+||.||+|.. .++..+|||++..... ..+.+.+|++++++++|+||+++++.+.. ++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-GDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-CCEEEEEEe
Confidence 3677788999999999999995 4678999999865432 34678999999999999999999997765 468999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+++++|.+++..... ...++|.....++.+++.||+|||+. +|+||||||+||++++++.+|++|||.+...
T Consensus 80 ~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~ 152 (267)
T cd06610 80 YLSGGSLLDIMKSSYP----RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASL 152 (267)
T ss_pred ccCCCcHHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence 9999999999965321 12478999999999999999999975 8999999999999999999999999987654
Q ss_pred CCCCcce--eeeeeccCCCCccccCCCC-CCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhccccccccc
Q 002462 691 GGDAHQS--RITRLLRLPQSSEQGSSGS-LTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLPYISIYDK 766 (919)
Q Consensus 691 ~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 766 (919)
....... ......+...+..++.... ...+.++|||||||++|||+||+.|+....... ..+..... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~--------~ 224 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND--------P 224 (267)
T ss_pred ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC--------C
Confidence 4322111 0011112222323332222 256778999999999999999999997654322 11111110 0
Q ss_pred ccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
........ .....+ .+..++..|++.+|++||++.+|++
T Consensus 225 ~~~~~~~~-----~~~~~~---~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGAD-----YKKYSK---SFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccc-----cccccH---HHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000 001112 3456888999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=278.43 Aligned_cols=250 Identities=18% Similarity=0.246 Sum_probs=176.8
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc------cHHHHHHHHHHHhhcCCCCccceeeEEeecC-CcE
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV------KTEAYLLELDFFSKVSHARLVPLLGHCMERE-NEK 605 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~------~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~-~~~ 605 (919)
.+|...++||+|+||.||+|.. .+|..||||++..... ..+.+.+|++++++++||||+++++++.+.. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4677889999999999999986 4588999998853221 1346888999999999999999999765432 357
Q ss_pred EEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcc
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS 685 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg 685 (919)
++||||+++|+|.+++.+.. .+++...++++.+++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg 151 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFG 151 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCc
Confidence 79999999999999886432 267788889999999999999975 79999999999999999999999999
Q ss_pred hhhhcCCCCc-ceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccc
Q 002462 686 EVCAQGGDAH-QSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIY 764 (919)
Q Consensus 686 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~ 764 (919)
.+........ ........+...+..++......++.++|||||||++|||+||+.|+........ .......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~----- 224 (265)
T cd06652 152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IFKIATQ----- 224 (265)
T ss_pred cccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HHHHhcC-----
Confidence 7764321100 0001111122233333433334567889999999999999999999875432221 1111000
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 765 DKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 765 ~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
-..+.. .+.... .+..+...|+. +|++||++++|++
T Consensus 225 -------~~~~~~--~~~~~~---~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 225 -------PTNPVL--PPHVSD---HCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -------CCCCCC--chhhCH---HHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 001111 111111 23445667774 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=277.08 Aligned_cols=246 Identities=20% Similarity=0.285 Sum_probs=182.0
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
|...+.||+|+||.||++.. .++..+|||++..... ..+.|.+|++++++++||||+++++.+.. ++..++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~ 80 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-DKALMIVMEY 80 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-CCEEEEEEec
Confidence 56678999999999999985 4678999999865432 24578999999999999999999997654 5678999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC-CceeeCCcchhhhc
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK-FEVRLGSLSEVCAQ 690 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~-~~~kl~dfg~~~~~ 690 (919)
+++|+|.+++..... ..+++..+.+++.++++||+|||+. +|+||||||+||+++++ ..+|++|||.+...
T Consensus 81 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 81 APGGTLAEYIQKRCN-----SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred CCCCCHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 999999999975432 3478999999999999999999985 89999999999999855 56899999977654
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
....... ...+.+.+..++.......+.++|||||||++|||+||+.|+................ ..
T Consensus 153 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~----------~~ 219 (256)
T cd08220 153 SSKSKAY---TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT----------FA 219 (256)
T ss_pred CCCcccc---ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC----------CC
Confidence 3221111 1122333333443333456788999999999999999999987654332221111100 00
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.+.+ .... .+..+...||+.+|++||+|.++++
T Consensus 220 ~~~~-------~~~~---~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 PISD-------RYSP---DLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCC-------CcCH---HHHHHHHHHccCChhhCCCHHHHhh
Confidence 0100 0111 2456788999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=281.94 Aligned_cols=267 Identities=18% Similarity=0.222 Sum_probs=183.8
Q ss_pred CCcccccccCCCCcEEEEEec-CCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeec-CCcEEEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMER-ENEKFLVYK 610 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~-~~~~~lV~E 610 (919)
|...+.||+|+||.||+|+.. +|..+|||++.... ...+.+.+|++++++++|+|++++++++... .+..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 345678999999999999865 58899999997653 2245788999999999999999999988764 257999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+++ +|.+++.+.. ..+++.++..++.++++||+|||+. +++|+||||+||++++++.+|++|||.+...
T Consensus 81 ~~~~-~l~~~~~~~~------~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~ 150 (287)
T cd07840 81 YMDH-DLTGLLDSPE------VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPY 150 (287)
T ss_pred cccc-cHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeec
Confidence 9985 8888875432 2488999999999999999999985 7999999999999999999999999987654
Q ss_pred CCCCcceeeeeeccCCCCccccC-CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELV 769 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (919)
....... .+.......+..++. .+...++.++||||||+++|||+||+.|+...........+...............
T Consensus 151 ~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 151 TKRNSAD-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred cCCCccc-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence 3322100 011111122222331 22334678899999999999999999999876543322222111110000000000
Q ss_pred ccc-----ccCCCCCCcc---hHHH--HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 770 TKI-----VDPSLIIDED---LLEE--VWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 770 ~~i-----~d~~l~~~~~---~~~~--~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.++ ..+....... .... ...+..++..|++.+|.+||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 0000000000 0011 234677899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=279.59 Aligned_cols=246 Identities=18% Similarity=0.278 Sum_probs=181.7
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc--cHHHHHHHHHHHhhcC---CCCccceeeEEeecCCcEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV--KTEAYLLELDFFSKVS---HARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~---H~niV~l~g~c~~~~~~~~lV 608 (919)
.|+..+.||+|+||.||+|+. .++..||||.++.... ..+++.+|++++++++ |||+++++++|.+ +...++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-GPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-CCEEEEE
Confidence 355667899999999999995 5789999999865432 2457889999999997 9999999998875 4578999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++++|.+++... .++|...+.++.++++||+|||+. +|+||||||+||++++++.++++|||.+.
T Consensus 81 ~e~~~~~~L~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06917 81 MEYAEGGSVRTLMKAG--------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAA 149 (277)
T ss_pred EecCCCCcHHHHHHcc--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCcee
Confidence 9999999999987532 488999999999999999999975 89999999999999999999999999776
Q ss_pred hcCCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccc
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKE 767 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 767 (919)
........ .....+...+..++.. +...++.++|||||||++|||+||+.|+.............
T Consensus 150 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~------------ 215 (277)
T cd06917 150 LLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP------------ 215 (277)
T ss_pred ecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc------------
Confidence 54332211 1111222223333322 22346778999999999999999999997654322111110
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 768 LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 768 ~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
....+.+..+. ... .+.+++..|++.+|++||++.++++
T Consensus 216 ---~~~~~~~~~~~-~~~---~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 216 ---KSKPPRLEDNG-YSK---LLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ---cCCCCCCCccc-CCH---HHHHHHHHHcCCCcccCcCHHHHhh
Confidence 00111111110 112 3566888999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=280.13 Aligned_cols=262 Identities=15% Similarity=0.142 Sum_probs=178.4
Q ss_pred CcccccccCCCCcEEEEEe-cCCccEEEEEeccccc--cHHHHHHHHHHHhhcC-CCCccceeeEEeecC-CcEEEEEEe
Q 002462 537 SDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV--KTEAYLLELDFFSKVS-HARLVPLLGHCMERE-NEKFLVYKY 611 (919)
Q Consensus 537 ~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~-~~~~lV~Ey 611 (919)
...+.||+|+||.||+|.. .++..||||++..... ......+|+.++.++. |+||+++++++.+.. +..++||||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 4457899999999999985 4688999999864322 2334568999999996 999999999887541 578999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
++ |+|.+.+.... ..++|.+...++.++++||+|||+. +|+||||||+||++++ +.+||+|||.+....
T Consensus 82 ~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 82 MD-MNLYELIKGRK------RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred CC-ccHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 97 58888876432 2489999999999999999999985 8999999999999999 999999999876543
Q ss_pred CCCcceeeeeeccCCCCccccC-CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccc-----cc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISI-----YD 765 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~-----~~ 765 (919)
..... ....+.+.+..++. .+....+.++|||||||++|||+||+.|+...+..+.............. ..
T Consensus 151 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 151 SKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred cCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 22111 11112222333331 12234567899999999999999999999876654332222211110000 00
Q ss_pred cccccccccCCCCCCcch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 766 KELVTKIVDPSLIIDEDL----LEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 766 ~~~~~~i~d~~l~~~~~~----~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.........+... .... ...-..+..++..|++++|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKK-GTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccc-cccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000000 0000 001134567889999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=281.86 Aligned_cols=266 Identities=18% Similarity=0.207 Sum_probs=184.2
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
|...+.||+|+||.||+|.. .+|..||||++..... ..+.|.+|+.++++++||||+++++++.. +...++||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e~ 80 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-GSGFVLVMEY 80 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-CCeeEEEecc
Confidence 55667899999999999996 4689999999865432 24679999999999999999999998765 5678999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+ +++|.+++.... ..+++.++.+++.++++||+|||+. +|+||||||+||++++++.++++|||.+....
T Consensus 81 ~-~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~ 150 (286)
T cd07832 81 M-PSDLSEVLRDEE------RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFS 150 (286)
T ss_pred c-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence 9 999999986533 3488999999999999999999975 89999999999999999999999999876553
Q ss_pred CCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccc------c
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISI------Y 764 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~------~ 764 (919)
..... ......+...+..++.. +...++.++||||+||++|||+||+.++....+......+......... .
T Consensus 151 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 151 EEEPR-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred CCCCC-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence 32210 01111122223333322 2234577899999999999999998887665543322222111100000 0
Q ss_pred ccccccccccCCC---CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 765 DKELVTKIVDPSL---IIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 765 ~~~~~~~i~d~~l---~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.......+..+.- ...+...+.-..+..++.+|++.+|.+||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000001110000 000000001134567889999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=284.44 Aligned_cols=249 Identities=19% Similarity=0.295 Sum_probs=183.0
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
++|...+.||+|+||.||+|.. .++..||+|.+...... .+.|.+|+.++++++||||++++++|.. .+..++||||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-GDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-CCcEEEEEec
Confidence 4566678899999999999984 56789999998654333 4678999999999999999999998876 4579999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+++|+|.+++.+. .+++.++..|+.++++||+|||+. +|+||||||+||++++++.+||+|||.+....
T Consensus 98 ~~~~~L~~~~~~~--------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 98 LAGGSLTDVVTET--------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (293)
T ss_pred CCCCcHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence 9999999988542 377889999999999999999975 89999999999999999999999999765443
Q ss_pred CCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTK 771 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 771 (919)
...... ....+.+.+..++......++.++|||||||++||++||+.||...........+. .. ..
T Consensus 167 ~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~-~~------~~----- 232 (293)
T cd06647 167 PEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TN------GT----- 232 (293)
T ss_pred cccccc--ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-cC------CC-----
Confidence 222111 11122223333333333356778999999999999999999997654322110000 00 00
Q ss_pred cccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 772 IVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 772 i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
+.......... .+..++..||+.+|++||++.+++..
T Consensus 233 ---~~~~~~~~~~~---~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 ---PELQNPEKLSA---IFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ---CCCCCccccCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000011111 24567889999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=276.50 Aligned_cols=251 Identities=21% Similarity=0.312 Sum_probs=186.7
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
++|...+.||+|++|.||+|+.. ++..||||++..... ..++|.+|++.+.+++|+||+++++++.. ++..++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-EGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-CCeEEEEEE
Confidence 36777889999999999999976 489999999876543 35689999999999999999999998775 468999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+++++|.+++... ..+++..+.+++.++++||+|||+. .+++||||||+||+++.++.++++|||.+...
T Consensus 80 ~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~ 150 (264)
T cd06623 80 YMDGGSLADLLKKV-------GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVL 150 (264)
T ss_pred ecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceec
Confidence 99999999999653 2478899999999999999999972 38999999999999999999999999977654
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
....... ....+...+..++......++.++||||||+++|||+||+.|+.........+.+..... .
T Consensus 151 ~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-------~--- 218 (264)
T cd06623 151 ENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-------G--- 218 (264)
T ss_pred ccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc-------C---
Confidence 3322211 011122223333333334667889999999999999999999876542111111111110 0
Q ss_pred ccccCCCCCCcc-hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 771 KIVDPSLIIDED-LLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 771 ~i~d~~l~~~~~-~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..+.+ +.. .. ..+..++..|++++|++||++.++++
T Consensus 219 --~~~~~--~~~~~~---~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 219 --PPPSL--PAEEFS---PEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred --CCCCC--CcccCC---HHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00111 111 11 13556788999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=296.20 Aligned_cols=205 Identities=17% Similarity=0.243 Sum_probs=162.4
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++|...+.||+|+||.||+++.. ++..||||.+..... ..+.+.+|++++.+++|||||++++.+.+ ++..++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-KRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence 36778899999999999999864 688999999864321 23567889999999999999999997654 5678999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
||||++|+|.+++.+.. .+++.....++.+++.||+|||+. +||||||||+|||++.++.+||+|||++.
T Consensus 80 ~E~~~gg~L~~~l~~~~-------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~ 149 (360)
T cd05627 80 MEFLPGGDMMTLLMKKD-------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCT 149 (360)
T ss_pred EeCCCCccHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCc
Confidence 99999999999986542 377888889999999999999974 89999999999999999999999999876
Q ss_pred hcCCCCcc---------------------------------eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHH
Q 002462 689 AQGGDAHQ---------------------------------SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLEL 735 (919)
Q Consensus 689 ~~~~~~~~---------------------------------~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEl 735 (919)
........ .......+++.+.+++......++.++|||||||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel 229 (360)
T cd05627 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (360)
T ss_pred ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeec
Confidence 43211000 000112344555555554445678889999999999999
Q ss_pred HcCCCCCCCCChhH
Q 002462 736 VTGKMGISASSDAQ 749 (919)
Q Consensus 736 lTGk~p~~~~~~~~ 749 (919)
+||+.||.......
T Consensus 230 ~tG~~Pf~~~~~~~ 243 (360)
T cd05627 230 LIGYPPFCSETPQE 243 (360)
T ss_pred ccCCCCCCCCCHHH
Confidence 99999998766543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=266.20 Aligned_cols=200 Identities=22% Similarity=0.267 Sum_probs=171.6
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
.+|.....||.|+||+|...+. .+|..+|+|.++.... +.+...+|..+|+.+.||.+|++.+-|.+ .+..++|
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d-~~~lymv 122 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD-NSNLYMV 122 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc-CCeEEEE
Confidence 4577778899999999999885 4678899999976543 23567789999999999999999998775 4689999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|.|..+|++.+. ++.....-+|.+|+.||+|||+. .||+||+||+|||||.+|..||.|||.++
T Consensus 123 meyv~GGElFS~Lrk~~r-------F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK 192 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR-------FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAK 192 (355)
T ss_pred EeccCCccHHHHHHhcCC-------CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceE
Confidence 999999999999987543 55556667999999999999985 89999999999999999999999999998
Q ss_pred hcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ 749 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~ 749 (919)
...+. +-+..++|+|.+++...+..+...+|.|||||++|||+.|.+||...++..
T Consensus 193 ~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~ 248 (355)
T KOG0616|consen 193 RVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ 248 (355)
T ss_pred EecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH
Confidence 77554 345789999999988877778888999999999999999999998877644
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=279.26 Aligned_cols=246 Identities=20% Similarity=0.235 Sum_probs=181.8
Q ss_pred cccCCCCcEEEEEecC-CccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCC
Q 002462 542 IKNGHSGDLFRGILEG-GIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGD 616 (919)
Q Consensus 542 ig~G~~G~Vy~g~l~~-g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~Gs 616 (919)
||+|+||.||+++..+ |..+|+|.+..... ..+.+.+|++++.+++||||+++++.+.. +...++||||+++|+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCc
Confidence 6899999999999764 89999999865433 24578899999999999999999986654 567899999999999
Q ss_pred hhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcc
Q 002462 617 LSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQ 696 (919)
Q Consensus 617 L~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~ 696 (919)
|.+++.+.. .+++..+.+|+.++++||+|||+. +|+||||+|+||++++++.+|++|||.+.........
T Consensus 80 L~~~l~~~~-------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 80 LASLLENVG-------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred HHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence 999986532 478999999999999999999975 8999999999999999999999999977654322110
Q ss_pred ------eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 697 ------SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 697 ------~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
.......+.+.+..++.......+.++||||||+++|||+||+.|+......+....+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 218 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI----------- 218 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-----------
Confidence 011111222233333333333467789999999999999999999987665443222211000
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
.. ........ .+..++..|++.+|++||++.+|.+.|+.
T Consensus 219 ---~~--~~~~~~~~---~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 219 ---EW--PEDVEVSD---EAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred ---CC--CccccCCH---HHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00 00000011 24568889999999999999888877764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=288.39 Aligned_cols=202 Identities=20% Similarity=0.224 Sum_probs=158.3
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
+|...+.||+|+||.||+++.. ++..||||.++.... ..+.|.+|+.++.+++|+||+++++++.+ ++..++||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~ 80 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-ENNLYLVM 80 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-CCeEEEEE
Confidence 5777889999999999999954 588999999864221 23568899999999999999999997654 56899999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
||+++|+|.+++.+.. ..+++.+...++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.+..
T Consensus 81 e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 151 (331)
T cd05597 81 DYYVGGDLLTLLSKFE------DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLR 151 (331)
T ss_pred ecCCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceee
Confidence 9999999999986532 2377788888999999999999985 899999999999999999999999998754
Q ss_pred cCCCCcceeeeeeccCCCCccccCC-----CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCCh
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSS-----GSLTATCPYDVYCFGKVLLELVTGKMGISASSD 747 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~ 747 (919)
........ .....+++.+.+++.. +...++.++|||||||++|||+||+.||.....
T Consensus 152 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~ 213 (331)
T cd05597 152 LLADGTVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred cCCCCCcc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH
Confidence 43221111 1111233444444322 223467789999999999999999999976554
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=280.25 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=183.0
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
+|...+.||+|+||.||++... ++..||+|++..... ..++|.+|++++++++||||++++++|.. ++..++|+||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-NGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-CCEEEEEEEe
Confidence 5666788999999999999975 588999999865432 34679999999999999999999998876 4689999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+++++|.+++.... ..++.....+++.++++||+|||+. .+|+||||||+||++++++.+||+|||.+....
T Consensus 81 ~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 81 MDGGSLDKILKEVQ------GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred cCCCcHHHHHHHcc------CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 99999999986542 2477888889999999999999972 389999999999999999999999999765432
Q ss_pred CCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCCh--hHHHHHHHhhcccccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSD--AQVKEILEQTLPYISIYDKELV 769 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 769 (919)
...... ..+...+..++......++.++||||||+++|||+||+.|+..... ......+.....
T Consensus 153 ~~~~~~----~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 218 (265)
T cd06605 153 NSLAKT----FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---------- 218 (265)
T ss_pred HHHhhc----ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc----------
Confidence 211110 1222233333333334677889999999999999999999865421 111111111100
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 770 ~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
...+.+... ...+ .+..++..|+..+|++||++.+++.
T Consensus 219 --~~~~~~~~~-~~~~---~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 219 --EPPPRLPSG-KFSP---DFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --CCCCCCChh-hcCH---HHHHHHHHHcCCCchhCcCHHHHhh
Confidence 000111000 0111 2456888999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=281.18 Aligned_cols=263 Identities=19% Similarity=0.239 Sum_probs=182.5
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
|...+.||+|++|.||+|.. .+|..||||++...... .+.|.+|++++++++|||++++++++.+ ++..++||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-ENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-CCeEEEEEec
Confidence 34567899999999999985 47899999998654322 3568899999999999999999998876 4679999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
++ ++|.+++..... ..++|.++++++.++++||+|||+. +++||||+|+||++++++.+|++|||.+....
T Consensus 80 ~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 80 LD-LDLKKYMDSSPL-----TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred cC-cCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 95 689998865431 3489999999999999999999974 89999999999999999999999999876443
Q ss_pred CCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhccccc-c-----
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLPYIS-I----- 763 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~~~~~-~----- 763 (919)
...... ....+.+.+..++.. +...++.++|||||||++|||+||+.|+....+.. ...++........ .
T Consensus 151 ~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 151 VPVRTY--THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT 228 (283)
T ss_pred CCcccc--CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh
Confidence 221110 001112223333322 22345778999999999999999999997665432 2222221110000 0
Q ss_pred ccccc---ccccccCCCC-CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 764 YDKEL---VTKIVDPSLI-IDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 764 ~~~~~---~~~i~d~~l~-~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
...+. ..+...+... ..+... ..+.+++.+|++.+|++||+|++|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 229 SLPDYKPTFPKWARQDLSKVVPNLD---EDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hchhhhhhcccccccchhhhcCCCC---HHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 0000000000 000011 23567899999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=281.54 Aligned_cols=200 Identities=19% Similarity=0.289 Sum_probs=155.1
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
++|...+.||+|+||.||+|... ++..||||.+..... ....+.+|++++++++|+||+++++++.+ ++..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-KKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-CCeEEEEEe
Confidence 46777789999999999999965 678999999865432 23457889999999999999999998765 467999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+++ +|.+++.+.. ..+++.+...++.++++||.|||+. +|+||||||+||++++++.+|++|||.+...
T Consensus 84 ~~~~-~L~~~~~~~~------~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 84 YLDT-DLKQYMDDCG------GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred cCCC-CHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcccccccc
Confidence 9984 9999886543 2478888889999999999999985 8999999999999999999999999987643
Q ss_pred CCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCC
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASS 746 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~ 746 (919)
....... ......+.+.+++.. +...++.++|||||||++|||+||+.|+....
T Consensus 154 ~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 154 SVPSKTY--SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred CCCCccc--cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 2211110 000112222223322 23346778999999999999999999997554
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=283.45 Aligned_cols=264 Identities=17% Similarity=0.186 Sum_probs=178.0
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
|...+.||+|+||.||+|+. .+|..||+|++...... .+.+.+|++++++++||||+++++++.+ .+..++|+||
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 80 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-DKKLTLVFEY 80 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-CCceEEEEec
Confidence 55567899999999999986 46889999998653322 3568889999999999999999997765 4678999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
++ |+|.+++.... ..+++.+...|+.+|++||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 81 ~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 81 CD-QDLKKYFDSCN------GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred CC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 98 57888775432 2388999999999999999999985 89999999999999999999999999876543
Q ss_pred CCCcceeeeeeccCCCCccccC-CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChh-H-HHHHHHhhccccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDA-Q-VKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~-~-~~~~~~~~~~~~~~~~~~~ 768 (919)
..... .....+.+.+..++. .+...++.++|||||||++|||+||+.|+....+. . .........+ .....-..
T Consensus 151 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 227 (284)
T cd07839 151 IPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT-PTEESWPG 227 (284)
T ss_pred CCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCC-CChHHhHH
Confidence 22111 011112222333332 22234577899999999999999999986543322 1 1111110000 00000000
Q ss_pred ccccccC----CCCCC----cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 769 VTKIVDP----SLIID----EDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 769 ~~~i~d~----~l~~~----~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+.++.+. ..... +....--..+.+++..|++.+|.+|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000 00000 000000123456889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=290.10 Aligned_cols=204 Identities=18% Similarity=0.194 Sum_probs=160.1
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++|...+.||+|+||.||+++.. ++..||||.+..... ..+.|.+|+.++.+++|+||+++++++.+ ++..++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-ENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence 35777889999999999999864 578899999864321 23458889999999999999999997654 5689999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++.+.. ..+++.....++.+++.||+|||+. +|+||||||+|||++.++.+||+|||.+.
T Consensus 80 ~Ey~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~ 150 (331)
T cd05624 80 MDYYVGGDLLTLLSKFE------DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCL 150 (331)
T ss_pred EeCCCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecccee
Confidence 99999999999997532 2377888888999999999999974 89999999999999999999999999876
Q ss_pred hcCCCCcceeeeeeccCCCCccccCCCC-----CCCCCCCcchhHHHHHHHHHcCCCCCCCCChh
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGS-----LTATCPYDVYCFGKVLLELVTGKMGISASSDA 748 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~ 748 (919)
........ ......+++.+.+++.... ..++.++|||||||++|||+||+.||......
T Consensus 151 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~ 214 (331)
T cd05624 151 KMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred eccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH
Confidence 54332211 1112234444544443221 34677899999999999999999999866543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=282.32 Aligned_cols=267 Identities=19% Similarity=0.250 Sum_probs=183.4
Q ss_pred HhCCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecC-----
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERE----- 602 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~----- 602 (919)
+.++|...+.||+|+||.||+|... +|..||||+++.... ....+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4567888899999999999999975 588999999965432 2356788999999999999999999886532
Q ss_pred ----CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCc
Q 002462 603 ----NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFE 678 (919)
Q Consensus 603 ----~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~ 678 (919)
+..++|+||+++ ++...+.... ..++|.+...|+.+++.||+|||+. +|+||||||+||++++++.
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGL------VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCc
Confidence 268999999986 6766665431 2489999999999999999999985 8999999999999999999
Q ss_pred eeeCCcchhhhcCCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhh
Q 002462 679 VRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQT 757 (919)
Q Consensus 679 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~ 757 (919)
+||+|||.+.......... .......+.+..++.. +....+.++|||||||++|||+||+.|+....+.+....+...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~ 233 (302)
T cd07864 155 IKLADFGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233 (302)
T ss_pred EEeCcccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 9999999876543222110 0000111122222211 2234567899999999999999999999866543322222211
Q ss_pred c--cccccc----ccccccccccCCCCC-------CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 758 L--PYISIY----DKELVTKIVDPSLII-------DEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 758 ~--~~~~~~----~~~~~~~i~d~~l~~-------~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
. +....+ ..... ...++.-.. .+... ..+..++..|++.+|++||++.+|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYF-NTMKPKKQYRRRLREEFSFIP---TPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccc-cccccccccccchhhhcCCCC---HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 000000 00000 000000000 00011 13567888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=291.07 Aligned_cols=240 Identities=21% Similarity=0.336 Sum_probs=191.3
Q ss_pred hCCCCcccccccCCCCcEEEEEecC-CccEEEEEeccccc----cHHHHHHHHHHHhhcC-CCCccceeeEEeecCCcEE
Q 002462 533 TGDFSDANLIKNGHSGDLFRGILEG-GIPVVIKRIDLQSV----KTEAYLLELDFFSKVS-HARLVPLLGHCMERENEKF 606 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l~~-g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~~~~~ 606 (919)
..+|....+||+|+||+|+.+.+.+ +..+|||.++.... ..+..+.|-+++.-.. ||-++.|++ |++..+..|
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~-~fQT~~~l~ 445 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFS-CFQTKEHLF 445 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccc-ccccCCeEE
Confidence 4578888999999999999999754 67889999976543 2456778888887775 999999998 777788899
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcch
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~ 686 (919)
.||||+.+||+..+.+.. .++..+..-+|..|+-||.|||+. +||+||||-.|||||.+|.+||+|||+
T Consensus 446 fvmey~~Ggdm~~~~~~~--------~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHTD--------VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred EEEEecCCCcEEEEEecc--------cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccc
Confidence 999999999966555432 366666667899999999999985 899999999999999999999999999
Q ss_pred hhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHH-HHhhcccccccc
Q 002462 687 VCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEI-LEQTLPYISIYD 765 (919)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~-~~~~~~~~~~~~ 765 (919)
.+...+... ..+++.++|++++++......||...|.|||||+||||++|..||.+.+.+++-+- +.....|
T Consensus 515 cKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~y----- 587 (694)
T KOG0694|consen 515 CKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRY----- 587 (694)
T ss_pred ccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC-----
Confidence 886543322 35678999999999988888999999999999999999999999998876654322 2211111
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 002462 766 KELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLM 808 (919)
Q Consensus 766 ~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm 808 (919)
|+ .+..| .+.|+.+-+..+|++|--+
T Consensus 588 ---------P~-----~ls~e---a~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 588 ---------PR-----FLSKE---AIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---------CC-----cccHH---HHHHHHHHhccCcccccCC
Confidence 11 11222 3557778899999999777
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=282.77 Aligned_cols=264 Identities=19% Similarity=0.238 Sum_probs=183.0
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecC-CcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERE-NEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~-~~~~lV 608 (919)
++|...+.||+|+||.||+|... ++..||||+++..... ...+.+|++++.+++||||+++++++...+ +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 35677789999999999999965 5889999999654322 346788999999999999999999887542 578999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||++ ++|.+.+.... ..+++.+..+|+.++++||+|||+. +|+||||||+||++++++.+||+|||.+.
T Consensus 85 ~e~~~-~~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~ 154 (293)
T cd07843 85 MEYVE-HDLKSLMETMK------QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR 154 (293)
T ss_pred ehhcC-cCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCcee
Confidence 99998 59988886533 1488999999999999999999975 79999999999999999999999999776
Q ss_pred hcCCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHH-HHHHhhc-cc-----
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVK-EILEQTL-PY----- 760 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~-~~~~~~~-~~----- 760 (919)
........ .....+.+.+..++.. +....+.++|||||||++|||+||+.|+......... ....... |.
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 155 EYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred eccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 54332110 0111122223333322 2233577899999999999999999999876543321 1111100 00
Q ss_pred -c---ccccccccccc----ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 761 -I---SIYDKELVTKI----VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 761 -~---~~~~~~~~~~i----~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+ .........+. ++..+... .. -..+.+++..|++.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPAL-SL---SDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred Hhhccchhcccccccccchhhhcccccc-CC---ChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 00000000000 00111000 00 122456888999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=279.24 Aligned_cols=250 Identities=20% Similarity=0.271 Sum_probs=177.8
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc--cHHHHHHHHHH-HhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV--KTEAYLLELDF-FSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~--~~~~f~~Ei~~-l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
++|...+.||+|+||.||+|+.. +|..||||+++.... ...++..|+.+ ++..+|||||++++++.+ ++..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-EGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-CCcEEEEh
Confidence 36778889999999999999864 689999999875432 23456677765 566789999999998875 46799999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
|||+ |+|.+++..... ....+++.+..+++.|++.||+|||+. .+|+||||||+||++++++.+||+|||.+..
T Consensus 80 e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~ 153 (283)
T cd06617 80 EVMD-TSLDKFYKKVYD---KGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGY 153 (283)
T ss_pred hhhc-ccHHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9997 788888764321 114589999999999999999999974 3799999999999999999999999998765
Q ss_pred cCCCCcceeeeeeccCCCCccccCC----CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCCh--hHHHHHHHhhcccccc
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSS----GSLTATCPYDVYCFGKVLLELVTGKMGISASSD--AQVKEILEQTLPYISI 763 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~--~~~~~~~~~~~~~~~~ 763 (919)
....... +...+...+..++.. ....++.++|||||||++|||+||+.|+..... ..........
T Consensus 154 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------ 224 (283)
T cd06617 154 LVDSVAK---TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP------ 224 (283)
T ss_pred ccccccc---ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC------
Confidence 4321111 111122222222221 113457789999999999999999999864321 1111111110
Q ss_pred cccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 764 YDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 764 ~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.+.+.. +...+ .+..++..|++.+|++||++.+|+.
T Consensus 225 ----------~~~~~~-~~~~~---~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 ----------SPQLPA-EKFSP---EFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ----------CCCCCc-cccCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 011100 01112 2456888999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=287.25 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=177.3
Q ss_pred ccccccCCCCcEEEEE-ecCCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCC
Q 002462 539 ANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGD 616 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~Gs 616 (919)
.-++|+|.||+||.|+ +.+...+|||.+...... .+-...||.+.++++|+|||+++|.|.+ ++..-|.||-+||||
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVPGGS 658 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCCCCc
Confidence 4579999999999999 455678999999655433 3446789999999999999999997765 467789999999999
Q ss_pred hhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCC-CCceeeCCcchhhhcCCCCc
Q 002462 617 LSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD-KFEVRLGSLSEVCAQGGDAH 695 (919)
Q Consensus 617 L~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~-~~~~kl~dfg~~~~~~~~~~ 695 (919)
|.+.|+.+=++..+ ...+.--+..||.+||.|||+. .|||||||..|||++. .|..||+|||..+...+-.-
T Consensus 659 LSsLLrskWGPlKD----NEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP 731 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKD----NESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP 731 (1226)
T ss_pred HHHHHHhccCCCcc----chhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc
Confidence 99999865432111 2233344577999999999986 8999999999999985 68999999998776544322
Q ss_pred -c--eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 696 -Q--SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 696 -~--~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
+ .+.+--+++|+..++|..| |..++|||||||++.||.|||+||......+...+--+. + +
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RG---YG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGm------y------K- 795 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRG---YGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGM------Y------K- 795 (1226)
T ss_pred cccccccchhhhChHhhccCCcC---CCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcc------e------e-
Confidence 1 1122234455555555444 455679999999999999999999765433221111110 0 1
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+.|.+ .++..+++ ...+++|..++|.+||++++++.
T Consensus 796 vHP~i--Peelsaea---k~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 796 VHPPI--PEELSAEA---KNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cCCCC--cHHHHHHH---HHHHHHHcCCCcccCccHHHhcc
Confidence 12222 23333333 34778999999999999998875
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=282.47 Aligned_cols=269 Identities=19% Similarity=0.226 Sum_probs=181.8
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc---cHHHHHHHHHHHhhcC-CCCccceeeEEeecCC----c
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV---KTEAYLLELDFFSKVS-HARLVPLLGHCMEREN----E 604 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~~----~ 604 (919)
++|...+.||+|+||.||+|... +|..||||++..... ..+.+.+|++++++++ ||||+++++++...+. .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 35778889999999999999964 689999998865432 2357889999999995 6999999997765322 2
Q ss_pred EEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCC-CCceeeCC
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD-KFEVRLGS 683 (919)
Q Consensus 605 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~-~~~~kl~d 683 (919)
.++||||+++ +|.+++...... ....+++.+...++.+|++||+|||+. +|+||||||+||++|. ++.+|++|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG--PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEee
Confidence 7999999995 898888654321 123589999999999999999999975 8999999999999998 89999999
Q ss_pred cchhhhcCCCCcceeeeeeccCCCCccccC-CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhc-cc
Q 002462 684 LSEVCAQGGDAHQSRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTL-PY 760 (919)
Q Consensus 684 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~-~~ 760 (919)
||.+.......... ....+.+.+..++. .+...++.++|||||||++|||+||+.|+...++.. ......... |.
T Consensus 155 fg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 232 (295)
T cd07837 155 LGLGRAFSIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232 (295)
T ss_pred cccceecCCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99776432211110 00111222333332 123346788999999999999999999997655432 222222110 00
Q ss_pred cccccccccccccc----CCCCCCcch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 761 ISIYDKELVTKIVD----PSLIIDEDL----LEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 761 ~~~~~~~~~~~i~d----~~l~~~~~~----~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.... .......+ +... .... ...-..+..++..|++++|++||++.+++.
T Consensus 233 ~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVW--PGVSKLRDWHEFPQWK-PQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhC--cchhhccchhhcCccc-chhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 00000000 0000 0000 000123566889999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=278.68 Aligned_cols=266 Identities=19% Similarity=0.259 Sum_probs=183.5
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
+|...+.||+|++|.||+|+.. +|..||||++..... ..+.+.+|++++++++|+||+++++++.+ .+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-ENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-CCcEEEEEec
Confidence 4677889999999999999964 688999999875433 24567889999999999999999998876 4578999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+++ +|.+++..... ...++|.+..+++.++++||+|||+. +|+||||||+||++++++.+|++|||.+....
T Consensus 80 ~~~-~l~~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 80 MDK-DLKKYMDTHGV----RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred CCc-cHHHHHHhcCC----CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 995 88888764331 13489999999999999999999974 89999999999999999999999999876543
Q ss_pred CCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH-HHHHHhhc-cccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTL-PYISIYDKEL 768 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~-~~~~~~~~-~~~~~~~~~~ 768 (919)
...... ........+..++.. +...++.++|||||||++|||+||+.|+...+..+. ....+... |..... +.
T Consensus 152 ~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 227 (284)
T cd07836 152 IPVNTF--SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW--PG 227 (284)
T ss_pred CCcccc--ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH--HH
Confidence 211110 001112222223321 233457789999999999999999999987654332 22222111 100000 00
Q ss_pred ccc--cccCCCCC-CcchHH-----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 769 VTK--IVDPSLII-DEDLLE-----EVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 769 ~~~--i~d~~l~~-~~~~~~-----~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+.. ........ ...... .-..+.++...|++.+|.+||++.+|++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 228 ISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 00000000 000000 0123456888999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=287.19 Aligned_cols=203 Identities=20% Similarity=0.221 Sum_probs=159.4
Q ss_pred CCCcccccccCCCCcEEEEEecC-CccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILEG-GIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~-g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
+|...++||+|+||.||+++..+ +..+|+|.+..... ..+.|..|+.++.+++|+||+++++++.+ ++..++||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~ 80 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-ENNLYLVM 80 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCEEEEEE
Confidence 57778899999999999999654 67899999854221 23458889999999999999999997654 56899999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
||+++|+|.+++.+.. ..+++.....|+.+++.||+|||+. +|+||||||+|||++.++.+||+|||.+..
T Consensus 81 ey~~~g~L~~~l~~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~ 151 (332)
T cd05623 81 DYYVGGDLLTLLSKFE------DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLK 151 (332)
T ss_pred eccCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchhee
Confidence 9999999999997532 2378888889999999999999984 899999999999999999999999998764
Q ss_pred cCCCCcceeeeeeccCCCCccccCC-----CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChh
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSS-----GSLTATCPYDVYCFGKVLLELVTGKMGISASSDA 748 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~ 748 (919)
....... ......+++.+..++.. +...++.++|||||||++|||+||+.||...+..
T Consensus 152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~ 214 (332)
T cd05623 152 LMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (332)
T ss_pred cccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH
Confidence 3221111 11112344444444432 2335678899999999999999999999876543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=289.87 Aligned_cols=235 Identities=17% Similarity=0.167 Sum_probs=169.3
Q ss_pred cccCCCCcEEEEEe-cCCccEEEEEecccccc----HHHHHHHHHHHhhc---CCCCccceeeEEeecCCcEEEEEEecC
Q 002462 542 IKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK----TEAYLLELDFFSKV---SHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 542 ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l---~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
||+|+||.||+|+. .+|..||||++...... ...+..|..++.+. +||||+++++++.+ .+..++||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-DSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-CCeEEEEEcCCC
Confidence 79999999999985 46889999998643221 23456677777766 69999999986654 567999999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|.+++.+.. .+++.+...|+.|+++||+|||+. +|+||||||+|||+++++.+||+|||.+......
T Consensus 80 ~g~L~~~l~~~~-------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 80 GGELFWHLQKEG-------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTD 149 (330)
T ss_pred CChHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC
Confidence 999999886432 378888899999999999999985 8999999999999999999999999987643221
Q ss_pred CcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
... .....+++.|..++.. +...++.++|||||||++|||+||+.||......+....+.... . .+
T Consensus 150 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------~---~~ 216 (330)
T cd05586 150 NKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK--------V---RF 216 (330)
T ss_pred CCC--ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC--------C---CC
Confidence 111 1112234444444432 23346788999999999999999999998765443222111100 0 00
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMR 809 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~ 809 (919)
+. ....++ +..+...|++.+|.+||++.
T Consensus 217 --~~----~~~~~~---~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 217 --PK----NVLSDE---GRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred --CC----ccCCHH---HHHHHHHHcCCCHHHCCCCC
Confidence 00 001111 34577899999999999654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=279.48 Aligned_cols=241 Identities=20% Similarity=0.210 Sum_probs=180.1
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEecccc----ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQS----VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~----~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
+|...+.||+|+||.||++... ++..||||.+.... ...+.+.+|++++++++||||+++++++.+ ++..++||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~ 80 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-DSNLYLVM 80 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCeEEEEE
Confidence 5667789999999999999864 68899999986432 124578899999999999999999997765 46789999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
||+++|+|.+++.+.. .+++..+..++.++++||+|||+. +|+||||||+||++++++.+||+|||.+..
T Consensus 81 e~~~~~~L~~~~~~~~-------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 150 (290)
T cd05580 81 EYVPGGELFSHLRKSG-------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKR 150 (290)
T ss_pred ecCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence 9999999999986542 378888999999999999999984 899999999999999999999999998765
Q ss_pred cCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccc
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELV 769 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (919)
...... ...+.+.+..++.......+.++||||||+++|||+||+.|+...........+....
T Consensus 151 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 214 (290)
T cd05580 151 VKGRTY-----TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK----------- 214 (290)
T ss_pred cCCCCC-----CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 543311 1123333444443333356778999999999999999999997655332221111100
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 002462 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP-----LMRYIL 812 (919)
Q Consensus 770 ~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RP-----sm~~V~ 812 (919)
......... .+..+...|++.+|.+|| +.+|++
T Consensus 215 -------~~~~~~~~~---~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 215 -------VRFPSFFSP---DAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred -------ccCCccCCH---HHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 000111111 234577899999999999 455554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=289.27 Aligned_cols=267 Identities=16% Similarity=0.196 Sum_probs=183.4
Q ss_pred hCCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecC----CcE
Q 002462 533 TGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERE----NEK 605 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~----~~~ 605 (919)
+++|...+.||+|+||.||+|+. .+|..||||++..... ..+.+.+|+.++++++|+|||++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46788889999999999999984 5689999999864322 2456889999999999999999999765432 247
Q ss_pred EEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcc
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS 685 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg 685 (919)
++||||+++ +|.+.+.. ..+++.....|+.++++||+|||+. +|+||||||+||+++.++.+|++|||
T Consensus 84 ~lv~e~~~~-~l~~~~~~--------~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg 151 (336)
T cd07849 84 YIVQELMET-DLYKLIKT--------QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFG 151 (336)
T ss_pred EEEehhccc-CHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccc
Confidence 999999985 78776643 2388888999999999999999985 89999999999999999999999999
Q ss_pred hhhhcCCCCc-ceeeeeeccCCCCccccC-CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccc
Q 002462 686 EVCAQGGDAH-QSRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISI 763 (919)
Q Consensus 686 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~ 763 (919)
.+........ ........+++.+.+++. .+...++.++|||||||++|||+||+.|+...........+.......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~-- 229 (336)
T cd07849 152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP-- 229 (336)
T ss_pred ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC--
Confidence 8765432111 111111122333333432 222346778999999999999999999997654332222111111100
Q ss_pred cccccccccccCCC-------CCCc--c---h-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 764 YDKELVTKIVDPSL-------IIDE--D---L-LEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 764 ~~~~~~~~i~d~~l-------~~~~--~---~-~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
..+....+.+... .... . . ...-..+..++..|++.+|++||++.++++.
T Consensus 230 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 230 -SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred -CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0011111111000 0000 0 0 0011235678999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=270.73 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=185.9
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc-cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV-KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~-~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
+|...+.||+|++|.||++... ++..+++|++..... ..+.+.+|++++++++|+|++++++++.. ++..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-KDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEEecC
Confidence 3566788999999999999975 688999999976554 45679999999999999999999997765 46789999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++++|.+++.... ..++|..+..|+.++++||+|||.. +++||||||+||++++++.++|.|||.+.....
T Consensus 80 ~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 80 SGGSLKDLLKSTN------QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD 150 (253)
T ss_pred CCCcHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccc
Confidence 9999999986542 3489999999999999999999984 899999999999999999999999997765543
Q ss_pred CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccc
Q 002462 693 DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
... .....+...+..++.......+.++||||||+++|||+||+.|+...+........... .....
T Consensus 151 ~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------~~~~~ 217 (253)
T cd05122 151 TKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN----------GPPGL 217 (253)
T ss_pred ccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc----------CCCCc
Confidence 221 01112222333333333334778899999999999999999999766433222211110 00011
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.++ ..... .+..++..|++.+|++||++.+|++
T Consensus 218 ~~~-----~~~~~---~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 218 RNP-----EKWSD---EFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred Ccc-----cccCH---HHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 00011 2556788999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=281.57 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=175.6
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc--cHHHHHHHHHHHhhcC-CCCccceeeEEeecCCcEEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV--KTEAYLLELDFFSKVS-HARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~~~~~lV~E 610 (919)
+|.....||+|+||.||++.. .+|..||||++..... ....|.+|+.++.++. |+|||+++|++.. ++..++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-EGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-CCcEEEEEe
Confidence 344557899999999999985 4578999999865432 2457899999999997 9999999998765 467899999
Q ss_pred ecCCCChhhh---hhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchh
Q 002462 611 YMPNGDLSSS---LYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 611 y~~~GsL~~~---L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~ 687 (919)
|++. ++.+. ++... ...+++....+++.++++||+|||+. .+|+||||||+||+++.++.+||+|||++
T Consensus 84 ~~~~-~l~~l~~~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 155 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVL-----KSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155 (288)
T ss_pred cccC-CHHHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchh
Confidence 9874 55443 22211 13588999999999999999999974 37999999999999999999999999987
Q ss_pred hhcCCCCcceeeeeeccCCCCccccCCCC---CCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccc
Q 002462 688 CAQGGDAHQSRITRLLRLPQSSEQGSSGS---LTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIY 764 (919)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~ 764 (919)
......... ....+...+..++.... ..++.++|||||||++|||+||+.|+..... .... +.....
T Consensus 156 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~-~~~~~~----- 225 (288)
T cd06616 156 GQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-VFDQ-LTQVVK----- 225 (288)
T ss_pred HHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-HHHH-HhhhcC-----
Confidence 654322111 01112222333332222 2567889999999999999999999865431 1111 111000
Q ss_pred ccccccccccCCCCCCc--chHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 765 DKELVTKIVDPSLIIDE--DLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 765 ~~~~~~~i~d~~l~~~~--~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
. ..+.+..+. .... .+..++.+|++.+|++||++.+|++
T Consensus 226 --~-----~~~~~~~~~~~~~~~---~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 226 --G-----DPPILSNSEEREFSP---SFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred --C-----CCCcCCCcCCCccCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 001111110 1112 3567888999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=270.95 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=185.7
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecC-CcEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERE-NEKFLVY 609 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~-~~~~lV~ 609 (919)
+|...+.||+|++|.||+|... ++..|+||++..... ..+.+.+|++++++++|+||+++++++.+.. ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999976 688999999876553 3567899999999999999999999876531 5789999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
||+++++|.+++.... .++|.++..++.++++||+|||+. +++|+||+|+||++++++.++|+|||.+..
T Consensus 81 e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 150 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKR 150 (260)
T ss_pred EecCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence 9999999999986432 489999999999999999999984 899999999999999999999999997665
Q ss_pred cCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccc
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELV 769 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (919)
..................+..++.......+.++||||||++++||++|+.|+....+.. ....... .....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~-------~~~~~ 222 (260)
T cd06606 151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-AALYKIG-------SSGEP 222 (260)
T ss_pred cccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHhcc-------ccCCC
Confidence 443321000111122233334444444457888999999999999999999997655211 1111100 00000
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 770 ~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..+ .+.... .+..++.+|++.+|++||++.++++
T Consensus 223 ~~~-------~~~~~~---~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 PEI-------PEHLSE---EAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCC-------CcccCH---HHHHHHHHhCcCChhhCCCHHHHhh
Confidence 000 111111 3556788999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=281.10 Aligned_cols=243 Identities=23% Similarity=0.348 Sum_probs=179.2
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc----HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK----TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
|...+.||+|+||.||+|+. .+|..||+|++...... .+++.+|++++++++|||+|+++++|.+ ++..++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 105 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-EHTAWLVME 105 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCeEEEEEe
Confidence 56678899999999999995 46889999998643221 3468899999999999999999998876 457899999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|++ |+|.+.+.... ..++|.++..|+.++|+||.|||+. +|+||||||+||++++++.+|++|||.+...
T Consensus 106 ~~~-g~l~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 106 YCL-GSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIA 175 (317)
T ss_pred CCC-CCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence 997 58877775432 2489999999999999999999975 8999999999999999999999999976543
Q ss_pred CCCCcceeeeeeccCCCCccccCC---CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH-HHHHHhhccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSS---GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTLPYISIYDK 766 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 766 (919)
..... ..+.+.+..++.. ....++.++|||||||++|||+||+.|+........ ..+.....+
T Consensus 176 ~~~~~------~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~------- 242 (317)
T cd06635 176 SPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP------- 242 (317)
T ss_pred CCccc------ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC-------
Confidence 22111 1122223333321 123467789999999999999999999876543221 112111100
Q ss_pred ccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L 815 (919)
... .+...+ .+..++.+|++.+|.+||++.+|++.+
T Consensus 243 ---------~~~-~~~~~~---~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 243 ---------TLQ-SNEWSD---YFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred ---------CCC-CccccH---HHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 000 011111 255688899999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=283.77 Aligned_cols=252 Identities=19% Similarity=0.230 Sum_probs=182.8
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEecccccc----HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVK----TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
+|...+.||+|+||.||+|... ++..||||.+...... .+.+..|++++.+++|+||+++++++.+ +...++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~ 80 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-ETYLCLVM 80 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-CCEEEEEE
Confidence 5777889999999999999965 4899999998654322 3568899999999999999999997765 56789999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
||+++|+|.+++.+... ..+++.....++.++++||+|||.. +|+||||||+||+++.++.++++|||.+..
T Consensus 81 e~~~~~~L~~~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 152 (316)
T cd05574 81 DYCPGGELFRLLQRQPG-----KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQ 152 (316)
T ss_pred EecCCCCHHHHHHhCCC-----CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence 99999999999864321 3488899999999999999999975 899999999999999999999999997764
Q ss_pred cCCCCccee---------------------------eeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCC
Q 002462 690 QGGDAHQSR---------------------------ITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGI 742 (919)
Q Consensus 690 ~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~ 742 (919)
......... .....++..+..++......++.++|||||||++|||+||+.|+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf 232 (316)
T cd05574 153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232 (316)
T ss_pred ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence 422111000 00011222333333333345677899999999999999999999
Q ss_pred CCCChhHH-HHHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 002462 743 SASSDAQV-KEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815 (919)
Q Consensus 743 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L 815 (919)
........ ........+ ........+ .+..++..|++.+|++||+++..++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~---~~~~li~~~l~~~p~~R~s~~~~~~~l 286 (316)
T cd05574 233 KGSNRDETFSNILKKEVT-----------------FPGSPPVSS---SARDLIRKLLVKDPSKRLGSKRGAAEI 286 (316)
T ss_pred CCCchHHHHHHHhcCCcc-----------------CCCccccCH---HHHHHHHHHccCCHhHCCCchhhHHHH
Confidence 76554321 111111000 000000111 355688899999999999955544444
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=281.87 Aligned_cols=249 Identities=22% Similarity=0.312 Sum_probs=177.0
Q ss_pred CCCCcccccccCCCCcEEEEEecC-CccEEEEEeccccc--cHHHHHHHHHHHhhcC-CCCccceeeEEeecCCcEEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEG-GIPVVIKRIDLQSV--KTEAYLLELDFFSKVS-HARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~-g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~~~~~lV~ 609 (919)
++|...+.||+|+||.||+|...+ +..||||+++.... ...++..|++++.+.+ ||||++++|+|.+ +...++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-DSDVFICM 93 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-CCeEEEEe
Confidence 456667899999999999999865 88999999865432 2456778888887776 9999999999876 45799999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
||++ ++|.+.+.... ..++|.++.+|+.++++||+|||+. .+|+||||||+||++++++.+||+|||.+..
T Consensus 94 e~~~-~~l~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ------GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred eccC-cCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence 9986 46766654322 2589999999999999999999963 3799999999999999999999999998764
Q ss_pred cCCCCcceeeeeeccCCCCccccCCC----CCCCCCCCcchhHHHHHHHHHcCCCCCCCCChh-H-HHHHHHhhcccccc
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSSG----SLTATCPYDVYCFGKVLLELVTGKMGISASSDA-Q-VKEILEQTLPYISI 763 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~-~-~~~~~~~~~~~~~~ 763 (919)
....... ....+.+.+..++... ...++.++|||||||++|||+||+.|+...... + ...++....+
T Consensus 165 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 237 (296)
T cd06618 165 LVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP---- 237 (296)
T ss_pred ccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC----
Confidence 4321111 1111122222222221 123677899999999999999999998653221 1 1111111100
Q ss_pred cccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 764 YDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 764 ~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
.........+ .+..++.+|++.+|.+||++.+|++.
T Consensus 238 ------------~~~~~~~~~~---~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 ------------SLPPNEGFSP---DFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ------------CCCCCCCCCH---HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000112 35668889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=290.73 Aligned_cols=241 Identities=19% Similarity=0.333 Sum_probs=185.9
Q ss_pred ccccccCCCCcEEEEEe-cCCccEEEEEec---ccc--ccHHHHHHHHHHHhhcCCCCccceeeEEeecCC-cEEEEEEe
Q 002462 539 ANLIKNGHSGDLFRGIL-EGGIPVVIKRID---LQS--VKTEAYLLELDFFSKVSHARLVPLLGHCMEREN-EKFLVYKY 611 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~---~~~--~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~-~~~lV~Ey 611 (919)
..+||+|.|=+||||.- ..|..||=-.++ ... ...+.|..|+.+|+.|+|||||+++.++.+..+ ..-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 45799999999999984 457777633222 222 224789999999999999999999998775433 45789999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC-CceeeCCcchhhhc
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK-FEVRLGSLSEVCAQ 690 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~-~~~kl~dfg~~~~~ 690 (919)
|..|+|..++.+.+. ++.....+.+.||.+||.|||++ .|||||||||..||+|+.+ |.+||||+|+|...
T Consensus 125 ~TSGtLr~Y~kk~~~-------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR-------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred ccCCcHHHHHHHhcc-------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 999999999876543 55556677899999999999995 7899999999999999865 89999999999877
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCC-hhHHHH-HHHhhccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASS-DAQVKE-ILEQTLPYISIYDKEL 768 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~-~~~~~~-~~~~~~~~~~~~~~~~ 768 (919)
..... ..+.|+|+.++++... -.|.+..||||||+.++||+|+..||.... ++++.+ +..+.. ++.
T Consensus 197 r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK-------P~s 264 (632)
T KOG0584|consen 197 RKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK-------PAA 264 (632)
T ss_pred hcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC-------HHH
Confidence 54332 3367888888877655 357888999999999999999999998754 344333 223322 234
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+.++-||. +..++..|+.. .++|||+.|+++
T Consensus 265 l~kV~dPe-------------vr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 265 LSKVKDPE-------------VREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hhccCCHH-------------HHHHHHHHhcC-chhccCHHHHhh
Confidence 44444432 44578899999 999999999986
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=279.25 Aligned_cols=242 Identities=19% Similarity=0.305 Sum_probs=180.2
Q ss_pred cccccCCCCcEEEEEe-cCCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCCh
Q 002462 540 NLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDL 617 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL 617 (919)
.+||+|+||.||+|.. .+|..||||++...... .+.|.+|+.++++++|+||+++++++.. ++..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-CCEEEEEEecCCCCcH
Confidence 5799999999999986 57889999998654333 4578999999999999999999998765 4689999999999999
Q ss_pred hhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcce
Q 002462 618 SSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQS 697 (919)
Q Consensus 618 ~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~~ 697 (919)
.+++... .++|.....++.+++.||+|||+. +|+||||||+||++++++.++++|||.+..........
T Consensus 105 ~~~~~~~--------~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~ 173 (292)
T cd06657 105 TDIVTHT--------RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173 (292)
T ss_pred HHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence 9877432 378889999999999999999985 89999999999999999999999999765433221111
Q ss_pred eeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccccCCC
Q 002462 698 RITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSL 777 (919)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l 777 (919)
....+.+.+..++......++.++|||||||++|||+||+.|+...........+....+ +.+
T Consensus 174 --~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~---------------~~~ 236 (292)
T cd06657 174 --KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---------------PKL 236 (292)
T ss_pred --cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC---------------ccc
Confidence 111223334444443444567889999999999999999999976554433222222111 000
Q ss_pred CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 778 IIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 778 ~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
........ .+..++..|++.+|.+||++.+|++
T Consensus 237 ~~~~~~~~---~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 237 KNLHKVSP---SLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCcccCCH---HHHHHHHHHHhCCcccCcCHHHHhc
Confidence 00000011 2445778999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=281.16 Aligned_cols=269 Identities=19% Similarity=0.249 Sum_probs=182.0
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecC-------
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERE------- 602 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~------- 602 (919)
++|.....||+|+||.||+|.. .++..||||++...... ...+.+|++++++++||||++++++|...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 4677888999999999999986 46889999998543221 345678999999999999999999886532
Q ss_pred CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeC
Q 002462 603 NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG 682 (919)
Q Consensus 603 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~ 682 (919)
...++||||+++ +|.+.+.... ..+++.+..+|+.++++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~ 161 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN------VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLA 161 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEEC
Confidence 235999999974 7887775432 2488999999999999999999985 89999999999999999999999
Q ss_pred CcchhhhcCCCCcc--eeeeeeccCCCCccccC-CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcc
Q 002462 683 SLSEVCAQGGDAHQ--SRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLP 759 (919)
Q Consensus 683 dfg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~ 759 (919)
|||.+......... .......+...+.+++. .+...++.++|||||||++|||+||+.|+...........+.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99987654321111 00111111222333332 2333456789999999999999999999987665433333222110
Q ss_pred ccc--cc----ccccccccccCCCCCCcchHH------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 760 YIS--IY----DKELVTKIVDPSLIIDEDLLE------EVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 760 ~~~--~~----~~~~~~~i~d~~l~~~~~~~~------~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
... .. ..+....+..+.-. ...... +-..+.+++..|++.+|++||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQ-KRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CCChhhcccccchhhhhhccCCCcc-chhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 00 00000000000000 000000 0123457899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=286.71 Aligned_cols=270 Identities=15% Similarity=0.215 Sum_probs=183.5
Q ss_pred cCHHHHHHHh----CCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCcccee
Q 002462 524 FTYQQLLAAT----GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLL 595 (919)
Q Consensus 524 ~~~~~l~~at----~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~ 595 (919)
|+.+|+.+++ ++|...+.||+|+||.||+|+. .+|..||||++..... ..+.+.+|++++++++||||++++
T Consensus 1 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~ 80 (342)
T cd07879 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80 (342)
T ss_pred CchhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchh
Confidence 4455666664 6788889999999999999985 5689999999864321 235688999999999999999999
Q ss_pred eEEeecC-----CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCc
Q 002462 596 GHCMERE-----NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASS 670 (919)
Q Consensus 596 g~c~~~~-----~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~N 670 (919)
+++.... ...++|+||+.. +|..++. ..+++.....++.++++||+|||.. +|+||||||+|
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~N 147 (342)
T cd07879 81 DVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG---------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGN 147 (342)
T ss_pred heecccccCCCCceEEEEeccccc-CHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHH
Confidence 9775432 246899999974 6665541 1378888999999999999999985 79999999999
Q ss_pred eecCCCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH
Q 002462 671 ILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ 749 (919)
Q Consensus 671 ILld~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~ 749 (919)
|+++.++.+|++|||.+........... +.+.+..++.. +...++.++|||||||++|||+||+.||.......
T Consensus 148 Ill~~~~~~kL~dfg~~~~~~~~~~~~~-----~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~ 222 (342)
T cd07879 148 LAVNEDCELKILDFGLARHADAEMTGYV-----VTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 222 (342)
T ss_pred EEECCCCCEEEeeCCCCcCCCCCCCCce-----eeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999998765432221111 12222233322 22346778999999999999999999998765332
Q ss_pred -HHHHHHhhccccc--c---ccccccccccc--CCCCCCcchH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 750 -VKEILEQTLPYIS--I---YDKELVTKIVD--PSLIIDEDLL----EEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 750 -~~~~~~~~~~~~~--~---~~~~~~~~i~d--~~l~~~~~~~----~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
...... ..+... . .........++ +... ..... ..-..+..++..|++.+|.+||++.+|+.
T Consensus 223 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 223 QLTQILK-VTGVPGPEFVQKLEDKAAKSYIKSLPKYP-RKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHHHHH-hcCCCCHHHHHHhcccchHHHHhhcCCcc-cchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 211111 110000 0 00000000000 0000 00000 00113557889999999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=273.41 Aligned_cols=252 Identities=20% Similarity=0.321 Sum_probs=179.6
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc-------cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEE
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV-------KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKF 606 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~-------~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~ 606 (919)
+|+..+.||+|+||.||+|.. .++..||+|.+..... ..++|.+|++++++++|+|||++++++.+ .+..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-DSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-CCeEE
Confidence 466778999999999999984 6788999999864321 13578899999999999999999998865 45789
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCC-ceeeCCcc
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF-EVRLGSLS 685 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~-~~kl~dfg 685 (919)
+||||+++|+|.+++.+.. ++++.....++.++++||+|||+. +++||||||+||+++.++ .+|++|||
T Consensus 80 ~v~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg 149 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYG-------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFG 149 (268)
T ss_pred EEEeccCCCcHHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccc
Confidence 9999999999999986432 478889999999999999999985 899999999999998775 69999999
Q ss_pred hhhhcCCCCcce-e-eeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccc
Q 002462 686 EVCAQGGDAHQS-R-ITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISI 763 (919)
Q Consensus 686 ~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~ 763 (919)
.+.......... . .....++..+..++......++.++||||+|+++|||+||+.|+.................
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---- 225 (268)
T cd06630 150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS---- 225 (268)
T ss_pred cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc----
Confidence 875543221100 0 0011122223333322223567789999999999999999999865432211111111000
Q ss_pred cccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 764 YDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 764 ~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
....+.. ++.... .+..++..|++.+|++||++.++++
T Consensus 226 -------~~~~~~~--~~~~~~---~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 -------ATTAPSI--PEHLSP---GLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -------cCCCCCC--chhhCH---HHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0000111 111111 2455788999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=272.63 Aligned_cols=242 Identities=19% Similarity=0.272 Sum_probs=186.3
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEeccccccHH----HHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTE----AYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~----~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
|...+.+|+|.||.|-++.- ..|..||||.++.+..+.+ ...+||++|+.++||||+.++..+ +..+...||||
T Consensus 55 yE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-ENkdKIvivME 133 (668)
T KOG0611|consen 55 YEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-ENKDKIVIVME 133 (668)
T ss_pred HHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-cCCceEEEEEE
Confidence 33445799999999999984 7799999999977665532 467899999999999999999954 55667899999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|..+|.|.+++.+++ .|+....-.+..||..|+.|+|.. ++||||||-.|||||++.++||+|||+.-..
T Consensus 134 YaS~GeLYDYiSer~-------~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 134 YASGGELYDYISERG-------SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred ecCCccHHHHHHHhc-------cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 999999999997553 477778888999999999999985 8999999999999999999999999987654
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCC-CCCCcchhHHHHHHHHHcCCCCCCCCChhHHHH-HHHhhccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTA-TCPYDVYCFGKVLLELVTGKMGISASSDAQVKE-ILEQTLPYISIYDKEL 768 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 768 (919)
.... ...++.+.|-|..++...+..| ....|-||+||+||-|+-|..||++.+-..+.. +-.+++
T Consensus 204 ~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY---------- 270 (668)
T KOG0611|consen 204 ADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY---------- 270 (668)
T ss_pred cccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc----------
Confidence 3322 2344566666666555443333 456899999999999999999999876433221 111111
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
. .|.-.. ...-++.+.+..+|++|.|+.+|...
T Consensus 271 -r---EP~~PS---------dA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 271 -R---EPETPS---------DASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred -c---CCCCCc---------hHHHHHHHHHhcCcccchhHHHHhhh
Confidence 0 111111 13347889999999999999999863
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-29 Score=273.44 Aligned_cols=264 Identities=17% Similarity=0.200 Sum_probs=179.7
Q ss_pred CCcccccccCCCCcEEEEEecC-CccEEEEEecccccc---HHHHHHHHHHHhhc---CCCCccceeeEEeecCC----c
Q 002462 536 FSDANLIKNGHSGDLFRGILEG-GIPVVIKRIDLQSVK---TEAYLLELDFFSKV---SHARLVPLLGHCMEREN----E 604 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~~-g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l---~H~niV~l~g~c~~~~~----~ 604 (919)
|...+.||+|+||.||+|+... +..||||++...... ...+.+|++++.++ +|+||+++++++...+. .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4556789999999999999764 899999999643222 34577888877666 59999999998876432 2
Q ss_pred EEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCc
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSL 684 (919)
Q Consensus 605 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~df 684 (919)
.++||||++ ++|.+++.+... ..++|.++..++.++++||+|||+. +|+||||||+||++++++.+|++||
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~df 151 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-----PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADF 151 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEecc
Confidence 899999998 489888865321 2489999999999999999999985 7999999999999999999999999
Q ss_pred chhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhcc-c--
Q 002462 685 SEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLP-Y-- 760 (919)
Q Consensus 685 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~~-~-- 760 (919)
|.+......... ....+...+..++.......+.++|||||||++|||+||+.|+......+ ...+...... .
T Consensus 152 g~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 152 GLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228 (287)
T ss_pred CcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChH
Confidence 977654322111 01111222333333333456788999999999999999999988765443 2333322110 0
Q ss_pred ----ccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 761 ----ISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 761 ----~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
................. .....+-...+.+++..|++.+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSF--KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcCCCcccchhhcccccccch--hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000000000000 0000011123456889999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=279.91 Aligned_cols=269 Identities=22% Similarity=0.244 Sum_probs=184.3
Q ss_pred hCCCCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecC-CcEEE
Q 002462 533 TGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERE-NEKFL 607 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~-~~~~l 607 (919)
.++|...+.||+|+||.||+|.. .+|..||+|++...... ...+.+|++++++++|+||+++++++.+.. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 35688889999999999999996 45899999998654322 235678999999999999999999876432 35799
Q ss_pred EEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchh
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~ 687 (919)
||||++ ++|.+++.... ..++|.+...++.++++||+|||+. +|+||||||+||++++++.+||+|||.+
T Consensus 86 v~e~~~-~~l~~~l~~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~ 155 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP------TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLA 155 (309)
T ss_pred EEecCC-CCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcccee
Confidence 999997 48888876432 3489999999999999999999985 7999999999999999999999999987
Q ss_pred hhcCCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccc--ccc
Q 002462 688 CAQGGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYI--SIY 764 (919)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~--~~~ 764 (919)
.......... ......+.+..++.. +...++.++|||||||++|||+||+.|+...++.+....+....... ...
T Consensus 156 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 156 RTYGLPAKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred eecCCccCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 6543221110 111112223333322 23346778999999999999999999998776544332222211100 000
Q ss_pred c----ccccccc-ccC-CCCCCcch-HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 765 D----KELVTKI-VDP-SLIIDEDL-LEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 765 ~----~~~~~~i-~d~-~l~~~~~~-~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
. ....... +.. ........ ...-..+..++..|++.+|++||++.+|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0000000 000 00000000 000123456889999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=273.84 Aligned_cols=246 Identities=18% Similarity=0.173 Sum_probs=181.7
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
+|...+.||+|+||.||+|... ++..||+|.+..... ..+.+.+|++++++++||||+++++++.+ ++..++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-EENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-CCeEEEEE
Confidence 4667789999999999999965 588999999864331 24678999999999999999999997654 56799999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
||+++++|.+++... ..+++.+...|+.++++||+|||+. +|+|+||||+||++++++.++++|||.+..
T Consensus 80 e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~ 149 (258)
T cd05578 80 DLLLGGDLRYHLSQK-------VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATK 149 (258)
T ss_pred eCCCCCCHHHHHHhc-------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccc
Confidence 999999999998643 2478889999999999999999974 899999999999999999999999997765
Q ss_pred cCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccc
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELV 769 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (919)
...... .....+...+..++.......+.++||||||+++|||+||+.|+..........++.... . .
T Consensus 150 ~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------~-~ 217 (258)
T cd05578 150 VTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE--------T-A 217 (258)
T ss_pred cCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc--------c-c
Confidence 432211 111122223333443334457788999999999999999999998765322122211110 0 0
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 002462 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLM--RYIL 812 (919)
Q Consensus 770 ~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm--~~V~ 812 (919)
.... .+.... .+..++.+|++.+|.+||++ +|+.
T Consensus 218 ~~~~------~~~~~~---~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLY------PATWST---EAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccC------cccCcH---HHHHHHHHHccCChhHcCCccHHHHh
Confidence 0000 111112 34567889999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=283.90 Aligned_cols=270 Identities=16% Similarity=0.216 Sum_probs=183.6
Q ss_pred hCCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeec---CCcE
Q 002462 533 TGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMER---ENEK 605 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~---~~~~ 605 (919)
..+|...+.||+|+||.||+|+. .+|..||+|++..... ..+.+.+|+.++++++|||||++++++... ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36788888999999999999985 4689999999865322 245678899999999999999999876432 2357
Q ss_pred EEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcc
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS 685 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg 685 (919)
++||||+. |+|.+++.... .+++.....++.++++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg 152 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ-------PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFG 152 (334)
T ss_pred EEEEehhh-hhHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccc
Confidence 99999996 68988885432 378999999999999999999984 89999999999999999999999999
Q ss_pred hhhhcCCCC--cceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhc--cc
Q 002462 686 EVCAQGGDA--HQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTL--PY 760 (919)
Q Consensus 686 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~--~~ 760 (919)
.+....... .........+...+..++.. +...++.++|||||||++|||++|+.||...+.......+.... |.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~ 232 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS 232 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence 876442211 11111112223333333322 22346788999999999999999999997765433222111110 10
Q ss_pred cccc---cccccccccc---CCCCCC-cch-HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 761 ISIY---DKELVTKIVD---PSLIID-EDL-LEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 761 ~~~~---~~~~~~~i~d---~~l~~~-~~~-~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.... ..+.+.+.++ ...... ... ...-..+..++..|++.+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000 0011111110 000000 000 001123567889999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=273.50 Aligned_cols=265 Identities=17% Similarity=0.215 Sum_probs=180.6
Q ss_pred CCcccccccCCCCcEEEEEec-CCccEEEEEeccccc--cHHHHHHHHHHHhhcC-CCCccceeeEEeecCCcEEEEEEe
Q 002462 536 FSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV--KTEAYLLELDFFSKVS-HARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
|...+.||+|+||.||+|+.. ++..||||++..... ....+.+|+..+++++ |+||+++++++.+ ++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEec
Confidence 345678999999999999975 478899999865432 2234567999999999 9999999998766 5689999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+ +|+|.+++..... ..++|.++..++.++++||+|||+. +|+|+||||+||++++++.++|+|||.+....
T Consensus 80 ~-~~~l~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~ 150 (283)
T cd07830 80 M-EGNLYQLMKDRKG-----KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIR 150 (283)
T ss_pred C-CCCHHHHHHhccc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceecc
Confidence 9 8899998865431 3489999999999999999999985 89999999999999999999999999776443
Q ss_pred CCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH-HHHHHhhccccc-ccc-cc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTLPYIS-IYD-KE 767 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~-~~~~~~~~~~~~-~~~-~~ 767 (919)
..... ....+...+..++.. +...++.++||||||+++|||+||+.|+........ .......-+... ... ..
T Consensus 151 ~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07830 151 SRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY 227 (283)
T ss_pred CCCCc---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHh
Confidence 21111 011111222222221 223467889999999999999999999876544321 111111000000 000 00
Q ss_pred cccccccCCCCC--Ccch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 768 LVTKIVDPSLII--DEDL----LEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 768 ~~~~i~d~~l~~--~~~~----~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.....++..+.. .... ...-..+..++..|++.+|++||+++||+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 228 KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000000 0000 001134667899999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=276.65 Aligned_cols=265 Identities=18% Similarity=0.254 Sum_probs=178.8
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
++|...+.||+|++|.||+|... +|..||||++..... ..+.|.+|++++++++||||+++++++.. ++..++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-CCeEEEEE
Confidence 45777889999999999999864 688999998864332 23568899999999999999999998765 46899999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCC-CCceeeCCcchhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD-KFEVRLGSLSEVC 688 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~-~~~~kl~dfg~~~ 688 (919)
||++ ++|.+++..... ..+++.....++.+++.||+|||+. +|+||||||+||++++ +..+|++|||.+.
T Consensus 81 e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~ 151 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPD-----FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151 (294)
T ss_pred eccc-ccHHHHHHhCCC-----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccccccc
Confidence 9996 578887754321 2356777788999999999999985 8999999999999985 5678999999876
Q ss_pred hcCCCCcceeeeeeccCCCCccccC-CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHh-hcccccccc
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQ-TLPYISIYD 765 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~-~~~~~~~~~ 765 (919)
......... ....+.+.+..++. .+...++.++|||||||++|||+||+.|+......+ ..+.... ..|......
T Consensus 152 ~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (294)
T PLN00009 152 AFGIPVRTF--THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWP 229 (294)
T ss_pred ccCCCcccc--ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 543221110 11111222223332 222346778999999999999999999997654432 2222111 111100000
Q ss_pred -----ccc---ccccccCCCC-CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 766 -----KEL---VTKIVDPSLI-IDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 766 -----~~~---~~~i~d~~l~-~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
++. ........+. ..+...+ .+.+++.+|++.+|++||+|.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 230 GVTSLPDYKSAFPKWPPKDLATVVPTLEP---AGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccccchhhhhhcccCCCCCHHHhCcCCCh---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0000000000 0001111 2456888999999999999999986
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=275.36 Aligned_cols=240 Identities=18% Similarity=0.202 Sum_probs=168.9
Q ss_pred ccccCCCCcEEEEEe-cCCccEEEEEecccccc----HHHHHHHHHHH---hhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 541 LIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK----TEAYLLELDFF---SKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 541 ~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~----~~~f~~Ei~~l---~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
+||+|+||.||++.. .+|..||||.+...... ...+.+|..++ ...+||||+.+++++.. ++..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-PDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-CCeEEEEEecC
Confidence 489999999999986 46889999988643321 23345555443 34479999999987765 45789999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++|+|.+++.... .++|.+...|+.|+++||+|||+. +|+||||||+|||+++++.+|++|||.+.....
T Consensus 80 ~~~~L~~~i~~~~-------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 80 NGGDLHYHLSQHG-------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 149 (279)
T ss_pred CCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence 9999999886432 389999999999999999999985 799999999999999999999999998764322
Q ss_pred CCcceeeeeeccCCCCccccCCC-CCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccc
Q 002462 693 DAHQSRITRLLRLPQSSEQGSSG-SLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTK 771 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 771 (919)
.... ...++..+..++... ...++.++|||||||++|||+||+.||..........+......
T Consensus 150 ~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~------------ 213 (279)
T cd05633 150 KKPH----ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT------------ 213 (279)
T ss_pred cCcc----CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc------------
Confidence 1111 112233333333321 23467789999999999999999999975432221111111000
Q ss_pred cccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002462 772 IVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP-----LMRYILK 813 (919)
Q Consensus 772 i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RP-----sm~~V~~ 813 (919)
.+..+ .+.... .+..+...|++.+|++|| +++++++
T Consensus 214 -~~~~~--~~~~~~---~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 214 -VNVEL--PDSFSP---ELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred -CCcCC--ccccCH---HHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 00111 111112 245577899999999999 5887765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=276.95 Aligned_cols=269 Identities=21% Similarity=0.259 Sum_probs=183.8
Q ss_pred hCCCCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCC-----
Q 002462 533 TGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMEREN----- 603 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~----- 603 (919)
+++|...+.||+|+||.||+|+. .++..||||++...... ...+.+|++++++++||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46788889999999999999985 46889999998643322 3467899999999999999999997765332
Q ss_pred --cEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceee
Q 002462 604 --EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRL 681 (919)
Q Consensus 604 --~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl 681 (919)
..++||||++. +|...+.... ..+++.+...|+.++++||+|||+. +|+||||||+||++++++.+|+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~------~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l 156 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS------VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKI 156 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 36999999985 6777665422 2488999999999999999999985 8999999999999999999999
Q ss_pred CCcchhhhcCCCCcce---------eeeeeccCCCCccccC-CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHH
Q 002462 682 GSLSEVCAQGGDAHQS---------RITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVK 751 (919)
Q Consensus 682 ~dfg~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~-~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~ 751 (919)
+|||.+.......... ..+...+.+.+..++. .+...++.++|||||||++|||+||+.|+....+....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~ 236 (311)
T cd07866 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236 (311)
T ss_pred CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999876543221110 0011112222333332 22334677899999999999999999999876654322
Q ss_pred H-HHHhhc-cccc-ccccccccccc----cCCCCCCcchHH----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 752 E-ILEQTL-PYIS-IYDKELVTKIV----DPSLIIDEDLLE----EVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 752 ~-~~~~~~-~~~~-~~~~~~~~~i~----d~~l~~~~~~~~----~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+ +..... +... ......+.... .+.. .....+ ....+.+++..|++.+|++||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNY--PRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCC--CccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 2 221110 0000 00000011110 0000 000100 1134667899999999999999998874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=272.94 Aligned_cols=244 Identities=20% Similarity=0.235 Sum_probs=174.8
Q ss_pred cccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCC
Q 002462 542 IKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGD 616 (919)
Q Consensus 542 ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~Gs 616 (919)
||+|+||+||++.. .+|..||+|.+..... ..+.|..|++++++++||||+++++++.. .+..++||||+++|+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-KDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-CCeEEEEEecCCCCc
Confidence 69999999999984 5688999999864322 23467889999999999999999987654 567999999999999
Q ss_pred hhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcc
Q 002462 617 LSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQ 696 (919)
Q Consensus 617 L~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~ 696 (919)
|.+++.+... ..+++.++..++.++++||.|||+. +|+||||||+||++++++.+|++|||.+.........
T Consensus 80 L~~~l~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 151 (277)
T cd05577 80 LKYHIYNVGE-----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI 151 (277)
T ss_pred HHHHHHHcCc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcc
Confidence 9999975432 2488999999999999999999985 8999999999999999999999999987654322111
Q ss_pred eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH-HHHHHhhcccccccccccccccccC
Q 002462 697 SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTLPYISIYDKELVTKIVDP 775 (919)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~d~ 775 (919)
....+...+..++......++.++|||||||++|||+||+.|+........ ..+...... . ..
T Consensus 152 ---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------~--~~ 215 (277)
T cd05577 152 ---KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-----------M--AV 215 (277)
T ss_pred ---ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-----------c--cc
Confidence 111122233333333333477889999999999999999999976543111 111111000 0 00
Q ss_pred CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHH-HHHHh
Q 002462 776 SLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRY-ILKAL 815 (919)
Q Consensus 776 ~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~-V~~~L 815 (919)
. ....... .+..+...|++.+|++||++++ .+..|
T Consensus 216 ~--~~~~~~~---~~~~li~~~l~~~p~~R~~~~~~~~~~l 251 (277)
T cd05577 216 E--YPDKFSP---EAKDLCEALLQKDPEKRLGCRGGSADEV 251 (277)
T ss_pred c--CCccCCH---HHHHHHHHHccCChhHccCCCcccHHHH
Confidence 0 0001111 2455778999999999996665 44433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=270.04 Aligned_cols=248 Identities=21% Similarity=0.285 Sum_probs=185.7
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
+|...+.||+|+||.||++.. .++..+|||++..... ...++.+|++++++++|+||+++++++.+ ....++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-GNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-CCEEEEEeh
Confidence 366678999999999999974 4678999999865432 24578899999999999999999997765 467999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+++++|.+++.+... ....+++.....++.++++||+|||+. +++||||||.||+++++..+|++|||.+...
T Consensus 80 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~ 153 (256)
T cd08530 80 YAPFGDLSKAISKRKK---KRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL 153 (256)
T ss_pred hcCCCCHHHHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhh
Confidence 9999999999865321 124589999999999999999999975 8999999999999999999999999987665
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
...... ...+.+.+..++......++.++||||||+++|||++|+.|+...........+.. ....
T Consensus 154 ~~~~~~----~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----------~~~~ 219 (256)
T cd08530 154 KKNMAK----TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR----------GKYP 219 (256)
T ss_pred ccCCcc----cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----------CCCC
Confidence 433111 11122233333333334567789999999999999999999987654433222211 0000
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.+ ..... ..+..++..|++.+|++||++.++++
T Consensus 220 ~~-------~~~~~---~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 PI-------PPIYS---QDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CC-------chhhC---HHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 00111 23567889999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=269.61 Aligned_cols=236 Identities=17% Similarity=0.205 Sum_probs=173.9
Q ss_pred cccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCC
Q 002462 542 IKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGD 616 (919)
Q Consensus 542 ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~Gs 616 (919)
||+|+||.||+++.. ++..||||++..... ..+.|.+|++++++++||||+++++++.+ ++..++||||+++|+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-KKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-CCccEEEEecCCCCc
Confidence 699999999999965 478999999865332 24578999999999999999999997765 467899999999999
Q ss_pred hhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcc
Q 002462 617 LSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQ 696 (919)
Q Consensus 617 L~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~ 696 (919)
|.+++.+.. .+++.++..++.++++||+|||+. +++|+||||+||+++.++.+|++|||.+.........
T Consensus 80 L~~~l~~~~-------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~ 149 (262)
T cd05572 80 LWTILRDRG-------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT 149 (262)
T ss_pred HHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccc
Confidence 999997542 278888999999999999999984 8999999999999999999999999987655332111
Q ss_pred eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccccCC
Q 002462 697 SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPS 776 (919)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 776 (919)
....+.+.+..++......++.++||||||+++|||+||+.|+........ +....... ... .
T Consensus 150 ---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~-----~~~--------~ 212 (262)
T cd05572 150 ---WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EIYNDILK-----GNG--------K 212 (262)
T ss_pred ---ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HHHHHHhc-----cCC--------C
Confidence 111223334444433334567889999999999999999999976652111 11111000 000 0
Q ss_pred CCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 002462 777 LIIDEDLLEEVWAMAIVARSCLNPKPTRRPLM 808 (919)
Q Consensus 777 l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm 808 (919)
........+ .+..++..||+.+|++||+|
T Consensus 213 ~~~~~~~~~---~~~~~i~~~l~~~p~~R~~~ 241 (262)
T cd05572 213 LEFPNYIDK---AAKDLIKQLLRRNPEERLGN 241 (262)
T ss_pred CCCCcccCH---HHHHHHHHHccCChhhCcCC
Confidence 000111111 35668889999999999993
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=273.97 Aligned_cols=260 Identities=18% Similarity=0.247 Sum_probs=181.4
Q ss_pred CcccccccCCCCcEEEEEe-cCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 537 SDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 537 ~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
...+.||+|++|.||+|.. .+|..+|+|++...... .+.+.+|++++++++|+||+++++++.. ++..++||||+
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~ 80 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-KGDLYLVFEFM 80 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-CCCEEEEEecc
Confidence 3456799999999999986 46889999998654332 4678899999999999999999998765 46789999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++ +|.+++..+. ..+++.++..++.++++||+|||.. +|+||||||+||++++++.+|++|||.+.....
T Consensus 81 ~~-~l~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 81 DT-DLYKLIKDRQ------RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGS 150 (283)
T ss_pred CC-CHHHHHHhhc------ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence 85 8888886532 2488999999999999999999985 899999999999999999999999997765433
Q ss_pred CCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH-HHHHHhhccccccccccccc
Q 002462 693 DAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 770 (919)
.... .........+..++.. +....+.++||||||+++|||+||+.|+...+..+. ....+. ..... .+...
T Consensus 151 ~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~ 224 (283)
T cd05118 151 PVRP--YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRT-LGTPD---PEVWP 224 (283)
T ss_pred Cccc--ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-cCCCc---hHhcc
Confidence 2210 0111112222222222 222577889999999999999999999977654332 222111 10000 00000
Q ss_pred cccc-----------CCCCCCcchH-HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 771 KIVD-----------PSLIIDEDLL-EEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 771 ~i~d-----------~~l~~~~~~~-~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
...+ ......+... .--..+..++..|++.+|.+||+|++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0000000000 01124567899999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=282.79 Aligned_cols=198 Identities=17% Similarity=0.232 Sum_probs=154.0
Q ss_pred hCCCCcccccccCCCCcEEEEEe-cCCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecC-----C
Q 002462 533 TGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERE-----N 603 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~-----~ 603 (919)
.+.|...+.||+|+||.||+|.. .+|..||||++.... ...+.+.+|++++++++||||+++++++.... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 46788889999999999999985 578999999985422 12356788999999999999999999765321 2
Q ss_pred cEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCC
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS 683 (919)
Q Consensus 604 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~d 683 (919)
..++||||++ |+|.+.+.. .+++.+...++.++++||+|||.. +|+||||||+||+++.++.+|++|
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~---------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM---------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence 4699999997 578777642 167788889999999999999985 899999999999999999999999
Q ss_pred cchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCC
Q 002462 684 LSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASS 746 (919)
Q Consensus 684 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~ 746 (919)
||.+......... ....+.+.+..++......++.++|||||||++|||+||+.|+...+
T Consensus 162 fg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 162 FGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred CccceeCCCCCCC---CCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 9988754332111 11112222333333333457788999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=279.61 Aligned_cols=265 Identities=17% Similarity=0.188 Sum_probs=183.7
Q ss_pred HHHHhCCCCcccccccCCCCcEEEEEe-cCCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCc
Q 002462 529 LLAATGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERENE 604 (919)
Q Consensus 529 l~~at~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~ 604 (919)
+...+++|...+.||+|+||.||++.. .+|..||||++.... ...+.+.+|++++.+++|||||++++++......
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 445788899999999999999999984 478999999885322 2246788999999999999999999987665567
Q ss_pred EEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCc
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSL 684 (919)
Q Consensus 605 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~df 684 (919)
.++||||+. ++|.+++... .+++.....++.++++||+|||+. +|+||||||+||++++++.+|++||
T Consensus 85 ~~lv~e~~~-~~L~~~~~~~--------~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~df 152 (328)
T cd07856 85 IYFVTELLG-TDLHRLLTSR--------PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDF 152 (328)
T ss_pred EEEEeehhc-cCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcc
Confidence 899999984 6888877532 266777788999999999999985 8999999999999999999999999
Q ss_pred chhhhcCCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccc
Q 002462 685 SEVCAQGGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISI 763 (919)
Q Consensus 685 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~ 763 (919)
|.+.......... .+.+.+..++.. +...++.++|||||||++|||+||+.|+...........+.......
T Consensus 153 g~~~~~~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~-- 225 (328)
T cd07856 153 GLARIQDPQMTGY-----VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTP-- 225 (328)
T ss_pred ccccccCCCcCCC-----cccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC--
Confidence 9876543221111 112222223221 22346778999999999999999999997665432211111111000
Q ss_pred cccccccccccC-------CCC--CCcchHH----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 764 YDKELVTKIVDP-------SLI--IDEDLLE----EVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 764 ~~~~~~~~i~d~-------~l~--~~~~~~~----~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..+....+.+. .+. ......+ .-..+..++.+|++.+|++||++.+++.
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 226 -PDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred -CHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 000 0000000 0124567889999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=275.49 Aligned_cols=244 Identities=17% Similarity=0.236 Sum_probs=180.8
Q ss_pred HhCCCCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc----HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEE
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK----TEAYLLELDFFSKVSHARLVPLLGHCMERENEKF 606 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~ 606 (919)
..++|....+||+|+||.||.++- ..|..+|+|+++..... .+....|-.+|....+|+||+|+. .++..+..|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyY-sFQD~~~LY 217 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYY-SFQDKEYLY 217 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEE-EecCCCeeE
Confidence 346899999999999999999985 56899999999765432 345778999999999999999996 455567899
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcch
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~ 686 (919)
|||||+||||+...|.+.+- |+....-.++.+.+-|++-+|.. ++|||||||.|+|||..|.+||+|||+
T Consensus 218 LiMEylPGGD~mTLL~~~~~-------L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDT-------LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred EEEEecCCccHHHHHHhcCc-------CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccc
Confidence 99999999999999976542 43333334566788899999985 999999999999999999999999997
Q ss_pred hhhcCC----C-----------C-------cc-----ee------------------eeeeccCCCCccccCCCCCCCCC
Q 002462 687 VCAQGG----D-----------A-------HQ-----SR------------------ITRLLRLPQSSEQGSSGSLTATC 721 (919)
Q Consensus 687 ~~~~~~----~-----------~-------~~-----~~------------------~~~~~~~~~~~~~~~~~~~~~t~ 721 (919)
+..... . . .. .. .-...|+|.|++++..-...|..
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~ 367 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK 367 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence 643210 0 0 00 00 00145667777777665556778
Q ss_pred CCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhc--ccccccccccccccccCCCCCCcchHHHHHHHHHHHHHcc
Q 002462 722 PYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTL--PYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCL 798 (919)
Q Consensus 722 ~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~ 798 (919)
.+|.||+|||+|||+.|-+||...++.+ ..+++.|.. .++. +.....|+ .+++.+|+
T Consensus 368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-----------------~~~~s~eA---~DLI~rll 427 (550)
T KOG0605|consen 368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-----------------EVDLSDEA---KDLITRLL 427 (550)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-----------------cCcccHHH---HHHHHHHh
Confidence 8999999999999999999999887765 344555431 1110 11112333 34666777
Q ss_pred CCCCCCCCC
Q 002462 799 NPKPTRRPL 807 (919)
Q Consensus 799 ~~~P~~RPs 807 (919)
. +|++|--
T Consensus 428 ~-d~~~RLG 435 (550)
T KOG0605|consen 428 C-DPENRLG 435 (550)
T ss_pred c-CHHHhcC
Confidence 7 9999975
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=269.30 Aligned_cols=244 Identities=15% Similarity=0.133 Sum_probs=173.3
Q ss_pred cccccCCCCcEEEEEe-cCCccEEEEEecccccc----HHHHHHHHHH-HhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK----TEAYLLELDF-FSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~----~~~f~~Ei~~-l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
..||+|+||.||+|.. .+|..||||.+...... ...+..|..+ ....+|+|++++++++.+ ++..++||||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-KDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-CCeEEEEEeccC
Confidence 3589999999999986 46889999998643321 2234556554 445689999999998765 567999999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|.+++.... .+++....+|+.++++||.|||.. +|+||||||+||++++++.+|++|||.+......
T Consensus 81 ~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 150 (260)
T cd05611 81 GGDCASLIKTLG-------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN 150 (260)
T ss_pred CCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc
Confidence 999999986432 367788889999999999999985 8999999999999999999999999976643221
Q ss_pred CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 773 (919)
. ...+.+.+..++......++.++|||||||++|||+||+.|+..........-+..... ..
T Consensus 151 ~------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~----- 212 (260)
T cd05611 151 K------KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI-------NW----- 212 (260)
T ss_pred c------cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc-------CC-----
Confidence 1 11122223333322223467889999999999999999999976654432221111000 00
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 774 d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
.+.. .+.... .+..++..|++.+|++||++.++.+.|..
T Consensus 213 ~~~~--~~~~~~---~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 213 PEEV--KEFCSP---EAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred CCcc--cccCCH---HHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 0000 001111 25568899999999999998877776653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=282.56 Aligned_cols=274 Identities=15% Similarity=0.217 Sum_probs=187.7
Q ss_pred ccCHHHHHHHhCCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEE
Q 002462 523 SFTYQQLLAATGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHC 598 (919)
Q Consensus 523 ~~~~~~l~~at~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c 598 (919)
..+.+++..++++|.....||+|+||.||+|.. .+|..||||++..... ..+.+.+|++++.+++|||||++++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 445667788899999999999999999999984 5788999999864322 245688999999999999999999976
Q ss_pred eecC-----CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceec
Q 002462 599 MERE-----NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILL 673 (919)
Q Consensus 599 ~~~~-----~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILl 673 (919)
.... ...++++||+ +++|.+++..+ .++|.++..|+.++++||+|||+. +|+||||||+||++
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll 153 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAV 153 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEE
Confidence 5321 2367888876 78998877432 378999999999999999999985 89999999999999
Q ss_pred CCCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HH
Q 002462 674 DDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VK 751 (919)
Q Consensus 674 d~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~ 751 (919)
++++.+|++|||.+......... ..++..+..++.. +...++.++|||||||++|||+||+.|+....... ..
T Consensus 154 ~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 228 (345)
T cd07877 154 NEDCELKILDFGLARHTDDEMTG-----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 228 (345)
T ss_pred cCCCCEEEecccccccccccccc-----cccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999987654322111 1122223333321 22346778999999999999999999997654332 22
Q ss_pred HHHHhhc-ccccc---ccccccc---cccc--CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 752 EILEQTL-PYISI---YDKELVT---KIVD--PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 752 ~~~~~~~-~~~~~---~~~~~~~---~i~d--~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..+.... +.... ....... ..++ +...........-..+..++..|++.+|.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 229 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 2221110 00000 0000000 0000 000000000000113567889999999999999998875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=282.67 Aligned_cols=267 Identities=17% Similarity=0.198 Sum_probs=181.1
Q ss_pred hCCCCcccccccCCCCcEEEEEe-cCCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecC----Cc
Q 002462 533 TGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERE----NE 604 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~----~~ 604 (919)
.+.|.....||+|+||.||+|+. .+|..||||++.... .....+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 34677788999999999999984 568999999986432 22356788999999999999999999775432 24
Q ss_pred EEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCc
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSL 684 (919)
Q Consensus 605 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~df 684 (919)
.++||||+. ++|.+++... ..+++.....|+.++++||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Df 152 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-------QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDF 152 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcC
Confidence 799999997 6888887543 2378888999999999999999985 8999999999999999999999999
Q ss_pred chhhhcCCCCcceeeeeeccCCCCccccCCC-CCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhc--ccc
Q 002462 685 SEVCAQGGDAHQSRITRLLRLPQSSEQGSSG-SLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTL--PYI 761 (919)
Q Consensus 685 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~--~~~ 761 (919)
|.+......... .....+...+..++... ...++.++|||||||++|||++|+.|+...+............ +..
T Consensus 153 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 153 GLARTTSEKGDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred ccccccCCCccc--ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 987754322110 01111122222333221 1246778999999999999999999997654332211111110 000
Q ss_pred ccc---ccccccccc-------cCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 762 SIY---DKELVTKIV-------DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 762 ~~~---~~~~~~~i~-------d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
... ......+.+ ++... ......-..+..++.+|++.+|++||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFA--RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHH--HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000 000000000 00000 0000011235678899999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=275.95 Aligned_cols=263 Identities=19% Similarity=0.257 Sum_probs=177.0
Q ss_pred cccccC--CCCcEEEEEe-cCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecC
Q 002462 540 NLIKNG--HSGDLFRGIL-EGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G--~~G~Vy~g~l-~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
..||+| +||+||++.. .+|..||||.+...... .+.|.+|+.+++.++|||||++++++.. ++..++||||++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-GSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-CCceEEEEeccc
Confidence 356766 8999999985 57899999998754322 3578899999999999999999998865 467899999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCC
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~ 693 (919)
+|+|.+++.+... ..+++.....++.++++||+|||+. +|+||||||+|||++.++.+|++||+........
T Consensus 83 ~~~l~~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 83 YGSANSLLKTYFP-----EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRN 154 (328)
T ss_pred CCCHHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhcc
Confidence 9999998875432 2378888899999999999999974 8999999999999999999999999754332111
Q ss_pred Ccceee--e--e-eccCCCCccccCC--CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhcccccc--
Q 002462 694 AHQSRI--T--R-LLRLPQSSEQGSS--GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLPYISI-- 763 (919)
Q Consensus 694 ~~~~~~--~--~-~~~~~~~~~~~~~--~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~~~~~~-- 763 (919)
...... . . ......+..++.. +...++.++|||||||++|||++|+.|+....... ....+... ++...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 233 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGP-PYSPLDI 233 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCC-CCCCccc
Confidence 110000 0 0 0001112222221 12346778999999999999999999997654322 11111110 00000
Q ss_pred ----------------ccc---------ccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 764 ----------------YDK---------ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 764 ----------------~~~---------~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.+. .....+.+..+.. +.....-..+..++..|++.+|++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRT-PSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccc-hhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 0000111111110 001112234677999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=267.32 Aligned_cols=250 Identities=19% Similarity=0.288 Sum_probs=178.9
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEecccc------ccHHHHHHHHHHHhhcCCCCccceeeEEeecC-CcE
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQS------VKTEAYLLELDFFSKVSHARLVPLLGHCMERE-NEK 605 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~------~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~-~~~ 605 (919)
.+|...++||+|+||.||+|.. .+|..||+|.+.... ...+.|.+|++++++++|+||+++++++.+.. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 3677889999999999999985 568999999875321 11357889999999999999999999775432 357
Q ss_pred EEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcc
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS 685 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg 685 (919)
++|+||+++++|.+++.... .+++.+..+|+.++++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 151 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG 151 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccc
Confidence 89999999999999886432 367888889999999999999975 89999999999999999999999999
Q ss_pred hhhhcCCCCc-ceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccc
Q 002462 686 EVCAQGGDAH-QSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIY 764 (919)
Q Consensus 686 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~ 764 (919)
.++....... ........+...+..++......++.++|||||||++|||+||+.|+....... .........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~---- 225 (264)
T cd06653 152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKIATQP---- 225 (264)
T ss_pred cccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHHHHcCC----
Confidence 8764321100 000111222333444443333456788999999999999999999997543222 111111000
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 765 DKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 765 ~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..+.+ .....+ .+..+...|++ +|.+||+..+++.
T Consensus 226 --------~~~~~--p~~~~~---~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 --------TKPML--PDGVSD---ACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --------CCCCC--CcccCH---HHHHHHHHHhc-CcccCccHHHHhc
Confidence 00111 111112 24557788998 4799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=274.39 Aligned_cols=253 Identities=17% Similarity=0.192 Sum_probs=179.1
Q ss_pred CCcccccccCCCCcEEEEEe----cCCccEEEEEeccccc-----cHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcE
Q 002462 536 FSDANLIKNGHSGDLFRGIL----EGGIPVVIKRIDLQSV-----KTEAYLLELDFFSKV-SHARLVPLLGHCMERENEK 605 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l----~~g~~vavK~l~~~~~-----~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~ 605 (919)
|...+.||+|+||.||+++. .++..||||.+..... ..+.|.+|++++.++ +||||+++++.+ +.+...
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-~~~~~~ 80 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-QTDTKL 80 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-ecCCEE
Confidence 55667899999999999874 3568899999864321 235688999999999 599999999855 445678
Q ss_pred EEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcc
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS 685 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg 685 (919)
++||||+++|+|.+++.... .+++.+...++.++++||+|||+. +++||||||+||+++.++.++++|||
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg 150 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-------HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFG 150 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-------CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECc
Confidence 99999999999999986432 378888899999999999999974 89999999999999999999999999
Q ss_pred hhhhcCCCCcceeeeeeccCCCCccccCCCCC--CCCCCCcchhHHHHHHHHHcCCCCCCCCChh-HHHHHHHhhccccc
Q 002462 686 EVCAQGGDAHQSRITRLLRLPQSSEQGSSGSL--TATCPYDVYCFGKVLLELVTGKMGISASSDA-QVKEILEQTLPYIS 762 (919)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~t~~~DVySfGvvLlEllTGk~p~~~~~~~-~~~~~~~~~~~~~~ 762 (919)
.+.......... .....+...+..++..... ..+.++||||||+++|||+||+.|+...... ...++......
T Consensus 151 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--- 226 (288)
T cd05583 151 LSKEFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--- 226 (288)
T ss_pred cccccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc---
Confidence 876533221100 0011122223333322221 2567899999999999999999998543211 11111111100
Q ss_pred ccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 763 IYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 763 ~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
. ++.. ...... .+..++.+|++.+|++|||+++|.+.|+.+
T Consensus 227 --------~--~~~~--~~~~~~---~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 227 --------S--KPPF--PKTMSA---EARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --------c--CCCC--CcccCH---HHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 0000 011111 245578899999999999999999888753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=266.47 Aligned_cols=262 Identities=21% Similarity=0.242 Sum_probs=185.1
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEec--cc-cccHHHHHHHHHHHhhcCCCCccceeeEEee----cCCcE
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRID--LQ-SVKTEAYLLELDFFSKVSHARLVPLLGHCME----RENEK 605 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~--~~-~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~----~~~~~ 605 (919)
..|...+.||+|.||.|.++.. .+|..||||++. .. ....++-.+|+++|+.++|+|||.+...... .-++.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 3444457899999999999984 678999999995 22 2235678899999999999999999986543 12468
Q ss_pred EEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcc
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS 685 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg 685 (919)
|+|+|+|+ -||.+.++... .|+-....-+..|+.+||.|+|+. .|+|||+||+|+|++.+-..||+|||
T Consensus 102 YiV~elMe-tDL~~iik~~~-------~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 102 YLVFELME-TDLHQIIKSQQ-------DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred EEehhHHh-hHHHHHHHcCc-------cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 99999995 58988886543 254444555788999999999986 89999999999999999999999999
Q ss_pred hhhhcCC-----CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccc
Q 002462 686 EVCAQGG-----DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPY 760 (919)
Q Consensus 686 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~ 760 (919)
+|+.... .......|+.+++|+-.. ....||...||||.|||+.||+|||+=|.+.+.......+....+.
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll----~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLL----NSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT 246 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHh----ccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence 9998742 223445677777776442 2346788899999999999999999988776544333333333322
Q ss_pred ccccccccccccccCC-------CC-CCcchHHH-----HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 761 ISIYDKELVTKIVDPS-------LI-IDEDLLEE-----VWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 761 ~~~~~~~~~~~i~d~~-------l~-~~~~~~~~-----~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
++ ++.+..+-.+. +. ........ -...+++..+.+..||.+|+|.+|.++
T Consensus 247 P~---~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 247 PS---EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred CC---HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 21 11111111000 00 00000000 012455777889999999999998875
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=264.30 Aligned_cols=245 Identities=20% Similarity=0.319 Sum_probs=182.6
Q ss_pred CCcccccccCCCCcEEEEEec-CCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 536 FSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
|...+.||+|++|.||+|+.. ++..||||.+..... ..+.+.+|++++++++|+|++++++++.+ ++..++||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~ 80 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-SDSLYIILEY 80 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-CCEEEEEEec
Confidence 556789999999999999854 678999999976543 34678999999999999999999998765 4678999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
+++++|.+++.+. ..++|..+..++.+++.||.|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 81 ~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 150 (254)
T cd06627 81 AENGSLRQIIKKF-------GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN 150 (254)
T ss_pred CCCCcHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence 9999999988643 2488999999999999999999975 89999999999999999999999999876553
Q ss_pred CCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTK 771 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 771 (919)
..... .....+...+..++......++.++||||||+++|||+||+.|+.............. ... .
T Consensus 151 ~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~----------~~~-~ 217 (254)
T cd06627 151 DVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ----------DDH-P 217 (254)
T ss_pred CCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc----------cCC-C
Confidence 32211 0111222233333333333467789999999999999999999876543221111100 000 0
Q ss_pred cccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 772 IVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 772 i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.+. ....+ .+..++.+|++.+|++||++.+++.
T Consensus 218 ~~~------~~~~~---~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLP------EGISP---ELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCC------CCCCH---HHHHHHHHHHhCChhhCcCHHHHhc
Confidence 011 11112 2446788999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=275.47 Aligned_cols=205 Identities=17% Similarity=0.249 Sum_probs=152.9
Q ss_pred CCcccccccCCCCcEEEEEec---CCccEEEEEecccc---c-cHHHHHHHHHHHhhcCCCCccceeeEEeecC-CcEEE
Q 002462 536 FSDANLIKNGHSGDLFRGILE---GGIPVVIKRIDLQS---V-KTEAYLLELDFFSKVSHARLVPLLGHCMERE-NEKFL 607 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~---~g~~vavK~l~~~~---~-~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~-~~~~l 607 (919)
|.....||+|+||.||+|+.. ++..||||.+.... . ..+.+.+|++++++++||||+++++++.+.. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 556678999999999999964 47899999987532 1 2456889999999999999999999887641 46899
Q ss_pred EEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCC----CCceeeCC
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD----KFEVRLGS 683 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~----~~~~kl~d 683 (919)
||||+++ +|.+.+...... ....++......|+.|+++||+|||+. +|+||||||+||+++. ++.+|++|
T Consensus 82 v~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQA--KRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEeCCCc-CHHHHHHhhccC--CCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 9999985 676666432211 113578888889999999999999975 7999999999999999 89999999
Q ss_pred cchhhhcCCCCcc-eeeeeeccCCCCccccC-CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCC
Q 002462 684 LSEVCAQGGDAHQ-SRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASS 746 (919)
Q Consensus 684 fg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~ 746 (919)
||.+......... .......+.+.+.+++. .+...++.++|||||||++|||+||+.|+....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 9987654322110 00001112222333332 223346778999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=276.12 Aligned_cols=262 Identities=18% Similarity=0.187 Sum_probs=171.9
Q ss_pred cccCCCCcEEEEEecCCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCChh
Q 002462 542 IKNGHSGDLFRGILEGGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLS 618 (919)
Q Consensus 542 ig~G~~G~Vy~g~l~~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL~ 618 (919)
+|.|+++.||++.. +|..||||++.... ...+.+.+|++++++++|+||+++++++.+ ++..+++|||+++|+|.
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-DSELYVVSPLMAYGSCE 87 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-CCeEEEEEeccCCCCHH
Confidence 44455555566554 68899999986542 234679999999999999999999997765 46789999999999999
Q ss_pred hhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcc--
Q 002462 619 SSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQ-- 696 (919)
Q Consensus 619 ~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~-- 696 (919)
+++.+... ..+++.....++.++++||+|||+. +|+||||||+||++++++.+|++||+.+.........
T Consensus 88 ~~l~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 88 DLLKTHFP-----EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99975422 2377888889999999999999985 8999999999999999999999999976543221110
Q ss_pred ---eeeeeeccCCCCccccCCC--CCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhcccccc-----cc
Q 002462 697 ---SRITRLLRLPQSSEQGSSG--SLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLPYISI-----YD 765 (919)
Q Consensus 697 ---~~~~~~~~~~~~~~~~~~~--~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~~~~~~-----~~ 765 (919)
...........+..++... ...++.++|||||||++|||+||+.||....... ..+......+..-. ..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 0000011111222222211 1246778999999999999999999997654322 11111111110000 00
Q ss_pred cccccc----cccCCCCCCc--c-hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 766 KELVTK----IVDPSLIIDE--D-LLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 766 ~~~~~~----i~d~~l~~~~--~-~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
...... ..++...... . ....-..+..++..||+.+|++||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000000 1111110000 0 0111124566889999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=277.53 Aligned_cols=246 Identities=20% Similarity=0.263 Sum_probs=195.6
Q ss_pred CCCcccccccCCCCcEEEEEecC-CccEEEEEeccccc----cHHHHHHHHHHHhhcC-CCCccceeeEEeecCCcEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILEG-GIPVVIKRIDLQSV----KTEAYLLELDFFSKVS-HARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~-g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~~~~~lV 608 (919)
.|...+.||+|.||.||+++-.. |..+|+|.+..... ..+.+.+|+++|.++. |||||.+.+.+.. ....++|
T Consensus 36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-~~~~~lv 114 (382)
T KOG0032|consen 36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-PDSVYLV 114 (382)
T ss_pred cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-CCeEEEE
Confidence 34555789999999999999655 99999999965443 2367899999999999 9999999997654 5689999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC----CceeeCCc
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK----FEVRLGSL 684 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~----~~~kl~df 684 (919)
||++.+|.|.+.+.+. .++......++.+++.|+.|||+ .+|||||+||+|+|+... +.+|++||
T Consensus 115 mEL~~GGeLfd~i~~~--------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK--------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEecCCchHHHHHHHc--------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 9999999999999754 16777888999999999999998 499999999999999754 47999999
Q ss_pred chhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHH-HHHhhcccccc
Q 002462 685 SEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKE-ILEQTLPYISI 763 (919)
Q Consensus 685 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~-~~~~~~~~~~~ 763 (919)
|++..... ........++|.|.+++..+...++.+.||||.||++|.|++|..||.+.+...... +....+.
T Consensus 184 Gla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~---- 256 (382)
T KOG0032|consen 184 GLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFD---- 256 (382)
T ss_pred CCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCC----
Confidence 99987665 234566788999999988887889999999999999999999999998877544322 2221110
Q ss_pred cccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 764 YDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 764 ~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.-++.. +...+. +-.+...++..+|.+|+++.++++
T Consensus 257 --------f~~~~w---~~is~~---akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 257 --------FTSEPW---DDISES---AKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred --------CCCCCc---cccCHH---HHHHHHHhcccCcccCCCHHHHhc
Confidence 001100 111222 345778999999999999999998
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=288.20 Aligned_cols=198 Identities=22% Similarity=0.296 Sum_probs=163.4
Q ss_pred cccccccCCCCcEEEEE-ecCCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeec-----CCcEEEEE
Q 002462 538 DANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMER-----ENEKFLVY 609 (919)
Q Consensus 538 ~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~-----~~~~~lV~ 609 (919)
..+.||+|+||.||+|+ -+.|..||||.++.... ..+.+.+|+++|++++|+|||++++.=.+. .....+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 35689999999999999 67899999999976443 367899999999999999999999842211 12468999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecC--CCC--ceeeCCcc
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLD--DKF--EVRLGSLS 685 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld--~~~--~~kl~dfg 685 (919)
|||++|||...|.+..+ ...|+..+-+.+..+++.||.|||+. +||||||||.||++- +++ .-||.|||
T Consensus 97 EyC~gGsL~~~L~~PEN----~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPEN----AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eecCCCcHHHHhcCccc----ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 99999999999976433 34588899999999999999999975 899999999999984 333 47999999
Q ss_pred hhhhcCCCCcceeeeeeccCCCCccccCCC-CCCCCCCCcchhHHHHHHHHHcCCCCCCCC
Q 002462 686 EVCAQGGDAHQSRITRLLRLPQSSEQGSSG-SLTATCPYDVYCFGKVLLELVTGKMGISAS 745 (919)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~t~~~DVySfGvvLlEllTGk~p~~~~ 745 (919)
.|+....+. .++.++|+++|..|.... ...++.-+|.|||||++||.+||..||-..
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 998776554 466788888888777655 356777789999999999999999999654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=273.95 Aligned_cols=243 Identities=25% Similarity=0.343 Sum_probs=177.4
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
|+..+.||+|+||.||+|+. .++..||||.+..... ..+++.+|++++++++|+|++++++++.. .+..++|||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 95 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLVME 95 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCeeEEEEE
Confidence 55567899999999999995 4678899999864321 23568899999999999999999998876 467899999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+. |+|.+.+.... ..+++.++..++.+++.||.|||+. +|+||||||+||+++.++.+|++|||.+...
T Consensus 96 ~~~-~~l~~~~~~~~------~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 96 YCL-GSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred ccC-CCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 997 68887775432 2478889999999999999999975 8999999999999999999999999977644
Q ss_pred CCCCcceeeeeeccCCCCccccCC---CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH-HHHHHhhccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSS---GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTLPYISIYDK 766 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 766 (919)
..... ..+.+.+..++.. ....++.++|||||||++|||+||+.|+......+. ..+.....
T Consensus 166 ~~~~~------~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------- 231 (308)
T cd06634 166 APANX------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-------- 231 (308)
T ss_pred cCccc------ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC--------
Confidence 32111 1122223333321 122467789999999999999999999865443221 11111111
Q ss_pred ccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L 815 (919)
+... ...... .+..++.+||+.+|.+||++.+|++.-
T Consensus 232 --------~~~~-~~~~~~---~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 --------PALQ-SGHWSE---YFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred --------CCcC-cccccH---HHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0000 001111 245688899999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=263.71 Aligned_cols=250 Identities=20% Similarity=0.294 Sum_probs=185.8
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
+|...+.||+|+||.||++... ++..||+|++..... ..+++.+|++++++++|+|++++++.+.. ++..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-KGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-CCEEEEEEE
Confidence 3566788999999999999964 588999999975433 34678899999999999999999997765 467899999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|+++++|.+++.+... ....+++.+...|+.++++||+|||+. +++|+||||+||++++++.++++|||.+...
T Consensus 80 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 153 (258)
T cd08215 80 YADGGDLSQKIKKQKK---EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVL 153 (258)
T ss_pred ecCCCcHHHHHHHhhc---cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeec
Confidence 9999999999875421 124589999999999999999999985 8999999999999999999999999977654
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
...... .....+.+.+..++......++.++||||||+++|||++|+.|+............... ..
T Consensus 154 ~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~----------~~- 220 (258)
T cd08215 154 SSTVDL--AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG----------QY- 220 (258)
T ss_pred ccCcce--ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcC----------CC-
Confidence 332211 11112222333333333345677899999999999999999998766533322211110 00
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+.+ .....+ .+..++..|++.+|++||++.++++
T Consensus 221 ----~~~--~~~~~~---~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 ----PPI--PSQYSS---ELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ----CCC--CCCCCH---HHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 001112 2456888999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=270.21 Aligned_cols=263 Identities=21% Similarity=0.228 Sum_probs=180.9
Q ss_pred CCcccccccCCCCcEEEEEec-CCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 536 FSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
|.....||+|+||.||+|+.. ++..||+|.+.... ...+.+..|++++++++|+||+++++++.+. +..++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-RKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-CceEEEecC
Confidence 344568999999999999965 48999999987643 2246788999999999999999999987754 679999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
++ ++|.+++.+.. ..+++.++.+++.++++||+|||+. +|+||||||+||++++++.+||+|||.+....
T Consensus 80 ~~-~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~ 149 (282)
T cd07829 80 CD-MDLKKYLDKRP------GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFG 149 (282)
T ss_pred cC-cCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccC
Confidence 98 58999987542 2488999999999999999999985 89999999999999999999999999776543
Q ss_pred CCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccc--c-----
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYIS--I----- 763 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~--~----- 763 (919)
...... ........+..++.. +...++.++|||||||++|||+||+.|+...........+........ .
T Consensus 150 ~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 150 IPLRTY--THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred CCcccc--CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhc
Confidence 221110 011111122222222 222567789999999999999999999876554322111111000000 0
Q ss_pred -c--ccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 764 -Y--DKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 764 -~--~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
. ............. .......-..+..++..|++.+|++||++.+|+.
T Consensus 228 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 228 KLPDYKPTFPKFPPKDL--EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccccCccch--HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 0000000000000 0000000123667889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=270.13 Aligned_cols=241 Identities=17% Similarity=0.205 Sum_probs=170.8
Q ss_pred CCcccccccCCCCcEEEEEe----cCCccEEEEEeccccc-----cHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcE
Q 002462 536 FSDANLIKNGHSGDLFRGIL----EGGIPVVIKRIDLQSV-----KTEAYLLELDFFSKV-SHARLVPLLGHCMERENEK 605 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l----~~g~~vavK~l~~~~~-----~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~ 605 (919)
|...+.||+|+||.||++.. .+|..||+|++..... ..+.+.+|++++.++ +|+||+++++++ +.+...
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-~~~~~~ 80 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-QTDTKL 80 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-ecCCeE
Confidence 55667899999999999985 4688999999864321 246788999999999 599999999855 445678
Q ss_pred EEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcc
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS 685 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg 685 (919)
++||||+++|+|.+++.... .+++.+...++.++++||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 150 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG 150 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCc
Confidence 99999999999999986532 367778888899999999999984 89999999999999999999999999
Q ss_pred hhhhcCCCCcceeeeeeccCCCCccccCCC--CCCCCCCCcchhHHHHHHHHHcCCCCCCCCChh-HHHHHHHhhccccc
Q 002462 686 EVCAQGGDAHQSRITRLLRLPQSSEQGSSG--SLTATCPYDVYCFGKVLLELVTGKMGISASSDA-QVKEILEQTLPYIS 762 (919)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~-~~~~~~~~~~~~~~ 762 (919)
.+.......... .....+...+..++... ....+.++|||||||++|||+||+.|+...... ....+.......
T Consensus 151 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-- 227 (290)
T cd05613 151 LSKEFHEDEVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-- 227 (290)
T ss_pred cceecccccccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence 876543221111 01112222333333222 223567889999999999999999998643221 112222211100
Q ss_pred ccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCC
Q 002462 763 IYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP 806 (919)
Q Consensus 763 ~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RP 806 (919)
++.. ...... .+..++..|++.+|++||
T Consensus 228 -----------~~~~--~~~~~~---~~~~ll~~~l~~~p~~R~ 255 (290)
T cd05613 228 -----------EPPY--PQEMSA---LAKDIIQRLLMKDPKKRL 255 (290)
T ss_pred -----------CCCC--CccCCH---HHHHHHHHHhcCCHHHhc
Confidence 0000 000111 245678899999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=271.59 Aligned_cols=258 Identities=10% Similarity=0.086 Sum_probs=168.7
Q ss_pred CCCCcccccccCCCCcEEEEEecCC----ccEEEEEecccccc--H----------HHHHHHHHHHhhcCCCCccceeeE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEGG----IPVVIKRIDLQSVK--T----------EAYLLELDFFSKVSHARLVPLLGH 597 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~g----~~vavK~l~~~~~~--~----------~~f~~Ei~~l~~l~H~niV~l~g~ 597 (919)
+.|...++||+|+||.||+|...++ ..+|+|........ . .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 3577778999999999999997553 45666654322211 1 112334455667899999999997
Q ss_pred EeecCC---cEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecC
Q 002462 598 CMEREN---EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLD 674 (919)
Q Consensus 598 c~~~~~---~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld 674 (919)
+..... ..++++|++.. ++.+.+... ...++.....|+.++|+||+|||+. +|+||||||+|||++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~ 160 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI-------KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD 160 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh-------ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 654322 23566776543 454444321 1246777889999999999999975 899999999999999
Q ss_pred CCCceeeCCcchhhhcCCCCcc-----eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCCh-h
Q 002462 675 DKFEVRLGSLSEVCAQGGDAHQ-----SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSD-A 748 (919)
Q Consensus 675 ~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~-~ 748 (919)
.++.++|+|||+++........ .......+++.+..++......++.++|||||||++|||+||+.||..... .
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 9999999999988754321110 000112344445555544445678899999999999999999999986632 2
Q ss_pred HHHHHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 749 QVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
........ +.+..+..+.+... ...+ .+.+++..|++.+|++||++.++.+.++
T Consensus 241 ~~~~~~~~----------~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 241 NLIHAAKC----------DFIKRLHEGKIKIK-NANK---FIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHhHH----------HHHHHhhhhhhccC-CCCH---HHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 21111110 00111111111001 1112 2556888999999999999999998763
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=279.09 Aligned_cols=268 Identities=16% Similarity=0.226 Sum_probs=179.3
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecC---------
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERE--------- 602 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~--------- 602 (919)
++|...+.||+|+||.||+|+. .+|..||+|++...... .+.+.+|++++++++||||+++++++....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5677788999999999999985 56889999998655433 467889999999999999999998654322
Q ss_pred ----CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecC-CCC
Q 002462 603 ----NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLD-DKF 677 (919)
Q Consensus 603 ----~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld-~~~ 677 (919)
...++||||++ ++|.+++... .+++.....++.|+++||.|||+. +|+||||||+||+++ ++.
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~ 152 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG--------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence 24689999998 5888777421 377888899999999999999975 899999999999998 456
Q ss_pred ceeeCCcchhhhcCCCCc-ceeeeeeccCCCCccccC-CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 002462 678 EVRLGSLSEVCAQGGDAH-QSRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILE 755 (919)
Q Consensus 678 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~ 755 (919)
.+|++|||.+........ ........+...+.+++. .+...++.++|||||||++|||+||+.|+....+........
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 789999998764322110 000001111222222332 122346678999999999999999999998766543222222
Q ss_pred hhcccccccccccccccccCCC----CCCcchHH-----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 756 QTLPYISIYDKELVTKIVDPSL----IIDEDLLE-----EVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 756 ~~~~~~~~~~~~~~~~i~d~~l----~~~~~~~~-----~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
...|.....+.......+.... ........ --..+..++..|++.+|.+||++.+|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 2222111101100000000000 00000000 0123556889999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=270.95 Aligned_cols=242 Identities=21% Similarity=0.314 Sum_probs=176.2
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
|...+.||+|+||.||+|+. .+|..||+|++..... ..+++.+|++++++++|||++++++++.+ ....++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-EHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEEe
Confidence 33456799999999999985 4688999999864332 13568899999999999999999998876 467899999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
|++ |+|.+.+.... ..++|.++..++.+++.||+|||+. +|+||||||+||++++++.+|++|||.+...
T Consensus 102 ~~~-~~l~~~l~~~~------~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 102 YCL-GSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred cCC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 996 67877775432 2488999999999999999999975 8999999999999999999999999976533
Q ss_pred CCCCcceeeeeeccCCCCccccCC---CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSS---GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKE 767 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 767 (919)
.... ...+...+..++.. ....++.++|||||||++|||+||+.|+................
T Consensus 172 ~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--------- 236 (313)
T cd06633 172 SPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--------- 236 (313)
T ss_pred CCCC------CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC---------
Confidence 2111 11122222223322 12346778999999999999999999987655433222111100
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 768 LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 768 ~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
......+ .... .+..++..|++.+|.+||++.+++.
T Consensus 237 -~~~~~~~------~~~~---~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 237 -SPTLQSN------EWTD---SFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -CCCCCcc------ccCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001011 0111 2456888999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=277.56 Aligned_cols=267 Identities=18% Similarity=0.183 Sum_probs=184.6
Q ss_pred CCcccccccCCCCcEEEEEec-CCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecC----CcEEE
Q 002462 536 FSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERE----NEKFL 607 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~----~~~~l 607 (919)
|...+.||+|+||.||+|+.. +|..||||++.... ...+.|.+|++++++++|+||+++++++.... ...++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 556678999999999999965 48899999986532 22467899999999999999999999887543 36899
Q ss_pred EEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchh
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~ 687 (919)
||||++ ++|.+++.+.. .+++..+..|+.++++||+|||+. +|+||||||.|||++.++.++++|||.+
T Consensus 82 v~e~~~-~~l~~~l~~~~-------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 82 VTELME-TDLHKVIKSPQ-------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred Eecchh-hhHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence 999999 58988886432 488999999999999999999985 8999999999999999999999999987
Q ss_pred hhcCCCCc-ceeeeeeccCCCCccccCCCCC-CCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccc-
Q 002462 688 CAQGGDAH-QSRITRLLRLPQSSEQGSSGSL-TATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIY- 764 (919)
Q Consensus 688 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~- 764 (919)
........ ........+.+.+..++..... .++.++||||||+++|||+||+.||......+....+..........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 75433211 0001111222233333333223 57788999999999999999999998776544322222111110000
Q ss_pred ----ccccccccccCCCCCCcchHH-----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 765 ----DKELVTKIVDPSLIIDEDLLE-----EVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 765 ----~~~~~~~i~d~~l~~~~~~~~-----~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
......+.+...-........ .-..+..++..||+.+|.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 000000000000000000000 0123566889999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=269.37 Aligned_cols=247 Identities=18% Similarity=0.263 Sum_probs=182.4
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHHHHhhcC-CCCccceeeEEeecCCcEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELDFFSKVS-HARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~~~~~lV 608 (919)
+|...+.||+|+||.||+|+.. +|..||+|.+..... ..+.+.+|++++.+++ ||||+++++++.. ++..++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~lv 80 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-EENLYFV 80 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-CceEEEE
Confidence 5667788999999999999964 689999999865322 2356889999999999 9999999997654 5678999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++|+|.+++.+.. .++|.+...|+.+++.||+|||+. +++|+||||+||+++.++.++++|||.+.
T Consensus 81 ~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~ 150 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAK 150 (280)
T ss_pred EcCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCcccc
Confidence 99999999999986532 489999999999999999999975 89999999999999999999999999876
Q ss_pred hcCCCCcc------------------eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH
Q 002462 689 AQGGDAHQ------------------SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV 750 (919)
Q Consensus 689 ~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~ 750 (919)
........ .......+...+..++......++.++||||||++++|++||+.|+........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 230 (280)
T cd05581 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230 (280)
T ss_pred ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 54332210 000111122233333333334567789999999999999999999986653221
Q ss_pred HHHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 002462 751 KEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLM----RYILK 813 (919)
Q Consensus 751 ~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm----~~V~~ 813 (919)
...+.. ..........+ .+..++..|++.+|++||++ +++++
T Consensus 231 ~~~~~~------------------~~~~~~~~~~~---~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQKILK------------------LEYSFPPNFPP---DAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHh------------------cCCCCCCccCH---HHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111110 00000011111 25668899999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-31 Score=266.62 Aligned_cols=247 Identities=19% Similarity=0.304 Sum_probs=188.7
Q ss_pred CCcccccccCCCCcEEEEE-ecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCC
Q 002462 536 FSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPN 614 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~ 614 (919)
|+...++|+|+||.|||+. -+.|..||||++.... ..++...||.+|.+...|.+|+++|-++.. ...++|||||--
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~-sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKH-SDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccC-CceEeehhhcCC
Confidence 4445689999999999998 4679999999996544 456789999999999999999999988764 579999999999
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCC
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~ 694 (919)
|+..+.++.++ .+|.....-.|..+..+||+|||.- .=||||||+.||||+.++.+|++|||.+.......
T Consensus 113 GSiSDI~R~R~------K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 113 GSISDIMRARR------KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred CcHHHHHHHhc------CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99999997554 3477777888999999999999974 67999999999999999999999999876543321
Q ss_pred cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccccccc
Q 002462 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVD 774 (919)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d 774 (919)
..+ .++.++|.+++++......|.+++||||+|++..||..||+|+..-.+... .-.+.... .
T Consensus 184 -AKR-NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-------IFMIPT~P--------P 246 (502)
T KOG0574|consen 184 -AKR-NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-------IFMIPTKP--------P 246 (502)
T ss_pred -Hhh-CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-------eEeccCCC--------C
Confidence 111 235677777777766667789999999999999999999999875432110 00000000 1
Q ss_pred CCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 775 PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 775 ~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
|.+...+.... ..-+....|+-.+|++|-|+.++++
T Consensus 247 PTF~KPE~WS~---~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 247 PTFKKPEEWSS---EFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCCChHhhhh---HHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 11111121122 3556788999999999999887764
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=267.08 Aligned_cols=240 Identities=18% Similarity=0.193 Sum_probs=169.2
Q ss_pred ccccCCCCcEEEEEe-cCCccEEEEEecccccc----HHHHHHHHH---HHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 541 LIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK----TEAYLLELD---FFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 541 ~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~----~~~f~~Ei~---~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
+||+|+||.||++.. .+|..||||.+...... ...+..|.. .++...||||+++++++.+ ++..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-CCEEEEEEecC
Confidence 489999999999985 46889999998654321 223444543 4455689999999986654 56789999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++|+|.+++... ..++|.++..|+.++++||+|||+. +|+||||||+||++++++.+|++|||.+.....
T Consensus 80 ~g~~L~~~l~~~-------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 80 NGGDLHYHLSQH-------GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 149 (278)
T ss_pred CCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence 999999888543 2489999999999999999999984 799999999999999999999999998764432
Q ss_pred CCcceeeeeeccCCCCccccCCC-CCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccc
Q 002462 693 DAHQSRITRLLRLPQSSEQGSSG-SLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTK 771 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 771 (919)
.... ...+...+..++... ...++.++|||||||++|||+||+.|+................
T Consensus 150 ~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 212 (278)
T cd05606 150 KKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL------------- 212 (278)
T ss_pred cCCc----CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-------------
Confidence 1111 112233333333322 2246778999999999999999999997653221111111000
Q ss_pred cccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002462 772 IVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP-----LMRYILK 813 (919)
Q Consensus 772 i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RP-----sm~~V~~ 813 (919)
..++.+. ..... .+..++..|+..+|++|| ++.++++
T Consensus 213 ~~~~~~~--~~~s~---~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 213 TMAVELP--DSFSP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ccCCCCC--CcCCH---HHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 0011111 00111 355678899999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=253.40 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=188.8
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc-----c----HHHHHHHHHHHhhcC-CCCccceeeEEeecC
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV-----K----TEAYLLELDFFSKVS-HARLVPLLGHCMERE 602 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~-----~----~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~ 602 (919)
+.|.+.++||+|....|-++.. ++|...|+|++..... . .++-.+|+++|+++. ||+|+.+..++ +.+
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y-es~ 95 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY-ESD 95 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-cCc
Confidence 4567788999999999999874 5678999999864321 1 356778999999985 99999999965 556
Q ss_pred CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeC
Q 002462 603 NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG 682 (919)
Q Consensus 603 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~ 682 (919)
...++|+|.|+.|.|.++|..+- .|+...--+|..++.+|++|||.. .||||||||.|||+|+++++||+
T Consensus 96 sF~FlVFdl~prGELFDyLts~V-------tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV-------TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe-------eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEe
Confidence 78899999999999999996542 367777778999999999999985 89999999999999999999999
Q ss_pred CcchhhhcCCCCcceeeeeeccCCCCccccCC------CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHH
Q 002462 683 SLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS------GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILE 755 (919)
Q Consensus 683 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~ 755 (919)
|||.++....... .....++|+|.++++. +...|+...|.|+.|||+|.|+.|.+||-.....- +..+++
T Consensus 166 DFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime 242 (411)
T KOG0599|consen 166 DFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME 242 (411)
T ss_pred ccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh
Confidence 9999987654322 3456778887776643 23456777899999999999999999986543211 122222
Q ss_pred hhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 756 QTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 756 ~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+.+.+- .+++ .+--..+.+++.+|++.||.+|-|.+|+++
T Consensus 243 GkyqF~---speW---------------adis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 243 GKYQFR---SPEW---------------ADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cccccC---Ccch---------------hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 222111 1111 111112456889999999999999999875
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=291.04 Aligned_cols=201 Identities=14% Similarity=0.162 Sum_probs=144.8
Q ss_pred hCCCCcccccccCCCCcEEEEEecC--CccEEEE------------------EeccccccHHHHHHHHHHHhhcCCCCcc
Q 002462 533 TGDFSDANLIKNGHSGDLFRGILEG--GIPVVIK------------------RIDLQSVKTEAYLLELDFFSKVSHARLV 592 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l~~--g~~vavK------------------~l~~~~~~~~~f~~Ei~~l~~l~H~niV 592 (919)
.++|...+.||+|+||+||++.... +..+++| ++.......+.|.+|+++|++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4678888999999999999987543 2222222 1111111235688999999999999999
Q ss_pred ceeeEEeecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCcee
Q 002462 593 PLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSIL 672 (919)
Q Consensus 593 ~l~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NIL 672 (919)
++++++.. .+..++|+||+. ++|.+++........ ......+..+|+.|+++||+|||+. +||||||||+|||
T Consensus 227 ~l~~~~~~-~~~~~lv~e~~~-~~l~~~l~~~~~~~~--~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL 299 (501)
T PHA03210 227 KIEEILRS-EANTYMITQKYD-FDLYSFMYDEAFDWK--DRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299 (501)
T ss_pred cEeEEEEE-CCeeEEEEeccc-cCHHHHHhhcccccc--ccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 99998765 467899999986 577777754321111 1123445568999999999999984 8999999999999
Q ss_pred cCCCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCC
Q 002462 673 LDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMG 741 (919)
Q Consensus 673 ld~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p 741 (919)
++.++.+||+|||+++......... .....++..+..++......++.++|||||||++|||++|+.+
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999887553321111 1112334444444544445678889999999999999998864
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=272.28 Aligned_cols=261 Identities=20% Similarity=0.204 Sum_probs=176.5
Q ss_pred ccccccCCCCcEEEEEe-cCCccEEEEEecccccc---------------HHHHHHHHHHHhhcCCCCccceeeEEeecC
Q 002462 539 ANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK---------------TEAYLLELDFFSKVSHARLVPLLGHCMERE 602 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~---------------~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~ 602 (919)
.+.||+|+||.||+|+. .++..||||++...... ...+.+|++++++++|+|||++++++.. +
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~ 92 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE-G 92 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec-C
Confidence 46799999999999985 46899999988543221 1247889999999999999999998765 4
Q ss_pred CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeC
Q 002462 603 NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG 682 (919)
Q Consensus 603 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~ 682 (919)
+..++||||++ |+|.+++..+ ..+++.....++.++++||+|||+. +|+||||||+||+++.++.+|++
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRK-------IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEEC
Confidence 68899999997 6898888543 2377888899999999999999974 89999999999999999999999
Q ss_pred CcchhhhcCCCCc------------ceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH
Q 002462 683 SLSEVCAQGGDAH------------QSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ 749 (919)
Q Consensus 683 dfg~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~ 749 (919)
|||.+........ ..........+.+..++.. +...++.++|||||||++|||+||+.|+....+.+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9998765431110 0000001112222233322 22345778999999999999999999998766543
Q ss_pred HH-HHHHhhc-ccccccccc-cc------cccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 750 VK-EILEQTL-PYISIYDKE-LV------TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 750 ~~-~~~~~~~-~~~~~~~~~-~~------~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.. ....... |........ .+ .....+... +.....-..+.+++..|++.+|++||++.+|+.
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK--TIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH--HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 22 2222110 000000000 00 000000000 000000123556889999999999999999985
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=274.78 Aligned_cols=264 Identities=17% Similarity=0.224 Sum_probs=179.5
Q ss_pred HhCCCCcccccccCCCCcEEEEE-ecCCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecC-----
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERE----- 602 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~----- 602 (919)
..++|...+.||+|+||.||+|. ..+|..||||++..... ..+.+.+|++++++++|||||++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 35678888999999999999998 45789999999854322 2356889999999999999999999765432
Q ss_pred CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeC
Q 002462 603 NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG 682 (919)
Q Consensus 603 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~ 682 (919)
...++||||+ +++|.+++.. ..+++.+...|+.++++||+|||.. +|+||||||+||++++++.+|++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~--------~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH--------EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 1358999999 6788877743 2378899999999999999999985 89999999999999999999999
Q ss_pred CcchhhhcCCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhccc
Q 002462 683 SLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLPY 760 (919)
Q Consensus 683 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~~~ 760 (919)
|||.+.......... .+.+.+..++.. +...++.++|||||||++|||++|+.|+....... ..+......+.
T Consensus 161 dfg~~~~~~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 161 DFGLARQTDSEMTGY-----VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred ecccccccccCcccc-----ccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999876543222111 112222222221 12346778999999999999999999997654322 22221111100
Q ss_pred cccc----cccccccccc--CCCCCCcch---H-HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 761 ISIY----DKELVTKIVD--PSLIIDEDL---L-EEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 761 ~~~~----~~~~~~~i~d--~~l~~~~~~---~-~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.... ........+. +... .... . ..-..+..++.+|++.+|++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFR-KKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccC-cchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 0000000000 0000 0000 0 00112557889999999999999999884
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=276.95 Aligned_cols=265 Identities=17% Similarity=0.219 Sum_probs=181.0
Q ss_pred HhCCCCcccccccCCCCcEEEEEec-CCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecCC----
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMEREN---- 603 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~---- 603 (919)
..++|.....||+|+||.||+|+.. ++..||||++.... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567888899999999999999964 57899999986432 123567889999999999999999986543221
Q ss_pred -cEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeC
Q 002462 604 -EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG 682 (919)
Q Consensus 604 -~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~ 682 (919)
..++|+||+ +++|.+++.. ..+++.+...++.++++||+|||+. +|+||||||+||++++++.+||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~ 160 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKIL 160 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEc
Confidence 379999998 5699888753 2488999999999999999999985 89999999999999999999999
Q ss_pred CcchhhhcCCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhccc
Q 002462 683 SLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLPY 760 (919)
Q Consensus 683 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~~~ 760 (919)
|||.+......... ...+..+..++.. +...++.++|||||||++|||+||+.|+....... ...+.+.....
T Consensus 161 dfg~~~~~~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~ 235 (343)
T cd07851 161 DFGLARHTDDEMTG-----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP 235 (343)
T ss_pred cccccccccccccC-----CcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Confidence 99987654322111 1112222222221 22356778999999999999999999997655432 22222211000
Q ss_pred cc-c---cccccccccccCCCCCC-cchH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 761 IS-I---YDKELVTKIVDPSLIID-EDLL----EEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 761 ~~-~---~~~~~~~~i~d~~l~~~-~~~~----~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.. . ...+.....+....... .... ..-..+..++..|++.+|++|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00 0 00000000000000000 0000 01124667899999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=273.68 Aligned_cols=264 Identities=18% Similarity=0.169 Sum_probs=177.8
Q ss_pred CCcccccccCCCCcEEEEEec-C--CccEEEEEecccc---ccHHHHHHHHHHHhhc-CCCCccceeeEEeec---CCcE
Q 002462 536 FSDANLIKNGHSGDLFRGILE-G--GIPVVIKRIDLQS---VKTEAYLLELDFFSKV-SHARLVPLLGHCMER---ENEK 605 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~-~--g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~---~~~~ 605 (919)
|...+.||+|+||.||+++.. . +..||||++.... ...+.+.+|++++.++ +|||||++++++... ....
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 566788999999999999964 3 6789999986422 1245788999999999 499999999976432 2346
Q ss_pred EEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcc
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS 685 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg 685 (919)
++++||+. ++|.+++... ..+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 82 ~~~~e~~~-~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg 150 (332)
T cd07857 82 YLYEELME-ADLHQIIRSG-------QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFG 150 (332)
T ss_pred EEEEeccc-CCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCC
Confidence 88889887 6898888543 2488999999999999999999985 89999999999999999999999999
Q ss_pred hhhhcCCCCcc--eeeeeeccCCCCccccC-CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccc
Q 002462 686 EVCAQGGDAHQ--SRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYIS 762 (919)
Q Consensus 686 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~ 762 (919)
.+......... .......+++.+..++. .+...++.++|||||||++|||++|+.|+...........+.......
T Consensus 151 ~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~- 229 (332)
T cd07857 151 LARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP- 229 (332)
T ss_pred CceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC-
Confidence 87643321110 00111223333333332 222356788999999999999999999987665432221111111000
Q ss_pred ccccccccccccC-------------CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 763 IYDKELVTKIVDP-------------SLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 763 ~~~~~~~~~i~d~-------------~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..+...++.++ ...........-..+..++.+|++.+|.+||++.++++
T Consensus 230 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 230 --DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred --CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00111111000 00000000000123567889999999999999999863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-28 Score=261.24 Aligned_cols=248 Identities=17% Similarity=0.167 Sum_probs=174.5
Q ss_pred HHHHHHHhCCCCccccc--ccCCCCcEEEEEe-cCCccEEEEEeccccccHHHHHHHHHHHhhc-CCCCccceeeEEeec
Q 002462 526 YQQLLAATGDFSDANLI--KNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKV-SHARLVPLLGHCMER 601 (919)
Q Consensus 526 ~~~l~~at~~f~~~~~i--g~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~ 601 (919)
..++....++|...+.+ |+|+||.||+++. .++..+|+|.+........ |+.....+ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~- 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTT- 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEec-
Confidence 34455555666666666 9999999999985 5678899998864332211 22222222 79999999998765
Q ss_pred CCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCC-cee
Q 002462 602 ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF-EVR 680 (919)
Q Consensus 602 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~-~~k 680 (919)
++..++||||+++|+|.+++.... .++|.+...++.++++||+|||+. +|+||||||+||+++.++ .++
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~ 150 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG-------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIY 150 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEE
Confidence 458999999999999999986532 489999999999999999999985 799999999999999998 999
Q ss_pred eCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH--HHHHHHhhc
Q 002462 681 LGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ--VKEILEQTL 758 (919)
Q Consensus 681 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~--~~~~~~~~~ 758 (919)
++|||.+........ ..+...+.+++......++.++|||||||++|||+||+.|+....+.. ...+.....
T Consensus 151 l~dfg~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 224 (267)
T PHA03390 151 LCDYGLCKIIGTPSC------YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ 224 (267)
T ss_pred EecCccceecCCCcc------CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc
Confidence 999997765432211 112233333443333456788999999999999999999997544322 111211100
Q ss_pred ccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 002462 759 PYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPL-MRYILK 813 (919)
Q Consensus 759 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPs-m~~V~~ 813 (919)
. ..-.+. ..+ . .+..+...|++.+|.+||+ ++++++
T Consensus 225 --------~---~~~~~~-~~~----~---~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 --------K---KLPFIK-NVS----K---NANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --------c---cCCccc-ccC----H---HHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 000000 011 1 2456778999999999995 688763
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=262.22 Aligned_cols=248 Identities=19% Similarity=0.235 Sum_probs=173.6
Q ss_pred CCcccccccCCCCcEEEEEecC-CccEEEEEecc---cc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGILEG-GIPVVIKRIDL---QS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~~-g~~vavK~l~~---~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
|...+.||+|+||.||+++... +..+++|.++. .. ....++..|+.++++++||||+++++++.+. ...++|
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv 80 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-DAFCII 80 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-CceEEE
Confidence 4456789999999999998543 34455555432 11 1234577899999999999999999987654 578999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||+++++|.+++..... ....++|.+++.++.++++||.|||+. +|+||||||+||+++++ .+|++|||.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~~-~~~l~d~g~~~ 153 (260)
T cd08222 81 TEYCEGRDLDCKLEELKH---TGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKNN-LLKIGDFGVSR 153 (260)
T ss_pred EEeCCCCCHHHHHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeecC-CEeecccCcee
Confidence 999999999998865321 123589999999999999999999974 89999999999999864 59999999776
Q ss_pred hcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccc
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (919)
........ .....+.+.+..++......++.++||||||+++|||+||+.|+...............
T Consensus 154 ~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~----------- 220 (260)
T cd08222 154 LLMGSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG----------- 220 (260)
T ss_pred ecCCCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-----------
Confidence 54322111 01111222333333333334677899999999999999999998654432211111000
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..+.. +..... .+..++.+|++.+|++||++.++++
T Consensus 221 ----~~~~~--~~~~~~---~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 ----PTPSL--PETYSR---QLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----CCCCC--cchhcH---HHHHHHHHHhcCChhhCcCHHHHhh
Confidence 01111 111111 3456888999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=253.25 Aligned_cols=248 Identities=19% Similarity=0.252 Sum_probs=188.3
Q ss_pred CCCCcccccccCCCCcEEEEE-ecCCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
+.|+..++||+|.|..|||.. -+.|+..|+|.++.... ..++..+|+++-..++|||||+|+.-. ..++..++|+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-QEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-cccceeEEEE
Confidence 345556789999999999987 56789999998875433 357788999999999999999999854 4467899999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC---CceeeCCcch
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK---FEVRLGSLSE 686 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~---~~~kl~dfg~ 686 (919)
|+|.+|+|..-+-.+. ..+....-....||.++|.|.|.. +|||||+||.|+||... --+|++|||+
T Consensus 90 e~m~G~dl~~eIV~R~-------~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGv 159 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE-------FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGL 159 (355)
T ss_pred ecccchHHHHHHHHHH-------HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccce
Confidence 9999999987765431 134445566788999999999986 89999999999999644 4589999999
Q ss_pred hhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH-HHHHHhhcccccccc
Q 002462 687 VCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTLPYISIYD 765 (919)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~-~~~~~~~~~~~~~~~ 765 (919)
+...++. .......++|.++.++....-.+++++|||+-|||||-|+.|+.||.+.+...+ +.+...++.+.+
T Consensus 160 Ai~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~--- 233 (355)
T KOG0033|consen 160 AIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPS--- 233 (355)
T ss_pred EEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCC---
Confidence 9877622 223445788888888877777899999999999999999999999988654433 233333321111
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 766 KELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 766 ~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
++ . +...++ ...+..+.+..+|++|-|..|.++
T Consensus 234 ~~---------w---~~is~~---Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 234 PE---------W---DTVTPE---AKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cc---------c---CcCCHH---HHHHHHHHhccChhhhccHHHHhC
Confidence 00 0 011222 334777889999999999998875
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-29 Score=274.83 Aligned_cols=245 Identities=18% Similarity=0.283 Sum_probs=180.5
Q ss_pred ccccCCCCcEEEEEecC-CccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCChh
Q 002462 541 LIKNGHSGDLFRGILEG-GIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLS 618 (919)
Q Consensus 541 ~ig~G~~G~Vy~g~l~~-g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL~ 618 (919)
.||.|.||.|||++-++ +...|.|++...... .++|+-||++|+...||+||+|++.++- ++..++..|||+||-.+
T Consensus 39 ELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-enkLwiliEFC~GGAVD 117 (1187)
T KOG0579|consen 39 ELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-ENKLWILIEFCGGGAVD 117 (1187)
T ss_pred hhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-cCceEEEEeecCCchHh
Confidence 48899999999998654 556688888765543 5789999999999999999999996653 46799999999999998
Q ss_pred hhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCC---c
Q 002462 619 SSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA---H 695 (919)
Q Consensus 619 ~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~---~ 695 (919)
..+-.-+ ..|+..+..-|+.++..||.|||+. .|||||||+.|||+.-+|.++++|||.+....... .
T Consensus 118 aimlEL~------r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 118 AIMLELG------RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred HHHHHhc------cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence 8875432 3478888888999999999999986 89999999999999999999999999654321110 0
Q ss_pred ceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccccC
Q 002462 696 QSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDP 775 (919)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 775 (919)
....+.++++|+....++.....|.+++||||||++|.||..+.+|....++..+.--+...- .|
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe---------------PP 253 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---------------PP 253 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC---------------CC
Confidence 111223334444444445556678999999999999999999999987655432211111111 12
Q ss_pred CCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 776 SLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 776 ~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.+..... .-..+.++...|+..+|..||+..++++
T Consensus 254 TLlqPS~---Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 254 TLLQPSH---WSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cccCcch---hhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 2211111 1123455778999999999999999875
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=257.42 Aligned_cols=235 Identities=21% Similarity=0.238 Sum_probs=174.5
Q ss_pred cccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCC
Q 002462 542 IKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGD 616 (919)
Q Consensus 542 ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~Gs 616 (919)
||+|+||.||++... ++..+|+|.+..... ..+.+..|++++++++|+||+++++.+.. ++..++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCc
Confidence 699999999999965 588999999865433 23578899999999999999999987654 567899999999999
Q ss_pred hhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcc
Q 002462 617 LSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQ 696 (919)
Q Consensus 617 L~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~ 696 (919)
|.+++.... .+++.....++.++++||.|||+. +++|+||||+||++++++.++++|||.+.........
T Consensus 80 L~~~l~~~~-------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 80 LFSHLSKEG-------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR 149 (250)
T ss_pred HHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCc
Confidence 999986432 378999999999999999999984 8999999999999999999999999977654332110
Q ss_pred eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccccCC
Q 002462 697 SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPS 776 (919)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 776 (919)
.....+...+..++.......+.++||||||+++||+++|+.|+...........+.. ..
T Consensus 150 --~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------------~~ 209 (250)
T cd05123 150 --TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK------------------DP 209 (250)
T ss_pred --ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc------------------CC
Confidence 0111122223333333333467789999999999999999999976554322222111 00
Q ss_pred CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002462 777 LIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRY 810 (919)
Q Consensus 777 l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~ 810 (919)
+........ .+..++..|+..+|++||++++
T Consensus 210 ~~~~~~~~~---~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 210 LRFPEFLSP---EARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCCCH---HHHHHHHHHhcCCHhhCCCccc
Confidence 001111111 2456888999999999999965
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=271.43 Aligned_cols=247 Identities=19% Similarity=0.280 Sum_probs=182.9
Q ss_pred HhCCCCcccccccCCCCcEEEEE-ecCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEE
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~l 607 (919)
.++.|.....||+|.|++|..|+ ...|..||||.++..... .+.+.+|+++|..++|||||+++.+ ++.....|+
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v-~~t~~~lyl 132 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV-IETEATLYL 132 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee-eeecceeEE
Confidence 35677788899999999999998 456899999999765543 3558899999999999999999995 555678999
Q ss_pred EEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchh
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~ 687 (919)
||||+.+|.++++|.+.....+ ...-.+..|+.+|++|+|.. .|||||||+.|||||.++++||+|||+.
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e-------~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS 202 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKE-------KEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFS 202 (596)
T ss_pred EEEeccCchhHHHHHhcccchh-------hhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccc
Confidence 9999999999999987654221 23345677899999999986 7999999999999999999999999977
Q ss_pred hhcCCCCcceeeeeeccCCCCccccCCCCC-CCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccc
Q 002462 688 CAQGGDAHQSRITRLLRLPQSSEQGSSGSL-TATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDK 766 (919)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (919)
-....... .....+.+.+.+++..... ...+++|+||+|||||-|+.|..||++..-.++..
T Consensus 203 ~~~~~~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~-------------- 265 (596)
T KOG0586|consen 203 TFFDYGLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP-------------- 265 (596)
T ss_pred eeeccccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc--------------
Confidence 65542221 2345667777766654333 34567899999999999999999999765322211
Q ss_pred ccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+++...+.++.....+. -.+.+.-+-.+|.+|+++.+|.+
T Consensus 266 ----rvl~gk~rIp~~ms~dc---e~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 266 ----RVLRGKYRIPFYMSCDC---EDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ----hheeeeecccceeechh---HHHHHHhhccCccccCCHHHhhh
Confidence 11111112222211221 22455667788888888888765
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-30 Score=255.13 Aligned_cols=256 Identities=22% Similarity=0.327 Sum_probs=180.3
Q ss_pred ccCHHHHHHHhCCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc--cHHHHHHHHHHHhhc-CCCCccceeeEE
Q 002462 523 SFTYQQLLAATGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV--KTEAYLLELDFFSKV-SHARLVPLLGHC 598 (919)
Q Consensus 523 ~~~~~~l~~at~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l-~H~niV~l~g~c 598 (919)
.|+-++|.. ...||.|.||+|+|-.. +.|+..|||++..... .+++|+.|.++..+- +-||||+++|.+
T Consensus 60 ~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 60 TFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred ccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 355555543 35799999999999874 6799999999976554 356899999887665 589999999999
Q ss_pred eecCCcEEEEEEecCCCChhhhh---hccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCC
Q 002462 599 MERENEKFLVYKYMPNGDLSSSL---YRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD 675 (919)
Q Consensus 599 ~~~~~~~~lV~Ey~~~GsL~~~L---~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~ 675 (919)
+. ++..|+.||.|.- ||+.+- +.... ..++..-.-+|+..+.+||.||-++ ..||||||||+|||||.
T Consensus 133 F~-EGdcWiCMELMd~-SlDklYk~vy~vq~-----~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr 203 (361)
T KOG1006|consen 133 FS-EGDCWICMELMDI-SLDKLYKRVYSVQK-----SRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDR 203 (361)
T ss_pred hc-CCceeeeHHHHhh-hHHHHHHHHHHHHh-----ccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEec
Confidence 86 5689999999974 664432 22111 1244444557888889999999986 58999999999999999
Q ss_pred CCceeeCCcchhhhcCCCCcce--eeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCCh--hHHH
Q 002462 676 KFEVRLGSLSEVCAQGGDAHQS--RITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSD--AQVK 751 (919)
Q Consensus 676 ~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~--~~~~ 751 (919)
.+.+|++|||......+....+ ..-+.+.+|+-.++... .+.-+|||||+|++|+|+.||+.|+...+. +++.
T Consensus 204 ~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~---gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~ 280 (361)
T KOG1006|consen 204 HGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDK---GYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC 280 (361)
T ss_pred CCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccC---CcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH
Confidence 9999999999765443221111 11223444443333322 367789999999999999999999976543 1222
Q ss_pred HHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 752 EILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 752 ~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.++.+.. |.+..+.+..+-...|...+..|+-++-++||...++.+
T Consensus 281 ~Vv~gdp----------------p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 281 QVVIGDP----------------PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHcCCC----------------CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 2222211 122223333334445777888999999999999988765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=289.06 Aligned_cols=255 Identities=20% Similarity=0.291 Sum_probs=173.5
Q ss_pred HHHhCCCCcccccccCCCCcEEEEE-ecCCccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecC----
Q 002462 530 LAATGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERE---- 602 (919)
Q Consensus 530 ~~at~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~---- 602 (919)
.+...+|.+-.+||+||||.|||++ --||..+|||+|...... -....+|++++++++|||||+++..+++..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 5667889999999999999999998 448999999999876522 345778999999999999999886543310
Q ss_pred --------------------------------------------------------------------------------
Q 002462 603 -------------------------------------------------------------------------------- 602 (919)
Q Consensus 603 -------------------------------------------------------------------------------- 602 (919)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHH
Q 002462 603 ----------------------------------NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAE 648 (919)
Q Consensus 603 ----------------------------------~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~ 648 (919)
...||=||||+.-.|.+.++++... . .-..-.++..+|++
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~----~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--S----QRDEAWRLFREILE 708 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--h----hhHHHHHHHHHHHH
Confidence 0135667777776666666543210 0 11223568999999
Q ss_pred HhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC----------C------CCcceeeeeeccCCCCcccc
Q 002462 649 GLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG----------G------DAHQSRITRLLRLPQSSEQG 712 (919)
Q Consensus 649 gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~----------~------~~~~~~~~~~~~~~~~~~~~ 712 (919)
||+|+|+. +||||||||.||+||++..+||+|||++.... . .......+...|+.-|.+|+
T Consensus 709 GLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 709 GLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence 99999986 79999999999999999999999999987621 0 00011123334444444444
Q ss_pred CCCC---CCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccccCCCCCCcc-hHHHHH
Q 002462 713 SSGS---LTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDED-LLEEVW 788 (919)
Q Consensus 713 ~~~~---~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~-~~~~~~ 788 (919)
..+. ..|+.|.|+||+|||++||+- ||... .+-...+.. +-++.+..+++ ..+++.
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~---------------LR~g~iP~~~~f~~~~~~ 845 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTN---------------LRKGSIPEPADFFDPEHP 845 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHh---------------cccCCCCCCcccccccch
Confidence 3332 368999999999999999985 44321 111111111 11222222211 112223
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 789 AMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 789 ~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.-+.++.+.++.||++|||+.|++.
T Consensus 846 ~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 846 EEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHHHhcCCCccCCCHHHHhh
Confidence 3466888999999999999999975
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-29 Score=298.28 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=176.9
Q ss_pred hCCCCcccccccCCCCcEEEEE-ecCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 533 TGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
+-++...+.||.|.||.||-|+ +++|...|||.++..... -+...+|+.++..++|||+|+.+|.=.. .++.+|.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-Rekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-REKVYIF 1312 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-HHHHHHH
Confidence 3345667899999999999998 788999999988655433 2457789999999999999999996554 4578999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
||||++|+|.+.+...+. ++..---.+..|++.|++|||++ +||||||||.||+||.++.+|.+|||.|.
T Consensus 1313 MEyC~~GsLa~ll~~gri-------~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI-------EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHhccCcHHHHHHhcch-------hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeeccccee
Confidence 999999999999865432 22222223567899999999986 89999999999999999999999999876
Q ss_pred hcCCCCc--ceeeeeeccCCCCccccCCCCCC---CCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhccccc
Q 002462 689 AQGGDAH--QSRITRLLRLPQSSEQGSSGSLT---ATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLPYIS 762 (919)
Q Consensus 689 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~---~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~~~~~ 762 (919)
....... ......+.++|.|++++..-... ---+.||||+|||++||+|||+||...+.+- +..-|..
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~------ 1456 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA------ 1456 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc------
Confidence 5543321 11122356677777666442111 1123699999999999999999997654321 1111110
Q ss_pred ccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 763 IYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 763 ~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
---|++ ++....+- .+....|++.||++|-++.++++
T Consensus 1457 ---------gh~Pq~--P~~ls~~g---~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1457 ---------GHKPQI--PERLSSEG---RDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ---------cCCCCC--chhhhHhH---HHHHHHHHhcCchhhhHHHHHHH
Confidence 011221 11112221 23567999999999977665543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=274.08 Aligned_cols=208 Identities=18% Similarity=0.249 Sum_probs=147.6
Q ss_pred HhCCCCcccccccCCCCcEEEEEe-----------------cCCccEEEEEecccccc-HHH--------------HHHH
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGIL-----------------EGGIPVVIKRIDLQSVK-TEA--------------YLLE 579 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~l-----------------~~g~~vavK~l~~~~~~-~~~--------------f~~E 579 (919)
.+++|...++||+|+||.||+|.+ .++..||||+++..... .++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999974 23567999999654322 223 4457
Q ss_pred HHHHhhcCCCCc-----cceeeEEeec-------CCcEEEEEEecCCCChhhhhhccCCCC-----------------Cc
Q 002462 580 LDFFSKVSHARL-----VPLLGHCMER-------ENEKFLVYKYMPNGDLSSSLYRKTNTE-----------------DD 630 (919)
Q Consensus 580 i~~l~~l~H~ni-----V~l~g~c~~~-------~~~~~lV~Ey~~~GsL~~~L~~~~~~~-----------------~~ 630 (919)
+.++.+++|.++ ++++|||... .++.+||||||++|+|.++|+...... ..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 788888887765 7788887532 246899999999999999997542210 01
Q ss_pred cCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcceeeeeeccCCCCcc
Q 002462 631 LQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSE 710 (919)
Q Consensus 631 ~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (919)
...++|..+..|+.++++||+|||+. +|+||||||+|||++.++.+||+|||.+........... ......+.|..
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP-LYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc-cccCCCcceeC
Confidence 12468888999999999999999985 799999999999999999999999998764322111110 00111222222
Q ss_pred ccCCCC----------------------CCCCCCCcchhHHHHHHHHHcCCC-CCC
Q 002462 711 QGSSGS----------------------LTATCPYDVYCFGKVLLELVTGKM-GIS 743 (919)
Q Consensus 711 ~~~~~~----------------------~~~t~~~DVySfGvvLlEllTGk~-p~~ 743 (919)
++.... .....+.||||+|||+|||++|.. |+.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 221110 011234799999999999999885 654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=289.64 Aligned_cols=144 Identities=21% Similarity=0.274 Sum_probs=124.8
Q ss_pred CCCCcccccccCCCCcEEEEEec-CCccEEEEEecccccc----HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVK----TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++|...+.||+|+||.||+|... ++..||||++...... .+.+..|++++..++|||||++++++.. .+..++|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-ANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-CCEEEEE
Confidence 46777889999999999999965 6889999998653321 3568899999999999999999987654 5689999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
||||++|+|.+++.... .+++....+|+.+|+.||+|||.. +||||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~-------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG-------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999986532 377888899999999999999985 89999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=263.69 Aligned_cols=249 Identities=18% Similarity=0.239 Sum_probs=184.6
Q ss_pred CCcccccccCCCCcEEEEEecCCccEEEEEecccccc---HHHHHHHHHHHhhcC-CCCccceeeEEeecCCcEEEEEEe
Q 002462 536 FSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVS-HARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
|...+.||+||...||+..-.+...+|+|++.....+ ...|.+|++.|.+++ |.+||+|+.|-.. ++..|+||||
T Consensus 363 Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~~lYmvmE~ 441 (677)
T KOG0596|consen 363 YEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DGYLYMVMEC 441 (677)
T ss_pred hhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-CceEEEEeec
Confidence 4455789999999999999888889999988654433 467999999999996 9999999998665 6789999998
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
=+ -||.++|.++.. ...+| .+..+-.++..++.|.|.+ +|||.||||.|.|+= +|..||.|||.|....
T Consensus 442 Gd-~DL~kiL~k~~~-----~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 442 GD-IDLNKILKKKKS-----IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred cc-ccHHHHHHhccC-----CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 54 589999976643 22456 4556888999999999986 999999999999885 4679999999998876
Q ss_pred CCCcceeeeeeccCCCCccccCC-----------CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSS-----------GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPY 760 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~ 760 (919)
.++....-..-.+++.|+.++.. .....+.++||||+|||||+|+-||.||..-. ...
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~------ 579 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQI------ 579 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHH------
Confidence 65543222223444444443322 12346778999999999999999999985321 111
Q ss_pred ccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 761 ISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 761 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..+..|.||.-..+.....+-+++..+|..|++.||.+||++.|+++
T Consensus 580 ------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 ------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 12334555533222111222334778999999999999999999986
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=257.84 Aligned_cols=245 Identities=20% Similarity=0.246 Sum_probs=184.4
Q ss_pred CCCcccccccCCCCcEEEEE-ecCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
=|+.++-||+|+|..|-.++ .=.|..||||+++..... .-..++|++-|+-++|||||+|+. .++.....|||.|
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYE-ViDTQTKlyLiLE 97 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYE-VIDTQTKLYLILE 97 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeee-hhcccceEEEEEE
Confidence 35556789999999998886 456889999999765543 456889999999999999999999 4566667899999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC-CceeeCCcchhhh
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK-FEVRLGSLSEVCA 689 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~-~~~kl~dfg~~~~ 689 (919)
.=.+|+|++++-++.. .|...-..++..||..|+.|.|.- .+|||||||+||.+-+. +-+|+.|||..-.
T Consensus 98 LGD~GDl~DyImKHe~------Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE------GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNK 168 (864)
T ss_pred ecCCchHHHHHHhhhc------cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecccccc
Confidence 9999999999976532 255555678899999999999974 79999999999987654 7899999997654
Q ss_pred cCCCCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccc
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (919)
...... .++..+.-.|.+++.. |...-.++.||||+|||||-|++|+.||...++ .+.
T Consensus 169 f~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND------------------SET 227 (864)
T KOG4717|consen 169 FQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND------------------SET 227 (864)
T ss_pred CCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc------------------hhh
Confidence 332211 2223333334444433 222223457999999999999999999976554 345
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+..|+|...........| +.+++...+..+|.+|.+.+||+.
T Consensus 228 LTmImDCKYtvPshvS~e---CrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 228 LTMIMDCKYTVPSHVSKE---CRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhhhcccccCchhhhHH---HHHHHHHHHhcCchhhccHHHHhc
Confidence 566777666555444444 345778889999999999999975
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=245.69 Aligned_cols=236 Identities=23% Similarity=0.293 Sum_probs=175.0
Q ss_pred CCCcEEEEEecC-CccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCChhhhhh
Q 002462 546 HSGDLFRGILEG-GIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLY 622 (919)
Q Consensus 546 ~~G~Vy~g~l~~-g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL~~~L~ 622 (919)
+||.||+|+..+ |..+|+|++...... .+.|.+|++.+++++|+||++++|++.. ....++||||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-EDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-CCEEEEEEeCCCCCCHHHHHH
Confidence 589999999764 899999999755433 4789999999999999999999998876 457899999999999999886
Q ss_pred ccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcceeeeee
Q 002462 623 RKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRL 702 (919)
Q Consensus 623 ~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 702 (919)
... .+++.+...++.++++|++|||.. +|+|+||+|+||++++++.++++|||.+........ ....
T Consensus 80 ~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 146 (244)
T smart00220 80 KRG-------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---LTTF 146 (244)
T ss_pred hcc-------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccc---cccc
Confidence 432 278899999999999999999985 899999999999999999999999997765433211 1111
Q ss_pred ccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCC-ChhHHHHHHHhhcccccccccccccccccCCCCCCc
Q 002462 703 LRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISAS-SDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDE 781 (919)
Q Consensus 703 ~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~ 781 (919)
.+...+..++.......+.++||||||++++||+||+.|+... ......+........ .... ..
T Consensus 147 ~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~----~~ 211 (244)
T smart00220 147 VGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP-----------FPPP----EW 211 (244)
T ss_pred cCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-----------Cccc----cc
Confidence 1222233333322345677899999999999999999998763 322222222211100 0000 00
Q ss_pred chHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 782 DLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 782 ~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
... ..+..++.+|+..+|++||++.++++
T Consensus 212 ~~~---~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 212 KIS---PEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cCC---HHHHHHHHHHccCCchhccCHHHHhh
Confidence 011 13566889999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=248.36 Aligned_cols=221 Identities=21% Similarity=0.208 Sum_probs=160.5
Q ss_pred CCCCcEEEEEe-cCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCChhhhhhc
Q 002462 545 GHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYR 623 (919)
Q Consensus 545 G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~ 623 (919)
|.||.||+++- .+|..+|+|++.... .+.+|...+....||||+++++++.+ .+..++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVS-EDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheec-CCeEEEEEecCCCCCHHHHHHH
Confidence 89999999984 568899999986542 34456666667789999999997765 4678999999999999999865
Q ss_pred cCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcceeeeeec
Q 002462 624 KTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLL 703 (919)
Q Consensus 624 ~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 703 (919)
.. .+++.....++.++++||+|||.. +|+||||||+||+++.++.++++|||.+...........
T Consensus 79 ~~-------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~----- 143 (237)
T cd05576 79 FL-------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEA----- 143 (237)
T ss_pred hc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccccccCC-----
Confidence 32 388999999999999999999974 899999999999999999999999997654432211111
Q ss_pred cCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccccCCCCCCcch
Q 002462 704 RLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDL 783 (919)
Q Consensus 704 ~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 783 (919)
....+..++......++.++||||+||++|||+||+.|+...... . . .. ..+ + + ....
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~----~---------~~---~~~-~--~--~~~~ 201 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I----N---------TH---TTL-N--I--PEWV 201 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c----c---------cc---ccc-C--C--cccC
Confidence 111223333333345677899999999999999999876432110 0 0 00 000 0 0 0111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002462 784 LEEVWAMAIVARSCLNPKPTRRPLMRY 810 (919)
Q Consensus 784 ~~~~~~~~~la~~C~~~~P~~RPsm~~ 810 (919)
.+ .+..+..+|++.+|++||++.+
T Consensus 202 ~~---~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 202 SE---EARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CH---HHHHHHHHHccCCHHHhcCCCc
Confidence 11 2456788999999999999744
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=261.70 Aligned_cols=199 Identities=20% Similarity=0.283 Sum_probs=161.2
Q ss_pred CCCcccccccCCCCcEEEEE-ecCCccEEEEEeccccccHHHHHHHHHHHhhcC-C-----CCccceeeEEeecCCcEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVS-H-----ARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~-H-----~niV~l~g~c~~~~~~~~l 607 (919)
.|...++||+|.||.|.||. ...++.||||.++-...-..+-..|+.+|..++ | -|+|++++|..- .+..||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-r~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-RNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-ccceee
Confidence 35557899999999999998 566899999999765544455567999999998 5 379999997765 568999
Q ss_pred EEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC--CceeeCCcc
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK--FEVRLGSLS 685 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~--~~~kl~dfg 685 (919)
|+|.+.. +|.++|....- ..|+......|+.||+.||.+||.. +|||+||||+||||-+- -.+||.|||
T Consensus 266 VfELL~~-NLYellK~n~f-----~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKF-----RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred eehhhhh-hHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence 9999875 89999965432 3377777788999999999999974 89999999999999754 479999999
Q ss_pred hhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChh
Q 002462 686 EVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDA 748 (919)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~ 748 (919)
.+|.......+..-+|.+++|+.. -+..|.++.||||||||+.||+||.+=|.+.+..
T Consensus 337 SSc~~~q~vytYiQSRfYRAPEVI-----LGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 337 SSCFESQRVYTYIQSRFYRAPEVI-----LGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred cccccCCcceeeeeccccccchhh-----ccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 999887666655556777776533 3457888999999999999999997766666554
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=246.41 Aligned_cols=243 Identities=21% Similarity=0.246 Sum_probs=172.7
Q ss_pred CCcccccccCCCCcEEEEEecCC-ccEEEEEecccccc----HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGILEGG-IPVVIKRIDLQSVK----TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~~g-~~vavK~l~~~~~~----~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
|...+.||.|.-|+||.+.+.+. ...|+|+++..... ..+...|-+||+.+.||-+..|++.. +.+...|||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-et~~~~cl~me 157 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-ETDKYSCLVME 157 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-eccceeEEEEe
Confidence 44456899999999999998764 78999999765432 23566799999999999999999965 55678999999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
||+||+|...++++.. ..++....--+|..|.-||+|||- .+||.|||||+||||-++|.+-++||-+....
T Consensus 158 yCpGGdL~~LrqkQp~-----~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPG-----KRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred cCCCccHHHHHhhCCC-----CccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999988876543 235444444578889999999997 59999999999999999999999998654322
Q ss_pred CCC--Ccc-----------------------------e-----------------------eeeeeccCCCCccccCCCC
Q 002462 691 GGD--AHQ-----------------------------S-----------------------RITRLLRLPQSSEQGSSGS 716 (919)
Q Consensus 691 ~~~--~~~-----------------------------~-----------------------~~~~~~~~~~~~~~~~~~~ 716 (919)
... ... . +.....++.+|.+++...+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 100 000 0 0001122333444443333
Q ss_pred CCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHH
Q 002462 717 LTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVAR 795 (919)
Q Consensus 717 ~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~ 795 (919)
-..+.+.|.|+|||+||||+.|+.||.+.+..+ +..++.+. +...+. .+-..++.+|+.
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~-------------------l~Fp~~-~~vs~~akDLIr 369 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP-------------------LKFPEE-PEVSSAAKDLIR 369 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC-------------------CcCCCC-CcchhHHHHHHH
Confidence 344567899999999999999999998876543 33333322 111111 111234566888
Q ss_pred HccCCCCCCCCC
Q 002462 796 SCLNPKPTRRPL 807 (919)
Q Consensus 796 ~C~~~~P~~RPs 807 (919)
.-+.+||.+|--
T Consensus 370 ~LLvKdP~kRlg 381 (459)
T KOG0610|consen 370 KLLVKDPSKRLG 381 (459)
T ss_pred HHhccChhhhhc
Confidence 999999999977
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=238.71 Aligned_cols=242 Identities=20% Similarity=0.297 Sum_probs=169.6
Q ss_pred cccccCCCCcEEEEEec-CCccEEEEEecccccc--HHHHHHHHHHHhhcC-CCCccceeeEEeecCCcEEEEEEecCCC
Q 002462 540 NLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVK--TEAYLLELDFFSKVS-HARLVPLLGHCMERENEKFLVYKYMPNG 615 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~~~~~lV~Ey~~~G 615 (919)
..||.|..|.|+|++.. .|..+|||.+.....+ .++.+..++++.+-+ .|.||+.+||+.. +...++.||.|.-
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~-n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-NTDVFICMELMST- 175 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-CchHHHHHHHHHH-
Confidence 46999999999999965 5889999999765544 356788888888776 7999999998875 4568899999964
Q ss_pred ChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCc
Q 002462 616 DLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAH 695 (919)
Q Consensus 616 sL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~ 695 (919)
-+++.|.+-.. +++..-.=++...+.+||.||.+. ++||||||||+|||+|+.+++|++|||.+........
T Consensus 176 C~ekLlkrik~------piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 176 CAEKLLKRIKG------PIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHHHhcC------CchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 34455544322 244444457888899999999985 5899999999999999999999999998765433221
Q ss_pred ceeeeeeccCCCCccccCCC---CCCCCCCCcchhHHHHHHHHHcCCCCCCCCCh-hHH-HHHHHhhccccccccccccc
Q 002462 696 QSRITRLLRLPQSSEQGSSG---SLTATCPYDVYCFGKVLLELVTGKMGISASSD-AQV-KEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~---~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~ 770 (919)
. ++..+-+.|++++... ...|...+|||||||.|+||+||+.|+.+... .+. ..+++ ..|
T Consensus 248 h---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~eP----------- 312 (391)
T KOG0983|consen 248 H---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEP----------- 312 (391)
T ss_pred c---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCC-----------
Confidence 1 2223333333333221 23566678999999999999999999987432 222 22222 111
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
|.+........ ....+...|+..|+.+||.-.++++
T Consensus 313 ----P~L~~~~gFSp---~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 313 ----PLLPGHMGFSP---DFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ----CCCCcccCcCH---HHHHHHHHHhhcCcccCcchHHHhc
Confidence 12211111111 1344667899999999999988765
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-28 Score=266.15 Aligned_cols=292 Identities=24% Similarity=0.249 Sum_probs=240.6
Q ss_pred cChhhhcCCCCCCEEecCCCCCCCCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCccccc
Q 002462 108 FAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLG 187 (919)
Q Consensus 108 ~~~~~l~~L~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~ 187 (919)
+....|.-+..|++||||.|.++ .||..-+..-.++++|+|++|.|+..--..|.+|.+|..|.|+.|+++...+..|.
T Consensus 140 v~se~L~~l~alrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk 218 (873)
T KOG4194|consen 140 VTSEELSALPALRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFK 218 (873)
T ss_pred ccHHHHHhHhhhhhhhhhhchhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhh
Confidence 34457778888999999998774 55544333456899999999999888888899999999999999999866667788
Q ss_pred CCCCCCEEEccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEE
Q 002462 188 QLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDL 267 (919)
Q Consensus 188 ~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 267 (919)
+|++|+.|+|..|+|.-.---.|.+|++|+.|.|..|.+...-...|..|.++++|+|+.|+++..-..++.+|+.|+.|
T Consensus 219 ~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L 298 (873)
T KOG4194|consen 219 RLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQL 298 (873)
T ss_pred hcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhh
Confidence 89999999999999874434578889999999999999886666678889999999999999988777888999999999
Q ss_pred EcCCCCCCCCCchhhhccccCCEEEccCCcCCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEccCCCC
Q 002462 268 DLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNF 347 (919)
Q Consensus 268 ~Ls~N~l~g~~p~~l~~l~~L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 347 (919)
+||+|.+...-++.+...++|+.|+|++|+|+ .++...|..++.|++|+|++|+++..-...|..+.+|+.|||++|.+
T Consensus 299 ~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~-~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~l 377 (873)
T KOG4194|consen 299 DLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT-RLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNEL 377 (873)
T ss_pred ccchhhhheeecchhhhcccceeEeccccccc-cCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeE
Confidence 99999999888899999999999999999998 56777778899999999999999988888899999999999999999
Q ss_pred CCCCCcc--cccCCCCCcEEEccCCcCcc---CCCCCCCCCcEEEccCCcCCCcCCccc
Q 002462 348 TGPLPNS--RSNVNTSTVELNISQNMFYG---GLTPVLGRFRLVDLSGNYFEGRVPEYV 401 (919)
Q Consensus 348 ~g~ip~~--~~~~~~~l~~L~ls~N~~~g---~~~~~l~~L~~ldLs~N~l~g~ip~~~ 401 (919)
++.|-+. .++.+.+|..|++.+|++.. .-+..+..|+.|||.+|.+...-|+.+
T Consensus 378 s~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAF 436 (873)
T KOG4194|consen 378 SWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAF 436 (873)
T ss_pred EEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeeccccc
Confidence 8776542 34557888899999998753 233568889999999998875555543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=272.41 Aligned_cols=269 Identities=18% Similarity=0.187 Sum_probs=156.4
Q ss_pred HhCCCCcccccccCCCCcEEEEEecC-----CccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeE-E----eec
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGILEG-----GIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGH-C----MER 601 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~l~~-----g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~-c----~~~ 601 (919)
..++|...+.||+|+||.||+|+..+ +..||||++..... .+.+..| .+.+..|.+++.++.. . ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 56789999999999999999999754 68999999854321 2222222 1222233333332221 1 123
Q ss_pred CCcEEEEEEecCCCChhhhhhccCCCCC-------------ccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCC
Q 002462 602 ENEKFLVYKYMPNGDLSSSLYRKTNTED-------------DLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQA 668 (919)
Q Consensus 602 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~-------------~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~ 668 (919)
+.+.++||||+++|+|.+++........ ............|+.|+++||+|||+. +||||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCH
Confidence 4578999999999999999865421100 000011223446899999999999985 899999999
Q ss_pred CceecCC-CCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCC----------------------CCCCCCCCcc
Q 002462 669 SSILLDD-KFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSG----------------------SLTATCPYDV 725 (919)
Q Consensus 669 ~NILld~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~t~~~DV 725 (919)
+|||+|+ ++.+||+|||+++......... .....+.+.|..++... ...+..++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999996 5799999999987543211110 11122223333322110 0124456799
Q ss_pred hhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccccCCCCCC----cchHH-HHHHHHHHHHHccCC
Q 002462 726 YCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIID----EDLLE-EVWAMAIVARSCLNP 800 (919)
Q Consensus 726 ySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~----~~~~~-~~~~~~~la~~C~~~ 800 (919)
||||||||||+++..+.+... ......+...- ++.......+++....+ .+..+ .-....++...|++.
T Consensus 363 wSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRND-----YDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcC-----CcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 999999999999876643211 11111111000 00000011111110000 00000 001123588899999
Q ss_pred CCCCCCCHHHHHH
Q 002462 801 KPTRRPLMRYILK 813 (919)
Q Consensus 801 ~P~~RPsm~~V~~ 813 (919)
||++|||++++++
T Consensus 437 dP~kR~ta~e~L~ 449 (566)
T PLN03225 437 KGRQRISAKAALA 449 (566)
T ss_pred CcccCCCHHHHhC
Confidence 9999999999986
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=248.04 Aligned_cols=200 Identities=23% Similarity=0.268 Sum_probs=165.7
Q ss_pred CCCCcccccccCCCCcEEEEEe-cCCccEEEEEecccccc----HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK----TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
+.|+.-++||+||||.||.++. ..|+.+|.|+++....+ ...-++|-.+|.+++-+-||.+- |.+++.+..++|
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVsla-YAfeTkd~LClV 263 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLA-YAFETKDALCLV 263 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEe-eeecCCCceEEE
Confidence 4588889999999999999985 46899999998765543 23457899999999999888765 566777889999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
+..|.+|||.-||+..++ ..++..+.+-+|.+|+-||++||.+ .||.||+||.|||||+.+.++|+|+|+|.
T Consensus 264 LtlMNGGDLkfHiyn~g~-----~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-----PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred EEeecCCceeEEeeccCC-----CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEE
Confidence 999999999999987653 2377777788999999999999986 89999999999999999999999999998
Q ss_pred hcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCC
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISAS 745 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~ 745 (919)
....... .+...++.+|++++......|+...|.||+||+||||+.|+.||-..
T Consensus 336 ei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 336 EIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred ecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 6644322 12225677777777666556888899999999999999999998643
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=244.50 Aligned_cols=251 Identities=17% Similarity=0.205 Sum_probs=179.8
Q ss_pred ccccccCCCCcEEEEE-ecCCccEEEEEecccccc----H----HHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 539 ANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK----T----EAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~----~----~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
.++||+|||..|||+. +.....||||.-...... . +.-.+|-++.+.+.||.||+++.|..-..+..|-|.
T Consensus 468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL 547 (775)
T KOG1151|consen 468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL 547 (775)
T ss_pred HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence 3679999999999998 666788999975433221 1 234679999999999999999998765556789999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCC---CCceeeCCcch
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD---KFEVRLGSLSE 686 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~---~~~~kl~dfg~ 686 (919)
|||++-||+-+|...+. ++....-.|+.+|..||.||.+ ..|||||-||||.||||-+ -+++||.|||+
T Consensus 548 EYceGNDLDFYLKQhkl-------mSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 548 EYCEGNDLDFYLKQHKL-------MSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred eecCCCchhHHHHhhhh-------hhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 99999999998865432 4556677899999999999987 5789999999999999964 47899999999
Q ss_pred hhhcCCCCcce-----eeeeeccCCCCccccCC--C--CCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhh
Q 002462 687 VCAQGGDAHQS-----RITRLLRLPQSSEQGSS--G--SLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQT 757 (919)
Q Consensus 687 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~--~--~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~ 757 (919)
.+...++...+ ..+...++++|..++.+ | ....++|.||||.|||.|..+-||+||..... ..++++..
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdILqeN 697 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDILQEN 697 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHHhhh
Confidence 99876654332 22334555566555543 3 45689999999999999999999999975432 12222211
Q ss_pred cccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002462 758 LPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYIL 812 (919)
Q Consensus 758 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~ 812 (919)
.+.+.-.-.+...+....+ .-..+.+|+++.-++|-...++.
T Consensus 698 ----------TIlkAtEVqFP~KPvVsse---AkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 698 ----------TILKATEVQFPPKPVVSSE---AKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ----------chhcceeccCCCCCccCHH---HHHHHHHHHHhhhhhhhhHHHHc
Confidence 0111100011111111222 23477899999999997655543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-27 Score=260.98 Aligned_cols=286 Identities=26% Similarity=0.262 Sum_probs=203.1
Q ss_pred hhhhcCCCCCCEEecCCCCCCCCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCC
Q 002462 110 ADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQL 189 (919)
Q Consensus 110 ~~~l~~L~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L 189 (919)
...+.+|.+|+.+++..|.|. .||.... ...+|+.|+|.+|.|+.+-..++..++.|+.||||.|.|+..--.+|..-
T Consensus 95 ~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~-~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~ 172 (873)
T KOG4194|consen 95 FEFFYNLPNLQEVNLNKNELT-RIPRFGH-ESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAK 172 (873)
T ss_pred HHHHhcCCcceeeeeccchhh-hcccccc-cccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCC
Confidence 456778889999999888874 6776543 36678888888888887777778888888888888888875444456666
Q ss_pred CCCCEEEccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEc
Q 002462 190 SVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDL 269 (919)
Q Consensus 190 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 269 (919)
.++++|+|++|+|+..--..|.++.+|..|.|+.|.++...+..|.+|++|+.|+|..|+|.-.---.|.+|++|+.|.|
T Consensus 173 ~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlkl 252 (873)
T KOG4194|consen 173 VNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKL 252 (873)
T ss_pred CCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhh
Confidence 67888888888888777777888888888888888888655566777888888888888775332345667777777777
Q ss_pred CCCCCCCCCchhhhccccCCEEEccCCcCCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCC
Q 002462 270 SMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTG 349 (919)
Q Consensus 270 s~N~l~g~~p~~l~~l~~L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 349 (919)
..|.++..-...|..+.++++|+|..|+++.. ....+-+++.|+.|+|++|.+..+-++.+...++|+.|||++|+++
T Consensus 253 qrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~v-n~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~- 330 (873)
T KOG4194|consen 253 QRNDISKLDDGAFYGLEKMEHLNLETNRLQAV-NEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT- 330 (873)
T ss_pred hhcCcccccCcceeeecccceeecccchhhhh-hcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccc-
Confidence 77777766666677777777777777777632 2333346677777777777777777777777777777777777777
Q ss_pred CCCcccccCCCCCcEEEccCCcCc---cCCCCCCCCCcEEEccCCcCCCcCCc
Q 002462 350 PLPNSRSNVNTSTVELNISQNMFY---GGLTPVLGRFRLVDLSGNYFEGRVPE 399 (919)
Q Consensus 350 ~ip~~~~~~~~~l~~L~ls~N~~~---g~~~~~l~~L~~ldLs~N~l~g~ip~ 399 (919)
.++...+..+..|.+|+|++|.+. ...+..+.+|+.|||++|.+++.|-+
T Consensus 331 ~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IED 383 (873)
T KOG4194|consen 331 RLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIED 383 (873)
T ss_pred cCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEec
Confidence 444455555666777777777653 22334466677777777777666544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=261.35 Aligned_cols=261 Identities=19% Similarity=0.281 Sum_probs=195.9
Q ss_pred CHHHHHHHhCCCCcccccccCCCCcEEEEE-ecCCccEEEEEeccccccHHHHHHHHHHHhhc-CCCCccceeeEEeec-
Q 002462 525 TYQQLLAATGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKV-SHARLVPLLGHCMER- 601 (919)
Q Consensus 525 ~~~~l~~at~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~- 601 (919)
.++.+-.-++-|...+.||+|.+|.|||++ .++|+.+|||.++.....+++...|.++++.. .|||++.++|++.-.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 344444456677788999999999999998 77899999999988777778888999999988 599999999987632
Q ss_pred ---CCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCc
Q 002462 602 ---ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFE 678 (919)
Q Consensus 602 ---~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~ 678 (919)
+++.|||||||.+||..+.+..-. ...++|....-|+.++.+||.+||.. .+||||||-.||||.+++.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-----g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~ 161 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-----GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAE 161 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-----ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCc
Confidence 468999999999999999885432 24588998889999999999999985 7999999999999999999
Q ss_pred eeeCCcchhhhcCCCCcceeeeeeccCCCCccccC-----CCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHH
Q 002462 679 VRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGS-----SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEI 753 (919)
Q Consensus 679 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~ 753 (919)
+|+.|||............ .+..++|.+++++. .....++..+||||+|++..||.-|.+|+.+.-+.-. +
T Consensus 162 VKLvDFGvSaQldsT~grR--nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra--L 237 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDSTVGRR--NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA--L 237 (953)
T ss_pred EEEeeeeeeeeeecccccc--cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--h
Confidence 9999999776554322211 11234444444433 3345677788999999999999999999866543211 1
Q ss_pred HHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 754 LEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
+. +|. . =.|.+... .....++-..+..|+..+-.+||++.+.++
T Consensus 238 F~--IpR---N--------PPPkLkrp---~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 FL--IPR---N--------PPPKLKRP---KKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred cc--CCC---C--------CCccccch---hhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 00 000 0 01112111 122335667889999999999999998875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=210.65 Aligned_cols=203 Identities=22% Similarity=0.317 Sum_probs=152.4
Q ss_pred CCcccccccCCCCcEEEEE-ecCCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 536 FSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
|+..++||+|.||+||||+ .+.+..||+|++..+... ...-++||-+++.++|+|||+++..... +...-+|+||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-dkkltlvfe~ 82 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVFEF 82 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-CceeEEeHHH
Confidence 4455789999999999998 566889999999765433 3567899999999999999999996553 5567899999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
|.. +|.++...-.+ .++-...-....|..+||.|.|++ .+.|||+||.|.|++.+++.|++|||+++..+
T Consensus 83 cdq-dlkkyfdslng------~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafg 152 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNG------DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFG 152 (292)
T ss_pred hhH-HHHHHHHhcCC------cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcC
Confidence 985 67666543322 366666677899999999999986 79999999999999999999999999999876
Q ss_pred CCCcce---eeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc-CCCCCCCCC-hhHHHHH
Q 002462 692 GDAHQS---RITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASS-DAQVKEI 753 (919)
Q Consensus 692 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~-~~~~~~~ 753 (919)
-..... ..+-.++.| .-.+|..-|++..|+||-|||+.|+.. |++-|.+.+ ++++..+
T Consensus 153 ipvrcysaevvtlwyrpp----dvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkri 215 (292)
T KOG0662|consen 153 IPVRCYSAEVVTLWYRPP----DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_pred CceEeeeceeeeeeccCc----ceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHH
Confidence 433211 122222222 123344567778899999999999986 554444443 2344443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=254.75 Aligned_cols=236 Identities=18% Similarity=0.186 Sum_probs=173.7
Q ss_pred CCCcccccccCCCCcEEEEE-ecCCccEEEEEeccccccHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEEEEEEec
Q 002462 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
.+.....+|.|+|+.|-++. ...++..+||.+..... +-.+|+.++.+. +|||||++.+.|.+ +.+.++|||++
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---~~~~e~~~~~~~~~h~niv~~~~v~~~-~~~~~~v~e~l 398 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---DNQDEIPISLLVRDHPNIVKSHDVYED-GKEIYLVMELL 398 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheecccccc---ccccccchhhhhcCCCcceeecceecC-Cceeeeeehhc
Confidence 33344559999999999998 45678899999965522 233577676666 69999999998765 56899999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceec-CCCCceeeCCcchhhhcC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILL-DDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILl-d~~~~~kl~dfg~~~~~~ 691 (919)
.+|-|.+.+..++. .. ..+..|+.+++.|+.|||++ +|||||+||+|||+ ++.+.+++.|||.++...
T Consensus 399 ~g~ell~ri~~~~~-------~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 399 DGGELLRRIRSKPE-------FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred cccHHHHHHHhcch-------hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99998888865432 12 56678999999999999985 89999999999999 588999999999988766
Q ss_pred CCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChh-HHHHHHHhhccccccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDA-QVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
........+. .|.+++......+|+.+|+|||||+||||+||+.|+...... ++..-+.
T Consensus 468 ~~~~tp~~t~-----~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~--------------- 527 (612)
T KOG0603|consen 468 RSCDTPALTL-----QYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ--------------- 527 (612)
T ss_pred hhhcccchhh-----cccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc---------------
Confidence 5522222232 234444444567899999999999999999999999765433 2211111
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.+.. .+...++ ...|...|++.+|.+||+|.++..
T Consensus 528 ---~~~~--s~~vS~~---AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 528 ---MPKF--SECVSDE---AKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---CCcc--ccccCHH---HHHHHHHhccCChhhCcChhhhcc
Confidence 1111 0111122 345788999999999999999875
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-26 Score=231.57 Aligned_cols=271 Identities=14% Similarity=0.202 Sum_probs=185.7
Q ss_pred cCHHHHHHHhCCCCcccccccCCCCcEEEEE-ecCCccEEEEEecccccc-HHHHHHHHHHHhhcC-CCCccceeeEEee
Q 002462 524 FTYQQLLAATGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVS-HARLVPLLGHCME 600 (919)
Q Consensus 524 ~~~~~l~~at~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~-H~niV~l~g~c~~ 600 (919)
-+|+|+.+-|+ ++||+|.|+.|--++ +.+|..+|||.++..... +....+|++++.+.+ |+||+.|+.|+.
T Consensus 73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE- 146 (463)
T KOG0607|consen 73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE- 146 (463)
T ss_pred chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc-
Confidence 35788888885 589999999999987 889999999999765433 567889999999996 999999999764
Q ss_pred cCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC---C
Q 002462 601 RENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK---F 677 (919)
Q Consensus 601 ~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~---~ 677 (919)
.+...|||||-|.+|+|..+++++.. ++..+.-++..+||.||.|||.. +|.|||+||.|||-.+- -
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~~~-------F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vs 216 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKRKH-------FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVS 216 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHhhh-------ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcC
Confidence 45678999999999999999986543 66667788999999999999985 89999999999997643 3
Q ss_pred ceeeCCcchhhhcCCCCccee-----eeeeccCCCCccccCC-----CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCCh
Q 002462 678 EVRLGSLSEVCAQGGDAHQSR-----ITRLLRLPQSSEQGSS-----GSLTATCPYDVYCFGKVLLELVTGKMGISASSD 747 (919)
Q Consensus 678 ~~kl~dfg~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~-----~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~ 747 (919)
-+||+||-+.....-....+. ..+..+..++++++.. ....|..++|.||+|||||-|++|..||.+..+
T Consensus 217 PvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 217 PVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred ceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 489999865443211111111 1122333334444322 123466778999999999999999999987654
Q ss_pred hHHHHHHHhhcccccccccccccccccCCCCCCcchHHHHH-HHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 748 AQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVW-AMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~-~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
++. -|-++. +. ..-.......|-+......+.....+. ...+++..-+..+|.+|-++.+|+.
T Consensus 297 ~dC-GWdrGe-~C-r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 297 ADC-GWDRGE-VC-RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CcC-CccCCC-cc-HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 221 010000 00 000011223333333333222222221 1234666677799999998888875
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=227.56 Aligned_cols=252 Identities=15% Similarity=0.187 Sum_probs=186.1
Q ss_pred hCCCCc-ccccccCCCCcEEEEEe-cCCccEEEEEeccccccHHHHHHHHHHHhhc-CCCCccceeeEEeec---CCcEE
Q 002462 533 TGDFSD-ANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKV-SHARLVPLLGHCMER---ENEKF 606 (919)
Q Consensus 533 t~~f~~-~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~---~~~~~ 606 (919)
|.+|+. ..+||-|-.|.|-.+.. ..|...|+|.+.... .-.+|+++.-+. .|||||.++..+... ..-.+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 445543 36899999999999874 457889999884332 235788876665 599999999865321 22467
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCC---CCceeeCC
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD---KFEVRLGS 683 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~---~~~~kl~d 683 (919)
+|||+|++|.|...+..++. +.++..+.-.|..+|+.|+.|||+. .|.||||||+|+|-.. |-..|++|
T Consensus 136 iVmE~meGGeLfsriq~~g~-----~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGD-----QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeeecccchHHHHHHHHccc-----ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 99999999999999976543 4588888999999999999999984 8999999999999864 46789999
Q ss_pred cchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccc
Q 002462 684 LSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISI 763 (919)
Q Consensus 684 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~ 763 (919)
||.|+..... ....+...+|.|.+++..|.-+|...+|+||+||++|-|++|-+||.......
T Consensus 208 fGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-------------- 270 (400)
T KOG0604|consen 208 FGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------------- 270 (400)
T ss_pred cccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc--------------
Confidence 9999865421 12334455667777777777777777899999999999999999997543211
Q ss_pred cccccccccccCCCCCCcchHHHHHHHH-HHHHHccCCCCCCCCCHHHHHH
Q 002462 764 YDKELVTKIVDPSLIIDEDLLEEVWAMA-IVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 764 ~~~~~~~~i~d~~l~~~~~~~~~~~~~~-~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..++.-.+|........+....++.+++ ++++.-+..+|++|-|+.++..
T Consensus 271 ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 271 ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 0122223333334433333345555444 4777889999999999999975
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=228.26 Aligned_cols=206 Identities=17% Similarity=0.204 Sum_probs=166.3
Q ss_pred CCCCcccccccCCCCcEEEEE-ecCCccEEEEEecccccc-HH---HHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK-TE---AYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~-~~---~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
++|+..+++|+|.||+|..++ -..|+.+|+|.++..-.- ++ .-+.|-++|...+||-+..|-. .++..+..|.|
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKY-sFQt~drlCFV 246 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKY-SFQTQDRLCFV 246 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhh-hhccCceEEEE
Confidence 578888999999999999988 456889999998654332 22 3456999999999999988764 55666789999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|||..+|.|.-+|.+.+. ++..+.--+-..|..||.|||+. .||.||+|-.|.|||.|+.+||+|||+.+
T Consensus 247 MeyanGGeLf~HLsrer~-------FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERV-------FSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred EEEccCceEeeehhhhhc-------ccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccch
Confidence 999999999999976543 22222223567789999999985 89999999999999999999999999876
Q ss_pred hcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHH
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKE 752 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~ 752 (919)
...... ....++.++|+|.+++......|....|.|..|||+|||++||.||...+.+.+-+
T Consensus 317 E~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFe 378 (516)
T KOG0690|consen 317 EEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFE 378 (516)
T ss_pred hccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHH
Confidence 543322 23456889999999988877788888999999999999999999998766544433
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=216.95 Aligned_cols=210 Identities=18% Similarity=0.258 Sum_probs=153.4
Q ss_pred ccccccCCCCcEEEEE-ecCCccEEEEEeccccc--cHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEEEEEEecCC
Q 002462 539 ANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSV--KTEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFLVYKYMPN 614 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~lV~Ey~~~ 614 (919)
...||+|+||.|=+-+ ..+|+..|||++...-. ..++.++|+++..+- ..|-+|.++|..+. +...++.||.|.-
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-egdvwIcME~M~t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-EGDVWICMELMDT 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-cccEEEeHHHhhh
Confidence 3569999999998877 46899999999965432 345678899887665 68999999997665 5689999999985
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCC
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~ 694 (919)
||+.+-.+-- .....++..-.=+||..|.+||.|||+. ..|||||+||+|||++.++.+|++|||.+.......
T Consensus 130 -Sldkfy~~v~---~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 130 -SLDKFYRKVL---KKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred -hHHHHHHHHH---hcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 7766543210 1112355556678999999999999985 689999999999999999999999999765543322
Q ss_pred cce--eeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCC-h-hHHHHHHHh
Q 002462 695 HQS--RITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASS-D-AQVKEILEQ 756 (919)
Q Consensus 695 ~~~--~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~-~-~~~~~~~~~ 756 (919)
..+ ..-..+.+|+-..++.... .|+-|+||||+|+.+.||.++|.|++... + .++...|+.
T Consensus 204 Akt~daGCkpYmaPEri~~e~n~~-gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 204 AKTMDAGCKPYMAPERINPELNQK-GYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred HHHHhcCCCccCChhhcCcccCcc-cceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 111 1112344454444443332 68889999999999999999999997643 2 234455544
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-25 Score=232.97 Aligned_cols=209 Identities=18% Similarity=0.269 Sum_probs=167.3
Q ss_pred HHHHHhCCCCcccccccCCCCcEEEEEecC-CccEEEEEecccccc----HHHHHHHHHHHhhc-CCCCccceeeEEeec
Q 002462 528 QLLAATGDFSDANLIKNGHSGDLFRGILEG-GIPVVIKRIDLQSVK----TEAYLLELDFFSKV-SHARLVPLLGHCMER 601 (919)
Q Consensus 528 ~l~~at~~f~~~~~ig~G~~G~Vy~g~l~~-g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~ 601 (919)
+..++| +|....+||+|+||.|..|.-++ ...+|||.++.+-.- .+--+.|-++|+-- +-|-+|.++. |++.
T Consensus 344 d~i~~t-DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHS-cFQT 421 (683)
T KOG0696|consen 344 DRIKAT-DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHS-CFQT 421 (683)
T ss_pred cceeec-ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHH-Hhhh
Confidence 344454 68889999999999999997654 467899998654321 23345677777765 4677888887 7777
Q ss_pred CCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceee
Q 002462 602 ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRL 681 (919)
Q Consensus 602 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl 681 (919)
-+..|.||||+.+|+|--++..-+. +..+..+-+|..||-||-|||+. +||.||||-.|||||.++.+||
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~Gk-------FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi 491 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVGK-------FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKI 491 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhcc-------cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEe
Confidence 7789999999999999888865432 34445667899999999999985 9999999999999999999999
Q ss_pred CCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH
Q 002462 682 GSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV 750 (919)
Q Consensus 682 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~ 750 (919)
+|||+.+...-.. .+..+..++|.|.+++...+..|....|.|||||+||||+.|++||++.+.+++
T Consensus 492 ~DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el 558 (683)
T KOG0696|consen 492 ADFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 558 (683)
T ss_pred eecccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 9999876433222 223557899999999988888888889999999999999999999999876654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-26 Score=226.08 Aligned_cols=265 Identities=20% Similarity=0.285 Sum_probs=178.0
Q ss_pred cccccccCCCCcEEEEEec-CCccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecC-------CcEE
Q 002462 538 DANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERE-------NEKF 606 (919)
Q Consensus 538 ~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~-------~~~~ 606 (919)
...+||+|.||.||+++-. .|+.||+|++-....+ ...-++|+++|..++|+|+|.++..|.... ...+
T Consensus 21 k~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~y 100 (376)
T KOG0669|consen 21 KLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFY 100 (376)
T ss_pred HHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceee
Confidence 3468999999999999854 5678899876443222 355689999999999999999999885321 2479
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcch
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~ 686 (919)
+|+++|+. ||.-.|.... ..+...+.-++..+...||.|+|.. .|+|||+||.|+|++.++..|++|||+
T Consensus 101 lVf~~ceh-DLaGlLsn~~------vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 101 LVFDFCEH-DLAGLLSNRK------VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeHHHhhh-hHHHHhcCcc------ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 99999986 7887774321 3466777788999999999999985 899999999999999999999999999
Q ss_pred hhhcCCCCcc--eee-eeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhh------
Q 002462 687 VCAQGGDAHQ--SRI-TRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQT------ 757 (919)
Q Consensus 687 ~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~------ 757 (919)
++........ .+. .++...+.-+..-..|...++.+.|||.-|||+.||.||.+-+.+.+..+....+...
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9765321110 011 1111111112222346667888899999999999999999888776655433333321
Q ss_pred --cccccccccccccccccCCCCCC-cc-hHHHHH------HHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 758 --LPYISIYDKELVTKIVDPSLIID-ED-LLEEVW------AMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 758 --~~~~~~~~~~~~~~i~d~~l~~~-~~-~~~~~~------~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
+|-. ..-+....+--+.+... .. ..+.+. ..+++....+..||.+|++..+++..
T Consensus 251 evWP~~--d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 251 EVWPNV--DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCCc--ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1110 00000111100101000 00 001111 24567778899999999999998753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=218.31 Aligned_cols=209 Identities=26% Similarity=0.380 Sum_probs=164.8
Q ss_pred cccCCCCcEEEEEecC-CccEEEEEecccccc--HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCChh
Q 002462 542 IKNGHSGDLFRGILEG-GIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLS 618 (919)
Q Consensus 542 ig~G~~G~Vy~g~l~~-g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL~ 618 (919)
||+|++|.||++...+ +..++||++...... .+.+.+|++.+++++|++++++++++... ...++||||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-NHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-CeEEEEEecCCCCcHH
Confidence 6899999999999765 889999999766543 46799999999999999999999987653 5789999999999999
Q ss_pred hhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCC-CCceeeCCcchhhhcCCCCcce
Q 002462 619 SSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD-KFEVRLGSLSEVCAQGGDAHQS 697 (919)
Q Consensus 619 ~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~-~~~~kl~dfg~~~~~~~~~~~~ 697 (919)
+++.... ..+++..+..++.+++++|+|||+. +++|+||+|.||+++. +..++++||+.+........
T Consensus 80 ~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-- 148 (215)
T cd00180 80 DLLKENE------GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-- 148 (215)
T ss_pred HHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--
Confidence 9986532 2478999999999999999999985 8999999999999999 89999999987664432210
Q ss_pred eeeeeccCCCCccccCCCCC-CCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccccCC
Q 002462 698 RITRLLRLPQSSEQGSSGSL-TATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPS 776 (919)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~-~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 776 (919)
..........+..++..... ..+.+.|+|++|++++||
T Consensus 149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------- 187 (215)
T cd00180 149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------- 187 (215)
T ss_pred hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------
Confidence 00111112222222222222 556778999999999999
Q ss_pred CCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 777 LIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 777 l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
.++..++..|++.+|++||++.++++.
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 124457789999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-25 Score=226.10 Aligned_cols=200 Identities=18% Similarity=0.284 Sum_probs=155.6
Q ss_pred CCCcccccccCCCCcEEEEEecC-----CccEEEEEecccccc---HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILEG-----GIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKF 606 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~-----g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~ 606 (919)
.|.....||+|.||.|||++-.+ ...+|||+++..... ...-.+|+.+++.++|||||.|.-...+.+...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 45556789999999999997433 237899999765322 3456899999999999999999988777667789
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC----CceeeC
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK----FEVRLG 682 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~----~~~kl~ 682 (919)
++|||.+. ||...++-++... ...++-...-.|.-||..|+.|||+. -|+||||||+|||+..+ +.+||+
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~--~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASK--AKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEehhhhh-hHHHHHHHhccch--hccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 99999986 8888886443322 23577777778999999999999996 59999999999999877 899999
Q ss_pred CcchhhhcCCC------CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCC
Q 002462 683 SLSEVCAQGGD------AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISA 744 (919)
Q Consensus 683 dfg~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~ 744 (919)
|+|+++..... ......+-.+++|+.. .|...||.+.|||+.|||..||+|-++-|.+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELL----LGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELL----LGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHh----cccccccchhhhHHHHHHHHHHHccCccccc
Confidence 99999876432 1122334445555422 3455688889999999999999998876654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-25 Score=258.51 Aligned_cols=207 Identities=22% Similarity=0.297 Sum_probs=162.2
Q ss_pred HHHHHhCCCCcccccccCCCCcEEEEEec-CCccEEEEEecccc----ccHHHHHHHHHHHhhcCCCCccceeeEEeecC
Q 002462 528 QLLAATGDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQS----VKTEAYLLELDFFSKVSHARLVPLLGHCMERE 602 (919)
Q Consensus 528 ~l~~at~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~----~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~ 602 (919)
++.--..||....+||+|+||.|...+.. .+..+|.|+++... ....-|..|-++|.--..+-||.|+. .++++
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lhy-AFQD~ 147 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHY-AFQDE 147 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHH-HhcCc
Confidence 44445578999999999999999999865 47888999996532 22345888999999888999999986 45557
Q ss_pred CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeC
Q 002462 603 NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG 682 (919)
Q Consensus 603 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~ 682 (919)
.+.|+||||||||||-..|.+... .+=+|. | -++..|.-||.-||+ .+.|||||||.|||||..|.+|++
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~-----~pE~~A-r-FY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDR-----LPEDWA-R-FYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCC-----ChHHHH-H-HHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeec
Confidence 789999999999999999965431 123454 3 356678889999997 599999999999999999999999
Q ss_pred CcchhhhcCCCCcceeeeeeccCCCCccccCC-----CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCC
Q 002462 683 SLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS-----GSLTATCPYDVYCFGKVLLELVTGKMGISASS 746 (919)
Q Consensus 683 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~ 746 (919)
|||.......+.+. ......|+|.|..|+.. +...|...+|.||+||++|||+.|..||...+
T Consensus 218 DFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads 285 (1317)
T KOG0612|consen 218 DFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS 285 (1317)
T ss_pred cchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence 99966555444433 34456788887765432 22567778899999999999999999998654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=217.84 Aligned_cols=198 Identities=24% Similarity=0.307 Sum_probs=156.2
Q ss_pred CCcccccccCCCCcEEEEEecC-CccEEEEEeccccc--cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 536 FSDANLIKNGHSGDLFRGILEG-GIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~~-g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
|...+.||+|++|.||+|...+ +..+|||.+..... ..+.+.+|++.+.+++|+|++++++++.. ....++|+||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-PEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-CCceEEEEecc
Confidence 4456789999999999999875 88999999976544 35678999999999999999999998765 45789999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
++++|.+++..... .+++.+...++.+++++++|||.. +++|+|++++||+++.++.++++|||.+.....
T Consensus 80 ~~~~L~~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~ 150 (225)
T smart00221 80 EGGDLFDYLRKKGG------KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHR 150 (225)
T ss_pred CCCCHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence 99999999865321 178889999999999999999985 899999999999999999999999997765433
Q ss_pred CCcceeeeeeccCCCCccccCC-CCCCCCCCCcchhHHHHHHHHHcCCCCCCC
Q 002462 693 DAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISA 744 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~~DVySfGvvLlEllTGk~p~~~ 744 (919)
.... ..........+..++.. +....+.++|||+||++++||+||+.||+.
T Consensus 151 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 151 DLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2100 00111112222222222 334566689999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-24 Score=231.25 Aligned_cols=195 Identities=18% Similarity=0.261 Sum_probs=153.0
Q ss_pred ccccccCCCCcEEEEE-ecCCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCC
Q 002462 539 ANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPN 614 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~ 614 (919)
++++|+|.||+||-|. -++|+.||||.++.-. .+.++..+|+.+|.+++||.||.|.--| +..+..++|||-+.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-ETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-cCCceEEEEehhhcc
Confidence 4699999999999998 4679999999986533 3356788999999999999999988654 555678999999975
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC--C-ceeeCCcchhhhcC
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK--F-EVRLGSLSEVCAQG 691 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~--~-~~kl~dfg~~~~~~ 691 (919)
--|+-.|.... ..|+...-.-+..||..||.|||.. .|||+||||+||||.+. | .+|++|||.++..+
T Consensus 648 DMLEMILSsEk------gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg 718 (888)
T KOG4236|consen 648 DMLEMILSSEK------GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG 718 (888)
T ss_pred hHHHHHHHhhc------ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence 44554454332 2355554455788999999999985 89999999999999754 3 69999999999876
Q ss_pred CCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCC
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASS 746 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~ 746 (919)
..... ..+.++|.|.+++......|...-|+||.|||+|--++|..||....
T Consensus 719 EksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 719 EKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred hhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 54432 23567888887776554455556699999999999999999997654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-23 Score=219.93 Aligned_cols=266 Identities=19% Similarity=0.236 Sum_probs=185.7
Q ss_pred hCCCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccccHHHHHHHHHHHhhcCC--CC----ccceeeEEeecCCcE
Q 002462 533 TGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSH--AR----LVPLLGHCMERENEK 605 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H--~n----iV~l~g~c~~~~~~~ 605 (919)
++.|.....+|+|.||.|-++.. +.+..||||.++.-..-.++-+-|++++.++.+ |+ +|.+.+ |++-.+..
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~-wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRD-WFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh-hhhccCce
Confidence 55677778899999999999874 347899999997665556777889999999942 22 666666 45666789
Q ss_pred EEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCC----------
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD---------- 675 (919)
Q Consensus 606 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~---------- 675 (919)
+||+|.|. -|+.++|.... ..+++..+...|+.|+.++++|||+. .++|-||||+|||+-+
T Consensus 167 CivfellG-~S~~dFlk~N~-----y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 167 CIVFELLG-LSTFDFLKENN-----YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred EEEEeccC-hhHHHHhccCC-----ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence 99999883 48999996533 24577778889999999999999985 8999999999999832
Q ss_pred ----------CCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCC
Q 002462 676 ----------KFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISAS 745 (919)
Q Consensus 676 ----------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~ 745 (919)
+..+||.|||-|............|+-+++|+ ..-....+.++||||+||||.|+.||..-|...
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPE-----ViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPE-----VILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCcceeeeccccCCch-----heeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 23467889998776544433334455555554 334456788899999999999999999988766
Q ss_pred ChhHHHHHHHhhc-cccc-cccc--------------------ccccccccCCCCCCc---chHHHHHHHHHHHHHccCC
Q 002462 746 SDAQVKEILEQTL-PYIS-IYDK--------------------ELVTKIVDPSLIIDE---DLLEEVWAMAIVARSCLNP 800 (919)
Q Consensus 746 ~~~~~~~~~~~~~-~~~~-~~~~--------------------~~~~~i~d~~l~~~~---~~~~~~~~~~~la~~C~~~ 800 (919)
.+.+-...++... |.+. +..+ +....+.++...... ...+|...+.+|....+..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 5544223333222 1111 0000 011111221111100 0123455688899999999
Q ss_pred CCCCCCCHHHHHH
Q 002462 801 KPTRRPLMRYILK 813 (919)
Q Consensus 801 ~P~~RPsm~~V~~ 813 (919)
||++|+|.+|+++
T Consensus 393 DP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 393 DPARRITLREALS 405 (415)
T ss_pred CccccccHHHHhc
Confidence 9999999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-23 Score=239.07 Aligned_cols=247 Identities=20% Similarity=0.289 Sum_probs=170.2
Q ss_pred CCcccccccCCCCc-EEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEEEEEEecC
Q 002462 536 FSDANLIKNGHSGD-LFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 536 f~~~~~ig~G~~G~-Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~lV~Ey~~ 613 (919)
|+..+++|.|+.|+ ||+|..+ |++||||++-.... +-..+||..|..- .|||||+++|- ..+....||+.|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~--~~A~rEi~lL~eSD~H~NviRyyc~-E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF--DFAQREIQLLQESDEHPNVIRYYCS-EQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH--HHHHHHHHHHHhccCCCceEEEEee-ccCCceEEEEehHhh
Confidence 67778899998885 8999997 67999999843221 1234799999887 59999998752 223457899999997
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCC---C--CceeeCCcchhh
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD---K--FEVRLGSLSEVC 688 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~---~--~~~kl~dfg~~~ 688 (919)
.+|.+++............ ..-..+..|+++||++||+ ..||||||||.||||+. + ..|+|+|||+.+
T Consensus 587 -~sL~dlie~~~~d~~~~~~---i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSD---IDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred -hhHHHHHhccccchhhccc---ccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 4999999764111111111 2235677899999999998 38999999999999976 2 579999999988
Q ss_pred hcCCCCcc-eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcC-CCCCCCCChhHHHHHHHhhccccccccc
Q 002462 689 AQGGDAHQ-SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTG-KMGISASSDAQVKEILEQTLPYISIYDK 766 (919)
Q Consensus 689 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTG-k~p~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (919)
...++... ++.....++.++.+++......-+.+.|++|+|||+|-.+|| +.||......+ ..++....
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl~~~~-------- 730 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANILTGNY-------- 730 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhhcCcc--------
Confidence 76554332 223334455555555554444556678999999999999995 88986543322 12222111
Q ss_pred ccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
.+.++. ..++. ...+++...++++|..||++.+|+.
T Consensus 731 -~L~~L~-----~~~d~-----eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 731 -TLVHLE-----PLPDC-----EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -ceeeec-----cCchH-----HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111110 01111 3566888999999999999999974
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-23 Score=210.24 Aligned_cols=240 Identities=23% Similarity=0.373 Sum_probs=172.5
Q ss_pred ccccCCCCcEEEEEecCCccEEEEEeccccc---cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCCh
Q 002462 541 LIKNGHSGDLFRGILEGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDL 617 (919)
Q Consensus 541 ~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL 617 (919)
+|.+...|+.|||++.+. .+++|.++.... ..++|..|.-.|+-+.||||.+++|.|-.+. ...++..|||.|||
T Consensus 197 kl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-nlv~isq~mp~gsl 274 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-NLVIISQYMPFGSL 274 (448)
T ss_pred hhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-CceEeeeeccchHH
Confidence 578899999999999754 566677765443 3468999999999999999999999998764 68899999999999
Q ss_pred hhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeC--C--cchhhhcCCC
Q 002462 618 SSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG--S--LSEVCAQGGD 693 (919)
Q Consensus 618 ~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~--d--fg~~~~~~~~ 693 (919)
+..||...+ ..++-.|.++.|.++|+||+|||+- .|-|..--+.+..|++|++.++||+ | |+... .+
T Consensus 275 ynvlhe~t~-----vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe--~g- 345 (448)
T KOG0195|consen 275 YNVLHEQTS-----VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE--VG- 345 (448)
T ss_pred HHHHhcCcc-----EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec--cc-
Confidence 999997654 2356778899999999999999984 4445556799999999999999985 3 32111 11
Q ss_pred CcceeeeeeccCCCCccccCCCCC---CCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccccc
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSL---TATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~---~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (919)
+. ..|.+..++..... ..-..+|+|||.|+||||.|...||..-++.+..-.+ ++ +.++
T Consensus 346 -------r~-y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki--al--------eglr 407 (448)
T KOG0195|consen 346 -------RA-YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI--AL--------EGLR 407 (448)
T ss_pred -------cc-cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh--hh--------cccc
Confidence 11 11222222211110 1123469999999999999999999877665432111 00 1111
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
--+. +... ..|.+++.-|.++||.+||.+..|+-.||++
T Consensus 408 v~ip------pgis---~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 408 VHIP------PGIS---RHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccCC------CCcc---HHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 1111 1111 2477889999999999999999999999864
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-24 Score=238.55 Aligned_cols=298 Identities=27% Similarity=0.391 Sum_probs=210.3
Q ss_pred EEEEEcCCCcccCCCCCCCccChhhhcCCCCCCEEecCCCCCCCCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCC
Q 002462 88 VVGINISGFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTN 167 (919)
Q Consensus 88 v~~l~l~~~~~~~~g~~~~~~~~~~l~~L~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~ 167 (919)
|.++|+++... .|.-- +.....+++++-|.|....| -.+|+.++. |.+|++|.+++|++.. +-..++.|+.
T Consensus 9 VrGvDfsgNDF--sg~~F----P~~v~qMt~~~WLkLnrt~L-~~vPeEL~~-lqkLEHLs~~HN~L~~-vhGELs~Lp~ 79 (1255)
T KOG0444|consen 9 VRGVDFSGNDF--SGDRF----PHDVEQMTQMTWLKLNRTKL-EQVPEELSR-LQKLEHLSMAHNQLIS-VHGELSDLPR 79 (1255)
T ss_pred eecccccCCcC--CCCcC----chhHHHhhheeEEEechhhh-hhChHHHHH-HhhhhhhhhhhhhhHh-hhhhhccchh
Confidence 56677766432 12211 23556677777777766665 367888765 8888888888888763 4456777888
Q ss_pred CCEEEeeCCCCC-CCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCCcc-cCCCCCCCEEEc
Q 002462 168 LTSLYLSDNGLT-GTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNV 245 (919)
Q Consensus 168 L~~L~Ls~N~l~-g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-l~~l~~L~~L~L 245 (919)
|+.+.+.+|++. .-+|..+..|..|.+||||+|++. ..|..+..-+++-.|+||+|++. .||.. |.+|+.|-+|||
T Consensus 80 LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDL 157 (1255)
T KOG0444|consen 80 LRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDL 157 (1255)
T ss_pred hHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhcc
Confidence 888888888875 337777888888888888888887 67888888888888888888887 45554 567888888888
Q ss_pred cCCCCCCCCccccCCCCCCCEEEcCCCCCCCCCchhhhccccCCEEEccCCcCC-CCCCCcccCCCCCCCEEEccCCCCC
Q 002462 246 SNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLS-GNLSVNLFPTVSQLQIIVLRQNGFT 324 (919)
Q Consensus 246 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~ls~N~l~-g~i~~~~~~~l~~L~~L~L~~N~l~ 324 (919)
|+|++. .+|..+..|..|++|+|++|.+.-.--..+..+++|++|.+++.+-+ ..+|.++ ..+.+|..+||+.|++.
T Consensus 158 S~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsl-d~l~NL~dvDlS~N~Lp 235 (1255)
T KOG0444|consen 158 SNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSL-DDLHNLRDVDLSENNLP 235 (1255)
T ss_pred ccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCch-hhhhhhhhccccccCCC
Confidence 888885 56777788888888888888765322223334566777777765433 3566554 67888888899999886
Q ss_pred CCCccccCCCCCCCEEEccCCCCCCCCCcccccCCCCCcEEEccCCcCccCCCC---CCCCCcEEEccCCcCCC-cCCcc
Q 002462 325 GPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTP---VLGRFRLVDLSGNYFEG-RVPEY 400 (919)
Q Consensus 325 ~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~l~~L~ls~N~~~g~~~~---~l~~L~~ldLs~N~l~g-~ip~~ 400 (919)
..|+.+.++++|+.|+||+|+++. +. ........+.+||||+|+++. +|. .|++|+.|.+.+|+++- -||..
T Consensus 236 -~vPecly~l~~LrrLNLS~N~ite-L~-~~~~~W~~lEtLNlSrNQLt~-LP~avcKL~kL~kLy~n~NkL~FeGiPSG 311 (1255)
T KOG0444|consen 236 -IVPECLYKLRNLRRLNLSGNKITE-LN-MTEGEWENLETLNLSRNQLTV-LPDAVCKLTKLTKLYANNNKLTFEGIPSG 311 (1255)
T ss_pred -cchHHHhhhhhhheeccCcCceee-ee-ccHHHHhhhhhhccccchhcc-chHHHhhhHHHHHHHhccCcccccCCccc
Confidence 567788888999999999998873 22 122344577888999998864 343 36677888888887653 36766
Q ss_pred cc
Q 002462 401 VH 402 (919)
Q Consensus 401 ~~ 402 (919)
++
T Consensus 312 IG 313 (1255)
T KOG0444|consen 312 IG 313 (1255)
T ss_pred hh
Confidence 54
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-24 Score=238.84 Aligned_cols=280 Identities=29% Similarity=0.354 Sum_probs=207.3
Q ss_pred hhcCCCCCCEEecCCCCCC-CCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCccc-ccCC
Q 002462 112 ALVNLTHLASFNASRFLLP-GSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSS-LGQL 189 (919)
Q Consensus 112 ~l~~L~~L~~l~ls~n~l~-g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-l~~L 189 (919)
.|..|+.|+++.+..|+|. ..||+.++. |..|.+||||+|++. ..|..+.+-+++.+|+||+|+|. .||.. |.+|
T Consensus 73 ELs~Lp~LRsv~~R~N~LKnsGiP~diF~-l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinL 149 (1255)
T KOG0444|consen 73 ELSDLPRLRSVIVRDNNLKNSGIPTDIFR-LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINL 149 (1255)
T ss_pred hhccchhhHHHhhhccccccCCCCchhcc-cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhh
Confidence 4556677777777777664 347777765 788888888888876 56777777778888888888877 45543 5577
Q ss_pred CCCCEEEccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCCCC-CCCccccCCCCCCCEEE
Q 002462 190 SVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLA-SSIPAQLGDLDSLVDLD 268 (919)
Q Consensus 190 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~ 268 (919)
+.|-+||||+|++. .+|+.+..|.+|+.|+|++|.+.-.--..+-.|++|+.|.+++.+-+ ..+|.++..|.+|..+|
T Consensus 150 tDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvD 228 (1255)
T KOG0444|consen 150 TDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVD 228 (1255)
T ss_pred HhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhcc
Confidence 77888888888876 56777777888888888888765332333445667777777765433 35788899999999999
Q ss_pred cCCCCCCCCCchhhhccccCCEEEccCCcCCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEccCCCCC
Q 002462 269 LSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFT 348 (919)
Q Consensus 269 Ls~N~l~g~~p~~l~~l~~L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 348 (919)
||.|++. .+|..+-++++|+.|+||+|+|+. +.... ....+|++|+|+.|+++ .+|+.+..++.|+.|.+.+|+++
T Consensus 229 lS~N~Lp-~vPecly~l~~LrrLNLS~N~ite-L~~~~-~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~ 304 (1255)
T KOG0444|consen 229 LSENNLP-IVPECLYKLRNLRRLNLSGNKITE-LNMTE-GEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT 304 (1255)
T ss_pred ccccCCC-cchHHHhhhhhhheeccCcCceee-eeccH-HHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc
Confidence 9999997 789999999999999999999872 22221 34467899999999998 56788889999999999999876
Q ss_pred -CCCCcccccCCCCCcEEEccCCcCccCCCCC---CCCCcEEEccCCcCCCcCCcccc
Q 002462 349 -GPLPNSRSNVNTSTVELNISQNMFYGGLTPV---LGRFRLVDLSGNYFEGRVPEYVH 402 (919)
Q Consensus 349 -g~ip~~~~~~~~~l~~L~ls~N~~~g~~~~~---l~~L~~ldLs~N~l~g~ip~~~~ 402 (919)
.-||. ..+.+..|.++..++|.+. -+|.. ...|+.|.|++|++- .+|+.++
T Consensus 305 FeGiPS-GIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIH 359 (1255)
T KOG0444|consen 305 FEGIPS-GIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIH 359 (1255)
T ss_pred ccCCcc-chhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhh
Confidence 23663 4466778888888888764 34433 456888889999885 5777664
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-23 Score=206.56 Aligned_cols=255 Identities=16% Similarity=0.240 Sum_probs=173.3
Q ss_pred CCCcccccccCCCCcEEEEEec-CCccEEEEEeccccccHHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEEEEEEec
Q 002462 535 DFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVKTEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
.|...+.+|+|.||.+-.+..+ ..+.+|+|-+........+|.+|...=--+ .|.|||.-+...++..+..+.++||+
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 3556678999999999999865 457899999987777778899998654444 58999998888888777888999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecC-C-CCceeeCCcchhhhc
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLD-D-KFEVRLGSLSEVCAQ 690 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld-~-~~~~kl~dfg~~~~~ 690 (919)
|.|||.+.+-..+ +....--+|+.|++.|+.|+|+. .+||||||..|||+- . ...+|++|||.....
T Consensus 105 P~gdL~snv~~~G--------igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 105 PRGDLRSNVEAAG--------IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccchhhhhcCccc--------ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999998774322 44455668999999999999986 899999999999983 3 357999999987766
Q ss_pred CCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCC--hhHHHHHHHhhccccccccccc
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASS--DAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 768 (919)
+...+.......+-.|+..+.-..+........|||.||+|++-++||+.|+.... +....+|..|.- ..
T Consensus 174 g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~--------rk 245 (378)
T KOG1345|consen 174 GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK--------RK 245 (378)
T ss_pred CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc--------cc
Confidence 54332211111122222222222234445556799999999999999999998542 223344444321 11
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKAL 815 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L 815 (919)
...+ |+. ... ..+. +..+-.+-+.++|.+|=-..++.++.
T Consensus 246 ~~~~--P~~-F~~-fs~~---a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 246 NPAL--PKK-FNP-FSEK---ALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred CccC--chh-hcc-cCHH---HHHHHHHhcCCcccccchhHHHHHHH
Confidence 1111 110 000 1122 23344567888888886666665544
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-22 Score=221.94 Aligned_cols=215 Identities=21% Similarity=0.312 Sum_probs=160.1
Q ss_pred cCHHHHHHHhCC---CCcccccccCCCCcEEEEE-ecCCccEEEEEecccccc-H---HHHHHHHHHHhhcCCCCcccee
Q 002462 524 FTYQQLLAATGD---FSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK-T---EAYLLELDFFSKVSHARLVPLL 595 (919)
Q Consensus 524 ~~~~~l~~at~~---f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~-~---~~f~~Ei~~l~~l~H~niV~l~ 595 (919)
-.|-.|++|.-+ |-..+-||-|.||+|..+. .+....+|.|.+.....- + .....|-+||.....+-||+|+
T Consensus 616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred hhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 456667777654 5566779999999999987 444567899988654432 2 2356799999999999999999
Q ss_pred eEEeecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCC
Q 002462 596 GHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD 675 (919)
Q Consensus 596 g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~ 675 (919)
. .+++.+.+|+||||+|+||+-..|.+.+..+++ ..|+-|| .++-|++|.|. .++|||||||.|||||.
T Consensus 696 y-SFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~------LARFYIA-EltcAiesVHk---mGFIHRDiKPDNILIDr 764 (1034)
T KOG0608|consen 696 Y-SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEED------LARFYIA-ELTCAIESVHK---MGFIHRDIKPDNILIDR 764 (1034)
T ss_pred E-EeccCCceEEEEeccCCccHHHHHHHhccCHHH------HHHHHHH-HHHHHHHHHHh---ccceecccCccceEEcc
Confidence 6 455567899999999999999999776543322 2455454 68889999997 49999999999999999
Q ss_pred CCceeeCCcchhhhcC---------CCCcce-------------------------------eeeeeccCCCCccccCCC
Q 002462 676 KFEVRLGSLSEVCAQG---------GDAHQS-------------------------------RITRLLRLPQSSEQGSSG 715 (919)
Q Consensus 676 ~~~~kl~dfg~~~~~~---------~~~~~~-------------------------------~~~~~~~~~~~~~~~~~~ 715 (919)
|+.+||.|||+..... ...|.. ....+.+++.|.+++...
T Consensus 765 dGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~ 844 (1034)
T KOG0608|consen 765 DGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA 844 (1034)
T ss_pred CCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc
Confidence 9999999999753221 000100 001244556666666555
Q ss_pred CCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH
Q 002462 716 SLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ 749 (919)
Q Consensus 716 ~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~ 749 (919)
...++.-+|.||.|||||||+-|+.||-...+.+
T Consensus 845 r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 845 RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred ccCccccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 5567778899999999999999999998766544
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-22 Score=204.62 Aligned_cols=199 Identities=19% Similarity=0.260 Sum_probs=158.1
Q ss_pred hCCCCcccccccCCCCcEEEEEec-CCccEEEEEecccccc----HHHHHHHHHHHhhc-CCCCccceeeEEeecCCcEE
Q 002462 533 TGDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVK----TEAYLLELDFFSKV-SHARLVPLLGHCMERENEKF 606 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l-~H~niV~l~g~c~~~~~~~~ 606 (919)
.++|+...+||+|+|.+|..+++. ..+.+|+|+++..-.. .+-...|-.++.+. +||-+|-|+. |++.+...+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhs-cfqtesrlf 327 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHS-CFQTESRLF 327 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhh-hhcccceEE
Confidence 467888999999999999999865 4578899988643322 11234576777665 6999999998 777788899
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcch
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~ 686 (919)
.|.||+++|+|--++.+.+. |+....--+...|.-||.|||+. +||.||+|-.|||||..+.+|+.|+|+
T Consensus 328 fvieyv~ggdlmfhmqrqrk-------lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygm 397 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRK-------LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGM 397 (593)
T ss_pred EEEEEecCcceeeehhhhhc-------CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccch
Confidence 99999999999877765543 44444344666788999999986 899999999999999999999999998
Q ss_pred hhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCC
Q 002462 687 VCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISA 744 (919)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~ 744 (919)
.+..-.... ..+++.++|.|.+++....-.|....|.|++||+++||+.||.||+-
T Consensus 398 cke~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 398 CKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred hhcCCCCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 765432222 23557889999888877666777788999999999999999999974
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-22 Score=218.95 Aligned_cols=199 Identities=16% Similarity=0.180 Sum_probs=159.0
Q ss_pred cccccccCCCCcEEEEEecCCc-cEEEEEeccc----cccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEec
Q 002462 538 DANLIKNGHSGDLFRGILEGGI-PVVIKRIDLQ----SVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 538 ~~~~ig~G~~G~Vy~g~l~~g~-~vavK~l~~~----~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
...-||-||||.|=........ ..|.|.++.. ..+.+....|-.+|.+.+.|-||+|+--+.+ +...|+.||-|
T Consensus 424 ~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-~kyvYmLmEaC 502 (732)
T KOG0614|consen 424 RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-SKYVYMLMEAC 502 (732)
T ss_pred hhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-chhhhhhHHhh
Confidence 3346999999999887766543 3677776532 2335668889999999999999999985544 45789999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
-+|.|...|++++. ++-.+.--++..|.+|++|||.. +||.|||||+|.+||.++-+|+-|||.|+..+.
T Consensus 503 lGGElWTiLrdRg~-------Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 503 LGGELWTILRDRGS-------FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred cCchhhhhhhhcCC-------cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999987654 33334445788899999999985 899999999999999999999999999987754
Q ss_pred CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH
Q 002462 693 DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV 750 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~ 750 (919)
... .-++.++|+|.+++..-.......+|.||+|+++|||+||++||++.++...
T Consensus 573 g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt 627 (732)
T KOG0614|consen 573 GRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT 627 (732)
T ss_pred CCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH
Confidence 433 2346789998888766444455668999999999999999999998876543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.1e-21 Score=227.88 Aligned_cols=315 Identities=25% Similarity=0.372 Sum_probs=209.6
Q ss_pred CCHHHHHHHHHHHHhCCCCC------CCCCCCCCCCCCCC---------------CeeecCCCEEEEEcCCCcccCCCCC
Q 002462 46 SSRTELAALFELRSSLGLRR------RDWPRKVDPCLVWN---------------GVRCQNGSVVGINISGFRRTRLGSQ 104 (919)
Q Consensus 46 ~~~~e~~aLl~~k~~l~~~~------~~W~~~~~~C~~W~---------------gv~C~~~~v~~l~l~~~~~~~~g~~ 104 (919)
+.++|...+++..+.|..+. ..|....++|-.=. -|.|.++.||.+...|.........
T Consensus 60 ~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~~~~~~ 139 (754)
T PRK15370 60 ASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQASSASG 139 (754)
T ss_pred CCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCCCcccccccccccccccCCC
Confidence 46689999999999997642 35988888993111 2788877787776655321111000
Q ss_pred CCcc---C------------------hhhh-----cCCCCCCEEecCCCCCCCCCchhhhhCCCCCcEEEeecCCCCccC
Q 002462 105 NPRF---A------------------ADAL-----VNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVI 158 (919)
Q Consensus 105 ~~~~---~------------------~~~l-----~~L~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~ 158 (919)
+... . ..++ .-..+...|+++++.+. .+|..+ .++|+.|+|++|.|+. +
T Consensus 140 ~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~I---p~~L~~L~Ls~N~Lts-L 214 (754)
T PRK15370 140 SKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACI---PEQITTLILDNNELKS-L 214 (754)
T ss_pred CCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCccc---ccCCcEEEecCCCCCc-C
Confidence 0000 0 0011 11234567888877775 467654 2468888888888874 5
Q ss_pred CcCCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCCcccCCCC
Q 002462 159 PFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLS 238 (919)
Q Consensus 159 p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~ 238 (919)
|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. ++|+.|+|++|+++ .+|..+. .
T Consensus 215 P~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~ 283 (754)
T PRK15370 215 PENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--E 283 (754)
T ss_pred Chhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--C
Confidence 55443 57888888888887 5676554 36888888888887 5676654 57888888888887 4676654 4
Q ss_pred CCCEEEccCCCCCCCCccccCCCCCCCEEEcCCCCCCCCCchhhhccccCCEEEccCCcCCCCCCCcccCCCCCCCEEEc
Q 002462 239 KLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVL 318 (919)
Q Consensus 239 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L 318 (919)
+|+.|+|++|+|++ +|..+. ++|+.|+|++|+++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|
T Consensus 284 sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~---~sL~~L~L 353 (754)
T PRK15370 284 ELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP---PELQVLDV 353 (754)
T ss_pred CCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc---CcccEEEC
Confidence 78888888888874 555443 468888888888874 454432 578888888888874 565442 57888888
Q ss_pred cCCCCCCCCccccCCCCCCCEEEccCCCCCCCCCcccccCCCCCcEEEccCCcCccCCCCC-------CCCCcEEEccCC
Q 002462 319 RQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPV-------LGRFRLVDLSGN 391 (919)
Q Consensus 319 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~l~~L~ls~N~~~g~~~~~-------l~~L~~ldLs~N 391 (919)
++|+|+. +|..+ .++|+.|+|++|+|+ .+|... ...|..|++++|.+. .+|.. +.++..|+|.+|
T Consensus 354 s~N~L~~-LP~~l--p~~L~~LdLs~N~Lt-~LP~~l---~~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~N 425 (754)
T PRK15370 354 SKNQITV-LPETL--PPTITTLDVSRNALT-NLPENL---PAALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYN 425 (754)
T ss_pred CCCCCCc-CChhh--cCCcCEEECCCCcCC-CCCHhH---HHHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCC
Confidence 8888874 44444 257888888888887 455432 235777888888876 34432 245677888888
Q ss_pred cCC
Q 002462 392 YFE 394 (919)
Q Consensus 392 ~l~ 394 (919)
.|+
T Consensus 426 pls 428 (754)
T PRK15370 426 PFS 428 (754)
T ss_pred Ccc
Confidence 876
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.5e-22 Score=222.05 Aligned_cols=250 Identities=16% Similarity=0.272 Sum_probs=178.8
Q ss_pred CCCCcccccccCCCCcEEEEE-ecCCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 534 GDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
.+|.....+|.|.||.|||++ ...+..+|||.+++.... -.-..+|+-+++..+|||||.++|-+.. .+..+++|||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-~dklwicMEy 93 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-RDKLWICMEY 93 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-hcCcEEEEEe
Confidence 355566789999999999998 567899999999876654 2345679999999999999999997765 4578999999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
|.+|+|.+.-|.. .+|+..+.--++....+||+|||+. +=+|||||-.|||+.+.+.+|++|||.+...+
T Consensus 94 cgggslQdiy~~T-------gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT-------GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred cCCCcccceeeec-------ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhh
Confidence 9999999876643 2466667777788999999999985 56899999999999999999999999766543
Q ss_pred CCCcceeeeeeccCCCCccccCC---CCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccccc
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSS---GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (919)
...... ....++|.+++++.. ....|..++|||+.|+...|+---+.|....-+......+....
T Consensus 164 ati~Kr--ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~---------- 231 (829)
T KOG0576|consen 164 ATIAKR--KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSG---------- 231 (829)
T ss_pred hhhhhh--hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccC----------
Confidence 322111 123445555444432 12356778999999999999998888876544433222221111
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYIL 812 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~ 812 (919)
.+|.-..|..-. -..+=.+++.|+-.+|++||+.+..+
T Consensus 232 ----~qpp~lkDk~kw--s~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 232 ----FQPPTLKDKTKW--SEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred ----CCCCcccCCccc--hHHHHHHHHHHhcCCCccCCChhhhe
Confidence 111111121111 11233467789999999999987654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=192.25 Aligned_cols=204 Identities=18% Similarity=0.277 Sum_probs=148.7
Q ss_pred cCHHHHHHHh---CCCCcccccccCCCCcEEEEE-ecCCccEEEEEeccccccHHHHHHHHHHHhhcC-CCCccceeeEE
Q 002462 524 FTYQQLLAAT---GDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVS-HARLVPLLGHC 598 (919)
Q Consensus 524 ~~~~~l~~at---~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~-H~niV~l~g~c 598 (919)
+.||.....+ .+|...+.+|+|.|++||.|. ..+...++||.++.- +.+...+|+++|..++ |||||+|+...
T Consensus 25 WdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV 102 (338)
T KOG0668|consen 25 WDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIV 102 (338)
T ss_pred cchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhh
Confidence 4555443333 345567889999999999998 677788999998643 4456889999999998 99999999977
Q ss_pred eecC-CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC-
Q 002462 599 MERE-NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK- 676 (919)
Q Consensus 599 ~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~- 676 (919)
.++. ....||+||+.|-+.... +. .|+-....-...++.+||.|+|+. +|+|||+||.|+++|..
T Consensus 103 ~Dp~SktpaLiFE~v~n~Dfk~l-y~---------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~ 169 (338)
T KOG0668|consen 103 KDPESKTPSLIFEYVNNTDFKQL-YP---------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHEL 169 (338)
T ss_pred cCccccCchhHhhhhccccHHHH-hh---------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhh
Confidence 6543 246799999999886543 32 233334445778999999999985 99999999999999965
Q ss_pred CceeeCCcchhhhcCCC--CcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCC
Q 002462 677 FEVRLGSLSEVCAQGGD--AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASS 746 (919)
Q Consensus 677 ~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~ 746 (919)
-+.++.|.|+|-..... -.....++.+..|+... ....+...-|+|||||+|.+|+-.|.||....
T Consensus 170 rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLV----dy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 170 RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV----DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred ceeeeeecchHhhcCCCceeeeeeehhhcCCchhee----echhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 57899999988654322 22233344444443221 11223334599999999999999999997654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=243.76 Aligned_cols=196 Identities=17% Similarity=0.231 Sum_probs=130.4
Q ss_pred hcCC-CCccceeeEE-------eecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcC
Q 002462 585 KVSH-ARLVPLLGHC-------MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHE 656 (919)
Q Consensus 585 ~l~H-~niV~l~g~c-------~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~ 656 (919)
+++| +||+++++++ .+ ....+.++||+ .++|.++|.... ..+++.+.+.|+.||++||+|||+.
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~e~~-~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~ 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLD-DDSIVRALECE-DVSLRQWLDNPD------RSVDAFECFHVFRQIVEIVNAAHSQ 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccc-cchhhhhhccC-CccHHHHHhccc------ccccHHHHHHHHHHHHHHHHHHHhC
Confidence 4556 5888888876 22 12467788988 459999996432 3489999999999999999999975
Q ss_pred CCCCeeeccCCCCceecCC-------------------CCceeeCCcchhhhcCCCCc--------------ceeeeeec
Q 002462 657 CTLPFVHRDVQASSILLDD-------------------KFEVRLGSLSEVCAQGGDAH--------------QSRITRLL 703 (919)
Q Consensus 657 ~~~~ivHrDlK~~NILld~-------------------~~~~kl~dfg~~~~~~~~~~--------------~~~~~~~~ 703 (919)
+||||||||+||||+. ++.+|++|||+++....... ........
T Consensus 100 ---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (793)
T PLN00181 100 ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAM 176 (793)
T ss_pred ---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccC
Confidence 8999999999999954 45667777776653211000 00001123
Q ss_pred cCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhcccccccccccccccccCCCCCCcch
Q 002462 704 RLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDL 783 (919)
Q Consensus 704 ~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~ 783 (919)
+++.|.+|+......++.++|||||||+||||+||..|+..... ....+... ...+..
T Consensus 177 gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-~~~~~~~~---------------~~~~~~------ 234 (793)
T PLN00181 177 EMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-TMSSLRHR---------------VLPPQI------ 234 (793)
T ss_pred CCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-HHHHHHHh---------------hcChhh------
Confidence 44556666655555688999999999999999999887542111 11111111 111110
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 784 LEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 784 ~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
..+......++..|++++|.+||+|.||++
T Consensus 235 ~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 235 LLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 111122446778999999999999999975
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-22 Score=201.76 Aligned_cols=202 Identities=18% Similarity=0.278 Sum_probs=152.3
Q ss_pred CCcccccccCCCCcEEEEEe-cCCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecC-----CcEE
Q 002462 536 FSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERE-----NEKF 606 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~-----~~~~ 606 (919)
...++-||-|.||.||..+- ++|+.||.|++..-- ...+.|.+|+++|.-++|.|++..+..- ++. .+.|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDIL-QPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDIL-QPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhc-CCCCchHHHHHH
Confidence 44567899999999998874 579999999984221 2246799999999999999999988843 332 2578
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcch
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~ 686 (919)
+|.|.|.. ||.+.+... +.|+-....-...||.+||.|||+. +|.||||||.|.|++.+-..||+|||+
T Consensus 134 V~TELmQS-DLHKIIVSP-------Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGL 202 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSP-------QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGL 202 (449)
T ss_pred HHHHHHHh-hhhheeccC-------CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccc
Confidence 89999975 777776432 3354444445678999999999986 899999999999999999999999999
Q ss_pred hhhcCCCCc----ceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHH
Q 002462 687 VCAQGGDAH----QSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEI 753 (919)
Q Consensus 687 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~ 753 (919)
++....+.. +...+..+++|+.. .|...|+...||||.|||..||+-.|.-|...++.+..+.
T Consensus 203 ARvee~d~~~hMTqEVVTQYYRAPEiL----MGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~l 269 (449)
T KOG0664|consen 203 ARTWDQRDRLNMTHEVVTQYYRAPELL----MGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQM 269 (449)
T ss_pred ccccchhhhhhhHHHHHHHHhccHHHh----hcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHH
Confidence 987654322 22334455555422 2455688889999999999999998888877766544333
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.8e-20 Score=218.43 Aligned_cols=241 Identities=28% Similarity=0.353 Sum_probs=183.3
Q ss_pred CCCCEEecCCCCCCCCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCEEE
Q 002462 117 THLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLD 196 (919)
Q Consensus 117 ~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L~ 196 (919)
.+|+.|+++.|.+. .||. .+++|++|+|++|+|+. +|.. .++|+.|+|++|.|+ .+|..+ .+|+.|+
T Consensus 222 ~~L~~L~L~~N~Lt-~LP~----lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~ 288 (788)
T PRK15387 222 AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLW 288 (788)
T ss_pred cCCCEEEccCCcCC-CCCC----CCCCCcEEEecCCccCc-ccCc---ccccceeeccCCchh-hhhhch---hhcCEEE
Confidence 37888999999886 4775 26889999999999985 4542 468899999999987 455533 5688899
Q ss_pred ccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcCCCCCCC
Q 002462 197 LSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSG 276 (919)
Q Consensus 197 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 276 (919)
|++|+++. +|.. +++|+.|+|++|++++ +|... .+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++
T Consensus 289 Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~ 356 (788)
T PRK15387 289 IFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS 356 (788)
T ss_pred CcCCcccc-cccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccCC
Confidence 99999984 5643 4789999999999985 55432 457888999999974 5642 2578999999999985
Q ss_pred CCchhhhccccCCEEEccCCcCCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCCCCCcccc
Q 002462 277 SVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRS 356 (919)
Q Consensus 277 ~~p~~l~~l~~L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~ 356 (919)
+|.. ..+|+.|++++|.|+. +|.. ..+|+.|+|++|+|++.+ .. .++|+.|++++|+|++ +|..
T Consensus 357 -LP~l---p~~L~~L~Ls~N~L~~-LP~l----~~~L~~LdLs~N~Lt~LP-~l---~s~L~~LdLS~N~Lss-IP~l-- 420 (788)
T PRK15387 357 -LPTL---PSELYKLWAYNNRLTS-LPAL----PSGLKELIVSGNRLTSLP-VL---PSELKELMVSGNRLTS-LPML-- 420 (788)
T ss_pred -CCCC---Ccccceehhhcccccc-Cccc----ccccceEEecCCcccCCC-Cc---ccCCCEEEccCCcCCC-CCcc--
Confidence 5543 3567888999999884 6642 357899999999998744 32 3679999999999984 6743
Q ss_pred cCCCCCcEEEccCCcCccCCCCC---CCCCcEEEccCCcCCCcCCccc
Q 002462 357 NVNTSTVELNISQNMFYGGLTPV---LGRFRLVDLSGNYFEGRVPEYV 401 (919)
Q Consensus 357 ~~~~~l~~L~ls~N~~~g~~~~~---l~~L~~ldLs~N~l~g~ip~~~ 401 (919)
...|..|++++|++. .+|.. +.+|+.|+|++|+|+|.+|..+
T Consensus 421 --~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 421 --PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred --hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 246778999999987 56653 6788899999999999888765
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.2e-19 Score=225.49 Aligned_cols=279 Identities=19% Similarity=0.224 Sum_probs=176.5
Q ss_pred hhhcCCCCCCEEecCCCC------CCCCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcc
Q 002462 111 DALVNLTHLASFNASRFL------LPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPS 184 (919)
Q Consensus 111 ~~l~~L~~L~~l~ls~n~------l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 184 (919)
.++.++.+|+.|.+..+. ....+|..+..-..+|+.|++.+|.+. .+|..| .+.+|+.|+|.+|++. .+|.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 456667777777665432 223455544331234666666666553 445444 3456666666666655 4555
Q ss_pred cccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCC
Q 002462 185 SLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSL 264 (919)
Q Consensus 185 ~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 264 (919)
.+..+++|+.|+|++|...+.+|. +..+++|+.|+|++|.....+|..++++++|+.|++++|.....+|..+ ++++|
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL 706 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL 706 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence 556666666666665544444553 5556666666666655545566666666666666666654444555544 45566
Q ss_pred CEEEcCCCCCCCCCchhhhccccCCEEEccCCcCCCCCCCc-----------------------------ccCCCCCCCE
Q 002462 265 VDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVN-----------------------------LFPTVSQLQI 315 (919)
Q Consensus 265 ~~L~Ls~N~l~g~~p~~l~~l~~L~~L~ls~N~l~g~i~~~-----------------------------~~~~l~~L~~ 315 (919)
+.|+|++|...+.+|.. ..+|+.|++++|.+. .+|.. .+...++|+.
T Consensus 707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~ 782 (1153)
T PLN03210 707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTR 782 (1153)
T ss_pred CEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccccccccccccccccchhhccccccccchhhhhccccchh
Confidence 66666665544444432 234555555555543 22221 1122457899
Q ss_pred EEccCCCCCCCCccccCCCCCCCEEEccCCCCCCCCCcccccCCCCCcEEEccCCcCccCCCCCCCCCcEEEccCCcCCC
Q 002462 316 IVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFEG 395 (919)
Q Consensus 316 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~l~~L~ls~N~~~g~~~~~l~~L~~ldLs~N~l~g 395 (919)
|+|++|...+.+|..++++++|+.|+|++|+..+.+|... .+.+|+.|++++|.....+|....+|+.|+|++|.++
T Consensus 783 L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~--~L~sL~~L~Ls~c~~L~~~p~~~~nL~~L~Ls~n~i~- 859 (1153)
T PLN03210 783 LFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI--NLESLESLDLSGCSRLRTFPDISTNISDLNLSRTGIE- 859 (1153)
T ss_pred eeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC--CccccCEEECCCCCccccccccccccCEeECCCCCCc-
Confidence 9999998888899999999999999999987666788543 4678999999998777777777789999999999997
Q ss_pred cCCccc
Q 002462 396 RVPEYV 401 (919)
Q Consensus 396 ~ip~~~ 401 (919)
.+|.++
T Consensus 860 ~iP~si 865 (1153)
T PLN03210 860 EVPWWI 865 (1153)
T ss_pred cChHHH
Confidence 577655
|
syringae 6; Provisional |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=183.76 Aligned_cols=166 Identities=17% Similarity=0.151 Sum_probs=115.0
Q ss_pred CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCC
Q 002462 615 GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694 (919)
Q Consensus 615 GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~ 694 (919)
|+|.+++..++ ..++|.++..|+.|+++||+|||+.. ||+|||+++++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~ 63 (176)
T smart00750 1 VSLADILEVRG------RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ 63 (176)
T ss_pred CcHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc
Confidence 78999997532 24899999999999999999999852 999999999999999 99776543322
Q ss_pred cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChh--HHHHHHHhhccccccccccccccc
Q 002462 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDA--QVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i 772 (919)
. .+++.|.+++......++.++|||||||++|||+||+.|+...... ....+.....+.
T Consensus 64 ~-------~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------ 124 (176)
T smart00750 64 S-------RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD------------ 124 (176)
T ss_pred C-------CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC------------
Confidence 1 2334455555444456788999999999999999999998654321 122222211100
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~ 817 (919)
++.-........+...+..++.+|++.+|.+||++.++++.+..
T Consensus 125 -~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 125 -DPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred -CccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 00000001111111246778999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.6e-23 Score=216.43 Aligned_cols=227 Identities=30% Similarity=0.488 Sum_probs=155.6
Q ss_pred hhcCCCCCCEEecCCCCCCCCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCC
Q 002462 112 ALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSV 191 (919)
Q Consensus 112 ~l~~L~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~ 191 (919)
.+.+|..|..|++..|.+. ++|+.++. +..++.|+.++|+++ .+|..++++.+|+.|+.++|.+. .+|++++.+..
T Consensus 63 dl~nL~~l~vl~~~~n~l~-~lp~aig~-l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~ 138 (565)
T KOG0472|consen 63 DLKNLACLTVLNVHDNKLS-QLPAAIGE-LEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLD 138 (565)
T ss_pred hhhcccceeEEEeccchhh-hCCHHHHH-HHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhh
Confidence 4566777777777777663 56666665 777777777777776 56667777777777777777776 56667777777
Q ss_pred CCEEEccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcCC
Q 002462 192 LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSM 271 (919)
Q Consensus 192 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 271 (919)
|+.|+..+|+++ ..|+.+.++.+|..|++.+|+++. +|+..-+++.|++||...|.+. .+|..++.+.+|+.|+|..
T Consensus 139 l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~ 215 (565)
T KOG0472|consen 139 LEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRR 215 (565)
T ss_pred hhhhhccccccc-cCchHHHHHHHHHHhhccccchhh-CCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhh
Confidence 777777777776 566677777777777777777764 3333334777777777777663 5677777777777777777
Q ss_pred CCCCCCCchhhhccccCCEEEccCCcCCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCC
Q 002462 272 NSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTG 349 (919)
Q Consensus 272 N~l~g~~p~~l~~l~~L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 349 (919)
|++. .+| +|.++..|..|+++.|++. .+|......+.+|.+|||+.|+++. .|+.+.-+.+|.+||+|+|.+++
T Consensus 216 Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke-~Pde~clLrsL~rLDlSNN~is~ 289 (565)
T KOG0472|consen 216 NKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKE-VPDEICLLRSLERLDLSNNDISS 289 (565)
T ss_pred cccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeecccccccc-CchHHHHhhhhhhhcccCCcccc
Confidence 7775 455 6677777777777777765 5666666666677777777777764 44555566667777777777664
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.7e-20 Score=203.56 Aligned_cols=139 Identities=16% Similarity=0.134 Sum_probs=110.6
Q ss_pred HhCCCCcccccccCCCCcEEEEEec--CCccEEEEEecccc------ccHHHHHHHHHHHhhcCCCCccceeeEEeecCC
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGILE--GGIPVVIKRIDLQS------VKTEAYLLELDFFSKVSHARLVPLLGHCMEREN 603 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~l~--~g~~vavK~l~~~~------~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~ 603 (919)
.-++|...+.||+|+||+||+|+.. ++..||||++.... ...+.|.+|+++|++++|+|+|+.+..+ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 3466888899999999999999864 57788999875321 1245689999999999999999754322 3
Q ss_pred cEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccC-CCCceecCCCCceeeC
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDV-QASSILLDDKFEVRLG 682 (919)
Q Consensus 604 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDl-K~~NILld~~~~~kl~ 682 (919)
..++|||||++++|.. +. .. . ..+++.++++||+|||+. +|||||| ||+|||++.++.+||+
T Consensus 92 ~~~LVmE~~~G~~L~~-~~-~~------~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-AR-PH------G------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred CcEEEEEccCCCCHHH-hC-cc------c------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEE
Confidence 5799999999999962 21 10 0 135677899999999985 8999999 9999999999999999
Q ss_pred CcchhhhcC
Q 002462 683 SLSEVCAQG 691 (919)
Q Consensus 683 dfg~~~~~~ 691 (919)
|||+++...
T Consensus 155 DFGlA~~~~ 163 (365)
T PRK09188 155 DFQLASVFR 163 (365)
T ss_pred ECccceecc
Confidence 999887553
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-20 Score=203.76 Aligned_cols=195 Identities=18% Similarity=0.238 Sum_probs=150.3
Q ss_pred CCCCcccccccCCCCcEEEEEecC-CccEEEEEeccccccHHH---------HHHHHHHHhhcC---CCCccceeeEEee
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEG-GIPVVIKRIDLQSVKTEA---------YLLELDFFSKVS---HARLVPLLGHCME 600 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~-g~~vavK~l~~~~~~~~~---------f~~Ei~~l~~l~---H~niV~l~g~c~~ 600 (919)
.+|.....+|+|.||.|..+..+. ...|+||.+...+.-.+. .-.||++|+.++ |+||++++.++ +
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF-E 639 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF-E 639 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee-e
Confidence 457777899999999999999654 568999988654432222 346999999998 99999999976 4
Q ss_pred cCCcEEEEEEec-CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCce
Q 002462 601 RENEKFLVYKYM-PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEV 679 (919)
Q Consensus 601 ~~~~~~lV~Ey~-~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~ 679 (919)
.++..||++|-- ++-||.+++..+. .++....--|..||+.|.++||+. +|||||||-+||.+|.++-+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp-------~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~ 709 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP-------RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFV 709 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC-------ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeE
Confidence 567889999864 5667889886554 366677778999999999999986 99999999999999999999
Q ss_pred eeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCC-CCCCcchhHHHHHHHHHcCCCCCC
Q 002462 680 RLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTA-TCPYDVYCFGKVLLELVTGKMGIS 743 (919)
Q Consensus 680 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-t~~~DVySfGvvLlEllTGk~p~~ 743 (919)
|+.|||.+...... .+..+.++..+.+++..|+..| ..+-|||++||+||.++-...|+.
T Consensus 710 klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 710 KLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEeeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999977644221 1233445555556665554443 334699999999999998887764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.3e-20 Score=220.70 Aligned_cols=272 Identities=24% Similarity=0.377 Sum_probs=208.3
Q ss_pred eeecCCCEEEEEcCCCcccCCCCCCCccChhhhcCCCCCCEEecCCCCCCCCCchhhhhCCCCCcEEEeecCCCCccCCc
Q 002462 81 VRCQNGSVVGINISGFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPF 160 (919)
Q Consensus 81 v~C~~~~v~~l~l~~~~~~~~g~~~~~~~~~~l~~L~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~ 160 (919)
..|-....+.+++++...+.+ +. .+ .++|+.|++++|.+. .+|..+ .++|++|+|++|.|+. +|.
T Consensus 173 ~~Cl~~~~~~L~L~~~~LtsL---P~-----~I--p~~L~~L~Ls~N~Lt-sLP~~l---~~nL~~L~Ls~N~Lts-LP~ 237 (754)
T PRK15370 173 RDCLKNNKTELRLKILGLTTI---PA-----CI--PEQITTLILDNNELK-SLPENL---QGNIKTLYANSNQLTS-IPA 237 (754)
T ss_pred HhhcccCceEEEeCCCCcCcC---Cc-----cc--ccCCcEEEecCCCCC-cCChhh---ccCCCEEECCCCcccc-CCh
Confidence 356556678888887654432 21 11 247899999999997 688776 4689999999999984 566
Q ss_pred CCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCCcccCCCCCC
Q 002462 161 SLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKL 240 (919)
Q Consensus 161 ~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L 240 (919)
.+. .+|+.|+|++|++. .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++ +|..+. ++|
T Consensus 238 ~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL 306 (754)
T PRK15370 238 TLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGI 306 (754)
T ss_pred hhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhH
Confidence 553 57999999999998 6787765 58999999999998 5787664 589999999999994 676553 479
Q ss_pred CEEEccCCCCCCCCccccCCCCCCCEEEcCCCCCCCCCchhhhccccCCEEEccCCcCCCCCCCcccCCCCCCCEEEccC
Q 002462 241 QYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQ 320 (919)
Q Consensus 241 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L~~ 320 (919)
+.|+|++|+++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|++++|+|+ .+|..+ .++|+.|+|++
T Consensus 307 ~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l---p~~L~~LdLs~ 376 (754)
T PRK15370 307 THLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL---PPTITTLDVSR 376 (754)
T ss_pred HHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh---cCCcCEEECCC
Confidence 999999999985 565543 689999999999985 776664 68999999999997 466544 25899999999
Q ss_pred CCCCCCCccccCCCCCCCEEEccCCCCCCCCCcccc---cCCCCCcEEEccCCcCccCCCCCCCCCcEEEccCCcCCCc
Q 002462 321 NGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRS---NVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFEGR 396 (919)
Q Consensus 321 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~---~~~~~l~~L~ls~N~~~g~~~~~l~~L~~ldLs~N~l~g~ 396 (919)
|+|+..++. +. .+|+.|++++|+|+ .+|.... .....+..|++.+|.|.. ..+.+|+.+ ++.|.+.|.
T Consensus 377 N~Lt~LP~~-l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~---~tl~~L~~L-l~s~~~~gp 447 (754)
T PRK15370 377 NALTNLPEN-LP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE---RTIQNMQRL-MSSVGYQGP 447 (754)
T ss_pred CcCCCCCHh-HH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH---HHHHHHHHh-hhcccccCC
Confidence 999975543 32 47999999999998 5665332 234667899999999874 345556666 455666554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.4e-19 Score=212.93 Aligned_cols=255 Identities=29% Similarity=0.330 Sum_probs=198.6
Q ss_pred CCCCEEecCCCCCCCCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCEEE
Q 002462 117 THLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLD 196 (919)
Q Consensus 117 ~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L~ 196 (919)
..-..|+++.|.|. .||+.+. ++|+.|+|++|+|+. +|. .+++|++|+|++|+|+ .+|.. ..+|+.|+
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~---~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~ 268 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELS 268 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh---cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccceee
Confidence 44668999999997 7998774 489999999999985 564 3589999999999999 46653 46899999
Q ss_pred ccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcCCCCCCC
Q 002462 197 LSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSG 276 (919)
Q Consensus 197 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 276 (919)
|++|.|+ .+|.. ..+|+.|+|++|+++ .+|.. +++|+.|+|++|+|++ +|.. ..+|+.|++++|+|++
T Consensus 269 Ls~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~ 336 (788)
T PRK15387 269 IFSNPLT-HLPAL---PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS 336 (788)
T ss_pred ccCCchh-hhhhc---hhhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCcccc
Confidence 9999998 45653 367889999999998 46653 4789999999999986 4543 2468889999999984
Q ss_pred CCchhhhccccCCEEEccCCcCCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCCCCCcccc
Q 002462 277 SVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRS 356 (919)
Q Consensus 277 ~~p~~l~~l~~L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~ 356 (919)
+|.. ..+|+.|+|++|+|++ +|.. ..+|+.|++++|+|+. +|.. ..+|+.|+|++|+|++ +|..
T Consensus 337 -LP~l---p~~Lq~LdLS~N~Ls~-LP~l----p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l-- 400 (788)
T PRK15387 337 -LPTL---PSGLQELSVSDNQLAS-LPTL----PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL-- 400 (788)
T ss_pred -cccc---ccccceEecCCCccCC-CCCC----Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc--
Confidence 6642 2579999999999984 5532 3578899999999996 4443 3679999999999995 6642
Q ss_pred cCCCCCcEEEccCCcCccCCCCCCCCCcEEEccCCcCCCcCCccccc--cc--CCCCcccCCC
Q 002462 357 NVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHS--NA--SSLDSNCLQN 415 (919)
Q Consensus 357 ~~~~~l~~L~ls~N~~~g~~~~~l~~L~~ldLs~N~l~g~ip~~~~~--~~--~~l~~n~l~~ 415 (919)
...|..|++++|.+.+ +|....+|+.|+|++|+|+ .+|..+.. ++ ..+++|.|++
T Consensus 401 --~s~L~~LdLS~N~Lss-IP~l~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~ 459 (788)
T PRK15387 401 --PSELKELMVSGNRLTS-LPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE 459 (788)
T ss_pred --ccCCCEEEccCCcCCC-CCcchhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCc
Confidence 3578999999999985 7776778999999999998 78876531 11 1445565554
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-22 Score=214.39 Aligned_cols=263 Identities=30% Similarity=0.441 Sum_probs=220.6
Q ss_pred CCCEEecCCCCCCCCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCEEEc
Q 002462 118 HLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDL 197 (919)
Q Consensus 118 ~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L~L 197 (919)
-|+.+.+++|.+.-.-++ +- +|..|.+|++++|.++ ..|++++.+..++.|+.++|+++ .+|..++++.+|..|+.
T Consensus 46 ~l~~lils~N~l~~l~~d-l~-nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~ 121 (565)
T KOG0472|consen 46 DLQKLILSHNDLEVLRED-LK-NLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDC 121 (565)
T ss_pred chhhhhhccCchhhccHh-hh-cccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhc
Confidence 355677788877544444 32 4899999999999997 67889999999999999999998 79999999999999999
Q ss_pred cCCcCCCCCCccccCCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcCCCCCCCC
Q 002462 198 SRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGS 277 (919)
Q Consensus 198 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 277 (919)
++|.+. .+|++++.+..|..|+..+|+++ .+|..++++.+|..|++.+|.+....|..+ +++.|++||...|-+. .
T Consensus 122 s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-t 197 (565)
T KOG0472|consen 122 SSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-T 197 (565)
T ss_pred ccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-c
Confidence 999998 67888999999999999999998 688899999999999999999986555555 4999999999999885 8
Q ss_pred CchhhhccccCCEEEccCCcCCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCCCCCccccc
Q 002462 278 VPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSN 357 (919)
Q Consensus 278 ~p~~l~~l~~L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~ 357 (919)
+|..++.+.+|..|++..|.+. .+| -|+.++.|..|+++.|++...+.....++++|.+|||.+|+++ ..|... -
T Consensus 198 lP~~lg~l~~L~~LyL~~Nki~-~lP--ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~-c 272 (565)
T KOG0472|consen 198 LPPELGGLESLELLYLRRNKIR-FLP--EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEI-C 272 (565)
T ss_pred CChhhcchhhhHHHHhhhcccc-cCC--CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHH-H
Confidence 9999999999999999999997 566 4799999999999999998777777779999999999999998 677544 3
Q ss_pred CCCCCcEEEccCCcCccCCCCCCCC--CcEEEccCCcCC
Q 002462 358 VNTSTVELNISQNMFYGGLTPVLGR--FRLVDLSGNYFE 394 (919)
Q Consensus 358 ~~~~l~~L~ls~N~~~g~~~~~l~~--L~~ldLs~N~l~ 394 (919)
.+.+|..||+|+|.+++ +|..+++ |+.|-+-+|.+.
T Consensus 273 lLrsL~rLDlSNN~is~-Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 273 LLRSLERLDLSNNDISS-LPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred HhhhhhhhcccCCcccc-CCcccccceeeehhhcCCchH
Confidence 45678888888888875 4545554 456667777663
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.3e-19 Score=191.61 Aligned_cols=135 Identities=22% Similarity=0.332 Sum_probs=109.1
Q ss_pred CCCCcccccccCCCCcEEEEE-ecCCccEEEEEeccccccHHHHHHHHHHHhhcC-----CC---CccceeeEEeec---
Q 002462 534 GDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVS-----HA---RLVPLLGHCMER--- 601 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~-----H~---niV~l~g~c~~~--- 601 (919)
+.|-..++||=|+|.+||.+. ..+.+.||+|+.+....-.+.-+.||++|++++ |+ .||+|+.++.-.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 445567889999999999998 456789999999877666788889999999984 33 599999976432
Q ss_pred CCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC
Q 002462 602 ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK 676 (919)
Q Consensus 602 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~ 676 (919)
+...++|+||+- -+|..++.+... +.++....-+|+.||..||.|||.+| +|||-||||.||||..+
T Consensus 158 G~HVCMVfEvLG-dnLLklI~~s~Y-----rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 158 GQHVCMVFEVLG-DNLLKLIKYSNY-----RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CcEEEEEehhhh-hHHHHHHHHhCC-----CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 236899999984 478888865432 33677778899999999999999998 79999999999999543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=187.57 Aligned_cols=172 Identities=22% Similarity=0.327 Sum_probs=134.0
Q ss_pred CCccEEEEEecccc---ccHHHHHHHHHHHhhcCCCCccceeeEEeecC-----CcEEEEEEecCCCChhhhhhccCCCC
Q 002462 557 GGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLLGHCMERE-----NEKFLVYKYMPNGDLSSSLYRKTNTE 628 (919)
Q Consensus 557 ~g~~vavK~l~~~~---~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~-----~~~~lV~Ey~~~GsL~~~L~~~~~~~ 628 (919)
.+.+||+|++...- ...++-.+|..++..+.|+|||+++.+..-.. .+.|+|||||. ++|...++-
T Consensus 40 ~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~----- 113 (369)
T KOG0665|consen 40 LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILM----- 113 (369)
T ss_pred ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHH-----
Confidence 37899999884331 12345678999999999999999999654221 25799999998 488888762
Q ss_pred CccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCc--ceeeeeeccCC
Q 002462 629 DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAH--QSRITRLLRLP 706 (919)
Q Consensus 629 ~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~ 706 (919)
.++..+.-.|..|+..|..|||+. +|+||||||+||++..+...||.|||.++....+.. ....+|.+++|
T Consensus 114 ----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrap 186 (369)
T KOG0665|consen 114 ----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAP 186 (369)
T ss_pred ----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCc
Confidence 266677778999999999999985 899999999999999999999999999987655422 23445666665
Q ss_pred CCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCC
Q 002462 707 QSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASS 746 (919)
Q Consensus 707 ~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~ 746 (919)
+.. -+..+++.+||||.||++.||++|+.=|.+..
T Consensus 187 evi-----l~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d 221 (369)
T KOG0665|consen 187 EVI-----LGMGYKENVDIWSVGCIMGELILGTVLFPGKD 221 (369)
T ss_pred hhe-----eccCCcccchhhhhhhHHHHHhhceEEecCch
Confidence 432 22347888999999999999999998776543
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.9e-18 Score=215.47 Aligned_cols=268 Identities=23% Similarity=0.264 Sum_probs=194.5
Q ss_pred CCCCCCEEecCCCCCCCCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCE
Q 002462 115 NLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSV 194 (919)
Q Consensus 115 ~L~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~ 194 (919)
.+.+|+.|++++|.+. .+|..+. .+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+|..+.++++|+.
T Consensus 609 ~~~~L~~L~L~~s~l~-~L~~~~~-~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~ 685 (1153)
T PLN03210 609 RPENLVKLQMQGSKLE-KLWDGVH-SLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLED 685 (1153)
T ss_pred CccCCcEEECcCcccc-ccccccc-cCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCE
Confidence 4678889999988874 5666664 489999999998776667774 888999999999998777788999999999999
Q ss_pred EEccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcCCCCC
Q 002462 195 LDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSL 274 (919)
Q Consensus 195 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 274 (919)
|++++|...+.+|..+ ++++|+.|+|++|...+.+|.. .++|++|+|++|.+. .+|..+ .+++|+.|++.++..
T Consensus 686 L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~ 759 (1153)
T PLN03210 686 LDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKS 759 (1153)
T ss_pred EeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccch
Confidence 9999876666788766 7889999999998766666653 457888999999885 566654 567777777766332
Q ss_pred -------CCCCchhhhccccCCEEEccCCcCCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEccCCCC
Q 002462 275 -------SGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNF 347 (919)
Q Consensus 275 -------~g~~p~~l~~l~~L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 347 (919)
....+..+...++|+.|++++|...+.+|.. +.++++|+.|+|++|...+.+|..+ ++++|+.|+|++|..
T Consensus 760 ~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~s-i~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~ 837 (1153)
T PLN03210 760 EKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSS-IQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSR 837 (1153)
T ss_pred hhccccccccchhhhhccccchheeCCCCCCccccChh-hhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCc
Confidence 1112222334467888888888777777765 4778888888888776555566554 678888888888766
Q ss_pred CCCCCcccccCCCCCcEEEccCCcCccCCCC---CCCCCcEEEccC-CcCCCcCCc
Q 002462 348 TGPLPNSRSNVNTSTVELNISQNMFYGGLTP---VLGRFRLVDLSG-NYFEGRVPE 399 (919)
Q Consensus 348 ~g~ip~~~~~~~~~l~~L~ls~N~~~g~~~~---~l~~L~~ldLs~-N~l~g~ip~ 399 (919)
...+|.. ..++..|+|++|.+.. +|. .+.+|+.|+|++ |++.+ +|.
T Consensus 838 L~~~p~~----~~nL~~L~Ls~n~i~~-iP~si~~l~~L~~L~L~~C~~L~~-l~~ 887 (1153)
T PLN03210 838 LRTFPDI----STNISDLNLSRTGIEE-VPWWIEKFSNLSFLDMNGCNNLQR-VSL 887 (1153)
T ss_pred ccccccc----ccccCEeECCCCCCcc-ChHHHhcCCCCCEEECCCCCCcCc-cCc
Confidence 5556632 3567788888887753 443 366788888877 44543 444
|
syringae 6; Provisional |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7e-19 Score=198.53 Aligned_cols=218 Identities=21% Similarity=0.307 Sum_probs=150.3
Q ss_pred HhhcCCCCccceeeEEeecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCee
Q 002462 583 FSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFV 662 (919)
Q Consensus 583 l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~iv 662 (919)
|+.+.|.|+.+++|.|++. .+.++|.+||..|+|.+.+... ...++|.-+..+..++++||+|||+. +--.
T Consensus 1 l~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~~------~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~ 71 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSNE------DIKLDYFFILSFIRDISKGLAYLHNS--PIGY 71 (484)
T ss_pred CcccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhcc------ccCccHHHHHHHHHHHHHHHHHHhcC--ccee
Confidence 4678999999999999985 6899999999999999999753 24599999999999999999999984 2239
Q ss_pred eccCCCCceecCCCCceeeCCcchhhhcCCC----C-cceeeeeeccCCCCccccCCCC--CCCCCCCcchhHHHHHHHH
Q 002462 663 HRDVQASSILLDDKFEVRLGSLSEVCAQGGD----A-HQSRITRLLRLPQSSEQGSSGS--LTATCPYDVYCFGKVLLEL 735 (919)
Q Consensus 663 HrDlK~~NILld~~~~~kl~dfg~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~~--~~~t~~~DVySfGvvLlEl 735 (919)
|+.+|++|+++|..+.+|++|||+....... . +.......+..|+......... ...+.++||||||++++|+
T Consensus 72 hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 72 HGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred eeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 9999999999999999999999977665321 1 1111111222222111110011 1256778999999999999
Q ss_pred HcCCCCCCCCChhH-HHHHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 736 VTGKMGISASSDAQ-VKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 736 lTGk~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
++.+.||+...... ..+.+..... .-.....|.+....+..+ .+..++..||.++|.+||+++.|-..
T Consensus 152 ~~r~~~~~~~~~~~~~~eii~~~~~--------~~~~~~rP~i~~~~e~~~---~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDPDEIILRVKK--------GGSNPFRPSIELLNELPP---ELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred HhccCccccccccCChHHHHHHHHh--------cCCCCcCcchhhhhhcch---HHHHHHHHhcccChhhCccHHHHHhh
Confidence 99999997632211 1222222110 011122233221111111 46778899999999999999999988
Q ss_pred hhcccc
Q 002462 815 LENPLK 820 (919)
Q Consensus 815 L~~~~~ 820 (919)
++.+.+
T Consensus 221 ~~~~~~ 226 (484)
T KOG1023|consen 221 LLTINK 226 (484)
T ss_pred hhhhcc
Confidence 875544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.3e-19 Score=180.06 Aligned_cols=137 Identities=12% Similarity=0.160 Sum_probs=105.2
Q ss_pred cccccCCCCcEEEEEecCCccEEEEEecccccc----------HHHH-----------------HHHHHHHhhcCCCCcc
Q 002462 540 NLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK----------TEAY-----------------LLELDFFSKVSHARLV 592 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~----------~~~f-----------------~~Ei~~l~~l~H~niV 592 (919)
..||+|+||.||+|...+|..||||+++..... ...| ..|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999889999999998654211 0122 3499999999988874
Q ss_pred ceeeEEeecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCcee
Q 002462 593 PLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSIL 672 (919)
Q Consensus 593 ~l~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NIL 672 (919)
....+. .. ..+|||||++++++....... ..+++.+..+++.+++.+|+|+||. .+||||||||+|||
T Consensus 83 ~p~~~~--~~-~~~iVmE~i~g~~l~~~~~~~-------~~~~~~~~~~i~~qi~~~L~~l~H~--~giiHrDlkP~NIl 150 (190)
T cd05147 83 CPEPIL--LK-SHVLVMEFIGDDGWAAPRLKD-------APLSESKARELYLQVIQIMRILYQD--CRLVHADLSEYNLL 150 (190)
T ss_pred CCcEEE--ec-CCEEEEEEeCCCCCcchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEE
Confidence 433322 12 348999999998776543221 2377888899999999999999543 27999999999999
Q ss_pred cCCCCceeeCCcchhhh
Q 002462 673 LDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 673 ld~~~~~kl~dfg~~~~ 689 (919)
+++ +.+++.|||.+..
T Consensus 151 i~~-~~v~LiDFG~a~~ 166 (190)
T cd05147 151 YHD-GKLYIIDVSQSVE 166 (190)
T ss_pred EEC-CcEEEEEcccccc
Confidence 984 7899999997753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=187.35 Aligned_cols=201 Identities=19% Similarity=0.289 Sum_probs=146.8
Q ss_pred HhCCCCcccccccCCCCcEEEEEec----CCccEEEEEeccccccHHHHHHHHHHHhhcC-CCCccceeeEEeecCCcEE
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGILE----GGIPVVIKRIDLQSVKTEAYLLELDFFSKVS-HARLVPLLGHCMERENEKF 606 (919)
Q Consensus 532 at~~f~~~~~ig~G~~G~Vy~g~l~----~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~~~~~ 606 (919)
..+.|...++||+|.|++||++.+. ....||+|.+...+. .....+|++.|..+. |.||+++.+ |...++...
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~-~~rnnd~v~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNG-CFRNNDQVA 111 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchh-hhccCCeeE
Confidence 3456788899999999999999853 357899999976543 345889999999996 899999998 666778899
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC-CceeeCCcc
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK-FEVRLGSLS 685 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~-~~~kl~dfg 685 (919)
+|+||++.-+-.+++.. ++............+||+|+|+. +||||||||+|+|-+.. ..-.|.|||
T Consensus 112 ivlp~~~H~~f~~l~~~----------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS----------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred EEecccCccCHHHHHhc----------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence 99999999888777642 45556666788899999999985 99999999999999865 556789999
Q ss_pred hhhhcCCCC-----------ccee-ee------eecc---C-----------C--CCccccCCCC---------CCCCCC
Q 002462 686 EVCAQGGDA-----------HQSR-IT------RLLR---L-----------P--QSSEQGSSGS---------LTATCP 722 (919)
Q Consensus 686 ~~~~~~~~~-----------~~~~-~~------~~~~---~-----------~--~~~~~~~~~~---------~~~t~~ 722 (919)
++-...... +... .. .... . + .+.-.|+.|. ..-|++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 986322111 0000 00 0000 0 0 0111122221 223667
Q ss_pred CcchhHHHHHHHHHcCCCCCCCCCh
Q 002462 723 YDVYCFGKVLLELVTGKMGISASSD 747 (919)
Q Consensus 723 ~DVySfGvvLlEllTGk~p~~~~~~ 747 (919)
.||||-|||++-+++++.||....+
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~d 283 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKD 283 (418)
T ss_pred cceeeccceeehhhccccccccCcc
Confidence 8999999999999999999976543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.7e-19 Score=190.93 Aligned_cols=201 Identities=21% Similarity=0.265 Sum_probs=151.1
Q ss_pred CCcccccccCCCCcEEEEE-ecCCccEEEEEeccccccHHHHHHHHHHHhhcCC------CCccceeeEEeecCCcEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSH------ARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H------~niV~l~g~c~~~~~~~~lV 608 (919)
|......|+|-|++|.+|. ...|..||||.|.....-.+.=+.|+++|.+|+- -+.|+|+-++. ..+..|||
T Consensus 434 Y~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~-hknHLClV 512 (752)
T KOG0670|consen 434 YEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK-HKNHLCLV 512 (752)
T ss_pred eEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh-hcceeEEE
Confidence 4444457999999999998 4557899999997665555566789999999952 36788877654 35689999
Q ss_pred EEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC-CceeeCCcchh
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK-FEVRLGSLSEV 687 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~-~~~kl~dfg~~ 687 (919)
+|-+. -+|.+.|.+.+... .|.....-.+|.|+.-||..|-.. +|+|.||||.|||+++. ...||+|||.|
T Consensus 513 FE~Ls-lNLRevLKKyG~nv----GL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 513 FEPLS-LNLREVLKKYGRNV----GLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred ehhhh-chHHHHHHHhCccc----ceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccc
Confidence 99876 47888886654321 244444456788999999999873 89999999999999976 56899999988
Q ss_pred hhcCCCCc-ceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHH
Q 002462 688 CAQGGDAH-QSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV 750 (919)
Q Consensus 688 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~ 750 (919)
........ ...++++|++|+ ..-+..|.++-|+||.||.||||.||+.-|.+.+..++
T Consensus 585 ~~~~eneitPYLVSRFYRaPE-----IiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M 643 (752)
T KOG0670|consen 585 SFASENEITPYLVSRFYRAPE-----IILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM 643 (752)
T ss_pred cccccccccHHHHHHhccCcc-----eeecCcccCCccceeeceeeEEeeccceecCCCCcHHH
Confidence 76654332 233455666554 33345778888999999999999999999988776553
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.4e-18 Score=175.13 Aligned_cols=138 Identities=13% Similarity=0.139 Sum_probs=107.4
Q ss_pred cccccCCCCcEEEEEecCCccEEEEEecccccc---------------------------HHHHHHHHHHHhhcCCCCcc
Q 002462 540 NLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK---------------------------TEAYLLELDFFSKVSHARLV 592 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~---------------------------~~~f~~Ei~~l~~l~H~niV 592 (919)
..||+|+||.||+|+..+|..||||.++..... ...+..|.+.+.+++|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 479999999999999888999999998654210 11235799999999999986
Q ss_pred ceeeEEeecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCcee
Q 002462 593 PLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSIL 672 (919)
Q Consensus 593 ~l~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NIL 672 (919)
....+... ..++||||++++++....... ..++..+..+|+.+++++|.|+|+. .+|+||||||.|||
T Consensus 83 ~p~~~~~~---~~~lVmE~~~g~~~~~~~l~~-------~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIl 150 (190)
T cd05145 83 VPEPILLK---KNVLVMEFIGDDGSPAPRLKD-------VPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNIL 150 (190)
T ss_pred CceEEEec---CCEEEEEEecCCCchhhhhhh-------ccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEE
Confidence 55554332 358999999998654432111 1256667889999999999999982 28999999999999
Q ss_pred cCCCCceeeCCcchhhhc
Q 002462 673 LDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 673 ld~~~~~kl~dfg~~~~~ 690 (919)
++ ++.+++.|||.+...
T Consensus 151 l~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 151 YH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred EE-CCCEEEEEcccceec
Confidence 99 789999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-16 Score=174.17 Aligned_cols=257 Identities=20% Similarity=0.236 Sum_probs=176.7
Q ss_pred CCcccccccCCCCcEEEEEecCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCC-CccceeeEEeecCCcEEEEEE
Q 002462 536 FSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHA-RLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~-niV~l~g~c~~~~~~~~lV~E 610 (919)
|.....||.|+||.||++... ..+|+|.+..... ..+.|.+|+.+++++.|+ +++++..+.. .....++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-DEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-cCCEEEEEEe
Confidence 344567999999999999877 7889999865433 256799999999999998 7999999774 3444799999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCC-ceeeCCcchhhh
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF-EVRLGSLSEVCA 689 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~-~~kl~dfg~~~~ 689 (919)
|+.++++.+.+...... ..+.......+..+++.+++|+|.. +++|||+||+||+++... .+++.|||.++.
T Consensus 79 ~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK----GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKL 151 (384)
T ss_pred cCCCCcHHHHHHhcccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence 99999999666433210 2467778889999999999999986 699999999999999988 799999998874
Q ss_pred cCCCCcce----eeeeeccCCCCccccCCCC---CCCCCCCcchhHHHHHHHHHcCCCCCCCCCh----hHHHHHHHhhc
Q 002462 690 QGGDAHQS----RITRLLRLPQSSEQGSSGS---LTATCPYDVYCFGKVLLELVTGKMGISASSD----AQVKEILEQTL 758 (919)
Q Consensus 690 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~---~~~t~~~DVySfGvvLlEllTGk~p~~~~~~----~~~~~~~~~~~ 758 (919)
........ ......+...+..++.... ..+....|+||+|++++++++|+.|+..... ......+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 231 (384)
T COG0515 152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231 (384)
T ss_pred cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence 43322110 1122233333444443332 3566778999999999999999999765542 22222222111
Q ss_pred ccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 759 PYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 759 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
. ........+ ... ......+..+...|+..+|..|.++.+....
T Consensus 232 ~-------~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 T-------PSLASPLSP----SNP-ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred C-------cccccccCc----ccc-chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000000 000 0111234557778888899999999887654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-19 Score=209.44 Aligned_cols=241 Identities=28% Similarity=0.379 Sum_probs=146.9
Q ss_pred CCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEecc
Q 002462 143 TLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDIS 222 (919)
Q Consensus 143 ~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 222 (919)
+|+++|+++|++++ +|..++.+.+|+.|+..+|+|+ .+|..+...++|+.|++.+|.++ .+|.....++.|++|+|.
T Consensus 242 nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 242 NLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred cceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeeh
Confidence 34444444444442 2244444444444444444443 34444444444444444444444 334444444444444444
Q ss_pred CCcCCCCCCccc-CCCC-CCCEEEccCCCCCCCCccccCCCCCCCEEEcCCCCCCCCCchhhhccccCCEEEccCCcCCC
Q 002462 223 SNYLTGSIPPGL-GTLS-KLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSG 300 (919)
Q Consensus 223 ~N~l~g~~p~~l-~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~ls~N~l~g 300 (919)
.|++. .+|+.+ .-+. +|..|+.+.|.+....--.=..+..|+.|++.+|.|+...-..+.+..+|+.|+|++|.|.
T Consensus 319 ~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~- 396 (1081)
T KOG0618|consen 319 SNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN- 396 (1081)
T ss_pred hcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-
Confidence 44443 222221 1111 1333444444443211001112455778888888888877778888889999999999886
Q ss_pred CCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCCCCCcccccCCCCCcEEEccCCcCccC-CCCC
Q 002462 301 NLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGG-LTPV 379 (919)
Q Consensus 301 ~i~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~l~~L~ls~N~~~g~-~~~~ 379 (919)
.+|...+.++..|+.|+||+|+|+. +|+.+.+++.|++|...+|++. .+|+ ...+..|+.+|+|.|.+.-. +|..
T Consensus 397 ~fpas~~~kle~LeeL~LSGNkL~~-Lp~tva~~~~L~tL~ahsN~l~-~fPe--~~~l~qL~~lDlS~N~L~~~~l~~~ 472 (1081)
T KOG0618|consen 397 SFPASKLRKLEELEELNLSGNKLTT-LPDTVANLGRLHTLRAHSNQLL-SFPE--LAQLPQLKVLDLSCNNLSEVTLPEA 472 (1081)
T ss_pred cCCHHHHhchHHhHHHhcccchhhh-hhHHHHhhhhhHHHhhcCCcee-echh--hhhcCcceEEecccchhhhhhhhhh
Confidence 6788888888889999999999885 4578888888999998888887 5663 34567888899999887643 3322
Q ss_pred C--CCCcEEEccCCc
Q 002462 380 L--GRFRLVDLSGNY 392 (919)
Q Consensus 380 l--~~L~~ldLs~N~ 392 (919)
+ ++|++|||++|.
T Consensus 473 ~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 473 LPSPNLKYLDLSGNT 487 (1081)
T ss_pred CCCcccceeeccCCc
Confidence 2 578999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.3e-18 Score=174.85 Aligned_cols=170 Identities=13% Similarity=0.094 Sum_probs=124.7
Q ss_pred hCCCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHH----------HHHHHHHHHhhcCCCCccceeeEEeecC
Q 002462 533 TGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTE----------AYLLELDFFSKVSHARLVPLLGHCMERE 602 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~----------~f~~Ei~~l~~l~H~niV~l~g~c~~~~ 602 (919)
.+.|...+++|+|+||.||.... ++..+|||.+.......+ .|.+|++.+.+++|++|..+..+.....
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 46789999999999999999655 566899999965433222 2678999999999999999988754322
Q ss_pred -------CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCC
Q 002462 603 -------NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD 675 (919)
Q Consensus 603 -------~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~ 675 (919)
+..+|||||+++.+|.++.. ++ ..+..+++.+|..+|.. +|+|||+||+||+++.
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----------~~----~~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----------IS----EDVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK 170 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-----------cc----HHHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence 34789999999999977631 11 12455889999999985 8999999999999999
Q ss_pred CCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHH
Q 002462 676 KFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELV 736 (919)
Q Consensus 676 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEll 736 (919)
++ +++.|||............. ... ...+..++|+|||||.+.-..
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~d~---------~vl-----er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAKDR---------IDL-----ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhHHH---------HHH-----HhHhcccccccceeEeehHHH
Confidence 88 99999985543321111100 000 011234689999999877553
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.6e-19 Score=207.09 Aligned_cols=264 Identities=30% Similarity=0.440 Sum_probs=210.5
Q ss_pred CCCCCEEecCCCCCCCCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCEE
Q 002462 116 LTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVL 195 (919)
Q Consensus 116 L~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L 195 (919)
-.+|++++++.|.+. .+|+|++. +.+|+.|+..+|+|+ .+|..+...++|+.|.+.+|.+. -+|.....++.|++|
T Consensus 240 p~nl~~~dis~n~l~-~lp~wi~~-~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tL 315 (1081)
T KOG0618|consen 240 PLNLQYLDISHNNLS-NLPEWIGA-CANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTL 315 (1081)
T ss_pred cccceeeecchhhhh-cchHHHHh-cccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeee
Confidence 357899999999986 48899986 999999999999995 78889999999999999999998 688888899999999
Q ss_pred EccCCcCCCCCCcc-ccCCCC-CCEEeccCCcCCCCCCc-ccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcCCC
Q 002462 196 DLSRNSLTGNIPTS-FGLLKN-LSSLDISSNYLTGSIPP-GLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMN 272 (919)
Q Consensus 196 ~Ls~N~l~~~~p~~-~~~l~~-L~~L~Ls~N~l~g~~p~-~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 272 (919)
+|..|+|. .+|+. |..+.. |+.|+.+.|.+.. .|. +=..++.|+.|++.+|.|+...-..|.+...|+.|+|++|
T Consensus 316 dL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~-lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyN 393 (1081)
T KOG0618|consen 316 DLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLST-LPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYN 393 (1081)
T ss_pred eehhcccc-ccchHHHhhhhHHHHHHhhhhccccc-cccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccc
Confidence 99999997 45553 343433 7788888888873 332 2234677999999999999877777889999999999999
Q ss_pred CCCCCCchhhhccccCCEEEccCCcCCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCC-CC
Q 002462 273 SLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTG-PL 351 (919)
Q Consensus 273 ~l~g~~p~~l~~l~~L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g-~i 351 (919)
+|.......+.++..|+.|+||+|.++ .+|..+ .++..|++|...+|++...+ .+..++.|+.+|+|.|+|+- .+
T Consensus 394 rL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tv-a~~~~L~tL~ahsN~l~~fP--e~~~l~qL~~lDlS~N~L~~~~l 469 (1081)
T KOG0618|consen 394 RLNSFPASKLRKLEELEELNLSGNKLT-TLPDTV-ANLGRLHTLRAHSNQLLSFP--ELAQLPQLKVLDLSCNNLSEVTL 469 (1081)
T ss_pred ccccCCHHHHhchHHhHHHhcccchhh-hhhHHH-HhhhhhHHHhhcCCceeech--hhhhcCcceEEecccchhhhhhh
Confidence 997444456789999999999999998 677554 78889999999999998654 67899999999999999973 33
Q ss_pred CcccccCCCCCcEEEccCCc---CccCCCCCCCCCcEEEccCC
Q 002462 352 PNSRSNVNTSTVELNISQNM---FYGGLTPVLGRFRLVDLSGN 391 (919)
Q Consensus 352 p~~~~~~~~~l~~L~ls~N~---~~g~~~~~l~~L~~ldLs~N 391 (919)
|... ....|++||+++|. |.-.-.+.+..+...++.-|
T Consensus 470 ~~~~--p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 470 PEAL--PSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred hhhC--CCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 4321 12789999999997 33333345566666666666
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.9e-19 Score=190.46 Aligned_cols=249 Identities=23% Similarity=0.273 Sum_probs=151.6
Q ss_pred CEEecCCCCCCCCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeC-CCCCCCCcccccCCCCCCEEEcc
Q 002462 120 ASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSD-NGLTGTIPSSLGQLSVLSVLDLS 198 (919)
Q Consensus 120 ~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~l~~L~~L~~L~Ls 198 (919)
..+.|..|.+ ..||+..++.+++|+.||||+|.|+.+-|.+|.+|.+|..|-|.+ |+|+..-...|++|..|+-|.+.
T Consensus 70 veirLdqN~I-~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN 148 (498)
T KOG4237|consen 70 VEIRLDQNQI-SSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN 148 (498)
T ss_pred eEEEeccCCc-ccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence 3466667776 467877777788888888888888888888888888887777666 88885555678888888888888
Q ss_pred CCcCCCCCCccccCCCCCCEEeccCCcCCCCCCc-ccCCCCCCCEEEccCCCCCC------------CCccccCCCCCCC
Q 002462 199 RNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPP-GLGTLSKLQYLNVSNNSLAS------------SIPAQLGDLDSLV 265 (919)
Q Consensus 199 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~l~~l~~L~~L~Ls~N~l~~------------~~p~~l~~l~~L~ 265 (919)
-|++.-...+.|..|++|..|.|.+|.+. .++. .|..+.+++.+.+..|.+.. ..|.+++...-..
T Consensus 149 an~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 149 ANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred hhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 88888777788888888888888888887 4454 67888888888888887421 1222233222222
Q ss_pred EEEcCCCCCC-------------------------CCCc-hhhhccccCCEEEccCCcCCCCCCCcccCCCCCCCEEEcc
Q 002462 266 DLDLSMNSLS-------------------------GSVP-SELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLR 319 (919)
Q Consensus 266 ~L~Ls~N~l~-------------------------g~~p-~~l~~l~~L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L~ 319 (919)
...+.++++. +.-| ..|.+|++|+.|+|++|++++ |....|..+..++.|.|.
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~-i~~~aFe~~a~l~eL~L~ 306 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITR-IEDGAFEGAAELQELYLT 306 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccch-hhhhhhcchhhhhhhhcC
Confidence 2222222221 1222 124455555555555555542 333344555555555555
Q ss_pred CCCCCCCCccccCCCCCCCEEEccCCCCCCCCCcccccCCCCCcEEEccCCcC
Q 002462 320 QNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMF 372 (919)
Q Consensus 320 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~l~~L~ls~N~~ 372 (919)
.|++..+-...|.++..|+.|+|++|+|+-.-| ..+....+|.+|+|-.|.|
T Consensus 307 ~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~-~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 307 RNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAP-GAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred cchHHHHHHHhhhccccceeeeecCCeeEEEec-ccccccceeeeeehccCcc
Confidence 555544444445555555555555555553333 2223333444444444433
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2e-19 Score=169.98 Aligned_cols=154 Identities=31% Similarity=0.522 Sum_probs=83.7
Q ss_pred CCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEe
Q 002462 141 LPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLD 220 (919)
Q Consensus 141 L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 220 (919)
+.+++.|.||+|.++ .+|+.+..|.+|+.|++++|++. .+|.++..+++|+.|+++-|++. .+|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 344444555555554 34444555555555555555554 45555555555555555555554 4555555555555555
Q ss_pred ccCCcCC-CCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcCCCCCCCCCchhhhccccCCEEEccCCcCC
Q 002462 221 ISSNYLT-GSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLS 299 (919)
Q Consensus 221 Ls~N~l~-g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~ls~N~l~ 299 (919)
|.+|++. ..+|..|..|+.|+.|+|++|.|. .+|..++++++|+.|.+..|.+- .+|.+++.|+.|+.|.+.+|.++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 5555554 234555555555555555555553 45555555555555555555554 45566666666666666666554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.1e-17 Score=167.07 Aligned_cols=135 Identities=12% Similarity=0.102 Sum_probs=101.9
Q ss_pred CCcccccccCCCCcEEEEEecCCccEEEEEeccccc-cHHHHHHHHHHHhhc-----CCCCccceeeEEeecC--Cc-EE
Q 002462 536 FSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSV-KTEAYLLELDFFSKV-----SHARLVPLLGHCMERE--NE-KF 606 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~-~~~~f~~Ei~~l~~l-----~H~niV~l~g~c~~~~--~~-~~ 606 (919)
.+...+||+|+||.||+ .-.++. .+||++..... ..+++.+|+++++++ .||||++++|+..+.. +. ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567999999999996 333343 47998865433 356799999999999 5799999999776542 23 33
Q ss_pred EEEEe--cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHh-hhhhcCCCCCeeeccCCCCceecCC----CCce
Q 002462 607 LVYKY--MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGL-SYLHHECTLPFVHRDVQASSILLDD----KFEV 679 (919)
Q Consensus 607 lV~Ey--~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL-~yLH~~~~~~ivHrDlK~~NILld~----~~~~ 679 (919)
+|+|| +++|+|.+++.+.. ++.. ..++.++..++ +|||+. +||||||||+|||++. +..+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~--------~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR--------YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred EEecCCCCcchhHHHHHHccc--------ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcE
Confidence 78999 66899999995421 3333 24567777777 999985 8999999999999974 3479
Q ss_pred eeCCcc
Q 002462 680 RLGSLS 685 (919)
Q Consensus 680 kl~dfg 685 (919)
+|.||+
T Consensus 149 ~LiDg~ 154 (210)
T PRK10345 149 VVCDNI 154 (210)
T ss_pred EEEECC
Confidence 999954
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.8e-19 Score=195.56 Aligned_cols=183 Identities=27% Similarity=0.292 Sum_probs=78.6
Q ss_pred CCCCCEEecCCCCCCCC----CchhhhhCCCCCcEEEeecCCCCc------cCCcCCCCCCCCCEEEeeCCCCCCCCccc
Q 002462 116 LTHLASFNASRFLLPGS----IPDWLGQQLPTLQALDLRSCSISG------VIPFSLGNLTNLTSLYLSDNGLTGTIPSS 185 (919)
Q Consensus 116 L~~L~~l~ls~n~l~g~----ip~~~~~~L~~L~~LdLs~N~l~g------~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 185 (919)
+..|+.++++++.+... ++..+. ..++|++|+++.+.+.+ .++..+..+++|+.|+|++|.+.+..+..
T Consensus 22 l~~L~~l~l~~~~l~~~~~~~i~~~l~-~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~ 100 (319)
T cd00116 22 LLCLQVLRLEGNTLGEEAAKALASALR-PQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGV 100 (319)
T ss_pred HhhccEEeecCCCCcHHHHHHHHHHHh-hCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHH
Confidence 34455555555544321 222222 24445555555554431 12223444455555555555554433333
Q ss_pred ccCCCC---CCEEEccCCcCCC----CCCccccCC-CCCCEEeccCCcCCCC----CCcccCCCCCCCEEEccCCCCCCC
Q 002462 186 LGQLSV---LSVLDLSRNSLTG----NIPTSFGLL-KNLSSLDISSNYLTGS----IPPGLGTLSKLQYLNVSNNSLASS 253 (919)
Q Consensus 186 l~~L~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~~~ 253 (919)
+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++.
T Consensus 101 ~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 180 (319)
T cd00116 101 LESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDA 180 (319)
T ss_pred HHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchH
Confidence 333333 5555555555442 112223333 4555555555555421 122233444455555555555421
Q ss_pred ----CccccCCCCCCCEEEcCCCCCCCC----CchhhhccccCCEEEccCCcCC
Q 002462 254 ----IPAQLGDLDSLVDLDLSMNSLSGS----VPSELRGLRSLQKFVIGNNFLS 299 (919)
Q Consensus 254 ----~p~~l~~l~~L~~L~Ls~N~l~g~----~p~~l~~l~~L~~L~ls~N~l~ 299 (919)
++..+..+++|++|+|++|.+.+. +...+..+++|++|++++|.++
T Consensus 181 ~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~ 234 (319)
T cd00116 181 GIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234 (319)
T ss_pred HHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCc
Confidence 222233334555555555554422 1222333444555555544443
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-18 Score=192.58 Aligned_cols=226 Identities=24% Similarity=0.271 Sum_probs=139.7
Q ss_pred EecCCCCCC-CCCchhhhhCCCCCcEEEeecCCCCcc----CCcCCCCCCCCCEEEeeCCCCCC------CCcccccCCC
Q 002462 122 FNASRFLLP-GSIPDWLGQQLPTLQALDLRSCSISGV----IPFSLGNLTNLTSLYLSDNGLTG------TIPSSLGQLS 190 (919)
Q Consensus 122 l~ls~n~l~-g~ip~~~~~~L~~L~~LdLs~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g------~~p~~l~~L~ 190 (919)
|+|..+.+. ...+..+ ..+.+|++|+|++|.++.. ++..+...++|+.|++++|.+.+ .++..+..++
T Consensus 3 l~L~~~~l~~~~~~~~~-~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 3 LSLKGELLKTERATELL-PKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred cccccCcccccchHHHH-HHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 456666665 3344333 3478899999999988543 55566778888999998888762 2345567778
Q ss_pred CCCEEEccCCcCCCCCCccccCCCC---CCEEeccCCcCCC----CCCcccCCC-CCCCEEEccCCCCCCC----Ccccc
Q 002462 191 VLSVLDLSRNSLTGNIPTSFGLLKN---LSSLDISSNYLTG----SIPPGLGTL-SKLQYLNVSNNSLASS----IPAQL 258 (919)
Q Consensus 191 ~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~g----~~p~~l~~l-~~L~~L~Ls~N~l~~~----~p~~l 258 (919)
+|+.|+|++|.+.+..+..+..+.+ |++|++++|.+++ .+...+..+ ++|+.|+|++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 8888888888887666666655555 8888888887763 223344555 7778888888877742 23345
Q ss_pred CCCCCCCEEEcCCCCCCCC----CchhhhccccCCEEEccCCcCCCCCCC---cccCCCCCCCEEEccCCCCCCCCcccc
Q 002462 259 GDLDSLVDLDLSMNSLSGS----VPSELRGLRSLQKFVIGNNFLSGNLSV---NLFPTVSQLQIIVLRQNGFTGPPPDVL 331 (919)
Q Consensus 259 ~~l~~L~~L~Ls~N~l~g~----~p~~l~~l~~L~~L~ls~N~l~g~i~~---~~~~~l~~L~~L~L~~N~l~~~~p~~l 331 (919)
..+++|++|+|++|.+++. ++..+..+++|+.|++++|.+++.-.. ..+..+++|++|++++|.+++.....+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 5666777777777777642 233344455677777777766532111 112344556666666666554211111
Q ss_pred C-----CCCCCCEEEccCCCCC
Q 002462 332 W-----SMPQLRLLDISRNNFT 348 (919)
Q Consensus 332 ~-----~l~~L~~L~Ls~N~l~ 348 (919)
. ..+.|+.|++++|.++
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHhccCCCceEEEccCCCCC
Confidence 1 1245566666655554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=9.4e-17 Score=162.56 Aligned_cols=184 Identities=14% Similarity=0.067 Sum_probs=126.5
Q ss_pred CcccccccCCCCcEEEEEecCCccEEEEEecccccc-----HHHHHHHHHHHhhcC-CCCccceeeEEeecCCcEEEEEE
Q 002462 537 SDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK-----TEAYLLELDFFSKVS-HARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 537 ~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~-----~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~~~~~lV~E 610 (919)
.....|++|+||+||...- ++..++.+.+.....- ...|.+|+++|+++. |+++.+++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEEEe
Confidence 3456899999999996544 6778888888655432 225889999999995 4789888884 24689999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccC-CCCceecCCCCceeeCCcchhhh
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDV-QASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDl-K~~NILld~~~~~kl~dfg~~~~ 689 (919)
|+++.+|...+.. ....+..+++++|+|+|.. +|||||| ||.|||++.++.++|.|||.+..
T Consensus 79 yI~G~~L~~~~~~--------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~ 141 (218)
T PRK12274 79 YLAGAAMYQRPPR--------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVR 141 (218)
T ss_pred eecCccHHhhhhh--------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence 9999988654311 1134677889999999985 8999999 79999999999999999998874
Q ss_pred cCCCCcc------eeee---e--eccCCCCccccCCCCC-CCC-CCCcchhHHHHHHHHHcCCCCCC
Q 002462 690 QGGDAHQ------SRIT---R--LLRLPQSSEQGSSGSL-TAT-CPYDVYCFGKVLLELVTGKMGIS 743 (919)
Q Consensus 690 ~~~~~~~------~~~~---~--~~~~~~~~~~~~~~~~-~~t-~~~DVySfGvvLlEllTGk~p~~ 743 (919)
......- .-.. + ..+.+++..+....-. ..+ ...+.++-|.-+|.++||+.+.-
T Consensus 142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 4322210 0000 0 0012222221111000 011 12378899999999999998753
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.8e-19 Score=166.02 Aligned_cols=166 Identities=31% Similarity=0.562 Sum_probs=113.3
Q ss_pred hhcCCCCCCEEecCCCCCCCCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCC
Q 002462 112 ALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSV 191 (919)
Q Consensus 112 ~l~~L~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~ 191 (919)
.+.++.+++.|.||+|.++ .+|+.+.. |.+|+.|++++|+|. .+|.+++.++.|+.|+++-|++. .+|..|+.++.
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~-l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~ 103 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAE-LKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPA 103 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHH-hhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCch
Confidence 4556666666777777664 45666654 777777777777775 46667777777777777777766 56777777777
Q ss_pred CCEEEccCCcCCC-CCCccccCCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcC
Q 002462 192 LSVLDLSRNSLTG-NIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLS 270 (919)
Q Consensus 192 L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 270 (919)
|++|||++|+++. .+|..|..++.|+.|+|++|.|. .+|+.++++++||.|.+..|.+. .+|..++.++.|++|.+.
T Consensus 104 levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiq 181 (264)
T KOG0617|consen 104 LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQ 181 (264)
T ss_pred hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcc
Confidence 7777777777653 46667777777777777777776 56667777777777777777665 467777777777777777
Q ss_pred CCCCCCCCchhhhc
Q 002462 271 MNSLSGSVPSELRG 284 (919)
Q Consensus 271 ~N~l~g~~p~~l~~ 284 (919)
+|+++ .+|.++++
T Consensus 182 gnrl~-vlppel~~ 194 (264)
T KOG0617|consen 182 GNRLT-VLPPELAN 194 (264)
T ss_pred cceee-ecChhhhh
Confidence 77776 45555543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.9e-16 Score=161.35 Aligned_cols=132 Identities=19% Similarity=0.233 Sum_probs=109.2
Q ss_pred cccccCCCCcEEEEEecCCccEEEEEeccccc---------cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEE
Q 002462 540 NLIKNGHSGDLFRGILEGGIPVVIKRIDLQSV---------KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~---------~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~E 610 (919)
+.||+|++|.||+|.. +|..|+||+...... ..+.+.+|++++.+++|++|.....++... +..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-ENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-CCCEEEEE
Confidence 4799999999999987 567899997653321 124578899999999999998877776653 46889999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
|+++++|.+.+... .+ ++.+|+.+++.+|+++|.. +++|||+||.|||++ ++.+++.|||.+.
T Consensus 80 ~~~G~~L~~~~~~~----------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 80 YIEGEPLKDLINSN----------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EeCCcCHHHHHHhc----------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 99999999988532 22 7889999999999999985 899999999999999 7889999998543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=7e-16 Score=159.22 Aligned_cols=142 Identities=17% Similarity=0.151 Sum_probs=108.6
Q ss_pred HHHHHhCCCCcccccccCCCCcEEEEEecCCccEEEEEecccccc-----------------------HHHHHHHHHHHh
Q 002462 528 QLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK-----------------------TEAYLLELDFFS 584 (919)
Q Consensus 528 ~l~~at~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~-----------------------~~~f~~Ei~~l~ 584 (919)
++.+.-.-+...+.||+|+||.||+|..++|..||||+++..... ...+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 333333335667899999999999999888999999987543210 123677999999
Q ss_pred hcCCCC--ccceeeEEeecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCee
Q 002462 585 KVSHAR--LVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFV 662 (919)
Q Consensus 585 ~l~H~n--iV~l~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~iv 662 (919)
++.|++ +.+.++. ...++||||+++++|.+.... .....++.++++++.++|+. +|+
T Consensus 89 ~l~~~~i~v~~~~~~-----~~~~lv~e~~~g~~L~~~~~~-------------~~~~~~~~~i~~~l~~lh~~---gi~ 147 (198)
T cd05144 89 ALYEEGFPVPKPIDW-----NRHAVVMEYIDGVELYRVRVL-------------EDPEEVLDEILEEIVKAYKH---GII 147 (198)
T ss_pred HHHHcCCCCCceeec-----CCceEEEEEeCCcchhhcccc-------------ccHHHHHHHHHHHHHHHHHC---CCC
Confidence 998884 4444431 346899999999998765321 12346888999999999984 899
Q ss_pred eccCCCCceecCCCCceeeCCcchhhhc
Q 002462 663 HRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 663 HrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
||||||+||+++++++++|.|||.+...
T Consensus 148 H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 148 HGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred cCCCCcccEEEcCCCcEEEEECCccccC
Confidence 9999999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.6e-16 Score=162.78 Aligned_cols=139 Identities=14% Similarity=0.155 Sum_probs=106.2
Q ss_pred CCCcccccccCCCCcEEEEE--ecCCccEEEEEecccccc-------------------------HHHHHHHHHHHhhcC
Q 002462 535 DFSDANLIKNGHSGDLFRGI--LEGGIPVVIKRIDLQSVK-------------------------TEAYLLELDFFSKVS 587 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~--l~~g~~vavK~l~~~~~~-------------------------~~~f~~Ei~~l~~l~ 587 (919)
.|...+.||+|+||.||+|+ ..+|..||||.+...... ...+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 35567789999999999998 678999999998643210 123568999999998
Q ss_pred CCCc--cceeeEEeecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCC-eeec
Q 002462 588 HARL--VPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLP-FVHR 664 (919)
Q Consensus 588 H~ni--V~l~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~-ivHr 664 (919)
|..+ .+++++ ...++||||+++++|...+.... .+...+...|+.+++++++|||.. + |+||
T Consensus 109 ~~~i~~p~~~~~-----~~~~lV~E~~~g~~L~~~~~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~ 173 (237)
T smart00090 109 EAGVPVPKPIAW-----RRNVLVMEFIGGDGLPAPRLKDV-------EPEEEEEFELYDDILEEMRKLYKE---GELVHG 173 (237)
T ss_pred hcCCCCCeeeEe-----cCceEEEEEecCCcccccccccC-------CcchHHHHHHHHHHHHHHHHHHhc---CCEEeC
Confidence 6443 333332 23589999999999876542221 134445578999999999999985 6 9999
Q ss_pred cCCCCceecCCCCceeeCCcchhhh
Q 002462 665 DVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 665 DlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
||||+||+++ ++++++.|||.+..
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhc
Confidence 9999999999 88999999997653
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.6e-16 Score=184.74 Aligned_cols=136 Identities=21% Similarity=0.216 Sum_probs=108.6
Q ss_pred hCCCCcccccccCCCCcEEEEEecCCccEEEEE-eccc-c-------ccHHHHHHHHHHHhhcCCCCccceeeEEeecCC
Q 002462 533 TGDFSDANLIKNGHSGDLFRGILEGGIPVVIKR-IDLQ-S-------VKTEAYLLELDFFSKVSHARLVPLLGHCMEREN 603 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~-l~~~-~-------~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~ 603 (919)
...|...++||+|+||.||+|.+.+.. +++|+ +... . ...+.+.+|++++.+++|++++....++... .
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-E 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-C
Confidence 344566789999999999999986554 44443 2211 1 1125688999999999999999888877753 4
Q ss_pred cEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCC
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS 683 (919)
Q Consensus 604 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~d 683 (919)
..++||||+++++|.+++. .+.+++.+++++|+|||+. +|+|||+||+|||+ +++.++|.|
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liD 470 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLID 470 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEe
Confidence 6789999999999988773 3567899999999999985 89999999999999 577899999
Q ss_pred cchhhh
Q 002462 684 LSEVCA 689 (919)
Q Consensus 684 fg~~~~ 689 (919)
||.++.
T Consensus 471 FGla~~ 476 (535)
T PRK09605 471 FGLGKY 476 (535)
T ss_pred Cccccc
Confidence 996653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=183.33 Aligned_cols=156 Identities=37% Similarity=0.577 Sum_probs=87.2
Q ss_pred CCCHHHHHHHHHHHHhCCCCC-CCCCCCCCCCC----CCCCeeecCCCEEEEEcCCCcccCCCCCCCccChhhhcCCCCC
Q 002462 45 LSSRTELAALFELRSSLGLRR-RDWPRKVDPCL----VWNGVRCQNGSVVGINISGFRRTRLGSQNPRFAADALVNLTHL 119 (919)
Q Consensus 45 ~~~~~e~~aLl~~k~~l~~~~-~~W~~~~~~C~----~W~gv~C~~~~v~~l~l~~~~~~~~g~~~~~~~~~~l~~L~~L 119 (919)
.+.+.|.+||+++|+++.... .+|.. |+|+ .|.||.|.....+ ....+
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~~~~W~g--~~C~p~~~~w~Gv~C~~~~~~-------------------------~~~~v 420 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPLRFGWNG--DPCVPQQHPWSGADCQFDSTK-------------------------GKWFI 420 (623)
T ss_pred ccCchHHHHHHHHHHhcCCcccCCCCC--CCCCCcccccccceeeccCCC-------------------------CceEE
Confidence 356789999999999997643 48963 6774 7999999521000 00123
Q ss_pred CEEecCCCCCCCCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCEEEccC
Q 002462 120 ASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSR 199 (919)
Q Consensus 120 ~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L~Ls~ 199 (919)
+.|+|++|.+.|.+|..+.. |++|+.|+|++|.|.|.+|..++ ++++|+.|+|++
T Consensus 421 ~~L~L~~n~L~g~ip~~i~~-L~~L~~L~Ls~N~l~g~iP~~~~------------------------~l~~L~~LdLs~ 475 (623)
T PLN03150 421 DGLGLDNQGLRGFIPNDISK-LRHLQSINLSGNSIRGNIPPSLG------------------------SITSLEVLDLSY 475 (623)
T ss_pred EEEECCCCCccccCCHHHhC-CCCCCEEECCCCcccCcCChHHh------------------------CCCCCCEEECCC
Confidence 34455555555555555443 55555555555555554544444 444555555555
Q ss_pred CcCCCCCCccccCCCCCCEEeccCCcCCCCCCcccCCC-CCCCEEEccCCCCCC
Q 002462 200 NSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTL-SKLQYLNVSNNSLAS 252 (919)
Q Consensus 200 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l-~~L~~L~Ls~N~l~~ 252 (919)
|+++|.+|..+++|++|+.|+|++|+++|.+|..++.+ .++..+++.+|....
T Consensus 476 N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc 529 (623)
T PLN03150 476 NSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLC 529 (623)
T ss_pred CCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCcccc
Confidence 55555555555555555555555555555555554432 345566777775443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=1e-15 Score=157.99 Aligned_cols=128 Identities=20% Similarity=0.209 Sum_probs=103.0
Q ss_pred ccccCCCCcEEEEEecCCccEEEEEeccccc---------cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 541 LIKNGHSGDLFRGILEGGIPVVIKRIDLQSV---------KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 541 ~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~---------~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
+||+|+||.||+|.+ +|..|+||+...... ..+.+.+|++++.+++|+++.....++... +..++||||
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-DNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-CCCEEEEEE
Confidence 489999999999985 567899998643211 124677899999999998866655555543 457899999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
+++++|.+.+.... ..++.+++++|++||.. +++|||+||.||+++ ++.+++.|||.+.
T Consensus 79 ~~g~~l~~~~~~~~--------------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 79 IEGKPLKDVIEEGN--------------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred ECCccHHHHHhhcH--------------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 99999998874321 07899999999999985 899999999999999 7899999998654
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.8e-15 Score=162.41 Aligned_cols=258 Identities=17% Similarity=0.161 Sum_probs=167.1
Q ss_pred CCCcccccccCCCCcEEEEEecCC--ccEEEEEecccccc-HHHHHHHHHHHhhcCC----CCccceeeEEeecCCcEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILEGG--IPVVIKRIDLQSVK-TEAYLLELDFFSKVSH----ARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~g--~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H----~niV~l~g~c~~~~~~~~l 607 (919)
.|.....||+|+||.||.+.-... ..+|+|........ ...+..|+.++..+.+ +++..++......+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 677889999999999999986553 47888876543222 2267789999998873 4677777644233457899
Q ss_pred EEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC-----CceeeC
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK-----FEVRLG 682 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~-----~~~kl~ 682 (919)
||+.+ +-+|.+...... ...++-.+.++||.|+..+|+|+|+. ++|||||||.|+++... ..+.+.
T Consensus 99 VM~l~-G~sL~dl~~~~~-----~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-----PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred EEecc-CccHHHHHHhCC-----CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEE
Confidence 99876 568888654332 23478889999999999999999985 89999999999999865 468899
Q ss_pred Ccchhh--hcCCCCcce-ee-----eeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH-HHHH
Q 002462 683 SLSEVC--AQGGDAHQS-RI-----TRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEI 753 (919)
Q Consensus 683 dfg~~~--~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~-~~~~ 753 (919)
|||+++ ......... +. ....++..+...........+.+-|+||++-++.|+..|..|+....... ..++
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 999998 322111110 00 00112222222222222334556799999999999999999986654321 1111
Q ss_pred HHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 002462 754 LEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~~~ 818 (919)
..... ...... . .....++ +..+...+-..+..++|.-..+...++..
T Consensus 250 ~~~~~-----------~~~~~~-~--~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 250 EKDPR-----------KLLTDR-F--GDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHhh-----------hhcccc-c--cCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 11100 001110 0 0011222 33344455568889999999998887653
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.6e-18 Score=178.08 Aligned_cols=251 Identities=21% Similarity=0.226 Sum_probs=174.4
Q ss_pred CCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCEEEccC-CcCCCCCCccccCCCCCCEEec
Q 002462 143 TLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSR-NSLTGNIPTSFGLLKNLSSLDI 221 (919)
Q Consensus 143 ~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L 221 (919)
.-..|+|..|+|+.+.|.+|+.+++|+.|||++|+|+-+-|.+|.+|.+|..|-+.+ |+|+...-..|++|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 456799999999999999999999999999999999999999999999988876655 9999776778999999999999
Q ss_pred cCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcCCCCCC------------CCCchhhhccccCC
Q 002462 222 SSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLS------------GSVPSELRGLRSLQ 289 (919)
Q Consensus 222 s~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~------------g~~p~~l~~l~~L~ 289 (919)
.-|++.-...+.|..|++|..|.|.+|.+...--..|..+.+++.+.+..|.+- -..|.++++.+-..
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 999999888888999999999999999997544448899999999999998842 12333333333322
Q ss_pred EEEccCCc-------------------------CCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEccC
Q 002462 290 KFVIGNNF-------------------------LSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISR 344 (919)
Q Consensus 290 ~L~ls~N~-------------------------l~g~i~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 344 (919)
-..+.++. ..+..|..-|..+++|+.|+|++|+++++-+.+|.++..++.|.|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 22222222 22233333455566666666666666666666666666666666666
Q ss_pred CCCCCCCCcccccCCCCCcEEEccCCcCccCCC---CCCCCCcEEEccCCcCC
Q 002462 345 NNFTGPLPNSRSNVNTSTVELNISQNMFYGGLT---PVLGRFRLVDLSGNYFE 394 (919)
Q Consensus 345 N~l~g~ip~~~~~~~~~l~~L~ls~N~~~g~~~---~~l~~L~~ldLs~N~l~ 394 (919)
|++. .+....+..+..|..|+|.+|+++...| ..+..|..|+|-.|.|.
T Consensus 308 N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 308 NKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred chHH-HHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 6654 2222233334455555555555543333 22334445555555543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.2e-14 Score=137.95 Aligned_cols=133 Identities=17% Similarity=0.152 Sum_probs=110.4
Q ss_pred ccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCC--CCccceeeEEeecCCcEEEEEEecCCCC
Q 002462 539 ANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSH--ARLVPLLGHCMERENEKFLVYKYMPNGD 616 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H--~niV~l~g~c~~~~~~~~lV~Ey~~~Gs 616 (919)
.+.||+|.++.||++...+ ..++||....... ..+|.+|+.++.+++| .++.+++++... .+..+++|||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGES-DGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-CCccEEEEEecCCee
Confidence 4679999999999999865 6899998865433 4678999999999987 488888886543 457899999999887
Q ss_pred hhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 617 LSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 617 L~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
+... ++..+..++.+++++|+++|.....+++|||+||.||++++...+++.||+.++
T Consensus 80 ~~~~--------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 80 LDEV--------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred cccC--------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 7543 455678899999999999998655689999999999999998999999998544
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.2e-14 Score=148.41 Aligned_cols=134 Identities=18% Similarity=0.231 Sum_probs=95.9
Q ss_pred cccccCCCCcEEEEEecCCccEEEEEecccccc---HHHH----------------------HHHHHHHhhcCCCC--cc
Q 002462 540 NLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK---TEAY----------------------LLELDFFSKVSHAR--LV 592 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~---~~~f----------------------~~Ei~~l~~l~H~n--iV 592 (919)
+.||+|+||.||+|...+|..||||++...... ...+ ..|.+.+.++++.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 579999999999999888999999988643221 1111 35666777775543 33
Q ss_pred ceeeEEeecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCcee
Q 002462 593 PLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSIL 672 (919)
Q Consensus 593 ~l~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NIL 672 (919)
+.++ + ...++||||+++|.+......... .. .+..+++.+++.++.++|.+ .+|+||||||+||+
T Consensus 83 ~~~~-~----~~~~lv~e~~~g~~~~~~~l~~~~-------~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nil 147 (187)
T cd05119 83 KPID-L----NRHVLVMEFIGGDGIPAPRLKDVR-------LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNIL 147 (187)
T ss_pred ceEe-c----CCCEEEEEEeCCCCccChhhhhhh-------hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEE
Confidence 3333 1 246899999999764322111100 00 34568899999999999973 38999999999999
Q ss_pred cCCCCceeeCCcchhhh
Q 002462 673 LDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 673 ld~~~~~kl~dfg~~~~ 689 (919)
++ ++.+++.|||.+..
T Consensus 148 i~-~~~~~liDfg~a~~ 163 (187)
T cd05119 148 VD-DGKVYIIDVPQAVE 163 (187)
T ss_pred EE-CCcEEEEECccccc
Confidence 99 89999999996643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.8e-15 Score=176.43 Aligned_cols=251 Identities=15% Similarity=0.150 Sum_probs=157.8
Q ss_pred cccccccCCCCcEEEEEe-cCCccEEEEEecc---ccccH----HHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 538 DANLIKNGHSGDLFRGIL-EGGIPVVIKRIDL---QSVKT----EAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 538 ~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~---~~~~~----~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
..+++|.|.+|.|+..+- ......+.|.... ..... ..+..|.-+-++++|+|++..+..+.+.. ..+-+|
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-~~~~~m 400 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-GILQSM 400 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-cchhhh
Confidence 457899999997777663 2333344443221 11111 12556888888999999988887666543 344559
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
|||++ ||...+-+.. .+.-..+-.+..|+.+|+.|+|+. +|.|||+|+.|+++..++.+||.|||.+..
T Consensus 401 E~~~~-Dlf~~~~~~~-------~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG-------KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASV 469 (601)
T ss_pred hcccH-HHHHHHhccc-------ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCccee
Confidence 99999 9999886531 255556777889999999999985 899999999999999999999999996543
Q ss_pred cCC--CCcceeeeeeccCCCCccccCCCCCCC-CCCCcchhHHHHHHHHHcCCCCCCCCChhHHHHHHHhhccccccccc
Q 002462 690 QGG--DAHQSRITRLLRLPQSSEQGSSGSLTA-TCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDK 766 (919)
Q Consensus 690 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (919)
... ...........+...|.+++..-...+ ....||||-|||+..|++|+.||......+... ... ...
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~~-------~~~ 541 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KTN-------NYS 541 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hhh-------ccc
Confidence 321 110011122233333444443222222 234699999999999999999986543221100 000 000
Q ss_pred ccccccccCCCCCCcchHHH-HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 767 ELVTKIVDPSLIIDEDLLEE-VWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~-~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
... .+... ....... -.+...++.+.++.+|.+|-+|.+|++
T Consensus 542 ~~~-~~~~~----~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 542 DQR-NIFEG----PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccc-ccccC----hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000 00000 0011111 112345778889999999999999986
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.50 E-value=8.9e-15 Score=155.97 Aligned_cols=203 Identities=22% Similarity=0.265 Sum_probs=122.4
Q ss_pred cccccccCCCCcEEEEEec-CCccEEEEEeccccc----cHHHHHHHHHHHhhcCC-----------CCccceeeEEee-
Q 002462 538 DANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSH-----------ARLVPLLGHCME- 600 (919)
Q Consensus 538 ~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H-----------~niV~l~g~c~~- 600 (919)
....||.|+++.||+++.. .|.++|||..-.... ..+++.+|.-....+.+ +-++++--.-+.
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 4578999999999999964 589999998743322 24677777766655443 222222111111
Q ss_pred ------cC---C-----cEEEEEEecCCCChhhhh---hccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeee
Q 002462 601 ------RE---N-----EKFLVYKYMPNGDLSSSL---YRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVH 663 (919)
Q Consensus 601 ------~~---~-----~~~lV~Ey~~~GsL~~~L---~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivH 663 (919)
.. . ..+++|+-+. +||.+.+ +..... ...+....|+.|..|+.+-+++||+. +|||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~---~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQT---HSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTT---SHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred CCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccc---cchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 00 0 2367777774 6887775 322211 23466778899999999999999996 8999
Q ss_pred ccCCCCceecCCCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccC---CCCCCCCCCCcchhHHHHHHHHHcCCC
Q 002462 664 RDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGS---SGSLTATCPYDVYCFGKVLLELVTGKM 740 (919)
Q Consensus 664 rDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~t~~~DVySfGvvLlEllTGk~ 740 (919)
+||||+|++++.+|.++++||+.....+........+..+..|+...... .....+|.+.|.|++|+++|.|.+|+.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999999985544332111111111111111000000 022346778899999999999999999
Q ss_pred CCCCCCh
Q 002462 741 GISASSD 747 (919)
Q Consensus 741 p~~~~~~ 747 (919)
|++...+
T Consensus 249 Pf~~~~~ 255 (288)
T PF14531_consen 249 PFGLSSP 255 (288)
T ss_dssp STCCCGG
T ss_pred CCCCCCc
Confidence 9986543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.9e-14 Score=138.88 Aligned_cols=212 Identities=18% Similarity=0.250 Sum_probs=142.9
Q ss_pred CHHHHHHHhCCCCcccccccCCCCcEEEEE-ecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCC
Q 002462 525 TYQQLLAATGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMEREN 603 (919)
Q Consensus 525 ~~~~l~~at~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~ 603 (919)
+.+++..+ +.|...+.||.|+||.+|.|. +.+|..||||.-... ....+..-|.++...++|--=++-+-++.....
T Consensus 7 s~~~~iv~-gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 7 SLEELIVG-GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred chhhheec-cceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 34444444 567788999999999999998 788999999975332 233457789999999987432332223333345
Q ss_pred cEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC---Ccee
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK---FEVR 680 (919)
Q Consensus 604 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~---~~~k 680 (919)
.-.+|||.. +-||++.+.-.. ..++-.+.+-+|-|+..-++|+|.. .+|||||||.|.|..-+ -.+.
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC~------R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~ 154 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFCS------RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLY 154 (341)
T ss_pred cceeeeecc-CccHHHHHHHHh------hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEE
Confidence 678999987 568888764221 2377788899999999999999986 69999999999998744 3577
Q ss_pred eCCcchhhhcCCCCcceee-----eeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChh
Q 002462 681 LGSLSEVCAQGGDAHQSRI-----TRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDA 748 (919)
Q Consensus 681 l~dfg~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~ 748 (919)
+.|||+++..-......++ ....++..+..-...-...-+..-|+=|.|-||.-.--|+.||.+-...
T Consensus 155 LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 155 LIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred EEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 8999998754322111111 0111111111111000011123459999999999999999999876543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.2e-13 Score=144.40 Aligned_cols=134 Identities=16% Similarity=0.156 Sum_probs=102.5
Q ss_pred ccccc-cCCCCcEEEEEecCCccEEEEEecccc--------------ccHHHHHHHHHHHhhcCCCCc--cceeeEEeec
Q 002462 539 ANLIK-NGHSGDLFRGILEGGIPVVIKRIDLQS--------------VKTEAYLLELDFFSKVSHARL--VPLLGHCMER 601 (919)
Q Consensus 539 ~~~ig-~G~~G~Vy~g~l~~g~~vavK~l~~~~--------------~~~~~f~~Ei~~l~~l~H~ni--V~l~g~c~~~ 601 (919)
..+|| .||.|+||+.... +..+|||+..... .....+.+|++++.+++|++| .+.++++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 9999999999886 5678999874321 112457889999999999885 6777765543
Q ss_pred CCc---EEEEEEecCC-CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCC
Q 002462 602 ENE---KFLVYKYMPN-GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF 677 (919)
Q Consensus 602 ~~~---~~lV~Ey~~~-GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~ 677 (919)
... .++|+||+++ .+|.+++... .++. ....+++++|.+||+. +|+||||||.|||++.+.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--------~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--------PLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDG 179 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--------CCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCC
Confidence 332 2599999997 6898887432 1222 2356789999999985 899999999999999988
Q ss_pred ceeeCCcchhh
Q 002462 678 EVRLGSLSEVC 688 (919)
Q Consensus 678 ~~kl~dfg~~~ 688 (919)
.++|.|||.+.
T Consensus 180 ~v~LIDfg~~~ 190 (239)
T PRK01723 180 KFWLIDFDRGE 190 (239)
T ss_pred CEEEEECCCcc
Confidence 99999998554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.2e-14 Score=161.91 Aligned_cols=185 Identities=18% Similarity=0.197 Sum_probs=135.5
Q ss_pred ccccCCCCcEEEEE----ecCCccEEEEEecccccc---HHHHHHHHHHHhhcC-CCCccceeeEEeecCCcEEEEEEec
Q 002462 541 LIKNGHSGDLFRGI----LEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVS-HARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 541 ~ig~G~~G~Vy~g~----l~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
++|+|.||.|+... .+.|..+|.|.+...... +.....|-.++..++ ||-+|++.. +++.+...+++.+|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhy-afqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHY-AFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeee-eeccccchhHhhhhc
Confidence 37899999998643 344677888877543322 124556888888887 999999885 677778899999999
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
.+|+|...+..... .+...--......|-+++.+|.- .|+|||+|++||++|.+|.+|+.|||+.+....
T Consensus 80 rgg~lft~l~~~~~-------f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~ 149 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVM-------FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK 149 (612)
T ss_pred ccchhhhccccCCc-------hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHh
Confidence 99999988865432 33333333455678889999974 899999999999999999999999998775432
Q ss_pred CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCC
Q 002462 693 DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISA 744 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~ 744 (919)
.... .++..|.+++... ......|.|||||+++||+||-.|+..
T Consensus 150 ~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 150 EKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 2211 2233334433332 234457999999999999999999876
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.2e-13 Score=162.96 Aligned_cols=194 Identities=14% Similarity=0.153 Sum_probs=134.9
Q ss_pred CCCCcccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcC---CCCccceeeEEeecCCcEEEEEE
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVS---HARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~---H~niV~l~g~c~~~~~~~~lV~E 610 (919)
..|.....||+|+||.||+|.-.+|..||+|.=...... +|.-=.+++.||+ -+-|..+.. |+--.+.-+||+|
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~-a~~~~~~S~lv~e 774 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISS-AHVFQNASVLVSE 774 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHH-HHccCCcceeeee
Confidence 357778899999999999999888999999986544322 2333345555665 122333333 2222356789999
Q ss_pred ecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCC-------CCceeeCC
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD-------KFEVRLGS 683 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~-------~~~~kl~d 683 (919)
|.+.|+|.+++... ...+|.--+.|+.++++-++.||.. .|||+||||.|.||.. ....+|.|
T Consensus 775 y~~~Gtlld~~N~~-------~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 775 YSPYGTLLDLINTN-------KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred ccccccHHHhhccC-------CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEe
Confidence 99999999998632 2378888899999999999999985 8999999999999943 34578999
Q ss_pred cchhhhcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCC
Q 002462 684 LSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKM 740 (919)
Q Consensus 684 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~ 740 (919)
||.+....--.....+...+.+....-.++..+...+...|-|.+..+++-|+-|+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 997654321111122222232222222233334466778899999999999999874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.4e-13 Score=162.31 Aligned_cols=245 Identities=20% Similarity=0.212 Sum_probs=157.5
Q ss_pred CCCcccccccCCCCcEEEEEecCCccEEEEEecccc--ccHHHHHH---HHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQS--VKTEAYLL---ELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~--~~~~~f~~---Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
++...+-+|++.|=+|.||+-+.|. |+||++-... ..-+.|.+ |++ +.-++|||.+++.-. .+.+...|||=
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-LVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-HHhhHHHHHHH
Confidence 5666778999999999999998887 9999884332 22344544 555 556799999987753 44455667888
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
+|..+ +|+|.|.-+ ..|.-.+..=||.|+..||.-.|.. +|.|+|||++|||+..---+.++||.-.+.
T Consensus 101 qyvkh-nLyDRlSTR-------PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTR-------PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKP 169 (1431)
T ss_pred HHHhh-hhhhhhccc-------hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCC
Confidence 88865 677776422 2355556666999999999999985 899999999999999888888999864432
Q ss_pred c---CCCCcc--eeeeeeccCCCCccccCC----C-------CCCCCCCCcchhHHHHHHHHHc-CCCCCCCCChhHHHH
Q 002462 690 Q---GGDAHQ--SRITRLLRLPQSSEQGSS----G-------SLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKE 752 (919)
Q Consensus 690 ~---~~~~~~--~~~~~~~~~~~~~~~~~~----~-------~~~~t~~~DVySfGvvLlEllT-Gk~p~~~~~~~~~~~ 752 (919)
. .++... ..+.+-.+-..|.+++.+ | ....+.+-||||.|||+.||++ |+++|... ++-+
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---QL~a 246 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---QLLA 246 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---HHHh
Confidence 1 111100 000000000011111111 0 1125667799999999999987 77777532 1111
Q ss_pred HHHhhcccccccccc-cccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002462 753 ILEQTLPYISIYDKE-LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 753 ~~~~~~~~~~~~~~~-~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~ 814 (919)
+-.+ ..++.+ .+++|-|+. +..+.+..++.+|++|-++.+.++.
T Consensus 247 Yr~~-----~~~~~e~~Le~Ied~~-------------~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 247 YRSG-----NADDPEQLLEKIEDVS-------------LRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred Hhcc-----CccCHHHHHHhCcCcc-------------HHHHHHHHHccCchhccCHHHHHHh
Confidence 1111 011222 233343332 2346678899999999999999876
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.1e-12 Score=137.43 Aligned_cols=197 Identities=19% Similarity=0.233 Sum_probs=117.4
Q ss_pred cCCCCccceeeEEeec--------------------------CCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHH
Q 002462 586 VSHARLVPLLGHCMER--------------------------ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITR 639 (919)
Q Consensus 586 l~H~niV~l~g~c~~~--------------------------~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~r 639 (919)
-+|||||++.+++.+. ....|+||.-.+. +|..+|..+. .+...+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--------~s~r~~ 343 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--------RSYRTG 343 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--------CchHHH
Confidence 3699999988865431 1246777776654 6777775432 344455
Q ss_pred HHHHHHHHHHhhhhhcCCCCCeeeccCCCCceec--CCCCc--eeeCCcchhhhcCCCCcc----eeee-----eeccCC
Q 002462 640 LKIAIGAAEGLSYLHHECTLPFVHRDVQASSILL--DDKFE--VRLGSLSEVCAQGGDAHQ----SRIT-----RLLRLP 706 (919)
Q Consensus 640 l~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILl--d~~~~--~kl~dfg~~~~~~~~~~~----~~~~-----~~~~~~ 706 (919)
.-|..|..+|..|||.+ +|.|||+|+.|||| |+|.. ..|+|||.........-+ +... ...++|
T Consensus 344 ~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAP 420 (598)
T KOG4158|consen 344 RVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAP 420 (598)
T ss_pred HHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecch
Confidence 66888999999999985 89999999999997 56654 457999954332211110 0000 011112
Q ss_pred CC--ccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhH--HHHHHHhhcccccccccccccccccCCCCCCcc
Q 002462 707 QS--SEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ--VKEILEQTLPYISIYDKELVTKIVDPSLIIDED 782 (919)
Q Consensus 707 ~~--~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~ 782 (919)
+. ..++-... .-..|+|.|+-|.+.||+++..-||....... ...+-+...| . +. +.
T Consensus 421 Ei~ta~PGp~av-vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP-----------a-----lp--~~ 481 (598)
T KOG4158|consen 421 EIATAVPGPNAV-VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP-----------A-----LP--SR 481 (598)
T ss_pred hhhhcCCCCcee-eccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC-----------C-----Cc--cc
Confidence 10 01111111 12357899999999999999999998743321 1111111111 1 10 00
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 002462 783 LLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816 (919)
Q Consensus 783 ~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~~L~ 816 (919)
.... +.++...-++.+|++||+..-....|.
T Consensus 482 vpp~---~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 482 VPPV---ARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred CChH---HHHHHHHHhcCCccccCCccHHHhHHH
Confidence 1111 234667789999999999876666554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.2e-12 Score=148.53 Aligned_cols=143 Identities=17% Similarity=0.145 Sum_probs=102.8
Q ss_pred CCCcccccccCCCCcEEEEEecCCccEEEEEecccccc-----------------------------------------H
Q 002462 535 DFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK-----------------------------------------T 573 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~-----------------------------------------~ 573 (919)
.|+ .+.||.|++|.||+|++.+|..||||+.+..-.. +
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 354 3689999999999999999999999998543100 0
Q ss_pred HHHHHHHHHHhhcC----CCCccceeeEEeecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHH-
Q 002462 574 EAYLLELDFFSKVS----HARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAE- 648 (919)
Q Consensus 574 ~~f~~Ei~~l~~l~----H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~- 648 (919)
-+|.+|++.+.+++ |.+-|.+-..+.+.....+|||||+++++|.+....... .. .+.+++..+++
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~------~~---~~~~ia~~~~~~ 268 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA------GL---DRKALAENLARS 268 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc------CC---CHHHHHHHHHHH
Confidence 13666777766663 333344333343334568999999999999987643211 12 24567777766
Q ss_pred HhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 649 GLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 649 gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
.+..+|.. +++|+|+||.||++++++.+++.|||.+...
T Consensus 269 ~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 269 FLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 46777864 8999999999999999999999999976543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.5e-14 Score=156.29 Aligned_cols=169 Identities=38% Similarity=0.550 Sum_probs=83.5
Q ss_pred EEecCCCCCCCCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCEEEccCC
Q 002462 121 SFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRN 200 (919)
Q Consensus 121 ~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L~Ls~N 200 (919)
..||+.|.+. .+|..+-. +-.|+.|.|..|.|. .+|..+++|..|++|||+.|+++ .+|..++.|+ |++|-+++|
T Consensus 79 ~aDlsrNR~~-elp~~~~~-f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNN 153 (722)
T KOG0532|consen 79 FADLSRNRFS-ELPEEACA-FVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNN 153 (722)
T ss_pred hhhccccccc-cCchHHHH-HHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecC
Confidence 3444555442 34444332 444555555555554 44555555555555555555554 4444444443 455555555
Q ss_pred cCCCCCCccccCCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcCCCCCCCCCch
Q 002462 201 SLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPS 280 (919)
Q Consensus 201 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 280 (919)
+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. .+|+++..| .|..||+|.|+++ .+|-
T Consensus 154 kl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv 228 (722)
T KOG0532|consen 154 KLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPV 228 (722)
T ss_pred ccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecch
Confidence 554 44555555555555555555554 44555555555555555555554 234444433 2455555555554 4455
Q ss_pred hhhccccCCEEEccCCcCC
Q 002462 281 ELRGLRSLQKFVIGNNFLS 299 (919)
Q Consensus 281 ~l~~l~~L~~L~ls~N~l~ 299 (919)
.|.+|+.|++|.|.+|.|.
T Consensus 229 ~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 229 DFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhhhhhhheeeeeccCCCC
Confidence 5555555555555555443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=9.7e-12 Score=129.87 Aligned_cols=202 Identities=15% Similarity=0.155 Sum_probs=136.0
Q ss_pred CCCcccccccCCCCcEEEEE-ecCCccEEEEEeccccccHHHHHHHHHHHhhcCC-CCccceeeEEeecCCcEEEEEEec
Q 002462 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSH-ARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H-~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
+|....+||+|+||..+.|+ +-++.+||||.-...+ ...+...|-+..+.+.+ +.|-.++.|--+ +-.-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-~APQLrdEYr~YKlL~g~~GIP~vYYFGqe-G~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-EAPQLRDEYRTYKLLGGTEGIPQVYYFGQE-GKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC-CcchHHHHHHHHHHHcCCCCCCceeeeccc-cchhhhhhhhh
Confidence 46677899999999999998 7789999999654332 22345567767766654 566555543222 33567999987
Q ss_pred CCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCC-----ceeeCCcchh
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF-----EVRLGSLSEV 687 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~-----~~kl~dfg~~ 687 (919)
+-||++...-.+ ..++..+.+.||+|+..-++|+|+. .+|.|||||.|.||..-+ .+.+.|||+|
T Consensus 107 -GPSLEDLFD~Cg------R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 107 -GPSLEDLFDLCG------RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred -CcCHHHHHHHhc------CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 568877663222 2377788999999999999999985 799999999999997543 4788999999
Q ss_pred hhcCCCCcceee-----eeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChh
Q 002462 688 CAQGGDAHQSRI-----TRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDA 748 (919)
Q Consensus 688 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~ 748 (919)
+.........++ ..+.++..|+.-.+.-+..-+..-|.=|+|=|.+-.+-|..||.+-...
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 864322111100 0011111121111111111233459999999999999999999876443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.6e-12 Score=135.39 Aligned_cols=205 Identities=22% Similarity=0.350 Sum_probs=126.1
Q ss_pred HHHhhcCCCCccceeeEEeecC----CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcC
Q 002462 581 DFFSKVSHARLVPLLGHCMERE----NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHE 656 (919)
Q Consensus 581 ~~l~~l~H~niV~l~g~c~~~~----~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~ 656 (919)
.-|-++-|-|||+++.|+.+.. ....++.|||..|+|..+|++-.... ..+....--+.+.||..||.|||+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~---~a~~~~~wkkw~tqIlsal~yLhs- 194 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ---KALFQKAWKKWCTQILSALSYLHS- 194 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh---hhhhHHHHHHHHHHHHhhhhhhhc-
Confidence 4455678999999999875432 24578999999999999997643221 123223334678999999999998
Q ss_pred CCCCeeeccCCCCceecCCCCceeeCCcchhh--hcCCCCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHH
Q 002462 657 CTLPFVHRDVQASSILLDDKFEVRLGSLSEVC--AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLE 734 (919)
Q Consensus 657 ~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlE 734 (919)
|.|+|+|+++...-|++..++-+|++.-.-.. ............+-.+.+++..+.+......+.++|||+||...+|
T Consensus 195 ~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 195 CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 89999999999999999999999987421000 0000000000011112333333333333345667899999999999
Q ss_pred HHcCCCC-CCCCChhHHHHHHHhhcccccccccccccccccCCCCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002462 735 LVTGKMG-ISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 735 llTGk~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~la~~C~~~~P~~RPsm~~V~~ 813 (919)
|..|..- ....+....++-+..+. -..-++ . -...+..|++.+|..||+|++.+.
T Consensus 275 mailEiq~tnseS~~~~ee~ia~~i-----------~~len~-------l------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVEVEENIANVI-----------IGLENG-------L------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHHheeccCCCcceeehhhhhhhhe-----------eeccCc-------c------ccCcCcccccCCCCCCcchhhhhc
Confidence 9887752 22222111111111100 000000 0 012456899999999999998865
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.8e-13 Score=146.88 Aligned_cols=124 Identities=19% Similarity=0.267 Sum_probs=97.5
Q ss_pred cEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCC
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS 683 (919)
Q Consensus 604 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~d 683 (919)
..++.|++|..++|.+||.+++.. ...+|..-++++.++|.|+.| .+.+|||+||.||....+...||+|
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~----e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG----EERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc----cccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhh
Confidence 468999999999999999755432 346788889999999999999 2689999999999999999999999
Q ss_pred cchhhhcCCCC----cceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHc
Q 002462 684 LSEVCAQGGDA----HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT 737 (919)
Q Consensus 684 fg~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllT 737 (919)
||+........ .....+...++..|+.++...+..|+.|+||||+|++|+|+++
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99876554333 1111233445555666665555678999999999999999987
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.30 E-value=7.3e-14 Score=154.63 Aligned_cols=176 Identities=37% Similarity=0.529 Sum_probs=124.6
Q ss_pred CCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEe
Q 002462 141 LPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLD 220 (919)
Q Consensus 141 L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 220 (919)
|..-...||+.|++. .+|..+..+..|+.|.|.+|.+. .+|..+++|..|.+|||+.|+++ .+|..+..|+ |+.|-
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 555566788888886 57777777777888888888776 67778888888888888888877 5677766665 77777
Q ss_pred ccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcCCCCCCCCCchhhhccccCCEEEccCCcCCC
Q 002462 221 ISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSG 300 (919)
Q Consensus 221 Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~ls~N~l~g 300 (919)
+++|+++ .+|..++.+..|..|+.+.|.+. .+|..++++.+|+.|.+..|++. .+|.++..| .|..||+++|+++
T Consensus 150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis- 224 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS- 224 (722)
T ss_pred EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-
Confidence 7777776 67777777777777777777775 56777777777777777777776 456666543 3666666666665
Q ss_pred CCCCcccCCCCCCCEEEccCCCCCCC
Q 002462 301 NLSVNLFPTVSQLQIIVLRQNGFTGP 326 (919)
Q Consensus 301 ~i~~~~~~~l~~L~~L~L~~N~l~~~ 326 (919)
.||.. |..++.|++|.|.+|.|...
T Consensus 225 ~iPv~-fr~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 225 YLPVD-FRKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred ecchh-hhhhhhheeeeeccCCCCCC
Confidence 45544 35566666666666666543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.24 E-value=9.7e-12 Score=142.63 Aligned_cols=199 Identities=36% Similarity=0.483 Sum_probs=129.4
Q ss_pred EEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCC-CCCEEEccCCcCCCCCCccccCCCCCCEEeccCC
Q 002462 146 ALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLS-VLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSN 224 (919)
Q Consensus 146 ~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 224 (919)
.|+++.|.+... +..+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 456666655322 223444566677777777766 4555555553 6777777777765 45556667777777777777
Q ss_pred cCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcCCCCCCCCCchhhhccccCCEEEccCCcCCCCCCC
Q 002462 225 YLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSV 304 (919)
Q Consensus 225 ~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~ls~N~l~g~i~~ 304 (919)
+++ .+|...+.+++|+.|++++|++. .+|..+..+..|++|.+++|.+. .++..+.++.++..+.+.+|++... .
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~--~ 248 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL--P 248 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec--c
Confidence 776 45555556677777777777775 45555555556777777777432 4555666777777777777766531 1
Q ss_pred cccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCCCCCcc
Q 002462 305 NLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNS 354 (919)
Q Consensus 305 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~ 354 (919)
.....+++|+.|++++|.++...+ +..+.+|+.|++++|.+...+|..
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred chhccccccceecccccccccccc--ccccCccCEEeccCccccccchhh
Confidence 234666778888888888876655 778888888888888888766643
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.3e-11 Score=148.64 Aligned_cols=113 Identities=38% Similarity=0.617 Sum_probs=105.1
Q ss_pred CCCEEEeeCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEcc
Q 002462 167 NLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVS 246 (919)
Q Consensus 167 ~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls 246 (919)
.++.|+|++|.++|.+|..++.|++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+++|.+|..+++|++|++|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccCCC-CCCCEEEcCCCCCCCCCc
Q 002462 247 NNSLASSIPAQLGDL-DSLVDLDLSMNSLSGSVP 279 (919)
Q Consensus 247 ~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~g~~p 279 (919)
+|+++|.+|..++.+ .++..+++.+|......|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999998864 577899999997654444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.23 E-value=8.9e-12 Score=142.93 Aligned_cols=180 Identities=36% Similarity=0.555 Sum_probs=84.4
Q ss_pred CCCCcEEEeecCCCCccCCcCCCCCC-CCCEEEeeCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEE
Q 002462 141 LPTLQALDLRSCSISGVIPFSLGNLT-NLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSL 219 (919)
Q Consensus 141 L~~L~~LdLs~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 219 (919)
++.++.|++.+|.++ .+|.....+. +|+.|++++|.+. .+|..+.++++|+.|++++|+++ .+|...+.+++|+.|
T Consensus 115 ~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L 191 (394)
T COG4886 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL 191 (394)
T ss_pred ccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhe
Confidence 344555555555554 2333344442 5555555555554 34444455555555555555554 333333344555555
Q ss_pred eccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcCCCCCCCCCchhhhccccCCEEEccCCcCC
Q 002462 220 DISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLS 299 (919)
Q Consensus 220 ~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~ls~N~l~ 299 (919)
++++|+++ .+|..+..+..|++|.+++|.+. .++..+.++.++..|.+.+|++.. ++..++.+.+|+.|++++|.++
T Consensus 192 ~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~ 268 (394)
T COG4886 192 DLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQIS 268 (394)
T ss_pred eccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccchhccccccceecccccccc
Confidence 55555554 34444334444555555555321 233344445555555555554432 2344444555555555555554
Q ss_pred CCCCCcccCCCCCCCEEEccCCCCCCCCcc
Q 002462 300 GNLSVNLFPTVSQLQIIVLRQNGFTGPPPD 329 (919)
Q Consensus 300 g~i~~~~~~~l~~L~~L~L~~N~l~~~~p~ 329 (919)
. ++. +..+.+|+.|++++|.++..+|.
T Consensus 269 ~-i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 269 S-ISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred c-ccc--ccccCccCEEeccCccccccchh
Confidence 2 222 34444555555555555544443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=9.2e-12 Score=147.38 Aligned_cols=172 Identities=20% Similarity=0.294 Sum_probs=116.7
Q ss_pred hCCCCcccccccCCCCcEEEEEecC-CccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 533 TGDFSDANLIKNGHSGDLFRGILEG-GIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l~~-g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
..+|+..++|-.|.||.||..+... .++.|. +++.+.. .+ +||..+-| ..+.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l----il-----------Rnilt~a~-------npfvv--- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL----IL-----------RNILTFAG-------NPFVV--- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccch----hh-----------hccccccC-------Cccee---
Confidence 4688899999999999999876432 345555 3322211 11 12222111 23333
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcC
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~ 691 (919)
||-...+..-+. .++ +.+.+++|||+- +|||||+||.|.|+..-+.+|+.|||+.+...
T Consensus 136 ---gDc~tllk~~g~-----lPv----------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP-----LPV----------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred ---chhhhhcccCCC-----Ccc----------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 444444422111 111 127789999984 99999999999999999999999999775432
Q ss_pred C-------------CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCCCCCChhHHH
Q 002462 692 G-------------DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVK 751 (919)
Q Consensus 692 ~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~~~~~~~~~~ 751 (919)
. .+++.....+.++|+|..++..-...|..++|.|++|+|+||.+-|+.||++..++++.
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf 267 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF 267 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH
Confidence 1 11222234467888888887766666778899999999999999999999999887653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=1e-10 Score=117.27 Aligned_cols=128 Identities=16% Similarity=0.086 Sum_probs=94.8
Q ss_pred cccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCChhh
Q 002462 540 NLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSS 619 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL~~ 619 (919)
+.|+.|.++.||+.... |..|++|...........+..|++++..+.+.++++-+-++.. ...++||||+++.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccc
Confidence 46889999999999876 6689999875443223457789999999987776654433322 24689999999988764
Q ss_pred hhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCC--CCCeeeccCCCCceecCCCCceeeCCcch
Q 002462 620 SLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHEC--TLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 620 ~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~--~~~ivHrDlK~~NILld~~~~~kl~dfg~ 686 (919)
.- . ..-.++.+++++|+.||... ...++|+|+||.||+++ +..+++.||+.
T Consensus 81 ~~------------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 81 ED------------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred cc------------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 30 0 01235678899999999853 23479999999999999 56789999974
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.6e-10 Score=134.57 Aligned_cols=143 Identities=16% Similarity=0.124 Sum_probs=94.3
Q ss_pred CCCCcccccccCCCCcEEEEEecC-CccEEEEEeccccc---------------------------c--------H----
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEG-GIPVVIKRIDLQSV---------------------------K--------T---- 573 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~-g~~vavK~l~~~~~---------------------------~--------~---- 573 (919)
.+|+. +-||+|++|.||+|++.+ |+.||||+++..-. + .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35766 789999999999999988 99999999864310 0 0
Q ss_pred --HHHHHHHHHHhhcC----CCCccceeeEEeecCCcEEEEEEecCCCChhhh--hhccCCCCCccCCCCHHHHHHHHHH
Q 002462 574 --EAYLLELDFFSKVS----HARLVPLLGHCMERENEKFLVYKYMPNGDLSSS--LYRKTNTEDDLQSLDWITRLKIAIG 645 (919)
Q Consensus 574 --~~f~~Ei~~l~~l~----H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL~~~--L~~~~~~~~~~~~l~w~~rl~Ia~~ 645 (919)
-+|.+|+..+.+++ |.+.|.+=..+.+-....+||||||+|+++.+. +...+ .+ +-+++..
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--------~d---~~~la~~ 267 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--------TD---MKLLAER 267 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--------CC---HHHHHHH
Confidence 13566776666663 444444333333333468899999999999874 22211 11 1223322
Q ss_pred HHHHhhhhhcCCCCCeeeccCCCCceecCCCC----ceeeCCcchhhhc
Q 002462 646 AAEGLSYLHHECTLPFVHRDVQASSILLDDKF----EVRLGSLSEVCAQ 690 (919)
Q Consensus 646 iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~----~~kl~dfg~~~~~ 690 (919)
.++. |++.-...+++|+|+||.||+++.++ .+++.|||.+...
T Consensus 268 ~v~~--~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 268 GVEV--FFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHH--HHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 2221 22221224899999999999999988 8999999976544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.8e-09 Score=113.09 Aligned_cols=140 Identities=19% Similarity=0.215 Sum_probs=107.4
Q ss_pred cccccCCCCcEEEEEecCCccEEEEEeccccc--cHHHHHHHHHHHhhcCCCC--ccceeeEEeecC--CcEEEEEEecC
Q 002462 540 NLIKNGHSGDLFRGILEGGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHAR--LVPLLGHCMERE--NEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~n--iV~l~g~c~~~~--~~~~lV~Ey~~ 613 (919)
..|+.|.++.||+....+|..++||....... ...++..|++++..+++.+ +.++++++.+.. +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999988778999998765433 2456889999999998644 566777654321 24689999999
Q ss_pred CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcC-------------------------------------
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHE------------------------------------- 656 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~------------------------------------- 656 (919)
++++.+.+.. ..++..++..++.+++++|++||+.
T Consensus 84 G~~l~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 84 GRVLRDRLLR--------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred CEecCCCCCC--------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 9988776531 1366777888899999999999852
Q ss_pred ----------------CCCCeeeccCCCCceecCC--CCceeeCCcchh
Q 002462 657 ----------------CTLPFVHRDVQASSILLDD--KFEVRLGSLSEV 687 (919)
Q Consensus 657 ----------------~~~~ivHrDlK~~NILld~--~~~~kl~dfg~~ 687 (919)
....++|+|+.+.||+++. +..+.|.||..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~ 204 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELA 204 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccc
Confidence 1246899999999999998 566788998643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.4e-10 Score=125.56 Aligned_cols=211 Identities=23% Similarity=0.232 Sum_probs=124.0
Q ss_pred cCCCCCCEEecCCCCCCCCCch-hhhhCCCCCcEEEeecCCCCccC--CcCCCCCCCCCEEEeeCCCCCCCCccc-ccCC
Q 002462 114 VNLTHLASFNASRFLLPGSIPD-WLGQQLPTLQALDLRSCSISGVI--PFSLGNLTNLTSLYLSDNGLTGTIPSS-LGQL 189 (919)
Q Consensus 114 ~~L~~L~~l~ls~n~l~g~ip~-~~~~~L~~L~~LdLs~N~l~g~~--p~~~~~l~~L~~L~Ls~N~l~g~~p~~-l~~L 189 (919)
.++.+|+...|.+.... -++. .....|++++.||||.|-|.... -.....|++|+.|+|+.|++.-..... -..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 46677776666544331 1111 22344777788888877766432 223456777778888887775322221 1245
Q ss_pred CCCCEEEccCCcCCCC-CCccccCCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCc--cccCCCCCCCE
Q 002462 190 SVLSVLDLSRNSLTGN-IPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIP--AQLGDLDSLVD 266 (919)
Q Consensus 190 ~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~ 266 (919)
++|+.|.|+.|.|+-. +-.....+++|+.|+|..|...+........+..|+.|+|++|++.. .+ ...+.++.|+.
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhh
Confidence 6777777777777632 11123456777778887775322222334446677778888777753 22 23566777777
Q ss_pred EEcCCCCCCCC-Cchh-----hhccccCCEEEccCCcCCCCCCCcccCCCCCCCEEEccCCCCCCC
Q 002462 267 LDLSMNSLSGS-VPSE-----LRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGP 326 (919)
Q Consensus 267 L~Ls~N~l~g~-~p~~-----l~~l~~L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L~~N~l~~~ 326 (919)
|+++.+.+... .|+. ...+++|++|+++.|++...-..+-...+.+|+.|.+..|.|+..
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 77777766532 2222 345677888888888875433333334556677777777777643
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.3e-10 Score=125.89 Aligned_cols=210 Identities=23% Similarity=0.197 Sum_probs=150.5
Q ss_pred CCCCCcEEEeecCCCCccCC-cCCCCCCCCCEEEeeCCCCCCCCc--ccccCCCCCCEEEccCCcCCCCCCccc-cCCCC
Q 002462 140 QLPTLQALDLRSCSISGVIP-FSLGNLTNLTSLYLSDNGLTGTIP--SSLGQLSVLSVLDLSRNSLTGNIPTSF-GLLKN 215 (919)
Q Consensus 140 ~L~~L~~LdLs~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~~p--~~l~~L~~L~~L~Ls~N~l~~~~p~~~-~~l~~ 215 (919)
++.+|+...|.++...-..- .-...|++++.|||+.|-|....| .-...|++|+.|+|+.|++.-...... ..+++
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 57889999999988752211 245679999999999998875433 335689999999999999974433322 35788
Q ss_pred CCEEeccCCcCCCC-CCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcCCCCCCCCC-chhhhccccCCEEEc
Q 002462 216 LSSLDISSNYLTGS-IPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSV-PSELRGLRSLQKFVI 293 (919)
Q Consensus 216 L~~L~Ls~N~l~g~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~-p~~l~~l~~L~~L~l 293 (919)
|+.|.|+.|.|+.. +-..+..+++|+.|+|..|...+........+..|++|||++|++-..- -...+.++.|..|++
T Consensus 199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnl 278 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNL 278 (505)
T ss_pred hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhc
Confidence 99999999998832 1122446789999999999644443344556788999999999986322 145678889999999
Q ss_pred cCCcCCCCC-CCc----ccCCCCCCCEEEccCCCCCCCC-ccccCCCCCCCEEEccCCCCCC
Q 002462 294 GNNFLSGNL-SVN----LFPTVSQLQIIVLRQNGFTGPP-PDVLWSMPQLRLLDISRNNFTG 349 (919)
Q Consensus 294 s~N~l~g~i-~~~----~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~g 349 (919)
+.+.+...- |+. .....++|+.|++..|++.... -..+..+++|+.|.+..|.|+-
T Consensus 279 s~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 279 SSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred cccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 998876321 111 1245678999999999995422 2335567788888888888874
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.3e-10 Score=116.71 Aligned_cols=137 Identities=25% Similarity=0.293 Sum_probs=91.2
Q ss_pred ccccCCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcCCCCCCCCCchhhhcccc
Q 002462 208 TSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRS 287 (919)
Q Consensus 208 ~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~ 287 (919)
..+.....|+.||||+|.++ .+..+..-+++++.|++|+|.+... ..+..|.+|+.||||+|.++ .+..+-.+|.+
T Consensus 278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGN 353 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGN 353 (490)
T ss_pred EecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcC
Confidence 34444556677777777666 4555555666777777777776532 23666677777777777765 34445556777
Q ss_pred CCEEEccCCcCCCCCCCcccCCCCCCCEEEccCCCCCCCC-ccccCCCCCCCEEEccCCCCCCCC
Q 002462 288 LQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPP-PDVLWSMPQLRLLDISRNNFTGPL 351 (919)
Q Consensus 288 L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~g~i 351 (919)
++.|.|+.|.+.. ++ -+..+-+|..||+++|++...- -..++++|.|++|.|.+|.+.+..
T Consensus 354 IKtL~La~N~iE~-LS--GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 354 IKTLKLAQNKIET-LS--GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred EeeeehhhhhHhh-hh--hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 7777777776642 11 1345667788888888876432 245889999999999999998643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.4e-10 Score=132.19 Aligned_cols=199 Identities=20% Similarity=0.224 Sum_probs=138.0
Q ss_pred ccccccCCCCcEEEEEecC--CccEEEEEeccccccH---HHHHHHHHHHhhcC-CCCccceeeEEeecCCcEEEEEEec
Q 002462 539 ANLIKNGHSGDLFRGILEG--GIPVVIKRIDLQSVKT---EAYLLELDFFSKVS-HARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~l~~--g~~vavK~l~~~~~~~---~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~~~~~lV~Ey~ 612 (919)
..-||+|.|+.|-.....+ ...+|+|.+....... +....|..+-.++. |+|++.+++...+ .+..+++.||.
T Consensus 25 ~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~-~~~~~~~~~~s 103 (601)
T KOG0590|consen 25 SRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS-PRSYLLSLSYS 103 (601)
T ss_pred cccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC-CcccccccCcc
Confidence 3458999999998776533 3556777765443222 23334777777777 9999999995544 56789999999
Q ss_pred CCCChhhhh-hccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCC-ceeeCCcchhhhc
Q 002462 613 PNGDLSSSL-YRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF-EVRLGSLSEVCAQ 690 (919)
Q Consensus 613 ~~GsL~~~L-~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~-~~kl~dfg~~~~~ 690 (919)
.+|++.+.+ +.... ..+-...-.+..+...|+.|+|.+ ..+.|||+||+|.+++..+ ..|++|||.+...
T Consensus 104 ~g~~~f~~i~~~~~~------~~~~~~~~~~~~ql~s~l~~~H~~--~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 104 DGGSLFSKISHPDST------GTSSSSASRYLPQLNSGLSYLHPE--NGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cccccccccccCCcc------CCCCcchhhhhhhhccCccccCcc--cccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999888 33210 011112234567889999999942 3799999999999999999 9999999988655
Q ss_pred CC-CCcceeeeeecc-CCCCccccCCCC-CCCCCCCcchhHHHHHHHHHcCCCCCCCCC
Q 002462 691 GG-DAHQSRITRLLR-LPQSSEQGSSGS-LTATCPYDVYCFGKVLLELVTGKMGISASS 746 (919)
Q Consensus 691 ~~-~~~~~~~~~~~~-~~~~~~~~~~~~-~~~t~~~DVySfGvvLlEllTGk~p~~~~~ 746 (919)
.. ...........+ .+.+..++..-. .......||||.|+++.-+++|..|++...
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 44 222222233334 445554443322 123345699999999999999999987654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.1e-10 Score=116.89 Aligned_cols=137 Identities=22% Similarity=0.197 Sum_probs=92.9
Q ss_pred cccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcCCCCCCCCCchhhhccccCCEEEccCCcCCCCCCCcccCCCC
Q 002462 232 PGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVS 311 (919)
Q Consensus 232 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~ls~N~l~g~i~~~~~~~l~ 311 (919)
..+.....|+.||||+|.|+ .+.++..-++.++.|++|+|.+.. + ..+..|.+|+.||||+|.++.. . .+-..+-
T Consensus 278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls~~-~-Gwh~KLG 352 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLAEC-V-GWHLKLG 352 (490)
T ss_pred EecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhHhh-h-hhHhhhc
Confidence 33444567888888888886 466667777888888888888863 2 3377788888888888887632 1 1224567
Q ss_pred CCCEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCCCCCcccccCCCCCcEEEccCCcCccC
Q 002462 312 QLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGG 375 (919)
Q Consensus 312 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~l~~L~ls~N~~~g~ 375 (919)
+++.|.|++|.+... ..++.+-+|..||+++|++...---...+.++-|..+.|.+|.+.+.
T Consensus 353 NIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 353 NIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred CEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 788888888877432 23556777888888888886322222334555677777888877653
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.2e-09 Score=108.78 Aligned_cols=84 Identities=37% Similarity=0.526 Sum_probs=16.6
Q ss_pred cCCCCCCEEEccCCcCCCCCCcccc-CCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCcccc-CCCCCC
Q 002462 187 GQLSVLSVLDLSRNSLTGNIPTSFG-LLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQL-GDLDSL 264 (919)
Q Consensus 187 ~~L~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L 264 (919)
.+..++++|+|.+|.|+. + +.++ .+.+|+.|+|++|.++. ++ .+..+++|+.|++++|+|+. +...+ ..+++|
T Consensus 16 ~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L 90 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNL 90 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT-
T ss_pred cccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCcC
Confidence 344456666666666653 2 2333 35556666666666552 22 34455555555555555543 22222 234455
Q ss_pred CEEEcCCCCCC
Q 002462 265 VDLDLSMNSLS 275 (919)
Q Consensus 265 ~~L~Ls~N~l~ 275 (919)
++|+|++|++.
T Consensus 91 ~~L~L~~N~I~ 101 (175)
T PF14580_consen 91 QELYLSNNKIS 101 (175)
T ss_dssp -EEE-TTS---
T ss_pred CEEECcCCcCC
Confidence 55555555543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.4e-10 Score=130.42 Aligned_cols=241 Identities=28% Similarity=0.294 Sum_probs=147.2
Q ss_pred CCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEe
Q 002462 141 LPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLD 220 (919)
Q Consensus 141 L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 220 (919)
+..++.+++..|.|.. +-..+..+++|+.|+|.+|+|.. +...+..+.+|++|+|++|.|+... .+..++.|+.|+
T Consensus 71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~ 146 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELN 146 (414)
T ss_pred hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhhhe
Confidence 6667777777777763 33346777888888888888874 3333667778888888888887543 355666788888
Q ss_pred ccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCc-cccCCCCCCCEEEcCCCCCCCCCchhhhccccCCEEEccCCcCC
Q 002462 221 ISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIP-AQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLS 299 (919)
Q Consensus 221 Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~ls~N~l~ 299 (919)
+++|.++.. ..+..+.+|+.+++++|.+...-+ . +..+.+|+.+++..|.+.. ...+..+..+..+++..|.++
T Consensus 147 l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 147 LSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred eccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccce
Confidence 888887632 345567788888888888765433 2 4667778888888887753 223344445555577777765
Q ss_pred CCCCCcccCCCC--CCCEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCCCCCcccccCCCCCcEEEccCCcCccCC-
Q 002462 300 GNLSVNLFPTVS--QLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGL- 376 (919)
Q Consensus 300 g~i~~~~~~~l~--~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~l~~L~ls~N~~~g~~- 376 (919)
-.-+. ..+. .|+.+++++|.+.... ..+..+..+..|++.+|++...-. ......+..+.++.|.+....
T Consensus 222 ~~~~l---~~~~~~~L~~l~l~~n~i~~~~-~~~~~~~~l~~l~~~~n~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 294 (414)
T KOG0531|consen 222 KLEGL---NELVMLHLRELYLSGNRISRSP-EGLENLKNLPVLDLSSNRISNLEG---LERLPKLSELWLNDNKLALSEA 294 (414)
T ss_pred eccCc---ccchhHHHHHHhcccCcccccc-ccccccccccccchhhcccccccc---ccccchHHHhccCcchhcchhh
Confidence 22111 1122 2777888888776432 445567778888888887763221 122334445555555543210
Q ss_pred ------CCCCCCCcEEEccCCcCCCcC
Q 002462 377 ------TPVLGRFRLVDLSGNYFEGRV 397 (919)
Q Consensus 377 ------~~~l~~L~~ldLs~N~l~g~i 397 (919)
-.....++.+.+..|+.....
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
T KOG0531|consen 295 ISQEYITSAAPTLVTLTLELNPIRKIS 321 (414)
T ss_pred hhccccccccccccccccccCcccccc
Confidence 112344555666666555433
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.7e-09 Score=107.76 Aligned_cols=124 Identities=32% Similarity=0.359 Sum_probs=31.7
Q ss_pred CCCcEEEeecCCCCccCCcCCC-CCCCCCEEEeeCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEe
Q 002462 142 PTLQALDLRSCSISGVIPFSLG-NLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLD 220 (919)
Q Consensus 142 ~~L~~LdLs~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 220 (919)
..+++|+|++|.|+.+ ..++ .+.+|+.|+|++|.|+. ++ .+..++.|++|+|++|+|+. ++..+.
T Consensus 19 ~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~--------- 84 (175)
T PF14580_consen 19 VKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLD--------- 84 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHH---------
T ss_pred cccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchH---------
Confidence 3455555555555432 1233 34555555555555542 21 24444555555555555542 222221
Q ss_pred ccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCC-ccccCCCCCCCEEEcCCCCCCCCCc---hhhhccccCCEEEc
Q 002462 221 ISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSI-PAQLGDLDSLVDLDLSMNSLSGSVP---SELRGLRSLQKFVI 293 (919)
Q Consensus 221 Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~g~~p---~~l~~l~~L~~L~l 293 (919)
..+++|+.|+|++|+|...- -..+..+++|+.|+|.+|.++..-- ..+..+++|+.||-
T Consensus 85 --------------~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 85 --------------KNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp --------------HH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred --------------HhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 13444444444444443211 1234455666666666666653211 23455666666654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=3.8e-08 Score=112.97 Aligned_cols=165 Identities=20% Similarity=0.275 Sum_probs=111.0
Q ss_pred ecCCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEecCCCChhhhhhccCCCCCccCC
Q 002462 555 LEGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQS 633 (919)
Q Consensus 555 l~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~ 633 (919)
..++.+|.|...+..... .+...+-++.|+.+|||||++++. |++.++..|||+|-+. -|..+|..... ..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~-t~e~~~~~ylvTErV~--Pl~~~lk~l~~-----~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLD-TTEEEGTLYLVTERVR--PLETVLKELGK-----EE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhh-hhcccCceEEEeeccc--cHHHHHHHhHH-----HH
Confidence 567889999888655442 234556789999999999999998 6666678899999875 35555543221 01
Q ss_pred CCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCCCCcceeeeeeccCCCCccccC
Q 002462 634 LDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGS 713 (919)
Q Consensus 634 l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (919)
+. -.+.+|+.||.|||++| .++|++|.-..|++++.++.||++|-.++...+............. +..+..
T Consensus 106 v~-----~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s--~~~P~~ 176 (690)
T KOG1243|consen 106 VC-----LGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIES--FDDPEE 176 (690)
T ss_pred HH-----HHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhc--ccChhh
Confidence 22 24678999999999887 6999999999999999999999998766544332210000000000 000110
Q ss_pred CCCCCCCCCCcchhHHHHHHHHHcC
Q 002462 714 SGSLTATCPYDVYCFGKVLLELVTG 738 (919)
Q Consensus 714 ~~~~~~t~~~DVySfGvvLlEllTG 738 (919)
.+. -+...|.|-||++++|++.|
T Consensus 177 ~~~--s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDP--SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCc--cccchhhhhHHHHHHHHhCc
Confidence 000 01224999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.71 E-value=6.9e-08 Score=98.20 Aligned_cols=133 Identities=14% Similarity=0.128 Sum_probs=90.1
Q ss_pred cccccCCCCcEEEEEecC-------CccEEEEEeccccc----------------------c-HHHHH----HHHHHHhh
Q 002462 540 NLIKNGHSGDLFRGILEG-------GIPVVIKRIDLQSV----------------------K-TEAYL----LELDFFSK 585 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~-------g~~vavK~l~~~~~----------------------~-~~~f~----~Ei~~l~~ 585 (919)
..||.|.-+.||.|.-.+ +..+|||..+.... . .+.+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 368999999999998553 47899997542110 0 12233 79999999
Q ss_pred cCCC--CccceeeEEeecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeee
Q 002462 586 VSHA--RLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVH 663 (919)
Q Consensus 586 l~H~--niV~l~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivH 663 (919)
++-. ++=++++ + ...+|||||+.++.+....-+. ..++..+..++..+++++|.++||. .+|||
T Consensus 83 l~~~Gv~vP~pi~-~----~~~~lvME~Ig~~~~~~~~Lkd-------~~~~~~~~~~i~~~i~~~l~~l~H~--~glVH 148 (197)
T cd05146 83 MQKAGIPCPEVVV-L----KKHVLVMSFIGDDQVPAPKLKD-------AKLNDEEMKNAYYQVLSMMKQLYKE--CNLVH 148 (197)
T ss_pred HHHcCCCCCeEEE-e----cCCEEEEEEcCCCCccchhhhc-------cccCHHHHHHHHHHHHHHHHHHHHh--CCeec
Confidence 8643 4444444 2 2468999999876543221111 0133334456778999999999433 28999
Q ss_pred ccCCCCceecCCCCceeeCCcchh
Q 002462 664 RDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 664 rDlK~~NILld~~~~~kl~dfg~~ 687 (919)
+|+++.|||+++ +.+.+.|||-+
T Consensus 149 GDLs~~NIL~~~-~~v~iIDF~qa 171 (197)
T cd05146 149 ADLSEYNMLWHD-GKVWFIDVSQS 171 (197)
T ss_pred CCCCHHHEEEEC-CcEEEEECCCc
Confidence 999999999974 67999999843
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.4e-08 Score=125.14 Aligned_cols=180 Identities=27% Similarity=0.302 Sum_probs=108.2
Q ss_pred CCCCCEEecCCCCC-CCCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCE
Q 002462 116 LTHLASFNASRFLL-PGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSV 194 (919)
Q Consensus 116 L~~L~~l~ls~n~l-~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~ 194 (919)
.+.|++|-+..|.. ...++..++..++.|++|||++|.=-+.+|..+++|-+|++|+|++..++ .+|..+.+|..|.+
T Consensus 544 ~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~ 622 (889)
T KOG4658|consen 544 NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIY 622 (889)
T ss_pred CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhe
Confidence 33566776666652 45666666666888888888877766778888888888888888888877 67888888888888
Q ss_pred EEccCCcCCCCCCccccCCCCCCEEeccCCcC--CCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCC----EEE
Q 002462 195 LDLSRNSLTGNIPTSFGLLKNLSSLDISSNYL--TGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLV----DLD 268 (919)
Q Consensus 195 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l--~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~----~L~ 268 (919)
||+..+.-...+|..+..|.+|++|.+..-.. +...-..+.+|.+|+.|....... .+-..+..++.|. .+.
T Consensus 623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~ 700 (889)
T KOG4658|consen 623 LNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLS 700 (889)
T ss_pred eccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhh
Confidence 88887776656666666678888877765431 111222233444444444432222 0111122222222 222
Q ss_pred cCCCCCCCCCchhhhccccCCEEEccCCcCC
Q 002462 269 LSMNSLSGSVPSELRGLRSLQKFVIGNNFLS 299 (919)
Q Consensus 269 Ls~N~l~g~~p~~l~~l~~L~~L~ls~N~l~ 299 (919)
+..+.. ...+..+..+.+|+.|.+.+..+.
T Consensus 701 ~~~~~~-~~~~~~~~~l~~L~~L~i~~~~~~ 730 (889)
T KOG4658|consen 701 IEGCSK-RTLISSLGSLGNLEELSILDCGIS 730 (889)
T ss_pred hccccc-ceeecccccccCcceEEEEcCCCc
Confidence 222222 234455667778888888777664
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.4e-09 Score=115.22 Aligned_cols=239 Identities=23% Similarity=0.321 Sum_probs=129.0
Q ss_pred CCEEEEEcCCCcccCCCCCCCccChhhhcCCCCCCEEecCCCCCCCC----Cchhhh------hCCCCCcEEEeecCCCC
Q 002462 86 GSVVGINISGFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGS----IPDWLG------QQLPTLQALDLRSCSIS 155 (919)
Q Consensus 86 ~~v~~l~l~~~~~~~~g~~~~~~~~~~l~~L~~L~~l~ls~n~l~g~----ip~~~~------~~L~~L~~LdLs~N~l~ 155 (919)
..++.|+|+|.. .|..........|.+.+.|+.-++|.. ++|. ||+.+- ...+.|++||||.|.|.
T Consensus 30 ~s~~~l~lsgnt---~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G 105 (382)
T KOG1909|consen 30 DSLTKLDLSGNT---FGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG 105 (382)
T ss_pred CceEEEeccCCc---hhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence 357888888853 232222222345777888888888764 4454 444321 13568888888888876
Q ss_pred ccCCcC----CCCCCCCCEEEeeCCCCCCC----C---------cccccCCCCCCEEEccCCcCCCC----CCccccCCC
Q 002462 156 GVIPFS----LGNLTNLTSLYLSDNGLTGT----I---------PSSLGQLSVLSVLDLSRNSLTGN----IPTSFGLLK 214 (919)
Q Consensus 156 g~~p~~----~~~l~~L~~L~Ls~N~l~g~----~---------p~~l~~L~~L~~L~Ls~N~l~~~----~p~~~~~l~ 214 (919)
-.-+.. +..++.|++|+|.+|.+... + ....+.-+.|+++..++|++... +...|...+
T Consensus 106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~ 185 (382)
T KOG1909|consen 106 PKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHP 185 (382)
T ss_pred ccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhcc
Confidence 433333 35677888888888877511 1 11123344566666666665421 112334445
Q ss_pred CCCEEeccCCcCCCC----CCcccCCCCCCCEEEccCCCCCCC----CccccCCCCCCCEEEcCCCCCCCCCchhhhccc
Q 002462 215 NLSSLDISSNYLTGS----IPPGLGTLSKLQYLNVSNNSLASS----IPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLR 286 (919)
Q Consensus 215 ~L~~L~Ls~N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~g~~p~~l~~l~ 286 (919)
.|+.+.++.|.+... +-..|..++.|+.|||.+|.|+.. +-..+..++.|+.|++++|.+...-...|..
T Consensus 186 ~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~-- 263 (382)
T KOG1909|consen 186 TLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVD-- 263 (382)
T ss_pred ccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHH--
Confidence 566666666554310 112234555555555555555421 1223344445555555555544322211110
Q ss_pred cCCEEEccCCcCCCCCCCcccCCCCCCCEEEccCCCCCCC----CccccCCCCCCCEEEccCCCCC
Q 002462 287 SLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGP----PPDVLWSMPQLRLLDISRNNFT 348 (919)
Q Consensus 287 ~L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 348 (919)
.+-...+.|++|.|.+|.++.. +...+...+.|..|+|++|.+.
T Consensus 264 ------------------al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 264 ------------------ALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ------------------HHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 0112345677777777776532 2333456788889999999883
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.3e-09 Score=121.33 Aligned_cols=247 Identities=27% Similarity=0.291 Sum_probs=155.4
Q ss_pred CCCCCCEEecCCCCCCCCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCE
Q 002462 115 NLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSV 194 (919)
Q Consensus 115 ~L~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~ 194 (919)
.++.+..+++..|.+.- +-..+. .+.+|+.|+|..|.|..+.. .+..+++|++|+|++|.|+... .+..++.|+.
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~-~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~ 144 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLS-KLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKE 144 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccc-cccceeeeeccccchhhccc-chhhhhcchheecccccccccc--chhhccchhh
Confidence 34555566666665532 212222 37888888888888875432 2677888888888888887543 3566777888
Q ss_pred EEccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCC-cccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcCCCC
Q 002462 195 LDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIP-PGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNS 273 (919)
Q Consensus 195 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 273 (919)
|++++|.|+.. ..+..+++|+.+++++|.+...-+ . ...+.+|+.+++.+|.+.. ...+..+..+..+++..|.
T Consensus 145 L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhccccc
Confidence 88888888742 345568888888888888874433 1 4677888888888888853 2334444555556777777
Q ss_pred CCCCCchhhhccc--cCCEEEccCCcCCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCCCC
Q 002462 274 LSGSVPSELRGLR--SLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPL 351 (919)
Q Consensus 274 l~g~~p~~l~~l~--~L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~i 351 (919)
++-.-+ +..+. .|+.+++++|.+.-. + ..+..+..+..|++.+|++...-. +...+.+..+.+..|.+....
T Consensus 220 i~~~~~--l~~~~~~~L~~l~l~~n~i~~~-~-~~~~~~~~l~~l~~~~n~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 293 (414)
T KOG0531|consen 220 ISKLEG--LNELVMLHLRELYLSGNRISRS-P-EGLENLKNLPVLDLSSNRISNLEG--LERLPKLSELWLNDNKLALSE 293 (414)
T ss_pred ceeccC--cccchhHHHHHHhcccCccccc-c-ccccccccccccchhhcccccccc--ccccchHHHhccCcchhcchh
Confidence 763322 11222 377788888877621 1 223566778888888888765432 345566777777777766321
Q ss_pred ---CcccccCCCCCcEEEccCCcCccCCC
Q 002462 352 ---PNSRSNVNTSTVELNISQNMFYGGLT 377 (919)
Q Consensus 352 ---p~~~~~~~~~l~~L~ls~N~~~g~~~ 377 (919)
..........+..+.+..|......+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 294 AISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred hhhccccccccccccccccccCccccccc
Confidence 11112233455566666666555443
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.1e-08 Score=82.17 Aligned_cols=61 Identities=43% Similarity=0.623 Sum_probs=37.1
Q ss_pred CCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCEEEccCCcC
Q 002462 142 PTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSL 202 (919)
Q Consensus 142 ~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L~Ls~N~l 202 (919)
|+|++|+|++|+|+...+..|.++++|++|+|++|+++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566666666666655555666666666666666666655555566666666666666553
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.4e-08 Score=80.88 Aligned_cols=58 Identities=48% Similarity=0.671 Sum_probs=25.7
Q ss_pred CCEEEccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCC
Q 002462 192 LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNS 249 (919)
Q Consensus 192 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~ 249 (919)
|++|+|++|+|+...+..|.++++|++|++++|.++...|..|.++++|++|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 4444444444443333344444444444444444443333344444444444444443
|
... |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.54 E-value=8.6e-08 Score=109.27 Aligned_cols=197 Identities=21% Similarity=0.228 Sum_probs=133.8
Q ss_pred HHHHhCCCCcccccccCCCCcEEEEEe--cCCccEEEEEecccccc--HHHH-HHHHHHHhhc-CCCCccceeeEEeecC
Q 002462 529 LLAATGDFSDANLIKNGHSGDLFRGIL--EGGIPVVIKRIDLQSVK--TEAY-LLELDFFSKV-SHARLVPLLGHCMERE 602 (919)
Q Consensus 529 l~~at~~f~~~~~ig~G~~G~Vy~g~l--~~g~~vavK~l~~~~~~--~~~f-~~Ei~~l~~l-~H~niV~l~g~c~~~~ 602 (919)
...-+.+|.....||.|.|+.||+... .++..+++|.+...... .+.| +.|+-+...+ .|.++|...-.+.+ .
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-L 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-c
Confidence 445677899999999999999999874 46788999987443322 2222 3465555555 47777776554444 3
Q ss_pred CcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC-Cceee
Q 002462 603 NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK-FEVRL 681 (919)
Q Consensus 603 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~-~~~kl 681 (919)
...|+=-||+.++++...+.- .+.++...++++..+++.++.|+|+ +.++|+|+||+||++..+ +.-++
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~-------~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~ 408 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVT-------SQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKL 408 (524)
T ss_pred ccccCchhhhcCcchhhhhHH-------HHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhc
Confidence 457788999999998766521 1335666788899999999999996 589999999999999886 88889
Q ss_pred CCcchhhhcCCCCc-ceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCC
Q 002462 682 GSLSEVCAQGGDAH-QSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKM 740 (919)
Q Consensus 682 ~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~ 740 (919)
+||+......-... ...+.+.+.. .........+-.+.|+||||.-..|.+||..
T Consensus 409 ~~~~~~t~~~~~~~~~~~~~r~~p~----~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 409 GDFGCWTRLAFSSGVFHHIDRLYPI----AEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred cccccccccceeccccccccccccc----chhhccccccccccccccccccccccccCcc
Confidence 99986642111100 0111222210 1111111234457899999999999999875
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.7e-08 Score=121.41 Aligned_cols=149 Identities=34% Similarity=0.424 Sum_probs=76.8
Q ss_pred CCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCC--CCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEE
Q 002462 142 PTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNG--LTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSL 219 (919)
Q Consensus 142 ~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~--l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 219 (919)
...+...+-+|.+. .++.... .++|++|-+..|. +.-..+..|..++.|++|||++|.--+.+|..++.|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 34455555555543 1222221 2256666666654 322222234556666666666655555566666666666666
Q ss_pred eccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCccccCCCCCCCEEEcCCCC--CCCCCchhhhccccCCEEEc
Q 002462 220 DISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNS--LSGSVPSELRGLRSLQKFVI 293 (919)
Q Consensus 220 ~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~--l~g~~p~~l~~l~~L~~L~l 293 (919)
+|++..+. .+|.++++|.+|.+|++..+.....+|..+..|.+|++|.+..-. .....-..+.+|.+|+.|..
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~ 675 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI 675 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence 66666665 556666666666666666555444445555556666666654432 22222233344444444444
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.53 E-value=9.4e-08 Score=108.97 Aligned_cols=199 Identities=19% Similarity=0.185 Sum_probs=129.5
Q ss_pred CCccccccc--CCCCcEEEEEe---cCCccEEEEEec--ccc-ccHHHHHHHHHHHhhcC-CCCccceeeEEeecCCcEE
Q 002462 536 FSDANLIKN--GHSGDLFRGIL---EGGIPVVIKRID--LQS-VKTEAYLLELDFFSKVS-HARLVPLLGHCMERENEKF 606 (919)
Q Consensus 536 f~~~~~ig~--G~~G~Vy~g~l---~~g~~vavK~l~--~~~-~~~~~f~~Ei~~l~~l~-H~niV~l~g~c~~~~~~~~ 606 (919)
|....-+|+ |.+|.||++.. .++..+|+|+-+ ... .....=.+|+....+++ |+|.|+..-.. +..+..+
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-e~~~~lf 194 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-EGSGILF 194 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-ccCCcce
Confidence 444567899 99999999987 567889999743 221 11223356777777775 99999977644 4456788
Q ss_pred EEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCC-CceeeCCcc
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK-FEVRLGSLS 685 (919)
Q Consensus 607 lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~-~~~kl~dfg 685 (919)
+=.|++. .+|..+-+......+. .+-|..-.....--+.||+.+|.. .|+|-|+||.||++..+ ...+++||+
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~~p~--~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNFLPD--NLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhcccccCCc--hhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 8888876 6888877654331111 133322222222223399999985 89999999999999999 889999999
Q ss_pred hhhhcCCCCcceeeeee---ccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCCC
Q 002462 686 EVCAQGGDAHQSRITRL---LRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGI 742 (919)
Q Consensus 686 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p~ 742 (919)
+................ .+-..|..++.. ...++...|+||+|.|.+|.++|-...
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccc
Confidence 88766543322211111 111112222221 124667789999999999999987643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=5.1e-07 Score=88.85 Aligned_cols=128 Identities=20% Similarity=0.228 Sum_probs=93.1
Q ss_pred ccccCCCCcEEEEEecCCccEEEEE-eccccc--------cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEEEe
Q 002462 541 LIKNGHSGDLFRGILEGGIPVVIKR-IDLQSV--------KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 541 ~ig~G~~G~Vy~g~l~~g~~vavK~-l~~~~~--------~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~Ey 611 (919)
+|++|.-..+|.+.+.+. ++++|. +...-. ..+.-.+|+.++.+++--.|-...=|.++. +...|+|||
T Consensus 3 ~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~-~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP-DNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC-CCCEEEEEE
Confidence 688999999999987544 466663 322111 124567899999998754443322234454 467899999
Q ss_pred cCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
+++-.|.+.|... +..++..|-+-+.-||.. +|||+|+.++||++..+. +.+.|||++.
T Consensus 81 I~G~~lkd~l~~~--------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 81 IEGELLKDALEEA--------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred eCChhHHHHHHhc--------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccc
Confidence 9998888887432 345667777778889986 899999999999998765 8899999765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=2e-06 Score=92.47 Aligned_cols=139 Identities=12% Similarity=0.048 Sum_probs=96.5
Q ss_pred cccccCCCCcEEEEEecCCccEEEEEecccccc------------HHHHHHHHHHHhhcCCCC--ccceeeEEeec----
Q 002462 540 NLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK------------TEAYLLELDFFSKVSHAR--LVPLLGHCMER---- 601 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~------------~~~f~~Ei~~l~~l~H~n--iV~l~g~c~~~---- 601 (919)
+++-+-....|++..+ +|..+.||+....... ...+.+|...+.+++..+ ..++++|....
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4555555566888777 4678999977432211 124788999998885433 44455554322
Q ss_pred CCcEEEEEEecCCC-ChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCC-----
Q 002462 602 ENEKFLVYKYMPNG-DLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD----- 675 (919)
Q Consensus 602 ~~~~~lV~Ey~~~G-sL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~----- 675 (919)
....+||+||+++- +|.+++..... ...+-..+.+|+.++|+.++-||.. +|+|+|++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~-----~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT-----NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCC
Confidence 12478999999986 78888742111 1123345668899999999999986 8999999999999985
Q ss_pred --CCceeeCCcchh
Q 002462 676 --KFEVRLGSLSEV 687 (919)
Q Consensus 676 --~~~~kl~dfg~~ 687 (919)
++.+.+.||+.+
T Consensus 179 ~~~~~~~LIDl~r~ 192 (268)
T PRK15123 179 EEDLKLSVIDLHRA 192 (268)
T ss_pred CCCceEEEEECCcc
Confidence 467888899754
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.1e-08 Score=104.21 Aligned_cols=188 Identities=19% Similarity=0.222 Sum_probs=133.2
Q ss_pred hhhcCCCCCCEEecCCCCCCCCCchhh---hhCCCCCcEEEeecCCCCcc-------------CCcCCCCCCCCCEEEee
Q 002462 111 DALVNLTHLASFNASRFLLPGSIPDWL---GQQLPTLQALDLRSCSISGV-------------IPFSLGNLTNLTSLYLS 174 (919)
Q Consensus 111 ~~l~~L~~L~~l~ls~n~l~g~ip~~~---~~~L~~L~~LdLs~N~l~g~-------------~p~~~~~l~~L~~L~Ls 174 (919)
.+|....+|+++|||.|.|.-.-+..+ .+++..|++|.|.||.+.-. .-.-.++-+.|+++...
T Consensus 86 ~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~ 165 (382)
T KOG1909|consen 86 KALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICG 165 (382)
T ss_pred HHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEee
Confidence 466777899999999999865554433 24588999999999988521 12234567889999999
Q ss_pred CCCCCCC----CcccccCCCCCCEEEccCCcCCCC----CCccccCCCCCCEEeccCCcCCCC----CCcccCCCCCCCE
Q 002462 175 DNGLTGT----IPSSLGQLSVLSVLDLSRNSLTGN----IPTSFGLLKNLSSLDISSNYLTGS----IPPGLGTLSKLQY 242 (919)
Q Consensus 175 ~N~l~g~----~p~~l~~L~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~l~~l~~L~~ 242 (919)
.|++... +-..|...+.|+.+.+..|.|.-. +-..|..+++|+.|||.+|-|+-. +...+..++.|+.
T Consensus 166 rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~E 245 (382)
T KOG1909|consen 166 RNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRE 245 (382)
T ss_pred ccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchhee
Confidence 9998632 234567778999999999988521 223567899999999999998732 3345677889999
Q ss_pred EEccCCCCCCCCcccc-----CCCCCCCEEEcCCCCCCCC----CchhhhccccCCEEEccCCcC
Q 002462 243 LNVSNNSLASSIPAQL-----GDLDSLVDLDLSMNSLSGS----VPSELRGLRSLQKFVIGNNFL 298 (919)
Q Consensus 243 L~Ls~N~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~g~----~p~~l~~l~~L~~L~ls~N~l 298 (919)
|++++|.+...--..| ...++|+.|.|.+|.++.. +-..+...+.|..|+|+.|.+
T Consensus 246 l~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 246 LNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred ecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 9999999975322222 2367888899988888632 222233445555555555555
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=7.4e-09 Score=118.13 Aligned_cols=196 Identities=27% Similarity=0.325 Sum_probs=91.6
Q ss_pred CCCCCEEecCCCCCCCCC-chhhhhCCCCCcEEEeecCCCCccCCcCCCC-CCCCCEEEeeCCCCC----------CCCc
Q 002462 116 LTHLASFNASRFLLPGSI-PDWLGQQLPTLQALDLRSCSISGVIPFSLGN-LTNLTSLYLSDNGLT----------GTIP 183 (919)
Q Consensus 116 L~~L~~l~ls~n~l~g~i-p~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~-l~~L~~L~Ls~N~l~----------g~~p 183 (919)
|+++..|.+-...-.+.. |-.++. +.+|++|.|.++.|... ..+.. -.+|+.|.-. |.+. |.+-
T Consensus 83 lqkt~~lkl~~~pa~~pt~pi~ifp-F~sLr~LElrg~~L~~~--~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ 158 (1096)
T KOG1859|consen 83 LQKTKVLKLLPSPARDPTEPISIFP-FRSLRVLELRGCDLSTA--KGLQELRHQLEKLICH-NSLDALRHVFASCGGDIS 158 (1096)
T ss_pred HhhheeeeecccCCCCCCCCceecc-ccceeeEEecCcchhhh--hhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccc
Confidence 344444444333323333 445554 88999999999887531 00100 0122222211 1111 1111
Q ss_pred ccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCcc-ccCCCC
Q 002462 184 SSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPA-QLGDLD 262 (919)
Q Consensus 184 ~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~ 262 (919)
.++ ....|.+.+.++|.+. .+..++.-++.|+.|||++|+++.. +.+..|++|++|||++|.+.. +|. ....+.
T Consensus 159 ns~-~Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc~ 233 (1096)
T KOG1859|consen 159 NSP-VWNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRH-VPQLSMVGCK 233 (1096)
T ss_pred cch-hhhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhcc-ccccchhhhh
Confidence 111 1123555555666654 3445555556666666666666532 245556666666666666642 221 111222
Q ss_pred CCCEEEcCCCCCCCCCchhhhccccCCEEEccCCcCCCCCCCcccCCCCCCCEEEccCCCC
Q 002462 263 SLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGF 323 (919)
Q Consensus 263 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L~~N~l 323 (919)
|+.|.|++|.++.. ..+.+|++|+.||+++|-|.+.-....+..+..|+.|.|.+|.+
T Consensus 234 -L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 234 -LQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL 291 (1096)
T ss_pred -heeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence 56666666655421 23445555666666666555432222223344445555555544
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.1e-08 Score=116.88 Aligned_cols=175 Identities=31% Similarity=0.303 Sum_probs=107.1
Q ss_pred hhhcCCCCCCEEecCCCCCCC---CCchhhhhCCCCCcEEEeecCCCC----------ccCCcCCCCCCCCCEEEeeCCC
Q 002462 111 DALVNLTHLASFNASRFLLPG---SIPDWLGQQLPTLQALDLRSCSIS----------GVIPFSLGNLTNLTSLYLSDNG 177 (919)
Q Consensus 111 ~~l~~L~~L~~l~ls~n~l~g---~ip~~~~~~L~~L~~LdLs~N~l~----------g~~p~~~~~l~~L~~L~Ls~N~ 177 (919)
-.+.-+..|+.|.+.+..+.. -++ + -..|++|.- .|.+. |.+-.++. -..|.+.+.++|.
T Consensus 103 i~ifpF~sLr~LElrg~~L~~~~GL~~--l---r~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~~-Wn~L~~a~fsyN~ 175 (1096)
T KOG1859|consen 103 ISIFPFRSLRVLELRGCDLSTAKGLQE--L---RHQLEKLIC-HNSLDALRHVFASCGGDISNSPV-WNKLATASFSYNR 175 (1096)
T ss_pred ceeccccceeeEEecCcchhhhhhhHH--H---HHhhhhhhh-hccHHHHHHHHHHhccccccchh-hhhHhhhhcchhh
Confidence 356778899999998887642 111 0 012333321 12111 11111111 1246677777777
Q ss_pred CCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCCcc-cCCCCCCCEEEccCCCCCCCCcc
Q 002462 178 LTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVSNNSLASSIPA 256 (919)
Q Consensus 178 l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~ 256 (919)
+. .+..++.-++.|+.|||++|+++.. +.+..|+.|++|||++|.+. .+|.. ...+ +|+.|+|.+|.++.. .
T Consensus 176 L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lrnN~l~tL--~ 248 (1096)
T KOG1859|consen 176 LV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLRNNALTTL--R 248 (1096)
T ss_pred HH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeeeecccHHHhh--h
Confidence 76 4566677777788888888887643 26677788888888888876 34432 2223 388888888877643 2
Q ss_pred ccCCCCCCCEEEcCCCCCCCCCc-hhhhccccCCEEEccCCcCC
Q 002462 257 QLGDLDSLVDLDLSMNSLSGSVP-SELRGLRSLQKFVIGNNFLS 299 (919)
Q Consensus 257 ~l~~l~~L~~L~Ls~N~l~g~~p-~~l~~l~~L~~L~ls~N~l~ 299 (919)
.+.+|.+|+.|||++|-|.+.-- ..+..|..|+.|+|.+|.+.
T Consensus 249 gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 249 GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 46677888888888887765321 22456677788888888764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.1e-06 Score=84.01 Aligned_cols=141 Identities=18% Similarity=0.200 Sum_probs=94.3
Q ss_pred cccccccCCCCcEEEEEecCCccEEEE-Eecccc--------ccHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEE
Q 002462 538 DANLIKNGHSGDLFRGILEGGIPVVIK-RIDLQS--------VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 538 ~~~~ig~G~~G~Vy~g~l~~g~~vavK-~l~~~~--------~~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV 608 (919)
...+|-+|.-+.||+|.+. |....|| |..... .......+|++.+.+++--.|---.=+..+. ..-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT-YGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec-CCCeEE
Confidence 4568999999999999987 4455565 332211 1134677899999998644432222223343 345799
Q ss_pred EEecCC-CChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCC---ceeeCCc
Q 002462 609 YKYMPN-GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF---EVRLGSL 684 (919)
Q Consensus 609 ~Ey~~~-GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~---~~kl~df 684 (919)
|||+++ -++.+++......+. .+. .-...+..|-+-+.-||.+ .|||+||.++||+|..++ .+.+.||
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~----~d~-~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdf 160 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDES----EDE-GLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDF 160 (229)
T ss_pred EEeccchhHHHHHHHHHccCcc----cch-hHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEee
Confidence 999987 367777765433221 111 1146677788889999986 899999999999997654 4578899
Q ss_pred chhh
Q 002462 685 SEVC 688 (919)
Q Consensus 685 g~~~ 688 (919)
|+..
T Consensus 161 gls~ 164 (229)
T KOG3087|consen 161 GLSS 164 (229)
T ss_pred cchh
Confidence 8654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.28 E-value=4.6e-06 Score=84.55 Aligned_cols=123 Identities=20% Similarity=0.214 Sum_probs=75.8
Q ss_pred cEEEEEecCCccEEEEEeccccc----------------------c-----HHHHHHHHHHHhhcCCCCc-cceeeEEee
Q 002462 549 DLFRGILEGGIPVVIKRIDLQSV----------------------K-----TEAYLLELDFFSKVSHARL-VPLLGHCME 600 (919)
Q Consensus 549 ~Vy~g~l~~g~~vavK~l~~~~~----------------------~-----~~~f~~Ei~~l~~l~H~ni-V~l~g~c~~ 600 (919)
.||.|.-.+|..||||.-..... . .....+|.+.|.++...++ |+-.- .+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~-~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPY-DYN 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EE-EEE
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEE-EEe
Confidence 49999999999999997543110 0 1235679999999987754 43332 222
Q ss_pred cCCcEEEEEEecC--CCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCc
Q 002462 601 RENEKFLVYKYMP--NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFE 678 (919)
Q Consensus 601 ~~~~~~lV~Ey~~--~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~ 678 (919)
..+|||||++ +..+.. |.... ++......+..++.+.+..+++. .+|||+|+.+.|||++++ .
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~~~--------~~~~~~~~~~~~il~~~~~~~~~--~givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKDVD--------LSPEEPKELLEEILEEIIKMLHK--AGIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHHCG--------GGGSTHHHHHHHHHHHHHHHHHC--TTEEESS-STTSEEEETT-C
T ss_pred ---CCEEEEEecCCCccchhh-HHhcc--------ccchhHHHHHHHHHHHHHHHHHh--cCceecCCChhhEEeecc-e
Confidence 3479999999 544433 32211 10112345667777767665433 389999999999999988 8
Q ss_pred eeeCCcchh
Q 002462 679 VRLGSLSEV 687 (919)
Q Consensus 679 ~kl~dfg~~ 687 (919)
+.+.|||.+
T Consensus 145 ~~iIDf~qa 153 (188)
T PF01163_consen 145 VYIIDFGQA 153 (188)
T ss_dssp EEE--GTTE
T ss_pred EEEEecCcc
Confidence 999999844
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.19 E-value=2e-06 Score=64.78 Aligned_cols=36 Identities=33% Similarity=0.798 Sum_probs=26.5
Q ss_pred HHHHHHHHHHHHhCCC-C---CCCCCCC--CCCCCCCCCeeec
Q 002462 48 RTELAALFELRSSLGL-R---RRDWPRK--VDPCLVWNGVRCQ 84 (919)
Q Consensus 48 ~~e~~aLl~~k~~l~~-~---~~~W~~~--~~~C~~W~gv~C~ 84 (919)
++|++||++||+++.. . +.+|... .+|| +|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C-~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC-SWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC-CSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe-eeccEEeC
Confidence 4799999999999984 3 5899887 4655 89999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.16 E-value=9.5e-06 Score=90.76 Aligned_cols=173 Identities=18% Similarity=0.214 Sum_probs=117.3
Q ss_pred CCcEEEEE-ecCCccEEEEEecccccc-HHHHHHHHHHHhhcCCCCccceeeEEee---cCCcEEEEEEecCC-CChhhh
Q 002462 547 SGDLFRGI-LEGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCME---RENEKFLVYKYMPN-GDLSSS 620 (919)
Q Consensus 547 ~G~Vy~g~-l~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~niV~l~g~c~~---~~~~~~lV~Ey~~~-GsL~~~ 620 (919)
.-+.||+. -.||..++.||++..+.. ...-..-++.++++.|.|+|++...... .+...++||+|.|+ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35789987 568999999999543322 1122345788999999999999886541 13357899999996 556665
Q ss_pred hhccC-CC-------CCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhcCC
Q 002462 621 LYRKT-NT-------EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 621 L~~~~-~~-------~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~~~ 692 (919)
-.... .. .......+......++.|++.||.|+|+. +..-+-|-+++||++.+.+++|+..|..-....
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 43221 11 11122345566678999999999999985 677799999999999999999877653322211
Q ss_pred CCcceeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCCC
Q 002462 693 DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMG 741 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~p 741 (919)
+.. .+. .--.+-|.=-||++++-|.||...
T Consensus 446 d~~------------~~l-------e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT------------EPL-------ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC------------cch-------hHHhhhhHHHHHHHHHHHhhcccc
Confidence 110 000 001234899999999999999543
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.05 E-value=5.4e-07 Score=93.54 Aligned_cols=192 Identities=28% Similarity=0.280 Sum_probs=85.4
Q ss_pred hhhCCCCCcEEEeecCCCCc--cCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCEEEccCCcCCCC-CCccccCC
Q 002462 137 LGQQLPTLQALDLRSCSISG--VIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGN-IPTSFGLL 213 (919)
Q Consensus 137 ~~~~L~~L~~LdLs~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~-~p~~~~~l 213 (919)
++...+.++.|||.+|.|+. .+-..+.+|+.|++|+|+.|.+...|-..-..+.+|++|-|.+..+.-. .-..+..+
T Consensus 66 ~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~l 145 (418)
T KOG2982|consen 66 FGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDL 145 (418)
T ss_pred HHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcc
Confidence 44456667777777777653 2333345666666666666666533322112344566666655554321 11223334
Q ss_pred CCCCEEeccCCcCCCCCCcccCCCCCCCEEEccCCCCCCCCcc--ccCCCCCCCEEEcCCCCCCCCCchhhhccccCCEE
Q 002462 214 KNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPA--QLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKF 291 (919)
Q Consensus 214 ~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L 291 (919)
+.++.|++|.|.+. .+++..|.+...-|. .+..++.+..+.++-|++.. -++++..+
T Consensus 146 P~vtelHmS~N~~r--------------q~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r-------~Fpnv~sv 204 (418)
T KOG2982|consen 146 PKVTELHMSDNSLR--------------QLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSR-------IFPNVNSV 204 (418)
T ss_pred hhhhhhhhccchhh--------------hhccccccccccchhhhhhhcCCcHHHHHHHHHhHHh-------hcccchhe
Confidence 44444444444221 122222222211110 01111122222222233322 22345555
Q ss_pred EccCCcCCCCCCCcccCCCCCCCEEEccCCCCCCC-CccccCCCCCCCEEEccCCCCCC
Q 002462 292 VIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGP-PPDVLWSMPQLRLLDISRNNFTG 349 (919)
Q Consensus 292 ~ls~N~l~g~i~~~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~g 349 (919)
.+..|.+...-...-+..++.+..|+|+.|++..- --+.+..+++|..|.+++|.+..
T Consensus 205 ~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 205 FVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred eeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence 55555554332222334444455566666665432 12334556666666666665553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=4e-06 Score=100.60 Aligned_cols=204 Identities=19% Similarity=0.167 Sum_probs=121.2
Q ss_pred CCCcccccccCCCCcEEEEEe-cCCccEEEEEeccccc----cHHHHHHHHHHHhhcCCCCccceeeEEeecCCcEEEEE
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~niV~l~g~c~~~~~~~~lV~ 609 (919)
+|...+-+-+|.++.++-..- ..|..-++|....... +.+....+-.++-..+||-+|...-- .......+||+
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-FPCRSPLPLVG 883 (1205)
T ss_pred cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-CCCCCCcchhh
Confidence 344445567788888876542 1232223332221111 11222222222222345656644432 11234578999
Q ss_pred EecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhh
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~ 689 (919)
+|..+|+|...||..+..... +.|.-| ..+..+++|||.. .++|||+||.|+|...++..+++||+....
T Consensus 884 ~~~~~~~~~Skl~~~~~~sae------paRs~i-~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGCLSAE------PARSPI-LERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred HHhccCCchhhhhcCCCcccc------cccchh-HHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence 999999999999865421111 122222 2356789999984 589999999999999999999999974332
Q ss_pred cCC------CC-cc----------------------eeeeeeccCCCCccccCCCCCCCCCCCcchhHHHHHHHHHcCCC
Q 002462 690 QGG------DA-HQ----------------------SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKM 740 (919)
Q Consensus 690 ~~~------~~-~~----------------------~~~~~~~~~~~~~~~~~~~~~~~t~~~DVySfGvvLlEllTGk~ 740 (919)
.+. .. .. ..-....+++.+.+++..........+|.|++|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 211 00 00 00111234444555555555555667899999999999999999
Q ss_pred CCCCCChhH
Q 002462 741 GISASSDAQ 749 (919)
Q Consensus 741 p~~~~~~~~ 749 (919)
|+....+..
T Consensus 1034 p~na~tpq~ 1042 (1205)
T KOG0606|consen 1034 PFNAETPQQ 1042 (1205)
T ss_pred CCCCcchhh
Confidence 998776543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.98 E-value=3.8e-07 Score=84.53 Aligned_cols=83 Identities=23% Similarity=0.287 Sum_probs=37.4
Q ss_pred CCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEecc
Q 002462 143 TLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDIS 222 (919)
Q Consensus 143 ~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 222 (919)
.|+..+|++|.|....+..-..++.++.|+|++|.|+ .+|..+..++.|+.|+++.|.|. ..|.-|..|.+|-.||..
T Consensus 54 el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~ 131 (177)
T KOG4579|consen 54 ELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSP 131 (177)
T ss_pred eEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCC
Confidence 3444455555554222221223334455555555554 34444555555555555555544 234444444444445444
Q ss_pred CCcCC
Q 002462 223 SNYLT 227 (919)
Q Consensus 223 ~N~l~ 227 (919)
+|.+.
T Consensus 132 ~na~~ 136 (177)
T KOG4579|consen 132 ENARA 136 (177)
T ss_pred CCccc
Confidence 44443
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.96 E-value=2.8e-05 Score=79.20 Aligned_cols=102 Identities=27% Similarity=0.340 Sum_probs=80.6
Q ss_pred HHHHHHhhcCC-CCccceeeEEeecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHHHhhhhhcC
Q 002462 578 LELDFFSKVSH-ARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHE 656 (919)
Q Consensus 578 ~Ei~~l~~l~H-~niV~l~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~ 656 (919)
.|.-+|..+.+ +++.+++|+|- .++|.||.+.+++... +.. ......-+|.+|.+||+++.+.+++|++.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG-----~~~v~E~~~~~~~~~~-~~~---l~~~~~~~w~~R~~iA~~lL~~l~~l~~~ 78 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG-----RFYVVEYVGAGSLYGI-YRP---LSQFLQSPWEQRAKIALQLLELLEELDHG 78 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC-----CEEEEEeecCcccccc-ccc---cccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 57788888887 59999999992 4689999998876532 000 01112368999999999999999999996
Q ss_pred CCCCeeeccCCCCceecCCCCceeeCCcchhh
Q 002462 657 CTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 657 ~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~ 688 (919)
....+.-.|++++|+-+++++++|+.|...+.
T Consensus 79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred CCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 65568889999999999999999999976443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00012 Score=77.10 Aligned_cols=73 Identities=15% Similarity=0.084 Sum_probs=50.7
Q ss_pred ccccccCCCCcEEEEEecCCccEEEEEeccccccHHHHHHHHHHHhhcCCCCc--cceeeEEeecCCcEEEEEEecCCCC
Q 002462 539 ANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARL--VPLLGHCMERENEKFLVYKYMPNGD 616 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~ni--V~l~g~c~~~~~~~~lV~Ey~~~Gs 616 (919)
-..||+|..+.||+. .|..+++|...... ...+..+|.+++..+..-.+ -+.++++ +..+...+|||+++|.+
T Consensus 6 ~~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~-~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 6 WTQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLV-EDGGRLGLIYELIVGKR 80 (226)
T ss_pred heeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEE-ecCCeeeeeeeecCCcc
Confidence 357999999999983 24467788765432 33456789999998875544 4445544 33445688999999863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.89 E-value=2.1e-06 Score=89.27 Aligned_cols=189 Identities=26% Similarity=0.295 Sum_probs=98.7
Q ss_pred CCCCCCEEEeeCCCCCC--CCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEeccCCcCCCCC-CcccCCCCCC
Q 002462 164 NLTNLTSLYLSDNGLTG--TIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSI-PPGLGTLSKL 240 (919)
Q Consensus 164 ~l~~L~~L~Ls~N~l~g--~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~-p~~l~~l~~L 240 (919)
..+.++.|||.+|.|+. .+-.-+.+|+.|++|+|+.|+++..|-..=..+.+|+.|-|.+..+...- ...+..++++
T Consensus 69 ~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~v 148 (418)
T KOG2982|consen 69 SVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKV 148 (418)
T ss_pred HhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhh
Confidence 35667777777777763 23333556777777777777776433221134556777776666554322 2234456666
Q ss_pred CEEEccCCCCCCCCccccCCCCCCCEEEcCCCCCCCCCch--hhhccccCCEEEccCCcCCCCCCCcccCCCCCCCEEEc
Q 002462 241 QYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPS--ELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVL 318 (919)
Q Consensus 241 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~--~l~~l~~L~~L~ls~N~l~g~i~~~~~~~l~~L~~L~L 318 (919)
+.|++|.|++. .+++..|-....-|. .+..++.+..++++-|++... .+++..+.+
T Consensus 149 telHmS~N~~r--------------q~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~--------Fpnv~sv~v 206 (418)
T KOG2982|consen 149 TELHMSDNSLR--------------QLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI--------FPNVNSVFV 206 (418)
T ss_pred hhhhhccchhh--------------hhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh--------cccchheee
Confidence 66666666432 222333322221111 122233344444455555422 234556666
Q ss_pred cCCCCCCC-CccccCCCCCCCEEEccCCCCCCCCCcccccCCCCCcEEEccCCcCcc
Q 002462 319 RQNGFTGP-PPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYG 374 (919)
Q Consensus 319 ~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~l~~L~ls~N~~~g 374 (919)
..|.+... -...+..++.+..|+|+.|++-.--.-...+..+.+..|.+++|.+..
T Consensus 207 ~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 207 CEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred ecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence 66765432 223344566777888888877632221122445566666666665543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.80 E-value=9e-05 Score=86.35 Aligned_cols=141 Identities=17% Similarity=0.212 Sum_probs=94.6
Q ss_pred CCCcccccccCCCCcEEEEEecCCccEEEEEecccc---------------------------cc----HH---------
Q 002462 535 DFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQS---------------------------VK----TE--------- 574 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~---------------------------~~----~~--------- 574 (919)
.|+ .+-|+.++-|.||+|++.+|..||||+....- .. .+
T Consensus 127 eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 127 EFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred HcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 344 35799999999999999999999999874310 00 01
Q ss_pred -HHHHHHHHHhhcC-----CCCccceeeEEeecCCcEEEEEEecCCCChhhhhhccCCCCCccCCCCHHHHHHHHHHHHH
Q 002462 575 -AYLLELDFFSKVS-----HARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAE 648 (919)
Q Consensus 575 -~f~~Ei~~l~~l~-----H~niV~l~g~c~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~ 648 (919)
+|.+|..-+.+++ .+++ ++=..|++-.+...|+|||++|-.+.+...-+.. .++ +-.|+...++
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~------g~d---~k~ia~~~~~ 275 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA------GID---RKELAELLVR 275 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhc------CCC---HHHHHHHHHH
Confidence 3556776666653 2333 2222344444578999999999999888532211 133 3345554444
Q ss_pred Hh--hhhhcCCCCCeeeccCCCCceecCCCCceeeCCcchhhhc
Q 002462 649 GL--SYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 649 gL--~yLH~~~~~~ivHrDlK~~NILld~~~~~kl~dfg~~~~~ 690 (919)
+. +-+++ +++|.|.-|.||+++.++..-+-|||.....
T Consensus 276 ~f~~q~~~d----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 276 AFLRQLLRD----GFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HHHHHHHhc----CccccCCCccceEEecCCcEEEEcCcceecC
Confidence 32 11222 7999999999999999999999999976544
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.79 E-value=2.1e-06 Score=79.68 Aligned_cols=116 Identities=22% Similarity=0.235 Sum_probs=90.5
Q ss_pred hhcCCCCCCEEecCCCCCCCCCchhhhhCCCCCcEEEeecCCCCccCCcCCCCCCCCCEEEeeCCCCCCCCcccccCCCC
Q 002462 112 ALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSV 191 (919)
Q Consensus 112 ~l~~L~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~L~~ 191 (919)
.+....+|...++++|.| ..+|+.|...++.++.|+|++|.|+ .+|..+..++.|+.|+++.|.|. ..|..+..|.+
T Consensus 48 ~l~~~~el~~i~ls~N~f-k~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~ 124 (177)
T KOG4579|consen 48 MLSKGYELTKISLSDNGF-KKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIK 124 (177)
T ss_pred HHhCCceEEEEecccchh-hhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHh
Confidence 456677888889999988 4688888887889999999999998 57888999999999999999998 68888888999
Q ss_pred CCEEEccCCcCCCCCCccccCCCCCCEEeccCCcCCCCCC
Q 002462 192 LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIP 231 (919)
Q Consensus 192 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 231 (919)
|-.|+..+|.+. .+|-.+---+++-..++.++.+.+.-+
T Consensus 125 l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 125 LDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred HHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 999999999986 455443222233333445555554443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 919 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-29 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-25 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-19 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-18 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-17 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-13 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-10 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-07 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 6e-07 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-06 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-04 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-04 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-04 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-04 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 919 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-78 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-75 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-70 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-70 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-69 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-63 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 9e-50 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-45 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-44 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-73 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 4e-62 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-26 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 6e-05 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 4e-69 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 8e-66 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 9e-61 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-49 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-48 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 8e-46 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-43 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 9e-39 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-38 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-25 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-49 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 7e-49 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 9e-44 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-43 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 6e-28 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-13 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-47 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 8e-45 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-42 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-40 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-36 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-44 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-38 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-35 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 6e-33 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-29 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-23 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-43 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 9e-42 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-40 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 8e-40 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-32 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-29 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 6e-40 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 6e-40 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-38 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-33 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-33 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 7e-28 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-21 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-38 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-38 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-22 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-17 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 6e-38 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-37 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-35 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 9e-31 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 9e-26 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 9e-26 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-06 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-36 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-36 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-34 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-31 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-30 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-27 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 8e-36 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-31 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-17 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-35 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 7e-35 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-34 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-34 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 5e-33 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-31 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-21 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-34 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 4e-33 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 4e-28 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-33 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-32 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-31 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-30 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-30 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 7e-29 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-14 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-33 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-26 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-08 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 9e-33 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-30 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-30 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-25 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-19 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-32 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-27 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-16 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-13 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-31 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-31 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-30 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-27 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-24 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-20 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-14 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-31 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-31 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-12 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-31 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-29 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-28 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 4e-25 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-21 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-20 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-16 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-08 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-31 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-27 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 7e-25 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-18 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-31 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-23 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-30 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-30 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-12 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 4e-30 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-29 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-27 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-26 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-24 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-19 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-15 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-08 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-29 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 9e-29 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-20 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-28 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-28 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-21 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 4e-28 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 9e-28 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-27 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-26 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-17 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-27 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-26 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 8e-19 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-27 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-26 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-26 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 7e-26 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 6e-17 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-13 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-26 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 6e-22 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-06 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-26 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-26 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-23 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-22 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 4e-21 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-04 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-25 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 4e-24 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-09 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 6e-24 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 7e-18 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-06 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 7e-24 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-20 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-19 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 9e-19 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-15 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 8e-24 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 8e-23 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-19 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 6e-17 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-23 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-19 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-23 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-23 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 4e-23 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-23 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-20 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 6e-20 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-18 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 7e-23 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 8e-23 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-21 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-17 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 8e-15 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-22 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-22 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-21 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-19 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 9e-22 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 7e-11 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-21 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 6e-21 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-17 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 8e-20 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-17 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-18 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-18 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-18 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-17 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-13 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 6e-09 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-16 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 6e-12 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-16 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 6e-07 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 5e-16 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-15 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-15 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-12 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-15 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-15 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-14 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 8e-15 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-14 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-14 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-13 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 4e-12 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 9e-10 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-07 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 5e-14 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 9e-14 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-13 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-13 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-13 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-13 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-12 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-04 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 3e-13 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 5e-13 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 6e-13 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 6e-13 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-12 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-12 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-10 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-12 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-12 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 4e-12 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-04 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-12 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-11 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-12 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-11 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-12 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 5e-12 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 5e-12 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 7e-12 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-11 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-10 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-11 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-11 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-11 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-11 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-10 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-07 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 2e-11 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-11 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-09 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 4e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 8e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-04 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-11 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 6e-11 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 6e-11 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 6e-11 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 8e-11 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 9e-11 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-10 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-10 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-10 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 4e-07 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-10 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-10 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-10 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-10 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-07 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-10 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-10 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-10 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-10 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 3e-10 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 4e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 6e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-06 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 5e-10 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 6e-10 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 7e-10 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 7e-10 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 9e-10 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 9e-10 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 1e-09 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 1e-08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 7e-06 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-09 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-09 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-09 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-09 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-09 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-09 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-09 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 4e-09 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 3e-05 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 5e-05 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 5e-09 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-04 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 5e-09 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 6e-09 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 7e-09 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 7e-09 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 8e-09 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 8e-09 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 8e-09 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 8e-09 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 9e-09 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-08 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-08 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 5e-07 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-08 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 4e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 5e-08 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 8e-08 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 8e-08 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 1e-07 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 8e-05 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-07 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-07 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-07 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-07 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-07 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-07 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-07 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 4e-07 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 4e-07 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 5e-07 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 8e-07 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 4e-06 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 3e-04 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 9e-07 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 3e-06 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 9e-06 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 1e-05 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 5e-05 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-05 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-05 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-04 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-04 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 6e-04 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 4e-04 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 9e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 1e-78
Identities = 109/420 (25%), Positives = 169/420 (40%), Gaps = 65/420 (15%)
Query: 46 SSRTELAALFELRSSL--GLRRRDWPRKVDPCLVWNGVRCQNGSVVGINISGFR-RTRLG 102
S E+ L + L DW +PC ++GV C++ V I++S
Sbjct: 9 SLYREIHQLISFKDVLPDKNLLPDWSSNKNPCT-FDGVTCRDDKVTSIDLSSKPLNVGFS 67
Query: 103 SQNPRF--------------------------------------------AADALVNLTH 118
+ + +L + +
Sbjct: 68 AVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSG 127
Query: 119 LASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSL---GNLTNLTSLYLSD 175
L N S L G +L +L+ LDL + SISG L L +S
Sbjct: 128 LKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISG 187
Query: 176 NGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLG 235
N ++G + + + L LD+S N+ + IP G L LDIS N L+G +
Sbjct: 188 NKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAIS 244
Query: 236 TLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRG-LRSLQKFVIG 294
T ++L+ LN+S+N IP L SL L L+ N +G +P L G +L +
Sbjct: 245 TCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLS 302
Query: 295 NNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGP-PPDVLWSMPQLRLLDISRNNFTGPLPN 353
N G + + S L+ + L N F+G P D L M L++LD+S N F+G LP
Sbjct: 303 GNHFYGAVPPFFG-SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE 361
Query: 354 SRSNVNTSTVELNISQNMFYGGLTPVLGRFRL-----VDLSGNYFEGRVPEYVHSNASSL 408
S +N++ S + L++S N F G + P L + + L N F G++P + SN S L
Sbjct: 362 SLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL-SNCSEL 420
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 2e-75
Identities = 99/308 (32%), Positives = 142/308 (46%), Gaps = 9/308 (2%)
Query: 115 NLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLS 174
L L + + G IPD+L TL LDL G +P G+ + L SL LS
Sbjct: 267 PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALS 326
Query: 175 DNGLTGTIP-SSLGQLSVLSVLDLSRNSLTGNIPTSFG-LLKNLSSLDISSNYLTGSIPP 232
N +G +P +L ++ L VLDLS N +G +P S L +L +LD+SSN +G I P
Sbjct: 327 SNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILP 386
Query: 233 GLG--TLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQK 290
L + LQ L + NN IP L + LV L LS N LSG++PS L L L+
Sbjct: 387 NLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD 446
Query: 291 FVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGP 350
+ N L G + L V L+ ++L N TG P L + L + +S N TG
Sbjct: 447 LKLWLNMLEGEIPQELM-YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGE 505
Query: 351 LPNSRSNVNTSTVELNISQNMFYGGLTPVLGRF---RLVDLSGNYFEGRVPEYVHSNASS 407
+P + L +S N F G + LG +DL+ N F G +P + +
Sbjct: 506 IPKWIGR-LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK 564
Query: 408 LDSNCLQN 415
+ +N +
Sbjct: 565 IAANFIAG 572
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 1e-70
Identities = 89/314 (28%), Positives = 135/314 (42%), Gaps = 28/314 (8%)
Query: 115 NLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLT-NLTSLYL 173
+ + L S S G +P ++ L+ LDL SG +P SL NL+ +L +L L
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 174 SDNGLTGTIPSSLGQ--LSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIP 231
S N +G I +L Q + L L L N TG IP + L SL +S NYL+G+IP
Sbjct: 376 SSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP 435
Query: 232 PGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKF 291
LG+LSKL+ L + N L IP +L + +L L L N L+G +PS L +L
Sbjct: 436 SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWI 495
Query: 292 VIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPL 351
+ NN L+G + + + L I+ L N F+G P L L LD++ N F G +
Sbjct: 496 SLSNNRLTGEIPKWIG-RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 554
Query: 352 PNS---------------------RSNVNTSTVELNISQNMFYGGLTPVLGRF---RLVD 387
P + +++ + F G + L R +
Sbjct: 555 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCN 614
Query: 388 LSGNYFEGRVPEYV 401
++ + G
Sbjct: 615 ITSRVYGGHTSPTF 628
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 3e-70
Identities = 88/301 (29%), Positives = 135/301 (44%), Gaps = 15/301 (4%)
Query: 115 NLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLS 174
L S + G + + + L+ LD+ S + S IP LG+ + L L +S
Sbjct: 176 GCGELKHLAISGNKISGDVD--VSR-CVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDIS 231
Query: 175 DNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGL 234
N L+G ++ + L +L++S N G IP LK+L L ++ N TG IP L
Sbjct: 232 GNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFL 289
Query: 235 -GTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSE-LRGLRSLQKFV 292
G L L++S N ++P G L L LS N+ SG +P + L +R L+
Sbjct: 290 SGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLD 349
Query: 293 IGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLW--SMPQLRLLDISRNNFTGP 350
+ N SG L +L + L + L N F+GP L L+ L + N FTG
Sbjct: 350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409
Query: 351 LPNSRSNVNTSTVELNISQNMFYGGLTPVLGRF---RLVDLSGNYFEGRVPEYVHSNASS 407
+P + SN + V L++S N G + LG R + L N EG +P+ + +
Sbjct: 410 IPPTLSNC-SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL-MYVKT 467
Query: 408 L 408
L
Sbjct: 468 L 468
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 4e-69
Identities = 96/294 (32%), Positives = 141/294 (47%), Gaps = 13/294 (4%)
Query: 113 LVNLT-HLASFNASRFLLPGSIPDWLGQ-QLPTLQALDLRSCSISGVIPFSLGNLTNLTS 170
L NL+ L + + S G I L Q TLQ L L++ +G IP +L N + L S
Sbjct: 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 422
Query: 171 LYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSI 230
L+LS N L+GTIPSSLG LS L L L N L G IP +K L +L + N LTG I
Sbjct: 423 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEI 482
Query: 231 PPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQK 290
P GL + L ++++SNN L IP +G L++L L LS NS SG++P+EL RSL
Sbjct: 483 PSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIW 542
Query: 291 FVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRN--NFT 348
+ N +G + +F Q + N G + + + + N F
Sbjct: 543 LDLNTNLFNGTIPAAMF-----KQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ 597
Query: 349 GPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLV---DLSGNYFEGRVPE 399
G + + ++ NI+ ++ G +P + D+S N G +P+
Sbjct: 598 GIRSEQLNRL-STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 7e-63
Identities = 86/303 (28%), Positives = 135/303 (44%), Gaps = 13/303 (4%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTS 170
L N + L S + S L G+IP LG L L+ L L + G IP L + L +
Sbjct: 412 PTLSNCSELVSLHLSFNYLSGTIPSSLGS-LSKLRDLKLWLNMLEGEIPQELMYVKTLET 470
Query: 171 LYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSI 230
L L N LTG IPS L + L+ + LS N LTG IP G L+NL+ L +S+N +G+I
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530
Query: 231 PPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQK 290
P LG L +L+++ N +IPA + ++ N ++G ++ ++
Sbjct: 531 PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKE 586
Query: 291 FVIGNNF--LSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFT 348
N G S L +S + + G + + LD+S N +
Sbjct: 587 CHGAGNLLEFQGIRSEQLN-RLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLS 645
Query: 349 GPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLV---DLSGNYFEGRVPEYVHSNA 405
G +P ++ LN+ N G + +G R + DLS N +GR+P+ + S
Sbjct: 646 GYIPKEIGSM-PYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAM-SAL 703
Query: 406 SSL 408
+ L
Sbjct: 704 TML 706
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 9e-50
Identities = 73/289 (25%), Positives = 109/289 (37%), Gaps = 54/289 (18%)
Query: 113 LVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLY 172
L N T+L + S L G IP W+G+ L L L L + S SG IP LG+ +L L
Sbjct: 486 LSNCTNLNWISLSNNRLTGEIPKWIGR-LENLAILKLSNNSFSGNIPAELGDCRSLIWLD 544
Query: 173 LSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNY--LTGSI 230
L+ N GTIP+++ + S ++ N + G + N G
Sbjct: 545 LNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIR 600
Query: 231 PPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQK 290
L LS N+++ + S++ LD+S N LSG +P E+ + L
Sbjct: 601 SEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLF- 659
Query: 291 FVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGP 350
L NL N +G PD + + L +LD+S N G
Sbjct: 660 ------IL--NLG----------------HNDISGSIPDEVGDLRGLNILDLSSNKLDGR 695
Query: 351 LPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPE 399
+P + S + T +DLS N G +PE
Sbjct: 696 IPQAMSALTMLTE----------------------IDLSNNNLSGPIPE 722
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 7e-45
Identities = 57/242 (23%), Positives = 94/242 (38%), Gaps = 32/242 (13%)
Query: 115 NLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLS 174
L +LA S G+IP LG +L LDL + +G IP ++ + ++
Sbjct: 512 RLENLAILKLSNNSFSGNIPAELGD-CRSLIWLDLNTNLFNGTIPAAMFKQSGK----IA 566
Query: 175 DNGLTGTIPSSLGQLSVLSVLDLSRN--SLTGNIPTSFGLLKNLSSLDISSNYLTGSIPP 232
N + G + + + N G L + +I+S G P
Sbjct: 567 ANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSP 626
Query: 233 GLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFV 292
+ +L++S N L+ IP ++G + L L+L N +SGS+P E+ LR L
Sbjct: 627 TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNIL- 685
Query: 293 IGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLP 352
+LS N G P + ++ L +D+S NN +GP+P
Sbjct: 686 --------DLS----------------SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721
Query: 353 NS 354
Sbjct: 722 EM 723
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-44
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 115 NLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLS 174
+ L + + L G+IP + +Q + + I+G + N + +
Sbjct: 536 DCRSLIWLDLNTNLFNGTIPAAMFKQS-----GKIAANFIAGKRYVYIKNDGMKKECHGA 590
Query: 175 DNG--LTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPP 232
N G L +LS + +++ G+ +F ++ LD+S N L+G IP
Sbjct: 591 GNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650
Query: 233 GLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFV 292
+G++ L LN+ +N ++ SIP ++GDL L LDLS N L G +P + L L +
Sbjct: 651 EIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710
Query: 293 IGNNFLSGNLSVNLFPTVSQLQ 314
+ NN LSG + P + Q +
Sbjct: 711 LSNNNLSGPI-----PEMGQFE 727
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 2e-73
Identities = 88/330 (26%), Positives = 130/330 (39%), Gaps = 42/330 (12%)
Query: 45 LSSRTELAALFELRSSLG--LRRRDWPRKVDPC-LVWNGVRCQNGSVVGINISGFRRTRL 101
L + + AL +++ LG W D C W GV C
Sbjct: 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLC------------------ 43
Query: 102 GSQNPRFAADALVNLTHLASFNASRFLLPGS--IPDWLGQQLPTLQALDLRS-CSISGVI 158
D + + + S LP IP L LP L L + ++ G I
Sbjct: 44 ---------DTDTQTYRVNNLDLSGLNLPKPYPIPSSLAN-LPYLNFLYIGGINNLVGPI 93
Query: 159 PFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSS 218
P ++ LT L LY++ ++G IP L Q+ L LD S N+L+G +P S L NL
Sbjct: 94 PPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153
Query: 219 LDISSNYLTGSIPPGLGTLSKL-QYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGS 277
+ N ++G+IP G+ SKL + +S N L IP +L +L +DLS N L G
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGD 212
Query: 278 VPSELRGLRSLQKFVIGNNFLSGNLS--VNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMP 335
++ QK + N L+ +L L + LR N G P L +
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS----KNLNGLDLRNNRIYGTLPQGLTQLK 268
Query: 336 QLRLLDISRNNFTGPLPNSRSNVNTSTVEL 365
L L++S NN G +P +
Sbjct: 269 FLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 4e-62
Identities = 70/305 (22%), Positives = 122/305 (40%), Gaps = 59/305 (19%)
Query: 112 ALVNLTHLASFNAS----RFLLPGSIPDWLGQQLPTLQALDLRSCSISGV--IPFSLGNL 165
L N T L+S+ + G + D Q + LDL ++ IP SL NL
Sbjct: 17 DLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQ-TYRVNNLDLSGLNLPKPYPIPSSLANL 75
Query: 166 TNLTSLYLSD-NGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSN 224
L LY+ N L G IP ++ +L+ L L ++ +++G IP +K L +LD S N
Sbjct: 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135
Query: 225 YLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLV-DLDLSMNSLSGSVPSELR 283
L+G++PP + +L L + N ++ +IP G L + +S N L+G +P
Sbjct: 136 ALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF- 194
Query: 284 GLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDIS 343
NL+ L + L +N G + S + + ++
Sbjct: 195 ----------------ANLN---------LAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 344 RNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHS 403
+N+ L ++ +S+N+ +DL N G +P+ + +
Sbjct: 230 KNSLAFDLG-----------KVGLSKNLNG------------LDLRNNRIYGTLPQGL-T 265
Query: 404 NASSL 408
L
Sbjct: 266 QLKFL 270
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 37/116 (31%), Positives = 54/116 (46%), Gaps = 4/116 (3%)
Query: 118 HLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNG 177
+LA + SR +L G G Q + L S++ + +G NL L L +N
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGS-DKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNR 255
Query: 178 LTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSN-YLTGSIPP 232
+ GT+P L QL L L++S N+L G IP G L+ ++N L GS P
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPLP 310
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 6e-05
Identities = 17/74 (22%), Positives = 32/74 (43%), Gaps = 3/74 (4%)
Query: 113 LVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLY 172
+ +L + + G++P L Q L L +L++ ++ G IP GNL
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQ-LKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSA 297
Query: 173 LSDN-GLTGTIPSS 185
++N L G+ +
Sbjct: 298 YANNKCLCGSPLPA 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 4e-69
Identities = 98/333 (29%), Positives = 145/333 (43%), Gaps = 38/333 (11%)
Query: 503 PAGSSLPPPGASINFTNLGESFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVV 562
S +S L AT +F LI +G G +++G+L G V
Sbjct: 8 ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVA 67
Query: 563 IKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSL 621
+KR +S + E + E++ S H LV L+G C E NE L+YKYM NG+L L
Sbjct: 68 LKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-RNEMILIYKYMENGNLKRHL 126
Query: 622 YRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRL 681
Y S+ W RL+I IGAA GL YLH +HRDV++ +ILLD+ F ++
Sbjct: 127 YGSDL---PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180
Query: 682 ---GSLSEVCAQGGDAHQSRITRLLRLPQSSEQGS----------SGSLTATCPYDVYCF 728
G +S+ + H S T + +G+ G LT DVY F
Sbjct: 181 TDFG-ISKKGTELDQTHLS--TVV--------KGTLGYIDPEYFIKGRLTEKS--DVYSF 227
Query: 729 GKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVW 788
G VL E++ + I S ++ + E + ++ + +IVDP+L E +
Sbjct: 228 GVVLFEVLCARSAIVQSLPREMVNLAEWAVES---HNNGQLEQIVDPNLADKIR-PESLR 283
Query: 789 AMAIVARSCLNPKPTRRPLMRYILKALENPLKV 821
A CL RP M +L LE L++
Sbjct: 284 KFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 8e-66
Identities = 92/306 (30%), Positives = 155/306 (50%), Gaps = 29/306 (9%)
Query: 523 SFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDL---QSVKTEAYLLE 579
F+ ++L A+ +FS+ N++ G G +++G L G V +KR+ Q + + + E
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ-FQTE 77
Query: 580 LDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITR 639
++ S H L+ L G CM E+ LVY YM NG ++S L + + LDW R
Sbjct: 78 VEMISMAVHRNLLRLRGFCMT-PTERLLVYPYMANGSVASCLRER---PESQPPLDWPKR 133
Query: 640 LKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQS 697
+IA+G+A GL+YLH C +HRDV+A++ILLD++FE +G L+++ D H +
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVT 192
Query: 698 RITRLL-----RLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGK--MGISASSDAQV 750
T + P E S+G + DV+ +G +LLEL+TG+ ++ ++
Sbjct: 193 --TAVRGTIGHIAP---EYLSTGKSSEKT--DVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 751 KEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRY 810
+L+ + ++ + +VD L + EEV + VA C P RP M
Sbjct: 246 VMLLDWVKG---LLKEKKLEALVDVDLQGNYK-DEEVEQLIQVALLCTQSSPMERPKMSE 301
Query: 811 ILKALE 816
+++ LE
Sbjct: 302 VVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 9e-61
Identities = 80/316 (25%), Positives = 142/316 (44%), Gaps = 49/316 (15%)
Query: 523 SFTYQQLLAATGDFSD------ANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKT--- 573
SF++ +L T +F + N + G G +++G + V +K++ T
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKKLAAMVDITTEE 72
Query: 574 --EAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDL 631
+ + E+ +K H LV LLG + ++ LVY YMPNG L L D
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSD-GDDLCLVYVYMPNGSLLDRLSCL----DGT 127
Query: 632 QSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCA 689
L W R KIA GAA G+++LH +HRD+++++ILLD+ F ++ L+
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 690 QGGDAHQSRITRLLRLPQSSEQG---------SSGSLTATCPYDVYCFGKVLLELVTGKM 740
+ + +R++ G G +T D+Y FG VLLE++TG
Sbjct: 185 KFAQTVMT--SRIV--------GTTAYMAPEALRGEITPKS--DIYSFGVVLLEIITGLP 232
Query: 741 GISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNP 800
+ + Q+ +L+ +++ + +D + ++ V AM VA CL+
Sbjct: 233 AVDEHREPQL--LLDIKEEIED--EEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHE 286
Query: 801 KPTRRPLMRYILKALE 816
K +RP ++ + + L+
Sbjct: 287 KKNKRPDIKKVQQLLQ 302
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-49
Identities = 55/286 (19%), Positives = 105/286 (36%), Gaps = 14/286 (4%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSV 191
+PD L + L+L + + + + LTSL + N ++ P +L +
Sbjct: 18 QVPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPM 74
Query: 192 LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLA 251
L VL+L N L+ +F NL+ L + SN + L L++S+N L+
Sbjct: 75 LKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS 134
Query: 252 SSIPAQLGDLDSLVDLDLSMNSLSGSVPSELR--GLRSLQKFVIGNNFLSGNLSVNLFPT 309
S+ L++L +L LS N + EL SL+K + +N + S F
Sbjct: 135 STKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE-FSPGCFHA 193
Query: 310 VSQLQIIVLRQNGFTGPPPDVL---WSMPQLRLLDISRNNFTGPLPNSRSNVNTST-VEL 365
+ +L + L + L + +R L +S + + + + + L
Sbjct: 194 IGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTML 253
Query: 366 NISQNMFYGGLTPVLGRF---RLVDLSGNYFEGRVPEYVHSNASSL 408
++S N L N + + + ++
Sbjct: 254 DLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH-LFSHSLHGLFNV 298
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-48
Identities = 65/296 (21%), Positives = 111/296 (37%), Gaps = 15/296 (5%)
Query: 110 ADALVNLTHLASFNASR-FLLPGSIPDWLGQQLPT--LQALDLRSCSISGVIPFSLGNLT 166
++ L +L + S F ++ + L L L+L IS + + L
Sbjct: 346 SNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405
Query: 167 NLTSLYLSDNGLTGTIP-SSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNY 225
+L L L N + + L + + LS N SF L+ +L L +
Sbjct: 406 HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA 465
Query: 226 LTG--SIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLS-------- 275
L S P L L L++SNN++A+ L L+ L LDL N+L+
Sbjct: 466 LKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANP 525
Query: 276 GSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMP 335
G L+GL L + +N + V +F + +L+II L N P V +
Sbjct: 526 GGPIYFLKGLSHLHILNLESNGFDE-IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQV 584
Query: 336 QLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGN 391
L+ L++ +N T + EL++ N F + ++ +
Sbjct: 585 SLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHT 640
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 8e-46
Identities = 60/290 (20%), Positives = 108/290 (37%), Gaps = 19/290 (6%)
Query: 143 TLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSL 202
+ + D ++ +P L TN+T L L+ N L ++ + S L+ LD+ N++
Sbjct: 5 SHEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 203 TGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLD 262
+ P L L L++ N L+ + L L++ +NS+
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 263 SLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTV--SQLQIIVLRQ 320
+L+ LDLS N LS + L +LQ+ ++ NN + L S L+ + L
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA-LKSEELDIFANSSLKKLELSS 180
Query: 321 NGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNS--RSNVNTSTVELNISQNMFYGGLTP 378
N P ++ +L L ++ L NTS L++S +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 379 VLGRFRLV-----DLSGNYFEGRVPEYVHSNASSL-----DSNCLQNVPN 418
+ DLS N V + L + N +Q++ +
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNV-VGNDSFAWLPQLEYFFLEYNNIQHLFS 289
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-43
Identities = 61/349 (17%), Positives = 109/349 (31%), Gaps = 31/349 (8%)
Query: 108 FAADALVNLTHLASFNASRFLLPGSIPDWLGQ--QLPTLQALDLRSCSISGVIPFSLGNL 165
F+ + L + L S+ + L +++ L L + +S + L
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL 245
Query: 166 --TNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISS 223
TNLT L LS N L S L L L N++ S L N+ L++
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
Query: 224 NY---------LTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSL 274
++ L L L++LN+ +N + L +L L LS +
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365
Query: 275 SGSVPSEL----RGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTG-PPPD 329
S + L + N +S + + F + L+++ L N
Sbjct: 366 SLRTLTNETFVSLAHSPLHILNLTKNKISK-IESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
Query: 330 VLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRF------ 383
+ + + +S N + NS + S L + + + F
Sbjct: 425 EWRGLENIFEIYLSYNKYLQLTRNSFAL-VPSLQRLMLRRVALK-NVDSSPSPFQPLRNL 482
Query: 384 RLVDLSGNYFEGRVPEYVHSNAS----SLDSNCLQNVPNQRTLVDCSSF 428
++DLS N + + L N L + F
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYF 531
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 9e-39
Identities = 53/249 (21%), Positives = 86/249 (34%), Gaps = 13/249 (5%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTS 170
DA L HL + + + + L + + L + S + +L
Sbjct: 399 DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQR 458
Query: 171 LYLSDNGLTG--TIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLT- 227
L L L + PS L L++LDLS N++ L+ L LD+ N L
Sbjct: 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR 518
Query: 228 -------GSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPS 280
G L LS L LN+ +N DL L +DL +N+L+ S
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 281 ELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLL 340
SL+ + N ++ P L + +R N F + W + +
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWF---VNWI 635
Query: 341 DISRNNFTG 349
+ + N
Sbjct: 636 NETHTNIPE 644
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-38
Identities = 49/238 (20%), Positives = 88/238 (36%), Gaps = 13/238 (5%)
Query: 166 TNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNY 225
+ S LT +P L + ++VL+L+ N L +F L+SLD+ N
Sbjct: 4 VSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 226 LTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGL 285
++ P L L+ LN+ +N L+ +L +L L NS+ +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 286 RSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVL--WSMPQLRLLDIS 343
++L + +N LS + + LQ ++L N + L ++ L+ L++S
Sbjct: 121 KNLITLDLSHNGLSS-TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 344 RNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRF------RLVDLSGNYFEG 395
N P + L ++ LT L R + LS +
Sbjct: 180 SNQIKEFSPGCFHAI-GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-25
Identities = 39/195 (20%), Positives = 71/195 (36%), Gaps = 15/195 (7%)
Query: 110 ADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSIS--------GVIPFS 161
L +L + S + D L + L L+ LDL+ +++ G +
Sbjct: 473 PSPFQPLRNLTILDLSNNNIANINDDML-EGLEKLEILDLQHNNLARLWKHANPGGPIYF 531
Query: 162 LGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDI 221
L L++L L L NG L L ++DL N+L + F +L SL++
Sbjct: 532 LKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNL 591
Query: 222 SSNYLTGSIPPGLGT-LSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSV-- 278
N +T G L L++ N + + ++ + + ++ LS
Sbjct: 592 QKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLC 651
Query: 279 --PSELRGLRSLQKF 291
P G ++ F
Sbjct: 652 NTPPHYHG-FPVRLF 665
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-49
Identities = 49/340 (14%), Positives = 97/340 (28%), Gaps = 39/340 (11%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTS 170
A++ LT L F + + NL +LT
Sbjct: 200 KAVMRLTKLRQFYMGNSPFVAENI------CEAWENENSEYAQQYKTEDLKWDNLKDLTD 253
Query: 171 LYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLT--------GNIPTSFGLLKNLSSLDIS 222
+ + + +P+ L L + +++++ N + + + + I
Sbjct: 254 VEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIG 313
Query: 223 SNYL-TGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSE 281
N L T + L + KL L N L +PA G L L+L+ N ++ +
Sbjct: 314 YNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANF 372
Query: 282 LRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMP------ 335
++ +N L ++ +VS + I N +
Sbjct: 373 CGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKG 432
Query: 336 -QLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMF-------YGGLTPVLGRF---R 384
+ +++S N + S + +N+ NM
Sbjct: 433 INVSSINLSNNQISKFPKELFST-GSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLT 491
Query: 385 LVDLSGNYFEGRVPEYVHSNASSL-----DSNCLQNVPNQ 419
+DL N ++ + L N P Q
Sbjct: 492 SIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQ 531
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 7e-49
Identities = 67/433 (15%), Positives = 128/433 (29%), Gaps = 78/433 (18%)
Query: 67 DWPRKVDPCL--VWNGVRC-QNGSVVGINISGFRRT---------------------RLG 102
+W + + GV NG V G+++ GF +
Sbjct: 59 NWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK 118
Query: 103 SQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLG-QQLPTLQALDLRSCSISGVIPFS 161
F + R + D+ + L + S I S
Sbjct: 119 VNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS 178
Query: 162 LGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTG----------------- 204
T + N +T + ++ +L+ L + +
Sbjct: 179 SRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ 237
Query: 205 --NIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLAS--------SI 254
+ LK+L+ +++ + +P L L ++Q +NV+ N S
Sbjct: 238 YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQA 297
Query: 255 PAQLGDLDSLVDLDLSMNSL-SGSVPSELRGLRSLQKFVIGNNFLSGNLS--VNLFPTVS 311
A + + + + N+L + V + L+ ++ L N L G L +
Sbjct: 298 LADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSE----I 353
Query: 312 QLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVN-TSTVELNISQN 370
+L + L N T P + Q+ L + N +PN + + ++ S N
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYN 412
Query: 371 MFYG-------GLTPVLGRF---RLVDLSGNYFEGRVPEYVHSNASSL-----DSNCLQN 415
L P + ++LS N E + S S L N L
Sbjct: 413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKE-LFSTGSPLSSINLMGNMLTE 471
Query: 416 VPNQRTLVDCSSF 428
+P + +F
Sbjct: 472 IPKNSLKDENENF 484
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 9e-44
Identities = 46/255 (18%), Positives = 93/255 (36%), Gaps = 30/255 (11%)
Query: 115 NLTHLASFNASRFLLPGSIPDWLG-QQLPTLQALDLRSCSISGV-------IPFSLGNLT 166
+ + + + L IP+ + + + A+D I V + +
Sbjct: 375 FTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGI 433
Query: 167 NLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTG-------NIPTSFGLLKNLSSL 219
N++S+ LS+N ++ S LS ++L N LT + +F L+S+
Sbjct: 434 NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSI 493
Query: 220 DISSNYLTGSIPP--GLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDL------DLSM 271
D+ N LT + TL L +++S NS S P Q + +L D
Sbjct: 494 DLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDAQG 551
Query: 272 NSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVL 331
N P + SL + IG+N + ++ + P + ++ ++ N +
Sbjct: 552 NRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP---NISVLDIKDNPNISIDLSYV 607
Query: 332 WSMPQLRLLDISRNN 346
+ + + +
Sbjct: 608 CPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-43
Identities = 49/284 (17%), Positives = 94/284 (33%), Gaps = 47/284 (16%)
Query: 111 DALVNLTHLASFNAS--RFLLPGSIPDWLGQQLPTLQALDLRSCSISGV-IPFSLGNLTN 167
A + LAS N + + IP ++ L + + F +++
Sbjct: 347 PAFGSEIKLASLNLAYNQI---TEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSV 403
Query: 168 LTSLYLSDNGLTG-------TIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLD 220
++++ S N + + + + +S ++LS N ++ F LSS++
Sbjct: 404 MSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSIN 463
Query: 221 ISSNYLTG-------SIPPGLGTLSKLQYLNVSNNSLASSIPA--QLGDLDSLVDLDLSM 271
+ N LT L +++ N L + + + L LV +DLS
Sbjct: 464 LMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSY 522
Query: 272 NSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVL 331
NS S P++ +L+ F I N + N P+ +
Sbjct: 523 NSFSK-FPTQPLNSSTLKGFGIRNQRD-------------------AQGNRTLREWPEGI 562
Query: 332 WSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGG 375
P L L I N+ + + + L+I N
Sbjct: 563 TLCPSLTQLQIGSNDIRK-VNEK---ITPNISVLDIKDNPNISI 602
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-28
Identities = 29/179 (16%), Positives = 53/179 (29%), Gaps = 19/179 (10%)
Query: 111 DALVNLTHLASFNASR-------FLLPGSIPDWLGQQLPTLQALDLRSCSISGVIP-FSL 162
+ + L+S N + L ++DLR ++ + F
Sbjct: 451 ELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN-TYLLTSIDLRFNKLTKLSDDFRA 509
Query: 163 GNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVL------DLSRNSLTGNIPTSFGLLKNL 216
L L + LS N + P+ S L D N P L +L
Sbjct: 510 TTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSL 568
Query: 217 SSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLS 275
+ L I SN + + + + L++ +N S + + L +
Sbjct: 569 TQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-13
Identities = 27/224 (12%), Positives = 58/224 (25%), Gaps = 14/224 (6%)
Query: 203 TGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLD 262
I L + +L+ + G + N + + L
Sbjct: 26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF----NKELDMWGAQPGVSLNSNG 81
Query: 263 SLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQ---LQIIVLR 319
+ L L SG VP + L L+ +G++ N + +S +
Sbjct: 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 320 QNGFTGPPPDVL--WSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLT 377
+ + D L I+ + + S ++ N ++
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI-TLKDTQIGQLSNNI-TFVS 199
Query: 378 PVLGRF---RLVDLSGNYFEGRVPEYVHSNASSLDSNCLQNVPN 418
+ R R + + F N +S + +
Sbjct: 200 KAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDL 243
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-47
Identities = 61/306 (19%), Positives = 103/306 (33%), Gaps = 22/306 (7%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSV 191
IPD L + + LDL + + +S + L L LS + + LS
Sbjct: 21 KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 192 LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLA 251
LS L L+ N + +F L +L L L +G L L+ LNV++N +
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 252 S-SIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTV 310
S +P +L +L LDLS N + ++LR L + + + LS N + P
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD-LSLNPMNFIQPGA 196
Query: 311 ---SQLQIIVLRQNGFTGP-PPDVLWSMPQLRLLDISRNNFTG--PLPNSRSNVNTSTVE 364
+L + LR N + + + L + + F L +
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 365 LNISQN------MFYGGLTPVLGRFRLV---DLSGNYFEGRVPEYVHSNASSLD--SNCL 413
L I + + + + V L E + L+ +
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF 316
Query: 414 QNVPNQ 419
P
Sbjct: 317 GQFPTL 322
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 8e-45
Identities = 69/318 (21%), Positives = 107/318 (33%), Gaps = 32/318 (10%)
Query: 106 PRFAADALVNLTHL--ASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLG 163
+F AL L +L F + L L + + L S +I V FS
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS-- 301
Query: 164 NLTNLTSLYLSDNGLT-------------------GTIPSSLGQLSVLSVLDLSRNSLT- 203
L L + G S L L LDLSRN L+
Sbjct: 302 YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSF 361
Query: 204 -GNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQ-LGDL 261
G S +L LD+S N + + L +L++L+ +++L L
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 420
Query: 262 DSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQN 321
+L+ LD+S + GL SL+ + N N ++F + L + L Q
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 322 GFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYG----GLT 377
P S+ L++L++S NNF S L+ S N L
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC-LNSLQVLDYSLNHIMTSKKQELQ 539
Query: 378 PVLGRFRLVDLSGNYFEG 395
++L+ N F
Sbjct: 540 HFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-42
Identities = 62/238 (26%), Positives = 98/238 (41%), Gaps = 7/238 (2%)
Query: 110 ADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFS-LGNLTNL 168
+ + T L + S + ++LG L L+ LD + ++ + FS +L NL
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVITMSSNFLG--LEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423
Query: 169 TSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNI-PTSFGLLKNLSSLDISSNYLT 227
L +S LS L VL ++ NS N P F L+NL+ LD+S L
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 228 GSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGL-R 286
P +LS LQ LN+S+N+ S L+SL LD S+N + S EL+
Sbjct: 484 QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS 543
Query: 287 SLQKFVIGNNFLSGNLSVNLFPT-VSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDIS 343
SL + N + F + + +++ P MP + L+I+
Sbjct: 544 SLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-40
Identities = 52/263 (19%), Positives = 87/263 (33%), Gaps = 20/263 (7%)
Query: 164 NLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISS 223
+ N+T + IP +L LDLS N L SF L LD+S
Sbjct: 6 VVPNIT-YQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 224 NYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELR 283
+ +LS L L ++ N + S L SL L +L+ +
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 284 GLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRL---- 339
L++L++ + +N + F ++ L+ + L N L + Q+ L
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 340 LDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPV----LGRFRLVDLSGNYFEG 395
LD+S N P + + L + N + L + L F
Sbjct: 182 LDLSLNPMNFIQPGAFKEIRLHK--LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
Query: 396 RVPEYVHSNASSLDSNCLQNVPN 418
N D + L+ + N
Sbjct: 240 ------EGNLEKFDKSALEGLCN 256
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-36
Identities = 66/335 (19%), Positives = 115/335 (34%), Gaps = 40/335 (11%)
Query: 110 ADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGV-IPFSLGNLTNL 168
A L+ L A L +G L TL+ L++ I +P NLTNL
Sbjct: 93 LGAFSGLSSLQKLVAVETNLASLENFPIG-HLKTLKELNVAHNLIQSFKLPEYFSNLTNL 151
Query: 169 TSLYLSDNGLTGTIPSSLGQLSVLSV----LDLSRNSLTGNIPTSFGLLKNLSSLDISSN 224
L LS N + + L L + + LDLS N + P +F + L L + +N
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNN 210
Query: 225 YLTGSIPPG-LGTLSKLQYLNVSNNSLASSIPAQLGD---LDSLVDLDLSMNSLS----- 275
+ + ++ + L+ L+ + + + D L+ L +L + L+
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 276 -GSVPSELRGLRSLQKFVIGNNFLSG----------------NLSVNLFPTVSQLQIIVL 318
+ L ++ F + + + N FPT+ + L
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL 330
Query: 319 RQNGFTGPPPDVLWSMPQLRLLDISRN--NFTGPLPNSRSNVNTSTVELNISQNMFYGGL 376
G +P L LD+SRN +F G S TS L++S N +
Sbjct: 331 TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG-TTSLKYLDLSFNGVI-TM 388
Query: 377 TPVLGRF---RLVDLSGNYFEGRVPEYVHSNASSL 408
+ +D + + V + +L
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-44
Identities = 50/341 (14%), Positives = 95/341 (27%), Gaps = 43/341 (12%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTS 170
A+ LT L + + + S NL +LT
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNI------AVDWEDANSDYAKQYENEELSWSNLKDLTD 495
Query: 171 LYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTG---------NIPTSFGLLKNLSSLDI 221
+ L + +P L L L L+++ N + + +
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYM 555
Query: 222 SSNYLTGSIPP--GLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVP 279
N L P L + KL L+ +N + + A G L DL L N + +P
Sbjct: 556 GYNNLE-EFPASASLQKMVKLGLLDCVHNKV-RHLEA-FGTNVKLTDLKLDYNQIE-EIP 611
Query: 280 SEL-RGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLR 338
+ ++ +N L ++ +V + + N ++ SM +
Sbjct: 612 EDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYK 671
Query: 339 L-----LDISRNNFTGPLPNSRSNVNTSTVELNISQNMF-------YGGLTPVLGRF--- 383
+ +S N + + + +S N+
Sbjct: 672 GINASTVTLSYNEIQKFPTELFAT-GSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLL 730
Query: 384 RLVDLSGNYFEGRVPEYVHSNASSL-----DSNCLQNVPNQ 419
+DL N ++ + L NC + P Q
Sbjct: 731 TTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQ 771
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 3e-38
Identities = 42/275 (15%), Positives = 84/275 (30%), Gaps = 41/275 (14%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGV-IPFSLGNLTNLT 169
+A L + IP+ ++ L + + F+ ++ +
Sbjct: 589 EAFGTNVKLTDLKLDYNQI-EEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMG 647
Query: 170 SLYLSDNGLTGTIPSSLGQLSV-----LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSN 224
S+ S N + + + S + LS N + F +S++ +S+N
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN 707
Query: 225 YLT-------GSIPPGLGTLSKLQYLNVSNNSLASSIPAQL--GDLDSLVDLDLSMNSLS 275
+T L +++ N L +S+ L L ++D+S N S
Sbjct: 708 LMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSDDFRATTLPYLSNMDVSYNCFS 766
Query: 276 GSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMP 335
S P++ L+ F + N P + + P
Sbjct: 767 -SFPTQPLNSSQLKAF---------GIRHQRD----------AEGNRILRQWPTGITTCP 806
Query: 336 QLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQN 370
L L I N+ + + L+I+ N
Sbjct: 807 SLIQLQIGSNDIRK-VDEKLT---PQLYILDIADN 837
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-35
Identities = 57/377 (15%), Positives = 113/377 (29%), Gaps = 62/377 (16%)
Query: 101 LGSQNPRFAADALVNLTHLASFNASRFL-LPGSIPDWLGQQLPTLQALDLRSCSISGVIP 159
L +N R+ + + N H ++N ++ L + G P + L L G +P
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP 340
Query: 160 FSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFG-LLKNLSS 218
++G LT L L + T + + + + ++ + + F + L+
Sbjct: 341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNL 400
Query: 219 LDISSNYLTG----------------------------SIPPGLGTLSKLQYLNVSNNSL 250
D+ + + I + L+KLQ + +N+
Sbjct: 401 SDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPF 460
Query: 251 ASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTV 310
A D + + L+ L + N L L+ +
Sbjct: 461 TYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD-L 514
Query: 311 SQLQIIVLRQNGFTGPP---------PDVLWSMPQLRLLDISRNNFTGPLPNSRSNVN-T 360
+LQ + + N D + P++++ + NN P S S
Sbjct: 515 PELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMV 573
Query: 361 STVELNISQNMF-----YGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASSL-----DS 410
L+ N +G + + L N E +PE + +
Sbjct: 574 KLGLLDCVHNKVRHLEAFGTNV----KLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSH 628
Query: 411 NCLQNVPNQRTLVDCSS 427
N L+ +PN
Sbjct: 629 NKLKYIPNIFNAKSVYV 645
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 6e-33
Identities = 40/229 (17%), Positives = 79/229 (34%), Gaps = 25/229 (10%)
Query: 113 LVNLTHLASFNASRFLL---PGSIPDWLGQ-QLPTLQALDLRSCSISGVIPFSLGNLTNL 168
++ + S + S + +I + + + L I + +
Sbjct: 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI 699
Query: 169 TSLYLSDNGLT-------GTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGL--LKNLSSL 219
+++ LS+N +T + +L+ +DL N LT + F L LS++
Sbjct: 700 STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNM 758
Query: 220 DISSNYLTGSIPPGLGTLSKLQYLN------VSNNSLASSIPAQLGDLDSLVDLDLSMNS 273
D+S N + S P S+L+ N + P + SL+ L + N
Sbjct: 759 DVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND 817
Query: 274 LSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNG 322
+ V +L L I +N ++ V + + VL +
Sbjct: 818 IR-KVDEKL--TPQLYILDIADNPNI-SIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-29
Identities = 34/205 (16%), Positives = 68/205 (33%), Gaps = 22/205 (10%)
Query: 108 FAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSIS-------GVIPF 160
+ + ++ S + + + + L + ++
Sbjct: 664 SCSMDDYKGINASTVTLSYNEIQKFPTELFAT-GSPISTIILSNNLMTSIPENSLKPKDG 722
Query: 161 SLGNLTNLTSLYLSDNGLTGTIPSSL--GQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSS 218
+ N LT++ L N LT ++ L LS +D+S N + PT L +
Sbjct: 723 NYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKA 780
Query: 219 LDI------SSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMN 272
I N + P G+ T L L + +N + + +L L LD++ N
Sbjct: 781 FGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADN 837
Query: 273 SL-SGSVPSELRGLRSLQKFVIGNN 296
S V S + + ++ +
Sbjct: 838 PNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-23
Identities = 27/163 (16%), Positives = 57/163 (34%), Gaps = 14/163 (8%)
Query: 131 GSIPDWLGQQLPTLQALDLRSCSISGVIP-FSLGNLTNLTSLYLSDNGLTGTIPSSLGQL 189
L +DLR ++ + F L L+++ +S N + + P+
Sbjct: 718 KPKDGNYKN-TYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNS 775
Query: 190 SVLSVLDLSR------NSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYL 243
S L + N + PT +L L I SN + + L +L L
Sbjct: 776 SQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYIL 832
Query: 244 NVSNNSLAS-SIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGL 285
++++N S + + +++ + L + + G+
Sbjct: 833 DIADNPNISIDVTSVCPYIEAGM-YVLLYDKTQDIRGCDALGI 874
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-43
Identities = 60/326 (18%), Positives = 112/326 (34%), Gaps = 20/326 (6%)
Query: 106 PRFAADALVNLTHLA-SFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGN 164
+ +L + P G ++++++L+ + +
Sbjct: 220 KGLKNSTIQSLWLGTFEDMDDEDISPAVFE---GLCEMSVESINLQKHYFFNISSNTFHC 276
Query: 165 LTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSN 224
+ L L L+ L+ +PS L LS L L LS N S +L+ L I N
Sbjct: 277 FSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGN 335
Query: 225 YLTGSIPPG-LGTLSKLQYLNVSNNSLASS--IPAQLGDLDSLVDLDLSMNSLSGSVPSE 281
+ G L L L+ L++S++ + +S QL +L L L+LS N
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395
Query: 282 LRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLD 341
+ L+ + L + + F + L+++ L + + +P L+ L+
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455
Query: 342 ISRNNFTGPLPNSRSNVN--TSTVELNISQNMFYGGLTPV----LGRFRLVDLSGNYFEG 395
+ N+F +++ L +S + L VDLS N
Sbjct: 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL-SSIDQHAFTSLKMMNHVDLSHNRLTS 514
Query: 396 RVPEYVHSNASS----LDSNCLQNVP 417
S+ L SN + +
Sbjct: 515 -SSIEALSHLKGIYLNLASNHISIIL 539
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 9e-42
Identities = 56/245 (22%), Positives = 88/245 (35%), Gaps = 8/245 (3%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSI--SGVIPFSLGNLTNL 168
+ N L + + + L L+ LDL I S L NL++L
Sbjct: 319 ISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHL 378
Query: 169 TSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTS-FGLLKNLSSLDISSNYLT 227
SL LS N + + L +LDL+ L S F L L L++S + L
Sbjct: 379 QSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD 438
Query: 228 GSIPPGLGTLSKLQYLNVSNNSLASSI---PAQLGDLDSLVDLDLSMNSLSGSVPSELRG 284
S L LQ+LN+ N L L L L LS LS
Sbjct: 439 ISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTS 498
Query: 285 LRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISR 344
L+ + + +N L+ S+ + + + L N + P +L + Q R +++ +
Sbjct: 499 LKMMNHVDLSHNRLTS-SSIEALSHLKGIYLN-LASNHISIILPSLLPILSQQRTINLRQ 556
Query: 345 NNFTG 349
N
Sbjct: 557 NPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-40
Identities = 61/266 (22%), Positives = 100/266 (37%), Gaps = 16/266 (6%)
Query: 113 LVNLTHLA-SFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVI-PFSLGNLTNLTS 170
L L L S N L S P+L L ++ + + L NL NL
Sbjct: 300 LSTLKKLVLSANKFENLCQISA-----SNFPSLTHLSIKGNTKRLELGTGCLENLENLRE 354
Query: 171 LYLSDNGLT--GTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTG 228
L LS + + L LS L L+LS N +F L LD++ L
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
Query: 229 SIPPG-LGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSG---SVPSELRG 284
L L+ LN+S++ L S L +L L+L N + L+
Sbjct: 415 KDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474
Query: 285 LRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISR 344
L L+ V+ LS + + F ++ + + L N T + L + + L +++
Sbjct: 475 LGRLEILVLSFCDLSS-IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYL-NLAS 532
Query: 345 NNFTGPLPNSRSNVNTSTVELNISQN 370
N+ + LP+ + +N+ QN
Sbjct: 533 NHISIILPSLLPI-LSQQRTINLRQN 557
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-40
Identities = 46/300 (15%), Positives = 99/300 (33%), Gaps = 20/300 (6%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSV 191
IP L + + L+ + + + L NLT L L+ + +
Sbjct: 26 EIPGTL---PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHR 82
Query: 192 LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLA 251
L L L+ N L T+ K L L ++ L L+ L + +N ++
Sbjct: 83 LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142
Query: 252 SSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVI--GNNFLSGNLSVNLFPT 309
S + + L LD N++ ++ L+ + N ++G + F +
Sbjct: 143 SIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDS 201
Query: 310 VSQLQIIVLRQNGFTGPPPDVLW--SMPQLRLLDISRNNFTGPLPNS-RSNVNTSTVELN 366
+ Q + L ++ L L + P S +N
Sbjct: 202 -AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN 260
Query: 367 ISQNMFYGGLTPV----LGRFRLVDLSGNYFEGRVPEYVHSNAS----SLDSNCLQNVPN 418
+ ++ F+ ++ + +DL+ + +P + ++ L +N +N+
Sbjct: 261 LQKHYFF-NISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQ 318
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-32
Identities = 56/245 (22%), Positives = 88/245 (35%), Gaps = 11/245 (4%)
Query: 108 FAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFS-LGNLT 166
L NL+HL S N S + ++ P L+ LDL + S NL
Sbjct: 367 CCNLQLRNLSHLQSLNLSYNEPLSLKTEAF-KECPQLELLDLAFTRLKVKDAQSPFQNLH 425
Query: 167 NLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSS---LDISS 223
L L LS + L + L L L+L N L+ L L +S
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
Query: 224 NYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELR 283
L+ +L + ++++S+N L SS L L + L+L+ N +S +PS L
Sbjct: 486 CDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLP 544
Query: 284 GLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDIS 343
L + + N L S F L+ + + P LR + +S
Sbjct: 545 ILSQQRTINLRQNPLDCTCSNIYF-----LEWYKENMQKLEDTEDTLCENPPLLRGVRLS 599
Query: 344 RNNFT 348
+
Sbjct: 600 DVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-29
Identities = 39/246 (15%), Positives = 78/246 (31%), Gaps = 10/246 (4%)
Query: 194 VLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASS 253
+ L IP L + L+ S N L L L +L+++ +
Sbjct: 16 TYNCENLGLN-EIPG--TLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 254 IPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQL 313
L L L+ N L + L G ++L+ +S + L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTL 131
Query: 314 QIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNV-NTSTVELNISQNMF 372
+ + L N + + +L++LD N S++ + + LN++ N
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 373 YG--GLTPVLGRFRLVDLSGNYFEGRVPE-YVHSNASSLDSNCLQNVPNQRTLVDCSSFY 429
G F+ ++ G + + +S SL ++ + + F
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFED--MDDEDISPAVFE 249
Query: 430 AARGLS 435
+S
Sbjct: 250 GLCEMS 255
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-40
Identities = 55/314 (17%), Positives = 103/314 (32%), Gaps = 26/314 (8%)
Query: 521 GESFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLEL 580
G + L + + G G +++ L V +K +Q ++ E+
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE-YVAVKIFPIQDKQSWQNEYEV 69
Query: 581 DFFSKVSHARLVPLLGHCMEREN---EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWI 637
+ H ++ +G + + +L+ + G LS L + W
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--------VSWN 121
Query: 638 TRLKIAIGAAEGLSYLHHE-------CTLPFVHRDVQASSILLDDKFEVRLG--SLSEVC 688
IA A GL+YLH + HRD+++ ++LL + + L+
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 689 AQGGDAHQSRI---TRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISAS 745
G A + TR P+ E + A D+Y G VL EL +
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241
Query: 746 SDAQVKEILEQTLPYISIYD--KELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPT 803
D + E+ + S+ D + +V K P L + + C +
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301
Query: 804 RRPLMRYILKALEN 817
R + + +
Sbjct: 302 ARLSAGCVGERITQ 315
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-40
Identities = 60/306 (19%), Positives = 108/306 (35%), Gaps = 23/306 (7%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSV 191
+PD + + + +DL + + +S N + L L LS + + L
Sbjct: 25 KVPDDIP---SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHH 81
Query: 192 LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLA 251
LS L L+ N + P SF L +L +L L +G L L+ LNV++N +
Sbjct: 82 LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH 141
Query: 252 S-SIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFV----IGNNFLSGNLSVNL 306
S +PA +L +LV +DLS N + ++L+ LR + + N + +
Sbjct: 142 SCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQA 200
Query: 307 FPTVSQLQIIVLRQNGFTG-PPPDVLWSMPQLRLLDISRNNFTGPLPNSRSN-------V 358
F + L + LR N + L ++ L + + F
Sbjct: 201 FQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259
Query: 359 NTSTVELNISQNMFYGGLTPVLGRF---RLVDLSGNYFEGRVPEYVHSNASSLD--SNCL 413
+ + E ++ + + L+G + H SL L
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQL 319
Query: 414 QNVPNQ 419
+ P
Sbjct: 320 KQFPTL 325
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-38
Identities = 64/287 (22%), Positives = 112/287 (39%), Gaps = 16/287 (5%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTS 170
L ++++ + + + + D + Q+L + C + P +L L S
Sbjct: 279 VKFHCLANVSAMSLAGVSI-KYLED--VPKHFKWQSLSIIRCQLKQ-FPTL--DLPFLKS 332
Query: 171 LYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLK--NLSSLDISSNYLTG 228
L L+ N + I L LS LDLSRN+L+ + S+ L +L LD+S N
Sbjct: 333 LTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI- 389
Query: 229 SIPPGLGTLSKLQYLNVSNNSLASSIPAQ-LGDLDSLVDLDLSMNSLSGSVPSELRGLRS 287
+ L +LQ+L+ +++L L+ L+ LD+S + GL S
Sbjct: 390 IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTS 449
Query: 288 LQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNF 347
L + N N N+F + L + L + V ++ +L+LL++S NN
Sbjct: 450 LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509
Query: 348 TGPLPNSRSNVNTSTVELNISQNMFYG---GLTPVLGRFRLVDLSGN 391
+ + S L+ S N L +L+ N
Sbjct: 510 LFLDSSHYNQ-LYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-33
Identities = 50/275 (18%), Positives = 89/275 (32%), Gaps = 20/275 (7%)
Query: 156 GVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKN 215
G + + + N+T D L+ +P + S +DLS N L SF
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 216 LSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLS 275
L LD+S + L L L ++ N + S P L SL +L L+
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 276 GSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMP 335
+ L +L+K + +NF+ F ++ L + L N + L +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 336 QLRL----LDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPV----LGRFRLVD 387
+ LD+S N + EL + N + L +
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQ--AFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHR 235
Query: 388 LSGNYFEGRVPEYVHSNASSLDSNCLQNVPNQRTL 422
L F+ N + + ++ + +
Sbjct: 236 LILGEFKD------ERNLEIFEPSIMEGLCDVTID 264
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-33
Identities = 53/195 (27%), Positives = 81/195 (41%), Gaps = 9/195 (4%)
Query: 108 FAADALVNLTHLA-SFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFS-LGNL 165
++ +L HL SFN + + L LQ LD + ++ V FS +L
Sbjct: 370 YSDLGTNSLRHLDLSFNGAI-----IMSANF-MGLEELQHLDFQHSTLKRVTEFSAFLSL 423
Query: 166 TNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTS-FGLLKNLSSLDISSN 224
L L +S L+ L+ L ++ NS N ++ F NL+ LD+S
Sbjct: 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483
Query: 225 YLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRG 284
L TL +LQ LN+S+N+L + L SL LD S N + S
Sbjct: 484 QLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHF 543
Query: 285 LRSLQKFVIGNNFLS 299
+SL F + NN ++
Sbjct: 544 PKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-28
Identities = 53/329 (16%), Positives = 96/329 (29%), Gaps = 30/329 (9%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLT- 169
+ L L N + + L L +DL I + L L
Sbjct: 122 FPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQ 181
Query: 170 ---SLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIP-TSFGLLKNLSSLDISSNY 225
SL +S N + I Q L L L N + NI T L L +
Sbjct: 182 VNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGE 240
Query: 226 LTGSIP---PGLGTLSKLQYLNV-----SNNSLASSIPAQLGDLDSLVDLDLSMNSLSGS 277
+ L + + + + S + L ++ + L+ S+
Sbjct: 241 FKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY- 299
Query: 278 VPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQL 337
++ Q I L +++L L+ + L N + ++P L
Sbjct: 300 -LEDVPKHFKWQSLSIIRCQLKQFPTLDL----PFLKSLTLTMNKGSISFK--KVALPSL 352
Query: 338 RLLDISRNNFTGPLPNSRSNVN-TSTVELNISQNMFY--GGLTPVLGRFRLVDLSGNYFE 394
LD+SRN + S S++ S L++S N L + +D + +
Sbjct: 353 SYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLK 412
Query: 395 GRVPEYVHSNASSL-----DSNCLQNVPN 418
+ L + +
Sbjct: 413 RVTEFSAFLSLEKLLYLDISYTNTKIDFD 441
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-21
Identities = 31/164 (18%), Positives = 57/164 (34%), Gaps = 3/164 (1%)
Query: 110 ADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLT 169
+ LT L + + + + L LDL C + + L L
Sbjct: 441 DGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ 500
Query: 170 SLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGS 229
L +S N L S QL LS LD S N + + K+L+ ++++N +
Sbjct: 501 LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-C 559
Query: 230 IPPGLGTLSKLQYLNVSNNSLASSIPAQLGDL--DSLVDLDLSM 271
I L ++ ++ A ++ ++D + S
Sbjct: 560 ICEHQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLDFNNST 603
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 6e-38
Identities = 46/238 (19%), Positives = 90/238 (37%), Gaps = 29/238 (12%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSV 191
PD + L LQ + + + + +P ++ L +L L+ N L +P+S+ L+
Sbjct: 95 QFPDQAFR-LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNR 151
Query: 192 LSVLDLSRNSLTGNIPTSFG---------LLKNLSSLDISSNYLTGSIPPGLGTLSKLQY 242
L L + +P L NL SL + + S+P + L L+
Sbjct: 152 LRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKS 210
Query: 243 LNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKF-VIGNNFLS-- 299
L + N+ L S++ + L L +LDL + + P G L++ + + L
Sbjct: 211 LKIRNSPL-SALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTL 269
Query: 300 ----GNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPN 353
L+ QL+ + LR P ++ +P ++ + + +
Sbjct: 270 PLDIHRLT--------QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 58/277 (20%), Positives = 106/277 (38%), Gaps = 34/277 (12%)
Query: 113 LVNLTHLASFNASRFLLPGSIPDWLGQ-QLPTLQALDLRSCSISGVIPFSLGNLTNLTSL 171
N + + L + D L P AL+LRS + P L++L +
Sbjct: 52 QANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHM 109
Query: 172 YLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIP 231
+ GL +P ++ Q + L L L+RN L +P S L L L I + +P
Sbjct: 110 TIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167
Query: 232 PGLG---------TLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSEL 282
L L LQ L + + S+PA + +L +L L + + LS ++ +
Sbjct: 168 EPLASTDASGEHQGLVNLQSLRLEWTGI-RSLPASIANLQNLKSLKIRNSPLS-ALGPAI 225
Query: 283 RGLRSLQKFVI-GNNFLS------GNLSVNLFPTVSQLQIIVLR-QNGFTGPPPDVLWSM 334
L L++ + G L G + L+ ++L+ + P D + +
Sbjct: 226 HHLPKLEELDLRGCTALRNYPPIFGGR--------APLKRLILKDCSNLLTLPLD-IHRL 276
Query: 335 PQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNM 371
QL LD+ LP+ + + + + + ++
Sbjct: 277 TQLEKLDLRGCVNLSRLPSLIAQL-PANCIILVPPHL 312
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 46/205 (22%), Positives = 83/205 (40%), Gaps = 14/205 (6%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGN------ 164
D + L + +R L ++P + L L+ L +R+C +P L +
Sbjct: 121 DTMQQFAGLETLTLARNPLR-ALPASIAS-LNRLRELSIRACPELTELPEPLASTDASGE 178
Query: 165 ---LTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDI 221
L NL SL L G+ ++P+S+ L L L + + L+ + + L L LD+
Sbjct: 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDL 236
Query: 222 SSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSE 281
+ PP G + L+ L + + S ++P + L L LDL +PS
Sbjct: 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296
Query: 282 LRGLRSLQKFVIGNNFLSGNLSVNL 306
+ L + ++ + L L +
Sbjct: 297 IAQLPANCIILVPPH-LQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 38/252 (15%), Positives = 74/252 (29%), Gaps = 48/252 (19%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLT-----------------NLTSLYLSDNGLTG- 180
+ L + + L N + +
Sbjct: 9 HHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRAL 68
Query: 181 -TIPSSLGQLSV--LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTL 237
L + L+L L P L +L + I + L +P +
Sbjct: 69 KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQF 126
Query: 238 SKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSEL---------RGLRSL 288
+ L+ L ++ N L ++PA + L+ L +L + +P L +GL +L
Sbjct: 127 AGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
Query: 289 QKFVIGNNFLS------GNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDI 342
Q + + NL L+ + +R + + P + +P+L LD+
Sbjct: 186 QSLRLEWTGIRSLPASIANL--------QNLKSLKIRNSPLSALGPA-IHHLPKLEELDL 236
Query: 343 SRNNFTGPLPNS 354
P
Sbjct: 237 RGCTALRNYPPI 248
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 34/165 (20%), Positives = 56/165 (33%), Gaps = 8/165 (4%)
Query: 101 LGSQNPRFAADALVNLTHL-ASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIP 159
L S + LVNL L + R S+P + L L++L +R+ +S +
Sbjct: 170 LASTDASGEHQGLVNLQSLRLEWTGIR-----SLPASIAN-LQNLKSLKIRNSPLSA-LG 222
Query: 160 FSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSL 219
++ +L L L L P G + L L L S +P L L L
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL 282
Query: 220 DISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSL 264
D+ +P + L + V + A + +
Sbjct: 283 DLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 37/239 (15%), Positives = 73/239 (30%), Gaps = 35/239 (14%)
Query: 161 SLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGL-------- 212
+ + +LY + L Q D +R S
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGR 66
Query: 213 -------------LKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLG 259
+L++ S L P LS LQ++ + L +P +
Sbjct: 67 ALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQ 124
Query: 260 DLDSLVDLDLSMNSLSGSVPSELRGLRSLQKF-VIGNNFLS------GNLSV-NLFPTVS 311
L L L+ N L ++P+ + L L++ + L+ + +
Sbjct: 125 QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLV 183
Query: 312 QLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQN 370
LQ + L G P + ++ L+ L I + + L + ++ EL++
Sbjct: 184 NLQSLRLEWTGIRSLPAS-IANLQNLKSLKIRNSPLSA-LGPAIHHL-PKLEELDLRGC 239
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-06
Identities = 18/145 (12%), Positives = 35/145 (24%), Gaps = 7/145 (4%)
Query: 228 GSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRS 287
GS S + L ++ L + D + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 288 LQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNF 347
Q L + T + LR P + + L+ + I
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQFPDQ-AFRLSHLQHMTIDAAGL 116
Query: 348 TGPLPNSRSNVNTSTVELNISQNMF 372
LP++ L +++N
Sbjct: 117 ME-LPDTMQQF-AGLETLTLARNPL 139
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-36
Identities = 59/309 (19%), Positives = 118/309 (38%), Gaps = 47/309 (15%)
Query: 112 ALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFS---------- 161
L + + + SI + L L+ L+L I+ + P S
Sbjct: 39 TQEELESITKLVVAGEKV-ASIQGI--EYLTNLEYLNLNGNQITDISPLSNLVKLTNLYI 95
Query: 162 ----------LGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFG 211
L NLTNL LYL+++ ++ S L L+ + L+L N ++
Sbjct: 96 GTNKITDISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS-PLS 152
Query: 212 LLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSM 271
+ L+ L ++ + + P + L+ L L+++ N + P L L SL +
Sbjct: 153 NMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYV 208
Query: 272 NSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVL 331
N ++ + + + L IGNN ++ ++ +SQL + + N + +
Sbjct: 209 NQITDI--TPVANMTRLNSLKIGNNKIT---DLSPLANLSQLTWLEIGTNQISDINA--V 261
Query: 332 WSMPQLRLLDISRNNFTGPLPNSRSNVN--TSTVELNISQNMFYGGLTPVLGRF---RLV 386
+ +L++L++ N + S +N + L ++ N V+G +
Sbjct: 262 KDLTKLKMLNVGSNQISDI-----SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316
Query: 387 DLSGNYFEG 395
LS N+
Sbjct: 317 FLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-36
Identities = 58/283 (20%), Positives = 109/283 (38%), Gaps = 44/283 (15%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFS--------- 161
L NL L + + + L L L+ L L +IS + P +
Sbjct: 82 SPLSNLVKLTNLYIGTNKI--TDISALQN-LTNLRELYLNEDNISDISPLANLTKMYSLN 138
Query: 162 ------------LGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTS 209
L N+T L L ++++ + P + L+ L L L+ N + P
Sbjct: 139 LGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP-- 194
Query: 210 FGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDL 269
L +L N +T P + +++L L + NN + P L +L L L++
Sbjct: 195 LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEI 250
Query: 270 SMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPD 329
N +S + ++ L L+ +G+N +S +++ +SQL + L N +
Sbjct: 251 GTNQISD--INAVKDLTKLKMLNVGSNQIS---DISVLNNLSQLNSLFLNNNQLGNEDME 305
Query: 330 VLWSMPQLRLLDISRNNFTG--PLPNSRSNVNTSTVELNISQN 370
V+ + L L +S+N+ T PL + + + +
Sbjct: 306 VIGGLTNLTTLFLSQNHITDIRPLAS-----LSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 134 bits (341), Expect = 1e-34
Identities = 53/246 (21%), Positives = 91/246 (36%), Gaps = 24/246 (9%)
Query: 128 LLPGSIPDWLG-QQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSL 186
LP I L L+ S++ V+ L ++T L ++ + +
Sbjct: 7 TLPAPINQIFPDADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVAS--IQGI 62
Query: 187 GQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVS 246
L+ L L+L+ N +T P L L++L I +N +T L L+ L+ L ++
Sbjct: 63 EYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLN 118
Query: 247 NNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNL 306
++++ P L +L + L+L N S S L + L + + + V
Sbjct: 119 EDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVK---DVTP 172
Query: 307 FPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTG--PLPNSRSNVNTSTVE 364
++ L + L N P L S+ L N T P+ N T
Sbjct: 173 IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVAN-----MTRLNS 225
Query: 365 LNISQN 370
L I N
Sbjct: 226 LKIGNN 231
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 47/229 (20%), Positives = 88/229 (38%), Gaps = 23/229 (10%)
Query: 144 LQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLT 203
L I+ + P +L L +T + +L ++ L ++ +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 204 GNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDS 263
+I L NL L+++ N +T P L L KL L + N + + I A L +L +
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI-TDISA-LQNLTN 111
Query: 264 LVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGF 323
L +L L+ +++S S L L + +G N +LS ++ L + + ++
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSP--LSNMTGLNYLTVTESKV 167
Query: 324 TGPPPDVLWSMPQLRLLDISRNNFTG--PLPNSRSNVNTSTVELNISQN 370
P + ++ L L ++ N PL + TS N
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIEDISPLAS-----LTSLHYFTAYVN 209
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 41/161 (25%), Positives = 69/161 (42%), Gaps = 10/161 (6%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLS 198
L +L I+ + P + N+T L SL + +N +T P L LS L+ L++
Sbjct: 196 ASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIG 251
Query: 199 RNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQL 258
N ++ + L L L++ SN ++ L LS+L L ++NN L + +
Sbjct: 252 TNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVI 307
Query: 259 GDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLS 299
G L +L L LS N ++ L L + N +
Sbjct: 308 GGLTNLTTLFLSQNHITDI--RPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 38/165 (23%), Positives = 72/165 (43%), Gaps = 11/165 (6%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTS 170
L +LT L F A + P + + L +L + + I+ + P L NL+ LT
Sbjct: 193 SPLASLTSLHYFTAYVNQITDITP--VAN-MTRLNSLKIGNNKITDLSP--LANLSQLTW 247
Query: 171 LYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSI 230
L + N ++ +++ L+ L +L++ N ++ + L L+SL +++N L
Sbjct: 248 LEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNED 303
Query: 231 PPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLS 275
+G L+ L L +S N + P L L + D + +
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-36
Identities = 64/248 (25%), Positives = 102/248 (41%), Gaps = 13/248 (5%)
Query: 129 LPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLT--GTIPSSL 186
+P IP + L+L S + + LT LT L LS NGL+ G S
Sbjct: 22 VPTGIP-------SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSD 74
Query: 187 GQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGL-GTLSKLQYLNV 245
+ L LDLS N + + ++F L+ L LD + L + +L L YL++
Sbjct: 75 FGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 133
Query: 246 SNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSE-LRGLRSLQKFVIGNNFLSGNLSV 304
S+ + L SL L ++ NS + + LR+L + L LS
Sbjct: 134 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSP 192
Query: 305 NLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVE 364
F ++S LQ++ + N F + L++LD S N+ + +S
Sbjct: 193 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 252
Query: 365 LNISQNMF 372
LN++QN F
Sbjct: 253 LNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 54/242 (22%), Positives = 95/242 (39%), Gaps = 13/242 (5%)
Query: 158 IPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLT--GNIPTSFGLLKN 215
+P + ++ T L L N L +L+ L+ L LS N L+ G S +
Sbjct: 22 VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 216 LSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQ--LGDLDSLVDLDLSMNS 273
L LD+S N + ++ L +L++L+ +++L + L +L+ LD+S
Sbjct: 80 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTH 137
Query: 274 LSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWS 333
+ GL SL+ + N N ++F + L + L Q P S
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197
Query: 334 MPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMF----YGGLTPVLGRFRLVDLS 389
+ L++L++S NNF + S L+ S N L ++L+
Sbjct: 198 LSSLQVLNMSHNNFFSLDTFPYKCL-NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 256
Query: 390 GN 391
N
Sbjct: 257 QN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 41/160 (25%), Positives = 66/160 (41%), Gaps = 10/160 (6%)
Query: 96 FRRTRLGSQNPRFAADALVNLTHLA-SFNASRFLLPGSIPDWLGQQLPTLQALDLRSCS- 153
F+ + L + +L NL +L S +R + + L +L+ L + S
Sbjct: 108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-----VAFNGIFNGLSSLEVLKMAGNSF 162
Query: 154 ISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLL 213
+P L NLT L LS L P++ LS L VL++S N+ + L
Sbjct: 163 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 222
Query: 214 KNLSSLDISSNYLTGSIPPGL--GTLSKLQYLNVSNNSLA 251
+L LD S N++ + S L +LN++ N A
Sbjct: 223 NSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 49/295 (16%), Positives = 103/295 (34%), Gaps = 22/295 (7%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSV 191
+I + + Q + + S+ + + N+ L LS N L+ + L +
Sbjct: 1 AIHE-IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 192 LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLA 251
L +L+LS N L L L +LD+++NY+ + ++ L+ +NN++
Sbjct: 60 LELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-ELLV----GPSIETLHAANNNI- 111
Query: 252 SSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVS 311
S + ++ L+ N ++ + +Q + N + L +
Sbjct: 112 SRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 312 QLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNM 371
L+ + L+ N V +L+ LD+S N + + +++ N
Sbjct: 170 TLEHLNLQYNFIYDVKGQV--VFAKLKTLDLSSNKLAF-MGPEFQSA-AGVTWISLRNNK 225
Query: 372 FYGGLTPVLGRF---RLVDLSGNYFEGRVPEYVHSNA---SSLDSNCLQNVPNQR 420
+ L DL GN F S ++ ++ + Q
Sbjct: 226 L-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 38/203 (18%), Positives = 79/203 (38%), Gaps = 8/203 (3%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLS 198
P+++ L + +IS V S ++YL++N +T G S + LDL
Sbjct: 96 LVGPSIETLHAANNNISRV---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152
Query: 199 RNSLTG-NIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQ 257
N + N L L++ N++ + + +KL+ L++S+N L + + +
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKL-AFMGPE 209
Query: 258 LGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIV 317
+ + L N L + LR ++L+ F + N + F ++Q +
Sbjct: 210 FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA 268
Query: 318 LRQNGFTGPPPDVLWSMPQLRLL 340
+ + ++P L
Sbjct: 269 KQTVKKLTGQNEEECTVPTLGHY 291
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-34
Identities = 59/264 (22%), Positives = 104/264 (39%), Gaps = 7/264 (2%)
Query: 109 AADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNL 168
A NL +L + L IP + L L LD+ I ++ + +L NL
Sbjct: 72 EPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNL 130
Query: 169 TSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTG 228
SL + DN L + L+ L L L + +LT + L L L + +
Sbjct: 131 KSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN- 189
Query: 229 SIPPG-LGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSE-LRGLR 286
+I L +L+ L +S+ ++ +L L ++ +L+ +VP +R L
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLV 248
Query: 287 SLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNN 346
L+ + N +S + ++ + +LQ I L P + LR+L++S N
Sbjct: 249 YLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ 307
Query: 347 FTGPLPNSRSNVNTSTVELNISQN 370
T L S + + L + N
Sbjct: 308 LTT-LEESVFHSVGNLETLILDSN 330
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-34
Identities = 77/341 (22%), Positives = 128/341 (37%), Gaps = 39/341 (11%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSV 191
++ P L+ L+L +S V P + NL NL +L L N L LS
Sbjct: 46 TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSN 105
Query: 192 LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVSNNSL 250
L+ LD+S N + + F L NL SL++ N L I L+ L+ L + +L
Sbjct: 106 LTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNL 164
Query: 251 ASSIPAQ-LGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPT 309
+SIP + L L L+ L L +++ + L L+ I + ++ N
Sbjct: 165 -TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG 223
Query: 310 VSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQ 369
++ L + + T P + + LR L++S N + + E+ +
Sbjct: 224 LN-LTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHE-LLRLQEIQLVG 281
Query: 370 N--------MFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASSLDSNCLQNVPNQRT 421
F G L R++++SGN ++L+ + +V N T
Sbjct: 282 GQLAVVEPYAFRG-----LNYLRVLNVSGNQL------------TTLEESVFHSVGNLET 324
Query: 422 LV--------DCSSFYAARGLSFDNFGRPNATQPPPPETSG 454
L+ DC + R NF R T P G
Sbjct: 325 LILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPEFVQG 365
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-33
Identities = 56/240 (23%), Positives = 102/240 (42%), Gaps = 6/240 (2%)
Query: 110 ADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLT 169
L++L + S + + D++ Q L L++L++ + + + L +L
Sbjct: 97 LGVFTGLSNLTKLDISENKI-VILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLE 155
Query: 170 SLYLSDNGLTGTIPS-SLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTG 228
L L LT +IP+ +L L L VL L ++ SF L L L+IS
Sbjct: 156 QLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD 214
Query: 229 SIPPGLGTLSKLQYLNVSNNSLASSIPAQ-LGDLDSLVDLDLSMNSLSGSVPSELRGLRS 287
++ P L L++++ +L +++P + L L L+LS N +S S L L
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNL-TAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLR 273
Query: 288 LQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNF 347
LQ+ + L+ + F ++ L+++ + N T V S+ L L + N
Sbjct: 274 LQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 70/306 (22%), Positives = 112/306 (36%), Gaps = 36/306 (11%)
Query: 129 LPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQ 188
+P IP + LDL I + + +L L L++N ++ P +
Sbjct: 26 VPEGIP-------TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNN 78
Query: 189 LSVLSVLDLSRNSLTGNIPT-SFGLLKNLSSLDISSNYLTGSIPPGL-GTLSKLQYLNVS 246
L L L L N L IP F L NL+ LDIS N + + + L L+ L V
Sbjct: 79 LFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVG 136
Query: 247 NNSLASSIPAQ-LGDLDSLVDLDLSMNSLSGSVPSE-LRGLRSLQKFVIGNNFLSGNLSV 304
+N L I + L+SL L L +L+ S+P+E L L L + + ++ +
Sbjct: 137 DNDL-VYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRD 193
Query: 305 NLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVE 364
F + +L+++ + + L L I+ N T +P
Sbjct: 194 YSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRF 252
Query: 365 LNISQN--------MFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASSL-----DSN 411
LN+S N M + L R + + L G V Y + L N
Sbjct: 253 LNLSYNPISTIEGSMLHE-----LLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGN 306
Query: 412 CLQNVP 417
L +
Sbjct: 307 QLTTLE 312
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 53/275 (19%), Positives = 97/275 (35%), Gaps = 34/275 (12%)
Query: 110 ADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLT 169
+AL +L L + +I D+ ++L L+ L++ + + NLT
Sbjct: 169 TEALSHLHGLIVLRLRHLNI-NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227
Query: 170 SLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGS 229
SL ++ LT ++ L L L+LS N ++ + L L + + L
Sbjct: 228 SLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-V 286
Query: 230 IPPG-LGTLSKLQYLNVSNNSLASSIPAQL-GDLDSLVDLDLSMNSLS------------ 275
+ P L+ L+ LNVS N L +++ + + +L L L N L+
Sbjct: 287 VEPYAFRGLNYLRVLNVSGNQL-TTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRR 345
Query: 276 -------GSV----PSELRG--LRSLQKFVIGNNFLSGNLSVNLFP----TVSQLQIIVL 318
P ++G + ++ N F + V + +
Sbjct: 346 WRLNFNRQQPTCATPEFVQGKEFKDFPDVLLPNYFTCRRARIRDRKAQQVFVDEGHTVQF 405
Query: 319 RQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPN 353
PPP +LW P+ L+ N P+
Sbjct: 406 VCRADGDPPPAILWLSPRKHLVSAKSNGRLTVFPD 440
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-34
Identities = 63/291 (21%), Positives = 113/291 (38%), Gaps = 25/291 (8%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTS 170
L LT+L S A+ + P L L L L + + + +LTNLT
Sbjct: 193 SVLAKLTNLESLIATNNQISDITPL---GILTNLDELSLNGNQLKDIGTLA--SLTNLTD 247
Query: 171 LYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSI 230
L L++N ++ P L L+ L+ L L N ++ P L L++L+++ N L
Sbjct: 248 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDIS 303
Query: 231 PPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQK 290
P + L L YL + N+++ P + L L L N +S S L L ++
Sbjct: 304 P--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINW 357
Query: 291 FVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGP 350
G+N +S + ++++ + L +T P + + + + +N
Sbjct: 358 LSAGHNQIS---DLTPLANLTRITQLGLNDQAWTNAPVNYK---ANVSIPNTVKNVTGAL 411
Query: 351 LPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRL---VDLSGNYFEGRVP 398
+ + + S E +I+ N+ V F + F G V
Sbjct: 412 IAPATISDGGSYTEPDITWNLP-SYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-33
Identities = 55/259 (21%), Positives = 101/259 (38%), Gaps = 24/259 (9%)
Query: 112 ALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSL 171
L + + ++ L + L I + + L NLT +
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVSQ---TDLDQVTTLQADRLGIKSIDG--VEYLNNLTQI 73
Query: 172 YLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIP 231
S+N LT P L L+ L + ++ N + P L NL+ L + +N +T P
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129
Query: 232 PGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKF 291
L L+ L L +S+N++ S I A L L SL L L L +L++
Sbjct: 130 --LKNLTNLNRLELSSNTI-SDISA-LSGLTSLQQLSFGNQVTD---LKPLANLTTLERL 182
Query: 292 VIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPL 351
I +N +S +++ ++ L+ ++ N + P L + L L ++ N
Sbjct: 183 DISSNKVS---DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG 237
Query: 352 PNSRSNVNTSTVELNISQN 370
+ T+ +L+++ N
Sbjct: 238 TLAS---LTNLTDLDLANN 253
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-28
Identities = 50/249 (20%), Positives = 93/249 (37%), Gaps = 39/249 (15%)
Query: 142 PTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNS 201
P A + I+ + F+ L L +T T+ L ++ L R
Sbjct: 2 PLGSATITQDTPINQI--FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG 57
Query: 202 LTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDL 261
+ L NL+ ++ S+N LT P L L+KL + ++NN +A P L +L
Sbjct: 58 IK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANL 111
Query: 262 DSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSG-------------NLSVNL-- 306
+L L L N ++ L+ L +L + + +N +S + +
Sbjct: 112 TNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD 169
Query: 307 ---FPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTG--PLPNSRSNVNTS 361
++ L+ + + N + L + L L + N + PL T+
Sbjct: 170 LKPLANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITPLGI-----LTN 222
Query: 362 TVELNISQN 370
EL+++ N
Sbjct: 223 LDELSLNGN 231
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-33
Identities = 65/319 (20%), Positives = 115/319 (36%), Gaps = 37/319 (11%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTI-PSSLGQLS 190
+P Q L T + L L I V S L L L L TI + L
Sbjct: 18 QVP----QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLP 73
Query: 191 VLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG--LGTLSKLQYLNVSNN 248
L +LDL + + P +F L +L L + L+ ++ L L L++S N
Sbjct: 74 NLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN 133
Query: 249 SLAS-SIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLR--SLQKFVIGNNFLSGNLSVN 305
+ S + G L+SL +D S N + EL L+ +L F + N L +SV+
Sbjct: 134 QIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVD 193
Query: 306 LFPTVSQLQIIVLR-----------------QNGFTGPPPDVLWSMPQLRLLDISRNNFT 348
++ + +VL N + L + +N
Sbjct: 194 WGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253
Query: 349 GPLPNSRSNVNTSTVE-LNISQNMFY---GGLTPVLGRFRLVDLSGNYFEGRVPEYVHSN 404
P N+ + + S+V L++S + + L ++++L+ N ++ +
Sbjct: 254 DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYG 312
Query: 405 ASSL-----DSNCLQNVPN 418
+L N L + +
Sbjct: 313 LDNLQVLNLSYNLLGELYS 331
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-32
Identities = 67/400 (16%), Positives = 132/400 (33%), Gaps = 64/400 (16%)
Query: 138 GQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDL 197
G +++ LDL + + L +L L L+ N + + L L VL+L
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321
Query: 198 SRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVSNNSLASSIPA 256
S N L ++F L ++ +D+ N++ I L KLQ L++ +N+L +
Sbjct: 322 SYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALTT---- 376
Query: 257 QLGDLDSLVDLDLSMNSLSG---------------------SVPSELRGLRSLQKFVIGN 295
+ + S+ D+ LS N L + L + LQ ++
Sbjct: 377 -IHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQ 435
Query: 296 NFLSGNLSVNLFPTVSQLQIIVLRQNGF-----TGPPPDVLWSMPQLRLLDISRNNFTGP 350
N S L+ + L +N T DV + L++L ++ N
Sbjct: 436 NRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNS- 494
Query: 351 LPNSRSNVNTSTVELNISQNMF-YGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASS-- 407
LP + T+ L+++ N + ++D+S N V + S
Sbjct: 495 LPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLL-APNPDVFVSLSVLD 553
Query: 408 LDSNCL-----------------QNVPNQRTLVDCSSFYAARGLSFDNFGRPNATQPPPP 450
+ N + + C + G+S +
Sbjct: 554 ITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSL---------ST 604
Query: 451 ETSGDSNRKIIVLSAVLGGFGLIVLLVLLALLALCFCKKR 490
E + + ++ + + L L+ +L + +
Sbjct: 605 EGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGF 644
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-31
Identities = 67/321 (20%), Positives = 119/321 (37%), Gaps = 30/321 (9%)
Query: 115 NLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNL--TNLTSLY 172
N + + S L + +I + L +++ L
Sbjct: 214 NGWTVDITGNFSNAISKSQAFSL-ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272
Query: 173 LSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPP 232
LS + L L VL+L+ N + +F L NL L++S N L +
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYS 331
Query: 233 G-LGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKF 291
L K+ Y+++ N +A L+ L LDL N+L + + + S+
Sbjct: 332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDI 386
Query: 292 VIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTG-PPPDVLWSMPQLRLLDISRNNFTGP 350
FLSGN V L +I L +N L +P L++L +++N F+
Sbjct: 387 -----FLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSC 441
Query: 351 LPNSRSNVNTSTVELNISQNMFYGGLTPV--------LGRFRLVDLSGNYFEGRVPEYVH 402
+ + N S +L + +NM L +++ L+ NY +P V
Sbjct: 442 SGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVF 500
Query: 403 SNASSL-----DSNCLQNVPN 418
S+ ++L +SN L + +
Sbjct: 501 SHLTALRGLSLNSNRLTVLSH 521
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-30
Identities = 74/346 (21%), Positives = 124/346 (35%), Gaps = 36/346 (10%)
Query: 110 ADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLT 169
A + L L P +I + LP L+ LDL S I + P + L +L
Sbjct: 41 ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLF 100
Query: 170 SLYLSDNGLTGTI--PSSLGQLSVLSVLDLSRNSLTG-NIPTSFGLLKNLSSLDISSNYL 226
L L GL+ + L L+ LDLS+N + + SFG L +L S+D SSN +
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160
Query: 227 TGSIPPGLGTLS--KLQYLNVSNNSLASSIPAQLGDLD------SLVDLDLSMN------ 272
L L L + +++ NSL S + G L LD+S N
Sbjct: 161 FLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDI 220
Query: 273 ------SLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFP--TVSQLQIIVLRQNGFT 324
++S S L + G + + + N F S ++ + L
Sbjct: 221 TGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVF 279
Query: 325 GPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQN---MFYGGLTPVLG 381
V ++ L++L+++ N + + + LN+S N Y L
Sbjct: 280 SLNSRVFETLKDLKVLNLAYNKINK-IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLP 338
Query: 382 RFRLVDLSGNYFEGRVPEYVHSNASSL-----DSNCLQNVPNQRTL 422
+ +DL N+ + + L N L + ++
Sbjct: 339 KVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALTTIHFIPSI 383
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-30
Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 20/263 (7%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTS 170
+A L +L N S LL G + LP + +DL+ I+ + + L L +
Sbjct: 308 EAFYGLDNLQVLNLSYNLL-GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQT 366
Query: 171 LYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTG-S 229
L L DN LT ++ + + + LS N L + + + +S N L
Sbjct: 367 LDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLD 417
Query: 230 IPPGLGTLSKLQYLNVSNNSLAS-SIPAQLGDLDSLVDLDLSMNSLSGSVPSEL-----R 283
I L + LQ L ++ N +S S + SL L L N L + +EL
Sbjct: 418 ILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFE 477
Query: 284 GLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDIS 343
GL LQ + +N+L+ +L +F ++ L+ + L N T + L L +LDIS
Sbjct: 478 GLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDIS 534
Query: 344 RNNFTGPLPNSRSNVNTSTVELN 366
RN P P+ +++ + N
Sbjct: 535 RNQLLAPNPDVFVSLSVLDITHN 557
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-29
Identities = 67/345 (19%), Positives = 113/345 (32%), Gaps = 28/345 (8%)
Query: 107 RFAADALVNLTHLASFNASR-FLLPGSIPDWLGQQLPTLQALDLRSCSISGV-IPFSLGN 164
DA L HL L + D + L L LDL I + + S G
Sbjct: 87 FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGK 146
Query: 165 LTNLTSLYLSDNGLTGTIPSSLGQLSV--LSVLDLSRNSLTGNIPTSFGLLKN------L 216
L +L S+ S N + L L LS L+ NSL + +G N L
Sbjct: 147 LNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVL 206
Query: 217 SSLDISSNYLT------------GSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLD-- 262
LD+S N T S L + +++ L
Sbjct: 207 EILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARS 266
Query: 263 SLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNG 322
S+ LDLS + L+ L+ + N ++ ++ F + LQ++ L N
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNL 325
Query: 323 FTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGR 382
+ +P++ +D+ +N+ + + L++ N +
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFL-EKLQTLDLRDNAL--TTIHFIPS 382
Query: 383 FRLVDLSGNYFEGRVPEYVHSNASSLDSNCLQNVPNQRTLVDCSS 427
+ LSGN + +N L N L+N+ L+
Sbjct: 383 IPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPH 427
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 4e-14
Identities = 28/159 (17%), Positives = 53/159 (33%), Gaps = 9/159 (5%)
Query: 241 QYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSG 300
+ +L + +P L++ L LS N + S L LQ +G+ +
Sbjct: 7 RIAFYRFCNL-TQVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 301 NLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNT 360
+ F + L+I+ L + PD + L L + + + N
Sbjct: 63 TIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122
Query: 361 STVE-LNISQNMFY----GGLTPVLGRFRLVDLSGNYFE 394
+ L++S+N L + +D S N
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 49/294 (16%), Positives = 104/294 (35%), Gaps = 22/294 (7%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSV 191
+I + + Q + + S+ + + N+ L LS N L+ + L +
Sbjct: 1 AIHE-IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 192 LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLA 251
L +L+LS N L L L +LD+++NY+ L ++ L+ +NN++
Sbjct: 60 LELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI- 111
Query: 252 SSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVS 311
S + ++ L+ N ++ + +Q + N + L +
Sbjct: 112 SRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 312 QLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNM 371
L+ + L+ N V+ +L+ LD+S N + + +++ N
Sbjct: 170 TLEHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLAF-MGPEFQSA-AGVTWISLRNNK 225
Query: 372 FYGGLTPVLGRF---RLVDLSGNYFEGRVPEYV---HSNASSLDSNCLQNVPNQ 419
+ L DL GN F + ++ ++ + Q
Sbjct: 226 L-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 33/289 (11%), Positives = 77/289 (26%), Gaps = 9/289 (3%)
Query: 110 ADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLT 169
+ + + + L TL+ L+L+ I + + L
Sbjct: 137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLK 194
Query: 170 SLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGS 229
+L LS N L + + ++ + L N L I + +NL D+ N
Sbjct: 195 TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252
Query: 230 IPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQ 289
+ + + V+ ++ + L +L+
Sbjct: 253 TLRDFFSKN-QRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALK 311
Query: 290 KFVIGNNFLSGNLSVNL---FPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNN 346
+ G+ + L ++ + I + + V L+ +
Sbjct: 312 RKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKA 371
Query: 347 FTGPLPNSR-SNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFE 394
+ N R ++ + T +L+ +E
Sbjct: 372 LDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 12/173 (6%), Positives = 39/173 (22%), Gaps = 6/173 (3%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTG----TIPSSLG 187
+ ++ + + L L + G +
Sbjct: 274 KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERE 333
Query: 188 QLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSN 247
+ +D + I + +L+ L + G ++L
Sbjct: 334 NQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQA 393
Query: 248 NSLASSIPAQLGDLDSLVDLDLSMNSLS-GSVPSELRGLRSLQKFVIGNNFLS 299
+ + L L + V + +++ + + + +
Sbjct: 394 VGQ-IELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-33
Identities = 55/279 (19%), Positives = 101/279 (36%), Gaps = 18/279 (6%)
Query: 74 PCLVWNGVRCQNGSVVGINISGFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSI 133
L+ + ++G S++ + V + + +F L
Sbjct: 244 LKLLRYILELSEVEFDDCTLNGLGDFNP-SESDVVSELGKVETVTIRRLHIPQFYL-FYD 301
Query: 134 PDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTI---PSSLGQLS 190
+ L ++ + + + + V +L +L L LS+N + + G
Sbjct: 302 LSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP 361
Query: 191 VLSVLDLSRNSLT--GNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNN 248
L L LS+N L LKNL+SLDIS N +P K+++LN+S+
Sbjct: 362 SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSST 420
Query: 249 SLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFP 308
+ + +L LD+S N+L S L L+ L I N L L
Sbjct: 421 GI-RVVKT--CIPQTLEVLDVSNNNLD-SFSLFLPRLQEL---YISRNKLK-TLPDASLF 472
Query: 309 TVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNF 347
L ++ + +N P + + L+ + + N +
Sbjct: 473 P--VLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 58/314 (18%), Positives = 100/314 (31%), Gaps = 32/314 (10%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSV 191
SIP L +++LDL I+ + L NL L L + + + L
Sbjct: 19 SIPSGL---TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS 75
Query: 192 LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGL-GTLSKLQYLNVSNNSL 250
L LDLS N L+ + FG L +L L++ N L L+ LQ L + N
Sbjct: 76 LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135
Query: 251 ASSIPAQ-LGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPT 309
S I L SL +L++ SL L+ +R + + + + L
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADI 194
Query: 310 VSQLQIIVLRQNGFTGPPPDV-----------LWSMPQLRLLDISRNNFTGPLPNSRSNV 358
+S ++ + LR + L D S N L
Sbjct: 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS 254
Query: 359 NTSTVELNISQ---------NMFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASS-- 407
+ ++ ++ R + + Y V+S
Sbjct: 255 EVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL-FYDLSTVYSLLEKVK 313
Query: 408 ---LDSNCLQNVPN 418
++++ + VP
Sbjct: 314 RITVENSKVFLVPC 327
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-30
Identities = 49/262 (18%), Positives = 95/262 (36%), Gaps = 19/262 (7%)
Query: 118 HLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNG 177
L + + + T++ L + + + L + + + ++
Sbjct: 262 TLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321
Query: 178 LTGTIPSSLGQLSVLSVLDLSRNSLTGNI---PTSFGLLKNLSSLDISSNYLTGSIPPGL 234
+ S L L LDLS N + G +L +L +S N+L S+
Sbjct: 322 VFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTG 380
Query: 235 GT---LSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKF 291
L L L++S N+ +P + + L+LS + V + + ++L+
Sbjct: 381 EILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVL 436
Query: 292 VIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPL 351
+ NN L + S+ L +LQ + + +N P L P L ++ ISRN
Sbjct: 437 DVSNNNLD-SFSLFL----PRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVP 489
Query: 352 PNSRSNVNTSTVELNISQNMFY 373
TS ++ + N +
Sbjct: 490 DGIFDR-LTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-25
Identities = 63/361 (17%), Positives = 118/361 (32%), Gaps = 58/361 (16%)
Query: 109 AADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNL 168
NLT+L + I L +L L++++ S+ SL ++ ++
Sbjct: 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDI 174
Query: 169 TSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSL--------- 219
L L + + LS + L+L +L + + + S +
Sbjct: 175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234
Query: 220 -------------------------DISSNYLTGSIPPGLGTLSKL--------QYLNVS 246
D + N L P +S+L + L++
Sbjct: 235 LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIP 294
Query: 247 NNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVN- 305
L + L+ + + + + + S + L+SL+ + N + N
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS 354
Query: 306 -LFPTVSQLQIIVLRQNGFT--GPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTST 362
LQ +VL QN ++L ++ L LDISRN F P+P+S
Sbjct: 355 ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWP-EKM 412
Query: 363 VELNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASSL-----DSNCLQNVP 417
LN+S T + ++D+S N + L N L+ +P
Sbjct: 413 RFLNLSSTGIRVVKTCIPQTLEVLDVSNNNL-----DSFSLFLPRLQELYISRNKLKTLP 467
Query: 418 N 418
+
Sbjct: 468 D 468
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-19
Identities = 49/209 (23%), Positives = 78/209 (37%), Gaps = 10/209 (4%)
Query: 192 LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVSNNSL 250
V D S T +IP+ GL + SLD+S N +T I G L + LQ L + ++ +
Sbjct: 7 SGVCDGRSRSFT-SIPS--GLTAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRI 62
Query: 251 ASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTV 310
+ L SL LDLS N LS S L SL+ + N +LFP +
Sbjct: 63 NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 311 SQLQIIVL-RQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQ 369
+ LQ + + F+ + L L+I + S ++ L +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSI-RDIHHLTLHL 181
Query: 370 N---MFYGGLTPVLGRFRLVDLSGNYFEG 395
+ +L R ++L
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLAR 210
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 13/222 (5%)
Query: 129 LPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQ 188
+P IP Q + L IS V S NLT L+L N L ++
Sbjct: 26 VPVGIP-------AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTG 78
Query: 189 LSVLSVLDLSRNSLTGNIP-TSFGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVS 246
L++L LDLS N+ ++ +F L L +L + L + PG L+ LQYL +
Sbjct: 79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQ 137
Query: 247 NNSLASSIPAQ-LGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVN 305
+N+L ++P DL +L L L N +S RGL SL + ++ N ++ ++ +
Sbjct: 138 DNAL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPH 195
Query: 306 LFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNF 347
F + +L + L N + P + L + L+ L ++ N +
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 47/208 (22%), Positives = 81/208 (38%), Gaps = 7/208 (3%)
Query: 166 TNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNY 225
++L N ++ +S L++L L N L +F L L LD+S N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 226 LTGSIPPG-LGTLSKLQYLNVSNNSLASSIPAQ-LGDLDSLVDLDLSMNSLSGSVPSE-L 282
S+ P L +L L++ L + L +L L L N+L ++P +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNALQ-ALPDDTF 149
Query: 283 RGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDI 342
R L +L + N +S ++ F + L ++L QN P + +L L +
Sbjct: 150 RDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 343 SRNNFTGPLPNSRSNVNTSTVELNISQN 370
NN + LP + L ++ N
Sbjct: 209 FANNLSA-LPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 37/142 (26%), Positives = 63/142 (44%), Gaps = 3/142 (2%)
Query: 110 ADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLT 169
L L + + R L + L + L LQ L L+ ++ + + +L NLT
Sbjct: 98 PATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLT 156
Query: 170 SLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGS 229
L+L N ++ + L L L L +N + P +F L L +L + +N L+ +
Sbjct: 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-A 215
Query: 230 IPPG-LGTLSKLQYLNVSNNSL 250
+P L L LQYL +++N
Sbjct: 216 LPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 36/209 (17%), Positives = 68/209 (32%), Gaps = 31/209 (14%)
Query: 214 KNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNS 273
+ + L ++P G+ + Q + + N ++ A +L L L N
Sbjct: 11 EPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 274 LSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWS 333
L+ + GL L++ + +N ++ F + +L + L + G P +
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG 127
Query: 334 MPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYF 393
+ L+ L + N + + F LG + L GN
Sbjct: 128 LAALQYLYLQDNALQ-----------------ALPDDTFRD-----LGNLTHLFLHGNRI 165
Query: 394 EGRVPEYVHSNASSL-----DSNCLQNVP 417
VPE SL N + +V
Sbjct: 166 S-SVPERAFRGLHSLDRLLLHQNRVAHVH 193
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 60/309 (19%), Positives = 104/309 (33%), Gaps = 28/309 (9%)
Query: 129 LPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQ 188
+P ++P + + LDL + + +S + L L LS + +
Sbjct: 22 IPDNLP-------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS 74
Query: 189 LSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNN 248
LS LS L L+ N + +F L +L L L +G L L+ LNV++N
Sbjct: 75 LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134
Query: 249 SLAS-SIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGN----LS 303
+ S +P +L +L LDLS N + ++LR L + + + LS N +
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD-LSLNPMNFIQ 193
Query: 304 VNLFPTVSQLQIIVLRQNGFTGP-PPDVLWSMPQLRLLDISRNNFTG-------PLPNSR 355
F + L + LR N + + + L + + F
Sbjct: 194 PGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252
Query: 356 SNVNTSTVELNISQNMFYG----GLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASSLD-- 409
N + E ++ +Y L L L E + L+
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELV 312
Query: 410 SNCLQNVPN 418
+ P
Sbjct: 313 NCKFGQFPT 321
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 54/233 (23%), Positives = 96/233 (41%), Gaps = 12/233 (5%)
Query: 144 LQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLT 203
Q L+L +C F L +L L + N S + L L LDLSRN L+
Sbjct: 306 WQHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLS 360
Query: 204 --GNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQ--LG 259
G S +L LD+S N + ++ L +L++L+ +++L +
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFL 418
Query: 260 DLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLR 319
L +L+ LD+S + GL SL+ + N N ++F + L + L
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 320 QNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMF 372
Q P S+ L++L+++ N +P+ + TS ++ + N +
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLKS-VPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-30
Identities = 60/200 (30%), Positives = 88/200 (44%), Gaps = 8/200 (4%)
Query: 138 GQQLPTLQALDLRSCSIS--GVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVL 195
LP+L+ LDL +S G S T+L L LS NG+ T+ S+ L L L
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 401
Query: 196 DLSRNSLTGNIPTS-FGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVSNNSLASS 253
D ++L S F L+NL LDIS + G LS L+ L ++ NS +
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQEN 460
Query: 254 IPAQ-LGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQ 312
+L +L LDLS L P+ L SLQ + +N L ++ +F ++
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTS 519
Query: 313 LQIIVLRQNGFTGPPPDVLW 332
LQ I L N + P + +
Sbjct: 520 LQKIWLHTNPWDCSCPRIDY 539
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-27
Identities = 54/264 (20%), Positives = 90/264 (34%), Gaps = 22/264 (8%)
Query: 164 NLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISS 223
+ N+T + IP +L LDLS N L SF L LD+S
Sbjct: 6 VVPNIT-YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 224 NYLTGSIPPG-LGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSEL 282
+ +I G +LS L L ++ N + S L SL L +L+ +
Sbjct: 62 CEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 283 RGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRL--- 339
L++L++ + +N + F ++ L+ + L N L + Q+ L
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 340 -LDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPV----LGRFRLVDLSGNYFE 394
LD+S N P + + L + N + L + L F
Sbjct: 181 SLDLSLNPMNFIQPGAFKEIRLHK--LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 395 GRVPEYVHSNASSLDSNCLQNVPN 418
N D + L+ + N
Sbjct: 239 N------EGNLEKFDKSALEGLCN 256
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-24
Identities = 46/174 (26%), Positives = 69/174 (39%), Gaps = 12/174 (6%)
Query: 110 ADALVNLTHLASFNASR---FLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFS-LGNL 165
+ + T L + S + + L L+ LD + ++ + FS +L
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVITMSSNFL-----GLEQLEHLDFQHSNLKQMSEFSVFLSL 420
Query: 166 TNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPT-SFGLLKNLSSLDISSN 224
NL L +S LS L VL ++ NS N F L+NL+ LD+S
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 225 YLTGSIPPG-LGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGS 277
L + P +LS LQ LN+++N L S L SL + L N S
Sbjct: 481 QLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 9e-20
Identities = 48/333 (14%), Positives = 94/333 (28%), Gaps = 70/333 (21%)
Query: 100 RLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGV-- 157
+ L L F G++ + L L L + ++ +
Sbjct: 211 FDSLNVMKTCIQGLAGLEVH-RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDY 269
Query: 158 ----IPFSLGNLTNLTSLYLSDNGLTGTIPSS-LGQLSVLSVLDLSRNSLTGNIPTSFGL 212
I LTN++S L + S L +++
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFP------TLK 323
Query: 213 LKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLA--SSIPAQLGDLDSLVDLDLS 270
LK+L L +SN + + L L++L++S N L+ SL LDLS
Sbjct: 324 LKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 271 MNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDV 330
N + ++ S GL L+ ++ L ++F ++ L + + +
Sbjct: 382 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 331 LWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSG 390
+ L +L ++G
Sbjct: 441 FNGLSSLEVLK----------------------------------------------MAG 454
Query: 391 NYFEGRVPEYVHSNASSL-----DSNCLQNVPN 418
N F+ + + +L L+ +
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-14
Identities = 36/138 (26%), Positives = 54/138 (39%), Gaps = 7/138 (5%)
Query: 96 FRRTRLGSQNPRFAADALVNLTHL-ASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSI 154
F+ + L + +L NL +L S +R G L +L+ L + S
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF-----NGLSSLEVLKMAGNSF 457
Query: 155 SGVI-PFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLL 213
P L NLT L LS L P++ LS L VL+++ N L F L
Sbjct: 458 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRL 517
Query: 214 KNLSSLDISSNYLTGSIP 231
+L + + +N S P
Sbjct: 518 TSLQKIWLHTNPWDCSCP 535
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 8/212 (3%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLS 198
+ L L+ L L I + + L NL +L L DN LT + LS L L L
Sbjct: 85 KHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR 144
Query: 199 RNSLTGNIPT-SFGLLKNLSSLDISS-NYLTGSIPPG-LGTLSKLQYLNVSNNSLASSIP 255
N + +IP+ +F + +L LD+ L+ I G LS L+YLN++ +L IP
Sbjct: 145 NNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNL-REIP 201
Query: 256 AQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQI 315
L L L +LDLS N LS P +GL LQK + + + + N F + L
Sbjct: 202 N-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVE 259
Query: 316 IVLRQNGFTGPPPDVLWSMPQLRLLDISRNNF 347
I L N T P D+ + L + + N +
Sbjct: 260 INLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-31
Identities = 55/246 (22%), Positives = 99/246 (40%), Gaps = 14/246 (5%)
Query: 129 LPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQ 188
+P I + L+L I + S +L +L L LS N + +
Sbjct: 58 VPDGIS-------TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNG 110
Query: 189 LSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGL-GTLSKLQYLNVSN 247
L+ L+ L+L N LT +F L L L + +N + SIP + L+ L++
Sbjct: 111 LANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGE 169
Query: 248 NSLASSIPAQ-LGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNL 306
S I L +L L+L+M +L +P+ L L L + + N LS +
Sbjct: 170 LKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGS 226
Query: 307 FPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELN 366
F + LQ + + Q+ + ++ L ++++ NN T LP+ ++
Sbjct: 227 FQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL-LPHDLFTPLHHLERIH 285
Query: 367 ISQNMF 372
+ N +
Sbjct: 286 LHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 32/130 (24%), Positives = 53/130 (40%), Gaps = 5/130 (3%)
Query: 97 RRTRLGSQNP--RFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSI 154
RR LG + A L++L N + L IP+ L L LDL +
Sbjct: 163 RRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTP--LIKLDELDLSGNHL 219
Query: 155 SGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLK 214
S + P S L +L L++ + + ++ L L ++L+ N+LT F L
Sbjct: 220 SAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279
Query: 215 NLSSLDISSN 224
+L + + N
Sbjct: 280 HLERIHLHHN 289
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-31
Identities = 62/322 (19%), Positives = 115/322 (35%), Gaps = 35/322 (10%)
Query: 108 FAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTN 167
+ + L + + +P L ++ L+L I + ++
Sbjct: 36 YFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHT 94
Query: 168 LTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLT 227
+ LY+ N + P + +L+VL L RN L+ F L++L +S+N L
Sbjct: 95 IQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE 154
Query: 228 GSIPPGLGT-LSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLR 286
I + LQ L +S+N L + + L + SL ++S N L S L
Sbjct: 155 -RIEDDTFQATTSLQNLQLSSNRL-THVD--LSLIPSLFHANVSYNLL-----STLAIPI 205
Query: 287 SLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNN 346
++++ +N ++ + + +L I+ L+ N T L + P L +D+S N
Sbjct: 206 AVEELDASHNSIN-VVRGPVN---VELTILKLQHNNLTDTA--WLLNYPGLVEVDLSYNE 259
Query: 347 FTGPLPNSRSNVNTSTVELNISQN-------MFYGGLTPVLGRFRLVDLSGNYFEGRVPE 399
+ L IS N + +++DLS N+ V
Sbjct: 260 LEK-IMYHPFVKMQRLERLYISNNRLVALNLYGQP-----IPTLKVLDLSHNHLL-HVER 312
Query: 400 YVHSNAS----SLDSNCLQNVP 417
LD N + +
Sbjct: 313 NQPQFDRLENLYLDHNSIVTLK 334
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-29
Identities = 49/239 (20%), Positives = 88/239 (36%), Gaps = 20/239 (8%)
Query: 110 ADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLT 169
N L + + S L I D Q +LQ L L S ++ L + +L
Sbjct: 134 RGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLF 189
Query: 170 SLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGS 229
+S N L+ +L + LD S NS+ + + L+ L + N LT
Sbjct: 190 HANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVR--GPVNVELTILKLQHNNLTD- 240
Query: 230 IPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQ 289
L L +++S N L + + L L +S N L ++ + + +L+
Sbjct: 241 -TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK 298
Query: 290 KFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFT 348
+ +N L ++ N +L+ + L N L+ L +S N++
Sbjct: 299 VLDLSHNHLL-HVERNQPQ-FDRLENLYLDHNSIVTLKLSTH---HTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-28
Identities = 53/292 (18%), Positives = 99/292 (33%), Gaps = 34/292 (11%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLS 198
Q + + + F L N + ++ + + L + +L+L+
Sbjct: 18 QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 77
Query: 199 RNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVSNNSLASSIPAQ 257
+ +F + L + N + +PP + L L + N L SS+P
Sbjct: 78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL-SSLPRG 135
Query: 258 L-GDLDSLVDLDLSMNSLSGSVPSE-LRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQI 315
+ + L L +S N+L + + + SLQ + +N L+ ++ ++L P L
Sbjct: 136 IFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP---SLFH 190
Query: 316 IVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGG 375
+ N + L + LD S N+ + VN L + N
Sbjct: 191 ANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRG---PVNVELTILKLQHNN---- 237
Query: 376 LTPV-----LGRFRLVDLSGNYFEGRVPEYVHSNASSL-----DSNCLQNVP 417
LT VDLS N E ++ + L +N L +
Sbjct: 238 LTDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALN 288
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-25
Identities = 45/175 (25%), Positives = 71/175 (40%), Gaps = 10/175 (5%)
Query: 141 LPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRN 200
++ LD SI+ V LT L L N LT + L L +DLS N
Sbjct: 204 PIAVEELDASHNSINVV---RGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYN 258
Query: 201 SLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGD 260
L + F ++ L L IS+N L ++ + L+ L++S+N L +
Sbjct: 259 ELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQ 316
Query: 261 LDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQI 315
D L +L L NS+ S L++L + +N N LF V++ +
Sbjct: 317 FDRLENLYLDHNSIVTLKLSTHHTLKNLT---LSHNDWDCNSLRALFRNVARPAV 368
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-21
Identities = 36/181 (19%), Positives = 65/181 (35%), Gaps = 17/181 (9%)
Query: 111 DALVNLTHL-ASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLT 169
+ + L AS N+ + L L L+ +++ N L
Sbjct: 202 AIPIAVEELDASHNSINVVRGPV--------NVELTILKLQHNNLTDTAWLL--NYPGLV 251
Query: 170 SLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGS 229
+ LS N L + ++ L L +S N L + + L LD+S N+L
Sbjct: 252 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-H 309
Query: 230 IPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSEL-RGLRSL 288
+ +L+ L + +NS+ ++ L +L +L LS N + L R +
Sbjct: 310 VERNQPQFDRLENLYLDHNSI-VTLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARP 366
Query: 289 Q 289
Sbjct: 367 A 367
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 40/240 (16%), Positives = 83/240 (34%), Gaps = 12/240 (5%)
Query: 181 TIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG-LGTLSK 239
I S+L V + + + L N + ++ + +P L + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70
Query: 240 LQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLS 299
++ LN+++ + ++ L + N++ P + + L V+ N LS
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
Query: 300 GNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVN 359
+L +F +L + + N D + L+ L +S N T + ++
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD---LSLI 185
Query: 360 TSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASSLD--SNCLQNVP 417
S N+S N+ + +D S N V V+ + L N L +
Sbjct: 186 PSLFHANVSYNLL--STLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLTDTA 242
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-16
Identities = 37/215 (17%), Positives = 73/215 (33%), Gaps = 28/215 (13%)
Query: 212 LLKNLSSLDISSNYLTGSIPPGL--GTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDL 269
L + D+ + T + G TL+ + + N+++ A L + L+L
Sbjct: 17 LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL 76
Query: 270 SMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPD 329
+ + ++QK +G N + L ++F V L ++VL +N + P
Sbjct: 77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRG 135
Query: 330 VLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLS 389
+ + P+L L +S NN I + F + + LS
Sbjct: 136 IFHNTPKLTTLSMSNNNLE-----------------RIEDDTFQA-----TTSLQNLQLS 173
Query: 390 GNYFEGRVPEYVHSNASSLD--SNCLQNVPNQRTL 422
N V + + + N L + +
Sbjct: 174 SNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAV 207
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 28/179 (15%), Positives = 54/179 (30%), Gaps = 11/179 (6%)
Query: 247 NNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNL 306
I + L D+ + M + E L + + N+ + L L
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL 64
Query: 307 FPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELN 366
+ Q++++ L ++ L + N LP L
Sbjct: 65 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLV 123
Query: 367 ISQN---MFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASSL-----DSNCLQNVP 417
+ +N G+ + + +S N E R+ + +SL SN L +V
Sbjct: 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVD 181
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-31
Identities = 70/322 (21%), Positives = 113/322 (35%), Gaps = 47/322 (14%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQL------------PTLQALDLRSCSISGVI 158
N+ + + + P G+Q L+L + +S +
Sbjct: 28 VEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SL 86
Query: 159 PFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSS 218
P +L SL S N LT +P L L V + + +L+ P L
Sbjct: 87 PELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEY 135
Query: 219 LDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSV 278
L +S+N L +P L S L+ ++V NNSL +P SL + N L
Sbjct: 136 LGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSL-KKLPDLPP---SLEFIAAGNNQL--EE 187
Query: 279 PSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLR 338
EL+ L L NN L L L+ IV N P L ++P L
Sbjct: 188 LPELQNLPFLTAIYADNNSLK-----KLPDLPLSLESIVAGNNILEELPE--LQNLPFLT 240
Query: 339 LLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVP 398
+ N LP+ ++ LN+ N L + +D+S N F +
Sbjct: 241 TIYADNNLLKT-LPDLPPSLE----ALNVRDNYL-TDLPELPQSLTFLDVSENIFS-GLS 293
Query: 399 EYVHSNAS-SLDSNCLQNVPNQ 419
E + + SN ++++ +
Sbjct: 294 ELPPNLYYLNASSNEIRSLCDL 315
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-27
Identities = 51/244 (20%), Positives = 87/244 (35%), Gaps = 40/244 (16%)
Query: 140 QLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSV----- 194
LQ S +++ +P N+ + T Y + + P G+ ++V
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 195 --------LDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVS 246
L+L+ L+ ++P +L SL S N LT +P +L L N +
Sbjct: 68 CLDRQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNN 122
Query: 247 NNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNL 306
+L+ P L L +S N L +P EL+ L+ + NN L L
Sbjct: 123 LKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-----KL 168
Query: 307 FPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELN 366
L+ I N P L ++P L + N+ LP+ ++ +
Sbjct: 169 PDLPPSLEFIAAGNNQLEELPE--LQNLPFLTAIYADNNSLKK-LPDLPLSLE----SIV 221
Query: 367 ISQN 370
N
Sbjct: 222 AGNN 225
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-25
Identities = 50/258 (19%), Positives = 94/258 (36%), Gaps = 41/258 (15%)
Query: 113 LVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLY 172
L NL L + A LL ++PD L+AL++R ++ +P +LT L
Sbjct: 233 LQNLPFLTTIYADNNLL-KTLPDLPPS----LEALNVRDNYLTD-LPELPQSLTFLDVSE 286
Query: 173 LSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPP 232
+GL+ P+ L L+ S N + ++ L +L L++S+N L +P
Sbjct: 287 NIFSGLSELPPN-------LYYLNASSNEIR-SLC---DLPPSLEELNVSNNKLI-ELPA 334
Query: 233 GLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFV 292
+L+ L S N L + +P +L L + N L P + L+
Sbjct: 335 LPP---RLERLIASFNHL-AEVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLR--- 383
Query: 293 IGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLP 352
+ + L+ + + N P + L ++ P
Sbjct: 384 ------MNSHLAEVPELPQNLKQLHVETNPLREFPD----IPESVEDLRMNSERVVDPYE 433
Query: 353 NSRSNVNTSTVELNISQN 370
+ T +E ++ ++
Sbjct: 434 FAHE--TTDKLEDDVFEH 449
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 39/205 (19%), Positives = 63/205 (30%), Gaps = 41/205 (20%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTS 170
+ +LT L L P L L+ S I + +L
Sbjct: 274 ELPQSLTFLDVSENIFSGLSELPP--------NLYYLNASSNEIRSLC----DLPPSLEE 321
Query: 171 LYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSI 230
L +S+N L +P+ +L L S N L +P L +NL L + N L
Sbjct: 322 LNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPE---LPQNLKQLHVEYNPLR-EF 372
Query: 231 PPGLGTL----------------SKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSL 274
P ++ L+ L+V N L P S+ DL ++ +
Sbjct: 373 PDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPL-REFPDIPE---SVEDLRMNSERV 428
Query: 275 SGSVPSELRGLRSLQKFVIGNNFLS 299
L+ V ++
Sbjct: 429 VDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 56/306 (18%), Positives = 112/306 (36%), Gaps = 39/306 (12%)
Query: 129 LPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQ 188
+P +P P LDL++ I+ + NL NL +L L +N ++ P +
Sbjct: 46 VPKDLP-------PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP 98
Query: 189 LSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVSN 247
L L L LS+N L +P + K L L + N +T + L+++ + +
Sbjct: 99 LVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGT 154
Query: 248 NSLASS-IPAQ-LGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVN 305
N L SS I + L + ++ +++ ++P L SL + + N ++ +
Sbjct: 155 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAA 210
Query: 306 LFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVEL 365
++ L + L N + L + P LR L ++ N +P ++ + +
Sbjct: 211 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLAD-HKYIQVV 268
Query: 366 NISQNMF---------YGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASSLDSNCLQNV 416
+ N G + V L N + + + + V
Sbjct: 269 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ----------YWEIQPSTFRCV 318
Query: 417 PNQRTL 422
+ +
Sbjct: 319 YVRAAV 324
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 53/249 (21%), Positives = 94/249 (37%), Gaps = 23/249 (9%)
Query: 109 AADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNL 168
+ A L L S+ L +P+ + TLQ L + I+ V L +
Sbjct: 92 SPGAFAPLVKLERLYLSKNQLK-ELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQM 147
Query: 169 TSLYLSDNGLTGTI--PSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYL 226
+ L N L + + + LS + ++ ++T IP GL +L+ L + N +
Sbjct: 148 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKI 204
Query: 227 TGSIPPG-LGTLSKLQYLNVSNNSLASSIPAQ-LGDLDSLVDLDLSMNSLSGSVPSELRG 284
T + L L+ L L +S NS+ S++ L + L +L L+ N L VP L
Sbjct: 205 T-KVDAASLKGLNNLAKLGLSFNSI-SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261
Query: 285 LRSLQKFVIGNNFLSGNLSVNLFPTV------SQLQIIVLRQN--GFTGPPPDVLWSMPQ 336
+ +Q + NN +S + N F + + L N + P +
Sbjct: 262 HKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 320
Query: 337 LRLLDISRN 345
+ +
Sbjct: 321 RAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 62/260 (23%), Positives = 96/260 (36%), Gaps = 42/260 (16%)
Query: 167 NLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYL 226
+L + SD GL +P L ++LDL N +T F LKNL +L + +N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 227 TGSIPPG-LGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSE-LRG 284
+ I PG L KL+ L +S N L +P ++ +L +L + N ++ V G
Sbjct: 89 S-KISPGAFAPLVKLERLYLSKNQL-KELPEKM--PKTLQELRVHENEIT-KVRKSVFNG 143
Query: 285 LRSLQKFVIGNNFL-SGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDIS 343
L + +G N L S + F + +L I + T P + P L L +
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLD 200
Query: 344 RNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHS 403
N T + G L + LS N V +
Sbjct: 201 GNKIT-----------------KVDAASLKG-----LNNLAKLGLSFNSIS-AVDNGSLA 237
Query: 404 NASSL-----DSNCLQNVPN 418
N L ++N L VP
Sbjct: 238 NTPHLRELHLNNNKLVKVPG 257
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-30
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 8/219 (3%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSV 191
I + L L+ L L SI + + L +L +L L DN LT + LS
Sbjct: 89 MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSK 148
Query: 192 LSVLDLSRNSLTGNIPT-SFGLLKNLSSLDISS-NYLTGSIPPG-LGTLSKLQYLNVSNN 248
L L L N + +IP+ +F + +L LD+ L I G L L+YLN+
Sbjct: 149 LRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMC 206
Query: 249 SLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFP 308
++ +P L L L +L++S N P GL SL+K + N+ +S + N F
Sbjct: 207 NI-KDMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFD 263
Query: 309 TVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNF 347
++ L + L N + P D+ + L L + N +
Sbjct: 264 GLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-30
Identities = 54/247 (21%), Positives = 101/247 (40%), Gaps = 16/247 (6%)
Query: 129 LPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQ 188
+P IP + L+L +I + + +L +L L L N + +
Sbjct: 69 VPQGIP-------SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNG 121
Query: 189 LSVLSVLDLSRNSLTGNIPT-SFGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVS 246
L+ L+ L+L N LT IP+ +F L L L + +N + SIP + L L++
Sbjct: 122 LASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLG 179
Query: 247 NNSLASSIPAQ-LGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVN 305
I L +L L+L M ++ +P+ L L L++ + N +
Sbjct: 180 ELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP-EIRPG 236
Query: 306 LFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVEL 365
F +S L+ + + + + + + L L+++ NN + LP+ VEL
Sbjct: 237 SFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS-LPHDLFTPLRYLVEL 295
Query: 366 NISQNMF 372
++ N +
Sbjct: 296 HLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 27/130 (20%), Positives = 53/130 (40%), Gaps = 5/130 (3%)
Query: 97 RRTRLGSQNP--RFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSI 154
R LG + A L +L N + +P+ L L+ L++
Sbjct: 174 MRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTP--LVGLEELEMSGNHF 230
Query: 155 SGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLK 214
+ P S L++L L++ ++ ++ ++ L+ L L+L+ N+L+ F L+
Sbjct: 231 PEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290
Query: 215 NLSSLDISSN 224
L L + N
Sbjct: 291 YLVELHLHHN 300
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 60/306 (19%), Positives = 111/306 (36%), Gaps = 69/306 (22%)
Query: 535 DFSDANL---IKNGHSGDLFRGILEGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSH 588
DF N + HSG+L++G +G +V+K + ++ K+ + E SH
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRWQG-NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 589 ARLVPLLGHCMERENEKF-LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAA 647
++P+LG C L+ +MP G L + L+ TN +D +K A+ A
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-----FVVDQSQAVKFALDMA 121
Query: 648 EGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQ 707
G+++LH + + S+++D+ R + A
Sbjct: 122 RGMAFLHT-LEPLIPRHALNSRSVMIDEDMTAR------IS----MADVKFSF------- 163
Query: 708 SSEQGSSGS-------LTATCPY-------DVYCFGKVLLELVTGKMGISASSDAQVKEI 753
G + P D++ F +L ELVT ++
Sbjct: 164 -QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV------------- 209
Query: 754 LEQTLPYISIYDKELVTKIVDPSL--IIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYI 811
P+ + + E+ K+ L I + ++ + + C+N P +RP I
Sbjct: 210 -----PFADLSNMEIGMKVALEGLRPTIPPGISPH---VSKLMKICMNEDPAKRPKFDMI 261
Query: 812 LKALEN 817
+ LE
Sbjct: 262 VPILEK 267
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-29
Identities = 63/323 (19%), Positives = 118/323 (36%), Gaps = 37/323 (11%)
Query: 108 FAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTN 167
+ + L + + +P L ++ L+L I + ++
Sbjct: 42 YFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHT 100
Query: 168 LTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTS-FGLLKNLSSLDISSNYL 226
+ LY+ N + P + +L+VL L RN L+ ++P F L++L +S+N L
Sbjct: 101 IQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNL 159
Query: 227 TGSIPPG-LGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGL 285
I + LQ L +S+N L + + L + SL ++S N L S L
Sbjct: 160 E-RIEDDTFQATTSLQNLQLSSNRL-THVD--LSLIPSLFHANVSYNLL-----STLAIP 210
Query: 286 RSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRN 345
++++ +N ++ + + +L I+ L+ N T L + P L +D+S N
Sbjct: 211 IAVEELDASHNSIN-VVRGPVNV---ELTILKLQHNNLTDTA--WLLNYPGLVEVDLSYN 264
Query: 346 NFTGPLPNSRSNVNTSTVELNISQN-------MFYGGLTPVLGRFRLVDLSGNYFEGRVP 398
+ L IS N + +++DLS N+ V
Sbjct: 265 ELEK-IMYHPFVKMQRLERLYISNNRLVALNLYGQP-----IPTLKVLDLSHNHLL-HVE 317
Query: 399 EYVHSNAS----SLDSNCLQNVP 417
LD N + +
Sbjct: 318 RNQPQFDRLENLYLDHNSIVTLK 340
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 51/240 (21%), Positives = 89/240 (37%), Gaps = 22/240 (9%)
Query: 110 ADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLT 169
N L + + S L I D Q +LQ L L S ++ V L + +L
Sbjct: 140 RGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLF 195
Query: 170 SLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGS 229
+S N L+ +L + LD S NS+ + + L+ L + N LT
Sbjct: 196 HANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVR--GPVNVELTILKLQHNNLTD- 246
Query: 230 IPPGLGTLSKLQYLNVSNNSLASSIPAQ-LGDLDSLVDLDLSMNSLSGSVPSELRGLRSL 288
L L +++S N L I + L L +S N L ++ + + +L
Sbjct: 247 -TAWLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL 303
Query: 289 QKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFT 348
+ + +N L ++ N +L+ + L N L+ L +S N++
Sbjct: 304 KVLDLSHNHLL-HVERNQPQ-FDRLENLYLDHNSIVTLKLSTH---HTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 53/291 (18%), Positives = 97/291 (33%), Gaps = 32/291 (10%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLS 198
Q + + + F L N + ++ + + L + +L+L+
Sbjct: 24 QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 83
Query: 199 RNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVSNNSLASSIPAQ 257
+ +F + L + N + +PP + L L + N L SS+P
Sbjct: 84 DLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL-SSLPRG 141
Query: 258 L-GDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQII 316
+ + L L +S N+L + SLQ + +N L+ ++ ++L P L
Sbjct: 142 IFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP---SLFHA 197
Query: 317 VLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGL 376
+ N + L + LD S N+ + VN L + N L
Sbjct: 198 NVSYNLLS-----TLAIPIAVEELDASHNSINV-VR---GPVNVELTILKLQHNN----L 244
Query: 377 TPV-----LGRFRLVDLSGNYFEGRVPEYVHSNASSL-----DSNCLQNVP 417
T VDLS N E ++ + L +N L +
Sbjct: 245 TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALN 294
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 46/181 (25%), Positives = 73/181 (40%), Gaps = 10/181 (5%)
Query: 141 LPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRN 200
++ LD SI+ V LT L L N LT + L L +DLS N
Sbjct: 210 PIAVEELDASHNSINVV---RGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYN 264
Query: 201 SLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGD 260
L + F ++ L L IS+N L ++ + L+ L++S+N L +
Sbjct: 265 ELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQ 322
Query: 261 LDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQ 320
D L +L L NS+ S L++L + +N N LF V++ + Q
Sbjct: 323 FDRLENLYLDHNSIVTLKLSTHHTLKNLT---LSHNDWDCNSLRALFRNVARPAVDDADQ 379
Query: 321 N 321
+
Sbjct: 380 H 380
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 1e-19
Identities = 40/240 (16%), Positives = 83/240 (34%), Gaps = 12/240 (5%)
Query: 181 TIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG-LGTLSK 239
I S+L V + + + L N + ++ + +P L + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76
Query: 240 LQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLS 299
++ LN+++ + ++ L + N++ P + + L V+ N LS
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 300 GNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVN 359
+L +F +L + + N D + L+ L +S N T + ++
Sbjct: 137 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD---LSLI 191
Query: 360 TSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASSLD--SNCLQNVP 417
S N+S N+ + +D S N V V+ + L N L +
Sbjct: 192 PSLFHANVSYNLL--STLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLTDTA 248
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 3e-15
Identities = 38/210 (18%), Positives = 76/210 (36%), Gaps = 5/210 (2%)
Query: 212 LLKNLSSLDISSNYLTGSIPPGL--GTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDL 269
L + D+ + T + G TL+ + + N+++ A L + L+L
Sbjct: 23 LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL 82
Query: 270 SMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPD 329
+ + ++QK +G N + L ++F V L ++VL +N + P
Sbjct: 83 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRG 141
Query: 330 VLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLS 389
+ + P+L L +S NN + + TS L +S N ++ ++S
Sbjct: 142 IFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVS 200
Query: 390 GNYFEGRVPEYVHSNASSLDSNCLQNVPNQ 419
N + + N + V
Sbjct: 201 YNLLS-TLAIPIAVEELDASHNSINVVRGP 229
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 31/190 (16%), Positives = 58/190 (30%), Gaps = 12/190 (6%)
Query: 237 LSKLQYLNV-SNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGN 295
+ Q NV I + L D+ + M + E L + + N
Sbjct: 1 VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60
Query: 296 NFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSR 355
+ + L L + Q++++ L ++ L + N LP
Sbjct: 61 STMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHV 118
Query: 356 SNVNTSTVELNISQN---MFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASSL---- 408
L + +N G+ + + +S N E R+ + +SL
Sbjct: 119 FQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQ 177
Query: 409 -DSNCLQNVP 417
SN L +V
Sbjct: 178 LSSNRLTHVD 187
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 57/304 (18%), Positives = 114/304 (37%), Gaps = 70/304 (23%)
Query: 535 DFSDANLIKN---GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARL 591
D+ + + + G G + + V IK+I+ +S + +A+++EL S+V+H +
Sbjct: 6 DYKEIEVEEVVGRGAFGVVCKAKWRA-KDVAIKQIESESER-KAFIVELRQLSRVNHPNI 63
Query: 592 VPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLS 651
V L G C+ N LV +Y G L + L+ + + ++G++
Sbjct: 64 VKLYGACL---NPVCLVMEYAEGGSLYNVLHGAEPLPY----YTAAHAMSWCLQCSQGVA 116
Query: 652 YLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQ 711
YLH +HRD++ ++LL V ++C D + Q
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTV-----LKIC----DFGTACD----------IQ 157
Query: 712 GSSGSLTATCPY---------------DVYCFGKVLLELVTGKM---GISASSDAQVKEI 753
+ + + DV+ +G +L E++T + I + + +
Sbjct: 158 THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV 217
Query: 754 LEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
T P + K + + E L+ C + P++RP M I+K
Sbjct: 218 HNGTRPPLI--------KNLPKPI---ESLMT----------RCWSKDPSQRPSMEEIVK 256
Query: 814 ALEN 817
+ +
Sbjct: 257 IMTH 260
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 51/222 (22%), Positives = 86/222 (38%), Gaps = 17/222 (7%)
Query: 129 LPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQ 188
+P I P LDL++ IS + L +L +L L +N ++ +
Sbjct: 48 VPKEIS-------PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSP 100
Query: 189 LSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVSN 247
L L L +S+N L IP L +L L I N + +P G L + + +
Sbjct: 101 LRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGG 156
Query: 248 NSLASS-IPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNL 306
N L +S D L L +S L+ +P +L +L + + +N + + +
Sbjct: 157 NPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELED 212
Query: 307 FPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFT 348
S+L + L N L +P LR L + N +
Sbjct: 213 LLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 38/195 (19%), Positives = 62/195 (31%), Gaps = 21/195 (10%)
Query: 113 LVNLTHLA-SFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSL 171
L N+ + N L L L L + ++G+ L L
Sbjct: 146 LRNMNCIEMGGNP---LENSGFEPGAFDGL-KLNYLRISEAKLTGI---PKDLPETLNEL 198
Query: 172 YLSDNGLTGTIPS-SLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSI 230
+L N + I L + S L L L N + S L L L + +N L+ +
Sbjct: 199 HLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RV 256
Query: 231 PPGLGTLSKLQYLNVSNNSLASSIPAQ-------LGDLDSLVDLDLSMNSLSGSV--PSE 281
P GL L LQ + + N++ + + + L N + P+
Sbjct: 257 PAGLPDLKLLQVVYLHTNNI-TKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPAT 315
Query: 282 LRGLRSLQKFVIGNN 296
R + GN
Sbjct: 316 FRCVTDRLAIQFGNY 330
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 51/331 (15%), Positives = 95/331 (28%), Gaps = 55/331 (16%)
Query: 524 FTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK-----TEAYLL 578
+ + LI G G +++G L PV +K + + Y +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRV 61
Query: 579 ELDFFSKVSHARLVPLLGHCMER----ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSL 634
+ H + + E LV +Y PNG L L T
Sbjct: 62 -----PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--------S 108
Query: 635 DWITRLKIAIGAAEGLSYLHHE------CTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688
DW++ ++A GL+YLH E HRD+ + ++L+ + +
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG--L 166
Query: 689 AQGGDAHQSRITRLLRLPQSSEQG-----------SSGSLTATCPY----DVYCFGKVLL 733
+ ++ SE G + +L D+Y G +
Sbjct: 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
Query: 734 ELVTGKMGISASSDAQVKEILEQTL----PYISIYDKELVTKIVDPSLIIDEDLLEE--- 786
E+ + ++ QT P + + P E E
Sbjct: 227 EIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPK--FPEAWKENSLA 284
Query: 787 VWAMAIVARSCLNPKPTRRPLMRYILKALEN 817
V ++ C + R + + +
Sbjct: 285 VRSLKETIEDCWDQDAEARLTAQXAEERMAE 315
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 55/277 (19%), Positives = 89/277 (32%), Gaps = 23/277 (8%)
Query: 90 GINISGFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQL--PTLQAL 147
G ++ + + D + +L+ L +P I + L LQ L
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLS-LKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 148 DLRSCSISGVIPFSLGNLT--NLTSLYLSDNGLTG--TIPSSLGQLSV--LSVLDLSRNS 201
L + ++G P L T +L L L + + L Q L VL +++
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 202 LTGNIPTSFGLLKNLSSLDISSNYLTGSIP----PGLGTLSKLQYLNVSNNSLAS---SI 254
+ LS+LD+S N G LQ L + N + +
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 255 PAQLGDLDSLVDLDLSMNSLSGSVPSEL-RGLRSLQKFVIGNNFLSGNLSVNLFPTVSQL 313
A L LDLS NSL + + L + L + L +L
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA---KL 276
Query: 314 QIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGP 350
++ L N P +PQ+ L + N F
Sbjct: 277 SVLDLSYNRLDRNPS--PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 3e-21
Identities = 49/270 (18%), Positives = 94/270 (34%), Gaps = 17/270 (6%)
Query: 142 PTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNS 201
P +C + + G + L D + + + L L +
Sbjct: 20 PKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAAR 79
Query: 202 LTGNIPTSFGLLKNLSS---LDISSNYLTGSIPPGLG--TLSKLQYLNVSNNSLASSIPA 256
+ I + +S L + + +TG+ PP L T L LN+ N S ++ A
Sbjct: 80 IPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW-ATRDA 138
Query: 257 QLGDLDSLVDLDLSMNSLSGSV-----PSELRGLRSLQKFVIGNNFLSGNLSVN---LFP 308
L +L + L + S++ + ++R +L + +N G +
Sbjct: 139 WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198
Query: 309 TVSQLQIIVLRQNGFT---GPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVEL 365
LQ++ LR G G + + QL+ LD+S N+ + + L
Sbjct: 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSL 258
Query: 366 NISQNMFYGGLTPVLGRFRLVDLSGNYFEG 395
N+S + + ++DLS N +
Sbjct: 259 NLSFTGLKQVPKGLPAKLSVLDLSYNRLDR 288
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 66/312 (21%), Positives = 107/312 (34%), Gaps = 74/312 (23%)
Query: 535 DFSDANLIKNGHSGDLFRGILEG-GIPVVIKRIDLQSVKTEAYLL--------ELDFFSK 585
+ I G G + +G L V IK + L + E ++ E+ S
Sbjct: 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 586 VSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIG 645
++H +V L G N +V +++P GDL L K + + W +L++ +
Sbjct: 80 LNHPNIVKLYGLMH---NPPRMVMEFVPCGDLYHRLLDKAH------PIKWSVKLRLMLD 130
Query: 646 AAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRL 705
A G+ Y+ + P VHRD+++ +I L E VCA+ D S+
Sbjct: 131 IALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENA-----PVCAKVADFGLSQQ------ 178
Query: 706 PQSSEQGSSGSLTATCPY-----------------DVYCFGKVLLELVTGKM---GISAS 745
S L + D Y F +L ++TG+ S
Sbjct: 179 ----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234
Query: 746 SDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRR 805
+ I E+ L I ED + V C + P +R
Sbjct: 235 KIKFINMIREEGL-----------------RPTIPEDCPPR---LRNVIELCWSGDPKKR 274
Query: 806 PLMRYILKALEN 817
P YI+K L
Sbjct: 275 PHFSYIVKELSE 286
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 69/300 (23%), Positives = 123/300 (41%), Gaps = 56/300 (18%)
Query: 535 DFSD---ANLIKNGHSGDLFRGILEGGIPVVIKRI---DLQSVKTEAYLLELDFFSKVSH 588
+ D I G G + R G V +K + D + + +L E+ ++ H
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 589 ARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAE 648
+V +G + N +V +Y+ G SLYR + + LD RL +A A+
Sbjct: 94 PNIVLFMGAVTQPPN-LSIVTEYLSRG----SLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 649 GLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRI-T----- 700
G++YLH+ P VHR++++ ++L+D K+ V++ LS + A + +S T
Sbjct: 149 GMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 207
Query: 701 -RLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLP 759
+LR S+E+ DVY FG +L EL T + P
Sbjct: 208 PEVLRDEPSNEK---------S--DVYSFGVILWELATLQQ------------------P 238
Query: 760 YISIYDKELVTKIVDPSL--IIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817
+ ++ ++V + I +L + +A + C +P +RP I+ L
Sbjct: 239 WGNLNPAQVVAAVGFKCKRLEIPRNLNPQ---VAAIIEGCWTNEPWKRPSFATIMDLLRP 295
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 59/279 (21%), Positives = 107/279 (38%), Gaps = 29/279 (10%)
Query: 129 LPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPS-SLG 187
+P + +++LDL + I+ + L NL +L L+ NG+ TI S
Sbjct: 46 IPSGLT-------EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFS 97
Query: 188 QLSVLSVLDLSRNSLTGNIPTS-FGLLKNLSSLDISSNYLTGSIPPG--LGTLSKLQYLN 244
L L LDLS N L+ N+ +S F L +L+ L++ N ++ L+KLQ L
Sbjct: 98 SLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILR 155
Query: 245 VSNNSLASSIPAQ-LGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLS 303
V N + I + L L +L++ + L P L+ ++++ ++ L
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLL 214
Query: 304 VNLFPTVSQLQIIVLRQNGFTGPPP--------DVLWSMPQLRLLDISRNNFTGPLPNSR 355
S ++ + LR + L R + I+ + +
Sbjct: 215 EIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLN 274
Query: 356 SNVNTSTVELNISQN---MFYGGLTPVLGRFRLVDLSGN 391
+ +EL S+N G+ L + + L N
Sbjct: 275 Q--ISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 54/254 (21%), Positives = 92/254 (36%), Gaps = 17/254 (6%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSL-GQLS 190
I + Q+ LQAL L S I+ + S +L +L L LS N L+ + SS LS
Sbjct: 66 YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLS 124
Query: 191 VLSVLDLSRNSLTGNIPTS-FGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVSNN 248
L+ L+L N TS F L L L + + I L+ L+ L + +
Sbjct: 125 SLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184
Query: 249 SLASSIPAQ-LGDLDSLVDLDLSMNSLSGSVPSEL-RGLRSLQKFVIGNNFLSGN----- 301
L S + L + ++ L L M + S++ + + L
Sbjct: 185 DL-QSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSEL 242
Query: 302 --LSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVN 359
N + + + +L + L L+ SRN +P+ +
Sbjct: 243 STGETNSLIKKFTFRNVKITDESLFQVMK-LLNQISGLLELEFSRNQLKS-VPDGIFDRL 300
Query: 360 TSTVELNISQNMFY 373
TS ++ + N +
Sbjct: 301 TSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 34/174 (19%), Positives = 56/174 (32%), Gaps = 11/174 (6%)
Query: 110 ADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLT 169
+LT L I L L+ L++ + + P SL ++ N++
Sbjct: 142 TSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVS 201
Query: 170 SLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPT--------SFGLLKNLSSLDI 221
L L + + S + L+L L + S ++ I
Sbjct: 202 HLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 222 SSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQ-LGDLDSLVDLDLSMNSL 274
+ L + L +S L L S N L S+P L SL + L N
Sbjct: 262 TDESLF-QVMKLLNQISGLLELEFSRNQL-KSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-27
Identities = 76/314 (24%), Positives = 121/314 (38%), Gaps = 54/314 (17%)
Query: 125 SRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPS 184
R + + L L ++ ++ +P L ++T+L + DN LT ++P+
Sbjct: 26 GRAAVVQKMRACLNNGNAVL---NVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA 78
Query: 185 SLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTL------- 237
+ L L++S N LT ++P L LS +L ++P GL L
Sbjct: 79 LPPE---LRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQL 133
Query: 238 -------SKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQK 290
LQ L+VS+N L +S+PA L L N L+ S+P GL+ L
Sbjct: 134 TSLPVLPPGLQELSVSDNQL-ASLPALPS---ELCKLWAYNNQLT-SLPMLPSGLQELS- 187
Query: 291 FVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGP 350
+S N +L S+L + N T P L+ L +S N T
Sbjct: 188 -------VSDNQLASLPTLPSELYKLWAYNNRLTSLPA----LPSGLKELIVSGNRLTS- 235
Query: 351 LPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNAS---- 406
LP S + EL +S N L + + + N R+PE + +S
Sbjct: 236 LPVLPSELK----ELMVSGNRL-TSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTV 289
Query: 407 SLDSNCLQNVPNQR 420
+L+ N L Q
Sbjct: 290 NLEGNPLSERTLQA 303
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-26
Identities = 64/269 (23%), Positives = 104/269 (38%), Gaps = 48/269 (17%)
Query: 116 LTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSD 175
H+ + L S+P + L+ L++ ++ +P L L+
Sbjct: 60 PAHITTLVIPDNNLT-SLPALPPE----LRTLEVSGNQLT-SLPVLPPGLLELSIFSNPL 113
Query: 176 NGLTGTIPSSLGQLSV--------------LSVLDLSRNSLTGNIPTSFGLLKNLSSLDI 221
L +PS L +L + L L +S N L ++P L L
Sbjct: 114 THLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA-SLPALPS---ELCKLWA 168
Query: 222 SSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSE 281
+N LT S+P LQ L+VS+N L +S+P +L L + + SL P+
Sbjct: 169 YNNQLT-SLPMLPS---GLQELSVSDNQL-ASLPTLPSELYKLWAYNNRLTSL----PAL 219
Query: 282 LRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLD 341
GL+ L +SGN +L S+L+ +++ N T P L L
Sbjct: 220 PSGLKELI--------VSGNRLTSLPVLPSELKELMVSGNRLTSLPM----LPSGLLSLS 267
Query: 342 ISRNNFTGPLPNSRSNVNTSTVELNISQN 370
+ RN T LP S + +S +N+ N
Sbjct: 268 VYRNQLTR-LPESLIH-LSSETTVNLEGN 294
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 8e-19
Identities = 38/158 (24%), Positives = 62/158 (39%), Gaps = 17/158 (10%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSV 191
S+P + L L + ++ +P + L L +S N LT ++P +L
Sbjct: 195 SLPTLPSE----LYKLWAYNNRLT-SLP---ALPSGLKELIVSGNRLT-SLPVLPSELKE 245
Query: 192 LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLA 251
L +S N LT ++P L SL + N LT +P L LS +N+ N L+
Sbjct: 246 L---MVSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
Query: 252 SSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQ 289
L ++ S + + S R R+L
Sbjct: 298 ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALH 335
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 70/304 (23%), Positives = 118/304 (38%), Gaps = 59/304 (19%)
Query: 535 DFSD---ANLIKNGHSGDLFRGILEGGIPVVIKRI-----DLQSVKTEAYLLELDFFSKV 586
DF++ +I G G ++R G V +K + S E E F+ +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 587 SHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGA 646
H ++ L G C++ N LV ++ G L+ L K + + A+
Sbjct: 64 KHPNIIALRGVCLKEPN-LCLVMEFARGGPLNRVLSGK--------RIPPDILVNWAVQI 114
Query: 647 AEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLP 706
A G++YLH E +P +HRD+++S+IL+ K E G LS + D +R
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVE--NGDLSNKILKITDFGLAREWH----- 167
Query: 707 QSSEQGSSGSL--TA-----TCPY----DVYCFGKVLLELVTGKMGISASSDAQVKEILE 755
++++ ++G+ A + DV+ +G +L EL+TG++
Sbjct: 168 RTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV--------------- 212
Query: 756 QTLPYISIYDKELVTKIVDPS--LIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
P+ I + + L I E A + C NP P RP IL
Sbjct: 213 ---PFRGIDGLAVAYGVAMNKLALPIPSTCPEP---FAKLMEDCWNPDPHSRPSFTNILD 266
Query: 814 ALEN 817
L
Sbjct: 267 QLTT 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 60/313 (19%), Positives = 115/313 (36%), Gaps = 73/313 (23%)
Query: 535 DFSDANLIK---NGHSGDLFRGILEGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSH 588
+ + +G G +++G G V +K +++ + + +A+ E+ K H
Sbjct: 22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79
Query: 589 ARLVPLLGHCMERENEKF-LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAA 647
++ +G+ + +V ++ L L+ + + IA A
Sbjct: 80 VNILLFMGYSTA---PQLAIVTQWCEGSSLYHHLHASET------KFEMKKLIDIARQTA 130
Query: 648 EGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQ 707
G+ YLH +HRD+++++I L + V++ GD +
Sbjct: 131 RGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKI----------GDFGLATEKSRWSGSH 177
Query: 708 SSEQGSSGSL--TA--------TCPY----DVYCFGKVLLELVTGKMGISASSDAQVKEI 753
E SGS+ A + PY DVY FG VL EL+TG++
Sbjct: 178 QFE-QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL------------- 223
Query: 754 LEQTLPYISIYDKELVTKIVD------PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPL 807
PY +I +++ + ++V + + + M + CL K RP
Sbjct: 224 -----PYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR---MKRLMAECLKKKRDERPS 275
Query: 808 MRYILKALENPLK 820
IL +E +
Sbjct: 276 FPRILAEIEELAR 288
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 69/260 (26%), Positives = 113/260 (43%), Gaps = 23/260 (8%)
Query: 113 LVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLY 172
+L + + +A + +I Q L L L+L+ I+ + P NLT +T L
Sbjct: 37 QADLDGITTLSAFGTGV-TTIEGV--QYLNNLIGLELKDNQITDLAPLK--NLTKITELE 91
Query: 173 LSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPP 232
LS N L + S++ L + LDL+ +T P L NL L + N +T +I P
Sbjct: 92 LSGNPLK-NV-SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP 146
Query: 233 GLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFV 292
L L+ LQYL++ N + S + L +L L L N +S S L L +L +
Sbjct: 147 -LAGLTNLQYLSIGNAQV-SDLTP-LANLSKLTTLKADDNKISDI--SPLASLPNLIEVH 201
Query: 293 IGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPL- 351
+ NN +S V+ S L I+ L T P L + ++ + P+
Sbjct: 202 LKNNQIS---DVSPLANTSNLFIVTLTNQTITNQPVFYN---NNLVVPNVVKGPSGAPIA 255
Query: 352 PNSRSNVNTSTVELNISQNM 371
P + S+ N + N++ N+
Sbjct: 256 PATISD-NGTYASPNLTWNL 274
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 47/231 (20%), Positives = 100/231 (43%), Gaps = 20/231 (8%)
Query: 140 QLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSR 199
L + +++ + + +L +T+L G+T TI + L+ L L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKD 72
Query: 200 NSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLG 259
N +T ++ L ++ L++S N L ++ + L ++ L++++ + + + L
Sbjct: 73 NQIT-DLA-PLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQI-TDVTP-LA 126
Query: 260 DLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLR 319
L +L L L +N ++ S L GL +LQ IGN +S + +S+L +
Sbjct: 127 GLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS---DLTPLANLSKLTTLKAD 181
Query: 320 QNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQN 370
N + P L S+P L + + N + P + ++ + ++
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSPLAN---TSNLFIVTLTNQ 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 45/213 (21%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 160 FSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSL 219
F L N + + +T + L ++ L +T I L NL L
Sbjct: 13 FPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGL 68
Query: 220 DISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVP 279
++ N +T + P L L+K+ L +S N L ++ A + L S+ LDL+ ++
Sbjct: 69 ELKDNQIT-DLAP-LKNLTKITELELSGNPL-KNVSA-IAGLQSIKTLDLTSTQITD--V 122
Query: 280 SELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRL 339
+ L GL +LQ + N ++ +++ ++ LQ + + + P L ++ +L
Sbjct: 123 TPLAGLSNLQVLYLDLNQIT---NISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTT 177
Query: 340 LDISRNNFTG--PLPNSRSNVNTSTVELNISQN 370
L N + PL + + +E+++ N
Sbjct: 178 LKADDNKISDISPLAS-----LPNLIEVHLKNN 205
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 34/165 (20%), Positives = 65/165 (39%), Gaps = 13/165 (7%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLG-QQLPTLQALDLRSCSISGVIPFSLGNLTNLT 169
A+ L + + + + I D L LQ L L I+ + P L LTNL
Sbjct: 101 SAIAGLQSIKTLDLTS----TQITDVTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQ 154
Query: 170 SLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGS 229
L + + ++ + L LS L+ L N ++ +I L NL + + +N ++
Sbjct: 155 YLSIGNAQVSDL--TPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQIS-D 209
Query: 230 IPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSL 274
+ P L S L + ++N ++ + +L + +
Sbjct: 210 VSP-LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 35/138 (25%), Positives = 59/138 (42%), Gaps = 10/138 (7%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLS 198
L LQ L + + +S + P L NL+ LT+L DN ++ S L L L + L
Sbjct: 148 AGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLK 203
Query: 199 RNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLN-VSNNSLASSIPAQ 257
N ++ ++ NL + +++ +T + P + L N V S A PA
Sbjct: 204 NNQIS-DVS-PLANTSNLFIVTLTNQTIT-NQPVFY--NNNLVVPNVVKGPSGAPIAPAT 258
Query: 258 LGDLDSLVDLDLSMNSLS 275
+ D + +L+ N S
Sbjct: 259 ISDNGTYASPNLTWNLTS 276
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 32/138 (23%), Positives = 62/138 (44%), Gaps = 5/138 (3%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLS 198
+ ++ L + + + P + L+NL L + +T +L L+ L++LD+S
Sbjct: 63 EYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120
Query: 199 RNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQL 258
++ +I T L ++S+D+S N I P L TL +L+ LN+ + + +
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--I 177
Query: 259 GDLDSLVDLDLSMNSLSG 276
D L L ++ G
Sbjct: 178 EDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-22
Identities = 33/190 (17%), Positives = 74/190 (38%), Gaps = 11/190 (5%)
Query: 160 FSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSL 219
+ L + + Q++ L+ + L+ ++T ++ T N+ L
Sbjct: 17 IPDSTFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDL 71
Query: 220 DISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVP 279
I++ + T + P + LS L+ L + + S L L SL LD+S ++ S+
Sbjct: 72 TINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129
Query: 280 SELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRL 339
+++ L + + N ++ T+ +L+ + ++ +G + P+L
Sbjct: 130 TKINTLPKVNSIDLSYNGAITDIMP--LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQ 185
Query: 340 LDISRNNFTG 349
L G
Sbjct: 186 LYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 24/199 (12%), Positives = 60/199 (30%), Gaps = 59/199 (29%)
Query: 195 LDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSI 254
L ++S + + +L+ + +++ +T + G+ ++ L ++N +
Sbjct: 28 GLLGQSSTA---NITEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNYN 82
Query: 255 PAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQ 314
P + L +L L + ++ L GL
Sbjct: 83 P--ISGLSNLERLRIMGKDVTSDKIPNLSGL----------------------------- 111
Query: 315 IIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYG 374
L LLDIS + + + +++S N
Sbjct: 112 --------------------TSLTLLDISHSAHDDSILTKINT-LPKVNSIDLSYNGAIT 150
Query: 375 GLTPV--LGRFRLVDLSGN 391
+ P+ L + +++ +
Sbjct: 151 DIMPLKTLPELKSLNIQFD 169
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 53/312 (16%), Positives = 104/312 (33%), Gaps = 60/312 (19%)
Query: 535 DFSD---ANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSH 588
F LI G G ++ G G V I+ ID++ + +A+ E+ + + H
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 589 ARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAE 648
+V +G CM + ++ L S + LD +IA +
Sbjct: 89 ENVVLFMGACMSPPH-LAIITSLCKGRTLYSVVRDAKI------VLDVNKTRQIAQEIVK 141
Query: 649 GLSYLHHECTLPFVHRDVQASSILLDDK------FEV-RLGSLSEVCAQGGDAHQSRITR 701
G+ YLH + +H+D+++ ++ D+ F + + + + +
Sbjct: 142 GMGYLHAK---GILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 702 ------LLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKM---GISASS-DAQVK 751
++R + + DV+ G + EL + A + Q+
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHS--DVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256
Query: 752 EILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYI 811
++ L I + KE+ D+L C + RP +
Sbjct: 257 TGMKPNLSQIGM-GKEIS------------DILL----------FCWAFEQEERPTFTKL 293
Query: 812 LKALENPLKVVR 823
+ LE K R
Sbjct: 294 MDMLEKLPKRNR 305
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 5e-26
Identities = 45/219 (20%), Positives = 91/219 (41%), Gaps = 17/219 (7%)
Query: 140 QLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSR 199
+L+ S++ + L ++ + +++ + ++ + L ++ L L+
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 200 NSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLG 259
N LT +I LKNL L + N + + L L KL+ L++ +N + S I L
Sbjct: 75 NKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGI-SDING-LV 128
Query: 260 DLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLR 319
L L L L N + + + L L L + +N +S + +++LQ + L
Sbjct: 129 HLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS---DIVPLAGLTKLQNLYLS 183
Query: 320 QNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNV 358
+N + L + L +L++ N +SN+
Sbjct: 184 KNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNL 220
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 56/235 (23%), Positives = 93/235 (39%), Gaps = 24/235 (10%)
Query: 140 QLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSR 199
+L ++ + + I V + L N+T L+L+ N LT I L L L L L
Sbjct: 41 ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDE 96
Query: 200 NSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLG 259
N + ++ +S LK L SL + N ++ I L L +L+ L + NN + + I L
Sbjct: 97 NKIK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI-TDITV-LS 150
Query: 260 DLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLR 319
L L L L N +S + L GL LQ + N +S + + L ++ L
Sbjct: 151 RLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS---DLRALAGLKNLDVLELF 205
Query: 320 QNGFTGPPPD---VLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNM 371
P + L ++ D S P S+ + N+ ++
Sbjct: 206 SQECLNKPINHQSNLVVPNTVKNTDGSLVT-----PEIISDDGDYE-KPNVKWHL 254
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 44/229 (19%), Positives = 88/229 (38%), Gaps = 24/229 (10%)
Query: 144 LQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLT 203
+ S I + P L +T + +L+ + + + + +
Sbjct: 1 MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 204 GNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDS 263
++ L N++ L ++ N LT I P L L L +L + N + + + L DL
Sbjct: 57 -SV-QGIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKI-KDLSS-LKDLKK 110
Query: 264 LVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGF 323
L L L N + S + L L L+ +GNN ++ + + +++L + L N
Sbjct: 111 LKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKIT---DITVLSRLTKLDTLSLEDNQI 165
Query: 324 TGPPPDVLWSMPQLRLLDISRNNFT--GPLPNSRSNVNTSTVELNISQN 370
+ P L + +L+ L +S+N+ + L + L +
Sbjct: 166 SDIVP--LAGLTKLQNLYLSKNHISDLRALAG-----LKNLDVLELFSQ 207
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 97.9 bits (243), Expect = 4e-21
Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 15/216 (6%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLS 198
Q LP + L L ++ + P L NL NL L+L +N + + SSL L L L L
Sbjct: 62 QYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLE 117
Query: 199 RNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQL 258
N ++ +I L L SL + +N +T I L L+KL L++ +N + S I L
Sbjct: 118 HNGIS-DI-NGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQI-SDIVP-L 171
Query: 259 GDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVL 318
L L +L LS N + S L GL++L + + N +N + +
Sbjct: 172 AGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKN 228
Query: 319 RQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNS 354
+ P+++ ++ + S
Sbjct: 229 TDG--SLVTPEIISDDGDYEKPNVKWHLPEFTNEVS 262
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 3e-04
Identities = 23/117 (19%), Positives = 35/117 (29%), Gaps = 7/117 (5%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTS 170
L LT L + + + I L LQ L L IS + L L NL
Sbjct: 147 TVLSRLTKLDTLSLEDNQI-SDIVPL--AGLTKLQNLYLSKNHISDLRA--LAGLKNLDV 201
Query: 171 LYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLT 227
L L + L V + + + SL S + ++ +
Sbjct: 202 LELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDD--GDYEKPNVKWHLPE 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 41/229 (17%), Positives = 79/229 (34%), Gaps = 16/229 (6%)
Query: 129 LPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSS-LG 187
+P +P L + + + +L + +S N + I +
Sbjct: 24 IPSDLP-------RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFS 76
Query: 188 QLSVLSVLDLSR-NSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGT-LSKLQYLNV 245
L L + + + N+L P +F L NL L IS+ + +P + L++
Sbjct: 77 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDI 135
Query: 246 SNNSLASSIPAQL--GDLDSLVDLDLSMNSLSGSVPSE-LRGLRSLQKFVIGNNFLSGNL 302
+N +I G V L L+ N + + + G + + + NN L L
Sbjct: 136 QDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-EL 193
Query: 303 SVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPL 351
++F S I+ + + P L ++ +LR L
Sbjct: 194 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTL 242
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 26/145 (17%), Positives = 45/145 (31%), Gaps = 8/145 (5%)
Query: 106 PRFAADALVNLTHLA-SFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGN 164
P + L N + + + L + L L I + +
Sbjct: 120 PDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFES---VILWLNKNGIQEIHNSAFNG 176
Query: 165 LTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSN 224
+N L S +LD+SR + ++P+ L+NL L S
Sbjct: 177 TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPS--YGLENLKKLRARST 233
Query: 225 YLTGSIPPGLGTLSKLQYLNVSNNS 249
Y +P L L L +++ S
Sbjct: 234 YNLKKLPT-LEKLVALMEASLTYPS 257
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 43/261 (16%), Positives = 90/261 (34%), Gaps = 33/261 (12%)
Query: 113 LVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLY 172
+L+ + +N W + ++ L + + L
Sbjct: 10 NFSLSQNSFYNTISGTYADYFSAW--DKWEKQALPGENRNEAVSLLKECL--INQFSELQ 65
Query: 173 LSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPP 232
L+ L+ ++P +L ++VL++++N+L ++P +L LD N L+ ++P
Sbjct: 66 LNRLNLS-SLPDNLPPQ--ITVLEITQNALI-SLPELPA---SLEYLDACDNRLS-TLPE 117
Query: 233 GLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFV 292
L++L+V NN L + +P L ++ N L+ +P L L
Sbjct: 118 LPA---SLKHLDVDNNQL-TMLPELPA---LLEYINADNNQLT-MLPELPTSLEVL---- 165
Query: 293 IGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDV--LWSMPQLRL-LDISRNNFTG 349
+ N L L+ + + N P + + N T
Sbjct: 166 ----SVRNNQLTFLPELPESLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRITH 221
Query: 350 PLPNSRSNVNTSTVELNISQN 370
+P + + T + + N
Sbjct: 222 -IPENILS-LDPTCTIILEDN 240
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 7e-18
Identities = 37/184 (20%), Positives = 65/184 (35%), Gaps = 24/184 (13%)
Query: 111 DALVNLTHL-ASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLT 169
+ +L HL N L P+ L+ ++ + ++ ++P T+L
Sbjct: 117 ELPASLKHLDVDNNQLTML-----PELPAL----LEYINADNNQLT-MLPELP---TSLE 163
Query: 170 SLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSS----LDISSNY 225
L + +N LT +P L LD+S N L ++P + N
Sbjct: 164 VLSVRNNQLT-FLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENR 218
Query: 226 LTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGL 285
+T IP + +L + + +N L+S I L + D S S +
Sbjct: 219 IT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLH 277
Query: 286 RSLQ 289
R L
Sbjct: 278 RPLA 281
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 23/130 (17%), Positives = 44/130 (33%), Gaps = 10/130 (7%)
Query: 111 DALVNLTHLASFNASRFLLPGSIPDWLGQ---QLPTLQALDLRSCSISGVIPFSLGNLTN 167
+ +L L + S LL S+P + T R I+ IP ++ +L
Sbjct: 177 ELPESLEAL---DVSTNLL-ESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDP 231
Query: 168 LTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLT 227
++ L DN L+ I SL Q + R + + + D + +
Sbjct: 232 TCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQN--TLHRPLADAVTAWFP 289
Query: 228 GSIPPGLGTL 237
+ + +
Sbjct: 290 ENKQSDVSQI 299
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-24
Identities = 48/253 (18%), Positives = 93/253 (36%), Gaps = 13/253 (5%)
Query: 103 SQNPRFAADALVNLTHLASFNASRFLLPG----SIPDWLGQQLPTLQALDLRSCSISGVI 158
+ N LV T + F+ S L G D+ G L L + S
Sbjct: 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQ 292
Query: 159 PFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSS 218
+ +N+ + +G ++S LD S N LT + + G L L +
Sbjct: 293 SYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET 352
Query: 219 LDISSNYLTGSIPPGLG---TLSKLQYLNVSNNSLASSIPAQLGD-LDSLVDLDLSMNSL 274
L + N L + + LQ L++S NS++ SL+ L++S N L
Sbjct: 353 LILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411
Query: 275 SGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSM 334
+ ++ L ++ + +N + ++ + + LQ + + N P + +
Sbjct: 412 TDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVK-LEALQELNVASNQLKSVPDGIFDRL 467
Query: 335 PQLRLLDISRNNF 347
L+ + + N +
Sbjct: 468 TSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 2e-20
Identities = 48/277 (17%), Positives = 88/277 (31%), Gaps = 17/277 (6%)
Query: 166 TNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNY 225
T L +S N ++ S + LS L +L +S N + + F + L LD+S N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 226 LTGSIPPGLGTLSKLQYLNVSNNSLAS-SIPAQLGDLDSLVDLDLSMNSLSGSVPSELRG 284
L I L++L++S N+ + I + G++ L L LS L S +
Sbjct: 81 LV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 285 LRSLQKFVIGNNFLSGNLSVNLFP--TVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDI 342
L + ++ L I+ F + ++ L L +I
Sbjct: 138 LNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 343 SRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVH 402
S + + N LT ++ + N F + H
Sbjct: 198 KCVLEDNKCSYFLSIL------AKLQTNPKLSNLT-----LNNIETTWNSFIRILQLVWH 246
Query: 403 SNASSLDSNCLQNVPNQRTLVDCSSFYAARGLSFDNF 439
+ + ++ S + + LS
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQV 283
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-19
Identities = 61/315 (19%), Positives = 99/315 (31%), Gaps = 29/315 (9%)
Query: 142 PTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNS 201
L++ IS + + +L+ L L +S N + S L LDLS N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 202 LTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG--LGTLSKLQYLNVSNNSLASSIPAQLG 259
L I NL LD+S N ++P G +S+L++L +S L S +
Sbjct: 81 LV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 260 DLDSL-VDLDLSMNSLSGSVPSELRGLR--SLQKFVIGNNFLS----------GNLSVNL 306
L+ V L L P L+ SL N NL ++
Sbjct: 137 HLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196
Query: 307 FPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELN 366
V + + + S L ++ + N+F L +T+ +
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVW---HTTVWYFS 253
Query: 367 ISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASSLDSNCLQNVPNQRTL--VD 424
IS G FR D SG + V S+ + + + + +
Sbjct: 254 ISNVKLQG-----QLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308
Query: 425 CSSFYAARGLSFDNF 439
S L
Sbjct: 309 VSGTRMVHMLCPSKI 323
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 9e-19
Identities = 37/219 (16%), Positives = 80/219 (36%), Gaps = 14/219 (6%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLG-----NLTNLTSLYLSDNGLTGTIPSSLGQLSVLS 193
T+ + + + G + F +L L+ + + S ++
Sbjct: 244 VWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMN 303
Query: 194 VLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASS 253
+ + + + + LD S+N LT ++ G L++L+ L + N L
Sbjct: 304 IKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL-KE 362
Query: 254 IPAQLGDLDSLV---DLDLSMNSLSGSVPSEL-RGLRSLQKFVIGNNFLSGNLSVNLFPT 309
+ + LD+S NS+S +SL + +N L+ + L P
Sbjct: 363 LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP- 421
Query: 310 VSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFT 348
+++++ L N P V+ + L+ L+++ N
Sbjct: 422 --RIKVLDLHSNKIKSIPKQVV-KLEALQELNVASNQLK 457
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 3e-15
Identities = 54/346 (15%), Positives = 115/346 (33%), Gaps = 28/346 (8%)
Query: 99 TRLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVI 158
LG +++ + HL L + L L +
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKE 177
Query: 159 PFSLGNLTNLTSLYLSDNGLTG-----------TIPSSLGQLSVLSVLDLSRNSLTGNIP 207
+ +++ T L + + +I + L LS L L+ T N
Sbjct: 178 FHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSF 237
Query: 208 TSFGLLKNLSS---LDISSNYLTGSIPPGLG-----TLSKLQYLNVSNNSLASSIPAQLG 259
L ++ IS+ L G + +L L V ++
Sbjct: 238 IRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYE 297
Query: 260 DLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLR 319
++ + +++ + NN L+ + +++L+ ++L+
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT-DTVFENCGHLTELETLILQ 356
Query: 320 QNGFT--GPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLT 377
N ++ M L+ LDIS+N+ + + S + LN+S N+ +
Sbjct: 357 MNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416
Query: 378 PVLGR-FRLVDLSGNYFEGRVPEYVHSNAS----SLDSNCLQNVPN 418
L +++DL N + +P+ V + ++ SN L++VP+
Sbjct: 417 RCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPD 461
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 45/219 (20%), Positives = 92/219 (42%), Gaps = 17/219 (7%)
Query: 140 QLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSR 199
+L+ S++ + + L ++ + +++ + ++ + L ++ L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77
Query: 200 NSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLG 259
N LT +I LKNL L + N + + L L KL+ L++ +N + S I L
Sbjct: 78 NKLT-DI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGI-SDING-LV 131
Query: 260 DLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLR 319
L L L L N ++ + L L L + +N +S + +++LQ + L
Sbjct: 132 HLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS---DIVPLAGLTKLQNLYLS 186
Query: 320 QNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNV 358
+N + L + L +L++ N +SN+
Sbjct: 187 KNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNL 223
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 55/235 (23%), Positives = 91/235 (38%), Gaps = 24/235 (10%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLS 198
+L ++ + + I V L N+T L+L+ N LT L L L L L
Sbjct: 43 NELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLD 98
Query: 199 RNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQL 258
N + ++ +S LK L SL + N ++ I L L +L+ L + NN + + I L
Sbjct: 99 ENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI-TDITV-L 152
Query: 259 GDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVL 318
L L L L N +S + L GL LQ + N +S + + L ++ L
Sbjct: 153 SRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS---DLRALAGLKNLDVLEL 207
Query: 319 RQNGFTGPPPD---VLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQN 370
P + L ++ D S P S+ + + N+ +
Sbjct: 208 FSQECLNKPINHQSNLVVPNTVKNTDGSLVT-----PEIISD-DGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 43/213 (20%), Positives = 85/213 (39%), Gaps = 22/213 (10%)
Query: 160 FSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSL 219
FS L +T + +L+ + + + + + ++ L N++ L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 73
Query: 220 DISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVP 279
++ N LT I P L L L +L + N + + + L DL L L L N + S
Sbjct: 74 FLNGNKLT-DIKP-LANLKNLGWLFLDENKV-KDLSS-LKDLKKLKSLSLEHNGI--SDI 127
Query: 280 SELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRL 339
+ L L L+ +GNN ++ + + +++L + L N + P L + +L+
Sbjct: 128 NGLVHLPQLESLYLGNNKIT---DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN 182
Query: 340 LDISRNNFT--GPLPNSRSNVNTSTVELNISQN 370
L +S+N+ + L + L +
Sbjct: 183 LYLSKNHISDLRALAG-----LKNLDVLELFSQ 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 37/167 (22%), Positives = 67/167 (40%), Gaps = 10/167 (5%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLS 198
+ L L++L L IS + L +L L SLYL +N + T + L +L+ L L L
Sbjct: 109 KDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLE 164
Query: 199 RNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQL 258
N ++ +I L L +L +S N+++ + L L L L + + +
Sbjct: 165 DNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQ 220
Query: 259 GDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVN 305
+L + + SL P + +K + + V+
Sbjct: 221 SNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEFTNEVS 265
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 54/224 (24%), Positives = 90/224 (40%), Gaps = 20/224 (8%)
Query: 130 PGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSL-GQ 188
P ++P + + LDL + + +S + L L LS + TI
Sbjct: 23 PDNLP-------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQS 74
Query: 189 LSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGL-GTLSKLQYLNVSN 247
LS LS L L+ N + +F L +L L L S+ G L L+ LNV++
Sbjct: 75 LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAH 133
Query: 248 NSLASSIPAQL-GDLDSLVDLDLSMNSLSGSVPSE-LRGLRSLQKFVIGNNFLSGN---- 301
N + S + +L +L LDLS N + S+ LR L + + + LS N
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNL-SLDLSLNPMNF 191
Query: 302 LSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRN 345
+ F + +L+ + L N P + + L+ + + N
Sbjct: 192 IQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 48/214 (22%), Positives = 87/214 (40%), Gaps = 16/214 (7%)
Query: 166 TNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTS-FGLLKNLSSLDISSN 224
+ +L LS N L S L VLDLSR + I + L +LS+L ++ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 225 YLTGSIPPGL-GTLSKLQYLNVSNNSLASSIPAQL-GDLDSLVDLDLSMNSLSGSVPSE- 281
+ S+ G LS LQ L +L +S+ G L +L +L+++ N + S
Sbjct: 87 PIQ-SLALGAFSGLSSLQKLVAVETNL-ASLENFPIGHLKTLKELNVAHNLIQ-SFKLPE 143
Query: 282 -LRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLR----QNGFTGPPPDVLWSMPQ 336
L +L+ + +N + ++ + Q+ ++ L N P +
Sbjct: 144 YFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIR 201
Query: 337 LRLLDISRNNFTGPLPNSRSNVNTSTVELNISQN 370
L+ L + N +P+ + TS ++ + N
Sbjct: 202 LKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 234
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 54/305 (17%), Positives = 99/305 (32%), Gaps = 46/305 (15%)
Query: 540 NLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFF--SKVSHARLVPLLGH 597
I G G+++RG G V +K + + ++ E + + + H ++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAA 104
Query: 598 CMERENEK---FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLH 654
+ +LV Y +G L L R T + +K+A+ A GL++LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--------VTVEGMIKLALSTASGLAHLH 156
Query: 655 HE-----CTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRLPQ 707
E HRD+++ +IL+ + L+ T + +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR--------HDSATDTIDIAP 208
Query: 708 SSEQG----------SSGSLTATCPY----DVYCFGKVLLELVTGKMGISASSDAQV-KE 752
+ G D+Y G V E+ D Q+
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268
Query: 753 ILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYIL 812
L + P + K + + + P++ E + MA + R C R I
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
Query: 813 KALEN 817
K L
Sbjct: 329 KTLSQ 333
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 55/332 (16%), Positives = 110/332 (33%), Gaps = 64/332 (19%)
Query: 545 GHSGDLFRGILEG-GIPVVIKRIDLQSVKTEAYLL-ELDFFSKVSHARLVPLLGHCMERE 602
G G + G +V+K + +T+ L E+ + H ++ +G + +
Sbjct: 21 GCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK 80
Query: 603 NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFV 662
+ +Y+ G L + + W R+ A A G++YLH ++ +
Sbjct: 81 RL-NFITEYIKGGTLRGIIKSMDS------QYPWSQRVSFAKDIASGMAYLH---SMNII 130
Query: 663 HRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS-GSLTA 719
HRD+ + + L+ + V + L+ + + Q R L+ P ++ + G+
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVD--EKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 720 TCP-------Y----DVYCFGKVLLELVTGKM---GISASSDA---QVKEILEQTLPYIS 762
P Y DV+ FG VL E++ + V+ L++ P
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP--- 245
Query: 763 IYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLKVV 822
PS + C + P +RP + LE +
Sbjct: 246 --------PNCPPSF-------------FPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284
Query: 823 REENSGSARLRTTSSRGSWNAALFGSWRQSSS 854
+L + ++R+ S
Sbjct: 285 AGHLPLGPQLEQLDR------GFWETYRRGES 310
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 53/293 (18%), Positives = 97/293 (33%), Gaps = 30/293 (10%)
Query: 132 SIPDWLGQQLPT-LQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPS-SLGQL 189
+P+ LP + +DL SI+ + S L +L L + I + + L
Sbjct: 24 QVPE-----LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGL 78
Query: 190 SVLSVLDLSRNSLTGNIPTS-FGLLKNLSSLDISSNYLTGS-IPPGL-GTLSKLQYLNVS 246
S L +L L N + T F L NL L ++ L G+ + L+ L+ L +
Sbjct: 79 SSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137
Query: 247 NNSLASSIPAQLGD-LDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVN 305
+N++ PA + LDL+ N + +L + F LS
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKH-------FTLLRLSSI 190
Query: 306 LFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVEL 365
+ + + + + LD+S N F + + T
Sbjct: 191 --------TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQ 242
Query: 366 NISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASSLDSNCLQNVPN 418
++ + Y + G D F+G V + L + + +
Sbjct: 243 SLILSNSYNMGS-SFGHTNFKDPDNFTFKGLEASGVKT--CDLSKSKIFALLK 292
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-20
Identities = 49/288 (17%), Positives = 90/288 (31%), Gaps = 31/288 (10%)
Query: 169 TSLYLSDNGLTG--TIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYL 226
+ + GL +P+ + + +DLS NS+ TSF L++L L +
Sbjct: 13 YNAICINRGLHQVPELPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTP 66
Query: 227 TGSIPPGL-GTLSKLQYLNVSNNSLASSIPAQ-LGDLDSLVDLDLSMNSL-SGSVPSEL- 282
I LS L L + N + L +L L L+ +L +
Sbjct: 67 GLVIRNNTFRGLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFF 125
Query: 283 RGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMP--QLRLL 340
+ L SL+ V+ +N + + F + + ++ L N + L + LL
Sbjct: 126 KPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL 185
Query: 341 DISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPEY 400
+S + +DLSGN F+ + +
Sbjct: 186 RLSSITLQDMNEYWLG---------WEKCGNPFK-----NTSITTLDLSGNGFKESMAKR 231
Query: 401 VHS--NASSLDSNCLQNVPNQRTLVDCSSFYAARGLSFDNFGRPNATQ 446
+ + S L N N + ++F +F
Sbjct: 232 FFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKT 279
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 6e-20
Identities = 65/350 (18%), Positives = 119/350 (34%), Gaps = 49/350 (14%)
Query: 110 ADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLT 169
+ L L + I + + L +L L L + + L NL
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLE 106
Query: 170 SLYLSDNGLTGTI--PSSLGQLSVLSVLDLSRNSLTGNIP-TSFGLLKNLSSLDISSNYL 226
L L+ L G + + L+ L +L L N++ P + F ++ LD++ N +
Sbjct: 107 VLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV 166
Query: 227 TGSIPPGL---GTLSKLQYLNVSNNSLASSIPAQLGD--------LDSLVDLDLSMNSLS 275
SI L +S+ +L LG S+ LDLS N
Sbjct: 167 K-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK 225
Query: 276 GSVPSELRGLRSLQK----FVIGNNFLSGNLSVNLFP----------TVSQLQIIVLRQN 321
S+ + K + + + + F S ++ L ++
Sbjct: 226 ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKS 285
Query: 322 GFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQN--------MFY 373
V L L +++N + ++ T ++LN+SQN MF
Sbjct: 286 KIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFE 344
Query: 374 GGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNAS-----SLDSNCLQNVPN 418
L + ++DLS N+ + + +LD+N L++VP+
Sbjct: 345 N-----LDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPD 388
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 42/272 (15%), Positives = 94/272 (34%), Gaps = 28/272 (10%)
Query: 100 RLGSQNPRFAADALVNLTHLA-SFNASRFLLPGSIPDWLGQQLPTL-----QALDLRSCS 153
+ P + L +FN + + + ++ G+ L D+
Sbjct: 140 NIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYW 199
Query: 154 ISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVL-------------DLSRN 200
+ + T++T+L LS NG ++ + +
Sbjct: 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259
Query: 201 SLTGNIPTSFGLLK--NLSSLDISSNYLTGSIPPGL-GTLSKLQYLNVSNNSLASSIPAQ 257
+ +F L+ + + D+S + + ++ + + L+ L ++ N + + I
Sbjct: 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEI-NKIDDN 317
Query: 258 LGD-LDSLVDLDLSMNSLSGSVPSEL-RGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQI 315
L L+ L+LS N L S+ S + L L+ + N + L F + L+
Sbjct: 318 AFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKE 375
Query: 316 IVLRQNGFTGPPPDVLWSMPQLRLLDISRNNF 347
+ L N P + + L+ + + N +
Sbjct: 376 LALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 7e-23
Identities = 54/306 (17%), Positives = 97/306 (31%), Gaps = 48/306 (15%)
Query: 540 NLIKNGHSGDLFRGILEGGIPVVIKRI---DLQSVKTEAYLLELDFFSKVSHARLVPLLG 596
I G G+++ G G V +K + S E + + + H ++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQT---VLMRHENILGFIA 98
Query: 597 HCMERENEK---FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL 653
++ +L+ Y NG L L T LD + LK+A + GL +L
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--------LDAKSMLKLAYSSVSGLCHL 150
Query: 654 HHE-----CTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRLP 706
H E HRD+++ +IL+ + L+ + +P
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD--------IP 202
Query: 707 QSSEQG----------SSGSLTATCPY----DVYCFGKVLLELVTGKMGISASSDAQVK- 751
++ G D+Y FG +L E+ + + Q+
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262
Query: 752 EILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYI 811
L + P + + K + PS E + M + C P R +
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322
Query: 812 LKALEN 817
K L
Sbjct: 323 KKTLAK 328
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 50/167 (29%), Positives = 77/167 (46%), Gaps = 8/167 (4%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSV 191
+ L L+L ++ + G L L +L LS N L ++P L
Sbjct: 45 TFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPA 101
Query: 192 LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGL-GTLSKLQYLNVSNNSL 250
L+VLD+S N LT + L L L + N L ++PPGL KL+ L+++NN+L
Sbjct: 102 LTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNL 160
Query: 251 ASSIPAQLGD-LDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNN 296
+ +PA L + L++L L L NSL ++P G L + N
Sbjct: 161 -TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 139 QQLPTLQALDLRSCSISGV---IPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVL 195
++ + ++ +++ + +P + T L+LS+N L ++L + L+ L
Sbjct: 7 SKVASHLEVNCDKRNLTALPPDLP------KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 196 DLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIP 255
+L R LT + G L L +LD+S N L S+P TL L L+VS N L +S+P
Sbjct: 61 NLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL-TSLP 116
Query: 256 AQLGD-LDSLVDLDLSMNSLSGSVPSEL-RGLRSLQKFVIGNNFLSGNLSVNLFPTVSQL 313
L L +L L N L ++P L L+K + NN L+ L L + L
Sbjct: 117 LGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENL 174
Query: 314 QIIVLRQNGFTGPPPDVLWSMPQLRLLDISRN 345
++L++N P + L + N
Sbjct: 175 DTLLLQENSLYTIPKGF-FGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 42/186 (22%), Positives = 72/186 (38%), Gaps = 33/186 (17%)
Query: 164 NLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISS 223
+ + + LT +P ++P + + L +S
Sbjct: 8 KVASHLEVNCDKRNLT-ALPP--------------------DLPK------DTTILHLSE 40
Query: 224 NYLTGSIPPG-LGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSEL 282
N L + L ++L LN+ L + + G L L LDLS N L S+P
Sbjct: 41 NLLY-TFSLATLMPYTRLTQLNLDRAEL-TKLQV-DGTLPVLGTLDLSHNQLQ-SLPLLG 96
Query: 283 RGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDI 342
+ L +L + N L+ +L + + +LQ + L+ N PP +L P+L L +
Sbjct: 97 QTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155
Query: 343 SRNNFT 348
+ NN T
Sbjct: 156 ANNNLT 161
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 8e-15
Identities = 43/142 (30%), Positives = 59/142 (41%), Gaps = 10/142 (7%)
Query: 109 AADALVNLTHLA-SFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTN 167
L L L S N + S+P LGQ LP L LD+ ++ + +L L
Sbjct: 72 VDGTLPVLGTLDLSHNQLQ-----SLPL-LGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125
Query: 168 LTSLYLSDNGLTGTIPSSL-GQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYL 226
L LYL N L T+P L L L L+ N+LT L+NL +L + N L
Sbjct: 126 LQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 227 TGSIPPGLGTLSKLQYLNVSNN 248
+IP G L + + N
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGN 205
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 56/306 (18%), Positives = 106/306 (34%), Gaps = 48/306 (15%)
Query: 540 NLIKNGHSGDLFRGILEGGIPVVIKRI---DLQSVKTEAYLLELDFFSKVSHARLVPLLG 596
+ G G+++RG G V +K D +S E L + H ++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNT---VMLRHENILGFIA 69
Query: 597 HCMERENEK---FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL 653
M + +L+ Y G L L T LD ++ L+I + A GL++L
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--------LDTVSCLRIVLSIASGLAHL 121
Query: 654 HHE-----CTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRLP 706
H E HRD+++ +IL+ + + L+ + +Q + L +
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN--------QLDVG 173
Query: 707 QSSEQGS---------SGSLTATCPY-----DVYCFGKVLLELVTGKMGISASSDAQV-K 751
+ G+ ++ C D++ FG VL E+ + D +
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233
Query: 752 EILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYI 811
+ P K + P++ + ++A + + C P+ R I
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
Query: 812 LKALEN 817
K L
Sbjct: 294 KKTLTK 299
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-22
Identities = 44/229 (19%), Positives = 74/229 (32%), Gaps = 24/229 (10%)
Query: 140 QLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSR 199
Q L L+ + +I+ + L LT L S N LT I + L+ L+ D S
Sbjct: 189 QNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSV 242
Query: 200 NSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLG 259
N LT + L L++L L I L ++L Y + +
Sbjct: 243 NPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VT 294
Query: 260 DLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLR 319
L LD ++ +L L + N L+ L V+ +L+ +
Sbjct: 295 HNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELDVSHNT---KLKSLSCV 347
Query: 320 QNGFTGPPPDVLWSMPQLRLLDISRNNFTG-PLPNSRSNVNTSTVELNI 367
+ +P L + P +N T V ++
Sbjct: 348 NAHIQDFSS--VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-21
Identities = 49/227 (21%), Positives = 85/227 (37%), Gaps = 24/227 (10%)
Query: 144 LQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLT 203
+ + + S L LTSL ++ +T + + +L+ L+ L + N++T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT 77
Query: 204 GNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDS 263
+ NL+ L SN LT ++ + L+KL YLN N L + + +
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL-TKLD--VSQNPL 128
Query: 264 LVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGF 323
L L+ + N+L+ + + L + N L V QL + N
Sbjct: 129 LTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVTPQT---QLTTLDCSFNKI 182
Query: 324 TGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQN 370
T + L L+ NN T L ++ N L+ S N
Sbjct: 183 TELD---VSQNKLLNRLNCDTNNITK-LDLNQ---NIQLTFLDCSSN 222
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 40/235 (17%), Positives = 68/235 (28%), Gaps = 26/235 (11%)
Query: 140 QLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSR 199
Q L LD S ++ + LT LT S N LT + S LS L+ L +
Sbjct: 210 QNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQ 263
Query: 200 NSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLG 259
L I + L + + ++L L+ + + + L
Sbjct: 264 TDLL-EIDLTH--NTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGI-TELD--LS 315
Query: 260 DLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLR 319
LV L L+ L+ + + L+ N + + + L
Sbjct: 316 QNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ---DFSSVGKIPALNNNFEA 369
Query: 320 QNGFTGPPPDV-----LWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQ 369
+ P + L LLD N P + +T +
Sbjct: 370 EGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN-IEPGDGGVYDQATNTITWEN 423
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 9e-22
Identities = 43/216 (19%), Positives = 81/216 (37%), Gaps = 15/216 (6%)
Query: 141 LPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPS-SLGQLSVLSVLDLSR 199
P+ Q L L + + + NL N++ +Y+S + + S S LS ++ +++
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 200 NSLTGNIPTS-FGLLKNLSSLDISSNYLTGSIPPG--LGTLSKLQYLNVSNNSLASSIPA 256
I L L L I + L P + + L +++N +SIP
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 257 QL--GDLDSLVDLDLSMNSLSGSVPSE-LRGLRSLQKFVIGNNFLSGNLSVNLF-PTVSQ 312
G + + L L N + SV G + ++ N +L+ + + F S
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLT-VIDKDAFGGVYSG 206
Query: 313 LQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFT 348
++ + Q T P L + +L N +T
Sbjct: 207 PSLLDVSQTSVTALPSKGLEHLKELIAR----NTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 28/187 (14%), Positives = 63/187 (33%), Gaps = 33/187 (17%)
Query: 190 SVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVSNN 248
++ + IP L + +L + +L +IP L + + VS +
Sbjct: 11 HQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSID 65
Query: 249 SLASSIPAQL-GDLDSLVDLDLSMNSLSGSVPSE-LRGLRSLQKFVIGNNFLSGNLSVNL 306
+ + +L + +++ + + L+ L L+ I N
Sbjct: 66 VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT---------- 115
Query: 307 FPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLP-NSRSNVNTSTVEL 365
L++ P ++S +L+I+ N + +P N+ + T+ L
Sbjct: 116 -----GLKMF---------PDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL 161
Query: 366 NISQNMF 372
+ N F
Sbjct: 162 KLYNNGF 168
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 129 LPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSL-G 187
+P +IP + LDL+S +S + + LT L LYL+DN L T+P+ +
Sbjct: 31 IPSNIP-------ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFK 82
Query: 188 QLSVLSVLDLSRNSLTGNIPTS-FGLLKNLSSLDISSNYLTGSIPPGL-GTLSKLQYLNV 245
+L L L ++ N L +P F L NL+ L + N L S+PP + +L+KL YL++
Sbjct: 83 ELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSL 140
Query: 246 SNNSLASSIPAQLGD-LDSLVDLDLSMNSLSGSVPSEL-RGLRSLQKFVIGNNFLSGNLS 303
N L S+P + D L SL +L L N L VP L L+ + NN L +
Sbjct: 141 GYNEL-QSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVP 197
Query: 304 VNLFPTVSQLQIIVLRQNGFTGPPPDVLW 332
F ++ +L+++ L++N + +++
Sbjct: 198 EGAFDSLEKLKMLQLQENPWDCTCNGIIY 226
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 7/183 (3%)
Query: 166 TNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNY 225
+ L L N L+ + +L+ L +L L+ N L F LKNL +L ++ N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96
Query: 226 LTGSIPPGLGT-LSKLQYLNVSNNSLASSIPAQLGD-LDSLVDLDLSMNSLSGSVPSEL- 282
L ++P G+ L L L + N L S+P ++ D L L L L N L S+P +
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 283 RGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDI 342
L SL++ + NN L + F +++L+ + L N P S+ +L++L +
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 343 SRN 345
N
Sbjct: 213 QEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 20/208 (9%)
Query: 144 LQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLT 203
L D CS + N S+ S LT IPS + LDL N L+
Sbjct: 4 LCKKDGGVCSCNN----------NKNSVDCSSKKLT-AIPS--NIPADTKKLDLQSNKLS 50
Query: 204 GNIPTSFGLLKNLSSLDISSNYLTGSIPPGL-GTLSKLQYLNVSNNSLASSIPAQLGD-L 261
+F L L L ++ N L ++P G+ L L+ L V++N L + +P + D L
Sbjct: 51 SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQL 108
Query: 262 DSLVDLDLSMNSLSGSVPSEL-RGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQ 320
+L +L L N L S+P + L L +G N L +L +F ++ L+ + L
Sbjct: 109 VNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYN 166
Query: 321 NGFTGPPPDVLWSMPQLRLLDISRNNFT 348
N P + +L+ L + N
Sbjct: 167 NQLKRVPEGAFDKLTELKTLKLDNNQLK 194
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-20
Identities = 42/189 (22%), Positives = 77/189 (40%), Gaps = 16/189 (8%)
Query: 160 FSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSL 219
F L N L +T S +LS + + +++ ++ NL L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKEL 68
Query: 220 DISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVP 279
+S N ++ + P L L+KL+ L+V+ N L ++ L L L N L
Sbjct: 69 HLSHNQIS-DLSP-LKDLTKLEELSVNRNRL-KNLNG--IPSACLSRLFLDNNELRD--T 121
Query: 280 SELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRL 339
L L++L+ I NN L S+ + +S+L+++ L N T L + ++
Sbjct: 122 DSLIHLKNLEILSIRNNKLK---SIVMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNW 176
Query: 340 LDISRNNFT 348
+D++
Sbjct: 177 IDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 44/150 (29%), Positives = 62/150 (41%), Gaps = 11/150 (7%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLS 198
Q L+ L L IS + P L +LT L L ++ N L + + + LS L L
Sbjct: 60 QFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK-NL-NGIPSAC-LSRLFLD 114
Query: 199 RNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQL 258
N L S LKNL L I +N L SI LG LSKL+ L++ N + ++ L
Sbjct: 115 NNELRD--TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEI-TNTGG-L 168
Query: 259 GDLDSLVDLDLSMNSLSGSVPSELRGLRSL 288
L + +DL+ L
Sbjct: 169 TRLKKVNWIDLTGQKCVNEPVKYQPELYIT 198
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-18
Identities = 41/237 (17%), Positives = 92/237 (38%), Gaps = 14/237 (5%)
Query: 121 SFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPF-----SLGNLTNLTSLYLSD 175
+ S+ + ++ L++ + +I+ I S L +L ++ +
Sbjct: 255 TLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKN 314
Query: 176 NGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLG 235
+ + + +++ LS + + + L+ + N T S+ G
Sbjct: 315 QVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCS 374
Query: 236 TLSKLQYLNVSNNSLAS--SIPAQLGDLDSLVDLDLSMNSLSGSVPSEL-RGLRSLQKFV 292
TL +LQ L + N L + + ++ SL LD+S+NSL+ S+
Sbjct: 375 TLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLN 434
Query: 293 IGNNFLSGNLSVNLFPT-VSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFT 348
+ +N L+ ++F +++++ L N P DV + L+ L+++ N
Sbjct: 435 LSSN----MLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVT-HLQALQELNVASNQLK 486
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 47/191 (24%), Positives = 79/191 (41%), Gaps = 14/191 (7%)
Query: 111 DALVNLTHLA-SFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLT 169
+ S + + F+ + L+ + + L L
Sbjct: 326 SVFAEMNIKMLSISDTPFIHMVCP-----PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQ 380
Query: 170 SLYLSDNGLT--GTIPSSLGQLSVLSVLDLSRNSLT-GNIPTSFGLLKNLSSLDISSNYL 226
+L L NGL + +S L LD+S NSL + +++ L++SSN L
Sbjct: 381 TLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNML 440
Query: 227 TGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSE-LRGL 285
TGS+ L K++ L++ NN + SIP + L +L +L+++ N L SVP L
Sbjct: 441 TGSVFRCL--PPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRL 496
Query: 286 RSLQKFVIGNN 296
SLQ + +N
Sbjct: 497 TSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 44/243 (18%), Positives = 87/243 (35%), Gaps = 13/243 (5%)
Query: 113 LVNLTHLASFNASRFLLPGSI----PDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNL 168
+ N + I + L +L +++ +
Sbjct: 272 FFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEM 331
Query: 169 TSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTG 228
LS + S + L+ ++N T ++ LK L +L + N L
Sbjct: 332 NIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK- 390
Query: 229 SIPPG---LGTLSKLQYLNVSNNSLASSIPAQL-GDLDSLVDLDLSMNSLSGSVPSELRG 284
+ +S L+ L+VS NSL S + +S++ L+LS N L+GSV L
Sbjct: 391 NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL-- 448
Query: 285 LRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISR 344
++ + NN + ++ ++ + LQ + + N P V + L+ + +
Sbjct: 449 PPKVKVLDLHNNRIM-SIPKDVTH-LQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHD 506
Query: 345 NNF 347
N +
Sbjct: 507 NPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 4e-17
Identities = 60/339 (17%), Positives = 115/339 (33%), Gaps = 28/339 (8%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSL-GQLS 190
+P L P +AL L SIS + + L+ L L LS N + ++ +
Sbjct: 45 HVPKDL---PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQ 100
Query: 191 VLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG--LGTLSKLQYLNVSNN 248
L LD+S N L NI + +L LD+S N +P G L+KL +L +S
Sbjct: 101 DLEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAA 156
Query: 249 SLASSIPAQLGDLD-SLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLF 307
+ L S + LDL + G L+ + ++ + + SV +
Sbjct: 157 KFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHP--NSLFSVQVN 214
Query: 308 PTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNI 367
+V+ L + L L + + N T + T + +
Sbjct: 215 MSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT-----LQHIETTWKCSVKL 269
Query: 368 SQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNAS-SLDSNCLQNVPNQRTLVDCS 426
Q + + +++ R+ + + +L S +++V NQ L
Sbjct: 270 FQFFWPRPVE-------YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 427 S-FYAARGLSFDNFGRPNATQPPPPETSGDSNRKIIVLS 464
+ + ++ + S+ + +
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFT 361
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 65/333 (19%), Positives = 113/333 (33%), Gaps = 27/333 (8%)
Query: 108 FAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTN 167
A ++L+ + S + G L L S+ V ++
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLH-LVFHPNSLFSVQVN--MSVNA 219
Query: 168 LTSLYLSDNGLTG-------TIPSSLGQLSVLSVLDLSRNSLTGNIPT---SFGLLKNLS 217
L L LS+ L T S L + L + L T F + +
Sbjct: 220 LGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279
Query: 218 SLDISSNYLTGSIPPGLGT-----LSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMN 272
L+I + +T I T L L +V N S A + LS++
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339
Query: 273 SLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFT--GPPPDV 330
S N + + T+ +LQ ++L++NG +
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQGCSTLKRLQTLILQRNGLKNFFKVALM 398
Query: 331 LWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVL-GRFRLVDLS 389
+M L LD+S N+ + S + LN+S NM G + L + +++DL
Sbjct: 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLH 458
Query: 390 GNYFEGRVPEYVHSNAS----SLDSNCLQNVPN 418
N +P+ V + ++ SN L++VP+
Sbjct: 459 NNRIM-SIPKDVTHLQALQELNVASNQLKSVPD 490
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 47/276 (17%), Positives = 91/276 (32%), Gaps = 46/276 (16%)
Query: 111 DALVNLTHLA-SFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLT 169
+ +L HL SFN D + GNLT LT
Sbjct: 118 CPMASLRHLDLSFN------------------------DFDVLPVCKEF----GNLTKLT 149
Query: 170 SLYLSDNGLTGTIPSSLGQLSVLSV-LDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTG 228
L LS + L + + LDL + G S + N + L + + +
Sbjct: 150 FLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSL 208
Query: 229 SIPPGLGTLSKLQYLNVSNNSL-------ASSIPAQLGDLDSLVDLDLSMNSLSGSVPSE 281
+++ L +L +SN L + ++L +L+++ L + +
Sbjct: 209 FSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVK 268
Query: 282 LRGL---RSLQKFVIGNNFLSGNLSVNLFP----TVSQLQIIVLRQNGFTGPPPDVLWSM 334
L R ++ I N ++ + F + L I ++ F +
Sbjct: 269 LFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVF 328
Query: 335 PQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQN 370
++ + +S ++ T + +S LN +QN
Sbjct: 329 AEMNIKMLSISD-TPFIHMVCPPSPSSFTFLNFTQN 363
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 47/198 (23%), Positives = 70/198 (35%), Gaps = 42/198 (21%)
Query: 129 LPGSIPDWLGQQLPTLQALDLRSCSISGVIP-FSLGNLTNLTSLYLSDNGLTGTIPSSLG 187
+P S+P LDL ++S + ++ LTNL SL LS N L I
Sbjct: 33 VPQSLP-------SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FIS---- 80
Query: 188 QLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVS 246
+F + NL LD+SSN+L ++ L L+ L +
Sbjct: 81 -------------------SEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLY 120
Query: 247 NNSLASSIPA-QLGDLDSLVDLDLSMNSLSGSVPSE----LRGLRSLQKFVIGNNFLSGN 301
NN + + D+ L L LS N +S P E L L + +N L
Sbjct: 121 NNHI-VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-K 177
Query: 302 LSVNLFPTVSQLQIIVLR 319
L + + L
Sbjct: 178 LPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 37/179 (20%), Positives = 60/179 (33%), Gaps = 35/179 (19%)
Query: 100 RLGSQNPRFAADALVNLTHLA-SFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVI 158
L + L NL L S N F+ + +P L+ LDL S + +
Sbjct: 50 NLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF-----VPVPNLRYLDLSSNHLHTLD 104
Query: 159 PFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSS 218
F +L L L L +N + + +F + L
Sbjct: 105 EFLFSDLQALEVLLLYNNHIV-VVD-----------------------RNAFEDMAQLQK 140
Query: 219 LDISSNYLTGSIPPG----LGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNS 273
L +S N ++ P L KL L++S+N L L L + V L +++
Sbjct: 141 LYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 81.7 bits (201), Expect = 3e-16
Identities = 37/181 (20%), Positives = 67/181 (37%), Gaps = 19/181 (10%)
Query: 147 LDLRSCSISGVIPFSLGNLTNLTSL--------YLSDNGLTGTIPSSLGQLSVLSVLDLS 198
L +R+ +L + L ++ + + + + VL L+
Sbjct: 390 LLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLA 449
Query: 199 RNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQL 258
LT + L ++ LD+S N L ++PP L L L+ L S+N+L ++ +
Sbjct: 450 HKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL-ENVDG-V 504
Query: 259 GDLDSLVDLDLSMNSLSG-SVPSELRGLRSLQKFVIGNNFLSG-----NLSVNLFPTVSQ 312
+L L +L L N L + L L + N L + P+VS
Sbjct: 505 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 564
Query: 313 L 313
+
Sbjct: 565 I 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 79.8 bits (196), Expect = 2e-15
Identities = 39/214 (18%), Positives = 81/214 (37%), Gaps = 17/214 (7%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLD-- 196
++ LQ+ + + P + L + L + + L +L S L +D
Sbjct: 359 EKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLL-YEKETLQYFSTLKAVDPM 417
Query: 197 ------LSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSL 250
R+ ++ L ++ LT + L L + +L++S+N L
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRL 475
Query: 251 ASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTV 310
++P L L L L S N+L +V + L LQ+ ++ NN L + ++ +
Sbjct: 476 -RALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSC 532
Query: 311 SQLQIIVLRQNGFTGPPP---DVLWSMPQLRLLD 341
+L ++ L+ N + +P + +
Sbjct: 533 PRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 52.1 bits (124), Expect = 6e-07
Identities = 37/214 (17%), Positives = 69/214 (32%), Gaps = 44/214 (20%)
Query: 140 QLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSR 199
L +L S S V+ L + L L + TI + L L +
Sbjct: 347 TDEQLFRCEL-SVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETL 405
Query: 200 NSLTGNIPTSFGLLKNLSSLDIS-----SNYLTGSIPPGLGTLSKLQYLNVSNNSLASSI 254
+ LK + + + + + ++ L++++ L + +
Sbjct: 406 QYFST--------LKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL-TVL 456
Query: 255 PAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQ 314
L L + LDLS N L ++P L LR L+ +N L N+
Sbjct: 457 CH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-----NV-------- 501
Query: 315 IIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFT 348
D + ++P+L+ L + N
Sbjct: 502 --------------DGVANLPRLQELLLCNNRLQ 521
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-16
Identities = 34/133 (25%), Positives = 57/133 (42%), Gaps = 4/133 (3%)
Query: 166 TNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNY 225
+T + L N + P + L +DLS N ++ P +F L++L+SL + N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 226 LTGSIPPGL-GTLSKLQYLNVSNNSLASSIPAQLGD-LDSLVDLDLSMNSLSGSVPSELR 283
+T +P L L LQ L ++ N + + + L +L L L N L
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 284 GLRSLQKFVIGNN 296
LR++Q + N
Sbjct: 150 PLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 31/146 (21%), Positives = 61/146 (41%), Gaps = 13/146 (8%)
Query: 130 PGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPS-SLGQ 188
P ++P T+ + L +I + P + L + LS+N ++ + +
Sbjct: 27 PTNLP-------ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQG 78
Query: 189 LSVLSVLDLSRNSLTGNIPTS-FGLLKNLSSLDISSNYLTGSIPPGL-GTLSKLQYLNVS 246
L L+ L L N +T +P S F L +L L +++N + + L L L++
Sbjct: 79 LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLY 136
Query: 247 NNSLASSIPAQLGDLDSLVDLDLSMN 272
+N L + L ++ + L+ N
Sbjct: 137 DNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 27/120 (22%), Positives = 46/120 (38%), Gaps = 6/120 (5%)
Query: 106 PRFAADALVNLTHLA-SFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGN 164
P A L + S N L P + Q L +L +L L I+ +
Sbjct: 48 PPGAFSPYKKLRRIDLSNNQISELAPDAF-----QGLRSLNSLVLYGNKITELPKSLFEG 102
Query: 165 LTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSN 224
L +L L L+ N + + L L++L L N L +F L+ + ++ ++ N
Sbjct: 103 LFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 39/138 (28%), Positives = 59/138 (42%), Gaps = 9/138 (6%)
Query: 138 GQQLPTLQALDLRSCSISGV--IPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVL 195
+ ++L I + + +L L L LS N + I SSL + L +L
Sbjct: 19 SVVATEAEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRIL 75
Query: 196 DLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLAS-SI 254
L RN + I + L L IS N + S+ G+ L L+ L +SNN + +
Sbjct: 76 SLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGE 132
Query: 255 PAQLGDLDSLVDLDLSMN 272
+L LD L DL L+ N
Sbjct: 133 IDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 30/157 (19%), Positives = 63/157 (40%), Gaps = 16/157 (10%)
Query: 195 LDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSI 254
L + + + LK L +S+N + I L + L+ L++ N + I
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLI-KKI 85
Query: 255 PAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQ 314
D+L +L +S N ++ S + L +L+ + NN ++ ++ + +L+
Sbjct: 86 ENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143
Query: 315 IIVLRQNGFTGPPPD----------VLWSMPQLRLLD 341
++L N + V+ +P L+ LD
Sbjct: 144 DLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 4e-15
Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENE 604
G G+++ G G V IK + ++ EA+L E K+ H +LV L E
Sbjct: 195 GCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI- 253
Query: 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHR 664
++V +YM G L L + + L + +A A G++Y+ +VHR
Sbjct: 254 -YIVTEYMSKGSLLDFL-----KGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 665 DVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRLP---QSSEQGSSGSLTA 719
D++A++IL+ + ++ L A+ + ++ + + P + E G T
Sbjct: 305 DLRAANILVGENLVCKVADFGL----ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 720 TCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQ 756
DV+ FG +L EL T G++ + +V + +E+
Sbjct: 361 KS--DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 53/156 (33%), Positives = 73/156 (46%), Gaps = 8/156 (5%)
Query: 145 QALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSL-GQLSVLSVLDLSRNSLT 203
+ LDL+S ++ + + LT LT L L N L T+ + + L+ L L L+ N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 204 GNIPTSFGLLKNLSSLDISSNYLTGSIPPGL-GTLSKLQYLNVSNNSLASSIPAQLGD-L 261
F L L L + N L S+P G+ L+KL+ L ++ N L SIPA D L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKL 154
Query: 262 DSLVDLDLSMNSLSGSVP-SELRGLRSLQKFVIGNN 296
+L L LS N L SVP L LQ + N
Sbjct: 155 TNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 46/161 (28%), Positives = 72/161 (44%), Gaps = 11/161 (6%)
Query: 166 TNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNY 225
+ L L GL ++ L+ L+ L+L N L F L L +L +++N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94
Query: 226 LTGSIPPGL-GTLSKLQYLNVSNNSLASSIPAQLGDLDSLVD---LDLSMNSLSGSVPSE 281
L S+P G+ L++L L + N L S+P+ G D L L L+ N L S+P+
Sbjct: 95 LA-SLPLGVFDHLTQLDKLYLGGNQL-KSLPS--GVFDRLTKLKELRLNTNQLQ-SIPAG 149
Query: 282 L-RGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQN 321
L +LQ + N L ++ F + +LQ I L N
Sbjct: 150 AFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 8e-15
Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 32/224 (14%)
Query: 545 GHSGDLFRGILEG-GIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMEREN 603
G G+++ G+ + + V +K + +++ E +L E ++ H LV LLG C
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP- 289
Query: 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVH 663
+++ ++M G+L L R+ N Q + + L +A + + YL + F+H
Sbjct: 290 PFYIITEFMTYGNLLDYL-RECNR----QEVSAVVLLYMATQISSAMEYLEKKN---FIH 341
Query: 664 RDVQASSILLDDKFEV--------RLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQG--S 713
R++ A + L+ + V RL + A G + T P+S S
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKFS 397
Query: 714 SGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQ 756
S DV+ FG +L E+ T G +QV E+LE+
Sbjct: 398 IKS-------DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 2e-14
Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENE 604
G G+++ G G V IK + ++ EA+L E K+ H +LV L E
Sbjct: 278 GCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI- 336
Query: 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHR 664
++V +YM G L L + + L + +A A G++Y+ +VHR
Sbjct: 337 -YIVTEYMSKGSLLDFL-----KGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 387
Query: 665 DVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRLP---QSSEQGSSGSLTA 719
D++A++IL+ + ++ L A+ + ++ + + P + E G T
Sbjct: 388 DLRAANILVGENLVCKVADFGL----ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 720 TCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQ 756
DV+ FG +L EL T G++ + +V + +E+
Sbjct: 444 KS--DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 64/335 (19%), Positives = 100/335 (29%), Gaps = 80/335 (23%)
Query: 137 LGQQLPTLQALDLRSCSIS----GVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQL--- 189
L +Q L L++C ++ GV+ +L L L L+LSDN L L +
Sbjct: 80 LQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLD 139
Query: 190 --SVLSVLDLSRNSLTGNIPTSFGLL----KNLSSLDISSNYLTGS----IPPGLG-TLS 238
L L L SL+ + + L +S+N + + + GL +
Sbjct: 140 PQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPC 199
Query: 239 KLQYLNVSNNSL----ASSIPAQLGDLDSLVDLDLSMNSLSGS-----VPSELRGLRSLQ 289
+L+ L + + + + + SL +L L N L P L L+
Sbjct: 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR 259
Query: 290 KFVIGNNF-----------------------LSGN---------LSVNLFPTVSQLQIIV 317
I L+GN L L QL+ +
Sbjct: 260 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW 319
Query: 318 LRQNGFTGPPPD-------VLWSMPQLRLLDISRNNFTGP----LPNSRSNVNTSTVELN 366
++ FT VL L L IS N L + L
Sbjct: 320 VKSCSFT---AACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLW 376
Query: 367 ISQNMF----YGGLTPVLGR---FRLVDLSGNYFE 394
++ L L R +DLS N
Sbjct: 377 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 52/272 (19%), Positives = 85/272 (31%), Gaps = 62/272 (22%)
Query: 137 LGQQLPTLQALDLRSCSIS--GVIPFS--LGNLTNLTSLYLSDNGLTGTIPSSLGQL--- 189
L L Q + L C ++ S L L L L N L + Q
Sbjct: 23 LLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82
Query: 190 --SVLSVLDLSRNSLT----GNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLS----- 238
+ L L LT G + ++ L L L +S N L + GL L
Sbjct: 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA---GLQLLCEGLLD 139
Query: 239 ---KLQYLNVSNNSL----ASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKF 291
+L+ L + SL + + L +L +S N ++ + G+R L +
Sbjct: 140 PQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEA------GVRVLCQG 193
Query: 292 VIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPD-------VLWSMPQLRLLDISR 344
+ + QL+ + L G T D ++ S LR L +
Sbjct: 194 LKDSP--------------CQLEALKLESCGVT---SDNCRDLCGIVASKASLRELALGS 236
Query: 345 NNFTGP----LPNSRSNVNTSTVELNISQNMF 372
N L + ++ L I +
Sbjct: 237 NKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 268
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-12
Identities = 58/276 (21%), Positives = 90/276 (32%), Gaps = 45/276 (16%)
Query: 139 QQLPTLQALDLRSCSIS--GVIPFSLG---NLTNLTSLYLSDNGLT----GTIPSSLGQL 189
+ P + L + + I+ GV G + L +L L G+T + +
Sbjct: 167 RAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASK 226
Query: 190 SVLSVLDLSRNSLT--GNIPTSFGLLK---NLSSLDISSNYLT----GSIPPGLGTLSKL 240
+ L L L N L G GLL L +L I +T G + L L
Sbjct: 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL 286
Query: 241 QYLNVSNNSL----ASSIPAQLGDLD-SLVDLDLSMNSLSG----SVPSELRGLRSLQKF 291
+ L+++ N L A + L + L L + S + S L R L +
Sbjct: 287 KELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL 346
Query: 292 VIGNNFLSG----NLSVNLFPTVSQLQIIVLRQNGFTGPPPD-------VLWSMPQLRLL 340
I NN L L L S L+++ L + L + LR L
Sbjct: 347 QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS---DSSCSSLAATLLANHSLREL 403
Query: 341 DISRNNFTGP----LPNSRSNVNTSTVELNISQNMF 372
D+S N L S +L + +
Sbjct: 404 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 9e-10
Identities = 45/229 (19%), Positives = 80/229 (34%), Gaps = 42/229 (18%)
Query: 166 TNLTSLYLSDNGLTGT-IPSSLGQLSVLSVLDLSRNSLT----GNIPTSFGLLKNLSSLD 220
++ SL + L+ L L V+ L LT +I ++ + L+ L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 221 ISSNYLTGS----IPPGLGTLS-KLQYLNVSNNSL----ASSIPAQLGDLDSLVDLDLSM 271
+ SN L + GL T S K+Q L++ N L + + L L +L +L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 272 NSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPP--- 328
N L + GL+ L + ++ +L+ + L +
Sbjct: 123 NLLGDA------GLQLLCEGLLDPQ--------------CRLEKLQLEYCSLSAASCEPL 162
Query: 329 -DVLWSMPQLRLLDISRNNFTGP----LPNSRSNVNTSTVELNISQNMF 372
VL + P + L +S N+ L + L +
Sbjct: 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGV 211
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 35/135 (25%), Positives = 53/135 (39%), Gaps = 24/135 (17%)
Query: 137 LGQQLPTLQALDLRSCSIS--GVIPFS--LGNLTNLTSLYLSDNGLTGTIPSSLGQL--- 189
L + L++L ++SCS + FS L L L +S+N L L Q
Sbjct: 308 LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQ 367
Query: 190 --SVLSVLDLSRNSLT--GNIPTSFGLLKN--LSSLDISSNYLTGSIPPGLGTLS----- 238
SVL VL L+ ++ + LL N L LD+S+N L G+ L
Sbjct: 368 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG---DAGILQLVESVRQ 424
Query: 239 ---KLQYLNVSNNSL 250
L+ L + +
Sbjct: 425 PGCLLEQLVLYDIYW 439
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 65/307 (21%), Positives = 114/307 (37%), Gaps = 72/307 (23%)
Query: 545 GHSGDLFRGILEGG----IPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHC 598
GH G ++ G I IK + + EA+L E ++H ++ L+G
Sbjct: 32 GHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIM 91
Query: 599 MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL--HHE 656
+ E ++ YM +GDL + R ++ L + + A G+ YL
Sbjct: 92 LPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDL-----ISFGLQVARGMEYLAEQK- 144
Query: 657 CTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRLP------QS 708
FVHRD+ A + +LD+ F V++ L+ + + + R RLP +S
Sbjct: 145 ----FVHRDLAARNCMLDESFTVKVADFGLARD-ILDREYYSVQQHRHARLPVKWTALES 199
Query: 709 SEQG--SSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYD 765
+ ++ S DV+ FG +L EL+T G PY I
Sbjct: 200 LQTYRFTTKS-------DVWSFGVLLWELLTRGAP------------------PYRHIDP 234
Query: 766 KELVTKIVD------PSLIIDEDLLEEVWA-MAIVARSCLNPKPTRRPLMRYILKALENP 818
+L + P E + ++ M + C P RP R ++ +E
Sbjct: 235 FDLTHFLAQGRRLPQP-----EYCPDSLYQVM----QQCWEADPAVRPTFRVLVGEVEQI 285
Query: 819 LKVVREE 825
+ + +
Sbjct: 286 VSALLGD 292
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 65/338 (19%), Positives = 124/338 (36%), Gaps = 64/338 (18%)
Query: 504 AGSSLPPPGASINFTNLGESFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVI 563
+L G + N + + + Q L G FS +L++ H G +
Sbjct: 13 GRENLYFQGHMVIIDN--KHYLFIQKLG-EGGFSYVDLVEGLHDGHF----------YAL 59
Query: 564 KRIDLQSVKTEAYLL-ELDFFSKVSHARLVPLLGHCMERENEK---FLVYKYMPNGDLSS 619
KRI + E D +H ++ L+ +C+ K +L+ + G L +
Sbjct: 60 KRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWN 119
Query: 620 SLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEV 679
+ R + + L + D I L + +G GL +H + + HRD++ ++ILL D+ +
Sbjct: 120 EIERLKDKGNFL-TEDQI--LWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQP 173
Query: 680 RL---GSLSEVCAQGGDAHQSRITRLLRLPQSS------E--QGSSGSLTATCPYDVYCF 728
L GS+++ C + Q+ + + + E S DV+
Sbjct: 174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHC-VIDERTDVWSL 232
Query: 729 GKVLLELVTGKM---GISASSDAQVKEILEQ-TLPYISIYDKELVTKIVDPSLIIDEDLL 784
G VL ++ G+ + D+ + Q ++P + L L+
Sbjct: 233 GCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALW------QLL------ 280
Query: 785 EEVWAMAIVARSCLNPKPTRRPLMRYILK---ALENPL 819
S + P +RP + +L AL+ P
Sbjct: 281 ----------NSMMTVDPHQRPHIPLLLSQLEALQPPA 308
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 46/284 (16%), Positives = 88/284 (30%), Gaps = 59/284 (20%)
Query: 541 LIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSV-KTEAYLL--ELDFFSKVSHARLVPLLG 596
I G +++G+ E + V + + + K+E E + + H +V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 597 HCMERENEKFLVY---KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL 653
K + + M +G L + ++ W ++ +GL +L
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQI------LKGLQFL 145
Query: 654 HHECTLPFVHRDVQASSILLDDKF-EVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQG 712
H T P +HRD++ +I + V++G L G + + G
Sbjct: 146 H-TRTPPIIHRDLKCDNIFITGPTGSVKIGDL------GLATLKRASFA------KAVIG 192
Query: 713 SS-------GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYD 765
+ DVY FG +LE+ T + PY +
Sbjct: 193 TPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEY------------------PYSECQN 234
Query: 766 KELVTKIV---DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP 806
+ + V D+ + E I+ C+ R
Sbjct: 235 AAQIYRRVTSGVKPASFDKVAIPE--VKEII-EGCIRQNKDERY 275
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 34/141 (24%), Positives = 64/141 (45%), Gaps = 13/141 (9%)
Query: 545 GHSGDLFRGILEGG-IPVVIKRI--DLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMER 601
G+ G++F G L V +K L +L E + SH +V L+G C ++
Sbjct: 125 GNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184
Query: 602 ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPF 661
+ ++V + + GD + + +T L T L++ AA G+ YL +
Sbjct: 185 Q-PIYIVMELVQGGDFLT--FLRTEG----ARLRVKTLLQMVGDAAAGMEYLESK---CC 234
Query: 662 VHRDVQASSILLDDKFEVRLG 682
+HRD+ A + L+ +K +++
Sbjct: 235 IHRDLAARNCLVTEKNVLKIS 255
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 47/227 (20%), Positives = 94/227 (41%), Gaps = 40/227 (17%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENE 604
G G+++ V +K + S+ EA+L E + + H +LV L +
Sbjct: 199 GQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT--KEP 256
Query: 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHR 664
+++ ++M G L L ++ L L + + AEG++++ ++HR
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIEQRN---YIHR 308
Query: 665 DVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSL-----TA 719
D++A++IL+ ++ D +R+ + + G+ TA
Sbjct: 309 DLRAANILVSASLVCKI----------ADFGLARV-----IEDNEYTAREGAKFPIKWTA 353
Query: 720 ---------TCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQ 756
T DV+ FG +L+E+VT G++ S+ +V LE+
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 35/138 (25%), Positives = 66/138 (47%), Gaps = 10/138 (7%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENE 604
G G+++ G G V +K + S+ +A+L E + ++ H RLV L +
Sbjct: 24 GQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI- 82
Query: 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHR 664
+++ +YM NG L + KT L L +A AEG++++ ++HR
Sbjct: 83 -YIITEYMENGSLVD--FLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 665 DVQASSILLDDKFEVRLG 682
D++A++IL+ D ++
Sbjct: 134 DLRAANILVSDTLSCKIA 151
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 70/307 (22%), Positives = 117/307 (38%), Gaps = 80/307 (26%)
Query: 545 GHSGDLFRGILEGG----IPVVIK--RIDLQSVKT-EAYLLELDFFSKVSHARLVPLLGH 597
G G + G L+ + V +K ++D S + E +L E SH ++ LLG
Sbjct: 45 GEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104
Query: 598 CMERENEK----FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL 653
C+E ++ ++ +M GDL + L + E + + T LK + A G+ YL
Sbjct: 105 CIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLLKFMVDIALGMEYL 163
Query: 654 --HHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQS---RITRLLRLP 706
+ F+HRD+ A + +L D V + LS+ + R R+ ++P
Sbjct: 164 SNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSK------KIYSGDYYRQGRIAKMP 212
Query: 707 ------QSSEQG--SSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQT 757
+S +S S DV+ FG + E+ T G
Sbjct: 213 VKWIAIESLADRVYTSKS-------DVWAFGVTMWEIATRGMT----------------- 248
Query: 758 LPYISIYDKELVTKIVD------PSLIIDEDLLEEVWA-MAIVARSCLNPKPTRRPLMRY 810
PY + + E+ ++ P ED L+E++ M SC P RP
Sbjct: 249 -PYPGVQNHEMYDYLLHGHRLKQP-----EDCLDELYEIM----YSCWRTDPLDRPTFSV 298
Query: 811 ILKALEN 817
+ LE
Sbjct: 299 LRLQLEK 305
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 27/135 (20%), Positives = 55/135 (40%), Gaps = 7/135 (5%)
Query: 166 TNLTSLYLSDNGLTGTIPSSL-GQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSN 224
L L++N T + + +L L ++ S N +T +F ++ + ++SN
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 225 YLTGSIPPGL-GTLSKLQYLNVSNNSLASSIPAQLGD-LDSLVDLDLSMNSLSGSVPSE- 281
L ++ + L L+ L + +N + + + L S+ L L N ++ +V
Sbjct: 92 RLE-NVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA 148
Query: 282 LRGLRSLQKFVIGNN 296
L SL + N
Sbjct: 149 FDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 27/113 (23%), Positives = 51/113 (45%), Gaps = 6/113 (5%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSL-GQLSVLSVLDL 197
++LP L+ ++ + I+ + + + + + L+ N L + + L L L L
Sbjct: 54 KKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLML 112
Query: 198 SRNSLTGNIPT-SFGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVSNN 248
N +T + SF L ++ L + N +T ++ PG TL L LN+ N
Sbjct: 113 RSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 38/184 (20%), Positives = 71/184 (38%), Gaps = 33/184 (17%)
Query: 167 NLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPT-SFGLLKNLSSLDISSNY 225
T++ S+ L IP + + L L+ N T T F L L ++ S+N
Sbjct: 12 EGTTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNK 68
Query: 226 LTGSIPPG-LGTLSKLQYLNVSNNSLASSIPAQLGD-LDSLVDLDLSMNSLSGSVPSELR 283
+T I G S + + +++N L ++ ++ L+SL L L N ++ V ++
Sbjct: 69 IT-DIEEGAFEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDS- 124
Query: 284 GLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDIS 343
F +S ++++ L N T P ++ L L++
Sbjct: 125 -----------------------FIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLL 161
Query: 344 RNNF 347
N F
Sbjct: 162 ANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 27/128 (21%), Positives = 49/128 (38%), Gaps = 5/128 (3%)
Query: 222 SSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIP-AQLGDLDSLVDLDLSMNSLSGSVPS 280
S+ L IP + L ++NN L L ++ S N ++
Sbjct: 19 SNQKLN-KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEG 75
Query: 281 ELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLL 340
G + + ++ +N L N+ +F + L+ ++LR N T D + +RLL
Sbjct: 76 AFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLL 134
Query: 341 DISRNNFT 348
+ N T
Sbjct: 135 SLYDNQIT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 23/91 (25%), Positives = 40/91 (43%), Gaps = 6/91 (6%)
Query: 111 DALVNLTHLA-SFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLT 169
+ + + + N ++ + + L +L+ L LRS I+ V S L+++
Sbjct: 78 EGASGVNEILLTSNRLE-----NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR 132
Query: 170 SLYLSDNGLTGTIPSSLGQLSVLSVLDLSRN 200
L L DN +T P + L LS L+L N
Sbjct: 133 LLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 37/138 (26%), Positives = 64/138 (46%), Gaps = 10/138 (7%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENE 604
G G + G V IK I ++ E ++ E + K+SH +LV L G C+ +
Sbjct: 19 GQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-EQAP 77
Query: 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHR 664
LV ++M +G LS L R ++L L + + EG++YL C +HR
Sbjct: 78 ICLVTEFMEHGCLSDYL-RTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC---VIHR 128
Query: 665 DVQASSILLDDKFEVRLG 682
D+ A + L+ + +++
Sbjct: 129 DLAARNCLVGENQVIKVS 146
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 39/140 (27%), Positives = 64/140 (45%), Gaps = 14/140 (10%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENE 604
G G + G G V IK I S+ + ++ E +SH +LV L G C ++
Sbjct: 35 GQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-KQRP 93
Query: 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL--HHECTLPFV 662
F++ +YM NG L + L R+ Q L L++ E + YL F+
Sbjct: 94 IFIITEYMANGCLLNYL-REMRHRFQTQQL-----LEMCKDVCEAMEYLESKQ-----FL 142
Query: 663 HRDVQASSILLDDKFEVRLG 682
HRD+ A + L++D+ V++
Sbjct: 143 HRDLAARNCLVNDQGVVKVS 162
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 6e-13
Identities = 36/138 (26%), Positives = 66/138 (47%), Gaps = 10/138 (7%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENE 604
G G + G +G V +K I S+ + + E K+SH +LV G C +E
Sbjct: 19 GQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS-KEYP 77
Query: 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHR 664
++V +Y+ NG L + Y +++ + L+ L++ EG+++L F+HR
Sbjct: 78 IYIVTEYISNGCLLN--YLRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHR 128
Query: 665 DVQASSILLDDKFEVRLG 682
D+ A + L+D V++
Sbjct: 129 DLAARNCLVDRDLCVKVS 146
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 63/315 (20%), Positives = 111/315 (35%), Gaps = 88/315 (27%)
Query: 545 GHSGDLFRGILEGG----IPVVIK----------RIDLQSVKTEAYLLELDFFSKVSHAR 590
GH G ++ G L I +K + E ++ SH
Sbjct: 36 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT---EGIIM-----KDFSHPN 87
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGL 650
++ LLG C+ E +V YM +GDL + + R ++ L + + A+G+
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDL-----IGFGLQVAKGM 141
Query: 651 SYL--HHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRLP 706
YL FVHRD+ A + +LD+KF V++ L+ + + +LP
Sbjct: 142 KYLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLP 195
Query: 707 ------QSSEQG--SSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQT 757
+S + ++ S DV+ FG +L EL+T G
Sbjct: 196 VKWMALESLQTQKFTTKS-------DVWSFGVLLWELMTRGAP----------------- 231
Query: 758 LPYISIYDKELVTKIVD------PSLIIDEDLLEEVWA-MAIVARSCLNPKPTRRPLMRY 810
PY + ++ ++ P E + ++ M C +PK RP
Sbjct: 232 -PYPDVNTFDITVYLLQGRRLLQP-----EYCPDPLYEVM----LKCWHPKAEMRPSFSE 281
Query: 811 ILKALENPLKVVREE 825
++ + E
Sbjct: 282 LVSRISAIFSTFIGE 296
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 37/135 (27%), Positives = 58/135 (42%), Gaps = 10/135 (7%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENE 604
G GD+ G G V +K I +A+L E +++ H+ LV LLG +E +
Sbjct: 204 GEFGDVMLGDYRG-NKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261
Query: 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHR 664
++V +YM G L L L LK ++ E + YL FVHR
Sbjct: 262 LYIVTEYMAKGSLVDYL-----RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 665 DVQASSILLDDKFEV 679
D+ A ++L+ +
Sbjct: 314 DLAARNVLVSEDNVA 328
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 52/319 (16%), Positives = 103/319 (32%), Gaps = 76/319 (23%)
Query: 143 TLQALDLRSCSISGV----IPFSLGNLTNLTSLYLSDNGLTGT----IPSSLGQLSVLSV 194
+++ L+ +I+ + L ++ + LS N + + ++ L +
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 195 LDLSRNS---LTGNIPTSFGLL-------KNLSSLDISSNYLTG----SIPPGLGTLSKL 240
+ S + IP + LL L ++ +S N + L + L
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 241 QYLNVSNNSL----ASSIPAQLGDLD---------SLVDLDLSMNSL-SGSVP---SELR 283
++L + NN L + I L +L L + N L +GS+ +
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 184
Query: 284 GLRSLQKFVIGNN---------FLSGNLSVNLFPTVSQLQIIVLRQNGFT-------GPP 327
R L + N L L+ +L+++ L+ N FT
Sbjct: 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC-----QELKVLDLQDNTFTHLGSSALA-- 237
Query: 328 PDVLWSMPQLRLLDISRNNFTGP----LPNS-RSNVNTSTVELNISQN--------MFYG 374
L S P LR L ++ + + ++ N L + N
Sbjct: 238 -IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT 296
Query: 375 GLTPVLGRFRLVDLSGNYF 393
+ + ++L+GN F
Sbjct: 297 VIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 40/263 (15%), Positives = 75/263 (28%), Gaps = 56/263 (21%)
Query: 139 QQLPTLQALDLRSCSIS----------GVIPFSLGNLTNLTSLYLSDNGLTGT----IPS 184
L+ + ++ +L L ++ LSDN T +
Sbjct: 57 ASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLID 116
Query: 185 SLGQLSVLSVLDLSRNSLT-------------GNIPTSFGLLKNLSSLDISSNYLTG--- 228
L + + L L L N L + L S+ N L
Sbjct: 117 FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSM 176
Query: 229 -SIPPGLGTLSKLQYLNVSNNSL----ASSIPAQ-LGDLDSLVDLDLSMNSLSG----SV 278
+ L + + N + + + L L LDL N+ + ++
Sbjct: 177 KEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 236
Query: 279 PSELRGLRSLQKFVIGNN--------FLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDV 330
L+ +L++ + + + S LQ + L+ N
Sbjct: 237 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG---LQTLRLQYNEIELDAVRT 293
Query: 331 L-----WSMPQLRLLDISRNNFT 348
L MP L L+++ N F+
Sbjct: 294 LKTVIDEKMPDLLFLELNGNRFS 316
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 61/311 (19%), Positives = 113/311 (36%), Gaps = 81/311 (26%)
Query: 545 GHSGDLFRGILEGG----IPVVIK--RIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGH 597
G G + L+ + V +K + D+ + E +L E + H + L+G
Sbjct: 34 GEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93
Query: 598 CMERENEK-----FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSY 652
+ + ++ +M +GDL + L + ++ +L T ++ + A G+ Y
Sbjct: 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLPLQTLVRFMVDIACGMEY 152
Query: 653 L--HHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQS---RITRLLRL 705
L + F+HRD+ A + +L + V + LS + R +L
Sbjct: 153 LSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSR------KIYSGDYYRQGCASKL 201
Query: 706 P------QSSEQG--SSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQ 756
P +S + S DV+ FG + E++T G+
Sbjct: 202 PVKWLALESLADNLYTVHS-------DVWAFGVTMWEIMTRGQT---------------- 238
Query: 757 TLPYISIYDKELVTKIVD------PSLIIDEDLLEEVWA-MAIVARSCLNPKPTRRPLMR 809
PY I + E+ ++ P + +EEV+ M C + P +RP
Sbjct: 239 --PYAGIENAEIYNYLIGGNRLKQP-----PECMEEVYDLM----YQCWSADPKQRPSFT 287
Query: 810 YILKALENPLK 820
+ LEN L
Sbjct: 288 CLRMELENILG 298
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 60/297 (20%), Positives = 108/297 (36%), Gaps = 55/297 (18%)
Query: 545 GHSGDLFRGILEG-----GIPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGH 597
GH G + + G V +K + D + E+D + H ++ G
Sbjct: 42 GHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGC 101
Query: 598 CMERENEK-FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHE 656
C + LV +Y+P G L L R + L L A EG++YLH
Sbjct: 102 CEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL--------LLFAQQICEGMAYLH-- 151
Query: 657 CTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRL----PQSSE 710
++HRD+ A ++LLD+ V++G L++ +G + ++ R + P+ +
Sbjct: 152 -AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210
Query: 711 QG--SSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKE 767
+ S DV+ FG L EL+T S + + +
Sbjct: 211 EYKFYYAS-------DVWSFGVTLYELLTHCDSSQSPPTKFLE----LIGIAQGQMTVLR 259
Query: 768 LVTKIVD------PSLIIDEDLLEEVWA-MAIVARSCLNPKPTRRPLMRYILKALEN 817
L + P + EV+ M ++C + + RP ++ L+
Sbjct: 260 LTELLERGERLPRP-----DKCPAEVYHLM----KNCWETEASFRPTFENLIPILKT 307
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 33/109 (30%), Positives = 52/109 (47%), Gaps = 5/109 (4%)
Query: 166 TNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNY 225
++T LYL N T +P L L+++DLS N ++ SF + L +L +S N
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89
Query: 226 LTGSIPPGL-GTLSKLQYLNVSNNSLASSIPAQLGD-LDSLVDLDLSMN 272
L IPP L L+ L++ N + S +P + L +L L + N
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 30/103 (29%), Positives = 42/103 (40%), Gaps = 11/103 (10%)
Query: 246 SNNSLAS---SIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNL 302
SN L IP + +L L N + VP EL + L + NN +S L
Sbjct: 18 SNKGLKVLPKGIPR------DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TL 69
Query: 303 SVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRN 345
S F ++QL ++L N PP + LRLL + N
Sbjct: 70 SNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGN 112
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 28/87 (32%), Positives = 40/87 (45%), Gaps = 2/87 (2%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLS 198
L +DL + IS + S N+T L +L LS N L P + L L +L L
Sbjct: 51 SNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110
Query: 199 RNSLTGNIPT-SFGLLKNLSSLDISSN 224
N ++ +P +F L LS L I +N
Sbjct: 111 GNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-12
Identities = 33/121 (27%), Positives = 57/121 (47%), Gaps = 6/121 (4%)
Query: 135 DWLGQQLPTLQALDLRSCSIS-GVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLS 193
+ + ++ L L +C + G I NL L L + GL ++ S+L +L L
Sbjct: 17 ELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLK 74
Query: 194 VLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLT--GSIPPGLGTLSKLQYLNVSNNSLA 251
L+LS N + G + L NL+ L++S N L ++ P L L L+ L++ N +
Sbjct: 75 KLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVT 133
Query: 252 S 252
+
Sbjct: 134 N 134
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-11
Identities = 39/162 (24%), Positives = 60/162 (37%), Gaps = 34/162 (20%)
Query: 183 PSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQY 242
P+++ +L VLD +++ G I NL L + + L S+ L L KL+
Sbjct: 23 PAAVREL----VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKK 75
Query: 243 LNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNL 302
L +S N + + L +L L+LS N L S L L+ L+
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLEC------------ 121
Query: 303 SVNLFPTVSQLQIIVLRQNGFTGPP---PDVLWSMPQLRLLD 341
L+ + L T V +PQL LD
Sbjct: 122 ----------LKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 30/87 (34%), Positives = 39/87 (44%), Gaps = 6/87 (6%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLT--GTIPSSLGQLSVLSVLD 196
+LP L+ L+L I G + L NLT L LS N L T+ L +L L LD
Sbjct: 68 PKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLD 126
Query: 197 LSRNSLT---GNIPTSFGLLKNLSSLD 220
L +T + F LL L+ LD
Sbjct: 127 LFNCEVTNLNDYRESVFKLLPQLTYLD 153
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 43/136 (31%), Positives = 56/136 (41%), Gaps = 11/136 (8%)
Query: 166 TNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNY 225
TN LYL DN +T P L L L L N L F L L+ LD+ +N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99
Query: 226 LTGSIPPGL-GTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRG 284
LT +P + L L+ L + N L + +P + L L L L N L S+P G
Sbjct: 100 LT-VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK-SIP---HG 153
Query: 285 ----LRSLQKFVIGNN 296
L SL + N
Sbjct: 154 AFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 49/145 (33%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 130 PGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSL-GQ 188
P IP Q L L I+ + P +L NL LYL N L +P +
Sbjct: 35 PAGIP-------TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDS 86
Query: 189 LSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNN 248
L+ L+VLDL N LT F L +L L + N LT +P G+ L+ L +L + N
Sbjct: 87 LTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
Query: 249 SLASSIPAQLGD-LDSLVDLDLSMN 272
L SIP D L SL L N
Sbjct: 146 QL-KSIPHGAFDRLSSLTHAYLFGN 169
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 38/135 (28%), Positives = 59/135 (43%), Gaps = 10/135 (7%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENE 604
G GD+ G G V +K I +A+L E +++ H+ LV LLG +E +
Sbjct: 32 GEFGDVMLGDYRG-NKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89
Query: 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHR 664
++V +YM G L L R L LK ++ E + YL FVHR
Sbjct: 90 LYIVTEYMAKGSLVDYL-R----SRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 665 DVQASSILLDDKFEV 679
D+ A ++L+ +
Sbjct: 142 DLAARNVLVSEDNVA 156
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 58/304 (19%), Positives = 101/304 (33%), Gaps = 77/304 (25%)
Query: 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKT---EAYLLELDFFSKVSHAR 590
G + I+ G + V K +D S+ + + E++ ++ H
Sbjct: 17 GSYGRCQKIRRKSDGKIL----------VWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 591 LVPLLGHCMERENEKF-LVYKYMPNGDLSSSLYRKTNTEDDL---QSLDWITRLKIAIGA 646
+V ++R N +V +Y GDL+S + + T L L +T+L
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL------ 120
Query: 647 AEGLSYLHHECTLPF--VHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRL 702
L H +HRD++ +++ LD K V+LG L+ + ++ +
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--- 177
Query: 703 LRLPQSSEQGSSGS-------LTATCPY----DVYCFGKVLLELVTGKMGISASSDAQ-V 750
G+ Y D++ G +L EL +A S +
Sbjct: 178 ------------GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA 225
Query: 751 KEILEQTLPYI-SIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMR 809
+I E I Y EL +I LN K RP +
Sbjct: 226 GKIREGKFRRIPYRYSDELN------EII----------------TRMLNLKDYHRPSVE 263
Query: 810 YILK 813
IL+
Sbjct: 264 EILE 267
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 62/315 (19%), Positives = 110/315 (34%), Gaps = 88/315 (27%)
Query: 545 GHSGDLFRGILEGG----IPVVIK----------RIDLQSVKTEAYLLELDFFSKVSHAR 590
GH G ++ G L I +K + E ++ SH
Sbjct: 100 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT---EGIIM-----KDFSHPN 151
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGL 650
++ LLG C+ E +V YM +GDL + + R ++ L + + A+G+
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDL-----IGFGLQVAKGM 205
Query: 651 SYL--HHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRLP 706
+L FVHRD+ A + +LD+KF V++ L+ + +LP
Sbjct: 206 KFLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVHNKTGAKLP 259
Query: 707 ------QSSEQG--SSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQT 757
+S + ++ S DV+ FG +L EL+T G
Sbjct: 260 VKWMALESLQTQKFTTKS-------DVWSFGVLLWELMTRGAP----------------- 295
Query: 758 LPYISIYDKELVTKIVD------PSLIIDEDLLEEVWA-MAIVARSCLNPKPTRRPLMRY 810
PY + ++ ++ P E + ++ M C +PK RP
Sbjct: 296 -PYPDVNTFDITVYLLQGRRLLQP-----EYCPDPLYEVM----LKCWHPKAEMRPSFSE 345
Query: 811 ILKALENPLKVVREE 825
++ + E
Sbjct: 346 LVSRISAIFSTFIGE 360
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 35/139 (25%), Positives = 69/139 (49%), Gaps = 10/139 (7%)
Query: 545 GHSGDLFRGILEGG-IPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMEREN 603
G G+++ G+ + + V +K + +++ E +L E ++ H LV LLG C RE
Sbjct: 24 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-REP 82
Query: 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVH 663
+++ ++M G+L L R+ N Q + + L +A + + YL + F+H
Sbjct: 83 PFYIITEFMTYGNLLDYL-RECNR----QEVSAVVLLYMATQISSAMEYLEKKN---FIH 134
Query: 664 RDVQASSILLDDKFEVRLG 682
RD+ A + L+ + V++
Sbjct: 135 RDLAARNCLVGENHLVKVA 153
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 48/151 (31%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 152 CSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFG 211
C G G T L L N L +L+ L+ L L N L F
Sbjct: 14 CYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFN 73
Query: 212 LLKNLSSLDISSNYLTGSIPPGL-GTLSKLQYLNVSNNSLASSIPAQLGD-LDSLVDLDL 269
L +L+ L++S+N L S+P G+ L++L+ L ++ N L S+P + D L L DL L
Sbjct: 74 KLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRL 131
Query: 270 SMNSLSGSVPSELRG----LRSLQKFVIGNN 296
N L SVP G L SLQ + +N
Sbjct: 132 YQNQLK-SVP---DGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 43/139 (30%), Positives = 61/139 (43%), Gaps = 12/139 (8%)
Query: 130 PGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQL 189
P IP LDL + S+ + LT+LT LYL N L +L
Sbjct: 23 PTGIPA-------QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKL 75
Query: 190 SVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGL-GTLSKLQYLNVSNN 248
+ L+ L+LS N L F L L L +++N L S+P G+ L++L+ L + N
Sbjct: 76 TSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQN 134
Query: 249 SLASSIPAQLGDLDSLVDL 267
L S+P G D L L
Sbjct: 135 QL-KSVPD--GVFDRLTSL 150
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 59/300 (19%), Positives = 114/300 (38%), Gaps = 53/300 (17%)
Query: 545 GHSGDLFRGILEG-----GIPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGH 597
GH G + + G V +K + + E++ + H +V G
Sbjct: 32 GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGI 91
Query: 598 CMERENEK-FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHE 656
C E L+ +++P+G L L + N + Q L + A+ +G+ YL
Sbjct: 92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY------AVQICKGMDYLG-- 143
Query: 657 CTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRL----PQSSE 710
+ +VHRD+ A ++L++ + +V++G L++ + + + R + P+
Sbjct: 144 -SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202
Query: 711 QG--SSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKE 767
Q S DV+ FG L EL+T S + + + +
Sbjct: 203 QSKFYIAS-------DVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMTVTR 251
Query: 768 LVTKIVD------PSLIIDEDLLEEVWA-MAIVARSCLNPKPTRRPLMRYILKALENPLK 820
LV + + P + +EV+ M R C +P+ R + +++ E LK
Sbjct: 252 LVNTLKEGKRLPCP-----PNCPDEVYQLM----RKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 58/359 (16%), Positives = 115/359 (32%), Gaps = 106/359 (29%)
Query: 491 TPNQRGVGVGPVPAGSSLPPPGASINFTNLGESFTYQQLLAATGDFSDANLIKNGHSGDL 550
+G+ PVP + + L +F ++ + G FS+ G
Sbjct: 2 DEQSQGMQGPPVPQFQPQKALRPDMGYNTL-ANFRIEKKIG-RGQFSEVYRAACLLDGVP 59
Query: 551 FRGILEGGIPVVIKRIDLQSVKT----EAYLLELDFFSKVSHARLVPLLGHCMERENEKF 606
V +K++ + + + E+D +++H ++ +E +NE
Sbjct: 60 ----------VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELN 108
Query: 607 LVYKYMPNGDLSSSL--YRKTNT---EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPF 661
+V + GDLS + ++K E + + +L L ++H +
Sbjct: 109 IVLELADAGDLSRMIKHFKKQKRLIPERTV--WKYFVQL------CSALEHMHSRRVM-- 158
Query: 662 VHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATC 721
HRD++ +++ + V+LG L + R S + +
Sbjct: 159 -HRDIKPANVFITATGVVKLGDLG-------------LGRFF--------SSKTTAAHSL 196
Query: 722 ---PY----------------DVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYIS 762
PY D++ G +L E+ + P+
Sbjct: 197 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------------------SPFYG 238
Query: 763 IYD--KELVTKIVD------PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
L KI PS E+L + + C+NP P +RP + Y+
Sbjct: 239 DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ-------LVNMCINPDPEKRPDVTYVYD 290
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 33/149 (22%), Positives = 64/149 (42%), Gaps = 23/149 (15%)
Query: 545 GHSGDLFRGIL--------EGGIPVVIKRIDLQSVKT-EAYLLELDFFSKVSHARLVPLL 595
G +F+G+ V++K +D E++ SK+SH LV
Sbjct: 19 GTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNY 78
Query: 596 GHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL-- 653
G C+ + E LV +++ G L + L + N ++ + +L++A A + +L
Sbjct: 79 GVCVCGD-ENILVQEFVKFGSLDTYLKKNKN------CINILWKLEVAKQLAAAMHFLEE 131
Query: 654 HHECTLPFVHRDVQASSILLDDKFEVRLG 682
+ +H +V A +ILL + + + G
Sbjct: 132 NT-----LIHGNVCAKNILLIREEDRKTG 155
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-11
Identities = 29/114 (25%), Positives = 53/114 (46%), Gaps = 6/114 (5%)
Query: 138 GQQLPTLQALDLRSCSIS-GVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLD 196
+ ++ L L + + G + L L + GLT +I ++L +L+ L L+
Sbjct: 13 NRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLE 70
Query: 197 LSRNSLTGNIPTSFGLLKNLSSLDISSNYLT--GSIPPGLGTLSKLQYLNVSNN 248
LS N ++G + NL+ L++S N + +I P L L L+ L++ N
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-10
Identities = 39/162 (24%), Positives = 63/162 (38%), Gaps = 34/162 (20%)
Query: 183 PSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQY 242
PS + +L VLD SR++ G + + L L + LT SI L L+KL+
Sbjct: 16 PSDVKEL----VLDNSRSNE-GKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKK 68
Query: 243 LNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNL 302
L +S+N ++ + +L L+LS N + S + L+ L+
Sbjct: 69 LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLEN------------ 114
Query: 303 SVNLFPTVSQLQIIVLRQNGFTGPP---PDVLWSMPQLRLLD 341
L+ + L T +V +PQL LD
Sbjct: 115 ----------LKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 3/89 (3%)
Query: 137 LGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLD 196
L + L+ L + ++ + L L L LSDN ++G + + L+ L+
Sbjct: 37 LTDEFEELEFLSTINVGLTSIANLP--KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94
Query: 197 LSRNSLTG-NIPTSFGLLKNLSSLDISSN 224
LS N + + L+NL SLD+ +
Sbjct: 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 52/252 (20%), Positives = 79/252 (31%), Gaps = 30/252 (11%)
Query: 143 TLQALDLRSCSIS--GVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQL-----SVLSVL 195
L ++L SC + G+ L L N L L L ++ L
Sbjct: 102 ALDEVNLASCQLDPAGLRTLLPV-FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTL 160
Query: 196 DLSRNSLT--GNIPTSFGLLKN--LSSLDISSNYLT----GSIPPGLGTLSKLQYLNVSN 247
LS N LT G GL N ++ L + L + L +LQ LNV+
Sbjct: 161 RLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAY 220
Query: 248 NSL----ASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLS 303
N A ++ + SL L L N LS + LR L G + +L+
Sbjct: 221 NGAGDTAALALARAAREHPSLELLHLYFNELS---SEGRQVLRDLGGAAEGGARVVVSLT 277
Query: 304 VNLFPTVSQLQII--VLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSN---V 358
+ I+ V R + +L L D+ + P ++ V
Sbjct: 278 EGTAVSEYWSVILSEVQRNL--NSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRV 335
Query: 359 NTSTVELNISQN 370
L
Sbjct: 336 EGEVRALLEQLG 347
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 46/245 (18%), Positives = 86/245 (35%), Gaps = 40/245 (16%)
Query: 143 TLQALDLRSCSIS--GVIPFS---LGNLTNLTSLYLSDNGLTGTIPSSLGQL-----SVL 192
++ +L+L S+ N+TSL LS N L+ L + +
Sbjct: 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTI 111
Query: 193 SVLDLSRNSLT--GNIPTSFGLLKN---LSSLDISSNYLTG----SIPPGLGTL-SKLQY 242
+VLDL N + + ++SL++ N L + L + + +
Sbjct: 112 TVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNS 171
Query: 243 LNVSNNSL----ASSIPAQLGDLD-SLVDLDLSMNSLSGSVPSEL-RGLRS----LQKFV 292
LN+ N+L + + L + S+ LDLS N L +EL S +
Sbjct: 172 LNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLN 231
Query: 293 IGNNFLSG---NLSVNLFPTVSQLQIIVLRQNGFTGPPPD-------VLWSMPQLRLLDI 342
+ N L G L ++ LQ + L + + ++ ++ L+D
Sbjct: 232 LCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDK 291
Query: 343 SRNNF 347
+
Sbjct: 292 NGKEI 296
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 26/165 (15%), Positives = 57/165 (34%), Gaps = 26/165 (15%)
Query: 137 LGQQLPTLQALDLRSCSIS--GVIPFSLG---NLTNLTSLYLSDNGLTGTIPSSLGQL-- 189
++ +L+LR + N+ SL L N L + L +
Sbjct: 133 FSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLA 192
Query: 190 ---SVLSVLDLSRNSLT--GNIPTSFGLLKN---LSSLDISSNYLTGS----IPPGLGTL 237
+ ++ LDLS N L ++ + SL++ N L G + +L
Sbjct: 193 SIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSL 252
Query: 238 SKLQYLNVSNNSL-------ASSIPAQLGDLDSLVDLDLSMNSLS 275
LQ + + + + ++ A ++ ++ +D + +
Sbjct: 253 KHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 47/252 (18%), Positives = 85/252 (33%), Gaps = 45/252 (17%)
Query: 162 LGNLTNLTSLYLSDNGLTGTIPSSLGQL-----SVLSVLDLSRNSLT--GNIPTSFGLLK 214
+TSL LS N L L Q + ++ L+LS NSL + L
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 215 N---LSSLDISSNYLTGSIPPGLGTLSK--------LQYLNVSNNSL----ASSIPAQLG 259
++SL++S N+L+ L K + L++ N +S
Sbjct: 78 IPANVTSLNLSGNFLSYK---SSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFS 134
Query: 260 DLD-SLVDLDLSMNSLSGSVPSEL-RGLR----SLQKFVIGNNFLSGN----LSVNLFPT 309
+L S+ L+L N L EL + L ++ + N L+ L+ L
Sbjct: 135 NLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASI 194
Query: 310 VSQLQIIVLRQNGFTGPPPDVLWSM-----PQLRLLDISRNNFTGP----LPNSRSNVNT 360
+ + + L N L + + L++ N GP L + +
Sbjct: 195 PASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDS-LK 253
Query: 361 STVELNISQNMF 372
+ + ++
Sbjct: 254 HLQTVYLDYDIV 265
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 25/155 (16%), Positives = 58/155 (37%), Gaps = 21/155 (13%)
Query: 143 TLQALDLRSCSIS--GVIPFSLG---NLTNLTSLYLSDNGLTGTIPSSLGQL-----SVL 192
+ +L+LR +++ + ++TSL LS N L + L + + +
Sbjct: 168 NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHV 227
Query: 193 SVLDLSRNSLTG----NIPTSFGLLKNLSSLDISSNYLTG-------SIPPGLGTLSKLQ 241
L+L N L G N+ LK+L ++ + + + ++ + K+
Sbjct: 228 VSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKII 287
Query: 242 YLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSG 276
++ + + S + +L + + SL
Sbjct: 288 LVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLN 322
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 20/155 (12%), Positives = 45/155 (29%), Gaps = 37/155 (23%)
Query: 137 LGQQLPTLQALDLRSCSISGV----IPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVL 192
+ +L+L + G + +L +L ++YL + + +S
Sbjct: 220 FSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDI--------VKNMSKE 271
Query: 193 SVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLS--------KLQYLN 244
L +F ++ + +D + + P +S K +
Sbjct: 272 QCKALGA---------AFPNIQKIILVDKNGKEIH---PSHSIPISNLIRELSGKADVPS 319
Query: 245 VSNNSL-----ASSIPAQLGDLDSLVDLDLSMNSL 274
+ N L + L D L + + L
Sbjct: 320 LLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 57/300 (19%), Positives = 112/300 (37%), Gaps = 59/300 (19%)
Query: 545 GHSGDLFRGILEG-----GIPVVIKRI------DLQSVKTEAYLLELDFFSKVSHARLVP 593
G+ G + + G V +K++ L+ + E +L + H +V
Sbjct: 52 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL-----KSLQHDNIVK 106
Query: 594 LLGHCMERENEK-FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSY 652
G C L+ +Y+P G L L + + +D I L+ +G+ Y
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEY 160
Query: 653 LHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRL----P 706
L + ++HRD+ +IL++++ V++G L++V Q + ++ + + P
Sbjct: 161 LGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 217
Query: 707 QSSEQG--SSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIY 764
+S + S S DV+ FG VL EL T + S + +
Sbjct: 218 ESLTESKFSVAS-------DVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGNDKQGQMI 268
Query: 765 DKELVTKIVD------PSLIIDEDLLEEVWA-MAIVARSCLNPKPTRRPLMRYILKALEN 817
L+ + + P + +E++ M C N +RP R + ++
Sbjct: 269 VFHLIELLKNNGRLPRP-----DGCPDEIYMIM----TECWNNNVNQRPSFRDLALRVDQ 319
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 51/234 (21%), Positives = 76/234 (32%), Gaps = 50/234 (21%)
Query: 533 TGDFSDANLIKNGHS--GDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLL---ELDFFSKV 586
G + +I G + G V ++RI+L++ E EL
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 587 SHARLVPLLGHCMERENEKFLVYKYMPNG---DLSSSLYRKTNTEDDLQSLDWITRLKIA 643
+H +VP +NE ++V +M G DL + + E IA
Sbjct: 84 NHPNIVPYRA-TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL-----------AIA 131
Query: 644 I---GAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRIT 700
G + L Y+HH +VHR V+AS IL+ +V L L Q +
Sbjct: 132 YILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLR-SNLSMISHGQRQRV 187
Query: 701 RLLRLPQSS-----------EQGSSGSLTATCPY----DVYCFGKVLLELVTGK 739
S +Q G Y D+Y G EL G
Sbjct: 188 VHDFPKYSVKVLPWLSPEVLQQNLQG-------YDAKSDIYSVGITACELANGH 234
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 57/300 (19%), Positives = 110/300 (36%), Gaps = 59/300 (19%)
Query: 545 GHSGDLFRGILEG-----GIPVVIKRI------DLQSVKTEAYLLELDFFSKVSHARLVP 593
G+ G + + G V +K++ L+ + E +L + H +V
Sbjct: 21 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL-----KSLQHDNIVK 75
Query: 594 LLGHCMERENE-KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSY 652
G C L+ +Y+P G L L + D ++ L + +G+ Y
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------TSQICKGMEY 129
Query: 653 LHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRL----P 706
L T ++HRD+ +IL++++ V++G L++V Q + + + + P
Sbjct: 130 LG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186
Query: 707 QSSEQG--SSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIY 764
+S + S S DV+ FG VL EL T + S + +
Sbjct: 187 ESLTESKFSVAS-------DVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGNDKQGQMI 237
Query: 765 DKELVTKIVD------PSLIIDEDLLEEVWA-MAIVARSCLNPKPTRRPLMRYILKALEN 817
L+ + + P + +E++ M C N +RP R + ++
Sbjct: 238 VFHLIELLKNNGRLPRP-----DGCPDEIYMIM----TECWNNNVNQRPSFRDLALRVDQ 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 63/301 (20%), Positives = 103/301 (34%), Gaps = 80/301 (26%)
Query: 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHAR 590
G F A L+K+ G VIK I++ + E E+ + + H
Sbjct: 35 GSFGKAILVKSTEDGRQ----------YVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNT---EDDLQSLDWITRLKIAIGAA 647
+V E ++V Y GDL + + ED + LDW ++
Sbjct: 85 IVQYRESFEE-NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI--LDWFVQI------C 135
Query: 648 EGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRL 705
L ++H L HRD+++ +I L V+LG ++ V + ++ I
Sbjct: 136 LALKHVHDRKIL---HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI------ 186
Query: 706 PQSSEQGSSGS-------LTATCPY----DVYCFGKVLLELVTGKMGISASSDAQ-VKEI 753
G+ + PY D++ G VL EL T K A S V +I
Sbjct: 187 ---------GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI 237
Query: 754 LEQTLPYI-SIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYIL 812
+ + P + Y +L SL+ P RP + IL
Sbjct: 238 ISGSFPPVSLHYSYDLR------SLV----------------SQLFKRNPRDRPSVNSIL 275
Query: 813 K 813
+
Sbjct: 276 E 276
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 8e-11
Identities = 39/144 (27%), Positives = 62/144 (43%), Gaps = 17/144 (11%)
Query: 545 GHSGDLFRGIL----EGGIPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHC 598
G GD+ +GI + V IK + E +L E + H +V L+G
Sbjct: 26 GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 85
Query: 599 MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECT 658
E N +++ + G+L S L + DL SL + A + L+YL +
Sbjct: 86 TE--NPVWIIMELCTLGELRSFL-QVRKYSLDLASL-----ILYAYQLSTALAYLESKR- 136
Query: 659 LPFVHRDVQASSILLDDKFEVRLG 682
FVHRD+ A ++L+ V+LG
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLG 158
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 46/228 (20%), Positives = 86/228 (37%), Gaps = 36/228 (15%)
Query: 545 GHSGDLFRGIL---EGGIPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCM 599
G+ G + +G+ + I V IK + + TE + E ++ + +V L+G C
Sbjct: 21 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 80
Query: 600 ERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL--HHEC 657
LV + G L L + + ++ + G+ YL +
Sbjct: 81 AEAL--MLVMEMAGGGPLHKFL-VGKR-----EEIPVSNVAELLHQVSMGMKYLEEKN-- 130
Query: 658 TLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRL----PQSSEQ 711
FVHRD+ A ++LL ++ ++ LS+ + +R L P+
Sbjct: 131 ---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 712 G--SSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQ 756
SS S DV+ +G + E ++ G+ +V +EQ
Sbjct: 188 RKFSSRS-------DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 53/230 (23%), Positives = 96/230 (41%), Gaps = 39/230 (16%)
Query: 545 GHSGDLFRGIL-----EGGIPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGH 597
G G +++G+ + IPV IK R + L E + V + + LLG
Sbjct: 26 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85
Query: 598 CMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHEC 657
C+ + L+ + MP G L + R+ Q L L + A+G++YL
Sbjct: 86 CLT--STVQLITQLMPFGCLLDYV-REHKDNIGSQYL-----LNWCVQIAKGMNYLEDRR 137
Query: 658 TLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRL-LRL--PQSSEQG 712
VHRD+ A ++L+ V++ L+++ + + ++ ++ +S
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 713 --SSGSLTATCPYDVYCFGKVLLELVT-GKM---GISASSDAQVKEILEQ 756
+ S DV+ +G + EL+T G GI AS ++ ILE+
Sbjct: 195 IYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEK 234
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 35/145 (24%), Positives = 67/145 (46%), Gaps = 17/145 (11%)
Query: 545 GHSGDLFRGIL-----EGGIPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGH 597
G G++++G+L + +PV IK + + +L E + SH ++ L G
Sbjct: 55 GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGV 114
Query: 598 CMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHEC 657
+ + ++ +YM NG L L R+ + E + L + + G A G+ YL +
Sbjct: 115 ISKYKP-MMIITEYMENGALDKFL-REKDGEFSVLQL-----VGMLRGIAAGMKYLANMN 167
Query: 658 TLPFVHRDVQASSILLDDKFEVRLG 682
+VHRD+ A +IL++ ++
Sbjct: 168 ---YVHRDLAARNILVNSNLVCKVS 189
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 35/161 (21%), Positives = 55/161 (34%), Gaps = 30/161 (18%)
Query: 184 SSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYL 243
+ LDL + I L ++D S N + + G L +L+ L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTL 69
Query: 244 NVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLS 303
V+NN + L L +L L+ NSL EL L L
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSL-----VELGDLDPLASL------------ 112
Query: 304 VNLFPTVSQLQIIVLRQNGFTGPP---PDVLWSMPQLRLLD 341
L + + +N T V++ +PQ+R+LD
Sbjct: 113 -------KSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 24/89 (26%), Positives = 35/89 (39%), Gaps = 3/89 (3%)
Query: 137 LGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLD 196
LG L A+D I + F L L +L +++N + L L+ L
Sbjct: 37 LGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94
Query: 197 LSRNSLTG-NIPTSFGLLKNLSSLDISSN 224
L+ NSL LK+L+ L I N
Sbjct: 95 LTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 30/146 (20%), Positives = 60/146 (41%), Gaps = 21/146 (14%)
Query: 545 GHSGDLFRGILEGG----IPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHC 598
G G+++ G+ I V +K + D E ++ E + H +V L+G
Sbjct: 23 GFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII 82
Query: 599 MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL--HHE 656
E +++ + P G+L L + + +L + ++ + ++YL +
Sbjct: 83 EE--EPTWIIMELYPYGELGHYL-ERNKNSLKVLTL-----VLYSLQICKAMAYLESIN- 133
Query: 657 CTLPFVHRDVQASSILLDDKFEVRLG 682
VHRD+ +IL+ V+LG
Sbjct: 134 ----CVHRDIAVRNILVASPECVKLG 155
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 45/184 (24%), Positives = 75/184 (40%), Gaps = 34/184 (18%)
Query: 533 TGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARL 591
G F L+ NG G +++G ++ G IK +D+ + E E++ K SH R
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 592 VP------LLGHCMERENEKFLVYKYMPNG---DLSSSLYRKTNTEDDLQSLDWITRLKI 642
+ + + +++ +LV ++ G DL + T E+ I
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE-----------WI 131
Query: 643 AI---GAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRL---GSLSEVCAQGGDAHQ 696
A GLS+LH +HRD++ ++LL + EV+L G V AQ
Sbjct: 132 AYICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFG----VSAQLDRTVG 184
Query: 697 SRIT 700
R T
Sbjct: 185 RRNT 188
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 44/205 (21%), Positives = 85/205 (41%), Gaps = 35/205 (17%)
Query: 143 TLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSL 202
+L+ S++ + + L ++ + +++ + ++ + L + L L N L
Sbjct: 20 ETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKL 75
Query: 203 TGNIPTSFGLLKNLSSLDISSNYLTGSIPPGL-GTLSKLQYLNVSNNSLASSIPAQLGD- 260
+I + L NL+ L ++ N L S+P G+ L+ L+ L + N L S +P + D
Sbjct: 76 H-DIS-ALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDK 131
Query: 261 LDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQ 320
L +L L+L+ N L S+P +F ++ L + L
Sbjct: 132 LTNLTYLNLAHNQLQ-SLPK------------------------GVFDKLTNLTELDLSY 166
Query: 321 NGFTGPPPDVLWSMPQLRLLDISRN 345
N P V + QL+ L + +N
Sbjct: 167 NQLQSLPEGVFDKLTQLKDLRLYQN 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 42/130 (32%), Positives = 63/130 (48%), Gaps = 7/130 (5%)
Query: 140 QLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSL-GQLSVLSVLDLS 198
+L L L L + + LTNL L L +N L ++P + +L+ L+ L+L+
Sbjct: 83 ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLA 141
Query: 199 RNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGL-GTLSKLQYLNVSNNSLASSIPAQ 257
N L F L NL+ LD+S N L S+P G+ L++L+ L + N L S+P
Sbjct: 142 HNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL-KSVPD- 198
Query: 258 LGDLDSLVDL 267
G D L L
Sbjct: 199 -GVFDRLTSL 207
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 27/157 (17%), Positives = 57/157 (36%), Gaps = 37/157 (23%)
Query: 195 LDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSI 254
+L + S+T + + L ++ + +++ + G+ L ++YL + N L
Sbjct: 24 ANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHD-- 77
Query: 255 PAQLGDLDSLVD---LDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVS 311
+ L L + L L+ N L +L +F ++
Sbjct: 78 ---ISALKELTNLTYLILTGNQLQ-------------------------SLPNGVFDKLT 109
Query: 312 QLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFT 348
L+ +VL +N P V + L L+++ N
Sbjct: 110 NLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ 146
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 53/315 (16%), Positives = 106/315 (33%), Gaps = 81/315 (25%)
Query: 533 TGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLV 592
G F +N IK+I K L E+ + ++H +V
Sbjct: 16 QGAFGQVVKARNALDSRY----------YAIKKIRHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 593 PLLGHCMERENEK------------FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRL 640
+ER N F+ +Y NG L ++ + + + ++
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 641 KIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSR 698
E LSY+H + +HRD++ +I +D+ V++G L++ + D
Sbjct: 126 ------LEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD----- 171
Query: 699 ITRLLRLPQSSEQGSSGSLTATC--PY-----------------DVYCFGKVLLELVTGK 739
+L+L + GSS +LT+ D+Y G + E++
Sbjct: 172 ---ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF 228
Query: 740 MGISASSDAQV-KEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCL 798
+ + K++ ++ + +D + +I R +
Sbjct: 229 S--TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKK--II----------------RLLI 268
Query: 799 NPKPTRRPLMRYILK 813
+ P +RP R +L
Sbjct: 269 DHDPNKRPGARTLLN 283
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 32/144 (22%), Positives = 59/144 (40%), Gaps = 16/144 (11%)
Query: 545 GHSGDLFRGIL----EGGIPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHC 598
G SG++ G L + +PV IK + + +L E + H ++ L G
Sbjct: 60 GDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV 119
Query: 599 MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECT 658
+V +YM NG L + + +T+ + + + G G+ YL
Sbjct: 120 TRGR-LAMIVTEYMENGSLDT--FLRTHDG----QFTIMQLVGMLRGVGAGMRYLSDLG- 171
Query: 659 LPFVHRDVQASSILLDDKFEVRLG 682
+VHRD+ A ++L+D ++
Sbjct: 172 --YVHRDLAARNVLVDSNLVCKVS 193
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 36/144 (25%), Positives = 59/144 (40%), Gaps = 16/144 (11%)
Query: 545 GHSGDLFRGILEGG------IPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLG 596
G G+++ G + G + V +K +L+E SK +H +V +G
Sbjct: 41 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 100
Query: 597 HCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL--H 654
++ +F++ + M GDL S L SL + L +A A G YL +
Sbjct: 101 VSLQSL-PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 159
Query: 655 HECTLPFVHRDVQASSILLDDKFE 678
H F+HRD+ A + LL
Sbjct: 160 H-----FIHRDIAARNCLLTCPGP 178
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 34/141 (24%), Positives = 60/141 (42%), Gaps = 22/141 (15%)
Query: 540 NLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHC 598
+ G G++ R + G +K++ L+ + E EL + +S R+VPL G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE----ELVACAGLSSPRIVPLYG-- 117
Query: 599 MERENEKFLVY-KYMPNGDLSSSLYRKTNTEDDLQSLDWITR--LKIAIGAAEGLSYLHH 655
RE ++ + + G L L ++ + ++L + L EGL YLH
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRAL-YYLGQAL-------EGLEYLHT 168
Query: 656 ECTLPFVHRDVQASSILLDDK 676
+H DV+A ++LL
Sbjct: 169 RRI---LHGDVKADNVLLSSD 186
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 62/310 (20%), Positives = 119/310 (38%), Gaps = 66/310 (21%)
Query: 545 GHSGDLFRGILEGG------IPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLG 596
G G ++ G+ +G V IK + +L E + + +V LLG
Sbjct: 36 GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95
Query: 597 HCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITR---LKIAIGAAEGLSYL 653
+ ++ + M GDL S L + L + +++A A+G++YL
Sbjct: 96 VVS-QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 154
Query: 654 HHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQS---RITRLLRLP-- 706
+ FVHRD+ A + ++ + F V++G ++ D +++ R LP
Sbjct: 155 N---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR------DIYETDYYRKGGKGLLPVR 205
Query: 707 -QSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIY 764
S E G T DV+ FG VL E+ T + PY +
Sbjct: 206 WMSPESLKDGVFTTYS--DVWSFGVVLWEIATLAEQ------------------PYQGLS 245
Query: 765 DKELVTKIVD------PSLIIDEDLLEEVWA-MAIVARSCLNPKPTRRPLMRYILKALEN 817
+++++ +++ P ++ + ++ M R C P RP I+ +++
Sbjct: 246 NEQVLRFVMEGGLLDKP-----DNCPDMLFELM----RMCWQYNPKMRPSFLEIISSIKE 296
Query: 818 PLKVVREENS 827
++ E S
Sbjct: 297 EMEPGFREVS 306
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 4e-10
Identities = 45/226 (19%), Positives = 85/226 (37%), Gaps = 32/226 (14%)
Query: 545 GHSGDLFRGILEGG---IPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCM 599
G+ G + +G+ I V IK + + TE + E ++ + +V L+G C
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406
Query: 600 ERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTL 659
LV + G L + E + ++ + G+ YL +
Sbjct: 407 AEAL--MLVMEMAGGGPLHK--FLVGKRE----EIPVSNVAELLHQVSMGMKYLEEKN-- 456
Query: 660 PFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRL----PQSSEQG- 712
FVHR++ A ++LL ++ ++ LS+ + +R L P+
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 713 -SSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQ 756
SS S DV+ +G + E ++ G+ +V +EQ
Sbjct: 516 FSSRS-------DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 4e-10
Identities = 25/111 (22%), Positives = 43/111 (38%), Gaps = 5/111 (4%)
Query: 190 SVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVSNN 248
S L +R+ + +NL+ L I + + L L +L+ L + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 249 SLASSIPAQ-LGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFL 298
L + L L+LS N+L S+ + SLQ+ V+ N L
Sbjct: 67 GL-RFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 7e-08
Identities = 23/97 (23%), Positives = 35/97 (36%), Gaps = 3/97 (3%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIP-FSLGNLTNLTSLYLSDNGLTGTIPSSLGQLS 190
L L L + + + L L L +L + +GL P +
Sbjct: 22 DSLHHL-PGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP 80
Query: 191 VLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLT 227
LS L+LS N+L + L +L L +S N L
Sbjct: 81 RLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 23/113 (20%), Positives = 37/113 (32%), Gaps = 6/113 (5%)
Query: 214 KNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQ-LGDLDSLVDLDLSMN 272
S L + + L L L + N + + L L L +L + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 273 SLSGSVPSE-LRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFT 324
L V + L + + N L +LS +S LQ +VL N
Sbjct: 67 GLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 6e-07
Identities = 27/131 (20%), Positives = 40/131 (30%), Gaps = 23/131 (17%)
Query: 75 CLVWNGVRCQNGSVVGINISGFRRTRLGSQNPRFAADALVNLTHL--ASFNASRFLLPGS 132
+G+RC R NLT L + + L
Sbjct: 7 PHGSSGLRCT-------------RDGALDSLHHLPG--AENLTELYIENQQHLQHLELRD 51
Query: 133 IPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVL 192
+ + L L+ L + + V P + L+ L LS N L ++ Q L
Sbjct: 52 L-----RGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSL 105
Query: 193 SVLDLSRNSLT 203
L LS N L
Sbjct: 106 QELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 16/96 (16%), Positives = 36/96 (37%)
Query: 271 MNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDV 330
+ L G +L + I N +L + + +L+ + + ++G PD
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 331 LWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELN 366
P+L L++S N + ++ + L+
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLS 111
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 37/145 (25%), Positives = 58/145 (40%), Gaps = 18/145 (12%)
Query: 545 GHSGDLFRGIL-----EGGIPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGH 597
G G + +G+ IPV IK +A + + HA +V LLG
Sbjct: 24 GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGL 83
Query: 598 CMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHEC 657
C LV +Y+P G L + R+ Q L L + A+G+ YL
Sbjct: 84 CPGSSL--QLVTQYLPLGSLLDHV-RQHRGALGPQLL-----LNWGVQIAKGMYYLEEHG 135
Query: 658 TLPFVHRDVQASSILLDDKFEVRLG 682
VHR++ A ++LL +V++
Sbjct: 136 ---MVHRNLAARNVLLKSPSQVQVA 157
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 36/144 (25%), Positives = 59/144 (40%), Gaps = 16/144 (11%)
Query: 545 GHSGDLFRGILEGG------IPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLG 596
G G+++ G + G + V +K +L+E SK +H +V +G
Sbjct: 82 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 141
Query: 597 HCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL--H 654
++ +F++ + M GDL S L SL + L +A A G YL +
Sbjct: 142 VSLQSL-PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 200
Query: 655 HECTLPFVHRDVQASSILLDDKFE 678
H F+HRD+ A + LL
Sbjct: 201 H-----FIHRDIAARNCLLTCPGP 219
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 48/314 (15%), Positives = 100/314 (31%), Gaps = 102/314 (32%)
Query: 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDL--QSVKTEAYLLE----------LD 581
G F K+ G + VIKR+ + + E L
Sbjct: 22 GGFGQVFKAKHRIDGKTY----------VIKRVKYNNEKAEREVKALAKLDHVNIVHYNG 71
Query: 582 FFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTN---TEDDLQSLDWIT 638
+ + + F+ ++ G L + ++ + +L+
Sbjct: 72 CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV--LALELFE 129
Query: 639 RLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSR 698
++ +G+ Y+H + + +RD++ S+I L D +V++G G
Sbjct: 130 QI------TKGVDYIHSKKLI---NRDLKPSNIFLVDTKQVKIGDF------G------- 167
Query: 699 ITRLLRLPQSSEQGSSGSLTATC--------------PY----DVYCFGKVLLELVTGKM 740
+ L+ + G T + Y D+Y G +L EL+
Sbjct: 168 LVTSLK--------NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV-- 217
Query: 741 GISASSDAQV-KEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLN 799
+A ++ ++ + + I+DK+ +L+ + L+
Sbjct: 218 CDTAFETSKFFTDLRDGIIS--DIFDKKEK------TLL----------------QKLLS 253
Query: 800 PKPTRRPLMRYILK 813
KP RP IL+
Sbjct: 254 KKPEDRPNTSEILR 267
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 26/143 (18%), Positives = 55/143 (38%), Gaps = 22/143 (15%)
Query: 545 GHSGDLFRGILEGG---IPVVIKRI---DLQSVKTEAYLLELDFFSKVSHARLVPLLGHC 598
G+ G + +G + V +K + + L E + ++ + +V ++G C
Sbjct: 28 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87
Query: 599 MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL--HHE 656
LV + G L+ L + + + +++ + G+ YL +
Sbjct: 88 EA--ESWMLVMEMAELGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEESN- 137
Query: 657 CTLPFVHRDVQASSILLDDKFEV 679
FVHRD+ A ++LL +
Sbjct: 138 ----FVHRDLAARNVLLVTQHYA 156
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 9e-10
Identities = 35/176 (19%), Positives = 76/176 (43%), Gaps = 25/176 (14%)
Query: 533 TGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSV-KTEAYLLELDFFSKVSHAR 590
+ + +G G +++ E G K I+ +S + E Y++E++ + H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAI---GAA 647
+V LLG + + +++ ++ P G + + + + Q I +
Sbjct: 78 IVKLLG-AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---------IQVVCRQML 127
Query: 648 EGLSYLHHECTLPFVHRDVQASSILLDDKFEVRL---GSLSEVCAQGGDAHQSRIT 700
E L++LH + + HRD++A ++L+ + ++RL G V A+ Q R +
Sbjct: 128 EALNFLHSKRII---HRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDS 176
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 41/263 (15%), Positives = 75/263 (28%), Gaps = 39/263 (14%)
Query: 577 LLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDW 636
+ D +++ + + +L + + +SL
Sbjct: 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 205
Query: 637 ITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQ 696
RL++ + L+ LHH VH ++ I+LD + V L + G
Sbjct: 206 HARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE-HLVRDGARVV 261
Query: 697 SRITR------LLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV 750
S ++R L + T +D + G V+ +
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD----------- 310
Query: 751 KEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRY 810
LP I I + A++ L R L
Sbjct: 311 -------LPITKDAALGGSEWIFRSCKNIPQP------VRALL-EGFLRYPKEDRLL--- 353
Query: 811 ILKALENP-LKVVREENSGSARL 832
L+A+E P + +R E S + L
Sbjct: 354 PLQAMETPEYEQLRTELSAALPL 376
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 60.0 bits (144), Expect = 1e-09
Identities = 29/178 (16%), Positives = 63/178 (35%), Gaps = 23/178 (12%)
Query: 110 ADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSIS--GVIPFSLGNLTN 167
+ L + L + + + + P L++L++ S + V +L N
Sbjct: 165 SPVLDAMPLLNNLK----IKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPN 220
Query: 168 LTSLYL---SDNGLTGTIPSSL------GQLSVLSVLDLSRNSLTGNIPTSFG---LLKN 215
L L L ++ + + L L + + F +L
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280
Query: 216 LSSLDISSNYLTGS----IPPGLGTLSKLQYLNVSNNSLASSIPAQLGD-LDSLVDLD 268
L ++DIS+ LT + + + L+++N+ N L+ + +L L +D+
Sbjct: 281 LETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVS 338
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 57.3 bits (137), Expect = 1e-08
Identities = 34/277 (12%), Positives = 74/277 (26%), Gaps = 28/277 (10%)
Query: 34 FEPTFEQQLERLSSRTELAALFELRSSLGLRRRDWPRKVDPCLVWNGVRCQNGSVVGINI 93
++ ++ T E++ + + + + + +
Sbjct: 53 AGKLIAEKTKKGYVETLEEVAKEMKVEAKKYALSYDEAEEGVNLMDKILKDKKLP-SLKQ 111
Query: 94 SGFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDW---------LGQQLPTL 144
++ AD +V + F + L L +
Sbjct: 112 ITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAM 171
Query: 145 QALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLG--QLSVLSVLDLSRNSL 202
L+ + + NL SL + GL ++ + L L L L
Sbjct: 172 PLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVE 231
Query: 203 TGNIPTSFGLL---------KNLSSLDISSNYLTGSIPPGLGT---LSKLQYLNVSNNSL 250
+ NL L I + L +L+ +++S L
Sbjct: 232 DYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVL 291
Query: 251 ----ASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELR 283
A + + + L +++ N LS + EL+
Sbjct: 292 TDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQ 328
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.4 bits (114), Expect = 7e-06
Identities = 32/212 (15%), Positives = 62/212 (29%), Gaps = 29/212 (13%)
Query: 151 SCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVL----DLSRNSLTGNI 206
I+ I + + L+ D S + Q+ + VL L+ + G
Sbjct: 124 CSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTN 183
Query: 207 PTSFGLLK--NLSSLDISSNYLTGSIPPGLGT--LSKLQYLNVSNNSLASSIPAQLGDLD 262
S G NL SL+I S L S+ + L L+ L + +
Sbjct: 184 NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR 243
Query: 263 SLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLF--PTVSQLQIIVLRQ 320
L +L+ I + + + QL+ + +
Sbjct: 244 PLF---------------SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISA 288
Query: 321 NGFTGPP----PDVLWSMPQLRLLDISRNNFT 348
T D + + L+ +++ N +
Sbjct: 289 GVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 34/144 (23%), Positives = 59/144 (40%), Gaps = 16/144 (11%)
Query: 545 GHSGDLFRGIL----EGGIPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHC 598
G G++ G L + I V IK ++ + +L E + H ++ L G
Sbjct: 56 GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV 115
Query: 599 MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECT 658
+ + +V +YM NG L S L + I + + G A G+ YL
Sbjct: 116 TKSKP-VMIVTEYMENGSLDSFLRKHDA------QFTVIQLVGMLRGIASGMKYLSDMG- 167
Query: 659 LPFVHRDVQASSILLDDKFEVRLG 682
+VHRD+ A +IL++ ++
Sbjct: 168 --YVHRDLAARNILINSNLVCKVS 189
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 40/176 (22%), Positives = 70/176 (39%), Gaps = 27/176 (15%)
Query: 533 TGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQS-VKTEAYLLELDFFSKVSHAR 590
++ I G SG ++ + + G V I++++LQ K E + E+ + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAE-- 648
+V L +E ++V +Y+ G L+ + E +IA E
Sbjct: 79 IVNYLD-SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-----------QIAAVCRECL 126
Query: 649 -GLSYLHHECTLPFVHRDVQASSILLDDKFEVRL---GSLSEVCAQGGDAHQSRIT 700
L +LH +HRD+++ +ILL V+L G CAQ R T
Sbjct: 127 QALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRST 175
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 36/145 (24%), Positives = 61/145 (42%), Gaps = 18/145 (12%)
Query: 545 GHSGDLFRGIL-----EGGIPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGH 597
G G +++G+ + IPV IK R + L E + V + + LLG
Sbjct: 26 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85
Query: 598 CMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHEC 657
C+ + L+ + MP G L + R+ Q L L + A+G++YL
Sbjct: 86 CLT--STVQLITQLMPFGCLLDYV-REHKDNIGSQYL-----LNWCVQIAKGMNYLEDRR 137
Query: 658 TLPFVHRDVQASSILLDDKFEVRLG 682
VHRD+ A ++L+ V++
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKIT 159
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 33/153 (21%), Positives = 56/153 (36%), Gaps = 24/153 (15%)
Query: 548 GDLFRGILEGGIP------VVIKRIDLQSVKTEAYLL-ELDFFSKVSHARLVPLLGHCME 600
G +F P V +K + ++ E + + + H +V G C +
Sbjct: 29 GKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD 88
Query: 601 RENEKFLVYKYMPNGDL---------SSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLS 651
+ +V++YM +GDL + + L L IA A G+
Sbjct: 89 GDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMV 147
Query: 652 YL--HHECTLPFVHRDVQASSILLDDKFEVRLG 682
YL H FVHRD+ + L+ V++G
Sbjct: 148 YLASQH-----FVHRDLATRNCLVGANLLVKIG 175
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 43/174 (24%), Positives = 71/174 (40%), Gaps = 22/174 (12%)
Query: 533 TGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLL--ELDFFSKVSHA 589
F+ I G G++F+GI V IK IDL+ + E + E+ S+
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 590 RLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAI---GA 646
+ G ++ + +++ +Y+ G L E +IA
Sbjct: 81 YVTKYYG-SYLKDTKLWIIMEYLGGGSALDLLEPGPLDET-----------QIATILREI 128
Query: 647 AEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRIT 700
+GL YLH E + HRD++A+++LL + EV+L V Q D R T
Sbjct: 129 LKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFG-VAGQLTDTQIKRNT 178
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 38/146 (26%), Positives = 61/146 (41%), Gaps = 21/146 (14%)
Query: 545 GHSGDLFRGIL----EGGIPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHC 598
G GD+ +GI + V IK + E +L E + H +V L+G
Sbjct: 401 GQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 460
Query: 599 MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL--HHE 656
E N +++ + G+L S L + SLD + + A + L+YL
Sbjct: 461 TE--NPVWIIMELCTLGELRSFLQVRKF------SLDLASLILYAYQLSTALAYLESKR- 511
Query: 657 CTLPFVHRDVQASSILLDDKFEVRLG 682
FVHRD+ A ++L+ V+LG
Sbjct: 512 ----FVHRDIAARNVLVSSNDCVKLG 533
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-09
Identities = 36/146 (24%), Positives = 63/146 (43%), Gaps = 19/146 (13%)
Query: 545 GHSGDLFRGILEGG----IPVVIKRI----DLQSVKTEAYLLELDFFSKVSHARLVPLLG 596
G G + RG + + V +K + Q + ++ E++ + H L+ L G
Sbjct: 29 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88
Query: 597 HCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHE 656
+ +V + P G L L RK L +L + A+ AEG+ YL +
Sbjct: 89 VVLT--PPMKMVTELAPLGSLLDRL-RKHQGHFLLGTL-----SRYAVQVAEGMGYLESK 140
Query: 657 CTLPFVHRDVQASSILLDDKFEVRLG 682
F+HRD+ A ++LL + V++G
Sbjct: 141 R---FIHRDLAARNLLLATRDLVKIG 163
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 45/263 (17%), Positives = 88/263 (33%), Gaps = 20/263 (7%)
Query: 100 RLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDW---LGQQLPTLQALDLRSCSIS- 155
RL + P + L A FN G + W + L L+++ R +S
Sbjct: 67 RLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSD 126
Query: 156 -GVIPFSLGNLTNLTSLYLSD-NGLTGTIPSSLGQ-LSVLSVLDLSRNSLTGNIPTSFGL 212
+ + +L +L L +G T S+ + L + +S +
Sbjct: 127 LDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHE 186
Query: 213 L----KNLSSLDISSNYLTGSIPPGLGTLSK----LQYLNVSNNSLAS--SIPAQLGDLD 262
L +L L+ P L T+++ L + V + + +L+
Sbjct: 187 LAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLE 246
Query: 263 SLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQ-N 321
L+ + L R L + +G +++ N LFP +Q++ + L
Sbjct: 247 EFCGGSLNEDIGMPEKYMNLVFPRKLCR--LGLSYMGPNEMPILFPFAAQIRKLDLLYAL 304
Query: 322 GFTGPPPDVLWSMPQLRLLDISR 344
T ++ P L +L+
Sbjct: 305 LETEDHCTLIQKCPNLEVLETRN 327
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 26/181 (14%), Positives = 58/181 (32%), Gaps = 27/181 (14%)
Query: 137 LGQQLPTLQALDLRSCSISGVIPFSLGNLT------------NLTSLYLSDNGLT----G 180
L Q L+ L + + + G ++ L + + + +T
Sbjct: 337 LAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLE 396
Query: 181 TIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGL------LKNLSSLDISSNY--LTGSIPP 232
+I + L L ++ L R ++P G+ K L LT
Sbjct: 397 SIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLS 456
Query: 233 GLGTLSK-LQYLNVSNNSL-ASSIPAQLGDLDSLVDLDLSMNSLS-GSVPSELRGLRSLQ 289
+G S ++++ + + +L L++ S ++ + + L SL+
Sbjct: 457 YIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLR 516
Query: 290 K 290
Sbjct: 517 Y 517
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 36/253 (14%), Positives = 80/253 (31%), Gaps = 39/253 (15%)
Query: 115 NLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSC-SISGVIPFSLGNLTNLTSLYL 173
+ L + LL L Q+ P L+ L+ R+ G+ + L L +
Sbjct: 294 QIRKL---DLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQ-YCKQLKRLRI 349
Query: 174 SDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLT----GS 229
+ G +S ++ L++ + L + + + +T S
Sbjct: 350 ERGADEQGMEDEEGLVSQRGLIALAQG------------CQELEYMAVYVSDITNESLES 397
Query: 230 IPPGLGTLSKLQYLNVSNNS------LASSIPAQLGDLDSLVDLDLSMNS--LSGSVPSE 281
I L L + + + L + + + L L + L+ S
Sbjct: 398 IGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY 457
Query: 282 L-RGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPD-----VLWSMP 335
+ + +++ ++G S + LQ + +R F+ + + +P
Sbjct: 458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS----ERAIAAAVTKLP 513
Query: 336 QLRLLDISRNNFT 348
LR L + +
Sbjct: 514 SLRYLWVQGYRAS 526
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 166 TNLTSLYLSDNGLTGTIPSSL-GQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSN 224
+ T L L+DN L L G+L L L+L RN LTG P +F ++ L + N
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88
Query: 225 YLTGSIPPGL-GTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDL 267
+ I + L +L+ LN+ +N + S + G + L L
Sbjct: 89 KIK-EISNKMFLGLHQLKTLNLYDNQI-SCVMP--GSFEHLNSL 128
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 25/116 (21%), Positives = 49/116 (42%), Gaps = 26/116 (22%)
Query: 134 PDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLS 193
D L +LP L L+L+ ++G+ P + +++ L L +N + I + +
Sbjct: 46 SDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKM------- 97
Query: 194 VLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVSNN 248
F L L +L++ N ++ + PG L+ L LN+++N
Sbjct: 98 ----------------FLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 40/162 (24%), Positives = 64/162 (39%), Gaps = 13/162 (8%)
Query: 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLL--ELDFFSKVSHARL 591
D+ +I +G + + V IKRI+L+ +T L E+ S+ H +
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 592 VPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAE--- 648
V ++E +LV K + G + + K + IA E
Sbjct: 76 VSYYT-SFVVKDELWLVMKLLSGGSVLDII--KHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 649 GLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690
GL YLH +HRDV+A +ILL + V++ V A
Sbjct: 133 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADF-GVSAF 170
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 29/142 (20%), Positives = 54/142 (38%), Gaps = 16/142 (11%)
Query: 545 GHSGDLFRGILEG-----GIPVVIKRI-DLQSVKTEAYLLELDFFSKVSHARLVPLLGHC 598
G+ G + + G V +K++ + + E+ + +V G
Sbjct: 34 GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 93
Query: 599 MERENE-KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHEC 657
+ LV +Y+P+G L L ++ D L L + +G+ YL
Sbjct: 94 YGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRL-----LLYSSQICKGMEYLGSRR 147
Query: 658 TLPFVHRDVQASSILLDDKFEV 679
VHRD+ A +IL++ + V
Sbjct: 148 ---CVHRDLAARNILVESEAHV 166
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 42/266 (15%), Positives = 79/266 (29%), Gaps = 38/266 (14%)
Query: 576 YLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLD 635
++ D +++ + + +L + + +SL
Sbjct: 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 209
Query: 636 WITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAH 695
RL++ + L+ LHH VH ++ I+LD + V L + G +
Sbjct: 210 HHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE-HLVRDGASA 265
Query: 696 QSRITRL-----LRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV 750
S I R + G T +D + G + +
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD----------- 314
Query: 751 KEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRY 810
LP I +++ + V A++ L R L
Sbjct: 315 -------LPNTDDAALGGSEWIFRS----CKNIPQPVR--ALLEG-FLRYPKEDRLL--- 357
Query: 811 ILKALENP-LKVVREENSGSARLRTT 835
L+A+E P + +R E S + L T
Sbjct: 358 PLQAMETPEYEQLRTELSAALPLYQT 383
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 52/332 (15%), Positives = 100/332 (30%), Gaps = 87/332 (26%)
Query: 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDL--QSVKTEAYLLELDFFSKVSHARL 591
G F KN + IKRI L + + E + E+ +K+ H +
Sbjct: 16 GGFGVVFEAKNKVDDCNY----------AIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 592 VPLLGHCMERENEK-----------FLVYKYMPNGDLSSSL-YRKTNTE-DDLQSLDWIT 638
V +E+ + ++ + +L + R T E + L
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 639 RLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQ 696
++ AE + +LH + + HRD++ S+I V++G L Q +
Sbjct: 126 QI------AEAVEFLHSKGLM---HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 697 SRITRLLRLPQSSEQGSSGSLTATCPY---------------DVYCFGKVLLELVTGKMG 741
+ + G T Y D++ G +L EL+
Sbjct: 177 VLTPMPAYARHTGQVG-------TKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-PFS 228
Query: 742 ISASSDAQVKEILEQTLPYI-SIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNP 800
+ ++ P + + + + L+P
Sbjct: 229 TQMERVRTLTDVRNLKFPPLFTQKYPCEYVMV----------------------QDMLSP 266
Query: 801 KPTRRP-----LMRYILKALENPLKVVREENS 827
P RP + + + L+ P K V + S
Sbjct: 267 SPMERPEAINIIENAVFEDLDFPGKTVLRQRS 298
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 8e-09
Identities = 31/158 (19%), Positives = 58/158 (36%), Gaps = 25/158 (15%)
Query: 545 GHSGDLFRGIL------EGGIPVVIK--RIDLQSVKTEAYLLELDFFSKV-SHARLVPLL 595
G G + V +K + + A + EL + H +V LL
Sbjct: 38 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97
Query: 596 GHCMERENEKFLVYKYMPNGDLSSSL---------YRKTNTEDDLQSLDWITRLKIAIGA 646
G C + ++ ++ G+LS+ L Y+ + L + +
Sbjct: 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 157
Query: 647 AEGLSYL--HHECTLPFVHRDVQASSILLDDKFEVRLG 682
A+G+ +L +HRD+ A +ILL +K V++
Sbjct: 158 AKGMEFLASRK-----CIHRDLAARNILLSEKNVVKIC 190
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 35/152 (23%), Positives = 67/152 (44%), Gaps = 17/152 (11%)
Query: 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTE--AYLLELDFFSKVSHARL 591
DF + + G+ G +F+ G+ + K I L+ + EL + + +
Sbjct: 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 592 VPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNT--EDDLQSLDWITRLKIAIGAAEG 649
V G + E + ++M G L + +K E L K++I +G
Sbjct: 94 VGFYG-AFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILG--------KVSIAVIKG 143
Query: 650 LSYLHHECTLPFVHRDVQASSILLDDKFEVRL 681
L+YL + + +HRDV+ S+IL++ + E++L
Sbjct: 144 LTYLREKHKI--MHRDVKPSNILVNSRGEIKL 173
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 8e-09
Identities = 41/163 (25%), Positives = 60/163 (36%), Gaps = 39/163 (23%)
Query: 545 GHSGDLFRGILEGGIP------VVIK---------RIDLQSVKTEAYLLELDFFSKVSHA 589
G G +F +P V +K R D Q EA LL + + H
Sbjct: 52 GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELL-----TMLQHQ 103
Query: 590 RLVPLLGHCMERENEKFLVYKYMPNGDLSSSL--------YRKTNTEDDLQSLDWITRLK 641
+V G C E +V++YM +GDL+ L + L L
Sbjct: 104 HIVRFFGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 642 IAIGAAEGLSYL--HHECTLPFVHRDVQASSILLDDKFEVRLG 682
+A A G+ YL H FVHRD+ + L+ V++G
Sbjct: 163 VASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIG 200
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 8e-09
Identities = 35/165 (21%), Positives = 64/165 (38%), Gaps = 41/165 (24%)
Query: 545 GHSGDLFRGILEGG------IPVVIK----------RIDLQSVKTEAYLLELDFFSKVSH 588
G +++G L G V IK R + + EA L +++ H
Sbjct: 20 DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH---EAMLR-----ARLQH 71
Query: 589 ARLVPLLGHCMERENEKFLVYKYMPNGDL---------SSSLYRKTNTEDDLQSLDWITR 639
+V LLG ++ +++ Y +GDL S + + +L+
Sbjct: 72 PNVVCLLGVVT-KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 640 LKIAIGAAEGLSYL--HHECTLPFVHRDVQASSILLDDKFEVRLG 682
+ + A G+ YL HH VH+D+ ++L+ DK V++
Sbjct: 131 VHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKIS 170
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 39/175 (22%), Positives = 70/175 (40%), Gaps = 25/175 (14%)
Query: 533 TGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARL 591
F + G G +++ I E G V IK++ ++S + + E+ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHV 86
Query: 592 VPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAI---GAAE 648
V G + + ++V +Y G +S + + T + + IA +
Sbjct: 87 VKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE---------IATILQSTLK 136
Query: 649 GLSYLHHECTLPFVHRDVQASSILLDDKFEVRL---GSLSEVCAQGGDAHQSRIT 700
GL YLH +HRD++A +ILL+ + +L G V Q D R T
Sbjct: 137 GLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFG----VAGQLTDTMAKRNT 184
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 37/268 (13%), Positives = 73/268 (27%), Gaps = 26/268 (9%)
Query: 568 LQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNT 627
++ LL D + S L + +L+ + DL
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV 184
Query: 628 EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687
+ + + L + VH ++ + + LG +S +
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 688 CAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKM--GISAS 745
G S + E ++ + T T + + G + + + G+
Sbjct: 242 WKVGTRGPASSVPVTYAPR---EFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 746 SDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRR 805
+ +P T + D + L+ LN RR
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFV----KTLI----------GRFLNFDRRRR 344
Query: 806 PLMRYILKALENP-LKVVREENSGSARL 832
L L+A+E P ++ E S S
Sbjct: 345 LL---PLEAMETPEFLQLQNEISSSLST 369
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 36/176 (20%), Positives = 63/176 (35%), Gaps = 27/176 (15%)
Query: 533 TGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQS-VKTEAYLLELDFFSKVSHAR 590
I G +G + G V +K +DL+ + E E+ H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAE-- 648
+V + E +++ +++ G L+ + + E+ IA
Sbjct: 104 VVEMYK-SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ-----------IATVCEAVL 151
Query: 649 -GLSYLHHECTLPFVHRDVQASSILLDDKFEVRL---GSLSEVCAQGGDAHQSRIT 700
L+YLH + +HRD+++ SILL V+L G CAQ R +
Sbjct: 152 QALAYLHAQGV---IHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKS 200
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 33/152 (21%), Positives = 58/152 (38%), Gaps = 23/152 (15%)
Query: 545 GHSGDLFRGILEGG---IPVVIKRI--DLQSVKTEAYLLELDFFSKV-SHARLVPLLGHC 598
G+ G + + ++ + IKR+ + EL+ K+ H ++ LLG C
Sbjct: 36 GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95
Query: 599 MERENEKFLVYKYMPNGDL---------SSSLYRKTNTEDDLQSLDWITRLKIAIGAAEG 649
R +L +Y P+G+L + +L L A A G
Sbjct: 96 EHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 154
Query: 650 LSYL--HHECTLPFVHRDVQASSILLDDKFEV 679
+ YL F+HRD+ A +IL+ + +
Sbjct: 155 MDYLSQKQ-----FIHRDLAARNILVGENYVA 181
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 33/109 (30%), Positives = 51/109 (46%), Gaps = 4/109 (3%)
Query: 166 TNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNY 225
++ T L L N L +L+ L+ L LS+N + F L L+ L + N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87
Query: 226 LTGSIPPGL-GTLSKLQYLNVSNNSLASSIPAQLGD-LDSLVDLDLSMN 272
L S+P G+ L++L+ L + N L S+P + D L SL + L N
Sbjct: 88 LQ-SLPNGVFDKLTQLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 35/122 (28%), Positives = 55/122 (45%), Gaps = 13/122 (10%)
Query: 130 PGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSL-GQ 188
P IP + L+L S + + LT LT L LS N + ++P + +
Sbjct: 23 PTGIPS-------SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDK 74
Query: 189 LSVLSVLDLSRNSLTGNIPTS-FGLLKNLSSLDISSNYLTGSIPPG-LGTLSKLQYLNVS 246
L+ L++L L N L ++P F L L L + +N L S+P G L+ LQ + +
Sbjct: 75 LTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLH 132
Query: 247 NN 248
N
Sbjct: 133 TN 134
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 53/323 (16%), Positives = 105/323 (32%), Gaps = 93/323 (28%)
Query: 548 GDLFRGILEGGIPVVIKRIDLQSVKT----------EAYLLELDFFSKV-SHARLVPLLG 596
G + G K +VK + E++ + H ++ LLG
Sbjct: 95 GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154
Query: 597 HCMERENEKFLVYKYMPNGDLSSSL---------YRKTNTEDDLQSLDWITRLKIAIGAA 647
C + +++ +Y G+L L Y + + + + A
Sbjct: 155 ACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 213
Query: 648 EGLSYL--HHECTLPFVHRDVQASSILLDDKFEV--------RLGSLSEVCAQGGDAHQS 697
G+ YL +HRD+ A ++L+ + + R + + + +
Sbjct: 214 RGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG--- 265
Query: 698 RITRLLRLP------QSSEQG--SSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDA 748
RLP ++ + S DV+ FG ++ E+ T G
Sbjct: 266 ------RLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEIFTLGGS-------- 304
Query: 749 QVKEILEQTLPYISIYDKELVTKIVD------PSLIIDEDLLEEVWAMAIVARSCLNPKP 802
PY I +EL + + P + E++ M R C + P
Sbjct: 305 ----------PYPGIPVEELFKLLKEGHRMDKP-----ANCTNELYMM---MRDCWHAVP 346
Query: 803 TRRPLMRYILKALENPLKVVREE 825
++RP + +++ L+ L + E
Sbjct: 347 SQRPTFKQLVEDLDRILTLTTNE 369
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 47/306 (15%), Positives = 90/306 (29%), Gaps = 65/306 (21%)
Query: 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDL--------QSVKTEAYLLELDFFSK 585
+F + I +G G +F+ + G IKR Q+ E Y
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA----VL 67
Query: 586 VSHARLVPLLGHCMERENEKFLVY-KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAI 644
H+ +V E++ L+ +Y G L+ ++ + +
Sbjct: 68 GQHSHVVRYFSA--WAEDDHMLIQNEYCNGGSLADAISENYRIM---SYFKEAELKDLLL 122
Query: 645 GAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLR 704
GL Y+H VH D++ S+I + S + ++
Sbjct: 123 QVGRGLRYIHSMSL---VHMDIKPSNIFISRTSIPNAASEEGDEDDWASN--KVMFKIGD 177
Query: 705 LPQSSEQGSSGSLTATCPY----------------DVYCFGKVLLELVTGKMGISASSDA 748
L + S + D++ ++ + +
Sbjct: 178 LGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE--PLPRNGD 235
Query: 749 QVKEILEQTLPYI-SIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPL 807
Q EI + LP I + +E +LL + ++P P RRP
Sbjct: 236 QWHEIRQGRLPRIPQVLSQEF------------TELL----------KVMIHPDPERRPS 273
Query: 808 MRYILK 813
++K
Sbjct: 274 AMALVK 279
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 5e-08
Identities = 64/438 (14%), Positives = 129/438 (29%), Gaps = 162/438 (36%)
Query: 3 WSMLLLDDCECVKAMVDQRSVVMFFVMFLLLFEPTFEQQLERLSS-RTELAALFELRSSL 61
W L L +C + +++ L +P + + + S+ + + ++ L
Sbjct: 186 W--LNLKNCNSPETVLEM------LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237
Query: 62 GLRRRDWPRKVDPCL-----VWN-------GVRCQ------NGSVVGINISGFRRTRLGS 103
L+ + + CL V N + C+ V +S T +
Sbjct: 238 -LKSKPYEN----CLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDF-LSAATTTHISL 291
Query: 104 QNPR--FAADALVNLTHLASFNASRFLLPGSIPDWLG---QQLPTLQALDLRSCSIS--- 155
+ D + +L L +L Q LP + + +
Sbjct: 292 DHHSMTLTPDEVKSL--LLK--------------YLDCRPQDLP-REV-----LTTNPRR 329
Query: 156 -GVIPFSL--GNLTNLTSLYLSDNGLTGTIPSSLGQLS---------------------- 190
+I S+ G T +++ + LT I SSL L
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPT 389
Query: 191 -VLSVL--------------DLSRNSL--------TGNIP-------------------- 207
+LS++ L + SL T +IP
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSI 449
Query: 208 -TSFGLLKNLSSLDIS----SNY--------LTGSIPPGLGTLSKLQYLN-------VSN 247
+ + K S D+ Y L P TL ++ +L+ + +
Sbjct: 450 VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRH 509
Query: 248 NSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFV--IGNNFLSGNLSVN 305
+S A + + L++L L + + P R + ++ F+ I N +
Sbjct: 510 DSTAWNASGSI--LNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICS----- 562
Query: 306 LFPTVSQLQIIVLRQNGF 323
L+I ++ ++
Sbjct: 563 --KYTDLLRIALMAEDEA 578
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 54/325 (16%), Positives = 111/325 (34%), Gaps = 97/325 (29%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLEL-DFFSKVS-------HARLVPLLG 596
+ + + + + V +K +K +A +L D S++ H ++ LLG
Sbjct: 54 AEAVGIDKDKPKEAVTVAVK-----MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 108
Query: 597 HCMERENEKFLVYKYMPNGDLSSSL---------YRKTNTEDDLQSLDWITRLKIAIGAA 647
C + +++ +Y G+L L Y + + + + A
Sbjct: 109 ACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 167
Query: 648 EGLSYL--HHECTLPFVHRDVQASSILLDDKFEV--------RLGSLSEVCAQGGDAHQS 697
G+ YL +HRD+ A ++L+ + + R + + + +
Sbjct: 168 RGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG--- 219
Query: 698 RITRLLRLP------QSSEQG--SSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDA 748
RLP ++ + S DV+ FG ++ E+ T G
Sbjct: 220 ------RLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEIFTLGGS-------- 258
Query: 749 QVKEILEQTLPYISIYDKELVTKIVD------PSLIIDEDLLEEVWA-MAIVARSCLNPK 801
PY I +EL + + P + E++ M R C +
Sbjct: 259 ----------PYPGIPVEELFKLLKEGHRMDKP-----ANCTNELYMMM----RDCWHAV 299
Query: 802 PTRRPLMRYILKALENPLKVVREEN 826
P++RP + +++ L+ L + E
Sbjct: 300 PSQRPTFKQLVEDLDRILTLTTNEE 324
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 8e-08
Identities = 33/154 (21%), Positives = 65/154 (42%), Gaps = 20/154 (12%)
Query: 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTE--AYLLELDFFSK-VSHAR 590
D + + +G G +++ + G + +K++ K E L++LD K
Sbjct: 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPY 85
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTN---TEDDLQSLDWITRLKIAIGAA 647
+V G + F+ + M G + L ++ E L K+ +
Sbjct: 86 IVQCFG-TFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILG--------KMTVAIV 134
Query: 648 EGLSYLHHECTLPFVHRDVQASSILLDDKFEVRL 681
+ L YL + +HRDV+ S+ILLD++ +++L
Sbjct: 135 KALYYLKEK--HGVIHRDVKPSNILLDERGQIKL 166
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 52/253 (20%), Positives = 85/253 (33%), Gaps = 45/253 (17%)
Query: 75 CLVWNGVRCQNGSVVGINISGFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSIP 134
N G ++ + FR R P + + H+ + S ++ S
Sbjct: 54 LTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHM---DLSNSVIEVSTL 110
Query: 135 DWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLS------DNGLTGTIPSSLGQ 188
+ Q LQ L L +S I +L +NL L LS + L T+ SS +
Sbjct: 111 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQ-TLLSSCSR 169
Query: 189 LSVLSV------------------------LDLSRNSLTGNIPTSFGL------LKNLSS 218
L L++ L+LS N+ L NL
Sbjct: 170 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG--YRKNL-QKSDLSTLVRRCPNLVH 226
Query: 219 LDISS-NYLTGSIPPGLGTLSKLQYLNVSN-NSLASSIPAQLGDLDSLVDLDLSMNSLSG 276
LD+S L L+ LQ+L++S + +LG++ +L L + G
Sbjct: 227 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 286
Query: 277 SVPSELRGLRSLQ 289
++ L LQ
Sbjct: 287 TLQLLKEALPHLQ 299
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 45/265 (16%), Positives = 80/265 (30%), Gaps = 22/265 (8%)
Query: 91 INISGFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLR 150
+ L D L P +Q +DL
Sbjct: 42 LASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLS 101
Query: 151 SCSIS-GVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTS 209
+ I + L + L +L L L+ I ++L + S L L+LS S +
Sbjct: 102 NSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS---GF-SE 157
Query: 210 FGL------LKNLSSLDISSNYLTGSIPPGLGTL-----SKLQYLNVSNNSLA---SSIP 255
F L L L++S + + + LN+S S +
Sbjct: 158 FALQTLLSSCSRLDELNLSWCFDFTE--KHVQVAVAHVSETITQLNLSGYRKNLQKSDLS 215
Query: 256 AQLGDLDSLVDLDLSM-NSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQ 314
+ +LV LDLS L E L LQ + + ++ + L+
Sbjct: 216 TLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLK 275
Query: 315 IIVLRQNGFTGPPPDVLWSMPQLRL 339
+ + G + ++P L++
Sbjct: 276 TLQVFGIVPDGTLQLLKEALPHLQI 300
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 34/145 (23%), Positives = 60/145 (41%), Gaps = 24/145 (16%)
Query: 541 LIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKT-EAYLLELDFFSKVSHARLVPLLGHC 598
++ G G ++ G L + + IK I + + + E+ + H +V LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-- 86
Query: 599 MERENEKFLVY-KYMPNGDLSSSLYRK----TNTEDDLQSLDWITR--LKIAIGAAEGLS 651
EN ++ + +P G LS+ L K + E + T+ L EGL
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF---YTKQIL-------EGLK 136
Query: 652 YLHHECTLPFVHRDVQASSILLDDK 676
YLH VHRD++ ++L++
Sbjct: 137 YLHDNQI---VHRDIKGDNVLINTY 158
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 31/129 (24%), Positives = 49/129 (37%), Gaps = 26/129 (20%)
Query: 571 VKT----------EAYLLELDFFSKV-SHARLVPLLGHCMERENEKFLVYKYMPNGDLSS 619
VK EA + EL S + H +V LLG C ++ +Y GDL +
Sbjct: 81 VKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG-PVLVITEYCCYGDLLN 139
Query: 620 SLYRK-------TNTEDDLQSLDWITRLKIAIGAAEGLSYL--HHECTLPFVHRDVQASS 670
L RK + L + A+G+++L + +HRDV A +
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-----CIHRDVAARN 194
Query: 671 ILLDDKFEV 679
+LL +
Sbjct: 195 VLLTNGHVA 203
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 51/316 (16%), Positives = 98/316 (31%), Gaps = 79/316 (25%)
Query: 532 ATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLL-ELDFFSKVS-HA 589
A G F+ ++ SG +KR+ + ++ E+ F K+S H
Sbjct: 37 AEGGFAFVYEAQDVGSGRE----------YALKRLLSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 590 RLVPLLGHC------MERENEKFLVYKYMPNGDLSSSLYRKTN----TEDDLQSLDWITR 639
+V + +FL+ + G L L + + + D +
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV-------- 138
Query: 640 LKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRL---GSLSEVCAQGGDAHQ 696
LKI + ++H P +HRD++ ++LL ++ ++L GS
Sbjct: 139 LKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGS----ATTISHYPD 193
Query: 697 SRITRLLRLPQSSEQGSSGS----------LTATCPY----DVYCFGKVLLELVTGKMGI 742
+ R E + + L + P D++ G +L L +
Sbjct: 194 YSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ--- 250
Query: 743 SASSDAQVKEILEQ--TLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNP 800
D I+ ++P SLI R+ L
Sbjct: 251 HPFEDGAKLRIVNGKYSIPPHDTQYTVFH------SLI----------------RAMLQV 288
Query: 801 KPTRRPLMRYILKALE 816
P R + ++ L+
Sbjct: 289 NPEERLSIAEVVHQLQ 304
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 42/169 (24%), Positives = 69/169 (40%), Gaps = 29/169 (17%)
Query: 533 TGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTE----AYLLELDFFSKVS 587
FSD I +G G ++ + V IK++ ++ + E+ F K+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 588 HARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAI--- 644
H + G C RE+ +LV +Y +S L + ++IA
Sbjct: 113 HPNTIQYRG-CYLREHTAWLVMEYCLGS--ASDLLEVHKKP--------LQEVEIAAVTH 161
Query: 645 GAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRL---GSLSEVCAQ 690
GA +GL+YLH +HRDV+A +ILL + V+L G +
Sbjct: 162 GALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFG----SASI 203
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 59/319 (18%), Positives = 104/319 (32%), Gaps = 100/319 (31%)
Query: 548 GDLFRGILEG------GIPVVIKRIDLQSVKTEAYLLEL-DFFSKVS-------HARLVP 593
G + G + V +K +K A+L E S++ H +V
Sbjct: 37 GKVVEATAYGLIKSDAAMTVAVK-----MLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 594 LLGHCMERENEKFLVYKYMPNGDL-----------SSSLYRKTNTEDDLQSLDWITRLKI 642
LLG C ++ +Y GDL S EDD +LD L
Sbjct: 92 LLGACTIGG-PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 643 AIGAAEGLSYL--HHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSR 698
+ A+G+++L + +HRD+ A +ILL ++ L+ + +
Sbjct: 151 SYQVAKGMAFLASKN-----CIHRDLAARNILLTHGRITKICDFGLARDIKN-DSNYVVK 204
Query: 699 ITRLLRL----PQSSEQG--SSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVK 751
L + P+S + S DV+ +G L EL + G
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFES-------DVWSYGIFLWELFSLGSS----------- 246
Query: 752 EILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEV-------------WAMAIVARSCL 798
PY P + +D + + M + ++C
Sbjct: 247 -------PY--------------PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCW 285
Query: 799 NPKPTRRPLMRYILKALEN 817
+ P +RP + I++ +E
Sbjct: 286 DADPLKRPTFKQIVQLIEK 304
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 60/295 (20%), Positives = 106/295 (35%), Gaps = 62/295 (21%)
Query: 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTE--AYLLELDFFSKVS-HAR 590
D D I G G + + + G + +KRI + E L++LD + S
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGL 650
+V G + RE + ++ + M + + DD+ + + KI + + L
Sbjct: 83 IVQFYG-ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG--KITLATVKAL 138
Query: 651 SYLHHECTLPFVHRDVQASSILLDDKFEVRL---GSLSEVCAQGGDAHQSRIT------- 700
++L L +HRD++ S+ILLD ++L G + Q D+
Sbjct: 139 NHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFG----ISGQLVDSIAKTRDAGCRPYM 192
Query: 701 ---RLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQT 757
R+ S+ DV+ G L EL TG+
Sbjct: 193 APERI--------DPSASRQGYDVRSDVWSLGITLYELATGR------------------ 226
Query: 758 LPYISIY-DKELVTKIVD---PSLIIDEDLLEEVWAMAIVA--RSCLNPKPTRRP 806
PY + +T++V P L E E ++ + + CL ++RP
Sbjct: 227 FPYPKWNSVFDQLTQVVKGDPPQLSNSE---EREFSPSFINFVNLCLTKDESKRP 278
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 29/162 (17%), Positives = 58/162 (35%), Gaps = 33/162 (20%)
Query: 548 GDLFRGIL------EGGIPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCM 599
G + + G V +K + + + L E + +V+H ++ L G C
Sbjct: 37 GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96
Query: 600 ERENEKFLVYKYMPNGDLSSSL-----------------YRKTNTEDDLQSLDWITRLKI 642
+ L+ +Y G L L + D ++L +
Sbjct: 97 QDG-PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISF 155
Query: 643 AIGAAEGLSYL--HHECTLPFVHRDVQASSILLDDKFEVRLG 682
A ++G+ YL VHRD+ A +IL+ + ++++
Sbjct: 156 AWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKIS 192
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 27/157 (17%), Positives = 56/157 (35%), Gaps = 28/157 (17%)
Query: 548 GDLFRGILEGGIPVVIKRIDLQSVKT----------EAYLLELDFFSKV-SHARLVPLLG 596
G + G R+ +VK + E++ + H ++ LLG
Sbjct: 83 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 142
Query: 597 HCMERENEKFLVYKYMPNGDLSSSL---------YRKTNTEDDLQSLDWITRLKIAIGAA 647
C + +++ +Y G+L L Y + + + L + A A
Sbjct: 143 ACTQDG-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVA 201
Query: 648 EGLSYL--HHECTLPFVHRDVQASSILLDDKFEVRLG 682
G+ YL +HRD+ A ++L+ + +++
Sbjct: 202 RGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIA 233
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 32/151 (21%), Positives = 63/151 (41%), Gaps = 11/151 (7%)
Query: 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTE--AYLLELDFFSKVS-HAR 590
D + G G + + + G + +KRI E L++LD +
Sbjct: 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPF 67
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGL 650
V G + RE + ++ + M Y++ + D + KIA+ + L
Sbjct: 68 TVTFYG-ALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILG--KIAVSIVKAL 122
Query: 651 SYLHHECTLPFVHRDVQASSILLDDKFEVRL 681
+LH + L +HRDV+ S++L++ +V++
Sbjct: 123 EHLHSK--LSVIHRDVKPSNVLINALGQVKM 151
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 40/292 (13%), Positives = 79/292 (27%), Gaps = 34/292 (11%)
Query: 56 ELRSSLGLRRRDWPRKVDPCLVWNGVRCQNGSVVGINISGFRRTR--------LGSQNPR 107
E + + ++ R V + + G G
Sbjct: 41 ERWCRRKVFIGNCYAVSPATVIR---RFPK--VRSVELKGKPHFADFNLVPDGWGGYVYP 95
Query: 108 FAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCS-ISGV-IPFSLGNL 165
+ + T L R ++ + + + + L L SC S +
Sbjct: 96 WIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATC 155
Query: 166 TNLTSLYLSDNGLTGTIPSSLGQLSV----LSVLDLSRNSLTGNIPTSFGL------LKN 215
NL L L ++ + L L L++S L + + L N
Sbjct: 156 RNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNIS--CLASEV-SFSALERLVTRCPN 212
Query: 216 LSSLDISSNYLTGSIPPGLGTLSKLQYLNVS------NNSLASSIPAQLGDLDSLVDLDL 269
L SL ++ + L +L+ L + S + L L L
Sbjct: 213 LKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSG 272
Query: 270 SMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQN 321
+++ +P+ L + + V L +LQ + +
Sbjct: 273 FWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 42/236 (17%), Positives = 77/236 (32%), Gaps = 25/236 (10%)
Query: 137 LGQQLPTLQALDLRSCSISGVIPFSLG----NLTNLTSLYLSD--NGLTGTIPSSLGQLS 190
+ L+ LDLR + V L T+L SL +S + ++ + L
Sbjct: 151 IAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRC 210
Query: 191 V-LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNY------LTGSIPPGLGTLSKLQYL 243
L L L+R + T L L + + L +L+ L
Sbjct: 211 PNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCL 270
Query: 244 NVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSG-SVPSELRGLRSLQKFVIGNNFLSGNL 302
+ +++ + +PA L L+LS ++ + L LQ+ + + L
Sbjct: 271 SGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGL 330
Query: 303 SVNLFPTVSQLQIIVLRQNGFTGPPPD----------VLWSMPQLRLLDISRNNFT 348
V L T L+ + + + P+ V P+L + T
Sbjct: 331 EV-LASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMT 385
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 44/261 (16%), Positives = 86/261 (32%), Gaps = 46/261 (17%)
Query: 110 ADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSIS--GVIPFSLGNLTN 167
+ AL L + +P +P + L L+L ++ ++ L
Sbjct: 258 SVALSGCKELRCLSGFWDAVPAYLPA-VYSVCSRLTTLNLSYATVQSYDLVKL-LCQCPK 315
Query: 168 LTSLYL----SDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIP-TSFGL------LKNL 216
L L++ D GL + S+ L L V + N+ T GL L
Sbjct: 316 LQRLWVLDYIEDAGLE-VLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKL 374
Query: 217 SSLDISSNYLTGSIPPGLGTLSK----LQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMN 272
S+ +T + L T+++ + L ++ L++
Sbjct: 375 ESVLYFCRQMTNA---ALITIARNRPNMTRFR-------------LCIIEPKAPDYLTLE 418
Query: 273 SLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQ----LQIIVLRQNGFTGP-P 327
L + + + L++ LSG L+ +F + ++++ + G +
Sbjct: 419 PLDIGFGAIVEHCKDLRRLS-----LSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGM 473
Query: 328 PDVLWSMPQLRLLDISRNNFT 348
VL LR L+I F
Sbjct: 474 HHVLSGCDSLRKLEIRDCPFG 494
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 39/170 (22%), Positives = 64/170 (37%), Gaps = 49/170 (28%)
Query: 548 GDLFRGILEGGIP------VVIK----------RIDLQSVKTEAYLLELDFFSKVSHARL 591
G +F+ G +P V +K + D Q EA L+ ++ + +
Sbjct: 61 GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---EAALM-----AEFDNPNI 112
Query: 592 VPLLGHCMERENEKFLVYKYMPNGDLSSSL-----------------YRKTNTEDDLQSL 634
V LLG C + L+++YM GDL+ L R + L
Sbjct: 113 VKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 635 DWITRLKIAIGAAEGLSYL--HHECTLPFVHRDVQASSILLDDKFEVRLG 682
+L IA A G++YL FVHRD+ + L+ + V++
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIA 216
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 3e-06
Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 167 NLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYL 226
+ T + + L ++P+ G + L L+ N +T P F L NL L +SN L
Sbjct: 13 DQTLVNCQNIRLA-SVPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKL 69
Query: 227 TGSIPPGL-GTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDL 267
T +IP G+ L++L L++++N L SIP G D+L L
Sbjct: 70 T-AIPTGVFDKLTQLTQLDLNDNHL-KSIPR--GAFDNLKSL 107
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 47/346 (13%), Positives = 96/346 (27%), Gaps = 49/346 (14%)
Query: 506 SSLPPPGASINFTNLGESFTYQQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKR 565
LP F + LL G F+ G D V+K
Sbjct: 49 CKLPAIKPKTEFQLGSKLVYVHHLLG-EGAFAQVYEATQGDLNDAKNKQK-----FVLKV 102
Query: 566 IDLQSVKTEAYLL--ELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYR 623
+ E Y+ ++ + +N LV + G L +++
Sbjct: 103 QK-PANPWEFYIGTQLMERLKPSMQHMFMKFYS-AHLFQNGSVLVGELYSYGTLLNAINL 160
Query: 624 KTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS 683
NT + + + + A+ + +H +H D++ + +L + F
Sbjct: 161 YKNTPE--KVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGF------ 209
Query: 684 LSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATC--------------PY----DV 725
E + + + L + TA C P+ D
Sbjct: 210 -LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDY 268
Query: 726 YCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLE 785
+ + ++ G + + K E + ++ + L I +
Sbjct: 269 FGVAATVYCMLFGTYMKVKNEGGECK--PEGLFRR--LPHLDMWNEFFHVMLNIPDCHHL 324
Query: 786 EVWAMAIVARSCLNPKPTRRPLMRYILKALENPLKVVREENSGSAR 831
+ R L + + ++AL N L V+ E S +
Sbjct: 325 PSLDL---LRQKLKKVFQQHYTNK--IRALRNRLIVLLLECKRSRK 365
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 36/111 (32%), Positives = 52/111 (46%), Gaps = 21/111 (18%)
Query: 195 LDLSRNSLT---GNIPTSFGLLKNLSSLDISSNYLTGSIPPGL-GTLSKLQYLNVSNNSL 250
+D S SL IPT L + N +T + PG+ L++L L++ NN L
Sbjct: 14 VDCSGKSLASVPTGIPT------TTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQL 66
Query: 251 ASSIPAQLGD-LDSLVDLDLSMNSLSGSVPSELRG----LRSLQKFVIGNN 296
+ +PA + D L L L L+ N L S+P RG L+SL + NN
Sbjct: 67 -TVLPAGVFDKLTQLTQLSLNDNQLK-SIP---RGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 31/85 (36%), Positives = 42/85 (49%), Gaps = 4/85 (4%)
Query: 166 TNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTS-FGLLKNLSSLDISSN 224
T LYL DN +T P +L+ L+ LDL N LT +P F L L+ L ++ N
Sbjct: 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDN 88
Query: 225 YLTGSIPPG-LGTLSKLQYLNVSNN 248
L SIP G L L ++ + NN
Sbjct: 89 QLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 34/138 (24%), Positives = 56/138 (40%), Gaps = 35/138 (25%)
Query: 571 VKT----------EAYLLELDFFSKV-SHARLVPLLGHCMERENEKFLVYKYMPNGDLSS 619
VK EA + EL +++ SH +V LLG C +L+++Y GDL +
Sbjct: 80 VKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG-PIYLIFEYCCYGDLLN 138
Query: 620 SL-------------YRKTNTEDDLQSLDWITR---LKIAIGAAEGLSYL--HHECTLPF 661
L Y ++ + L+ +T L A A+G+ +L
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----C 193
Query: 662 VHRDVQASSILLDDKFEV 679
VHRD+ A ++L+ V
Sbjct: 194 VHRDLAARNVLVTHGKVV 211
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 53/302 (17%), Positives = 108/302 (35%), Gaps = 81/302 (26%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSH--ARLVPLLGHCM 599
G S +F+ + E IK ++L+ ++Y E+ + +K+ +++ L + +
Sbjct: 67 GGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126
Query: 600 ERENEKFLVYKYM--PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHEC 657
+ +Y M N DL+S L +K +S+D R E + +H
Sbjct: 127 TDQY----IYMVMECGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 658 TLPFVHRDVQASSILLDDKFEVRL---GSLSEVCAQGGDAHQSRITR------------- 701
VH D++ ++ L+ D ++L G A + + +
Sbjct: 176 I---VHSDLKPANFLIVDG-MLKLIDFG-----IANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 702 LLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYI 761
++ SS + + DV+ G +L + GK P+
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------------------TPFQ 268
Query: 762 SIYDK-ELVTKIVDPSLIID---------EDLLEEVWAMAIVARSCLNPKPTRRPLMRYI 811
I ++ + I+DP+ I+ +D+L + CL P +R + +
Sbjct: 269 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVL----------KCCLKRDPKQRISIPEL 318
Query: 812 LK 813
L
Sbjct: 319 LA 320
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 33/238 (13%), Positives = 73/238 (30%), Gaps = 61/238 (25%)
Query: 597 HCMERENEKFLVYKYMPNGDLSSSL-YRKTNTEDDLQ-SLDWITRLKIAIGAAEGLSYLH 654
+ ++ + +L + R + + + L ++ AE + +LH
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQI------AEAVEFLH 181
Query: 655 HECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS 714
+ +HRD++ S+I V++G V A D + + + +
Sbjct: 182 SKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV--------LTPMPAY 230
Query: 715 GSLTATC--------------PY----DVYCFGKVLLELVTGKMGISASSDAQV-KEILE 755
+ T Y D++ G +L EL+ + ++ ++
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS--TQMERVRIITDVRN 288
Query: 756 QTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
P + +V + L+P PT RP I++
Sbjct: 289 LKFPLLFTQKYPQEHMMV---------------------QDMLSPSPTERPEATDIIE 325
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 52/300 (17%), Positives = 108/300 (36%), Gaps = 77/300 (25%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSH--ARLVPLLGHCM 599
G S +F+ + E IK ++L+ ++Y E+ + +K+ +++ L +
Sbjct: 20 GGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-E 78
Query: 600 ERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTL 659
+ ++V + N DL+S L +K +S+D R E + +H
Sbjct: 79 ITDQYIYMVMEC-GNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQHGI- 129
Query: 660 PFVHRDVQASSILLDDKFEVRL---GSLSEVCAQGGDAHQSRITR-------------LL 703
VH D++ ++ L+ D ++L G A + + + +
Sbjct: 130 --VHSDLKPANFLIVDG-MLKLIDFG-----IANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 704 RLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISI 763
+ SS + + DV+ G +L + GK P+ I
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------------------TPFQQI 223
Query: 764 YDK-ELVTKIVDPSLIID---------EDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
++ + I+DP+ I+ +D+L + CL P +R + +L
Sbjct: 224 INQISKLHAIIDPNHEIEFPDIPEKDLQDVL----------KCCLKRDPKQRISIPELLA 273
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 52/299 (17%), Positives = 101/299 (33%), Gaps = 60/299 (20%)
Query: 535 DFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKT---EAYLL-ELDFFSKVSHAR 590
F +++ +G G + + V +KRI + E LL E D H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESD-----EHPN 79
Query: 591 LVPLLGHCMERENEK-FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEG 649
++ C E++ + ++ + L + +K L+ + + G
Sbjct: 80 VIRY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE------PITLLQQTTSG 130
Query: 650 LSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS-------LSEVCAQGGDAHQSRI--- 699
L++LH L VHRD++ +IL+ L + A G + R
Sbjct: 131 LAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 700 -TRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTL 758
T P+ + + T T D++ G V +++ +
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTV--DIFSAGCVFYYVISEG-----------------SH 228
Query: 759 PYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVAR----SCLNPKPTRRPLMRYILK 813
P+ ++ + SL D L ++AR + P +RP +++LK
Sbjct: 229 PFGKSLQRQANILLGACSL----DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 31/163 (19%), Positives = 52/163 (31%), Gaps = 17/163 (10%)
Query: 545 GHSGDLFRGILEG------GIPVVIKRI--DLQSVKTEAYLLELDFFSKV-SHARLVPLL 595
G G + G V +K + + A + EL + H +V LL
Sbjct: 33 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92
Query: 596 GHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHH 655
G C + ++ ++ G+LS+ L K N ++ R +G Y+
Sbjct: 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFR--------QGKDYVGA 144
Query: 656 ECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSR 698
D SS V SLS+V + +
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYK 187
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 44/241 (18%), Positives = 84/241 (34%), Gaps = 57/241 (23%)
Query: 598 CMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHEC 657
++ ++ LS + + L + + A+G+ +L
Sbjct: 154 DSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---A 210
Query: 658 TLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRL-LR--LPQSSEQG 712
+ +HRD+ A +ILL +K V++ L+ + D + RL L+ P++
Sbjct: 211 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 270
Query: 713 SSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772
T DV+ FG +L E+ + +G S PY
Sbjct: 271 VY-----TIQSDVWSFGVLLWEIFS--LGAS---------------PY------------ 296
Query: 773 VDPSLIIDEDLLEEV-------------WAMAIVARSCLNPKPTRRPLMRYILKALENPL 819
P + IDE+ + M C + +P++RP +++ L N L
Sbjct: 297 --PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354
Query: 820 K 820
+
Sbjct: 355 Q 355
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 52/294 (17%), Positives = 106/294 (36%), Gaps = 65/294 (22%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSH--ARLVPLLGHCM 599
G S +F+ + E IK ++L+ ++Y E+ + +K+ +++ L + +
Sbjct: 39 GGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98
Query: 600 ERENEKFLVYKYM--PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHEC 657
+ +Y M N DL+S L +K +S+D R E + +H
Sbjct: 99 TDQY----IYMVMECGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 658 TLPFVHRDVQASSILLDDKFEVRL---GSLSEVCAQGGDAHQSRITR------------- 701
VH D++ ++ L+ D ++L G A + + +
Sbjct: 148 ---IVHSDLKPANFLIVDG-MLKLIDFG-----IANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 702 LLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKM--GISASSDAQVKEILEQTLP 759
++ SS + + DV+ G +L + GK + +++ I++
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258
Query: 760 YISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
I D I + L D+L + CL P +R + +L
Sbjct: 259 -IEFPD------IPEKDLQ---DVL----------KCCLKRDPKQRISIPELLA 292
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 9e-04
Identities = 23/127 (18%), Positives = 47/127 (37%), Gaps = 20/127 (15%)
Query: 558 GIPVVIKRIDLQSVKTEAYLL--ELDFFSKVSHARLVPLLGHCMERENEK--FLVYKYMP 613
G IK + S + E + K++H +V L E + L+ ++ P
Sbjct: 34 GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCP 92
Query: 614 NGDLSSSLYRKTN----TEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQAS 669
G L + L +N E + + + + G+++L VHR+++
Sbjct: 93 CGSLYTVLEEPSNAYGLPESEFLIV--LRDV------VGGMNHLRE---NGIVHRNIKPG 141
Query: 670 SILLDDK 676
+I+
Sbjct: 142 NIMRVIG 148
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 919 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-37 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-37 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-34 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-33 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-32 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-32 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-31 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-31 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-31 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-31 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-30 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-30 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-30 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-29 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-29 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-29 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-28 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-27 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-27 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-26 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-26 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-26 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-26 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-26 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-25 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-25 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-25 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-25 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-25 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-25 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-24 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-24 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-24 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-24 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-19 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-22 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-22 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-04 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-21 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-20 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-20 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-19 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-19 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-19 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-19 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-19 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-18 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-04 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-18 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-17 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-17 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-17 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-16 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-16 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-10 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-15 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-12 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-12 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-11 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-11 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-05 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-08 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-07 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 7e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 3e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.002 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-37
Identities = 58/286 (20%), Positives = 117/286 (40%), Gaps = 32/286 (11%)
Query: 535 DFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPL 594
+ G G+++ G G V +K + S+ +A+L E + ++ H RLV L
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 595 LGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLH 654
+ +++ +YM NG L L + L L +A AEG++++
Sbjct: 74 YAVVT--QEPIYIITEYMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIE 126
Query: 655 HECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS 714
++HRD++A++IL+ D ++ + + +R + ++ + +
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 715 GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV- 773
T T DV+ FG +L E+VT +PY + + E++ +
Sbjct: 184 YG-TFTIKSDVWSFGILLTEIVTHG-----------------RIPYPGMTNPEVIQNLER 225
Query: 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819
++ ++ EE++ + R C +P RP Y+ LE+
Sbjct: 226 GYRMVRPDNCPEELYQ---LMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 4e-37
Identities = 53/299 (17%), Positives = 102/299 (34%), Gaps = 29/299 (9%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENE 604
G G+++RG G V +K + ++ E+ + H ++ + +
Sbjct: 14 GRFGEVWRGKWRG-EEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 72
Query: 605 K---FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHEC---- 657
+LV Y +G L L R T + +K+A+ A GL++LH E
Sbjct: 73 WTQLWLVSDYHEHGSLFDYLNRYT--------VTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 658 -TLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRLPQS------ 708
HRD+++ +IL+ + L+ D + +
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 709 SEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEI-LEQTLPYISIYDKE 767
+ + + D+Y G V E+ D Q+ L + P + K
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 768 LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLKVVREEN 826
+ + + P++ E + MA + R C R I K L ++ ++E
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS---QLSQQEG 300
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 3e-36
Identities = 60/292 (20%), Positives = 118/292 (40%), Gaps = 40/292 (13%)
Query: 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHAR 590
G + I +G G +++G G V +K +++ + + +A+ E+ K H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGL 650
++ +G+ + +V ++ L L+ + I + IA A+G+
Sbjct: 66 ILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHIIET------KFEMIKLIDIARQTAQGM 117
Query: 651 SYLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQS---RITRLLRL 705
YLH + +HRD+++++I L + V++G L+ V ++ +HQ + L
Sbjct: 118 DYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 706 PQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYD 765
P+ + DVY FG VL EL+TG++ S ++
Sbjct: 175 PEVIRMQDKNPYSFQS--DVYAFGIVLYELMTGQLPYSNINNRDQ-------------II 219
Query: 766 KELVTKIVDPSLI-IDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816
+ + P L + + + + + CL K RPL IL ++E
Sbjct: 220 FMVGRGYLSPDLSKVRSNCPKAMKR---LMAECLKKKRDERPLFPQILASIE 268
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 5e-35
Identities = 58/287 (20%), Positives = 108/287 (37%), Gaps = 39/287 (13%)
Query: 535 DFSDANLIK---NGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARL 591
+ + L++ G GD+ G G V +K I + +A+L E +++ H+ L
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYRGN-KVAVKCIKNDATA-QAFLAEASVMTQLRHSNL 62
Query: 592 VPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLS 651
V LLG +E + ++V +YM G L L + L LK ++ E +
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAME 117
Query: 652 YLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQ 711
YL FVHRD+ A ++L+ + ++ ++ P E
Sbjct: 118 YLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAP---EA 171
Query: 712 GSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTK 771
+ DV+ FG +L E+ + +PY I K++V +
Sbjct: 172 LREKKFSTKS--DVWSFGILLWEIYSFGR-----------------VPYPRIPLKDVVPR 212
Query: 772 IV-DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817
+ + + V+ V ++C + RP + + LE+
Sbjct: 213 VEKGYKMDAPDGCPPAVYE---VMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (329), Expect = 3e-34
Identities = 60/325 (18%), Positives = 113/325 (34%), Gaps = 52/325 (16%)
Query: 522 ESFTYQQLLAATGDFSDA---------NLIKNGHSGDLFRGIL----EGGIPVVIKRIDL 568
+ FT++ A +F+ +I G G++ G L + I V IK +
Sbjct: 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS 64
Query: 569 QSVKT--EAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTN 626
+ +L E + H ++ L + + ++ ++M NG L S L +
Sbjct: 65 GYTEKQRRDFLSEASIMGQFDHPNVIHLE-GVVTKSTPVMIITEFMENGSLDSFLRQNDG 123
Query: 627 TEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686
I + + G A G+ YL +VHRD+ A +IL++ ++
Sbjct: 124 QFT------VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174
Query: 687 VCAQGGDAHQSRITRLLRLPQSSEQGSSGSLT---ATCPYDVYCFGKVLLELVTGKMGIS 743
D T L + ++ T DV+ +G V+ E+++
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG---- 230
Query: 744 ASSDAQVKEILEQTLPYISIYDKELVTKIV-DPSLIIDEDLLEEVWAMAIVARSCLNPKP 802
PY + +++++ I D L D + + C
Sbjct: 231 -------------ERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ---LMLDCWQKDR 274
Query: 803 TRRPLMRYILKALENPLKVVREENS 827
RP I+ L+ K++R NS
Sbjct: 275 NHRPKFGQIVNTLD---KMIRNPNS 296
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (324), Expect = 1e-33
Identities = 61/288 (21%), Positives = 119/288 (41%), Gaps = 32/288 (11%)
Query: 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVP 593
D + + + G G+++ G+ + + V +K + +++ E +L E ++ H LV
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 594 LLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL 653
LLG C E +++ ++M G+L L Q + + L +A + + YL
Sbjct: 78 LLGVCTR-EPPFYIITEFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYL 131
Query: 654 HHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGS 713
F+HRD+ A + L+ + V++ GD + + + ++ +
Sbjct: 132 EK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 714 SGSLTATCPYDVYCFGKVLLELVTGKMGISASSD-AQVKEILEQTLPYISIYDKELVTKI 772
+ + + DV+ FG +L E+ T M D +QV E+LE+
Sbjct: 189 AYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---------------- 231
Query: 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820
D + E E+V+ + R+C P+ RP I +A E +
Sbjct: 232 -DYRMERPEGCPEKVYE---LMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-33
Identities = 61/286 (21%), Positives = 110/286 (38%), Gaps = 35/286 (12%)
Query: 535 DFSDANLIK---NGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARL 591
D S+ ++ +G G + G V IK I ++ E ++ E + K+SH +L
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 592 VPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLS 651
V L G C+E + LV+++M +G LS L + T L + + EG++
Sbjct: 63 VQLYGVCLE-QAPICLVFEFMEHGCLSDYLRTQRGLF------AAETLLGMCLDVCEGMA 115
Query: 652 YLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC-AQGGDAHQSRITRLLRLPQSSE 710
YL C +HRD+ A + L+ + +++ S T+ S E
Sbjct: 116 YLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 711 QGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770
S ++ DV+ FG ++ E+ + +PY + + E+V
Sbjct: 173 VFSFSRYSSKS--DVWSFGVLMWEVFSEG-----------------KIPYENRSNSEVVE 213
Query: 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816
I + L + + C +P RP +L+ L
Sbjct: 214 DISTGFRLYKPRLAST--HVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-32
Identities = 57/287 (19%), Positives = 111/287 (38%), Gaps = 32/287 (11%)
Query: 535 DFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPL 594
+ G G+++ G G V IK + ++ EA+L E K+ H +LV L
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 595 LGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLH 654
E ++V +YM G L L +T + L + +A A G++Y+
Sbjct: 78 YAVVS--EEPIYIVTEYMSKGSLLDFLKGETG-----KYLRLPQLVDMAAQIASGMAYVE 130
Query: 655 HECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS 714
+VHRD++A++IL+ + ++ + + +R + ++ + +
Sbjct: 131 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 715 GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV- 773
T DV+ FG +L EL T +PY + ++E++ ++
Sbjct: 188 YG-RFTIKSDVWSFGILLTELTTKG-----------------RVPYPGMVNREVLDQVER 229
Query: 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820
+ + E + + C +P RP Y+ LE+
Sbjct: 230 GYRMPCPPECPESLHD---LMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 9e-32
Identities = 61/287 (21%), Positives = 105/287 (36%), Gaps = 34/287 (11%)
Query: 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKT---EAYLLELDFFSKVSHAR 590
D+ I G G + G +V K +D S+ + + E++ ++ H
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 591 LVPLLGHCMERENEK-FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEG 649
+V ++R N ++V +Y GDL+S + + T Q LD L++
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER---QYLDEEFVLRVMTQLTLA 121
Query: 650 LSYLH--HECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQ 707
L H + +HRD++ +++ LD K V+LG D ++
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 708 SSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKE 767
S EQ + S D++ G +L EL P+ + KE
Sbjct: 182 SPEQMNRMSYNEKS--DIWSLGCLLYELCALMP------------------PFTAFSQKE 221
Query: 768 LVTKIVDPSLI-IDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
L KI + I +E+ + LN K RP + IL+
Sbjct: 222 LAGKIREGKFRRIPYRYSDELNE---IITRMLNLKDYHRPSVEEILE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 1e-31
Identities = 59/287 (20%), Positives = 107/287 (37%), Gaps = 35/287 (12%)
Query: 535 DFSDANLIK---NGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARL 591
D D +K G G + G G V IK I S+ + ++ E +SH +L
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 592 VPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLS 651
V L G C + + F++ +YM NG L + L + L++ E +
Sbjct: 62 VQLYGVCTK-QRPIFIITEYMANGCLLNYLREMRHR------FQTQQLLEMCKDVCEAME 114
Query: 652 YLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSS-E 710
YL + F+HRD+ A + L++D+ V++ D + S + + S E
Sbjct: 115 YLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171
Query: 711 QGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770
++ D++ FG ++ E+ + +PY + E
Sbjct: 172 VLMYSKFSSKS--DIWAFGVLMWEIYSLG-----------------KMPYERFTNSETAE 212
Query: 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817
I + L E + + SC + K RP + +L + +
Sbjct: 213 HIAQGLRLYRPHLASE--KVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 4e-31
Identities = 68/304 (22%), Positives = 113/304 (37%), Gaps = 47/304 (15%)
Query: 535 DFSDANLIKNGHSGDLFRGILEGG---IPVVIKRIDLQSVKT--EAYLLELDFFSKVS-H 588
D ++I G+ G + + ++ + IKR+ + K + EL+ K+ H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 589 ARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDL---------QSLDWITR 639
++ LLG C E +L +Y P+G+L L + E D +L
Sbjct: 71 PNIINLLGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 640 LKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQS 697
L A A G+ YL F+HRD+ A +IL+ + + ++ LS
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 698 RITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQT 757
R+ +S T DV+ +G +L E+V+
Sbjct: 187 RLPVRWMAIESLNYS-----VYTTNSDVWSYGVLLWEIVSLGG----------------- 224
Query: 758 LPYISIYDKELVTKIV-DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816
PY + EL K+ L + +EV+ + R C KP RP IL +L
Sbjct: 225 TPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYD---LMRQCWREKPYERPSFAQILVSLN 281
Query: 817 NPLK 820
L+
Sbjct: 282 RMLE 285
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 7e-31
Identities = 53/311 (17%), Positives = 113/311 (36%), Gaps = 41/311 (13%)
Query: 527 QQLLAATGDFSDANL-IKNGHSGDLFRGIL---EGGIPVVIKRIDLQSVK--TEAYLLEL 580
++L + A++ + G+ G + +G+ + I V IK + + K TE + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 581 DFFSKVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRL 640
++ + +V L+G C + LV + G L L K + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVA 112
Query: 641 KIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSR 698
++ + G+ YL + FVHRD+ A ++LL ++ ++ LS+ + +R
Sbjct: 113 ELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169
Query: 699 ITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTL 758
L + + + + DV+ +G + E ++
Sbjct: 170 SAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYG-----------------QK 211
Query: 759 PYISIYDKELVTKIVD-PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817
PY + E++ I + + E++A + C K RP + + +
Sbjct: 212 PYKKMKGPEVMAFIEQGKRMECPPECPPELYA---LMSDCWIYKWEDRPDFLTVEQRMRA 268
Query: 818 PLKVVREENSG 828
+ + G
Sbjct: 269 CYYSLASKVEG 279
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 7e-31
Identities = 58/295 (19%), Positives = 108/295 (36%), Gaps = 36/295 (12%)
Query: 540 NLIKNGHSGDLFRGILEG----GIPVVIKRIDLQS--VKTEAYLLELDFFSKVSHARLVP 593
+I GH G ++ G L I +K ++ + + +L E SH ++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 594 LLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL 653
LLG C+ E +V YM +GDL + + +T + + + A+G +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKG---M 143
Query: 654 HHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRLPQSSEQ 711
+ FVHRD+ A + +LD+KF V++ L+ T +
Sbjct: 144 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 712 GSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTK 771
S + T DV+ FG +L EL+T PY + ++
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRG-----------------APPYPDVNTFDITVY 246
Query: 772 IVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLKVVREEN 826
++ ++ + + + V C +PK RP ++ + E+
Sbjct: 247 LLQGRRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 4e-30
Identities = 46/298 (15%), Positives = 100/298 (33%), Gaps = 44/298 (14%)
Query: 538 DANLIKNGHSGDLFRGILEG---GIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARL 591
+ + +G+ G + +G + V +K + ++ + L E + ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 592 VPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLS 651
V ++G C LV + G L+ L + + + +++ + G+
Sbjct: 71 VRMIGICEA--ESWMLVMEMAELGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMK 121
Query: 652 YLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLP---QS 708
YL FVHRD+ A ++LL + ++ A D + + + P +
Sbjct: 122 YLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 709 SEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768
E + ++ DV+ FG ++ E + PY + E+
Sbjct: 179 PECINYYKFSSKS--DVWSFGVLMWEAFSYG-----------------QKPYRGMKGSEV 219
Query: 769 VTKIV-DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLKVVREE 825
+ + E++ + C RP + L N V E
Sbjct: 220 TAMLEKGERMGCPAGCPREMYD---LMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (297), Expect = 5e-30
Identities = 58/311 (18%), Positives = 105/311 (33%), Gaps = 54/311 (17%)
Query: 535 DFSDANLIKNGHSGDLFRGILEG------GIPVVIKRIDLQSVK--TEAYLLELDFFSKV 586
+ I G G +F+ G V +K + ++ + E ++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 587 SHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLY-----------------RKTNTED 629
+ +V LLG L+++YM GDL+ L R +
Sbjct: 74 DNPNIVKLLG-VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 630 DLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEV 687
L +L IA A G++YL FVHRD+ + L+ + V++ LS
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 688 CAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSD 747
+ E T DV+ +G VL E+ + +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTES--DVWAYGVVLWEIFSYGL------- 240
Query: 748 AQVKEILEQTLPYISIYDKELVTKIVDPSLI-IDEDLLEEVWAMAIVARSCLNPKPTRRP 806
PY + +E++ + D +++ E+ E++ + R C + P RP
Sbjct: 241 ----------QPYYGMAHEEVIYYVRDGNILACPENCPLELYN---LMRLCWSKLPADRP 287
Query: 807 LMRYILKALEN 817
I + L+
Sbjct: 288 SFCSIHRILQR 298
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 8e-30
Identities = 49/275 (17%), Positives = 98/275 (35%), Gaps = 35/275 (12%)
Query: 545 GHSGDLFRGI-LEGGIPVVIKRIDLQSVKT-EAYLLELDFFSKVSHARLVPLLGHCMERE 602
G G +++ E + K ID +S + E Y++E+D + H +V LL E
Sbjct: 23 GAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-E 81
Query: 603 NEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFV 662
N +++ ++ G + + + + L + + L+YLH +
Sbjct: 82 NNLWILIEFCAGGAVDAVMLELE------RPLTESQIQVVCKQTLDALNYLHD---NKII 132
Query: 663 HRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLL-RLPQSSEQGSSGSLTA 719
HRD++A +IL +++L +S + S I P+ +S
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 192
Query: 720 TCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTLPYISIYDKELVTKIVDPSLI 778
DV+ G L+E+ + + +V +I + P ++ + +
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR------WSSNFK 246
Query: 779 IDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
D L + CL R +L+
Sbjct: 247 ---DFL----------KKCLEKNVDARWTTSQLLQ 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-29
Identities = 55/298 (18%), Positives = 115/298 (38%), Gaps = 36/298 (12%)
Query: 535 DFSDANLIKNGHSGDLFRGILEG------GIPVVIKRIDLQSVKTE--AYLLELDFFSKV 586
+ + + G G ++ G+ +G V IK ++ + E +L E +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 587 SHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLY---RKTNTEDDLQSLDWITRLKIA 643
+ +V LLG + ++ + M GDL S L L +++A
Sbjct: 81 NCHHVVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 644 IGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLL 703
A+G++YL+ FVHRD+ A + ++ + F V++G + + + L
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 704 RLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISI 763
+ S T DV+ FG VL E+ T PY +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----------------QPYQGL 239
Query: 764 YDKELVTKIVDPSLI-IDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820
+++++ +++ L+ ++ + ++ + R C P RP I+ +++ ++
Sbjct: 240 SNEQVLRFVMEGGLLDKPDNCPDMLFE---LMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (290), Expect = 7e-29
Identities = 60/285 (21%), Positives = 97/285 (34%), Gaps = 42/285 (14%)
Query: 536 FSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKT----EAYLLELDFFSKVSHAR 590
FSD I +G G ++ + V IK++ ++ + + E+ F K+ H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGL 650
+ G RE+ +LV +Y K + L + + GA +GL
Sbjct: 77 TIQYRGCY-LREHTAWLVMEYCLGSASDLLEVHK-------KPLQEVEIAAVTHGALQGL 128
Query: 651 SYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSE 710
+YLH +HRDV+A +ILL + V+LG + A+ T P+
Sbjct: 129 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANSFVGTPYWMAPEVIL 184
Query: 711 QGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770
G DV+ G +EL K P ++ +
Sbjct: 185 AMDEGQYDGKV--DVWSLGITCIELAERK------------------PPLFNMNAMSALY 224
Query: 771 KIV--DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
I + + E SCL P RP +LK
Sbjct: 225 HIAQNESPALQSGHWSEYFRNF---VDSCLQKIPQDRPTSEVLLK 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 7e-29
Identities = 59/308 (19%), Positives = 114/308 (37%), Gaps = 46/308 (14%)
Query: 535 DFSDANLIKNGHSGDLFRGILEG------GIPVVIKRIDLQSVKT--EAYLLELDFFSKV 586
S + G G + G + V +K + + T EA + EL S +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 587 S-HARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNT-----------EDDLQSL 634
H +V LLG C ++ +Y GDL + L RK ++ EDD +L
Sbjct: 84 GNHMNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 635 DWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDA 694
D L + A+G+++L + +HRD+ A +ILL ++ D+
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 695 HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGK--MGISASSDAQVKE 752
+ + S + T DV+ +G L EL + D++ +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 753 ILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYIL 812
++++ ++ E E++ + ++C + P +RP + I+
Sbjct: 260 MIKEGFR-----------------MLSPEHAPAEMYD---IMKTCWDADPLKRPTFKQIV 299
Query: 813 KALENPLK 820
+ +E +
Sbjct: 300 QLIEKQIS 307
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 6e-28
Identities = 62/314 (19%), Positives = 111/314 (35%), Gaps = 55/314 (17%)
Query: 535 DFSDANLIKNGHSGDLFRGILEG------GIPVVIKRIDLQSVKTE--AYLLELDFFSKV 586
+ ++ +G G + G I V +K + ++ +E A + EL +++
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 587 -SHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRK----------------TNTED 629
SH +V LLG C +L+++Y GDL + L K E+
Sbjct: 98 GSHENIVNLLGACTL-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 630 DLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEV 687
DL L + L A A+G+ +L + VHRD+ A ++L+ V++ L+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 688 CAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSD 747
+ RL + E G T V+ +G +L E+ +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSD--VWSYGILLWEIFSLG-------- 263
Query: 748 AQVKEILEQTLPYISIYDKELVTKIVD--PSLIIDEDLLEEVWAMAIVARSCLNPKPTRR 805
PY I K++ + EE++ + +SC +R
Sbjct: 264 ---------VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYI---IMQSCWAFDSRKR 311
Query: 806 PLMRYILKALENPL 819
P + L L
Sbjct: 312 PSFPNLTSFLGCQL 325
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-27
Identities = 51/307 (16%), Positives = 104/307 (33%), Gaps = 44/307 (14%)
Query: 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKT--EAYLLELDFFSKVSHARL 591
DF + + G+ G +F+ G+ + K I L+ + EL + + +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 592 VPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLS 651
V G + E + ++M G L L + + K++I +GL+
Sbjct: 67 VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLT 118
Query: 652 YLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRLPQSS 709
YL + +HRDV+ S+IL++ + E++L +S A+ TR P
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSP--- 172
Query: 710 EQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELV 769
E+ + D++ G L+E+ G+ I +++ + + +
Sbjct: 173 ERLQGTHYSVQS--DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230
Query: 770 TKIVDPSLIIDEDLLEEVWAMAIVA-----------------------RSCLNPKPTRRP 806
P D + ++ CL P R
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290
Query: 807 LMRYILK 813
++ ++
Sbjct: 291 DLKQLMV 297
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-27
Identities = 50/286 (17%), Positives = 97/286 (33%), Gaps = 37/286 (12%)
Query: 534 GDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHAR 590
D+ + G G++ + V +K +D++ E E+ ++H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGL 650
+V GH N ++L +Y G+L + + + G+
Sbjct: 65 VVKFYGHR-REGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGV 116
Query: 651 SYLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRLPQS 708
YLH HRD++ ++LLD++ +++ L+ V +
Sbjct: 117 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173
Query: 709 SEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSD-AQVKEILEQTLPYISIYDKE 767
E P DV+ G VL ++ G++ SD Q ++ Y++ + K
Sbjct: 174 PELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK- 231
Query: 768 LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
+D + + LL L P+ R + I K
Sbjct: 232 -----IDSAPL---ALL----------HKILVENPSARITIPDIKK 259
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-26
Identities = 53/296 (17%), Positives = 110/296 (37%), Gaps = 39/296 (13%)
Query: 535 DFSDANLIKNGHSGDLFRGILEGG-----IPVVIKRIDLQSVKTE--AYLLELDFFSKVS 587
+ +I G G++++G+L+ +PV IK + + + +L E + S
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 588 HARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAA 647
H ++ L G + ++ +YM NG L L K + + + G A
Sbjct: 68 HHNIIRLEGVISK-YKPMMIITEYMENGALDKFLREKDGE------FSVLQLVGMLRGIA 120
Query: 648 EGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRL 705
G+ + + +VHRD+ A +IL++ ++ LS V +A + + +
Sbjct: 121 AGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 706 PQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYD 765
++ + S + DV+ FG V+ E++T
Sbjct: 178 RWTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGE------------------RPYWELS 218
Query: 766 KELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLKV 821
V K ++ + ++ A+ + C + RRP I+ L+ ++
Sbjct: 219 NHEVMKAINDGFRLPTP-MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-26
Identities = 58/294 (19%), Positives = 106/294 (36%), Gaps = 44/294 (14%)
Query: 535 DFSDANLIKNGHSGDLFRGILEG----GIPVVIKRIDLQSVKT----EAYLLELDFFSKV 586
D + +G G + RG + + V +K + + + ++ E++ +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 587 SHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGA 646
H L+ L G + +V + P G L L + T + A+
Sbjct: 69 DHRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLRKHQG------HFLLGTLSRYAVQV 120
Query: 647 AEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLR 704
AEG+ YL + F+HRD+ A ++LL + V++G L Q D + + R +
Sbjct: 121 AEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 705 LPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIY 764
+ + T + D + FG L E+ T P+I +
Sbjct: 178 FAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYG-----------------QEPWIGLN 219
Query: 765 DKELVTKIV--DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816
+++ KI L ED ++++ V C KP RP + L
Sbjct: 220 GSQILHKIDKEGERLPRPEDCPQDIYN---VMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 4e-26
Identities = 45/286 (15%), Positives = 99/286 (34%), Gaps = 40/286 (13%)
Query: 533 TGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLL-ELDFFSKVSHAR 590
++ I G SG ++ + + G V I++++LQ + ++ E+ + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGL 650
+V L + +E ++V +Y+ G L+ + E + + L
Sbjct: 79 IVNYLDSYLV-GDELWVVMEYLAGGSLTDVVTETCMDEGQ--------IAAVCRECLQAL 129
Query: 651 SYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSE 710
+LH +HRD+++ +ILL V+L + + + E
Sbjct: 130 EFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 711 QGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770
+ + D++ G + +E++ G+ PY++ +
Sbjct: 187 VVTRKAYGPKV--DIWSLGIMAIEMIEGE------------------PPYLNENPLRALY 226
Query: 771 KIV---DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
I P L E L CL+ +R + +L+
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDF---LNRCLDMDVEKRGSAKELLQ 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 4e-26
Identities = 44/287 (15%), Positives = 103/287 (35%), Gaps = 39/287 (13%)
Query: 545 GHSGDLFRGILEGGIPVVIKRIDLQSVKTEA--YLLELDFFSKVSHARLVPLLGHCMERE 602
+ L + V +K + + + + + E++ + + + L ++
Sbjct: 32 AEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91
Query: 603 NEKFLVYKYMPNGDLSSSL---------YRKTNTEDDLQSLDWITRLKIAIGAAEGLSYL 653
+++ +Y G+L L Y + + + L + A A G+ YL
Sbjct: 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 151
Query: 654 HHECTLPFVHRDVQASSILLDDKFEVRLGS--LSEVCAQGGDAHQSRITRLLRLPQSSEQ 711
+ +HRD+ A ++L+ + +++ L+ ++ RL + E
Sbjct: 152 ASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEA 208
Query: 712 GSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTK 771
T DV+ FG +L E+ T PY + +EL
Sbjct: 209 LFDRIYTHQS--DVWSFGVLLWEIFTLG-----------------GSPYPGVPVEELFKL 249
Query: 772 IVD-PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817
+ + + + E++ + R C + P++RP + +++ L+
Sbjct: 250 LKEGHRMDKPSNCTNELYM---MMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 6e-26
Identities = 46/284 (16%), Positives = 95/284 (33%), Gaps = 41/284 (14%)
Query: 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEA----YLLELDFFSKVSHA 589
DF + G G+++ + + +K + ++ E++ S + H
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 590 RLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEG 649
++ L G+ + +L+ +Y P G + L + + D A
Sbjct: 67 NILRLYGYFHD-ATRVYLILEYAPLGTVYRELQKLSK-------FDEQRTATYITELANA 118
Query: 650 LSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSS 709
LSY H +HRD++ ++LL E+++ + L LP
Sbjct: 119 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLP--P 173
Query: 710 EQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELV 769
E D++ G + E + GK P+ + +E
Sbjct: 174 EMIEGRMHDEKV--DLWSLGVLCYEFLVGK------------------PPFEANTYQETY 213
Query: 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
+I + + E + L P++RP++R +L+
Sbjct: 214 KRISRVEFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVLE 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-25
Identities = 52/296 (17%), Positives = 105/296 (35%), Gaps = 43/296 (14%)
Query: 535 DFSDANLIKNGHSGDLFRGIL-----EGGIPVVIKRIDLQSVK--TEAYLLELDFFSKVS 587
+F ++ +G G +++G+ + IPV IK + + + L E + V
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 588 HARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAA 647
+ + LLG C+ + L+ + MP G L + + L + A
Sbjct: 70 NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIG------SQYLLNWCVQIA 121
Query: 648 EGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRL 705
+G++YL VHRD+ A ++L+ V++ L+++ + + ++
Sbjct: 122 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 706 PQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIY 764
+ E T DV+ +G + EL+T G +++ ILE+
Sbjct: 179 WMALESILHRIYTHQS--DVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------- 228
Query: 765 DKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820
L +V+ + C RP R ++ +
Sbjct: 229 ---------GERLPQPPICTIDVYM---IMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 1e-25
Identities = 47/281 (16%), Positives = 95/281 (33%), Gaps = 47/281 (16%)
Query: 545 GHSGDLFRGIL-EGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCM- 599
G +++G+ E + V + + + + + + E + + H +V
Sbjct: 20 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 79
Query: 600 --ERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHEC 657
+ + LV + M +G L + L R + + +GL +LH
Sbjct: 80 TVKGKKCIVLVTELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 658 TLPFVHRDVQASSILLDDK-FEVRLGSLSEVCAQGGDAHQSRI-TRLLRLPQSSEQGSSG 715
P +HRD++ +I + V++G L + ++ I T P+ E+
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK--- 188
Query: 716 SLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV-- 773
DVY FG +LE+ T + PY + + + V
Sbjct: 189 ---YDESVDVYAFGMCMLEMATSE------------------YPYSECQNAAQIYRRVTS 227
Query: 774 -DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
D+ + EV + C+ R ++ +L
Sbjct: 228 GVKPASFDKVAIPEVKE---IIEGCIRQNKDERYSIKDLLN 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 2e-25
Identities = 59/296 (19%), Positives = 110/296 (37%), Gaps = 46/296 (15%)
Query: 541 LIKNGHSGDLFRGIL----EGGIPVVIKRIDLQSVKT--EAYLLELDFFSKVSHARLVPL 594
I G GD+ +GI + V IK + + E +L E + H +V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 595 LGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLH 654
+G E N +++ + G+L S L + SLD + + A + L+YL
Sbjct: 74 IGVITE--NPVWIIMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLE 125
Query: 655 HECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRLPQSSEQG 712
+ FVHRD+ A ++L+ V+LG LS S+ ++
Sbjct: 126 SKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 713 SSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772
T DV+ FG + E++ P+ + + +++ +I
Sbjct: 183 FRR---FTSASDVWMFGVCMWEILMHG-----------------VKPFQGVKNNDVIGRI 222
Query: 773 VD-PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLKVVREENS 827
+ L + + +++ + C P+RRP + L ++ EE +
Sbjct: 223 ENGERLPMPPNCPPTLYS---LMTKCWAYDPSRRPRFTELKAQLS---TILEEEKA 272
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 104 bits (260), Expect = 3e-25
Identities = 57/295 (19%), Positives = 94/295 (31%), Gaps = 45/295 (15%)
Query: 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKT----------EAYLLELDFF 583
++ ++ G S + R I +K ID+ + EA L E+D
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 584 SKVS-HARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKI 642
KVS H ++ L E FLV+ M G+L L K +L KI
Sbjct: 64 RKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKI 115
Query: 643 AIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRIT 700
E + LH L VHRD++ +ILLDD ++L S G + T
Sbjct: 116 MRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGT 172
Query: 701 RLLRLP-QSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLP 759
P + D++ G ++ L+ G P
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------------------PP 214
Query: 760 YISIYDKELVTKIVDPSLIIDEDLLEEVWAMAI-VARSCLNPKPTRRPLMRYILK 813
+ ++ I+ + ++ + L +P +R L
Sbjct: 215 FWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 105 bits (263), Expect = 5e-25
Identities = 44/280 (15%), Positives = 95/280 (33%), Gaps = 40/280 (14%)
Query: 541 LIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLL-ELDFFSKVSHARLVPLLGHC 598
+ +G G + R + G V K I+ + + E+ +++ H +L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 599 MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECT 658
+ + E L+ +++ G+L + + + + A EGL ++H
Sbjct: 96 ED-KYEMVLILEFLSGGELFDRIAAED------YKMSEAEVINYMRQACEGLKHMHE--- 145
Query: 659 LPFVHRDVQASSILLDDKFEVRLG----SLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS 714
VH D++ +I+ + K + L+ + T P+ ++
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP- 204
Query: 715 GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVD 774
D++ G + L++G P+ D E + +
Sbjct: 205 ----VGFYTDMWAIGVLGYVLLSGL------------------SPFAGEDDLETLQNVKR 242
Query: 775 PSLIIDEDLLEEVWAMAI-VARSCLNPKPTRRPLMRYILK 813
DED V A ++ L +P +R + L+
Sbjct: 243 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 5e-25
Identities = 57/303 (18%), Positives = 108/303 (35%), Gaps = 47/303 (15%)
Query: 540 NLIKNGHSGDLFRGILEG------GIPVVIKRIDLQSVKTE--AYLLELDFFSKVSHAR- 590
+ G G + G V +K + + +E A + EL + H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQS---------LDWITRLK 641
+V LLG C + ++ ++ G+LS+ L K N + L +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 642 IAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRI 699
+ A+G+ +L +HRD+ A +ILL +K V++ L+ + D +
Sbjct: 139 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 700 TRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLP 759
RL + E T DV+ FG +L E+ + P
Sbjct: 196 ARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGA-----------------SP 236
Query: 760 YISIYDKELVTKIV--DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817
Y + E + + + + E++ C + +P++RP +++ L N
Sbjct: 237 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ---TMLDCWHGEPSQRPTFSELVEHLGN 293
Query: 818 PLK 820
L+
Sbjct: 294 LLQ 296
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 1e-24
Identities = 49/289 (16%), Positives = 96/289 (33%), Gaps = 41/289 (14%)
Query: 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHA 589
DF ++ G + L IK ++ + + K E D S++ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 590 RLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEG 649
V L + + + + Y NG+L + + S D
Sbjct: 69 FFVKLYFTFQD-DEKLYFGLSYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSA 120
Query: 650 LSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQ-- 707
L YLH + +HRD++ +ILL++ +++ ++ Q+R + Q
Sbjct: 121 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 708 SSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKE 767
S E + S + D++ G ++ +LV G P+ + +
Sbjct: 178 SPELLTEKSACKSS--DLWALGCIIYQLVAGL------------------PPFRAGNEYL 217
Query: 768 LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALE 816
+ KI+ E + A +V + L T+R +
Sbjct: 218 IFQKIIKLEYDFPEKFFPK--ARDLVEK-LLVLDATKRLGCEEMEGYGP 263
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 104 bits (259), Expect = 1e-24
Identities = 59/341 (17%), Positives = 115/341 (33%), Gaps = 45/341 (13%)
Query: 541 LIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLL-ELDFFSKVSHARLVPLLGHC 598
+ G G + R G K + + + E+ S + H LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 599 MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECT 658
E +NE ++Y++M G+L + + N + ++ +GL ++H
Sbjct: 93 -EDDNEMVMIYEFMSGGELFEKVADEHN------KMSEDEAVEYMRQVCKGLCHMHENN- 144
Query: 659 LPFVHRDVQASSILLDDKF--EVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGS 716
+VH D++ +I+ K E++L + A ++T + E
Sbjct: 145 --YVHLDLKPENIMFTTKRSNELKLIDFG-LTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 201
Query: 717 LTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDPS 776
+ D++ G + L++G P+ D E + +
Sbjct: 202 VGYYT--DMWSVGVLSYILLSGL------------------SPFGGENDDETLRNVKSCD 241
Query: 777 LIIDEDLLEEVWAMAI-VARSCLNPKPTRRPLMRYILKALENPLKVVREENSGSARLRTT 835
+D+ + R L P R + +ALE+P + N+ +
Sbjct: 242 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIH---QALEHPW--LTPGNAPGRDSQIP 296
Query: 836 SSRGSWNAALFGSWRQSSSDVAAIPVPPNTKAEGTSSLKQS 876
SSR ++ D P+PP + SSL++
Sbjct: 297 SSR----YTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKH 333
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (253), Expect = 3e-24
Identities = 48/296 (16%), Positives = 94/296 (31%), Gaps = 47/296 (15%)
Query: 541 LIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCM 599
I +G GD++ G + G V IK +++ K +E + + +P + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 600 ERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTL 659
+ +V + + + + T L +A + Y+H +
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCS-------RKFSLKTVLLLADQMISRIEYIHSKN-- 123
Query: 660 PFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTA 719
F+HRDV+ + L+ + L D ++ R R Q + +LT
Sbjct: 124 -FIHRDVKPDNFLMGLGKKGNL-------VYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 720 TCPY---------------DVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIY 764
T Y D+ G VL+ G + A ++ E+
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK---- 231
Query: 765 DKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820
K+ P ++ + E C + + +P Y+ + N
Sbjct: 232 ------KMSTPIEVLCKGYPSEFATYL---NFCRSLRFDDKPDYSYLRQLFRNLFH 278
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 4e-24
Identities = 33/279 (11%), Positives = 88/279 (31%), Gaps = 39/279 (13%)
Query: 541 LIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCM 599
+ G G + R + + K + ++ E+ + H ++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF- 70
Query: 600 ERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTL 659
E E ++++++ D+ + L+ + E L +LH
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAF------ELNEREIVSYVHQVCEALQFLHS---H 121
Query: 660 PFVHRDVQASSILLDDKFEVRLG----SLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSG 715
H D++ +I+ + + + G + P+ +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD--- 178
Query: 716 SLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVDP 775
+ D++ G ++ L++G P+++ +++++ I++
Sbjct: 179 --VVSTATDMWSLGTLVYVLLSGI------------------NPFLAETNQQIIENIMNA 218
Query: 776 SLIIDEDLLEEVWAMAI-VARSCLNPKPTRRPLMRYILK 813
DE+ +E+ A+ L + R L+
Sbjct: 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (251), Expect = 2e-23
Identities = 51/280 (18%), Positives = 85/280 (30%), Gaps = 40/280 (14%)
Query: 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAY-------LLELDFFSKV 586
DFS +I G G+++ + G +K +D + +K + + L S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 587 SHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGA 646
+V + ++ + M GDL L + A
Sbjct: 65 DCPFIVCMSYAFHT-PDKLSFILDLMNGGDLHYHLSQHGVF-------SEADMRFYAAEI 116
Query: 647 AEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLP 706
GL ++H+ V+RD++ ++ILLD+ VR+ L C + +
Sbjct: 117 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGY 171
Query: 707 QSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDK 766
+ E G D + G +L +L+ G EI TL
Sbjct: 172 MAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 230
Query: 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP 806
P L LL L RR
Sbjct: 231 S-----FSPELR---SLL----------EGLLQRDVNRRL 252
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 98.2 bits (243), Expect = 6e-23
Identities = 58/291 (19%), Positives = 99/291 (34%), Gaps = 11/291 (3%)
Query: 151 SCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSF 210
CS G+ + L L +N +T L L L L N ++ P +F
Sbjct: 16 QCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75
Query: 211 GLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLS 270
L L L +S N L TL +L+ + S+ L +V+L +
Sbjct: 76 APLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN-QMIVVELGTN 134
Query: 271 MNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDV 330
SG +G++ L I + ++ + L P L + L N T
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP---SLTELHLDGNKITKVDAAS 190
Query: 331 LWSMPQLRLLDISRNNFTGPLPNSRSNVNT-STVELNISQNMFYGGLTPVLGRFRLVDLS 389
L + L L +S N+ + S +N + LN ++ + G ++V L
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH 250
Query: 390 GNYFEG-----RVPEYVHSNASSLDSNCLQNVPNQRTLVDCSSFYAARGLS 435
N P ++ +S L + P Q + S+F +
Sbjct: 251 NNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 301
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.2 bits (217), Expect = 2e-19
Identities = 54/245 (22%), Positives = 100/245 (40%), Gaps = 10/245 (4%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSV 191
I D + L L L L + IS + P + L L LYLS N L +P + +
Sbjct: 45 EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--T 101
Query: 192 LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYL--TGSIPPGLGTLSKLQYLNVSNNS 249
L L + N +T + F L + +++ +N L +G + KL Y+ +++ +
Sbjct: 102 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161
Query: 250 LASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPT 309
+ ++IP L SL +L L N ++ + L+GL +L K + N +S
Sbjct: 162 I-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV-DNGSLAN 217
Query: 310 VSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQ 369
L+ + L N P + ++++ + NN + N +T + + S
Sbjct: 218 TPHLRELHLNNNKLVKVPGGL-ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 276
Query: 370 NMFYG 374
+
Sbjct: 277 VSLFS 281
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 96.0 bits (238), Expect = 3e-22
Identities = 44/296 (14%), Positives = 75/296 (25%), Gaps = 45/296 (15%)
Query: 541 LIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCM 599
I G G +F G L V IK +S E + ++ +P + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 600 ERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTL 659
+ LV + G L + T A + +H
Sbjct: 71 QEGLHNVLVIDLL--GPSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHE---K 120
Query: 660 PFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTA 719
V+RD++ + L+ D + R Q +L+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNAN-----MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 720 TCPY---------------DVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIY 764
T Y D+ G V + + G + A K+ Y
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ----------KY 225
Query: 765 DKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820
++ K P + EE N P Y+ L+
Sbjct: 226 ERIGEKKQSTPLRELCAGFPEE---FYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 95.9 bits (238), Expect = 4e-22
Identities = 41/280 (14%), Positives = 87/280 (31%), Gaps = 37/280 (13%)
Query: 540 NLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLG 596
+++ G ++ V IK I +++ K + E+ K+ H +V L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 597 HCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHE 656
E +L+ + + G+L + K ++ + + YLH
Sbjct: 75 IY-ESGGHLYLIMQLVSGGELFDRIVEK-------GFYTERDASRLIFQVLDAVKYLHDL 126
Query: 657 CTLPFVHRDVQASSILLDDKFEVRLGS--LSEVCAQGGDAHQSRITRLLRLPQSSEQGSS 714
+ + LD+ ++ + LS++ G + T P+ Q
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP- 185
Query: 715 GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVD 774
+ D + G + L+ G P+ D +L +I+
Sbjct: 186 ----YSKAVDCWSIGVIAYILLCGY------------------PPFYDENDAKLFEQILK 223
Query: 775 PSLIIDEDLLEEVWAMAI-VARSCLNPKPTRRPLMRYILK 813
D +++ A R + P +R L+
Sbjct: 224 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 1e-21
Identities = 67/351 (19%), Positives = 125/351 (35%), Gaps = 41/351 (11%)
Query: 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVP 593
++D +I NG G +++ L + G V IK++ EL K+ H +V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 77
Query: 594 LLGHCMERENEK-----FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAE 648
L +K LV Y+P + + Q+L I
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK----QTLPVIYVKLYMYQLFR 133
Query: 649 GLSYLHHECTLPFVHRDVQASSILLDDKFE---VRLGSLSEVCAQGGDAHQSRITRLLRL 705
L+Y+H HRD++ ++LLD + ++ +G + ++ +
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSYICSR 186
Query: 706 PQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSD-AQVKEILEQTLPYISIY 764
+ + G+ T DV+ G VL EL+ G+ S Q+ EI++
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 765 DKELVTKIVDPSL--IIDEDLLEEVW------AMAIVARSCLNPKPTRRPLMRYILKALE 816
+E+ + I + A+A+ +R L PT R +A
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR-LLEYTPTARLTPL---EACA 302
Query: 817 NP-LKVVREENSGSARLRTTSSRGSWNAALFGSWRQSSSDVAAIPVPPNTK 866
+ +R+ N R T + ++ S+ +A I +PP+ +
Sbjct: 303 HSFFDELRDPNVKLPNGRDTPALFNFTT----QELSSNPPLATILIPPHAR 349
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 95.5 bits (236), Expect = 2e-21
Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 33/213 (15%)
Query: 104 QNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLG 163
N L LT+L S A+ + P + L L L + +L
Sbjct: 184 SNKVSDISVLAKLTNLESLIATNNQISDITPLGIL---TNLDELSLNGNQLKD--IGTLA 238
Query: 164 NLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIP---------------- 207
+LTNLT L L++N ++ P L L+ L+ L L N ++ P
Sbjct: 239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ 296
Query: 208 ----TSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDS 263
+ LKNL+ L + N ++ P + +L+KLQ L +NN + S + L +L +
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV--SDVSSLANLTN 352
Query: 264 LVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNN 296
+ L N +S P L L + + + +
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 85.8 bits (211), Expect = 2e-18
Identities = 51/235 (21%), Positives = 89/235 (37%), Gaps = 42/235 (17%)
Query: 136 WLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVL 195
+ +L L++L + IS + P LTNL L L+ N L +L L+ L+ L
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDL 246
Query: 196 DLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIP 255
DL+ N ++ P L L+ L + +N ++ P L L+ L L ++ N
Sbjct: 247 DLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ--LEDI 300
Query: 256 AQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQI 315
+ + +L +L L L N++S P + L LQ+ NN +S
Sbjct: 301 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--------------- 343
Query: 316 IVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQN 370
L ++ + L N + P + T +L ++
Sbjct: 344 ------------VSSLANLTNINWLSAGHNQISDLTPLANL---TRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 54.2 bits (129), Expect = 4e-08
Identities = 47/250 (18%), Positives = 79/250 (31%), Gaps = 29/250 (11%)
Query: 140 QLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSR 199
L + L I + + L NLT + S+N LT P L L+ L + ++
Sbjct: 42 DLDQVTTLQADRLGIKSID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 97
Query: 200 NSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLN--------------- 244
N + P + +L + + N
Sbjct: 98 NQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQ 157
Query: 245 VSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSV 304
+ + L +L +L LD+S N +S L +L+ + NN +S +
Sbjct: 158 QLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA--KLTNLESLIATNNQISDITPL 215
Query: 305 NLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVE 364
+ L + L N L S+ L LD++ N + P S T E
Sbjct: 216 GILT---NLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQISNLAPLSG---LTKLTE 267
Query: 365 LNISQNMFYG 374
L + N
Sbjct: 268 LKLGANQISN 277
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 4e-07
Identities = 29/128 (22%), Positives = 46/128 (35%), Gaps = 34/128 (26%)
Query: 149 LRSCSISGVIP----FSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTG 204
L S +I+ P F+ L L +T T+ + L ++ L R
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRL---- 54
Query: 205 NIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSL 264
+ S+D G+ L+ L +N SNN L P L +L L
Sbjct: 55 ----------GIKSID------------GVEYLNNLTQINFSNNQLTDITP--LKNLTKL 90
Query: 265 VDLDLSMN 272
VD+ ++ N
Sbjct: 91 VDILMNNN 98
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 9e-07
Identities = 52/297 (17%), Positives = 105/297 (35%), Gaps = 30/297 (10%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVL------ 192
+ L L ++ + ++ + P NLT L + +++N + P +
Sbjct: 63 EYLNNLTQINFSNNQLTDITPL--KNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNN 120
Query: 193 ---------SVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYL 243
++ +L+R L+ N + L L+SL S + L L+ L+ L
Sbjct: 121 QITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERL 180
Query: 244 NVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLS 303
++S+N S + L L +L L + N +S P + +L + + N L
Sbjct: 181 DISSNK--VSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--- 233
Query: 304 VNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTV 363
+ +++ L + L N + P L + +L L + N + P + + T
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL--AGLTALTN 289
Query: 364 ELNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPEYVHSNASSLD--SNCLQNVPN 418
+ L + L N P + L +N + +V +
Sbjct: 290 LELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSDVSS 346
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 1e-04
Identities = 15/79 (18%), Positives = 29/79 (36%), Gaps = 6/79 (7%)
Query: 213 LKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMN 272
L + +T ++ L ++ L + SI + L++L ++ S N
Sbjct: 21 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI-KSIDG-VEYLNNLTQINFSNN 76
Query: 273 SLSGSVPSELRGLRSLQKF 291
L+ P L+ L L
Sbjct: 77 QLTDITP--LKNLTKLVDI 93
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 92.3 bits (228), Expect = 5e-21
Identities = 45/287 (15%), Positives = 100/287 (34%), Gaps = 27/287 (9%)
Query: 540 NLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKT---EAYLLELDFFSKVSHARLVPLLG 596
I G G +++ G +K+I L+ + E+ ++ H+ +V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 597 HCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHE 656
+ LV++++ + L+ +T + G++Y H
Sbjct: 68 VIHT-KKRLVLVFEHLDQDLKKLLDVCE-------GGLESVTAKSFLLQLLNGIAYCHD- 118
Query: 657 CTLPFVHRDVQASSILLDDKFEVRLG--SLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS 714
+HRD++ ++L++ + E+++ L+ + I L GS
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 715 GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIVD 774
+ D++ G + E+V G S+A + + L + + VT++
Sbjct: 177 K---YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 775 -------PSLIIDEDLLEEVWAMAI-VARSCLNPKPTRRPLMRYILK 813
+ E L+ + I + L P +R + L+
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 3e-20
Identities = 52/302 (17%), Positives = 99/302 (32%), Gaps = 34/302 (11%)
Query: 532 ATGDFSDANLIKNGHSGDLFRG--ILEGGIPVVIKRIDLQSVKTEAYLL------ELDFF 583
A + I G G +F+ + GG V +KR+ +Q+ + L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 584 SKVSHARLVPLLGHCM----ERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITR 639
H +V L C +RE + LV++++ + + T
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE------PGVPTETI 118
Query: 640 LKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVR--LGSLSEVCAQGGDAHQS 697
+ GL +LH VHRD++ +IL+ +++ L+ + +
Sbjct: 119 KDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 175
Query: 698 RITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQT 757
+T R P+ Q + P D++ G + E+ K SSD +
Sbjct: 176 VVTLWYRAPEVLLQS-----SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230
Query: 758 LPYISIYDKELVTKIVDPSLIID-----EDLLEEVWAMAI-VARSCLNPKPTRRPLMRYI 811
+ D + + E + ++ + + CL P +R
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
Query: 812 LK 813
L
Sbjct: 291 LS 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 89.0 bits (220), Expect = 4e-20
Identities = 46/298 (15%), Positives = 97/298 (32%), Gaps = 45/298 (15%)
Query: 533 TGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLL----ELDFFSKVS 587
+ + ++ G ++ L V +K + + ++ L E + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 588 HARLVPLLGHCMERENEK---FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAI 644
H +V + ++V +Y+ L ++ + + +++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIA 118
Query: 645 GAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLL- 703
A + L++ H +HRDV+ ++I++ V++ A + T +
Sbjct: 119 DACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 704 --RLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYI 761
S EQ S+ A DVY G VL E++TG+ P+
Sbjct: 176 GTAQYLSPEQARGDSVDARS--DVYSLGCVLYEVLTGE------------------PPFT 215
Query: 762 SIYDKELVTKIVDPSLIIDEDLLEEV--WAMAIVARSCLNPKPTRRPL-MRYILKALE 816
+ + V I E + A+V + L P R + L
Sbjct: 216 GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLK-ALAKNPENRYQTAAEMRADLV 272
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 1e-19
Identities = 46/301 (15%), Positives = 100/301 (33%), Gaps = 23/301 (7%)
Query: 528 QLLAATGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKT--EAYLLELDFFS 584
Q+ +++ + I G G + + V IK+I +T + L E+
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 585 KVSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAI 644
+ H ++ + + + Y+ + + LY+ T Q L
Sbjct: 62 RFRHENIIGINDIIRA-PTIEQMKDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLY 116
Query: 645 GAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS--LSEVCAQGGDAHQSRITRL 702
GL Y+H +HRD++ S++LL+ ++++ L+ V D +
Sbjct: 117 QILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173
Query: 703 LRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYIS 762
+ + S T D++ G +L E+++ + + L S
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233
Query: 763 IYDKELVTKIVDPSLIID---------EDLLEEVWAMAI-VARSCLNPKPTRRPLMRYIL 812
D + + + ++ L + A+ + L P +R + L
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
Query: 813 K 813
Sbjct: 294 A 294
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.2 bits (218), Expect = 2e-19
Identities = 40/280 (14%), Positives = 90/280 (32%), Gaps = 34/280 (12%)
Query: 541 LIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVS-HARLVPLLGHC 598
++ G +G + + +K + E++ + S +V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 599 MERENEK---FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHH 655
+ +V + + G+L S + + + Q+ +I E + YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQYLHS 129
Query: 656 ECTLPFVHRDVQASSILLDDKFEV-RLGSLSEVCAQGGDAHQSRITRLLRLP-QSSEQGS 713
+ HRDV+ ++L K L A+ +H S T + E
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186
Query: 714 SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVTKIV 773
+C D++ G ++ L+ G ++ + ++ + V
Sbjct: 187 PEKYDKSC--DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244
Query: 774 DPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
+ L+ R+ L +PT+R + +
Sbjct: 245 SEEVK---MLI----------RNLLKTEPTQRMTITEFMN 271
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (214), Expect = 4e-19
Identities = 51/293 (17%), Positives = 103/293 (35%), Gaps = 27/293 (9%)
Query: 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKT---EAYLLELDFFSKVSHAR 590
+F I G G +++ G V +K+I L + + E+ +++H
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGL 650
+V LL + EN+ +LV++++ L + +GL
Sbjct: 63 IVKLLD-VIHTENKLYLVFEFLHQDLKKFMDAS------ALTGIPLPLIKSYLFQLLQGL 115
Query: 651 SYLHHECTLPFVHRDVQASSILLDDKFEVRLGS--LSEVCAQGGDAHQSRITRLLRLPQS 708
++ H +HRD++ ++L++ + ++L L+ + + L
Sbjct: 116 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 709 SEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768
G TA D++ G + E+VT + S+ + +TL
Sbjct: 173 ILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 769 VTKIVDPSLII----DEDLLEEVWAMAIVARS----CLNPKPTRRPLMRYILK 813
VT + D +D + V + RS L+ P +R + L
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.1 bits (212), Expect = 7e-19
Identities = 47/288 (16%), Positives = 90/288 (31%), Gaps = 26/288 (9%)
Query: 540 NLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK------TEAYLLELDFFSKVSHARLV 592
+ + G +++ V IK+I L L E+ ++SH ++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 593 PLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSY 652
LL ++ LV+ +M L + +GL Y
Sbjct: 64 GLLD-AFGHKSNISLVFDFMETDLEVIIKDNS-------LVLTPSHIKAYMLMTLQGLEY 115
Query: 653 LHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQG 712
LH +HRD++ +++LLD+ ++L + G + R ++ E
Sbjct: 116 LHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL- 171
Query: 713 SSGSLTATCPYDVYCFGKVLLELVTGKMGISASSD-AQVKEILEQTLP-----YISIYDK 766
G+ D++ G +L EL+ + SD Q+ I E + +
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231
Query: 767 ELVTKIVDPSLIIDEDLLEEVWAMAI-VARSCLNPKPTRRPLMRYILK 813
I + + + + P R LK
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 85.9 bits (212), Expect = 9e-19
Identities = 46/292 (15%), Positives = 97/292 (33%), Gaps = 46/292 (15%)
Query: 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHA 589
DF + G G + G +K + + V + E E S V+H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 590 RLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEG 649
++ + G + + F++ Y+ G+L S L + AAE
Sbjct: 65 FIIRMWGTFQD-AQQIFMIMDYIEGGELFSLLRKS----------QRFPNPVAKFYAAEV 113
Query: 650 LSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSS 709
L + + ++RD++ +ILLD +++ D + +
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF-AKYVPDVTYTLCGTPDYIA--P 170
Query: 710 EQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTLPYISIYDKEL 768
E S+ + D + FG ++ E++ G S+ + ++IL L + +++++
Sbjct: 171 EVVSTKPYNKSI--DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 228
Query: 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRY--ILKALENP 818
+DLL + ++R +P
Sbjct: 229 ------------KDLL----------SRLITRDLSQRLGNLQNGTEDVKNHP 258
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (209), Expect = 3e-18
Identities = 45/315 (14%), Positives = 99/315 (31%), Gaps = 39/315 (12%)
Query: 522 ESFTYQQLLAATGDFSDA----NLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK---T 573
F Q++ + + +G G + + G V IK++
Sbjct: 2 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 61
Query: 574 EAYLLELDFFSKVSHARLVPLLGHCMERE-----NEKFLVYKYMPNGDLSSSLYRKTNTE 628
+ EL + H ++ LL E + +LV +M G L +
Sbjct: 62 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH---- 115
Query: 629 DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688
+ L + +GL Y+H +HRD++ ++ +++ E+++
Sbjct: 116 ---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169
Query: 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDA 748
+ +TR R P+ + T D++ G ++ E++TGK S
Sbjct: 170 QADSEMTGYVVTRWYRAPEV----ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225
Query: 749 QVKEILEQTLPYISIYDKELVTKIVDPSLIID---------EDLLEEVWAMAI-VARSCL 798
+ + + + + + + +L +A+ + L
Sbjct: 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 285
Query: 799 NPKPTRRPLMRYILK 813
+R L
Sbjct: 286 VLDAEQRVTAGEALA 300
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.3 bits (205), Expect = 6e-18
Identities = 43/284 (15%), Positives = 93/284 (32%), Gaps = 49/284 (17%)
Query: 545 GHSGDLFRGI-LEGGIPVVIKRIDLQSVKT-------EAYLLELDFFSKVSHARLVPLLG 596
G + + G+ K I + K+ E E+ ++ H ++ L
Sbjct: 21 GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 80
Query: 597 HCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHE 656
E + + L+ + + G+L L K +SL + G+ ++
Sbjct: 81 VY-ENKTDVILILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGV---YYL 129
Query: 657 CTLPFVHRDVQASSILLDDKFEVRLG------SLSEVCAQGGDAHQSRITRLLRLPQSSE 710
+L H D++ +I+L D+ + L+ G + T P E
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP---E 186
Query: 711 QGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770
+ L D++ G + L++G P++ +E +
Sbjct: 187 IVNYEPLGLEA--DMWSIGVITYILLSGAS------------------PFLGDTKQETLA 226
Query: 771 KIVDPSLIIDEDLLEEVWAMAI-VARSCLNPKPTRRPLMRYILK 813
+ + +++ A+A R L P +R ++ L+
Sbjct: 227 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (203), Expect = 6e-18
Identities = 64/267 (23%), Positives = 109/267 (40%), Gaps = 11/267 (4%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSV 191
++P + Q + L IS V S NLT L+L N L ++ L++
Sbjct: 25 AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 192 LSVLDLSRNSLTGNI-PTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSL 250
L LDLS N+ ++ P +F L L +L + L P L+ LQYL + +N+L
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141
Query: 251 ASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTV 310
+ DL +L L L N +S RGL SL + ++ N ++ + + F +
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDL 200
Query: 311 SQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTG--PLPNSRSNVNTSTVELNIS 368
+L + L N + P + L + L+ L ++ N + + + + S
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQ----KFRGS 256
Query: 369 QNMFYGGLTPVLGRFRLVDLSGNYFEG 395
+ L L L L+ N +G
Sbjct: 257 SSEVPCSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (179), Expect = 8e-15
Identities = 53/240 (22%), Positives = 81/240 (33%), Gaps = 5/240 (2%)
Query: 110 ADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLT 169
A + +L +L Q + + V P + L L
Sbjct: 49 AASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLH 108
Query: 170 SLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGS 229
+L+L GL P L+ L L L N+L +F L NL+ L + N ++
Sbjct: 109 TLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168
Query: 230 IPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQ 289
L L L + N +A P DL L+ L L N+LS L LR+LQ
Sbjct: 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228
Query: 290 KFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTG 349
+ +N + P + LQ + P L L ++ N+ G
Sbjct: 229 YLRLNDNPWVCDC--RARPLWAWLQKFRGSSSEVPCSLPQRLAGRD---LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (95), Expect = 3e-04
Identities = 26/223 (11%), Positives = 60/223 (26%), Gaps = 31/223 (13%)
Query: 243 LNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQ------------- 289
+ L ++P + + + L N +S + R R+L
Sbjct: 16 TSCPQQGL-QAVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 290 -----------KFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLR 338
+ + +N ++ F + +L + L + G P + + L+
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132
Query: 339 LLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPV---LGRFRLVDLSGNYFEG 395
L + N ++ + + L + N L + L N
Sbjct: 133 YLYLQDNALQALPDDTFRD-LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 396 RVPEYVHSNASSLDSNCLQNVPNQRTLVDCSSFYAARGLSFDN 438
P + N + + A + L ++
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLND 234
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.4 bits (205), Expect = 7e-18
Identities = 46/305 (15%), Positives = 102/305 (33%), Gaps = 35/305 (11%)
Query: 534 GDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHA 589
+ I G G++F+ + G V +K++ +++ K L E+ + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 590 RLVPLLGHC-------MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKI 642
+V L+ C + +LV+ + + +L I R+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-----TLSEIKRVMQ 124
Query: 643 AIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRL---GSLSEVCAQGGDAHQSRI 699
+ L+ L++ +HRD++A+++L+ ++L G
Sbjct: 125 ML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179
Query: 700 TRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTL- 758
R++ L + G P D++ G ++ E+ T + +++ ++ Q
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239
Query: 759 -------PYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVA---RSCLNPKPTRRPLM 808
P + Y+ ++V +D L+ L P +R
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299
Query: 809 RYILK 813
L
Sbjct: 300 DDALN 304
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.1 bits (202), Expect = 1e-17
Identities = 45/284 (15%), Positives = 91/284 (32%), Gaps = 51/284 (17%)
Query: 541 LIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYL-------LELDFFSKVS--HAR 590
L+ +G G ++ GI + +PV IK ++ + L +E+ KVS +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 591 LVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGL 650
++ LL + L+ + + +L E +
Sbjct: 71 VIRLLDWFER-PDSFVLILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAV 123
Query: 651 SYLHHECTLPFVHRDVQASSILLD-DKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSS 709
+ H+ +HRD++ +IL+D ++ E++L + + P
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEW 180
Query: 710 EQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELV 769
+ V+ G +L ++V G + EI+ + + E
Sbjct: 181 IRYHRYH---GRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIRGQVFFRQRVSSEC- 231
Query: 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813
+ L+ R CL +P+ RP I
Sbjct: 232 -----------QHLI----------RWCLALRPSDRPTFEEIQN 254
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.5 bits (203), Expect = 2e-17
Identities = 54/290 (18%), Positives = 91/290 (31%), Gaps = 48/290 (16%)
Query: 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKT----EAYLLELDFFSKV-SH 588
DF ++ G G +F + IK + V E ++E S H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 589 ARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAE 648
L + +EN F V +Y+ GDL + D A
Sbjct: 63 PFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIIL 114
Query: 649 GLSYLHHECTLPFVHRDVQASSILLDDKFEVRL---GSLSEVCAQGGDAHQSRITRLLRL 705
GL +LH + V+RD++ +ILLD +++ G E + T
Sbjct: 115 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIA 171
Query: 706 PQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTLPYISIY 764
P+ D + FG +L E++ G+ + ++ I Y
Sbjct: 172 PEILLGQ-----KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL 226
Query: 765 DKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814
+KE DLL +P +R +R ++
Sbjct: 227 EKEAK------------DLL----------VKLFVREPEKRLGVRGDIRQ 254
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.8 bits (201), Expect = 2e-17
Identities = 47/283 (16%), Positives = 96/283 (33%), Gaps = 39/283 (13%)
Query: 535 DFSDANLIKNGHSGDLFRGIL----EGGIPVVIKRIDLQSVK-----TEAYLLELDFFSK 585
+F ++ G G +F + G +K + ++ TE E
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 586 VSHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIG 645
+ + + L + + E + L+ Y+ G+L + L ++ + T ++ I
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR----------ERFTEHEVQIY 134
Query: 646 AAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA-QGGDAHQSRITRLLR 704
E + L H L ++RD++ +ILLD V L + ++
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194
Query: 705 LPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIY 764
+ + G D + G ++ EL+TG P+
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA------------------SPFTVDG 236
Query: 765 DKELVTKIVDPSLIIDEDLLEEVWAMAI-VARSCLNPKPTRRP 806
+K +I L + +E+ A+A + + L P +R
Sbjct: 237 EKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRL 279
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 79.5 bits (195), Expect = 2e-16
Identities = 60/340 (17%), Positives = 117/340 (34%), Gaps = 48/340 (14%)
Query: 500 GPVPAGSSLPPPGASINFTNLGESFTYQQLLAATGDFSDANLIK---NGHSGDLFRGI-L 555
GPVP+ + + +N E + Y+ + G+ D L++ G ++F I +
Sbjct: 1 GPVPSRARVY---TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINI 57
Query: 556 EGGIPVVIKRIDLQSVKTEAYLLELDFFSKVS-HARLVPLLGHCMERENEK-FLVYKYMP 613
VV+K + VK + E+ + ++ L + + LV++++
Sbjct: 58 TNNEKVVVKILK--PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 115
Query: 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILL 673
N D + Q+L + L Y H +HRDV+ ++++
Sbjct: 116 NTDF----------KQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMI 162
Query: 674 D-DKFEVRLGS--LSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGK 730
D + ++RL L+E G + + +R + P+ D++ G
Sbjct: 163 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV----DYQMYDYSLDMWSLGC 218
Query: 731 VLLELVTGKMGISASSD--AQVKEIL-----EQTLPYISIYDKELVTKIVD--------- 774
+L ++ K D Q+ I E YI Y+ EL + D
Sbjct: 219 MLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR 278
Query: 775 PSLIIDEDLLEEVWAMAI-VARSCLNPKPTRRPLMRYILK 813
+ + V A+ L R R ++
Sbjct: 279 WERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.1 bits (194), Expect = 3e-16
Identities = 43/278 (15%), Positives = 87/278 (31%), Gaps = 41/278 (14%)
Query: 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAY----LLELDFFSKVSHA 589
DF L+ G G + G +K + + + + + E H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 590 RLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEG 649
L L + + + V +Y G+L L R+ T + AE
Sbjct: 66 FLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRE----------RVFTEERARFYGAEI 114
Query: 650 LSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSS 709
+S L + + V+RD++ +++LD +++ + G + + + P+
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG--LCKEGISDGATMKTFCGTPEYL 172
Query: 710 EQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKE-ILEQTLPYISIYDKEL 768
D + G V+ E++ G++ ++ E IL + + + E
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232
Query: 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP 806
LL L P +R
Sbjct: 233 K------------SLL----------AGLLKKDPKQRL 248
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.9 bits (188), Expect = 8e-16
Identities = 41/289 (14%), Positives = 96/289 (33%), Gaps = 29/289 (10%)
Query: 540 NLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVKT---EAYLLELDFFSKVSHARLVPLL 595
I G G +F+ E V +KR+ L + L E+ ++ H +V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 596 GHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHH 655
+ + + + ++S + L L
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----------LFQLLKGLGF 116
Query: 656 ECTLPFVHRDVQASSILLDDKFEVRLGS--LSEVCAQGGDAHQSRITRLLRLPQSSEQGS 713
+ +HRD++ ++L++ E++L + L+ + + + L P G+
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 714 SGSLTATCPYDVYCFGKVLLELVTGKMGI-SASSDAQVKEILEQTLPYISIYDKELVTKI 772
+ D++ G + EL + + + + + L + +TK+
Sbjct: 177 K---LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 773 VD-------PSLIIDEDLLEEVWAMAI-VARSCLNPKPTRRPLMRYILK 813
D P+ +++ ++ A + ++ L P +R L+
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 76.7 bits (187), Expect = 1e-15
Identities = 78/331 (23%), Positives = 117/331 (35%), Gaps = 34/331 (10%)
Query: 49 TELAALFELRSSLG--LRRRDWPRKVDPC-LVWNGVRCQNGSVVGINISGFRRTRLGSQN 105
+ AL +++ LG W D C W GV C +
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTY--------------- 50
Query: 106 PRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSC-SISGVIPFSLGN 164
+ +L + P IP L LP L L + ++ G IP ++
Sbjct: 51 ---------RVNNL-DLSGLNLPKPYPIPSSLA-NLPYLNFLYIGGINNLVGPIPPAIAK 99
Query: 165 LTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSN 224
LT L LY++ ++G IP L Q+ L LD S N+L+G +P S L NL + N
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159
Query: 225 YLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRG 284
++G+IP G+ SKL + + + +L +DLS N L G
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFG- 218
Query: 285 LRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISR 344
I S + L + LR N G P L + L L++S
Sbjct: 219 -SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 345 NNFTGPLPNSRSNVNTSTVELNISQNMFYGG 375
NN G +P + + N G
Sbjct: 278 NNLCGEIPQGGNLQRFD--VSAYANNKCLCG 306
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 68.6 bits (166), Expect = 5e-13
Identities = 22/63 (34%), Positives = 29/63 (46%), Gaps = 1/63 (1%)
Query: 193 SVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLAS 252
+ LDL N + G +P LK L SL++S N L G IP G L + +NN
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLC 305
Query: 253 SIP 255
P
Sbjct: 306 GSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 68.2 bits (165), Expect = 7e-13
Identities = 26/68 (38%), Positives = 35/68 (51%), Gaps = 2/68 (2%)
Query: 166 TNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSN- 224
NL L L +N + GT+P L QL L L++S N+L G IP G L+ ++N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
Query: 225 YLTGSIPP 232
L GS P
Sbjct: 303 CLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 68.2 bits (165), Expect = 8e-13
Identities = 58/271 (21%), Positives = 107/271 (39%), Gaps = 11/271 (4%)
Query: 151 SCSISGVIPFSLGNLTNLTSLYLSDNGLTG--TIPSSLGQLSVLSVLDLSRN-SLTGNIP 207
+ + GV+ + + +L LS L IPSSL L L+ L + +L G IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 208 TSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDL 267
+ L L L I+ ++G+IP L + L L+ S N+L+ ++P + L +LV +
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 268 DLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPP 327
N +SG++P L + + L+ + PT + L + + +
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISR---NRLTGKIPPTFANLNLAFVDLSRNMLEG 211
Query: 328 PDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVLGRF---R 384
+ I + + ++ + L++ N YG L L +
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271
Query: 385 LVDLSGNYFEGRVPEYVHSNASSLDSNCLQN 415
+++S N G +P+ N D + N
Sbjct: 272 SLNVSFNNLCGEIPQG--GNLQRFDVSAYAN 300
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 66.7 bits (161), Expect = 3e-12
Identities = 22/60 (36%), Positives = 26/60 (43%), Gaps = 1/60 (1%)
Query: 148 DLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIP 207
DLR+ I G +P L L L SL +S N L G IP G L V + N P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 61.7 bits (148), Expect = 1e-10
Identities = 25/66 (37%), Positives = 34/66 (51%), Gaps = 1/66 (1%)
Query: 214 KNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNS 273
KNL+ LD+ +N + G++P GL L L LNVS N+L IP Q G+L + N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
Query: 274 LSGSVP 279
P
Sbjct: 303 CLCGSP 308
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 76.0 bits (186), Expect = 3e-15
Identities = 48/277 (17%), Positives = 84/277 (30%), Gaps = 42/277 (15%)
Query: 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHA 589
F + G G + E G +K +D Q V + E L E V+
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 590 RLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEG 649
LV L + N V +Y+ G++ S L R A
Sbjct: 102 FLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLT 153
Query: 650 LSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSS 709
YLH ++RD++ ++L+D + +++ G T P
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAP--- 207
Query: 710 EQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELV 769
E S D + G ++ E+ G P+ + ++
Sbjct: 208 EIILSKGYNKAV--DWWALGVLIYEMAAGY------------------PPFFADQPIQIY 247
Query: 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP 806
KIV + ++ + R+ L T+R
Sbjct: 248 EKIVSGKVRFPSHFSSDLKDL---LRNLLQVDLTKRF 281
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.1 bits (160), Expect = 4e-12
Identities = 43/289 (14%), Positives = 95/289 (32%), Gaps = 27/289 (9%)
Query: 540 NLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQS---VKTEAYLLELDFFSKVSHARLVPLL 595
+ + +G G + + G+ V +K++ + + EL + H ++ LL
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 596 GHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHH 655
+ + Y+ + + L Q L + GL Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS 139
Query: 656 ECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSG 715
+HRD++ S++ +++ E+++ + TR R P+
Sbjct: 140 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMH- 195
Query: 716 SLTATCPYDVYCFGKVLLELVTGKMGISASSD-AQVKEILEQ----TLPYISIYDKELVT 770
D++ G ++ EL+TG+ + Q+K IL + E
Sbjct: 196 ---YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 771 KIVDPSLIIDEDLLEEVW------AMAIVARSCLNPKPTRRPLMRYILK 813
+ + + V+ A+ ++ + L +R L
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEK-MLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 65.8 bits (159), Expect = 6e-12
Identities = 46/311 (14%), Positives = 96/311 (30%), Gaps = 49/311 (15%)
Query: 545 GHSGDLFRGI-LEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMEREN 603
GH ++ + V +K + V TEA E+ +V+ A
Sbjct: 24 GHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 83
Query: 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSL--------DWITRLKIAIGAAEGLSYLHH 655
+ + + + + + E+ L + I +I+ GL Y+H
Sbjct: 84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR 143
Query: 656 ECTLPFVHRDVQASSILLD------DKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSS 709
C +H D++ ++L++ + ++++ L C S TR R P+
Sbjct: 144 RC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVL 201
Query: 710 EQGSSGSLTATCPYDVYCFGKVLLELVTGK---MGISASSDAQVKEILEQTLPYISIYDK 766
C D++ ++ EL+TG S + + + Q + +
Sbjct: 202 LGAP-----WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 767 ELVTKIVDPSLIID----------------EDLLEEVWAMAIVA--------RSCLNPKP 802
L+ + ED+L E + + L P
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316
Query: 803 TRRPLMRYILK 813
+R ++
Sbjct: 317 RKRADAGGLVN 327
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 64.8 bits (156), Expect = 1e-11
Identities = 22/93 (23%), Positives = 35/93 (37%), Gaps = 9/93 (9%)
Query: 149 LRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPT 208
+ S I +L L +S+N L +P+ +L L S N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVP- 320
Query: 209 SFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQ 241
L +NL L + N L P ++ L+
Sbjct: 321 --ELPQNLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.5 bits (137), Expect = 3e-09
Identities = 22/93 (23%), Positives = 32/93 (34%), Gaps = 9/93 (9%)
Query: 172 YLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIP 231
N + I S L L++S N L +P L L S N+L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVP 320
Query: 232 PGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSL 264
L+ L+V N L P ++ L
Sbjct: 321 E---LPQNLKQLHVEYNPL-REFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.2 bits (118), Expect = 7e-07
Identities = 25/92 (27%), Positives = 37/92 (40%), Gaps = 10/92 (10%)
Query: 224 NYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELR 283
N + I L+ LNVSNN L +PA L L S N L+ VP +
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPP---RLERLIASFNHLA-EVPELPQ 324
Query: 284 GLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQI 315
L+ L + N L ++ +V L++
Sbjct: 325 NLKQLH---VEYNPLRE--FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 18/69 (26%), Positives = 33/69 (47%), Gaps = 5/69 (7%)
Query: 212 LLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSM 271
L + L++++ L+ S+P L+ L S NSL + +P L SL+ + ++
Sbjct: 36 LDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSL-TELPELPQSLKSLLVDNNNL 90
Query: 272 NSLSGSVPS 280
+LS P
Sbjct: 91 KALSDLPPL 99
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.7 bits (101), Expect = 7e-05
Identities = 20/94 (21%), Positives = 36/94 (38%), Gaps = 10/94 (10%)
Query: 246 SNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVN 305
N+ ++ I + SL +L++S N L +P+ L L S N
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL--------IASFNHLAE 318
Query: 306 LFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRL 339
+ L+ + + N PD+ S+ LR+
Sbjct: 319 VPELPQNLKQLHVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 18/64 (28%), Positives = 29/64 (45%), Gaps = 5/64 (7%)
Query: 192 LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLA 251
L+L+ L+ ++P L +L SL S N LT +P +L L N + +L+
Sbjct: 40 AHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 94
Query: 252 SSIP 255
P
Sbjct: 95 DLPP 98
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 2e-04
Identities = 11/63 (17%), Positives = 20/63 (31%), Gaps = 9/63 (14%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSV 191
+P + L+ L ++ V NL L++ N L P +
Sbjct: 298 ELPALPPR----LERLIASFNHLAEVPEL----PQNLKQLHVEYNPLR-EFPDIPESVED 348
Query: 192 LSV 194
L +
Sbjct: 349 LRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 9e-04
Identities = 20/75 (26%), Positives = 32/75 (42%), Gaps = 8/75 (10%)
Query: 133 IPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVL 192
+ D L +Q L +L + +S +P +L SL S N LT +P L L
Sbjct: 32 LRDCLDRQAHEL---ELNNLGLS-SLP---ELPPHLESLVASCNSLT-ELPELPQSLKSL 83
Query: 193 SVLDLSRNSLTGNIP 207
V + + +L+ P
Sbjct: 84 LVDNNNLKALSDLPP 98
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 17/90 (18%), Positives = 31/90 (34%), Gaps = 10/90 (11%)
Query: 269 LSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPP 328
+N+ S + S SL++ + NN L L +L+ ++ N P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-----ELPALPPRLERLIASFNHLAEVPE 321
Query: 329 DVLWSMPQLRLLDISRNNFTGPLPNSRSNV 358
L+ L + N P+ +V
Sbjct: 322 ----LPQNLKQLHVEYNPLRE-FPDIPESV 346
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.6 bits (156), Expect = 2e-11
Identities = 48/301 (15%), Positives = 92/301 (30%), Gaps = 50/301 (16%)
Query: 545 GHSGDLFRGI-LEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHC-- 598
G G + V IK++ + EL V+H ++ LL
Sbjct: 28 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87
Query: 599 ---MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHH 655
+E + +LV + M + LD + G+ +LH
Sbjct: 88 QKTLEEFQDVYLVMELMDANLC----------QVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 656 ECTLPFVHRDVQASSILLDDKFEVR--LGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGS 713
+HRD++ S+I++ ++ L+ +TR R P+
Sbjct: 138 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 714 SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDA-QVKEILEQTLPYISIYDKELVTKI 772
D++ G ++ E+V K+ Q +++EQ + K+L +
Sbjct: 195 Y-----KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 773 VD-------------PSLIIDEDLLEEVWAMAIVA-------RSCLNPKPTRRPLMRYIL 812
+ P L D + + A L P +R + L
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 813 K 813
+
Sbjct: 310 Q 310
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 57.8 bits (139), Expect = 1e-10
Identities = 37/119 (31%), Positives = 51/119 (42%), Gaps = 7/119 (5%)
Query: 171 LYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSI 230
L+L+ LT + L QL +++ LDLS N L P + L+ L L S N L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE--N 57
Query: 231 PPGLGTLSKLQYLNVSNNSLAS-SIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSL 288
G+ L +LQ L + NN L + L LV L+L NSL L +
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.0 bits (124), Expect = 1e-08
Identities = 33/126 (26%), Positives = 50/126 (39%), Gaps = 11/126 (8%)
Query: 194 VLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASS 253
VL L+ LT + L ++ LD+S N L +PP L L L+ L S+N+L +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV 58
Query: 254 IPAQLGDLDSLVDLDLSMNSL-SGSVPSELRGLRSLQKFVIGNNFLSGNLS-----VNLF 307
+L L +L L N L + L L + N L +
Sbjct: 59 DGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 308 PTVSQL 313
P+VS +
Sbjct: 117 PSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.6 bits (123), Expect = 1e-08
Identities = 25/119 (21%), Positives = 50/119 (42%), Gaps = 8/119 (6%)
Query: 241 QYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSG 300
+ L++++ L ++ L L + LDLS N L P+ L +L+ + +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNA 54
Query: 301 NLSVNLFPTVSQLQIIVLRQNGFTG-PPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNV 358
+V+ + +LQ ++L N L S P+L LL++ N+ + +
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERL 112
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 3e-05
Identities = 24/107 (22%), Positives = 37/107 (34%), Gaps = 27/107 (25%)
Query: 139 QQLPTLQALDLRSCSISGVIPFSLGNLTNL----------------------TSLYLSDN 176
+QL + LDL + + P +L L L L L +N
Sbjct: 17 EQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNN 75
Query: 177 GLTGT-IPSSLGQLSVLSVLDLSRNSLT---GNIPTSFGLLKNLSSL 219
L + L L +L+L NSL G +L ++SS+
Sbjct: 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.9 bits (146), Expect = 1e-10
Identities = 48/212 (22%), Positives = 78/212 (36%), Gaps = 9/212 (4%)
Query: 161 SLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLD 220
+ + + + LT +P L + ++L LS N L + L+ L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 221 ISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPS 280
+ LT G TL L L++S+N L S V D+S N L+
Sbjct: 62 LDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLG 118
Query: 281 ELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLL 340
LRGL LQ+ + N L L L +L+ + L N T P +L + L L
Sbjct: 119 ALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 341 DISRNNFTGPLPNSRSNVNTSTVELNISQNMF 372
+ N+ +P + + N +
Sbjct: 178 LLQENSLY-TIPKGFFG-SHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 4e-08
Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 8/208 (3%)
Query: 140 QLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSR 199
++ + ++ +++ +P L + T L+LS+N L ++L + L+ L+L R
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 200 NSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLG 259
LT L L +LD+S N L G TL L L+VS N L S L
Sbjct: 65 AELTKLQVDGT--LPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGALR 121
Query: 260 DLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLR 319
L L +L L N L P L L+K + NN L+ L L + L ++L+
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQ 180
Query: 320 QNGFTGPPPDVLWSMPQLRLLDISRNNF 347
+N P + L + N +
Sbjct: 181 ENSLYTIPKG-FFGSHLLPFAFLHGNPW 207
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.9 bits (148), Expect = 2e-10
Identities = 19/92 (20%), Positives = 35/92 (38%), Gaps = 10/92 (10%)
Query: 167 NLTSLYLSDNGLTGT-IPSSLGQLSVLSVLDLSRNSLTG----NIPTSFGLLKNLSSLDI 221
++ SL + L+ L L V+ L LT +I ++ + L+ L++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 222 SSNYLTGSIPPGLGTL-----SKLQYLNVSNN 248
SN L + K+Q L++ N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.8 bits (145), Expect = 4e-10
Identities = 24/102 (23%), Positives = 37/102 (36%), Gaps = 10/102 (9%)
Query: 132 SIPDWLGQQLPTLQALDLRSCSISGV----IPFSLGNLTNLTSLYLSDNGLTGTIPSSLG 187
+ LGQ L+ L L C +S + +L +L L LS+N L L
Sbjct: 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418
Query: 188 Q-----LSVLSVLDLSRNSLTGNIPTSF-GLLKNLSSLDISS 223
+ +L L L + + L K+ SL + S
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.8 bits (140), Expect = 2e-09
Identities = 16/91 (17%), Positives = 26/91 (28%), Gaps = 10/91 (10%)
Query: 192 LSVLDLSRNSLTGN-IPTSFGLLKNLSSLDISSNYLTG----SIPPGLGTLSKLQYLNVS 246
+ LD+ L+ LL+ + + LT I L L LN+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 247 NNSLASSIPAQLGDL-----DSLVDLDLSMN 272
+N L + + L L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.1 bits (133), Expect = 1e-08
Identities = 20/96 (20%), Positives = 32/96 (33%), Gaps = 15/96 (15%)
Query: 164 NLTNLTSLYLSDNGLTGT----IPSSLGQLSVLSVLDLSRNSLTGNIPTSFG-----LLK 214
+ L L+L+D ++ + + ++L L LDLS N L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 215 NLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSL 250
L L + Y + + L L K SL
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEK------DKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.1 bits (133), Expect = 1e-08
Identities = 16/73 (21%), Positives = 29/73 (39%), Gaps = 5/73 (6%)
Query: 215 NLSSLDISSNYLTGSIPPGL-GTLSKLQYLNVSNNSL----ASSIPAQLGDLDSLVDLDL 269
++ SLDI L+ + L L + Q + + + L I + L +L +L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 270 SMNSLSGSVPSEL 282
N L +
Sbjct: 63 RSNELGDVGVHCV 75
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (129), Expect = 4e-08
Identities = 19/96 (19%), Positives = 36/96 (37%), Gaps = 9/96 (9%)
Query: 175 DNGLTGTIPSSLGQLSVLSVLDLSRNSLTGN----IPTSFGLLKNLSSLDISSNYLTGSI 230
D G+ SVL VL L+ ++ + + + +L LD+S+N L +
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413
Query: 231 PPGLGT-----LSKLQYLNVSNNSLASSIPAQLGDL 261
L L+ L + + + + +L L
Sbjct: 414 ILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 9e-08
Identities = 17/94 (18%), Positives = 28/94 (29%), Gaps = 12/94 (12%)
Query: 114 VNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGV----IPFSLGNLTNLT 169
+++ L + L + L L Q + L C ++ I +L L
Sbjct: 2 LDIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 58
Query: 170 SLYLSDNGLTGTIPSSLGQL-----SVLSVLDLS 198
L L N L + Q + L L
Sbjct: 59 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 3e-07
Identities = 18/82 (21%), Positives = 30/82 (36%), Gaps = 9/82 (10%)
Query: 214 KNLSSLDISSNYLTG----SIPPGLGTLSKLQYLNVSNNSLASSIPAQLGD-----LDSL 264
L L ++ ++ S+ L L+ L++SNN L + QL + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 265 VDLDLSMNSLSGSVPSELRGLR 286
L L S + L+ L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 5e-06
Identities = 17/95 (17%), Positives = 28/95 (29%), Gaps = 8/95 (8%)
Query: 287 SLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTG----PPPDVLWSMPQLRLLDI 342
+Q I LS L P + Q Q++ L G T L P L L++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 343 SRNNFTG----PLPNSRSNVNTSTVELNISQNMFY 373
N + + +L++
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 20/90 (22%), Positives = 37/90 (41%), Gaps = 12/90 (13%)
Query: 263 SLVDLDLSMNSLSG----SVPSELRGLRSLQKFVIGNNFLSGN----LSVNLFPTVSQLQ 314
L L L+ +S S+ + L SL++ + NN L L ++ L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 315 IIVLRQNGFTGPPPDVLWSM----PQLRLL 340
+VL ++ D L ++ P LR++
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 9e-10
Identities = 19/103 (18%), Positives = 35/103 (33%), Gaps = 7/103 (6%)
Query: 145 QALDLRSCSISGVIPFSLGNLT--NLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSL 202
Q LDL ++ P G L + + + + + + +DLS + +
Sbjct: 3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVI 58
Query: 203 TGN-IPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLN 244
+ + L +L + L+ I L S L LN
Sbjct: 59 EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (134), Expect = 5e-09
Identities = 17/98 (17%), Positives = 44/98 (44%), Gaps = 3/98 (3%)
Query: 195 LDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSL-ASS 253
LDL+ +L ++ L + + + +++ + + ++Q++++SN+ + S+
Sbjct: 5 LDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVST 62
Query: 254 IPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKF 291
+ L L +L L LS + + L +L +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 42/268 (15%), Positives = 88/268 (32%), Gaps = 41/268 (15%)
Query: 86 GSVVGINISGFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQ 145
G ++ + FR R P + + H+ + S ++ S + Q LQ
Sbjct: 18 GRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHM---DLSNSVIEVSTLHGILSQCSKLQ 74
Query: 146 ALDLRSCSISGVIPFSLGNLTNLTSL--------------------------------YL 173
L L +S I +L +NL L
Sbjct: 75 NLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDF 134
Query: 174 SDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYL-TGSIPP 232
++ + + ++ L++ +N ++ T NL LD+S + +
Sbjct: 135 TEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ 194
Query: 233 GLGTLSKLQYLNVSN-NSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKF 291
L+ LQ+L++S + +LG++ +L L + G++ L LQ
Sbjct: 195 EFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ-- 252
Query: 292 VIGNNFLSGNLSVNLFPTVSQLQIIVLR 319
I + + ++ +I ++
Sbjct: 253 -INCSHFT-TIARPTIGNKKNQEIWGIK 278
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 53.6 bits (128), Expect = 1e-08
Identities = 18/139 (12%), Positives = 44/139 (31%), Gaps = 9/139 (6%)
Query: 540 NLIKNGHSGDLFRGILEGGIPVVIK--RIDLQSVKTEAYLLELDFFSKVSHARLVPLLGH 597
L+ G +F E V+K ++ S K + A
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 598 -CMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHE 656
+++ + Y G+ ++ + +L + ++ E ++ +H
Sbjct: 66 RALQKLQGLAVPKVYAWEGN---AVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR 122
Query: 657 CTLPFVHRDVQASSILLDD 675
VH D+ ++L+ +
Sbjct: 123 G---IVHGDLSQYNVLVSE 138
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 3e-08
Identities = 34/206 (16%), Positives = 64/206 (31%), Gaps = 19/206 (9%)
Query: 160 FSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSL 219
F L N + + +T T+ + L ++ L +T I L NL L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGL 68
Query: 220 DISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVP 279
++ N +T P T L+ + S+I + + +
Sbjct: 69 ELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 280 SELRGLRSLQKFVIGNNFL-------------SGNLSVNLFPTVSQLQIIVLRQNGFTGP 326
S L+ L + + L + + +S+L + N +
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188
Query: 327 PPDVLWSMPQLRLLDISRNNFTGPLP 352
P L S+P L + + N + P
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 5e-08
Identities = 32/225 (14%), Positives = 72/225 (32%), Gaps = 26/225 (11%)
Query: 133 IPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVL 192
PD L + +++ + + +L +T+L G+T + L+ L
Sbjct: 13 FPD---PALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNL 65
Query: 193 SVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLAS 252
L+L N +T P L + +I + +
Sbjct: 66 IGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPL 125
Query: 253 SIPAQLGDLDSLVDLDLSMNSL--------------SGSVPSELRGLRSLQKFVIGNNFL 298
+ + L L ++ +++ L S + L L L +N +
Sbjct: 126 AGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKI 185
Query: 299 SGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDIS 343
S ++ ++ L + L+ N + P L + L ++ ++
Sbjct: 186 SD---ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 13/56 (23%), Positives = 24/56 (42%), Gaps = 4/56 (7%)
Query: 192 LSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSN 247
L+ L N ++ P L NL + + +N ++ P L S L + ++N
Sbjct: 175 LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 8e-05
Identities = 13/36 (36%), Positives = 20/36 (55%), Gaps = 2/36 (5%)
Query: 140 QLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSD 175
LP L + L++ IS V P L N +NL + L++
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 8e-04
Identities = 19/67 (28%), Positives = 29/67 (43%), Gaps = 4/67 (5%)
Query: 229 SIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSL 288
S L LSKL L +N ++ P L L +L+++ L N +S P L +L
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219
Query: 289 QKFVIGN 295
+ N
Sbjct: 220 FIVTLTN 226
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.0 bits (121), Expect = 5e-08
Identities = 23/117 (19%), Positives = 37/117 (31%), Gaps = 11/117 (9%)
Query: 113 LVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGV--IPFSLGNLTNLTS 170
LV N + + + + +P L +L+L + + + + + NL
Sbjct: 38 LVAQNIDVVLNRRSSMA--ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI 95
Query: 171 LYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFG-------LLKNLSSLD 220
L LS N L + L L L NSL+ L LD
Sbjct: 96 LNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (99), Expect = 5e-05
Identities = 29/162 (17%), Positives = 51/162 (31%), Gaps = 23/162 (14%)
Query: 182 IPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQ 241
+ + + S L L L+ S+ ++ + +L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELL 68
Query: 242 YLNVSNNSL--ASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLS 299
LN+SNN L + + + +L L+LS N L R L ++ + +L
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNEL-----KSERELDKIKGLKLEELWLD 123
Query: 300 GNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLD 341
GN + F S + P+L LD
Sbjct: 124 GNSLSDTFRDQSTYI-------------SAIRERFPKLLRLD 152
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 50.6 bits (119), Expect = 1e-07
Identities = 41/187 (21%), Positives = 68/187 (36%), Gaps = 9/187 (4%)
Query: 169 TSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSF-GLLKNLSSLDISSNYLT 227
T++ + GL IP + + L L+ N L G L +L L++ N LT
Sbjct: 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 228 GSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRS 287
G P S +Q L + N + L L L+L N +S +P L S
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 288 LQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNF 347
L + +N + N + F + + L P + +++ D+ + F
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKK--SLNGGAARCGAPSKVRD---VQIKDLPHSEF 182
Query: 348 TGPLPNS 354
NS
Sbjct: 183 KCSSENS 189
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.0 bits (107), Expect = 5e-06
Identities = 19/105 (18%), Positives = 39/105 (37%), Gaps = 4/105 (3%)
Query: 151 SCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSF 210
I + L L +L L DN ++ +P S L+ L+ L+L+ N N ++
Sbjct: 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW 146
Query: 211 GLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIP 255
+ L ++ P + +Q ++ ++ S
Sbjct: 147 -FAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFKCSSE 187
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 38.2 bits (87), Expect = 0.002
Identities = 41/189 (21%), Positives = 71/189 (37%), Gaps = 17/189 (8%)
Query: 151 SCSISGV---------IPFSLGNLTNLTSLYLSDNGLTGTI-PSSLGQLSVLSVLDLSRN 200
C + V IP + + T L L+DN L G+L L L+L RN
Sbjct: 7 HCEGTTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRN 64
Query: 201 SLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGD 260
LTG P +F ++ L + N + L +L+ LN+ +N ++ +P
Sbjct: 65 QLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEH 124
Query: 261 LDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQ 320
L+SL +L+ + + L +++ + G V +QI L
Sbjct: 125 LNSLT-----SLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPH 179
Query: 321 NGFTGPPPD 329
+ F +
Sbjct: 180 SEFKCSSEN 188
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (113), Expect = 6e-07
Identities = 27/151 (17%), Positives = 57/151 (37%), Gaps = 8/151 (5%)
Query: 197 LSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPA 256
L+ L + LD+ + I TL + ++ S+N + +
Sbjct: 3 LTAE-LIEQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-RKLDG 58
Query: 257 QLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQII 316
L L L ++ N + + L L + ++ NN L ++ ++ L +
Sbjct: 59 F-PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117
Query: 317 VLRQNGFTGPP---PDVLWSMPQLRLLDISR 344
+ +N T V++ +PQ+R+LD +
Sbjct: 118 CILRNPVTNKKHYRLYVIYKVPQVRVLDFQK 148
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 21/92 (22%), Positives = 33/92 (35%), Gaps = 3/92 (3%)
Query: 161 SLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLD 220
N L L + I + L +D S N + F LL+ L +L
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLL 69
Query: 221 ISSNYLTGSIPPGLGTLSKLQYLNVSNNSLAS 252
+++N + L L L ++NNSL
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVE 101
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 7e-04
Identities = 26/134 (19%), Positives = 44/134 (32%), Gaps = 7/134 (5%)
Query: 141 LPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRN 200
+ LDLR I VI L ++ SDN + L L L ++ N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNNN 73
Query: 201 SLTGNIPTSFGLLKNLSSLDISSNYLTG----SIPPGLGTLSKLQYLNVSNNSLASSIPA 256
+ L +L+ L +++N L L +L+ L L +
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133
Query: 257 QLGDLDSLVDLDLS 270
+ + + LD
Sbjct: 134 VIYKVPQVRVLDFQ 147
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 48.9 bits (115), Expect = 6e-07
Identities = 29/207 (14%), Positives = 66/207 (31%), Gaps = 19/207 (9%)
Query: 148 DLRSCSISGVIP----FSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLT 203
L S +I+ P FS L +T + + +L+ + + + + +
Sbjct: 2 PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 59
Query: 204 GNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDS 263
+ L N++ L ++ N LT P L+ L+ L
Sbjct: 60 SVQGIQY--LPNVTKLFLNGNKLTDIKP-----LANLKNLGWLFLDENKVKDLSSLKDLK 112
Query: 264 LVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGF 323
+ ++ + + + ++ N + L + L N
Sbjct: 113 KLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKL----DTLSLEDNQI 168
Query: 324 TGPPPDVLWSMPQLRLLDISRNNFTGP 350
+ P L + +L+ L +S+N+ +
Sbjct: 169 SDIVP--LAGLTKLQNLYLSKNHISDL 193
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 35/217 (16%), Positives = 75/217 (34%), Gaps = 22/217 (10%)
Query: 132 SIPDWLGQ-----QLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSL 186
++P + Q +L+ S++ + + L ++ + +++ + +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--I 64
Query: 187 GQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVS 246
L ++ L L+ N LT P LKNL L + N + + ++S
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLK----DLKKLKSLS 118
Query: 247 NNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNL 306
S L L L L L N ++ L K + + +
Sbjct: 119 LEHNGISDINGLVHLPQLESLYLGNNKITDITVL-----SRLTKLDTLSLEDNQISDIVP 173
Query: 307 FPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDIS 343
+++LQ + L +N + L + L +L++
Sbjct: 174 LAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 42/183 (22%), Positives = 70/183 (38%), Gaps = 27/183 (14%)
Query: 132 SIPDWLGQ-QLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLS 190
S+ D + Q +L ++ + + I V + L N+T L+L+ N LT P L L
Sbjct: 35 SVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLK 90
Query: 191 VLSVLDLSRNSLTGNIPTS------------------FGLLKNLSSLDISSNYLTGSIPP 232
L L L N + GL+ + +
Sbjct: 91 NLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDIT 150
Query: 233 GLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFV 292
L L+KL L++ +N ++ +P L L L +L LS N +S L GL++L
Sbjct: 151 VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLE 206
Query: 293 IGN 295
+ +
Sbjct: 207 LFS 209
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (103), Expect = 1e-05
Identities = 28/149 (18%), Positives = 52/149 (34%), Gaps = 3/149 (2%)
Query: 190 SVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGL-GTLSKLQYLNVSNN 248
S L +R+ + +NL+ L I + + L +L+ L + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 249 SLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFP 308
L P L L+LS N+L S+ + SLQ+ V+ N L + ++
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQ 125
Query: 309 TVSQLQIIVLRQNGFTGPPPDVLWSMPQL 337
+ + + + L MP
Sbjct: 126 RWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 7e-05
Identities = 30/134 (22%), Positives = 46/134 (34%), Gaps = 3/134 (2%)
Query: 158 IPFSLGNLTNLTSLYLSDNGLTGTIPS-SLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNL 216
L NLT LY+ + + L L L L + ++ L P +F L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 217 SSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQ-LGDLDSLVDLDLSMNSLS 275
S L++S N L S+ LQ L +S N L S + L + + L
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQ 141
Query: 276 GSVPSELRGLRSLQ 289
L + +
Sbjct: 142 CHGQGPLAHMPNAS 155
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.3 bits (105), Expect = 1e-05
Identities = 10/54 (18%), Positives = 19/54 (35%), Gaps = 3/54 (5%)
Query: 131 GSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPS 184
+P+ + LD+ I + + L NL L + L +P+
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (104), Expect = 2e-05
Identities = 12/50 (24%), Positives = 16/50 (32%), Gaps = 3/50 (6%)
Query: 206 IPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIP 255
F LDIS + GL L KL+ + N +P
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.1 bits (102), Expect = 3e-05
Identities = 9/69 (13%), Positives = 17/69 (24%), Gaps = 13/69 (18%)
Query: 152 CSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFG 211
++ + + L +S + L L L
Sbjct: 187 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN------------ 234
Query: 212 LLKNLSSLD 220
LK L +L+
Sbjct: 235 -LKKLPTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 14/86 (16%), Positives = 23/86 (26%), Gaps = 3/86 (3%)
Query: 147 LDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNI 206
L L I + + +N L S +LD+SR +
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 207 PTSFGLLKNLSSLDISSNYLTGSIPP 232
LK L + + +P
Sbjct: 218 SYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.001
Identities = 13/64 (20%), Positives = 22/64 (34%), Gaps = 3/64 (4%)
Query: 167 NLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYL 226
+ ++ +T IPS L L L +F +L ++IS N +
Sbjct: 9 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 227 TGSI 230
I
Sbjct: 66 LEVI 69
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.7 bits (104), Expect = 1e-05
Identities = 33/191 (17%), Positives = 62/191 (32%), Gaps = 15/191 (7%)
Query: 160 FSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSL 219
F+ L L +T T+ + L ++ L R + +I L NL+ +
Sbjct: 12 FTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQI 67
Query: 220 DISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVP 279
+ S+N LT P T +N + + + + + + +
Sbjct: 68 NFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 127
Query: 280 SELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRL 339
+ L L + + ++ LQ + N T P L ++ L
Sbjct: 128 TNLNRLELSSNTISDISA---------LSGLTSLQQLNFSSNQVTDLKP--LANLTTLER 176
Query: 340 LDISRNNFTGP 350
LDIS N +
Sbjct: 177 LDISSNKVSDI 187
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 13/73 (17%), Positives = 27/73 (36%), Gaps = 7/73 (9%)
Query: 133 IPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVL 192
D L L +++ + + +L +T+L G+ + L+ L
Sbjct: 12 FTD---TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNL 64
Query: 193 SVLDLSRNSLTGN 205
+ ++ S N LT
Sbjct: 65 TQINFSNNQLTDI 77
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 34/166 (20%), Positives = 57/166 (34%), Gaps = 21/166 (12%)
Query: 140 QLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSR 199
L + L I + + L NLT + S+N LT P V +++ ++
Sbjct: 38 DLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQ 95
Query: 200 NSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYL---------------- 243
+ + L + ++ L L
Sbjct: 96 IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQL 155
Query: 244 NVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSG-SVPSELRGLRSL 288
N S+N + P L +L +L LD+S N +S SV ++L L SL
Sbjct: 156 NFSSNQVTDLKP--LANLTTLERLDISSNKVSDISVLAKLTNLESL 199
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 11/92 (11%), Positives = 29/92 (31%), Gaps = 8/92 (8%)
Query: 143 TLQALDLRSCSISGV----IPFSLGNLTNLTSLYLSDNGLTG----TIPSSLGQLSVLSV 194
+++ L+ +I+ + L ++ + LS N + + ++ L +
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 195 LDLSRNSLTGNIPTSFGLLKNLSSLDISSNYL 226
+ S L+ L + L
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 3e-04
Identities = 10/80 (12%), Positives = 27/80 (33%), Gaps = 12/80 (15%)
Query: 172 YLSDNGLTGTIPSSLGQ------LSVLSVLDLSRNSLTGNIPTS-----FGLLKNLSSLD 220
L+D L+ +++ L L L N + + + + +L L+
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 221 ISSNYLTGSIPPGLGTLSKL 240
++ N + + ++
Sbjct: 309 LNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 3e-04
Identities = 12/79 (15%), Positives = 26/79 (32%), Gaps = 12/79 (15%)
Query: 149 LRSCSISGVIPFSLGN------LTNLTSLYLSDNGLTGTIPSSL-----GQLSVLSVLDL 197
L C +S ++ + L +L L N + +L ++ L L+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 198 SRNSLTGNIPTSFGLLKNL 216
+ N ++ +
Sbjct: 310 NGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 4e-04
Identities = 11/96 (11%), Positives = 28/96 (29%), Gaps = 9/96 (9%)
Query: 187 GQLSVLSVLDLSRNSLTGN----IPTSFGLLKNLSSLDISSNYLTG----SIPPGLGTLS 238
+ S + L +++T + ++ + +S N + + + +
Sbjct: 1 ARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 59
Query: 239 KLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSL 274
L+ S+ L L+ L L
Sbjct: 60 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 6e-04
Identities = 12/82 (14%), Positives = 25/82 (30%), Gaps = 12/82 (14%)
Query: 197 LSRNSLTGNIPT------SFGLLKNLSSLDISSNYLTGSIPPGLGT-----LSKLQYLNV 245
L+ L+ S L +L + N + L T + L +L +
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 246 SNNSLASSIPAQLGDLDSLVDL 267
+ N S + ++ +
Sbjct: 310 NGNRF-SEEDDVVDEIREVFST 330
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 9e-04
Identities = 11/66 (16%), Positives = 25/66 (37%), Gaps = 8/66 (12%)
Query: 132 SIPDWLGQ-QLPTLQALDLRSCSISGVIPFSL-----GNLTNLTSLYLSDNGLT--GTIP 183
++ D + + LQ L L+ I +L + +L L L+ N + +
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVV 321
Query: 184 SSLGQL 189
+ ++
Sbjct: 322 DEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.003
Identities = 11/64 (17%), Positives = 26/64 (40%), Gaps = 5/64 (7%)
Query: 239 KLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSG----SVPSELRGLRSLQKFVIG 294
L+ ++ S+ A L + DS+ ++ LS N++ + + + L+
Sbjct: 9 SLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 295 NNFL 298
+ F
Sbjct: 68 DIFT 71
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 31/180 (17%), Positives = 66/180 (36%), Gaps = 24/180 (13%)
Query: 181 TIPSSLGQLSVLS---VLDLSRNSLTGNIP------TSFGLLKNLSSLDISSNYLTGSIP 231
TI ++ + + L G IP + LK L +S+N + I
Sbjct: 6 TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS 64
Query: 232 PGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKF 291
L + L+ L++ N + D + +L ++ + S + L +L+
Sbjct: 65 S-LSGMENLRILSLGRNL---IKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVL 120
Query: 292 VIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPD----------VLWSMPQLRLLD 341
+ NN ++ ++ + +L+ ++L N + V+ +P L+ LD
Sbjct: 121 YMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 38.5 bits (88), Expect = 0.002
Identities = 17/72 (23%), Positives = 30/72 (41%), Gaps = 10/72 (13%)
Query: 132 SIPDWLG--QQLPTLQALDLRSCSISGVIP------FSLGNLTNLTSLYLSDNGLTGTIP 183
+I D + ++ ++ A + + G+IP +L L L LS N + I
Sbjct: 6 TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS 64
Query: 184 SSLGQLSVLSVL 195
SL + L +L
Sbjct: 65 -SLSGMENLRIL 75
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 919 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.98 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.98 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.98 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.93 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.91 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.9 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.89 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.89 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.89 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.88 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.87 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.85 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.85 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.78 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.74 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.74 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.73 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.71 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.69 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.68 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.67 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.67 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.66 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.57 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.53 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.52 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.51 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.73 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.64 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.48 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.08 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.94 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.9 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.49 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.3 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.32 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 89.07 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=379.71 Aligned_cols=269 Identities=21% Similarity=0.330 Sum_probs=208.2
Q ss_pred CCCCHHHHHHHHCCCCC---------CCCCCCCCCCCEEEEEECC-C---CCEEEEEECCCCC--CHHHHHHHHHHHHHC
Q ss_conf 65579999998399983---------2333458888489999549-9---6189999515531--089999999998616
Q 002462 522 ESFTYQQLLAATGDFSD---------ANLIKNGHSGDLFRGILEG-G---IPVVIKRIDLQSV--KTEAYLLELDFFSKV 586 (919)
Q Consensus 522 ~~~~~~~l~~~t~~f~~---------~~~ig~G~~G~Vy~g~l~~-g---~~vavK~l~~~~~--~~~~f~~Ei~~l~~l 586 (919)
..+||+++.+++.+|+. .++||+|+||.||+|.... + ..||||++..... ..++|.+|+++|+++
T Consensus 5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 84 (299)
T d1jpaa_ 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84 (299)
T ss_dssp CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred CCCCHHHHHHHHHHHCHHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHC
T ss_conf 98887989999960462208004278569802788299999995799788999999978445989999999999999857
Q ss_pred CCCCCCCEEEEEEECCCCEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCC
Q ss_conf 99984136558860488179999722799810010006999775677799999999999999855451289999264468
Q 002462 587 SHARLVPLLGHCMERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDV 666 (919)
Q Consensus 587 ~H~NiV~l~g~c~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDl 666 (919)
+|||||+++|+|.+ ++..++|||||++|+|.+++.... ..++|.++++|+.|+|+||+|||+. +||||||
T Consensus 85 ~HpnIv~l~g~~~~-~~~~~iv~Ey~~~g~L~~~~~~~~------~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDl 154 (299)
T d1jpaa_ 85 DHPNVIHLEGVVTK-STPVMIITEFMENGSLDSFLRQND------GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDL 154 (299)
T ss_dssp CCTTBCCEEEEECS-SSSCEEEEECCTTEEHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred CCCCCCCEEEEEEE-CCEEEEEEEECCCCCCEEEECCCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCC
T ss_conf 99888618999962-887799997227985300210456------7999999999999999988988527---9835761
Q ss_pred CCCCEECCCCCCEEECCCCHHHHCCCCCCCEE---EEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCC
Q ss_conf 89960017999622488500240389985103---552025777754567787799977860348999999990-99999
Q 002462 667 QASSILLDDKFEVRLGSLSEVCAQGGDAHQSR---ITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGI 742 (919)
Q Consensus 667 K~~NILld~~~~~ki~dfg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllT-G~~p~ 742 (919)
||+|||+|.++.+||+|||.++.......... .....+++.+++|+......++.++|||||||++|||+| |+.||
T Consensus 155 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf 234 (299)
T d1jpaa_ 155 AARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234 (299)
T ss_dssp CGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCEEEECCCCCEEECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCC
T ss_conf 50448988999199888443157567777653650256668830038788836997861214453578999986799999
Q ss_pred CCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 899946899999841233111232220110268888890069999999999987159999999998999999202323
Q 002462 743 SASSDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 743 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~~ 820 (919)
......+....+..... +.......++ +..++..||+.+|++||+|++|++.|+..++
T Consensus 235 ~~~~~~~~~~~i~~~~~-----------------~~~~~~~~~~---l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 235 WDMTNQDVINAIEQDYR-----------------LPPPMDCPSA---LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp TTCCHHHHHHHHHTTCC-----------------CCCCTTCCHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHCCCC-----------------CCCCCCCHHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf 99999999999973788-----------------9997422699---9999999758797689299999999999841
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.10 Aligned_cols=255 Identities=22% Similarity=0.334 Sum_probs=202.0
Q ss_pred CCCCCCCCCCCCCCCCEEEEEECCCCCEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEECC
Q ss_conf 99983233345888848999954996189999515531089999999998616999841365588604881799997227
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~Ey~~ 613 (919)
.+|.....||+|+||.||+|.+.++..||||+++......++|.+|++++++++|||||+++|+|.+ ++..++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCCCCEECC-CCCEEEEEEECC
T ss_conf 9958888982088829999998899999999987886768999999999996689975653524315-993379998369
Q ss_pred CCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHHHCCCC
Q ss_conf 99810010006999775677799999999999999855451289999264468899600179996224885002403899
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~~~~~~ 693 (919)
+|+|.+++.... ..++|.++++|+.|+|+||.|||+. +|+||||||+|||+|+++.+||+|||.++.....
T Consensus 84 ~g~L~~~l~~~~------~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 84 HGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp TCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred CCCHHHHHHCCC------CCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEECCCC
T ss_conf 991899752013------4788999999999999987765316---4310443153266668877686553210023688
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCC-CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 851035520257777545677877999778603489999999909-9999899946899999841233111232220110
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTG-KMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG-~~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~i 772 (919)
.... .....+++.+.+|+......++.++|||||||++|||+|+ ++|+...+..+....+.... ..
T Consensus 155 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~------------~~ 221 (263)
T d1sm2a_ 155 QYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------------RL 221 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC------------CC
T ss_pred CCEE-ECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC------------CC
T ss_conf 7335-0430017666785786079998403321059999999878988877899999999998068------------88
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 26888889006999999999998715999999999899999920232
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~ 819 (919)
..|.. ..+ .+..++..||+.+|++||+|++|++.|+++.
T Consensus 222 ~~p~~-----~~~---~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 222 YKPRL-----AST---HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCCTT-----SCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCC-----CCH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 99543-----679---9999999976579768919999999999998
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.89 Aligned_cols=259 Identities=21% Similarity=0.359 Sum_probs=198.3
Q ss_pred CCCCCCCCCCCCCCCCEEEEEECCCCCEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEE
Q ss_conf 99983233345888848999954996189999515531---089999999998616999841365588604881799997
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~E 610 (919)
++|...+.||+|+||.||+|++.+ .||||+++.... ..+.|.+|++++++++|||||+++|+|.+ +..++|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEECC--EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC--CEEEEEEE
T ss_conf 518998898307885899999999--89999997346998999999999999984799878645679715--58999996
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHHHC
Q ss_conf 22799810010006999775677799999999999999855451289999264468899600179996224885002403
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~~~ 690 (919)
||++|+|.++++.... .++|.++++|+.|+|+||+|||+. +||||||||+|||+|+++.+||+|||.++..
T Consensus 84 y~~~g~L~~~l~~~~~------~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET------KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp CCCEEEHHHHHHTSCC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred CCCCCCHHHHHHHCCC------CCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCCEEEC
T ss_conf 5899888999852357------899999999999999998887509---9951614789979818997887500221333
Q ss_pred CCCCCCEEEEEECCCCCCCCCCCCC---CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHH-HHHHHHHHCCCCCCCCC
Q ss_conf 8998510355202577775456778---7799977860348999999990999998999468-99999841233111232
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSG---SLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLPYISIYDK 766 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~-~~~~~~~~~p~~~~~~~ 766 (919)
.............+++.|++|+... ...++.++|||||||++|||+||+.||...+... ....+......
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~------ 228 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS------ 228 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC------
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC------
T ss_conf 55677631256655743179999950568999953151635999999997889989989699999999658889------
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 2201102688888900699999999999871599999999989999992023232
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLKV 821 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~~~ 821 (919)
....++ .....++ +..++.+||+.+|++||||++|++.|+...+.
T Consensus 229 p~~~~~-------~~~~~~~---l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 229 PDLSKV-------RSNCPKA---MKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CCGGGS-------CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCHHC-------CCCCHHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 860003-------6555499---99999997588976892999999999999970
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.38 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=197.8
Q ss_pred CCCCCCCCCCCCCCCCEEEEEECCCCCEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEECC
Q ss_conf 99983233345888848999954996189999515531089999999998616999841365588604881799997227
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~Ey~~ 613 (919)
++|...+.||+|+||.||+|.+.++..||||+++......++|.+|++++++++|||||+++|+|.+ +..++|||||+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEECCT
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCEEEEEEECC
T ss_conf 9938867981079828999999999999999986476888999999999986799988578731045--97699999578
Q ss_pred CCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHHHCCCC
Q ss_conf 99810010006999775677799999999999999855451289999264468899600179996224885002403899
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~~~~~~ 693 (919)
+|+|.++++.... ..++|.++++|+.++|+||.|||+. +||||||||+|||+|+++.+||+|||.++.....
T Consensus 91 ~g~L~~~~~~~~~-----~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 91 NGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp TCBHHHHTTSHHH-----HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCHHHHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCEEECCCC
T ss_conf 9828888751478-----9887889999999999999999748---9546756422515620244042341014773588
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 851035520257777545677877999778603489999999909999-9899946899999841233111232220110
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMG-ISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p-~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~i 772 (919)
.... .....+++.+.+|+......++.++|||||||++|||+||..| +......+....+..... .
T Consensus 163 ~~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~------------~ 229 (272)
T d1qpca_ 163 EYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------------M 229 (272)
T ss_dssp CEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------C
T ss_pred CCCC-CCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC------------C
T ss_conf 6442-03567744445828983799982456452579999999689888888899999999970688------------8
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 26888889006999999999998715999999999899999920232
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~ 819 (919)
..| ....++ +..++..||+.+|++||||.+|++.|++..
T Consensus 230 ~~p-----~~~~~~---l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 230 VRP-----DNCPEE---LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCC-----TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC-----CCCHHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 896-----557199---999999975889768939999999861132
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=362.12 Aligned_cols=256 Identities=23% Similarity=0.356 Sum_probs=199.8
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEC-CCCCEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEEC
Q ss_conf 99983233345888848999954-99618999951553108999999999861699984136558860488179999722
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~Ey~ 612 (919)
++|...+.||+|+||.||+|+.. ++..||||++.......++|.+|+++|++++|||||+++|+|.+ ++..++|||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCHHHHHHHHHHHHHHCCCCCEECCCCCEEE-CCEEEEEEECC
T ss_conf 99398659820888089999999999699999977761039999999999986799988267752745-78547876314
Q ss_pred CCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHHHCCC
Q ss_conf 79981001000699977567779999999999999985545128999926446889960017999622488500240389
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~~~~~ 692 (919)
++|+|.+++.+... ..++|..++.|+.|+|+||.|||+. +||||||||+|||+|+++.+||+|||.++....
T Consensus 96 ~~g~l~~~l~~~~~-----~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 96 TYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp TTCBHHHHHHHSCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred CCCCHHHHHHHCCC-----CCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEECCC
T ss_conf 67606777530355-----4157999999999999978889878---930576045768998999289832445465378
Q ss_pred CCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCC-CCCHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 985103552025777754567787799977860348999999990999998-9994689999984123311123222011
Q 002462 693 DAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGIS-ASSDAQVKEILEQTLPYISIYDKELVTK 771 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 771 (919)
..... .+...+++.+.+|+......++.++|||||||++|||+||+.|+. ..+.......+.....
T Consensus 168 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~------------ 234 (287)
T d1opja_ 168 DTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------------ 234 (287)
T ss_dssp SSSEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC------------
T ss_pred CCCEE-ECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC------------
T ss_conf 87221-03556654666927872799981043021789999998679988774259999999855888------------
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 026888889006999999999998715999999999899999920232
Q 002462 772 IVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 772 i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~ 819 (919)
+. ......++ +..++..||+.+|.+||||.+|++.|+...
T Consensus 235 ---~~--~~~~~~~~---l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 235 ---ME--RPEGCPEK---VYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ---CC--CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---CC--CCCCCHHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf ---88--87433099---999999975779768939999999999998
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.44 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=203.5
Q ss_pred CCCCCCCCCCCCCCCCEEEEEECCCCCEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEECC
Q ss_conf 99983233345888848999954996189999515531089999999998616999841365588604881799997227
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~Ey~~ 613 (919)
++|...+.||+|+||+||+|+.+++..||||.+.......++|.+|++++++++|||||+++|+|.+ ++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECC-SSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCCEEEEEECCC
T ss_conf 9979968982078839999998899899999987475778999999999996689860158899850-781699997048
Q ss_pred CCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHHHCCCC
Q ss_conf 99810010006999775677799999999999999855451289999264468899600179996224885002403899
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~~~~~~ 693 (919)
+|+|.+++.... ..++|..+.+|+.|+|+||.|||+. +|+||||||+|||+|+++.+||+|||.++.....
T Consensus 83 ~g~l~~~~~~~~------~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 83 NGCLLNYLREMR------HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp TEEHHHHHHSGG------GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred CCCHHHHHHCCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEECCCC
T ss_conf 993888641024------6776899999999999999987546---8434665413588769984798861442023578
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 85103552025777754567787799977860348999999990-99999899946899999841233111232220110
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllT-G~~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~i 772 (919)
.... .....+++.+.+|+......++.++|||||||++|||+| |+.||...+..+....+.... ..
T Consensus 154 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~------------~~ 220 (258)
T d1k2pa_ 154 EYTS-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL------------RL 220 (258)
T ss_dssp SCCC-CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC------------CC
T ss_pred CCEE-ECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC------------CC
T ss_conf 7225-2465788775780786379988521033643246739755999988999999999998079------------78
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 268888890069999999999987159999999998999999202
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~ 817 (919)
..|. ...+ .+..++..||+.+|++||||.+|++.|.+
T Consensus 221 ~~p~-----~~~~---~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 221 YRPH-----LASE---KVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCT-----TCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCC-----CCCH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 9965-----4659---99999999766897689399999987418
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.71 Aligned_cols=255 Identities=19% Similarity=0.249 Sum_probs=195.7
Q ss_pred CCCCCCC-CCCCCCCCEEEEEEC---CCCCEEEEEECCCCCC--HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 9983233-345888848999954---9961899995155310--899999999986169998413655886048817999
Q 002462 535 DFSDANL-IKNGHSGDLFRGILE---GGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 535 ~f~~~~~-ig~G~~G~Vy~g~l~---~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV 608 (919)
+|...++ ||+|+||.||+|... ++..||||.++..... .++|.+|+++|++++|||||+++|+|.. +..++|
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~lv 86 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLV 86 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEE
T ss_pred CEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CEEEEE
T ss_conf 718878487306080999999960897689999998820397899999999999986799888068656036--807999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHH
Q ss_conf 97227998100100069997756777999999999999998554512899992644688996001799962248850024
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~ 688 (919)
||||++|+|.+++.... ..++|.++++|+.|+|+||+|||+. +||||||||+|||++.++.+||+|||.++
T Consensus 87 mE~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp EECCTTEEHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEECCCCCHHHHHHCCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHH
T ss_conf 98078996899752125------6999999999999999987899868---81057676466045468854203313421
Q ss_pred HCCCCCCCE-EEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf 038998510-3552025777754567787799977860348999999990-99999899946899999841233111232
Q 002462 689 AQGGDAHQS-RITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDK 766 (919)
Q Consensus 689 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllT-G~~p~~~~~~~~~~~~~~~~~p~~~~~~~ 766 (919)
......... ......+++.+.+|+......++.++|||||||++|||+| |+.||......+....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~------- 230 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------- 230 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-------
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC-------
T ss_conf 1554343211356211374335868872799995412322017899999389999999799999999981899-------
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 220110268888890069999999999987159999999998999999202323
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~~ 820 (919)
+ ...+...++ +..++..||+.+|++||+|.+|++.|+.+..
T Consensus 231 --------~--~~p~~~~~~---l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 231 --------M--ECPPECPPE---LYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp --------C--CCCTTCCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------C--CCCCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf --------9--999767899---9999999757797689099999999999999
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.30 Aligned_cols=260 Identities=22% Similarity=0.287 Sum_probs=199.3
Q ss_pred CCCCCCCCCCCCCCCCEEEEEECCC------CCEEEEEECCCCC--CHHHHHHHHHHHHHC-CCCCCCCEEEEEEECCCC
Q ss_conf 9998323334588884899995499------6189999515531--089999999998616-999841365588604881
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEGG------IPVVIKRIDLQSV--KTEAYLLELDFFSKV-SHARLVPLLGHCMERENE 604 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~g------~~vavK~l~~~~~--~~~~f~~Ei~~l~~l-~H~NiV~l~g~c~~~~~~ 604 (919)
++|...+.||+|+||.||+|+.... ..||||.+..... ..+.|.+|+.++.++ +|||||+++|+|.+ .+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-SGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSS
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCE
T ss_conf 9939701983078819999998578855420499999966335878999999999999971589968687788862-995
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCC
Q ss_conf 799997227998100100069997----------------7567779999999999999985545128999926446889
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTE----------------DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQA 668 (919)
Q Consensus 605 ~~LV~Ey~~~GsL~~~L~~~~~~~----------------~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~ 668 (919)
.++|||||++|+|.++|+.+.... .....++|..++.|+.|+|+||+|||+. +||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCH
T ss_conf 89999727999599999862577751022100001222001257789999999999999999999739---905052703
Q ss_pred CCEECCCCCCEEECCCCHHHHCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCH
Q ss_conf 960017999622488500240389985103552025777754567787799977860348999999990-9999989994
Q 002462 669 SSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSD 747 (919)
Q Consensus 669 ~NILld~~~~~ki~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllT-G~~p~~~~~~ 747 (919)
+|||++.++.+||+|||.++...............+++.+++|+......++.++|||||||++|||+| |+.||.+.+.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred HCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf 21443459828985142222045778615623435787657838872799996330300039999998389999999898
Q ss_pred -HHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf -6899999841233111232220110268888890069999999999987159999999998999999202
Q 002462 748 -AQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 748 -~~~~~~~~~~~p~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~ 817 (919)
......+..... + .......++ +..++..||+.+|++||||+||++.|..
T Consensus 273 ~~~~~~~~~~~~~---------------~--~~p~~~~~~---l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 DANFYKLIQNGFK---------------M--DQPFYATEE---IYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp SHHHHHHHHTTCC---------------C--CCCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHCCCC---------------C--CCCCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 9999999856998---------------9--988767899---9999999758896689399999999748
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.28 Aligned_cols=258 Identities=20% Similarity=0.314 Sum_probs=197.2
Q ss_pred CCCCCCCCCCCCCCCCEEEEEECCC-----CCEEEEEECCCCCC--HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEE
Q ss_conf 9998323334588884899995499-----61899995155310--8999999999861699984136558860488179
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEGG-----IPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKF 606 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~g-----~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~ 606 (919)
..|...++||+|+||.||+|.+... ..||||++...... .++|.+|++++++++|||||+++|+|.+. +..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-KPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CCEE
T ss_conf 996861598117790999999968998787999999988445968999999999999856898783236778338-8038
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCH
Q ss_conf 99972279981001000699977567779999999999999985545128999926446889960017999622488500
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 607 LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~ 686 (919)
+|||||.+|++.+.+.... ..++|.++++|+.|+|+||+|||+. +||||||||+|||+|.++.+||+|||.
T Consensus 86 ~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EEEEECCCCCCHHHHHCCC------CCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCCCH
T ss_conf 9997213574022210234------5420899999999999854121212---342576564427888998499845510
Q ss_pred HHHCCCCCCC-EEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHHHCCCCCCC
Q ss_conf 2403899851-0355202577775456778779997786034899999999099999-8999468999998412331112
Q 002462 687 VCAQGGDAHQ-SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGI-SASSDAQVKEILEQTLPYISIY 764 (919)
Q Consensus 687 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~-~~~~~~~~~~~~~~~~p~~~~~ 764 (919)
++........ .......+++.|.+|+......++.++|||||||++|||+||+.|+ ...+..+....+.....
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~----- 231 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR----- 231 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----
T ss_pred HHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC-----
T ss_conf 300357876526742677773434888870499997355634489899999679886556899999999863578-----
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 322201102688888900699999999999871599999999989999992023232
Q 002462 765 DKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLKV 821 (919)
Q Consensus 765 ~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~~~ 821 (919)
+. ......++ +..++.+||+.+|++||+|.+|++.|+..++.
T Consensus 232 ----------~~--~~~~~~~~---l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 232 ----------LP--TPMDCPSA---IYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----------CC--CCTTCBHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----------CC--CCHHHHHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ----------99--85045799---99999997767976893999999999998669
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=356.64 Aligned_cols=264 Identities=20% Similarity=0.240 Sum_probs=203.9
Q ss_pred HHCCCCCCCCCCCCCCCCEEEEEECC------CCCEEEEEECCCCCC--HHHHHHHHHHHHHCCCCCCCCEEEEEEECCC
Q ss_conf 83999832333458888489999549------961899995155310--8999999999861699984136558860488
Q 002462 532 ATGDFSDANLIKNGHSGDLFRGILEG------GIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMEREN 603 (919)
Q Consensus 532 ~t~~f~~~~~ig~G~~G~Vy~g~l~~------g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~ 603 (919)
..++|...+.||+|+||.||+|++.+ +..||||+++..... .++|.+|++++++++|||||+++|+|.. .+
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~ 89 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-GK 89 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SS
T ss_pred CHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECC-CC
T ss_conf 98893886798207883999999888765778829999998821085799999999999996689976552466605-98
Q ss_pred CEEEEEEECCCCCHHHHHHCCCCC-----------------CCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCC
Q ss_conf 179999722799810010006999-----------------775677799999999999999855451289999264468
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNT-----------------EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDV 666 (919)
Q Consensus 604 ~~~LV~Ey~~~GsL~~~L~~~~~~-----------------~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDl 666 (919)
..++||||+++|+|.++++..... ......++|.++++|+.|+|+||+|||+. +||||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CEEEEEE
T ss_conf 0389998158992999998527554210000111001210346788989999999999999985541357---8685488
Q ss_pred CCCCEECCCCCCEEECCCCHHHHCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC-CCCCCC
Q ss_conf 8996001799962248850024038998510355202577775456778779997786034899999999099-999899
Q 002462 667 QASSILLDDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGK-MGISAS 745 (919)
Q Consensus 667 K~~NILld~~~~~ki~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~-~p~~~~ 745 (919)
||+|||+|.++.+||+|||.++...........+...+++.+.+++......++.++||||||||+|||+||. +|+...
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCC
T ss_conf 40116898999289833144211367764111577776767679899726889805630252362999980689999998
Q ss_pred CHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 94689999984123311123222011026888889006999999999998715999999999899999920232
Q 002462 746 SDAQVKEILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 746 ~~~~~~~~~~~~~p~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~ 819 (919)
+..+....+.... ... .++....+ +..++..||+.+|++||||.||+++|+.+.
T Consensus 247 ~~~e~~~~v~~~~----------~~~-------~p~~~~~~---~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 AHEEVIYYVRDGN----------ILA-------CPENCPLE---LYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CHHHHHHHHHTTC----------CCC-------CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CHHHHHHHHHCCC----------CCC-------CCCCCHHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 9999999997399----------788-------87325299---999999974889657939999999999842
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.10 Aligned_cols=256 Identities=21% Similarity=0.303 Sum_probs=200.8
Q ss_pred CCCCCCCCCCCCCCCCEEEEEECCCCCEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEECC
Q ss_conf 99983233345888848999954996189999515531089999999998616999841365588604881799997227
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~Ey~~ 613 (919)
.+|...+.||+|+||.||+|+..++..||||++.......++|.+|+.++++++|||||+++|+|.+ +..++|||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~--~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCT
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC--CCEEEEEEECC
T ss_conf 9979846993079809999999999999999988044888999999999986666788689999823--97599999447
Q ss_pred CCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHHHCCCC
Q ss_conf 99810010006999775677799999999999999855451289999264468899600179996224885002403899
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~~~~~~ 693 (919)
+|+|.+.++.... ..++|.++++|+.++|+||+|||+. +|+||||||+|||+|+++.+||+|||.++.....
T Consensus 95 ~g~l~~~~~~~~~-----~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 95 KGSLLDFLKGETG-----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp TCBHHHHHSHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred CCCHHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHHHCCCC
T ss_conf 9943542000035-----5305999999999999999987541---1433531230799989992998442555425688
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 8510355202577775456778779997786034899999999099999-899946899999841233111232220110
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGI-SASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~-~~~~~~~~~~~~~~~~p~~~~~~~~~~~~i 772 (919)
.... .....+++.+.+|+......++.++||||||+++|||+||+.|+ ......+....+.....
T Consensus 167 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~------------- 232 (285)
T d1fmka3 167 EYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------- 232 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------------
T ss_pred CCEE-ECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC-------------
T ss_conf 7335-24545566545808983799891774132358999998689999988889999999982689-------------
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 268888890069999999999987159999999998999999202323
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~~ 820 (919)
+ ...+...++ +..++.+||+.+|++||+|.+|+++|+....
T Consensus 233 --~--~~~~~~~~~---l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 233 --M--PCPPECPES---LHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp --C--CCCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred --C--CCCCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf --9--998323799---9999999756697589199999998766623
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.84 Aligned_cols=248 Identities=18% Similarity=0.233 Sum_probs=194.4
Q ss_pred CCCCCCCCCCEEEEEECC---CCCEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEECC
Q ss_conf 333458888489999549---96189999515531---089999999998616999841365588604881799997227
Q 002462 540 NLIKNGHSGDLFRGILEG---GIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~---g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~Ey~~ 613 (919)
..||+|+||.||+|.+.+ +..||||++..... ..++|.+|+++|++++|||||+++|+|.. +..+||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~--~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC--CCEEEEEECCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505--97799997478
Q ss_pred CCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHHHCCCC
Q ss_conf 99810010006999775677799999999999999855451289999264468899600179996224885002403899
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~~~~~~ 693 (919)
+|+|.+++.+.. .++|.++++|+.|+|+||+|||+. +||||||||+|||++.++.+|++|||+++.....
T Consensus 91 ~g~L~~~l~~~~-------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 91 LGPLNKYLQQNR-------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp TEEHHHHHHHCT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred CCCHHHHHHHCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCC
T ss_conf 896899975225-------789999999999999997668747---9556777611310235675123413453313432
Q ss_pred CCCE-EEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 8510-3552025777754567787799977860348999999990-9999989994689999984123311123222011
Q 002462 694 AHQS-RITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTK 771 (919)
Q Consensus 694 ~~~~-~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllT-G~~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 771 (919)
.... ......+++.+++|+......++.++|||||||++|||+| |+.||...+..+....+....+
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~------------ 228 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER------------ 228 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------
T ss_pred CCCCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC------------
T ss_conf 34432244567784203916653799984344303403132896589999999899999999982899------------
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 026888889006999999999998715999999999899999920232
Q 002462 772 IVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 772 i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~ 819 (919)
+..+....++ +..++..||+.+|++||+|++|+..|+.+.
T Consensus 229 -----~~~p~~~~~~---~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 229 -----MGCPAGCPRE---MYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp -----CCCCTTCCHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHCHH
T ss_conf -----9998656799---999999975889768909899999852887
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.85 Aligned_cols=275 Identities=19% Similarity=0.205 Sum_probs=191.3
Q ss_pred CCCCCCCCCCCCCCEEEEEECCCCCEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC---CEEEEEEEC
Q ss_conf 98323334588884899995499618999951553108999999999861699984136558860488---179999722
Q 002462 536 FSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMEREN---EKFLVYKYM 612 (919)
Q Consensus 536 f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~---~~~LV~Ey~ 612 (919)
+...+.||+|+||.||+|++ +|..||||+++........+..|+..+++++|||||+++|+|.+.+. ..++|||||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEEECC
T ss_conf 99988982078819999999-99899999987200467999999999962799868326889983798604899999646
Q ss_pred CCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC-----CCCEEECCCCCCCEECCCCCCEEECCCCHH
Q ss_conf 799810010006999775677799999999999999855451289-----999264468899600179996224885002
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHEC-----TLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~-----~~~IiHrDlK~~NILld~~~~~ki~dfg~~ 687 (919)
++|+|.++|++. .++|.++++++.++|+||+|||+.+ .++||||||||+|||+|+++.+||+|||++
T Consensus 84 ~~g~L~~~l~~~--------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 84 EHGSLFDYLNRY--------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp TTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCCCHHHHHHCC--------CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCC
T ss_conf 698989998658--------999899999999999999998876652046898661531731357868877688763866
Q ss_pred HHCCCCCCC--EEEEEECCCCCCCCCCCCCC------CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHHHC
Q ss_conf 403899851--03552025777754567787------7999778603489999999909999989994689999-98412
Q 002462 688 CAQGGDAHQ--SRITRLLRLPQSSEQGSSGS------LTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEI-LEQTL 758 (919)
Q Consensus 688 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~------~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~-~~~~~ 758 (919)
+........ .......+++.|.+|+.... ..++.++||||||||+|||+||+.|+........... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred CCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCC
T ss_conf 23467776200135525035476782210565454677767501220159999999628998876631124101225564
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 3311123222011026888889006999999999998715999999999899999920232
Q 002462 759 PYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 759 p~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~ 819 (919)
+..............+|.+.......+....+..++.+||+.+|++||||.||++.|+...
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 3099999987502468887765577689999999999976069858959999999999888
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.82 Aligned_cols=256 Identities=20% Similarity=0.296 Sum_probs=200.7
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEC-CCC----CEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEE
Q ss_conf 99983233345888848999954-996----18999951553--108999999999861699984136558860488179
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE-GGI----PVVIKRIDLQS--VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKF 606 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~-~g~----~vavK~l~~~~--~~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~ 606 (919)
.+|...++||+|+||.||+|... +|. .||||++.... ...++|.+|++++++++|||||+++|+|.+ +..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC--CCEE
T ss_conf 99978319820899299999995899889899999996513497999999999999986799888158999961--9836
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCH
Q ss_conf 99972279981001000699977567779999999999999985545128999926446889960017999622488500
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 607 LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~ 686 (919)
+++||+++|+|.+.+.... ..++|..+++|+.|+|+||+|||+. +||||||||+|||+|.++.+||+|||.
T Consensus 87 ~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGl 157 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGL 157 (317)
T ss_dssp EEEECCTTCBHHHHHHHTS------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred EEEEECCCCCCCCCCCCCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCCC
T ss_conf 9998426874010111334------5799999999999999999999876---950476212031167998758602552
Q ss_pred HHHCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHHCCCCCCCC
Q ss_conf 240389985103552025777754567787799977860348999999990-9999989994689999984123311123
Q 002462 687 VCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYD 765 (919)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllT-G~~p~~~~~~~~~~~~~~~~~p~~~~~~ 765 (919)
++...............+++.+.+|+......++.++|||||||++|||+| |+.|+...+..+....+.....
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~------ 231 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER------ 231 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC------
T ss_pred CEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC------
T ss_conf 22335444532236510586446708874699983565440799999999779999999998999999975998------
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 2220110268888890069999999999987159999999998999999202323
Q 002462 766 KELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 766 ~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~~ 820 (919)
+..++...++ +..++..||+.+|.+||+|++|+..|+...+
T Consensus 232 -----------~~~p~~~~~~---~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 232 -----------LPQPPICTID---VYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -----------CCCCTTBCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------CCCCCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf -----------9998556899---9999998478993469199999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.91 Aligned_cols=254 Identities=23% Similarity=0.356 Sum_probs=191.9
Q ss_pred CCCCCCCCCCCEEEEEECCC----CCEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEEC
Q ss_conf 23334588884899995499----6189999515531--08999999999861699984136558860488179999722
Q 002462 539 ANLIKNGHSGDLFRGILEGG----IPVVIKRIDLQSV--KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~l~~g----~~vavK~l~~~~~--~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~Ey~ 612 (919)
.++||+|+||+||+|++.+. ..||||+++.... ..++|.+|+++|++++|||||+++|+|.+.++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHHHCCC
Q ss_conf 79981001000699977567779999999999999985545128999926446889960017999622488500240389
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~~~~~ 692 (919)
++|+|.++++... ..++|..+++|+.|+|+||.|||+. +|+||||||+|||+|+++.+||+|||.++....
T Consensus 112 ~~g~l~~~~~~~~------~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 112 KHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp TTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred ECCCHHHHHCCCC------CCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCCC
T ss_conf 0674144210134------5404899999999988765200336---762577668757677999889910652322556
Q ss_pred CCCCE--EEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 98510--35520257777545677877999778603489999999909999989994-6899999841233111232220
Q 002462 693 DAHQS--RITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSD-AQVKEILEQTLPYISIYDKELV 769 (919)
Q Consensus 693 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~-~~~~~~~~~~~p~~~~~~~~~~ 769 (919)
..... ......+++.+.+|+......++.++||||||+++|||+||+.|+..... ......+....
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~----------- 251 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR----------- 251 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC-----------
T ss_pred CCCCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC-----------
T ss_conf 655531002565556455676887437999745746619999999978999988899999999998089-----------
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 1102688888900699999999999871599999999989999992023232
Q 002462 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLKV 821 (919)
Q Consensus 770 ~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~~~ 821 (919)
....|. ...++ +..++..||+.+|++||+|.||++.|+...+.
T Consensus 252 -~~~~p~-----~~~~~---l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 252 -RLLQPE-----YCPDP---LYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -CCCCCT-----TCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCCCC-----CCCHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf -889964-----47599---99999997688976893999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.42 Aligned_cols=247 Identities=18% Similarity=0.286 Sum_probs=194.8
Q ss_pred CCCCCCCCCCCCCCCCEEEEE-ECCCCCEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 999832333458888489999-54996189999515531-0899999999986169998413655886048817999972
Q 002462 534 GDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSV-KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~-~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~Ey 611 (919)
++|...+.||+|+||.||+|. ..+|..||||++..... ..+.+.+|++++++++|||||++++++.+ ++..|+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCEEEEEEEE
T ss_conf 053887898128582999999989998999999843017279999999999986799988058577988-9998999970
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHHHCC
Q ss_conf 27998100100069997756777999999999999998554512899992644688996001799962248850024038
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~~~~ 691 (919)
|++|+|.+.+.++ .++..+...|+.|++.||+|||+. +||||||||+|||++.++.+|++|||.++...
T Consensus 99 ~~gg~L~~~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 99 LAGGSLTDVVTET--------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (293)
T ss_dssp CTTCBHHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEEC
T ss_conf 3798089886415--------999999999999999999999987---97226776888688789968642515641321
Q ss_pred CCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHHHCCCCCCCCCCCCC
Q ss_conf 9985103552025777754567787799977860348999999990999998999468999-998412331112322201
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKE-ILEQTLPYISIYDKELVT 770 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~-~~~~~~p~~~~~~~~~~~ 770 (919)
..... .....+++.|.+|+......++.++||||+||++|||+||+.||...+...... ......+..
T Consensus 168 ~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~--------- 236 (293)
T d1yhwa1 168 PEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--------- 236 (293)
T ss_dssp STTCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC---------
T ss_pred CCCCC--CCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC---------
T ss_conf 36664--4444447773682664479988012031372999998048899899799999999985799988---------
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 1026888889006999999999998715999999999899999
Q 002462 771 KIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 771 ~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
...+...++ +..++.+||+.+|.+||++.|+++
T Consensus 237 -------~~~~~~s~~---~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 -------QNPEKLSAI---FRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -------SSGGGSCHH---HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -------CCCCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -------885537999---999999986699668909999964
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.45 Aligned_cols=250 Identities=18% Similarity=0.259 Sum_probs=192.4
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCC--HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEE
Q ss_conf 9998323334588884899995-49961899995155310--89999999998616999841365588604881799997
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~E 610 (919)
++|...+.||+|+||.||+|+. .+|..||||+++..... .+.|.+|++++++++|||||++++++.+ ++..|+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEE
T ss_conf 4608998972174809999999999979999998456641279999999999985799888469654046-743679886
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHHHC
Q ss_conf 22799810010006999775677799999999999999855451289999264468899600179996224885002403
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~~~ 690 (919)
|+++|+|.+++.+.. .+++.+...|+.|+++||.|||+. +||||||||+|||+++++.+||+|||.++..
T Consensus 84 y~~gg~L~~~l~~~~-------~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI-------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 153 (271)
T ss_dssp CCTTEEGGGGSBTTT-------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEE
T ss_conf 458980899975379-------999999999999999999999975---9835754689978878998798323142240
Q ss_pred CCCCCCEEEEEECCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHHHCCCCCCCCCCC
Q ss_conf 8998510355202577775456778779-997786034899999999099999899946899-99984123311123222
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLT-ATCPYDVYCFGKVLLELVTGKMGISASSDAQVK-EILEQTLPYISIYDKEL 768 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~-~~~~~~~p~~~~~~~~~ 768 (919)
.........+...+++.|++|+...... ++.++||||+||++|||+||+.||....+.... ..........
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~------- 226 (271)
T d1nvra_ 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------- 226 (271)
T ss_dssp EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS-------
T ss_pred CCCCCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC-------
T ss_conf 4688653111325574742872861899999710161737999999829978888985999999986388878-------
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 011026888889006999999999998715999999999899999
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
.+ .....++ +..++.+|++.+|++|||++|+++
T Consensus 227 -----~~----~~~~s~~---~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 -----NP----WKKIDSA---PLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -----TT----GGGSCHH---HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CC----CCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -----86----4469999---999999976799668909999961
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.74 Aligned_cols=255 Identities=21% Similarity=0.294 Sum_probs=199.0
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCCCCEEEEEEEC-CCCEEEE
Q ss_conf 9998323334588884899995-49961899995155310---89999999998616999841365588604-8817999
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMER-ENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~-~~~~~LV 608 (919)
++|...+.||+|+||.||+|+. .+|..||||.+...... .+.|.+|++++++++|||||++++++.+. ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--CCCEEECCCCCCCEECCCCCCEEECCCCH
Q ss_conf 9722799810010006999775677799999999999999855451289--99926446889960017999622488500
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHEC--TLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~--~~~IiHrDlK~~NILld~~~~~ki~dfg~ 686 (919)
||||++|+|.+++.+... ....+++.+...|+.|++.||.|||+.. ..+||||||||+|||++.++.+||+|||.
T Consensus 84 mEy~~~g~L~~~i~~~~~---~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 84 MEYCEGGDLASVITKGTK---ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EECCTTEEHHHHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EECCCCCCHHHHHHHCCC---CCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCC
T ss_conf 956899938999985154---57899999999999999999999997167788788586765425747888579800100
Q ss_pred HHHCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf 24038998510355202577775456778779997786034899999999099999899946899999841233111232
Q 002462 687 VCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDK 766 (919)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~~~~~~~ 766 (919)
++........ .....+++.|++|+......++.++|||||||++|||+||+.||...+..+....+....
T Consensus 161 a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~-------- 230 (269)
T d2java1 161 ARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-------- 230 (269)
T ss_dssp HHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--------
T ss_pred EEECCCCCCC--CCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHCCC--------
T ss_conf 0322457775--566778823279999839999938988752789999801889989989999999997189--------
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 22011026888889006999999999998715999999999899999
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
...+ .....++ +..++.+||+.+|.+||++.|+++
T Consensus 231 --~~~~-------~~~~s~~---l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 --FRRI-------PYRYSDE---LNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --CCCC-------CTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCC-------CCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf --9889-------7435999---999999976799557918999972
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.54 Aligned_cols=264 Identities=21% Similarity=0.283 Sum_probs=200.7
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEC------CCCCEEEEEECCCCCC--HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCE
Q ss_conf 99983233345888848999954------9961899995155310--899999999986169998413655886048817
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE------GGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEK 605 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~------~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~ 605 (919)
++|.....||+|+||.||+|.+. .+..||||+++..... ...|.+|++++++++|||||+++|+|.. ++..
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~ 98 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQPT 98 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-SSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCCE
T ss_conf 991883598207881899999878644778968999998701286899999999999997699988412547842-8810
Q ss_pred EEEEEECCCCCHHHHHHCCCCC---CCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEEC
Q ss_conf 9999722799810010006999---7756777999999999999998554512899992644688996001799962248
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNT---EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLG 682 (919)
Q Consensus 606 ~LV~Ey~~~GsL~~~L~~~~~~---~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~ 682 (919)
++|||||++|+|.++++..... ......++|.++++|+.++|+||.|||+. +||||||||+|||+|+++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCCCEEEEE
T ss_conf 677760489988999875033211344468879999999999999999987647---96543286775403599649994
Q ss_pred CCCHHHHCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC-CCCCCCCHHHHHHHHHHHCCCC
Q ss_conf 850024038998510355202577775456778779997786034899999999099-9998999468999998412331
Q 002462 683 SLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGK-MGISASSDAQVKEILEQTLPYI 761 (919)
Q Consensus 683 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~-~p~~~~~~~~~~~~~~~~~p~~ 761 (919)
|||+++...............+++.+.+++......++.++||||||+++|||+||+ .|+...+..+....+....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~--- 252 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG--- 252 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC---
T ss_pred ECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC---
T ss_conf 24542023577630313402316323788887369988333444378999999968999999989999999998088---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 112322201102688888900699999999999871599999999989999992023232
Q 002462 762 SIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLKV 821 (919)
Q Consensus 762 ~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~~~ 821 (919)
. .+ ......+ .+..++.+||+.+|.+||+|.+|++.|+..+..
T Consensus 253 ------~----~~----~p~~~~~---~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 253 ------L----LD----KPDNCPD---MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp ------C----CC----CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ------C----CC----CCCCCHH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCC
T ss_conf ------8----88----8633539---999999997577965893999999997876177
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.03 Aligned_cols=263 Identities=19% Similarity=0.288 Sum_probs=194.4
Q ss_pred HCCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCC--HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 39998323334588884899995-49961899995155310--8999999999861699984136558860488179999
Q 002462 533 TGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~ 609 (919)
.++|...+.||+|+||.||+|+. .+|..||+|+++..... .+.+.+|+.+|++++|||||+++++|.+ ++..++||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE-CCEEEEEE
T ss_conf 56888978971277809999999899969999998754097899999999999986799999949999998-99999999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHHH
Q ss_conf 72279981001000699977567779999999999999985545128999926446889960017999622488500240
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~~ 689 (919)
|||++|+|.+++.+.. .+++.....++.|+++||.|||+. .+||||||||+|||+++++.+||+|||.++.
T Consensus 84 Ey~~gg~L~~~l~~~~-------~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG-------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp ECCTTEEHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred ECCCCCCHHHHHHHCC-------CCCHHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEECCCCCEEEEECCCCCC
T ss_conf 7679986899874249-------999999999999999999999985--9997144577994687899899954877625
Q ss_pred CCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-HHCCCC-------
Q ss_conf 389985103552025777754567787799977860348999999990999998999468999998-412331-------
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILE-QTLPYI------- 761 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~-~~~p~~------- 761 (919)
..... .....+++.|.+|+......++.++||||+|||+|||+||+.||.+.+..+...... ......
T Consensus 155 ~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 155 LIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp HHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred CCCCC----CCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
T ss_conf 67886----21113771411946875899894888998999999999888998998878999999887517754577421
Q ss_pred CCCCC----------------CCCCCCCC---CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 11232----------------22011026---888889006999999999998715999999999899999
Q 002462 762 SIYDK----------------ELVTKIVD---PSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 762 ~~~~~----------------~~~~~i~d---~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
..... +....+.. +.+... .... .+..++.+|++.+|.+|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~---~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSG-VFSL---EFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------------CCCCHHHHHHHHHTSCCCCCCBT-TBCH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC-CCCH---HHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 23332211112223541347788766502687667644-4899---9999999986899467908999960
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.73 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=195.3
Q ss_pred CCCCCCCCCCCCCCCCEEEEEECCCCCEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEECC
Q ss_conf 99983233345888848999954996189999515531089999999998616999841365588604881799997227
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYMP 613 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~Ey~~ 613 (919)
++|...+.||+|+||.||+|.+. |..||||+++.+. ..++|.+|++++++++|||||+++|+|.+..+..++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCHH-HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECCC
T ss_conf 99488579820798089999999-9099999988577-799999999999867898985498788723892899996369
Q ss_pred CCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHHHCCCC
Q ss_conf 99810010006999775677799999999999999855451289999264468899600179996224885002403899
Q 002462 614 NGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGGD 693 (919)
Q Consensus 614 ~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~~~~~~ 693 (919)
+|+|.++|+.... ..++|..+++|+.|+|.||.|||+. +||||||||+|||++.++.+|++|||.++.....
T Consensus 85 ~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 85 KGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp TEEHHHHHHHHHH-----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred CCCHHHHHHHCCC-----CCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEECCCC
T ss_conf 9989999874578-----8889999999999998523211337---6553666567601468997763245600344787
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 85103552025777754567787799977860348999999990-99999899946899999841233111232220110
Q 002462 694 AHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDKELVTKI 772 (919)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllT-G~~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~i 772 (919)
... ..+++.+.+|+......++.++||||||+++|||+| |+.|+......+....+....
T Consensus 157 ~~~-----~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~-------------- 217 (262)
T d1byga_ 157 QDT-----GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-------------- 217 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC--------------
T ss_pred CCC-----CCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC--------------
T ss_conf 765-----5666467781787279888588777579999999978999999999999999998089--------------
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 2688888900699999999999871599999999989999992023
Q 002462 773 VDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENP 818 (919)
Q Consensus 773 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~ 818 (919)
.+.. ...... ++..++.+||+.+|.+||+|.+|+++|+..
T Consensus 218 -~~~~--~~~~~~---~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 218 -KMDA--PDGCPP---AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp -CCCC--CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCC--CCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf -9999--765799---999999997566976893999999999999
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.61 Aligned_cols=260 Identities=23% Similarity=0.346 Sum_probs=195.0
Q ss_pred CCCCCCCCCCCCCCCCEEEEEECC-CC--CEEEEEECCCCC--CHHHHHHHHHHHHHC-CCCCCCCEEEEEEECCCCEEE
Q ss_conf 999832333458888489999549-96--189999515531--089999999998616-999841365588604881799
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEG-GI--PVVIKRIDLQSV--KTEAYLLELDFFSKV-SHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~-g~--~vavK~l~~~~~--~~~~f~~Ei~~l~~l-~H~NiV~l~g~c~~~~~~~~L 607 (919)
++|...++||+|+||.||+|+..+ +. .||||++..... ..++|.+|+++|+++ +|||||+++|+|.+ ++..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TTEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC-CCEEEE
T ss_conf 9968877982078828999999899969999999978233857999999999999862289988367888841-873699
Q ss_pred EEEECCCCCHHHHHHCCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCC
Q ss_conf 99722799810010006999---------775677799999999999999855451289999264468899600179996
Q 002462 608 VYKYMPNGDLSSSLYRKTNT---------EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFE 678 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~---------~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~ 678 (919)
||||+++|+|.++|++.... ......++|.++++++.|+|+||.|||+. +||||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCC
T ss_conf 9980289869999864035555512310123457899999999999999998766308---9545550520489868876
Q ss_pred EEECCCCHHHHCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC-CCCCCCCHHHHHHHHHHH
Q ss_conf 2248850024038998510355202577775456778779997786034899999999099-999899946899999841
Q 002462 679 VRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGK-MGISASSDAQVKEILEQT 757 (919)
Q Consensus 679 ~ki~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~-~p~~~~~~~~~~~~~~~~ 757 (919)
+||+|||.++........ ....+++.+.+|+......++.++|||||||++|||+||. .|+...+..+....+...
T Consensus 166 ~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp EEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred EEECCCCCCCCCCCCCCC---CCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC
T ss_conf 387434432244422345---53013775555387526999962215313889999983689999999999999999826
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 233111232220110268888890069999999999987159999999998999999202323
Q 002462 758 LPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 758 ~p~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~~ 820 (919)
. .+. ......++ +..++.+||+.+|++||+|++|++.|++..+
T Consensus 243 ~---------------~~~--~~~~~~~~---~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 243 Y---------------RLE--KPLNCDDE---VYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp C---------------CCC--CCTTBCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C---------------CCC--CCCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 8---------------888--87667899---9999999767896689499999999999986
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.23 Aligned_cols=244 Identities=17% Similarity=0.262 Sum_probs=194.6
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 9998323334588884899995-4996189999515531----0899999999986169998413655886048817999
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV 608 (919)
++|...+.||+|+||.||+|+. .++..||+|.+..... ..+.+.+|++++++++|||||++++++.+ ++..++|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE-CCEEEEE
T ss_conf 376998898517785899999989994999999816885676899999999999985688888859999998-9998999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHH
Q ss_conf 97227998100100069997756777999999999999998554512899992644688996001799962248850024
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~ 688 (919)
||||++|+|.+++.+.. .+++.+...|+.|+++||+|||+. +||||||||+|||++.++.+|++|||.++
T Consensus 85 mEy~~~g~L~~~l~~~~-------~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~ 154 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLS-------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV 154 (263)
T ss_dssp EECCTTCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred EEECCCCCHHHHHHHCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEEE
T ss_conf 85047985898875048-------999999999999999999999988---94652202344146689987115556335
Q ss_pred HCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 03899851035520257777545677877999778603489999999909999989994689999984123311123222
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~~~~~~~~~ 768 (919)
....... ....+++.+.+|+......++.++|||||||++|||+||+.||...+..+....+....+.
T Consensus 155 ~~~~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-------- 222 (263)
T d2j4za1 155 HAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-------- 222 (263)
T ss_dssp CCCCCCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--------
T ss_pred ECCCCCC----CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC--------
T ss_conf 4488852----3557887634999975899893144046759999983299998889999999999718999--------
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 011026888889006999999999998715999999999899999
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
.++...++ +..++..|++.+|++|||++|+++
T Consensus 223 ----------~p~~~s~~---~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 ----------FPDFVTEG---ARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----------CCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------CCCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ----------98668999---999999976479768909999971
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.17 Aligned_cols=248 Identities=18% Similarity=0.271 Sum_probs=189.4
Q ss_pred CCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCC-HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEEC
Q ss_conf 998323334588884899995-49961899995155310-8999999999861699984136558860488179999722
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~Ey~ 612 (919)
.|.....||+|+||.||+|.. .++..||||+++..... .+.|.+|+++|++++|||||++++++.+ ++..++|||||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lvmEy~ 91 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIEFC 91 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECC
T ss_pred CEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE-CCEEEEEEECC
T ss_conf 75984799307781999999999993999999872899999999999999986799998849889800-99589999627
Q ss_pred CCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHHHCCC
Q ss_conf 79981001000699977567779999999999999985545128999926446889960017999622488500240389
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQGG 692 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~~~~~ 692 (919)
++|+|.+++.+.. ..+++.+...|+.|+++||.|||+. +||||||||+|||++.++.+||+|||.++....
T Consensus 92 ~~g~L~~~~~~~~------~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 92 AGGAVDAVMLELE------RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp TTEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred CCCCHHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHCCCC
T ss_conf 9981889998628------9999999999999999999999988---988714070031487899989971612303577
Q ss_pred CCCCEEEEEECCCCCCCCCCCC-----CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHHHCCCCCCCCC
Q ss_conf 9851035520257777545677-----87799977860348999999990999998999468999-99841233111232
Q 002462 693 DAHQSRITRLLRLPQSSEQGSS-----GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKE-ILEQTLPYISIYDK 766 (919)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~-~~~~~~p~~~~~~~ 766 (919)
... ......+++.+.+|+.. ....++.++|||||||++|||+||+.||...+..+... +.....+.
T Consensus 163 ~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~------ 234 (288)
T d2jfla1 163 TIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT------ 234 (288)
T ss_dssp HHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC------
T ss_pred CCC--CCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC------
T ss_conf 864--100102562647999983202578888806657878999999820889999989999999997079987------
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 22011026888889006999999999998715999999999899999
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
+.......++ +..++..||+.+|++|||+.|+++
T Consensus 235 ----------~~~~~~~s~~---~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 ----------LAQPSRWSSN---FKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----------CSSGGGSCHH---HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----------CCCCCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ----------7765669999---999999976699668919999962
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=336.63 Aligned_cols=251 Identities=16% Similarity=0.193 Sum_probs=196.3
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCC-HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 9998323334588884899995-49961899995155310-899999999986169998413655886048817999972
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~Ey 611 (919)
++|.....||+|+||.||+|+. .+|..||||++...... .+.+.+|++++++++|||||++++++.+ ++..++||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-TTEEEEEECC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE-CCEEEEEEEC
T ss_conf 575898898407681999999889998999999845243169999999999986799799929999998-9999999985
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCC--CCCEEECCCCHHHH
Q ss_conf 2799810010006999775677799999999999999855451289999264468899600179--99622488500240
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD--KFEVRLGSLSEVCA 689 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~--~~~~ki~dfg~~~~ 689 (919)
|++|+|.+++.+.. ..+++.....|+.|++.||.|||+. +||||||||+|||++. ++.+||+|||.++.
T Consensus 105 ~~gg~L~~~l~~~~------~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 105 MSGGELFEKVADEH------NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp CCSCBHHHHHTCTT------SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred CCCCCHHHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCHHEE
T ss_conf 79988999997623------7899999999999999999999756---97600015467364168898699954521044
Q ss_pred CCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 38998510355202577775456778779997786034899999999099999899946899999841233111232220
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELV 769 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 769 (919)
...... .....+++.|++|+......++.++||||+||++|||+||+.||.+.+..+...-+....... .....
T Consensus 176 ~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~ 249 (350)
T d1koaa2 176 LDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM---DDSAF 249 (350)
T ss_dssp CCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS---CCGGG
T ss_pred CCCCCC---CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC---CCCCC
T ss_conf 256543---200068624218899758998726765546599999985989989979999999998478898---94223
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 110268888890069999999999987159999999998999999
Q 002462 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 770 ~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~ 814 (919)
....+ .+..++.+|++.+|++|||+.|+++.
T Consensus 250 -----------~~~s~---~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 250 -----------SGISE---DGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -----------GGCCH---HHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -----------CCCCH---HHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----------58999---99999999756896679089998629
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.44 Aligned_cols=245 Identities=18% Similarity=0.282 Sum_probs=187.4
Q ss_pred CCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCCCCEEEEEEEC---CCCEEEEE
Q ss_conf 8323334588884899995-4996189999515531---089999999998616999841365588604---88179999
Q 002462 537 SDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMER---ENEKFLVY 609 (919)
Q Consensus 537 ~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~---~~~~~LV~ 609 (919)
.....||+|+||.||+|.. .++..||+|++..... ..+.|.+|+++|++++|||||+++|++... +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECC-CCCCEEECCCCHHH
Q ss_conf 72279981001000699977567779999999999999985545128999926446889960017-99962248850024
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLD-DKFEVRLGSLSEVC 688 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld-~~~~~ki~dfg~~~ 688 (919)
|||++|+|.+++.+.. .+++.+...|+.|+++||+|||+. .++||||||||.|||++ +++.+||+|||.++
T Consensus 92 E~~~~g~L~~~l~~~~-------~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp ECCCSCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred ECCCCCCHHHHHHCCC-------CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEECCCCHHHCEEECCCCCEEEEECCCCE
T ss_conf 5789894899975135-------546999999999999999999978-99799687674351166799988980057654
Q ss_pred HCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHH-HHHHHHHHCCCCCCCCCC
Q ss_conf 0389985103552025777754567787799977860348999999990999998999468-999998412331112322
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ-VKEILEQTLPYISIYDKE 767 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~-~~~~~~~~~p~~~~~~~~ 767 (919)
....... ....+++.|++|+.... .++.++|||||||++|||+||+.||....... ....+....+ +.
T Consensus 164 ~~~~~~~----~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~------~~ 232 (270)
T d1t4ha_ 164 LKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK------PA 232 (270)
T ss_dssp GCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC------CG
T ss_pred ECCCCCC----CCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC------CC
T ss_conf 2368766----77553813008988478-9998671100799999998788999876559999999973899------86
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 2011026888889006999999999998715999999999899999
Q 002462 768 LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 768 ~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
.. +....++ +..++.+||+++|++|||+.|+++
T Consensus 233 ~~----------~~~~~~~---~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 SF----------DKVAIPE---VKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GG----------GGCCCHH---HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC----------CCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 56----------7557899---999999976379758929999967
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.36 Aligned_cols=262 Identities=22% Similarity=0.322 Sum_probs=201.0
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEC------CCCCEEEEEECCCCCC--HHHHHHHHHHHHHC-CCCCCCCEEEEEEECCCC
Q ss_conf 99983233345888848999954------9961899995155310--89999999998616-999841365588604881
Q 002462 534 GDFSDANLIKNGHSGDLFRGILE------GGIPVVIKRIDLQSVK--TEAYLLELDFFSKV-SHARLVPLLGHCMERENE 604 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~------~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l-~H~NiV~l~g~c~~~~~~ 604 (919)
++|...+.||+|+||.||+|++. .+..||||++...... ..+|.+|+.+++++ +|||||+++|+|.+ .+.
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-~~~ 101 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-GGP 101 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSS
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE-CCE
T ss_conf 9969854982068829999998066447788699999987424877999999999998762699988789989831-997
Q ss_pred EEEEEEECCCCCHHHHHHCCCCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEC
Q ss_conf 79999722799810010006999-----------7756777999999999999998554512899992644688996001
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNT-----------EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILL 673 (919)
Q Consensus 605 ~~LV~Ey~~~GsL~~~L~~~~~~-----------~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILl 673 (919)
.++|||||++|+|.+++++.... ......+++..+++|+.|+|+||+|||.. +||||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCC
T ss_conf 899997379987999998535665444445332223345889999999999999999988757---92666241021000
Q ss_pred CCCCCEEECCCCHHHHCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCH-HHHH
Q ss_conf 7999622488500240389985103552025777754567787799977860348999999990-9999989994-6899
Q 002462 674 DDKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSD-AQVK 751 (919)
Q Consensus 674 d~~~~~ki~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllT-G~~p~~~~~~-~~~~ 751 (919)
+.++.+|++|||.++...............+++.+.+++......++.++|||||||++|||+| |++|+..... ....
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred CCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 02575210234010233678861586201359687677886179999740010258999999858998877899899999
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 99984123311123222011026888889006999999999998715999999999899999920232
Q 002462 752 EILEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 752 ~~~~~~~p~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~ 819 (919)
.++....+. .. .+...+ .+..++.+||+.+|.+||+|.+|+++|+..+
T Consensus 259 ~~i~~~~~~------------~~-----~~~~~~---~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 259 KMIKEGFRM------------LS-----PEHAPA---EMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHHHTCCC------------CC-----CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHCCCCC------------CC-----CCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 998668988------------98-----543659---9999999975779657929999999998765
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=338.17 Aligned_cols=242 Identities=23% Similarity=0.322 Sum_probs=188.6
Q ss_pred CCCCCCCCCCCCCCCEEEEE-ECCCCCEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 99832333458888489999-549961899995155310----8999999999861699984136558860488179999
Q 002462 535 DFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK----TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~ 609 (919)
.|...+.||+|+||.||+|+ ..++..||||++...... .+.|.+|+++|++++|||||+++|++.+ ++..|+||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCEEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998-99889999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHHH
Q ss_conf 72279981001000699977567779999999999999985545128999926446889960017999622488500240
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~~ 689 (919)
|||++|+|..++..+ ..+++.+...|+.|++.||.|||+. +||||||||+|||+++++.+||+|||.+..
T Consensus 95 E~~~~g~l~~~~~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (309)
T ss_dssp ECCSEEHHHHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EECCCCCHHHHHHHC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCCC
T ss_conf 806999457899737-------9999999999999999999999868---976667884217987999789844365334
Q ss_pred CCCCCCCEEEEEECCCCCCCCCCCCC---CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHHHCCCCCCCC
Q ss_conf 38998510355202577775456778---779997786034899999999099999899946899-99984123311123
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSSG---SLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVK-EILEQTLPYISIYD 765 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~-~~~~~~~p~~~~~~ 765 (919)
.... ....+++.|++|+... ...++.++|||||||++|||+||+.||......+.. .......|..
T Consensus 165 ~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 234 (309)
T d1u5ra_ 165 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---- 234 (309)
T ss_dssp SSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC----
T ss_pred CCCC------CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC----
T ss_conf 6778------731347663688998346788867214545589999999878899999799999999982899988----
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 222011026888889006999999999998715999999999899999
Q 002462 766 KELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 766 ~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
. .....+ .+..++..||+.+|.+|||+.++++
T Consensus 235 -------~------~~~~s~---~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 -------Q------SGHWSE---YFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -------S------CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------C------CCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -------8------788899---9999999977379657918999971
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=334.70 Aligned_cols=250 Identities=15% Similarity=0.181 Sum_probs=195.1
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCC-HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 9998323334588884899995-49961899995155310-899999999986169998413655886048817999972
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK-TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~-~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~Ey 611 (919)
++|...+.||+|+||.||+|+- .+|..||||.+...... .+.+.+|++++++++|||||++++++.+ ++..|+||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE-CCEEEEEEEC
T ss_conf 035998999317782999999989997999999887264679999999999986799798919999998-9999999982
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECC--CCCCEEECCCCHHHH
Q ss_conf 279981001000699977567779999999999999985545128999926446889960017--999622488500240
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLD--DKFEVRLGSLSEVCA 689 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld--~~~~~ki~dfg~~~~ 689 (919)
|++|+|.+.+.... ..+++.+...|+.+++.||.|||+. +||||||||.|||++ .++.+||+|||.+..
T Consensus 108 ~~gg~L~~~~~~~~------~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 108 LSGGELFDRIAAED------YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp CCCCBHHHHTTCTT------CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred CCCCHHHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCCEE
T ss_conf 89980888898638------9989999999999999999999977---92651314455311346788489952563034
Q ss_pred CCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 38998510355202577775456778779997786034899999999099999899946899999841233111232220
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELV 769 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 769 (919)
...... .....+++.+.+|+......++.++||||+||++|||+||+.||.+.+.......+....+..
T Consensus 179 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~-------- 247 (352)
T d1koba_ 179 LNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF-------- 247 (352)
T ss_dssp CCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC--------
T ss_pred CCCCCC---EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC--------
T ss_conf 378872---010047645348999747998976333898999999996889989979999999998478898--------
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 11026888889006999999999998715999999999899999
Q 002462 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 770 ~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
.+.. ......+ +..++..|++.+|.+|||+.|+++
T Consensus 248 ----~~~~--~~~~s~~---~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 ----DEDA--FSSVSPE---AKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ----CSST--TTTSCHH---HHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ----CCCC--CCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ----9300--2479999---999999975699668918999960
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=335.86 Aligned_cols=250 Identities=14% Similarity=0.186 Sum_probs=195.4
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCC--HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEE
Q ss_conf 9998323334588884899995-49961899995155310--89999999998616999841365588604881799997
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~E 610 (919)
+.|...+.||+|+||.||+|.. .++..||||.+...... .+.+.+|+++|++++|||||++++++.+ ++..|+|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-GGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE-CCEEEEEEE
T ss_conf 6669988994065839999999999989999998157731289999999999986799899919899998-998889885
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECC---CCCCEEECCCCHH
Q ss_conf 2279981001000699977567779999999999999985545128999926446889960017---9996224885002
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLD---DKFEVRLGSLSEV 687 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld---~~~~~ki~dfg~~ 687 (919)
||++|+|.+++.+.. .+++.+...|+.|++.||+|||+. +||||||||.|||+. +++.+|++|||.+
T Consensus 88 ~~~gg~L~~~l~~~~-------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG-------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp CCCSCBHHHHHHTCS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred CCCCCCHHHHHHCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCCEE
T ss_conf 268984888653036-------788789999999999998752413---0556870463001104688824998315435
Q ss_pred HHCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 40389985103552025777754567787799977860348999999990999998999468999998412331112322
Q 002462 688 CAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKE 767 (919)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~~~~~~~~ 767 (919)
+....... .....+++.+++|+......++.++||||+||++|||+||+.||......+....+.......
T Consensus 158 ~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~------ 228 (307)
T d1a06a_ 158 KMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF------ 228 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC------
T ss_pred EECCCCCE---EEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC------
T ss_conf 87258970---440032842259188737999807873451599999985979999989999999986168777------
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 20110268888890069999999999987159999999998999999
Q 002462 768 LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 768 ~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~ 814 (919)
+.. ......++ +..++..|++.+|++|||+.|+++.
T Consensus 229 ------~~~--~~~~~s~~---~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 ------DSP--YWDDISDS---AKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ------CTT--TTTTSCHH---HHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ------CCC--CCCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ------876--66678999---9999999760897579189998629
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.42 Aligned_cols=262 Identities=17% Similarity=0.281 Sum_probs=199.5
Q ss_pred CCCCCCCCCCCCCCCEEEEEECC--------CCCEEEEEECCCCCC--HHHHHHHHHHHHHC-CCCCCCCEEEEEEECCC
Q ss_conf 99832333458888489999549--------961899995155310--89999999998616-99984136558860488
Q 002462 535 DFSDANLIKNGHSGDLFRGILEG--------GIPVVIKRIDLQSVK--TEAYLLELDFFSKV-SHARLVPLLGHCMEREN 603 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l~~--------g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l-~H~NiV~l~g~c~~~~~ 603 (919)
+|...+.||+|+||.||+|+... +..||||+++..... ..+|.+|+..+.++ +|||||+++|+|.+ ++
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~-~~ 92 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DG 92 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred HEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCC-CC
T ss_conf 96970098516782899999857875556675499999988112868899999999999981399969734652201-88
Q ss_pred CEEEEEEECCCCCHHHHHHCCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECC
Q ss_conf 179999722799810010006999---------77567779999999999999985545128999926446889960017
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNT---------EDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLD 674 (919)
Q Consensus 604 ~~~LV~Ey~~~GsL~~~L~~~~~~---------~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld 674 (919)
..++|||||++|+|.+++...... ......++|.++++++.|+|.||+|||+. +||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred EEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCEEEC
T ss_conf 68999973699909999986067764322233457434679999999999999999876637---978630221022454
Q ss_pred CCCCEEECCCCHHHHCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCHHHHHHH
Q ss_conf 999622488500240389985103552025777754567787799977860348999999990-9999989994689999
Q 002462 675 DKFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEI 753 (919)
Q Consensus 675 ~~~~~ki~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllT-G~~p~~~~~~~~~~~~ 753 (919)
.++.+|++|||.++...............+++.+.+++......++.++||||||||+|||+| |+.|+......+....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~ 249 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHH
T ss_conf 78976762211101135555543146678884663266751798882555477588888740179898999999999999
Q ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 9841233111232220110268888890069999999999987159999999998999999202323
Q 002462 754 LEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 754 ~~~~~p~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~~ 820 (919)
+...... .......++ +..++.+||+.+|++||||.||++.|+..+.
T Consensus 250 i~~~~~~-----------------~~p~~~~~~---l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 250 LKEGHRM-----------------DKPSNCTNE---LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHTTCCC-----------------CCCSSCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHCCCCC-----------------CCCCCCHHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 9728888-----------------987435299---9999999766797679399999999988860
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.87 Aligned_cols=264 Identities=20% Similarity=0.226 Sum_probs=197.2
Q ss_pred CCCCCCCCCCCCCCCCEEEEEECC------CCCEEEEEECCCCCC--HHHHHHHHHHHHHC-CCCCCCCEEEEEEECCCC
Q ss_conf 999832333458888489999549------961899995155310--89999999998616-999841365588604881
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEG------GIPVVIKRIDLQSVK--TEAYLLELDFFSKV-SHARLVPLLGHCMERENE 604 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~------g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l-~H~NiV~l~g~c~~~~~~ 604 (919)
++|...+.||+|+||.||+|.... +..||||++...... .+.|..|+..+.++ +|+|||.++++|.+.+..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCE
T ss_conf 99798449841678399999986777555783999999860017178999999999988614998499741154047975
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCC
Q ss_conf 799997227998100100069997---------75677799999999999999855451289999264468899600179
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTE---------DDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD 675 (919)
Q Consensus 605 ~~LV~Ey~~~GsL~~~L~~~~~~~---------~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~ 675 (919)
.++|||||++|+|.++|+...... .....++|.+++.|+.|+|+||.|||+. +||||||||+|||+|+
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECC
T ss_conf 7999984589929999985366666532220233214689999999999999999988737---9717867731065779
Q ss_pred CCCEEECCCCHHHHCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC-CCCCCCCHH-HHHHH
Q ss_conf 9962248850024038998510355202577775456778779997786034899999999099-999899946-89999
Q 002462 676 KFEVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGK-MGISASSDA-QVKEI 753 (919)
Q Consensus 676 ~~~~ki~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~-~p~~~~~~~-~~~~~ 753 (919)
++.+||+|||.++...........+...+++.+.+|+......++.++|||||||++|||+||. .|+...... .....
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 98289845752001135665222475166721020368646889966322136789999986889999899989999999
Q ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 9841233111232220110268888890069999999999987159999999998999999202323
Q 002462 754 LEQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 754 ~~~~~p~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~~ 820 (919)
+..... +. ..+...++ +..++..||+.+|++||||.+|++.|++.++
T Consensus 250 ~~~~~~---------------~~--~~~~~~~~---l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 250 LKEGTR---------------MR--APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHTCC---------------CC--CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHCCCC---------------CC--CCCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 963898---------------88--88657899---9999999767796679199999999979986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.33 Aligned_cols=254 Identities=22% Similarity=0.290 Sum_probs=196.8
Q ss_pred CCCCCCCCCCCCCCCCEEEEEECC----CCCEEEEEECCCCCC--HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEE
Q ss_conf 999832333458888489999549----961899995155310--89999999998616999841365588604881799
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEG----GIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~----g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~L 607 (919)
.+|...+.||+|+||.||+|+... +..||||.+...... .+.|.+|++++++++|||||+++|+|.+ +..++
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCEE
T ss_pred HHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC--CEEEE
T ss_conf 9969877993078829999999369964499999993656687999999999999986899998569889953--74799
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHH
Q ss_conf 99722799810010006999775677799999999999999855451289999264468899600179996224885002
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~ 687 (919)
||||+++|+|.+++.... ..+++.+++.++.|+++||.|||+. +||||||||+|||+++++.+|++|||.+
T Consensus 85 v~E~~~~g~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp EEECCTTEEHHHHHHHTT------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred EEEECCCCCHHHHHHCCC------CCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCHHH
T ss_conf 998406980776542247------8999999999999998775230226---7441410265532067896787650342
Q ss_pred HHCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf 40389985103552025777754567787799977860348999999990-99999899946899999841233111232
Q 002462 688 CAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISIYDK 766 (919)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllT-G~~p~~~~~~~~~~~~~~~~~p~~~~~~~ 766 (919)
+........ ..+...+++.+.+++......++.++|||||||++|||+| |++|+...+..+....+.....
T Consensus 156 ~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~------- 227 (273)
T d1mp8a_ 156 RYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------- 227 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-------
T ss_pred EECCCCCCE-ECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC-------
T ss_conf 133677623-305400583103266751699887452444247899998269999888999999999981899-------
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 22011026888889006999999999998715999999999899999920232
Q 002462 767 ELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPL 819 (919)
Q Consensus 767 ~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~ 819 (919)
. .......++ +..++..||+.+|++||||.+|++.|+.++
T Consensus 228 --~--------~~~~~~~~~---~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 228 --L--------PMPPNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp --C--------CCCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --C--------CCCCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf --9--------898777999---999999976879768929999999999997
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.67 Aligned_cols=254 Identities=21% Similarity=0.288 Sum_probs=194.0
Q ss_pred CCCCCCCCCCCCCCCCEEEEEECC--C--CCEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCE
Q ss_conf 999832333458888489999549--9--6189999515531----0899999999986169998413655886048817
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEG--G--IPVVIKRIDLQSV----KTEAYLLELDFFSKVSHARLVPLLGHCMERENEK 605 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~--g--~~vavK~l~~~~~----~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~ 605 (919)
++|.....||+|+||.||+|+... + ..||||.+..... ..++|.+|+++|++++|||||+++|+|.+ +..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~--~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSC
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740--100
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCC
Q ss_conf 99997227998100100069997756777999999999999998554512899992644688996001799962248850
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS 685 (919)
Q Consensus 606 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg 685 (919)
++|||||++|++.+.+.... ..++|..++.++.|+|+||.|||+. +|+||||||+|||++.++.+|++|||
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfG 156 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG 156 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred HEEEEEECCCCHHHHHHCCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCCH
T ss_conf 11465423861254442126------8999999999999999999875217---87520566888156556543325611
Q ss_pred HHHHCCCCCCCEEEE-EECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf 024038998510355-2025777754567787799977860348999999990-99999899946899999841233111
Q 002462 686 EVCAQGGDAHQSRIT-RLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVT-GKMGISASSDAQVKEILEQTLPYISI 763 (919)
Q Consensus 686 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllT-G~~p~~~~~~~~~~~~~~~~~p~~~~ 763 (919)
.++............ ...+++.+.+|+......++.++|||||||++|||+| |+.||.+.+..+....+.....
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~---- 232 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE---- 232 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC----
T ss_pred HHHHCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC----
T ss_conf 5553035887526547632573107999983799994215661489999999689999999699999999984799----
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 232220110268888890069999999999987159999999998999999202
Q 002462 764 YDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALEN 817 (919)
Q Consensus 764 ~~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~ 817 (919)
. + ...+....+ +..++..||+.+|++||||.+|++.|++
T Consensus 233 ----~------~--~~~~~~~~~---l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 233 ----R------L--PRPEDCPQD---IYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ----C------C--CCCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----C------C--CCCCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf ----9------9--985445399---9999999768896679299999999996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.41 Aligned_cols=249 Identities=17% Similarity=0.211 Sum_probs=197.5
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 9998323334588884899995-499618999951553----10899999999986169998413655886048817999
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQS----VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~----~~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV 608 (919)
.+|.....||+|+||.||+|.. .++..||||.+.... ...+.+.+|++++++++|||||++++++.+ ++..|+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-SSEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCEEEEE
T ss_conf 877898898508790999999989997999999865775577789999999999987688886179999998-9988999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHH
Q ss_conf 97227998100100069997756777999999999999998554512899992644688996001799962248850024
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~ 688 (919)
||||++|+|.+++.... .+++.....++.|++.||+|||+. +||||||||+|||+++++.+|++|||.++
T Consensus 87 mEy~~gg~L~~~~~~~~-------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~ 156 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIG-------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK 156 (288)
T ss_dssp ECCCTTEEHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EECCCCCCHHHHHHCCC-------CCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCCE
T ss_conf 97048987777653159-------999999999999999999762165---08847677412366888538860321024
Q ss_pred HCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 03899851035520257777545677877999778603489999999909999989994689999984123311123222
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~~~~~~~~~ 768 (919)
...............+++.|.+|+......++.++||||+||++|||+||+.||...+.......+....+
T Consensus 157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--------- 227 (288)
T d1uu3a_ 157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY--------- 227 (288)
T ss_dssp ECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC---------
T ss_pred ECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC---------
T ss_conf 22567764333555677552584400268989666230456999998038899899599999999971899---------
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 0110268888890069999999999987159999999998999999
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~ 814 (919)
..++...++ +..++..|++.+|++|||++|+...
T Consensus 228 ---------~~p~~~s~~---~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 ---------DFPEKFFPK---ARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ---------CCCTTCCHH---HHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ---------CCCCCCCHH---HHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf ---------998547999---9999999855797689197897377
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.91 Aligned_cols=249 Identities=14% Similarity=0.151 Sum_probs=192.1
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCC-------CHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCE
Q ss_conf 9998323334588884899995-4996189999515531-------0899999999986169998413655886048817
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV-------KTEAYLLELDFFSKVSHARLVPLLGHCMERENEK 605 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~-------~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~ 605 (919)
+.|...+.||+|+||.||+|.. .+|..||||.+..... ..+.|.+|+++|++++|||||++++++.+ ++..
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~ 88 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTDV 88 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE-CCEE
T ss_conf 677982798117895999999999998999999875663213406899999999999986799899938899997-9989
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCC----CEEE
Q ss_conf 999972279981001000699977567779999999999999985545128999926446889960017999----6224
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF----EVRL 681 (919)
Q Consensus 606 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~----~~ki 681 (919)
|+|||||++|+|.+++.... .+++.+...|+.|++.||+|||+. +||||||||+|||++.+. .+|+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-------~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred EEEEECCCCCCCCCHHCCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEEE
T ss_conf 99998677864310010356-------421557899999999998766625---42211333012798258986664696
Q ss_pred CCCCHHHHCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf 88500240389985103552025777754567787799977860348999999990999998999468999998412331
Q 002462 682 GSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYI 761 (919)
Q Consensus 682 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~~ 761 (919)
+|||.+........ .....+++.+.+|+......++.++|||||||++|||+||+.||.+.+..+....+......
T Consensus 159 ~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~- 234 (293)
T d1jksa_ 159 IDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE- 234 (293)
T ss_dssp CCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC-
T ss_pred CCHHHHHHCCCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC-
T ss_conf 43344210577763---12247777430999981899997665221409999997088998899999999999816888-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 1123222011026888889006999999999998715999999999899999
Q 002462 762 SIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 762 ~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
......+. ... .+..++..||+.+|++||++.++++
T Consensus 235 -------~~~~~~~~------~s~---~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 -------FEDEYFSN------TSA---LAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -------CCHHHHTT------SCH---HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------CCCHHCCC------CCH---HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -------87010478------899---9999999986389668919999961
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=328.89 Aligned_cols=247 Identities=19% Similarity=0.214 Sum_probs=186.8
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCC----HHHHHH---HHHHHHHCCCCCCCCEEEEEEECCCCE
Q ss_conf 9998323334588884899995-49961899995155310----899999---999986169998413655886048817
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK----TEAYLL---ELDFFSKVSHARLVPLLGHCMERENEK 605 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~----~~~f~~---Ei~~l~~l~H~NiV~l~g~c~~~~~~~ 605 (919)
++|...++||+|+||.||+|+. .+|..||||++...... ...+.+ |+++++.++|||||++++++.+ ++..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE-CCEE
T ss_conf 768510188428890999999999997999999845875426679999999999999850899858899999998-9988
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCC
Q ss_conf 99997227998100100069997756777999999999999998554512899992644688996001799962248850
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS 685 (919)
Q Consensus 606 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg 685 (919)
|+|||||++|+|.++|.+.. .+++.....|+.+++.||.|||+. +||||||||+|||++.++.+||+|||
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~-------~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFG 152 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG-------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG 152 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCT
T ss_pred EEEEEECCCCCHHHHHHHCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEEEC
T ss_conf 99999148983899987325-------532789999999999999999977---96220444221678588967982201
Q ss_pred HHHHCCCCCCCEEEEEECCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCC
Q ss_conf 024038998510355202577775456778-7799977860348999999990999998999468999998412331112
Q 002462 686 EVCAQGGDAHQSRITRLLRLPQSSEQGSSG-SLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIY 764 (919)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~~~~~ 764 (919)
.++....... ....+++.+.+|+... ...++.++||||+||++|||+||+.||..................
T Consensus 153 la~~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~---- 224 (364)
T d1omwa3 153 LACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---- 224 (364)
T ss_dssp TCEECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC----
T ss_pred EEEECCCCCC----CCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC----
T ss_conf 0233378864----33113455421687603899984410467789999998599988889989999999860468----
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCH-----HHHHH
Q ss_conf 32220110268888890069999999999987159999999998-----99999
Q 002462 765 DKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLM-----RYILK 813 (919)
Q Consensus 765 ~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm-----~~v~~ 813 (919)
.........++ +..++..|++.+|++||++ .++++
T Consensus 225 -----------~~~~~~~~s~~---~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 -----------AVELPDSFSPE---LRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -----------CCCCCSSSCHH---HHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -----------CCCCCCCCCHH---HHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf -----------88788778999---99999998566988808874357999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.92 Aligned_cols=249 Identities=12% Similarity=0.157 Sum_probs=194.6
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEEC
Q ss_conf 9998323334588884899995-499618999951553108999999999861699984136558860488179999722
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~Ey~ 612 (919)
++|...+.||+|+||.||+|.. .++..||||.++........+.+|+++|++++|||||++++++.+ ++..|+|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-MEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEEECCC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEE-CCEEEEEEECC
T ss_conf 10588789831778399999998999699999975786659999999999985799798909899988-99889999538
Q ss_pred CCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCC--CCCEEECCCCHHHHC
Q ss_conf 799810010006999775677799999999999999855451289999264468899600179--996224885002403
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD--KFEVRLGSLSEVCAQ 690 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~--~~~~ki~dfg~~~~~ 690 (919)
++|+|.+.+.... ..+++.+...|+.|+++||.|||+. +|+||||||+|||++. ...+|++|||.++..
T Consensus 84 ~gg~L~~~i~~~~------~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 84 SGLDIFERINTSA------FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCBHHHHHTSSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred CCCCHHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCHHHCC
T ss_conf 9980889987538------9999999999999999999999876---997513554443443788518997644111003
Q ss_pred CCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HHHCCCCCCCCCCCC
Q ss_conf 8998510355202577775456778779997786034899999999099999899946899999-841233111232220
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEIL-EQTLPYISIYDKELV 769 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~-~~~~p~~~~~~~~~~ 769 (919)
..... .....+++.+..++......++.++||||+||++|||+||+.||...+.......+ .....+.
T Consensus 155 ~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-------- 223 (321)
T d1tkia_ 155 KPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-------- 223 (321)
T ss_dssp CTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC--------
T ss_pred CCCCC---CCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC--------
T ss_conf 46775---3212233222340210487778401130279999999828999999899999999983899988--------
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 11026888889006999999999998715999999999899999
Q 002462 770 TKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 770 ~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
....+. ..+ .+..++..|++.+|.+||++.|+++
T Consensus 224 -~~~~~~------~s~---~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 224 -EEAFKE------ISI---EAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -HHHHTT------SCH---HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -HHHCCC------CCH---HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -022367------899---9999999986699668909999963
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.39 Aligned_cols=246 Identities=16% Similarity=0.190 Sum_probs=193.9
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 9998323334588884899995-499618999951553----10899999999986169998413655886048817999
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQS----VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~----~~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV 608 (919)
++|...+.||+|+||.||+|.. .+|..||||+++... ...+.+.+|+.+|++++|||||++++++.+ ++..|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCCCCCC
T ss_conf 742898898317684999999989998999999815654497999999999999986799988778764035-6421110
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHH
Q ss_conf 97227998100100069997756777999999999999998554512899992644688996001799962248850024
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~ 688 (919)
||||++|+|.+++.+.. .++......++.+++.||+|||+. +||||||||+|||+|.++.+||+|||.++
T Consensus 84 ~ey~~gg~L~~~~~~~~-------~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~ 153 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER-------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153 (337)
T ss_dssp EECCTTCBHHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EECCCCCCHHHHHHCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCCCC
T ss_conf 00357986055553256-------775999999999996521134315---96224647778476589988882056520
Q ss_pred HCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 03899851035520257777545677877999778603489999999909999989994689999984123311123222
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~~~~~~~~~ 768 (919)
....... ......+++.+.+|+......++.++||||+||++|||+||+.||.+.+..+....+....+.
T Consensus 154 ~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~-------- 223 (337)
T d1o6la_ 154 EGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-------- 223 (337)
T ss_dssp CSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------
T ss_pred CCCCCCC--CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC--------
T ss_conf 0356786--205510088996666504898883331022306788998789999996999999998528998--------
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 011026888889006999999999998715999999999-----899999
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPL-----MRYILK 813 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----m~~v~~ 813 (919)
-| .....+ +..++..|++.+|++||+ +.++++
T Consensus 224 -----~p-----~~~s~~---~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 -----FP-----RTLSPE---AKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CC-----TTSCHH---HHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CC-----CCCCHH---HHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf -----98-----668999---99999866638934422565234999972
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=321.90 Aligned_cols=243 Identities=16% Similarity=0.175 Sum_probs=192.8
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 9998323334588884899995-499618999951553----10899999999986169998413655886048817999
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQS----VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~----~~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV 608 (919)
++|...+.||+|+||.||+|+. .+|..||||++.... ...+.+.+|+.++++++|||||++++++.+ ++..|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEE-CCEEEEE
T ss_conf 470888897207680899999989997999999845775488999999999999986369675330356852-8800567
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHH
Q ss_conf 97227998100100069997756777999999999999998554512899992644688996001799962248850024
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~ 688 (919)
||||++|+|...+.... .+++.....++.|++.||+|||+. +||||||||+|||++.++.+||+|||.++
T Consensus 83 mE~~~gg~l~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~ 152 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQ-------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK 152 (316)
T ss_dssp ECCCCSCBHHHHHHHTS-------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEECCCCCCCCCCCCCC-------CCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCCE
T ss_conf 65037863223432222-------111007999999998765541247---67705568105038689988983175216
Q ss_pred HCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 03899851035520257777545677877999778603489999999909999989994689999984123311123222
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~~~~~~~~~ 768 (919)
...... ....+++.|++|+......++.++||||+||++|||+||+.||...+..+....+....+
T Consensus 153 ~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--------- 218 (316)
T d1fota_ 153 YVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--------- 218 (316)
T ss_dssp ECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC---------
T ss_pred EECCCC-----CCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC---------
T ss_conf 712456-----434576343599998389998043046533368999759899999699999999970898---------
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 01102688888900699999999999871599999999-----9899999
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP-----LMRYILK 813 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----sm~~v~~ 813 (919)
...+...++ +..++.+|++.+|.+|| +++++++
T Consensus 219 ---------~~p~~~s~~---~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 ---------RFPPFFNED---VKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ---------CCCTTSCHH---HHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---------CCCCCCCHH---HHHHHHHHHHHCHHHCCCCCHHHHHHHHC
T ss_conf ---------899778999---99999999544997666431021999981
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=321.17 Aligned_cols=243 Identities=19% Similarity=0.184 Sum_probs=192.2
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 9998323334588884899995-499618999951553----10899999999986169998413655886048817999
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQS----VKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLV 608 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~----~~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV 608 (919)
++|...+.||+|+||.||+|+. .+|..||||.+.... ...+.+.+|+++|++++|||||++++++.. ....++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCC-CCCCCCC
T ss_conf 370898896117680899999989998999999826774588999999999999997487727403444432-2222322
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHH
Q ss_conf 97227998100100069997756777999999999999998554512899992644688996001799962248850024
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~ 688 (919)
+||+++|+|.+++.+.. .+++.+...|+.|++.||.|||+. +||||||||+|||++.++.+||+|||.++
T Consensus 120 ~e~~~~g~l~~~l~~~~-------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~ 189 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG-------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK 189 (350)
T ss_dssp EECCTTCBHHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCCCCCHHHHHHHCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEE
T ss_conf 22334662266675158-------989999999999999989999859---98617679999360778978861010333
Q ss_pred HCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 03899851035520257777545677877999778603489999999909999989994689999984123311123222
Q 002462 689 AQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKEL 768 (919)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~~~~~~~~~ 768 (919)
....... ...+++.|++|+......++.++||||+||++|||+||+.||.+.+.......+....+.
T Consensus 190 ~~~~~~~-----~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-------- 256 (350)
T d1rdqe_ 190 RVKGRTW-----TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-------- 256 (350)
T ss_dssp ECSSCBC-----CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------
T ss_pred ECCCCCC-----CCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC--------
T ss_conf 2256664-----336763567889971799885331145007899997588998995999999998617988--------
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 01102688888900699999999999871599999999-----9899999
Q 002462 769 VTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP-----LMRYILK 813 (919)
Q Consensus 769 ~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----sm~~v~~ 813 (919)
. ......+ +..++..|++.+|.+|+ ++.++++
T Consensus 257 -----~-----p~~~s~~---~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 -----F-----PSHFSSD---LKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----C-----CTTCCHH---HHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----C-----CCCCCHH---HHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf -----9-----7668999---99999998340998606553454999971
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=321.60 Aligned_cols=256 Identities=15% Similarity=0.205 Sum_probs=197.0
Q ss_pred CCCCCCCCCCCCCCCCEEEEE-ECCCCCEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCCCCEEEEEEECCC---CE
Q ss_conf 999832333458888489999-549961899995155310----8999999999861699984136558860488---17
Q 002462 534 GDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK----TEAYLLELDFFSKVSHARLVPLLGHCMEREN---EK 605 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~----~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~---~~ 605 (919)
++|...+.||+|+||.||+|. ..+|..||||.+...... .+.|.+|++++++++|||||++++++..... ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEE
T ss_conf 20698689960899299999999999899999985566469899999999999998569998873114354326887669
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCC
Q ss_conf 99997227998100100069997756777999999999999998554512899992644688996001799962248850
Q 002462 606 FLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLS 685 (919)
Q Consensus 606 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg 685 (919)
|+||||+++|+|.+++.... .+++.+...|+.|++.||+|||+. +||||||||+|||++.+...++.||+
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~-------~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEG-------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHC-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCT
T ss_pred EEEEECCCCCEEHHHHCCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHH
T ss_conf 99997788987101120358-------999999999999999999999857---95276346755665754320100344
Q ss_pred HHHHCCCCC-CCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHHHCCCCCC
Q ss_conf 024038998-510355202577775456778779997786034899999999099999899946899-999841233111
Q 002462 686 EVCAQGGDA-HQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVK-EILEQTLPYISI 763 (919)
Q Consensus 686 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~-~~~~~~~p~~~~ 763 (919)
.+....... .........+++.+.+|+......++.++|||||||++|||+||+.||...+..+.. ..+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~-- 234 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP-- 234 (277)
T ss_dssp TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG--
T ss_pred HHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC--
T ss_conf 432212354433334642576243699998399999663202652899999769799899699999999984699997--
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHC
Q ss_conf 2322201102688888900699999999999871599999999-98999999202
Q 002462 764 YDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRP-LMRYILKALEN 817 (919)
Q Consensus 764 ~~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-sm~~v~~~L~~ 817 (919)
.... ....++ +..++.+|++++|.+|| +++++...|..
T Consensus 235 -------~~~~------~~~s~~---l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 235 -------SARH------EGLSAD---LDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp -------GGTS------SSCCHH---HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -------CHHC------CCCCHH---HHHHHHHHCCCCHHHCHHHHHHHHHHHHH
T ss_conf -------1003------478999---99999998667976777399999999999
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=320.67 Aligned_cols=252 Identities=15% Similarity=0.201 Sum_probs=188.8
Q ss_pred HCCCCCC-CCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCCHHHHHHHHHHHHHC-CCCCCCCEEEEEEE---CCCCEE
Q ss_conf 3999832-3334588884899995-4996189999515531089999999998616-99984136558860---488179
Q 002462 533 TGDFSDA-NLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKV-SHARLVPLLGHCME---RENEKF 606 (919)
Q Consensus 533 t~~f~~~-~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l-~H~NiV~l~g~c~~---~~~~~~ 606 (919)
.++|... .+||+|+||.||+|.. .++..||||.++. .+.+.+|++++.++ +|||||++++++.. .+...|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEE
T ss_conf 14879810796545486999999889998999999897----47799999999986699997829899950346897899
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCC---CCCEEECC
Q ss_conf 999722799810010006999775677799999999999999855451289999264468899600179---99622488
Q 002462 607 LVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD---KFEVRLGS 683 (919)
Q Consensus 607 LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~---~~~~ki~d 683 (919)
+|||||++|+|.+++.++.. ..+++.+...|+.|++.||+|||+. +|+||||||+|||+++ ++.+|++|
T Consensus 86 ivmEy~~gg~L~~~i~~~~~-----~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSC-----CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEECCCCCCHHHHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 99977899849999986278-----7757999999999999999999976---986444100220113555566311354
Q ss_pred CCHHHHCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf 50024038998510355202577775456778779997786034899999999099999899946899999841233111
Q 002462 684 LSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISI 763 (919)
Q Consensus 684 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~~~~ 763 (919)
||.++....... .....+++.+++|+......++.++||||+||++|||+||+.||.+.+.......+.
T Consensus 158 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~-------- 226 (335)
T d2ozaa1 158 FGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-------- 226 (335)
T ss_dssp CTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------
T ss_pred CCEEEECCCCCC---CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHH--------
T ss_conf 551233368886---432267756379277748988888888764516778865889988988778899999--------
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHH-HHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 23222011026888889006999-999999998715999999999899999
Q 002462 764 YDKELVTKIVDPSLIIDEDLLEE-VWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 764 ~~~~~~~~i~d~~l~~~~~~~~~-~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
..+.............. -..+..++..|++.+|++||++.|+++
T Consensus 227 ------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 227 ------TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ------HHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ------998538888898543469999999999975699657909999970
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=319.57 Aligned_cols=248 Identities=22% Similarity=0.274 Sum_probs=188.5
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCC----------HHHHHHHHHHHHHCC-CCCCCCEEEEEEEC
Q ss_conf 9998323334588884899995-49961899995155310----------899999999986169-99841365588604
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK----------TEAYLLELDFFSKVS-HARLVPLLGHCMER 601 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~----------~~~f~~Ei~~l~~l~-H~NiV~l~g~c~~~ 601 (919)
.+|...+.||+|+||.||+|+- .++..||||.+...... .+.+.+|+.++++++ |||||++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC-
T ss_conf 6388852884176849999999999989999999624464114788899999999999999985079974799762146-
Q ss_pred CCCEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEE
Q ss_conf 88179999722799810010006999775677799999999999999855451289999264468899600179996224
Q 002462 602 ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRL 681 (919)
Q Consensus 602 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki 681 (919)
++..|+|||||++|+|.++|.... .+++.+...++.|+++||+|||+. +||||||||+|||++.+..+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl 151 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKL 151 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred CCCEEEEEECCCCCHHHHHHHHCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEE
T ss_conf 760599997689866899998659-------999999999999999999999875---9943234625489868998387
Q ss_pred CCCCHHHHCCCCCCCEEEEEECCCCCCCCCCCC------CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH-HH
Q ss_conf 885002403899851035520257777545677------87799977860348999999990999998999468999-99
Q 002462 682 GSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSS------GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKE-IL 754 (919)
Q Consensus 682 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~-~~ 754 (919)
+|||.++........ +...+++.+..++.. ....++.++||||+|||+|||+||+.||.+.+...... +.
T Consensus 152 ~DFG~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~ 228 (277)
T d1phka_ 152 TDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228 (277)
T ss_dssp CCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCHHEEECCCCCCE---EEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHHH
T ss_conf 124031672688721---34524678889888605344567889923318565602310322888988999999999998
Q ss_pred HHHCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 84123311123222011026888889006999999999998715999999999899999
Q 002462 755 EQTLPYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 755 ~~~~p~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
.....+. .+. .....++ +..++.+|++++|++||++.||++
T Consensus 229 ~~~~~~~------------~~~---~~~~s~~---~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 SGNYQFG------------SPE---WDDYSDT---VKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HTCCCCC------------TTT---GGGSCHH---HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HCCCCCC------------CCC---CCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 1898889------------854---3468999---999999976589668919999973
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.31 Aligned_cols=246 Identities=19% Similarity=0.251 Sum_probs=192.0
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCC----CCHHHHHHHHHHHH-HCCCCCCCCEEEEEEECCCCEEE
Q ss_conf 9998323334588884899995-499618999951553----10899999999986-16999841365588604881799
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQS----VKTEAYLLELDFFS-KVSHARLVPLLGHCMERENEKFL 607 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~----~~~~~f~~Ei~~l~-~l~H~NiV~l~g~c~~~~~~~~L 607 (919)
++|...+.||+|+||+||+|+. .++..||||.+.... ...+.+..|+.++. .++|||||++++++.+ ++..|+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCCEEE
T ss_conf 9718865894087828999999999989999998055533848999999999999984799968789889704-983167
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHH
Q ss_conf 99722799810010006999775677799999999999999855451289999264468899600179996224885002
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~ 687 (919)
|||||++|+|.+++.... .++..+...++.+++.||+|||+. +||||||||+|||+++++.+|++|||.+
T Consensus 81 vmEy~~~g~L~~~i~~~~-------~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a 150 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCH-------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 150 (320)
T ss_dssp EEECCTTCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEECCCCCHHHHHHCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHH
T ss_conf 775037980899864047-------899999999999999999999868---9340347654044448996301555302
Q ss_pred HHCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 40389985103552025777754567787799977860348999999990999998999468999998412331112322
Q 002462 688 CAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKE 767 (919)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~~~~~~~~ 767 (919)
+....... ..+...+++.+.+|+......++.++||||+||++|||+||+.||.+.+..+....+....+..
T Consensus 151 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~------ 222 (320)
T d1xjda_ 151 KENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY------ 222 (320)
T ss_dssp BCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------
T ss_pred HHCCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC------
T ss_conf 32356653--3454578777689999827998832320112278989873889999989999999997189989------
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 201102688888900699999999999871599999999989-9999
Q 002462 768 LVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMR-YILK 813 (919)
Q Consensus 768 ~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~-~v~~ 813 (919)
| .....+ +..++.+|++.+|++||++. ++++
T Consensus 223 -------p-----~~~s~~---~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 -------P-----RWLEKE---AKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -------C-----TTSCHH---HHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -------C-----CCCCHH---HHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf -------7-----567999---9999999654489878388999980
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=315.88 Aligned_cols=268 Identities=18% Similarity=0.225 Sum_probs=189.1
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 9998323334588884899995-49961899995155310---8999999999861699984136558860488179999
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~ 609 (919)
++|...+.||+|+||.||+|+. .++..||||++...... .+.+.+|++++++++|||||++++++.+ ++..|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCC-CCCEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322-43203788
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHHH
Q ss_conf 72279981001000699977567779999999999999985545128999926446889960017999622488500240
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~~ 689 (919)
||+.++ +.+.+..... ..+++.+...++.|++.||.|||+. +||||||||+|||++.+..+|++|||.++.
T Consensus 81 e~~~~~-~~~~~~~~~~-----~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~ 151 (298)
T d1gz8a_ 81 EFLHQD-LKKFMDASAL-----TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARA 151 (298)
T ss_dssp ECCSEE-HHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred EECCCC-HHHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCEE
T ss_conf 623774-4555442025-----6888899999999999999986528---899213571140113467621035786134
Q ss_pred CCCCCCCEEEEEECCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHHHCCCCCCCCCC
Q ss_conf 389985103552025777754567-78779997786034899999999099999899946899-9998412331112322
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVK-EILEQTLPYISIYDKE 767 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~-~~~~~~~p~~~~~~~~ 767 (919)
....... .....+++.+.+++. .....++.++||||+||++|||+||+.||.+.+..... ........ .......
T Consensus 152 ~~~~~~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~ 228 (298)
T d1gz8a_ 152 FGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT-PDEVVWP 228 (298)
T ss_dssp HCCCSBC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTST
T ss_pred CCCCCCC--CEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCC-CCHHHCC
T ss_conf 3688641--001036521541122136657774221033331342796687998988999999999983289-8333144
Q ss_pred CCCCCCCC--CC--CCCCCHHHH----HHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 20110268--88--889006999----9999999987159999999998999999
Q 002462 768 LVTKIVDP--SL--IIDEDLLEE----VWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 768 ~~~~i~d~--~l--~~~~~~~~~----~~~~~~l~~~Cl~~~P~~RPsm~~v~~~ 814 (919)
......+. .. ......... -..+..++.+|++.+|++|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 4222421243454322220444166789999999999763995579189999678
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=315.60 Aligned_cols=262 Identities=18% Similarity=0.166 Sum_probs=184.7
Q ss_pred CCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCC------HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 23334588884899995-49961899995155310------899999999986169998413655886048817999972
Q 002462 539 ANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK------TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 539 ~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~------~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~Ey 611 (919)
.++||+|+||+||+|.. .+|..||||+++..... .+.+.+|++++++++|||||++++++.. ++..++||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-~~~~~ivmE~ 81 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KSNISLVFDF 81 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TTCCEEEEEC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCCEEEHHHH
T ss_conf 638512728299999999999699999984202124567999999999999986799998689854225-8740220455
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHHHCC
Q ss_conf 27998100100069997756777999999999999998554512899992644688996001799962248850024038
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQG 691 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~~~~ 691 (919)
+++|++....... ..+++.+...++.|++.||+|||+. +||||||||+|||++.++.+||+|||.++...
T Consensus 82 ~~~~~~~~~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 82 METDLEVIIKDNS-------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 151 (299)
T ss_dssp CSEEHHHHHTTCC-------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred HCCHHHHHHHHCC-------CCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCCC
T ss_conf 3450776554126-------6778999999999999999886316---35503577625885377841146576100057
Q ss_pred CCCCCEEEEEECCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 99851035520257777545677-87799977860348999999990999998999468999998412331112322201
Q 002462 692 GDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELVT 770 (919)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 770 (919)
..... .....+++.+.+++.. +...++.++|||||||++|||+||+.||.+.++.+....+......+.........
T Consensus 152 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 152 SPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp SCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred CCCCC--CCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHH
T ss_conf 87554--3302047333639997267788805643630428999985969999999999999999851899725452100
Q ss_pred CCCC-CCCC-CCCCHHHH-----HHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 1026-8888-89006999-----999999998715999999999899999
Q 002462 771 KIVD-PSLI-IDEDLLEE-----VWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 771 ~i~d-~~l~-~~~~~~~~-----~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
...+ .... ........ -..+..++..|++.+|++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 02134430347898867856568999999999976389456908999967
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=313.17 Aligned_cols=264 Identities=17% Similarity=0.232 Sum_probs=189.4
Q ss_pred CCCCCCCCCCCCCCCCEEEEEECCCCCEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEE
Q ss_conf 999832333458888489999549961899995155310---89999999998616999841365588604881799997
Q 002462 534 GDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYK 610 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~E 610 (919)
++|...+.||+|+||.||+|...+|..||||++...... .+.|.+|+.+|++++|||||++++++.. ++..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEEE
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC-CCCEEEEEE
T ss_conf 9963431872277818999996899999999981232685899999999999986799868766012046-773158997
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHHHC
Q ss_conf 22799810010006999775677799999999999999855451289999264468899600179996224885002403
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCAQ 690 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~~~ 690 (919)
|+.++.+....... ..++..+...|+.|++.||+|||+. +||||||||+|||++.++.+|++|||.+...
T Consensus 81 ~~~~~~~~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCE-------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF 150 (286)
T ss_dssp CCSEEHHHHHHTST-------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred EEHHHHHHHHHHHC-------CCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEEC
T ss_conf 40045678998604-------7751445689999999999986057---4882678775056868997873236643011
Q ss_pred CCCCCCEEEEEECCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 899851035520257777545677-8779997786034899999999099999899946899999841233111232220
Q 002462 691 GGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYDKELV 769 (919)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 769 (919)
....... ....+.+.+.+++.. +...++.++||||+||++|||+||+.||...+......-+......+........
T Consensus 151 ~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 151 GIPVRKY--THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred CCCCCCC--CEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCH
T ss_conf 4676541--01024311013788717888884100211175899997797998988989999999986389971104212
Q ss_pred CCCC--CCCCC----C-----CCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 1102--68888----8-----9006999999999998715999999999899999
Q 002462 770 TKIV--DPSLI----I-----DEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 770 ~~i~--d~~l~----~-----~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
.... +.... . .+.... .+..++..|++.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~---~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDE---SGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHCCCCCCCCCCCCHHHHCCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 333221433333567646665125899---9999999986689668909999856
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=306.24 Aligned_cols=293 Identities=30% Similarity=0.467 Sum_probs=214.9
Q ss_pred CCCHHHHHHHHHHHHHCCCC--CCCCCCCCCCCC-CCCCEEECC----CCEEEEECCCCCCCCCCCCCCCCCHHHHCCCC
Q ss_conf 79999999999999937999--999999999999-977714059----99999990898656788889846711111899
Q 002462 45 LSSRTELAALFELRSSLGLR--RRDWPRKVDPCL-VWNGVRCQN----GSVVGINISGFRRTRLGSQNPRFAADALVNLT 117 (919)
Q Consensus 45 ~~~~~e~~aL~~~~~~l~~~--~~~W~~~~~~C~-~W~gv~C~~----~~v~~l~l~~~~~~~~~~~~~~~~~~~l~~l~ 117 (919)
+|.++|++||++||+++.++ .++|..++|||. .|.||+|++ +||+.+++++.+....
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~---------------- 65 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP---------------- 65 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSC----------------
T ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCC----------------
T ss_conf 9898999999999997799986778899999988948896974899947988998989988888----------------
Q ss_pred CCCEEECCCCCCCCCCCHHHHHCCCCCCEEEEEC-CCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 7897866998799888536651899876998015-879855886778999898999107989998961124999988998
Q 002462 118 HLASFNASRFLLPGSIPDWLGQQLPTLQALDLRS-CSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLD 196 (919)
Q Consensus 118 ~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~-n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~ 196 (919)
+.+|+.+++ |++|++|||++ |.+.|.+|.+|+++++|++|+|++|++.+..+..+..+..|+.++
T Consensus 66 -------------~~lp~~l~~-L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~ 131 (313)
T d1ogqa_ 66 -------------YPIPSSLAN-LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp -------------EECCGGGGG-CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred -------------CCCCHHHHC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCC
T ss_conf -------------879847846-753352020265433300243114542001102035643443322222011100111
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC-CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 55896998898222289999988656874787799546799989-88870289889998522499999988986799798
Q 002462 197 LSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKL-QYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLS 275 (919)
Q Consensus 197 Ls~N~l~~~~P~~~~~l~~L~~L~Ls~N~l~~~lp~~l~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 275 (919)
++.|.+.+.+|..+..+++|+.+++++|.+.+.+|..+..+.++ +.++++.|.+++..|..+..+.. ..+++..+.+.
T Consensus 132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~ 210 (313)
T d1ogqa_ 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEEE
T ss_pred CCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCC
T ss_conf 12245555685122067400000023553356203121443112323102246435332433222222-23333334332
Q ss_pred CCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 77954442264587897158768999897646999887789846789989984002899999789866897989999555
Q 002462 276 GSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSR 355 (919)
Q Consensus 276 ~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~ 355 (919)
+.+|..+..+++++.+++.+|.+.+.++ .+..+++|+.|+|++|+++|.+|..+..+++|++|+|++|+++|.+|..
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~--~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~- 287 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG--KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG- 287 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGG--GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCC-
T ss_conf 2222222222221112222222222222--2224554444447657066608768847999998979588351668986-
Q ss_pred CCCCCCCCEEECCCCCC
Q ss_conf 45788874898668837
Q 002462 356 SNVNTSTVELNISQNMF 372 (919)
Q Consensus 356 ~~~~~~l~~l~ls~N~~ 372 (919)
..+..+..+++++|.+
T Consensus 288 -~~L~~L~~l~l~~N~~ 303 (313)
T d1ogqa_ 288 -GNLQRFDVSAYANNKC 303 (313)
T ss_dssp -TTGGGSCGGGTCSSSE
T ss_pred -CCCCCCCHHHHCCCCC
T ss_conf -6679989788688950
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=308.38 Aligned_cols=266 Identities=17% Similarity=0.199 Sum_probs=186.8
Q ss_pred HCCCCCCCCCCCCCCCCEEEEEE-CC-CCCEEEEEECCCCCC---HHHHHHHHHHHHHC---CCCCCCCEEEEEEEC---
Q ss_conf 39998323334588884899995-49-961899995155310---89999999998616---999841365588604---
Q 002462 533 TGDFSDANLIKNGHSGDLFRGIL-EG-GIPVVIKRIDLQSVK---TEAYLLELDFFSKV---SHARLVPLLGHCMER--- 601 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l-~~-g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l---~H~NiV~l~g~c~~~--- 601 (919)
.++|.....||+|+||.||+|+. .+ +..||||++...... ...+.+|+.+++.+ +|||||+++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred -CCCEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEE
Q ss_conf -8817999972279981001000699977567779999999999999985545128999926446889960017999622
Q 002462 602 -ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVR 680 (919)
Q Consensus 602 -~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~k 680 (919)
....++++||+++|.+........ ..+++.....|+.|++.||+|||+. +||||||||+|||+++++.+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~------~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~k 156 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE------PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 156 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred CCCEEEEEEEECCCCCHHHHHHCCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEE
T ss_conf 6746999997405871444443037------8999899999999999999999758---898357986278985899754
Q ss_pred ECCCCHHHHCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 48850024038998510355202577775456778779997786034899999999099999899946899999841233
Q 002462 681 LGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPY 760 (919)
Q Consensus 681 i~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~ 760 (919)
++|||.+........ .....+++.+.+|+......++.++||||+||++|||+||+.||.+.++......+......
T Consensus 157 l~dfg~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 157 LADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp ECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred ECCHHHHHHHCCCCC---CCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCC
T ss_conf 210001011002345---77765485114831001798881110003289999998787998998989999999984079
Q ss_pred CC--CCCCC------CCCCCCCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 11--12322------2011026888-889006999999999998715999999999899999
Q 002462 761 IS--IYDKE------LVTKIVDPSL-IIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 761 ~~--~~~~~------~~~~i~d~~l-~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
+. ..... .......... .......+ .+..++.+|++.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~---~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDE---LGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCH---HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 9611053211110333022345645440445899---9999999987489667918999966
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=306.51 Aligned_cols=263 Identities=20% Similarity=0.196 Sum_probs=180.3
Q ss_pred CCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECC-----CCEEEE
Q ss_conf 998323334588884899995-49961899995155310899999999986169998413655886048-----817999
Q 002462 535 DFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERE-----NEKFLV 608 (919)
Q Consensus 535 ~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~-----~~~~LV 608 (919)
+|...++||+|+||+||+|+. .+|..||||++..... .+.+|+++|++++|||||++++++.... ...++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH---HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEEE
T ss_conf 76751698217683999999999997999999881606---899999999866898987387899744765773189999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCC-CCEEECCCCHH
Q ss_conf 97227998100100069997756777999999999999998554512899992644688996001799-96224885002
Q 002462 609 YKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK-FEVRLGSLSEV 687 (919)
Q Consensus 609 ~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~-~~~ki~dfg~~ 687 (919)
||||++|.+....+... ....+++.+...|+.|+++||+|||+. +||||||||+|||++.+ ..+||+|||.+
T Consensus 98 ~Ey~~~~~~~~l~~~~~----~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSR----AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EECCSEEHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EECCCCCCHHHHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCCH
T ss_conf 84168860788886310----368999999999999999999999866---87645788603787358971167336605
Q ss_pred HHCCCCCCCEEEEEECCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHHHC-CCC---
Q ss_conf 40389985103552025777754567-7877999778603489999999909999989994689-99998412-331---
Q 002462 688 CAQGGDAHQSRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTL-PYI--- 761 (919)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~-~~~~~~~~-p~~--- 761 (919)
+........ ....+++.+.+++. .+...++.++||||+||++|||+||+.||...+.... ..++...- +..
T Consensus 171 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 171 KQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp EECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred HHCCCCCCC---CCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHH
T ss_conf 440477653---20025555568277640468882100024652778550287998987999999999997489817765
Q ss_pred ----CCCCCCCCCCCCCCCC--CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf ----1123222011026888--889006999999999998715999999999899999
Q 002462 762 ----SIYDKELVTKIVDPSL--IIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 762 ----~~~~~~~~~~i~d~~l--~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
..+............. ........ .+..++.+|++.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~---~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPP---EAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHCCCHHHCCCCCCCCCCHHHHCCCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 430621011035544567444431568999---9999999976589557929999966
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=302.21 Aligned_cols=268 Identities=15% Similarity=0.132 Sum_probs=187.8
Q ss_pred CCCCCCCCCCCCCCCCEEEEE-ECCCCCEEEEEECCCCCC--HHHHHHHHHHHHHCCCCCCCCEEEEEEECC---CCEEE
Q ss_conf 999832333458888489999-549961899995155310--899999999986169998413655886048---81799
Q 002462 534 GDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK--TEAYLLELDFFSKVSHARLVPLLGHCMERE---NEKFL 607 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~--~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~---~~~~L 607 (919)
..|.....||+|+||.||+|+ ..+|..||||+++..... .+.+.+|+++|++++|||||+++++|.... ...++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEE
T ss_conf 98599789940648099999999999499999980310958999999999999976898988588899505645541499
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHH
Q ss_conf 99722799810010006999775677799999999999999855451289999264468899600179996224885002
Q 002462 608 VYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEV 687 (919)
Q Consensus 608 V~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~ 687 (919)
+++|+.+|+|.+++..+ .+++.....|+.|++.||+|||+. +||||||||+|||++.++.+||+|||.+
T Consensus 88 l~~~~~~g~L~~~l~~~--------~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ--------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp EEEECCCEEHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEECCCCHHHHHHCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCE
T ss_conf 99962598656644058--------999999999999999999999978---9867778764378879997787545705
Q ss_pred HHCCCCCCC-EEEEEECCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
Q ss_conf 403899851-035520257777545677-877999778603489999999909999989994689999984123311123
Q 002462 688 CAQGGDAHQ-SRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYISIYD 765 (919)
Q Consensus 688 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~~~~~~ 765 (919)
......... .......+++.+.+++.. ....++.++||||+||++|||+||+.||...+...................
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred EECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf 65047776410101102652000387860478887410100467013377669799788888999998765206997566
Q ss_pred CC-------CCCCCCCCCCCCCCCHHHH-----HHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 22-------2011026888889006999-----9999999987159999999998999999
Q 002462 766 KE-------LVTKIVDPSLIIDEDLLEE-----VWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 766 ~~-------~~~~i~d~~l~~~~~~~~~-----~~~~~~l~~~Cl~~~P~~RPsm~~v~~~ 814 (919)
.. .......+..... .... -..+..++..|++.||.+||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKV--PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCC--CHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCCCCCCCCCC--CHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 4234332222024467755778--7778378999999999999764895679089998619
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=303.43 Aligned_cols=261 Identities=15% Similarity=0.196 Sum_probs=184.8
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCCCCEEEEEEECC-----CC
Q ss_conf 9998323334588884899995-49961899995155310---899999999986169998413655886048-----81
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERE-----NE 604 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~-----~~ 604 (919)
+.|.....||+|+||.||+|.. .+|..||||++...... .+.+.+|+++|++++|||||+++++|...+ ..
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCCE
T ss_conf 71899889801778199999999999899999985222596999999999999986689875479998635765555415
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCC
Q ss_conf 79999722799810010006999775677799999999999999855451289999264468899600179996224885
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSL 684 (919)
Q Consensus 605 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~df 684 (919)
.++||||+ +++|....... .+++.....|+.|++.||.|||+. +||||||||+|||++.++.+|++||
T Consensus 98 ~~lv~e~~-~~~l~~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKHE--------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CEEEEECC-SEEHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEECC-CCCHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCCC
T ss_conf 99998405-52189998740--------226999999999999999998737---8764566851111210012211343
Q ss_pred CHHHHCCCCCCCEEEEEECCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC-CCCC
Q ss_conf 002403899851035520257777545677-87799977860348999999990999998999468999998412-3311
Q 002462 685 SEVCAQGGDAHQSRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTL-PYIS 762 (919)
Q Consensus 685 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~-p~~~ 762 (919)
|.++......... .+++.+.+++.. +...++.++||||+||++|||+||+.||...+............ ....
T Consensus 166 g~a~~~~~~~~~~-----~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 166 GLARQADSEMTGY-----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp TTCEECCSSCCSS-----CSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred CCEECCCCCCCCC-----CCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCH
T ss_conf 1022068763102-----45533358899817878996501030038999999786998889768999999850378848
Q ss_pred C----CCCC-------CCCCCCCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 1----2322-------20110268888-890069999999999987159999999998999999
Q 002462 763 I----YDKE-------LVTKIVDPSLI-IDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 763 ~----~~~~-------~~~~i~d~~l~-~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~ 814 (919)
. .... .+.+.....+. ....... .+..++..|+..+|++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~---~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP---LAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCH---HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 88865300034433115786665566775568999---99999999772995579299999639
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=296.70 Aligned_cols=271 Identities=15% Similarity=0.170 Sum_probs=188.5
Q ss_pred HCCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCCCCEEEEEEEC-------
Q ss_conf 39998323334588884899995-4996189999515531---089999999998616999841365588604-------
Q 002462 533 TGDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSV---KTEAYLLELDFFSKVSHARLVPLLGHCMER------- 601 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~---~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~------- 601 (919)
.++|...+.||+|+||+||+|+. .+|..||||++..... ..+++.+|+++|++++||||+++++.+...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCCEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEE
Q ss_conf 88179999722799810010006999775677799999999999999855451289999264468899600179996224
Q 002462 602 ENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRL 681 (919)
Q Consensus 602 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki 681 (919)
++..++||||++++.+....... ..+.......|+.|+++||.|||+. +||||||||+|||++.++.+|+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~-------~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl 158 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL-------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL 158 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEE
T ss_pred CCEEEEEEECCCCCCCCHHHHCC-------CCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEE
T ss_conf 76389998535787410122203-------4433089999999999999885229---9885676722203668996876
Q ss_pred CCCCHHHHCCCCCCC--EEEEEECCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf 885002403899851--035520257777545677-87799977860348999999990999998999468999998412
Q 002462 682 GSLSEVCAQGGDAHQ--SRITRLLRLPQSSEQGSS-GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTL 758 (919)
Q Consensus 682 ~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~ 758 (919)
+|||.+......... .......+++.+.+++.. +...++.++||||+||++|||+||+.||....+......+....
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~ 238 (318)
T d3blha1 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238 (318)
T ss_dssp CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHC
T ss_conf 31350022355444321135660249787428997079998917870067864661744879989989999999999841
Q ss_pred CCCC-CCCCC----CCCCCCCCCCCCCCCHHHHH------HHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 3311-12322----20110268888890069999------99999998715999999999899999
Q 002462 759 PYIS-IYDKE----LVTKIVDPSLIIDEDLLEEV------WAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 759 p~~~-~~~~~----~~~~i~d~~l~~~~~~~~~~------~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
.... ..... .................+.. ..+.+++.+|++.+|++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 899825534432034443320133445550334044459989999999987389658909999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=301.63 Aligned_cols=262 Identities=16% Similarity=0.205 Sum_probs=193.1
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEEC
Q ss_conf 9998323334588884899995-499618999951553108999999999861699984136558860488179999722
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVYKYM 612 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~Ey~ 612 (919)
+.|.....||+|+||.||+|+. .+|..||||.+..... .+++..|++++++++|+|+|..++.|....+..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC-CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEEC
T ss_conf 889996898507880999999988998999999721005-8889999999997038996017999995198778999873
Q ss_pred CCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECC---CCCCEEECCCCHHHH
Q ss_conf 79981001000699977567779999999999999985545128999926446889960017---999622488500240
Q 002462 613 PNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLD---DKFEVRLGSLSEVCA 689 (919)
Q Consensus 613 ~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld---~~~~~ki~dfg~~~~ 689 (919)
. |+|.+.+.... ..+++.+...++.+++.||+|||+. +||||||||+|||++ .+..+|++|||.++.
T Consensus 86 ~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 86 G-PSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp C-CBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred C-CCHHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCCCCEE
T ss_conf 8-71333244306------8876899999999999999999979---944266787660643357776156504675134
Q ss_pred CCCCCCC-----EEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC-CCCCC
Q ss_conf 3899851-----03552025777754567787799977860348999999990999998999468999998412-33111
Q 002462 690 QGGDAHQ-----SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTL-PYISI 763 (919)
Q Consensus 690 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~-p~~~~ 763 (919)
....... .......+++.+++++......++.++|||||||++|||+||+.||...........+.... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~- 234 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS- 234 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-
T ss_pred CCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCC-
T ss_conf 2554455410001357767873532999991899898321886177899998498766553057799999985235678-
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 232220110268888890069999999999987159999999998999999202323
Q 002462 764 YDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 764 ~~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~~ 820 (919)
...... . ....++ +..++..||+.+|++||++.++.+.|+.+..
T Consensus 235 ---~~~~~~-~------~~~p~~---~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 235 ---TPIEVL-C------KGYPSE---FATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ---SCHHHH-T------TTSCHH---HHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ---CCHHHH-C------CCCCHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ---983575-3------478899---9999999843995579199999999999999
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=307.09 Aligned_cols=238 Identities=19% Similarity=0.257 Sum_probs=179.4
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCC-------HHHHHHHHHHHHHCC--CCCCCCEEEEEEECCC
Q ss_conf 9998323334588884899995-49961899995155310-------899999999986169--9984136558860488
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK-------TEAYLLELDFFSKVS--HARLVPLLGHCMEREN 603 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~-------~~~f~~Ei~~l~~l~--H~NiV~l~g~c~~~~~ 603 (919)
++|...++||+|+||.||+|+. .+|..||||++...... ...+.+|+.++++++ |||||++++++.+ ++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-~~ 82 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-PD 82 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-SS
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE-CC
T ss_conf 83799679840878399999999999799999985688443345567999999999999743589881279999830-99
Q ss_pred CEEEEEEECCC-CCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCC-CCEEE
Q ss_conf 17999972279-98100100069997756777999999999999998554512899992644688996001799-96224
Q 002462 604 EKFLVYKYMPN-GDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK-FEVRL 681 (919)
Q Consensus 604 ~~~LV~Ey~~~-GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~-~~~ki 681 (919)
..++||||+.+ +++.+++.... .+++.+...++.|+++||+|||+. +||||||||+|||++.+ ..+|+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~-------~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl 152 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG-------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKL 152 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred EEEEEEEECCCCCHHHHHHHCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEEEE
T ss_conf 68999983368622899986158-------999999999999999999999877---97556676111477447884897
Q ss_pred CCCCHHHHCCCCCCCEEEEEECCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 8850024038998510355202577775456778779-997786034899999999099999899946899999841233
Q 002462 682 GSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLT-ATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPY 760 (919)
Q Consensus 682 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~ 760 (919)
+|||.++....... +...+++.+.+|+...... ++.++||||+||++|||+||+.||.... ........
T Consensus 153 ~DFG~a~~~~~~~~----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~~~~~~- 222 (273)
T d1xwsa_ 153 IDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIRGQVF- 222 (273)
T ss_dssp CCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHHCCCC-
T ss_pred CCCCCCEECCCCCC----CCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH-----HHHHCCCC-
T ss_conf 75465353244455----665658774799998489978865332554034536756889988736-----77615447-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 11123222011026888889006999999999998715999999999899999
Q 002462 761 ISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 761 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
..+ ...++ +..++.+|++.+|++|||++|+++
T Consensus 223 ------------~~~------~~s~~---~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 223 ------------FRQ------RVSSE---CQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ------------CSS------CCCHH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------CCC------CCCHH---HHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ------------787------79999---999999976089758939999853
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=296.73 Aligned_cols=263 Identities=18% Similarity=0.174 Sum_probs=184.0
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 9998323334588884899995-49961899995155310---8999999999861699984136558860488179999
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMERENEKFLVY 609 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~~~~~~LV~ 609 (919)
++|...+.||+|+||+||+|+. .++..||||+++..... .+.+.+|+.++++++|||||+++++|.. ....++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCC-CCCEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444-43115886
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHHH
Q ss_conf 72279981001000699977567779999999999999985545128999926446889960017999622488500240
Q 002462 610 KYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVCA 689 (919)
Q Consensus 610 Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~~ 689 (919)
||+.+++|...+.... .+++.....++.|+++||+|||+. +||||||||+|||++.+..+|++|||.++.
T Consensus 81 ~~~~~~~l~~~~~~~~-------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~ 150 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNG-------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp ECCSEEHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EECCCCCCCCCCCCCC-------CCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHHC
T ss_conf 3023322211212356-------540367899999999998774339---986001467612113378266520460110
Q ss_pred CCCCCCCEEEEEECCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCH-HHH-HHHHHHHCCCCCCCCC
Q ss_conf 389985103552025777754567-7877999778603489999999909999989994-689-9999841233111232
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSD-AQV-KEILEQTLPYISIYDK 766 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~-~~~-~~~~~~~~p~~~~~~~ 766 (919)
........ ......+.+.+++. .+...++.++||||+||++|||+||+.|+....+ .+. ........+......
T Consensus 151 ~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 227 (292)
T d1unla_ 151 FGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW- 227 (292)
T ss_dssp CCSCCSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC-
T ss_pred CCCCCCCC--EEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHH-
T ss_conf 46887510--010344310146675069888804440265418899851899998899999999999861189973551-
Q ss_pred CCCCCCCCC----------CC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 220110268----------88-889006999999999998715999999999899999
Q 002462 767 ELVTKIVDP----------SL-IIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 767 ~~~~~i~d~----------~l-~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
....+..+. .. .......+ .+..++.+|++.+|.+|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~---~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNA---TGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCH---HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCCCCCCCCHHHHCCCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 344322211334445443104330656899---9999999986499668909999964
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=291.61 Aligned_cols=265 Identities=17% Similarity=0.157 Sum_probs=187.1
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCCCCEEEEEEEC-----CCC
Q ss_conf 9998323334588884899995-49961899995155310---89999999998616999841365588604-----881
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMER-----ENE 604 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~-----~~~ 604 (919)
++|...++||+|+||+||+|+. .+|..||||++...... .+.+.+|+.++++++|||||++++++... ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCC
Q ss_conf 79999722799810010006999775677799999999999999855451289999264468899600179996224885
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSL 684 (919)
Q Consensus 605 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~df 684 (919)
.|+|||||.+|.+ +.++ ..+++.....++.+++.||.|||+. +|+||||||.|||++.+...|++||
T Consensus 97 ~~iv~Ey~~~~l~-~~~~---------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp EEEEEECCSEEHH-HHHT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEECCCHHHH-HHHH---------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECH
T ss_conf 6999841446778-7650---------3899999999999999999886522---1124567763211365443132010
Q ss_pred CHHHHCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHHHC-CCCC
Q ss_conf 00240389985103552025777754567787799977860348999999990999998999468999-998412-3311
Q 002462 685 SEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKE-ILEQTL-PYIS 762 (919)
Q Consensus 685 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~-~~~~~~-p~~~ 762 (919)
+..+....... .+...+++.+.+|+......++.++||||+||++|||++|+.||.+.+...... .+.... +...
T Consensus 164 ~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 164 GLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp CC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred HHHHCCCCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHH
T ss_conf 23211466655---332214655558133147777877433356625789865989988897788999999720589879
Q ss_pred CCC-----------------CCCCCCCCCCCC-CCC-CCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 123-----------------222011026888-889-0069999999999987159999999998999999
Q 002462 763 IYD-----------------KELVTKIVDPSL-IID-EDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKA 814 (919)
Q Consensus 763 ~~~-----------------~~~~~~i~d~~l-~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~ 814 (919)
... ......+..... ..+ +........+..++.+|++.+|++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 99876566777764175435666421264333543210133379999999999876994579089999669
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=293.22 Aligned_cols=265 Identities=12% Similarity=0.174 Sum_probs=185.4
Q ss_pred HCCCCCCCCCCCCCCCCEEEEE-ECCCCCEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCCCCEEEEEEEC----CCC
Q ss_conf 3999832333458888489999-549961899995155310---89999999998616999841365588604----881
Q 002462 533 TGDFSDANLIKNGHSGDLFRGI-LEGGIPVVIKRIDLQSVK---TEAYLLELDFFSKVSHARLVPLLGHCMER----ENE 604 (919)
Q Consensus 533 t~~f~~~~~ig~G~~G~Vy~g~-l~~g~~vavK~l~~~~~~---~~~f~~Ei~~l~~l~H~NiV~l~g~c~~~----~~~ 604 (919)
.++|.....||+|+||+||+|+ ..+|..||||++...... .+.+.+|+++|++++|||+|++++++... +..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECCC
Q ss_conf 79999722799810010006999775677799999999999999855451289999264468899600179996224885
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGSL 684 (919)
Q Consensus 605 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~df 684 (919)
.+++++|+.+|+|.+++..+ .+++.+...|+.|++.||+|||+. +||||||||+|||++.++.+|++||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~--------~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~df 165 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ--------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 165 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEEECCCCHHHHCCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 49999962588623200224--------530999999999999999999738---8765166776334554322001321
Q ss_pred CHHHHCCCCCCCEEEEEECCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCC-
Q ss_conf 00240389985103552025777754567-7877999778603489999999909999989994689999984123311-
Q 002462 685 SEVCAQGGDAHQSRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEILEQTLPYIS- 762 (919)
Q Consensus 685 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~~~~~~p~~~- 762 (919)
|.+.......... .+++.+.+++. .+...++.++||||+||++|||+||+.||.+.+.......+........
T Consensus 166 g~a~~~~~~~~~~-----~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 166 GLARHTDDEMTGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp ----CCTGGGSSS-----CHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred CHHCCCCCCCCCC-----CCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCH
T ss_conf 0001257544443-----45435558355337756785512432058999997688997889889999999973079975
Q ss_pred -CC---CCCCCCCCCCCCCCCCCCHHHH-----HHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf -12---3222011026888889006999-----999999998715999999999899999
Q 002462 763 -IY---DKELVTKIVDPSLIIDEDLLEE-----VWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 763 -~~---~~~~~~~i~d~~l~~~~~~~~~-----~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
.. ...................... -..+..++.+|++.+|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 773200102445444303557875556626789999999999977588345938999855
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=295.86 Aligned_cols=250 Identities=18% Similarity=0.176 Sum_probs=180.6
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-C---CCCCEEEEEECCCCC-----CHHHHHHHHHHHHHCCC-CCCCCEEEEEEECCC
Q ss_conf 9998323334588884899995-4---996189999515531-----08999999999861699-984136558860488
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-E---GGIPVVIKRIDLQSV-----KTEAYLLELDFFSKVSH-ARLVPLLGHCMEREN 603 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~---~g~~vavK~l~~~~~-----~~~~f~~Ei~~l~~l~H-~NiV~l~g~c~~~~~ 603 (919)
++|...+.||+|+||.||+|.- . +|..||||.++.... ..+.+.+|++++++++| ||||++++++.+ ..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-~~ 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-ET 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-TT
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024-87
Q ss_pred CEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCCEEECC
Q ss_conf 17999972279981001000699977567779999999999999985545128999926446889960017999622488
Q 002462 604 EKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFEVRLGS 683 (919)
Q Consensus 604 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~~ki~d 683 (919)
..++|+|||.+|+|.+++..... +.......++.|++.||+|+|+. +||||||||+|||+|.++.+|++|
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~-------~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~D 172 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRER-------FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTD 172 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESC
T ss_pred CEEEEEECCCCCHHHHHHHHCCC-------CCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEEE
T ss_conf 30012312341179999873045-------43788888899999999885149---989654773201246999888741
Q ss_pred CCHHHHCCCCCCCEEEEEECCCCCCCCCCCC--CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHHHCCC
Q ss_conf 5002403899851035520257777545677--877999778603489999999909999989994689-9999841233
Q 002462 684 LSEVCAQGGDAHQSRITRLLRLPQSSEQGSS--GSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQV-KEILEQTLPY 760 (919)
Q Consensus 684 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~-~~~~~~~~p~ 760 (919)
||.++......... .....+++.+..++.. ....++.++||||+||+||||+||+.||...+.... ..........
T Consensus 173 FG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~ 251 (322)
T d1vzoa_ 173 FGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251 (322)
T ss_dssp SSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred CCCHHHHCCCCCCC-CCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCC
T ss_conf 32022203444432-21222333331068760577688713251777799999976899988887777999999833568
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 11123222011026888889006999999999998715999999999-----899999
Q 002462 761 ISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPL-----MRYILK 813 (919)
Q Consensus 761 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----m~~v~~ 813 (919)
.........++ +..++.+|++++|.+||+ ++|+++
T Consensus 252 ---------------~~~~~~~~s~~---~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ---------------EPPYPQEMSAL---AKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---------------CCCCCTTSCHH---HHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---------------CCCCCCCCCHH---HHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf ---------------99886547999---99999997445898819997450999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=288.13 Aligned_cols=259 Identities=15% Similarity=0.146 Sum_probs=179.8
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCCHHHHHHHHHHHHHCC-CCCCCCEEEEEEEC-CCCEEEEEE
Q ss_conf 9998323334588884899995-49961899995155310899999999986169-99841365588604-881799997
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKVS-HARLVPLLGHCMER-ENEKFLVYK 610 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~-H~NiV~l~g~c~~~-~~~~~LV~E 610 (919)
++|.....||+|+||+||+|+. .++..||||+++.. ..+.+.+|+++|.+++ |||||++++++... ....++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEEE
T ss_conf 6718978983174819999998899979999998889--99999999999985157998767999998168771268886
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCC-CCEEECCCCHHHH
Q ss_conf 227998100100069997756777999999999999998554512899992644688996001799-9622488500240
Q 002462 611 YMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDK-FEVRLGSLSEVCA 689 (919)
Q Consensus 611 y~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~-~~~ki~dfg~~~~ 689 (919)
||++|+|.+... .++......|+.|++.||.|||+. +||||||||+|||++.+ ..+|++|||.+..
T Consensus 113 ~~~~~~L~~~~~----------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 113 HVNNTDFKQLYQ----------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp CCCSCBGGGTTT----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred ECCCCCHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCCEE
T ss_conf 317985899746----------899999999999999999887643---3443456441237748998366415654266
Q ss_pred CCCCCCCEEEEEECCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHHHCC------CC
Q ss_conf 389985103552025777754567-78779997786034899999999099999899946899-99984123------31
Q 002462 690 QGGDAHQSRITRLLRLPQSSEQGS-SGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVK-EILEQTLP------YI 761 (919)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~-~~~~~~~p------~~ 761 (919)
....... ....+++.+.+|+. .+...++.++||||+|+++||+++|+.||....+.... ..+..... +.
T Consensus 180 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 180 YHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp CCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred CCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHH
T ss_conf 4688744---4322486424761026888888452323354555876048899988760189999999987884155555
Q ss_pred ---CCCCCCCCCCCCC--C-----CCCCC---CCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf ---1123222011026--8-----88889---006999999999998715999999999899999
Q 002462 762 ---SIYDKELVTKIVD--P-----SLIID---EDLLEEVWAMAIVARSCLNPKPTRRPLMRYILK 813 (919)
Q Consensus 762 ---~~~~~~~~~~i~d--~-----~l~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~ 813 (919)
..........+.. + ..... ....+ .+..++.+|++.+|++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~---~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP---EALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 4225444743000003334331121155211244899---9999999986699568908999964
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=287.01 Aligned_cols=259 Identities=14% Similarity=0.096 Sum_probs=192.5
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCCHHHHHHHHHHHHHCCC-CCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 9998323334588884899995-499618999951553108999999999861699-98413655886048817999972
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSH-ARLVPLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H-~NiV~l~g~c~~~~~~~~LV~Ey 611 (919)
++|.....||+|+||.||+|+. .+|..||||.+..... .+.+.+|++.+.+++| +|++.+++++.+ +...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCCCEEEEEEEC-CCCCEEEEEE
T ss_conf 806997998417882999999988997999999750258-29999999999996489998779999601-8811799996
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCC-----CCCEEECCCCH
Q ss_conf 2799810010006999775677799999999999999855451289999264468899600179-----99622488500
Q 002462 612 MPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDD-----KFEVRLGSLSE 686 (919)
Q Consensus 612 ~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~-----~~~~ki~dfg~ 686 (919)
+ +|+|.+.+.... ..+++.+...|+.+++.||+|||+. +||||||||+|||++. +..+|++|||.
T Consensus 83 ~-~~~l~~~~~~~~------~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 83 L-GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp C-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred C-CCCHHHHHHHHC------CCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEECCCCE
T ss_conf 4-888799997520------3110689999999999999999977---96626677131523475434479568723660
Q ss_pred HHHCCCCCCC-----EEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH---HHHHC
Q ss_conf 2403899851-----035520257777545677877999778603489999999909999989994689999---98412
Q 002462 687 VCAQGGDAHQ-----SRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQVKEI---LEQTL 758 (919)
Q Consensus 687 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~~~~~---~~~~~ 758 (919)
++........ .......+++.+++|+......++.++||||||+++|||+||+.||.+......... +....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~ 232 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred EEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCC
T ss_conf 57714676654111024676277510267989648888869998983199999986987678853021999999997056
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 33111232220110268888890069999999999987159999999998999999202323
Q 002462 759 PYISIYDKELVTKIVDPSLIIDEDLLEEVWAMAIVARSCLNPKPTRRPLMRYILKALENPLK 820 (919)
Q Consensus 759 p~~~~~~~~~~~~i~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPsm~~v~~~L~~~~~ 820 (919)
.. ....++ .+. ..++ +..++..|++.+|++||+++.+.+.|++.+.
T Consensus 233 ~~------~~~~~l-~~~------~p~~---l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 233 QS------TPLREL-CAG------FPEE---FYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HH------SCHHHH-TTT------SCHH---HHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CC------CCHHHH-CCC------CCHH---HHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH
T ss_conf 79------995896-579------9899---9999999843993008599999999999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=261.08 Aligned_cols=269 Identities=17% Similarity=0.239 Sum_probs=179.0
Q ss_pred CCCCCCCCCCCCCCCCEEEEEE-CCCCCEEEEEECCCCCCHHHHHHHHHHHHHCCC-----------CCCCCEEEEEEE-
Q ss_conf 9998323334588884899995-499618999951553108999999999861699-----------984136558860-
Q 002462 534 GDFSDANLIKNGHSGDLFRGIL-EGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSH-----------ARLVPLLGHCME- 600 (919)
Q Consensus 534 ~~f~~~~~ig~G~~G~Vy~g~l-~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H-----------~NiV~l~g~c~~- 600 (919)
+.|.....||+|+||.||+|+. .+|..||||+++......+.+.+|++++.+++| +|||++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 85799899750778189999999999799999983431336899999999998401455555422767647899876312
Q ss_pred CCCCEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCC---
Q ss_conf 48817999972279981001000699977567779999999999999985545128999926446889960017999---
Q 002462 601 RENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKF--- 677 (919)
Q Consensus 601 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~--- 677 (919)
.....+++++++..+........... ...++......++.++++||+|||+. .+|+||||||+|||++.+.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYE----HRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTT
T ss_pred CCCCEEEEEEECCCCCCCCCCCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHEEEECCCCCC
T ss_conf 56520234320003542000001223----46786899999999999998887640--5864656770570563057656
Q ss_pred ---CEEECCCCHHHHCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHH-----
Q ss_conf ---622488500240389985103552025777754567787799977860348999999990999998999468-----
Q 002462 678 ---EVRLGSLSEVCAQGGDAHQSRITRLLRLPQSSEQGSSGSLTATCPYDVYCFGKVLLELVTGKMGISASSDAQ----- 749 (919)
Q Consensus 678 ---~~ki~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~sDVySfGvvLlEllTG~~p~~~~~~~~----- 749 (919)
.+++.|||.+......... ..+++.+.+|+......++.++||||+||+++||+||+.||.......
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHYTN-----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp TEEEEEECCCTTCEETTBCCCS-----CCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CCCEEEEEECCCCCCCCCCCCC-----CCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHH
T ss_conf 4430567531442123445422-----36652105713214667776432012378999998788998987554321026
Q ss_pred --HHHHHH--HHCCCCCC---------CC-CCCCCCCCCCCCCC--------CCCHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf --999998--41233111---------23-22201102688888--------9006999999999998715999999999
Q 002462 750 --VKEILE--QTLPYISI---------YD-KELVTKIVDPSLII--------DEDLLEEVWAMAIVARSCLNPKPTRRPL 807 (919)
Q Consensus 750 --~~~~~~--~~~p~~~~---------~~-~~~~~~i~d~~l~~--------~~~~~~~~~~~~~l~~~Cl~~~P~~RPs 807 (919)
....+. ...+.... .. ......+....... ..........+..+..+|+..||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC
T ss_conf 89999999837998788624532200013201220243235776444210001567435899999999987799457908
Q ss_pred HHHHHH
Q ss_conf 899999
Q 002462 808 MRYILK 813 (919)
Q Consensus 808 m~~v~~ 813 (919)
++|+++
T Consensus 322 a~e~L~ 327 (362)
T d1q8ya_ 322 AGGLVN 327 (362)
T ss_dssp HHHHHT
T ss_pred HHHHHC
T ss_conf 999966
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=4.9e-41 Score=232.56 Aligned_cols=251 Identities=29% Similarity=0.448 Sum_probs=218.1
Q ss_pred CCCCEEEEECCCCCC--CCCCCCCCCCCCCEEEEEC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 987699801587985--5886778999898999107-9899989611249999889985589699889822228999998
Q 002462 142 PTLQALDLRSCSISG--VIPFSLGNLTNLTSLYLSD-NGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSS 218 (919)
Q Consensus 142 ~~L~~LdLs~n~l~g--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~ 218 (919)
.+++.|||++|.+.| .+|.++++|++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCC
T ss_conf 79889989899888888798478467533520202654333002431145420011020356434433222220111001
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC-CEEECCCCCCCCCCCHHHHCCCCCCEEECCCCC
Q ss_conf 8656874787799546799989888702898899985224999999-889867997987795444226458789715876
Q 002462 219 LDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSL-VDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNF 297 (919)
Q Consensus 219 L~Ls~N~l~~~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~ 297 (919)
++++.|.+.+.+|..+.++++|+.+++++|.+.+.+|..+..+..+ +.++++.|++++..|..+..+..+ .+++..+.
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~ 208 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSE
T ss_pred CCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCC
T ss_conf 11122455556851220674000000235533562031214431123231022464353324332222222-33333343
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 89998976469998877898467899899840028999997898668979899995554578887489866883755788
Q 002462 298 LSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLT 377 (919)
Q Consensus 298 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~l~~l~ls~N~~~g~~~ 377 (919)
..+.++.. +..+.+++.+++.+|.+.+.+| .+..+++|+.|++++|+++|.+|... ..++.++.|++++|.+.|.+|
T Consensus 209 ~~~~~~~~-~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l-~~L~~L~~L~Ls~N~l~g~iP 285 (313)
T d1ogqa_ 209 LEGDASVL-FGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGL-TQLKFLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp EEECCGGG-CCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGG-GGCTTCCEEECCSSEEEEECC
T ss_pred CCCCCCCC-CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHH-HCCCCCCEEECCCCCCCCCCC
T ss_conf 32222222-2222221112222222222222-22245544444476570666087688-479999989795883516689
Q ss_pred CC--CCCCCEEECCCCC-CCCC
Q ss_conf 78--9998599831776-7775
Q 002462 378 PV--LGRFRLVDLSGNY-FEGR 396 (919)
Q Consensus 378 ~~--l~~l~~l~ls~N~-l~g~ 396 (919)
.. +.+|+.+++++|+ ++|.
T Consensus 286 ~~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 286 QGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp CSTTGGGSCGGGTCSSSEEEST
T ss_pred CCCCCCCCCHHHHCCCCCCCCC
T ss_conf 8666799897886889500198
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-34 Score=195.49 Aligned_cols=251 Identities=25% Similarity=0.272 Sum_probs=196.0
Q ss_pred CCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECC-CCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 987699801587985588677899989899910798999896112499998899855-8969988982222899999886
Q 002462 142 PTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLS-RNSLTGNIPTSFGLLKNLSSLD 220 (919)
Q Consensus 142 ~~L~~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls-~N~l~~~~P~~~~~l~~L~~L~ 220 (919)
+.+++|+|++|.|+...+..|.++++|++|++++|.+....+..+.++..+..+... .|.+....|..|.++++|+.|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEE
T ss_conf 99888977488179879778641421300001344543321112122222222222210223544620101010277875
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCC
Q ss_conf 56874787799546799989888702898899985224999999889867997987795444226458789715876899
Q 002462 221 ISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSG 300 (919)
Q Consensus 221 Ls~N~l~~~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 300 (919)
+++|.+....+..+....+|+.+++++|.+++..+..|..+++|+.|++++|++....+..|.++++|+.+++++|.+.+
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCC
T ss_conf 68854432013533200012110200143144580574043405022314176566256665465634131421143466
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 98976469998877898467899899840028999997898668979899995554578887489866883755788789
Q 002462 301 NLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPVL 380 (919)
Q Consensus 301 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~l~~l~ls~N~~~g~~~~~l 380 (919)
.. ...|..+++|+.|++++|.+.+.++..|..+++|++|++++|++.+..+.... ...+..+....+.+.+..|..+
T Consensus 192 i~-~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l--~~~l~~~~~~~~~~~C~~p~~l 268 (284)
T d1ozna_ 192 VH-PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL--WAWLQKFRGSSSEVPCSLPQRL 268 (284)
T ss_dssp EC-TTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHH--HHHHHHCCSEECCCBEEESGGG
T ss_pred CC-HHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCHHH--HHHHHHCCCCCCCEEECCCHHH
T ss_conf 28-16766532000233333522100000235546568898119988787564699--9999867388886674796698
Q ss_pred CCCCEEECCCCCCCC
Q ss_conf 998599831776777
Q 002462 381 GRFRLVDLSGNYFEG 395 (919)
Q Consensus 381 ~~l~~l~ls~N~l~g 395 (919)
......+++.+.|+|
T Consensus 269 ~g~~l~~l~~~~l~g 283 (284)
T d1ozna_ 269 AGRDLKRLAANDLQG 283 (284)
T ss_dssp TTCBGGGSCGGGSCC
T ss_pred CCCCCCCCCHHHCCC
T ss_conf 498534189888789
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=3.6e-30 Score=174.65 Aligned_cols=282 Identities=27% Similarity=0.330 Sum_probs=152.6
Q ss_pred CCEEEEECCCCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 99999990898656788889846711111899789786699879988853665189987699801587985588677899
Q 002462 86 GSVVGINISGFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNL 165 (919)
Q Consensus 86 ~~v~~l~l~~~~~~~~~~~~~~~~~~~l~~l~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~n~l~g~~p~~~~~l 165 (919)
..++.+++++..... .+.+..+++|+.|++++|.+.+ +|+ +. ++++|++|++++|.+.+.. .++.+
T Consensus 44 ~~l~~L~l~~~~I~~---------l~gl~~L~nL~~L~Ls~N~l~~-l~~-l~-~L~~L~~L~L~~n~i~~i~--~l~~l 109 (384)
T d2omza2 44 DQVTTLQADRLGIKS---------IDGVEYLNNLTQINFSNNQLTD-ITP-LK-NLTKLVDILMNNNQIADIT--PLANL 109 (384)
T ss_dssp TTCCEEECCSSCCCC---------CTTGGGCTTCCEEECCSSCCCC-CGG-GT-TCTTCCEEECCSSCCCCCG--GGTTC
T ss_pred CCCCEEECCCCCCCC---------CCCCCCCCCCCEEECCCCCCCC-CCC-CC-CCCCCCCCCCCCCCCCCCC--CCCCC
T ss_conf 787899899989877---------6242458999989681881798-863-34-7711010301343332222--11123
Q ss_pred CCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCC-----------------------------------------C
Q ss_conf 98989991079899989611249999889985589699-----------------------------------------8
Q 002462 166 TNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLT-----------------------------------------G 204 (919)
Q Consensus 166 ~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~-----------------------------------------~ 204 (919)
++|+.|++++|.+++..+ ......+..+....|.+. .
T Consensus 110 ~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (384)
T d2omza2 110 TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKV 187 (384)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCC
T ss_pred CCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC
T ss_conf 343334433222222222--222222211213466313100232222112222212322011112454211011222433
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHC
Q ss_conf 89822228999998865687478779954679998988870289889998522499999988986799798779544422
Q 002462 205 NIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRG 284 (919)
Q Consensus 205 ~~P~~~~~l~~L~~L~Ls~N~l~~~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 284 (919)
.....+..++++..+++++|.+++..| +...++|+.|++++|.++. + ..+..+++|+.|++++|.+.+.. .+..
T Consensus 188 ~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~ 261 (384)
T d2omza2 188 SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSG 261 (384)
T ss_dssp CCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTT
T ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCC-C-CHHHCCCCCCHHCCCCCCCCCCC--CCCC
T ss_conf 321100223532333035774478786--4445778788887777789-6-13432565341004467447877--5355
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 64587897158768999897646999887789846789989984002899999789866897989999555457888748
Q 002462 285 LRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVE 364 (919)
Q Consensus 285 l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~l~~ 364 (919)
+++|+.|+++.|.+.+..+ +..+..++.+.+..|.+.+.. .+..+++++.|++++|++++..+ +..++.++.
T Consensus 262 ~~~L~~L~l~~~~l~~~~~---~~~~~~l~~l~~~~n~l~~~~--~~~~~~~l~~L~ls~n~l~~l~~---l~~l~~L~~ 333 (384)
T d2omza2 262 LTKLTELKLGANQISNISP---LAGLTALTNLELNENQLEDIS--PISNLKNLTYLTLYFNNISDISP---VSSLTKLQR 333 (384)
T ss_dssp CTTCSEEECCSSCCCCCGG---GTTCTTCSEEECCSSCCSCCG--GGGGCTTCSEEECCSSCCSCCGG---GGGCTTCCE
T ss_pred CCCCCEEECCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCC--CCCHHCCCCEEECCCCCCCCCCC---CCCCCCCCE
T ss_conf 4668775456744578773---235652222332323333322--10000246767777887789845---366898898
Q ss_pred EECCCCCCCCCC-CCCCCCCCEEECCCCCCCCCC
Q ss_conf 986688375578-878999859983177677757
Q 002462 365 LNISQNMFYGGL-TPVLGRFRLVDLSGNYFEGRV 397 (919)
Q Consensus 365 l~ls~N~~~g~~-~~~l~~l~~l~ls~N~l~g~i 397 (919)
|++++|.+.... ...+++|+.+++++|++++..
T Consensus 334 L~L~~n~l~~l~~l~~l~~L~~L~l~~N~l~~l~ 367 (384)
T d2omza2 334 LFFANNKVSDVSSLANLTNINWLSAGHNQISDLT 367 (384)
T ss_dssp EECCSSCCCCCGGGGGCTTCCEEECCSSCCCBCG
T ss_pred EECCCCCCCCCHHHCCCCCCCEEECCCCCCCCCH
T ss_conf 9898998999746708999998989799589980
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.98 E-value=2.4e-29 Score=170.30 Aligned_cols=258 Identities=22% Similarity=0.294 Sum_probs=202.1
Q ss_pred CCCCEEECCCCCCCCCCCHHHHHCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 97897866998799888536651899876998015879855886778999898999107989998961124999988998
Q 002462 117 THLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLD 196 (919)
Q Consensus 117 ~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~ 196 (919)
+.++.|++++|.+. .+|+..+..+++|++|++++|.+....|..|.++++|++|++++|+++ .+|..+ ...+..|+
T Consensus 31 ~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~ 106 (305)
T d1xkua_ 31 PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELR 106 (305)
T ss_dssp TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEE
T ss_pred CCCCEEECCCCCCC-CCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCCCCC-CCCCCH--HHHHHHHH
T ss_conf 99798978499189-869657604656523112344344523566527985578315687567-676400--11132321
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCC--CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 5589699889822228999998865687478--77995467999898887028988999852249999998898679979
Q 002462 197 LSRNSLTGNIPTSFGLLKNLSSLDISSNYLT--GSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSL 274 (919)
Q Consensus 197 Ls~N~l~~~~P~~~~~l~~L~~L~Ls~N~l~--~~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 274 (919)
+..|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++.+|.+.. +|.. .+++|+.|++++|..
T Consensus 107 ~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~--~~~~L~~L~l~~n~~ 183 (305)
T d1xkua_ 107 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQG--LPPSLTELHLDGNKI 183 (305)
T ss_dssp CCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSS--CCTTCSEEECTTSCC
T ss_pred CCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCC--CCCCCCEEECCCCCC
T ss_conf 0246102344445401331100001233333467776422345656712034677451-6710--177667898978867
Q ss_pred CCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC
Q ss_conf 87795444226458789715876899989764699988778984678998998400289999978986689798999955
Q 002462 275 SGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNS 354 (919)
Q Consensus 275 ~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~ 354 (919)
....+..+.+++.++.|++++|.+.+ ++...+..+++|+.|+|++|.++.. |..+..+++|+.|++++|+++ .++..
T Consensus 184 ~~~~~~~~~~~~~l~~L~~s~n~l~~-~~~~~~~~l~~L~~L~L~~N~L~~l-p~~l~~l~~L~~L~Ls~N~i~-~i~~~ 260 (305)
T d1xkua_ 184 TKVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNIS-AIGSN 260 (305)
T ss_dssp CEECTGGGTTCTTCCEEECCSSCCCE-ECTTTGGGSTTCCEEECCSSCCSSC-CTTTTTCSSCCEEECCSSCCC-CCCTT
T ss_pred CCCCHHHHHCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCEEEECCCCCCCCC-CCCCCCCCCCCEEECCCCCCC-CCCHH
T ss_conf 78882676413413301544553322-2345433443322430255400246-311033467898989898657-63810
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCCC
Q ss_conf 5457888748986688375578878999859983177677-75783
Q 002462 355 RSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFE-GRVPE 399 (919)
Q Consensus 355 ~~~~~~~l~~l~ls~N~~~g~~~~~l~~l~~l~ls~N~l~-g~ip~ 399 (919)
.+... .....+.+|+.+++++|.++ ..++.
T Consensus 261 ~f~~~---------------~~~~~~~~L~~L~L~~N~~~~~~~~~ 291 (305)
T d1xkua_ 261 DFCPP---------------GYNTKKASYSGVSLFSNPVQYWEIQP 291 (305)
T ss_dssp SSSCS---------------SCCTTSCCCSEEECCSSSSCGGGSCG
T ss_pred HCCCC---------------CHHCCCCCCCEEECCCCCCCCCCCCH
T ss_conf 02672---------------10021588897889899576676897
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.98 E-value=1.5e-29 Score=171.38 Aligned_cols=223 Identities=22% Similarity=0.298 Sum_probs=160.7
Q ss_pred CCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 98769980158798558867789998989991079899989611249999889985589699889822228999998865
Q 002462 142 PTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDI 221 (919)
Q Consensus 142 ~~L~~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~L 221 (919)
+.+++|+|++|.++...+..|.++++|++|++++|.+....|..|.++++|+.|++++|+++ .+|..+ ...+..|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~ 107 (305)
T d1xkua_ 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRV 107 (305)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEEC
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCCCCC-CCCCCH--HHHHHHHHC
T ss_conf 99798978499189869657604656523112344344523566527985578315687567-676400--111323210
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCC--CCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCC
Q ss_conf 6874787799546799989888702898899--98522499999988986799798779544422645878971587689
Q 002462 222 SSNYLTGSIPPGLGTLSKLQYLNVSNNSLAS--SIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLS 299 (919)
Q Consensus 222 s~N~l~~~lp~~l~~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 299 (919)
..|.+....+..+.....+..+....|.... ..+..+..+++|+.+++.+|.+. .+|.. .+++|+.|++++|...
T Consensus 108 ~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~--~~~~L~~L~l~~n~~~ 184 (305)
T d1xkua_ 108 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG--LPPSLTELHLDGNKIT 184 (305)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSS--CCTTCSEEECTTSCCC
T ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCC--CCCCCCEEECCCCCCC
T ss_conf 24610234444540133110000123333346777642234565671203467745-16710--1776678989788677
Q ss_pred CCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC
Q ss_conf 99897646999887789846789989984002899999789866897989999555457888748986688375578878
Q 002462 300 GNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLTPV 379 (919)
Q Consensus 300 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~l~~l~ls~N~~~g~~~~~ 379 (919)
...+ ..|..++.++.|.+++|.+.+..+..+..+++|+.|+|++|+++ .+|... ..
T Consensus 185 ~~~~-~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l-~~--------------------- 240 (305)
T d1xkua_ 185 KVDA-ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL-AD--------------------- 240 (305)
T ss_dssp EECT-GGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTT-TT---------------------
T ss_pred CCCH-HHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCC-CC---------------------
T ss_conf 8882-67641341330154455332223454334433224302554002-463110-33---------------------
Q ss_pred CCCCCEEECCCCCCC
Q ss_conf 999859983177677
Q 002462 380 LGRFRLVDLSGNYFE 394 (919)
Q Consensus 380 l~~l~~l~ls~N~l~ 394 (919)
+++|+.+++++|.++
T Consensus 241 l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 241 HKYIQVVYLHNNNIS 255 (305)
T ss_dssp CSSCCEEECCSSCCC
T ss_pred CCCCCEEECCCCCCC
T ss_conf 467898989898657
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=8.2e-31 Score=178.07 Aligned_cols=207 Identities=21% Similarity=0.242 Sum_probs=121.7
Q ss_pred CCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC-CCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 989899910798999896112499998899855896998898222289999988656-8747877995467999898887
Q 002462 166 TNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDIS-SNYLTGSIPPGLGTLSKLQYLN 244 (919)
Q Consensus 166 ~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~Ls-~N~l~~~lp~~l~~l~~L~~L~ 244 (919)
.++++|+|++|+|+...+..|.++++|+.|++++|.+....+..+..+..+..++.. .|.++...+..|.++++|++|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEE
T ss_conf 99888977488179879778641421300001344543321112122222222222210223544620101010277875
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 02898899985224999999889867997987795444226458789715876899989764699988778984678998
Q 002462 245 VSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFT 324 (919)
Q Consensus 245 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 324 (919)
+++|.+....+..+....+|+.+++++|+++...+..|..+++|+.|++++|.+.. ++...|..+++|+.+++.+|+++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~-l~~~~f~~l~~L~~l~l~~N~l~ 190 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVA 190 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCC-CCHHHHCCCCCCCHHHHHHCCCC
T ss_conf 68854432013533200012110200143144580574043405022314176566-25666546563413142114346
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 99840028999997898668979899995554578887489866883755
Q 002462 325 GPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYG 374 (919)
Q Consensus 325 ~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~l~~l~ls~N~~~g 374 (919)
+..|..|..+++|++|++++|++.+..+ ..+.....+..+++++|.+.+
T Consensus 191 ~i~~~~f~~l~~L~~L~l~~N~i~~~~~-~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 191 HVHPHAFRDLGRLMTLYLFANNLSALPT-EALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSCCCH-HHHTTCTTCCEEECCSSCEEC
T ss_pred CCCHHHHHHHHHCCCCCCCCCCCCCCCC-CCCCCCCCCCEEEECCCCCCC
T ss_conf 6281676653200023333352210000-023554656889811998878
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=4.5e-29 Score=168.83 Aligned_cols=259 Identities=24% Similarity=0.321 Sum_probs=121.8
Q ss_pred CCCCCEEECCCCCCCCCCCHHHHHCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEE
Q ss_conf 99789786699879988853665189987699801587985588677899989899910798999896112499998899
Q 002462 116 LTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVL 195 (919)
Q Consensus 116 l~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L 195 (919)
+.+|+.|+++++.+.. +. .+. .|++|++|||++|.+++.. .++++++|++|++++|.+.+ ++ .+.++++|+.|
T Consensus 43 l~~l~~L~l~~~~I~~-l~-gl~-~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~-i~-~l~~l~~L~~L 115 (384)
T d2omza2 43 LDQVTTLQADRLGIKS-ID-GVE-YLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL 115 (384)
T ss_dssp HTTCCEEECCSSCCCC-CT-TGG-GCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGTTCTTCCEE
T ss_pred HCCCCEEECCCCCCCC-CC-CCC-CCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCC
T ss_conf 5787899899989877-62-424-5899998968188179886--33477110103013433322-22-11123343334
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-----------------------------------------CCCCCCC
Q ss_conf 85589699889822228999998865687478-----------------------------------------7799546
Q 002462 196 DLSRNSLTGNIPTSFGLLKNLSSLDISSNYLT-----------------------------------------GSIPPGL 234 (919)
Q Consensus 196 ~Ls~N~l~~~~P~~~~~l~~L~~L~Ls~N~l~-----------------------------------------~~lp~~l 234 (919)
++++|.+++..+. .....+..+....|.+. ......+
T Consensus 116 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (384)
T d2omza2 116 TLFNNQITDIDPL--KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193 (384)
T ss_dssp ECCSSCCCCCGGG--TTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGG
T ss_pred CCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 4332222222222--22222211213466313100232222112222212322011112454211011222433321100
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 79998988870289889998522499999988986799798779544422645878971587689998976469998877
Q 002462 235 GTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQ 314 (919)
Q Consensus 235 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 314 (919)
..+++++.+++++|.+++..| +....+|+.|++++|.+.. + ..+..+++|+.+++++|.+.+..+ +..+++|+
T Consensus 194 ~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~---~~~~~~L~ 266 (384)
T d2omza2 194 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP---LSGLTKLT 266 (384)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG---GTTCTTCS
T ss_pred CCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCC-C-CHHHCCCCCCHHCCCCCCCCCCCC---CCCCCCCC
T ss_conf 223532333035774478786--4445778788887777789-6-134325653410044674478775---35546687
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-CCCCCCCEEECCCCCC
Q ss_conf 898467899899840028999997898668979899995554578887489866883755788-7899985998317767
Q 002462 315 IIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMFYGGLT-PVLGRFRLVDLSGNYF 393 (919)
Q Consensus 315 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~l~~l~ls~N~~~g~~~-~~l~~l~~l~ls~N~l 393 (919)
.+++++|.+++..+ +..++.++.++++.|.+.+. +. ......+..+++++|.+.+-.+ ..+++|+.+++++|.+
T Consensus 267 ~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~~-~~--~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l 341 (384)
T d2omza2 267 ELKLGANQISNISP--LAGLTALTNLELNENQLEDI-SP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKV 341 (384)
T ss_dssp EEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCC-GG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCC
T ss_pred EEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-CC--CCHHCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCC
T ss_conf 75456744578773--23565222233232333332-21--000024676777788778984536689889898989989
Q ss_pred CC
Q ss_conf 77
Q 002462 394 EG 395 (919)
Q Consensus 394 ~g 395 (919)
++
T Consensus 342 ~~ 343 (384)
T d2omza2 342 SD 343 (384)
T ss_dssp CC
T ss_pred CC
T ss_conf 99
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.2e-29 Score=168.47 Aligned_cols=129 Identities=33% Similarity=0.323 Sum_probs=48.7
Q ss_pred CCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 87699801587985588677899989899910798999896112499998899855896998898222289999988656
Q 002462 143 TLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDIS 222 (919)
Q Consensus 143 ~L~~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~Ls 222 (919)
+|++|||++|.|++..+..|.++++|++|+|++|+++ .+| .++.+++|+.|+|++|++.. .+..+..+++|+.|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCC
T ss_conf 8898988499289859778634565522135665444-431-11112232111112222211-11121222222222222
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 8747877995467999898887028988999852249999998898679979
Q 002462 223 SNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSL 274 (919)
Q Consensus 223 ~N~l~~~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 274 (919)
+|.+....+..+..+.+++.|++++|.+....+..+..+++|+.|++++|++
T Consensus 109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCC
T ss_conf 2311011001122221111221243421022123332211100000001565
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-28 Score=166.28 Aligned_cols=199 Identities=27% Similarity=0.285 Sum_probs=109.7
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 99876998015879855886778999898999107989998961124999988998558969988982222899999886
Q 002462 141 LPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLD 220 (919)
Q Consensus 141 L~~L~~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~ 220 (919)
...+...|.+++.++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+++. +| .++.+++|+.|+
T Consensus 9 ~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 83 (266)
T d1p9ag_ 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLD 83 (266)
T ss_dssp STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEE
T ss_pred CCCCEEEECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCC
T ss_conf 689869980699988-6196757--688989884992898597786345655221356654444-31-111122321111
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCC
Q ss_conf 56874787799546799989888702898899985224999999889867997987795444226458789715876899
Q 002462 221 ISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSG 300 (919)
Q Consensus 221 Ls~N~l~~~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 300 (919)
|++|+++ ..+..+..+++|++|++++|.+....+..+..+.+++.|++++|.+....+.
T Consensus 84 Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~-------------------- 142 (266)
T d1p9ag_ 84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG-------------------- 142 (266)
T ss_dssp CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTT--------------------
T ss_pred CCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCC--------------------
T ss_conf 1222221-1111212222222222222311011001122221111221243421022123--------------------
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 989764699988778984678998998400289999978986689798999955545788874898668837
Q 002462 301 NLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMF 372 (919)
Q Consensus 301 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~l~~l~ls~N~~ 372 (919)
.+..+.+|+.+++++|++++.++..|..+++|++|+|++|+++ .+|...+ ....+..+++++|.|
T Consensus 143 -----~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~-~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 143 -----LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF-GSHLLPFAFLHGNPW 207 (266)
T ss_dssp -----TTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTT-TTCCCSEEECCSCCB
T ss_pred -----CCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHC-CCCCCCEEEECCCCC
T ss_conf -----3322111000000015652237200134212423430139785-5686677-788899998369998
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=2.5e-28 Score=164.85 Aligned_cols=167 Identities=13% Similarity=0.114 Sum_probs=114.0
Q ss_pred CCCCCCCCCCCCEEEEEECCCCCEEEEEECCCCC-------------------CHHHHHHHHHHHHHCCCCCCCCEEEEE
Q ss_conf 3233345888848999954996189999515531-------------------089999999998616999841365588
Q 002462 538 DANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSV-------------------KTEAYLLELDFFSKVSHARLVPLLGHC 598 (919)
Q Consensus 538 ~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~-------------------~~~~f~~Ei~~l~~l~H~NiV~l~g~c 598 (919)
..+.||+|+||.||+|...+|..||||.+..... ....+..|...+.+++|.+++..+++
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~- 82 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW- 82 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE-
T ss_pred HCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE-
T ss_conf 2778024856599999979999999999860443466655656300088899999977899999998169991449986-
Q ss_pred EECCCCEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEECCCCCC
Q ss_conf 60488179999722799810010006999775677799999999999999855451289999264468899600179996
Q 002462 599 MERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHHECTLPFVHRDVQASSILLDDKFE 678 (919)
Q Consensus 599 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~~~~~~IiHrDlK~~NILld~~~~ 678 (919)
. ..+++|||++++.+.+. +.....+++.++++|++|||.. +|+||||||+|||++++ .
T Consensus 83 -~---~~~lvme~~~~~~~~~l--------------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~ 140 (191)
T d1zara2 83 -E---GNAVLMELIDAKELYRV--------------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-G 140 (191)
T ss_dssp -E---TTEEEEECCCCEEGGGC--------------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-E
T ss_pred -C---CCEEEEEEECCCCCCCH--------------HHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-C
T ss_conf -2---88899995045654200--------------1578999999999999998268---88983689036114289-8
Q ss_pred EEECCCCHHHHCCCCCCCEEEEEEC-CCCCCCCCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 2248850024038998510355202-577775456778779997786034899999
Q 002462 679 VRLGSLSEVCAQGGDAHQSRITRLL-RLPQSSEQGSSGSLTATCPYDVYCFGKVLL 733 (919)
Q Consensus 679 ~ki~dfg~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~t~~sDVySfGvvLl 733 (919)
+++.|||.+.............+.. ....+ . ...|..++||||..--++
T Consensus 141 ~~liDFG~a~~~~~~~~~~~l~rd~~~~~~~-----f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 141 IWIIDFPQSVEVGEEGWREILERDVRNIITY-----F-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp EEECCCTTCEETTSTTHHHHHHHHHHHHHHH-----H-HHHHCCCCCHHHHHHHHH
T ss_pred EEEEECCCCCCCCCCCCHHHHHHHHHHHHHH-----H-CCCCCCCCCHHHHHHHHH
T ss_conf 9998778843089987099998779999999-----7-578998446899999874
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.93 E-value=7.1e-22 Score=130.45 Aligned_cols=270 Identities=23% Similarity=0.271 Sum_probs=154.2
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCEEEEECCCCCCCCCCCCCCCC
Q ss_conf 99999908986567888898467111118997897866998799888536651899876998015879855886778999
Q 002462 87 SVVGINISGFRRTRLGSQNPRFAADALVNLTHLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLT 166 (919)
Q Consensus 87 ~v~~l~l~~~~~~~~~~~~~~~~~~~l~~l~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~n~l~g~~p~~~~~l~ 166 (919)
+...++|++.+.+.++ . .+++|+.|++++|.+. .+|.. +.+|+.|++++|.++. ++. + .+
T Consensus 39 ~l~~LdLs~~~L~~lp---~--------~~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~~-l~~-l--p~ 98 (353)
T d1jl5a_ 39 QAHELELNNLGLSSLP---E--------LPPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLKA-LSD-L--PP 98 (353)
T ss_dssp TCSEEECTTSCCSCCC---S--------CCTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCSC-CCS-C--CT
T ss_pred CCCEEEECCCCCCCCC---C--------CCCCCCEEECCCCCCC-CCCCC----HHHHHHHHHHHCCCCH-HHH-H--CC
T ss_conf 9989993799988788---9--------8789888989999796-33620----3320332665514320-321-0--22
Q ss_pred CCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 89899910798999896112499998899855896998898222289999988656874787799546799989888702
Q 002462 167 NLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVS 246 (919)
Q Consensus 167 ~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~Ls~N~l~~~lp~~l~~l~~L~~L~L~ 246 (919)
.|++|++++|.+. .+|. ++.+++|+.|++++|.+.. .+.. ...+..+.+..+... ....+..++.++.|.+.
T Consensus 99 ~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~ 170 (353)
T d1jl5a_ 99 LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYAD 170 (353)
T ss_dssp TCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECC
T ss_pred CCCCCCCCCCCCC-CCCC-HHHHCCCEEECCCCCCCCC-CCCC---CCCCCCHHHCCCCCC--CCCCCCCCCCCEECCCC
T ss_conf 1111133455432-2210-0110131231135651001-3223---333210000122222--33320001222001112
Q ss_pred CCCCCCCC------------------CCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 89889998------------------522499999988986799798779544422645878971587689998976469
Q 002462 247 NNSLASSI------------------PAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFP 308 (919)
Q Consensus 247 ~N~l~~~~------------------p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 308 (919)
.|.+.... ...+..++.|+.+++++|.... ++. ...++..+.+..+.+.... .
T Consensus 171 ~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~~-----~ 241 (353)
T d1jl5a_ 171 NNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDLP-----E 241 (353)
T ss_dssp SSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCCC-----C
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCC---CCCCCCCCCCCCCCCCCCC-----C
T ss_conf 334432222122222233444322221223455533312225422234-553---2334333222333334443-----3
Q ss_pred CCCCCCEEECCCCCCCC----------------CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 99887789846789989----------------98400289999978986689798999955545788874898668837
Q 002462 309 TVSQLQIIVLRQNGFTG----------------PPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNISQNMF 372 (919)
Q Consensus 309 ~l~~L~~L~L~~N~l~~----------------~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~l~~l~ls~N~~ 372 (919)
....+....+..+.+.+ .++.....+++|+.|++++|++. .+|.. ...+..|++++|.+
T Consensus 242 ~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~L~~N~L 316 (353)
T d1jl5a_ 242 LPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL----PPRLERLIASFNHL 316 (353)
T ss_dssp CCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCCC----CCCCCEEECCCCCC
T ss_conf 34432222222233322234530001233335753234566898898979799168-35665----48799898999968
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCCCCCC
Q ss_conf 5578878999859983177677757831
Q 002462 373 YGGLTPVLGRFRLVDLSGNYFEGRVPEY 400 (919)
Q Consensus 373 ~g~~~~~l~~l~~l~ls~N~l~g~ip~~ 400 (919)
. .+|..+.+|+.+++++|.++ .+|+.
T Consensus 317 ~-~l~~~~~~L~~L~L~~N~L~-~lp~~ 342 (353)
T d1jl5a_ 317 A-EVPELPQNLKQLHVEYNPLR-EFPDI 342 (353)
T ss_dssp S-CCCCCCTTCCEEECCSSCCS-SCCCC
T ss_pred C-CCCCCCCCCCEEECCCCCCC-CCCCC
T ss_conf 7-54532288898987699189-77765
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=6.8e-24 Score=141.22 Aligned_cols=199 Identities=19% Similarity=0.161 Sum_probs=128.9
Q ss_pred CCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCC-CCCCCCCCCCCEEECC-CCCCCCCCCCCCCCCCCCCEE
Q ss_conf 98769980158798558867789998989991079899989-6112499998899855-896998898222289999988
Q 002462 142 PTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTI-PSSLGQLSVLSVLDLS-RNSLTGNIPTSFGLLKNLSSL 219 (919)
Q Consensus 142 ~~L~~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~L~~L~~L~Ls-~N~l~~~~P~~~~~l~~L~~L 219 (919)
+++++|||++|.+....+..|.++++|++|+|++|.+...+ +..|.+++.++.+.+. .|++....+..|..+++|+.+
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 98899987699189649668614643232110221124201001122222222211111234322222212222222222
Q ss_pred ECCCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCCCCCCCCC-CCCEEECCCCCCCCCCCHHHHCCCCCCEE-ECCCC
Q ss_conf 6568747877995-467999898887028988999852249999-99889867997987795444226458789-71587
Q 002462 220 DISSNYLTGSIPP-GLGTLSKLQYLNVSNNSLASSIPAQLGDLD-SLVDLDLSMNSLSGSVPSELRGLRSLQKF-VIGNN 296 (919)
Q Consensus 220 ~Ls~N~l~~~lp~-~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L-~l~~N 296 (919)
++++|.+....+. .+..+..+..+...++.+....+..+..+. .++.|++++|+++...+..+ ...++..+ ++.+|
T Consensus 109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n 187 (242)
T d1xwdc1 109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNN 187 (242)
T ss_dssp EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCT
T ss_pred CCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCC-CCHHHHCCCCCCCC
T ss_conf 34211112554333222111122222221211122222222223310012200123333222222-20111012123543
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 6899989764699988778984678998998400289999978986
Q 002462 297 FLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDI 342 (919)
Q Consensus 297 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 342 (919)
.+. .++...|..+++|+.|++++|+++..++..|.++++|+.+++
T Consensus 188 ~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 188 NLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp TCC-CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred CCC-CCCHHHHCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCCCCC
T ss_conf 246-424788668999998989799289459779737713414767
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.90 E-value=6.4e-20 Score=120.04 Aligned_cols=252 Identities=28% Similarity=0.370 Sum_probs=160.0
Q ss_pred CCCCEEECCCCCCCCCCCHHHHHCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 97897866998799888536651899876998015879855886778999898999107989998961124999988998
Q 002462 117 THLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLD 196 (919)
Q Consensus 117 ~~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~ 196 (919)
.+++.|+++++.++ .+|+. +++|++|+|++|.|+ .+|..+ .+|+.|++++|+++ .++. + ...|++|+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~----~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL----PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC----CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEE
T ss_pred CCCCEEEECCCCCC-CCCCC----CCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCC-HHHH-H--CCCCCCCC
T ss_conf 69989993799988-78898----789888989999796-336203---32033266551432-0321-0--22111113
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 55896998898222289999988656874787799546799989888702898899985224999999889867997987
Q 002462 197 LSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSG 276 (919)
Q Consensus 197 Ls~N~l~~~~P~~~~~l~~L~~L~Ls~N~l~~~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 276 (919)
+++|.+. .+|. ++.+++|+.|++++|.+.. .+.. ...+..+.+..+... ....+..+..++.+++..|.+..
T Consensus 105 L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~ 176 (353)
T d1jl5a_ 105 VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKK 176 (353)
T ss_dssp CCSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSS
T ss_pred CCCCCCC-CCCC-HHHHCCCEEECCCCCCCCC-CCCC---CCCCCCHHHCCCCCC--CCCCCCCCCCCEECCCCCCCCCC
T ss_conf 3455432-2210-0110131231135651001-3223---333210000122222--33320001222001112334432
Q ss_pred CCC------------------HHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 795------------------44422645878971587689998976469998877898467899899840028999997
Q 002462 277 SVP------------------SELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLR 338 (919)
Q Consensus 277 ~~p------------------~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 338 (919)
... ..+..++.|+.++++.|.... ++ ....++..+.+..+.+..... ....+.
T Consensus 177 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~----~~~~~l~~~~~~~~~~~~~~~----~~~~l~ 247 (353)
T d1jl5a_ 177 LPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LP----DLPPSLEALNVRDNYLTDLPE----LPQSLT 247 (353)
T ss_dssp CCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CC----SCCTTCCEEECCSSCCSCCCC----CCTTCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CC----CCCCCCCCCCCCCCCCCCCCC----CCCCCC
T ss_conf 222122222233444322221223455533312225422234-55----323343332223333344433----344322
Q ss_pred EEECCCCCCCCC--CCC-------------CCCCCCCCCCEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC
Q ss_conf 898668979899--995-------------55457888748986688375578878999859983177677757831
Q 002462 339 LLDISRNNFTGP--LPN-------------SRSNVNTSTVELNISQNMFYGGLTPVLGRFRLVDLSGNYFEGRVPEY 400 (919)
Q Consensus 339 ~L~Ls~N~l~g~--ip~-------------~~~~~~~~l~~l~ls~N~~~g~~~~~l~~l~~l~ls~N~l~g~ip~~ 400 (919)
.+++..+.+.+. ++. ........+++|++++|.+. .+|..+++|+.+++++|.++ .+|..
T Consensus 248 ~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~L~~L~L~~N~L~-~l~~~ 322 (353)
T d1jl5a_ 248 FLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLIASFNHLA-EVPEL 322 (353)
T ss_dssp EEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCCS-CCCCC
T ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCCCCCCCCEEECCCCCCC-CCCCC
T ss_conf 22222233322234530001233335753234566898898979799168-35665487998989999687-54532
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.89 E-value=4.9e-22 Score=131.30 Aligned_cols=186 Identities=26% Similarity=0.367 Sum_probs=95.1
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 99876998015879855886778999898999107989998961124999988998558969988982222899999886
Q 002462 141 LPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLD 220 (919)
Q Consensus 141 L~~L~~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~ 220 (919)
|.+|+.|++.+|.++. ++ .+..+++|++|++++|.+++.. .+..+++|+.+++++|.++ .++ .+..+++|+.++
T Consensus 40 l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~ 113 (227)
T d1h6ua2 40 LDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLD 113 (227)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCCC-CH-HHHCCCCCCEEECCCCEEECCC--CCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCC
T ss_conf 4886899777999976-64-5744888837635785320254--3112334320121112222-222-222222221221
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCC
Q ss_conf 56874787799546799989888702898899985224999999889867997987795444226458789715876899
Q 002462 221 ISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSG 300 (919)
Q Consensus 221 Ls~N~l~~~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 300 (919)
++.+...+. ..+...+.+..+.++++.+.... .+..+++|+.|++++|.+... ..+.++++|+.|++++|.+.+
T Consensus 114 l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~ 187 (227)
T d1h6ua2 114 LTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISD 187 (227)
T ss_dssp CTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCC--CHHCCCCCHHHHHCHHHHHCHHH--HHCCCCCCCCCCCCCCCCCCC--HHHCCCCCCEECCCCCCCCCC
T ss_conf 222443311--00000230122200000000000--001021110023333333310--010564633564458884177
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 9897646999887789846789989984002899999789866
Q 002462 301 NLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDIS 343 (919)
Q Consensus 301 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 343 (919)
++ .+..+++|+.|++++|+++...| +.++++|+.|+++
T Consensus 188 -l~--~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 188 -IS--PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp -CG--GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred -CH--HHCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEEEE
T ss_conf -85--34479999989795996899802--0369998989712
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=4.9e-22 Score=131.31 Aligned_cols=204 Identities=20% Similarity=0.228 Sum_probs=107.8
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCCEEECCC
Q ss_conf 699801587985588677899989899910798999896112499998899855896998898-2222899999886568
Q 002462 145 QALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIP-TSFGLLKNLSSLDISS 223 (919)
Q Consensus 145 ~~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P-~~~~~l~~L~~L~Ls~ 223 (919)
+.++.++..++ .+|..+ ..++++|+|++|+++...+..|.++++|++|++++|.+...++ ..|..+++++.+++..
T Consensus 11 ~~i~c~~~~l~-~iP~~l--~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCS--CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEECCCCC-CCCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCC
T ss_conf 99998189988-768888--998899987699189649668614643232110221124201001122222222211111
Q ss_pred -CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCCHHHHCCC-CCCEEECCCCCCCC
Q ss_conf -747877995467999898887028988999852-249999998898679979877954442264-58789715876899
Q 002462 224 -NYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPA-QLGDLDSLVDLDLSMNSLSGSVPSELRGLR-SLQKFVIGNNFLSG 300 (919)
Q Consensus 224 -N~l~~~lp~~l~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~l~~N~l~~ 300 (919)
|.+....+..|..+++|+.|++.+|.+....+. .+..+..+..+...++.+....+..+..++ .+..+++.+|.+.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~- 166 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ- 166 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-
T ss_conf 2343222222122222222223421111255433322211112222222121112222222222331001220012333-
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC
Q ss_conf 98976469998877898467899899840028999997898668979899995
Q 002462 301 NLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPN 353 (919)
Q Consensus 301 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~ 353 (919)
.++...|.....++.+.+.+|.++..++..|.++++|+.|++++|+++ .+|.
T Consensus 167 ~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~ 218 (242)
T d1xwdc1 167 EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPS 218 (242)
T ss_dssp EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC-CCCS
T ss_pred CCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCC-CCCH
T ss_conf 322222220111012123543246424788668999998989799289-4597
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.89 E-value=6.7e-22 Score=130.61 Aligned_cols=208 Identities=23% Similarity=0.358 Sum_probs=146.1
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 99876998015879855886778999898999107989998961124999988998558969988982222899999886
Q 002462 141 LPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLD 220 (919)
Q Consensus 141 L~~L~~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~ 220 (919)
|..+..++++.+.+++.. .+..+.+|+.|++.+|.++ .+ +.+..+++|+.|++++|.+++..| +..+++|+.++
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~ 91 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHHHCCCCCCCCC--CHHHCCCCCEEECCCCCCC-CC-HHHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCCC
T ss_conf 999999984888767757--9878488689977799997-66-457448888376357853202543--11233432012
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCC
Q ss_conf 56874787799546799989888702898899985224999999889867997987795444226458789715876899
Q 002462 221 ISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSG 300 (919)
Q Consensus 221 Ls~N~l~~~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 300 (919)
+++|.++ .+ ..+..+++|+.+.++.+...+.. .+.....+..+.++.+.+... ..+...++|+.|++++|.+..
T Consensus 92 ~~~n~~~-~i-~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~ 165 (227)
T d1h6ua2 92 LSGNPLK-NV-SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSD 165 (227)
T ss_dssp CCSCCCS-CC-GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCC
T ss_pred CCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCCCC--HHCCCCCHHHHHCHHHHHCHH--HHHCCCCCCCCCCCCCCCCCC
T ss_conf 1112222-22-22222222212212224433110--000023012220000000000--000102111002333333331
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 98976469998877898467899899840028999997898668979899995554578887489866
Q 002462 301 NLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFTGPLPNSRSNVNTSTVELNIS 368 (919)
Q Consensus 301 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~l~~l~ls 368 (919)
.. .+..+++|+.|++++|.++...+ +..+++|++|++++|+++. ++. ...+..+..++++
T Consensus 166 ~~---~l~~l~~L~~L~Ls~n~l~~l~~--l~~l~~L~~L~Ls~N~lt~-i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 166 LT---PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD-VSP--LANTSNLFIVTLT 225 (227)
T ss_dssp CG---GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCB-CGG--GTTCTTCCEEEEE
T ss_pred CH---HHCCCCCCEECCCCCCCCCCCHH--HCCCCCCCEEECCCCCCCC-CCC--CCCCCCCCEEEEE
T ss_conf 00---10564633564458884177853--4479999989795996899-802--0369998989712
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.88 E-value=1.4e-22 Score=134.21 Aligned_cols=109 Identities=25% Similarity=0.327 Sum_probs=52.2
Q ss_pred CCCEEEEECCCCCCC-CCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 876998015879855-8867789998989991079899989611249999889985589699889822228999998865
Q 002462 143 TLQALDLRSCSISGV-IPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDI 221 (919)
Q Consensus 143 ~L~~LdLs~n~l~g~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~L 221 (919)
++++|+|++|.|++. .+..|.++++|+.|+|++|.+....+..+..+++|+.|+|++|++....|..|.++++|+.|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCC
T ss_conf 87889848987755302002578762721301363221212122211222210100355344349799807974655245
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 687478779954679998988870289889
Q 002462 222 SSNYLTGSIPPGLGTLSKLQYLNVSNNSLA 251 (919)
Q Consensus 222 s~N~l~~~lp~~l~~l~~L~~L~L~~N~l~ 251 (919)
++|.++...|..|..+++|++|+|++|.+.
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CCCCCCCCCHHHHCCCCCCCCCCCCCCCCC
T ss_conf 774535359778568753342000364434
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.88 E-value=1.5e-22 Score=134.00 Aligned_cols=129 Identities=27% Similarity=0.392 Sum_probs=72.4
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCC-CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 69980158798558867789998989991079899989-61124999988998558969988982222899999886568
Q 002462 145 QALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTI-PSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISS 223 (919)
Q Consensus 145 ~~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~Ls~ 223 (919)
+.++.+++.++ .+|..+. +++++|+|++|+|+..+ +..|.++++|+.|+|++|.+....+..|..+++|+.|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEECCCCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECC
T ss_conf 99997089967-0298989--78788984898775530200257876272130136322121212221122221010035
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 74787799546799989888702898899985224999999889867997987
Q 002462 224 NYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSG 276 (919)
Q Consensus 224 N~l~~~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 276 (919)
|++....|..|.++++|++|+|++|.+++..+..|..+++|++|+|++|.+..
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 53443497998079746552457745353597785687533420003644343
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.87 E-value=4.2e-21 Score=126.35 Aligned_cols=165 Identities=28% Similarity=0.394 Sum_probs=77.0
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 99876998015879855886778999898999107989998961124999988998558969988982222899999886
Q 002462 141 LPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLD 220 (919)
Q Consensus 141 L~~L~~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~ 220 (919)
|.+|+.|++++|.+.... .+..+++|++|+|++|++++ ++ .+.++++|+.|++++|+++. +| .+..+++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred HCCCCEEECCCCCCCCCH--HHHHCCCCCEEECCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCC
T ss_conf 548458978279888744--47648998987698960258-60-11358621201433333212-22-121222111223
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCC
Q ss_conf 56874787799546799989888702898899985224999999889867997987795444226458789715876899
Q 002462 221 ISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSG 300 (919)
Q Consensus 221 Ls~N~l~~~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 300 (919)
+++|.+. .+ ..+..+++++.++++.|.++.. ..+..+++|+.+++++|++.+ ++ .
T Consensus 119 l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~-i~-~------------------- 173 (210)
T d1h6ta2 119 LEHNGIS-DI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-IV-P------------------- 173 (210)
T ss_dssp CTTSCCC-CC-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC-CG-G-------------------
T ss_pred CCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC-CC-C-------------------
T ss_conf 4565322-11-2201111122211222333454--310001332100134643025-64-5-------------------
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 98976469998877898467899899840028999997898668
Q 002462 301 NLSVNLFPTVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISR 344 (919)
Q Consensus 301 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 344 (919)
+..+++|+.|++++|.++.. + .+..+++|++|+|++
T Consensus 174 ------l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 174 ------LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFS 209 (210)
T ss_dssp ------GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEE
T ss_pred ------CCCCCCCCEEECCCCCCCCC-H-HHCCCCCCCEEECCC
T ss_conf ------36789899998979989987-2-116999989997118
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=1.6e-20 Score=123.22 Aligned_cols=38 Identities=24% Similarity=0.428 Sum_probs=19.9
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 9988778984678998998400289999978986689798
Q 002462 309 TVSQLQIIVLRQNGFTGPPPDVLWSMPQLRLLDISRNNFT 348 (919)
Q Consensus 309 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 348 (919)
.+++|+.+++++|.+++..+ +..+++|+.|++++|+++
T Consensus 154 ~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 154 RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp GCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred CCCCCCCCCCCCCCCCCCCC--CCCCCCCCEEECCCCCCC
T ss_conf 01332100134643025645--367898999989799899
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85 E-value=5.1e-20 Score=120.58 Aligned_cols=146 Identities=29% Similarity=0.430 Sum_probs=77.3
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 99876998015879855886778999898999107989998961124999988998558969988982222899999886
Q 002462 141 LPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLD 220 (919)
Q Consensus 141 L~~L~~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~ 220 (919)
+.+++.|++++|.+.. ++ .+..+++|++|+|++|++++ ++. +.++++|+.|++++|.+.. ++ .+.++++|+.|+
T Consensus 39 l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred HCCCCEEECCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCC
T ss_conf 4687899899999977-52-02137886757545655667-640-1677522311112222222-21-111122322211
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCC
Q ss_conf 568747877995467999898887028988999852249999998898679979877954442264587897158768
Q 002462 221 ISSNYLTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFL 298 (919)
Q Consensus 221 Ls~N~l~~~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l 298 (919)
+++|..... ..+..+++|+.|++++|.+.. ++ .+..+++|+.|++.+|++++ ++ .+.++++|+.|++++|.+
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLDISSNKV 184 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCC
T ss_pred CCCCCCCCC--CCCCHHHHHHHHHHHHHHHCC-CC-CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCCCC
T ss_conf 122222232--100012236776431111002-34-33321111112234555567-70-116799899997879979
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85 E-value=8.3e-20 Score=119.45 Aligned_cols=165 Identities=24% Similarity=0.358 Sum_probs=81.6
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 99801587985588677899989899910798999896112499998899855896998898222289999988656874
Q 002462 146 ALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNY 225 (919)
Q Consensus 146 ~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~Ls~N~ 225 (919)
.+.++.+.+++.++ ...+.++++|++++|.++ .+ +.+..+++|++|++++|.+++. ++ +..+++|+.|+++.|.
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l-~~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-CC-TTGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSC
T ss_pred HHHHCCCCCCCCCC--HHHHCCCCEEECCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCC
T ss_conf 99967787788559--879468789989999997-75-2021378867575456556676-40-1677522311112222
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCC
Q ss_conf 78779954679998988870289889998522499999988986799798779544422645878971587689998976
Q 002462 226 LTGSIPPGLGTLSKLQYLNVSNNSLASSIPAQLGDLDSLVDLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVN 305 (919)
Q Consensus 226 l~~~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~ 305 (919)
+. .++ .+.++++|+.|++++|.+... ..+..+++|+.|++++|++.. ++ .+..+++|+.|++.+|.+.+. +
T Consensus 96 ~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l-~-- 166 (199)
T d2omxa2 96 IA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDL-K-- 166 (199)
T ss_dssp CC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC-G--
T ss_pred CC-CCC-CCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHCC-CC-CCCCCCCCCCCCCCCCCCCCC-C--
T ss_conf 22-221-111122322211122222232--100012236776431111002-34-333211111122345555677-0--
Q ss_pred CCCCCCCCCEEECCCCCCCC
Q ss_conf 46999887789846789989
Q 002462 306 LFPTVSQLQIIVLRQNGFTG 325 (919)
Q Consensus 306 ~~~~l~~L~~L~L~~N~l~~ 325 (919)
.+..+++|+.|++++|+++.
T Consensus 167 ~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 167 PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp GGTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCCEEECCCCCCCC
T ss_conf 11679989999787997998
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=1.7e-22 Score=133.84 Aligned_cols=90 Identities=29% Similarity=0.305 Sum_probs=46.7
Q ss_pred HCCCCCCCEEECCCCCCCC----CCCHHHHHCCCCCCEEEEECCCCCC----CCCCCCC-CCCCCCEEEEECCCCCCC--
Q ss_conf 1189978978669987998----8853665189987699801587985----5886778-999898999107989998--
Q 002462 113 LVNLTHLASFNASRFLLPG----SIPDWLGQQLPTLQALDLRSCSISG----VIPFSLG-NLTNLTSLYLSDNGLTGT-- 181 (919)
Q Consensus 113 l~~l~~L~~l~ls~n~l~g----~ip~~~~~~L~~L~~LdLs~n~l~g----~~p~~~~-~l~~L~~L~L~~N~l~~~-- 181 (919)
+..++++++|++++|.+.. .|...+. .+++|+.|||++|.++. .+...+. ...+|+.|+|++|.++..
T Consensus 23 ~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~-~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~ 101 (460)
T d1z7xw1 23 LPLLQQCQVVRLDDCGLTEARCKDISSALR-VNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101 (460)
T ss_dssp HHHHTTCSEEEEESSCCCHHHHHHHHHHHH-TCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGH
T ss_pred HHHCCCCCEEEECCCCCCHHHHHHHHHHHH-CCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCCCC
T ss_conf 976779999982899998899999999985-3999888979598597289999999984378877887788877543221
Q ss_pred --CCCCCCCCCCCCEEECCCCCCC
Q ss_conf --9611249999889985589699
Q 002462 182 --IPSSLGQLSVLSVLDLSRNSLT 203 (919)
Q Consensus 182 --~p~~l~~L~~L~~L~Ls~N~l~ 203 (919)
++..+..+++|+.|++++|.+.
T Consensus 102 ~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 102 GVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp HHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCHHHCCCCCCCCCCCCCCCH
T ss_conf 012110000343200244433202
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=1.7e-20 Score=123.06 Aligned_cols=108 Identities=24% Similarity=0.314 Sum_probs=54.9
Q ss_pred CCEEECCCCCCCCCC-CHHHHHCCCCCCEEEEECCCCCC----CCCCCCCCCCCCCEEEEECCCCCCC----CCCCCC-C
Q ss_conf 897866998799888-53665189987699801587985----5886778999898999107989998----961124-9
Q 002462 119 LASFNASRFLLPGSI-PDWLGQQLPTLQALDLRSCSISG----VIPFSLGNLTNLTSLYLSDNGLTGT----IPSSLG-Q 188 (919)
Q Consensus 119 L~~l~ls~n~l~g~i-p~~~~~~L~~L~~LdLs~n~l~g----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~l~-~ 188 (919)
|+.|+++++.+.+.- ...+ ..++++++|+|++|.++. .+...+..+++|++|+|++|.++.. +...+. .
T Consensus 4 l~~ld~~~~~i~~~~~~~l~-~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 4 IQSLDIQCEELSDARWAELL-PLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEESCCCCHHHHHHHH-HHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCEEEEECCCCCHHHHHHHH-HHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf 77798208958868999999-76779999982899998899999999985399988897959859728999999998437
Q ss_pred CCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCC
Q ss_conf 99988998558969988----9822228999998865687478
Q 002462 189 LSVLSVLDLSRNSLTGN----IPTSFGLLKNLSSLDISSNYLT 227 (919)
Q Consensus 189 L~~L~~L~Ls~N~l~~~----~P~~~~~l~~L~~L~Ls~N~l~ 227 (919)
..+|+.|+|++|.++.. ++..+..+++|+.|++++|.+.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCH
T ss_conf 8877887788877543221012110000343200244433202
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=1.8e-19 Score=117.72 Aligned_cols=58 Identities=24% Similarity=0.255 Sum_probs=22.6
Q ss_pred CCCCEEEEECCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 9898999107989998-961124999988998558969988982222899999886568
Q 002462 166 TNLTSLYLSDNGLTGT-IPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISS 223 (919)
Q Consensus 166 ~~L~~L~L~~N~l~~~-~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~Ls~ 223 (919)
.+|++|+|++|.++.. ++..+..+++|++|+++++.++...+..+..+++|+.|++++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred CCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCC
T ss_conf 87887889898457779999997487765145234679867899985189975715100
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=2.2e-19 Score=117.22 Aligned_cols=155 Identities=25% Similarity=0.263 Sum_probs=79.6
Q ss_pred CCCCCEEEEECCCCCCC-CCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCC-CCCC-CCCCCCCCCCCC
Q ss_conf 99876998015879855-88677899989899910798999896112499998899855896-9988-982222899999
Q 002462 141 LPTLQALDLRSCSISGV-IPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNS-LTGN-IPTSFGLLKNLS 217 (919)
Q Consensus 141 L~~L~~LdLs~n~l~g~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~-l~~~-~P~~~~~l~~L~ 217 (919)
...|++|||++|.+... +...+..+++|++|+|++|.++...+..++.+++|+.|+++++. ++.. +..-+..+++|+
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~ 124 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCC
T ss_conf 78788788989845777999999748776514523467986789998518997571510013412355403657887435
Q ss_pred EEECCCCC-CCCC-CCCCCC-CCCCCCEEECCCCC--CCCC-CCCCCCCCCCCCEEECCCC-CCCCCCCHHHHCCCCCCE
Q ss_conf 88656874-7877-995467-99989888702898--8999-8522499999988986799-798779544422645878
Q 002462 218 SLDISSNY-LTGS-IPPGLG-TLSKLQYLNVSNNS--LASS-IPAQLGDLDSLVDLDLSMN-SLSGSVPSELRGLRSLQK 290 (919)
Q Consensus 218 ~L~Ls~N~-l~~~-lp~~l~-~l~~L~~L~L~~N~--l~~~-~p~~l~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~ 290 (919)
.|+++++. ++.. +...+. ..++|+.|+++++. ++.. +.....++++|++|++++| .+++.....+.++++|++
T Consensus 125 ~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~ 204 (284)
T d2astb2 125 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 204 (284)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred CCCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCE
T ss_conf 65224533233322000100011111012213554244444343423232221235532234778303333213576877
Q ss_pred EECCC
Q ss_conf 97158
Q 002462 291 FVIGN 295 (919)
Q Consensus 291 L~l~~ 295 (919)
|++++
T Consensus 205 L~L~~ 209 (284)
T d2astb2 205 LSLSR 209 (284)
T ss_dssp EECTT
T ss_pred EECCC
T ss_conf 98999
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=1.3e-17 Score=107.68 Aligned_cols=81 Identities=23% Similarity=0.220 Sum_probs=28.2
Q ss_pred CCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 87699801587985588677899989899910798999896112499998899855896998898222289999988656
Q 002462 143 TLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDIS 222 (919)
Q Consensus 143 ~L~~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~Ls 222 (919)
.|++|||++|.|+. ++..+..+.+|+.|+|++|.++ .++ .+..+++|+.|++++|.++...+..+..+++|+.|+++
T Consensus 19 ~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 19 RDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp SCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred CCCEEECCCCCCCC-CCCCCCCCCCCCEEECCCCCCC-CCC-CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCEEC
T ss_conf 48489788997886-5762004145998989799787-647-74457613064310213457776322334534434203
Q ss_pred CCCC
Q ss_conf 8747
Q 002462 223 SNYL 226 (919)
Q Consensus 223 ~N~l 226 (919)
+|.+
T Consensus 96 ~N~i 99 (162)
T d1a9na_ 96 NNSL 99 (162)
T ss_dssp SCCC
T ss_pred CCCC
T ss_conf 0001
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.69 E-value=3.7e-19 Score=115.96 Aligned_cols=235 Identities=16% Similarity=0.135 Sum_probs=95.6
Q ss_pred CCCCCEEEEECCCCCC----CCCCCCCCCCCCCEEEEECCCCCCC----------CCCCCCCCCCCCEEECCCCCCCCC-
Q ss_conf 9987699801587985----5886778999898999107989998----------961124999988998558969988-
Q 002462 141 LPTLQALDLRSCSISG----VIPFSLGNLTNLTSLYLSDNGLTGT----------IPSSLGQLSVLSVLDLSRNSLTGN- 205 (919)
Q Consensus 141 L~~L~~LdLs~n~l~g----~~p~~~~~l~~L~~L~L~~N~l~~~----------~p~~l~~L~~L~~L~Ls~N~l~~~- 205 (919)
...|+.|+|++|.+.. .+...+...++|+.|+++++..... +...+...++|+.|+|++|.+...
T Consensus 30 ~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 109 (344)
T d2ca6a1 30 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 109 (344)
T ss_dssp CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred CCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 89978897849837789999999999858998888887775433454210678799988754777563300001345543
Q ss_pred ---CCCCCCCCCCCCEEECCCCCCCCCCCC-------------CCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCC
Q ss_conf ---982222899999886568747877995-------------467999898887028988999----852249999998
Q 002462 206 ---IPTSFGLLKNLSSLDISSNYLTGSIPP-------------GLGTLSKLQYLNVSNNSLASS----IPAQLGDLDSLV 265 (919)
Q Consensus 206 ---~P~~~~~l~~L~~L~Ls~N~l~~~lp~-------------~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~ 265 (919)
+...+...++|+.|++++|.+...-.. .....+.|+.|.+++|.+... +...+.....|+
T Consensus 110 ~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~ 189 (344)
T d2ca6a1 110 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH 189 (344)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCC
T ss_pred CCCHHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCHHHHHHHHC
T ss_conf 33101110023432100000246666543111121222211000146764211101365013554332211112333213
Q ss_pred EEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEE
Q ss_conf 8986799798779544422645878971587689998976469998877898467899899----840028999997898
Q 002462 266 DLDLSMNSLSGSVPSELRGLRSLQKFVIGNNFLSGNLSVNLFPTVSQLQIIVLRQNGFTGP----PPDVLWSMPQLRLLD 341 (919)
Q Consensus 266 ~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ 341 (919)
.|++++|.+...-... .....+...++|+.|++++|.++.. +...+...++|+.|+
T Consensus 190 ~L~L~~n~i~~~g~~~--------------------~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~ 249 (344)
T d2ca6a1 190 TVKMVQNGIRPEGIEH--------------------LLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG 249 (344)
T ss_dssp EEECCSSCCCHHHHHH--------------------HHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred CCCCCCCCCCCCCCCC--------------------CHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHH
T ss_conf 3543332222222320--------------------02433211012112223333222222223444332322111103
Q ss_pred CCCCCCCCCCCCCCC-----CCCCCCCEEECCCCCCCCC--------CCCCCCCCCEEECCCCCCCC
Q ss_conf 668979899995554-----5788874898668837557--------88789998599831776777
Q 002462 342 ISRNNFTGPLPNSRS-----NVNTSTVELNISQNMFYGG--------LTPVLGRFRLVDLSGNYFEG 395 (919)
Q Consensus 342 Ls~N~l~g~ip~~~~-----~~~~~l~~l~ls~N~~~g~--------~~~~l~~l~~l~ls~N~l~g 395 (919)
+++|.+.+.-..... .....+..|++++|.+... +......|+.+++++|.|..
T Consensus 250 Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCC
T ss_conf 0047567156678887763156888898989898698089999999997038999989787980898
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.68 E-value=9.1e-19 Score=113.90 Aligned_cols=240 Identities=20% Similarity=0.211 Sum_probs=147.3
Q ss_pred HHHHCCCCCCCEEECCCCCCCCCCCHHHH---HCCCCCCEEEEECCCCCCC----------CCCCCCCCCCCCEEEEECC
Q ss_conf 11111899789786699879988853665---1899876998015879855----------8867789998989991079
Q 002462 110 ADALVNLTHLASFNASRFLLPGSIPDWLG---QQLPTLQALDLRSCSISGV----------IPFSLGNLTNLTSLYLSDN 176 (919)
Q Consensus 110 ~~~l~~l~~L~~l~ls~n~l~g~ip~~~~---~~L~~L~~LdLs~n~l~g~----------~p~~~~~l~~L~~L~L~~N 176 (919)
...+.+.+.|+.+++++|.+...-...++ ...+.|+.|+++.+..... +...+...++|+.|+|++|
T Consensus 24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n 103 (344)
T d2ca6a1 24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 103 (344)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred HHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 99996389978897849837789999999999858998888887775433454210678799988754777563300001
Q ss_pred CCCCC----CCCCCCCCCCCCEEECCCCCCCCCCC-------------CCCCCCCCCCEEECCCCCCCCC----CCCCCC
Q ss_conf 89998----96112499998899855896998898-------------2222899999886568747877----995467
Q 002462 177 GLTGT----IPSSLGQLSVLSVLDLSRNSLTGNIP-------------TSFGLLKNLSSLDISSNYLTGS----IPPGLG 235 (919)
Q Consensus 177 ~l~~~----~p~~l~~L~~L~~L~Ls~N~l~~~~P-------------~~~~~l~~L~~L~Ls~N~l~~~----lp~~l~ 235 (919)
.+... +...+...++|+.|++++|.+...-. ......+.|+.++++.|.+... +...+.
T Consensus 104 ~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~ 183 (344)
T d2ca6a1 104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183 (344)
T ss_dssp CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCHHH
T ss_conf 34554333101110023432100000246666543111121222211000146764211101365013554332211112
Q ss_pred CCCCCCEEECCCCCCCCC-----CCCCCCCCCCCCEEECCCCCCCCC----CCHHHHCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 999898887028988999-----852249999998898679979877----95444226458789715876899989764
Q 002462 236 TLSKLQYLNVSNNSLASS-----IPAQLGDLDSLVDLDLSMNSLSGS----VPSELRGLRSLQKFVIGNNFLSGNLSVNL 306 (919)
Q Consensus 236 ~l~~L~~L~L~~N~l~~~-----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~~~~~ 306 (919)
..+.|+.|+++.|.+... +...+...++|+.|++++|.+... +...+...++|+.|++++|.+.+.-...+
T Consensus 184 ~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l 263 (344)
T d2ca6a1 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 263 (344)
T ss_dssp HCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHH
T ss_pred HHHHHCCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHH
T ss_conf 33321335433322222223200243321101211222333322222222344433232211110300475671566788
Q ss_pred ---C--CCCCCCCEEECCCCCCCCCC----CCCC-CCCCCCCEEECCCCCCCC
Q ss_conf ---6--99988778984678998998----4002-899999789866897989
Q 002462 307 ---F--PTVSQLQIIVLRQNGFTGPP----PDVL-WSMPQLRLLDISRNNFTG 349 (919)
Q Consensus 307 ---~--~~l~~L~~L~L~~N~l~~~~----p~~~-~~l~~L~~L~Ls~N~l~g 349 (919)
+ .....|+.|++++|.++..- ...+ ...++|++|++++|++..
T Consensus 264 ~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 264 VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCC
T ss_conf 87763156888898989898698089999999997038999989787980898
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=5.2e-17 Score=104.56 Aligned_cols=111 Identities=24% Similarity=0.233 Sum_probs=54.8
Q ss_pred CCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 78999898999107989998961124999988998558969988982222899999886568747877995467999898
Q 002462 162 LGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQ 241 (919)
Q Consensus 162 ~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~Ls~N~l~~~lp~~l~~l~~L~ 241 (919)
+.++..|++|+|++|+|+ .++..+..+.+|+.|+|++|.+.. ++ .|..+++|+.|++++|.++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred CCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCC-CC-CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCC
T ss_conf 168574848978899788-657620041459989897997876-47-744576130643102134577763223345344
Q ss_pred EEECCCCCCCCCCC-CCCCCCCCCCEEECCCCCCC
Q ss_conf 88702898899985-22499999988986799798
Q 002462 242 YLNVSNNSLASSIP-AQLGDLDSLVDLDLSMNSLS 275 (919)
Q Consensus 242 ~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~ 275 (919)
.|++++|.+..... ..+..+++|+.|++++|.+.
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCC
T ss_conf 34203000166542110013653206640799634
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.67 E-value=5.8e-16 Score=98.95 Aligned_cols=77 Identities=32% Similarity=0.417 Sum_probs=30.6
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 99801587985588677899989899910798999896112499998899855896998898222289999988656874
Q 002462 146 ALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNY 225 (919)
Q Consensus 146 ~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~Ls~N~ 225 (919)
+|||++|.++ .++ .+..+.+|++|++++|+++ .+|..++.+++|+.|++++|.++. +| .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEECCCCCCC-CCC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCCC
T ss_conf 8986899898-871-0105898898979787168-652156554313545324321123-57-41233555768888986
Q ss_pred CC
Q ss_conf 78
Q 002462 226 LT 227 (919)
Q Consensus 226 l~ 227 (919)
+.
T Consensus 77 i~ 78 (124)
T d1dcea3 77 LQ 78 (124)
T ss_dssp CC
T ss_pred CC
T ss_conf 58
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.66 E-value=2.5e-16 Score=100.87 Aligned_cols=102 Identities=36% Similarity=0.452 Sum_probs=55.2
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 89991079899989611249999889985589699889822228999998865687478779954679998988870289
Q 002462 169 TSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTLSKLQYLNVSNN 248 (919)
Q Consensus 169 ~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~Ls~N~l~~~lp~~l~~l~~L~~L~L~~N 248 (919)
|+|+|++|+++ .++ .+..+.+|++|++++|.+. .+|..+..+++|+.|++++|.++. +| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEECCCCCCC-CCC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCC
T ss_conf 98986899898-871-0105898898979787168-652156554313545324321123-57-4123355576888898
Q ss_pred CCCCCCC-CCCCCCCCCCEEECCCCCCC
Q ss_conf 8899985-22499999988986799798
Q 002462 249 SLASSIP-AQLGDLDSLVDLDLSMNSLS 275 (919)
Q Consensus 249 ~l~~~~p-~~l~~l~~L~~L~L~~N~l~ 275 (919)
.+..... ..+..+++|+.|++++|.++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCCCCCHHHCCCCCCCEEECCCCCCC
T ss_conf 6588888256537999999989799688
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.57 E-value=3.1e-18 Score=111.06 Aligned_cols=81 Identities=28% Similarity=0.308 Sum_probs=31.1
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 99876998015879855886778999898999107989998961124999988998558969988982222899999886
Q 002462 141 LPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLD 220 (919)
Q Consensus 141 L~~L~~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~ 220 (919)
|++|++|+|++|.+.. ++ .+..+++|++|+|++|.++ .+|..+..+.+|+.|++++|.++. + ..+..+++|+.|+
T Consensus 47 L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~ 121 (198)
T d1m9la_ 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVLY 121 (198)
T ss_dssp TTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEEE
T ss_pred CCCCCEEECCCCCCCC-CC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCC
T ss_conf 6046151994468998-64-4247825357341353432-100003322123333333322222-2-2222222341112
Q ss_pred CCCCCC
Q ss_conf 568747
Q 002462 221 ISSNYL 226 (919)
Q Consensus 221 Ls~N~l 226 (919)
+++|.+
T Consensus 122 L~~N~i 127 (198)
T d1m9la_ 122 MSNNKI 127 (198)
T ss_dssp ESEEEC
T ss_pred CCCCHH
T ss_conf 341021
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.53 E-value=2e-17 Score=106.81 Aligned_cols=113 Identities=32% Similarity=0.390 Sum_probs=59.6
Q ss_pred CCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 88677899989899910798999896112499998899855896998898222289999988656874787799546799
Q 002462 158 IPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPGLGTL 237 (919)
Q Consensus 158 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~Ls~N~l~~~lp~~l~~l 237 (919)
++.++..+++|++|+|++|+++ .++ .+.++++|+.|+|++|.+. .+|..+..+++|+.|++++|.++. + +.+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred HHHHHHCCCCCCEEECCCCCCC-CCC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC-C-CCCCCC
T ss_conf 2467762604615199446899-864-4247825357341353432-100003322123333333322222-2-222222
Q ss_pred CCCCEEECCCCCCCCCCC-CCCCCCCCCCEEECCCCCCC
Q ss_conf 989888702898899985-22499999988986799798
Q 002462 238 SKLQYLNVSNNSLASSIP-AQLGDLDSLVDLDLSMNSLS 275 (919)
Q Consensus 238 ~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~ 275 (919)
++|+.|++++|.++.... ..+..+++|+.|++++|.+.
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred CCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCC
T ss_conf 234111234102125542212367776302342798434
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=2e-14 Score=90.80 Aligned_cols=63 Identities=25% Similarity=0.262 Sum_probs=24.2
Q ss_pred CCCCCEEEEECC-CCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 998769980158-798558867789998989991079899989611249999889985589699
Q 002462 141 LPTLQALDLRSC-SISGVIPFSLGNLTNLTSLYLSDNGLTGTIPSSLGQLSVLSVLDLSRNSLT 203 (919)
Q Consensus 141 L~~L~~LdLs~n-~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~ 203 (919)
+++|+.|++++| .+....+..|.++++|+.|+|++|+++...|..|..+++|++|+|++|+++
T Consensus 30 l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 93 (156)
T d2ifga3 30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (156)
T ss_dssp CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred CCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC
T ss_conf 6565743168986644369212256666672162021247742011124554333322678785
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=1.2e-13 Score=86.53 Aligned_cols=67 Identities=30% Similarity=0.355 Sum_probs=26.6
Q ss_pred CCCCCCCCCEEEEECCC-CCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 77899989899910798-99989611249999889985589699889822228999998865687478
Q 002462 161 SLGNLTNLTSLYLSDNG-LTGTIPSSLGQLSVLSVLDLSRNSLTGNIPTSFGLLKNLSSLDISSNYLT 227 (919)
Q Consensus 161 ~~~~l~~L~~L~L~~N~-l~~~~p~~l~~L~~L~~L~Ls~N~l~~~~P~~~~~l~~L~~L~Ls~N~l~ 227 (919)
.+..+++|++|++++|+ ++..-+..|.++++|+.|+|++|+++...|..|..+++|+.|+|++|+++
T Consensus 26 ~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 93 (156)
T d2ifga3 26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (156)
T ss_dssp TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred CCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC
T ss_conf 02576565743168986644369212256666672162021247742011124554333322678785
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.73 E-value=9.7e-08 Score=55.15 Aligned_cols=146 Identities=16% Similarity=0.073 Sum_probs=81.6
Q ss_pred HHHHHHHCCCCCCCCCCCCCCCCEEEEEECCCCCEEEEEECCCCC-CHHHHHHHHHHHHHCC-CCCCCCEEEEEEECCCC
Q ss_conf 999998399983233345888848999954996189999515531-0899999999986169-99841365588604881
Q 002462 527 QQLLAATGDFSDANLIKNGHSGDLFRGILEGGIPVVIKRIDLQSV-KTEAYLLELDFFSKVS-HARLVPLLGHCMERENE 604 (919)
Q Consensus 527 ~~l~~~t~~f~~~~~ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~-~~~~f~~Ei~~l~~l~-H~NiV~l~g~c~~~~~~ 604 (919)
.++.+....|......+-++...||+.... +..+++|+...... ....+.+|...+..++ +--+-+++.++. .++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~-~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-HDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-ETTE
T ss_pred HHHHHHHHCEEEEECCCCCCCCCEEEEEEC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEE-CCCC
T ss_conf 999975135279976789987718999908-98699998488765325569999999998760699872899975-0896
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC-----------------------------
Q ss_conf 799997227998100100069997756777999999999999998554512-----------------------------
Q 002462 605 KFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGLSYLHH----------------------------- 655 (919)
Q Consensus 605 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL~yLH~----------------------------- 655 (919)
.++||+++++..+.+..... -. .-+++.++++.++.||.
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~---------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE---------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD 152 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC---------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred EEEEEEECCCCCCCCCCCCC---------CC---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
T ss_conf 49999860433435433440---------26---9999998999999985568421435764465655577899877655
Q ss_pred ------------------------C---CCCCEEECCCCCCCEECCCCCCEEECCCCH
Q ss_conf ------------------------8---999926446889960017999622488500
Q 002462 656 ------------------------E---CTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 656 ------------------------~---~~~~IiHrDlK~~NILld~~~~~ki~dfg~ 686 (919)
. -.+.++|+|+.+.|||++++...-+-||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~ 210 (263)
T d1j7la_ 153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGR 210 (263)
T ss_dssp CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTT
T ss_pred HHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHH
T ss_conf 5543033232005799999999844986781789860047642364996599960231
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.64 E-value=2.4e-10 Score=68.99 Aligned_cols=121 Identities=21% Similarity=0.161 Sum_probs=0.0
Q ss_pred CCCEEECCCCCCCCCCCHHHHHCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCC--CCCCCCCCCCCCEE
Q ss_conf 7897866998799888536651899876998015879855886778999898999107989998--96112499998899
Q 002462 118 HLASFNASRFLLPGSIPDWLGQQLPTLQALDLRSCSISGVIPFSLGNLTNLTSLYLSDNGLTGT--IPSSLGQLSVLSVL 195 (919)
Q Consensus 118 ~L~~l~ls~n~l~g~ip~~~~~~L~~L~~LdLs~n~l~g~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~l~~L~~L~~L 195 (919)
....++++.+.....+.. +..+..+++..+... .++..+..+++|++|+|++|+++.. ++..+..+++|+.|
T Consensus 23 ~~~~Ldls~l~~~~~l~~-----~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L 96 (162)
T d1koha1 23 SQQALDLKGLRSDPDLVA-----QNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96 (162)
T ss_dssp SSCCBCCCCCSSCTTTTT-----TTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCC
T ss_pred HHCEEECCCCCCCCHHHH-----CCCHHHCCHHHHHHH-HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCC
T ss_conf 308653435989821554-----664011225556766-60788974878788637776666773158898658856100
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC-------CCCCCCCCEEE
Q ss_conf 85589699889822228999998865687478779954-------67999898887
Q 002462 196 DLSRNSLTGNIPTSFGLLKNLSSLDISSNYLTGSIPPG-------LGTLSKLQYLN 244 (919)
Q Consensus 196 ~Ls~N~l~~~~P~~~~~l~~L~~L~Ls~N~l~~~lp~~-------l~~l~~L~~L~ 244 (919)
+|++|.+....+-.+....+|+.|++++|++....... +..+++|+.||
T Consensus 97 ~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred CCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHHHHCCCCCEEC
T ss_conf 04357213423442220331042664899767676661569999999889978799
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.48 E-value=6.4e-07 Score=50.77 Aligned_cols=142 Identities=18% Similarity=0.102 Sum_probs=76.6
Q ss_pred CCCCCCC-CCEEEEEECCCCCEEEEEECCCCCCHHHHHHHHHHHHHCCCCC--CCCEEEEEEECCCCEEEEEEECCCCCH
Q ss_conf 3345888-8489999549961899995155310899999999986169998--413655886048817999972279981
Q 002462 541 LIKNGHS-GDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHAR--LVPLLGHCMERENEKFLVYKYMPNGDL 617 (919)
Q Consensus 541 ~ig~G~~-G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~N--iV~l~g~c~~~~~~~~LV~Ey~~~GsL 617 (919)
.+..|.. ..||+....++..+++|.-..... ..+..|...+..+.... +-++++++.+ ++..++||+|+++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--NELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT--SCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH--HHHHHHHHHHHHHHHCCCCCCCEEEECCC-CCCEEEEEEEEECCCC
T ss_conf 76786547758999938987899995896677--68999999999998659998861322245-6615999874413554
Q ss_pred HHH-----------------HHCCCCCCCCCCCCCHHHHHHHHHH--------------------HHHHHHHHHC----C
Q ss_conf 001-----------------0006999775677799999999999--------------------9998554512----8
Q 002462 618 SSS-----------------LYRKTNTEDDLQSLDWITRLKIAIG--------------------AAEGLSYLHH----E 656 (919)
Q Consensus 618 ~~~-----------------L~~~~~~~~~~~~l~w~~rl~Ia~~--------------------iA~gL~yLH~----~ 656 (919)
.+. ||.... ......-.+..++.-... ....+..+.. .
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 172 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDP-ATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDG 172 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCG-GGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSS
T ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCH-HHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCC
T ss_conf 32212689999999999998736885-44887554124688999999875411011340112137999999998718765
Q ss_pred CCCCEEECCCCCCCEECCCCCCEEECCCCH
Q ss_conf 999926446889960017999622488500
Q 002462 657 CTLPFVHRDVQASSILLDDKFEVRLGSLSE 686 (919)
Q Consensus 657 ~~~~IiHrDlK~~NILld~~~~~ki~dfg~ 686 (919)
..+.++|+|+.+.|||++++..+.|.||..
T Consensus 173 ~~~~liHgD~~~~Nvl~~~~~~~~iID~~~ 202 (255)
T d1nd4a_ 173 EDLVVTHGDACLPNIMVENGRFSGFIDCGR 202 (255)
T ss_dssp CCEEEECSSCCGGGEEEETTEEEEECCCTT
T ss_pred CCCEEEECCCCCCCEEEECCCEEEEEECHH
T ss_conf 795678678887635773796589998533
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.08 E-value=5.9e-07 Score=50.97 Aligned_cols=11 Identities=9% Similarity=0.208 Sum_probs=4.2
Q ss_pred CCCCEEECCCC
Q ss_conf 98988870289
Q 002462 238 SKLQYLNVSNN 248 (919)
Q Consensus 238 ~~L~~L~L~~N 248 (919)
++|+.|++++|
T Consensus 100 ~sL~~L~l~~n 110 (167)
T d1pgva_ 100 QSIVEFKADNQ 110 (167)
T ss_dssp CCCSEEECCCC
T ss_pred CCCCEEECCCC
T ss_conf 93898778877
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.94 E-value=6.5e-05 Score=40.08 Aligned_cols=75 Identities=11% Similarity=0.109 Sum_probs=45.3
Q ss_pred CCCCCCCCCCEEEEEECC-CCCEEEEEECCC--------CCCHHHHHHHHHHHHHCC-C-CC-CCCEEEEEEECCCCEEE
Q ss_conf 333458888489999549-961899995155--------310899999999986169-9-98-41365588604881799
Q 002462 540 NLIKNGHSGDLFRGILEG-GIPVVIKRIDLQ--------SVKTEAYLLELDFFSKVS-H-AR-LVPLLGHCMERENEKFL 607 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~-g~~vavK~l~~~--------~~~~~~f~~Ei~~l~~l~-H-~N-iV~l~g~c~~~~~~~~L 607 (919)
..||.|....||+....+ +..++||.-... ....+....|.+.|..+. + |. +.++++ ++. +..++
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~-~~~~l 108 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDT-EMAVT 108 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EET-TTTEE
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEE--ECC-CCCEE
T ss_conf 980798527689999579984899961771303467778887789999999999865057988552899--859-88779
Q ss_pred EEEECCCCCH
Q ss_conf 9972279981
Q 002462 608 VYKYMPNGDL 617 (919)
Q Consensus 608 V~Ey~~~GsL 617 (919)
||||+++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.90 E-value=2.9e-05 Score=41.97 Aligned_cols=164 Identities=15% Similarity=0.149 Sum_probs=84.0
Q ss_pred CCCHHHHHHHHCCC---CCCCCCC-CCCCCCEEEEEECCCCCEEEEEECCCCCCHHHHHHHHHHHHHCCCCCC-----CC
Q ss_conf 55799999983999---8323334-588884899995499618999951553108999999999861699984-----13
Q 002462 523 SFTYQQLLAATGDF---SDANLIK-NGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARL-----VP 593 (919)
Q Consensus 523 ~~~~~~l~~~t~~f---~~~~~ig-~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~Ni-----V~ 593 (919)
.+|.+.+..|...+ .+..+.- .+---.||+...++|..+++|.-.......+++..|...+..+....+ +.
T Consensus 7 ~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~ 86 (325)
T d1zyla1 7 TLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVA 86 (325)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCC
T ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCCCCCCEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCCEE
T ss_conf 66979999999975999775723256612026999838999799998478778899999999999999855998787520
Q ss_pred EEE-EEEECCCCEEEEEEECCCCCHH--------------HHHHCC--CCCCCCCCCCCHHHH-----------------
Q ss_conf 655-8860488179999722799810--------------010006--999775677799999-----------------
Q 002462 594 LLG-HCMERENEKFLVYKYMPNGDLS--------------SSLYRK--TNTEDDLQSLDWITR----------------- 639 (919)
Q Consensus 594 l~g-~c~~~~~~~~LV~Ey~~~GsL~--------------~~L~~~--~~~~~~~~~l~w~~r----------------- 639 (919)
.-| ...+.++..+.+++|+++..+. -.+|.. .........+++...
T Consensus 87 ~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~ 166 (325)
T d1zyla1 87 FNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSG 166 (325)
T ss_dssp BTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTT
T ss_pred CCCCEEEEEEEEEEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHH
T ss_conf 68980566534799998652776889999999999899999988630357865567789788766568999874769988
Q ss_pred -----HHHHHHHHHHHH-HHHCCCCCCEEECCCCCCCEECCCCCCEEECCCCHHH
Q ss_conf -----999999999855-4512899992644688996001799962248850024
Q 002462 640 -----LKIAIGAAEGLS-YLHHECTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 640 -----l~Ia~~iA~gL~-yLH~~~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~ 688 (919)
..++..+...+. ++.......+||+|+.+.|||++++ ..+.||+.++
T Consensus 167 ~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 167 LKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp THHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCEEECCCCCCCCEEEECC--CEEEECHHCC
T ss_conf 9899999999999999984545687120247888042878389--3588652014
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.49 E-value=0.00032 Score=36.41 Aligned_cols=74 Identities=26% Similarity=0.261 Sum_probs=44.0
Q ss_pred CCCCCCCCCCEEEEEECCCC-------CEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCC-CEEEEEEECCCCEEEEEEE
Q ss_conf 33345888848999954996-------189999515531089999999998616999841-3655886048817999972
Q 002462 540 NLIKNGHSGDLFRGILEGGI-------PVVIKRIDLQSVKTEAYLLELDFFSKVSHARLV-PLLGHCMERENEKFLVYKY 611 (919)
Q Consensus 540 ~~ig~G~~G~Vy~g~l~~g~-------~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~NiV-~l~g~c~~~~~~~~LV~Ey 611 (919)
..|+.|-.-.+|+....++. ..+|.|+........+..+|..+++.+.-.+++ ++++++ + + .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-~--~--g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-S--G--GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-T--T--EEEECC
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEC-C--C--CEEEEE
T ss_conf 9917853343489996887754457898179996599611658999999999997579998089981-8--9--569997
Q ss_pred CCCCCHH
Q ss_conf 2799810
Q 002462 612 MPNGDLS 618 (919)
Q Consensus 612 ~~~GsL~ 618 (919)
+++-.+.
T Consensus 123 i~g~~l~ 129 (395)
T d1nw1a_ 123 IPSRPLS 129 (395)
T ss_dssp CCEEECC
T ss_pred ECCCCCC
T ss_conf 3455488
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.30 E-value=9.5e-06 Score=44.55 Aligned_cols=12 Identities=8% Similarity=0.246 Sum_probs=4.7
Q ss_pred CCCCCEEECCCC
Q ss_conf 999988986799
Q 002462 261 LDSLVDLDLSMN 272 (919)
Q Consensus 261 l~~L~~L~L~~N 272 (919)
.++|+.|+++.+
T Consensus 131 n~~L~~L~l~~~ 142 (166)
T d1io0a_ 131 NTTLLKFGYHFT 142 (166)
T ss_dssp CSSCCEEECCCS
T ss_pred CCCCCEEECCCC
T ss_conf 998478858189
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.32 E-value=0.041 Score=25.16 Aligned_cols=32 Identities=13% Similarity=0.130 Sum_probs=26.2
Q ss_pred CCCCEEECCCCCCCEECCCCCCEEECCCCHHH
Q ss_conf 99992644688996001799962248850024
Q 002462 657 CTLPFVHRDVQASSILLDDKFEVRLGSLSEVC 688 (919)
Q Consensus 657 ~~~~IiHrDlK~~NILld~~~~~ki~dfg~~~ 688 (919)
...++||+|+.+.||+++.+...-|-||+.++
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 54503337863656402045412674222123
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=89.07 E-value=0.33 Score=20.34 Aligned_cols=125 Identities=14% Similarity=0.134 Sum_probs=68.4
Q ss_pred CCCCCCCCEEEEEECCCCCEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEE----------------------
Q ss_conf 3458888489999549961899995155310899999999986169998413655886----------------------
Q 002462 542 IKNGHSGDLFRGILEGGIPVVIKRIDLQSVKTEAYLLELDFFSKVSHARLVPLLGHCM---------------------- 599 (919)
Q Consensus 542 ig~G~~G~Vy~g~l~~g~~vavK~l~~~~~~~~~f~~Ei~~l~~l~H~NiV~l~g~c~---------------------- 599 (919)
+.++|.+-|+-.... +..+++|.- .....+.|..|+...-.++-|..+-+. .|-
T Consensus 76 ~s~~Gs~Gv~FV~~e-~gaiVlK~s--~tta~E~y~~eLAr~LGvpvPqmRvI~-~~~~E~~~~~~~~l~~~e~d~~I~s 151 (342)
T d1cjaa_ 76 RSEKGTEGLFFVETE-SGVFIVKRS--TNIESETFCSLLCMRLGLHAPKVRVVS-SNSEEGTNMLECLAAIDKSFRVITT 151 (342)
T ss_dssp ECCSTTSCEEEEEES-SCEEEEECC--TTHHHHHHHHHHHHHHTCCCCCEEEEE-SSSHHHHHHHHHHHHHCSSSCHHHH
T ss_pred EEECCCCEEEEEECC-CCEEEEECC--CCHHHHHHHHHHHHHHCCCCCCEEEEC-CCCHHHHHHHHHHHCCCCHHHHHHH
T ss_conf 754698458999837-866999558--842999999999999599998568852-7778999987777437880478888
Q ss_pred ECCCCEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHCCCCCCEEECCC-CCCCEECCCCC
Q ss_conf 048817999972279981001000699977567779999999999999985-5451289999264468-89960017999
Q 002462 600 ERENEKFLVYKYMPNGDLSSSLYRKTNTEDDLQSLDWITRLKIAIGAAEGL-SYLHHECTLPFVHRDV-QASSILLDDKF 677 (919)
Q Consensus 600 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~l~w~~rl~Ia~~iA~gL-~yLH~~~~~~IiHrDl-K~~NILld~~~ 677 (919)
+-....+++|||.+|..|.+.-. .. ......- .+ -.+.|-.-++ .+++..+..|+++|+- -++||++++++
T Consensus 152 el~~A~~liMeYvpG~~l~e~~~--~~---a~~~fs~-~~-l~~LGkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n~ 224 (342)
T d1cjaa_ 152 LANQANILLMELVRGITLNKLTT--TS---APEVLTK-ST-MQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERG 224 (342)
T ss_dssp HTTCSEEEEEECCCEEESTTCCS--SS---HHHHSCH-HH-HHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBT
T ss_pred HHHCCCCEEEECCCCCCCCCCCC--CC---CHHHHCH-HH-HHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCEEEECCC
T ss_conf 87514401000327842012433--12---3011057-99-998656998999971776665211578870015770598
|